Psyllid ID: psy11571

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370--
Protein Sequence
DERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQGW
Secondary Structure (PSIPRED)
cHHHHccccEEEccccccccEEEEEEEEccEEEEEEEHHccHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccEEcccEEEEccccEEEEEEEccccHHHHHHHHccccccccHHHHHHHHHHHHHHHHHcccEEEcccccccccccccccccEEccccccEEEEEccccccccccccEEcccccccccccHHHHHcccccccccccccccHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccccccccHHHHHHHHHHcccccccccccccHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcccc
Secondary Structure Prediction (SSPRO)
cccHHHHHHHcEEEEEEccccccEEEEEEEEEccccEEEEEHEHcHHHHHHHHHHHHHHHHHHHHHHHccccccEEEEEEEEcccccEEEEEEEcccHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHcccEEccccHHEEccccccHHHEEEcccccEEEEcccHcHHccccccEEEcEEcccHHHHHHHHHHHcHcccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccccccccHHHHHHHHHHHcccHHHccccccHHcccccEEccccHHHHHccccHccccHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccEEEEccc
Coil and Loop (DISEMBL)
DERLRELEALflggpiqgkgrvFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHyafqddsnlYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHdlhyvhrpnhfafhlcrdikpdnvlldanghirladfgsclrlggdgtvqsnvavgtpdyispeILTAMEegrgrygpecdwwslgVCMYEmlygetpfyAESLVETYGKImnhqnsfdlpsdvgyeiSDDAKDLMRRLICSsdtrlgqngiaDFKMWSALFVSLsisprnhpwfqgiawdsirdsnapyipevssptdtshfdvdeagvrasdalppaaaspalsalhlpfvgftftqgw
Flexible Loop (DISEMBL)
DERLRELEAlflggpiqgkgrvFSIETLLDILLVLYDECCNSslrrektvsdFIEFVaklreerdvlvygdrrwITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQsnvavgtpdyisPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQGW
Low Complexity Region (SEG)
DERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRasdalppaaaspalsalHLPFVGFTFTQGW
Disordered region (IsUnstruct)
******LEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSN*************************************LSALHLPFVGFTFT***
Disordered Region (DISOPRED)
*ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAG*******************HLPFVGFTFTQ**
Disordered Region (DISEMBL)
DERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQGW
Disordered Region (DISPRO)
*ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAG*****ALPPAAASPALSALHLPFVGFTFT*GW
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
DERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQGW
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	372	2.2.26 [Sep-21-2011]
Q9W1B0	1637	Serine/threonine-protein	yes	N/A	0.873	0.198	0.600	1e-137
Q5VT25	1732	Serine/threonine-protein	yes	N/A	0.771	0.165	0.699	1e-128
Q3UU96	1719	Serine/threonine-protein	yes	N/A	0.771	0.166	0.696	1e-128
O54874	1732	Serine/threonine-protein	yes	N/A	0.771	0.165	0.696	1e-128
Q9Y5S2	1711	Serine/threonine-protein	no	N/A	0.771	0.167	0.683	1e-124
Q7TT49	1713	Serine/threonine-protein	no	N/A	0.771	0.167	0.683	1e-123
Q7TT50	1713	Serine/threonine-protein	no	N/A	0.771	0.167	0.683	1e-123
Q80UW5	1551	Serine/threonine-protein	no	N/A	0.774	0.185	0.614	1e-115
Q6DT37	1551	Serine/threonine-protein	no	N/A	0.771	0.185	0.619	1e-111
Q09013	629	Myotonin-protein kinase O	no	N/A	0.771	0.456	0.537	6e-88

>sp|Q9W1B0|GEK_DROME Serine/threonine-protein kinase Genghis Khan OS=Drosophila melanogaster GN=gek PE=1 SV=1

 Score =  487 bits (1254), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 247/411 (60%), Positives = 282/411 (68%), Gaps = 86/411 (20%)

Query: 19  KGRVFSIETLLDILLVLYDECCNSSLRREKTVSD-------FIEFVAKLR---------- 61
           +G  FS++ LLD  +VLYDEC NSSLRREK VSD       F+  V KLR          
Sbjct: 45  EGHQFSLDYLLDTFIVLYDECSNSSLRREKGVSDFLKLSKPFVHIVRKLRLSRDDFDILK 104

Query: 62  ------------------------------------------EERDVLVYGDRRWITNLH 79
                                                     EERDVLV+GDR+WITNLH
Sbjct: 105 IIGRGAFGEVCVVQMISTEKVYAMKILNKWEMLKRAETACFREERDVLVFGDRQWITNLH 164

Query: 80  YAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRP 139
           YAFQD+ NLYLVMDYYCGGDLLTLLSKFED+LPEDMAKFYI EM+LAI SIH + YVHR 
Sbjct: 165 YAFQDNINLYLVMDYYCGGDLLTLLSKFEDKLPEDMAKFYITEMILAINSIHQIRYVHR- 223

Query: 140 NHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTA 199
                    DIKPDNVLLD  GH+RLADFGSCLRL  DGTVQSNVAVGTPDYISPEIL A
Sbjct: 224 ---------DIKPDNVLLDKRGHVRLADFGSCLRLDKDGTVQSNVAVGTPDYISPEILRA 274

Query: 200 MEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSD--VGY 257
           ME+G+GRYG ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQN F+LPS   + Y
Sbjct: 275 MEDGKGRYGTECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNCFNLPSQETLNY 334

Query: 258 EISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDS 317
           ++S+ ++DL+ +LIC  + RLGQNGI DF               +HPWF GI W +IR  
Sbjct: 335 KVSETSQDLLCKLICIPENRLGQNGIQDF--------------MDHPWFVGIDWKNIRQG 380

Query: 318 NAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTF 368
            APY+PEVSSPTDTS+FDVD+  VR +D++PP +A+PA S  HLPF+GFTF
Sbjct: 381 PAPYVPEVSSPTDTSNFDVDDNDVRLTDSIPP-SANPAFSGFHLPFIGFTF 430

Acts as a downstream effector for the regulation of actin polymerization by Cdc42.
Drosophila melanogaster (taxid: 7227)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q5VT25|MRCKA_HUMAN Serine/threonine-protein kinase MRCK alpha OS=Homo sapiens GN=CDC42BPA PE=1 SV=1

 Score =  460 bits (1183), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 219/313 (69%), Positives = 250/313 (79%), Gaps = 26/313 (8%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
            A  REERDVLV GD +WIT LHYAFQDD+NLYLVMDYY GGDLLTLLSKFEDRLPEDMA
Sbjct: 119 TACFREERDVLVNGDNKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEDMA 178

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FY+AEMV+AI S+H LHYVHR          DIKPDN+L+D NGHIRLADFGSCL+L  
Sbjct: 179 RFYLAEMVIAIDSVHQLHYVHR----------DIKPDNILMDMNGHIRLADFGSCLKLME 228

Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
           DGTVQS+VAVGTPDYISPEIL AME+G+GRYGPECDWWSLGVCMYEMLYGETPFYAESLV
Sbjct: 229 DGTVQSSVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 288

Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSL 296
           ETYGKIMNH+  F  P+ V  ++S++AKDL+RRLICS + RLGQNGI DFK         
Sbjct: 289 ETYGKIMNHKERFQFPAQVT-DVSENAKDLIRRLICSREHRLGQNGIEDFK--------- 338

Query: 297 SISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPAL 356
                 HP+F GI WD+IR+  APYIPEVSSPTDTS+FDVD+  ++ S+ +PP   + A 
Sbjct: 339 -----KHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHT-AF 392

Query: 357 SALHLPFVGFTFT 369
           S  HLPFVGFT+T
Sbjct: 393 SGHHLPFVGFTYT 405

Serine/threonine-protein kinase which is an important downstream effector of CDC42 and plays a role in the regulation of cytoskeleton reorganization and cell migration. Regulates actin cytoskeletal reorganization via phosphorylation of PPP1R12C and MYL9/MLC2. In concert with MYO18A and LURAP1, is involved in modulating lamellar actomyosin retrograde flow that is crucial to cell protrusion and migration. Phosphorylates: PPP1R12A, LIMK1 and LIMK2. May play a role in TFRC-mediated iron uptake.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q3UU96|MRCKA_MOUSE Serine/threonine-protein kinase MRCK alpha OS=Mus musculus GN=Cdc42bpa PE=1 SV=2

 Score =  458 bits (1179), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 218/313 (69%), Positives = 250/313 (79%), Gaps = 26/313 (8%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
            A  REERDVLV GD +WIT LHYAFQDD+NLYLVMDYY GGDLLTLLSKFEDRLPE+MA
Sbjct: 119 TACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA 178

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FY+AEMV+AI S+H LHYVHR          DIKPDN+L+D NGHIRLADFGSCL+L  
Sbjct: 179 RFYLAEMVIAIDSVHQLHYVHR----------DIKPDNILMDMNGHIRLADFGSCLKLME 228

Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
           DGTVQS+VAVGTPDYISPEIL AME+G+GRYGPECDWWSLGVCMYEMLYGETPFYAESLV
Sbjct: 229 DGTVQSSVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 288

Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSL 296
           ETYGKIMNH+  F  P+ V  ++S++AKDL+RRLICS + RLGQNGI DFK         
Sbjct: 289 ETYGKIMNHKERFQFPAQV-TDVSENAKDLIRRLICSREHRLGQNGIEDFK--------- 338

Query: 297 SISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPAL 356
                 HP+F GI WD+IR+  APYIPEVSSPTDTS+FDVD+  ++ S+ +PP   + A 
Sbjct: 339 -----KHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHT-AF 392

Query: 357 SALHLPFVGFTFT 369
           S  HLPFVGFT+T
Sbjct: 393 SGHHLPFVGFTYT 405

Serine/threonine-protein kinase which is an important downstream effector of CDC42 and plays a role in the regulation of cytoskeleton reorganization and cell migration. Regulates actin cytoskeletal reorganization via phosphorylation of PPP1R12C and MYL9/MLC2. In concert with MYO18A and LRP35A, is involved in modulating lamellar actomyosin retrograde flow that is crucial to cell protrusion and migration. Phosphorylates: PPP1R12A, LIMK1 and LIMK2. May play a role in TFRC-mediated iron uptake.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O54874|MRCKA_RAT Serine/threonine-protein kinase MRCK alpha OS=Rattus norvegicus GN=Cdc42bpa PE=1 SV=1

 Score =  458 bits (1178), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 218/313 (69%), Positives = 250/313 (79%), Gaps = 26/313 (8%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
            A  REERDVLV GD +WIT LHYAFQDD+NLYLVMDYY GGDLLTLLSKFEDRLPE+MA
Sbjct: 119 TACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA 178

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FY+AEMV+AI S+H LHYVHR          DIKPDN+L+D NGHIRLADFGSCL+L  
Sbjct: 179 RFYLAEMVIAIDSVHQLHYVHR----------DIKPDNILMDMNGHIRLADFGSCLKLME 228

Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
           DGTVQS+VAVGTPDYISPEIL AME+G+GRYGPECDWWSLGVCMYEMLYGETPFYAESLV
Sbjct: 229 DGTVQSSVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 288

Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSL 296
           ETYGKIMNH+  F  P+ V  ++S++AKDL+RRLICS + RLGQNGI DFK         
Sbjct: 289 ETYGKIMNHKERFQFPTQV-TDVSENAKDLIRRLICSREHRLGQNGIEDFK--------- 338

Query: 297 SISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPAL 356
                 HP+F GI WD+IR+  APYIPEVSSPTDTS+FDVD+  ++ S+ +PP   + A 
Sbjct: 339 -----KHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHT-AF 392

Query: 357 SALHLPFVGFTFT 369
           S  HLPFVGFT+T
Sbjct: 393 SGHHLPFVGFTYT 405

Serine/threonine-protein kinase which is an important downstream effector of CDC42 and plays a role in the regulation of cytoskeleton reorganization and cell migration. Regulates actin cytoskeletal reorganization via phosphorylation of PPP1R12C and MYL9/MLC2. In concert with MYO18A and LURAP1, is involved in modulating lamellar actomyosin retrograde flow that is crucial to cell protrusion and migration. Phosphorylates: PPP1R12A, LIMK1 and LIMK2. May play a role in TFRC-mediated iron uptake.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9Y5S2|MRCKB_HUMAN Serine/threonine-protein kinase MRCK beta OS=Homo sapiens GN=CDC42BPB PE=1 SV=2

 Score =  446 bits (1147), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 214/313 (68%), Positives = 249/313 (79%), Gaps = 26/313 (8%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
            A  REERDVLV GD +WIT LHYAFQD+++LYLVMDYY GGDLLTLLSKFED+LPEDMA
Sbjct: 118 TACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMA 177

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FYI EMVLAI SIH LHYVHR          DIKPDNVLLD NGHIRLADFGSCL++  
Sbjct: 178 RFYIGEMVLAIDSIHQLHYVHR----------DIKPDNVLLDVNGHIRLADFGSCLKMND 227

Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
           DGTVQS+VAVGTPDYISPEIL AME+G G+YGPECDWWSLGVCMYEMLYGETPFYAESLV
Sbjct: 228 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 287

Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSL 296
           ETYGKIMNH+  F  PS V  ++S++AKDL++RLICS + RLGQNGI DFK         
Sbjct: 288 ETYGKIMNHEERFQFPSHV-TDVSEEAKDLIQRLICSRERRLGQNGIEDFK--------- 337

Query: 297 SISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPAL 356
                 H +F+G+ W++IR+  APYIP+VSSP+DTS+FDVD+  +R ++ LPP + +   
Sbjct: 338 -----KHAFFEGLNWENIRNLEAPYIPDVSSPSDTSNFDVDDDVLRNTEILPPGSHT-GF 391

Query: 357 SALHLPFVGFTFT 369
           S LHLPF+GFTFT
Sbjct: 392 SGLHLPFIGFTFT 404

Serine/threonine-protein kinase which is an important downstream effector of CDC42 and plays a role in the regulation of cytoskeleton reorganization and cell migration. Regulates actin cytoskeletal reorganization via phosphorylation of PPP1R12C and MYL9/MLC2. In concert with MYO18A and LURAP1, is involved in modulating lamellar actomyosin retrograde flow that is crucial to cell protrusion and migration. Phosphorylates PPP1R12A.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7TT49|MRCKB_RAT Serine/threonine-protein kinase MRCK beta OS=Rattus norvegicus GN=Cdc42bpb PE=1 SV=1

 Score =  443 bits (1139), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 214/313 (68%), Positives = 247/313 (78%), Gaps = 26/313 (8%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
            A  REERDVLV GD +WIT LHYAFQD++ LYLVMDYY GGDLLTLLSKFED+LPEDMA
Sbjct: 118 TACFREERDVLVNGDCQWITALHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDKLPEDMA 177

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FYI EMVLAI SIH LHYVHR          DIKPDNVLLD NGHIRLADFGSCL++  
Sbjct: 178 RFYIGEMVLAIDSIHQLHYVHR----------DIKPDNVLLDVNGHIRLADFGSCLKMND 227

Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
           DGTVQS+VAVGTPDYISPEIL AME+G G+YGPECDWWSLGVCMYEMLYGETPFYAESLV
Sbjct: 228 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 287

Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSL 296
           ETYGKIMNH+  F  PS V  ++S++AKDL++RLICS + RLGQNGI DFK         
Sbjct: 288 ETYGKIMNHEERFQFPSHVT-DVSEEAKDLIQRLICSRERRLGQNGIEDFK--------- 337

Query: 297 SISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPAL 356
                 H +F+G+ W++IR+  APYIP+VSSP+DTS+FDVD+  +R  + LPP + +   
Sbjct: 338 -----KHAFFEGLNWENIRNLEAPYIPDVSSPSDTSNFDVDDDVLRNIEILPPGSHT-GF 391

Query: 357 SALHLPFVGFTFT 369
           S LHLPF+GFTFT
Sbjct: 392 SGLHLPFIGFTFT 404

Serine/threonine-protein kinase which is an important downstream effector of CDC42 and plays a role in the regulation of cytoskeleton reorganization and cell migration. Regulates actin cytoskeletal reorganization via phosphorylation of PPP1R12C and MYL9/MLC2. In concert with MYO18A and LURAP1, is involved in modulating lamellar actomyosin retrograde flow that is crucial to cell protrusion and migration. Phosphorylates PPP1R12A.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7TT50|MRCKB_MOUSE Serine/threonine-protein kinase MRCK beta OS=Mus musculus GN=Cdc42bpb PE=1 SV=2

 Score =  442 bits (1138), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 214/313 (68%), Positives = 247/313 (78%), Gaps = 26/313 (8%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
            A  REERDVLV GD +WIT LHYAFQD++ LYLVMDYY GGDLLTLLSKFED+LPEDMA
Sbjct: 118 TACFREERDVLVNGDCQWITALHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDKLPEDMA 177

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FYI EMVLAI SIH LHYVHR          DIKPDNVLLD NGHIRLADFGSCL++  
Sbjct: 178 RFYIGEMVLAIDSIHQLHYVHR----------DIKPDNVLLDVNGHIRLADFGSCLKMND 227

Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
           DGTVQS+VAVGTPDYISPEIL AME+G G+YGPECDWWSLGVCMYEMLYGETPFYAESLV
Sbjct: 228 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 287

Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSL 296
           ETYGKIMNH+  F  PS V  ++S++AKDL++RLICS + RLGQNGI DFK         
Sbjct: 288 ETYGKIMNHEERFQFPSHVT-DVSEEAKDLIQRLICSRERRLGQNGIEDFK--------- 337

Query: 297 SISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPAL 356
                 H +F+G+ W++IR+  APYIP+VSSP+DTS+FDVD+  +R  + LPP + +   
Sbjct: 338 -----KHAFFEGLNWENIRNLEAPYIPDVSSPSDTSNFDVDDDMLRNIEILPPGSHT-GF 391

Query: 357 SALHLPFVGFTFT 369
           S LHLPF+GFTFT
Sbjct: 392 SGLHLPFIGFTFT 404

Serine/threonine-protein kinase which is an important downstream effector of CDC42 and plays a role in the regulation of cytoskeleton reorganization and cell migration. Regulates actin cytoskeletal reorganization via phosphorylation of PPP1R12C and MYL9/MLC2. In concert with MYO18A and LURAP1, is involved in modulating lamellar actomyosin retrograde flow that is crucial to cell protrusion and migration. Phosphorylates PPP1R12A.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q80UW5|MRCKG_MOUSE Serine/threonine-protein kinase MRCK gamma OS=Mus musculus GN=Cdc42bpg PE=2 SV=2

 Score =  415 bits (1066), Expect = e-115,   Method: Composition-based stats.
 Identities = 193/314 (61%), Positives = 234/314 (74%), Gaps = 26/314 (8%)

Query: 58  AKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAK 117
           A  REERDVLV GD RW+T LHYAFQD+  LYLVMDYY GGDLLTLLS+FEDRLP ++A+
Sbjct: 114 ACFREERDVLVKGDSRWVTALHYAFQDEEYLYLVMDYYAGGDLLTLLSRFEDRLPPELAQ 173

Query: 118 FYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD 177
           FY+AEMVLAI S+H L YVHR          D+KPDN+LLD NGHIRLADFGSCLRL  +
Sbjct: 174 FYLAEMVLAIHSLHQLGYVHR----------DVKPDNILLDMNGHIRLADFGSCLRLNNN 223

Query: 178 GTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 237
           G V S+VAVGTPDYISPEIL AMEEG+G YGP+CDWWSLGVC YE+L+GETPFYAESLVE
Sbjct: 224 GMVDSSVAVGTPDYISPEILQAMEEGKGHYGPQCDWWSLGVCAYELLFGETPFYAESLVE 283

Query: 238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLS 297
           TYGKIMNH++    P+DV  ++   A+DL+R+L+C  + RLG+ G+ DF           
Sbjct: 284 TYGKIMNHEDHLQFPADVT-DVPASAQDLIRQLLCRQEERLGRGGLDDF----------- 331

Query: 298 ISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALS 357
              R HP+F+G+ W+ +  S APYIPE+  P DTS+FDVD+  +   + LPP++   A S
Sbjct: 332 ---RKHPFFEGVDWERLATSTAPYIPELRGPMDTSNFDVDDDTLNRPETLPPSSHG-AFS 387

Query: 358 ALHLPFVGFTFTQG 371
             HLPFVGFT+T G
Sbjct: 388 GHHLPFVGFTYTSG 401

May act as a downstream effector of CDC42 in cytoskeletal reorganization. Contributes to the actomyosin contractility required for cell invasion, through the regulation of MYPT1 and thus MLC2 phosphorylation.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6DT37|MRCKG_HUMAN Serine/threonine-protein kinase MRCK gamma OS=Homo sapiens GN=CDC42BPG PE=1 SV=2

 Score =  402 bits (1034), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 194/313 (61%), Positives = 231/313 (73%), Gaps = 26/313 (8%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
            A  REERDVLV GD RW+T LHYAFQD+  LYLVMDYY GGDLLTLLS+FEDRLP ++A
Sbjct: 113 TACFREERDVLVKGDSRWVTTLHYAFQDEEYLYLVMDYYAGGDLLTLLSRFEDRLPPELA 172

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FY+AEMVLAI S+H L YVHR          D+KPDNVLLD NGHIRLADFGSCLRL  
Sbjct: 173 QFYLAEMVLAIHSLHQLGYVHR----------DVKPDNVLLDVNGHIRLADFGSCLRLNT 222

Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
           +G V S+VAVGTPDYISPEIL AMEEG+G YGP+CDWWSLGVC YE+L+GETPFYAESLV
Sbjct: 223 NGMVDSSVAVGTPDYISPEILQAMEEGKGHYGPQCDWWSLGVCAYELLFGETPFYAESLV 282

Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSL 296
           ETYGKIMNH++    P DV  ++   A+DL+R+L+C  + RLG+ G+ DF          
Sbjct: 283 ETYGKIMNHEDHLQFPPDV-PDVPASAQDLIRQLLCRQEERLGRGGLDDF---------- 331

Query: 297 SISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPAL 356
               RNHP+F+G+ W+ +  S APYIPE+  P DTS+FDVD+  +     LPP +   A 
Sbjct: 332 ----RNHPFFEGVDWERLASSTAPYIPELRGPMDTSNFDVDDDTLNHPGTLPPPSHG-AF 386

Query: 357 SALHLPFVGFTFT 369
           S  HLPFVGFT+T
Sbjct: 387 SGHHLPFVGFTYT 399

May act as a downstream effector of CDC42 in cytoskeletal reorganization. Contributes to the actomyosin contractility required for cell invasion, through the regulation of MYPT1 and thus MLC2 phosphorylation.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q09013|DMPK_HUMAN Myotonin-protein kinase OS=Homo sapiens GN=DMPK PE=1 SV=3

 Score =  324 bits (831), Expect = 6e-88,   Method: Compositional matrix adjust.
 Identities = 172/320 (53%), Positives = 220/320 (68%), Gaps = 33/320 (10%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           V+  REERDVLV GDRRWIT LH+AFQD++ LYLVM+YY GGDLLTLLSKF +R+P +MA
Sbjct: 113 VSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA 172

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FY+AE+V+AI S+H L YVH          RDIKPDN+LLD  GHIRLADFGSCL+L  
Sbjct: 173 RFYLAEIVMAIDSVHRLGYVH----------RDIKPDNILLDRCGHIRLADFGSCLKLRA 222

Query: 177 DGTVQSNVAVGTPDYISPEILTAM--EEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES 234
           DGTV+S VAVGTPDY+SPEIL A+    G G YGPECDWW+LGV  YEM YG+TPFYA+S
Sbjct: 223 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 282

Query: 235 LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFV 294
             ETYGKI++++    LP  V   + ++A+D ++RL+C  +TRLG+ G  DF        
Sbjct: 283 TAETYGKIVHYKEHLSLPL-VDEGVPEEARDFIQRLLCPPETRLGRGGAGDF-------- 333

Query: 295 SLSISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRA-----SDALPP 349
                 R HP+F G+ WD +RDS  P+ P+    TDT +FD+ E G+ A      + L  
Sbjct: 334 ------RTHPFFFGLDWDGLRDSVPPFTPDFEGATDTCNFDLVEDGLTAMVSGGGETLSD 387

Query: 350 AAASPALSALHLPFVGFTFT 369
                 L  +HLPFVG++++
Sbjct: 388 IREGAPL-GVHLPFVGYSYS 406

Non-receptor serine/threonine protein kinase which is necessary for the maintenance of skeletal muscle structure and function. May play a role in myocyte differentiation and survival by regulating the integrity of the nuclear envelope and the expression of muscle-specific genes. May also phosphorylate PPP1R12A and inhibit the myosin phosphatase activity to regulate myosin phosphorylation. Also critical to the modulation of cardiac contractility and to the maintenance of proper cardiac conduction activity probably through the regulation of cellular calcium homeostasis. Phosphorylates PLN, a regulator of calcium pumps and may regulate sarcoplasmic reticulum calcium uptake in myocytes. May also phosphorylate FXYD1/PLM which is able to induce chloride currents. May also play a role in synaptic plasticity.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	372
242024080	1772	serine/threonine-protein kinase MRCK bet	0.930	0.195	0.630	1e-154
321469741	1597	hypothetical protein DAPPUDRAFT_50846 [D	0.903	0.210	0.656	1e-149
345487692	1797	PREDICTED: serine/threonine-protein kina	0.779	0.161	0.787	1e-145
322801429	1769	hypothetical protein SINV_05404 [Solenop	0.779	0.163	0.787	1e-145
328786255	1794	PREDICTED: serine/threonine-protein kina	0.779	0.161	0.787	1e-145
340710704	1794	PREDICTED: serine/threonine-protein kina	0.779	0.161	0.784	1e-144
380014819	1953	PREDICTED: serine/threonine-protein kina	0.779	0.148	0.787	1e-144
350412784	1794	PREDICTED: serine/threonine-protein kina	0.779	0.161	0.784	1e-144
170041148	1696	myotonin-protein kinase [Culex quinquefa	0.922	0.202	0.599	1e-144
383852179	1796	PREDICTED: serine/threonine-protein kina	0.779	0.161	0.780	1e-143

>gi|242024080|ref|XP_002432458.1| serine/threonine-protein kinase MRCK beta, putative [Pediculus humanus corporis] gi|212517891|gb|EEB19720.1| serine/threonine-protein kinase MRCK beta, putative [Pediculus humanus corporis]

 Score =  552 bits (1422), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 271/430 (63%), Positives = 313/430 (72%), Gaps = 84/430 (19%)

Query: 1   DERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDEC--------------------- 39
           ++RL++LEALFLGGPIQG+G+ FS+ET LDILLVLYDEC                     
Sbjct: 20  EKRLQQLEALFLGGPIQGQGQCFSLETCLDILLVLYDECCNSSLRREKAVSDFIEFVKPV 79

Query: 40  --CNSSLRREKTVSDFIEFVAK------------------------------------LR 61
             C  +LR  +   + I+ + +                                     +
Sbjct: 80  ASCVKNLRLARDDFEIIKVIGRGAFGEVCVVKMKGSDKVFAMKILNKWEMLKRAETACFK 139

Query: 62  EERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA 121
           EERDVLVYGDRRWITNLHYAFQDD+NLYLVMDYYCGGDLLTLLSKFEDRLPEDMA+FYIA
Sbjct: 140 EERDVLVYGDRRWITNLHYAFQDDNNLYLVMDYYCGGDLLTLLSKFEDRLPEDMARFYIA 199

Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ 181
           EM+LA++SIH+L YVHR          DIKPDNVLLDANGHIRLADFGSCL+   DGTVQ
Sbjct: 200 EMILAVSSIHELRYVHR----------DIKPDNVLLDANGHIRLADFGSCLKFLEDGTVQ 249

Query: 182 SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 241
           SNV VGTPDYISPEIL AME+G+GRYGPECDWWSLGVCMYEMLYGETPFYAESL+ETYGK
Sbjct: 250 SNVTVGTPDYISPEILRAMEDGQGRYGPECDWWSLGVCMYEMLYGETPFYAESLIETYGK 309

Query: 242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPR 301
           IMNH+N FD P DVGYE++ +AKDL+++LICS++ RLGQNG+ DFK              
Sbjct: 310 IMNHKNCFDFPQDVGYEVTPEAKDLIKKLICSAEFRLGQNGVQDFK-------------- 355

Query: 302 NHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHL 361
           NH WF G+ WDSIRDS+APY+PEVSSPTDTS+FDVD+  +R SDA+PP AA+P  SALHL
Sbjct: 356 NHAWFDGLDWDSIRDSSAPYVPEVSSPTDTSNFDVDDTDIRTSDAVPP-AANPTFSALHL 414

Query: 362 PFVGFTFTQG 371
           PFVGFTFTQG
Sbjct: 415 PFVGFTFTQG 424

Source: Pediculus humanus corporis

Species: Pediculus humanus

Genus: Pediculus

Family: Pediculidae

Order: Phthiraptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|321469741|gb|EFX80720.1| hypothetical protein DAPPUDRAFT_50846 [Daphnia pulex]

 Score =  532 bits (1371), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 267/407 (65%), Positives = 299/407 (73%), Gaps = 71/407 (17%)

Query: 25  IETLLDILLVLYDECCNSSLRREKTVSDFIEF---------------------------- 56
           +ETLLD LLVLYDEC  S+LRREKTVSDF+E                             
Sbjct: 49  VETLLDALLVLYDECFTSALRREKTVSDFLELMKPSVSQIKSLRLTRDDFELIKVIGRGA 108

Query: 57  -----VAKLR--------------------------EERDVLVYGDRRWITNLHYAFQDD 85
                V KLR                          EERDVLV GDRRWIT+LHYAFQD+
Sbjct: 109 FGEVCVVKLRHTERVYAMKILNKWVMLKRAEAACFHEERDVLVRGDRRWITDLHYAFQDE 168

Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
           +NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFY+AEMVLAI SIH L YVHR       
Sbjct: 169 NNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYLAEMVLAIDSIHRLRYVHR------- 221

Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRG 205
              DIKPDNVLLDANGHIRLADFGSCLRL  DGTVQSNVA+GTPDYISPEIL AME+G+G
Sbjct: 222 ---DIKPDNVLLDANGHIRLADFGSCLRLREDGTVQSNVAIGTPDYISPEILRAMEDGQG 278

Query: 206 RYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKD 265
           RYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG+IMNH++ FD P+D G E+S+D KD
Sbjct: 279 RYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGRIMNHKSCFDFPTDSGLEVSEDGKD 338

Query: 266 LMRRLICSSDTRLGQNGIADFKMWSALFVSLS-ISPRNHPWFQGIAWDSIRDSNAPYIPE 324
           LMRRLICS++ RLGQNG++DF+    + + LS    +NHPWF GI WD+IRDS APYIPE
Sbjct: 339 LMRRLICSAEYRLGQNGLSDFQAKDRILMVLSNFRCQNHPWFSGIDWDNIRDSTAPYIPE 398

Query: 325 VSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQG 371
           VSSPTDTS+FDVD+  +R++D LPP A S   SALHLPF+GFT+TQG
Sbjct: 399 VSSPTDTSNFDVDDTDLRSADVLPPTANS-VFSALHLPFLGFTYTQG 444

Source: Daphnia pulex

Species: Daphnia pulex

Genus: Daphnia

Family: Daphniidae

Order: Diplostraca

Class: Branchiopoda

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|345487692|ref|XP_003425741.1| PREDICTED: serine/threonine-protein kinase Genghis Khan [Nasonia vitripennis]

 Score =  521 bits (1343), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 248/315 (78%), Positives = 269/315 (85%), Gaps = 25/315 (7%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
            A  REERDVLVYGDRRWITNLHYAFQDD+NLYLVMDYYCGGDLLTLLSKFEDRLPEDMA
Sbjct: 162 TACFREERDVLVYGDRRWITNLHYAFQDDNNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 221

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FYIAEMVLAI SIHDL YVHR          DIKPDNVLLDANGHIRLADFGSCLRL  
Sbjct: 222 RFYIAEMVLAIGSIHDLRYVHR----------DIKPDNVLLDANGHIRLADFGSCLRLFE 271

Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
           DGTVQSNVAVGTPDYISPEIL AME+G+GRYGPECDWWSLGVCMYEMLYGETPFYAESLV
Sbjct: 272 DGTVQSNVAVGTPDYISPEILRAMEDGQGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 331

Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSL 296
           ETYGKIMNH+N FD P+D  Y++S++AKDLMR+LICSS+ RLGQNGI DFK         
Sbjct: 332 ETYGKIMNHKNCFDFPTDDIYDVSEEAKDLMRKLICSSEFRLGQNGIEDFK--------- 382

Query: 297 SISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPAL 356
                 HPWF+G+ WD+IRDS APYIPEVSSPTDTS+FDVD+  VR+SDA+PP+A S A 
Sbjct: 383 -----KHPWFEGVNWDTIRDSTAPYIPEVSSPTDTSNFDVDDTDVRSSDAVPPSANS-AF 436

Query: 357 SALHLPFVGFTFTQG 371
           SALHLPFVGF+FTQG
Sbjct: 437 SALHLPFVGFSFTQG 451

Source: Nasonia vitripennis

Species: Nasonia vitripennis

Genus: Nasonia

Family: Pteromalidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|322801429|gb|EFZ22090.1| hypothetical protein SINV_05404 [Solenopsis invicta]

 Score =  520 bits (1338), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 248/315 (78%), Positives = 268/315 (85%), Gaps = 25/315 (7%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
            A  REERDVLVYGDRRWITNLHYAFQDD+NLYLVMDYYCGGDLLTLLSKFEDRLPEDMA
Sbjct: 162 TACFREERDVLVYGDRRWITNLHYAFQDDNNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 221

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FYIAEMVLAI SIHDL YVHR          DIKPDNVLLDANGHIRLADFGSCLRL  
Sbjct: 222 RFYIAEMVLAIGSIHDLRYVHR----------DIKPDNVLLDANGHIRLADFGSCLRLFE 271

Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
           DGTVQSNVAVGTPDYISPEIL AME+G+G+YGPECDWWSLGVCMYEMLYGETPFYAESLV
Sbjct: 272 DGTVQSNVAVGTPDYISPEILRAMEDGQGQYGPECDWWSLGVCMYEMLYGETPFYAESLV 331

Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSL 296
           ETYGKIMNH+N FD P+DV Y++S++AKDLMR+LICSSD RLGQNGI DFK         
Sbjct: 332 ETYGKIMNHKNCFDFPTDVMYDVSEEAKDLMRKLICSSDFRLGQNGIDDFK--------- 382

Query: 297 SISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPAL 356
                 HPWF G+ WD++RDS APYIPEVSSP+DTS+FDVD+  VR SDA+PPAA S A 
Sbjct: 383 -----KHPWFDGVDWDTLRDSTAPYIPEVSSPSDTSNFDVDDTDVRTSDAVPPAANS-AF 436

Query: 357 SALHLPFVGFTFTQG 371
           SALHLPFVGF+FTQG
Sbjct: 437 SALHLPFVGFSFTQG 451

Source: Solenopsis invicta

Species: Solenopsis invicta

Genus: Solenopsis

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|328786255|ref|XP_395596.4| PREDICTED: serine/threonine-protein kinase Genghis Khan [Apis mellifera]

 Score =  520 bits (1338), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 248/315 (78%), Positives = 268/315 (85%), Gaps = 25/315 (7%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
            A  REERDVLVYGDRRWITNLHYAFQDD+NLYLVMDYYCGGDLLTLLSKFEDRLPEDMA
Sbjct: 164 TAYFREERDVLVYGDRRWITNLHYAFQDDNNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 223

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FYIAEMVLAI SIHDL YVHR          DIKPDNVLLDANGHIRLADFGSCLRL  
Sbjct: 224 RFYIAEMVLAIGSIHDLRYVHR----------DIKPDNVLLDANGHIRLADFGSCLRLFE 273

Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
           DGT QSNVAVGTPDYISPEIL AME+G+G+YGPECDWWSLGVCMYEMLYGETPFYAESLV
Sbjct: 274 DGTAQSNVAVGTPDYISPEILRAMEDGQGQYGPECDWWSLGVCMYEMLYGETPFYAESLV 333

Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSL 296
           ETYGKIMNH+N FD P+D  YE+S++AKDLMR+LICSS+ RLGQNGI DFK         
Sbjct: 334 ETYGKIMNHKNCFDFPADDIYEVSEEAKDLMRKLICSSEFRLGQNGIDDFK--------- 384

Query: 297 SISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPAL 356
                 HPWF+G+ WD++RDS APYIPEVSSPTDTS+FDVD+  VR+SDA+PPAA S A 
Sbjct: 385 -----KHPWFEGVNWDTLRDSTAPYIPEVSSPTDTSNFDVDDTDVRSSDAVPPAANS-AF 438

Query: 357 SALHLPFVGFTFTQG 371
           SALHLPFVGFTFTQG
Sbjct: 439 SALHLPFVGFTFTQG 453

Source: Apis mellifera

Species: Apis mellifera

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|340710704|ref|XP_003393926.1| PREDICTED: serine/threonine-protein kinase Genghis Khan-like [Bombus terrestris]

 Score =  519 bits (1336), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 247/315 (78%), Positives = 268/315 (85%), Gaps = 25/315 (7%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
            A  REERDVLVYGDRRWITNLHYAFQDD+NLYLVMDYYCGGDLLTLLSKFEDRLPEDMA
Sbjct: 164 TAYFREERDVLVYGDRRWITNLHYAFQDDNNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 223

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FYIAEMVLAI SIHDL YVHR          DIKPDNVLLDANGHIRLADFGSCLRL  
Sbjct: 224 RFYIAEMVLAIGSIHDLRYVHR----------DIKPDNVLLDANGHIRLADFGSCLRLFE 273

Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
           DGT QSNVAVGTPDYISPEIL AME+G+G+YGPECDWWSLGVCMYEMLYGETPFYAESLV
Sbjct: 274 DGTAQSNVAVGTPDYISPEILRAMEDGQGQYGPECDWWSLGVCMYEMLYGETPFYAESLV 333

Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSL 296
           ETYGKIMNH+N FD P+D  YE+S++AKDLMR+LICSS+ RLGQNGI DFK         
Sbjct: 334 ETYGKIMNHKNCFDFPADDMYEVSEEAKDLMRKLICSSEFRLGQNGIDDFK--------- 384

Query: 297 SISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPAL 356
                 HPWF+G+ W+++RDS APYIPEVSSPTDTS+FDVD+  VR+SDA+PPAA S A 
Sbjct: 385 -----KHPWFEGVNWETLRDSTAPYIPEVSSPTDTSNFDVDDTDVRSSDAVPPAANS-AF 438

Query: 357 SALHLPFVGFTFTQG 371
           SALHLPFVGFTFTQG
Sbjct: 439 SALHLPFVGFTFTQG 453

Source: Bombus terrestris

Species: Bombus terrestris

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|380014819|ref|XP_003691414.1| PREDICTED: serine/threonine-protein kinase Genghis Khan-like [Apis florea]

 Score =  518 bits (1335), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 248/315 (78%), Positives = 268/315 (85%), Gaps = 25/315 (7%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
            A  REERDVLVYGDRRWITNLHYAFQDD+NLYLVMDYYCGGDLLTLLSKFEDRLPEDMA
Sbjct: 323 TAYFREERDVLVYGDRRWITNLHYAFQDDNNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 382

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FYIAEMVLAI SIHDL YVHR          DIKPDNVLLDANGHIRLADFGSCLRL  
Sbjct: 383 RFYIAEMVLAIGSIHDLRYVHR----------DIKPDNVLLDANGHIRLADFGSCLRLFE 432

Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
           DGT QSNVAVGTPDYISPEIL AME+G+G+YGPECDWWSLGVCMYEMLYGETPFYAESLV
Sbjct: 433 DGTAQSNVAVGTPDYISPEILRAMEDGQGQYGPECDWWSLGVCMYEMLYGETPFYAESLV 492

Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSL 296
           ETYGKIMNH+N FD P+D  YE+S++AKDLMR+LICSS+ RLGQNGI DFK         
Sbjct: 493 ETYGKIMNHKNCFDFPADDIYEVSEEAKDLMRKLICSSEFRLGQNGIDDFK--------- 543

Query: 297 SISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPAL 356
                 HPWF+G+ WD++RDS APYIPEVSSPTDTS+FDVD+  VR+SDA+PPAA S A 
Sbjct: 544 -----KHPWFEGVNWDTLRDSTAPYIPEVSSPTDTSNFDVDDTDVRSSDAVPPAANS-AF 597

Query: 357 SALHLPFVGFTFTQG 371
           SALHLPFVGFTFTQG
Sbjct: 598 SALHLPFVGFTFTQG 612

Source: Apis florea

Species: Apis florea

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|350412784|ref|XP_003489761.1| PREDICTED: serine/threonine-protein kinase Genghis Khan-like [Bombus impatiens]

 Score =  518 bits (1335), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 247/315 (78%), Positives = 268/315 (85%), Gaps = 25/315 (7%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
            A  REERDVLVYGDRRWITNLHYAFQDD+NLYLVMDYYCGGDLLTLLSKFEDRLPEDMA
Sbjct: 164 TAYFREERDVLVYGDRRWITNLHYAFQDDNNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 223

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FYIAEMVLAI SIHDL YVHR          DIKPDNVLLDANGHIRLADFGSCLRL  
Sbjct: 224 RFYIAEMVLAIGSIHDLRYVHR----------DIKPDNVLLDANGHIRLADFGSCLRLFE 273

Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
           DGT QSNVAVGTPDYISPEIL AME+G+G+YGPECDWWSLGVCMYEMLYGETPFYAESLV
Sbjct: 274 DGTAQSNVAVGTPDYISPEILRAMEDGQGQYGPECDWWSLGVCMYEMLYGETPFYAESLV 333

Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSL 296
           ETYGKIMNH+N FD P+D  YE+S++AKDLMR+LICSS+ RLGQNGI DFK         
Sbjct: 334 ETYGKIMNHKNCFDFPADDMYEVSEEAKDLMRKLICSSEFRLGQNGIDDFK--------- 384

Query: 297 SISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPAL 356
                 HPWF+G+ W+++RDS APYIPEVSSPTDTS+FDVD+  VR+SDA+PPAA S A 
Sbjct: 385 -----KHPWFEGVNWETLRDSTAPYIPEVSSPTDTSNFDVDDTDVRSSDAVPPAANS-AF 438

Query: 357 SALHLPFVGFTFTQG 371
           SALHLPFVGFTFTQG
Sbjct: 439 SALHLPFVGFTFTQG 453

Source: Bombus impatiens

Species: Bombus impatiens

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|170041148|ref|XP_001848336.1| myotonin-protein kinase [Culex quinquefasciatus] gi|167864701|gb|EDS28084.1| myotonin-protein kinase [Culex quinquefasciatus]

 Score =  516 bits (1330), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 262/437 (59%), Positives = 302/437 (69%), Gaps = 94/437 (21%)

Query: 3   RLRELEALFLGGPIQGKG---------RVFSIETLLDILLVLYDECCNSSLRREKTVSDF 53
           RLRELE+L +                 +  S+ETLLD  LVLYDECCNSSLRREKTVSDF
Sbjct: 24  RLRELESLIIDNVTSNNNLNSAGLSSEKFLSVETLLDTALVLYDECCNSSLRREKTVSDF 83

Query: 54  IEFVAKL----------REERDVL------------------------------------ 67
           IE +  +          RE+ +VL                                    
Sbjct: 84  IELIKSVVQCIKQLRLAREDFEVLKVIGRGAFGEVCVVRMNHTSQIYAMKILNKWEMLKR 143

Query: 68  -------------VYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPED 114
                        V+GDRRWITNLHYAFQDD NLYLVMDYYCGGDLLTLLSKFEDRLPED
Sbjct: 144 AETACFREERDVLVFGDRRWITNLHYAFQDDINLYLVMDYYCGGDLLTLLSKFEDRLPED 203

Query: 115 MAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL 174
           MA+FYIAEMVLAI SIH+L YVH          RDIKPDN++LDA+GH+RLADFGSCL+L
Sbjct: 204 MARFYIAEMVLAINSIHELKYVH----------RDIKPDNIVLDASGHVRLADFGSCLKL 253

Query: 175 GGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES 234
           G  GTVQSNVAVGTPDYISPEIL AME+G+G+YGPECDWWSLGVCMYEML+GETPFYAES
Sbjct: 254 GPQGTVQSNVAVGTPDYISPEILRAMEDGQGKYGPECDWWSLGVCMYEMLFGETPFYAES 313

Query: 235 LVETYGKIMNHQNSFDLPS-DVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALF 293
           LVETYGKIMNH+N FD P+ D  Y++S++AKDL++RLICS D RLGQNGI DFK      
Sbjct: 314 LVETYGKIMNHKNCFDFPNDDEEYQVSENAKDLIKRLICSPDYRLGQNGIEDFK------ 367

Query: 294 VSLSISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAAS 353
                   +HPWF+GI WD+IR+  APYIPEVSSPTDTS+FDVD+  ++ SDA+PP   +
Sbjct: 368 --------SHPWFEGIDWDTIRNGQAPYIPEVSSPTDTSNFDVDDTDIKLSDAVPP-TTN 418

Query: 354 PALSALHLPFVGFTFTQ 370
           PA S  HLPF+GFTFT+
Sbjct: 419 PAFSGHHLPFIGFTFTK 435

Source: Culex quinquefasciatus

Species: Culex quinquefasciatus

Genus: Culex

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|383852179|ref|XP_003701606.1| PREDICTED: serine/threonine-protein kinase MRCK alpha-like [Megachile rotundata]

 Score =  515 bits (1327), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 246/315 (78%), Positives = 268/315 (85%), Gaps = 25/315 (7%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
            A  REERDVLVYGDRRWITNLHYAFQDD+NLYLVMDYYCGGDLLTLLSKFEDRLPEDMA
Sbjct: 166 TACFREERDVLVYGDRRWITNLHYAFQDDNNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 225

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FYIAEMVLAI SIHDLHYVHR          DIKPDNVLLDANGHIRLADFGSCLRL  
Sbjct: 226 RFYIAEMVLAIVSIHDLHYVHR----------DIKPDNVLLDANGHIRLADFGSCLRLFE 275

Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
           DGTVQSNVAVGTPDYISPEIL AME+G+G YGPECDWWSLGVCMYEMLYGETPFYAESL+
Sbjct: 276 DGTVQSNVAVGTPDYISPEILRAMEDGQGLYGPECDWWSLGVCMYEMLYGETPFYAESLL 335

Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSL 296
           ETYGKIMNH+N FD P+D  Y++S++AKDLMR+LICSS+ RLGQNGI DFK         
Sbjct: 336 ETYGKIMNHKNCFDFPTDDMYDVSEEAKDLMRKLICSSEFRLGQNGIDDFK--------- 386

Query: 297 SISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPAL 356
                 HPWF+G+ W+++RDS APYIPEVSSPTDTS+FDVD+  VR SDA+PPAA S A 
Sbjct: 387 -----KHPWFEGVNWETLRDSTAPYIPEVSSPTDTSNFDVDDTDVRNSDAVPPAANS-AF 440

Query: 357 SALHLPFVGFTFTQG 371
           SALHLPFVGF+FTQG
Sbjct: 441 SALHLPFVGFSFTQG 455

Source: Megachile rotundata

Species: Megachile rotundata

Genus: Megachile

Family: Megachilidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	372
UNIPROTKB|F5H5N0	1699	CDC42BPA "Serine/threonine-pro	0.768	0.168	0.685	3.3e-125
UNIPROTKB|F1MH45	1718	CDC42BPA "Uncharacterized prot	0.768	0.166	0.685	4e-125
UNIPROTKB|F1PYU4	1719	CDC42BPA "Uncharacterized prot	0.768	0.166	0.685	4e-125
UNIPROTKB|Q5VT25	1732	CDC42BPA "Serine/threonine-pro	0.768	0.165	0.685	4.4e-125
UNIPROTKB|E2R1X7	1816	CDC42BPA "Uncharacterized prot	0.768	0.157	0.685	7.9e-125
MGI|MGI:2441841	1719	Cdc42bpa "CDC42 binding protei	0.768	0.166	0.682	1.4e-124
RGD|621406	1732	Cdc42bpa "CDC42 binding protei	0.768	0.165	0.682	1.6e-124
UNIPROTKB|O54874	1732	Cdc42bpa "Serine/threonine-pro	0.768	0.165	0.682	1.6e-124
UNIPROTKB|E1BWT5	1732	CDC42BPA "Uncharacterized prot	0.768	0.165	0.679	1.5e-123
ZFIN|ZDB-GENE-041014-372	1768	si:ch211-89p3.3 "si:ch211-89p3	0.768	0.161	0.689	3.9e-123

UNIPROTKB|F5H5N0 CDC42BPA "Serine/threonine-protein kinase MRCK alpha" [Homo sapiens (taxid:9606)]

 Score = 1093 (389.8 bits), Expect = 3.3e-125, Sum P(2) = 3.3e-125
 Identities = 214/312 (68%), Positives = 242/312 (77%)

Query:    58 AKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAK 117
             A  REERDVLV GD +WIT LHYAFQDD+NLYLVMDYY GGDLLTLLSKFEDRLPEDMA+
Sbjct:   120 ACFREERDVLVNGDNKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR 179

Query:   118 FYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD 177
             FY+AEMV+AI S+H LHYVHR          DIKPDN+L+D NGHIRLADFGSCL+L  D
Sbjct:   180 FYLAEMVIAIDSVHQLHYVHR----------DIKPDNILMDMNGHIRLADFGSCLKLMED 229

Query:   178 GTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 237
             GTVQS+VAVGTPDYISPEIL AME+G+GRYGPECDWWSLGVCMYEMLYGETPFYAESLVE
Sbjct:   230 GTVQSSVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 289

Query:   238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLS 297
             TYGKIMNH+  F  P+ V  ++S++AKDL+RRLICS + RLGQNGI DFK          
Sbjct:   290 TYGKIMNHKERFQFPAQVT-DVSENAKDLIRRLICSREHRLGQNGIEDFK---------- 338

Query:   298 ISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRXXXXXXXXXXXXXXX 357
                  HP+F GI WD+IR+  APYIPEVSSPTDTS+FDVD+  ++               
Sbjct:   339 ----KHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHTAFSG 394

Query:   358 XXHLPFVGFTFT 369
               HLPFVGFT+T
Sbjct:   395 H-HLPFVGFTYT 405

GO:0005083 "small GTPase regulator activity" evidence=IEA

GO:0005543 "phospholipid binding" evidence=IEA

GO:0031532 "actin cytoskeleton reorganization" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

UNIPROTKB|F1MH45 CDC42BPA "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 1093 (389.8 bits), Expect = 4.0e-125, Sum P(2) = 4.0e-125
 Identities = 214/312 (68%), Positives = 241/312 (77%)

Query:    58 AKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAK 117
             A  REERDVLV GD +WIT LHYAFQDD+NLYLVMDYY GGDLLTLLSKFEDRLPEDMA+
Sbjct:   120 ACFREERDVLVNGDNKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR 179

Query:   118 FYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD 177
             FY+AEMV+AI S+H LHYVHR          DIKPDN+L+D NGHIRLADFGSCL+L  D
Sbjct:   180 FYLAEMVIAIDSVHQLHYVHR----------DIKPDNILMDMNGHIRLADFGSCLKLMED 229

Query:   178 GTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 237
             GTVQS+VAVGTPDYISPEIL AME+G+GRYGPECDWWSLGVCMYEMLYGETPFYAESLVE
Sbjct:   230 GTVQSSVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 289

Query:   238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLS 297
             TYGKIMNH+  F  P  V  ++S++AKDL+RRLICS + RLGQNGI DFK          
Sbjct:   290 TYGKIMNHKERFQFPPQVS-DVSENAKDLIRRLICSREHRLGQNGIEDFK---------- 338

Query:   298 ISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRXXXXXXXXXXXXXXX 357
                  HP+F GI WD+IR+  APYIPEVSSPTDTS+FDVD+  ++               
Sbjct:   339 ----KHPFFNGIDWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHTAFSG 394

Query:   358 XXHLPFVGFTFT 369
               HLPFVGFT+T
Sbjct:   395 H-HLPFVGFTYT 405

GO:0042802 "identical protein binding" evidence=IEA

GO:0042641 "actomyosin" evidence=IEA

GO:0031532 "actin cytoskeleton reorganization" evidence=IEA

GO:0031032 "actomyosin structure organization" evidence=IEA

GO:0016477 "cell migration" evidence=IEA

GO:0007097 "nuclear migration" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0000287 "magnesium ion binding" evidence=IEA

GO:0000226 "microtubule cytoskeleton organization" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0005543 "phospholipid binding" evidence=IEA

GO:0005083 "small GTPase regulator activity" evidence=IEA

UNIPROTKB|F1PYU4 CDC42BPA "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 1093 (389.8 bits), Expect = 4.0e-125, Sum P(2) = 4.0e-125
 Identities = 214/312 (68%), Positives = 242/312 (77%)

Query:    58 AKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAK 117
             A  REERDVLV GD +WIT LHYAFQDD+NLYLVMDYY GGDLLTLLSKFEDRLPEDMA+
Sbjct:   120 ACFREERDVLVNGDNKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR 179

Query:   118 FYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD 177
             FY+AEMV+AI S+H LHYVHR          DIKPDN+L+D NGHIRLADFGSCL+L  D
Sbjct:   180 FYLAEMVIAIDSVHQLHYVHR----------DIKPDNILMDMNGHIRLADFGSCLKLMED 229

Query:   178 GTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 237
             GTVQS+VAVGTPDYISPEIL AME+G+GRYGPECDWWSLGVCMYEMLYGETPFYAESLVE
Sbjct:   230 GTVQSSVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 289

Query:   238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLS 297
             TYGKIMNH+  F  P+ V  ++S++AKDL+RRLICS + RLGQNGI DFK          
Sbjct:   290 TYGKIMNHKERFQFPAQVT-DVSENAKDLIRRLICSREHRLGQNGIEDFK---------- 338

Query:   298 ISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRXXXXXXXXXXXXXXX 357
                  HP+F GI WD+IR+  APYIPEVSSPTDTS+FDVD+  ++               
Sbjct:   339 ----KHPFFNGIDWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHTAFSG 394

Query:   358 XXHLPFVGFTFT 369
               HLPFVGFT+T
Sbjct:   395 H-HLPFVGFTYT 405

GO:0046872 "metal ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0031532 "actin cytoskeleton reorganization" evidence=IEA

GO:0005543 "phospholipid binding" evidence=IEA

GO:0005083 "small GTPase regulator activity" evidence=IEA

UNIPROTKB|Q5VT25 CDC42BPA "Serine/threonine-protein kinase MRCK alpha" [Homo sapiens (taxid:9606)]

 Score = 1093 (389.8 bits), Expect = 4.4e-125, Sum P(2) = 4.4e-125
 Identities = 214/312 (68%), Positives = 242/312 (77%)

Query:    58 AKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAK 117
             A  REERDVLV GD +WIT LHYAFQDD+NLYLVMDYY GGDLLTLLSKFEDRLPEDMA+
Sbjct:   120 ACFREERDVLVNGDNKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR 179

Query:   118 FYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD 177
             FY+AEMV+AI S+H LHYVHR          DIKPDN+L+D NGHIRLADFGSCL+L  D
Sbjct:   180 FYLAEMVIAIDSVHQLHYVHR----------DIKPDNILMDMNGHIRLADFGSCLKLMED 229

Query:   178 GTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 237
             GTVQS+VAVGTPDYISPEIL AME+G+GRYGPECDWWSLGVCMYEMLYGETPFYAESLVE
Sbjct:   230 GTVQSSVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 289

Query:   238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLS 297
             TYGKIMNH+  F  P+ V  ++S++AKDL+RRLICS + RLGQNGI DFK          
Sbjct:   290 TYGKIMNHKERFQFPAQVT-DVSENAKDLIRRLICSREHRLGQNGIEDFK---------- 338

Query:   298 ISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRXXXXXXXXXXXXXXX 357
                  HP+F GI WD+IR+  APYIPEVSSPTDTS+FDVD+  ++               
Sbjct:   339 ----KHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHTAFSG 394

Query:   358 XXHLPFVGFTFT 369
               HLPFVGFT+T
Sbjct:   395 H-HLPFVGFTYT 405

GO:0005083 "small GTPase regulator activity" evidence=IEA

GO:0005543 "phospholipid binding" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0000226 "microtubule cytoskeleton organization" evidence=IEA

GO:0007097 "nuclear migration" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0031532 "actin cytoskeleton reorganization" evidence=IDA

GO:0000287 "magnesium ion binding" evidence=IDA

GO:0005911 "cell-cell junction" evidence=ISS

GO:0031252 "cell leading edge" evidence=ISS

GO:0005524 "ATP binding" evidence=IDA

GO:0031032 "actomyosin structure organization" evidence=IMP

GO:0016477 "cell migration" evidence=IMP

GO:0042641 "actomyosin" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042802 "identical protein binding" evidence=IPI

UNIPROTKB|E2R1X7 CDC42BPA "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 1093 (389.8 bits), Expect = 7.9e-125, Sum P(2) = 7.9e-125
 Identities = 214/312 (68%), Positives = 242/312 (77%)

Query:    58 AKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAK 117
             A  REERDVLV GD +WIT LHYAFQDD+NLYLVMDYY GGDLLTLLSKFEDRLPEDMA+
Sbjct:   120 ACFREERDVLVNGDNKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR 179

Query:   118 FYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD 177
             FY+AEMV+AI S+H LHYVHR          DIKPDN+L+D NGHIRLADFGSCL+L  D
Sbjct:   180 FYLAEMVIAIDSVHQLHYVHR----------DIKPDNILMDMNGHIRLADFGSCLKLMED 229

Query:   178 GTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 237
             GTVQS+VAVGTPDYISPEIL AME+G+GRYGPECDWWSLGVCMYEMLYGETPFYAESLVE
Sbjct:   230 GTVQSSVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 289

Query:   238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLS 297
             TYGKIMNH+  F  P+ V  ++S++AKDL+RRLICS + RLGQNGI DFK          
Sbjct:   290 TYGKIMNHKERFQFPAQVT-DVSENAKDLIRRLICSREHRLGQNGIEDFK---------- 338

Query:   298 ISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRXXXXXXXXXXXXXXX 357
                  HP+F GI WD+IR+  APYIPEVSSPTDTS+FDVD+  ++               
Sbjct:   339 ----KHPFFNGIDWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHTAFSG 394

Query:   358 XXHLPFVGFTFT 369
               HLPFVGFT+T
Sbjct:   395 H-HLPFVGFTYT 405

GO:0046872 "metal ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0031532 "actin cytoskeleton reorganization" evidence=IEA

GO:0005543 "phospholipid binding" evidence=IEA

GO:0005083 "small GTPase regulator activity" evidence=IEA

MGI|MGI:2441841 Cdc42bpa "CDC42 binding protein kinase alpha" [Mus musculus (taxid:10090)]

 Score = 1088 (388.1 bits), Expect = 1.4e-124, Sum P(2) = 1.4e-124
 Identities = 213/312 (68%), Positives = 242/312 (77%)

Query:    58 AKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAK 117
             A  REERDVLV GD +WIT LHYAFQDD+NLYLVMDYY GGDLLTLLSKFEDRLPE+MA+
Sbjct:   120 ACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMAR 179

Query:   118 FYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD 177
             FY+AEMV+AI S+H LHYVHR          DIKPDN+L+D NGHIRLADFGSCL+L  D
Sbjct:   180 FYLAEMVIAIDSVHQLHYVHR----------DIKPDNILMDMNGHIRLADFGSCLKLMED 229

Query:   178 GTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 237
             GTVQS+VAVGTPDYISPEIL AME+G+GRYGPECDWWSLGVCMYEMLYGETPFYAESLVE
Sbjct:   230 GTVQSSVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 289

Query:   238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLS 297
             TYGKIMNH+  F  P+ V  ++S++AKDL+RRLICS + RLGQNGI DFK          
Sbjct:   290 TYGKIMNHKERFQFPAQVT-DVSENAKDLIRRLICSREHRLGQNGIEDFK---------- 338

Query:   298 ISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRXXXXXXXXXXXXXXX 357
                  HP+F GI WD+IR+  APYIPEVSSPTDTS+FDVD+  ++               
Sbjct:   339 ----KHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHTAFSG 394

Query:   358 XXHLPFVGFTFT 369
               HLPFVGFT+T
Sbjct:   395 H-HLPFVGFTYT 405

GO:0000166 "nucleotide binding" evidence=IEA

GO:0000226 "microtubule cytoskeleton organization" evidence=IMP

GO:0000287 "magnesium ion binding" evidence=ISO

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO

GO:0005083 "small GTPase regulator activity" evidence=IEA

GO:0005524 "ATP binding" evidence=ISO

GO:0005543 "phospholipid binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005911 "cell-cell junction" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=IEA;ISO

GO:0007010 "cytoskeleton organization" evidence=ISO

GO:0007097 "nuclear migration" evidence=IMP

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016477 "cell migration" evidence=ISO

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0031032 "actomyosin structure organization" evidence=ISO

GO:0031252 "cell leading edge" evidence=ISO

GO:0031532 "actin cytoskeleton reorganization" evidence=ISO

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0042641 "actomyosin" evidence=ISO

GO:0042802 "identical protein binding" evidence=ISO

GO:0046872 "metal ion binding" evidence=IEA

GO:0051056 "regulation of small GTPase mediated signal transduction" evidence=ISO

RGD|621406 Cdc42bpa "CDC42 binding protein kinase alpha" [Rattus norvegicus (taxid:10116)]

 Score = 1088 (388.1 bits), Expect = 1.6e-124, Sum P(2) = 1.6e-124
 Identities = 213/312 (68%), Positives = 242/312 (77%)

Query:    58 AKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAK 117
             A  REERDVLV GD +WIT LHYAFQDD+NLYLVMDYY GGDLLTLLSKFEDRLPE+MA+
Sbjct:   120 ACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMAR 179

Query:   118 FYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD 177
             FY+AEMV+AI S+H LHYVHR          DIKPDN+L+D NGHIRLADFGSCL+L  D
Sbjct:   180 FYLAEMVIAIDSVHQLHYVHR----------DIKPDNILMDMNGHIRLADFGSCLKLMED 229

Query:   178 GTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 237
             GTVQS+VAVGTPDYISPEIL AME+G+GRYGPECDWWSLGVCMYEMLYGETPFYAESLVE
Sbjct:   230 GTVQSSVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 289

Query:   238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLS 297
             TYGKIMNH+  F  P+ V  ++S++AKDL+RRLICS + RLGQNGI DFK          
Sbjct:   290 TYGKIMNHKERFQFPTQVT-DVSENAKDLIRRLICSREHRLGQNGIEDFK---------- 338

Query:   298 ISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRXXXXXXXXXXXXXXX 357
                  HP+F GI WD+IR+  APYIPEVSSPTDTS+FDVD+  ++               
Sbjct:   339 ----KHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHTAFSG 394

Query:   358 XXHLPFVGFTFT 369
               HLPFVGFT+T
Sbjct:   395 H-HLPFVGFTYT 405

GO:0000226 "microtubule cytoskeleton organization" evidence=IEA;ISO

GO:0000287 "magnesium ion binding" evidence=IEA;ISO;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISO;IDA

GO:0005083 "small GTPase regulator activity" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA;ISO;IDA

GO:0005543 "phospholipid binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005911 "cell-cell junction" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=ISO;IDA

GO:0007010 "cytoskeleton organization" evidence=IDA

GO:0007097 "nuclear migration" evidence=IEA;ISO

GO:0016477 "cell migration" evidence=IEA;ISO;IMP

GO:0031032 "actomyosin structure organization" evidence=IEA;ISO;IMP

GO:0031252 "cell leading edge" evidence=IDA

GO:0031532 "actin cytoskeleton reorganization" evidence=IEA;ISO;IDA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0042641 "actomyosin" evidence=IEA;ISO;IDA

GO:0042802 "identical protein binding" evidence=IEA;ISO;IPI

GO:0051056 "regulation of small GTPase mediated signal transduction" evidence=IDA

UNIPROTKB|O54874 Cdc42bpa "Serine/threonine-protein kinase MRCK alpha" [Rattus norvegicus (taxid:10116)]

 Score = 1088 (388.1 bits), Expect = 1.6e-124, Sum P(2) = 1.6e-124
 Identities = 213/312 (68%), Positives = 242/312 (77%)

Query:    58 AKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAK 117
             A  REERDVLV GD +WIT LHYAFQDD+NLYLVMDYY GGDLLTLLSKFEDRLPE+MA+
Sbjct:   120 ACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMAR 179

Query:   118 FYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD 177
             FY+AEMV+AI S+H LHYVHR          DIKPDN+L+D NGHIRLADFGSCL+L  D
Sbjct:   180 FYLAEMVIAIDSVHQLHYVHR----------DIKPDNILMDMNGHIRLADFGSCLKLMED 229

Query:   178 GTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 237
             GTVQS+VAVGTPDYISPEIL AME+G+GRYGPECDWWSLGVCMYEMLYGETPFYAESLVE
Sbjct:   230 GTVQSSVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 289

Query:   238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLS 297
             TYGKIMNH+  F  P+ V  ++S++AKDL+RRLICS + RLGQNGI DFK          
Sbjct:   290 TYGKIMNHKERFQFPTQVT-DVSENAKDLIRRLICSREHRLGQNGIEDFK---------- 338

Query:   298 ISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRXXXXXXXXXXXXXXX 357
                  HP+F GI WD+IR+  APYIPEVSSPTDTS+FDVD+  ++               
Sbjct:   339 ----KHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHTAFSG 394

Query:   358 XXHLPFVGFTFT 369
               HLPFVGFT+T
Sbjct:   395 H-HLPFVGFTYT 405

GO:0005083 "small GTPase regulator activity" evidence=IEA

GO:0005543 "phospholipid binding" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0042802 "identical protein binding" evidence=IPI

UNIPROTKB|E1BWT5 CDC42BPA "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 1082 (385.9 bits), Expect = 1.5e-123, Sum P(2) = 1.5e-123
 Identities = 212/312 (67%), Positives = 242/312 (77%)

Query:    58 AKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAK 117
             A  REERDVLV GD +WIT LHYAFQD++ LYLVMDYY GGDLLTLLSKFEDRLPEDMA+
Sbjct:   120 ACFREERDVLVNGDNQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR 179

Query:   118 FYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD 177
             FY+AEMV+AI S+H LHYVHR          DIKPDN+L+D NGHIRLADFGSCL+L  D
Sbjct:   180 FYLAEMVIAIDSVHQLHYVHR----------DIKPDNILMDMNGHIRLADFGSCLKLMED 229

Query:   178 GTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 237
             GTVQS+VAVGTPDYISPEIL AME+G+G+YGPECDWWSLGVCMYEMLYGETPFYAESLVE
Sbjct:   230 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 289

Query:   238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLS 297
             TYGKIMNH+  F  P+ V  ++S+ AKDL+RRLICS + RLGQNGI DFK          
Sbjct:   290 TYGKIMNHKERFQFPAQVT-DVSESAKDLIRRLICSREHRLGQNGIEDFK---------- 338

Query:   298 ISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRXXXXXXXXXXXXXXX 357
                 NHP+F GI WD+IR+ +APYIPEVSSPTDTS+FDVD+  ++               
Sbjct:   339 ----NHPFFAGIDWDNIRNCDAPYIPEVSSPTDTSNFDVDDDCLKNSETMPPPSHTAFSG 394

Query:   358 XXHLPFVGFTFT 369
               HLPFVGFT+T
Sbjct:   395 H-HLPFVGFTYT 405

GO:0005083 "small GTPase regulator activity" evidence=IEA

GO:0005543 "phospholipid binding" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0000226 "microtubule cytoskeleton organization" evidence=IEA

GO:0000287 "magnesium ion binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0007097 "nuclear migration" evidence=IEA

GO:0016477 "cell migration" evidence=IEA

GO:0031032 "actomyosin structure organization" evidence=IEA

GO:0031532 "actin cytoskeleton reorganization" evidence=IEA

GO:0042641 "actomyosin" evidence=IEA

GO:0042802 "identical protein binding" evidence=IEA

ZFIN|ZDB-GENE-041014-372 si:ch211-89p3.3 "si:ch211-89p3.3" [Danio rerio (taxid:7955)]

 Score = 1084 (386.6 bits), Expect = 3.9e-123, Sum P(2) = 3.9e-123
 Identities = 215/312 (68%), Positives = 240/312 (76%)

Query:    58 AKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAK 117
             A  REERDVLV GD +WIT LHYAFQD++NLYLVMDYY GGDLLTLLSKFEDRLPEDMAK
Sbjct:   120 ACFREERDVLVNGDCQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAK 179

Query:   118 FYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD 177
             FY+AEMVLAI S+H LHYVHR          DIKPDN+L+D NGHIRLADFGSCL+L  D
Sbjct:   180 FYLAEMVLAIDSVHQLHYVHR----------DIKPDNILMDMNGHIRLADFGSCLKLMED 229

Query:   178 GTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 237
             GTVQS+VAVGTPDYISPEIL AME+G+G+YGPECDWWSLGVCMYEMLYGETPFYAESLVE
Sbjct:   230 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 289

Query:   238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLS 297
             TYGKIMNH+  F  P  V  ++S+DAKDL+RRLICS + RLGQNGI DFK          
Sbjct:   290 TYGKIMNHKERFQFPLQVT-DVSEDAKDLVRRLICSREHRLGQNGIEDFKQ--------- 339

Query:   298 ISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRXXXXXXXXXXXXXXX 357
                  HP+F GI WD+IR   APYIPEVSSPTDTS+FDVD+  ++               
Sbjct:   340 -----HPFFTGIDWDNIRTCEAPYIPEVSSPTDTSNFDVDDDCLKNCETLPPPSHTAFSG 394

Query:   358 XXHLPFVGFTFT 369
               HLPFVGFT+T
Sbjct:   395 H-HLPFVGFTYT 405

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005083 "small GTPase regulator activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0031532 "actin cytoskeleton reorganization" evidence=IEA

GO:0005543 "phospholipid binding" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9W1B0	GEK_DROME	2, ., 7, ., 1, 1, ., 1	0.6009	0.8736	0.1985	yes	N/A
O54874	MRCKA_RAT	2, ., 7, ., 1, 1, ., 1	0.6964	0.7715	0.1657	yes	N/A
Q5VT25	MRCKA_HUMAN	2, ., 7, ., 1, 1, ., 1	0.6996	0.7715	0.1657	yes	N/A
Q3UU96	MRCKA_MOUSE	2, ., 7, ., 1, 1, ., 1	0.6964	0.7715	0.1669	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	372
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	0.0
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-164
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-162
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-126
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-116
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-112
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-104
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-93
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-91
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-88
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	9e-86
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-81
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-78
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-75
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-72
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-71
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-69
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	8e-68
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	8e-66
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-65
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-58
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-55
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-55
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-54
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	7e-54
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	8e-54
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	9e-53
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	9e-52
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-50
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-50
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-50
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-50
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-49
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-49
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-49
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-48
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	8e-48
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-47
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-47
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-46
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-46
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-44
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-43
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-43
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-42
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-42
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-41
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-41
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-40
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-39
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-39
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-39
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-39
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-38
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-38
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	9e-38
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-37
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	9e-37
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-36
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	8e-36
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-34
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-33
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-33
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-33
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-32
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-27
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-27
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	7e-27
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-26
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-26
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-25
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-25
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-25
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-25
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-25
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	8e-25
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-24
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-24
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-24
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-24
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-24
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-24
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	8e-24
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-23
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-23
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-22
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-22
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-22
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-22
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-21
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-21
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-21
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-21
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-20
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-20
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-20
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	8e-20
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-19
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-19
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-19
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-19
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-19
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-19
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-19
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-19
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-19
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-18
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-18
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-18
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	6e-18
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-18
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	9e-18
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-17
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-17
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-17
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-17
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-17
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-16
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-16
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-16
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-16
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-16
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-16
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	9e-16
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-15
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-15
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-15
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-15
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-15
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-15
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	5e-15
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	6e-15
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-15
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	7e-15
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	8e-15
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-14
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-14
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-14
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-14
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-14
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-14
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	7e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-13
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-13
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	7e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-12
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-12
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-12
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-12
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	7e-12
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-11
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-11
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-11
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-11
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-11
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-11
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	7e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	9e-11
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	9e-11
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-10
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-10
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-10
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	7e-10
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	8e-10
smart00133	64	smart00133, S_TK_X, Extension to Ser/Thr-type prot	1e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	8e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-08
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-08
pfam00433	47	pfam00433, Pkinase_C, Protein kinase C terminal do	3e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-08
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-08
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	6e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	7e-08
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	9e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-07
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-07
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	8e-07
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-06
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	4e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-06
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-06
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-06
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	8e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	9e-06
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-05
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-05
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	2e-05
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-05
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-05
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-05
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-05
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-05
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-05
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-05
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-05
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-05
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	8e-05
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-04
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-04
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-04
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-04
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-04
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-04
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-04
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-04
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-04
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-04
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-04
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-04
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	6e-04
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	8e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	8e-04
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	0.002
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	0.002
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	0.002
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	0.002
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	0.002
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	0.003
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	0.003
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	0.004
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	0.004

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  539 bits (1390), Expect = 0.0
 Identities = 225/313 (71%), Positives = 257/313 (82%), Gaps = 26/313 (8%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
            A  REERDVLV GDRRWITNLHYAFQD++NLYLVMDYY GGDLLTLLSKFEDRLPEDMA
Sbjct: 45  TACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMA 104

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FY+AEMVLAI S+H L YVHR          DIKPDNVLLD NGHIRLADFGSCLRL  
Sbjct: 105 RFYLAEMVLAIDSVHQLGYVHR----------DIKPDNVLLDKNGHIRLADFGSCLRLLA 154

Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
           DGTVQSNVAVGTPDYISPEIL AME+G+GRYGPECDWWSLGVCMYEMLYGETPFYAESLV
Sbjct: 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214

Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSL 296
           ETYGKIMNH+  F  P DV  ++S++AKDL+RRLICS +TRLG+NG+ DF          
Sbjct: 215 ETYGKIMNHKEHFQFPPDV-TDVSEEAKDLIRRLICSPETRLGRNGLQDF---------- 263

Query: 297 SISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPAL 356
               ++HP+F+GI WD+IR+S APY+PEVSSPTDTS+FDVD+  +R +++LPP ++  A 
Sbjct: 264 ----KDHPFFEGIDWDNIRNSTAPYVPEVSSPTDTSNFDVDDDDLRNTESLPP-SSHGAF 318

Query: 357 SALHLPFVGFTFT 369
           S  HLPFVGFT+T
Sbjct: 319 SGNHLPFVGFTYT 331

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  463 bits (1192), Expect = e-164
 Identities = 214/312 (68%), Positives = 248/312 (79%), Gaps = 26/312 (8%)

Query: 58  AKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAK 117
           A  REER+VLV GD +WIT LHYAFQD++ LYLVMDYY GGDLLTLLSKFEDRLPEDMA+
Sbjct: 46  ACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR 105

Query: 118 FYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD 177
           FYIAEMVLAI SIH LHYVHR          DIKPDNVLLD NGHIRLADFGSCL++  D
Sbjct: 106 FYIAEMVLAIHSIHQLHYVHR----------DIKPDNVLLDMNGHIRLADFGSCLKMNQD 155

Query: 178 GTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 237
           GTVQS+VAVGTPDYISPEIL AME+G G+YGPECDWWSLGVCMYEMLYGETPFYAESLVE
Sbjct: 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215

Query: 238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLS 297
           TYGKIMNH+  F  PS +  ++S++AKDL++RLICS + RLGQNGI DFK          
Sbjct: 216 TYGKIMNHEERFQFPSHIT-DVSEEAKDLIQRLICSRERRLGQNGIEDFK---------- 264

Query: 298 ISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALS 357
                H +F+GI W++IR+  APYIP+VSSP+DTS+FDVD+  +R  +  PP++ +   S
Sbjct: 265 ----KHAFFEGIDWENIRNLEAPYIPDVSSPSDTSNFDVDDDVLRNPEIAPPSSHT-GFS 319

Query: 358 ALHLPFVGFTFT 369
            LHLPFVGFT+T
Sbjct: 320 GLHLPFVGFTYT 331

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  457 bits (1178), Expect = e-162
 Identities = 218/312 (69%), Positives = 251/312 (80%), Gaps = 26/312 (8%)

Query: 58  AKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAK 117
           A  REERDVLV GD +WIT LHYAFQD++NLYLVMDYY GGDLLTLLSKFEDRLPEDMA+
Sbjct: 46  ACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR 105

Query: 118 FYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD 177
           FY+AEMV+AI S+H LHYVHR          DIKPDN+L+D NGHIRLADFGSCL+L  D
Sbjct: 106 FYLAEMVIAIDSVHQLHYVHR----------DIKPDNILMDMNGHIRLADFGSCLKLMED 155

Query: 178 GTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 237
           GTVQS+VAVGTPDYISPEIL AME+G+G+YGPECDWWSLGVCMYEMLYGETPFYAESLVE
Sbjct: 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215

Query: 238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLS 297
           TYGKIMNH+  F  P+ V  ++S+DAKDL+RRLICS + RLGQNGI DFK          
Sbjct: 216 TYGKIMNHKERFQFPAQVT-DVSEDAKDLIRRLICSREHRLGQNGIEDFK---------- 264

Query: 298 ISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALS 357
                HP+F GI WD+IR+  APYIPEVSSPTDTS+FDVD+  ++ S+ +PP + + A S
Sbjct: 265 ----QHPFFTGIDWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPPPSHT-AFS 319

Query: 358 ALHLPFVGFTFT 369
             HLPFVGFT+T
Sbjct: 320 GHHLPFVGFTYT 331

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  366 bits (942), Expect = e-126
 Identities = 142/342 (41%), Positives = 195/342 (57%), Gaps = 63/342 (18%)

Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPED 114
             +A +R ERD+L   D  WI  L+Y+FQD+ +LYLVM+Y  GGDL+ LL +  D  PE+
Sbjct: 43  NQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK-DVFPEE 101

Query: 115 MAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL 174
            A+FYIAE+VLA+ S+H L ++HR          DIKPDN+L+DA+GHI+LADFG C ++
Sbjct: 102 TARFYIAELVLALDSVHKLGFIHR----------DIKPDNILIDADGHIKLADFGLCKKM 151

Query: 175 GGDGT----------------------------VQSNVAVGTPDYISPEILTAMEEGRGR 206
                                            V++N  VGTPDYI+PE+L         
Sbjct: 152 NKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP----- 206

Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           YG ECDWWSLGV +YEMLYG  PFY+++L ETY KI+N + S   P D    +S +A DL
Sbjct: 207 YGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDP--PVSPEAIDL 264

Query: 267 MRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIPEVS 326
           + RL+C  + RLG     + K              +HP+F+GI W+++R++  P++PE+S
Sbjct: 265 ICRLLCDPEDRLGS--FEEIK--------------SHPFFKGIDWENLRETKPPFVPELS 308

Query: 327 SPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTF 368
           SP DTS+FD  E     SD L    +        L FVGFT+
Sbjct: 309 SPLDTSNFDDFEDDKDLSDYL-SQNSKKLNKGKQLAFVGFTY 349

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  343 bits (881), Expect = e-116
 Identities = 143/310 (46%), Positives = 205/310 (66%), Gaps = 34/310 (10%)

Query: 62  EERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA 121
           EERD++ + +  WI  LHYAFQDD  LY+VM+Y  GGDL+ L+S ++  +PE  A+FY A
Sbjct: 92  EERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD--IPEKWARFYTA 149

Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ 181
           E+VLA+ +IH + ++HR          D+KPDN+LLD +GH++LADFG+C+++  +G V+
Sbjct: 150 EVVLALDAIHSMGFIHR----------DVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR 199

Query: 182 SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 241
            + AVGTPDYISPE+L + + G G YG ECDWWS+GV +YEML G+TPFYA+SLV TY K
Sbjct: 200 CDTAVGTPDYISPEVLKS-QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK 258

Query: 242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPR 301
           IM+H+NS   P D+  EIS  AKDL+   +   + RLG+NG+ + K              
Sbjct: 259 IMDHKNSLTFPDDI--EISKQAKDLICAFLTDREVRLGRNGVDEIK-------------- 302

Query: 302 NHPWFQG--IAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSAL 359
           +HP+F+     +D+IR++ AP +PE+SS  DTS+FD  E   +  +  P      A +  
Sbjct: 303 SHPFFKNDQWTFDNIRETVAPVVPELSSDIDTSNFDDIEDDDKNEETFPL---PKAFAGN 359

Query: 360 HLPFVGFTFT 369
            LPF+GFT++
Sbjct: 360 QLPFIGFTYS 369

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  329 bits (845), Expect = e-112
 Identities = 149/324 (45%), Positives = 195/324 (60%), Gaps = 31/324 (9%)

Query: 47  EKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSK 106
           +K+V    E V+   EERD+L   +  WI  L YAFQD  NLYLVM+Y  GGDLL+LL++
Sbjct: 35  KKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNR 94

Query: 107 FEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLA 166
           +ED+  EDMA+FY+AE+VLAI S+H + YVH          RDIKP+NVL+D  GHI+LA
Sbjct: 95  YEDQFDEDMAQFYLAELVLAIHSVHQMGYVH----------RDIKPENVLIDRTGHIKLA 144

Query: 167 DFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAME-EGRGRYGPECDWWSLGVCMYEMLY 225
           DFGS  RL  +  V S + VGTPDYI+PE+LT M  +G+G YG ECDWWSLGV  YEM+Y
Sbjct: 145 DFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIY 204

Query: 226 GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIAD 285
           G +PF+  +  +TY  IMN Q     P D   ++S D  DL++ L+C    RLG  G+  
Sbjct: 205 GRSPFHEGTSAKTYNNIMNFQRFLKFPEDP--KVSSDFLDLIQSLLCGQKERLGYEGL-- 260

Query: 286 FKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDE-AGVRAS 344
                            HP+F  I W++IR+S  P++P + S  DTS+FD  E    R S
Sbjct: 261 ---------------CCHPFFSKIDWNNIRNSLPPFVPTLKSDDDTSNFDEPEKNSTRRS 305

Query: 345 DALPPAAASPALSALHLPFVGFTF 368
            +          S   LPFVGF+F
Sbjct: 306 QSSTTQLKPNGFSGKDLPFVGFSF 329

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  311 bits (800), Expect = e-104
 Identities = 139/352 (39%), Positives = 191/352 (54%), Gaps = 76/352 (21%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           VA +R ERD+L   D  W+  L+Y+FQD++ LYL+M+Y  GGD++TLL K +D   E+  
Sbjct: 45  VAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK-KDTFTEEET 103

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FYIAE +LAI SIH L Y+HR          DIKPDN+LLDA GHI+L+DFG C  L  
Sbjct: 104 RFYIAETILAIDSIHKLGYIHR----------DIKPDNLLLDAKGHIKLSDFGLCTGLKK 153

Query: 177 DG------------------TVQSNV-------------------AVGTPDYISPEILTA 199
                                +   +                    VGTPDYI+PE+   
Sbjct: 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVF-- 211

Query: 200 MEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEI 259
           ++ G   Y  ECDWWSLGV MYEML G  PF +++  ETY KI+N + +   P +V   +
Sbjct: 212 LQTG---YNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEV--PL 266

Query: 260 SDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNA 319
           S +AKDL++RL C ++ RLG NG+ + K               HP+F+G+ W+ IR+  A
Sbjct: 267 SPEAKDLIKRLCCEAERRLGNNGVNEIKS--------------HPFFKGVDWEHIRERPA 312

Query: 320 PYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALH---LPFVGFTF 368
           P IPE+ S TDTS+FD  E      D   P +  P    +    L F+G+T+
Sbjct: 313 PIIPELKSITDTSNFDDFE----EIDLDVPTSPGPPRGKIKSKDLAFIGYTY 360

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  284 bits (728), Expect = 1e-93
 Identities = 140/309 (45%), Positives = 200/309 (64%), Gaps = 34/309 (11%)

Query: 62  EERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA 121
           EERD++ + +  W+  L YAFQDD  LY+VM+Y  GGDL+ L+S ++  +PE  A+FY A
Sbjct: 92  EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTA 149

Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ 181
           E+VLA+ +IH + ++HR          D+KPDN+LLD +GH++LADFG+C+++  +G V+
Sbjct: 150 EVVLALDAIHSMGFIHR----------DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 199

Query: 182 SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 241
            + AVGTPDYISPE+L + + G G YG ECDWWS+GV +YEML G+TPFYA+SLV TY K
Sbjct: 200 CDTAVGTPDYISPEVLKS-QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK 258

Query: 242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPR 301
           IMNH+NS   P D   +IS +AK+L+   +   + RLG+NG+ + K              
Sbjct: 259 IMNHKNSLTFPDD--NDISKEAKNLICAFLTDREVRLGRNGVEEIK-------------- 302

Query: 302 NHPWFQG--IAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSAL 359
            H +F+    AW+++RD+ AP +P++SS  DTS+FD  E      +  P      A    
Sbjct: 303 RHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDIEEDKGEEETFP---IPKAFVGN 359

Query: 360 HLPFVGFTF 368
            LPFVGFT+
Sbjct: 360 QLPFVGFTY 368

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  279 bits (714), Expect = 1e-91
 Identities = 141/311 (45%), Positives = 201/311 (64%), Gaps = 38/311 (12%)

Query: 62  EERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA 121
           EERD++ + +  W+  L  AFQDD  LY+VM+Y  GGDL+ L+S ++  +PE  AKFY A
Sbjct: 92  EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWAKFYTA 149

Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ 181
           E+VLA+ +IH +  +HR          D+KPDN+LLD +GH++LADFG+C+++   G V+
Sbjct: 150 EVVLALDAIHSMGLIHR----------DVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR 199

Query: 182 SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 241
            + AVGTPDYISPE+L + + G G YG ECDWWS+GV ++EML G+TPFYA+SLV TY K
Sbjct: 200 CDTAVGTPDYISPEVLKS-QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSK 258

Query: 242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPR 301
           IM+H+NS + P DV  EIS  AK+L+   +   + RLG+NG+ + K              
Sbjct: 259 IMDHKNSLNFPEDV--EISKHAKNLICAFLTDREVRLGRNGVEEIK-------------- 302

Query: 302 NHPWFQGIA--WDSIRDSNAPYIPEVSSPTDTSHFD--VDEAGVRASDALPPAAASPALS 357
            HP+F+     WD+IR++ AP +PE+SS  D+S+FD   D+ G   +  +P A       
Sbjct: 303 QHPFFKNDQWNWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVETFPIPKAFVGN--- 359

Query: 358 ALHLPFVGFTF 368
              LPF+GFT+
Sbjct: 360 --QLPFIGFTY 368

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  270 bits (693), Expect = 2e-88
 Identities = 133/363 (36%), Positives = 187/363 (51%), Gaps = 85/363 (23%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           +A ++ ERDVL   D  W+ +L+Y+FQD   LYL+M++  GGDL+T+L K+ D   ED+ 
Sbjct: 45  LAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY-DTFSEDVT 103

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FY+AE VLAI ++H L ++HR          DIKPDN+L+D  GHI+L+DFG  L  G 
Sbjct: 104 RFYMAECVLAIEAVHKLGFIHR----------DIKPDNILIDRGGHIKLSDFG--LSTGF 151

Query: 177 DGTVQSNV------------------------------------------------AVGT 188
                S                                                   VGT
Sbjct: 152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGT 211

Query: 189 PDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNS 248
           PDYI+PEI       +G YG ECDWWSLG  M+E L G  PF +E+  ETY KI+N + +
Sbjct: 212 PDYIAPEIFL----QQG-YGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRET 266

Query: 249 FDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG 308
              P D+   +S +A+DL+RRLI +++ RLG+ G  + K              +HP+F+G
Sbjct: 267 LYFPDDI--HLSVEAEDLIRRLITNAENRLGRGGAHEIK--------------SHPFFRG 310

Query: 309 IAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAAS---PALSALHLPFVG 365
           + WD+IR   AP+IP++ S TDTS+F  DE            AA         L L F+G
Sbjct: 311 VDWDTIRQIRAPFIPQLKSITDTSYFPTDELEQVPEAPALKQAAPAQQEESVELDLAFIG 370

Query: 366 FTF 368
           +T+
Sbjct: 371 YTY 373

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  264 bits (676), Expect = 9e-86
 Identities = 129/360 (35%), Positives = 185/360 (51%), Gaps = 80/360 (22%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
            A ++ ERD+L   D  W+  L+Y+FQD  NLY VMDY  GGD+++LL +      ED+A
Sbjct: 45  AAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG-IFEEDLA 103

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSC--LRL 174
           +FYIAE+  AI S+H + ++HR          DIKPDN+L+D +GHI+L DFG C   R 
Sbjct: 104 RFYIAELTCAIESVHKMGFIHR----------DIKPDNILIDRDGHIKLTDFGLCTGFRW 153

Query: 175 GGDGT----------------------------------------VQSNVAVGTPDYISP 194
             D                                            ++  VGTP+YI+P
Sbjct: 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAP 213

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSD 254
           E+L      R  Y   CDWWS+GV +YEML G+ PF A++  ET  K++N + +  +PS 
Sbjct: 214 EVLL-----RTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQ 268

Query: 255 VGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDS- 313
              ++S +A DL+ RL C ++ RLG+NG  + K               HP+F+GI + S 
Sbjct: 269 A--KLSREASDLILRLCCGAEDRLGKNGADEIK--------------AHPFFKGIDFASL 312

Query: 314 IRDSNAPYIPEVSSPTDTSHFD-VDEAGVRASDALPPAAASP-ALSALHLP---FVGFTF 368
           IR   APYIP+++ PTDTS+FD VD   +R+ D+   +       +        F  FTF
Sbjct: 313 IRRQKAPYIPKITHPTDTSNFDPVDPEKLRSDDSGESSPDRNVKPNNRKRTEHAFYEFTF 372

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  248 bits (636), Expect = 3e-81
 Identities = 95/247 (38%), Positives = 135/247 (54%), Gaps = 38/247 (15%)

Query: 61  REERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYI 120
             ER++L   +  +I  LHYAFQ +  LYLV++Y  GG+L + LSK E R  E+ A+FY 
Sbjct: 41  LTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSK-EGRFSEERARFYA 99

Query: 121 AEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTV 180
           AE+VLA+  +H L  ++R          D+KP+N+LLDA+GHI+L DFG   +       
Sbjct: 100 AEIVLALEYLHSLGIIYR----------DLKPENILLDADGHIKLTDFGLA-KELSSEGS 148

Query: 181 QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 240
           ++N   GTP+Y++PE+L         YG   DWWSLGV +YEML G+ PFYAE   E Y 
Sbjct: 149 RTNTFCGTPEYLAPEVLL-----GKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYE 203

Query: 241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLGQNGIADFKMWSALFVSLSIS 299
           KI+  ++    P  +    S +A+DL+  L+      RLG  G  + K            
Sbjct: 204 KIL--KDPLRFPEFL----SPEARDLISGLLQKDPTKRLGSGGAEEIK------------ 245

Query: 300 PRNHPWF 306
              HP+F
Sbjct: 246 --AHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  244 bits (625), Expect = 1e-78
 Identities = 114/320 (35%), Positives = 162/320 (50%), Gaps = 53/320 (16%)

Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE 122
           ERD+L      W+  L YAFQDD  LYL M+Y  GGD  TLL+     L ED A+FY+AE
Sbjct: 51  ERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN-LGVLSEDHARFYMAE 109

Query: 123 MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQS 182
           M  A+ ++H+L Y+H          RD+KP+N L+DA+GHI+L DFG    L       +
Sbjct: 110 MFEAVDALHELGYIH----------RDLKPENFLIDASGHIKLTDFG----LSKGIVTYA 155

Query: 183 NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
           N  VG+PDY++PE+L     G+G Y    D+WSLG  +YE L G  PF   +  ET+  +
Sbjct: 156 NSVVGSPDYMAPEVL----RGKG-YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL 210

Query: 243 MNHQNSFDLPS--DVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISP 300
              + +   P   D  + +SD+A DL+ +LI     R G   + D K             
Sbjct: 211 KYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFG--SLEDIK------------- 255

Query: 301 RNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFD--VDEA----------GVRASDALP 348
            NHP+F+ + W+ +R+   P++PE+ S  DT +FD   +E             +A+    
Sbjct: 256 -NHPFFKEVDWNELRELKPPFVPELESEIDTGYFDDFENEDDMAKYKDVHEKKKAAGKGG 314

Query: 349 PAAASPALSALHLPFVGFTF 368
                P        FVGFTF
Sbjct: 315 ANGRDPGNRRK---FVGFTF 331

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  235 bits (601), Expect = 2e-75
 Identities = 115/292 (39%), Positives = 166/292 (56%), Gaps = 55/292 (18%)

Query: 57  VAKLRE------ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR 110
           + KL++      E+ +L      ++ NL+ +FQDDSNLYLVM+Y  GG+L + L K   R
Sbjct: 39  IVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK-SGR 97

Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGS 170
            PE +A+FY A++VLA+  +H L  V+          RD+KP+N+LLD++G+I++ DFG 
Sbjct: 98  FPEPVARFYAAQVVLALEYLHSLDIVY----------RDLKPENLLLDSDGYIKITDFGF 147

Query: 171 CLRLGGDG-TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
             R+ G   T+      GTP+Y++PEI+      +G YG   DWW+LG+ +YEML G  P
Sbjct: 148 AKRVKGRTYTL-----CGTPEYLAPEIIL----SKG-YGKAVDWWALGILIYEMLAGYPP 197

Query: 230 FYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSD--TRLG--QNGIAD 285
           F+ ++ ++ Y KI+        PS      S DAKDL+R L    D   RLG  +NG+ D
Sbjct: 198 FFDDNPIQIYEKILE--GKVRFPS----FFSPDAKDLIRNL-LQVDLTKRLGNLKNGVND 250

Query: 286 FKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFD 335
            K              NHPWF GI W ++  R   AP+IP+V  P DTS+FD
Sbjct: 251 IK--------------NHPWFAGIDWIALLQRKIEAPFIPKVKGPGDTSNFD 288

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  225 bits (576), Expect = 3e-72
 Identities = 96/257 (37%), Positives = 135/257 (52%), Gaps = 42/257 (16%)

Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE 122
           ERD+L      ++  L+Y+FQ   NLYLVM+Y  GGDL +LL      L ED+A+ YIAE
Sbjct: 43  ERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAE 101

Query: 123 MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG-------SCLRLG 175
           +VLA+  +H    +HR          D+KPDN+L+D+NGH++L DFG             
Sbjct: 102 IVLALEYLHSNGIIHR----------DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151

Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
            D   +    VGTPDYI+PE++     G+G +    DWWSLG  +YE L G  PF+ E+ 
Sbjct: 152 NDDEKEDKRIVGTPDYIAPEVIL----GQG-HSKTVDWWSLGCILYEFLVGIPPFHGETP 206

Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT-RLGQNGIADFKMWSALFV 294
            E +  I+N      +      E+SD+A DL+ +L+      RLG   I + K       
Sbjct: 207 EEIFQNILN----GKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK------- 255

Query: 295 SLSISPRNHPWFQGIAW 311
                  NHP+F+GI W
Sbjct: 256 -------NHPFFKGIDW 265

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  227 bits (580), Expect = 1e-71
 Identities = 137/352 (38%), Positives = 187/352 (53%), Gaps = 72/352 (20%)

Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPED 114
           E VA +R ERD+LV  D  W+  + Y+FQD  NLYL+M++  GGD++TLL K +D L E+
Sbjct: 43  EQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK-KDTLSEE 101

Query: 115 MAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL 174
             +FYIAE VLAI +IH L ++H          RDIKPDN+LLDA GH++L+DFG C  L
Sbjct: 102 ATQFYIAETVLAIDAIHQLGFIH----------RDIKPDNLLLDAKGHVKLSDFGLCTGL 151

Query: 175 G----------------GDGTVQ------------------SNVAVGTPDYISPEILTAM 200
                             D + Q                  +   VGTPDYI+PE+   M
Sbjct: 152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVF--M 209

Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEIS 260
           + G   Y   CDWWSLGV MYEML G  PF +E+  ETY K+MN + +   P +V   IS
Sbjct: 210 QTG---YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEV--PIS 264

Query: 261 DDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAP 320
           + AKDL+ R    S+ R+G NG+ + K              +HP+F+G+ W  IR+  A 
Sbjct: 265 EKAKDLILRFCTDSENRIGSNGVEEIK--------------SHPFFEGVDWGHIRERPAA 310

Query: 321 YIPEVSSPTDTSHFDVDEAGVRASDALPPAAAS--PALSALHLPFVGFTFTQ 370
              E+ S  DTS+FD        SD L PA  +  P   +    F+ +T+ +
Sbjct: 311 IPIEIKSIDDTSNFD----EFPESDILQPAENTIEPDYKSKDWVFLNYTYKR 358

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  221 bits (565), Expect = 2e-69
 Identities = 132/333 (39%), Positives = 177/333 (53%), Gaps = 70/333 (21%)

Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPED 114
           E V  +R ERD+LV  D  W+  + Y+FQD  NLYL+M++  GGD++TLL K +D L E+
Sbjct: 43  EQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK-KDTLTEE 101

Query: 115 MAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCL-- 172
             +FYIAE VLAI SIH L ++H          RDIKPDN+LLD+ GH++L+DFG C   
Sbjct: 102 ETQFYIAETVLAIDSIHQLGFIH----------RDIKPDNLLLDSKGHVKLSDFGLCTGL 151

Query: 173 --------------RLGGDGTVQSN------------------VAVGTPDYISPEILTAM 200
                          L  D T Q+                     VGTPDYI+PE+   M
Sbjct: 152 KKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVF--M 209

Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEIS 260
           + G   Y   CDWWSLGV MYEML G  PF +E+  ETY K+MN + +   P +V   IS
Sbjct: 210 QTG---YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEV--PIS 264

Query: 261 DDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAP 320
           + AKDL+ R  C  + R+G  G+ + K               +P+F+G+ W+ IR+  A 
Sbjct: 265 EKAKDLILRFCCEWEHRIGAPGVEEIK--------------TNPFFEGVDWEHIRERPAA 310

Query: 321 YIPEVSSPTDTSHFDVDEAGVRASDALPPAAAS 353
              E+ S  DTS+FD        SD L P  A+
Sbjct: 311 IPIEIKSIDDTSNFD----EFPDSDILKPTVAT 339

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score =  218 bits (556), Expect = 8e-68
 Identities = 129/345 (37%), Positives = 182/345 (52%), Gaps = 87/345 (25%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           VA ++ ERD+L   D  W+  L+Y+FQD  NLY VMDY  GGD+++LL + E   PE +A
Sbjct: 45  VAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRME-VFPEVLA 103

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADF-------- 168
           +FYIAE+ LAI S+H + ++HR          DIKPDN+L+D +GHI+L DF        
Sbjct: 104 RFYIAELTLAIESVHKMGFIHR----------DIKPDNILIDLDGHIKLTDFGLCTGFRW 153

Query: 169 ---------GSCLR------------------------LGGDGTVQ-----SNVAVGTPD 190
                    GS +R                        L    T Q     ++  VGTP+
Sbjct: 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPN 213

Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD 250
           YI+PE+L      R  Y   CDWWS+GV ++EML G+ PF A +  ET  K++N +N+  
Sbjct: 214 YIAPEVLL-----RKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLH 268

Query: 251 LPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIA 310
           +P  V  ++S +A DL+ +L CS++ RLG+NG  D K               HP+F  + 
Sbjct: 269 IPPQV--KLSPEAVDLITKLCCSAEERLGRNGADDIKA--------------HPFFSEVD 312

Query: 311 WDS-IRDSNAPYIPEVSSPTDTSHFD-VDEAGVRASDALPPAAAS 353
           + S IR   APY+P++S P DTS+FD V+E         P   AS
Sbjct: 313 FSSDIRTQPAPYVPKISHPMDTSNFDPVEEES-------PWNDAS 350

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  208 bits (533), Expect = 8e-66
 Identities = 82/223 (36%), Positives = 122/223 (54%), Gaps = 22/223 (9%)

Query: 51  SDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR 110
               +   ++  E  +L       I  L+  F+D+  LYLVM+Y  GGDL  LL K   R
Sbjct: 35  KKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKK-RGR 93

Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGS 170
           L ED A+FY+ +++ A+  +H    VHR          D+KP+N+LLD +GH++LADFG 
Sbjct: 94  LSEDEARFYLRQILSALEYLHSKGIVHR----------DLKPENILLDEDGHVKLADFGL 143

Query: 171 CLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
             +L     + +   VGTP+Y++PE+L         YG   D WSLGV +YE+L G+ PF
Sbjct: 144 ARQLDPGEKLTT--FVGTPEYMAPEVLL-----GKGYGKAVDIWSLGVILYELLTGKPPF 196

Query: 231 YAES-LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC 272
             +  L+E + KI   +  F  P     +IS +AKDL+R+L+ 
Sbjct: 197 PGDDQLLELFKKIGKPKPPFPPPEW---DISPEAKDLIRKLLV 236

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  212 bits (541), Expect = 1e-65
 Identities = 120/326 (36%), Positives = 173/326 (53%), Gaps = 79/326 (24%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           VA ++ ERD+L   D  W+  L+Y+FQD  NLY VMDY  GGD+++LL +     PED+A
Sbjct: 45  VAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-GIFPEDLA 103

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL-- 174
           +FYIAE+  A+ S+H + ++H          RDIKPDN+L+D +GHI+L DFG C     
Sbjct: 104 RFYIAELTCAVESVHKMGFIH----------RDIKPDNILIDRDGHIKLTDFGLCTGFRW 153

Query: 175 --------GGDGTVQSNV------------------------------------AVGTPD 190
                    GD   Q ++                                     VGTP+
Sbjct: 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPN 213

Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD 250
           YI+PE+L      R  Y   CDWWS+GV +YEML G+ PF A++ +ET  K++N Q S  
Sbjct: 214 YIAPEVLL-----RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLH 268

Query: 251 LPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIA 310
           +P     ++S +A DL+ +L    + RLG+NG  + K               HP+F+ I 
Sbjct: 269 IPPQA--KLSPEASDLIIKLCRGPEDRLGKNGADEIKA--------------HPFFKTID 312

Query: 311 WDS-IRDSNAPYIPEVSSPTDTSHFD 335
           + S +R  +APYIP+++ PTDTS+FD
Sbjct: 313 FSSDLRQQSAPYIPKITHPTDTSNFD 338

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  190 bits (485), Expect = 5e-58
 Identities = 97/305 (31%), Positives = 151/305 (49%), Gaps = 64/305 (20%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDM 115
           V ++  E+++L   D  ++  L+ +FQ ++ L LVMDY  GG+L  LL +     L E++
Sbjct: 45  VKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEV 104

Query: 116 AKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG 175
           A+FY AE++LA+  +H L  V+R          D+KP+N+LL  +GHI L+DF    +  
Sbjct: 105 ARFYAAEVLLALEYLHLLGIVYR----------DLKPENILLHESGHIMLSDFDLSKQSD 154

Query: 176 GDGTV----------------------------QSNVAVGTPDYISPEILTAMEEGRGRY 207
            +                               +SN  VGT +YI+PE+++    G G +
Sbjct: 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS----GDG-H 209

Query: 208 GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLM 267
           G   DWW+LG+ +YEMLYG TPF   +  ET+  I+  + +F  P      +S  A+DL+
Sbjct: 210 GSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTF--PGSPP--VSSSARDLI 265

Query: 268 RR-LICSSDTRLG-QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIPEV 325
           R+ L+     RLG + G A+ K               HP+F+G+ W  IR +  P IP  
Sbjct: 266 RKLLVKDPSKRLGSKRGAAEIK--------------QHPFFRGVNWALIRHTTPPIIPRP 311

Query: 326 SSPTD 330
               D
Sbjct: 312 DDGID 316

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  182 bits (463), Expect = 2e-55
 Identities = 93/258 (36%), Positives = 135/258 (52%), Gaps = 39/258 (15%)

Query: 57  VAKLREERDVL-VYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDM 115
           V  ++ ER ++ + G+  ++  L+Y+FQ    LYLVM+Y  GGD  +L+      LPED 
Sbjct: 40  VTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL-GGLPEDW 98

Query: 116 AKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG 175
           AK YIAE+VL +  +H    +HR          DIKP+N+L+D  GH++L DFG    L 
Sbjct: 99  AKQYIAEVVLGVEDLHQRGIIHR----------DIKPENLLIDQTGHLKLTDFG----LS 144

Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
            +G       VGTPDY++PE +     G G      DWWSLG  ++E L+G  PF+AE+ 
Sbjct: 145 RNGLENKKF-VGTPDYLAPETI----LGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETP 198

Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLGQNGIADFKMWSALFV 294
              +  I+      + P +V    S +A DL+ RL+C     RLG NG  + K       
Sbjct: 199 DAVFDNIL--SRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK------- 249

Query: 295 SLSISPRNHPWFQGIAWD 312
                  +HP+F+ I WD
Sbjct: 250 -------SHPFFKSINWD 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  183 bits (465), Expect = 5e-55
 Identities = 106/314 (33%), Positives = 154/314 (49%), Gaps = 44/314 (14%)

Query: 63  ERDVLVYGDRR-WITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA 121
           ER+VL+   +  ++  LHY+FQ    LY V+DY  GG+L   L + E   PE  A+FY A
Sbjct: 45  ERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQR-ERSFPEPRARFYAA 103

Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ 181
           E+  A+  +H L+ ++R          D+KP+N+LLD+ GH+ L DFG C + G + +  
Sbjct: 104 EIASALGYLHSLNIIYR----------DLKPENILLDSQGHVVLTDFGLC-KEGIEHSKT 152

Query: 182 SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 241
           ++   GTP+Y++PE+L         Y    DWW LG  +YEMLYG  PFY+    E Y  
Sbjct: 153 TSTFCGTPEYLAPEVLRKQP-----YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDN 207

Query: 242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT-RLGQNGIADFKMWSALFVSLSISP 300
           I+N       P  +   IS  A+ L+  L+    T RLG     DF              
Sbjct: 208 ILNK------PLRLKPNISVSARHLLEGLLQKDRTKRLGAKD--DFL-----------EI 248

Query: 301 RNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFDVD--EAGVRASDALPPAAASPAL 356
           +NH +F  I WD +  +    P+ P VS P D  HFD +  E  V  S    P +   + 
Sbjct: 249 KNHVFFSSINWDDLVNKKITPPFNPNVSGPMDLKHFDPEFTEEPVPNSVGKSPDSVLVSA 308

Query: 357 SALHL--PFVGFTF 368
           S       F+GF++
Sbjct: 309 SVKEADDAFLGFSY 322

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  180 bits (459), Expect = 4e-54
 Identities = 107/318 (33%), Positives = 166/318 (52%), Gaps = 49/318 (15%)

Query: 58  AKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAK 117
           A  + ER++L      +I +L YAFQ    LYL+++Y  GG+L   L + E    ED A 
Sbjct: 45  AHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLER-EGIFMEDTAC 103

Query: 118 FYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD 177
           FY++E+ LA+  +H    ++R          D+KP+N+LLDA GH++L DFG C     +
Sbjct: 104 FYLSEISLALEHLHQQGIIYR----------DLKPENILLDAQGHVKLTDFGLCKESIHE 153

Query: 178 GTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 237
           GTV ++   GT +Y++PEIL      R  +G   DWWSLG  MY+ML G  PF AE+  +
Sbjct: 154 GTV-THTFCGTIEYMAPEILM-----RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK 207

Query: 238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLGQNGIADFKMWSALFVSL 296
           T  KI+  +   +LP      ++ +A+DL+++L+  +  +RLG  G  D           
Sbjct: 208 TIDKIL--KGKLNLPP----YLTPEARDLLKKLLKRNPSSRLG-AGPGD----------- 249

Query: 297 SISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASP 354
           +   ++HP+F+ + WD +  R    P+ P + S  D S FD      + +   P    SP
Sbjct: 250 AAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEEDVSQFD-----SKFTRQTP--VDSP 302

Query: 355 ALSAL----HLPFVGFTF 368
             S L    +  F+GFT+
Sbjct: 303 DDSTLSESANQIFLGFTY 320

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  180 bits (458), Expect = 7e-54
 Identities = 120/329 (36%), Positives = 169/329 (51%), Gaps = 52/329 (15%)

Query: 57  VAKLREERDVLV---YGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPE 113
           VA    ER++LV     +  +I  L ++FQ DS+LYLV DY  GG+L   L K E R  E
Sbjct: 37  VAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK-EGRFSE 95

Query: 114 DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG-SCL 172
           D AKFYIAE+VLA+  +H    V+R          D+KP+N+LLDA GHI L DFG S  
Sbjct: 96  DRAKFYIAELVLALEHLHKYDIVYR----------DLKPENILLDATGHIALCDFGLSKA 145

Query: 173 RLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA 232
            L  + T  +N   GT +Y++PE+L   E+G   Y    D+WSLGV ++EM  G +PFYA
Sbjct: 146 NLTDNKT--TNTFCGTTEYLAPEVLLD-EKG---YTKHVDFWSLGVLVFEMCCGWSPFYA 199

Query: 233 ESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLGQNGIADFKMWSA 291
           E   + Y  I   +  F  P +V   +SD+ +  ++ L+  +   RLG            
Sbjct: 200 EDTQQMYRNIAFGKVRF--PKNV---LSDEGRQFVKGLLNRNPQHRLGA----------- 243

Query: 292 LFVSLSISPRNHPWFQGIAWD--SIRDSNAPYIPEVSSPTDTSHFD-------VDEAGV- 341
                ++  + HP+F  I WD  S +    P+ P V S  D S+FD       +  AG+ 
Sbjct: 244 --HRDAVELKEHPFFADIDWDLLSKKQITPPFKPIVDSDEDVSNFDPEFTNSSLLNAGIV 301

Query: 342 --RASDALPPAAASPALSALHLPFVGFTF 368
                  LP A ++P  S++   F GFTF
Sbjct: 302 PWEDVPGLPGANSTPLSSSVQENFRGFTF 330

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  178 bits (454), Expect = 8e-54
 Identities = 81/265 (30%), Positives = 125/265 (47%), Gaps = 56/265 (21%)

Query: 63  ERDVLVYGDR-RWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA 121
           E++VL   +    I  L+Y FQD+ NLY V++Y   G+LL  + K+   L E   +FY A
Sbjct: 51  EKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAA 109

Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ 181
           E++LA+  +H    +HR          D+KP+N+LLD + HI++ DFG+   L  + + +
Sbjct: 110 EILLALEYLHSKGIIHR----------DLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159

Query: 182 SNVA-------------------VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYE 222
           SN                     VGT +Y+SPE+L          G   D W+LG  +Y+
Sbjct: 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN-----EKPAGKSSDLWALGCIIYQ 214

Query: 223 MLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQN 281
           ML G+ PF   +   T+ KI+     +  P +       DAKDL+ +L+      RLG N
Sbjct: 215 MLTGKPPFRGSNEYLTFQKILK--LEYSFPPN----FPPDAKDLIEKLLVLDPQDRLGVN 268

Query: 282 GIADFKMWSALFVSLSISPRNHPWF 306
              D            +  + HP+F
Sbjct: 269 EGYD-----------EL--KAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  175 bits (446), Expect = 9e-53
 Identities = 82/255 (32%), Positives = 130/255 (50%), Gaps = 41/255 (16%)

Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE 122
           E+++L   +  +I  L+  F+D   +Y++M+Y  GG+L T+L        E  A+FYIA 
Sbjct: 43  EKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRD-RGLFDEYTARFYIAC 101

Query: 123 MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQS 182
           +VLA   +H+   ++R          D+KP+N+LLD+NG+++L DFG   +L       +
Sbjct: 102 VVLAFEYLHNRGIIYR----------DLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT 151

Query: 183 NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA--ESLVETYG 240
               GTP+Y++PEI+      +G Y    D+WSLG+ +YE+L G  PF    E  +E Y 
Sbjct: 152 --FCGTPEYVAPEII----LNKG-YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYN 204

Query: 241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT-RLG--QNGIADFKMWSALFVSLS 297
            I+      + P+     I   AKDL+++L+  +   RLG  + GI D K          
Sbjct: 205 DILKGNGKLEFPN----YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIK---------- 250

Query: 298 ISPRNHPWFQGIAWD 312
                H WF G  W+
Sbjct: 251 ----KHKWFNGFDWE 261

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  174 bits (443), Expect = 9e-52
 Identities = 95/271 (35%), Positives = 140/271 (51%), Gaps = 50/271 (18%)

Query: 74  WITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDL 133
           ++T LH  FQ    L+ VM+Y  GGDL+  + +   R  E  A+FY AE+VL +  +H+ 
Sbjct: 57  FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHER 115

Query: 134 HYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR--LGGDGTVQSNVAVGTPDY 191
             ++R          D+K DNVLLD+ GHI++ADFG C    LGG  T   +   GTPDY
Sbjct: 116 GIIYR----------DLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDY 162

Query: 192 ISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDL 251
           I+PEIL+        YGP  DWW+LGV +YEML G++PF  +   E +  I+  +     
Sbjct: 163 IAPEILSYQP-----YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE----- 212

Query: 252 PSDVGYE--ISDDAKDLMRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWF 306
              V Y   +S +AK +++  +  +   RLG    G  D K               HP+F
Sbjct: 213 ---VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIK--------------GHPFF 255

Query: 307 QGIAWDSI--RDSNAPYIPEVSSPTDTSHFD 335
           + I WD +  ++   P+ P++    D S+FD
Sbjct: 256 REIDWDKLERKEIKPPFKPKIKGRFDVSNFD 286

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  171 bits (435), Expect = 1e-50
 Identities = 106/313 (33%), Positives = 158/313 (50%), Gaps = 50/313 (15%)

Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE 122
           ERD+L   +  +I  LHYAFQ +  LYL++D+  GGDL T LSK E    E+  KFY+AE
Sbjct: 48  ERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAE 106

Query: 123 MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQS 182
           + LA+  +H L  ++          RD+KP+N+LLD  GHI+L DFG   +   D   ++
Sbjct: 107 LALALDHLHSLGIIY----------RDLKPENILLDEEGHIKLTDFGLS-KESIDHEKKA 155

Query: 183 NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
               GT +Y++PE++      R  +    DWWS GV M+EML G  PF  +   ET   I
Sbjct: 156 YSFCGTVEYMAPEVVN-----RRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210

Query: 243 MNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT-RLGQ--NGIADFKMWSALFVSLSIS 299
           +  +    +P      +S +A+ L+R L   +   RLG   +G+ + K            
Sbjct: 211 L--KAKLGMPQF----LSPEAQSLLRALFKRNPANRLGAGPDGVEEIK------------ 252

Query: 300 PRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFDVD--EAGVRASDALPPAAASPA 355
              HP+F  I W+ +  R+   P+ P V  P DT +FD +      + S  +PP+A +  
Sbjct: 253 --RHPFFSTIDWNKLYRREIKPPFKPAVGRPDDTFYFDPEFTSRTPKDSPGIPPSANA-- 308

Query: 356 LSALHLPFVGFTF 368
               H  F GF+F
Sbjct: 309 ----HQLFRGFSF 317

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  169 bits (431), Expect = 2e-50
 Identities = 92/271 (33%), Positives = 137/271 (50%), Gaps = 42/271 (15%)

Query: 61  REERDVLVYGDRR-WITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFY 119
           R ER VL    R  ++  LHYAFQ D+ L+L++DY  GG+L T L + E    E   + Y
Sbjct: 52  RTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE-HFTESEVRVY 110

Query: 120 IAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT 179
           IAE+VLA+  +H L  ++          RDIK +N+LLD+ GH+ L DFG       +  
Sbjct: 111 IAEIVLALDHLHQLGIIY----------RDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160

Query: 180 VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE----SL 235
            ++    GT +Y++PE++     G   +    DWWSLGV  +E+L G +PF  +    S 
Sbjct: 161 ERAYSFCGTIEYMAPEVIRGGSGG---HDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ 217

Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT-RLGQNGIADFKMWSALFV 294
            E   +I+  +  F  P      +S +A+D +++L+      RLG NG  + K       
Sbjct: 218 SEISRRILKSKPPF--PKT----MSAEARDFIQKLLEKDPKKRLGANGADEIK------- 264

Query: 295 SLSISPRNHPWFQGIAWDSIRDSN--APYIP 323
                  NHP+FQGI WD +      AP+ P
Sbjct: 265 -------NHPFFQGIDWDDLAAKRIPAPFKP 288

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  168 bits (428), Expect = 3e-50
 Identities = 85/251 (33%), Positives = 122/251 (48%), Gaps = 37/251 (14%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           V  +  ER +L   +  ++ NL Y+FQD+ N+YLV+D   GGDL   LS+   +  E+  
Sbjct: 44  VRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKV-KFSEEQV 102

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           KF+I E+VLA+  +H    +H          RDIKPDN+LLD  GH+ + DF    ++  
Sbjct: 103 KFWICEIVLALEYLHSKGIIH----------RDIKPDNILLDEQGHVHITDFNIATKVTP 152

Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
           D    +    GTP Y++PE+L      R  Y    DWWSLGV  YE L G+ P+   S  
Sbjct: 153 D--TLTTSTSGTPGYMAPEVLC-----RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT 205

Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI-CSSDTRLGQNGIADFKMWSALFVS 295
                I   Q + D+     +  S +A D + +L+      RLG N + D K        
Sbjct: 206 IRDQ-IRAKQETADVLYPATW--STEAIDAINKLLERDPQKRLGDN-LKDLK-------- 253

Query: 296 LSISPRNHPWF 306
                 NHP+F
Sbjct: 254 ------NHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  170 bits (432), Expect = 6e-50
 Identities = 95/300 (31%), Positives = 156/300 (52%), Gaps = 46/300 (15%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           V  + +E+ +L+     +I N+  +FQD++ +Y ++++  GG+L T L K   R P D+A
Sbjct: 62  VQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRK-AGRFPNDVA 120

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           KFY AE+VLA   +H    ++R          D+KP+N+LLD  GH+++ DFG   ++  
Sbjct: 121 KFYHAELVLAFEYLHSKDIIYR----------DLKPENLLLDNKGHVKVTDFGFAKKV-- 168

Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
               ++    GTP+Y++PE++    + +G +G   DWW++GV +YE + G  PF+ ++  
Sbjct: 169 --PDRTFTLCGTPEYLAPEVI----QSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPF 221

Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT-RLG--QNGIADFKMWSALF 293
             Y KI+        P+         A+DL++ L+ +  T RLG  + G+AD K      
Sbjct: 222 RIYEKIL--AGRLKFPNWF----DGRARDLVKGLLQTDHTKRLGTLKGGVADVK------ 269

Query: 294 VSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFD-VDEAGVRASDALPPA 350
                   NHP+F G  WD +  R   AP    V SP DTS+F+   ++ V     L  A
Sbjct: 270 --------NHPYFHGANWDKLYARYYPAPIPVRVKSPGDTSNFEKYPDSPVDRLPPLTAA 321

Length = 329

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  167 bits (425), Expect = 1e-49
 Identities = 73/201 (36%), Positives = 111/201 (55%), Gaps = 21/201 (10%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L  AF+D  +LYLVM+Y  GGDL   LS+    L ED AK    +++  +  +H   
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR-GGPLSEDEAKKIALQILRGLEYLHSNG 118

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          D+KP+N+LLD NG +++ADFG   +L    +  +   VGTP Y++P
Sbjct: 119 IIHR----------DLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTF-VGTPWYMAP 167

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMNHQNSFDL 251
           E+L     G   YGP+ D WSLGV +YE+L G+ PF  E+++   +   +I+     FD 
Sbjct: 168 EVL----LGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDE 223

Query: 252 PSDVGYEISDDAKDLMRRLIC 272
           P       S++AKDL+++ + 
Sbjct: 224 PKW--SSGSEEAKDLIKKCLN 242

Length = 260

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  168 bits (427), Expect = 1e-49
 Identities = 92/279 (32%), Positives = 138/279 (49%), Gaps = 45/279 (16%)

Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE 122
           E+ VL      +I  L +   D   LY++M+Y  GG+L + L +   R       FY +E
Sbjct: 51  EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLFYASE 109

Query: 123 MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQS 182
           +V A+  +H    V+R          D+KP+N+LLD  GHI+L DFG   +L  D T   
Sbjct: 110 IVCALEYLHSKEIVYR----------DLKPENILLDKEGHIKLTDFGFAKKLR-DRTW-- 156

Query: 183 NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
               GTP+Y++PE++ +    +       DWW+LG+ +YEML G  PF+ ++    Y KI
Sbjct: 157 -TLCGTPEYLAPEVIQSKGHNKA-----VDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210

Query: 243 MNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT-RLG--QNGIADFKMWSALFVSLSIS 299
           +  +  F    D+       AKDL+++L+    T RLG  +NG  D K            
Sbjct: 211 LAGKLEFPRHLDLY------AKDLIKKLLVVDRTRRLGNMKNGADDVK------------ 252

Query: 300 PRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFDV 336
             NH WF+ + WD +  R    P +P+VS   DTS+FD 
Sbjct: 253 --NHRWFKSVDWDDVPQRKLKPPIVPKVSHDGDTSNFDD 289

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  168 bits (427), Expect = 2e-49
 Identities = 102/276 (36%), Positives = 144/276 (52%), Gaps = 40/276 (14%)

Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE 122
           ER VL   +  +I  L ++FQ    LYLV+ +  GG+L   L + E R     A+FY AE
Sbjct: 43  ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQR-EGRFDLSRARFYTAE 101

Query: 123 MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQS 182
           ++ A+ ++H  + ++R          D+KP+N+LLD  GHI L DFG C +L      ++
Sbjct: 102 LLCALENLHKFNVIYR----------DLKPENILLDYQGHIALCDFGLC-KLNMKDDDKT 150

Query: 183 NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
           N   GTP+Y++PE+L     G G Y    DWW+LGV +YEML G  PFY E++ E Y KI
Sbjct: 151 NTFCGTPEYLAPELLL----GHG-YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI 205

Query: 243 MNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT-RLGQNGIADFKMWSALFVSLSISPR 301
           +  Q     P         DAKDL+  L+    T RLG NG  + K              
Sbjct: 206 L--QEPLRFPDG----FDRDAKDLLIGLLSRDPTRRLGYNGAQEIK-------------- 245

Query: 302 NHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFD 335
           NHP+F  ++W  +  +    P+ P VSS  DTS+FD
Sbjct: 246 NHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFD 281

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  165 bits (419), Expect = 2e-48
 Identities = 93/290 (32%), Positives = 150/290 (51%), Gaps = 52/290 (17%)

Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE 122
           ERD+L + +  ++ ++  +F+   +L +VM+Y  GGD  TLL K    LP DMA+ Y AE
Sbjct: 51  ERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLL-KNIGALPVDMARMYFAE 109

Query: 123 MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQS 182
            VLA+  +H+   VHR          D+KPDN+L+ + GHI+L DFG  L   G  ++ +
Sbjct: 110 TVLALEYLHNYGIVHR----------DLKPDNLLITSMGHIKLTDFG--LSKIGLMSLTT 157

Query: 183 NVA----------------VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYG 226
           N+                  GTP+YI+PE++      R  YG   DWW++G+ +YE L G
Sbjct: 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL-----RQGYGKPVDWWAMGIILYEFLVG 212

Query: 227 ETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT-RLGQNGIAD 285
             PF+ ++  E +G++++    +    +    +  DA+DL+ RL+  +   RLG  G  +
Sbjct: 213 CVPFFGDTPEELFGQVISDDIEWPEGDEA---LPADAQDLISRLLRQNPLERLGTGGAFE 269

Query: 286 FKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFD 335
            K               H +F G+ W+ +    A +IP++ S  DTS+FD
Sbjct: 270 VK--------------QHRFFLGLDWNGLLRQKAEFIPQLESEDDTSYFD 305

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  164 bits (416), Expect = 8e-48
 Identities = 108/312 (34%), Positives = 156/312 (50%), Gaps = 47/312 (15%)

Query: 63  ERDVLVYGDRR-WITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA 121
           ER VL       ++T+L   FQ   +L+ VM+Y  GGDL+  +     R  E  A+FY A
Sbjct: 45  ERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQS-SGRFDEARARFYAA 103

Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSC-LRLGGDGTV 180
           E++  +  +H    ++R          D+K DNVLLD +GHI++ADFG C   + G+G  
Sbjct: 104 EIICGLQFLHKKGIIYR----------DLKLDNVLLDKDGHIKIADFGMCKENMNGEGK- 152

Query: 181 QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 240
            ++   GTPDYI+PEIL        +Y    DWWS GV +YEML G++PF+ E   E + 
Sbjct: 153 -ASTFCGTPDYIAPEILKGQ-----KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD 206

Query: 241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLGQNGIADFKMWSALFVSLSIS 299
            I+N     D P    + IS +AKD + +L       RLG +G                 
Sbjct: 207 SILN-----DRPHFPRW-ISKEAKDCLSKLFERDPTKRLGVDG----------------D 244

Query: 300 PRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALS 357
            R HP+F+GI W+ +  R+   P+ P+V SP+D S+FD +    +    L P       S
Sbjct: 245 IRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNFDREFTNEKV--RLSPVDKKLLAS 302

Query: 358 ALHLPFVGFTFT 369
                F GF+FT
Sbjct: 303 MDQEQFRGFSFT 314

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  162 bits (413), Expect = 3e-47
 Identities = 99/315 (31%), Positives = 146/315 (46%), Gaps = 46/315 (14%)

Query: 62  EERDVLVYGDRR--WITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFY 119
           E+R        R  ++ NL   FQ + ++  VM+Y  GGDL+  +    D   E  A FY
Sbjct: 49  EKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH--TDVFSEPRAVFY 106

Query: 120 IAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT 179
            A +VL +  +H+   V+R          D+K DN+LLD  G +++ADFG C    G G 
Sbjct: 107 AACVVLGLQYLHENKIVYR----------DLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156

Query: 180 VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 239
             S    GTP++++PE+LT        Y    DWW LGV +YEML GE+PF  +   E +
Sbjct: 157 RTSTFC-GTPEFLAPEVLT-----ETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF 210

Query: 240 GKIMNHQNSFDLPSDVGYEI--SDDAKDLMRRLICSS-DTRLGQNGIADFKMWSALFVSL 296
             I+N         +V Y    S +A  +MRRL+  + + RLG +G  D +         
Sbjct: 211 DSIVN--------DEVRYPRFLSREAISIMRRLLRRNPERRLG-SGEKDAE--------- 252

Query: 297 SISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASP 354
               +  P+F+ I WD +  R    P++P +  P D S+FD +E    A    PP     
Sbjct: 253 --DVKKQPFFRDINWDDLLARKIKPPFVPTIKGPEDVSNFD-EEFTSEAPVLTPPREPRL 309

Query: 355 ALSALHLPFVGFTFT 369
                   F GF + 
Sbjct: 310 LTEEEQELFRGFDYV 324

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  162 bits (411), Expect = 5e-47
 Identities = 94/283 (33%), Positives = 147/283 (51%), Gaps = 40/283 (14%)

Query: 60  LREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFY 119
           + E+R + +     ++T LH  FQ    L+ VM+Y  GGDL+  + +   +  E  ++FY
Sbjct: 43  MTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQR-SRKFDEPRSRFY 101

Query: 120 IAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT 179
            AE+ LA      L ++HR  H   +  RD+K DN+LLDA GH +LADFG C + G    
Sbjct: 102 AAEVTLA------LMFLHR--HGVIY--RDLKLDNILLDAEGHCKLADFGMC-KEGILNG 150

Query: 180 VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 239
           V +    GTPDYI+PEIL  +E     YGP  DWW+LGV MYEM+ G+ PF A++  + +
Sbjct: 151 VTTTTFCGTPDYIAPEILQELE-----YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF 205

Query: 240 GKIMNHQNSFDLPSDVGYEI--SDDAKDLMRRLICSS-DTRLGQNGIADFKMWSALFVSL 296
             I++         DV Y +  S +A  +++  +  + + RLG                 
Sbjct: 206 ESILH--------DDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQ----------GG 247

Query: 297 SISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFDVD 337
             + + HP+F+ I W  +  R    P+ P++ +  D ++FD D
Sbjct: 248 EDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQD 290

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  160 bits (407), Expect = 2e-46
 Identities = 100/333 (30%), Positives = 165/333 (49%), Gaps = 53/333 (15%)

Query: 44  LRREKTVSDFIEFVAKLREERDVLVY-GDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLT 102
           +++ KTV          R ER+VL +     ++  LHYAFQ ++ L+L++DY  GG++ T
Sbjct: 42  VQKAKTVE-------HTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFT 94

Query: 103 LLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH 162
            L +  D   ED  +FY  E++LA+  +H L  V+R          DIK +N+LLD+ GH
Sbjct: 95  HLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYR----------DIKLENILLDSEGH 143

Query: 163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYE 222
           + L DFG       +   ++    GT +Y++PEI+     G+G +G   DWWSLG+ ++E
Sbjct: 144 VVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII----RGKGGHGKAVDWWSLGILIFE 199

Query: 223 MLYGETPFYAE----SLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTR 277
           +L G +PF  E    +  E   +I+     F  PS +G E    A+DL+ +L+      R
Sbjct: 200 LLTGASPFTLEGERNTQSEVSRRILKCDPPF--PSFIGPE----AQDLLHKLLRKDPKKR 253

Query: 278 LGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWD--SIRDSNAPYIPEVSSPTDTSHFD 335
           LG       ++            + HP+F+G+ W+  ++R  N P+ P + +  D  +F 
Sbjct: 254 LGAGPQGASEI------------KEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNF- 300

Query: 336 VDEAGVRASDALPPAAASPALSALHLPFVGFTF 368
             E          PA   P+ + +   F G++F
Sbjct: 301 -AEEFTNLEPVYSPAGTPPSGARV---FQGYSF 329

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  160 bits (406), Expect = 3e-46
 Identities = 105/313 (33%), Positives = 156/313 (49%), Gaps = 41/313 (13%)

Query: 63  ERDVLVYGDRR-WITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA 121
           ER+VL+   +  ++  LHY+FQ    LY V+DY  GG+L   L + E    E  A+FY A
Sbjct: 45  ERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQR-ERCFLEPRARFYAA 103

Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ 181
           E+  AI  +H L+ ++R          D+KP+N+LLD+ GH+ L DFG C + G +    
Sbjct: 104 EVASAIGYLHSLNIIYR----------DLKPENILLDSQGHVVLTDFGLC-KEGVEPEET 152

Query: 182 SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 241
           ++   GTP+Y++PE+L      +  Y    DWW LG  +YEMLYG  PFY+  + + Y  
Sbjct: 153 TSTFCGTPEYLAPEVLR-----KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDN 207

Query: 242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPR 301
           I++      LP       +  A DL+  L+   D R      ADF         L I  +
Sbjct: 208 ILHKP--LQLPGGK----TVAACDLLVGLL-HKDQRRRLGAKADF---------LEI--K 249

Query: 302 NHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFDVD--EAGVRASDALPPAAASPALS 357
           NH +F  I WD +  +    PY P V+ P D  HFD +  +  V +S    P   + + S
Sbjct: 250 NHVFFSPINWDDLYHKRITPPYNPNVAGPADLRHFDPEFTQEAVSSSVGQTPDLTASSSS 309

Query: 358 ALHLPFVGFTFTQ 370
           A    F+GF++  
Sbjct: 310 ASS-AFLGFSYAP 321

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  155 bits (392), Expect = 3e-44
 Identities = 107/319 (33%), Positives = 157/319 (49%), Gaps = 54/319 (16%)

Query: 63  ERDVLVYGDRR-WITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA 121
           ER+VL+   +  ++  LH++FQ    LY V+DY  GG+L   L + E    E  A+FY A
Sbjct: 45  ERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR-ERCFLEPRARFYAA 103

Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR-LGGDGTV 180
           E+  A+  +H L+ V+R          D+KP+N+LLD+ GHI L DFG C   +  +GT 
Sbjct: 104 EIASALGYLHSLNIVYR----------DLKPENILLDSQGHIVLTDFGLCKENIEHNGT- 152

Query: 181 QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 240
            ++   GTP+Y++PE+L      +  Y    DWW LG  +YEMLYG  PFY+ +  E Y 
Sbjct: 153 -TSTFCGTPEYLAPEVLH-----KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 206

Query: 241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT-RLGQNGIADFKMWSALFVSLSIS 299
            I+N       P  +   I++ A+ L+  L+    T RLG     DF           + 
Sbjct: 207 NILNK------PLQLKPNITNSARHLLEGLLQKDRTKRLGAKD--DF-----------ME 247

Query: 300 PRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFD---VDEA-----GVRASDALPP 349
            +NH +F  I WD +  +    P+ P VS P D  HFD    +E      G      L  
Sbjct: 248 IKNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNSIGQSPDSILVT 307

Query: 350 AAASPALSALHLPFVGFTF 368
           A+   A  A    F+GF++
Sbjct: 308 ASVKEAAEA----FLGFSY 322

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  153 bits (388), Expect = 1e-43
 Identities = 93/282 (32%), Positives = 140/282 (49%), Gaps = 35/282 (12%)

Query: 58  AKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAK 117
             + E+R + +  +  ++T L+  FQ    L+ VM++  GGDL+  + K   R  E  A+
Sbjct: 41  CTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEARAR 99

Query: 118 FYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD 177
           FY AE+  A+  +HD   ++R          D+K DNVLLD  GH +LADFG C     +
Sbjct: 100 FYAAEITSALMFLHDKGIIYR----------DLKLDNVLLDHEGHCKLADFGMCKEGIFN 149

Query: 178 GTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 237
           G   S    GTPDYI+PEIL  M      YGP  DWW++GV +YEML G  PF AE+  +
Sbjct: 150 GKTTSTFC-GTPDYIAPEILQEML-----YGPSVDWWAMGVLLYEMLCGHAPFEAENEDD 203

Query: 238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLS 297
            +  I+N +  +  P+ +  +  D  K  M +   +   RLG   +   +          
Sbjct: 204 LFEAILNDEVVY--PTWLSQDAVDILKAFMTK---NPTMRLGSLTLGGEEAILR------ 252

Query: 298 ISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFDVD 337
                HP+F+ + W+ +  R    P+ P + S  D S+FD D
Sbjct: 253 -----HPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNFDPD 289

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  153 bits (387), Expect = 2e-43
 Identities = 100/317 (31%), Positives = 141/317 (44%), Gaps = 53/317 (16%)

Query: 63  ERDVLVYGDR-RWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA 121
           E+ VL    +  ++T LH  FQ    LY VM+Y  GGDL+  + +   +  E  A FY A
Sbjct: 50  EKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GKFKEPHAVFYAA 108

Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR--LGGDGT 179
           E+ + +  +H    ++R          D+K DNV+LDA GHI++ADFG C     GG  T
Sbjct: 109 EIAIGLFFLHSKGIIYR----------DLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT 158

Query: 180 VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 239
                  GTPDYI+PEI+         YG   DWW+ GV +YEML G+ PF  E   E +
Sbjct: 159 ---RTFCGTPDYIAPEIIAYQP-----YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF 210

Query: 240 GKIMNHQNSFDLPSDVGYEISDDAKDLM-----RRLICSSDTRLGQNGIADFKMWSALFV 294
             IM H  S+  P  +  E     K L+     +RL C      G+  I           
Sbjct: 211 QSIMEHNVSY--PKSLSKEAVSICKGLLTKHPAKRLGCGPT---GERDI----------- 254

Query: 295 SLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAA 352
                 R H +F+ I W+ +  R+   P+ P+V       +F  D+   R    L P   
Sbjct: 255 ------REHAFFRRIDWEKLERREIQPPFKPKVKGRRSAENF--DKFFTREPPVLTPPDK 306

Query: 353 SPALSALHLPFVGFTFT 369
               +     F GF+F 
Sbjct: 307 LVIANIDQSEFQGFSFV 323

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  150 bits (380), Expect = 2e-42
 Identities = 91/280 (32%), Positives = 138/280 (49%), Gaps = 46/280 (16%)

Query: 63  ERDVLVYGDRR-WITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA 121
           ER+VL+   +  ++  LHY+FQ    LY V+D+  GG+L   L + E   PE  A+FY A
Sbjct: 45  ERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQR-ERSFPEPRARFYAA 103

Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ 181
           E+  A+  +H ++ V+R          D+KP+N+LLD+ GH+ L DFG C     +G  Q
Sbjct: 104 EIASALGYLHSINIVYR----------DLKPENILLDSQGHVVLTDFGLC----KEGIAQ 149

Query: 182 SNVAV---GTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 238
           S+      GTP+Y++PE++      +  Y    DWW LG  +YEMLYG  PFY   + E 
Sbjct: 150 SDTTTTFCGTPEYLAPEVIR-----KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM 204

Query: 239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT-RLGQNGIADFKMWSALFVSLS 297
           Y  I++       P  +    S  A  ++  L+      RLG     DF           
Sbjct: 205 YDNILHK------PLVLRPGASLTAWSILEELLEKDRQRRLGAK--EDF----------- 245

Query: 298 ISPRNHPWFQGIAWDSIRDSN--APYIPEVSSPTDTSHFD 335
           +  + HP+F+ ++W  +       P+ P V  P D S+FD
Sbjct: 246 LEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFD 285

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  149 bits (379), Expect = 2e-42
 Identities = 96/282 (34%), Positives = 135/282 (47%), Gaps = 38/282 (13%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           VA    E  VL      ++T L Y+FQ    L  VM+Y  GG+L   LS+ E    ED A
Sbjct: 39  VAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRA 97

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FY AE+V A+  +H    V+R          D+K +N++LD +GHI++ DFG C     
Sbjct: 98  RFYGAEIVSALGYLHSCDVVYR----------DLKLENLMLDKDGHIKITDFGLCKEGIS 147

Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
           DG        GTP+Y++PE+L   +     YG   DWW LGV MYEM+ G  PFY +   
Sbjct: 148 DGATMKTFC-GTPEYLAPEVLEDND-----YGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 201

Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT-RLGQNGIADFKMWSALFVS 295
           + +  I+  +  F  P      +S +AK L+  L+      RLG  G  D K        
Sbjct: 202 KLFELILMEEIRF--PR----TLSPEAKSLLAGLLKKDPKQRLG-GGPEDAKEIME---- 250

Query: 296 LSISPRNHPWFQGIAWDSIRDSN--APYIPEVSSPTDTSHFD 335
                  H +F  I W  +       P+ P+V+S TDT +FD
Sbjct: 251 -------HRFFASINWQDVVQKKLEPPFKPQVTSETDTRYFD 285

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  144 bits (366), Expect = 1e-41
 Identities = 56/150 (37%), Positives = 85/150 (56%), Gaps = 16/150 (10%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L+  F+D+++LYLVM+Y  GG L  LL + E +L ED     + +++  +  +H   
Sbjct: 53  IVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG 112

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDA-NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYIS 193
            +H          RD+KP+N+LLD+ NG ++LADFG   +L           VGTP Y++
Sbjct: 113 IIH----------RDLKPENILLDSDNGKVKLADFGLS-KLLTSDKSLLKTIVGTPAYMA 161

Query: 194 PEILTAMEEGRGRYGPECDWWSLGVCMYEM 223
           PE+L     G+G Y  + D WSLGV +YE+
Sbjct: 162 PEVL----LGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  147 bits (372), Expect = 2e-41
 Identities = 94/280 (33%), Positives = 144/280 (51%), Gaps = 48/280 (17%)

Query: 62  EERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLS---KFEDRLPEDMAKF 118
           E+R + +  +  ++T+L+  FQ   NL+ VM+Y  GGDL+  +    KF+  LP   A F
Sbjct: 45  EKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFD--LPR--ATF 100

Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
           Y AE++  +  +H    V+R          D+K DN+LLD +GHI++ADFG C +    G
Sbjct: 101 YAAEIICGLQFLHSKGIVYR----------DLKLDNILLDTDGHIKIADFGMC-KENMLG 149

Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 238
             ++    GTPDYI+PEIL        +Y    DWWS GV +YEML G++PF+     E 
Sbjct: 150 DAKTCTFCGTPDYIAPEILLGQ-----KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL 204

Query: 239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRL-ICSSDTRLGQNGIADFKMWSALFVSLS 297
           +  I       D P    + ++ +AKD++ +L +   + RLG  G               
Sbjct: 205 FQSI-----RMDNPCYPRW-LTREAKDILVKLFVREPERRLGVKG--------------- 243

Query: 298 ISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFD 335
              R HP+F+ I W ++  R+   P+ P+V S  D S+FD
Sbjct: 244 -DIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFD 282

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  145 bits (366), Expect = 3e-40
 Identities = 91/278 (32%), Positives = 141/278 (50%), Gaps = 45/278 (16%)

Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE 122
           ER +L Y +  +  NL+ +F+D+S LYLV+++  GG+  T L +   R P D+  FY A+
Sbjct: 81  ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQ 139

Query: 123 MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQS 182
           +VL    +  L+ V+R          D+KP+N+LLD +G I++ DFG    +      ++
Sbjct: 140 IVLIFEYLQSLNIVYR----------DLKPENLLLDKDGFIKMTDFGFAKVV----DTRT 185

Query: 183 NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
               GTP+YI+PEIL  +  G+       DWW+LG+ +YE+L G  PFYA   +  Y KI
Sbjct: 186 YTLCGTPEYIAPEILLNVGHGKA-----ADWWTLGIFIYEILVGCPPFYANEPLLIYQKI 240

Query: 243 MNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT-RLG--QNGIADFKMWSALFVSLSIS 299
           +     F    D      ++ K LM++L+    T R G  + G  + K            
Sbjct: 241 LEGIIYFPKFLD------NNCKHLMKKLLSHDLTKRYGNLKKGAQNVK------------ 282

Query: 300 PRNHPWFQGIAWDSIRDSN--APYIPEVSSPTDTSHFD 335
              HPWF  I W S+   N   PY P+  +  D+S+F+
Sbjct: 283 --EHPWFGNIDWVSLLHKNVEVPYKPKYKNVFDSSNFE 318

Length = 340

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  142 bits (359), Expect = 2e-39
 Identities = 101/328 (30%), Positives = 166/328 (50%), Gaps = 61/328 (18%)

Query: 12  LGGPIQGKGRVFSIETLL-DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG 70
           L   ++GKG  F+++ L  D++L+  D  C                   + E+R + +  
Sbjct: 12  LLAELKGKGEYFAVKALKKDVVLIDDDVECT------------------MVEKRVLALAW 53

Query: 71  DRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASI 130
           +  ++T+L+  FQ   +L+ VM++  GGDL+  +   + R     A FY AE+V  +  +
Sbjct: 54  ENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFL 112

Query: 131 HDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
           H    ++R          D+K DNV+LD +GHI++ADFG C +    G  +++   GTPD
Sbjct: 113 HSKGIIYR----------DLKLDNVMLDRDGHIKIADFGMC-KENVFGDNRASTFCGTPD 161

Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD 250
           YI+PEIL  +     +Y    DWWS GV +YEML G++PF+ +   E +  I       D
Sbjct: 162 YIAPEILQGL-----KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI-----RVD 211

Query: 251 LPSDVGYEISDDAKDLMRRLICSSDT-RLGQNGIADFKMWSALFVSLSISPRNHPWFQGI 309
            P    + I+ ++KD++ +L     T RLG  G                + R HP+F+ I
Sbjct: 212 TPHYPRW-ITKESKDILEKLFERDPTRRLGVVG----------------NIRGHPFFKTI 254

Query: 310 AWDSI--RDSNAPYIPEVSSPTDTSHFD 335
            W ++  R+ + P+ P+V SP+D S+FD
Sbjct: 255 NWTALEKRELDPPFKPKVKSPSDYSNFD 282

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  141 bits (357), Expect = 2e-39
 Identities = 93/271 (34%), Positives = 142/271 (52%), Gaps = 40/271 (14%)

Query: 61  REERDVLVYGDRR-WITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFY 119
           R ER VL +  +  ++  LHYAFQ D+ L+L++DY  GG+L T LS+ E R  E   + Y
Sbjct: 52  RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE-RFKEQEVQIY 110

Query: 120 IAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT 179
             E+VLA+  +H L  ++R          DIK +N+LLD+NGH+ L DFG       D  
Sbjct: 111 SGEIVLALEHLHKLGIIYR----------DIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160

Query: 180 VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE----SL 235
            ++    GT +Y++P+I+   + G  +     DWWS+GV MYE+L G +PF  +    S 
Sbjct: 161 ERAYSFCGTIEYMAPDIVRGGDGGHDK---AVDWWSMGVLMYELLTGASPFTVDGEKNSQ 217

Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLGQNGIADFKMWSALFV 294
            E   +I+  +  +  P     E+S  AKD+++RL+      RLG  G +D         
Sbjct: 218 AEISRRILKSEPPY--PQ----EMSALAKDIIQRLLMKDPKKRLG-CGPSD--------- 261

Query: 295 SLSISPRNHPWFQGIAWDSI--RDSNAPYIP 323
             +   + HP+FQ I WD +  +   AP+ P
Sbjct: 262 --ADEIKKHPFFQKINWDDLAAKKVPAPFKP 290

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  141 bits (358), Expect = 3e-39
 Identities = 91/276 (32%), Positives = 133/276 (48%), Gaps = 50/276 (18%)

Query: 74  WITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDL 133
           ++  LH  FQ +S L+ V+++  GGDL+  + + + +LPE+ A+FY AE+ LA      L
Sbjct: 57  FLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQR-QRKLPEEHARFYSAEISLA------L 109

Query: 134 HYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYIS 193
           +++H        + RD+K DNVLLDA GHI+L D+G C      G   S    GTP+YI+
Sbjct: 110 NFLHERGI----IYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC-GTPNYIA 164

Query: 194 PEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF-------YAESLVETYGKIMNHQ 246
           PEIL   +     YG   DWW+LGV M+EM+ G +PF         +   E Y   +  +
Sbjct: 165 PEILRGED-----YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE 219

Query: 247 NSFDLPSDVGYEISDDA-----KDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPR 301
               +P  +  + S        KD   RL C   T     G  D K              
Sbjct: 220 KQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQT-----GFRDIK-------------- 260

Query: 302 NHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFD 335
           +HP+F+ I WD +  +    PY P + S  D  +FD
Sbjct: 261 SHPFFRNIDWDLLEQKQVLPPYKPNIESDRDLDNFD 296

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  141 bits (356), Expect = 4e-39
 Identities = 100/315 (31%), Positives = 144/315 (45%), Gaps = 49/315 (15%)

Query: 62  EERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA 121
           E+R + + G   ++T LH  FQ    LY VM+Y  GGDL+  + +   R  E  A FY A
Sbjct: 50  EKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAA 108

Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ 181
           E+ + +  +H    ++R          D+K DNV+LD+ GHI++ADFG C     DG V 
Sbjct: 109 EIAIGLFFLHSKGIIYR----------DLKLDNVMLDSEGHIKIADFGMCKENMWDG-VT 157

Query: 182 SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 241
           +    GTPDYI+PEI+         YG   DWW+ GV +YEML G+ PF  E   E +  
Sbjct: 158 TKTFCGTPDYIAPEIIAYQP-----YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS 212

Query: 242 IMNHQNSFDLPSDVGYEISDDAKDLM-----RRLICSSDTRLGQNGIADFKMWSALFVSL 296
           IM H  ++  P  +  E     K LM     +RL C      G  G  D K         
Sbjct: 213 IMEHNVAY--PKSMSKEAVAICKGLMTKHPGKRLGC------GPEGERDIK--------- 255

Query: 297 SISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASP 354
                 H +F+ I W+ +  ++   PY P  +   D  +F  D+   R    L P     
Sbjct: 256 -----EHAFFRYIDWEKLERKEVQPPYKP-KACGRDAENF--DKFFTRHPPVLTPPDQEV 307

Query: 355 ALSALHLPFVGFTFT 369
            ++     F GF++ 
Sbjct: 308 IMNLDQSEFEGFSYV 322

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  137 bits (348), Expect = 2e-38
 Identities = 67/230 (29%), Positives = 111/230 (48%), Gaps = 36/230 (15%)

Query: 42  SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLL 101
            +L RE      I  ++ L+    V  YG  R          + + L + ++Y  GG L 
Sbjct: 44  EALERE------IRILSSLQHPNIVRYYGSER--DE------EKNTLNIFLEYVSGGSLS 89

Query: 102 TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG 161
           +LL KF  +LPE + + Y  +++  +A +H    VHR          DIK  N+L+D++G
Sbjct: 90  SLLKKF-GKLPEPVIRKYTRQILEGLAYLHSNGIVHR----------DIKGANILVDSDG 138

Query: 162 HIRLADFGSCLRLG-GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCM 220
            ++LADFG   RLG  +    +    GTP +++PE++   E     YG   D WSLG  +
Sbjct: 139 VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE-----YGRAADIWSLGCTV 193

Query: 221 YEMLYGETPFYA-ESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRR 269
            EM  G+ P+    + +    KI +     ++P      +S++AKD +R+
Sbjct: 194 IEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEH----LSEEAKDFLRK 239

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  138 bits (350), Expect = 3e-38
 Identities = 103/309 (33%), Positives = 148/309 (47%), Gaps = 41/309 (13%)

Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTL 103
           LR+E  ++   + VA    E  VL      ++T L YAFQ    L  VM+Y  GG+L   
Sbjct: 28  LRKEVIIAK--DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFH 85

Query: 104 LSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI 163
           LS+ E    E+ A+FY AE+V A+  +H    V+R          DIK +N++LD +GHI
Sbjct: 86  LSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYR----------DIKLENLMLDKDGHI 134

Query: 164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM 223
           ++ DFG C     DG        GTP+Y++PE+L   +     YG   DWW LGV MYEM
Sbjct: 135 KITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDND-----YGRAVDWWGLGVVMYEM 188

Query: 224 LYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLGQNG 282
           + G  PFY +     +  I+  +  F  P      +S +AK L+  L+      RLG  G
Sbjct: 189 MCGRLPFYNQDHERLFELILMEEIRF--PRT----LSPEAKSLLAGLLKKDPKQRLG-GG 241

Query: 283 IADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFDVDEAG 340
            +D K               H +F  I W  +  +    P+ P+V+S  DT +FD DE  
Sbjct: 242 PSDAK-----------EVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD-DEFT 289

Query: 341 VRASDALPP 349
            ++    PP
Sbjct: 290 AQSITITPP 298

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  137 bits (347), Expect = 9e-38
 Identities = 94/271 (34%), Positives = 130/271 (47%), Gaps = 47/271 (17%)

Query: 63  ERDVLVYGDRR-WITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA 121
           E+ VL   D+  ++T LH  FQ    LY VM+Y  GGDL+  + +   +  E  A FY A
Sbjct: 50  EKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAA 108

Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ 181
           E+ + +  +H    ++R          D+K DNV+LD+ GHI++ADFG C     DG V 
Sbjct: 109 EISVGLFFLHRRGIIYR----------DLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VT 157

Query: 182 SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 241
           +    GTPDYI+PEI+         YG   DWW+ GV +YEML G+ PF  E   E +  
Sbjct: 158 TRTFCGTPDYIAPEIIAYQP-----YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS 212

Query: 242 IMNHQNSFDLPSDVGYEISDDAKDLM-----RRLICSSDTRLGQNGIADFKMWSALFVSL 296
           IM H  S+  P  +  E     K LM     +RL C      G  G  D           
Sbjct: 213 IMEHNVSY--PKSLSKEAVSICKGLMTKHPSKRLGC------GPEGERDI---------- 254

Query: 297 SISPRNHPWFQGIAWDSI--RDSNAPYIPEV 325
               R H +F+ I WD +  R+   P+ P+V
Sbjct: 255 ----REHAFFRRIDWDKLENREIQPPFKPKV 281

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  136 bits (344), Expect = 3e-37
 Identities = 101/300 (33%), Positives = 145/300 (48%), Gaps = 47/300 (15%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           VA    E  VL      ++T+L Y+FQ    L  VM+Y  GG+L   LS+ E    ED  
Sbjct: 39  VAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSR-ERVFSEDRT 97

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FY AE+V A+  +H    V+R          D+K +N++LD +GHI++ DFG C + G 
Sbjct: 98  RFYGAEIVSALDYLHSGKIVYR----------DLKLENLMLDKDGHIKITDFGLC-KEGI 146

Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
                     GTP+Y++PE+L   + GR       DWW LGV MYEM+ G  PFY +   
Sbjct: 147 TDAATMKTFCGTPEYLAPEVLEDNDYGRA-----VDWWGLGVVMYEMMCGRLPFYNQ--- 198

Query: 237 ETYGKIMNHQNSFD--LPSDVGY--EISDDAKDLMR-RLICSSDTRLGQNGIADFKMWSA 291
                  +H+  F+  L  D+ +   +S DAK L+   LI   + RLG  G  D K    
Sbjct: 199 -------DHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLG-GGPDDAK---- 246

Query: 292 LFVSLSISPRNHPWFQGIAWDSIRDSN--APYIPEVSSPTDTSHFDVDEAGVRASDALPP 349
                      H +F G+ W  + D     P+ P+V+S TDT +FD +E   +     PP
Sbjct: 247 -------EIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTRYFD-EEFTAQTITITPP 298

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  135 bits (340), Expect = 9e-37
 Identities = 101/308 (32%), Positives = 147/308 (47%), Gaps = 38/308 (12%)

Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTL 103
           L++E  V+   + VA    E  VL      ++T L Y+FQ    L  VM+Y  GG+L   
Sbjct: 28  LKKEVIVAK--DEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFH 85

Query: 104 LSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI 163
           LS+ E    ED A+FY AE+V A      L Y+H   +  +   RD+K +N++LD +GHI
Sbjct: 86  LSR-ERVFSEDRARFYGAEIVSA------LDYLHSEKNVVY---RDLKLENLMLDKDGHI 135

Query: 164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM 223
           ++ DFG C     DG        GTP+Y++PE+L   +     YG   DWW LGV MYEM
Sbjct: 136 KITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDND-----YGRAVDWWGLGVVMYEM 189

Query: 224 LYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGI 283
           + G  PFY +   + +  I+  +  F  P  +  E    AK L+  L+     +    G 
Sbjct: 190 MCGRLPFYNQDHEKLFELILMEEIRF--PRTLSPE----AKSLLSGLLKKDPKQRLGGGP 243

Query: 284 ADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSN--APYIPEVSSPTDTSHFDVDEAGV 341
            D K               H +F GI W  + +     P+ P+V+S TDT +FD +E   
Sbjct: 244 DDAK-----------EIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDTRYFD-EEFTA 291

Query: 342 RASDALPP 349
           +     PP
Sbjct: 292 QMITITPP 299

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  134 bits (337), Expect = 7e-36
 Identities = 85/347 (24%), Positives = 138/347 (39%), Gaps = 38/347 (10%)

Query: 48  KTVSDFIEFVAKLREERDVLVY-GDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSK 106
           K +    + V +   E  +L        I  L+  FQD+ +LYLVM+Y  GG L  LL K
Sbjct: 32  KKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKK 91

Query: 107 --FEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH-I 163
              +  L E  A F +A+++ A+  +H    +HR          DIKP+N+LLD +G  +
Sbjct: 92  IGRKGPLSESEALFILAQILSALEYLHSKGIIHR----------DIKPENILLDRDGRVV 141

Query: 164 RLADFGSCLRLGGDGT-----VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGV 218
           +L DFG    L   G+        + +VGTP Y++PE+L  +           D WSLG+
Sbjct: 142 KLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAY--ASSSSDIWSLGI 199

Query: 219 CMYEMLYGETPFYAESLVETYGKIMNH-------QNSFDLPSDVGYEISDDAKDLMRRLI 271
            +YE+L G  PF  E       + +           +  L       IS  A DL+++L+
Sbjct: 200 TLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLL 259

Query: 272 CSS-DTRLGQNGIADFKMWSALFVSLSI-----SPRNHPWFQGIAWDSIRDSNAPYIPEV 325
                 RL     +   +   L   L +     S    P        S+  S    I  +
Sbjct: 260 AKDPKNRLS----SSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSL 315

Query: 326 SSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQGW 372
           +S   +      +    + +  P   +S   ++  L     +  +  
Sbjct: 316 NSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLLLSTASSKRSS 362

Length = 384

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  132 bits (334), Expect = 8e-36
 Identities = 88/272 (32%), Positives = 136/272 (50%), Gaps = 44/272 (16%)

Query: 74  WITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDL 133
           ++  LH  FQ  S L+LV++Y  GGDL+  + + + +LPE+ A+FY AE+ +A+  +H+ 
Sbjct: 57  FLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHER 115

Query: 134 HYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYIS 193
             ++R          D+K DNVLLDA+GHI+L D+G C    G G   S    GTP+YI+
Sbjct: 116 GIIYR----------DLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC-GTPNYIA 164

Query: 194 PEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF-----YAESLVETYGKIMNHQNS 248
           PEIL   E     YG   DWW+LGV M+EM+ G +PF       +   E Y   +  +  
Sbjct: 165 PEILRGEE-----YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP 219

Query: 249 FDLPSDVGYEISDDAKDLMRRLICSSDTRLG---QNGIADFKMWSALFVSLSISPRNHPW 305
             +P  +  + S   K  + +       RLG   Q G +D K              +H +
Sbjct: 220 IRIPRFLSVKASHVLKGFLNK---DPKERLGCQPQTGFSDIK--------------SHTF 262

Query: 306 FQGIAWDSI--RDSNAPYIPEVSSPTDTSHFD 335
           F+ I WD +  +    P+ P+++      +FD
Sbjct: 263 FRSIDWDLLEKKQVTPPFKPQITDDYGLENFD 294

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  129 bits (325), Expect = 2e-34
 Identities = 88/278 (31%), Positives = 136/278 (48%), Gaps = 54/278 (19%)

Query: 74  WITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDL 133
           ++  LH  FQ +S L+ V++Y  GGDL+  + + + +LPE+ A+FY AE+ LA+  +H+ 
Sbjct: 57  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHER 115

Query: 134 HYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSC---LRLGGDGTVQSNVAVGTPD 190
             ++R          D+K DNVLLD+ GHI+L D+G C   LR G      ++   GTP+
Sbjct: 116 GIIYR----------DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD----TTSTFCGTPN 161

Query: 191 YISPEILTAMEEGRGR-YGPECDWWSLGVCMYEMLYGETPF-------YAESLVETYGKI 242
           YI+PEIL      RG  YG   DWW+LGV M+EM+ G +PF         +   E Y   
Sbjct: 162 YIAPEIL------RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 215

Query: 243 MNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLG---QNGIADFKMWSALFVSLSIS 299
           +  +    +P  +  + +   K  + +       RLG   Q G AD +            
Sbjct: 216 VILEKQIRIPRSLSVKAASVLKSFLNK---DPKERLGCHPQTGFADIQ------------ 260

Query: 300 PRNHPWFQGIAWDSIRDSNA--PYIPEVSSPTDTSHFD 335
              HP+F+ + WD +       P+ P +S      +FD
Sbjct: 261 --GHPFFRNVDWDLMEQKQVVPPFKPNISGEFGLDNFD 296

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  124 bits (315), Expect = 2e-33
 Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 24/199 (12%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR---LPEDMAKFYIAEMVLAIASIH 131
           I   + +F++   L +VM+Y  GGDL   + K +      PE+    +  ++ LA+  +H
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120

Query: 132 DLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDY 191
               +HR          DIKP N+ L +NG ++L DFG    L     +   V VGTP Y
Sbjct: 121 SRKILHR----------DIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV-VGTPYY 169

Query: 192 ISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDL 251
           +SPE+     + +  Y  + D WSLG  +YE+   + PF  E+L+E   KI+  Q    +
Sbjct: 170 LSPELC----QNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYP-PI 223

Query: 252 PSDVGYEISDDAKDLMRRL 270
           PS   Y  S + ++L+  L
Sbjct: 224 PS--QY--SSELRNLVSSL 238

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  124 bits (313), Expect = 4e-33
 Identities = 75/256 (29%), Positives = 118/256 (46%), Gaps = 43/256 (16%)

Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-LPEDMAKFYIA 121
           E+ +L     R+I +L YAF+   +L LVM    GGDL   +    +   PE  A FY A
Sbjct: 43  EKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA 102

Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG-SCLRLGGDGTV 180
           +++  +  +H    V+R          D+KP+NVLLD +G++R++D G +    GG    
Sbjct: 103 QIICGLEHLHQRRIVYR----------DLKPENVLLDDHGNVRISDLGLAVELKGGKKIK 152

Query: 181 QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 240
                 GTP Y++PE+L         Y    DW++LG  +YEM+ G +PF          
Sbjct: 153 GR---AGTPGYMAPEVLQ-----GEVYDFSVDWFALGCTLYEMIAGRSPFRQRK-----E 199

Query: 241 KIMNH---QNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLG-QNGIADFKMWSALFVS 295
           K+      + + ++  +   + S +AKDL   L+    + RLG + G AD          
Sbjct: 200 KVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSAD---------- 249

Query: 296 LSISPRNHPWFQGIAW 311
                R HP F+ + W
Sbjct: 250 ---EVREHPLFKDLNW 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  123 bits (311), Expect = 6e-33
 Identities = 55/159 (34%), Positives = 85/159 (53%), Gaps = 16/159 (10%)

Query: 88  LYLVMDYYCGGDLLTLLSKFE---DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAF 144
           LY+VM+Y  GGDL  L+ K +     + E+     + +++LA+   ++ H    P +   
Sbjct: 76  LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL---YECHNRSDPGNTVL 132

Query: 145 HLCRDIKPDNVLLDANGHIRLADFGSCL-RLGGDGTVQSNVAVGTPDYISPEILTAMEEG 203
           H  RD+KP N+ LDAN +++L DFG  L ++ G  +  +   VGTP Y+SPE L  M   
Sbjct: 133 H--RDLKPANIFLDANNNVKLGDFG--LAKILGHDSSFAKTYVGTPYYMSPEQLNHM--- 185

Query: 204 RGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
              Y  + D WSLG  +YE+     PF A + ++   KI
Sbjct: 186 --SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI 222

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  122 bits (309), Expect = 1e-32
 Identities = 51/195 (26%), Positives = 88/195 (45%), Gaps = 20/195 (10%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I   + ++     L++VM++  GG L  LL      L E    +   E++  +  +H   
Sbjct: 59  IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +H          RDIK  N+LL ++G ++L DFG   +L    T   N  VGTP +++P
Sbjct: 119 IIH----------RDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMVGTPYWMAP 166

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSD 254
           E++         Y  + D WSLG+   E+  G+ P+     ++   KI        L + 
Sbjct: 167 EVIN-----GKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA-TNGPPGLRN- 219

Query: 255 VGYEISDDAKDLMRR 269
              + SD+ KD +++
Sbjct: 220 -PEKWSDEFKDFLKK 233

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  108 bits (271), Expect = 4e-27
 Identities = 50/160 (31%), Positives = 83/160 (51%), Gaps = 16/160 (10%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I + + ++     L++VM+Y  GG L  ++++   R+ E    +   E++  +  +H  +
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN 136

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          DIK DN+LL  +G ++LADFG   +L      + N  VGTP +++P
Sbjct: 137 VIHR----------DIKSDNILLSKDGSVKLADFGFAAQL-TKEKSKRNSVVGTPYWMAP 185

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES 234
           E++      R  YGP+ D WSLG+   EM  GE P+  E 
Sbjct: 186 EVIK-----RKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  108 bits (270), Expect = 5e-27
 Identities = 78/272 (28%), Positives = 129/272 (47%), Gaps = 44/272 (16%)

Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR---LPEDMAKFY 119
           E+ +L     R+I +L YAFQ  ++L LVM    GGDL   +   ++     PE  A FY
Sbjct: 43  EKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY 102

Query: 120 IAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT 179
            A+++  +  +H    ++R          D+KP+NVLLD +G++R++D G  + L  DG 
Sbjct: 103 TAQIISGLEHLHQRRIIYR----------DLKPENVLLDNDGNVRISDLGLAVEL-KDGQ 151

Query: 180 VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 239
            ++    GTP +++PE+L   E     Y    D+++LGV +YEM+    PF A       
Sbjct: 152 SKTKGYAGTPGFMAPELLQGEE-----YDFSVDYFALGVTLYEMIAARGPFRARG----- 201

Query: 240 GKIMNHQNSFDLPSD-VGY--EISDDAKDLMRRLICSS-DTRLG-QNGIADFKMWSALFV 294
            K+ N +    + +D V Y  + S  +K     L+    + RLG ++G  D         
Sbjct: 202 EKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCD--------- 252

Query: 295 SLSISPRNHPWFQGIAWDSIRDS--NAPYIPE 324
                 R HP F+ + W  +       P++P+
Sbjct: 253 ----GLRTHPLFRDLNWRQLEAGMLPPPFVPD 280

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  106 bits (268), Expect = 7e-27
 Identities = 51/184 (27%), Positives = 87/184 (47%), Gaps = 22/184 (11%)

Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH 141
            +   +LY++++Y   G L  ++ KF    PE +   Y+ +++  +A +H+   +HR   
Sbjct: 68  IETSDSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHR--- 123

Query: 142 FAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAME 201
                  DIK  N+L   +G ++LADFG   +L           VGTP +++PE++    
Sbjct: 124 -------DIKAANILTTKDGVVKLADFGVATKLNDVSK-DDASVVGTPYWMAPEVI---- 171

Query: 202 EGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISD 261
           E  G      D WSLG  + E+L G  P+Y  + +    +I+   +   LP      IS 
Sbjct: 172 EMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP-PLPEG----ISP 225

Query: 262 DAKD 265
           + KD
Sbjct: 226 ELKD 229

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  106 bits (266), Expect = 2e-26
 Identities = 72/270 (26%), Positives = 125/270 (46%), Gaps = 43/270 (15%)

Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDL-LTLLSKFEDRLPEDMAKFYIA 121
           E+ +L   + R++ +L YA++    L LV+    GGDL   + +       E+ A FY A
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109

Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ 181
           E+   +  +H    V+R          D+KP+N+LLD  GHIR++D G  + +    T++
Sbjct: 110 EITCGLEDLHRERIVYR----------DLKPENILLDDYGHIRISDLGLAVEIPEGETIR 159

Query: 182 SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF--YAESLV--E 237
               VGT  Y++PE++        RY    DWW LG  +YEM+ G++PF    E +   E
Sbjct: 160 GR--VGTVGYMAPEVVK-----NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE 212

Query: 238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT-RLGQNGIADFKMWSALFVSL 296
              ++   Q  +   S+   + S+ A+ + R+L+      RLG  G    ++        
Sbjct: 213 VERRVKEDQEEY---SE---KFSEAARSICRQLLTKDPGFRLGCRGEGAEEV-------- 258

Query: 297 SISPRNHPWFQGIAWDSIRDS--NAPYIPE 324
               + HP+F+   +  +       P+ P+
Sbjct: 259 ----KAHPFFRTANFKRLEAGMLEPPFCPD 284

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  105 bits (263), Expect = 5e-26
 Identities = 75/276 (27%), Positives = 124/276 (44%), Gaps = 55/276 (19%)

Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDL-LTLLSKFEDRLPEDMAKFYIA 121
           E+ +L   + R++ +L YA++    L LV+    GGDL   +    E    E  A FY A
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109

Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ 181
           E+   +  +H    V+R          D+KP+N+LLD +GHIR++D G  + +    T++
Sbjct: 110 EICCGLEDLHQERIVYR----------DLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 159

Query: 182 SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY---------- 231
               VGT  Y++PE++        RY    DWW+LG  +YEM+ G++PF           
Sbjct: 160 GR--VGTVGYMAPEVVK-----NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 212

Query: 232 AESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT-RLGQNGIADFKMWS 290
            E LV+            ++  +   + S DA+ L + L+C     RLG  G    ++  
Sbjct: 213 VERLVK------------EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREV-- 258

Query: 291 ALFVSLSISPRNHPWFQGIAWDSIRDS--NAPYIPE 324
                     + HP F+ I +  +       P+ P+
Sbjct: 259 ----------KEHPLFKQINFKRLEAGMLEPPFKPD 284

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  103 bits (257), Expect = 2e-25
 Identities = 66/191 (34%), Positives = 93/191 (48%), Gaps = 20/191 (10%)

Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRL-PEDMAKFYIAEMVLAIASIHDLHYVHRP 139
           +F+ D +LY+VM+Y  GGDL+  +     +L PED    +  +M L +  IH+   +HR 
Sbjct: 66  SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHR- 124

Query: 140 NHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTA 199
                    DIK  N+ L  NG ++L DFGS  RL       +   VGTP Y+ PEI   
Sbjct: 125 ---------DIKSKNIFLTQNGKVKLGDFGSA-RLLTSPGAYACTYVGTPYYVPPEIWEN 174

Query: 200 MEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD-LPSDVGYE 258
           M      Y  + D WSLG  +YE+   + PF A S      K+   Q S+  LPS   YE
Sbjct: 175 MP-----YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC--QGSYKPLPSHYSYE 227

Query: 259 ISDDAKDLMRR 269
           +    K + +R
Sbjct: 228 LRSLIKQMFKR 238

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  103 bits (259), Expect = 2e-25
 Identities = 62/212 (29%), Positives = 92/212 (43%), Gaps = 21/212 (9%)

Query: 60  LREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFY 119
           L  E   L   +  ++   + AF  +  + +V++Y  GG L  LL K   ++PE +   Y
Sbjct: 46  LLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVG-KIPEPVLA-Y 103

Query: 120 IAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT 179
           IA  +L       L Y+H   H   H  RDIKP N+L+++ G +++ADFG    L  +  
Sbjct: 104 IARQIL-----KGLDYLHTKRHI-IH--RDIKPSNLLINSKGEVKIADFGISKVL-ENTL 154

Query: 180 VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 239
            Q N  VGT  Y+SPE +         Y    D WSLG+ + E   G+ PF         
Sbjct: 155 DQCNTFVGTVTYMSPERIQGES-----YSYAADIWSLGLTLLECALGKFPF---LPPGQP 206

Query: 240 GKI--MNHQNSFDLPSDVGYEISDDAKDLMRR 269
                M        PS    E S + +D +  
Sbjct: 207 SFFELMQAICDGPPPSLPAEEFSPEFRDFISA 238

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  102 bits (256), Expect = 4e-25
 Identities = 69/272 (25%), Positives = 128/272 (47%), Gaps = 47/272 (17%)

Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDL-LTLLSKFEDRLPEDMAKFYIA 121
           E+ +L   + +++ NL YA++    L LV+    GGDL   + +       E+ A FY A
Sbjct: 50  EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109

Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ 181
           E++  +  +H  + V+R          D+KP+N+LLD  GHIR++D G  +++    +++
Sbjct: 110 EILCGLEDLHRENTVYR----------DLKPENILLDDYGHIRISDLGLAVKIPEGESIR 159

Query: 182 SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE----SLVE 237
               VGT  Y++PE+L        RY    D+W LG  +YEM+ G++PF          E
Sbjct: 160 GR--VGTVGYMAPEVLN-----NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE 212

Query: 238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICS-SDTRLG--QNGIADFKMWSALFV 294
              +++  +  +        + S++AK + + L+      RLG  + G  + K       
Sbjct: 213 VDRRVLETEEVYS------AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVK------- 259

Query: 295 SLSISPRNHPWFQGIAWDSIRDS--NAPYIPE 324
                   HP+F+ + +  +     + P++P+
Sbjct: 260 -------RHPFFRNMNFKRLEAGMLDPPFVPD 284

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  102 bits (255), Expect = 5e-25
 Identities = 68/233 (29%), Positives = 109/233 (46%), Gaps = 35/233 (15%)

Query: 41  NSSLRRE-KTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGD 99
           +   ++E   +   I+ +  L+ ER V  YG            +DD  L + M+Y  GG 
Sbjct: 41  SPETKKEVNALECEIQLLKNLQHERIVQYYG----------CLRDDETLSIFMEYMPGGS 90

Query: 100 LLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA 159
           +   L  +   L E + + Y  +++  +  +H    VHR          DIK  N+L D+
Sbjct: 91  VKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHR----------DIKGANILRDS 139

Query: 160 NGHIRLADFGSCLRLGG---DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSL 216
            G+++L DFG+  RL      GT   +V  GTP ++SPE+++    G G YG + D WS+
Sbjct: 140 AGNVKLGDFGASKRLQTICSSGTGMKSV-TGTPYWMSPEVIS----GEG-YGRKADVWSV 193

Query: 217 GVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRR 269
           G  + EML  + P+     +    KI     +  LPS V    S DA++ +RR
Sbjct: 194 GCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHV----SPDARNFLRR 242

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score =  102 bits (255), Expect = 5e-25
 Identities = 76/269 (28%), Positives = 123/269 (45%), Gaps = 41/269 (15%)

Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-LPEDMAKFYIA 121
           E+++L   +  +I NL YAF+  ++L LVM    GGDL   +    +R L  +    Y A
Sbjct: 43  EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102

Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL-GGDGTV 180
           ++   I  +H +  V+R          D+KP+NVLLD  G+ RL+D G  + L  G    
Sbjct: 103 QITCGILHLHSMDIVYR----------DMKPENVLLDDQGNCRLSDLGLAVELKDGKTIT 152

Query: 181 QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF--YAESLVET 238
           Q     GT  Y++PEIL   EE    Y    DW+++G  +YEM+ G TPF  + E + + 
Sbjct: 153 QR---AGTNGYMAPEIL--KEEP---YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE 204

Query: 239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLGQNGIADFKMWSALFVSLS 297
             K    ++            ++++KD+ R  +    + RLG     D            
Sbjct: 205 ELKRRTLEDEVKFEHQ---NFTEESKDICRLFLAKKPEDRLGSREKND------------ 249

Query: 298 ISPRNHPWFQGIAWDSIRDS--NAPYIPE 324
             PR H +F+ I +  +       P++P+
Sbjct: 250 -DPRKHEFFKTINFPRLEAGLIPPPFVPD 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  101 bits (254), Expect = 8e-25
 Identities = 77/272 (28%), Positives = 126/272 (46%), Gaps = 47/272 (17%)

Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDL-LTLLSKFEDRLPEDMAKFYIA 121
           E+ +L   + R++ +L YA++    L LV+    GGDL   + +       E  A FY A
Sbjct: 50  EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109

Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ 181
           E+   +  +     V+R          D+KP+N+LLD  GHIR++D G  +++    TV+
Sbjct: 110 ELCCGLEDLQRERIVYR----------DLKPENILLDDRGHIRISDLGLAVQIPEGETVR 159

Query: 182 SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF--YAESLV--E 237
               VGT  Y++PE++        +Y    DWW LG  +YEM+ G++PF    E +   E
Sbjct: 160 GR--VGTVGYMAPEVIN-----NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE 212

Query: 238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLG--QNGIADFKMWSALFV 294
              ++   Q  +   S+   + S+DAK + R L+  +   RLG   NG A  K       
Sbjct: 213 VDRRVKEDQEEY---SE---KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ------ 260

Query: 295 SLSISPRNHPWFQGIAWDSIRDS--NAPYIPE 324
                   HP F+ I +  +  +    P+ P+
Sbjct: 261 --------HPIFKNINFKRLEANMLEPPFCPD 284

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  101 bits (253), Expect = 1e-24
 Identities = 59/192 (30%), Positives = 95/192 (49%), Gaps = 26/192 (13%)

Query: 85  DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAF 144
              +Y+ M+Y C G  L  L +    L E + + Y  +++  +A +H    VHR      
Sbjct: 71  REKVYIFMEY-CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHR------ 123

Query: 145 HLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTV---QSNVAVGTPDYISPEILTAME 201
               DIKP N+ LD NG I+L DFG  ++L  + T    +     GTP Y++PE++T  +
Sbjct: 124 ----DIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179

Query: 202 -EGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH---QNSFDLPSDVGY 257
            +G GR     D WSLG  + EM  G+ P+   S ++   +IM H    +   +P  +  
Sbjct: 180 GKGHGR---AADIWSLGCVVLEMATGKRPW---SELDNEFQIMFHVGAGHKPPIPDSL-- 231

Query: 258 EISDDAKDLMRR 269
           ++S + KD + R
Sbjct: 232 QLSPEGKDFLDR 243

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score =  101 bits (253), Expect = 1e-24
 Identities = 64/205 (31%), Positives = 93/205 (45%), Gaps = 40/205 (19%)

Query: 77  NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYV 136
            L+Y+        L+MDY   GDL  LL K E +L E   K  I ++V A+  +H  + +
Sbjct: 73  KLYYSVTTLKGHVLIMDYIKDGDLFDLL-KKEGKLSEAEVKKIIRQLVEALNDLHKHNII 131

Query: 137 HRPNHFAFHLCRDIKPDNVLLD-ANGHIRLADFGSCLRLG----GDGTVQSNVAVGTPDY 191
           H  N        DIK +NVL D A   I L D+G C  +G     DGT+         DY
Sbjct: 132 H--N--------DIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTL---------DY 172

Query: 192 ISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF---YAESL-VETYGKIMNHQN 247
            SPE +         Y    DWW++GV  YE+L G+ PF     E L +E+    +  + 
Sbjct: 173 FSPEKIK-----GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLES----LLKRQ 223

Query: 248 SFDLPSDVGYEISDDAKDLMRRLIC 272
              LP      +S +A D ++ ++ 
Sbjct: 224 QKKLP--FIKNVSKNANDFVQSMLK 246

Length = 267

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  100 bits (250), Expect = 2e-24
 Identities = 50/173 (28%), Positives = 82/173 (47%), Gaps = 23/173 (13%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR---LPEDMAKFYIAEMVLAIASIH 131
           I +   AF D + L +VM+Y   GDL   +SK + +   +PE        +++  + ++H
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 132 DLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDY 191
           +   +HR          D+K  N+LL AN  +++ D G    L  +        +GTP Y
Sbjct: 121 EQKILHR----------DLKSANILLVANDLVKIGDLGISKVLKKNMA---KTQIGTPHY 167

Query: 192 ISPEILTAMEEGRGR-YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
           ++PE+       +GR Y  + D WSLG  +YEM     PF A S+ +   K+ 
Sbjct: 168 MAPEVW------KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ 214

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  100 bits (250), Expect = 2e-24
 Identities = 66/232 (28%), Positives = 110/232 (47%), Gaps = 37/232 (15%)

Query: 40  CNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGD 99
               L +E      I  ++KL+    V   G  R          ++ NLY+ ++   GG 
Sbjct: 45  AVKQLEQE------IALLSKLQHPNIVQYLGTER----------EEDNLYIFLELVPGGS 88

Query: 100 LLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA 159
           L  LL K+    PE + + Y  +++L +  +HD + VHR          DIK  N+L+D 
Sbjct: 89  LAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHR----------DIKGANILVDT 137

Query: 160 NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVC 219
           NG ++LADFG   ++      +S    G+P +++PE++      +G YG   D WSLG  
Sbjct: 138 NGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVIAQ----QGGYGLAADIWSLGCT 191

Query: 220 MYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           + EM  G+ P+   S +E    +     S +LP  +   +SD+AKD + + +
Sbjct: 192 VLEMATGKPPW---SQLEGVAAVFKIGRSKELPP-IPDHLSDEAKDFILKCL 239

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score =  104 bits (260), Expect = 3e-24
 Identities = 55/134 (41%), Positives = 77/134 (57%), Gaps = 15/134 (11%)

Query: 40  CNSSLRREKTV--SDFIE--FVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYY 95
            NS L   K V  +D I    V +++ ERD L      +I +L+Y+ Q  +N+YLVM+Y 
Sbjct: 27  NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYL 86

Query: 96  CGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNV 155
            GGD+ +LL  +     E+MA  YI+E+ LA      L Y+HR  H   H  RD+KPDN+
Sbjct: 87  IGGDVKSLLHIY-GYFDEEMAVKYISEVALA------LDYLHR--HGIIH--RDLKPDNM 135

Query: 156 LLDANGHIRLADFG 169
           L+   GHI+L DFG
Sbjct: 136 LISNEGHIKLTDFG 149

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 99.7 bits (249), Expect = 4e-24
 Identities = 50/162 (30%), Positives = 80/162 (49%), Gaps = 19/162 (11%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLL-SKF-EDRLPEDMAKFYIAEMVLAIASIHD 132
           +   + +F     L+LVM Y  GG LL ++ S +    L E +    + E++  +  +H 
Sbjct: 61  VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120

Query: 133 LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG--SCLRLGGDGTVQS-NVAVGTP 189
              +HR          DIK  N+LL  +G +++ADFG  + L  GGD T +     VGTP
Sbjct: 121 NGQIHR----------DIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTP 170

Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
            +++PE+   ME+  G Y  + D WS G+   E+  G  P+ 
Sbjct: 171 CWMAPEV---MEQVHG-YDFKADIWSFGITAIELATGAAPYS 208

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 98.8 bits (246), Expect = 8e-24
 Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 43/236 (18%)

Query: 49  TVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE 108
           T S+  E V  LR+E  ++   +   I  +  A  +DS+  L +++  GG +  LLSK+ 
Sbjct: 39  TSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY- 97

Query: 109 DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH-IRLAD 167
               E +   Y  +++  ++ +H+   +HR          D+K  N+L+D+ G  +R+AD
Sbjct: 98  GAFKEAVIINYTEQLLRGLSYLHENQIIHR----------DVKGANLLIDSTGQRLRIAD 147

Query: 168 FGSCLRLGGDGT----VQSNVAVGTPDYISPEILTAMEEGRGR-YGPECDWWSLGVCMYE 222
           FG+  RL   GT     Q  + +GT  +++PE+L      RG  YG  CD WS+G  + E
Sbjct: 148 FGAAARLAAKGTGAGEFQGQL-LGTIAFMAPEVL------RGEQYGRSCDVWSVGCVIIE 200

Query: 223 MLYGETPFYAESLVETYGKIMNHQNSFDL---------PSDVGYEISDDAKDLMRR 269
           M   + P+ AE           H N   L            +   +S   +D+  R
Sbjct: 201 MATAKPPWNAE----------KHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLR 246

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 97.2 bits (242), Expect = 3e-23
 Identities = 65/188 (34%), Positives = 95/188 (50%), Gaps = 20/188 (10%)

Query: 58  AKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-LPEDMA 116
             + E R VL   D  +I   + +F D   L +VM+Y   GDL  LL     R LPED  
Sbjct: 45  EAIDEAR-VLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQV 103

Query: 117 -KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG 175
            +F+I +++L +A +H    +HR          DIK  N+ LDA  ++++ D G   +L 
Sbjct: 104 WRFFI-QILLGLAHLHSKKILHR----------DIKSLNLFLDAYDNVKIGDLGVA-KLL 151

Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
            D T  +N  VGTP Y+SPE+    E+    Y  + D W+LGV +YE   G+ PF A + 
Sbjct: 152 SDNTNFANTIVGTPYYLSPELC---EDKP--YNEKSDVWALGVVLYECCTGKHPFDANNQ 206

Query: 236 VETYGKIM 243
                KI+
Sbjct: 207 GALILKII 214

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 97.3 bits (242), Expect = 3e-23
 Identities = 72/258 (27%), Positives = 123/258 (47%), Gaps = 38/258 (14%)

Query: 70  GDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS 129
           GD  +I  + YAF     L  ++D   GGDL   LS+       +M +FY AE++L +  
Sbjct: 54  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEM-RFYAAEIILGLEH 112

Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD-GTVQSNVAVGT 188
           +H+   V+R          D+KP N+LLD +GH+R++D G    L  D    + + +VGT
Sbjct: 113 MHNRFVVYR----------DLKPANILLDEHGHVRISDLG----LACDFSKKKPHASVGT 158

Query: 189 PDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG-KIMNHQN 247
             Y++PE+L   ++G   Y    DW+SLG  ++++L G +PF      + +    M    
Sbjct: 159 HGYMAPEVL---QKGVA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 214

Query: 248 SFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ 307
           + +LP     E+    + L++R +   + RLG  G    ++            + HP+F+
Sbjct: 215 AVELPDSFSPELRSLLEGLLQRDV---NRRLGCLGRGAQEV------------KEHPFFR 259

Query: 308 GIAWDSI--RDSNAPYIP 323
            + W  +  +    P IP
Sbjct: 260 SLDWQMVFLQKYPPPLIP 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 95.8 bits (239), Expect = 1e-22
 Identities = 57/181 (31%), Positives = 86/181 (47%), Gaps = 25/181 (13%)

Query: 51  SDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR 110
            D IE + +   E   L      +IT  + +F   S L+++M+Y  GG  L LL     +
Sbjct: 40  EDEIEDIQQ---EIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK--PGK 94

Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPN--HFAFHLCRDIKPDNVLLDANGHIRLADF 168
           L E     YIA ++  +  +  L Y+H     H      RDIK  N+LL   G ++LADF
Sbjct: 95  LDET----YIAFILREV--LLGLEYLHEEGKIH------RDIKAANILLSEEGDVKLADF 142

Query: 169 GSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGET 228
           G   +L      + N  VGTP +++PE++      +  Y  + D WSLG+   E+  GE 
Sbjct: 143 GVSGQL-TSTMSKRNTFVGTPFWMAPEVIK-----QSGYDEKADIWSLGITAIELAKGEP 196

Query: 229 P 229
           P
Sbjct: 197 P 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 94.9 bits (236), Expect = 1e-22
 Identities = 72/242 (29%), Positives = 115/242 (47%), Gaps = 61/242 (25%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +  LH     + +++LV+ +  GG L + +SKF   +PE+  K + AEMV+A+ ++H   
Sbjct: 47  MVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL-NIPEECVKRWAAEMVVALDALHREG 105

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG-------SCLRLGGDGTVQSNVAVG 187
            V          CRD+ P+N+LLD  GHI+L  F        SC     DG    N+   
Sbjct: 106 IV----------CRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM--- 147

Query: 188 TPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQN 247
              Y +PE+    EE        CDWWSLG  ++E+L G+T      LVE +   +N   
Sbjct: 148 ---YCAPEVGGISEETEA-----CDWWSLGAILFELLTGKT------LVECHPSGINTHT 193

Query: 248 SFDLPSDVGYEISDDAKDLMRRLICSSDTR---LGQNGIADFKMWSALFVSLSISPRNHP 304
           + ++P  V    S++A+ L+++L+  + T     G  G+ D K              +HP
Sbjct: 194 TLNIPEWV----SEEARSLLQQLLQFNPTERLGAGVAGVEDIK--------------SHP 235

Query: 305 WF 306
           +F
Sbjct: 236 FF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 95.8 bits (239), Expect = 1e-22
 Identities = 49/168 (29%), Positives = 76/168 (45%), Gaps = 15/168 (8%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +  L   F   S   LVM+Y    DL  +L   E  LPE   K Y+  ++  +A +H   
Sbjct: 61  VVKLLDVFPHGSGFVLVMEY-MPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          D+KP N+L+ A+G +++ADFG       +     +  V T  Y +P
Sbjct: 120 IMHR----------DLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAP 169

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
           E+L     G  +Y P  D W++G    E+L G   F  E+ +E    +
Sbjct: 170 ELLY----GARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIV 213

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 93.1 bits (232), Expect = 7e-22
 Identities = 42/150 (28%), Positives = 74/150 (49%), Gaps = 16/150 (10%)

Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH 141
           +  +++L++VM+Y   G +  ++      L E+     + + +  +  +H    +HR   
Sbjct: 67  YFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHR--- 123

Query: 142 FAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAME 201
                  DIK  N+LL+  G  +LADFG   +L  D   + N  +GTP +++PE++   E
Sbjct: 124 -------DIKAGNILLNEEGQAKLADFGVSGQL-TDTMAKRNTVIGTPFWMAPEVI--QE 173

Query: 202 EGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
            G   Y  + D WSLG+   EM  G+ P+ 
Sbjct: 174 IG---YNNKADIWSLGITAIEMAEGKPPYS 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 92.7 bits (231), Expect = 1e-21
 Identities = 57/183 (31%), Positives = 90/183 (49%), Gaps = 25/183 (13%)

Query: 60  LREERDVLV-YGDRRWITNLHYAF------QDDSNLYLVMDYYCGG----DLLTLLSKFE 108
           ++EE ++L  Y +   I   + AF       +D  L+LVM+  CGG    DL+  L K  
Sbjct: 49  IKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMEL-CGGGSVTDLVKGLRKKG 107

Query: 109 DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADF 168
            RL E+   + + E +  +A +H+   +HR          DIK  N+LL  N  ++L DF
Sbjct: 108 KRLKEEWIAYILRETLRGLAYLHENKVIHR----------DIKGQNILLTKNAEVKLVDF 157

Query: 169 GSCLRLGGDGTVQS-NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGE 227
           G   +L  D T+   N  +GTP +++PE++   E+    Y    D WSLG+   E+  G+
Sbjct: 158 GVSAQL--DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215

Query: 228 TPF 230
            P 
Sbjct: 216 PPL 218

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 91.0 bits (226), Expect = 4e-21
 Identities = 70/218 (32%), Positives = 110/218 (50%), Gaps = 26/218 (11%)

Query: 59  KLREE--RDVLVYGDRRWITNLHY--AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRL-PE 113
           K REE  ++V V  + +    + Y  +F+++ NLY+VMDY  GGDL   ++     L PE
Sbjct: 41  KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPE 100

Query: 114 DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR 173
           D    +  ++ LA+  +HD   +H          RDIK  N+ L  +G I+L DFG    
Sbjct: 101 DQILDWFVQICLALKHVHDRKILH----------RDIKSQNIFLTKDGTIKLGDFGIARV 150

Query: 174 LGGDGTVQ-SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA 232
           L  + TV+ +   +GTP Y+SPEI     E R  Y  + D W+LG  +YEM   +  F A
Sbjct: 151 L--NSTVELARTCIGTPYYLSPEIC----ENR-PYNNKSDIWALGCVLYEMCTLKHAFEA 203

Query: 233 ESLVETYGKIMNHQNSF-DLPSDVGYEISDDAKDLMRR 269
            ++     KI+  + S+  + S   Y++ +    L +R
Sbjct: 204 GNMKNLVLKII--RGSYPPVSSHYSYDLRNLVSQLFKR 239

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 91.9 bits (228), Expect = 4e-21
 Identities = 53/160 (33%), Positives = 85/160 (53%), Gaps = 24/160 (15%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           L++VM+Y  GG L  +++  E  + E        E + A+  +H    +HR         
Sbjct: 91  LWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHR--------- 139

Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
            DIK DN+LL  +G ++L DFG C ++  + + +S + VGTP +++PE++T     R  Y
Sbjct: 140 -DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVT-----RKAY 192

Query: 208 GPECDWWSLGVCMYEMLYGETPFYAES------LVETYGK 241
           GP+ D WSLG+   EM+ GE P+  E+      L+ T G 
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT 232

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 91.6 bits (227), Expect = 4e-21
 Identities = 69/247 (27%), Positives = 117/247 (47%), Gaps = 36/247 (14%)

Query: 70  GDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS 129
           GD  +I  + YAF     L  ++D   GGDL   LS+      ++M +FY  E++L +  
Sbjct: 54  GDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEM-RFYATEIILGLEH 112

Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD-GTVQSNVAVGT 188
           +H+   V+R          D+KP N+LLD +GH+R++D G    L  D    + + +VGT
Sbjct: 113 MHNRFVVYR----------DLKPANILLDEHGHVRISDLG----LACDFSKKKPHASVGT 158

Query: 189 PDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG-KIMNHQN 247
             Y++PE+L   ++G   Y    DW+SLG  ++++L G +PF      + +    M    
Sbjct: 159 HGYMAPEVL---QKGTA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTV 214

Query: 248 SFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ 307
           + +LP     E+    + L++R +     RLG  G              +   + H +F+
Sbjct: 215 NVELPDSFSPELKSLLEGLLQRDVSK---RLGCLGRG------------AQEVKEHVFFK 259

Query: 308 GIAWDSI 314
           GI W  +
Sbjct: 260 GIDWQQV 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 89.3 bits (222), Expect = 3e-20
 Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 16/168 (9%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L   F+   +LYLV ++    DL  L+   +  LPE + K Y+ +++  +A  H   
Sbjct: 60  IIKLLDVFRHKGDLYLVFEF-MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH--- 115

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
                +H   H  RD+KP+N+L++  G ++LADFG     G      ++  V T  Y +P
Sbjct: 116 -----SHGILH--RDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH-YVVTRWYRAP 167

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
           E+L     G   Y    D WS+G    E+L     F  +S ++   KI
Sbjct: 168 ELLL----GDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI 211

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 88.9 bits (221), Expect = 4e-20
 Identities = 57/170 (33%), Positives = 79/170 (46%), Gaps = 15/170 (8%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I NL  AF+    LYLV +Y     LL LL      LP D  + YI +++ AIA  H  +
Sbjct: 62  IVNLKEAFRRKGRLYLVFEY-VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN 120

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          DIKP+N+L+  +G ++L DFG    L           V T  Y +P
Sbjct: 121 IIHR----------DIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAP 170

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
           E+L     G   YG   D W++G  M E+L GE  F  +S ++    I  
Sbjct: 171 ELLV----GDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQK 216

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 88.6 bits (220), Expect = 4e-20
 Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 21/181 (11%)

Query: 50  VSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFED 109
           VSD    VA L +    L       IT  + ++     L+++M+Y  GG + TL+     
Sbjct: 43  VSDIQREVALLSQ----LRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA--G 96

Query: 110 RLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG 169
            + E      I E+++A+  IH +  +HR          DIK  N+L+   G+++L DFG
Sbjct: 97  PIAEKYISVIIREVLVALKYIHKVGVIHR----------DIKAANILVTNTGNVKLCDFG 146

Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
               L    + + +  VGTP +++PE++T   EG+  Y  + D WSLG+ +YEM  G  P
Sbjct: 147 VAALLN-QNSSKRSTFVGTPYWMAPEVIT---EGK-YYDTKADIWSLGITIYEMATGNPP 201

Query: 230 F 230
           +
Sbjct: 202 Y 202

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 87.9 bits (218), Expect = 8e-20
 Identities = 48/156 (30%), Positives = 87/156 (55%), Gaps = 20/156 (12%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVL-AIASIHDLHYVHRPNHFAFHL 146
           L++VM++  GG L  +++    R+ E+     +   VL A++ +H    +HR        
Sbjct: 91  LWVVMEFLEGGALTDIVT--HTRMNEEQIA-TVCLAVLKALSFLHAQGVIHR-------- 139

Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             DIK D++LL ++G ++L+DFG C ++  +   +    VGTP +++PE+++     R  
Sbjct: 140 --DIKSDSILLTSDGRVKLSDFGFCAQVSKE-VPRRKSLVGTPYWMAPEVIS-----RLP 191

Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
           YG E D WSLG+ + EM+ GE P++ E  ++   +I
Sbjct: 192 YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI 227

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 89.9 bits (223), Expect = 1e-19
 Identities = 49/151 (32%), Positives = 83/151 (54%), Gaps = 26/151 (17%)

Query: 186 VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           +GTPDY++PE+L     G+  +GP  DWW+LGVC++E L G  PF  E+  + +  I+N 
Sbjct: 541 LGTPDYLAPELLL----GKP-HGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNR 595

Query: 246 QNSFDLPSDVGYE-ISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHP 304
               D+P   G E +S +A++ +  L+    T+  + G+ + K               HP
Sbjct: 596 ----DIPWPEGEEKLSVNAQNAIEILLTMDPTK--RAGLKELK--------------QHP 635

Query: 305 WFQGIAWDSIRDSNAPYIPEVSSPTDTSHFD 335
            F G+ W+++++   P+IP+    TDTS+F+
Sbjct: 636 LFHGVDWENLQNQTMPFIPQPDDETDTSYFE 666

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 87.9 bits (217), Expect = 1e-19
 Identities = 54/160 (33%), Positives = 85/160 (53%), Gaps = 18/160 (11%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I N   +F     L++VM+Y  GG L  +++  E  + E        E + A+  +H   
Sbjct: 78  IVNFLDSFLVGDELFVVMEYLAGGSLTDVVT--ETCMDEAQIAAVCRECLQALEFLHANQ 135

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          DIK DNVLL  +G ++L DFG C ++  + + +S + VGTP +++P
Sbjct: 136 VIHR----------DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAP 184

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES 234
           E++T     R  YGP+ D WSLG+   EM+ GE P+  E+
Sbjct: 185 EVVT-----RKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 87.9 bits (217), Expect = 1e-19
 Identities = 50/147 (34%), Positives = 81/147 (55%), Gaps = 18/147 (12%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           L++VM+Y  GG L  +++  E  + E        E + A+  +H    +HR         
Sbjct: 92  LWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHR--------- 140

Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
            DIK DN+LL  +G ++L DFG C ++  + + +S + VGTP +++PE++T     R  Y
Sbjct: 141 -DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVT-----RKAY 193

Query: 208 GPECDWWSLGVCMYEMLYGETPFYAES 234
           GP+ D WSLG+   EM+ GE P+  E+
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNEN 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 86.7 bits (214), Expect = 3e-19
 Identities = 50/147 (34%), Positives = 81/147 (55%), Gaps = 18/147 (12%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           L++VM+Y  GG L  +++  E  + E        E + A+  +H    +HR         
Sbjct: 91  LWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALDFLHSNQVIHR--------- 139

Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
            DIK DN+LL  +G ++L DFG C ++  + + +S + VGTP +++PE++T     R  Y
Sbjct: 140 -DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVT-----RKAY 192

Query: 208 GPECDWWSLGVCMYEMLYGETPFYAES 234
           GP+ D WSLG+   EM+ GE P+  E+
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNEN 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 86.6 bits (214), Expect = 3e-19
 Identities = 48/155 (30%), Positives = 89/155 (57%), Gaps = 18/155 (11%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           L+++M++  GG L  ++S  + RL E+        ++ A+  +H    +HR         
Sbjct: 93  LWVLMEFLQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQGVIHR--------- 141

Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
            DIK D++LL  +G ++L+DFG C ++  D   + ++ VGTP +++PE+++     R  Y
Sbjct: 142 -DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL-VGTPYWMAPEVIS-----RTPY 194

Query: 208 GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
           G E D WSLG+ + EM+ GE P++++S V+   ++
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL 229

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 3e-19
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 15/158 (9%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I     ++     L++VM+Y  GG L  +       L E    +   E +  +A +H+  
Sbjct: 62  IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG 121

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQS-NVAVGTPDYIS 193
            +HR          DIK  N+LL  +G ++LADFG   +L    T+      +GTP +++
Sbjct: 122 KIHR----------DIKGANILLTEDGDVKLADFGVSAQL--TATIAKRKSFIGTPYWMA 169

Query: 194 PEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
           PE+  A  E +G Y  +CD W+LG+   E+   + P +
Sbjct: 170 PEV--AAVERKGGYDGKCDIWALGITAIELAELQPPMF 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 85.7 bits (213), Expect = 4e-19
 Identities = 45/169 (26%), Positives = 72/169 (42%), Gaps = 30/169 (17%)

Query: 84  DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRP 139
           ++  LY+VM+Y  GGDLL+ L K   +L   ++        L IA     +   +++HR 
Sbjct: 72  EEEPLYIVMEYMEGGDLLSYLRKNRPKLS--LSDLL--SFALQIARGMEYLESKNFIHR- 126

Query: 140 NHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYI---SPEI 196
                    D+   N L+  N  ++++DFG   R   D         G    I   +PE 
Sbjct: 127 ---------DLAARNCLVGENLVVKISDFGLS-RDLYDD--DYYRKRGGKLPIRWMAPES 174

Query: 197 LTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
           L       G++  + D WS GV ++E+   GE P+   S  E    + N
Sbjct: 175 LK-----EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKN 218

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 85.6 bits (213), Expect = 5e-19
 Identities = 49/171 (28%), Positives = 75/171 (43%), Gaps = 22/171 (12%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L      +  LYLV +Y C  DL   L K    L  ++ K  + +++  +A  H   
Sbjct: 60  IVKLLDVIHTERKLYLVFEY-CDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSN---VAVGTPDY 191
            +HR          D+KP N+L++ +G ++LADFG    L     +        V T  Y
Sbjct: 119 ILHR----------DLKPQNILINRDGVLKLADFG----LARAFGIPLRTYTHEVVTLWY 164

Query: 192 ISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            +PEIL   +     Y    D WS+G    EM+ G+  F  +S ++   KI
Sbjct: 165 RAPEILLGSKH----YSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKI 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 85.4 bits (212), Expect = 5e-19
 Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 21/152 (13%)

Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           AF ++ ++ + M+Y  GG L  +L + + R+PE +         +A+A +  L Y+H   
Sbjct: 67  AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK------IAVAVLKGLTYLHE-K 119

Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQS--NVAVGTPDYISPEILT 198
           H   H  RD+KP N+L+++ G I+L DFG   +L     V S     VGT  Y++PE + 
Sbjct: 120 HKIIH--RDVKPSNILVNSRGQIKLCDFGVSGQL-----VNSLAKTFVGTSSYMAPERIQ 172

Query: 199 AMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                   Y  + D WSLG+ + E+  G  P+
Sbjct: 173 G-----NDYSVKSDIWSLGLSLIELATGRFPY 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 84.5 bits (209), Expect = 8e-19
 Identities = 62/194 (31%), Positives = 91/194 (46%), Gaps = 28/194 (14%)

Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSK-FEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           F +D  L +VM+Y  GG L   + K     L ED    +  +++LA      LH+VH   
Sbjct: 68  FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------LHHVH--T 119

Query: 141 HFAFHLCRDIKPDNVLLDANGHI-RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTA 199
               H  RD+K  N+LLD +  + ++ DFG    L      ++   VGTP YISPE+   
Sbjct: 120 KLILH--RDLKTQNILLDKHKMVVKIGDFGISKILSSKS--KAYTVVGTPCYISPELC-- 173

Query: 200 MEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEI 259
             EG+  Y  + D W+LG  +YE+   +  F A +L     KIM+   +          I
Sbjct: 174 --EGK-PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA---------PI 221

Query: 260 SDDAKDLMRRLICS 273
           SD     +R+LI S
Sbjct: 222 SDRYSPDLRQLILS 235

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 83.6 bits (207), Expect = 2e-18
 Identities = 52/163 (31%), Positives = 83/163 (50%), Gaps = 17/163 (10%)

Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRL-PEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           F DD+ L + M+Y  GG L   + + + +L  E+M  +Y+ ++V A++ IH    +HR  
Sbjct: 68  FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHR-- 125

Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   DIK  N+ L   G I+L DFG    LG +    +   VGTP Y+SPE+   +
Sbjct: 126 --------DIKTLNIFLTKAGLIKLGDFGISKILGSE-YSMAETVVGTPYYMSPELCQGV 176

Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
           +     Y  + D W+LG  +YE+L  +  F A + +    KI+
Sbjct: 177 K-----YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV 214

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 83.9 bits (207), Expect = 2e-18
 Identities = 56/170 (32%), Positives = 83/170 (48%), Gaps = 18/170 (10%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRL-PEDMAKFYIAEMVLAIASIHDL 133
           I     +FQ++  L++VM+Y  GGDL+  +++    L  ED    +  ++ L +  IHD 
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120

Query: 134 HYVHRPNHFAFHLCRDIKPDNVLLDANGHI-RLADFGSCLRLGGDGTVQSNVAVGTPDYI 192
             +H          RDIK  N+ L  NG + +L DFG   R   D    +   VGTP Y+
Sbjct: 121 KILH----------RDIKSQNIFLSKNGMVAKLGDFGIA-RQLNDSMELAYTCVGTPYYL 169

Query: 193 SPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
           SPEI     + R  Y  + D WSLG  +YE+   + PF   +L +   KI
Sbjct: 170 SPEIC----QNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKI 214

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 82.4 bits (203), Expect = 5e-18
 Identities = 66/227 (29%), Positives = 106/227 (46%), Gaps = 32/227 (14%)

Query: 54  IEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPE 113
           I+ +  L+ ER V  YG  R         + +  L + M+Y  GG +   L  +   L E
Sbjct: 55  IQLLKNLQHERIVQYYGCLR--------DRAEKTLTIFMEYMPGGSVKDQLKAY-GALTE 105

Query: 114 DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR 173
            + + Y  +++  ++ +H    VHR          DIK  N+L D+ G+++L DFG+  R
Sbjct: 106 SVTRKYTRQILEGMSYLHSNMIVHR----------DIKGANILRDSAGNVKLGDFGASKR 155

Query: 174 LGG---DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
           L      GT   +V  GTP ++SPE+++    G G YG + D WSLG  + EML  + P+
Sbjct: 156 LQTICMSGTGIRSVT-GTPYWMSPEVIS----GEG-YGRKADVWSLGCTVVEMLTEKPPW 209

Query: 231 YAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTR 277
                +    KI     +  LPS     IS+ A+D +  +   +  R
Sbjct: 210 AEYEAMAAIFKIATQPTNPQLPS----HISEHARDFLGCIFVEARHR 252

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 82.8 bits (204), Expect = 5e-18
 Identities = 55/174 (31%), Positives = 89/174 (51%), Gaps = 18/174 (10%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           +  +++E  VL   D  +IT  + ++   + L+++M+Y  GG  L LL       P  + 
Sbjct: 46  IEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK------PGPLE 99

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           + YIA ++  I  +  L Y+H        + RDIK  NVLL   G ++LADFG   +L  
Sbjct: 100 ETYIATILREI--LKGLDYLHSERK----IHRDIKAANVLLSEQGDVKLADFGVAGQL-T 152

Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
           D  ++ N  VGTP +++PE++      +  Y  + D WSLG+   E+  GE P 
Sbjct: 153 DTQIKRNTFVGTPFWMAPEVIK-----QSAYDFKADIWSLGITAIELAKGEPPN 201

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 82.8 bits (204), Expect = 6e-18
 Identities = 54/173 (31%), Positives = 90/173 (52%), Gaps = 18/173 (10%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           +  +++E  VL   D  ++T  + ++  D+ L+++M+Y  GG  L LL       P  + 
Sbjct: 46  IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE------PGPLD 99

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +  IA ++  I  +  L Y+H        + RDIK  NVLL  +G ++LADFG   +L  
Sbjct: 100 ETQIATILREI--LKGLDYLHSEKK----IHRDIKAANVLLSEHGEVKLADFGVAGQL-T 152

Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           D  ++ N  VGTP +++PE++      +  Y  + D WSLG+   E+  GE P
Sbjct: 153 DTQIKRNTFVGTPFWMAPEVIK-----QSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 83.0 bits (206), Expect = 6e-18
 Identities = 58/220 (26%), Positives = 91/220 (41%), Gaps = 38/220 (17%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L   F   SN+ LV ++    DL  ++      L     K Y+   +  +  +H   
Sbjct: 64  IIGLLDVFGHKSNINLVFEF-METDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW 122

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          D+KP+N+L+ ++G ++LADFG     G      ++  V T  Y +P
Sbjct: 123 ILHR----------DLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAP 171

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM------NHQNS 248
           E+L     G   YG   D WS+G    E+L        +S ++  GKI         +N 
Sbjct: 172 ELLF----GARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENW 227

Query: 249 FD---LPSDVGYE-------------ISDDAKDLMRRLIC 272
                LP  V ++              SDDA DL++RL+ 
Sbjct: 228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLT 267

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 82.6 bits (205), Expect = 7e-18
 Identities = 47/157 (29%), Positives = 73/157 (46%), Gaps = 15/157 (9%)

Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
            ++Y+V +Y    DL  LL   E +  E   K Y+ +++  +  +H    +HR       
Sbjct: 73  GSIYMVFEY-MDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHR------- 124

Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRG 205
              DIK  N+L++ +G ++LADFG         +      V T  Y  PE+L     G  
Sbjct: 125 ---DIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLL----GAT 177

Query: 206 RYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
           RYGPE D WS+G  + E+  G+  F   + +E   KI
Sbjct: 178 RYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKI 214

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 81.8 bits (203), Expect = 9e-18
 Identities = 40/166 (24%), Positives = 69/166 (41%), Gaps = 23/166 (13%)

Query: 84  DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRP 139
           ++  L +VM+Y  GGDLL  L K   +    ++        L IA     +   +++HR 
Sbjct: 72  EEEPLMIVMEYMPGGDLLDYLRKNRPKEL-SLSDLL--SFALQIARGMEYLESKNFIHR- 127

Query: 140 NHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTA 199
                    D+   N L+  N  ++++DFG    L  D   +         +++PE L  
Sbjct: 128 ---------DLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK- 177

Query: 200 MEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
                G++  + D WS GV ++E+   GE P+   S  E    +  
Sbjct: 178 ----EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKK 219

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 56/173 (32%), Positives = 89/173 (51%), Gaps = 18/173 (10%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           +  +++E  VL   D  ++T  + ++   + L+++M+Y  GG  L LL       P D  
Sbjct: 46  IEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG----PFD-- 99

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +F IA M+  I  +  L Y+H        + RDIK  NVLL   G ++LADFG   +L  
Sbjct: 100 EFQIATMLKEI--LKGLDYLHSEKK----IHRDIKAANVLLSEQGDVKLADFGVAGQL-T 152

Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           D  ++ N  VGTP +++PE++      +  Y  + D WSLG+   E+  GE P
Sbjct: 153 DTQIKRNTFVGTPFWMAPEVIQ-----QSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 52/168 (30%), Positives = 96/168 (57%), Gaps = 18/168 (10%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           + +++ ++     L++VM++  GG L  +++    R+ E+     IA + L++  +  L 
Sbjct: 81  VVDMYNSYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQ----IATVCLSV--LRALS 132

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
           Y+H  N    H  RDIK D++LL ++G I+L+DFG C ++  +   +    VGTP +++P
Sbjct: 133 YLH--NQGVIH--RDIKSDSILLTSDGRIKLSDFGFCAQVSKE-VPKRKSLVGTPYWMAP 187

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
           E+++     R  YG E D WSLG+ + EM+ GE P++ E  ++   +I
Sbjct: 188 EVIS-----RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI 230

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 80.6 bits (199), Expect = 2e-17
 Identities = 64/200 (32%), Positives = 96/200 (48%), Gaps = 31/200 (15%)

Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKF--EDRL-PEDMAKFYIAEMVLAIASIHDLHYVH 137
           +F +++ L +V++    GDL  ++  F  + RL PE     Y  ++  A+  +H      
Sbjct: 70  SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS----K 125

Query: 138 RPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG---GDGTVQSNVAVGTPDYISP 194
           R  H      RDIKP NV + A G ++L D G    LG      T  ++  VGTP Y+SP
Sbjct: 126 RIMH------RDIKPANVFITATGVVKLGDLG----LGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHQNSFDLP 252
           E +   E G   Y  + D WSLG  +YEM   ++PFY +  +L     KI        LP
Sbjct: 176 ERIH--ENG---YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP-PLP 229

Query: 253 SDVGYEISDDAKDLMRRLIC 272
           +D     S++ +DL+ R I 
Sbjct: 230 AD---HYSEELRDLVSRCIN 246

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 80.8 bits (199), Expect = 3e-17
 Identities = 46/146 (31%), Positives = 84/146 (57%), Gaps = 18/146 (12%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           L++VM++  GG L  +++    R+ E+        ++ A++ +H    +HR         
Sbjct: 92  LWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQGVIHR--------- 140

Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
            DIK D++LL  +G ++L+DFG C ++  +   + ++ VGTP +++PE+++     R  Y
Sbjct: 141 -DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL-VGTPYWMAPELIS-----RLPY 193

Query: 208 GPECDWWSLGVCMYEMLYGETPFYAE 233
           GPE D WSLG+ + EM+ GE P++ E
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPPYFNE 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 79.9 bits (198), Expect = 4e-17
 Identities = 45/178 (25%), Positives = 73/178 (41%), Gaps = 29/178 (16%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----I 130
           I  L         LY+V +Y  GGDLL  L K  ++L        + +M L IA     +
Sbjct: 63  IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD----LLQMALQIAKGMEYL 118

Query: 131 HDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
              ++VHR          D+   N L+  N  ++++DFG    +  D         G   
Sbjct: 119 ESKNFVHR----------DLAARNCLVTENLVVKISDFGLSRDIYEDDY--YRKRGGGKL 166

Query: 191 ---YISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
              +++PE L       G++  + D WS GV ++E+   GE P+   S  E    + +
Sbjct: 167 PIKWMAPESLKD-----GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLED 219

Length = 258

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 20/197 (10%)

Query: 62  EERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR---LPEDMAKF 118
           +E D+L   +   +   + +F +D+ L +V++    GDL  ++  F+ +   +PE     
Sbjct: 51  KEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWK 110

Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
           Y  ++  A+  +H    +HR          DIKP NV + A G ++L D G   R     
Sbjct: 111 YFVQLCSALEHMHSRRVMHR----------DIKPANVFITATGVVKLGDLG-LGRFFSSK 159

Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL-VE 237
           T  ++  VGTP Y+SPE +   E G   Y  + D WSLG  +YEM   ++PFY + + + 
Sbjct: 160 TTAAHSLVGTPYYMSPERI--HENG---YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 214

Query: 238 TYGKIMNHQNSFDLPSD 254
           +  K +   +   LPSD
Sbjct: 215 SLCKKIEQCDYPPLPSD 231

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 53/170 (31%), Positives = 78/170 (45%), Gaps = 20/170 (11%)

Query: 69  YGDRRWITNLHYAF------QDDSNLYLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIA 121
           Y   R I   + AF        D  L+LVM++   G +  L+   + + L ED   +   
Sbjct: 69  YSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR 128

Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTV- 180
           E++  +A +H    +HR          DIK  NVLL  N  ++L DFG   +L  D TV 
Sbjct: 129 EILRGLAHLHAHKVIHR----------DIKGQNVLLTENAEVKLVDFGVSAQL--DRTVG 176

Query: 181 QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
           + N  +GTP +++PE++   E     Y    D WSLG+   EM  G  P 
Sbjct: 177 RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 78.0 bits (192), Expect = 2e-16
 Identities = 48/143 (33%), Positives = 72/143 (50%), Gaps = 17/143 (11%)

Query: 92  MDYYCGGDLLTLL-SKFED-RLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRD 149
           M+   GG L  LL SK+   +  E    FY  +++  +  +HD   VHR          D
Sbjct: 84  MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR----------D 133

Query: 150 IKPDNVLLDA-NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYG 208
           IK DNVL++  +G ++++DFG+  RL G          GT  Y++PE++   ++G   YG
Sbjct: 134 IKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT-GTLQYMAPEVI---DKGPRGYG 189

Query: 209 PECDWWSLGVCMYEMLYGETPFY 231
              D WSLG  + EM  G+ PF 
Sbjct: 190 APADIWSLGCTIVEMATGKPPFI 212

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 78.3 bits (193), Expect = 2e-16
 Identities = 52/171 (30%), Positives = 86/171 (50%), Gaps = 24/171 (14%)

Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE 122
           E  ++      +I + + AF +++N+ + M++   G L  +  K      E + K  IA 
Sbjct: 53  ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAV 110

Query: 123 MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQS 182
            V+    +  L+ VHR  H      RDIKP N+L+++ G I+L DFG        G + +
Sbjct: 111 AVVE--GLTYLYNVHRIMH------RDIKPSNILVNSRGQIKLCDFGV------SGELIN 156

Query: 183 NVA---VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
           ++A   VGT  Y+SPE +       G+Y  + D WSLG+ + E+  G+ PF
Sbjct: 157 SIADTFVGTSTYMSPERIQG-----GKYTVKSDVWSLGISIIELALGKFPF 202

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 77.8 bits (191), Expect = 2e-16
 Identities = 50/158 (31%), Positives = 79/158 (50%), Gaps = 19/158 (12%)

Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDR---LPEDMAKFYIAEMVLAIASIHDLHYVH 137
           +F +D+ L +V++    GDL  ++  F+ +   +PE     Y  ++  A+  +H    +H
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMH 129

Query: 138 RPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEIL 197
           R          DIKP NV + A G ++L D G   R     T  ++  VGTP Y+SPE +
Sbjct: 130 R----------DIKPANVFITATGVVKLGDLG-LGRFFSSKTTAAHSLVGTPYYMSPERI 178

Query: 198 TAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
              E G   Y  + D WSLG  +YEM   ++PFY + +
Sbjct: 179 --HENG---YNFKSDIWSLGCLLYEMAALQSPFYGDKM 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 65/212 (30%), Positives = 95/212 (44%), Gaps = 28/212 (13%)

Query: 43  SLRREKTVSDFIEF-----VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCG 97
           S  +EK V+ F+        A  R E   L   D   I      F+ D  L L+M+Y  G
Sbjct: 90  SDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSG 149

Query: 98  GDL-LTLLSKFEDRLP--EDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDN 154
           GDL   +  + ++ LP  E        ++VLA+  +H    +HR          D+K  N
Sbjct: 150 GDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHR----------DLKSAN 199

Query: 155 VLLDANGHIRLADFGSCLRLGGDGTVQSNVA---VGTPDYISPEILTAMEEGRGRYGPEC 211
           + L   G I+L DFG   +     +V  +VA    GTP Y++PE+       R RY  + 
Sbjct: 200 IFLMPTGIIKLGDFGFSKQY--SDSVSLDVASSFCGTPYYLAPELWE-----RKRYSKKA 252

Query: 212 DWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
           D WSLGV +YE+L    PF   S  E   +++
Sbjct: 253 DMWSLGVILYELLTLHRPFKGPSQREIMQQVL 284

Length = 478

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 77.5 bits (191), Expect = 3e-16
 Identities = 48/173 (27%), Positives = 80/173 (46%), Gaps = 19/173 (10%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCG---GDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIH 131
           I   +  F ++  LY+VMD   G   G+    L + + R  E+       +MVLA     
Sbjct: 71  IVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA----- 125

Query: 132 DLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDY 191
            L Y+H+      H  RD+ P+N++L  +  + + DFG   +   +  + S   VGT  Y
Sbjct: 126 -LRYLHK-EKRIVH--RDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS--VVGTILY 179

Query: 192 ISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
             PEI+         YG + D W+ G  +Y+M   + PFY+ +++    KI+ 
Sbjct: 180 SCPEIVKNEP-----YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE 227

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 78.8 bits (194), Expect = 6e-16
 Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 36/207 (17%)

Query: 80  YAFQDDSN------LYLVMDYYCGGDLLTLL---SKFEDRLPEDMAKFYIAEMVLAIASI 130
           +A +D  N      + LV+DY   GDL   +   +K      E  A     +++LA+  +
Sbjct: 100 FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHV 159

Query: 131 HDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVA---VG 187
           H  H +HR          DIK  N+LL +NG ++L DFG         TV  +V     G
Sbjct: 160 HSKHMIHR----------DIKSANILLCSNGLVKLGDFGFSKMYA--ATVSDDVGRTFCG 207

Query: 188 TPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQN 247
           TP Y++PEI       R  Y  + D +SLGV +YE+L  + PF  E++ E   K +  + 
Sbjct: 208 TPYYVAPEIWR-----RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR- 261

Query: 248 SFD-LPSDVGYEISDDAKDLMRRLICS 273
            +D LP      IS + ++++  L+ S
Sbjct: 262 -YDPLPP----SISPEMQEIVTALLSS 283

Length = 496

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 76.1 bits (187), Expect = 9e-16
 Identities = 60/178 (33%), Positives = 93/178 (52%), Gaps = 23/178 (12%)

Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           KL+EE D+L       I        DD+ + + M++  GG + ++L++F   LPE +   
Sbjct: 48  KLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRF-GPLPEPVFCK 106

Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL---G 175
           Y  +++  +A +H+   VHR          DIK +NV+L  NG I+L DFG   RL   G
Sbjct: 107 YTKQILDGVAYLHNNCVVHR----------DIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156

Query: 176 GDGTVQSNV---AVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
             GT  SN+     GTP +++PE++   E G GR   + D WS+G  ++EM  G+ P 
Sbjct: 157 LHGT-HSNMLKSMHGTPYWMAPEVIN--ESGYGR---KSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 64/227 (28%), Positives = 105/227 (46%), Gaps = 32/227 (14%)

Query: 54  IEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPE 113
           I+ +  L  ER V  YG  R           +  L + M++  GG +   L  +   L E
Sbjct: 55  IQLLKNLLHERIVQYYGCLR--------DPMERTLSIFMEHMPGGSIKDQLKSY-GALTE 105

Query: 114 DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR 173
           ++ + Y  +++  ++ +H    VHR          DIK  N+L D+ G+++L DFG+  R
Sbjct: 106 NVTRKYTRQILEGVSYLHSNMIVHR----------DIKGANILRDSVGNVKLGDFGASKR 155

Query: 174 LGG---DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
           L      GT   +V  GTP ++SPE+++    G G YG + D WS+G  + EML  + P+
Sbjct: 156 LQTICLSGTGMKSVT-GTPYWMSPEVIS----GEG-YGRKADIWSVGCTVVEMLTEKPPW 209

Query: 231 YAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTR 277
                +    KI     +  LP  V    SD  +D ++R+   +  R
Sbjct: 210 AEFEAMAAIFKIATQPTNPVLPPHV----SDHCRDFLKRIFVEAKLR 252

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 47/158 (29%), Positives = 79/158 (50%), Gaps = 14/158 (8%)

Query: 88  LYLVMDYYCGGDLLTL---LSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAF 144
           L+LV++   GG +  L   L     RL E M  + +   +L +  +H+   +HR      
Sbjct: 99  LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHR------ 152

Query: 145 HLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR 204
               D+K +N+LL   G ++L DFG   +L     ++ N +VGTP +++PE++   ++  
Sbjct: 153 ----DVKGNNILLTTEGGVKLVDFGVSAQLT-STRLRRNTSVGTPFWMAPEVIACEQQYD 207

Query: 205 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
             Y   CD WSLG+   E+  G+ P +    V+T  KI
Sbjct: 208 YSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 52/156 (33%), Positives = 77/156 (49%), Gaps = 22/156 (14%)

Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           AF  D  + + M++  GG L  +L K   R+PE+     + +  ++IA +  L Y+ R  
Sbjct: 67  AFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEN----ILGK--ISIAVLRGLTYL-REK 118

Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQS--NVAVGTPDYISPEILT 198
           H   H  RD+KP N+L+++ G I+L DFG   +L     + S  N  VGT  Y+SPE L 
Sbjct: 119 HKIMH--RDVKPSNILVNSRGEIKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERLQ 171

Query: 199 AMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES 234
                   Y  + D WSLG+ + EM  G  P     
Sbjct: 172 G-----THYTVQSDIWSLGLSLVEMAIGRYPIPPPD 202

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 34/205 (16%)

Query: 54  IEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPE 113
           I  + +LR E  V          NL   F+    LYLV ++     +L  L K+ + L E
Sbjct: 51  IRMLKQLRHENLV----------NLIEVFRRKKRLYLVFEF-VDHTVLDDLEKYPNGLDE 99

Query: 114 DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR 173
              + Y+ +++  I   H  + +HR          DIKP+N+L+  +G ++L DFG    
Sbjct: 100 SRVRKYLFQILRGIEFCHSHNIIHR----------DIKPENILVSQSGVVKLCDFGFART 149

Query: 174 LGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE 233
           L   G V ++  V T  Y +PE+L     G  +YG   D W++G  + EML GE  F  +
Sbjct: 150 LAAPGEVYTDY-VATRWYRAPELLV----GDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204

Query: 234 SLVETYGKIM--------NHQNSFD 250
           S ++    I+         HQ  F 
Sbjct: 205 SDIDQLYHIIKCLGNLIPRHQEIFQ 229

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 30/223 (13%)

Query: 58  AKLRE---ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGG--DLLTLLSKFEDRLP 112
           +K  +   E D+L      +I + + AF  +  +Y+ M+Y   G  D L       + +P
Sbjct: 41  SKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIP 100

Query: 113 EDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCL 172
           ED+ +       +  A +  L ++ +  H   H  RD+KP NVL++ NG ++L DFG   
Sbjct: 101 EDVLRR------ITYAVVKGLKFL-KEEHNIIH--RDVKPTNVLVNGNGQVKLCDFGV-- 149

Query: 173 RLGGDGTVQSNVA---VGTPDYISPE-ILTAMEEGRGRYGPECDWWSLGVCMYEMLYGET 228
                G + +++A   +G   Y++PE I +        Y  + D WSLG+ + EM  G  
Sbjct: 150 ----SGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRY 205

Query: 229 PFYAESLVETYGKI--MNHQNSFDLPSDVGYEISDDAKDLMRR 269
           P+  E+    + ++  +   +   LPS      SDDA+D + +
Sbjct: 206 PYPPETYANIFAQLSAIVDGDPPTLPSG----YSDDAQDFVAK 244

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 50/192 (26%), Positives = 84/192 (43%), Gaps = 56/192 (29%)

Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGS 170
           LPE   K Y+ +++ +      L ++HR  +  FH  RDIKP+N+L+  +  ++LADFGS
Sbjct: 97  LPEKRVKSYMYQLLKS------LDHMHR--NGIFH--RDIKPENILIKDD-ILKLADFGS 145

Query: 171 CLRLGGDGTVQSNVAVGTP--DYIS------PEILTAMEEGRGRYGPECDWWSLGVCMYE 222
           C            +    P  +YIS      PE L       G YGP+ D W++G   +E
Sbjct: 146 C----------RGIYSKPPYTEYISTRWYRAPECLLTD----GYYGPKMDIWAVGCVFFE 191

Query: 223 MLYGETPFYAESLVETYGKIMN----------------HQNSFDLPSDVGYEI------- 259
           +L     F   + ++   KI +                   +++ PS  G  +       
Sbjct: 192 ILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNA 251

Query: 260 SDDAKDLMRRLI 271
           S +  DL+++L+
Sbjct: 252 SAEGLDLLKKLL 263

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 74.3 bits (182), Expect = 5e-15
 Identities = 42/146 (28%), Positives = 75/146 (51%), Gaps = 14/146 (9%)

Query: 88  LYLVMDYYCGG---DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAF 144
           L+LV++   GG   DL+    K  +R+ E +  + + E ++ +  +H    +HR      
Sbjct: 95  LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHR------ 148

Query: 145 HLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR 204
               D+K +N+LL   G ++L DFG   +L     ++ N +VGTP +++PE++   ++  
Sbjct: 149 ----DVKGNNILLTTEGGVKLVDFGVSAQLT-STRLRRNTSVGTPFWMAPEVIACEQQLD 203

Query: 205 GRYGPECDWWSLGVCMYEMLYGETPF 230
             Y   CD WSLG+   E+  G+ P 
Sbjct: 204 STYDARCDVWSLGITAIELGDGDPPL 229

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 74.3 bits (183), Expect = 6e-15
 Identities = 46/144 (31%), Positives = 76/144 (52%), Gaps = 9/144 (6%)

Query: 102 TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG 161
           T L K   R+   + +  + +M +AI  +  LHY+ +  H   H  RD+KP N+LLDA+G
Sbjct: 98  TCLDKLLKRIQGPIPEDILGKMTVAI--VKALHYL-KEKHGVIH--RDVKPSNILLDASG 152

Query: 162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMY 221
           +++L DFG   RL  D   ++  A G   Y++PE +    +   +Y    D WSLG+ + 
Sbjct: 153 NVKLCDFGISGRL-VDSKAKTRSA-GCAAYMAPERIDP-PDPNPKYDIRADVWSLGISLV 209

Query: 222 EMLYGETPFY-AESLVETYGKIMN 244
           E+  G+ P+   ++  E   KI+ 
Sbjct: 210 ELATGQFPYKNCKTEFEVLTKILQ 233

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 74.0 bits (181), Expect = 6e-15
 Identities = 46/148 (31%), Positives = 73/148 (49%), Gaps = 14/148 (9%)

Query: 85  DSNLYLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFA 143
           D  L+LVM++   G +  L+   + + L E+   +   E++  ++ +H    +HR     
Sbjct: 81  DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHR----- 135

Query: 144 FHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTV-QSNVAVGTPDYISPEILTAMEE 202
                DIK  NVLL  N  ++L DFG   +L  D TV + N  +GTP +++PE++   E 
Sbjct: 136 -----DIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDEN 188

Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPF 230
               Y  + D WSLG+   EM  G  P 
Sbjct: 189 PDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 73.6 bits (181), Expect = 7e-15
 Identities = 50/184 (27%), Positives = 94/184 (51%), Gaps = 20/184 (10%)

Query: 47  EKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSK 106
           E+ + DF+        E D+L       I  L+ A+  ++ L++++++  GG L +++ +
Sbjct: 43  EEELEDFMV-------EIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLE 95

Query: 107 FEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLA 166
            E  L E   ++   +M+ A      L+++H  +H   H  RD+K  N+LL  +G ++LA
Sbjct: 96  LERGLTEPQIRYVCRQMLEA------LNFLH--SHKVIH--RDLKAGNILLTLDGDVKLA 145

Query: 167 DFGSCLRLGGDGTVQS-NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY 225
           DFG   +     T+Q  +  +GTP +++PE++         Y  + D WSLG+ + E+  
Sbjct: 146 DFGVSAK--NKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQ 203

Query: 226 GETP 229
            E P
Sbjct: 204 MEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 73.9 bits (181), Expect = 8e-15
 Identities = 51/163 (31%), Positives = 75/163 (46%), Gaps = 16/163 (9%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L  AF+    LYLV +Y    ++L LL +  + +P +  + YI +++ AI   H   
Sbjct: 62  IVELKEAFRRRGKLYLVFEY-VEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND 120

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            VHR          DIKP+N+L+  N  ++L DFG    L           V T  Y SP
Sbjct: 121 IVHR----------DIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSP 170

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 237
           E+L         YG   D WS+G  + E+  G+  F  ES ++
Sbjct: 171 ELLLG-----APYGKAVDMWSVGCILGELSDGQPLFPGESEID 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 62/240 (25%), Positives = 109/240 (45%), Gaps = 32/240 (13%)

Query: 34  VLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMD 93
           V +D     + +    +   I+ +  LR +R V  YG  R          ++  L + ++
Sbjct: 35  VPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLR--------DPEEKKLSIFVE 86

Query: 94  YYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPD 153
           Y  GG +   L  +   L E++ + Y  +++  ++ +H    VHR          DIK  
Sbjct: 87  YMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHR----------DIKGA 135

Query: 154 NVLLDANGHIRLADFGSCLRLGG---DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPE 210
           N+L D+ G+++L DFG+  R+      GT   +V  GTP ++SPE+++    G G YG +
Sbjct: 136 NILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT-GTPYWMSPEVIS----GEG-YGRK 189

Query: 211 CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRL 270
            D WS+   + EML  + P+     +    KI        LP  V    SD  +D ++++
Sbjct: 190 ADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGV----SDACRDFLKQI 245

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 72.9 bits (179), Expect = 1e-14
 Identities = 57/216 (26%), Positives = 103/216 (47%), Gaps = 21/216 (9%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYL--VMDYYCGGDLLTLLSKFEDRLPED 114
           V  LR E + L   D   I  + Y   + +  YL   ++Y  GG + + L  +  R  E 
Sbjct: 52  VKALRSEIETLKDLDHLNI--VQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQ 108

Query: 115 MAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL 174
           + +F+  +++  +A +H    +HR          D+K DN+L+DA+G  +++DFG   + 
Sbjct: 109 LVRFFTEQVLEGLAYLHSKGILHR----------DLKADNLLVDADGICKISDFGIS-KK 157

Query: 175 GGD--GTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA 232
             D     Q+    G+  +++PE++ +  +G   Y  + D WSLG  + EM  G  P+  
Sbjct: 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQG---YSAKVDIWSLGCVVLEMFAGRRPWSD 214

Query: 233 ESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMR 268
           E  +    K+ N +++  +P DV   +S  A D + 
Sbjct: 215 EEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLN 250

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 49/152 (32%), Positives = 72/152 (47%), Gaps = 18/152 (11%)

Query: 77  NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYV 136
           NL   F+    L+LV +Y C   +L  L K    +PE + K  I + + A+   H  + +
Sbjct: 64  NLIEVFRRKRKLHLVFEY-CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCI 122

Query: 137 HRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL-GGDGTVQSNVAVGTPDYISPE 195
           HR          D+KP+N+L+   G I+L DFG    L G        VA  T  Y +PE
Sbjct: 123 HR----------DVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA--TRWYRAPE 170

Query: 196 ILTAMEEGRGRYGPECDWWSLGVCMYEMLYGE 227
           +L     G  +YGP  D W++G    E+L G+
Sbjct: 171 LLV----GDTQYGPPVDVWAIGCVFAELLTGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 47/170 (27%), Positives = 84/170 (49%), Gaps = 13/170 (7%)

Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE 122
           E D+L   D   I  L  AF  ++NL++++++  GG +  ++ + E  L E   +    +
Sbjct: 52  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQ 111

Query: 123 MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQS 182
            + A+  +H+   +H          RD+K  N+L   +G I+LADFG   +     T+Q 
Sbjct: 112 TLEALNYLHENKIIH----------RDLKAGNILFTLDGDIKLADFGVSAK--NTRTIQR 159

Query: 183 NVA-VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
             + +GTP +++PE++         Y  + D WSLG+ + EM   E P +
Sbjct: 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHH 209

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 48/149 (32%), Positives = 77/149 (51%), Gaps = 22/149 (14%)

Query: 85  DSNLYLVMDYYCG--GDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHF 142
           +   +LVM+Y  G   D+L +  K        + +  IA +     ++  L Y+H  +H 
Sbjct: 87  EHTAWLVMEYCLGSASDILEVHKK-------PLQEVEIAAICHG--ALQGLAYLH--SHE 135

Query: 143 AFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEE 202
             H  RDIK  N+LL   G ++LADFGS   +       +N  VGTP +++PE++ AM+E
Sbjct: 136 RIH--RDIKAGNILLTEPGTVKLADFGSASLVS-----PANSFVGTPYWMAPEVILAMDE 188

Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFY 231
             G+Y  + D WSLG+   E+   + P +
Sbjct: 189 --GQYDGKVDVWSLGITCIELAERKPPLF 215

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 71.4 bits (176), Expect = 4e-14
 Identities = 42/173 (24%), Positives = 67/173 (38%), Gaps = 29/173 (16%)

Query: 84  DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF----YIAEMVLAIAS----IHDLHY 135
           ++  LYLV++Y  GGDLL  L K     P           +    + IA     +    +
Sbjct: 67  EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKF 126

Query: 136 VHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYI--- 192
           VHR          D+   N L+  +  ++++DFG    +  D   +     G    I   
Sbjct: 127 VHR----------DLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK--TGGKLPIRWM 174

Query: 193 SPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
           +PE L       G +  + D WS GV ++E+   G TP+   S  E    +  
Sbjct: 175 APESLK-----DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK 222

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 72.0 bits (176), Expect = 4e-14
 Identities = 55/167 (32%), Positives = 81/167 (48%), Gaps = 18/167 (10%)

Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE 122
           E  VL   +  +I   + AF  D  + + M++  GG L  +L K   R+PE +       
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILG----- 106

Query: 123 MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQS 182
             ++IA I  L Y+ R  H   H  RD+KP N+L+++ G I+L DFG   +L       +
Sbjct: 107 -KVSIAVIKGLTYL-REKHKIMH--RDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA 159

Query: 183 NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           N  VGT  Y+SPE L         Y  + D WS+G+ + EM  G  P
Sbjct: 160 NSFVGTRSYMSPERLQGTH-----YSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 70.8 bits (173), Expect = 6e-14
 Identities = 51/190 (26%), Positives = 90/190 (47%), Gaps = 22/190 (11%)

Query: 84  DDSNLYLVMDYYCGGDLLTLLSKFEDRL-PEDMAKFYIAEMVLAIASIHDLHYVHRPNHF 142
           +D  LY+VM +  GGDL   L + + +L PE+    +  ++ +A+  +H+ H +HR    
Sbjct: 71  EDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHR---- 126

Query: 143 AFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEE 202
                 D+K  NV L     I++ D G    L     + S + +GTP Y+SPE+ +    
Sbjct: 127 ------DLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTL-IGTPYYMSPELFSNKP- 178

Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDD 262
               Y  + D W+LG C+YEM   +  F A+ +     +I+  +    +P D   E+   
Sbjct: 179 ----YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP-PMPKDYSPELG-- 231

Query: 263 AKDLMRRLIC 272
             +L+  ++ 
Sbjct: 232 --ELIATMLS 239

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 71.2 bits (174), Expect = 7e-14
 Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 14/209 (6%)

Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE 122
           E ++L   +  +I  L  AF  D  L++++++  GG +  ++ + +  L E   +    +
Sbjct: 59  EIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQ 118

Query: 123 MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQS 182
           M+ A+  +H +  +HR          D+K  NVLL  +G I+LADFG   +     T+Q 
Sbjct: 119 MLEALQYLHSMKIIHR----------DLKAGNVLLTLDGDIKLADFGVSAK--NVKTLQR 166

Query: 183 NVA-VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 241
             + +GTP +++PE++         Y  + D WSLG+ + EM   E P +  + +    K
Sbjct: 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK 226

Query: 242 IMNHQ-NSFDLPSDVGYEISDDAKDLMRR 269
           I   +  +   PS    E  D  K  + +
Sbjct: 227 IAKSEPPTLSQPSKWSMEFRDFLKTALDK 255

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 48/147 (32%), Positives = 75/147 (51%), Gaps = 18/147 (12%)

Query: 85  DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAF 144
           +   +LVM+Y C G    LL   +  L E      +    +   ++  L Y+H  +H   
Sbjct: 93  EHTAWLVMEY-CLGSASDLLEVHKKPLQE------VEIAAITHGALQGLAYLH--SHNMI 143

Query: 145 HLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR 204
           H  RDIK  N+LL   G ++LADFGS        +  +N  VGTP +++PE++ AM+E  
Sbjct: 144 H--RDIKAGNILLTEPGQVKLADFGS-----ASKSSPANSFVGTPYWMAPEVILAMDE-- 194

Query: 205 GRYGPECDWWSLGVCMYEMLYGETPFY 231
           G+Y  + D WSLG+   E+   + P +
Sbjct: 195 GQYDGKVDVWSLGITCIELAERKPPLF 221

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 40/128 (31%), Positives = 65/128 (50%), Gaps = 23/128 (17%)

Query: 108 EDRLPEDM-AKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLA 166
           +  +PE++  K       +A+A++  L+Y+        H  RD+KP N+LLD NG+I+L 
Sbjct: 101 KSVIPEEILGK-------IAVATVKALNYLKE-ELKIIH--RDVKPSNILLDRNGNIKLC 150

Query: 167 DFGSCLRLGGDGTVQSNVA----VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYE 222
           DFG        G +  ++A     G   Y++PE +      R  Y    D WSLG+ +YE
Sbjct: 151 DFGIS------GQLVDSIAKTRDAGCRPYMAPERIDP--SARDGYDVRSDVWSLGITLYE 202

Query: 223 MLYGETPF 230
           +  G+ P+
Sbjct: 203 VATGKFPY 210

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 18/167 (10%)

Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE 122
           E  VL   +  +I   + AF  D  + + M++  GG L  +L K   R+PE++       
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KEAKRIPEEILG----- 106

Query: 123 MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQS 182
             ++IA +  L Y+ R  H   H  RD+KP N+L+++ G I+L DFG   +L       +
Sbjct: 107 -KVSIAVLRGLAYL-REKHQIMH--RDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA 159

Query: 183 NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           N  VGT  Y+SPE L         Y  + D WS+G+ + E+  G  P
Sbjct: 160 NSFVGTRSYMSPERLQGTH-----YSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 69.0 bits (169), Expect = 3e-13
 Identities = 62/215 (28%), Positives = 96/215 (44%), Gaps = 38/215 (17%)

Query: 79  HY-AFQD--DSNLYLVMDYYCGGDLLTLLSKFED---RLPEDMAKFYIAEMVL-AIASIH 131
           +Y AF D   S++ + M+Y  GG L ++  K +    R+ E +    IAE VL  ++ +H
Sbjct: 64  YYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-KIAESVLKGLSYLH 122

Query: 132 DLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSC--LRLGGDGTVQSNVAVGTP 189
               +HR          DIKP N+LL   G ++L DFG    L     GT       GT 
Sbjct: 123 SRKIIHR----------DIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTF-----TGTS 167

Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETYGKIMN 244
            Y++PE +         Y    D WSLG+ + E+     PF  E       +E    I+N
Sbjct: 168 FYMAPERIQG-----KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN 222

Query: 245 HQNSFDLPSDVGYEI--SDDAKDLMRRLICSSDTR 277
              + +L  + G  I  S++ KD +++ +    TR
Sbjct: 223 -MPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTR 256

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 68.2 bits (166), Expect = 7e-13
 Identities = 48/143 (33%), Positives = 73/143 (51%), Gaps = 18/143 (12%)

Query: 89  YLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCR 148
           +LVM+Y C G    LL   +  L E      +    +   ++  L Y+H  +H   H  R
Sbjct: 101 WLVMEY-CLGSASDLLEVHKKPLQE------VEIAAITHGALQGLAYLH--SHNMIH--R 149

Query: 149 DIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYG 208
           DIK  N+LL   G ++LADFGS           +N  VGTP +++PE++ AM+E  G+Y 
Sbjct: 150 DIKAGNILLTEPGQVKLADFGS-----ASIASPANSFVGTPYWMAPEVILAMDE--GQYD 202

Query: 209 PECDWWSLGVCMYEMLYGETPFY 231
            + D WSLG+   E+   + P +
Sbjct: 203 GKVDVWSLGITCIELAERKPPLF 225

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 28/178 (15%)

Query: 54  IEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPE 113
           + F+ KLR    +   G           +  +   +LVM+Y C G    LL   +  L E
Sbjct: 66  VRFLQKLRHPNTIQYRG----------CYLREHTAWLVMEY-CLGSASDLLEVHKKPLQE 114

Query: 114 DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR 173
                 +    +   ++  L Y+H  +H   H  RD+K  N+LL   G ++L DFGS   
Sbjct: 115 ------VEIAAVTHGALQGLAYLH--SHNMIH--RDVKAGNILLSEPGLVKLGDFGSASI 164

Query: 174 LGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
           +       +N  VGTP +++PE++ AM+E  G+Y  + D WSLG+   E+   + P +
Sbjct: 165 MA-----PANXFVGTPYWMAPEVILAMDE--GQYDGKVDVWSLGITCIELAERKPPLF 215

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 67.2 bits (165), Expect = 2e-12
 Identities = 63/225 (28%), Positives = 98/225 (43%), Gaps = 49/225 (21%)

Query: 77  NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVL-AIASIHDLHY 135
           N+  A ++D ++YLV +Y    DL  ++      + ED+ K YI   +L A+  IH  + 
Sbjct: 74  NVIKA-ENDKDIYLVFEYM-ETDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSGNV 128

Query: 136 VHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVA----VGTPDY 191
           +HR          D+KP N+LL+++  ++LADFG    L        N      V T  Y
Sbjct: 129 IHR----------DLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWY 178

Query: 192 ISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN------H 245
            +PEIL     G  RY    D WS+G  + EML G+  F   S +    KI+        
Sbjct: 179 RAPEILL----GSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234

Query: 246 QNSFDLPSDVGYEI-------------------SDDAKDLMRRLI 271
           ++   + S     +                   SDDA DL+++L+
Sbjct: 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLL 279

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 41/144 (28%), Positives = 69/144 (47%), Gaps = 14/144 (9%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           L++ M++ CGG  L  +      L E    +   E +  +  +H    +HR         
Sbjct: 81  LWICMEF-CGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHR--------- 130

Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
            DIK  N+LL  NGH++LADFG   ++      +    +GTP +++PE+  A  E +G Y
Sbjct: 131 -DIKGANILLTDNGHVKLADFGVSAQITAT-IAKRKSFIGTPYWMAPEV--AAVERKGGY 186

Query: 208 GPECDWWSLGVCMYEMLYGETPFY 231
              CD W++G+   E+   + P +
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMF 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 66.4 bits (163), Expect = 2e-12
 Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 26/154 (16%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-LPEDMAKFYIAEMVLAIASIHDL 133
           I  L   F+++  LY V +Y   G+L  L+   + +   E + +  I +++  +A IH  
Sbjct: 60  IVKLKEVFRENDELYFVFEY-MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH 118

Query: 134 HYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSN----VAVGTP 189
            +        FH  RD+KP+N+L+     +++ADFG   R      ++S       V T 
Sbjct: 119 GF--------FH--RDLKPENLLVSGPEVVKIADFG-LAR-----EIRSRPPYTDYVSTR 162

Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM 223
            Y +PEIL         Y    D W+LG  M E+
Sbjct: 163 WYRAPEILLR----STSYSSPVDIWALGCIMAEL 192

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 65.3 bits (160), Expect = 6e-12
 Identities = 41/158 (25%), Positives = 71/158 (44%), Gaps = 16/158 (10%)

Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
            +Y+VM+Y    DL +L+   +    +   K  + +++  +A +HD   +HR        
Sbjct: 80  KIYMVMEYV-EHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHR-------- 130

Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+K  N+LL+  G +++ DFG     G      + + V T  Y +PE+L     G   
Sbjct: 131 --DLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPELLL----GAKE 183

Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
           Y    D WS+G    E+L  +  F  +S ++   KI  
Sbjct: 184 YSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFK 221

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 64.4 bits (157), Expect = 7e-12
 Identities = 46/145 (31%), Positives = 70/145 (48%), Gaps = 17/145 (11%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           +Y+VM+   GG LLT L K ++RL        + +M L  A+   + Y+   N    H  
Sbjct: 67  IYIVMELVPGGSLLTFLRKKKNRLT----VKKLLQMSLDAAA--GMEYLESKN--CIH-- 116

Query: 148 RDIKPDNVLLDANGHIRLADFG-SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
           RD+   N L+  N  ++++DFG S    GG  TV   +      + +PE L       GR
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY-----GR 171

Query: 207 YGPECDWWSLGVCMYEML-YGETPF 230
           Y  E D WS G+ ++E    G+TP+
Sbjct: 172 YTSESDVWSYGILLWETFSLGDTPY 196

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 50/167 (29%), Positives = 76/167 (45%), Gaps = 28/167 (16%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTL-LSKFEDRLPED------MAKFYIAEMVLAI 127
           I  L      +S LYL+ ++      L++ L K+ D LP+       + K Y+ +++  I
Sbjct: 61  IVCLQDVLMQESRLYLIFEF------LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGI 114

Query: 128 ASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVG 187
              H    +HR          D+KP N+L+D  G I+LADFG     G    V ++  V 
Sbjct: 115 LFCHSRRVLHR----------DLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV- 163

Query: 188 TPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES 234
           T  Y +PE+L     G  RY    D WS+G    EM   +  F+ +S
Sbjct: 164 TLWYRAPEVLL----GSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS 206

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 47/207 (22%), Positives = 80/207 (38%), Gaps = 40/207 (19%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDR-LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           L LV ++    DL T LSK     LP +  K  + +++  +  +H    VHR        
Sbjct: 81  LTLVFEH-VDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHR-------- 131

Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+L+ ++G +++ADFG       +  + S V   T  Y +PE+L         
Sbjct: 132 --DLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--TLWYRAPEVLLQSS----- 182

Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN---------------------H 245
           Y    D WS+G    E+      F   S  +   KI +                      
Sbjct: 183 YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFP 242

Query: 246 QNSFDLPSDVGYEISDDAKDLMRRLIC 272
             +         EI ++  DL+++++ 
Sbjct: 243 SYTPRSFKSFVPEICEEGLDLLKKMLT 269

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 64/246 (26%), Positives = 91/246 (36%), Gaps = 53/246 (21%)

Query: 89  YLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCR 148
           Y+V  Y    DL  LL     +L E   K Y+ +++  I  +H+ H +HR          
Sbjct: 91  YMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHR---------- 139

Query: 149 DIKPDNVLLDANGHIRLADFG----------SCLRLGGDGTVQSNVAVGTPDYISPEILT 198
           DIK  N+L+D  G +++ADFG          +    GG GT +    V T  Y  PE+L 
Sbjct: 140 DIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLL 199

Query: 199 AMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM---------NHQNSF 249
               G  RY    D W +G    EM         +S ++    I                
Sbjct: 200 ----GERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWR 255

Query: 250 DLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPR-------- 301
            LP   G E      +  R L    + R G+ G     + S L   LS+ P         
Sbjct: 256 SLP---GCEGVHSFTNYPRTL----EERFGKLGPEGLDLLSKL---LSLDPYKRLTASDA 305

Query: 302 -NHPWF 306
             HP+F
Sbjct: 306 LEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 63.3 bits (154), Expect = 3e-11
 Identities = 48/150 (32%), Positives = 71/150 (47%), Gaps = 18/150 (12%)

Query: 83  QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHF 142
           +D    YLV +Y    DL+ LL        ED  K ++ +++  +   H  +++HR    
Sbjct: 86  KDKGAFYLVFEYM-DHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHR---- 140

Query: 143 AFHLCRDIKPDNVLLDANGHIRLADFG-SCLRLGGDGTVQSNVAVGTPDYISPEILTAME 201
                 DIK  N+LL+  G I+LADFG + L    +    +N  V T  Y  PE+L   E
Sbjct: 141 ------DIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTN-KVITLWYRPPELLLGEE 193

Query: 202 EGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
               RYGP  D WS G C+   L+ + P +
Sbjct: 194 ----RYGPAIDVWSCG-CILGELFTKKPIF 218

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 63.2 bits (154), Expect = 4e-11
 Identities = 48/146 (32%), Positives = 66/146 (45%), Gaps = 28/146 (19%)

Query: 86  SNLYLVMDYYCGGDLLTLLS----KFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH 141
            + YLV ++ C  DL  LLS    KF   L E      I +++  + +   L+Y+HR   
Sbjct: 92  GSFYLVFEF-CEHDLAGLLSNKNVKFT--LSE------IKKVMKMLLN--GLYYIHRNKI 140

Query: 142 FAFHLCRDIKPDNVLLDANGHIRLADFG----SCLRLGGDGTVQSNVAVGTPDYISPEIL 197
               L RD+K  N+L+  +G ++LADFG      L         +N  V T  Y  PE+L
Sbjct: 141 ----LHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLWYRPPELL 195

Query: 198 TAMEEGRGRYGPECDWWSLGVCMYEM 223
                G   YGP  D W  G  M EM
Sbjct: 196 L----GERDYGPPIDMWGAGCIMAEM 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 62.4 bits (151), Expect = 4e-11
 Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 14/144 (9%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           L++ M+Y CGG  L  +      L E    +   E +  +A +H    +HR         
Sbjct: 81  LWICMEY-CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHR--------- 130

Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
            DIK  N+LL  NG ++LADFG   ++      +    +GTP +++PE+  A  E  G Y
Sbjct: 131 -DIKGANILLTDNGDVKLADFGVAAKITAT-IAKRKSFIGTPYWMAPEV--AAVEKNGGY 186

Query: 208 GPECDWWSLGVCMYEMLYGETPFY 231
              CD W++G+   E+   + P +
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMF 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 62.9 bits (154), Expect = 4e-11
 Identities = 46/205 (22%), Positives = 89/205 (43%), Gaps = 28/205 (13%)

Query: 75  ITNLHYAFQDDSN-----LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS 129
           I  L    +  S      +Y+V +     DL  ++ K    L +D  ++++ +++     
Sbjct: 61  IIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVI-KSPQPLTDDHIQYFLYQILRG--- 115

Query: 130 IHDLHYVHRPN--HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVA-- 185
              L Y+H  N  H      RD+KP N+L+++N  +++ DFG    +  D   +  +   
Sbjct: 116 ---LKYLHSANVIH------RDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166

Query: 186 VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           V T  Y +PE+L +      RY    D WS+G    E+L  +  F     ++    I+  
Sbjct: 167 VVTRWYRAPELLLSSS----RYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEV 222

Query: 246 QNSFDLPSDVGYEISDDAKDLMRRL 270
             +     D+ +  S+ A++ ++ L
Sbjct: 223 LGTPS-EEDLKFITSEKARNYLKSL 246

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 5e-11
 Identities = 50/156 (32%), Positives = 69/156 (44%), Gaps = 27/156 (17%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTL-LSKFEDRLPED-----MAKFYIAEMVLAIA 128
           I  L      ++ LYLV ++      L L L K+ D  P       + K Y+ +++  IA
Sbjct: 60  IVRLLDVVHSENKLYLVFEF------LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113

Query: 129 SIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGT 188
             H     HR  H      RD+KP N+L+D  G ++LADFG   R  G         V T
Sbjct: 114 YCHS----HRVLH------RDLKPQNLLIDREGALKLADFG-LARAFGVPVRTYTHEVVT 162

Query: 189 PDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML 224
             Y +PEIL     G  +Y    D WS+G    EM+
Sbjct: 163 LWYRAPEILL----GSRQYSTPVDIWSIGCIFAEMV 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 62.5 bits (152), Expect = 5e-11
 Identities = 52/173 (30%), Positives = 76/173 (43%), Gaps = 25/173 (14%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFED-----RLPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L KF D      +P  + K Y+ +++  +A 
Sbjct: 61  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115

Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H     HR  H      RD+KP N+L++  G I+LADFG     G      ++  V T 
Sbjct: 116 CHS----HRVLH------RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TL 164

Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 165 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 213

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 62.5 bits (152), Expect = 7e-11
 Identities = 43/114 (37%), Positives = 60/114 (52%), Gaps = 16/114 (14%)

Query: 120 IAEMVLA-IASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
           +A  +L+ IA +H  H VHR          DIKP N+L+++  ++++ADFG   R+    
Sbjct: 173 VARQILSGIAYLHRRHIVHR----------DIKPSNLLINSAKNVKIADFGVS-RILAQT 221

Query: 179 TVQSNVAVGTPDYISPE-ILTAMEEGRGRY-GPECDWWSLGVCMYEMLYGETPF 230
               N +VGT  Y+SPE I T +    G Y G   D WSLGV + E   G  PF
Sbjct: 222 MDPCNSSVGTIAYMSPERINTDLNH--GAYDGYAGDIWSLGVSILEFYLGRFPF 273

Length = 353

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 61.5 bits (149), Expect = 9e-11
 Identities = 53/193 (27%), Positives = 80/193 (41%), Gaps = 45/193 (23%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDL---LTLLSKFEDRLPEDMAKFYIAEMVLAIASIH 131
           I   H +F +     ++ +Y  G DL   L  L      L E+    +  +++L +  +H
Sbjct: 64  IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123

Query: 132 DLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG-SCLRLGGDGTVQSNVAVGTPD 190
               +HR          D+K  N+ L  N  +++ DFG S L +G      +    GTP 
Sbjct: 124 QRRILHR----------DLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDL--ATTFTGTPY 170

Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEM-------------------LYGETPFY 231
           Y+SPE L    +G   Y  + D WSLG  +YEM                   + G TP  
Sbjct: 171 YMSPEALK--HQG---YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTP-- 223

Query: 232 AESLVETYGKIMN 244
             SL ETY + +N
Sbjct: 224 --SLPETYSRQLN 234

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 61.4 bits (149), Expect = 9e-11
 Identities = 47/191 (24%), Positives = 91/191 (47%), Gaps = 26/191 (13%)

Query: 84  DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFA 143
           D  +L + ++Y  GG +  LL+ +     E + + ++ +++  +  +H+   +HR     
Sbjct: 77  DADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHR----- 130

Query: 144 FHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAV-----GTPDYISPEILT 198
                DIK  N+L+D  G I+++DFG   +L  +              G+  +++PE++ 
Sbjct: 131 -----DIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK 185

Query: 199 AMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYE 258
                +  Y  + D WSLG  + EML G+ PF   + ++   KI     S ++PS+    
Sbjct: 186 -----QTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI-GENASPEIPSN---- 235

Query: 259 ISDDAKDLMRR 269
           IS +A D + +
Sbjct: 236 ISSEAIDFLEK 246

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 44/151 (29%), Positives = 67/151 (44%), Gaps = 16/151 (10%)

Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           +++LVM+Y C  DL +LL        E   K       L +  +  L Y+H   +F  H 
Sbjct: 82  SIFLVMEY-CEQDLASLLDNMPTPFSESQVK------CLMLQLLRGLQYLHE--NFIIH- 131

Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
            RD+K  N+LL   G +++ADFG   R  G         V T  Y +PE+L         
Sbjct: 132 -RDLKVSNLLLTDKGCLKIADFG-LARTYGLPAKPMTPKVVTLWYRAPELLLGCTT---- 185

Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVE 237
           Y    D W++G  + E+L  +     +S +E
Sbjct: 186 YTTAIDMWAVGCILAELLAHKPLLPGKSEIE 216

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 61.7 bits (149), Expect = 3e-10
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 45/212 (21%)

Query: 46  REKTVSDFIEFVAKLRE--ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDL--- 100
           +E+  S  +  V  +RE   ++++ Y DR       +  + +  LY++M++   GDL   
Sbjct: 52  KEREKSQLVIEVNVMRELKHKNIVRYIDR-------FLNKANQKLYILMEFCDAGDLSRN 104

Query: 101 ----LTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL 156
                 +  K E+    D+ +    +++ A+A  H+L     PN     L RD+KP N+ 
Sbjct: 105 IQKCYKMFGKIEEHAIVDITR----QLLHALAYCHNLK--DGPNGERV-LHRDLKPQNIF 157

Query: 157 L---------------DANGH--IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTA 199
           L               + NG    ++ DFG    +G +    S   VGTP Y SPE+L  
Sbjct: 158 LSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHS--CVGTPYYWSPELL-- 213

Query: 200 MEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
           + E +  Y  + D W+LG  +YE+  G+TPF+
Sbjct: 214 LHETKS-YDDKSDMWALGCIIYELCSGKTPFH 244

Length = 1021

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 44/182 (24%), Positives = 75/182 (41%), Gaps = 38/182 (20%)

Query: 87  NLYLVMDYYCGGDLLTL--------LSKFED---RLPEDMAKFYIAEMVLAIASIHDLHY 135
           N+  ++D Y  GD + L        L K  D   RL E   K  + +++  +  +H  ++
Sbjct: 81  NIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYF 140

Query: 136 VHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD----- 190
           +HR          D+ P N+ +++ G  ++ADFG   R G      +     T       
Sbjct: 141 MHR----------DLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190

Query: 191 --------YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
                   Y +PE+L     G  +Y    D WS+G    E+L G+  F  E+ ++  G+I
Sbjct: 191 TSKVVTLWYRAPELLM----GAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI 246

Query: 243 MN 244
             
Sbjct: 247 FE 248

Length = 335

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 59.3 bits (144), Expect = 6e-10
 Identities = 41/157 (26%), Positives = 70/157 (44%), Gaps = 20/157 (12%)

Query: 81  AFQDDSNLYLVMDYYCGGDLLTLL-SKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRP 139
           +F  DS LY+V      G    LL + F + LPE    F + +++ A+  IH   ++H  
Sbjct: 67  SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIH-- 124

Query: 140 NHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNV------AVGTPDYIS 193
                   R +K  ++LL  +G + L+     + +   G  Q  V      +V    ++S
Sbjct: 125 --------RSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLS 176

Query: 194 PEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
           PE+L    +G   Y  + D +S+G+   E+  G  PF
Sbjct: 177 PEVLQQNLQG---YNEKSDIYSVGITACELANGHVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 59.1 bits (143), Expect = 7e-10
 Identities = 45/179 (25%), Positives = 80/179 (44%), Gaps = 27/179 (15%)

Query: 54  IEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPE 113
           +E   ++  E ++L   D  +I   + AF  ++ + +  ++  GG L         ++PE
Sbjct: 40  VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSL-----DVYRKIPE 94

Query: 114 DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR 173
            +       +V  +  +  L  +HR          D+KP N+L++  G ++L DFG   +
Sbjct: 95  HVLGRIAVAVVKGLTYLWSLKILHR----------DVKPSNMLVNTRGQVKLCDFGVSTQ 144

Query: 174 LGGDGTVQS--NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
           L     V S     VGT  Y++PE ++  +     YG   D WSLG+   E+  G  P+
Sbjct: 145 L-----VNSIAKTYVGTNAYMAPERISGEQ-----YGIHSDVWSLGISFMELALGRFPY 193

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 58.6 bits (142), Expect = 8e-10
 Identities = 49/172 (28%), Positives = 73/172 (42%), Gaps = 18/172 (10%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR--LPEDMAKFYIAEMVLAIASIHD 132
           I  LH     ++ L LV +Y    DL   +     R  L  +  K +  +++  IA  H+
Sbjct: 60  IVRLHDVIHTENKLMLVFEY-MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118

Query: 133 LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYI 192
              +HR          D+KP N+L++  G ++LADFG     G      SN  V T  Y 
Sbjct: 119 NRVLHR----------DLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYR 167

Query: 193 SPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
           +P++L     G   Y    D WS+G  M EM+ G   F   +  +   KI  
Sbjct: 168 APDVLL----GSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFR 215

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|214529 smart00133, S_TK_X, Extension to Ser/Thr-type protein kinases

 Score = 53.1 bits (128), Expect = 1e-09
 Identities = 20/63 (31%), Positives = 34/63 (53%), Gaps = 4/63 (6%)

Query: 308 GIAWDSI--RDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVG 365
           GI WD +  ++   P++P++ SPTDTS+FD +      +  L P  +  +      PF G
Sbjct: 2   GIDWDKLENKEIEPPFVPKIKSPTDTSNFDPEF--TEETPVLTPVDSPLSGGIQQEPFRG 59

Query: 366 FTF 368
           F++
Sbjct: 60  FSY 62

Length = 64

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 38/121 (31%), Positives = 61/121 (50%), Gaps = 12/121 (9%)

Query: 110 RLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG 169
            +PED+    + ++ ++I  +  L Y+H       H  RD+KP NVL++ NG ++L DFG
Sbjct: 99  TIPEDI----LGKIAVSI--VKALEYLHSKLS-VIH--RDVKPSNVLINRNGQVKLCDFG 149

Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
               L     V   +  G   Y++PE +      +G Y  + D WSLG+ M E+  G  P
Sbjct: 150 ISGYLVDS--VAKTIDAGCKPYMAPERINPELNQKG-YDVKSDVWSLGITMIELATGRFP 206

Query: 230 F 230
           +
Sbjct: 207 Y 207

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 50/172 (29%), Positives = 77/172 (44%), Gaps = 22/172 (12%)

Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYY-CGGDLLTLLSKFEDRLPEDMAKFYIA 121
           E D+L     R I NL +A++  S + +VM  Y C  DL T + +      E      I 
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC--DLFTYVDRSGPLPLEQA--ITIQ 191

Query: 122 EMVL-AIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG-DGT 179
             +L A+A +H    +HR          D+K +N+ LD   +  L DFG+  +L     T
Sbjct: 192 RRLLEALAYLHGRGIIHR----------DVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241

Query: 180 VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
            Q     GT +  SPE+L A++     Y  + D WS G+ ++EM       +
Sbjct: 242 PQCYGWSGTLETNSPELL-ALDP----YCAKTDIWSAGLVLFEMSVKNVTLF 288

Length = 392

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 53/176 (30%), Positives = 81/176 (46%), Gaps = 22/176 (12%)

Query: 85  DSNLYLVMDYYCGGDLLTLLSKFEDR-LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFA 143
           ++ L LV ++    DL T L K  +  +P +     I +M+  +    D  + HR  H  
Sbjct: 81  ETKLTLVFEH-VDQDLTTYLDKVPEPGVPTET----IKDMMFQLLRGLDFLHSHRVVH-- 133

Query: 144 FHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEG 203
               RD+KP N+L+ ++G I+LADFG   R+       ++V V T  Y +PE+L      
Sbjct: 134 ----RDLKPQNILVTSSGQIKLADFG-LARIYSFQMALTSVVV-TLWYRAPEVLL----- 182

Query: 204 RGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN---HQNSFDLPSDVG 256
           +  Y    D WS+G    EM   +  F   S V+  GKI++        D P DV 
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 32/197 (16%)

Query: 82  FQDDSNL------YLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHY 135
           F  D +L      YLVM +  G DL  L+    ++L ED  +F + +M+  +  IH    
Sbjct: 83  FTPDLSLDRFHDFYLVMPFM-GTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAGI 139

Query: 136 VHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPE 195
           +HR          D+KP N+ ++ +  +++ DFG  L    D  +   V   T  Y +PE
Sbjct: 140 IHR----------DLKPGNLAVNEDCELKILDFG--LARQTDSEMTGYVV--TRWYRAPE 185

Query: 196 -ILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSD 254
            IL  M      Y    D WS+G  M EML G+  F     ++   +IM    +     +
Sbjct: 186 VILNWM-----HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGT--PSKE 238

Query: 255 VGYEI-SDDAKDLMRRL 270
              ++ S+DAK+ +++L
Sbjct: 239 FVQKLQSEDAKNYVKKL 255

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 57.4 bits (138), Expect = 4e-09
 Identities = 43/135 (31%), Positives = 64/135 (47%), Gaps = 19/135 (14%)

Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH-IRLADFG 169
           LP  + K Y  ++  A+A IH     HR          D+KP N+L+D N H ++L DFG
Sbjct: 167 LPLFLVKLYSYQLCRALAYIHSKFICHR----------DLKPQNLLIDPNTHTLKLCDFG 216

Query: 170 SCLRL-GGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGET 228
           S   L  G  +V     + +  Y +PE++     G   Y    D WSLG  + EM+ G  
Sbjct: 217 SAKNLLAGQRSVSY---ICSRFYRAPELML----GATNYTTHIDLWSLGCIIAEMILGYP 269

Query: 229 PFYAESLVETYGKIM 243
            F  +S V+   +I+
Sbjct: 270 IFSGQSSVDQLVRII 284

Length = 440

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 56.1 bits (135), Expect = 8e-09
 Identities = 46/165 (27%), Positives = 74/165 (44%), Gaps = 26/165 (15%)

Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRP 139
           +  +  + YLVM Y     + T L K     L ED  ++ + +M+  +  IH    +HR 
Sbjct: 88  SGDEFQDFYLVMPY-----MQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHR- 141

Query: 140 NHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPE-ILT 198
                    D+KP N+ ++ +  +++ DFG  L    D  +   V   T  Y +PE IL 
Sbjct: 142 ---------DLKPGNLAVNEDCELKILDFG--LARHADAEMTGYVV--TRWYRAPEVILN 188

Query: 199 AMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
            M      Y    D WS+G  M EML G+T F  +  ++   +I+
Sbjct: 189 WMH-----YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 228

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 40/149 (26%), Positives = 67/149 (44%), Gaps = 33/149 (22%)

Query: 90  LVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRD 149
           +V+ +Y   DL T L+K    LP D A     +++  +  +H    +HR          D
Sbjct: 134 MVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHR----------D 182

Query: 150 IKPDNVLLDANGHIRLADFGSC-------LRLGGDGTVQSNVAVGTPDYISPEILTAMEE 202
           +K +N+ ++    + + D G+          LG  GTV++N         +PE+L     
Sbjct: 183 VKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETN---------APEVL----- 228

Query: 203 GRGRYGPECDWWSLGVCMYEML-YGETPF 230
            R +Y  + D WS G+ ++EML Y  T F
Sbjct: 229 ARDKYNSKADIWSAGIVLFEMLAYPSTIF 257

Length = 357

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 34/104 (32%), Positives = 49/104 (47%), Gaps = 4/104 (3%)

Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
           H A  L RDIKP N+L+++N  +++ DFG       D +      V T  Y +PEIL   
Sbjct: 120 HSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILM-- 177

Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
             G   Y    D WS+G    E+L     F A+S ++    I +
Sbjct: 178 --GSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITD 219

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 45/163 (27%), Positives = 69/163 (42%), Gaps = 17/163 (10%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  LH     D +L LV +Y    DL   +    + +     K ++ +++  +A  H   
Sbjct: 66  IVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK 124

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          D+KP N+L++  G ++LADFG            SN  V T  Y  P
Sbjct: 125 VLHR----------DLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPP 173

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 237
           ++L     G   Y  + D W +G   +EM  G  P +  S VE
Sbjct: 174 DVLL----GSSEYSTQIDMWGVGCIFFEMASGR-PLFPGSTVE 211

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 51/190 (26%), Positives = 85/190 (44%), Gaps = 35/190 (18%)

Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           ++Y V +   G DL  LL+     L +   ++++ +++  +  +H    VHR        
Sbjct: 84  DIYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHR-------- 132

Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+L++ N  +++ DFG    L      Q    V T  Y +PEI+   +    +
Sbjct: 133 --DLKPSNILINENCDLKICDFG----LARIQDPQMTGYVSTRYYRAPEIMLTWQ----K 182

Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y  E D WS G    EML G+  F         GK  +H N F + +D+   +     D+
Sbjct: 183 YDVEVDIWSAGCIFAEMLEGKPLF--------PGK--DHVNQFSIITDL---LGTPPDDV 229

Query: 267 MRRLICSSDT 276
           +   ICS +T
Sbjct: 230 INT-ICSENT 238

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 54.6 bits (132), Expect = 3e-08
 Identities = 45/163 (27%), Positives = 76/163 (46%), Gaps = 24/163 (14%)

Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH 141
           FQD   +YLV  +  G DL  ++ K + +L +D  +F + +++  +  IH    +HR   
Sbjct: 92  FQD---VYLVT-HLMGADLNNIV-KCQ-KLSDDHIQFLVYQILRGLKYIHSAGIIHR--- 142

Query: 142 FAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAME 201
                  D+KP N+ ++ +  +++ DFG    L      +    V T  Y +PEI+    
Sbjct: 143 -------DLKPSNIAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIML--- 188

Query: 202 EGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
                Y    D WS+G  M E+L G+T F     ++   +IMN
Sbjct: 189 -NWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMN 230

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|215917 pfam00433, Pkinase_C, Protein kinase C terminal domain

 Score = 49.2 bits (118), Expect = 3e-08
 Identities = 16/46 (34%), Positives = 22/46 (47%), Gaps = 2/46 (4%)

Query: 324 EVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFT 369
           +V SPTDTS+FD +         L P  +    S   L F GF++ 
Sbjct: 1   KVKSPTDTSNFDPEF--TSEPPKLSPPDSEVLSSIDQLEFRGFSYV 44

Length = 47

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 49/163 (30%), Positives = 70/163 (42%), Gaps = 17/163 (10%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  LH     + +L LV +Y    DL   L    + +     K ++ ++      +  L+
Sbjct: 66  IVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQL------LRGLN 118

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
           Y HR       L RD+KP N+L++  G ++LADFG            SN  V T  Y  P
Sbjct: 119 YCHRRKV----LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPP 173

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 237
           +IL     G   Y  + D W +G   YEM  G  P +  S VE
Sbjct: 174 DILL----GSTDYSTQIDMWGVGCIFYEMSTGR-PLFPGSTVE 211

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 53.7 bits (129), Expect = 4e-08
 Identities = 54/175 (30%), Positives = 74/175 (42%), Gaps = 28/175 (16%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTL-LSKFEDRLPE-----DMAKFYIAEMVLAIA 128
           I  L      +  LYLV +Y      L L L K  D  P+      + K Y+ +++  IA
Sbjct: 63  IVRLQDVVHSEKRLYLVFEY------LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116

Query: 129 SIHDLHYVHRPNHFAFHLCRDIKPDNVLLD-ANGHIRLADFGSCLRLGGDGTVQSNVAVG 187
             H     HR  H      RD+KP N+L+D     ++LADFG   R  G         V 
Sbjct: 117 YCHS----HRVLH------RDLKPQNLLIDRRTNALKLADFG-LARAFGIPVRTFTHEVV 165

Query: 188 TPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
           T  Y +PEIL     G   Y    D WS+G    EM+  +  F  +S ++   KI
Sbjct: 166 TLWYRAPEILL----GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI 216

Length = 294

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 53.5 bits (128), Expect = 6e-08
 Identities = 43/156 (27%), Positives = 64/156 (41%), Gaps = 16/156 (10%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  LH        L LV +Y    DL   + K    L  +  K ++ +++  ++ IH  +
Sbjct: 65  IVLLHDIIHTKETLTLVFEY-VHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY 123

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          D+KP N+L+   G ++LADFG            SN  V T  Y  P
Sbjct: 124 ILHR----------DLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPP 172

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
           ++L     G   Y    D W +G    EM+ G   F
Sbjct: 173 DVLL----GSTEYSTCLDMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 54.4 bits (131), Expect = 6e-08
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 44/202 (21%)

Query: 80  YAFQDDSNL-YLVMDYYCGGDLLTLLSKF--EDRLPEDMAKFYIAEMVLAIASIHD---- 132
           Y+   D +  Y  M Y  G  L +LL     ++ L +++A       V A  SI      
Sbjct: 68  YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELA---EKTSVGAFLSIFHKICA 124

Query: 133 -LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVA------ 185
            + YVH        L RD+KPDN+LL   G + + D+G+ +    +     ++       
Sbjct: 125 TIEYVHSKGV----LHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180

Query: 186 -----------VGTPDYISPEILTAMEEGRGRYGPE-CDWWSLGVCMYEMLYGETPFYAE 233
                      VGTPDY++PE L       G    E  D ++LGV +Y+ML    P+  +
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERL------LGVPASESTDIYALGVILYQMLTLSFPYRRK 234

Query: 234 SLVETYGKIMNHQNSFDLPSDV 255
                 G+ +++++    P +V
Sbjct: 235 K-----GRKISYRDVILSPIEV 251

Length = 932

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 53.3 bits (128), Expect = 6e-08
 Identities = 45/169 (26%), Positives = 71/169 (42%), Gaps = 35/169 (20%)

Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDR--------LPEDMAKFYIAEMVLAIASIHDLHYVH 137
            +LYLV +Y     L + L KF D         LP    K ++ +++  +A  H    +H
Sbjct: 79  PSLYLVFEY-----LDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMH 133

Query: 138 RPNHFAFHLCRDIKPDNVLLD-ANGHIRLADFGSCLRLGGDGTV---QSNVAVGTPDYIS 193
           R          D+KP N+L+D   G +++AD G    LG   ++        + T  Y +
Sbjct: 134 R----------DLKPQNLLVDKQKGLLKIADLG----LGRAFSIPVKSYTHEIVTLWYRA 179

Query: 194 PEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
           PE+L     G   Y    D WS+G    EM   +  F  +S ++    I
Sbjct: 180 PEVLL----GSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHI 224

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 53.5 bits (129), Expect = 7e-08
 Identities = 38/141 (26%), Positives = 67/141 (47%), Gaps = 19/141 (13%)

Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           ++Y+VMD     DL  ++   +  L E+  ++++ +++  +  IH  + +HR        
Sbjct: 82  DVYVVMDLM-ESDLHHIIHSDQP-LTEEHIRYFLYQLLRGLKYIHSANVIHR-------- 131

Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVA---VGTPDYISPEILTAMEEG 203
             D+KP N+L++ +  +R+ DFG    L    T         V T  Y +PE+L ++ E 
Sbjct: 132 --DLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPE- 188

Query: 204 RGRYGPECDWWSLGVCMYEML 224
              Y    D WS+G    EML
Sbjct: 189 ---YTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 52.4 bits (126), Expect = 9e-08
 Identities = 39/161 (24%), Positives = 70/161 (43%), Gaps = 16/161 (9%)

Query: 85  DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAF 144
           ++ +++VM+    G+L + L   +  L       Y  ++  A+A +    +VH       
Sbjct: 78  ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVH------- 130

Query: 145 HLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR 204
              RDI   NVL+ +   ++L DFG    L  +   +++       +++PE +       
Sbjct: 131 ---RDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR---- 183

Query: 205 GRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
            R+    D W  GVCM+E+L  G  PF      +  G+I N
Sbjct: 184 -RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN 223

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 23/164 (14%)

Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ + +YLV +   G DL  ++ K + +L ++  +F I +++  +  IH    +HR  
Sbjct: 88  SIENFNEVYLVTNLM-GADLNNIV-KCQ-KLSDEHVQFLIYQLLRGLKYIHSAGIIHR-- 142

Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEI-LTA 199
                   D+KP NV ++ +  +R+ DFG  L    D  +   VA  T  Y +PEI L  
Sbjct: 143 --------DLKPSNVAVNEDCELRILDFG--LARQADDEMTGYVA--TRWYRAPEIMLNW 190

Query: 200 MEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
           M      Y    D WS+G  M E+L G+  F     ++   +IM
Sbjct: 191 MH-----YNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIM 229

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 43/163 (26%), Positives = 67/163 (41%), Gaps = 16/163 (9%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  LH     +  L LV +Y    DL   L    + +     K ++ +++  ++  H   
Sbjct: 65  IVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK 123

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          D+KP N+L++  G ++LADFG            SN  V T  Y  P
Sbjct: 124 ILHR----------DLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPP 172

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 237
           ++L     G   Y    D W +G  +YEM  G   F   ++ E
Sbjct: 173 DVLL----GSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE 211

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 42/137 (30%), Positives = 65/137 (47%), Gaps = 19/137 (13%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLP-EDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           +Y+VM+   GGD L+ L K +D L  + + KF       A+ +   + Y+   N    H 
Sbjct: 67  IYIVMELVPGGDFLSFLRKKKDELKTKQLVKF-------ALDAAAGMAYLESKN--CIH- 116

Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRG 205
            RD+   N L+  N  ++++DFG   R   DG   S+     P  + +PE L       G
Sbjct: 117 -RDLAARNCLVGENNVLKISDFGMS-RQEDDGIYSSSGLKQIPIKWTAPEALN-----YG 169

Query: 206 RYGPECDWWSLGVCMYE 222
           RY  E D WS G+ ++E
Sbjct: 170 RYSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 43/163 (26%), Positives = 69/163 (42%), Gaps = 16/163 (9%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L+     D  L LV +Y C  DL          +  ++ K ++ +++  +A  H  +
Sbjct: 61  IVRLYDVLHSDKKLTLVFEY-CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN 119

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          D+KP N+L++ NG ++LADFG   R  G      +  V T  Y  P
Sbjct: 120 VLHR----------DLKPQNLLINKNGELKLADFG-LARAFGIPVRCYSAEVVTLWYRPP 168

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 237
           ++L     G   Y    D WS G    E+     P +  + V+
Sbjct: 169 DVLF----GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 207

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 50.5 bits (121), Expect = 5e-07
 Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 20/157 (12%)

Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH 141
           F+D   +Y+V +     DL  ++ K  D L  +  +F++ +++ A      L Y+H  N 
Sbjct: 76  FKD---IYVVFELM-ESDLHQVI-KANDDLTPEHHQFFLYQLLRA------LKYIHTAN- 123

Query: 142 FAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG--TVQSNVAVGTPDYISPEILTA 199
             FH  RD+KP N+L +A+  +++ DFG       D    +     V T  Y +PE+  +
Sbjct: 124 -VFH--RDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180

Query: 200 MEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
                 +Y P  D WS+G    E+L G+  F  +++V
Sbjct: 181 F---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 214

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 50.5 bits (121), Expect = 5e-07
 Identities = 46/170 (27%), Positives = 68/170 (40%), Gaps = 30/170 (17%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDM----AKFYIAEMVLAIASI 130
           I  LH        L LV +Y     L T L ++ D     +     + ++ +++  +A  
Sbjct: 65  IVTLHDIIHTKKTLTLVFEY-----LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYC 119

Query: 131 HDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNV---AVG 187
           H    +HR          D+KP N+L+   G ++LADFG    L    +V S      V 
Sbjct: 120 HQRRVLHR----------DLKPQNLLISERGELKLADFG----LARAKSVPSKTYSNEVV 165

Query: 188 TPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 237
           T  Y  P++L     G   Y    D W +G   YEM  G   F   + VE
Sbjct: 166 TLWYRPPDVLL----GSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE 211

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 50.1 bits (120), Expect = 8e-07
 Identities = 41/138 (29%), Positives = 61/138 (44%), Gaps = 10/138 (7%)

Query: 133 LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYI 192
           L Y+H  N     L RD+KP N+LL+AN  +++ DFG   R   +        V T  Y 
Sbjct: 121 LKYIHSANV----LHRDLKPSNLLLNANCDLKICDFG-LARTTSEKGDFMTEYVVTRWYR 175

Query: 193 SPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLP 252
           +PE+L    E    Y    D WS+G    E+L  +  F  +  V     I     S    
Sbjct: 176 APELLLNCSE----YTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPS-E 230

Query: 253 SDVGYEISDDAKDLMRRL 270
            D+G+  ++ A+  +R L
Sbjct: 231 EDLGFIRNEKARRYIRSL 248

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 48.8 bits (116), Expect = 1e-06
 Identities = 43/147 (29%), Positives = 65/147 (44%), Gaps = 18/147 (12%)

Query: 99  DLLTLLSKFEDR-LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL 157
           DL T L K     LP +  K  + + +  +  +H    VHR          D+KP+N+L+
Sbjct: 92  DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHR----------DLKPENILV 141

Query: 158 DANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLG 217
            + G ++LADFG   R+       + V V T  Y +PE+L      +  Y    D WS+G
Sbjct: 142 TSGGQVKLADFG-LARIYSCQMALTPVVV-TLWYRAPEVLL-----QSTYATPVDMWSVG 194

Query: 218 VCMYEMLYGETPFYAESLVETYGKIMN 244
               EM   +  F   S  +  GKI +
Sbjct: 195 CIFAEMFRRKPLFCGNSEADQLGKIFD 221

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 43/159 (27%), Positives = 64/159 (40%), Gaps = 22/159 (13%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  LH        L  V +Y    DL   + +    L     + ++ +++  +A IH  H
Sbjct: 65  IVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH 123

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNV---AVGTPDY 191
            +HR          D+KP N+L+   G ++LADFG    L    ++ S      V T  Y
Sbjct: 124 ILHR----------DLKPQNLLISYLGELKLADFG----LARAKSIPSQTYSSEVVTLWY 169

Query: 192 ISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
             P++L     G   Y    D W  G    EML G+  F
Sbjct: 170 RPPDVLL----GATDYSSALDIWGAGCIFIEMLQGQPAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 38/164 (23%), Positives = 69/164 (42%), Gaps = 24/164 (14%)

Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH 141
           FQD   +Y+VM+         L    +  L  +   + + +M+  I  +H    +HR   
Sbjct: 101 FQD---VYIVMELMDA----NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR--- 150

Query: 142 FAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAME 201
                  D+KP N+++ ++  +++ DFG     G    +   V   T  Y +PE++  M 
Sbjct: 151 -------DLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMG 201

Query: 202 EGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
                Y    D WS+G  M EM+ G   F     ++ + K++  
Sbjct: 202 -----YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 48.2 bits (114), Expect = 4e-06
 Identities = 32/103 (31%), Positives = 47/103 (45%), Gaps = 15/103 (14%)

Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ 181
           +++ A+  IHD   +HR          DIK +N+ L+ +G I L DFG+ +    +    
Sbjct: 275 QLLCAVEYIHDKKLIHR----------DIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF 324

Query: 182 SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML 224
               VGT    SPEIL         Y    D WS G+ + +ML
Sbjct: 325 DYGWVGTVATNSPEIL-----AGDGYCEITDIWSCGLILLDML 362

Length = 501

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)

Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 90  SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 144

Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG    L      +    V T  Y +PEI+   
Sbjct: 145 --------DLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLNW 192

Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 193 MH----YNQTVDIWSVGCIMAELLTGRTLF 218

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 47.8 bits (113), Expect = 5e-06
 Identities = 39/164 (23%), Positives = 71/164 (43%), Gaps = 24/164 (14%)

Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH 141
           FQD   +YLVM+         L    +  L  +   + + +M+  I  +H    +HR   
Sbjct: 94  FQD---VYLVMELMDA----NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR--- 143

Query: 142 FAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAME 201
                  D+KP N+++ ++  +++ DFG   R  G   + +   V T  Y +PE++  M 
Sbjct: 144 -------DLKPSNIVVKSDCTLKILDFG-LARTAGTSFMMTPYVV-TRYYRAPEVILGMG 194

Query: 202 EGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
                Y    D WS+G  M EM+  +  F     ++ + K++  
Sbjct: 195 -----YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 47.3 bits (113), Expect = 6e-06
 Identities = 34/124 (27%), Positives = 56/124 (45%), Gaps = 18/124 (14%)

Query: 110 RLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG 169
            L  D  ++++ +++  +  IH  + +HR          D+KP N+LL+ N  +++ DFG
Sbjct: 102 HLSNDHIQYFLYQILRGLKYIHSANVLHR----------DLKPSNLLLNTNCDLKICDFG 151

Query: 170 SCLRL---GGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYG 226
              R+     D T      V T  Y +PEI+   +     Y    D WS+G  + EML  
Sbjct: 152 -LARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKG----YTKAIDIWSVGCILAEMLSN 206

Query: 227 ETPF 230
              F
Sbjct: 207 RPLF 210

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 46.9 bits (111), Expect = 6e-06
 Identities = 45/158 (28%), Positives = 72/158 (45%), Gaps = 27/158 (17%)

Query: 80  YAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR---LPE--DMAKFYIAEMVLAIASIHDLH 134
           YA   +  +Y+V +Y   G LL  L   E R   LP   DMA    A++   +A I  ++
Sbjct: 67  YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMA----AQVAAGMAYIERMN 122

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYIS 193
           Y+HR          D++  N+L+      ++ADFG   RL  D    +      P  + +
Sbjct: 123 YIHR----------DLRSANILVGDGLVCKIADFG-LARLIEDNEYTARQGAKFPIKWTA 171

Query: 194 PEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPF 230
           PE   A+    GR+  + D WS G+ + E++  G  P+
Sbjct: 172 PE--AAL---YGRFTIKSDVWSFGILLTELVTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 47.3 bits (112), Expect = 7e-06
 Identities = 31/108 (28%), Positives = 49/108 (45%), Gaps = 27/108 (25%)

Query: 133 LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGS-CLRL--------GGDGTVQSN 183
           + Y+H   +   H  RDIK +N+ ++  G + L DFG+ C  +        G  GT+ +N
Sbjct: 195 IQYLH--ENRIIH--RDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATN 250

Query: 184 VAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
                    +PE+L      R  YGP  D WS G+ ++EM       +
Sbjct: 251 ---------APELL-----ARDPYGPAVDIWSAGIVLFEMATCHDSLF 284

Length = 391

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 46.3 bits (110), Expect = 8e-06
 Identities = 41/193 (21%), Positives = 79/193 (40%), Gaps = 30/193 (15%)

Query: 54  IEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPE 113
           ++ + +LR +           + +L         +Y++ +    G LL  L   E ++  
Sbjct: 53  VQALKRLRHKH----------LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLP 102

Query: 114 DMAKFYIAEMVL-AIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCL 172
             +   +A  V   +A + + + +HR          D+   N+L+  +   ++ADFG   
Sbjct: 103 VASLIDMACQVAEGMAYLEEQNSIHR----------DLAARNILVGEDLVCKVADFGLAR 152

Query: 173 RLGGDGTVQSNVAVGTPDYISPEILTAMEE-GRGRYGPECDWWSLGVCMYEML-YGETPF 230
            +  D  + S+  +       P   TA E    G +  + D WS G+ +YEM  YG+ P+
Sbjct: 153 LIKEDVYLSSDKKI-------PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPY 205

Query: 231 YAESLVETYGKIM 243
              +  E Y +I 
Sbjct: 206 PGMNNHEVYDQIT 218

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 46.9 bits (111), Expect = 9e-06
 Identities = 38/162 (23%), Positives = 67/162 (41%), Gaps = 24/162 (14%)

Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH 141
           FQD   +YLVM+         L       L  +   + + +M+  I  +H    +HR   
Sbjct: 98  FQD---VYLVMELMDA----NLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHR--- 147

Query: 142 FAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAME 201
                  D+KP N+++ ++  +++ DFG  L             V T  Y +PE++  M 
Sbjct: 148 -------DLKPSNIVVKSDCTLKILDFG--LARTACTNFMMTPYVVTRYYRAPEVILGM- 197

Query: 202 EGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
                Y    D WS+G  M E++ G   F     ++ + K++
Sbjct: 198 ----GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVI 235

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 41/155 (26%), Positives = 62/155 (40%), Gaps = 41/155 (26%)

Query: 83  QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHF 142
           Q    L L+M+Y   G L   L K +  L + +   +  ++   +A +H  HY+HR    
Sbjct: 78  QGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL--LFAQQICEGMAYLHSQHYIHR---- 131

Query: 143 AFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEE 202
                 D+   NVLLD +  +++ DFG              +A   P+    E     E+
Sbjct: 132 ------DLAARNVLLDNDRLVKIGDFG--------------LAKAVPE--GHEYYRVRED 169

Query: 203 GRGR---YGPEC----------DWWSLGVCMYEML 224
           G      Y  EC          D WS GV +YE+L
Sbjct: 170 GDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 30/144 (20%), Positives = 62/144 (43%), Gaps = 18/144 (12%)

Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           +L L+M+Y   G L   L +  D++       + +++   +  +    Y+HR        
Sbjct: 82  SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHR-------- 133

Query: 147 CRDIKPDNVLLDANGHIRLADFG-SCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGR 204
             D+   N+L+++   ++++DFG + +               +P  + +PE L       
Sbjct: 134 --DLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR-----T 186

Query: 205 GRYGPECDWWSLGVCMYEML-YGE 227
            ++    D WS GV +YE+  YG+
Sbjct: 187 SKFSSASDVWSFGVTLYELFTYGD 210

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 40/158 (25%), Positives = 70/158 (44%), Gaps = 24/158 (15%)

Query: 82  FQDDSNLYLV---MDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHR 138
           F  D+ L++V   M Y    DL+   + F D + E    + +  ++ A+  IH + YVH 
Sbjct: 68  FIADNELWVVTSFMAYGSAKDLIC--THFMDGMSELAIAYILQGVLKALDYIHHMGYVH- 124

Query: 139 PNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNV------AVGTPDYI 192
                    R +K  ++L+  +G + L+   S L +   G     V      +V    ++
Sbjct: 125 ---------RSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWL 175

Query: 193 SPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
           SPE+L    +G   Y  + D +S+G+   E+  G  PF
Sbjct: 176 SPEVLQQNLQG---YDAKSDIYSVGITACELANGHVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 37/147 (25%), Positives = 64/147 (43%), Gaps = 18/147 (12%)

Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
            L LVM+   GG L   LS  +D +        + ++ + +  +   ++VHR        
Sbjct: 68  ALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR-------- 119

Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGT-P-DYISPEILTAMEEGR 204
             D+   NVLL    + +++DFG    LG D +     + G  P  + +PE +       
Sbjct: 120 --DLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR---- 173

Query: 205 GRYGPECDWWSLGVCMYEML-YGETPF 230
            ++    D WS G+ M+E   YG+ P+
Sbjct: 174 -KFSSRSDVWSYGITMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 42/158 (26%), Positives = 73/158 (46%), Gaps = 27/158 (17%)

Query: 80  YAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR---LPE--DMAKFYIAEMVLAIASIHDLH 134
           YA   +  +Y+V ++   G LL  L + + +   LP+  DMA    A++   +A I  ++
Sbjct: 67  YAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMA----AQIADGMAYIERMN 122

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYIS 193
           Y+HR          D++  N+L+  N   ++ADFG   RL  D    +      P  + +
Sbjct: 123 YIHR----------DLRAANILVGDNLVCKIADFG-LARLIEDNEYTARQGAKFPIKWTA 171

Query: 194 PEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPF 230
           PE         GR+  + D WS G+ + E++  G  P+
Sbjct: 172 PEAAL-----YGRFTIKSDVWSFGILLTELVTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 44.8 bits (106), Expect = 3e-05
 Identities = 48/190 (25%), Positives = 81/190 (42%), Gaps = 29/190 (15%)

Query: 52  DFIE---FVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE 108
           DFIE    + KL   + V +YG                 LY+V ++   G LL  L + +
Sbjct: 45  DFIEEAKVMMKLSHPKLVQLYG----------VCTQQKPLYIVTEFMENGCLLNYLRQRQ 94

Query: 109 DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADF 168
            +L +DM    +  M   +     + Y+ R +     + RD+   N L+ + G ++++DF
Sbjct: 95  GKLSKDM----LLSMCQDVC--EGMEYLERNSF----IHRDLAARNCLVSSTGVVKVSDF 144

Query: 169 GSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GE 227
           G    +  D    S+ A     +  PE+         +Y  + D WS GV M+E+   G+
Sbjct: 145 GMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF-----SKYSSKSDVWSFGVLMWEVFTEGK 199

Query: 228 TPFYAESLVE 237
            PF  +S  E
Sbjct: 200 MPFEKKSNYE 209

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 44.7 bits (105), Expect = 3e-05
 Identities = 49/183 (26%), Positives = 79/183 (43%), Gaps = 38/183 (20%)

Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFED---RL 111
           + + KLR E+ V +Y           A   +  +Y+V +Y   G LL  L        RL
Sbjct: 53  QVMKKLRHEKLVQLY-----------AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRL 101

Query: 112 PE--DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG 169
           P+  DMA    A++   +A +  ++YVHR          D++  N+L+  N   ++ADFG
Sbjct: 102 PQLVDMA----AQIASGMAYVERMNYVHR----------DLRAANILVGENLVCKVADFG 147

Query: 170 SCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GE 227
              RL  D    +      P  + +PE         GR+  + D WS G+ + E+   G 
Sbjct: 148 -LARLIEDNEYTARQGAKFPIKWTAPEAAL-----YGRFTIKSDVWSFGILLTELTTKGR 201

Query: 228 TPF 230
            P+
Sbjct: 202 VPY 204

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 42/191 (21%), Positives = 75/191 (39%), Gaps = 31/191 (16%)

Query: 46  REKTVS--DFIE---FVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDL 100
           RE  +S  DFIE    + KL     V +YG                 +++V +Y   G L
Sbjct: 37  REGAMSEDDFIEEAKVMMKLSHPNLVQLYG----------VCTKQRPIFIVTEYMANGCL 86

Query: 101 LTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN 160
           L  L + + +L  +     + +M   +     + Y+         + RD+   N L+  +
Sbjct: 87  LNYLRERKGKLGTEW----LLDMCSDVCE--AMEYLESNGF----IHRDLAARNCLVGED 136

Query: 161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCM 220
             ++++DFG    +  D    S        +  PE+         R+  + D WS GV M
Sbjct: 137 NVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFD-----YSRFSSKSDVWSFGVLM 191

Query: 221 YEMLY-GETPF 230
           +E+   G+ P+
Sbjct: 192 WEVFSEGKMPY 202

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 31/102 (30%), Positives = 49/102 (48%), Gaps = 12/102 (11%)

Query: 133 LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG-SCLRLGGDGTVQSNVA--VGTP 189
           L Y+H  N    H  RD+KP N+L++A+  +++ DFG +       G     +   V T 
Sbjct: 118 LKYIHSAN--VLH--RDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173

Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
            Y +PEI+ + +     Y    D WS+G C+   L G  P +
Sbjct: 174 WYRAPEIMLSFQ----SYTKAIDVWSVG-CILAELLGRKPVF 210

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 44.5 bits (105), Expect = 4e-05
 Identities = 35/159 (22%), Positives = 70/159 (44%), Gaps = 19/159 (11%)

Query: 89  YLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMV-LAIASIHDLHYVHRPNHFAFHLC 147
           Y++ ++   G+LL  L +   +    +   Y+A  +  A+  +   +++HR         
Sbjct: 78  YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR--------- 128

Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGR 206
            D+   N L+  N  +++ADFG   RL    T  ++     P  + +PE L        +
Sbjct: 129 -DLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESL-----AYNK 181

Query: 207 YGPECDWWSLGVCMYEM-LYGETPFYAESLVETYGKIMN 244
           +  + D W+ GV ++E+  YG +P+    L + Y  +  
Sbjct: 182 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 220

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 44.2 bits (105), Expect = 5e-05
 Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 27/150 (18%)

Query: 88  LYLVMDYYCGGDLLTLLSKFED---RLPE--DMAKFYIAEMVLAIASIHDLHYVHRPNHF 142
           +Y+V +Y   G LL  L   E    RLP+  DMA    A++   +A +   +Y+HR    
Sbjct: 76  IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMA----AQIAEGMAYLESRNYIHR---- 127

Query: 143 AFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAME 201
                 D+   N+L+  N   ++ADFG   RL  D    +      P  + +PE      
Sbjct: 128 ------DLAARNILVGENLVCKIADFG-LARLIEDDEYTAREGAKFPIKWTAPEAANY-- 178

Query: 202 EGRGRYGPECDWWSLGVCMYEML-YGETPF 230
              GR+  + D WS G+ + E++ YG  P+
Sbjct: 179 ---GRFTIKSDVWSFGILLTEIVTYGRVPY 205

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 44.2 bits (105), Expect = 5e-05
 Identities = 41/174 (23%), Positives = 74/174 (42%), Gaps = 39/174 (22%)

Query: 75  ITNLHYAFQDDSN--LYLVMDYYCGGDLLTLL----SKFEDRLPEDMAKFYIAEMVLAIA 128
           + +L   F + ++  +YL+ DY    DL  ++          +P  M K  + ++     
Sbjct: 64  VVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI----- 117

Query: 129 SIHDLHYVHRPNHFAFHLCRDIKPDNVLL----DANGHIRLADFG------SCLR--LGG 176
            ++ +HY+H  +++  H  RD+KP N+L+       G +++ D G      + L+     
Sbjct: 118 -LNGVHYLH--SNWVLH--RDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172

Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
           D  V       T  Y +PE+L     G   Y    D W++G    E+L  E  F
Sbjct: 173 DPVVV------TIWYRAPELLL----GARHYTKAIDIWAIGCIFAELLTLEPIF 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 43.5 bits (102), Expect = 8e-05
 Identities = 46/154 (29%), Positives = 65/154 (42%), Gaps = 19/154 (12%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           +Y+VM+   GGD LT L     RL     K  I  +  A A +  L   H       H  
Sbjct: 68  IYIVMELVQGGDFLTFLRTEGPRLK---VKELIQMVENAAAGMEYLESKH-----CIH-- 117

Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVG-TP-DYISPEILTAMEEGRG 205
           RD+   N L+     ++++DFG   R   DG   S   +   P  + +PE L       G
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMS-REEEDGVYASTGGMKQIPVKWTAPEALN-----YG 171

Query: 206 RYGPECDWWSLGVCMYEML-YGETPFYAESLVET 238
           RY  E D WS G+ ++E    G  P+   S  +T
Sbjct: 172 RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT 205

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 38/142 (26%), Positives = 60/142 (42%), Gaps = 23/142 (16%)

Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NL LVM+Y   G L   L K  +RL       Y +++   +  +    YVHR        
Sbjct: 81  NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHR-------- 132

Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD-----YISPEILTAME 201
             D+   N+L+++   +++ DFG    L  D   +    V  P      + +PE LT   
Sbjct: 133 --DLATRNILVESENRVKIGDFGLTKVLPQD---KEYYKVREPGESPIFWYAPESLT--- 184

Query: 202 EGRGRYGPECDWWSLGVCMYEM 223
               ++    D WS GV +YE+
Sbjct: 185 --ESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 46/195 (23%), Positives = 85/195 (43%), Gaps = 23/195 (11%)

Query: 41  NSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDL 100
           NS+    KT+      V    EE +++       +  L+     +  +Y++ +Y   G L
Sbjct: 29  NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSL 88

Query: 101 LTLLSKFED---RLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL 157
           L  L   E     LP+ +   + A++   +A I   +Y+HR          D++  NVL+
Sbjct: 89  LDFLKSDEGGKVLLPKLID--FSAQIAEGMAYIERKNYIHR----------DLRAANVLV 136

Query: 158 DANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSL 216
             +   ++ADFG   R+  D    +      P  + +PE +       G +  + D WS 
Sbjct: 137 SESLMCKIADFG-LARVIEDNEYTAREGAKFPIKWTAPEAINF-----GSFTIKSDVWSF 190

Query: 217 GVCMYEML-YGETPF 230
           G+ +YE++ YG+ P+
Sbjct: 191 GILLYEIVTYGKIPY 205

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 37/150 (24%), Positives = 69/150 (46%), Gaps = 25/150 (16%)

Query: 114 DMAKFYIAEMVLAIAS----IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG 169
           + + + +  M+  IA+    + D++YVHR          D+   N+L+++N   +++DFG
Sbjct: 103 EFSSYQLVGMLRGIAAGMKYLSDMNYVHR----------DLAARNILVNSNLECKVSDFG 152

Query: 170 SCLRLGGD--GTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYE-MLYG 226
               L  D  GT  ++       + +PE +        ++    D WS G+ M+E M +G
Sbjct: 153 LSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR-----KFTSASDVWSFGIVMWEVMSFG 207

Query: 227 ETPFYAESLVETYGKIMNHQNSFDLPSDVG 256
           E P++  S  E    I    + F LP+ + 
Sbjct: 208 ERPYWDMSNHEVMKAI---NDGFRLPAPMD 234

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 35/149 (23%), Positives = 66/149 (44%), Gaps = 27/149 (18%)

Query: 90  LVMDYYCGGDLLTLLSKFEDRL-PEDMAKFYIAEMVLAIAS----IHDLHYVHRPNHFAF 144
           ++ +Y   G L   L + + +          +  M+  IAS    + +++YVHR      
Sbjct: 82  IITEYMENGSLDKFLRENDGKFTVGQ-----LVGMLRGIASGMKYLSEMNYVHR------ 130

Query: 145 HLCRDIKPDNVLLDANGHIRLADFGSCLRLGG-DGTVQSNVAVGTPDYISPEILTAMEEG 203
               D+   N+L+++N   +++DFG   RL   + T  +        + +PE +      
Sbjct: 131 ----DLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA----- 181

Query: 204 RGRYGPECDWWSLGVCMYE-MLYGETPFY 231
             ++    D WS G+ M+E M YGE P++
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERPYW 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 48/221 (21%), Positives = 89/221 (40%), Gaps = 58/221 (26%)

Query: 43  SLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLT 102
           +LR+  T  +  EF+     E  ++   +   I  L      +   Y++M+   GGDLL+
Sbjct: 33  TLRKGATDQEKKEFLK----EAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLS 88

Query: 103 LLSKFEDRLPEDMAKFY--------IAEMVLAIAS----IHDLHYVHRPNHFAFHLCRDI 150
            L          + +F         + ++ L +A     +  +H++H          RD+
Sbjct: 89  YLRDAR------VERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIH----------RDL 132

Query: 151 KPDNVLLDANGH-----IRLADFG--------SCLRLGGDGTVQSNVAVGTPDYISPEIL 197
              N L+   G+     +++ DFG           R  G+G +          +++PE L
Sbjct: 133 AARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR-------WMAPESL 185

Query: 198 TAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVE 237
                  G++  + D WS GV M+E+L  G+ P+ A +  E
Sbjct: 186 L-----DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE 221

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 58/231 (25%), Positives = 98/231 (42%), Gaps = 20/231 (8%)

Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTL 103
           L+ + T  D  + V+++   + +   G  + I NL  A   D  LY++++Y   G+L   
Sbjct: 55  LKDDATEKDLSDLVSEMEMMKMI---GKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 111

Query: 104 LSKFEDRLPEDMAKFYIAEMVLAIASIHDL----HYVHRP-NHFAFHLC--RDIKPDNVL 156
           L     R P     + IA +     +  DL    + V R   + A   C  RD+   NVL
Sbjct: 112 LRA--RRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169

Query: 157 LDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWS 215
           +  N  +++ADFG    +      +       P  +++PE L         Y  + D WS
Sbjct: 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV-----YTHQSDVWS 224

Query: 216 LGVCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKD 265
            GV M+E+   G +P Y    VE   K++   +  D P++   E+    +D
Sbjct: 225 FGVLMWEIFTLGGSP-YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRD 274

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 52/205 (25%), Positives = 74/205 (36%), Gaps = 54/205 (26%)

Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTL 103
           L++E   +   EF+     E  V+   D   I  L    + +  L LVM+    G LL  
Sbjct: 31  LKQEHIAAGKKEFLR----EASVMAQLDHPCIVRLIGVCKGEP-LMLVMELAPLGPLLKY 85

Query: 104 LSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRPNHFAFHLCRDIKPDNVLLDA 159
           L K  +     +    + E+   +A     +   H+VHR          D+   NVLL  
Sbjct: 86  LKKRRE-----IPVSDLKELAHQVAMGMAYLESKHFVHR----------DLAARNVLLVN 130

Query: 160 NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR---GRYGPEC----- 211
               +++DFG    LG              DY       A   GR     Y PEC     
Sbjct: 131 RHQAKISDFGMSRALGAGS-----------DY-----YRATTAGRWPLKWYAPECINYGK 174

Query: 212 -----DWWSLGVCMYEML-YGETPF 230
                D WS GV ++E   YG  P+
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPY 199

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 46/179 (25%), Positives = 75/179 (41%), Gaps = 28/179 (15%)

Query: 85  DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAF 144
              L+ V +Y  G  L  +L+  +  LP       + +++ A+A  H+   VHR      
Sbjct: 51  PGLLFAVFEYVPGRTLREVLAA-DGALPAGETGRLMLQVLDALACAHNQGIVHR------ 103

Query: 145 HLCRDIKPDNVLLDANG---HIRLADFG-SCLRLG-GDGTVQSNVA----VGTPDYISPE 195
               D+KP N+++   G   H ++ DFG   L  G  D  V +       +GTP Y +PE
Sbjct: 104 ----DLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159

Query: 196 ILTAMEEGRGR-YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPS 253
            L      RG    P  D ++ G+   E L G+      S+ E   + ++  +   LP 
Sbjct: 160 QL------RGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVD-VSLPP 211

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 42/172 (24%), Positives = 73/172 (42%), Gaps = 23/172 (13%)

Query: 90  LVMDYYCGGDLLTLL--SKFEDR---LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAF 144
           +++ +   GDL + L  S+  D    LP  M   ++ ++   +  +    ++HR      
Sbjct: 83  VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHR------ 136

Query: 145 HLCRDIKPDNVLLDANGHIRLADFGSCLRL-GGDGTVQSNVAVGTPDYISPEILTAMEEG 203
               D+   N +L+ N ++ +ADFG   ++  GD   Q  +A     +I+ E L      
Sbjct: 137 ----DLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRV-- 190

Query: 204 RGRYGPECDWWSLGVCMYEM-LYGETPFYAESLVETYGKIMNHQNSFDLPSD 254
              Y  + D WS GV M+E+   G+TP+      E Y   +   N    P D
Sbjct: 191 ---YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY-DYLRQGNRLKQPPD 238

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 42/163 (25%), Positives = 72/163 (44%), Gaps = 28/163 (17%)

Query: 82  FQDDSNLYLVMDYYCGGDLLT--LLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRP 139
           FQD   +YLVM+      L+   L    +  L  +   + + +M+  I  +H    +HR 
Sbjct: 93  FQD---VYLVME------LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHR- 142

Query: 140 NHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTA 199
                    D+KP N+++ ++  +++ DFG   R  G   + +   V T  Y +PE++  
Sbjct: 143 ---------DLKPSNIVVKSDCTLKILDFG-LARTAGTSFMMTPYVV-TRYYRAPEVILG 191

Query: 200 MEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
           M      Y    D WS+G  M EM+ G   F     ++ + KI
Sbjct: 192 MG-----YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKI 229

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 25/223 (11%)

Query: 47  EKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSK 106
           EK +SD I  +  ++      + G  + I NL  A   D  LY++++Y   G+L   L  
Sbjct: 64  EKDLSDLISEMEMMK------MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-- 115

Query: 107 FEDRLPEDMAKFYIAEMV-LAIASIHDL----HYVHRP-NHFAFHLC--RDIKPDNVLLD 158
              R P  M   Y    V     S  DL    + V R   + A   C  RD+   NVL+ 
Sbjct: 116 -RARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174

Query: 159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLG 217
            +  +++ADFG    +      +       P  +++PE L         Y  + D WS G
Sbjct: 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-----IYTHQSDVWSFG 229

Query: 218 VCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEI 259
           V ++E+   G +P Y    VE   K++   +  D PS+   E+
Sbjct: 230 VLLWEIFTLGGSP-YPGVPVEELFKLLKEGHRMDKPSNCTNEL 271

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 41.2 bits (96), Expect = 5e-04
 Identities = 35/146 (23%), Positives = 66/146 (45%), Gaps = 19/146 (13%)

Query: 88  LYLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           +Y++ ++   G LL  L   E  + P      + A++   +A I   +Y+HR        
Sbjct: 75  IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR-------- 126

Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRG 205
             D++  N+L+ A+   ++ADFG   R+  D    +      P  + +PE +       G
Sbjct: 127 --DLRAANILVSASLVCKIADFG-LARVIEDNEYTAREGAKFPIKWTAPEAIN-----FG 178

Query: 206 RYGPECDWWSLGVCMYEML-YGETPF 230
            +  + D WS G+ + E++ YG  P+
Sbjct: 179 SFTIKSDVWSFGILLMEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 41.3 bits (97), Expect = 5e-04
 Identities = 48/231 (20%), Positives = 88/231 (38%), Gaps = 52/231 (22%)

Query: 34  VLYDECCNSSLRRE------KTVSDFIEFVAKLREER--DVLVYGDRRWITNLHYAFQDD 85
           V   EC +     +      KT+ +     A+   ER  ++L       I   +    + 
Sbjct: 21  VFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80

Query: 86  SNLYLVMDYYCGGDLLTLL------SKFEDRLPEDMAKFYIAEMV---LAIAS----IHD 132
               +V +Y   GDL   L      + F       M +  +++++   + IAS    +  
Sbjct: 81  DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS 140

Query: 133 LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG------SC--LRLGGDGTVQSNV 184
            H+VHR          D+   N L+  +  +++ DFG      +    R+GG   +    
Sbjct: 141 QHFVHR----------DLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR- 189

Query: 185 AVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAES 234
                 ++ PE +        ++  E D WS GV ++E+  YG+ P+Y  S
Sbjct: 190 ------WMPPESIM-----YRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS 229

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 40.8 bits (96), Expect = 6e-04
 Identities = 41/199 (20%), Positives = 73/199 (36%), Gaps = 35/199 (17%)

Query: 40  CNSSLRREKTVSDFIEFVA---KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC 96
           C  S +    + DF++  A    L  E  + +YG                 L +V +   
Sbjct: 30  CLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-----------THPLMMVTELAP 78

Query: 97  GGDLLTLLSK-FEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNV 155
            G LL  L K             Y  ++   +  +    ++HR          D+   N+
Sbjct: 79  LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHR----------DLAARNI 128

Query: 156 LLDANGHIRLADFGSCLRLGGDG---TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECD 212
           LL ++  +++ DFG    L  +     ++ ++ V    + +PE L         +    D
Sbjct: 129 LLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA-WCAPESLR-----TRTFSHASD 182

Query: 213 WWSLGVCMYEML-YGETPF 230
            W  GV ++EM  YGE P+
Sbjct: 183 VWMFGVTLWEMFTYGEEPW 201

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 40.4 bits (94), Expect = 8e-04
 Identities = 51/181 (28%), Positives = 80/181 (44%), Gaps = 17/181 (9%)

Query: 70  GDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLA-IA 128
           G    I NL  A +    LYL ++Y   G+LL  L K   R+ E    F IA    + ++
Sbjct: 65  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK--SRVLETDPAFAIANSTASTLS 122

Query: 129 SIHDLHY---VHRPNHFAFH---LCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQS 182
           S   LH+   V R   +      + RD+   N+L+  N   ++ADFG  L  G +  V+ 
Sbjct: 123 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG--LSRGQEVYVKK 180

Query: 183 NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGK 241
            +      +++ E L         Y    D WS GV ++E++  G TP+   +  E Y K
Sbjct: 181 TMGRLPVRWMAIESLN-----YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 235

Query: 242 I 242
           +
Sbjct: 236 L 236

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 41.0 bits (96), Expect = 8e-04
 Identities = 38/125 (30%), Positives = 51/125 (40%), Gaps = 16/125 (12%)

Query: 99  DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD 158
           DL T L      L          +++ AI  IH    +HR          DIK +NVL++
Sbjct: 245 DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHR----------DIKTENVLVN 294

Query: 159 ANGHIRLADFG-SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLG 217
               I L DFG +C   G   T       GT D  +PE+L         Y P  D WS G
Sbjct: 295 GPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAG-----DPYTPSVDIWSAG 349

Query: 218 VCMYE 222
           + ++E
Sbjct: 350 LVIFE 354

Length = 461

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 26/85 (30%), Positives = 42/85 (49%), Gaps = 8/85 (9%)

Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGR 206
           RD+   N L+  N  ++++DFG   R   D    S+     P  + SPE+ +       +
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMT-RFVLDDQYTSSTGTKFPVKWSSPEVFSF-----SK 177

Query: 207 YGPECDWWSLGVCMYEMLY-GETPF 230
           Y  + D WS GV M+E+   G+TP+
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGKTPY 202

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 43/151 (28%), Positives = 65/151 (43%), Gaps = 30/151 (19%)

Query: 90  LVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE---MVLAIAS----IHDLHYVHRPNHF 142
           +V +Y   G L   L K +        +F + +   M+  IAS    + D+ YVHR    
Sbjct: 82  IVTEYMENGSLDAFLRKHD-------GQFTVIQLVGMLRGIASGMKYLSDMGYVHR---- 130

Query: 143 AFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEE 202
                 D+   N+L+++N   +++DFG    L  D       A  T     P   TA E 
Sbjct: 131 ------DLAARNILVNSNLVCKVSDFGLSRVLEDD----PEAAYTTRGGKIPIRWTAPEA 180

Query: 203 GRGR-YGPECDWWSLGVCMYE-MLYGETPFY 231
              R +    D WS G+ M+E M YGE P++
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERPYW 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 36/148 (24%), Positives = 68/148 (45%), Gaps = 20/148 (13%)

Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
           +++Y+V +Y    DL  +L   +  L E+ A+ ++ +++  +  IH  + +HR       
Sbjct: 89  NSVYIVQEYM-ETDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHR------- 138

Query: 146 LCRDIKPDNVLLDANGHI-RLADFGSCLRLGGDGTVQSNVAVG--TPDYISPEILTAMEE 202
              D+KP NV ++    + ++ DFG    +    + +  ++ G  T  Y SP +L +   
Sbjct: 139 ---DLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNN 195

Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPF 230
               Y    D W+ G    EML G+  F
Sbjct: 196 ----YTKAIDMWAAGCIFAEMLTGKPLF 219

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 39.1 bits (91), Expect = 0.002
 Identities = 36/148 (24%), Positives = 64/148 (43%), Gaps = 18/148 (12%)

Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
           + + +V +Y   G L + L K E +L        +  +   +  + ++ YVH+    A H
Sbjct: 79  NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHK--GLAAH 136

Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR- 204
                    VL++++   +++ F    RL  D   +S     T    SP +  A E  + 
Sbjct: 137 --------KVLVNSDLVCKISGFR---RLQED---KSEAIYTTMSGKSPVLWAAPEAIQY 182

Query: 205 GRYGPECDWWSLGVCMYE-MLYGETPFY 231
             +    D WS G+ M+E M YGE P++
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERPYW 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 39.1 bits (91), Expect = 0.002
 Identities = 35/153 (22%), Positives = 60/153 (39%), Gaps = 39/153 (25%)

Query: 85  DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAF 144
            + + L+M++   G L   L + ++++       Y  ++   +  +    YVHR      
Sbjct: 80  GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHR------ 133

Query: 145 HLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG---TVQSNVAVGTPDYISPEILTAME 201
               D+   NVL+++   +++ DFG    +  D    TV+        D  SP       
Sbjct: 134 ----DLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD-------DLDSPVFW---- 178

Query: 202 EGRGRYGPEC----------DWWSLGVCMYEML 224
                Y PEC          D WS GV +YE+L
Sbjct: 179 -----YAPECLIQSKFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 38.6 bits (90), Expect = 0.003
 Identities = 40/150 (26%), Positives = 68/150 (45%), Gaps = 27/150 (18%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDR---LPE--DMAKFYIAEMVLAIASIHDLHYVHRPNHF 142
           +Y+V +    G LL  L     R   LP+  DMA    A++   +A +   +Y+HR    
Sbjct: 76  IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMA----AQVASGMAYLEAQNYIHR---- 127

Query: 143 AFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAME 201
                 D+   NVL+  N   ++ADFG   R+  +   ++      P  + +PE   A+ 
Sbjct: 128 ------DLAARNVLVGENNICKVADFG-LARVIKEDIYEAREGAKFPIKWTAPE--AALY 178

Query: 202 EGRGRYGPECDWWSLGVCMYEML-YGETPF 230
               R+  + D WS G+ + E++ YG  P+
Sbjct: 179 N---RFSIKSDVWSFGILLTEIVTYGRMPY 205

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 38.3 bits (89), Expect = 0.003
 Identities = 35/145 (24%), Positives = 62/145 (42%), Gaps = 18/145 (12%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           +Y+V +Y   G LL  L +   R           ++   +A +    ++HR         
Sbjct: 74  IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHR--------- 124

Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGR 206
            D+   N L+D  G ++++DFG   R   D    S+V    P  +  PE+L        +
Sbjct: 125 -DLAARNCLVDDQGCVKVSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEVLLYS-----K 177

Query: 207 YGPECDWWSLGVCMYEML-YGETPF 230
           +  + D W+ GV M+E+   G+ P+
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGKMPY 202

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 38.7 bits (90), Expect = 0.004
 Identities = 32/116 (27%), Positives = 53/116 (45%), Gaps = 20/116 (17%)

Query: 120 IAEMVLA-IASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
           IA+ V A +A + +  +VHR          D+   N L+  N  +++ADFG    +    
Sbjct: 135 IAKQVAAGMAYLSERKFVHR----------DLATRNCLVGENMVVKIADFGLSRNIYSAD 184

Query: 179 TVQSNVAVGTP-DYISPE-ILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFY 231
             +++     P  ++ PE I         RY  E D W+ GV ++E+  YG  P+Y
Sbjct: 185 YYKASENDAIPIRWMPPESIFYN------RYTTESDVWAYGVVLWEIFSYGMQPYY 234

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 38.1 bits (89), Expect = 0.004
 Identities = 39/163 (23%), Positives = 64/163 (39%), Gaps = 46/163 (28%)

Query: 89  YLVMDYYCGGDLLTLL-SKFED------RLPEDMAKFYIAEMVLAIAS----IHDLHYVH 137
            +VM+    GDL + L S+  +        P  + KF   +M   IA     +    +VH
Sbjct: 85  LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFI--QMAAEIADGMAYLAAKKFVH 142

Query: 138 RPNHFAFHLCRDIKPDNVLLDANGHIRLADFG--------SCLRLGGDGTVQSNVAVGTP 189
                     RD+   N ++  +  +++ DFG           R GG G +        P
Sbjct: 143 ----------RDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL--------P 184

Query: 190 -DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPF 230
             +++PE L       G +  + D WS GV ++EM    E P+
Sbjct: 185 VRWMAPESLKD-----GVFTTKSDVWSFGVVLWEMATLAEQPY 222

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	372
KOG0605|consensus	550		100.0
KOG0598|consensus	357		100.0
KOG0612|consensus	1317		100.0
KOG0694|consensus	694		100.0
KOG0616|consensus	355		100.0
KOG0610|consensus	459		100.0
KOG0592|consensus	604		100.0
KOG0690|consensus	516		100.0
KOG0615|consensus	475		100.0
KOG0608|consensus	1034		100.0
KOG0696|consensus	683		100.0
KOG0614|consensus	732		100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0575|consensus	592		100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0581|consensus	364		100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0986|consensus	591		100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0595|consensus	429		100.0
KOG0695|consensus	593		100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0588|consensus	786		100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0591|consensus	375		100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0661|consensus	538		100.0
KOG0033|consensus	355		100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0583|consensus	370		100.0
KOG0593|consensus	396		100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0600|consensus	560		100.0
KOG0597|consensus	808		100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0198|consensus	313		100.0
KOG0599|consensus	411		100.0
KOG0578|consensus	550		100.0
KOG0659|consensus	318		100.0
KOG0611|consensus	668		100.0
KOG0585|consensus	576		100.0
KOG0663|consensus	419		100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0582|consensus	516		100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0032|consensus	382		100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0580|consensus	281		100.0
KOG0660|consensus	359		100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0594|consensus	323		100.0
KOG4717|consensus	864		100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0192|consensus	362		100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0201|consensus	467		100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0589|consensus	426		100.0
KOG0604|consensus	400		100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0197|consensus	468		100.0
KOG0607|consensus	463		100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0658|consensus	364		100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0579|consensus	1187		100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG0596|consensus	677		100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG0577|consensus	948		100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG4236|consensus	888		100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG0667|consensus	586		100.0
KOG0574|consensus	502		100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG4721|consensus	904		100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG4279|consensus	1226		100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG0586|consensus	596		100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
KOG0983|consensus	391		100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
PTZ00284	467	protein kinase; Provisional	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG0662|consensus	292		100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG0584|consensus	632		100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG4645|consensus	1509		100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG1989|consensus	738		100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
KOG0193|consensus	678		100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG2345|consensus	302		100.0
KOG0603|consensus	612		100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG1026|consensus	774		100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG0666|consensus	438		100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG0194|consensus	474		100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG1151|consensus	775		100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG1035|consensus	1351		100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG1095|consensus	1025		100.0
KOG1187|consensus	361		100.0
KOG1006|consensus	361		100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0671|consensus	415		100.0
KOG0669|consensus	376		100.0
KOG4250|consensus	732		100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG4257|consensus	974		100.0
KOG0665|consensus	369		100.0
KOG0603|consensus	612		100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0587|consensus	953		100.0
KOG0668|consensus	338		100.0
KOG4278|consensus	1157		100.0
KOG1027|consensus	903		100.0
KOG0670|consensus	752		100.0
KOG0199|consensus	1039		100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0196|consensus	996		100.0
KOG0664|consensus	449		100.0
KOG0984|consensus	282		100.0
KOG1094|consensus	807		100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.98
KOG0200|consensus	609		99.97
KOG1025|consensus	1177		99.97
KOG0576|consensus	829		99.97
KOG3653|consensus	534		99.97
KOG0606|consensus	1205		99.97
KOG1290|consensus	590		99.97
KOG1167|consensus	418		99.97
KOG1152|consensus	772		99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG1345|consensus	378		99.96
KOG2052|consensus	513		99.96
KOG1024|consensus	563		99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG0590|consensus	601		99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
KOG1164|consensus	322		99.9
KOG1163|consensus	341		99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
KOG4158|consensus	598		99.88
KOG1165|consensus	449		99.87
KOG0606|consensus	1205		99.87
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.86
KOG0195|consensus	448		99.85
PRK12274	218	serine/threonine protein kinase; Provisional	99.85
KOG1240|consensus	1431		99.84
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.83
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.81
KOG1023|consensus	484		99.8
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.8
PRK10345	210	hypothetical protein; Provisional	99.78
KOG0590|consensus	601		99.75
KOG1033|consensus	516		99.74
smart00090	237	RIO RIO-like kinase.	99.71
PRK14879	211	serine/threonine protein kinase; Provisional	99.69
KOG1166|consensus	974		99.68
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.68
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.66
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.63
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.62
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.51
KOG0601|consensus	524		99.5
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.44
KOG1266|consensus	458		99.42
KOG1243|consensus	690		99.36
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.26
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.22
KOG0601|consensus	524		99.17
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.15
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.1
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.05
KOG2137|consensus	700		98.99
KOG3741|consensus	655		98.97
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.94
KOG3087|consensus	229		98.94
COG4248	637	Uncharacterized protein with protein kinase and he	98.92
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.81
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.78
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.71
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.54
KOG0576|consensus	829		98.51
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.51
KOG1035|consensus	1351		98.25
PRK09902	216	hypothetical protein; Provisional	98.22
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.18
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.17
smart00133	64	S_TK_X Extension to Ser/Thr-type protein kinases.	98.08
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.87
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.72
KOG1235|consensus	538		97.62
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.53
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.52
PLN02876	822	acyl-CoA dehydrogenase	97.52
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.5
KOG1826|consensus	2724		97.48
PF01636	239	APH: Phosphotransferase enzyme family This family	97.4
PRK10593	297	hypothetical protein; Provisional	97.36
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.03
PF00433	48	Pkinase_C: Protein kinase C terminal domain; Inter	96.84
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	96.77
KOG1093|consensus	725		96.68
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	96.64
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	96.58
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	96.52
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.39
PRK09550	401	mtnK methylthioribose kinase; Reviewed	96.19
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.17
PLN02236	344	choline kinase	95.98
KOG2268|consensus	465		95.58
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.06
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	94.46
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	93.88
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	93.85
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	92.59
PRK10271	188	thiK thiamine kinase; Provisional	92.58
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	91.85
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	91.77
PRK05231	319	homoserine kinase; Provisional	91.62
COG2334	331	Putative homoserine kinase type II (protein kinase	91.29
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	90.81
PTZ00384	383	choline kinase; Provisional	90.05
KOG2270|consensus	520		89.83
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	89.42
PLN02756	418	S-methyl-5-thioribose kinase	88.77
COG4499	434	Predicted membrane protein [Function unknown]	88.3
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	88.03
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	87.39

>KOG0605|consensus

Probab=100.00  E-value=3.7e-69  Score=504.84  Aligned_cols=325  Identities=43%  Similarity=0.769  Sum_probs=281.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      .|+.|..+|.|    |||+||.|++..+|..+|+|.++++.+...       +.++.++.|..+|...++|+||++|+.|
T Consensus       142 DFe~Lk~IgkG----AfGeVrLarKk~Tg~iyAmK~LkKS~M~~~-------~Qv~hV~aERdiL~~~ds~~vVKLyYsF  210 (550)
T KOG0605|consen  142 DFELLKVIGKG----AFGEVRLARKKDTGEIYAMKILKKSEMLKK-------NQVEHVRAERDILAEVDSPWVVKLYYSF  210 (550)
T ss_pred             cchhheeeccc----cceeEEEEEEccCCcEEeeecccHHHHHhh-------hhHHHHHHHHHHhhhcCCCcEEEEEEEe
Confidence            46677777777    899999999999999999999988776554       5678899999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      ++..++||||||++|||+..+|.+ .+.|+++.+++|+++++.|++.||+.|+||          |||||+|+|||..|+
T Consensus       211 QD~~~LYLiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIH----------RDIKPdNlLiD~~GH  279 (550)
T KOG0605|consen  211 QDKEYLYLIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIH----------RDIKPDNLLIDAKGH  279 (550)
T ss_pred             cCCCeeEEEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCccc----------ccCChhheeecCCCC
Confidence            999999999999999999999998 689999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCC---------------------Ccc-------------------------cccccccCCcccCccc
Q psy11571        163 IRLADFGSCLRLGGD---------------------GTV-------------------------QSNVAVGTPDYISPEI  196 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~---------------------~~~-------------------------~~~~~~gt~~y~aPE~  196 (372)
                      +||+|||+|.-....                     ...                         .....+|||.|+|||+
T Consensus       280 iKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEV  359 (550)
T KOG0605|consen  280 IKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEV  359 (550)
T ss_pred             EeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHH
Confidence            999999998543210                     000                         0123579999999999


Q ss_pred             ccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhccCCCC
Q psy11571        197 LTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT  276 (372)
Q Consensus       197 ~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~~p~~  276 (372)
                      +.+     ..|+..+||||||||+||||.|.+||.+.++.+++.+|+++...+.+|...  .++++++|||.+||+||++
T Consensus       360 ll~-----kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~--~~s~eA~DLI~rll~d~~~  432 (550)
T KOG0605|consen  360 LLG-----KGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEV--DLSDEAKDLITRLLCDPEN  432 (550)
T ss_pred             Hhc-----CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcC--cccHHHHHHHHHHhcCHHH
Confidence            994     559999999999999999999999999999999999999998888888765  6889999999999999999


Q ss_pred             CCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccccccCCCCCcCCCCCCCCCCCCCCCccccCCCCCCCCCCC-Ccc
Q psy11571        277 RLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAA-SPA  355 (372)
Q Consensus       277 R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  355 (372)
                      |++..++.||+              .||||++|+|+.|++..|||+|.+.++.|+++||+...+....+..+.... ...
T Consensus       433 RLG~~G~~EIK--------------~HPfF~~v~W~~l~~~~apfvP~v~~~~DT~yFddF~e~~~~~~~~~~~~~~~k~  498 (550)
T KOG0605|consen  433 RLGSKGAEEIK--------------KHPFFKGVDWDHLREMPAPFVPQVNSELDTQYFDDFPEEDSMTPTADKSGPSRKM  498 (550)
T ss_pred             hcCcccHHHHh--------------cCCccccCCcchhhcCCCCCCCCCCCcccccccccCcccccCcccccccccchhh
Confidence            99999999999              999999999999999999999999999999999966554332222111111 111


Q ss_pred             -------cccCCCCccCceeeC
Q psy11571        356 -------LSALHLPFVGFTFTQ  370 (372)
Q Consensus       356 -------~~~~~~~~~~~~~~~  370 (372)
                             .+..+..|.||||++
T Consensus       499 ~~~~~~~~~~~~~~FvgfTyk~  520 (550)
T KOG0605|consen  499 LSMVDTNNSSKDINFVGFTYKN  520 (550)
T ss_pred             hhcccccCCcccccccceeeec
Confidence                   235667799999997

>KOG0598|consensus

Probab=100.00  E-value=1.2e-68  Score=482.77  Aligned_cols=321  Identities=35%  Similarity=0.655  Sum_probs=277.0

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      .++.++.+|.|    ++|.|+.|++..+++.+|+|++++....+.       +..+.+.+|..||..++||+||+++..|
T Consensus        26 dF~~lkviGkG----~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-------~e~~~~~~Er~IL~~v~hPFiv~l~ysF   94 (357)
T KOG0598|consen   26 DFEILKVIGKG----SFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-------KEVRHTKAERNILSKIKHPFIVKLIYSF   94 (357)
T ss_pred             heeeeeeeecc----CCceEEEEEEcccCceeehhhhhhhHhhhh-------hhHHHHHHHHHHHHhCCCCcEeeeEEec
Confidence            34556666766    899999999999999999999988776654       3457788999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      ++...+|+|+||+.||+|..+|++ .+.++|+.+++|+++|+.||.|||++||||          |||||+|||+|.+|+
T Consensus        95 Qt~~kLylVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiy----------RDlKPENILLd~~GH  163 (357)
T KOG0598|consen   95 QTEEKLYLVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIY----------RDLKPENILLDEQGH  163 (357)
T ss_pred             ccCCeEEEEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeee----------ccCCHHHeeecCCCc
Confidence            999999999999999999999998 689999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      ++|+|||+|+.....+. .+.++|||+.|||||++.     ...|+.++||||||+++|||++|.+||.+.+...++.+|
T Consensus       164 i~LtDFgL~k~~~~~~~-~t~tfcGT~eYmAPEil~-----~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I  237 (357)
T KOG0598|consen  164 IKLTDFGLCKEDLKDGD-ATRTFCGTPEYMAPEILL-----GKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKI  237 (357)
T ss_pred             EEEeccccchhcccCCC-ccccccCCccccChHHHh-----cCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHH
Confidence            99999999986654433 345589999999999999     467999999999999999999999999999999999999


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCC-CCChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccCC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLG-QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSN  318 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s-~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~~  318 (372)
                      .++... ..|.    .++.++++||++||. +|++|++ ..++.+|+              .||||+++||+.+  ++..
T Consensus       238 ~~~k~~-~~p~----~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik--------------~HpfF~~inW~~l~~k~l~  298 (357)
T KOG0598|consen  238 LKGKLP-LPPG----YLSEEARDLLKKLLKRDPRQRLGGPGDAEEIK--------------RHPFFKGINWEKLLAKKLS  298 (357)
T ss_pred             hcCcCC-CCCc----cCCHHHHHHHHHHhccCHHHhcCCCCChHHhh--------------cCcccccCCHHHHHhcCCC
Confidence            986522 2222    589999999999999 9999997 45677777              9999999999998  6789


Q ss_pred             CCCcCCCCCCCCCCCCCCCccccCCCCCCC---CC-C-CCcccccCCCCccCceeeC
Q psy11571        319 APYIPEVSSPTDTSHFDVDEAGVRASDALP---PA-A-ASPALSALHLPFVGFTFTQ  370 (372)
Q Consensus       319 ~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~-~-~~~~~~~~~~~~~~~~~~~  370 (372)
                      |||+|.+.+..+.++||.+.+.....+...   |. . ...........|+||||..
T Consensus       299 PpF~P~~~~~~~~~~Fd~eft~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~gft~~~  355 (357)
T KOG0598|consen  299 PPFKPNVTGLEDTSNFDNEFTSYTVDYSPVDSSPDMSAFTAFSRTYNKIFPGFTYVA  355 (357)
T ss_pred             CCeecCCCCccccccccHHHHhccccCCccccCcccccccccccccccccCCccccC
Confidence            999999999999999999887654332222   11 1 2333446666799999975

>KOG0612|consensus

Probab=100.00  E-value=1.2e-67  Score=528.08  Aligned_cols=330  Identities=58%  Similarity=1.035  Sum_probs=303.8

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      +.|+++..+|.|    +||.|..|+...++++||+|.+++-...+.       .....|.+|..+|...+++.|++++++
T Consensus        75 ~DfeilKvIGrG----aFGEV~lVr~k~t~~VYAMK~lnK~eMlKr-------~~tA~F~EERDimv~~ns~Wiv~LhyA  143 (1317)
T KOG0612|consen   75 EDFEILKVIGRG----AFGEVALVRHKSTEKVYAMKILNKWEMLKR-------AETACFREERDIMVFGNSEWIVQLHYA  143 (1317)
T ss_pred             HhhHHHHHhccc----ccceeEEEEeeccccchhHHHhhHHHHhhc-------hhHHHHHHHhHHHHcCCcHHHHHHHHH
Confidence            468889999998    899999999999999999998876443322       123568899999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      |+++.++|+||||++||||..++.+.. .++++.+++|++.|+.||.-||+.|+||          |||||+|||+|..|
T Consensus       144 FQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVH----------RDiKPDNvLld~~G  212 (1317)
T KOG0612|consen  144 FQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVH----------RDIKPDNVLLDKSG  212 (1317)
T ss_pred             hcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhcccee----------ccCCcceeEecccC
Confidence            999999999999999999999999954 8999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      ++||+|||.|..+..++...+...+|||.|.|||++..+..+.+.|+..+||||+||++|||+.|..||..++..++|.+
T Consensus       213 HikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~K  292 (1317)
T KOG0612|consen  213 HIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGK  292 (1317)
T ss_pred             cEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHH
Confidence            99999999999999889988889999999999999998888878999999999999999999999999999999999999


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccccccCCCCC
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPY  321 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~~~~~p~  321 (372)
                      |++....+.+|...  .+|+++++||.++|++|+.|++-+++.+|+              .||||.+++|+.+++..|||
T Consensus       293 Im~hk~~l~FP~~~--~VSeeakdLI~~ll~~~e~RLgrngiedik--------------~HpFF~g~~W~~iR~~~pP~  356 (1317)
T KOG0612|consen  293 IMNHKESLSFPDET--DVSEEAKDLIEALLCDREVRLGRNGIEDIK--------------NHPFFEGIDWDNIRESVPPV  356 (1317)
T ss_pred             HhchhhhcCCCccc--ccCHHHHHHHHHHhcChhhhcccccHHHHH--------------hCccccCCChhhhhhcCCCC
Confidence            99998888999544  699999999999999999999999999999              99999999999999999999


Q ss_pred             cCCCCCCCCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceeeC
Q psy11571        322 IPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQ  370 (372)
Q Consensus       322 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (372)
                      +|.++|+.|++|||..+.........|| ..+.+++|.|.||+||||+.
T Consensus       357 vPevssd~DTsnFd~~~dd~~~~e~~p~-~~~~~f~Gn~LPFIGfTy~~  404 (1317)
T KOG0612|consen  357 VPEVSSDDDTSNFDVDEDDLRDAETFPP-RIPKAFSGNHLPFIGFTYTH  404 (1317)
T ss_pred             CCcCCCCCccccccccccccchhhccCC-CCCCCCcCCcCCeeeeeecc
Confidence            9999999999999887776665554444 56689999999999999983

>KOG0694|consensus

Probab=100.00  E-value=2.3e-66  Score=498.31  Aligned_cols=317  Identities=34%  Similarity=0.653  Sum_probs=281.1

Q ss_pred             HHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeeeEEEE
Q psy11571          5 RELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLHYAFQ   83 (372)
Q Consensus         5 ~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~~~~~   83 (372)
                      +.+..+|.|    .||.|+.+....+++.+|||++++..+-...       .++.++.|..|+.... ||++++++.+|+
T Consensus       371 ~~l~vLGkG----sFGkV~lae~k~~~e~yAIK~LKK~~Il~~d-------~Ve~~~~EkrI~~la~~HPFL~~L~~~fQ  439 (694)
T KOG0694|consen  371 RLLAVLGRG----SFGKVLLAELKGTNEYYAIKVLKKGDILQRD-------EVESLMCEKRIFELANRHPFLVNLFSCFQ  439 (694)
T ss_pred             EEEEEeccC----cCceEEEEEEcCCCcEEEEEEeeccceeccc-------cHHHHHHHHHHHHHhccCCeEeecccccc
Confidence            344556666    7999999999999999999999887766553       4566888999998875 999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcE
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI  163 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~v  163 (372)
                      +++++|+||||+.|||+..+.+.  +.+++..+++|+++|+.||.|||++|||+          ||||.+|||+|..|++
T Consensus       440 T~~~l~fvmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH~~~IIY----------RDlKLdNiLLD~eGh~  507 (694)
T KOG0694|consen  440 TKEHLFFVMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLHENGIIY----------RDLKLDNLLLDTEGHV  507 (694)
T ss_pred             cCCeEEEEEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHHhcCcee----------eecchhheEEcccCcE
Confidence            99999999999999995555443  78999999999999999999999999999          9999999999999999


Q ss_pred             EEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHh
Q psy11571        164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM  243 (372)
Q Consensus       164 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~  243 (372)
                      ||+|||+++.....+. .+.++||||.|||||++.+     ..|+.++|||||||+||||+.|..||.++++++++..|+
T Consensus       508 kiADFGlcKe~m~~g~-~TsTfCGTpey~aPEil~e-----~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~  581 (694)
T KOG0694|consen  508 KIADFGLCKEGMGQGD-RTSTFCGTPEFLAPEVLTE-----QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV  581 (694)
T ss_pred             EecccccccccCCCCC-ccccccCChhhcChhhhcc-----CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh
Confidence            9999999997654444 5677999999999999994     679999999999999999999999999999999999999


Q ss_pred             hccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCC--CChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccCC
Q psy11571        244 NHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQ--NGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSN  318 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~--~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~~  318 (372)
                      .....+  |.    .+|.++.+++++||. +|++|+++  .+..+|+              .||||+.|||++|  ++++
T Consensus       582 ~d~~~y--P~----~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~--------------~hpFFr~i~w~~L~~r~i~  641 (694)
T KOG0694|consen  582 NDEVRY--PR----FLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIK--------------KHPFFRSIDWDDLLNRRIK  641 (694)
T ss_pred             cCCCCC--CC----cccHHHHHHHHHHhccCcccccCCCCCCchhhh--------------hCCccccCCHHHHhhccCC
Confidence            876554  44    789999999999999 99999997  5677888              9999999999998  6789


Q ss_pred             CCCcCCCCCCCCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceeeCCC
Q psy11571        319 APYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQGW  372 (372)
Q Consensus       319 ~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (372)
                      |||+|.+.++.|.+|||.+++  .+.++|++..........+..|.||+|.++|
T Consensus       642 PPf~P~i~~~~D~snFd~eFt--~e~p~Lt~~~~~~l~~~~q~~F~~Fs~~~~~  693 (694)
T KOG0694|consen  642 PPFVPTIKGPEDVSNFDEEFT--SEKPALTPSDPRPLTEEEQEAFRDFSFVAEW  693 (694)
T ss_pred             CCCCcccCChhhhcccchhhh--cCCCccCCCCccccchhhHHHhcCccccCCC
Confidence            999999999999999999988  4456777766666677899999999999987

>KOG0616|consensus

Probab=100.00  E-value=1.1e-64  Score=443.19  Aligned_cols=288  Identities=39%  Similarity=0.729  Sum_probs=262.5

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      .|+.+..+|+|    .||+|-.|+...++.-+|+|.++...+.+-       ++++...+|..+|+.+.||+++++++.|
T Consensus        45 dfe~~~tlGtG----SFGrV~LVr~k~~g~yYAmKvL~k~~vVkl-------KQveH~~nEk~vL~~v~~PFlv~l~~t~  113 (355)
T KOG0616|consen   45 DFERLKTLGTG----SFGRVHLVREKHSGNYYAMKVLDKQKVVKL-------KQVEHTHNEKRVLKAVSHPFLVKLYGTF  113 (355)
T ss_pred             hhhheeeeccC----ccceEEEEEEccCCceeehhhcCHHHHHHH-------HHHHHHhhHHHHHhhccCceeEEEEEee
Confidence            46677777777    799999999999999999999988777664       5678889999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+.+++|+||||++||.|.+++++ .+++++..+++|++||+.||+|||+++|++          |||||+|||+|.+|+
T Consensus       114 ~d~~~lymvmeyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~~iiY----------RDLKPENiLlD~~G~  182 (355)
T KOG0616|consen  114 KDNSNLYMVMEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSLDIIY----------RDLKPENLLLDQNGH  182 (355)
T ss_pred             ccCCeEEEEEeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhcCeee----------ccCChHHeeeccCCc
Confidence            999999999999999999999998 589999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||+|+.+...    +.+.||||.|+|||+++     ...|+.++|||||||++|||+.|.+||.+.+...++++|
T Consensus       183 iKitDFGFAK~v~~r----T~TlCGTPeYLAPEii~-----sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI  253 (355)
T KOG0616|consen  183 IKITDFGFAKRVSGR----TWTLCGTPEYLAPEIIQ-----SKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI  253 (355)
T ss_pred             EEEEeccceEEecCc----EEEecCCccccChHHhh-----cCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH
Confidence            999999999987643    45689999999999999     477999999999999999999999999999999999999


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCC--CCChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDS  317 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s--~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~  317 (372)
                      +.+.  +.+|+    .++++++|||++||+ |-.+|.+  -++..+|+              .||||++++|+++  +++
T Consensus       254 ~~~~--v~fP~----~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk--------------~H~wF~~v~W~~i~~r~i  313 (355)
T KOG0616|consen  254 LEGK--VKFPS----YFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIK--------------NHPWFKGVDWEAILQRKI  313 (355)
T ss_pred             HhCc--ccCCc----ccCHHHHHHHHHHHhhhhHhhhcCcCCCccccc--------------cCcccccccHHHHhhccc
Confidence            9966  45576    789999999999999 9999987  24677777              9999999999998  678


Q ss_pred             CCCCcC-CCCCCCCCCCCCCCcccc
Q psy11571        318 NAPYIP-EVSSPTDTSHFDVDEAGV  341 (372)
Q Consensus       318 ~~p~~p-~~~~~~~~~~~~~~~~~~  341 (372)
                      ++||+| .+..+.|+++||....+.
T Consensus       314 e~P~~pp~~~~~gdtsnfd~y~e~~  338 (355)
T KOG0616|consen  314 EPPFEPPNIHGPGDTSNFDDYEEED  338 (355)
T ss_pred             cCCCCCccccCCccccccccccccc
Confidence            999988 889999999999876643

>KOG0610|consensus

Probab=100.00  E-value=1.7e-57  Score=414.32  Aligned_cols=284  Identities=37%  Similarity=0.628  Sum_probs=247.8

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      .++.|..+|.|    --|+||.|+...++..+|+|++.+..+...       +.+.++..|.+||+.++||+++.||..|
T Consensus        78 ~f~llk~LG~G----diG~VyL~~l~~t~~~fAmKVmdK~~l~~r-------kKl~Ra~tE~eIL~~lDHPFlPTLYa~f  146 (459)
T KOG0610|consen   78 HFRLLKRLGCG----DIGTVYLVELRGTNCLFAMKVMDKESLASR-------KKLKRAQTEREILSLLDHPFLPTLYASF  146 (459)
T ss_pred             HHHHHHHcCCC----CceeEEEEEecCCCceEEEEEecHHHHhhh-------hHHHHHHHHHHHHHhcCCCccchhhhee
Confidence            56788888888    589999999988899999999988777654       3456788899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +++...|++||||+||+|..+.+++ +..++++.+++|+++++.||+|||-+|||+          |||||+||||.++|
T Consensus       147 et~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivY----------RDLKPENILvredG  216 (459)
T KOG0610|consen  147 ETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVY----------RDLKPENILVREDG  216 (459)
T ss_pred             eccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceee----------ccCCcceeEEecCC
Confidence            9999999999999999999999875 457999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCC---------------------------------C-C---------------------cccccccc
Q psy11571        162 HIRLADFGSCLRLGG---------------------------------D-G---------------------TVQSNVAV  186 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~---------------------------------~-~---------------------~~~~~~~~  186 (372)
                      +|.|+||.++.....                                 . .                     ...++.++
T Consensus       217 HIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFV  296 (459)
T KOG0610|consen  217 HIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFV  296 (459)
T ss_pred             cEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccc
Confidence            999999998753310                                 0 0                     01234568


Q ss_pred             cCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHH
Q psy11571        187 GTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL  266 (372)
Q Consensus       187 gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~l  266 (372)
                      ||-.|+|||++.+     ...+.++|||+|||++|||+.|..||.+.+..+++.+|+.....+  |...  .++..++||
T Consensus       297 GThEYlAPEvI~G-----~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~F--p~~~--~vs~~akDL  367 (459)
T KOG0610|consen  297 GTHEYLAPEVIRG-----EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKF--PEEP--EVSSAAKDL  367 (459)
T ss_pred             cccccccceeeec-----CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcC--CCCC--cchhHHHHH
Confidence            9999999999995     457889999999999999999999999999999999999866544  4432  689999999


Q ss_pred             HHHhcc-CCCCCCC-CCChhhhhhhhhhhhccCCCCCCCCCcCCCCccccccCCCCCcCCCCCCCC
Q psy11571        267 MRRLIC-SSDTRLG-QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTD  330 (372)
Q Consensus       267 i~~lL~-~p~~R~s-~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~~~~~p~~p~~~~~~~  330 (372)
                      |++||. ||.+|++ ..++.||+              +||||++++|.-++-..||++|.......
T Consensus       368 Ir~LLvKdP~kRlg~~rGA~eIK--------------~HpFF~gVnWaLir~~~PP~iP~~~d~~~  419 (459)
T KOG0610|consen  368 IRKLLVKDPSKRLGSKRGAAEIK--------------RHPFFEGVNWALIRCARPPEIPKPVDGGL  419 (459)
T ss_pred             HHHHhccChhhhhccccchHHhh--------------cCccccCCChhheeccCCCcCCCccccCc
Confidence            999999 9999998 46788888              99999999999889999999998755443

>KOG0592|consensus

Probab=100.00  E-value=4.8e-58  Score=429.91  Aligned_cols=257  Identities=33%  Similarity=0.614  Sum_probs=230.8

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      .+.+|+++.+..+++.||+|+|.+..+.+++.+       +.+..|..+|.+| .||.|++||..|+|+..+|+|+||++
T Consensus        85 SYStV~~A~~~~t~keYAiKVl~K~~Iike~Kv-------kYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~  157 (604)
T KOG0592|consen   85 SYSTVVLAREKATGKEYAIKVLDKRYIIKEKKV-------KYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAP  157 (604)
T ss_pred             cceeEEEeeecCCCceeeHhhhhHHHHHhhccc-------chhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecC
Confidence            566788888888999999999999888887443       5578899999999 79999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCC
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG  176 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  176 (372)
                      +|+|.++|++ -+.|++..++.|++||+.||+|||++||||          |||||+|||+|++++++|+|||.|+.+..
T Consensus       158 nGdll~~i~K-~Gsfde~caR~YAAeIldAleylH~~GIIH----------RDlKPENILLd~dmhikITDFGsAK~l~~  226 (604)
T KOG0592|consen  158 NGDLLDLIKK-YGSFDETCARFYAAEILDALEYLHSNGIIH----------RDLKPENILLDKDGHIKITDFGSAKILSP  226 (604)
T ss_pred             CCcHHHHHHH-hCcchHHHHHHHHHHHHHHHHHHHhcCcee----------ccCChhheeEcCCCcEEEeeccccccCCh
Confidence            9999999999 589999999999999999999999999999          99999999999999999999999988753


Q ss_pred             CCc----------cc--ccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhh
Q psy11571        177 DGT----------VQ--SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN  244 (372)
Q Consensus       177 ~~~----------~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~  244 (372)
                      ...          ..  ..+++||..|.+||++.     ....++++|+|+||||+|+|+.|.+||.+.++.-++++|+.
T Consensus       227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~-----~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~  301 (604)
T KOG0592|consen  227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLN-----DSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA  301 (604)
T ss_pred             hhccccCccCcccccCcccceeeeecccCHHHhc-----CCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH
Confidence            211          11  24589999999999998     46789999999999999999999999999999999999998


Q ss_pred             ccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccccccCCCC
Q psy11571        245 HQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAP  320 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~~~~~p  320 (372)
                      ..  +.+|.    .+++.++|||+++|. ||.+|+|+++|   +              +||||.+|||+.|.+.+||
T Consensus       302 l~--y~fp~----~fp~~a~dLv~KLLv~dp~~Rlt~~qI---k--------------~HpFF~~Vdw~nlw~~~PP  355 (604)
T KOG0592|consen  302 LD--YEFPE----GFPEDARDLIKKLLVRDPSDRLTSQQI---K--------------AHPFFEGVDWENLWQQTPP  355 (604)
T ss_pred             hc--ccCCC----CCCHHHHHHHHHHHccCccccccHHHH---h--------------hCcccccCChhhhhhcCCC
Confidence            54  56666    789999999999999 99999987544   4              9999999999999877764

>KOG0690|consensus

Probab=100.00  E-value=1.7e-58  Score=408.73  Aligned_cols=320  Identities=31%  Similarity=0.546  Sum_probs=277.5

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      .+.-|..+|.|    .+|.|..|+...+++.+|+|.+++..+...       +.+..-..|..+|+...||++..+.+.|
T Consensus       169 dFdfLKvLGkG----TFGKVIL~rEKat~k~YAiKIlkKeviiak-------dEVAHTlTE~RVL~~~~HPFLt~LKYsF  237 (516)
T KOG0690|consen  169 DFDFLKVLGKG----TFGKVILCREKATGKLYAIKILKKEVIIAK-------DEVAHTLTENRVLQNCRHPFLTSLKYSF  237 (516)
T ss_pred             hhhHHHHhcCC----ccceEEEEeecccCceeehhhhhhhheeeh-------HHhhhhhhHHHHHHhccCcHHHHhhhhh
Confidence            45566777777    589999999999999999999887655443       2345567799999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      ++++++|+||||..||.|.-++.+ ...++|+.+++|-++|+.||.|||+++||.          ||||.+|+|+|.+|+
T Consensus       238 Qt~drlCFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivY----------RDlKLENLlLDkDGH  306 (516)
T KOG0690|consen  238 QTQDRLCFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVY----------RDLKLENLLLDKDGH  306 (516)
T ss_pred             ccCceEEEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeee----------eechhhhheeccCCc
Confidence            999999999999999999999988 578999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||+++.-...+. ...++||||.|+|||++..     ..|+.++|||.+||++|||++|+.||...+...++.-|
T Consensus       307 IKitDFGLCKE~I~~g~-t~kTFCGTPEYLAPEVleD-----nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI  380 (516)
T KOG0690|consen  307 IKITDFGLCKEEIKYGD-TTKTFCGTPEYLAPEVLED-----NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI  380 (516)
T ss_pred             eEeeecccchhcccccc-eeccccCChhhcCchhhcc-----ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH
Confidence            99999999987554443 3456999999999999984     67999999999999999999999999999999999999


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCC--CCChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDS  317 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s--~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~  317 (372)
                      +...  +.+|.    .++++++.|+..+|. ||.+|++  .+++.+|+              .|+||.++||+++  +++
T Consensus       381 l~ed--~kFPr----~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~--------------~h~FF~~v~W~~~~~Kki  440 (516)
T KOG0690|consen  381 LMED--LKFPR----TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIM--------------RHRFFASVDWEATYRKKI  440 (516)
T ss_pred             Hhhh--ccCCc----cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHH--------------hhhhhccCCHHHHHHhcc
Confidence            8865  45566    789999999999999 9999997  57899999              9999999999998  678


Q ss_pred             CCCCcCCCCCCCCCCCCCCCccccCCCCCCCCCCCCc--ccccCCCCccCceeeC
Q psy11571        318 NAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASP--ALSALHLPFVGFTFTQ  370 (372)
Q Consensus       318 ~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  370 (372)
                      .|||.|++.|..|+++||.+.++....-.+|....+.  .-.+.+..|+-|+|.+
T Consensus       441 ~PPfKPqVtSetDTryFD~EFT~q~v~lTPP~r~~~~~~~~~e~~~~FpQFsy~~  495 (516)
T KOG0690|consen  441 EPPFKPQVTSETDTRYFDEEFTSQPVTLTPPDRYGSTVDEDEERRPHFPQFSYSA  495 (516)
T ss_pred             CCCCCCCcccccchhhhhhhhhcceeEecCCCCCCcccchhhhhccCCcceeeec
Confidence            9999999999999999999988665443333333322  2346677899999875

>KOG0615|consensus

Probab=100.00  E-value=3.2e-57  Score=411.90  Aligned_cols=257  Identities=25%  Similarity=0.404  Sum_probs=220.2

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccCC
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCG   97 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~g   97 (372)
                      ++|.|-.++...+++.||+|.+..........   +......+++|+++|+.++|||||+++++|+..+..|+||||+.|
T Consensus       184 afg~Vkla~e~~tgk~vAiKIi~krk~~~~s~---~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~G  260 (475)
T KOG0615|consen  184 AFGLVKLAYEKKTGKQVAIKIINKRKSTGCSR---AIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEG  260 (475)
T ss_pred             ceeEEEEEEEcccCcEEEeeeeehhhcccccc---cccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecC
Confidence            78888888889999999999998776665432   112233377999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC---CcEEEeecCccccc
Q psy11571         98 GDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN---GHIRLADFGSCLRL  174 (372)
Q Consensus        98 g~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~---~~vkl~Dfg~a~~~  174 (372)
                      |+|.+.+-. ++.+.+...+.++.|++.|+.|||++||+|          |||||+|||+..+   ..+||+|||+|+..
T Consensus       261 GeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~H----------RDiKPeNILl~~~~e~~llKItDFGlAK~~  329 (475)
T KOG0615|consen  261 GELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIH----------RDIKPENILLSNDAEDCLLKITDFGLAKVS  329 (475)
T ss_pred             ccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcCccc----------ccCCcceEEeccCCcceEEEecccchhhcc
Confidence            999999987 688999999999999999999999999999          9999999999866   67999999999998


Q ss_pred             CCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHH-HHHHHhhccCCcCCCC
Q psy11571        175 GGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKIMNHQNSFDLPS  253 (372)
Q Consensus       175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~~~~~~~  253 (372)
                      +....  ..++||||.|.|||++.+.  |...+..++|+|||||+||-+++|.+||.+..... +.++|.++...+  -+
T Consensus       330 g~~sf--m~TlCGTpsYvAPEVl~~k--g~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f--~p  403 (475)
T KOG0615|consen  330 GEGSF--MKTLCGTPSYVAPEVLASK--GVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAF--GP  403 (475)
T ss_pred             cccee--hhhhcCCccccChhheecC--CeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccc--cC
Confidence            75433  3558999999999999853  23345568999999999999999999998876555 778888865444  44


Q ss_pred             CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCc
Q psy11571        254 DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAW  311 (372)
Q Consensus       254 ~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w  311 (372)
                      ..|..+|+++++||++||. ||++||++++++                 +||||+.+.-
T Consensus       404 ~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL-----------------~hpW~~~~~~  445 (475)
T KOG0615|consen  404 LQWDRISEEALDLINWMLVVDPENRPSADEAL-----------------NHPWFKDAPC  445 (475)
T ss_pred             hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHh-----------------cChhhhcccc
Confidence            4556899999999999999 999999988777                 9999997763

>KOG0608|consensus

Probab=100.00  E-value=7.2e-55  Score=413.42  Aligned_cols=286  Identities=43%  Similarity=0.813  Sum_probs=254.7

Q ss_pred             ccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         16 IQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        16 ~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      +|+||.|..|.+..+...+|.|.+.+..+...       +.+..++.|.+||...+++.||+||+.|++++++|+||+|+
T Consensus       639 vGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~r-------nQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYI  711 (1034)
T KOG0608|consen  639 VGAFGEVCLVRKVDTRALYAMKTLRKADVLMR-------NQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYI  711 (1034)
T ss_pred             ccccceeEEEeecchhhHHHHhhhHHHHHHhh-------hhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEecc
Confidence            34899999999999999999998877665543       45677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccC
Q psy11571         96 CGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG  175 (372)
Q Consensus        96 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~  175 (372)
                      +|||+..+|-+ -+-|+|+.+++|++++..|+++.|..|+||          |||||+|||||.+|++||+|||+|.-+.
T Consensus       712 PGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmGFIH----------RDiKPDNILIDrdGHIKLTDFGLCTGfR  780 (1034)
T KOG0608|consen  712 PGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMGFIH----------RDIKPDNILIDRDGHIKLTDFGLCTGFR  780 (1034)
T ss_pred             CCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhcccee----------cccCccceEEccCCceeeeeccccccce
Confidence            99999999987 588999999999999999999999999999          9999999999999999999999996432


Q ss_pred             C---------CCc--------------------------------ccccccccCCcccCcccccccccCCCCCCCcccee
Q psy11571        176 G---------DGT--------------------------------VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWW  214 (372)
Q Consensus       176 ~---------~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diw  214 (372)
                      -         ...                                ......+||+.|+|||++.     +..|+..+|||
T Consensus       781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~-----r~g~~q~cdww  855 (1034)
T KOG0608|consen  781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA-----RTGYTQLCDWW  855 (1034)
T ss_pred             eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc-----ccCccccchhh
Confidence            1         000                                0112357999999999998     56799999999


Q ss_pred             ehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCCChhhhhhhhhhhh
Q psy11571        215 SLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFV  294 (372)
Q Consensus       215 slGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~~p~~R~s~~~~~~i~~~~~~~~  294 (372)
                      |.|||||||+.|++||..+++.+.-.+|+++...+.++...  ++|+++.+||.+|++.++.|++.....+++       
T Consensus       856 s~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~--~ls~e~~~li~kLc~sad~RLGkng~d~vK-------  926 (1034)
T KOG0608|consen  856 SVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQG--NLSKEALDLIQKLCCSADSRLGKNGADQVK-------  926 (1034)
T ss_pred             HhhHHHHHHhhCCCCccCCCCCcceeeeeehhhcccccccc--ccCHHHHHHHHHHhcChhhhhcccchhhhh-------
Confidence            99999999999999999998888888888887777776544  799999999999999999999988888888       


Q ss_pred             ccCCCCCCCCCcCCCCccccccCCCCCcCCCCCCCCCCCCCCCccc
Q psy11571        295 SLSISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAG  340 (372)
Q Consensus       295 ~~~~~~~~hp~f~~~~w~~~~~~~~p~~p~~~~~~~~~~~~~~~~~  340 (372)
                             .||||++|||..+++..+||+|.+.-+.|++|||..+.+
T Consensus       927 -------aHpfFkgIDfsslRkq~ApYIP~ItHptDTSNFdpvdpe  965 (1034)
T KOG0608|consen  927 -------AHPFFKGIDFSSLRKQRAPYIPRITHPTDTSNFDPVDPE  965 (1034)
T ss_pred             -------cCccccccchHhhhhccCCcCccccCCCccccCCcCCcc
Confidence                   999999999999999999999999999999999976654

>KOG0696|consensus

Probab=100.00  E-value=2.8e-56  Score=405.31  Aligned_cols=308  Identities=33%  Similarity=0.601  Sum_probs=268.8

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      ++|.|-.+++.-+...+|+|.+++..+-....+       +.-..|..+|... .-|++++++.+|++-+.+|+||||+.
T Consensus       361 SFGKVlLaerkgtdELyAiKiLkKDViiQdDDv-------ectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvn  433 (683)
T KOG0696|consen  361 SFGKVLLAERKGTDELYAIKILKKDVIIQDDDV-------ECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVN  433 (683)
T ss_pred             ccceeeeecccCcchhhhhhhhccceeeecCcc-------cceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEec
Confidence            688888888888999999999988776655333       3345677888776 47899999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCC
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG  176 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  176 (372)
                      ||+|..+|++ -+++.|..+.+|+++|+.||-+||++||++          ||||.+|||++..|++||+|||+++...-
T Consensus       434 GGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiY----------RDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  434 GGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIY----------RDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             CchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeee----------eeccccceEeccCCceEeeeccccccccc
Confidence            9999999998 589999999999999999999999999999          99999999999999999999999986544


Q ss_pred             CCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCC
Q psy11571        177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVG  256 (372)
Q Consensus       177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  256 (372)
                      ++. .+.++||||.|+|||++.     ..+|+.++||||+||+||||+.|++||.+.++.+++..|+.....+  |.   
T Consensus       503 ~~~-TTkTFCGTPdYiAPEIi~-----YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsy--PK---  571 (683)
T KOG0696|consen  503 DGV-TTKTFCGTPDYIAPEIIA-----YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSY--PK---  571 (683)
T ss_pred             CCc-ceeeecCCCcccccceEE-----ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcC--cc---
Confidence            433 455699999999999998     6789999999999999999999999999999999999999876443  55   


Q ss_pred             CCCCHHHHHHHHHhcc-CCCCCCCCC--ChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccCCCCCcCCCCCCCCC
Q psy11571        257 YEISDDAKDLMRRLIC-SSDTRLGQN--GIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDT  331 (372)
Q Consensus       257 ~~~s~~~~~li~~lL~-~p~~R~s~~--~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~~~p~~p~~~~~~~~  331 (372)
                       .+|.++.++++.+|. +|.+|+++.  .-.+|.              .||||+.|||+.+  ++++|||.|.++-..+.
T Consensus       572 -slSkEAv~ickg~ltK~P~kRLGcg~~ge~di~--------------~H~FFR~iDWek~E~~eiqPPfkPk~k~~r~~  636 (683)
T KOG0696|consen  572 -SLSKEAVAICKGLLTKHPGKRLGCGPEGERDIR--------------EHPFFRRIDWEKLERREIQPPFKPKIKCGRDA  636 (683)
T ss_pred             -cccHHHHHHHHHHhhcCCccccCCCCccccchh--------------hCcchhhccHHHHhhccCCCCCCCccccCCch
Confidence             789999999999999 899999853  334444              9999999999998  67899999999999999


Q ss_pred             CCCCCCccccCCCCCCCCCCCCcccccCCCCccCceeeCC
Q psy11571        332 SHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQG  371 (372)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (372)
                      +|||...+  +..+.++|++..-.-+..+..|+||+|.|+
T Consensus       637 eNFD~~Ft--~~~~~lTPpD~~v~~nldq~eF~gFsfvNp  674 (683)
T KOG0696|consen  637 ENFDKFFT--REPTDLTPPDKLVMMNLDQSEFEGFSFVNP  674 (683)
T ss_pred             hhhhHHHh--cCCCCCCCchHHHHhcCchhhcCceeeeCh
Confidence            99999887  455567777765556677888999999885

>KOG0614|consensus

Probab=100.00  E-value=5.7e-56  Score=412.08  Aligned_cols=284  Identities=30%  Similarity=0.590  Sum_probs=260.9

Q ss_pred             ccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         16 IQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        16 ~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      .||||+|-.|+-......+|+|.+++......       +..+.+..|..+|..+.+|+||++|..|.++.++|++||-|
T Consensus       430 vGgFGRVELV~~~~~~~~fAlKilkK~hIVdt-------kQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaC  502 (732)
T KOG0614|consen  430 VGGFGRVELVKVNSQKATFALKILKKKHIVDT-------KQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEAC  502 (732)
T ss_pred             cCccceEEEEEecccchHHHHHHHhHhhccch-------hHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhh
Confidence            34999999998777777899999988777665       35577889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccC
Q psy11571         96 CGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG  175 (372)
Q Consensus        96 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~  175 (372)
                      -||.|+..++. ++.+.+..+++|+..++.|++|||++|||+          |||||+|++++.+|.+||.|||+|+.+.
T Consensus       503 lGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~iIY----------RDLKPENllLd~~Gy~KLVDFGFAKki~  571 (732)
T KOG0614|consen  503 LGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKGIIY----------RDLKPENLLLDNRGYLKLVDFGFAKKIG  571 (732)
T ss_pred             cCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcCcee----------ccCChhheeeccCCceEEeehhhHHHhc
Confidence            99999999998 689999999999999999999999999999          9999999999999999999999999987


Q ss_pred             CCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCC
Q psy11571        176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDV  255 (372)
Q Consensus       176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  255 (372)
                      ...  .+.++||||.|.|||++.+     ...+.++|.||||+++|||++|.+||.+.++..+++.|+++-..+.+|.  
T Consensus       572 ~g~--KTwTFcGTpEYVAPEIILn-----KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr--  642 (732)
T KOG0614|consen  572 SGR--KTWTFCGTPEYVAPEIILN-----KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPR--  642 (732)
T ss_pred             cCC--ceeeecCCcccccchhhhc-----cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhccc--
Confidence            665  4567999999999999994     5688999999999999999999999999999999999999988888887  


Q ss_pred             CCCCCHHHHHHHHHhcc-CCCCCCC--CCChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccCCCCCcCCCCCCCC
Q psy11571        256 GYEISDDAKDLMRRLIC-SSDTRLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTD  330 (372)
Q Consensus       256 ~~~~s~~~~~li~~lL~-~p~~R~s--~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~~~p~~p~~~~~~~  330 (372)
                        .++..+.+||++|.. +|.+|++  ..++.||+              +|.||.++||+.+  +...||++|.+.++.|
T Consensus       643 --~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIk--------------kH~Wf~gfdweglr~~~L~pPi~~~va~ptD  706 (732)
T KOG0614|consen  643 --RITKTATDLIKKLCRDNPTERLGYQKGGINDIK--------------KHRWFEGFDWEGLRSRTLPPPIIPSVANPTD  706 (732)
T ss_pred             --ccchhHHHHHHHHHhcCcHhhhccccCChHHHH--------------hhhhhhcCChhhhhhccCCCCccccCCCccc
Confidence              789999999999999 9999999  68899999              9999999999998  4578999999999999


Q ss_pred             CCCCCCCccccC
Q psy11571        331 TSHFDVDEAGVR  342 (372)
Q Consensus       331 ~~~~~~~~~~~~  342 (372)
                      .++||....+..
T Consensus       707 ~s~Fd~~p~dnd  718 (732)
T KOG0614|consen  707 VSNFDNFPPDND  718 (732)
T ss_pred             chhccCCCcccC
Confidence            999997765443

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=7.2e-54  Score=410.24  Aligned_cols=324  Identities=40%  Similarity=0.707  Sum_probs=262.3

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    ++|.||.+.+..+++.||+|.+.......       .+....+.+|+.++..++||||+++++.+
T Consensus         2 ~y~~~~~LG~G----~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~~~E~~il~~~~~~~iv~~~~~~   70 (363)
T cd05628           2 DFESLKVIGRG----AFGEVRLVQKKDTGHVYAMKILRKADMLE-------KEQVGHIRAERDILVEADSLWVVKMFYSF   70 (363)
T ss_pred             CceEeEEEEeC----CCEEEEEEEECCCCCEEEEEEEEHHHHHH-------hhHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            56677777777    89999999999999999999886543322       23456688899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+...+|+|||||+||+|.+++.+ .+.+++..++.++.|++.||+|||++||+|          |||||+|||++.++.
T Consensus        71 ~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givH----------rDlKp~NILi~~~~~  139 (363)
T cd05628          71 QDKLNLYLIMEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIH----------RDIKPDNLLLDSKGH  139 (363)
T ss_pred             ecCCeEEEEEcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEe----------cCCCHHHeEECCCCC
Confidence            999999999999999999999987 578999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCc----------------------------------ccccccccCCcccCcccccccccCCCCCC
Q psy11571        163 IRLADFGSCLRLGGDGT----------------------------------VQSNVAVGTPDYISPEILTAMEEGRGRYG  208 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  208 (372)
                      +||+|||+++.......                                  ......+||+.|+|||++.+     ..++
T Consensus       140 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~~  214 (363)
T cd05628         140 VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-----TGYN  214 (363)
T ss_pred             EEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-----CCCC
Confidence            99999999875432110                                  00123579999999999973     5688


Q ss_pred             CccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCCChhhhhh
Q psy11571        209 PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKM  288 (372)
Q Consensus       209 ~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~~p~~R~s~~~~~~i~~  288 (372)
                      .++|||||||++|||++|++||.+.+..+.+.++......+.+|...  .+++++++||.+|+.+|.+|++...+.+++ 
T Consensus       215 ~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~--~~s~~~~~li~~l~~~~~~r~~r~~~~ei~-  291 (363)
T cd05628         215 KLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEV--PISEKAKDLILRFCCEWEHRIGAPGVEEIK-  291 (363)
T ss_pred             CchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcC--CCCHHHHHHHHHHcCChhhcCCCCCHHHHh-
Confidence            99999999999999999999999999888888888755555555432  579999999999888777665544566777 


Q ss_pred             hhhhhhccCCCCCCCCCcCCCCccccccCCCCCcCCCCCCCCCCCCCCCccccCCCCCCCCCCC-CcccccCCCCccCce
Q psy11571        289 WSALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAA-SPALSALHLPFVGFT  367 (372)
Q Consensus       289 ~~~~~~~~~~~~~~hp~f~~~~w~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  367 (372)
                                   +||||++++|+.++...++..+.+.+..+.++|+.........+..+.+.. ..........|.|||
T Consensus       292 -------------~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (363)
T cd05628         292 -------------TNPFFEGVDWEHIRERPAAIPIEIKSIDDTSNFDEFPDSDILKPTVATSNHPETDYKNKDWVFINYT  358 (363)
T ss_pred             -------------CCCCCCCCCHHHHHhCCCCCCccCCCcchhhccCCCCccccccccccccCCcccccCcCCcccCCce
Confidence                         999999999999977666666677888888998865543332232222222 334556677799999


Q ss_pred             ee
Q psy11571        368 FT  369 (372)
Q Consensus       368 ~~  369 (372)
                      |.
T Consensus       359 ~~  360 (363)
T cd05628         359 YK  360 (363)
T ss_pred             ee
Confidence            97

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.7e-53  Score=402.79  Aligned_cols=331  Identities=67%  Similarity=1.152  Sum_probs=270.2

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    ++|.||+++...+++.+|+|.+........       .....+.+|+.++..++||||+++++++
T Consensus         2 ~y~~~~~lG~G----~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~i~~~~~~~   70 (332)
T cd05623           2 DFEILKVIGRG----AFGEVAVVKLKNADKVFAMKILNKWEMLKR-------AETACFREERDVLVNGDNQWITTLHYAF   70 (332)
T ss_pred             CceEEEEEEeC----CCeEEEEEEECCCCCEEEEEEEeHHHHHHh-------hHHHHHHHHHHHHhhCCCCCEeeEEEEE
Confidence            45666777777    899999999888899999998754322211       2234577899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+.+.+|+||||+++|+|.+++.+....+++..++.++.||+.||.|||++||+|          |||||+|||++.++.
T Consensus        71 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiH----------rDlkp~Nili~~~~~  140 (332)
T cd05623          71 QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH----------RDIKPDNILMDMNGH  140 (332)
T ss_pred             ecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe----------cCCCHHHEEECCCCC
Confidence            9999999999999999999999875567999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||++..............+||+.|+|||++.....+...++.++|||||||++|||++|+.||.+.+..+.+.++
T Consensus       141 ~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i  220 (332)
T cd05623         141 IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  220 (332)
T ss_pred             EEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            99999999876544333333346799999999999754333456889999999999999999999999999988888888


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccccccCCCCCc
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPYI  322 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~~~~~p~~  322 (372)
                      ........+|... ..+++++++||++||+.+.+|++...+.+++              +||||.+++|+.+....+|++
T Consensus       221 ~~~~~~~~~p~~~-~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~--------------~h~~f~~~~~~~~~~~~~~~~  285 (332)
T cd05623         221 MNHKERFQFPAQV-TDVSEDAKDLIRRLICSREHRLGQNGIEDFK--------------QHPFFTGIDWDNIRNCEAPYI  285 (332)
T ss_pred             hCCCccccCCCcc-ccCCHHHHHHHHHHccChhhhcCCCCHHHHh--------------CCCCcCCCCHHHHhhCCCCcc
Confidence            7765545444432 2679999999999998545555444566666              999999999999998999999


Q ss_pred             CCCCCCCCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceeeC
Q psy11571        323 PEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQ  370 (372)
Q Consensus       323 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (372)
                      |...++.+.++++............+|+.. .+.++.+.+|.||||++
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  332 (332)
T cd05623         286 PEVSSPTDTSNFDVDDDCLKNSETMPPPSH-TAFSGHHLPFVGFTYTS  332 (332)
T ss_pred             CCCCCCcccccCCCCcccccccCCCCCCCc-cccccCCCCcCCeeecC
Confidence            999999999998766555444444444333 35577899999999985

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-54  Score=410.47  Aligned_cols=324  Identities=44%  Similarity=0.800  Sum_probs=268.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||.+++..+++.||+|.+........       .....+.+|+.++..++||||+++++++
T Consensus         2 ~y~~~~~lG~G----~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~~~E~~il~~l~h~~iv~~~~~~   70 (364)
T cd05599           2 DFESIKVIGRG----AFGEVRLVQKKDTGHIYAMKKLRKSEMLEK-------EQVAHVRAERDILAEADNPWVVKLYYSF   70 (364)
T ss_pred             CceEEEEEEec----CCEEEEEEEECCCCCEEEEEEEEHHHhhhh-------hHHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence            45666777777    899999999999999999998865432221       2345678899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+++.+|+|||||+||+|.+++.. .+.+++..++.++.||+.||+|||++||+|          |||||+|||++.++.
T Consensus        71 ~~~~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH----------~Dlkp~NIl~~~~~~  139 (364)
T cd05599          71 QDENYLYLIMEYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIH----------RDIKPDNLLLDAKGH  139 (364)
T ss_pred             EcCCeEEEEECCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEe----------ccCCHHHeEECCCCC
Confidence            999999999999999999999987 568999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcc-------------------------------------cccccccCCcccCcccccccccCCC
Q psy11571        163 IRLADFGSCLRLGGDGTV-------------------------------------QSNVAVGTPDYISPEILTAMEEGRG  205 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~  205 (372)
                      ++|+|||+++........                                     .....+||+.|+|||++.     ..
T Consensus       140 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~  214 (364)
T cd05599         140 IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-----QT  214 (364)
T ss_pred             EEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHc-----CC
Confidence            999999998754321100                                     011246999999999997     35


Q ss_pred             CCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCCChhh
Q psy11571        206 RYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIAD  285 (372)
Q Consensus       206 ~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~~p~~R~s~~~~~~  285 (372)
                      .++.++|||||||++|||++|.+||.+.+..+....+......+..|...  .+++++++||++||.+|.+|++...+.+
T Consensus       215 ~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~--~~s~~~~~li~~ll~~p~~R~~~~~~~~  292 (364)
T cd05599         215 GYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEV--PLSPEAKDLIKRLCCEAERRLGNNGVNE  292 (364)
T ss_pred             CCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCC--CCCHHHHHHHHHHccCHhhcCCCCCHHH
Confidence            68999999999999999999999999999888888887765555555432  5799999999999999999998666777


Q ss_pred             hhhhhhhhhccCCCCCCCCCcCCCCccccccCCCCCcCCCCCCCCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccC
Q psy11571        286 FKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVG  365 (372)
Q Consensus       286 i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (372)
                      ++              .||||++++|+.+....+|++|...+..+.++|+..+......+..+ .......+..+..|.|
T Consensus       293 ll--------------~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  357 (364)
T cd05599         293 IK--------------SHPFFKGVDWEHIRERPAPIIPELKSITDTSNFDDFEEIDLDVPTSP-GPPRGKIKSKDLAFIG  357 (364)
T ss_pred             Hh--------------cCCCcCCCCHHHHhhcCCCCCCCCCCchhhhhccccccccccccCCC-ccccccccccCCCCCC
Confidence            77              99999999999998889999999999999999987555433332222 2223445677899999


Q ss_pred             ceeeC
Q psy11571        366 FTFTQ  370 (372)
Q Consensus       366 ~~~~~  370 (372)
                      |||++
T Consensus       358 ~~~~~  362 (364)
T cd05599         358 YTYKR  362 (364)
T ss_pred             CeeeC
Confidence            99975

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-53  Score=403.24  Aligned_cols=330  Identities=70%  Similarity=1.176  Sum_probs=273.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    ++|.||.++...+++.||+|.+.......       ....+.+.+|..++..++||||+++++++
T Consensus         2 ~y~~~~~lG~G----~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~   70 (331)
T cd05597           2 DFEILKVIGRG----AFGEVAVVKMKNTGQVYAMKILNKWEMLK-------RAETACFREERDVLVNGDRRWITNLHYAF   70 (331)
T ss_pred             CceEEEEEEec----CCeEEEEEEECCCCCEEEEEEEEHHHHhh-------hhhHHHHHHHHHHHHhCCCCCCCceEEEE
Confidence            46667777777    89999999999999999999876432211       12345578899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+++++|+||||++||+|.+++.+....+++..++.++.||+.||+|||++|++|          |||||+|||++.++.
T Consensus        71 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH----------~dlkp~Nill~~~~~  140 (331)
T cd05597          71 QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVH----------RDIKPDNVLLDKNGH  140 (331)
T ss_pred             ecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEE----------CCCCHHHEEECCCCC
Confidence            9999999999999999999999875568999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||++...............||+.|+|||++.....+...++.++|||||||++|+|++|+.||.+.+..+.+..+
T Consensus       141 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i  220 (331)
T cd05597         141 IRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  220 (331)
T ss_pred             EEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHH
Confidence            99999999876654333333335799999999999754333456788999999999999999999999998888888888


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccccccCCCCCc
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPYI  322 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~~~~~p~~  322 (372)
                      ......+.++... ..+++++++||++||+.|.+|++...+.+++              .||||.+++|+.+....+|+.
T Consensus       221 ~~~~~~~~~~~~~-~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l--------------~hp~~~~~~~~~~~~~~~~~~  285 (331)
T cd05597         221 MNHKEHFQFPPDV-TDVSEEAKDLIRRLICSPETRLGRNGLQDFK--------------DHPFFEGIDWDNIRNSTAPYV  285 (331)
T ss_pred             HcCCCcccCCCcc-CCCCHHHHHHHHHHccCcccccCCCCHHHHh--------------cCCCCCCCCHHHHhhCCCCcc
Confidence            7655545544432 2589999999999998555555444566666              999999999999988889999


Q ss_pred             CCCCCCCCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceee
Q psy11571        323 PEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFT  369 (372)
Q Consensus       323 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (372)
                      |...++.++++|+....+.......+|+. ....++.+.++.||||+
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  331 (331)
T cd05597         286 PEVSSPTDTSNFDVDDDDLRNTESLPPSS-HGAFSGNHLPFVGFTYT  331 (331)
T ss_pred             CcCCCcchhhhcCCcccccccccccCCCC-cCcCCcCCCCCCceeeC
Confidence            99999999999998887776666555544 36678899999999996

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0575|consensus

Probab=100.00  E-value=1.8e-54  Score=411.87  Aligned_cols=246  Identities=30%  Similarity=0.566  Sum_probs=223.5

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      |||.++|.++++.+|..||+|++.++.+...       ...+++.+|+++.+.++|||||+++++|++.+++|+|+|+|.
T Consensus        29 GgFA~cYe~~~~~tge~~A~KvVpk~~l~k~-------~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~  101 (592)
T KOG0575|consen   29 GGFARCYEARDLDTGEVVAVKVVPKKLLKKP-------KQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCH  101 (592)
T ss_pred             CcceEEEEEEEcCCCcEEEEEEeehHHhcCc-------chHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecC
Confidence            3888899999999999999999988777665       345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCC
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG  176 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  176 (372)
                      .++|..++++ ++.++|.+++.+++||+.||.|||+++|+|          ||||..|+|++++.+|||+|||+|..+..
T Consensus       102 ~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~~IiH----------RDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen  102 RGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSLGIIH----------RDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             CccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhcCcee----------cccchhheeecCcCcEEecccceeeeecC
Confidence            9999999996 789999999999999999999999999999          99999999999999999999999999875


Q ss_pred             CCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCC
Q psy11571        177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVG  256 (372)
Q Consensus       177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  256 (372)
                      ++. ...+.||||.|.|||++.     ...++..+||||+||+||.|++|+|||...+..+++.+|....  +.+|.   
T Consensus       171 ~~E-rk~TlCGTPNYIAPEVl~-----k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~--Y~~P~---  239 (592)
T KOG0575|consen  171 DGE-RKKTLCGTPNYIAPEVLN-----KSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE--YSMPS---  239 (592)
T ss_pred             ccc-ccceecCCCcccChhHhc-----cCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC--ccccc---
Confidence            543 345689999999999998     4668999999999999999999999999999999999998855  55566   


Q ss_pred             CCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCc-CCC
Q psy11571        257 YEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWF-QGI  309 (372)
Q Consensus       257 ~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f-~~~  309 (372)
                       .+|.++++||.+||+ ||.+|||+++++                 .|+|| +++
T Consensus       240 -~ls~~A~dLI~~lL~~~P~~Rpsl~~vL-----------------~h~Ff~~g~  276 (592)
T KOG0575|consen  240 -HLSAEAKDLIRKLLRPNPSERPSLDEVL-----------------DHPFFKSGF  276 (592)
T ss_pred             -ccCHHHHHHHHHHhcCCcccCCCHHHHh-----------------cCHhhhCCC
Confidence             789999999999999 999999876665                 99999 443

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.4e-53  Score=400.62  Aligned_cols=330  Identities=66%  Similarity=1.129  Sum_probs=271.3

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||+++...+++.+|+|.+.......       ......+.+|..++..++||||+++++++
T Consensus         2 ~y~i~~~lG~G----~fg~V~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~~~e~~~l~~~~~~~i~~l~~~~   70 (331)
T cd05624           2 DFEIIKVIGRG----AFGEVAVVKMKHTERIYAMKILNKWEMLK-------RAETACFREERNVLVNGDCQWITTLHYAF   70 (331)
T ss_pred             CceEEEEEeeC----CCeEEEEEEECCCCCEEEEEEEeHHHHHh-------hHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            46666777777    89999999999899999999876432211       12345577899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+.+..|+||||++||+|.+++.+....+++..++.++.|++.||.|||++||+|          |||||+|||++.++.
T Consensus        71 ~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiH----------rDlkp~Nill~~~~~  140 (331)
T cd05624          71 QDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH----------RDIKPDNVLLDMNGH  140 (331)
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeee----------ccCchHHEEEcCCCC
Confidence            9999999999999999999999875568999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||++..............+||+.|+|||++.+...+.+.++.++|+|||||++|+|++|+.||.+.+..+.+.++
T Consensus       141 ~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i  220 (331)
T cd05624         141 IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  220 (331)
T ss_pred             EEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHH
Confidence            99999999987654443333345799999999998753333356788999999999999999999999998888888888


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccccccCCCCCc
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPYI  322 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~~~~~p~~  322 (372)
                      ......+++|... ..+++++++||.+||..+.+|++...+.+++              +||||++++|+.++...+|+.
T Consensus       221 ~~~~~~~~~p~~~-~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~--------------~h~~f~~~~~~~~~~~~~~~~  285 (331)
T cd05624         221 MNHEERFQFPSHI-TDVSEEAKDLIQRLICSRERRLGQNGIEDFK--------------KHAFFEGIDWENIRNLEAPYI  285 (331)
T ss_pred             HcCCCcccCCCcc-ccCCHHHHHHHHHHccCchhhcCCCCHHHHh--------------cCCCcCCCCHHHHhhCCCCcc
Confidence            7765555555432 2579999999999999655676666677777              999999999999999999999


Q ss_pred             CCCCCCCCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceee
Q psy11571        323 PEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFT  369 (372)
Q Consensus       323 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (372)
                      |...++.+.++|+........+...++ .-+..++.-+.++.||||+
T Consensus       286 p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  331 (331)
T cd05624         286 PDVSSPSDTSNFDVDDDVLRNPEIAPP-SSHTGFSGLHLPFVGFTYT  331 (331)
T ss_pred             CCCCCcchhhhcCCccccccccccCCC-ccccccCCCCcCCCCceeC
Confidence            999999999998876654333332333 3346678888999999996

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-53  Score=406.32  Aligned_cols=325  Identities=41%  Similarity=0.746  Sum_probs=263.0

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||++.+..+++.||+|.+.......       .+.++.+.+|+.+++.++||||+++++++
T Consensus         2 ~y~~~~~lG~G----~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~~~E~~il~~l~hp~iv~~~~~~   70 (377)
T cd05629           2 DFHTVKVIGKG----AFGEVRLVQKKDTGKIYAMKTLLKSEMFK-------KDQLAHVKAERDVLAESDSPWVVSLYYSF   70 (377)
T ss_pred             CceEeEEEeec----CCEEEEEEEECCCCCEEEEEEEEHHHHHH-------hHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            56667777777    89999999999999999999875433221       13456788899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+...+|+||||++||+|.+++.. ...+++..++.++.|++.||+|||+.||+|          |||||+|||++.++.
T Consensus        71 ~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givH----------rDlkp~NIll~~~~~  139 (377)
T cd05629          71 QDAQYLYLIMEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIH----------RDIKPDNILIDRGGH  139 (377)
T ss_pred             EcCCeeEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeec----------cCCCHHHEEECCCCC
Confidence            999999999999999999999987 578999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCc------------c----------------------------------cccccccCCcccCccc
Q psy11571        163 IRLADFGSCLRLGGDGT------------V----------------------------------QSNVAVGTPDYISPEI  196 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~------------~----------------------------------~~~~~~gt~~y~aPE~  196 (372)
                      ++|+|||+++.......            .                                  .....+||+.|+|||+
T Consensus       140 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (377)
T cd05629         140 IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEI  219 (377)
T ss_pred             EEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHH
Confidence            99999999863211000            0                                  0012469999999999


Q ss_pred             ccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhccCCCC
Q psy11571        197 LTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT  276 (372)
Q Consensus       197 ~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~~p~~  276 (372)
                      +.     ...++.++|||||||++|||++|.+||.+.+..+.+.++......+.+|...  .++.++++||++||.+|.+
T Consensus       220 ~~-----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~--~~s~~~~dli~~lL~~~~~  292 (377)
T cd05629         220 FL-----QQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDI--HLSVEAEDLIRRLITNAEN  292 (377)
T ss_pred             Hc-----cCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCC--CCCHHHHHHHHHHhcCHhh
Confidence            97     3568999999999999999999999999988888888887655445555422  5799999999999998877


Q ss_pred             CCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccccccCCCCCcCCCCCCCCCCCCCCCccccC-C--CCCCCCCCCC
Q psy11571        277 RLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVR-A--SDALPPAAAS  353 (372)
Q Consensus       277 R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~  353 (372)
                      |++...+.+++              .||||++++|+.++...+|+.|.+.+..+..+|........ .  ....+++...
T Consensus       293 r~~r~~~~~~l--------------~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (377)
T cd05629         293 RLGRGGAHEIK--------------SHPFFRGVDWDTIRQIRAPFIPQLKSITDTSYFPTDELEQVPEAPALKQAAPAQQ  358 (377)
T ss_pred             cCCCCCHHHHh--------------cCCCcCCCCHHHHccCCCCcccCCCCccccccCCccccccCcccccccccccccc
Confidence            76545566666              99999999999999999999999999888888865544221 1  1112222334


Q ss_pred             cccccCCCCccCceeeC
Q psy11571        354 PALSALHLPFVGFTFTQ  370 (372)
Q Consensus       354 ~~~~~~~~~~~~~~~~~  370 (372)
                      +........|.||||+-
T Consensus       359 ~~~~~~~~~~~~~~~~~  375 (377)
T cd05629         359 EESVELDLAFIGYTYKR  375 (377)
T ss_pred             ccccccCcccccceecC
Confidence            55567788999999963

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0581|consensus

Probab=100.00  E-value=2.9e-53  Score=383.14  Aligned_cols=255  Identities=24%  Similarity=0.422  Sum_probs=224.8

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      .++.++.+|.|    ..|+||+|.+..+++.+|+|.+....- .        +..+++.+|+++++.++|||||++|++|
T Consensus        80 dle~~~~lG~G----~gG~V~kv~Hk~t~~i~AlK~I~~~~~-~--------~~~~Qi~rEl~il~~~~spyIV~~ygaF  146 (364)
T KOG0581|consen   80 DLERLGVLGSG----NGGTVYKVRHKPTGKIYALKVILLNID-P--------ALQKQILRELEILRSCQSPYIVGFYGAF  146 (364)
T ss_pred             HhhhhhhcccC----CCcEEEEEEEcCCCeEEEEEeecccCC-H--------HHHHHHHHHHHHHhhCCCCCeeeEeEEE
Confidence            57778888888    689999999999999999998843221 1        2457789999999999999999999999


Q ss_pred             EeCCe-EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         83 QDDSN-LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD-LHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        83 ~~~~~-~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      .++.. ++++||||.||+|.++++. .++++|.....++.+++.||.|||+ ++|||          |||||+|||+++.
T Consensus       147 ~~~~~~isI~mEYMDgGSLd~~~k~-~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIH----------RDIKPsNlLvNsk  215 (364)
T KOG0581|consen  147 YSNGEEISICMEYMDGGSLDDILKR-VGRIPEPVLGKIARAVLRGLSYLHEERKIIH----------RDIKPSNLLVNSK  215 (364)
T ss_pred             EeCCceEEeehhhcCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhccCeee----------ccCCHHHeeeccC
Confidence            99994 9999999999999999988 5889999999999999999999995 99999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC-----CH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE-----SL  235 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~-----~~  235 (372)
                      |.|||||||.++.+...   ..+++.||..|||||.+.+     ..|+.++||||||+.+.||++|+.||...     +.
T Consensus       216 GeVKicDFGVS~~lvnS---~a~tfvGT~~YMsPERi~g-----~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~  287 (364)
T KOG0581|consen  216 GEVKICDFGVSGILVNS---IANTFVGTSAYMSPERISG-----ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDI  287 (364)
T ss_pred             CCEEeccccccHHhhhh---hcccccccccccChhhhcC-----CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCH
Confidence            99999999999887544   4566899999999999994     67999999999999999999999999874     67


Q ss_pred             HHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCC
Q psy11571        236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       236 ~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~  310 (372)
                      .+++..|+.+ .++.+|..   .+|+++++||..||+ ||.+|+++++++                 +|||++...
T Consensus       288 ~~Ll~~Iv~~-ppP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl-----------------~Hpfi~~~~  342 (364)
T KOG0581|consen  288 FELLCAIVDE-PPPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLL-----------------QHPFIKKFE  342 (364)
T ss_pred             HHHHHHHhcC-CCCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHh-----------------cCHHHhhcc
Confidence            7888888875 34455553   489999999999999 999999987776                 999999654

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=8.6e-53  Score=405.49  Aligned_cols=325  Identities=39%  Similarity=0.699  Sum_probs=261.8

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    ++|.||++.+..+++.+|+|.+.......       .+..+.+.+|+.+++.++||||+++++.+
T Consensus         2 ~f~~~~~LG~G----~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~-------~~~~~~~~~E~~il~~~~h~~iv~~~~~~   70 (382)
T cd05625           2 MFVKIKTLGIG----AFGEVCLARKVDTKALYAMKTLRKKDVLL-------RNQVAHVKAERDILAEADNEWVVRLYYSF   70 (382)
T ss_pred             CcEEEEEEEeC----CCEEEEEEEECCCCCEEEEEEEeHHHhhh-------HHHHHHHHHHHHHHHhCCCCcCCeEEEEE
Confidence            56677788887    89999999999999999999876533222       23456788899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+++.+|+|||||++|+|.+++.+ .+.+++..++.++.||+.||.|||++||+|          |||||+|||++.+|.
T Consensus        71 ~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivH----------rDlKp~NILl~~~g~  139 (382)
T cd05625          71 QDKDNLYFVMDYIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIH----------RDIKPDNILIDRDGH  139 (382)
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeec----------CCCCHHHEEECCCCC
Confidence            999999999999999999999987 467899999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCC----------------------------------------------cccccccccCCcccCccc
Q psy11571        163 IRLADFGSCLRLGGDG----------------------------------------------TVQSNVAVGTPDYISPEI  196 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~----------------------------------------------~~~~~~~~gt~~y~aPE~  196 (372)
                      +||+|||++.......                                              .......+||+.|+|||+
T Consensus       140 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~  219 (382)
T cd05625         140 IKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEV  219 (382)
T ss_pred             EEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHH
Confidence            9999999975321000                                              000123479999999999


Q ss_pred             ccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhccCCCC
Q psy11571        197 LTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT  276 (372)
Q Consensus       197 ~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~~p~~  276 (372)
                      +.+     ..++.++|||||||++|||++|++||.+.+..+...++.........|..  ..+++++.++|.+|+.+|.+
T Consensus       220 ~~~-----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~--~~~s~~~~~li~~l~~~p~~  292 (382)
T cd05625         220 LLR-----TGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQ--AKLSPEASDLIIKLCRGPED  292 (382)
T ss_pred             hcC-----CCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCc--ccCCHHHHHHHHHHccCHhH
Confidence            973     56889999999999999999999999998888877777765544544432  26899999999998779999


Q ss_pred             CCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc-ccCCCCCcCCCCCCCCCCCCCCCccccCCCC-CC----CCC
Q psy11571        277 RLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI-RDSNAPYIPEVSSPTDTSHFDVDEAGVRASD-AL----PPA  350 (372)
Q Consensus       277 R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~-~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~-~~----~~~  350 (372)
                      |++...+.+++              .||||++++|... .+..+|+.|.+..+.++++|+..+.+....+ ..    +..
T Consensus       293 R~~~~~~~ei~--------------~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (382)
T cd05625         293 RLGKNGADEIK--------------AHPFFKTIDFSSDLRQQSAPYIPKITHPTDTSNFDPVDPDKLWSDDDKEGNVNDT  358 (382)
T ss_pred             cCCCCCHHHHh--------------cCCCcCCcChHHHHhcCCCCccCcCCCcchhhhcCCCCccccccccccccccccc
Confidence            99977788888              9999999999874 6678899999999999999986554321111 00    100


Q ss_pred             CC--CcccccCCCCccCceeeC
Q psy11571        351 AA--SPALSALHLPFVGFTFTQ  370 (372)
Q Consensus       351 ~~--~~~~~~~~~~~~~~~~~~  370 (372)
                      ..  ..........|.||||+.
T Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~  380 (382)
T cd05625         359 LNGWYKNGKHPEHAFYEFTFRR  380 (382)
T ss_pred             cccccccccccCcccccceecc
Confidence            00  123345567899999974

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.5e-52  Score=394.96  Aligned_cols=310  Identities=32%  Similarity=0.570  Sum_probs=253.8

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      |++|.||.+++..+++.+|+|.+........       .....+.+|+.+++.++||||+++++++.+.+.+|+||||++
T Consensus         6 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   78 (323)
T cd05571           6 GTFGKVILVREKATGKYYAMKILKKEVIIAK-------DEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEEHHHhhhh-------HHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence            4899999999999999999998765433221       234556789999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCC
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG  176 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  176 (372)
                      +|+|.+++.. .+.+++..++.++.||+.||+|||++||+|          |||||+|||++.++.+||+|||+++....
T Consensus        79 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH----------rDlkp~NIll~~~~~~kl~DfG~a~~~~~  147 (323)
T cd05571          79 GGELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVY----------RDLKLENLMLDKDGHIKITDFGLCKEGIS  147 (323)
T ss_pred             CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEe----------CCCCHHHEEECCCCCEEEeeCCCCccccc
Confidence            9999999987 578999999999999999999999999999          99999999999999999999999875432


Q ss_pred             CCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCC
Q psy11571        177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVG  256 (372)
Q Consensus       177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  256 (372)
                      ... .....+||+.|+|||++.+     ..++.++|||||||++|||++|..||.+.+.......+....  ..+|.   
T Consensus       148 ~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~--~~~p~---  216 (323)
T cd05571         148 DGA-TMKTFCGTPEYLAPEVLED-----NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPR---  216 (323)
T ss_pred             CCC-cccceecCccccChhhhcC-----CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--CCCCC---
Confidence            222 2234679999999999973     568999999999999999999999999988888877776643  33444   


Q ss_pred             CCCCHHHHHHHHHhcc-CCCCCCCCC--ChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccCCCCCcCCCCCCCCC
Q psy11571        257 YEISDDAKDLMRRLIC-SSDTRLGQN--GIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDT  331 (372)
Q Consensus       257 ~~~s~~~~~li~~lL~-~p~~R~s~~--~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~~~p~~p~~~~~~~~  331 (372)
                       .+++++.+||++||+ ||++||+..  .+.+++              +||||++++|+.+  +...+|+.|.+.+..++
T Consensus       217 -~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll--------------~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (323)
T cd05571         217 -TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIM--------------EHRFFASINWQDVVQKKLEPPFKPQVTSETDT  281 (323)
T ss_pred             -CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHH--------------cCCCcCCCCHHHHHhCCCCCCcCCCCCCcchh
Confidence             689999999999999 999999632  466666              9999999999987  45678999999999999


Q ss_pred             CCCCCCccccCCCCCCCCCCCCcc---cccCCCCccCceeeCC
Q psy11571        332 SHFDVDEAGVRASDALPPAAASPA---LSALHLPFVGFTFTQG  371 (372)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~  371 (372)
                      .+|+...+....... |+......   .......|++|+|.++
T Consensus       282 ~~~~~~~~~~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (323)
T cd05571         282 RYFDEEFTAQSITIT-PPDRYDSLGLLQLEERPHFPQFSYSAS  323 (323)
T ss_pred             hhcCcccccCCcccC-CCCcccccccccccccccCCCCeeeCC
Confidence            999876655333222 22222111   1245778999999763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=7.7e-53  Score=397.90  Aligned_cols=327  Identities=46%  Similarity=0.811  Sum_probs=268.8

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.++.|    ++|.||++.+..+++.+|+|.+........       +..+.+.+|+.+++.++||||+++++++
T Consensus         2 ~y~~~~~lg~G----~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~~~e~~i~~~~~~~~i~~~~~~~   70 (330)
T cd05601           2 DFDVKSLVGRG----HFGEVQVVREKATGDIYAMKVMKKSVLLAQ-------ETVSFFEEERDILSISNSPWIPQLQYAF   70 (330)
T ss_pred             CceEEEEEEec----cCEEEEEEEECCCCCEEEEEEEEHHHhhhh-------hHHHHHHHHHHHHHhCCCCCCcceeeEE
Confidence            35555666666    899999999999999999998875433221       2345678899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+.+.+|+||||+++|+|.+++.+....+++..++.++.||+.||.|||+.||+|          |||||+|||++.++.
T Consensus        71 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H----------~Dlkp~NIll~~~~~  140 (330)
T cd05601          71 QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVH----------RDIKPENVLIDRTGH  140 (330)
T ss_pred             ecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEc----------ccCchHheEECCCCC
Confidence            9999999999999999999999875578999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccC-CCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEG-RGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      +||+|||++...............||+.|+|||++...... ...++.++|||||||++|+|++|..||...+....+.+
T Consensus       141 ~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~  220 (330)
T cd05601         141 IKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNN  220 (330)
T ss_pred             EEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHH
Confidence            99999999987654433333345789999999998743221 34578899999999999999999999999888888888


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccccccCCCCC
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPY  321 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~~~~~p~  321 (372)
                      +........+|...  .++.++++||++||.+|.+||+++++.                 .||||+.++|+.+....+|+
T Consensus       221 i~~~~~~~~~~~~~--~~~~~~~~li~~ll~~p~~R~t~~~l~-----------------~h~~~~~~~~~~~~~~~~~~  281 (330)
T cd05601         221 IMNFQRFLKFPEDP--KVSSDFLDLIQSLLCGQKERLGYEGLC-----------------CHPFFSKIDWNNIRNSLPPF  281 (330)
T ss_pred             HHcCCCccCCCCCC--CCCHHHHHHHHHHccChhhCCCHHHHh-----------------CCCCcCCCCHHHHhhCCCCc
Confidence            87654444444422  579999999999999999999877665                 99999999999998888999


Q ss_pred             cCCCCCCCCCCCCCCCccccCCCC-CCCCCCCCcccccCCCCccCceee
Q psy11571        322 IPEVSSPTDTSHFDVDEAGVRASD-ALPPAAASPALSALHLPFVGFTFT  369 (372)
Q Consensus       322 ~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  369 (372)
                      .|.+....+.++|+.......... ..+....+..+++...+|.||.|+
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (330)
T cd05601         282 VPTLKSDDDTSNFDEPEKNSTRRSQSSTTQLKPNGFSGKDLPFVGFSFI  330 (330)
T ss_pred             cCcCCCcchhhhcCCCccccccccccccccCCCcCCCCCCCCccCceeC
Confidence            999999999999876554433222 223334455678889999999985

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-53  Score=401.69  Aligned_cols=320  Identities=45%  Similarity=0.850  Sum_probs=268.2

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||++.+..+++.||+|.+........       ...+.+.+|+.++..++||||+++++++
T Consensus         2 ~y~~~~~lg~G----~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~i~~~~~~~   70 (350)
T cd05573           2 DFEVIKVIGRG----AFGEVWLVRDKDTGQVYAMKVLRKSDMIKR-------NQIAHVRAERDILADADSPWIVKLYYSF   70 (350)
T ss_pred             CceEEEEEEeC----CcEEEEEEEECCCCCEEEEEEEEHHHHhhc-------cHHHHHHHHHHHHHhcCCCCccchhhhe
Confidence            56666777777    899999999999999999998765433221       2345678899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+++.+|+||||+++++|.+++.+ .+.+++..++.++.||+.||+|||++|++|          |||||+|||++.++.
T Consensus        71 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiH----------~Dlkp~NIll~~~~~  139 (350)
T cd05573          71 QDEEHLYLVMEYMPGGDLMNLLIR-KDVFPEETARFYIAELVLALDSVHKLGFIH----------RDIKPDNILIDADGH  139 (350)
T ss_pred             ecCCeEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeec----------cCCCHHHeEECCCCC
Confidence            999999999999999999999987 478999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCC----------------------------cccccccccCCcccCcccccccccCCCCCCCcccee
Q psy11571        163 IRLADFGSCLRLGGDG----------------------------TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWW  214 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diw  214 (372)
                      +||+|||++.......                            ........||+.|+|||++.+     ..++.++|||
T Consensus       140 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Diw  214 (350)
T cd05573         140 IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-----TPYGLECDWW  214 (350)
T ss_pred             EEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcC-----CCCCCceeeE
Confidence            9999999998664432                            112234579999999999984     5789999999


Q ss_pred             ehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-CCChhhhhhhhhhh
Q psy11571        215 SLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLG-QNGIADFKMWSALF  293 (372)
Q Consensus       215 slGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~~p~~R~s-~~~~~~i~~~~~~~  293 (372)
                      ||||++|+|++|+.||...+..+...++........+|...  .+++++++||.+||.+|.+|++ +++++         
T Consensus       215 SlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~--~~~~~~~~li~~ll~dp~~R~~s~~~ll---------  283 (350)
T cd05573         215 SLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDP--PVSPEAIDLICRLLCDPEDRLGSFEEIK---------  283 (350)
T ss_pred             ecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCC--CCCHHHHHHHHHHccChhhcCCCHHHHh---------
Confidence            99999999999999999998888888887744444445432  4799999999999999999998 66555         


Q ss_pred             hccCCCCCCCCCcCCCCccccccCCCCCcCCCCCCCCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceee
Q psy11571        294 VSLSISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFT  369 (372)
Q Consensus       294 ~~~~~~~~~hp~f~~~~w~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (372)
                              +||||++++|+......+|++|.++++.+.++|+..+.+....+. .+............+|.||+|.
T Consensus       284 --------~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  350 (350)
T cd05573         284 --------SHPFFKGIDWENLRETKPPFVPELSSPLDTSNFDDFEDDKDLSDY-LSQNSKKLNKGKQLAFVGFTYK  350 (350)
T ss_pred             --------cCCCcCCCCHHHHhhCCCCcCCCCCCchhhhhcCCCCcccccccc-cccccccccccccCccCCCccC
Confidence                    999999999999988889999999999999999987776554332 2223334455788999999994

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.6e-52  Score=399.11  Aligned_cols=322  Identities=41%  Similarity=0.729  Sum_probs=262.0

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+.++.+|.|    |+|.||.+.+..+++.||+|.+.......       .+..+.+.+|+.++..++||||+++++.+.
T Consensus         3 f~~~~~lG~G----~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   71 (360)
T cd05627           3 FESLKVIGRG----AFGEVRLVQKKDTGHIYAMKILRKADMLE-------KEQVAHIRAERDILVEADGAWVVKMFYSFQ   71 (360)
T ss_pred             ceEEEEEeeC----CCEEEEEEEECCCCCEEEEEEEEHHHHhh-------hhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            4556666666    89999999999999999999876433221       234567888999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcE
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI  163 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~v  163 (372)
                      +.+.+|+|||||+||+|.+++.+ .+.+++..++.++.|++.||.|||++||+|          |||||+|||++.+|.+
T Consensus        72 ~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givH----------rDLkp~NIli~~~~~v  140 (360)
T cd05627          72 DKRNLYLIMEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIH----------RDIKPDNLLLDAKGHV  140 (360)
T ss_pred             cCCEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEc----------cCCCHHHEEECCCCCE
Confidence            99999999999999999999987 578999999999999999999999999999          9999999999999999


Q ss_pred             EEeecCcccccCCCCc----------------------------------ccccccccCCcccCcccccccccCCCCCCC
Q psy11571        164 RLADFGSCLRLGGDGT----------------------------------VQSNVAVGTPDYISPEILTAMEEGRGRYGP  209 (372)
Q Consensus       164 kl~Dfg~a~~~~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~  209 (372)
                      +|+|||++........                                  ......+||+.|+|||++.+     ..++.
T Consensus       141 kL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~~~  215 (360)
T cd05627         141 KLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-----TGYNK  215 (360)
T ss_pred             EEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-----CCCCC
Confidence            9999999875432100                                  00123579999999999973     56889


Q ss_pred             ccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCCChhhhhhh
Q psy11571        210 ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMW  289 (372)
Q Consensus       210 ~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~~p~~R~s~~~~~~i~~~  289 (372)
                      ++|||||||++|||++|++||.+.+..+.+.++......+.+|...  .+++++++||.+|+.+|.+|+++..+.+++  
T Consensus       216 ~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~--~~s~~~~~li~~l~~~p~~R~~~~~~~ei~--  291 (360)
T cd05627         216 LCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEV--PISEKAKDLILRFCTDSENRIGSNGVEEIK--  291 (360)
T ss_pred             cceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCC--CCCHHHHHHHHHhccChhhcCCCCCHHHHh--
Confidence            9999999999999999999999999888888887655445555432  479999999999877999999988888888  


Q ss_pred             hhhhhccCCCCCCCCCcCCCCccccccCCCCCcCCCCCCCCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceee
Q psy11571        290 SALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFT  369 (372)
Q Consensus       290 ~~~~~~~~~~~~~hp~f~~~~w~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (372)
                                  .||||++++|+.+....++..+.+.+..+.++|+....+....  .+.....+-.+..++.|-+|+|.
T Consensus       292 ------------~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  357 (360)
T cd05627         292 ------------SHPFFEGVDWGHIRERPAAIPIEIKSIDDTSNFDEFPESDILQ--PAENTIEPDYKSKDWVFLNYTYK  357 (360)
T ss_pred             ------------cCCCCCCCCHHHHhcCCCCCCccCCCcchhhhcCCCCcccccC--CCccccccccCcCCcccCCceee
Confidence                        9999999999999766655556678888999997543321111  11222245566788889999997


Q ss_pred             C
Q psy11571        370 Q  370 (372)
Q Consensus       370 ~  370 (372)
                      +
T Consensus       358 ~  358 (360)
T cd05627         358 R  358 (360)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-51  Score=387.24  Aligned_cols=306  Identities=34%  Similarity=0.646  Sum_probs=254.9

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      ||+|.||++.+..+++.||+|.+........       .....+.+|+.++..++||||+++++++.+.+..|+||||++
T Consensus         4 G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   76 (312)
T cd05585           4 GSFGKVMQVRKRDTQRIYALKTIRKAHIVSR-------SEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFIN   76 (312)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEEHHHhhhh-------hHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCC
Confidence            4899999999998999999998764332221       234557789999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCC
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG  176 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  176 (372)
                      +|+|.+++.. .+.+++..++.++.||+.||.|||++||+|          |||||+|||++.++.++|+|||+++....
T Consensus        77 ~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H----------rDlkp~Nili~~~~~~kl~Dfg~~~~~~~  145 (312)
T cd05585          77 GGELFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIY----------RDLKPENILLDYQGHIALCDFGLCKLNMK  145 (312)
T ss_pred             CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEe----------CCCCHHHeEECCCCcEEEEECcccccCcc
Confidence            9999999987 578999999999999999999999999999          99999999999999999999999876432


Q ss_pred             CCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCC
Q psy11571        177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVG  256 (372)
Q Consensus       177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  256 (372)
                      ... .....+||+.|+|||++.+     ..++.++|||||||++|+|++|..||.+.+..+.+..+....  +.+|.   
T Consensus       146 ~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~--~~~~~---  214 (312)
T cd05585         146 DDD-KTNTFCGTPEYLAPELLLG-----HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP--LRFPD---  214 (312)
T ss_pred             CCC-ccccccCCcccCCHHHHcC-----CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC--CCCCC---
Confidence            222 2334679999999999983     568899999999999999999999999988888888877643  33444   


Q ss_pred             CCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccCCCCCcCCCCCCCCCCC
Q psy11571        257 YEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSH  333 (372)
Q Consensus       257 ~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~~~p~~p~~~~~~~~~~  333 (372)
                       .+++++++||.+||. ||.+|++...+.+++              .||||...+|..+  +...+|+.|.+.+..++++
T Consensus       215 -~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l--------------~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (312)
T cd05585         215 -GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK--------------NHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSN  279 (312)
T ss_pred             -cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH--------------cCCCcCCCCHHHHHhCCCCCCcCCCCCCccchhh
Confidence             689999999999999 999999988888888              9999999999876  4567899999999999999


Q ss_pred             CCCCccccCCCCCCCCCCCCcccccCCCCccCcee
Q psy11571        334 FDVDEAGVRASDALPPAAASPALSALHLPFVGFTF  368 (372)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (372)
                      |+.........+..  ...+...+..+.+|.||+|
T Consensus       280 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  312 (312)
T cd05585         280 FDEEFTREKPIDSV--VDDSHLSETVQQQFGGWSY  312 (312)
T ss_pred             cCccccccccccCC--CccccccchhccccCCCCC
Confidence            98665533222221  1222334456889999987

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.8e-52  Score=400.18  Aligned_cols=322  Identities=39%  Similarity=0.704  Sum_probs=254.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      .|+.++.+|.|    |+|.||++.+..+++.+|+|.+........       +..+.+.+|+.+++.++||||+++++++
T Consensus         2 ~f~~~~~LG~G----~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~-------~~~~~~~~E~~il~~l~h~~iv~l~~~~   70 (381)
T cd05626           2 MFVKIKTLGIG----AFGEVCLACKVDTHALYAMKTLRKKDVLNR-------NQVAHVKAERDILAEADNEWVVKLYYSF   70 (381)
T ss_pred             CceEEEEEeec----CCEEEEEEEECCCCCEEEEEEEEHHHhhhh-------HHHHHHHHHHHHHHhcCCCCeeeeEEEE
Confidence            45667777777    899999999999999999998875443322       2356688899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+.+.+|+|||||+||+|.+++.+ ...+++..++.++.||+.||.|||+.||+|          |||||+|||++.+++
T Consensus        71 ~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givH----------rDlKp~Nili~~~~~  139 (381)
T cd05626          71 QDKDNLYFVMDYIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIH----------RDIKPDNILIDLDGH  139 (381)
T ss_pred             ecCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeee----------cCCcHHHEEECCCCC
Confidence            999999999999999999999987 567999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCC----------------------------------------------cccccccccCCcccCccc
Q psy11571        163 IRLADFGSCLRLGGDG----------------------------------------------TVQSNVAVGTPDYISPEI  196 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~----------------------------------------------~~~~~~~~gt~~y~aPE~  196 (372)
                      +||+|||+++......                                              .......+||+.|+|||+
T Consensus       140 ~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~  219 (381)
T cd05626         140 IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEV  219 (381)
T ss_pred             EEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHH
Confidence            9999999975431100                                              000123579999999999


Q ss_pred             ccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-C--
Q psy11571        197 LTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-S--  273 (372)
Q Consensus       197 ~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~--  273 (372)
                      +.+     ..++.++|||||||++|||++|.+||...+..+...++......+..|...  .+++++++||.+||. +  
T Consensus       220 ~~~-----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~--~~s~~~~dli~~ll~~~~~  292 (381)
T cd05626         220 LLR-----KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQV--KLSPEAVDLITKLCCSAEE  292 (381)
T ss_pred             HcC-----CCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCC--CCCHHHHHHHHHHccCccc
Confidence            973     568899999999999999999999999888777777776544444444322  589999999999776 3  


Q ss_pred             CCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc-ccCCCCCcCCCCCCCCCCCCCCCccccCCCCCCCC-CC
Q psy11571        274 SDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI-RDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPP-AA  351 (372)
Q Consensus       274 p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~-~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  351 (372)
                      +..|+++++++                 .||||++++|... +...+|+.|.++.+.+.++|+....+.......+. ++
T Consensus       293 ~~~R~~~~~~l-----------------~hp~f~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (381)
T cd05626         293 RLGRNGADDIK-----------------AHPFFSEVDFSSDIRTQPAPYVPKISHPMDTSNFDPVEEESPWNDASGDSTR  355 (381)
T ss_pred             ccCCCCHHHHh-----------------cCcccCCCChhHHhhcCCCCccCcCCCcchhhhcCCCCcccccccCCccchh
Confidence            44588766555                 9999999999875 56678999999999999999865443221111111 11


Q ss_pred             -----CCcccccCCCCccCceeeC
Q psy11571        352 -----ASPALSALHLPFVGFTFTQ  370 (372)
Q Consensus       352 -----~~~~~~~~~~~~~~~~~~~  370 (372)
                           .++..+.....|.||||+.
T Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~  379 (381)
T cd05626         356 TWDTLCSPNGKHPEHAFYEFTFRR  379 (381)
T ss_pred             hhccccCcccccccccccccEeec
Confidence                 1223334467899999974

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.1e-51  Score=396.13  Aligned_cols=326  Identities=44%  Similarity=0.822  Sum_probs=262.0

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||++.+..+++.+|+|.+........       ...+.+.+|+.+++.++||||+++++++
T Consensus        44 ~y~i~~~lG~G----~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~-------~~~~~~~~e~~i~~~~~hp~iv~~~~~~  112 (371)
T cd05622          44 DYEVVKVIGRG----AFGEVQLVRHKSTRKVYAMKLLSKFEMIKR-------SDSAFFWEERDIMAFANSPWVVQLFYAF  112 (371)
T ss_pred             hcEEEEEEeec----CCeEEEEEEECCCCcEEEEEEEEHHHhhhh-------HHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            55666666666    899999999999999999998764332221       1234567899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .++..+|+|||||+||+|.+++..  ..+++..++.++.||+.||.|||++||+|          |||||+|||++.++.
T Consensus       113 ~~~~~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH----------rDLkp~NIll~~~~~  180 (371)
T cd05622         113 QDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIH----------RDVKPDNMLLDKSGH  180 (371)
T ss_pred             EcCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEe----------CCCCHHHEEECCCCC
Confidence            999999999999999999999976  56899999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||++..............+||+.|+|||++.+.. +...++.++|||||||++|||++|.+||.+.+....+.+|
T Consensus       181 ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i  259 (371)
T cd05622         181 LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG-GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI  259 (371)
T ss_pred             EEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccC-CCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999876544333334567999999999997421 1234788999999999999999999999999988888888


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCC--ccccccCCCC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIA--WDSIRDSNAP  320 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~--w~~~~~~~~p  320 (372)
                      +.....+.+|..  ..++..+++||.+||.+|..|++...+.+++              +||||++.+  |+.+++..+|
T Consensus       260 ~~~~~~~~~~~~--~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~--------------~h~~~~~~~~~~~~~~~~~~~  323 (371)
T cd05622         260 MNHKNSLTFPDD--NDISKEAKNLICAFLTDREVRLGRNGVEEIK--------------RHLFFKNDQWAWETLRDTVAP  323 (371)
T ss_pred             HcCCCcccCCCc--CCCCHHHHHHHHHHcCChhhhcCCCCHHHHh--------------cCcccCCCChhHHhcCCCCCC
Confidence            876554555542  2689999999999999777766655677777              999999854  5667888899


Q ss_pred             CcCCCCCCCCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceeeCC
Q psy11571        321 YIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQG  371 (372)
Q Consensus       321 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (372)
                      ++|.+.+..+.++|+....+.....   ....++.+.+.+.+|.||+|.++
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  371 (371)
T cd05622         324 VVPDLSSDIDTSNFDDIEEDKGEEE---TFPIPKAFVGNQLPFVGFTYYSN  371 (371)
T ss_pred             CCCCCCCcchhhhcCCCcccccccc---cCCCCccccccccccCCCeecCC
Confidence            9999999999888875443322111   11223444555699999999764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=6.6e-52  Score=397.52  Aligned_cols=321  Identities=45%  Similarity=0.820  Sum_probs=256.9

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    ++|.||++++..+++.+|+|.+........       ...+.+.+|+.+++.++||||+++++++
T Consensus        44 ~y~~~~~lg~G----~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~~~e~~il~~~~h~~iv~~~~~~  112 (370)
T cd05596          44 DFDVIKVIGRG----AFGEVQLVRHKSSKQVYAMKLLSKFEMIKR-------SDSAFFWEERDIMAHANSEWIVQLHYAF  112 (370)
T ss_pred             HcEEEEEEeeC----CCEEEEEEEECCCCCEEEEEEEEHHHhhhh-------hhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            34445555555    899999999999999999998764332221       1234467899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+++.+|+||||++||+|.+++..  ..+++..+..++.||+.||+|||++||+|          |||||+|||++.++.
T Consensus       113 ~~~~~~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH----------rDLkp~NILl~~~~~  180 (370)
T cd05596         113 QDDKYLYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIH----------RDVKPDNMLLDKSGH  180 (370)
T ss_pred             ecCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeec----------cCCCHHHEEEcCCCC
Confidence            999999999999999999999976  56899999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||++..............+||+.|+|||++.+... ...++.++|+|||||++|||++|.+||.+.+....+.++
T Consensus       181 ~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i  259 (370)
T cd05596         181 LKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGG-DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI  259 (370)
T ss_pred             EEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCC-CCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHH
Confidence            9999999998765433333344679999999999874211 234788999999999999999999999999988888888


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCC--CCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccc--cccC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDT--RLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDS--IRDS  317 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~--R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~--~~~~  317 (372)
                      ......+.+|...  .+|.++++||++||+ +|.+  |++++++   +              +||||++.+|..  ++..
T Consensus       260 ~~~~~~~~~~~~~--~~s~~~~~li~~~L~~~p~r~~R~s~~el---l--------------~h~~~~~~~~~~~~~~~~  320 (370)
T cd05596         260 MDHKNSLTFPDDI--EISKQAKDLICAFLTDREVRLGRNGVDEI---K--------------SHPFFKNDQWTFDNIRET  320 (370)
T ss_pred             HcCCCcCCCCCcC--CCCHHHHHHHHHHccChhhccCCCCHHHH---h--------------cCcccCCCChhhHHhcCC
Confidence            8765555555432  579999999999999 7766  8865544   4              999999988864  4677


Q ss_pred             CCCCcCCCCCCCCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceee
Q psy11571        318 NAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFT  369 (372)
Q Consensus       318 ~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (372)
                      .+|+.|..++..+.++|+....+.....   ....+..+...+..|.||+|.
T Consensus       321 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  369 (370)
T cd05596         321 VAPVVPELSSDIDTSNFDDIEDDDKNEE---TFPLPKAFAGNQLPFIGFTYS  369 (370)
T ss_pred             CcCccCcCCCcchhhhcCCccccccccc---cCCCccccccccCccCCCeec
Confidence            7899999999999999986554331111   112234445557789999985

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.6e-51  Score=394.73  Aligned_cols=324  Identities=44%  Similarity=0.834  Sum_probs=254.0

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||.+++..+++.+|+|.+........       ...+.+.+|+.+++.++||||+++++++
T Consensus        44 ~y~~~~~lG~G----~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~~~e~~i~~~~~hp~iv~~~~~~  112 (370)
T cd05621          44 DYDVVKVIGRG----AFGEVQLVRHKSSQKVYAMKLLSKFEMIKR-------SDSAFFWEERDIMAFANSPWVVQLFCAF  112 (370)
T ss_pred             HCeEEEEEEec----CCeEEEEEEECCCCCEEEEEEEEHHHhhhh-------hhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            44445555555    899999999999999999998764332221       1234567899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .++..+|+|||||+||+|.+++..  ..+++..++.++.||+.||+|||++||+|          |||||+|||++.++.
T Consensus       113 ~~~~~~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvH----------rDLKp~NILl~~~~~  180 (370)
T cd05621         113 QDDKYLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIH----------RDVKPDNMLLDKHGH  180 (370)
T ss_pred             EcCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEe----------cCCCHHHEEECCCCC
Confidence            999999999999999999999976  56899999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||++..............+||+.|+|||++.+.. ....++.++|+|||||++|+|++|.+||.+.+....+.++
T Consensus       181 ~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i  259 (370)
T cd05621         181 LKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQG-GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI  259 (370)
T ss_pred             EEEEecccceecccCCceecccCCCCcccCCHHHHhccC-CCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999876543333334567999999999997421 1234788999999999999999999999999988888888


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCc--cccccCCCC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAW--DSIRDSNAP  320 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w--~~~~~~~~p  320 (372)
                      ......+.+|...  .++..++++|.+||.++.+|++-..+.+++              +||||++.+|  ..++...+|
T Consensus       260 ~~~~~~~~~p~~~--~~s~~~~~li~~~L~~~~~r~~R~~~~e~l--------------~hp~~~~~~~~~~~~~~~~~~  323 (370)
T cd05621         260 MDHKNSLNFPEDV--EISKHAKNLICAFLTDREVRLGRNGVEEIK--------------QHPFFKNDQWNWDNIRETAAP  323 (370)
T ss_pred             HhCCcccCCCCcc--cCCHHHHHHHHHHccCchhccCCCCHHHHh--------------cCcccCCCCcChHhcCCCCCC
Confidence            8765555555532  579999999999998544433322355555              9999998665  455677889


Q ss_pred             CcCCCCCCCCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceee
Q psy11571        321 YIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFT  369 (372)
Q Consensus       321 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (372)
                      +.|.+++..+.++|+..+.........+.   +..+-+....|.||+|.
T Consensus       324 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  369 (370)
T cd05621         324 VVPELSSDIDSSNFDDIEDDKGDVETFPI---PKAFVGNQLPFIGFTYY  369 (370)
T ss_pred             cCCCCCCcchhhhcCCccccccccccCCC---CccccccccccCCCEec
Confidence            99999999999999865443222111111   12222335889999985

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.7e-51  Score=385.88  Aligned_cols=308  Identities=33%  Similarity=0.567  Sum_probs=249.9

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      |++|.||+++...+++.||+|.+........       ...+.+..|..++..+ +||||+++++++.+.+.+|+||||+
T Consensus         6 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~   78 (320)
T cd05590           6 GSFGKVMLARLKESGRLYAVKVLKKDVILQD-------DDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV   78 (320)
T ss_pred             CCCeEEEEEEEcCCCCEEEEEEEEHHHHhhc-------cHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence            4899999999998999999998765433222       1234456677777765 6999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccC
Q psy11571         96 CGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG  175 (372)
Q Consensus        96 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~  175 (372)
                      ++|+|.+++.+ ...+++..+..++.|++.||+|||++|++|          |||||+|||++.++.++|+|||+++...
T Consensus        79 ~~g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH----------~dlkp~NIli~~~~~~kL~DfG~~~~~~  147 (320)
T cd05590          79 NGGDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIY----------RDLKLDNVLLDHEGHCKLADFGMCKEGI  147 (320)
T ss_pred             CCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEe----------CCCCHHHeEECCCCcEEEeeCCCCeecC
Confidence            99999999987 568999999999999999999999999999          9999999999999999999999987643


Q ss_pred             CCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCC
Q psy11571        176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDV  255 (372)
Q Consensus       176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  255 (372)
                      .... ......||+.|+|||++.+     ..++.++|+|||||++|+|++|+.||.+.+..+.+..+.....  ..|.  
T Consensus       148 ~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~--~~~~--  217 (320)
T cd05590         148 FNGK-TTSTFCGTPDYIAPEILQE-----MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV--VYPT--  217 (320)
T ss_pred             cCCC-cccccccCccccCHHHHcC-----CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC--CCCC--
Confidence            2222 2234679999999999973     5688999999999999999999999999998888888876543  3344  


Q ss_pred             CCCCCHHHHHHHHHhcc-CCCCCCCCCC---hhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccCCCCCcCCCCCCC
Q psy11571        256 GYEISDDAKDLMRRLIC-SSDTRLGQNG---IADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPT  329 (372)
Q Consensus       256 ~~~~s~~~~~li~~lL~-~p~~R~s~~~---~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~~~p~~p~~~~~~  329 (372)
                        .++.++++||++||+ ||.+|+++.+   ..+++              .||||++++|+.+  +...||+.|.+.+..
T Consensus       218 --~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~--------------~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~  281 (320)
T cd05590         218 --WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAIL--------------RHPFFKELDWEKLNRRQIEPPFRPRIKSRE  281 (320)
T ss_pred             --CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHH--------------cCCCcCCCCHHHHHhCCCCCCcCCCCCCcc
Confidence              579999999999999 9999999743   35666              9999999999987  456889999999999


Q ss_pred             CCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceeeC
Q psy11571        330 DTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQ  370 (372)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (372)
                      +.++|+.......+.  +.+............+|.||+|.+
T Consensus       282 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  320 (320)
T cd05590         282 DVSNFDPDFIKEDPV--LTPIEESLLPMINQDEFRNFSYTA  320 (320)
T ss_pred             hhhhcCcccccCCcc--CCCCcccccccccccCcCCCcccC
Confidence            999998755543322  222222212223447899999874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.8e-51  Score=387.75  Aligned_cols=315  Identities=32%  Similarity=0.575  Sum_probs=255.5

Q ss_pred             HHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHH---hcCCCCceeeeeEE
Q psy11571          5 RELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVL---VYGDRRWITNLHYA   81 (372)
Q Consensus         5 ~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il---~~l~hp~Iv~l~~~   81 (372)
                      +.++.+|.|    ++|.||.+....+++.||+|.+........       ...+.+.+|..++   ..++||||++++++
T Consensus         2 ~i~~~lg~G----~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~   70 (324)
T cd05589           2 RCLAVLGRG----HFGKVLLAEYKKTGELYAIKALKKGDIIAR-------DEVESLMCEKRIFETANSERHPFLVNLFAC   70 (324)
T ss_pred             eEEEEEeec----CCEEEEEEEECCCCCEEEEEEEEHHHhhhh-------hHHHHHHHHHHHHHhccccCCCChhceeeE
Confidence            344555665    899999999988999999998875432222       1234455565554   56789999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+.+.+|+||||++|++|..++..  +.+++..++.++.||+.||.|||++|++|          |||||+||+++.++
T Consensus        71 ~~~~~~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivH----------rdlkp~Nill~~~~  138 (324)
T cd05589          71 FQTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVY----------RDLKLDNLLLDTEG  138 (324)
T ss_pred             EEcCCEEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEe----------cCCCHHHeEECCCC
Confidence            9999999999999999999998865  67999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .+||+|||+++....... .....+||+.|+|||++.+     ..++.++|+|||||++|+|++|+.||.+.+..+....
T Consensus       139 ~~kL~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~  212 (324)
T cd05589         139 FVKIADFGLCKEGMGFGD-RTSTFCGTPEFLAPEVLTE-----TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS  212 (324)
T ss_pred             cEEeCcccCCccCCCCCC-cccccccCccccCHhHhcC-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999875432222 2234679999999999973     5688999999999999999999999999988888888


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCC--ChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--cc
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQN--GIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RD  316 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~--~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~  316 (372)
                      +.....  ..|.    .++.++.++|++||+ ||.+||+..  .+.+++              +||||++++|..+  +.
T Consensus       213 i~~~~~--~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~--------------~~~~f~~~~~~~~~~~~  272 (324)
T cd05589         213 IVNDEV--RYPR----FLSREAISIMRRLLRRNPERRLGSGEKDAEDVK--------------KQPFFRDINWDDLLARK  272 (324)
T ss_pred             HHhCCC--CCCC----CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHh--------------hCCCcCCCCHHHHHhCC
Confidence            876543  3343    679999999999999 999999753  467777              9999999999886  45


Q ss_pred             CCCCCcCCCCCCCCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceee
Q psy11571        317 SNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFT  369 (372)
Q Consensus       317 ~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (372)
                      ..+|+.|.+....|.++|+..........+++ .......+..+..|.||+|+
T Consensus       273 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  324 (324)
T cd05589         273 IKPPFVPTIKGPEDVSNFDEEFTSEAPVLTPP-REPRLLTEEEQELFRGFDYV  324 (324)
T ss_pred             CCcCccCCCCCcchhhhcCccccccccccCCC-ccccccchhhhcccCCcccC
Confidence            67899999999999999887665443322222 22334567899999999996

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.7e-51  Score=384.57  Aligned_cols=307  Identities=34%  Similarity=0.621  Sum_probs=252.1

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      ||+|.||++++..+++.||+|.+........       ...+.+..|..++..+ +||||+++++++.+.+.+|+||||+
T Consensus         6 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   78 (318)
T cd05570           6 GSFGKVLLAELKGTDELYAVKVLKKDVILQD-------DDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV   78 (318)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEEHHHHhhh-------hHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence            3899999999988899999998875443222       2234566788888776 6999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccC
Q psy11571         96 CGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG  175 (372)
Q Consensus        96 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~  175 (372)
                      +||+|..++.+ .+.+++..+..++.||+.||.|||++|++|          |||||+||+++.++.++|+|||+++...
T Consensus        79 ~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH----------~dlkp~Nill~~~~~~kl~Dfg~~~~~~  147 (318)
T cd05570          79 NGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIY----------RDLKLDNVLLDSEGHIKIADFGMCKEGI  147 (318)
T ss_pred             CCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEc----------cCCCHHHeEECCCCcEEecccCCCeecC
Confidence            99999999987 468999999999999999999999999999          9999999999999999999999987532


Q ss_pred             CCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCC
Q psy11571        176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDV  255 (372)
Q Consensus       176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  255 (372)
                      .... .....+||+.|+|||++.+     ..++.++|+|||||++|+|++|+.||.+.+..+....+.....  .+|.  
T Consensus       148 ~~~~-~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~--~~~~--  217 (318)
T cd05570         148 LGGV-TTSTFCGTPDYIAPEILSY-----QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV--RYPR--  217 (318)
T ss_pred             cCCC-cccceecCccccCHHHhcC-----CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC--CCCC--
Confidence            2222 2233579999999999973     5688999999999999999999999999888888877776543  3343  


Q ss_pred             CCCCCHHHHHHHHHhcc-CCCCCCCC--CChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccCCCCCcCCCCCCCC
Q psy11571        256 GYEISDDAKDLMRRLIC-SSDTRLGQ--NGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTD  330 (372)
Q Consensus       256 ~~~~s~~~~~li~~lL~-~p~~R~s~--~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~~~p~~p~~~~~~~  330 (372)
                        .++.++.+||++||+ ||.+||++  ....+++              .||||+.++|+..  +...+|+.|.+.+..+
T Consensus       218 --~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (318)
T cd05570         218 --WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIK--------------GHPFFREIDWDKLERKEIKPPFKPKIKGRFD  281 (318)
T ss_pred             --cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHh--------------cCCCcCCCCHHHHHhCCCCCCcCCCCCCcch
Confidence              679999999999999 99999997  2224444              9999999999876  4567899999999999


Q ss_pred             CCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceee
Q psy11571        331 TSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFT  369 (372)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (372)
                      .++|+......  .+.+++.+........+++|+||+|+
T Consensus       282 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (318)
T cd05570         282 VSNFDDEFTKE--KPVLTPPDEAIIRNIDQEEFRGFSYI  318 (318)
T ss_pred             hhhcCchhccC--cccCCCCcccccccccccccCCCCCC
Confidence            99998665433  33445554444555677899999995

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=6.5e-51  Score=382.62  Aligned_cols=307  Identities=36%  Similarity=0.631  Sum_probs=253.3

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhc-CCCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVY-GDRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~-l~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      ||+|.||+++...+++.||+|.+........       ...+.+..|..++.. .+||||+++++++.+.+.+|+||||+
T Consensus         6 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~   78 (316)
T cd05592           6 GSFGKVMLAELKGTNEFFAIKALKKDVVLED-------DDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYL   78 (316)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEEHHHhhhh-------hhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence            4899999999988999999998775433222       122334456666654 58999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccC
Q psy11571         96 CGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG  175 (372)
Q Consensus        96 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~  175 (372)
                      +||+|..++.. ...+++..+..++.||+.||.|||++||+|          |||||+|||++.++.+||+|||+++...
T Consensus        79 ~gg~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH----------~dlkp~Nill~~~~~~kL~Dfg~a~~~~  147 (316)
T cd05592          79 NGGDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIY----------RDLKLDNVLLDKDGHIKIADFGMCKENM  147 (316)
T ss_pred             CCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEe----------CCCCHHHeEECCCCCEEEccCcCCeECC
Confidence            99999999987 568999999999999999999999999999          9999999999999999999999997643


Q ss_pred             CCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCC
Q psy11571        176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDV  255 (372)
Q Consensus       176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  255 (372)
                      ... ......+||+.|+|||++.+     ..++.++|+|||||++|+|++|..||.+.+..+.+..+....  ..+|.  
T Consensus       148 ~~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~~~--  217 (316)
T cd05592         148 NGE-GKASTFCGTPDYIAPEILKG-----QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR--PHFPR--  217 (316)
T ss_pred             CCC-CccccccCCccccCHHHHcC-----CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCC--
Confidence            322 22334679999999999973     568899999999999999999999999998888888776543  23343  


Q ss_pred             CCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccCCCCCcCCCCCCCCCC
Q psy11571        256 GYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTS  332 (372)
Q Consensus       256 ~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~~~p~~p~~~~~~~~~  332 (372)
                        .++.++.+||.+||+ +|.+|++..+  +++              .||||+.++|..+  +...+|+.|...++.+.+
T Consensus       218 --~~~~~~~~ll~~~l~~~P~~R~~~~~--~l~--------------~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (316)
T cd05592         218 --WISKEAKDCLSKLFERDPTKRLGVDG--DIR--------------QHPFFRGIDWERLEKREIPPPFKPKVKSPSDAS  279 (316)
T ss_pred             --CCCHHHHHHHHHHccCCHHHcCCChH--HHH--------------cCcccCCCCHHHHHhCCCCCCcCCCCCCcchhh
Confidence              689999999999999 9999998642  334              9999999999887  456788999999999999


Q ss_pred             CCCCCccccCCCCCCCCCCCCcccccCCCCccCceeeCC
Q psy11571        333 HFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQG  371 (372)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (372)
                      +|+.......  ..+.+.......+..+.+|.||.|.|+
T Consensus       280 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (316)
T cd05592         280 NFDREFTNEK--VRLSPVDKKLLASMDQEQFRGFSFTNP  316 (316)
T ss_pred             hcCccccccc--ccCCCccccccccccccccCCCcccCc
Confidence            9987766443  335555566667889999999999874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0986|consensus

Probab=100.00  E-value=3e-52  Score=383.03  Aligned_cols=276  Identities=28%  Similarity=0.535  Sum_probs=234.4

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      ||||.|+.+....+|+.+|+|.+.++.+...+-       -....+|..+|..+++|+||.+-++|++.+.+++||..|+
T Consensus       196 GGFGEV~acqvraTGKMYAcKkL~KKRiKkr~g-------e~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMN  268 (591)
T KOG0986|consen  196 GGFGEVCACQVRATGKMYACKKLDKKRIKKRKG-------ETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMN  268 (591)
T ss_pred             ccccceeEEEEecchhhHHHHHHHHHHHHHhhh-------hHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeec
Confidence            389999999999999999999998877665422       2335679999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccC
Q psy11571         97 GGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG  175 (372)
Q Consensus        97 gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~  175 (372)
                      ||||.-+|.+.+ ..+++..+++|+++|+.||++||+.+||+          |||||+|||+|+.|+++|+|+|+|..+.
T Consensus       269 GGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVY----------RDLKPeNILLDd~GhvRISDLGLAvei~  338 (591)
T KOG0986|consen  269 GGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVY----------RDLKPENILLDDHGHVRISDLGLAVEIP  338 (591)
T ss_pred             CCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceee----------ccCChhheeeccCCCeEeeccceEEecC
Confidence            999999998742 37999999999999999999999999999          9999999999999999999999999887


Q ss_pred             CCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH----HHHHHHhhccCCcCC
Q psy11571        176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV----ETYGKIMNHQNSFDL  251 (372)
Q Consensus       176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~----~~~~~i~~~~~~~~~  251 (372)
                      .......  .+||.+|||||++.+     ..|+.++|||||||++|||+.|+.||....+.    ++-.+++...  ..+
T Consensus       339 ~g~~~~~--rvGT~GYMAPEvl~n-----e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~--~ey  409 (591)
T KOG0986|consen  339 EGKPIRG--RVGTVGYMAPEVLQN-----EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP--EEY  409 (591)
T ss_pred             CCCcccc--ccCcccccCHHHHcC-----CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch--hhc
Confidence            6554433  589999999999994     66999999999999999999999999875433    4444454432  233


Q ss_pred             CCCCCCCCCHHHHHHHHHhcc-CCCCCCCCC--ChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccCCCCCcCCCC
Q psy11571        252 PSDVGYEISDDAKDLMRRLIC-SSDTRLGQN--GIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVS  326 (372)
Q Consensus       252 ~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~--~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~~~p~~p~~~  326 (372)
                      +.    .+|+++++|++.+|. ||++|++..  ...+++              .||||+++||..+  ....|||+|...
T Consensus       410 ~~----kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk--------------~HpfFk~lnw~rleagml~PPfiPdp~  471 (591)
T KOG0986|consen  410 SD----KFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVK--------------EHPFFKDLNWRRLEAGMLEPPFIPDPG  471 (591)
T ss_pred             cc----ccCHHHHHHHHHHHccCHHHhccCCCcCcchhh--------------hCcccccCCHhHHhccCCCCCCCCCcc
Confidence            43    789999999999999 999999964  456666              9999999999998  457899999886


Q ss_pred             CCCCCCCCCC
Q psy11571        327 SPTDTSHFDV  336 (372)
Q Consensus       327 ~~~~~~~~~~  336 (372)
                      .-.....+|.
T Consensus       472 aVyakDv~DI  481 (591)
T KOG0986|consen  472 AVYAKDVLDI  481 (591)
T ss_pred             ccchhhhhhh
Confidence            5555554444

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.5e-51  Score=385.81  Aligned_cols=283  Identities=34%  Similarity=0.644  Sum_probs=241.0

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+..+.+|.|    ++|.||.+....+++.||+|.+.......       .+..+.+.+|+.+++.++||||+++++++.
T Consensus        20 y~~~~~lg~G----~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   88 (329)
T PTZ00263         20 FEMGETLGTG----SFGRVRIAKHKGTGEYYAIKCLKKREILK-------MKQVQHVAQEKSILMELSHPFIVNMMCSFQ   88 (329)
T ss_pred             eEEEEEEEec----CCeEEEEEEECCCCCEEEEEEEEHHHHhh-------hhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            3344455555    89999999998899999999876543222       134566888999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcE
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI  163 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~v  163 (372)
                      +++.+|+||||++||+|.+++.+ .+.+++..++.++.||+.||+|||++||+|          |||||+|||++.++.+
T Consensus        89 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH----------~dlkp~NIll~~~~~~  157 (329)
T PTZ00263         89 DENRVYFLLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIY----------RDLKPENLLLDNKGHV  157 (329)
T ss_pred             cCCEEEEEEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeee----------cCCCHHHEEECCCCCE
Confidence            99999999999999999999987 578999999999999999999999999999          9999999999999999


Q ss_pred             EEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHh
Q psy11571        164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM  243 (372)
Q Consensus       164 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~  243 (372)
                      ||+|||+++......    ...+||+.|+|||++.+     ..++.++|||||||++|+|++|..||.+.+..+.+.++.
T Consensus       158 kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~  228 (329)
T PTZ00263        158 KVTDFGFAKKVPDRT----FTLCGTPEYLAPEVIQS-----KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL  228 (329)
T ss_pred             EEeeccCceEcCCCc----ceecCChhhcCHHHHcC-----CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh
Confidence            999999998764322    23579999999999983     557899999999999999999999999998888888887


Q ss_pred             hccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCC--CChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccCC
Q psy11571        244 NHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQ--NGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSN  318 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~--~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~~  318 (372)
                      .+.  +.+|.    .++..+++||++||+ ||.+|+++  ..+.+++              .||||++.+|+.+  +...
T Consensus       229 ~~~--~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll--------------~hp~f~~~~~~~~~~~~~~  288 (329)
T PTZ00263        229 AGR--LKFPN----WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK--------------NHPYFHGANWDKLYARYYP  288 (329)
T ss_pred             cCC--cCCCC----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh--------------cCCccCCCCHHHHHhCCCC
Confidence            653  34444    579999999999999 99999985  4577777              9999999999987  3456


Q ss_pred             CCCcCCCCCCCCCCCCCCC
Q psy11571        319 APYIPEVSSPTDTSHFDVD  337 (372)
Q Consensus       319 ~p~~p~~~~~~~~~~~~~~  337 (372)
                      +|..+.+.+..+..+|+..
T Consensus       289 ~~~~~~~~~~~~~~~~~~~  307 (329)
T PTZ00263        289 APIPVRVKSPGDTSNFEKY  307 (329)
T ss_pred             CCcCCCCCCcccchhccCC
Confidence            7777777888888888754

>KOG0595|consensus

Probab=100.00  E-value=3.9e-51  Score=372.50  Aligned_cols=249  Identities=26%  Similarity=0.430  Sum_probs=217.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      .|....++|.|    .||.||++++..++..||+|.+..+.+..+        ..+.+..|+.+|+.++|||||++++++
T Consensus        11 ~y~~~~~iG~G----sfavVykg~h~~~~~~VAIK~i~~~~l~~k--------~~e~L~~Ei~iLkel~H~nIV~l~d~~   78 (429)
T KOG0595|consen   11 DYELSREIGSG----SFAVVYKGRHKKSGTEVAIKCIAKKKLNKK--------LVELLLSEIKILKELKHPNIVRLLDCI   78 (429)
T ss_pred             cceehhhccCc----ceEEEEEeEeccCCceEEeeeehhhccCHH--------HHHHHHHHHHHHHhcCCcceeeEEEEE
Confidence            35555666666    799999999999999999999988876543        456788999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC--
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN--  160 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~--  160 (372)
                      ++++.+|+|||||.||||.+||++ .+.++|..++.++.||+.||++||+++|||          |||||+|||++.+  
T Consensus        79 ~~~~~i~lVMEyC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~~~IiH----------RDLKPQNiLLs~~~~  147 (429)
T KOG0595|consen   79 EDDDFIYLVMEYCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHENNIIH----------RDLKPQNILLSTTAR  147 (429)
T ss_pred             ecCCeEEEEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeee----------ccCCcceEEeccCCC
Confidence            999999999999999999999998 579999999999999999999999999999          9999999999864  


Q ss_pred             ----CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH
Q psy11571        161 ----GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV  236 (372)
Q Consensus       161 ----~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~  236 (372)
                          -.+||+|||+|+.+.....  ..+.||+|.|||||+++     ...|+.|+|+||+|+|+|+|++|++||...+..
T Consensus       148 ~~~~~~LKIADFGfAR~L~~~~~--a~tlcGSplYMAPEV~~-----~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~  220 (429)
T KOG0595|consen  148 NDTSPVLKIADFGFARFLQPGSM--AETLCGSPLYMAPEVIM-----SQQYDAKADLWSIGTILYQCLTGKPPFDAETPK  220 (429)
T ss_pred             CCCCceEEecccchhhhCCchhH--HHHhhCCccccCHHHHH-----hccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence                3589999999999875443  34589999999999998     478999999999999999999999999999999


Q ss_pred             HHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       237 ~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      +++..+.++....+.++.   .++..+.+|+..+|. +|..|.+..+..
T Consensus       221 eL~~~~~k~~~~~~~~~~---~~s~~~~~Ll~~ll~~~~~~~~~~~~~~  266 (429)
T KOG0595|consen  221 ELLLYIKKGNEIVPVLPA---ELSNPLRELLISLLQRNPKDRISFEDFF  266 (429)
T ss_pred             HHHHHHhccccccCchhh---hccCchhhhhhHHHhcCccccCchHHhh
Confidence            999988776654444433   678888899999999 999998755443

>KOG0695|consensus

Probab=100.00  E-value=2.8e-52  Score=370.76  Aligned_cols=308  Identities=30%  Similarity=0.594  Sum_probs=257.8

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      .+..|..|+..++.+.+|+|++++.-++..+.+       .=++.|..+..+. +||++|-++.+|++++.+++|.||++
T Consensus       262 syakvl~~~~~~t~qiyamkvvkkel~nddedi-------dwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~  334 (593)
T KOG0695|consen  262 SYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDI-------DWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN  334 (593)
T ss_pred             chhhhhheehcccceeeehhhHHHHhcCCcccc-------hhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence            344566777788999999999988777766433       3456788888765 69999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCC
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG  176 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  176 (372)
                      ||+|.-++++ +.+++|+.+++|..+|+.||.|||+.||+.          ||||.+|+|+|..|++||+|+|+++.--.
T Consensus       335 ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rgiiy----------rdlkldnvlldaeghikltdygmcke~l~  403 (593)
T KOG0695|consen  335 GGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERGIIY----------RDLKLDNVLLDAEGHIKLTDYGMCKEGLG  403 (593)
T ss_pred             Ccceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcCeee----------eeccccceEEccCCceeecccchhhcCCC
Confidence            9999999988 678999999999999999999999999999          99999999999999999999999987554


Q ss_pred             CCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCC--------CCHHHHHHHHhhccCC
Q psy11571        177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA--------ESLVETYGKIMNHQNS  248 (372)
Q Consensus       177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~--------~~~~~~~~~i~~~~~~  248 (372)
                      ++. .+.++||||.|.|||++++     ..|+.++|||+|||+++||+.|+.||.-        +++.-+++-|+..+. 
T Consensus       404 ~gd-~tstfcgtpnyiapeilrg-----eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi-  476 (593)
T KOG0695|consen  404 PGD-TTSTFCGTPNYIAPEILRG-----EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI-  476 (593)
T ss_pred             CCc-ccccccCCCcccchhhhcc-----cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc-
Confidence            444 3566999999999999995     6799999999999999999999999952        233345556666543 


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCC---ChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccCCCCCc
Q psy11571        249 FDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQN---GIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYI  322 (372)
Q Consensus       249 ~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~---~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~~~p~~  322 (372)
                       .+|.    .+|-.+..+++..|+ ||.+|++..   .+.+|+              .||||+.+||+.+  ++..|||.
T Consensus       477 -ripr----slsvkas~vlkgflnkdp~erlgc~~~~g~~dik--------------~h~ffr~idwd~leqk~v~ppf~  537 (593)
T KOG0695|consen  477 -RIPR----SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIK--------------SHAFFRSIDWDLLEQKQVLPPFQ  537 (593)
T ss_pred             -cccc----eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhh--------------cchhhhhCCHHHHhhcccCCCCC
Confidence             4465    678899999999999 999999853   566666              9999999999998  56789999


Q ss_pred             CCCCCCCCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceeeCC
Q psy11571        323 PEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQG  371 (372)
Q Consensus       323 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (372)
                      |.+++..+..+||...++..  +.++|.+.-..-...+..|.||+|+|+
T Consensus       538 p~i~~d~~l~~fd~qft~e~--~qltpdd~d~i~ridqsefegfeyinp  584 (593)
T KOG0695|consen  538 PQITDDYGLDNFDTQFTSEP--VQLTPDDEDAIKRIDQSEFEGFEYINP  584 (593)
T ss_pred             CccccccCccccccccccCC--cccCCCCHHHHHhcchhhcCcceecch
Confidence            99999999999999887543  345444443334567888999999985

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.4e-50  Score=381.52  Aligned_cols=316  Identities=33%  Similarity=0.569  Sum_probs=252.2

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYAF   82 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~~   82 (372)
                      |+.+..+|.|    |+|.||++++..+++.+|+|.+........       ...+.+..|..++..+ .||+|+++++++
T Consensus         2 f~~~~~lg~G----~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~~i~~~~~~~   70 (323)
T cd05616           2 FNFLMVLGKG----SFGKVMLAERKGTDELYAIKILKKDVVIQD-------DDVECTMVEKRVLALSGKPPFLTQLHSCF   70 (323)
T ss_pred             ceEEEEEeeC----CCeEEEEEEECCCCCEEEEEEEEHHHhhhh-------hHHHHHHHHHHHHHhccCCCeEeeEEEEE
Confidence            3445566666    899999999988999999998875433222       1233455677777665 589999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+.+.+|+||||+++|+|.+++.. .+.+++..+..++.||+.||.|||++||+|          |||||+|||++.++.
T Consensus        71 ~~~~~~~lv~E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH----------rDlkp~Nill~~~~~  139 (323)
T cd05616          71 QTMDRLYFVMEYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIY----------RDLKLDNVMLDSEGH  139 (323)
T ss_pred             ecCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEe----------cCCCHHHeEECCCCc
Confidence            999999999999999999999977 467999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||+++....... .....+||+.|+|||++.     ...++.++|||||||++|||++|+.||.+.+..+.+..+
T Consensus       140 ~kL~DfG~~~~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i  213 (323)
T cd05616         140 IKIADFGMCKENMWDGV-TTKTFCGTPDYIAPEIIA-----YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI  213 (323)
T ss_pred             EEEccCCCceecCCCCC-ccccCCCChhhcCHHHhc-----CCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999875432222 223467999999999998     356899999999999999999999999999988888888


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCC--CChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQ--NGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDS  317 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~--~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~  317 (372)
                      .....  .+|.    .++.++.+||.+||+ +|.+|+++  +...+++              .||||+.++|+.+  +..
T Consensus       214 ~~~~~--~~p~----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~--------------~h~~~~~~~~~~~~~~~~  273 (323)
T cd05616         214 MEHNV--AYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK--------------EHAFFRYIDWEKLERKEV  273 (323)
T ss_pred             HhCCC--CCCC----cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHh--------------cCCCcCCCCHHHHHhCCC
Confidence            77543  3344    689999999999999 99999986  3456666              9999999999988  456


Q ss_pred             CCCCcCCCCCCCCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceeeC
Q psy11571        318 NAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQ  370 (372)
Q Consensus       318 ~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (372)
                      .+|+.|.... .+..+|+......  .+..+|++...+..-....|.||+|.|
T Consensus       274 ~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (323)
T cd05616         274 QPPYKPKACG-RDAENFDKFFTRH--PPVLTPPDQEVIMNLDQSEFEGFSYVN  323 (323)
T ss_pred             CCCcCCcCCC-chhhhcCchhccC--CccCCCCCccccccccccccCCCcccC
Confidence            7899998754 6777777655532  233344444333333336799999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.5e-50  Score=379.80  Aligned_cols=308  Identities=33%  Similarity=0.635  Sum_probs=250.3

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHH-HHHhcCCCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREER-DVLVYGDRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~-~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      ||+|.||++.+..+++.||+|.+........       ...+.+..|. .+++.++||||+++++.+.+.+.+|+||||+
T Consensus         6 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~   78 (323)
T cd05575           6 GSFGKVLLAKHKADGKFYAVKVLQKKAILKK-------KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV   78 (323)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEEHHHHhhh-------hHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence            4899999999999999999998765433222       1122334444 4567899999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccC
Q psy11571         96 CGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG  175 (372)
Q Consensus        96 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~  175 (372)
                      ++|+|..++.+ ...+++..++.++.||+.||.|||++||+|          |||||+|||++.++.+||+|||+++...
T Consensus        79 ~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH----------~dikp~NIll~~~~~~kl~Dfg~~~~~~  147 (323)
T cd05575          79 NGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIY----------RDLKPENILLDSQGHVVLTDFGLCKEGI  147 (323)
T ss_pred             CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEe----------CCCCHHHeEECCCCcEEEeccCCCcccc
Confidence            99999999987 578999999999999999999999999999          9999999999999999999999987543


Q ss_pred             CCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCC
Q psy11571        176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDV  255 (372)
Q Consensus       176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  255 (372)
                      .... .....+||+.|+|||++.+     ..++.++|||||||++|+|++|..||.+.+..+.+.++.....  ..+.  
T Consensus       148 ~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~--  217 (323)
T cd05575         148 EHSK-TTSTFCGTPEYLAPEVLRK-----QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL--RLKP--  217 (323)
T ss_pred             cCCC-ccccccCChhhcChhhhcC-----CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC--CCCC--
Confidence            2221 2234579999999999973     5688999999999999999999999999988888888876532  2333  


Q ss_pred             CCCCCHHHHHHHHHhcc-CCCCCCCCC-ChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccCCCCCcCCCCCCCCC
Q psy11571        256 GYEISDDAKDLMRRLIC-SSDTRLGQN-GIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDT  331 (372)
Q Consensus       256 ~~~~s~~~~~li~~lL~-~p~~R~s~~-~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~~~p~~p~~~~~~~~  331 (372)
                        .++..+.++|++||+ +|.+|+++. .+.+++              .||||.+++|+.+  ....+|+.|...+..+.
T Consensus       218 --~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (323)
T cd05575         218 --NISVSARHLLEGLLQKDRTKRLGAKDDFLEIK--------------NHVFFSSINWDDLVNKKITPPFNPNVSGPMDL  281 (323)
T ss_pred             --CCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHH--------------cCCCcCCCCHHHHhhccCCCCcCCCCCCcchh
Confidence              579999999999999 999999974 566777              9999999999988  45678999999988888


Q ss_pred             CCCCCCccccCCCCCCCCC----CCCcccccCCCCccCcee
Q psy11571        332 SHFDVDEAGVRASDALPPA----AASPALSALHLPFVGFTF  368 (372)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~  368 (372)
                      .+|+....+...++..+.+    ....+.+.....|.||+|
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (323)
T cd05575         282 KHFDPEFTEEPVPNSVGKSPDSVLVSASVKEADDAFLGFSY  322 (323)
T ss_pred             hhcCccccccccccccCCCcccccccccccccccccCCCcc
Confidence            8888655443333322222    123456678899999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.5e-50  Score=380.69  Aligned_cols=308  Identities=31%  Similarity=0.600  Sum_probs=244.6

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      ||+|.||.+++..+++.||+|.+........       +..+.+.+|..++..+ +||||+++++++.+.+.+|+|||||
T Consensus         6 G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~-------~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~   78 (329)
T cd05588           6 GSYAKVLLVELKKTRRIYAMKVIKKELVNDD-------EDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV   78 (329)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEEHHHhhhh-------hHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence            4899999999999999999998875433222       2345677899999887 6999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccC
Q psy11571         96 CGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG  175 (372)
Q Consensus        96 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~  175 (372)
                      +||+|..++.+ .+.+++..++.++.||+.||.|||++|++|          |||||+|||++.++.+||+|||+++...
T Consensus        79 ~~g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH----------~dlkp~Nili~~~~~~kL~Dfg~~~~~~  147 (329)
T cd05588          79 SGGDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIY----------RDLKLDNVLLDAEGHIKLTDYGMCKEGI  147 (329)
T ss_pred             CCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEe----------cCCCHHHeEECCCCCEEECcCccccccc
Confidence            99999999877 578999999999999999999999999999          9999999999999999999999987532


Q ss_pred             CCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC---------CHHHHHHHHhhcc
Q psy11571        176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE---------SLVETYGKIMNHQ  246 (372)
Q Consensus       176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~---------~~~~~~~~i~~~~  246 (372)
                      .... .....+||+.|+|||++.+     ..++.++|+|||||++|+|++|+.||...         ........+....
T Consensus       148 ~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  221 (329)
T cd05588         148 RPGD-TTSTFCGTPNYIAPEILRG-----EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ  221 (329)
T ss_pred             cCCC-ccccccCCccccCHHHHcC-----CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC
Confidence            2221 2234679999999999983     56889999999999999999999999631         1122344444432


Q ss_pred             CCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCC---ChhhhhhhhhhhhccCCCCCCCCCcCCCCccccc--cCCCC
Q psy11571        247 NSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQN---GIADFKMWSALFVSLSISPRNHPWFQGIAWDSIR--DSNAP  320 (372)
Q Consensus       247 ~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~---~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~--~~~~p  320 (372)
                        ..+|.    .++..+.++|++||+ ||.+|++++   .+.+++              .||||..++|+.+.  ...+|
T Consensus       222 --~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~--------------~hp~~~~~~~~~~~~~~~~~~  281 (329)
T cd05588         222 --IRIPR----SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK--------------SHPFFRNIDWDLLEQKQVLPP  281 (329)
T ss_pred             --CCCCC----CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh--------------cCCCCCCCCHHHHHhCCCCCC
Confidence              33444    689999999999999 999999864   367777              99999999999873  46678


Q ss_pred             CcCCCCCCCCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceeeC
Q psy11571        321 YIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQ  370 (372)
Q Consensus       321 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (372)
                      +.|.+.+..+..+|+....+....  .+|..........+..|.||+|+|
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~~~~~~~~~~~~~  329 (329)
T cd05588         282 YKPNIESDRDLDNFDPQFTDEPVQ--LTPDDPDVIARIDQSEFEGFEYIN  329 (329)
T ss_pred             ccccCCCcchhhhcCCccccCccc--cCCCCccccccccccccCCCcccC
Confidence            899988888888887655432221  222222122234457899999986

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.9e-50  Score=380.76  Aligned_cols=317  Identities=32%  Similarity=0.559  Sum_probs=256.3

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCC-CceeeeeEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDR-RWITNLHYAF   82 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~h-p~Iv~l~~~~   82 (372)
                      |+.++.+|.|    |+|.||++++..+++.||+|.+........       ...+.+..|..++..+.| ++|+++++++
T Consensus         2 y~~~~~lg~G----~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~~i~~~~~~~   70 (324)
T cd05587           2 FNFLMVLGKG----SFGKVMLAERKGTDELYAIKILKKDVIIQD-------DDVECTMVEKRVLALPGKPPFLTQLHSCF   70 (324)
T ss_pred             ceEEEEEeec----cCeEEEEEEECCCCCEEEEEEEEHHHhhhh-------hHHHHHHHHHHHHHhcCCCCceeeeEEEE
Confidence            4455666666    899999999988999999998765433222       233456778888888875 5689999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+.+.+|+||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+|          |||||+|||++.++.
T Consensus        71 ~~~~~~~lv~E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH----------~dlkp~Nill~~~~~  139 (324)
T cd05587          71 QTMDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIY----------RDLKLDNVMLDAEGH  139 (324)
T ss_pred             EcCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEe----------cCCCHHHeEEcCCCC
Confidence            999999999999999999999987 567999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||++........ .....+||+.|+|||++.+     ..++.++|+|||||++|+|++|+.||.+.+..+.+..+
T Consensus       140 ~kL~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i  213 (324)
T cd05587         140 IKIADFGMCKENIFGGK-TTRTFCGTPDYIAPEIIAY-----QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI  213 (324)
T ss_pred             EEEeecCcceecCCCCC-ceeeecCCccccChhhhcC-----CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999875322211 2234579999999999983     56889999999999999999999999999988888888


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCC--ChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQN--GIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDS  317 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~--~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~  317 (372)
                      ....  ..+|.    .+++++.++|++||. ||.+|++..  ...+++              .||||+.++|+.+  +..
T Consensus       214 ~~~~--~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~--------------~hp~~~~~~~~~~~~~~~  273 (324)
T cd05587         214 MEHN--VSYPK----SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIR--------------EHAFFRRIDWEKLERREI  273 (324)
T ss_pred             HcCC--CCCCC----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh--------------cCCCcCCCCHHHHHhCCC
Confidence            7644  33344    689999999999999 999999862  335666              9999999999987  456


Q ss_pred             CCCCcCCCCCCCCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceeeC
Q psy11571        318 NAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQ  370 (372)
Q Consensus       318 ~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (372)
                      .+|+.|.+.+..+.++|+........  .+.|......-.-.+..|++|+|.|
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  324 (324)
T cd05587         274 QPPFKPKVKGRRSAENFDKFFTREPP--VLTPPDKLVIANIDQSEFQGFSFVN  324 (324)
T ss_pred             CCCccCcCCCcchhhhcCcccccCcc--ccCCCCccccccccccccCCCcccC
Confidence            78899999888899999876553332  2334444333344457899999975

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.8e-50  Score=377.51  Aligned_cols=308  Identities=32%  Similarity=0.584  Sum_probs=249.4

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      |++|.||++++..+++.||+|.+........       ...+.+..|..++..+ +||||+++++++.+.+.+|+||||+
T Consensus         6 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~   78 (321)
T cd05591           6 GSFGKVMLAELKGTDEVYAIKVLKKDVILQD-------DDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV   78 (321)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEeHHHhhhh-------hHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence            3899999999988899999998765433222       2234456688888755 7999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccC
Q psy11571         96 CGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG  175 (372)
Q Consensus        96 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~  175 (372)
                      ++|+|..++.. ...+++..++.++.||+.||.|||++||+|          |||||+|||++.++.+||+|||++....
T Consensus        79 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH----------rDikp~Nill~~~~~~kL~Dfg~~~~~~  147 (321)
T cd05591          79 NGGDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIY----------RDLKLDNILLDAEGHCKLADFGMCKEGI  147 (321)
T ss_pred             CCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeec----------cCCCHHHeEECCCCCEEEeecccceecc
Confidence            99999999987 568999999999999999999999999999          9999999999999999999999987643


Q ss_pred             CCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCC
Q psy11571        176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDV  255 (372)
Q Consensus       176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  255 (372)
                      .... ......||+.|+|||++.     ...++.++|||||||++|+|++|+.||.+.+..+.+..+.....  ..|.  
T Consensus       148 ~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~--~~p~--  217 (321)
T cd05591         148 LNGV-TTTTFCGTPDYIAPEILQ-----ELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV--LYPV--  217 (321)
T ss_pred             cCCc-cccccccCccccCHHHHc-----CCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCC--
Confidence            2222 223457999999999997     35688999999999999999999999999999988888877543  3343  


Q ss_pred             CCCCCHHHHHHHHHhcc-CCCCCCCCC----ChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccCCCCCcCCCCCC
Q psy11571        256 GYEISDDAKDLMRRLIC-SSDTRLGQN----GIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSP  328 (372)
Q Consensus       256 ~~~~s~~~~~li~~lL~-~p~~R~s~~----~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~~~p~~p~~~~~  328 (372)
                        .++.++.+||++||+ +|++|+++.    .+.+++              .||||.+++|+.+  +...+|+.|.....
T Consensus       218 --~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~--------------~hp~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (321)
T cd05591         218 --WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIK--------------QHPFFKEIDWVLLEQRKIKPPFKPKIKTK  281 (321)
T ss_pred             --CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHh--------------cCCccCCCCHHHHHhCCCCCCCCCCCCCc
Confidence              579999999999999 999999654    355666              9999999999987  45678899998888


Q ss_pred             CCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceeeC
Q psy11571        329 TDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQ  370 (372)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (372)
                      .+.++|+.....  ..+.+++......-+..+..|.||.|-|
T Consensus       282 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (321)
T cd05591         282 RDVNNFDQDFTK--EEPVLTPVDPAVIKQINQEEFRGFSFFN  321 (321)
T ss_pred             chhhhcCCcccc--CccccCCCCccccccccccccCCCcccC
Confidence            888888865542  2233444333223344556699998843

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0588|consensus

Probab=100.00  E-value=4.4e-51  Score=390.47  Aligned_cols=251  Identities=27%  Similarity=0.460  Sum_probs=221.3

Q ss_pred             cccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEec
Q psy11571         15 PIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDY   94 (372)
Q Consensus        15 ~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~   94 (372)
                      +.|+.|.|-.+++..+|+.+|||.+....-..+       .....+.+|+.+|+.+.||||+++|++++++.++|+|+||
T Consensus        21 G~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~-------s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   21 GKGSTGCVRLAKHAETGQLAAIKIIPKRSELSS-------SQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             cCCCCceehhhhcccccceeEEEeecccccccc-------ccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            344778888999999999999998877632221       1345578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCccccc
Q psy11571         95 YCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL  174 (372)
Q Consensus        95 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~  174 (372)
                      ++||.|++++-+ ++++++.++..++.||+.|+.|||..+|+|          |||||+|+|+|..+++||+|||+|...
T Consensus        94 v~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~icH----------RDLKpENlLLd~~~nIKIADFGMAsLe  162 (786)
T KOG0588|consen   94 VPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFNICH----------RDLKPENLLLDVKNNIKIADFGMASLE  162 (786)
T ss_pred             cCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhccee----------ccCCchhhhhhcccCEeeeccceeecc
Confidence            999999999988 689999999999999999999999999999          999999999999999999999999875


Q ss_pred             CCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCC
Q psy11571        175 GGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSD  254 (372)
Q Consensus       175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  254 (372)
                      ..+...  .+.||+|+|.|||++++    ....+.++||||+|||||.|+||+.||.+++...++.++.++.  +.+|. 
T Consensus       163 ~~gklL--eTSCGSPHYA~PEIV~G----~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~--f~MPs-  233 (786)
T KOG0588|consen  163 VPGKLL--ETSCGSPHYAAPEIVSG----RPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV--FEMPS-  233 (786)
T ss_pred             cCCccc--cccCCCcccCCchhhcC----CCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc--ccCCC-
Confidence            544433  34799999999999995    5566889999999999999999999999999999999998854  67776 


Q ss_pred             CCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcc
Q psy11571        255 VGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWD  312 (372)
Q Consensus       255 ~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~  312 (372)
                         .+|.++++||++||. ||++|+|.+++.                 +|||+.+..=.
T Consensus       234 ---~Is~eaQdLLr~ml~VDp~~RiT~~eI~-----------------kHP~l~g~~~~  272 (786)
T KOG0588|consen  234 ---NISSEAQDLLRRMLDVDPSTRITTEEIL-----------------KHPFLSGYTSL  272 (786)
T ss_pred             ---cCCHHHHHHHHHHhccCccccccHHHHh-----------------hCchhhcCCCC
Confidence               899999999999999 999999865554                 99999987543

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.5e-50  Score=376.88  Aligned_cols=307  Identities=32%  Similarity=0.557  Sum_probs=250.5

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhc-CCCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVY-GDRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~-l~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      ||+|.||++.+..+++.||+|.+.......+       ...+....|..++.. ++||||+++++++.+.+.+|+||||+
T Consensus         6 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~   78 (316)
T cd05619           6 GSFGKVFLAELKGTNQFFAIKALKKDVVLMD-------DDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYL   78 (316)
T ss_pred             CCCEEEEEEEECCCCCEEEEEEEEHHHhhhc-------chHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCC
Confidence            3899999999988999999998876443222       122334556677765 58999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccC
Q psy11571         96 CGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG  175 (372)
Q Consensus        96 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~  175 (372)
                      ++|+|.+++.. ...+++..+..++.|++.||.|||++|++|          |||||+|||++.++.+||+|||+++...
T Consensus        79 ~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH----------rdikp~Nil~~~~~~~kl~Dfg~~~~~~  147 (316)
T cd05619          79 NGGDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVY----------RDLKLDNILLDTDGHIKIADFGMCKENM  147 (316)
T ss_pred             CCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEe----------CCCCHHHEEECCCCCEEEccCCcceECC
Confidence            99999999987 467999999999999999999999999999          9999999999999999999999987543


Q ss_pred             CCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCC
Q psy11571        176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDV  255 (372)
Q Consensus       176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  255 (372)
                      .... ......||+.|+|||++.+     ..++.++|+|||||++|+|++|..||.+.+..+.+..+....  ..+|.  
T Consensus       148 ~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~~~~~--  217 (316)
T cd05619         148 LGDA-KTCTFCGTPDYIAPEILLG-----QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--PCYPR--  217 (316)
T ss_pred             CCCC-ceeeecCCccccCHHHHcC-----CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCc--
Confidence            2211 2234579999999999973     568899999999999999999999999988888877776543  22333  


Q ss_pred             CCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccCCCCCcCCCCCCCCCC
Q psy11571        256 GYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTS  332 (372)
Q Consensus       256 ~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~~~p~~p~~~~~~~~~  332 (372)
                        .++.++++||.+||+ +|.+|+++.+  +++              .||||+.++|..+  +...+|+.|...++.+.+
T Consensus       218 --~~~~~~~~li~~~l~~~P~~R~~~~~--~l~--------------~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (316)
T cd05619         218 --WLTREAKDILVKLFVREPERRLGVKG--DIR--------------QHPFFREIDWSALEEREIEPPFKPKVKSANDCS  279 (316)
T ss_pred             --cCCHHHHHHHHHHhccCHhhcCCChH--HHH--------------cCcccCCCCHHHHHhCCCCCCcCCCCCCccchh
Confidence              579999999999999 9999999752  334              9999999999987  456789999999999999


Q ss_pred             CCCCCccccCCCCCCCCCCCCcccccCCCCccCceeeCC
Q psy11571        333 HFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQG  371 (372)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (372)
                      +|+....+....  +........-+..+..|.||.|.++
T Consensus       280 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  316 (316)
T cd05619         280 NFDKEFLNEKPR--LSVTDRMLINSMDQNMFENFSFINP  316 (316)
T ss_pred             hcChhhhcCCcc--cCCCcccccccccccccCCCcccCc
Confidence            998876644332  2222333344678889999999874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=8.8e-50  Score=376.68  Aligned_cols=308  Identities=30%  Similarity=0.591  Sum_probs=244.2

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      |++|.||.++...+++.+|+|.+........       +..+.+.+|..++..+ .||||+++++++.+.+.+|+||||+
T Consensus         6 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (327)
T cd05617           6 GSYAKVLLVRLKKNDQIYAMKVVKKELVHDD-------EDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV   78 (327)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEEHHHhhhh-------hHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence            3899999999999999999998876543322       2345677888888877 6999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccC
Q psy11571         96 CGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG  175 (372)
Q Consensus        96 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~  175 (372)
                      ++|+|..++.. .+.+++..++.++.||+.||+|||++|++|          |||||+|||++.++.+||+|||+++...
T Consensus        79 ~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivH----------rDlkp~Nili~~~~~~kl~Dfg~~~~~~  147 (327)
T cd05617          79 NGGDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIY----------RDLKLDNVLLDADGHIKLTDYGMCKEGL  147 (327)
T ss_pred             CCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeec----------cCCCHHHEEEeCCCCEEEeccccceecc
Confidence            99999999877 468999999999999999999999999999          9999999999999999999999987533


Q ss_pred             CCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC-------CHHHHHHHHhhccCC
Q psy11571        176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE-------SLVETYGKIMNHQNS  248 (372)
Q Consensus       176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~-------~~~~~~~~i~~~~~~  248 (372)
                      .... .....+||+.|+|||++.+     ..++.++|+|||||++|+|++|..||...       ........+...  .
T Consensus       148 ~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~  219 (327)
T cd05617         148 GPGD-TTSTFCGTPNYIAPEILRG-----EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--P  219 (327)
T ss_pred             CCCC-ceecccCCcccCCHHHHCC-----CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--C
Confidence            2221 2234679999999999973     56889999999999999999999999632       222334444432  2


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCC---ChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccCCCCCc
Q psy11571        249 FDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQN---GIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYI  322 (372)
Q Consensus       249 ~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~---~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~~~p~~  322 (372)
                      ..+|.    .++..+.++|++||+ ||.+|+++.   .+.+++              .||||++++|+.+  +...+||.
T Consensus       220 ~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~--------------~h~~f~~~~~~~~~~~~~~~~~~  281 (327)
T cd05617         220 IRIPR----FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIK--------------SHTFFRSIDWDLLEKKQVTPPFK  281 (327)
T ss_pred             CCCCC----CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHH--------------cCCCCCCCCHHHHHhCCCCCCcc
Confidence            33444    679999999999999 999999864   566777              9999999999988  45678899


Q ss_pred             CCCCCCCCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceeeC
Q psy11571        323 PEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQ  370 (372)
Q Consensus       323 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (372)
                      |...+..+.++|+........  ...+......-......|.||+|+|
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  327 (327)
T cd05617         282 PQITDDYGLENFDTQFTSEPV--QLTPDDEDVIKRIDQSEFEGFEYIN  327 (327)
T ss_pred             CCCCCCcchhhcCCccccCcc--cCCCCCccccccccccccCCCcCCC
Confidence            999888888888765432211  1112222122223455799999986

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.8e-50  Score=376.73  Aligned_cols=307  Identities=32%  Similarity=0.549  Sum_probs=249.8

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhc-CCCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVY-GDRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~-l~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      ||+|.||.+++..+++.||+|.+.......+       ...+.+..|..++.. .+||||+++++++.+.+.+|+||||+
T Consensus         6 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~   78 (316)
T cd05620           6 GSFGKVLLAELKGKGEYFAVKALKKDVVLID-------DDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL   78 (316)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEEHHHhhhc-------chHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence            4899999999999999999998875433221       123345567777764 58999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccC
Q psy11571         96 CGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG  175 (372)
Q Consensus        96 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~  175 (372)
                      ++|+|..++.. ...+++..+..++.||+.||+|||++||+|          |||||+|||++.++.++|+|||+++...
T Consensus        79 ~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH----------rDlkp~Nil~~~~~~~kl~Dfg~~~~~~  147 (316)
T cd05620          79 NGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIY----------RDLKLDNVMLDRDGHIKIADFGMCKENV  147 (316)
T ss_pred             CCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEe----------cCCCHHHeEECCCCCEEeCccCCCeecc
Confidence            99999999987 568999999999999999999999999999          9999999999999999999999987532


Q ss_pred             CCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCC
Q psy11571        176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDV  255 (372)
Q Consensus       176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  255 (372)
                      .... .....+||+.|+|||++.+     ..++.++|||||||++|+|++|..||.+.+..+....+....  ..+|.  
T Consensus       148 ~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~--~~~~~--  217 (316)
T cd05620         148 FGDN-RASTFCGTPDYIAPEILQG-----LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT--PHYPR--  217 (316)
T ss_pred             cCCC-ceeccCCCcCccCHHHHcC-----CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCC--
Confidence            2111 2234679999999999983     568899999999999999999999999988888887776543  23343  


Q ss_pred             CCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccCCCCCcCCCCCCCCCC
Q psy11571        256 GYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTS  332 (372)
Q Consensus       256 ~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~~~p~~p~~~~~~~~~  332 (372)
                        .++.++++||++||+ ||++|+++.+  +++              +||||++++|..+  ....+|+.|....+.+.+
T Consensus       218 --~~~~~~~~li~~~l~~dP~~R~~~~~--~~~--------------~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (316)
T cd05620         218 --WITKESKDILEKLFERDPTRRLGVVG--NIR--------------GHPFFKTINWTALEKRELDPPFKPKVKSPSDYS  279 (316)
T ss_pred             --CCCHHHHHHHHHHccCCHHHcCCChH--HHH--------------cCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhh
Confidence              579999999999999 9999998632  334              8999999999987  456789999999999999


Q ss_pred             CCCCCccccCCCCCCCCCCCCcccccCCCCccCceeeCC
Q psy11571        333 HFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQG  371 (372)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (372)
                      +|+......  .+.+.........+..+..|.||.|.++
T Consensus       280 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (316)
T cd05620         280 NFDREFLSE--KPRLSYSDKNLIDSMDQSAFAGFSFINP  316 (316)
T ss_pred             hcCcccccc--CcccCCCcccccccccccCcCCCcccCC
Confidence            998655532  3333333433445677789999999874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=6.2e-50  Score=377.86  Aligned_cols=309  Identities=31%  Similarity=0.570  Sum_probs=249.8

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      ||+|.||.+++..+++.||+|.+........       .....+.+|+.+++.++||||+++++++.+.+.+|+||||++
T Consensus         6 G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~-------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~   78 (328)
T cd05593           6 GTFGKVILVREKASGKYYAMKILKKEVIIAK-------DEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN   78 (328)
T ss_pred             CCCEEEEEEEECCCCCEEEEEEEEHHHhhhh-------hHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCC
Confidence            4899999999999999999998865433222       234567789999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCC
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG  176 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  176 (372)
                      +|+|..++.. ...+++..++.++.||+.||+|||++||+|          |||||+|||++.++.+||+|||+++....
T Consensus        79 ~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH----------rDikp~NIll~~~~~~kL~DfG~~~~~~~  147 (328)
T cd05593          79 GGELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVY----------RDLKLENLMLDKDGHIKITDFGLCKEGIT  147 (328)
T ss_pred             CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEe----------cccCHHHeEECCCCcEEEecCcCCccCCC
Confidence            9999999877 567999999999999999999999999999          99999999999999999999999875432


Q ss_pred             CCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCC
Q psy11571        177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVG  256 (372)
Q Consensus       177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  256 (372)
                      ... .....+||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.+.+..+....+....  ..+|.   
T Consensus       148 ~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~--~~~p~---  216 (328)
T cd05593         148 DAA-TMKTFCGTPEYLAPEVLED-----NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED--IKFPR---  216 (328)
T ss_pred             ccc-ccccccCCcCccChhhhcC-----CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC--ccCCC---
Confidence            221 2233579999999999973     568899999999999999999999999888887777776543  34444   


Q ss_pred             CCCCHHHHHHHHHhcc-CCCCCCCC--CChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccCCCCCcCCCCCCCCC
Q psy11571        257 YEISDDAKDLMRRLIC-SSDTRLGQ--NGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDT  331 (372)
Q Consensus       257 ~~~s~~~~~li~~lL~-~p~~R~s~--~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~~~p~~p~~~~~~~~  331 (372)
                       .+++++.+||++||+ ||.+|++.  ..+.+++              +||||.+++|..+  ....+|+.|...++.+.
T Consensus       217 -~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il--------------~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (328)
T cd05593         217 -TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIM--------------RHSFFTGVNWQDVYDKKLVPPFKPQVTSETDT  281 (328)
T ss_pred             -CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHh--------------cCCCcCCCCHHHHHhCCCCCCcCCcCCCcchh
Confidence             689999999999999 99999853  3566777              9999999999987  45678899999999999


Q ss_pred             CCCCCCccccCCCCCCCCCCC-----CcccccCCCCccCceeeC
Q psy11571        332 SHFDVDEAGVRASDALPPAAA-----SPALSALHLPFVGFTFTQ  370 (372)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~  370 (372)
                      ..|+.......... .++...     ...-......|++|+|.+
T Consensus       282 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (328)
T cd05593         282 RYFDEEFTAQTITI-TPPEKYDEDGMDCMDNERRPHFPQFSYSA  324 (328)
T ss_pred             hhcCcccccCCccc-CCccccccccccccccccccccCCceeeC
Confidence            88886554322111 111110     011123457799999976

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2e-50  Score=382.86  Aligned_cols=283  Identities=34%  Similarity=0.646  Sum_probs=237.5

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhh-hhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDI-LLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~-~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      .|+.++.+|.|    ++|.||++....++ ..||+|.+........       ...+.+.+|+.++..++||||++++++
T Consensus        31 ~y~~~~~ig~G----~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~~E~~~l~~l~hp~Iv~~~~~   99 (340)
T PTZ00426         31 DFNFIRTLGTG----SFGRVILATYKNEDFPPVAIKRFEKSKIIKQ-------KQVDHVFSERKILNYINHPFCVNLYGS   99 (340)
T ss_pred             hcEEEEEEeec----CCeEEEEEEEECCCCeEEEEEEEEHHHhhhh-------hhHHHHHHHHHHHHhCCCCCCcceEEE
Confidence            34455556665    79999999765544 6899997765433222       234567889999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+.+.+|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+|          |||||+|||++.++
T Consensus       100 ~~~~~~~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH----------rDLkp~NILl~~~~  168 (340)
T PTZ00426        100 FKDESYLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVY----------RDLKPENLLLDKDG  168 (340)
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEc----------cCCCHHHEEECCCC
Confidence            9999999999999999999999987 568999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .+||+|||+++.....    .....||+.|+|||++.+     ..++.++|+|||||++|||++|.+||.+.+....+.+
T Consensus       169 ~ikL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~  239 (340)
T PTZ00426        169 FIKMTDFGFAKVVDTR----TYTLCGTPEYIAPEILLN-----VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK  239 (340)
T ss_pred             CEEEecCCCCeecCCC----cceecCChhhcCHHHHhC-----CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH
Confidence            9999999999875432    233679999999999973     5578999999999999999999999999988888888


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCC--CChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--cc
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQ--NGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RD  316 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~--~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~  316 (372)
                      +..+..  .+|.    .+++.++++|++||+ +|++|++.  ..+.+++              +||||++++|..+  +.
T Consensus       240 i~~~~~--~~p~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~--------------~hp~f~~~~~~~~~~~~  299 (340)
T PTZ00426        240 ILEGII--YFPK----FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVK--------------EHPWFGNIDWVSLLHKN  299 (340)
T ss_pred             HhcCCC--CCCC----CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHH--------------cCCCcCCCCHHHHHhCC
Confidence            877543  3344    679999999999999 99999852  2456666              9999999999987  45


Q ss_pred             CCCCCcCCCCCCCCCCCCCC
Q psy11571        317 SNAPYIPEVSSPTDTSHFDV  336 (372)
Q Consensus       317 ~~~p~~p~~~~~~~~~~~~~  336 (372)
                      ..+|+.|......+.++|+.
T Consensus       300 ~~~~~~p~~~~~~~~~~~~~  319 (340)
T PTZ00426        300 VEVPYKPKYKNVFDSSNFER  319 (340)
T ss_pred             CCCCcCCCCCCCcchhhcCC
Confidence            67899999988888888764

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.9e-50  Score=387.12  Aligned_cols=295  Identities=41%  Similarity=0.788  Sum_probs=245.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      .|+.++.+|.|    |+|.||++++..+++.||+|.+........       +..+.+.+|+.+++.++||||+++++.+
T Consensus         2 ~y~~~~~lG~G----~~g~V~~a~~~~~~~~~avK~~~~~~~~~~-------~~~~~~~~E~~il~~l~h~~iv~~~~~~   70 (376)
T cd05598           2 MFVKIKTIGIG----AFGEVCLVRKVDTNALYAMKTLRKADVLMR-------NQAAHVKAERDILAEADNEWVVKLYYSF   70 (376)
T ss_pred             CceEEEEEEeC----CCeEEEEEEECCCCCEEEEEEEcHHHHHhh-------hhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            46667777877    899999999999999999998765432221       2345678899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+++.+|+|||||++|+|.+++.+ .+.+++..++.++.||+.||+|||++||+|          |||||+|||++.++.
T Consensus        71 ~~~~~~~lv~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH----------rDlkp~Nill~~~~~  139 (376)
T cd05598          71 QDKDNLYFVMDYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIH----------RDIKPDNILIDRDGH  139 (376)
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEe----------CCCCHHHEEECCCCC
Confidence            999999999999999999999987 567899999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCC------------------------------------------CcccccccccCCcccCccccccc
Q psy11571        163 IRLADFGSCLRLGGD------------------------------------------GTVQSNVAVGTPDYISPEILTAM  200 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~  200 (372)
                      +||+|||+|......                                          ........+||+.|+|||++.+ 
T Consensus       140 ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-  218 (376)
T cd05598         140 IKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-  218 (376)
T ss_pred             EEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-
Confidence            999999997532100                                          0000123579999999999973 


Q ss_pred             ccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q psy11571        201 EEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQ  280 (372)
Q Consensus       201 ~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~~p~~R~s~  280 (372)
                          ..++.++|||||||++|+|++|+.||.+.+..+...++.........+..  ..+++++.+||.+|+.+|.+|++.
T Consensus       219 ----~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~--~~~s~~~~~li~~l~~~p~~R~~~  292 (376)
T cd05598         219 ----TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQ--AKLSREASDLILRLCCGAEDRLGK  292 (376)
T ss_pred             ----CCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCC--CCCCHHHHHHHHHHhcCHhhcCCC
Confidence                56889999999999999999999999998887777777655444444432  268999999999987799999966


Q ss_pred             CChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc-ccCCCCCcCCCCCCCCCCCCCCCccc
Q psy11571        281 NGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI-RDSNAPYIPEVSSPTDTSHFDVDEAG  340 (372)
Q Consensus       281 ~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~-~~~~~p~~p~~~~~~~~~~~~~~~~~  340 (372)
                      ..+.+++              +||||++++|..+ +...+|+.|.+..+.+.++|+....+
T Consensus       293 ~t~~ell--------------~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (376)
T cd05598         293 NGADEIK--------------AHPFFKGIDFASLIRRQKAPYIPKITHPTDTSNFDPVDPE  339 (376)
T ss_pred             CCHHHHh--------------CCCCcCCCCHHHHhhcCCCCCCCcCCCcchhhhcCCCCcc
Confidence            5666767              9999999999888 66778999999999999988765543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6.8e-50  Score=378.13  Aligned_cols=317  Identities=32%  Similarity=0.617  Sum_probs=248.6

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeee---hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeee
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETL---LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLH   79 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~---~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~   79 (372)
                      |+.++.+|.|    |+|.||.|++.   .+++.+|+|.+.......      .....+.+.+|..++..+ +||||++++
T Consensus         2 y~~~~~lg~G----~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~~i~~~~   71 (332)
T cd05614           2 FELLKVLGTG----AYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQ------KAKTVEHTRTERNVLEHVRQSPFLVTLH   71 (332)
T ss_pred             ceEEEEEeec----CCEEEEEEEEcccCCCCCEEEEEEEEHHHHhh------hhhHHHHHHHHHHHHHhccCCCCcccEE
Confidence            4455566666    89999998874   367899999876533221      123345677899999998 599999999


Q ss_pred             EEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC
Q psy11571         80 YAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA  159 (372)
Q Consensus        80 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~  159 (372)
                      +++.+.+.+|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+|          |||||+|||++.
T Consensus        72 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH----------rDlkp~Nili~~  140 (332)
T cd05614          72 YAFQTEAKLHLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVY----------RDIKLENILLDS  140 (332)
T ss_pred             EEEecCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEe----------cCCCHHHeEECC
Confidence            999999999999999999999999987 567999999999999999999999999999          999999999999


Q ss_pred             CCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC----CH
Q psy11571        160 NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE----SL  235 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~----~~  235 (372)
                      ++.+||+|||+++.............+||+.|+|||++.+    ...++.++|||||||++|+|++|..||...    ..
T Consensus       141 ~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~  216 (332)
T cd05614         141 EGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG----KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ  216 (332)
T ss_pred             CCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcC----CCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH
Confidence            9999999999997654333323334679999999999973    345788999999999999999999999643    23


Q ss_pred             HHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCC--ChhhhhhhhhhhhccCCCCCCCCCcCCCCcc
Q psy11571        236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQN--GIADFKMWSALFVSLSISPRNHPWFQGIAWD  312 (372)
Q Consensus       236 ~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~--~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~  312 (372)
                      ......+....  ..++.    .+++.+++||.+||+ ||++|+++.  .+.+++              +||||++++|.
T Consensus       217 ~~~~~~~~~~~--~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l--------------~h~~~~~~~~~  276 (332)
T cd05614         217 SEVSRRILKCD--PPFPS----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIK--------------EHPFFKGLDWE  276 (332)
T ss_pred             HHHHHHHhcCC--CCCCC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHH--------------cCCCcCCCCHH
Confidence            33444444432  23333    689999999999999 999999876  677777              99999999998


Q ss_pred             cc--ccCCCCCcCCCCCCCCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceeeC
Q psy11571        313 SI--RDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQ  370 (372)
Q Consensus       313 ~~--~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (372)
                      .+  ....+|+.|......+.++|...........  .++..   ....+..|+||+|.+
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~---~~~~~~~~~~~~~~~  331 (332)
T cd05614         277 ALALRKVNPPFRPSIRNELDVGNFAEEFTNLEPVY--SPAGT---PPSGARVFQGYSFVA  331 (332)
T ss_pred             HHHhCCCCCCcCCCCCCcchhhhcCcccccCCccc--CCCCC---CcccccccCCceecC
Confidence            87  4567899999988888888865544332221  11111   123467899999865

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.4e-49  Score=375.64  Aligned_cols=308  Identities=30%  Similarity=0.580  Sum_probs=241.0

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      ||+|.||++....+++.+|+|.+........       ...+.+.+|..++..+ +||||+++++++.+.+.+|+||||+
T Consensus         6 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~   78 (329)
T cd05618           6 GSYAKVLLVRLKKTERIYAMKVVKKELVNDD-------EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV   78 (329)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEEhhHhcch-------hHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence            4899999999999999999998876543322       2345577788888765 7999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccC
Q psy11571         96 CGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG  175 (372)
Q Consensus        96 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~  175 (372)
                      ++|+|..++.. ...+++..++.++.||+.||.|||++||+|          |||||+||+++.++.+||+|||+++...
T Consensus        79 ~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH----------~Dikp~Nili~~~~~~kL~DfG~~~~~~  147 (329)
T cd05618          79 NGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIY----------RDLKLDNVLLDSEGHIKLTDYGMCKEGL  147 (329)
T ss_pred             CCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeee----------CCCCHHHEEECCCCCEEEeeCCcccccc
Confidence            99999999877 578999999999999999999999999999          9999999999999999999999987543


Q ss_pred             CCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCC---------CCHHHHHHHHhhcc
Q psy11571        176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA---------ESLVETYGKIMNHQ  246 (372)
Q Consensus       176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~---------~~~~~~~~~i~~~~  246 (372)
                      .... .....+||+.|+|||++.+     ..++.++|+|||||++|+|++|+.||..         .........+....
T Consensus       148 ~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~  221 (329)
T cd05618         148 RPGD-TTSTFCGTPNYIAPEILRG-----EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ  221 (329)
T ss_pred             CCCC-ccccccCCccccCHHHHcC-----CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC
Confidence            2221 2234679999999999983     5688999999999999999999999952         11222344444432


Q ss_pred             CCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCC---ChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccCCCC
Q psy11571        247 NSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQN---GIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAP  320 (372)
Q Consensus       247 ~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~---~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~~~p  320 (372)
                        ..+|.    .++..+.+||++||+ ||++|+++.   .+.+++              +||||++++|+.+  ++..+|
T Consensus       222 --~~~p~----~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~--------------~hp~f~~~~~~~~~~~~~~~~  281 (329)
T cd05618         222 --IRIPR----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQ--------------GHPFFRNVDWDLMEQKQVVPP  281 (329)
T ss_pred             --CCCCC----CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHh--------------cCCCCCCCCHHHHHcCCCCcC
Confidence              33444    679999999999999 999999964   356777              9999999999877  456789


Q ss_pred             CcCCCCCCCCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceeeC
Q psy11571        321 YIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQ  370 (372)
Q Consensus       321 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (372)
                      +.|...+..+..+|+...........+......+.+  ....|.||.|+|
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  329 (329)
T cd05618         282 FKPNISGEFGLDNFDAQFTNEPVQLTPDDDDIVRKI--DQSEFEGFEYIN  329 (329)
T ss_pred             ccCCCCCcccchhcCcccccCCccCCCCcccccccc--cccccCCCcccC
Confidence            999888887777777543322211111111112222  336799999986

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-51  Score=377.76  Aligned_cols=283  Identities=33%  Similarity=0.651  Sum_probs=243.0

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.++.|    ++|.||++.+..+++.+|+|.+.......       .+..+.+.+|+.+++.++||||+++++++
T Consensus         2 ~y~~~~~lg~G----~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   70 (291)
T cd05612           2 DLERIKTVGTG----TFGRVHLVRDRISEHYYALKVMAIPEVIR-------LKQEQHVHNEKRVLKEVSHPFIIRLFWTE   70 (291)
T ss_pred             CceeeeeeecC----CCeEEEEEEEcCCCCEEEEEEEEHHHHhh-------hHHHHHHHHHHHHHHhCCCCcHhhhHhhh
Confidence            56667777777    89999999999899999999876533221       12345678899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+...+|+||||+++|+|.+++.+ .+.+++..++.++.||+.||+|||++|++|          |||||+|||++.+|.
T Consensus        71 ~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H----------~dlkp~NIli~~~~~  139 (291)
T cd05612          71 HDQRFLYMLMEYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVY----------RDLKPENILLDKEGH  139 (291)
T ss_pred             ccCCeEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeee----------cCCCHHHeEECCCCC
Confidence            999999999999999999999987 568999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||+++.....    ....+||+.|+|||++.+     ..++.++|||||||++|+|++|..||.+.+..+.+..+
T Consensus       140 ~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i  210 (291)
T cd05612         140 IKLTDFGFAKKLRDR----TWTLCGTPEYLAPEVIQS-----KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI  210 (291)
T ss_pred             EEEEecCcchhccCC----cccccCChhhcCHHHHcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999865432    123579999999999973     55789999999999999999999999999988888888


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCC--CChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQ--NGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDS  317 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~--~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~  317 (372)
                      ..+.  ..+|.    .++..+++||++||+ ||.+|++.  ..+.+++              .||||+.++|..+  ++.
T Consensus       211 ~~~~--~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l--------------~h~~~~~~~~~~~~~~~~  270 (291)
T cd05612         211 LAGK--LEFPR----HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVK--------------NHRWFKSVDWDDVPQRKL  270 (291)
T ss_pred             HhCC--cCCCc----cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHh--------------cCccccCCCHHHHhcCCC
Confidence            7754  33444    578999999999999 99999973  2456666              9999999999987  456


Q ss_pred             CCCCcCCCCCCCCCCCCCC
Q psy11571        318 NAPYIPEVSSPTDTSHFDV  336 (372)
Q Consensus       318 ~~p~~p~~~~~~~~~~~~~  336 (372)
                      .+|..|.+....++.+|+.
T Consensus       271 ~~~~~p~~~~~~~~~~~~~  289 (291)
T cd05612         271 KPPIVPKVSHDGDTSNFDD  289 (291)
T ss_pred             CCCEeCCCCCccccccccC
Confidence            7888999999999998875

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-50  Score=379.69  Aligned_cols=311  Identities=37%  Similarity=0.643  Sum_probs=247.5

Q ss_pred             ccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC---CCCceeeeeEEEEeCCeEEEEE
Q psy11571         16 IQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG---DRRWITNLHYAFQDDSNLYLVM   92 (372)
Q Consensus        16 ~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l---~hp~Iv~l~~~~~~~~~~~lv~   92 (372)
                      .||+|.||.+++..+++.||+|.+.........       .......|..++...   .||||+++++++.+.+.+|+||
T Consensus         3 ~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~-------~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~   75 (330)
T cd05586           3 KGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK-------EVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVT   75 (330)
T ss_pred             CCCceEEEEEEECCCCCEEEEEEEeHHHHhhhh-------HHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEE
Confidence            348999999999999999999987654332221       122334455565543   6999999999999999999999


Q ss_pred             eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCccc
Q psy11571         93 DYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCL  172 (372)
Q Consensus        93 E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~  172 (372)
                      ||+++|+|..++.+ .+.+++..++.++.||+.||+|||++||+|          |||||+|||++.++.++|+|||++.
T Consensus        76 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivH----------rDlkp~Nili~~~~~~kl~Dfg~a~  144 (330)
T cd05586          76 DYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVY----------RDLKPENILLDATGHIALCDFGLSK  144 (330)
T ss_pred             cCCCCChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEe----------ccCCHHHeEECCCCCEEEecCCcCc
Confidence            99999999999987 578999999999999999999999999999          9999999999999999999999987


Q ss_pred             ccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCC
Q psy11571        173 RLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLP  252 (372)
Q Consensus       173 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  252 (372)
                      ....... .....+||+.|+|||++.+    ...++.++|||||||++|+|++|..||.+.+..+.+.++..+...  ++
T Consensus       145 ~~~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~  217 (330)
T cd05586         145 ANLTDNK-TTNTFCGTTEYLAPEVLLD----EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR--FP  217 (330)
T ss_pred             CCCCCCC-CccCccCCccccCHHHHcC----CCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCC--CC
Confidence            5432222 2234679999999999873    345789999999999999999999999998888888887765433  33


Q ss_pred             CCCCCCCCHHHHHHHHHhcc-CCCCCCCCC-ChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccCCCCCcCCCCCC
Q psy11571        253 SDVGYEISDDAKDLMRRLIC-SSDTRLGQN-GIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSP  328 (372)
Q Consensus       253 ~~~~~~~s~~~~~li~~lL~-~p~~R~s~~-~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~~~p~~p~~~~~  328 (372)
                      ..   .+++++++||++||+ ||.+||++. .+.+++              .||||.+++|+.+  +...+|+.|.....
T Consensus       218 ~~---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll--------------~h~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (330)
T cd05586         218 KN---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELK--------------EHPFFADIDWDLLSKKQITPPFKPIVDSD  280 (330)
T ss_pred             Cc---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHh--------------cCccccCCCHHHHHhCCCCCCccCCCCCC
Confidence            32   579999999999999 999999753 577777              9999999999987  45678899988888


Q ss_pred             CCCCCCCCCccc----------cCCCCCCCCCCCCcccccCCCCccCcee
Q psy11571        329 TDTSHFDVDEAG----------VRASDALPPAAASPALSALHLPFVGFTF  368 (372)
Q Consensus       329 ~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (372)
                      .+.++|+.....          ....+..+....++..+.....|.||||
T Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~s~~~~~~~~~~~~  330 (330)
T cd05586         281 EDVSNFDPEFTNSSLLNAGIVPWEDVPGLPGANSTPLSSSVQENFRGFTF  330 (330)
T ss_pred             cchhhcCcccccccccccccccccccccCCCCCCCcCCHHHHhhcCCCCC
Confidence            888877653221          1122223333445556666788999998

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.4e-49  Score=374.94  Aligned_cols=310  Identities=32%  Similarity=0.624  Sum_probs=246.4

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      ||+|.||++++..+++.+|+|.+.........      .....+.++..+++.++||||+++++++.+.+.+|+||||++
T Consensus         6 G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~------~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05602           6 GSFGKVLLARHKAEEKFYAVKVLQKKAILKKK------EEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN   79 (325)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEEHHHHHhhh------HHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence            38999999999989999999988754332221      111223334445778999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCC
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG  176 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  176 (372)
                      +|+|.+++.. ...+++..++.++.||+.||.|||++||+|          |||||+|||++.++.+||+|||+++....
T Consensus        80 ~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiH----------rDlkp~Nili~~~~~~kl~DfG~a~~~~~  148 (325)
T cd05602          80 GGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVY----------RDLKPENILLDSQGHIVLTDFGLCKENIE  148 (325)
T ss_pred             CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEe----------cCCCHHHeEECCCCCEEEccCCCCccccc
Confidence            9999999987 567899999999999999999999999999          99999999999999999999999875432


Q ss_pred             CCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCC
Q psy11571        177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVG  256 (372)
Q Consensus       177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  256 (372)
                      ... .....+||+.|+|||++.+     ..++.++|||||||++|+|++|.+||.+.+..+.+..+.....  ..+.   
T Consensus       149 ~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~--~~~~---  217 (325)
T cd05602         149 HNG-TTSTFCGTPEYLAPEVLHK-----QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL--QLKP---  217 (325)
T ss_pred             CCC-CcccccCCccccCHHHHcC-----CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc--CCCC---
Confidence            221 2234679999999999983     5688999999999999999999999999988888888776432  2232   


Q ss_pred             CCCCHHHHHHHHHhcc-CCCCCCCCC-ChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccCCCCCcCCCCCCCCCC
Q psy11571        257 YEISDDAKDLMRRLIC-SSDTRLGQN-GIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTS  332 (372)
Q Consensus       257 ~~~s~~~~~li~~lL~-~p~~R~s~~-~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~~~p~~p~~~~~~~~~  332 (372)
                       .+++.+.++|.+||+ +|.+|+++. .+.+++              +|+||..++|+.+  ....+|+.|...++.+..
T Consensus       218 -~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (325)
T cd05602         218 -NITNSARHLLEGLLQKDRTKRLGAKDDFMEIK--------------NHIFFSPINWDDLINKKITPPFNPNVSGPNDLR  282 (325)
T ss_pred             -CCCHHHHHHHHHHcccCHHHCCCCCCCHHHHh--------------cCcccCCCCHHHHHhCCCCcCcCCCCCCcchhh
Confidence             689999999999999 999999975 466777              9999999999988  456788899998888888


Q ss_pred             CCCCCccccCCCCCCCCCCC----CcccccCCCCccCceee
Q psy11571        333 HFDVDEAGVRASDALPPAAA----SPALSALHLPFVGFTFT  369 (372)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~  369 (372)
                      +|+....+....+.......    ..........|.||+|-
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~  323 (325)
T cd05602         283 HFDPEFTEEPVPNSIGQSPDSILVTASVKEAAEAFLGFSYA  323 (325)
T ss_pred             hcCCccccCCcccccCCCchhhhhcccccccccccCCCccC
Confidence            88764433222211111111    22344556679999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.8e-50  Score=377.28  Aligned_cols=310  Identities=32%  Similarity=0.551  Sum_probs=249.7

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      ||+|.||++++..+++.||+|.+........       .....+.+|+.+++.++||||+++++++.+.+.+|+||||++
T Consensus         6 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~   78 (323)
T cd05595           6 GTFGKVILVREKATGRYYAMKILRKEVIIAK-------DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CCCEEEEEEEECCCCCEEEEEEEEHHHhhhh-------HHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence            4899999999999999999998765433221       234556779999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCC
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG  176 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  176 (372)
                      +|+|..++.. ...+++..++.++.||+.||.|||++|++|          |||||+|||++.++.+||+|||+++....
T Consensus        79 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH----------~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  147 (323)
T cd05595          79 GGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVY----------RDIKLENLMLDKDGHIKITDFGLCKEGIS  147 (323)
T ss_pred             CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEe----------cCCCHHHEEEcCCCCEEecccHHhccccC
Confidence            9999999977 567999999999999999999999999999          99999999999999999999999875432


Q ss_pred             CCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCC
Q psy11571        177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVG  256 (372)
Q Consensus       177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  256 (372)
                      ... ......||+.|+|||++.     ...++.++|+|||||++|+|++|+.||.+.+.......+....  ..+|.   
T Consensus       148 ~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~--~~~p~---  216 (323)
T cd05595         148 DGA-TMKTFCGTPEYLAPEVLE-----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPR---  216 (323)
T ss_pred             CCC-ccccccCCcCcCCccccc-----CCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCC---
Confidence            221 223357999999999997     3568899999999999999999999999988888877776543  33444   


Q ss_pred             CCCCHHHHHHHHHhcc-CCCCCCCC--CChhhhhhhhhhhhccCCCCCCCCCcCCCCccccc--cCCCCCcCCCCCCCCC
Q psy11571        257 YEISDDAKDLMRRLIC-SSDTRLGQ--NGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIR--DSNAPYIPEVSSPTDT  331 (372)
Q Consensus       257 ~~~s~~~~~li~~lL~-~p~~R~s~--~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~--~~~~p~~p~~~~~~~~  331 (372)
                       .+++++++||++||+ ||.+|++.  ..+.+++              +||||.+++|..+.  ...+|+.|...+..+.
T Consensus       217 -~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l--------------~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (323)
T cd05595         217 -TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM--------------EHRFFLSINWQDVVQKKLLPPFKPQVTSEVDT  281 (323)
T ss_pred             -CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHH--------------cCCCcCCCCHHHHHhCCCCCCcCCCCCChhhh
Confidence             689999999999999 99999953  3566777              99999999999873  4568899999999999


Q ss_pred             CCCCCCccccCCCCCCCCCCCCcccc--cCCCCccCceeeC
Q psy11571        332 SHFDVDEAGVRASDALPPAAASPALS--ALHLPFVGFTFTQ  370 (372)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  370 (372)
                      ..|+.+.........++....+....  .--..|++|||..
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (323)
T cd05595         282 RYFDDEFTAQSITITPPDRYDSLGLLELDQRTHFPQFSYSA  322 (323)
T ss_pred             hhcCcccccCCccCCCCcccccccccccccccccCCCcccC
Confidence            99886665433221111111111111  2234699999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.6e-49  Score=374.54  Aligned_cols=311  Identities=30%  Similarity=0.591  Sum_probs=248.4

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHH-HHhcCCCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERD-VLVYGDRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~-il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      ||+|.||.+++..+++.+|+|.+........       .....+..|.. +++.++||||+++++++...+.+|+||||+
T Consensus         6 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05604           6 GSFGKVLLAKRKLDGKCYAVKVLQKKIVLNR-------KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV   78 (325)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEEHHHhhhh-------hHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence            3899999999999999999998765433221       11223344444 567799999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccC
Q psy11571         96 CGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG  175 (372)
Q Consensus        96 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~  175 (372)
                      ++|+|..++.+ ...+++..++.++.||+.||.|||++|++|          |||||+|||++.++.+||+|||+++...
T Consensus        79 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH----------~Dlkp~NIll~~~~~~kL~DfG~~~~~~  147 (325)
T cd05604          79 NGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVY----------RDLKPENILLDSQGHVVLTDFGLCKEGI  147 (325)
T ss_pred             CCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeee----------cCCCHHHeEECCCCCEEEeecCCcccCC
Confidence            99999999877 578999999999999999999999999999          9999999999999999999999987543


Q ss_pred             CCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCC
Q psy11571        176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDV  255 (372)
Q Consensus       176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  255 (372)
                      .... .....+||+.|+|||++.     ...++.++|||||||++|+|++|.+||.+.+..+.+.++.....  ..+.  
T Consensus       148 ~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~--~~~~--  217 (325)
T cd05604         148 AQSD-TTTTFCGTPEYLAPEVIR-----KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL--VLRP--  217 (325)
T ss_pred             CCCC-CcccccCChhhCCHHHHc-----CCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc--cCCC--
Confidence            2211 223467999999999997     35688999999999999999999999999988888888876432  2222  


Q ss_pred             CCCCCHHHHHHHHHhcc-CCCCCCCCC-ChhhhhhhhhhhhccCCCCCCCCCcCCCCccccc--cCCCCCcCCCCCCCCC
Q psy11571        256 GYEISDDAKDLMRRLIC-SSDTRLGQN-GIADFKMWSALFVSLSISPRNHPWFQGIAWDSIR--DSNAPYIPEVSSPTDT  331 (372)
Q Consensus       256 ~~~~s~~~~~li~~lL~-~p~~R~s~~-~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~--~~~~p~~p~~~~~~~~  331 (372)
                        ..+..+.++|++||+ +|.+||++. .+.+++              .||||++++|..+.  ...+|+.|...+..+.
T Consensus       218 --~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~--------------~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (325)
T cd05604         218 --GASLTAWSILEELLEKDRQRRLGAKEDFLEIQ--------------EHPFFESLSWTDLEQKKIPPPFNPNVEGPDDI  281 (325)
T ss_pred             --CCCHHHHHHHHHHhccCHHhcCCCCCCHHHHh--------------cCCCcCCCCHHHHHhCCCCCCcCCcCCCcchh
Confidence              578999999999999 999999975 566777              99999999998873  4678899999888899


Q ss_pred             CCCCCCccccCCCCCC----CCCCCCcccccCCCCccCceeeCC
Q psy11571        332 SHFDVDEAGVRASDAL----PPAAASPALSALHLPFVGFTFTQG  371 (372)
Q Consensus       332 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  371 (372)
                      ++|+....+...+...    +++.........+..|.||+|..+
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (325)
T cd05604         282 SNFDAVFTEETVPYSVCFSSDYSIVNASVLEADDAFVGFSYAPP  325 (325)
T ss_pred             hhcCCccccCCcccCcccccccccccccccccccccCCCEecCC
Confidence            9888644432211111    111112334566888999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0591|consensus

Probab=100.00  E-value=2.5e-51  Score=357.00  Aligned_cols=246  Identities=30%  Similarity=0.463  Sum_probs=215.3

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeE-
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHY-   80 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~-   80 (372)
                      ..|++++++|.|    .||+||+|.++.+++.+|.|.+.-..+...        ..+.+..|+.+|++++|||||++++ 
T Consensus        19 ~~y~Il~~IG~G----sFg~vykv~~~~~g~l~a~K~i~f~~md~k--------~rq~~v~Ei~lLkQL~HpNIVqYy~~   86 (375)
T KOG0591|consen   19 ADYQILKKIGRG----SFGEVYKVQCLLDGKLVALKKIQFGMMDAK--------ARQDCVKEISLLKQLNHPNIVQYYAH   86 (375)
T ss_pred             HHHHHHHHHcCC----cchheEEeeeccCcchhhhhhcchhhccHH--------HHHHHHHHHHHHHhcCCchHHHHHHH
Confidence            368999999999    799999999999999999999884444332        3456778999999999999999998 


Q ss_pred             EEEeCCe-EEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh--cC--ceecCCCCCCCcCCCCCc
Q psy11571         81 AFQDDSN-LYLVMDYYCGGDLLTLLSKF---EDRLPEDMAKFYIAEMVLAIASIHD--LH--YVHRPNHFAFHLCRDIKP  152 (372)
Q Consensus        81 ~~~~~~~-~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~LH~--~~--ivH~~~~~~~~vhrDlkp  152 (372)
                      .|.++.. ++||||||.+|||.+.++..   +..++|..++.++.|++.||.++|+  .+  ++|          |||||
T Consensus        87 ~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmH----------RDIKP  156 (375)
T KOG0591|consen   87 SFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMH----------RDIKP  156 (375)
T ss_pred             hhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceee----------ccCcc
Confidence            5655555 89999999999999998754   4579999999999999999999999  44  788          99999


Q ss_pred             CcEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCC
Q psy11571        153 DNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA  232 (372)
Q Consensus       153 ~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~  232 (372)
                      .||+++.+|.|||+|||+++++....+ ...+.+|||.||+||.+.     ...|+.+|||||+||++|||+.-++||.+
T Consensus       157 aNIFl~~~gvvKLGDfGL~r~l~s~~t-fA~S~VGTPyYMSPE~i~-----~~~Y~~kSDiWslGCllyEMcaL~~PF~g  230 (375)
T KOG0591|consen  157 ANIFLTANGVVKLGDFGLGRFLSSKTT-FAHSLVGTPYYMSPERIH-----ESGYNFKSDIWSLGCLLYEMCALQSPFYG  230 (375)
T ss_pred             hheEEcCCCceeeccchhHhHhcchhH-HHHhhcCCCcccCHHHHh-----cCCCCcchhHHHHHHHHHHHHhcCCCccc
Confidence            999999999999999999999876544 445689999999999999     46799999999999999999999999999


Q ss_pred             CCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCC
Q psy11571        233 ESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLG  279 (372)
Q Consensus       233 ~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s  279 (372)
                      ++-.++..+|.++..+ ++|..   .+|.++..||..|++ ||+.||+
T Consensus       231 ~n~~~L~~KI~qgd~~-~~p~~---~YS~~l~~li~~ci~vd~~~RP~  274 (375)
T KOG0591|consen  231 DNLLSLCKKIEQGDYP-PLPDE---HYSTDLRELINMCIAVDPEQRPD  274 (375)
T ss_pred             ccHHHHHHHHHcCCCC-CCcHH---HhhhHHHHHHHHHccCCcccCCC
Confidence            9999999999887432 34432   689999999999999 9999997

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7e-50  Score=375.87  Aligned_cols=303  Identities=35%  Similarity=0.628  Sum_probs=245.6

Q ss_pred             cCCccEEEeeee---hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEe
Q psy11571         17 QGKGRVFSIETL---LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMD   93 (372)
Q Consensus        17 ~g~G~v~~v~~~---~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E   93 (372)
                      ||+|.||.+++.   .+++.+|+|.+.......        .....+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus         7 G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (318)
T cd05582           7 GSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV--------RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD   78 (318)
T ss_pred             CCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh--------hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence            389999999874   467899999876543321        123346779999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571         94 YYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus        94 ~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                      |+++|+|.+++.+ ...+++..++.++.||+.||.|||++|++|          |||||+||+++.++.++|+|||++..
T Consensus        79 ~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H----------~dlkp~Nil~~~~~~~kL~Dfg~~~~  147 (318)
T cd05582          79 FLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIY----------RDLKPENILLDEEGHIKLTDFGLSKE  147 (318)
T ss_pred             CCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEec----------CCCCHHHeEECCCCcEEEeeccCCcc
Confidence            9999999999977 567999999999999999999999999999          99999999999999999999999876


Q ss_pred             cCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCC
Q psy11571        174 LGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPS  253 (372)
Q Consensus       174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~  253 (372)
                      ...... ......||+.|+|||++.+     ..++.++|+|||||++|+|++|+.||.+.+..+....+....  ..+|.
T Consensus       148 ~~~~~~-~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~--~~~p~  219 (318)
T cd05582         148 SIDHEK-KAYSFCGTVEYMAPEVVNR-----RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK--LGMPQ  219 (318)
T ss_pred             cCCCCC-ceecccCChhhcCHHHHcC-----CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC--CCCCC
Confidence            543322 2234679999999999973     557889999999999999999999999988888888777643  33444


Q ss_pred             CCCCCCCHHHHHHHHHhcc-CCCCCCCCCC--hhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccCCCCCcCCCCCC
Q psy11571        254 DVGYEISDDAKDLMRRLIC-SSDTRLGQNG--IADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSP  328 (372)
Q Consensus       254 ~~~~~~s~~~~~li~~lL~-~p~~R~s~~~--~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~~~p~~p~~~~~  328 (372)
                          .+++++.+||++||+ ||++||++.+  +.+++              .||||+.++|..+  .+..+|+.|.....
T Consensus       220 ----~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (318)
T cd05582         220 ----FLSPEAQSLLRALFKRNPANRLGAGPDGVEEIK--------------RHPFFSTIDWNKLYRREIKPPFKPAVGRP  281 (318)
T ss_pred             ----CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHh--------------CCCCcCCCCHHHHHhcCCCCCcCCCCCCc
Confidence                679999999999999 9999999877  88888              9999999999987  34667888877766


Q ss_pred             CCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCcee
Q psy11571        329 TDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTF  368 (372)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (372)
                      .+...++.......    ..+....+..+..+..|.||+|
T Consensus       282 ~~~~~~~~~~~~~~----~~~~~~~~~s~~~~~~~~~~~~  317 (318)
T cd05582         282 DDTFYFDPEFTSRT----PKDSPGIPPSANAHQLFRGFSF  317 (318)
T ss_pred             chhhhcCcccccCc----cccCCCCccccccccccCCCEe
Confidence            66666665433211    1112222333456778999988

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-50  Score=380.40  Aligned_cols=287  Identities=38%  Similarity=0.663  Sum_probs=242.0

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.++.|    ++|.||++....+++.||+|.+.......       ....+.+.+|+.++..++||||+++++++
T Consensus         2 ~y~~~~~ig~G----~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~~e~~~l~~~~h~~iv~~~~~~   70 (333)
T cd05600           2 DFQILTQVGQG----GYGQVFLAKKKDTGEIVALKRMKKSLLFK-------LNEVRHVLTERDILTTTKSEWLVKLLYAF   70 (333)
T ss_pred             CcEEEEEEeec----CCeEEEEEEECCCCCEEEEEEEEHHHHhh-------hhHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence            35556666776    89999999998899999999876543222       23345678899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+.+..|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++|++|          |||||+|||++.++.
T Consensus        71 ~~~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH----------~dlkp~Nil~~~~~~  139 (333)
T cd05600          71 QDDEYLYLAMEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIH----------RDLKPENFLIDASGH  139 (333)
T ss_pred             EcCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------cCCCHHHEEECCCCC
Confidence            999999999999999999999987 568999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||++.....    ......||+.|+|||++.+     ..++.++|||||||++|||++|..||.+.+..+.+..+
T Consensus       140 ~kL~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i  210 (333)
T cd05600         140 IKLTDFGLSKGIVT----YANSVVGSPDYMAPEVLRG-----KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL  210 (333)
T ss_pred             EEEEeCcCCccccc----ccCCcccCccccChhHhcC-----CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH
Confidence            99999999976543    2234679999999999983     56899999999999999999999999998888887777


Q ss_pred             hhccCCcCCCCCC--CCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccccccCCC
Q psy11571        243 MNHQNSFDLPSDV--GYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNA  319 (372)
Q Consensus       243 ~~~~~~~~~~~~~--~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~~~~~  319 (372)
                      ......+..|...  ...+++++.+||.+||. +|.+|+++++++                 .||||++++|..+....+
T Consensus       211 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll-----------------~h~~~~~~~~~~~~~~~~  273 (333)
T cd05600         211 KYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIK-----------------NHPFFKEVDWNELRELKP  273 (333)
T ss_pred             HhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHH-----------------hCcccCCCCHHHHhhCCC
Confidence            6543333222211  12569999999999999 889999865554                 999999999999998899


Q ss_pred             CCcCCCCCCCCCCCCCCC
Q psy11571        320 PYIPEVSSPTDTSHFDVD  337 (372)
Q Consensus       320 p~~p~~~~~~~~~~~~~~  337 (372)
                      |+.|.+.+..+.+.|+..
T Consensus       274 ~~~~~~~~~~~~~~~~~~  291 (333)
T cd05600         274 PFVPELESEIDTGYFDDF  291 (333)
T ss_pred             CCCCCCCCcchhhhccCC
Confidence            999999888887777543

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.9e-49  Score=373.82  Aligned_cols=308  Identities=34%  Similarity=0.656  Sum_probs=246.6

Q ss_pred             cCCccEEEeeee---hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEe
Q psy11571         17 QGKGRVFSIETL---LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMD   93 (372)
Q Consensus        17 ~g~G~v~~v~~~---~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E   93 (372)
                      ||+|.||.|++.   .+++.||+|.+........      ......+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus         7 G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~------~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           7 GGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRN------QKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             cCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhh------hhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            389999999864   3678899998765433221      1234557789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571         94 YYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus        94 ~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                      |+++++|.+++.+ .+.+++..++.++.||+.||.|||++||+|          |||||+|||++.++.+||+|||+++.
T Consensus        81 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH----------~dlkp~Nil~~~~~~~kl~Dfg~~~~  149 (323)
T cd05584          81 YLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIY----------RDLKPENILLDAQGHVKLTDFGLCKE  149 (323)
T ss_pred             CCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeec----------CCCCHHHeEECCCCCEEEeeCcCCee
Confidence            9999999999987 577899999999999999999999999999          99999999999999999999999875


Q ss_pred             cCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCC
Q psy11571        174 LGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPS  253 (372)
Q Consensus       174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~  253 (372)
                      ...... ......||+.|+|||++.+     ..++.++|||||||++|||++|+.||.+.+......++....  ..+|.
T Consensus       150 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~--~~~~~  221 (323)
T cd05584         150 SIHEGT-VTHTFCGTIEYMAPEILMR-----SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK--LNLPP  221 (323)
T ss_pred             cccCCC-cccccCCCccccChhhccC-----CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCC
Confidence            433222 2233579999999999973     557889999999999999999999999988888888887653  34444


Q ss_pred             CCCCCCCHHHHHHHHHhcc-CCCCCCCC--CChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccCCCCCcCCCCCC
Q psy11571        254 DVGYEISDDAKDLMRRLIC-SSDTRLGQ--NGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSP  328 (372)
Q Consensus       254 ~~~~~~s~~~~~li~~lL~-~p~~R~s~--~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~~~p~~p~~~~~  328 (372)
                          .+++++.+||++||+ +|++|++.  ..+.+++              .||||+..+|+.+  ....+|+.+...+.
T Consensus       222 ----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~--------------~h~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (323)
T cd05584         222 ----YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQ--------------SHPFFRHVNWDDLLARKVEPPFKPLLQSE  283 (323)
T ss_pred             ----CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHh--------------cCCCcCCCCHHHHhcCCCCCCcCCCCCCc
Confidence                679999999999999 99999952  3355555              9999999999887  34567888888888


Q ss_pred             CCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceeeC
Q psy11571        329 TDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQ  370 (372)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (372)
                      .+.+.|+......  .+...+ ..+.........|.||+|-+
T Consensus       284 ~~~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~  322 (323)
T cd05584         284 EDVSQFDSKFTRQ--TPVDSP-DDSTLSESANQIFLGFTYVA  322 (323)
T ss_pred             chhhhcCchhccc--ccccCc-cccccccccccCcCCCeecC
Confidence            8888877544322  222122 22222333457899999965

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0661|consensus

Probab=100.00  E-value=5.8e-50  Score=370.33  Aligned_cols=261  Identities=25%  Similarity=0.358  Sum_probs=226.6

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeeeE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLHY   80 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~~   80 (372)
                      +||..++++|.|    .||.||+++...++..||+|.++.+...-++        .-+ .+|+..|++++ |||||++.+
T Consensus        10 ~RY~~i~klGDG----TfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee--------~~n-LREvksL~kln~hpniikL~E   76 (538)
T KOG0661|consen   10 DRYTVIRKLGDG----TFGSVYLAKSKETGELVAIKKMKKKFYSWEE--------CMN-LREVKSLRKLNPHPNIIKLKE   76 (538)
T ss_pred             HHHHHHHHhcCC----cceeEEEeeecCCCceeeHHHHHhhhccHHH--------HHH-HHHHHHHHhcCCCCcchhhHH
Confidence            699999999999    6999999999999999999999887665431        112 35899999998 999999999


Q ss_pred             EEEeCC-eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC
Q psy11571         81 AFQDDS-NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA  159 (372)
Q Consensus        81 ~~~~~~-~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~  159 (372)
                      ++.+.+ .+|+||||| ..+|+++++.++..++++.++.|+.||++||+|+|.+|+.|          ||+||+|||+..
T Consensus        77 vi~d~~~~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFH----------RDlKPENiLi~~  145 (538)
T KOG0661|consen   77 VIRDNDRILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFH----------RDLKPENILISG  145 (538)
T ss_pred             HhhccCceEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCccc----------ccCChhheEecc
Confidence            999988 999999999 67999999987788999999999999999999999999999          999999999998


Q ss_pred             CCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHH
Q psy11571        160 NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY  239 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~  239 (372)
                      +..+||+|||+|+.+.....+  +.++.|..|.|||++..    .+.|+.++|+||+|||++|+.+-++.|.|.++.+.+
T Consensus       146 ~~~iKiaDFGLARev~SkpPY--TeYVSTRWYRAPEvLLr----s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi  219 (538)
T KOG0661|consen  146 NDVIKIADFGLAREVRSKPPY--TEYVSTRWYRAPEVLLR----SGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQI  219 (538)
T ss_pred             cceeEecccccccccccCCCc--chhhhcccccchHHhhh----ccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHH
Confidence            899999999999988765544  34788999999999985    678999999999999999999999999999999888


Q ss_pred             HHHhhccCC-----------------cCCCCC-------CCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhh
Q psy11571        240 GKIMNHQNS-----------------FDLPSD-------VGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFV  294 (372)
Q Consensus       240 ~~i~~~~~~-----------------~~~~~~-------~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~  294 (372)
                      .+|+.--+.                 +.+|..       ...+.+.++.+||.+||. ||.+||||++++          
T Consensus       220 ~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al----------  289 (538)
T KOG0661|consen  220 YKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQAL----------  289 (538)
T ss_pred             HHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHh----------
Confidence            887642221                 112211       113578999999999999 999999988887          


Q ss_pred             ccCCCCCCCCCcCCC
Q psy11571        295 SLSISPRNHPWFQGI  309 (372)
Q Consensus       295 ~~~~~~~~hp~f~~~  309 (372)
                             +||||+.-
T Consensus       290 -------~~pffq~~  297 (538)
T KOG0661|consen  290 -------QHPFFQVG  297 (538)
T ss_pred             -------cCcccccc
Confidence                   99999964

>KOG0033|consensus

Probab=100.00  E-value=1.2e-50  Score=346.49  Aligned_cols=259  Identities=29%  Similarity=0.443  Sum_probs=228.2

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      +.|+.-+.++.|    .|..|+.+.+..+|+.+|+|.++...+...        ..+++.+|+.+.+.++||||+++++.
T Consensus        11 d~y~l~e~igkG----~FSvVrRc~~~~tg~~fa~kiin~~k~~~~--------~~e~l~rEarIC~~LqHP~IvrL~~t   78 (355)
T KOG0033|consen   11 DNYDVKEELGKG----AFSVVRRCVHKTTGLEFAAKIINTKKLSAR--------DFQKLEREARICRKLQHPNIVRLHDS   78 (355)
T ss_pred             hhhhHHHHHccC----chHHHHHHHhccchHHHHHHHhhhhhhccc--------cHHHHHHHHHHHHhcCCCcEeehhhh
Confidence            567777777776    688888888889999999999988776654        34668899999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+....|+|+|++.|++|..-|-. +.-++|..+..+++||+.+|.|+|.+||||          ||+||+|+++.+..
T Consensus        79 i~~~~~~ylvFe~m~G~dl~~eIV~-R~~ySEa~aSH~~rQiLeal~yCH~n~IvH----------RDvkP~nllLASK~  147 (355)
T KOG0033|consen   79 IQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILEALAYCHSNGIVH----------RDLKPENLLLASKA  147 (355)
T ss_pred             hcccceeEEEEecccchHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHhcCcee----------ccCChhheeeeecc
Confidence            9999999999999999999887755 367899999999999999999999999999          99999999996433


Q ss_pred             ---cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHH
Q psy11571        162 ---HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET  238 (372)
Q Consensus       162 ---~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~  238 (372)
                         -+||+|||+|..+.. +. ....+.|||.|||||++.     +.+|+..+||||.|||||-|+.|.+||.+.+...+
T Consensus       148 ~~A~vKL~~FGvAi~l~~-g~-~~~G~~GtP~fmaPEvvr-----kdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl  220 (355)
T KOG0033|consen  148 KGAAVKLADFGLAIEVND-GE-AWHGFAGTPGYLSPEVLK-----KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL  220 (355)
T ss_pred             CCCceeecccceEEEeCC-cc-ccccccCCCcccCHHHhh-----cCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH
Confidence               589999999998873 32 334578999999999998     57899999999999999999999999999999999


Q ss_pred             HHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       239 ~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      +++|+++.  +.+|+..+..+++++++||++||. ||.+|+|+.+++                 +|||+.+-
T Consensus       221 ye~I~~g~--yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL-----------------~HpWi~~r  273 (355)
T KOG0033|consen  221 YEQIKAGA--YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEAL-----------------KHPWICNR  273 (355)
T ss_pred             HHHHhccc--cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHh-----------------CCchhcch
Confidence            99999866  455666677999999999999999 999999988887                 99999864

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.3e-49  Score=373.17  Aligned_cols=313  Identities=33%  Similarity=0.562  Sum_probs=247.5

Q ss_pred             HHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeC
Q psy11571          7 LEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLHYAFQDD   85 (372)
Q Consensus         7 l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~~~~~~~   85 (372)
                      +..+|.|    ++|.||++++..+++.||+|.+........       ...+.+..|..++..+. ||+|+++++++.+.
T Consensus         5 ~~~lg~G----~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~   73 (323)
T cd05615           5 LMVLGKG----SFGKVMLAERKGTDELYAIKILKKDVVIQD-------DDVECTMVEKRVLALQDKPPFLTQLHSCFQTV   73 (323)
T ss_pred             EEEEEec----CCeEEEEEEECCCCCEEEEEEEEHHHhhhh-------hHHHHHHHHHHHHHhccCCCchhheeeEEecC
Confidence            3445555    899999999999999999998765433222       22345667888887775 67889999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEE
Q psy11571         86 SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRL  165 (372)
Q Consensus        86 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl  165 (372)
                      +.+|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++|++|          |||||+|||++.++.++|
T Consensus        74 ~~~~lv~Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH----------rDikp~Nill~~~~~ikL  142 (323)
T cd05615          74 DRLYFVMEYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIY----------RDLKLDNVMLDSEGHIKI  142 (323)
T ss_pred             CEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeec----------cCCCHHHeEECCCCCEEE
Confidence            999999999999999999987 578999999999999999999999999999          999999999999999999


Q ss_pred             eecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhc
Q psy11571        166 ADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH  245 (372)
Q Consensus       166 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~  245 (372)
                      +|||+++....... ......||+.|+|||++.+     ..++.++|+|||||++|+|++|.+||.+.+.......+...
T Consensus       143 ~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~  216 (323)
T cd05615         143 ADFGMCKEHMVDGV-TTRTFCGTPDYIAPEIIAY-----QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH  216 (323)
T ss_pred             eccccccccCCCCc-cccCccCCccccCHHHHcC-----CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence            99999876433222 2233579999999999973     56889999999999999999999999999888888888775


Q ss_pred             cCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCC--ChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccCCCC
Q psy11571        246 QNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQN--GIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAP  320 (372)
Q Consensus       246 ~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~--~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~~~p  320 (372)
                      ..  ..|.    .++.++.+++.+||+ +|.+|++..  ...+++              .||||+.++|..+  +...+|
T Consensus       217 ~~--~~p~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~--------------~h~~f~~~~~~~~~~~~~~~~  276 (323)
T cd05615         217 NV--SYPK----SLSKEAVSICKGLMTKHPSKRLGCGPEGERDIR--------------EHAFFRRIDWDKLENREIQPP  276 (323)
T ss_pred             CC--CCCc----cCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHh--------------cCcccCCCCHHHHhcCCCCcC
Confidence            43  3344    679999999999999 999999864  356666              9999999999988  446789


Q ss_pred             CcCCCCCCCCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceeeC
Q psy11571        321 YIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQ  370 (372)
Q Consensus       321 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (372)
                      +.|..+.. ...+|+..........  +++.......-....|.||+|.|
T Consensus       277 ~~~~~~~~-~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  323 (323)
T cd05615         277 FKPKVCGK-GAENFDKFFTRGQPVL--TPPDQLVIANIDQADFEGFSYVN  323 (323)
T ss_pred             ccCccCCC-chhhcCccccccCCCC--CCCcccccccccccccCCCcccC
Confidence            99976553 4677776554332222  22222111122225799999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=7.6e-49  Score=369.31  Aligned_cols=309  Identities=32%  Similarity=0.618  Sum_probs=245.2

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHH-HHHhcCCCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREER-DVLVYGDRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~-~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      ||+|.||++++..+++.+|+|.+........       .....+..|. .+++.++||||+++++++.+.+..|+||||+
T Consensus         6 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (321)
T cd05603           6 GSFGKVLLAKRKSDGSFYAVKVLQKKTILKK-------KEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV   78 (321)
T ss_pred             CCCEEEEEEEECCCCCEEEEEEEEHHHHHHh-------hHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence            3899999999999999999998765443222       1122333344 4678899999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccC
Q psy11571         96 CGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG  175 (372)
Q Consensus        96 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~  175 (372)
                      ++++|...+.. ...+++..++.++.||+.||.|||++||+|          |||||+||+++.+|.+||+|||+++...
T Consensus        79 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH----------~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  147 (321)
T cd05603          79 NGGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIY----------RDLKPENILLDSQGHVVLTDFGLCKEGV  147 (321)
T ss_pred             CCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEe----------ccCCHHHeEECCCCCEEEccCCCCccCC
Confidence            99999999877 567999999999999999999999999999          9999999999999999999999987532


Q ss_pred             CCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCC
Q psy11571        176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDV  255 (372)
Q Consensus       176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  255 (372)
                      .... .....+||+.|+|||++.+     ..++.++|+|||||++|+|++|..||.+.+....+..+....  ..+|.  
T Consensus       148 ~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--~~~~~--  217 (321)
T cd05603         148 EPEE-TTSTFCGTPEYLAPEVLRK-----EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP--LQLPG--  217 (321)
T ss_pred             CCCC-ccccccCCcccCCHHHhcC-----CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC--CCCCC--
Confidence            2221 2234679999999999973     568899999999999999999999999998888888877643  33343  


Q ss_pred             CCCCCHHHHHHHHHhcc-CCCCCCCC-CChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccCCCCCcCCCCCCCCC
Q psy11571        256 GYEISDDAKDLMRRLIC-SSDTRLGQ-NGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDT  331 (372)
Q Consensus       256 ~~~~s~~~~~li~~lL~-~p~~R~s~-~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~~~p~~p~~~~~~~~  331 (372)
                        ..+..+.++|.+||+ +|.+|+++ .++++++              +||||..++|+.+  ....+|+.|...++.+.
T Consensus       218 --~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (321)
T cd05603         218 --GKTVAACDLLVGLLHKDQRRRLGAKADFLEIK--------------NHVFFSPINWDDLYHKRITPPYNPNVAGPADL  281 (321)
T ss_pred             --CCCHHHHHHHHHHccCCHhhcCCCCCCHHHHh--------------CCCCcCCCCHHHHhcCCCCCCcCCCCCCcchh
Confidence              578999999999999 99999986 4677888              9999999999987  45678888888888888


Q ss_pred             CCCCCCccccCCCCCCCCCCC-CcccccCCCCccCceee
Q psy11571        332 SHFDVDEAGVRASDALPPAAA-SPALSALHLPFVGFTFT  369 (372)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  369 (372)
                      ..++................. ....+.....|.||+|.
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (321)
T cd05603         282 RHFDPEFTQEAVSSSVGQTPDLTASSSSASSAFLGFSYA  320 (321)
T ss_pred             hhcCCcccccccccccCCCCcccccccccccccCCCccC
Confidence            888765543332222221111 12222334458999885

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0583|consensus

Probab=100.00  E-value=5.2e-50  Score=380.28  Aligned_cols=257  Identities=32%  Similarity=0.534  Sum_probs=218.2

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeeeEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLHYAF   82 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~~~~   82 (372)
                      |+....+|.|    ++|.|+.+.+..++..||+|.+.........     ....+.+.+|+.+++.+. ||||+++++++
T Consensus        19 y~~~~~lG~G----sfgkV~~a~~~~t~~~vAiKii~~~~~~~~~-----~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~   89 (370)
T KOG0583|consen   19 YELGRTLGSG----SFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS-----QKLDELIKREISILRRLRSHPNIIRLLEVF   89 (370)
T ss_pred             eeeeeeecCC----CCeeEEEeeeccCCCeEEEEEechhcccccc-----cccchhhHHHHHHHHHhccCCCEeEEEEEE
Confidence            3333444444    6888999999999999999966654332111     123455668999999999 99999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC-C
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-G  161 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~-~  161 (372)
                      .+...+|+|||||.||+|.+++.+ .+++.|.+++.+++||+.|++|||++||+|          |||||+|||++.+ +
T Consensus        90 ~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~H----------RDLK~ENilld~~~~  158 (370)
T KOG0583|consen   90 ATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVH----------RDLKPENILLDGNEG  158 (370)
T ss_pred             ecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEee----------CCCCHHHEEecCCCC
Confidence            999999999999999999999998 799999999999999999999999999999          9999999999999 9


Q ss_pred             cEEEeecCcccccC-CCCcccccccccCCcccCcccccccccCCC-CCCCccceeehhHHHHHHhhCCCCCCCCCHHHHH
Q psy11571        162 HIRLADFGSCLRLG-GDGTVQSNVAVGTPDYISPEILTAMEEGRG-RYGPECDWWSLGVCMYEMLYGETPFYAESLVETY  239 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~  239 (372)
                      ++||+|||++.... .+.  ...+.|||+.|+|||++.+    .. .-+.++||||+||+||.|++|+.||...+...++
T Consensus       159 ~~Kl~DFG~s~~~~~~~~--~l~t~cGsp~Y~aPEvl~~----~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~  232 (370)
T KOG0583|consen  159 NLKLSDFGLSAISPGEDG--LLKTFCGSPAYAAPEVLSG----KGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLY  232 (370)
T ss_pred             CEEEeccccccccCCCCC--cccCCCCCcccCCHHHhCC----CCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHH
Confidence            99999999998873 322  3455899999999999995    33 3368999999999999999999999999999999


Q ss_pred             HHHhhccCCcCCCCCCCCCC-CHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        240 GKIMNHQNSFDLPSDVGYEI-SDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~-s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      .+|.++.  +.+|.    .+ |+++++||++||. ||.+|+++.   +|+              .||||+.-
T Consensus       233 ~ki~~~~--~~~p~----~~~S~~~~~Li~~mL~~~P~~R~t~~---~i~--------------~h~w~~~~  281 (370)
T KOG0583|consen  233 RKIRKGE--FKIPS----YLLSPEARSLIEKMLVPDPSTRITLL---EIL--------------EHPWFQKE  281 (370)
T ss_pred             HHHhcCC--ccCCC----CcCCHHHHHHHHHHcCCCcccCCCHH---HHh--------------hChhhccC
Confidence            9988754  56676    56 9999999999999 999999755   444              99999964

>KOG0593|consensus

Probab=100.00  E-value=1.3e-50  Score=355.66  Aligned_cols=263  Identities=26%  Similarity=0.397  Sum_probs=222.7

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.|+.+|.|    ++|.|+++++..+|+.||+|++..+.-...        .-+-..+|+.+|+++.|||+|.++++
T Consensus         2 ekYE~LgkvGEG----SYGvV~KCrnk~TgqIVAIKkF~Esedd~~--------VkKIAlREIrmLKqLkH~NLVnLiEV   69 (396)
T KOG0593|consen    2 EKYEKLGKVGEG----SYGVVMKCRNKDTGQIVAIKKFVESEDDPV--------VKKIALREIRMLKQLKHENLVNLIEV   69 (396)
T ss_pred             cHHhhhhccccC----cceEEEEeccCCcccEEEEEeeccCCccHH--------HHHHHHHHHHHHHhcccchHHHHHHH
Confidence            689999999999    799999999999999999998876554322        12335689999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      |.....+++|+|||.. ++.+-+......++++.++.|+.|++.|+.|+|++++||          |||||+|||++.+|
T Consensus        70 FrrkrklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IH----------RDIKPENILit~~g  138 (396)
T KOG0593|consen   70 FRRKRKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIH----------RDIKPENILITQNG  138 (396)
T ss_pred             HHhcceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeec----------ccCChhheEEecCC
Confidence            9999999999999955 777777776788999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .+||||||+|+.+...+. ..+.++.|..|.|||.+.+    ...|+.++||||+||++.||++|.+.|.+.+..+.+..
T Consensus       139 vvKLCDFGFAR~L~~pgd-~YTDYVATRWYRaPELLvG----DtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~  213 (396)
T KOG0593|consen  139 VVKLCDFGFARTLSAPGD-NYTDYVATRWYRAPELLVG----DTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYL  213 (396)
T ss_pred             cEEeccchhhHhhcCCcc-hhhhhhhhhhccChhhhcc----cCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHH
Confidence            999999999998875433 2344778999999999995    56799999999999999999999999999988877766


Q ss_pred             HhhccC-------------------CcCCCCC------CCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhc
Q psy11571        242 IMNHQN-------------------SFDLPSD------VGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVS  295 (372)
Q Consensus       242 i~~~~~-------------------~~~~~~~------~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~  295 (372)
                      |...-+                   .++.|..      ....++.-+.||+++||. ||++|++.++++           
T Consensus       214 I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll-----------  282 (396)
T KOG0593|consen  214 IRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL-----------  282 (396)
T ss_pred             HHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh-----------
Confidence            643211                   1111111      123678899999999999 999999988777           


Q ss_pred             cCCCCCCCCCcCCC
Q psy11571        296 LSISPRNHPWFQGI  309 (372)
Q Consensus       296 ~~~~~~~hp~f~~~  309 (372)
                            .||||.++
T Consensus       283 ------~H~yFd~~  290 (396)
T KOG0593|consen  283 ------HHPYFDGF  290 (396)
T ss_pred             ------cChHHHHH
Confidence                  99999654

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=8.2e-49  Score=369.73  Aligned_cols=310  Identities=32%  Similarity=0.569  Sum_probs=247.1

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      |++|.||.+.+..+++.||+|.+........       .....+.+|..++..++||||+++++++.+.+.+|+||||++
T Consensus         6 G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~-------~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~   78 (325)
T cd05594           6 GTFGKVILVKEKATGRYYAMKILKKEVIVAK-------DEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN   78 (325)
T ss_pred             CCCEEEEEEEECCCCCEEEEEEEEHHHhhhh-------hHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence            4899999999999999999998865433221       233456678999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccC
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD-LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG  175 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~  175 (372)
                      +|+|..++.. ...+++..++.++.||+.||.|||+ .||+|          |||||+|||++.++.+||+|||+++...
T Consensus        79 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivH----------rDikp~NIll~~~~~~kL~Dfg~~~~~~  147 (325)
T cd05594          79 GGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVY----------RDLKLENLMLDKDGHIKITDFGLCKEGI  147 (325)
T ss_pred             CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEe----------cCCCCCeEEECCCCCEEEecCCCCeecC
Confidence            9999999877 5679999999999999999999997 79999          9999999999999999999999987543


Q ss_pred             CCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCC
Q psy11571        176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDV  255 (372)
Q Consensus       176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  255 (372)
                      .... ......||+.|+|||++.+     ..++.++|||||||++|+|++|..||.+.+..+....+....  ..+|.  
T Consensus       148 ~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~--~~~p~--  217 (325)
T cd05594         148 KDGA-TMKTFCGTPEYLAPEVLED-----NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPR--  217 (325)
T ss_pred             CCCc-ccccccCCcccCCHHHHcc-----CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC--CCCCC--
Confidence            2222 1223579999999999973     568899999999999999999999999988888777776543  33444  


Q ss_pred             CCCCCHHHHHHHHHhcc-CCCCCCCC--CChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccCCCCCcCCCCCCCC
Q psy11571        256 GYEISDDAKDLMRRLIC-SSDTRLGQ--NGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTD  330 (372)
Q Consensus       256 ~~~~s~~~~~li~~lL~-~p~~R~s~--~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~~~p~~p~~~~~~~  330 (372)
                        .+++++.+||++||+ ||++|++.  ..+.+++              +||||.+++|..+  +...+|+.|...+..+
T Consensus       218 --~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il--------------~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (325)
T cd05594         218 --TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIM--------------QHKFFAGIVWQDVYEKKLVPPFKPQVTSETD  281 (325)
T ss_pred             --CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHh--------------cCCCcCCCCHHHHHhCCCCCCcCCcCCCcch
Confidence              689999999999999 99999853  2456666              9999999999977  3466889999999999


Q ss_pred             CCCCCCCccccCCCCCCCCCCC--CcccccCCCCccCceeeC
Q psy11571        331 TSHFDVDEAGVRASDALPPAAA--SPALSALHLPFVGFTFTQ  370 (372)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  370 (372)
                      ...|+.........-..+...+  .+.-...+..|+++.|.+
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (325)
T cd05594         282 TRYFDEEFTAQMITITPPDQDDSMETVDNERRPHFPQFSYSA  323 (325)
T ss_pred             hhhcCchhhcCccccCCCcccccccccccccccccCCceecC
Confidence            9988866543221111111111  122234556777777754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0600|consensus

Probab=100.00  E-value=7.6e-49  Score=365.32  Aligned_cols=262  Identities=26%  Similarity=0.375  Sum_probs=226.8

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      +-|+.|+++|.|    .+|.||++++..+|+.||+|++.......+        ......+|+.||++++||||++|.+.
T Consensus       117 ~~feki~kIGeG----Tyg~VYkAr~~~tgkivALKKvr~d~~~~~--------~~~t~~REI~ILr~l~HpNIikL~ei  184 (560)
T KOG0600|consen  117 DSFEKIEKIGEG----TYGQVYKARDLETGKIVALKKVRFDNEKEG--------FPITAIREIKILRRLDHPNIIKLEEI  184 (560)
T ss_pred             HHHHHHHHhcCc----chhheeEeeecccCcEEEEEEeecccCCCc--------chHHHHHHHHHHHhcCCCcccceeeE
Confidence            468999999999    599999999999999999999887665543        34456789999999999999999999


Q ss_pred             EEeC--CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC
Q psy11571         82 FQDD--SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA  159 (372)
Q Consensus        82 ~~~~--~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~  159 (372)
                      ..+.  ..+|||+|||+. ||.-++....-.|++.+++.|+.||+.||+|||++||+|          ||||..|||||.
T Consensus       185 vt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlH----------RDIK~SNiLidn  253 (560)
T KOG0600|consen  185 VTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLH----------RDIKGSNILIDN  253 (560)
T ss_pred             EEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeee----------ccccccceEEcC
Confidence            8877  689999999954 999999885568999999999999999999999999999          999999999999


Q ss_pred             CCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHH
Q psy11571        160 NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY  239 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~  239 (372)
                      +|.+||+|||+|++.........+..+-|..|.|||++.+    ...|+.++|+||+||||.||++|++.|.+.++.+.+
T Consensus       254 ~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG----~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl  329 (560)
T KOG0600|consen  254 NGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLG----ATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQL  329 (560)
T ss_pred             CCCEEeccccceeeccCCCCcccccceEEeeccChHHhcC----CcccccceeehhhhHHHHHHHcCCCCcCCccHHHHH
Confidence            9999999999999876655444455677999999999996    678999999999999999999999999999999999


Q ss_pred             HHHhhccCCc--------CCCCC---------------CCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhc
Q psy11571        240 GKIMNHQNSF--------DLPSD---------------VGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVS  295 (372)
Q Consensus       240 ~~i~~~~~~~--------~~~~~---------------~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~  295 (372)
                      .+|.+--+.+        .+|..               ....++..+.+|+..||. ||.+|.||.+++           
T Consensus       330 ~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL-----------  398 (560)
T KOG0600|consen  330 HKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL-----------  398 (560)
T ss_pred             HHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh-----------
Confidence            8886532222        11100               013678999999999999 999999988887           


Q ss_pred             cCCCCCCCCCcC
Q psy11571        296 LSISPRNHPWFQ  307 (372)
Q Consensus       296 ~~~~~~~hp~f~  307 (372)
                            .|+||.
T Consensus       399 ------~seyF~  404 (560)
T KOG0600|consen  399 ------QSEYFT  404 (560)
T ss_pred             ------cCcccc
Confidence                  899994

>KOG0597|consensus

Probab=100.00  E-value=1.4e-49  Score=373.68  Aligned_cols=254  Identities=28%  Similarity=0.513  Sum_probs=228.6

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|-.++.+|.|    .+|+||++++..+.+.||+|.+.+.....        +.++.+++|+++++.++|||||.++++
T Consensus         2 e~yhv~e~iG~G----sfg~VYKgrrK~t~~~vAik~i~K~gr~~--------k~l~~l~~ev~i~r~lkHpniv~m~es   69 (808)
T KOG0597|consen    2 EQYHVYEMIGEG----SFGRVYKGRRKYTIQVVAIKFIDKSGRNE--------KELKNLRQEVRILRSLKHPNIVEMLES   69 (808)
T ss_pred             cchhHHHHhcCC----ccceeeecccccceeEEEEEEehhcCCch--------HHHHHHHHHHHHHHhcCCcchhhHHHh
Confidence            578889999988    79999999999999999999876654433        246779999999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      |++..++|+|+|||.| +|..++.. .+.++|+.++.++.+++.||.|||+++|+|          ||+||.|||++..|
T Consensus        70 fEt~~~~~vVte~a~g-~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilh----------rd~kPqniLl~~~~  137 (808)
T KOG0597|consen   70 FETSAHLWVVTEYAVG-DLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILH----------RDMKPQNILLEKGG  137 (808)
T ss_pred             hcccceEEEEehhhhh-hHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCccc----------ccCCcceeeecCCC
Confidence            9999999999999966 99999988 789999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .+|+||||+|+.++.... ......|||.|||||++.     ...|+..+|+||||||+|||++|++||...+..++...
T Consensus       138 ~~KlcdFg~Ar~m~~~t~-vltsikGtPlYmAPElv~-----e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~  211 (808)
T KOG0597|consen  138 TLKLCDFGLARAMSTNTS-VLTSIKGTPLYMAPELVE-----EQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKS  211 (808)
T ss_pred             ceeechhhhhhhcccCce-eeeeccCcccccCHHHHc-----CCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHH
Confidence            999999999998766433 344568999999999998     47899999999999999999999999999999999999


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      |......  .|.    ..|..++.||+.+|. ||.+|+++.+++                 .|||.++
T Consensus       212 I~~d~v~--~p~----~~S~~f~nfl~gLL~kdP~~RltW~~Ll-----------------~HpF~k~  256 (808)
T KOG0597|consen  212 ILKDPVK--PPS----TASSSFVNFLQGLLIKDPAQRLTWTDLL-----------------GHPFWKG  256 (808)
T ss_pred             HhcCCCC--Ccc----cccHHHHHHHHHHhhcChhhcccHHHHh-----------------cChHHhh
Confidence            9876433  344    689999999999999 999999988777                 9999886

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.3e-48  Score=359.90  Aligned_cols=274  Identities=28%  Similarity=0.519  Sum_probs=222.0

Q ss_pred             HHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe
Q psy11571          5 RELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQD   84 (372)
Q Consensus         5 ~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~   84 (372)
                      +.++.+|.|    |+|.||++....+++.||+|.+........       .....+.+|+.++..++||||+++++++.+
T Consensus         3 ~~~~~lg~G----~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-------~~~~~~~~E~~il~~l~~~~iv~~~~~~~~   71 (285)
T cd05631           3 RHYRVLGKG----GFGEVCACQVRATGKMYACKKLEKKRIKKR-------KGEAMALNEKRILEKVNSRFVVSLAYAYET   71 (285)
T ss_pred             eEEEEEecC----CCEEEEEEEEecCCceEEEEEeeHhhhhhh-------hhHHHHHHHHHHHHhcCCCcEEEEEEEEcc
Confidence            344455555    899999999999999999998765543322       122346679999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcE
Q psy11571         85 DSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI  163 (372)
Q Consensus        85 ~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~v  163 (372)
                      .+.+++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.||+|          |||||+|||+++++.+
T Consensus        72 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH----------~dikp~Nill~~~~~~  141 (285)
T cd05631          72 KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY----------RDLKPENILLDDRGHI  141 (285)
T ss_pred             CCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEe----------CCCCHHHEEECCCCCE
Confidence            99999999999999999888653 346899999999999999999999999999          9999999999999999


Q ss_pred             EEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHh
Q psy11571        164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM  243 (372)
Q Consensus       164 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~  243 (372)
                      +|+|||++........  .....||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.+.+.......+.
T Consensus       142 kl~Dfg~~~~~~~~~~--~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~  214 (285)
T cd05631         142 RISDLGLAVQIPEGET--VRGRVGTVGYMAPEVINN-----EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD  214 (285)
T ss_pred             EEeeCCCcEEcCCCCe--ecCCCCCCCccCHhhhcC-----CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH
Confidence            9999999987543222  223578999999999983     568999999999999999999999998765432222221


Q ss_pred             hc--cCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCC--ChhhhhhhhhhhhccCCCCCCCCCcCCCCccccc--c
Q psy11571        244 NH--QNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQN--GIADFKMWSALFVSLSISPRNHPWFQGIAWDSIR--D  316 (372)
Q Consensus       244 ~~--~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~--~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~--~  316 (372)
                      ..  .....++.    .+++++.+||++||+ ||.+|+++.  .+.+++              +||||++++|+.+.  .
T Consensus       215 ~~~~~~~~~~~~----~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~--------------~h~~~~~~~~~~~~~~~  276 (285)
T cd05631         215 RRVKEDQEEYSE----KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVK--------------QHPIFKNINFKRLEANM  276 (285)
T ss_pred             HHhhcccccCCc----cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHh--------------cCHhhcCCCHHHHHhCc
Confidence            11  11122232    689999999999999 999999853  467777              99999999999994  4


Q ss_pred             CCCCCcCC
Q psy11571        317 SNAPYIPE  324 (372)
Q Consensus       317 ~~~p~~p~  324 (372)
                      ..|||.|.
T Consensus       277 ~~~~~~~~  284 (285)
T cd05631         277 LEPPFCPD  284 (285)
T ss_pred             CCcCCCCC
Confidence            58899985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0198|consensus

Probab=100.00  E-value=9.3e-49  Score=358.69  Aligned_cols=257  Identities=26%  Similarity=0.405  Sum_probs=212.3

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      +...+-+|.|    .+|+||.+....++...|+|.+......          ..+.+.+|+.+|..++|||||++++...
T Consensus        19 ~~~~~~lG~G----s~G~V~l~~~~~~g~~~AvK~v~~~~~~----------~~~~l~~Ei~iL~~l~~p~IV~~~G~~~   84 (313)
T KOG0198|consen   19 WSKGKLLGRG----SFGSVYLATNKKTGELMAVKSVELEDSP----------TSESLEREIRILSRLNHPNIVQYYGSSS   84 (313)
T ss_pred             hhhhccccCc----cceEEEEEEecCCCcceeeeeeecccch----------hHHHHHHHHHHHHhCCCCCEEeeCCccc
Confidence            4444555555    7999999999888999999988776211          1566889999999999999999999755


Q ss_pred             eCC--eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC-C
Q psy11571         84 DDS--NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA-N  160 (372)
Q Consensus        84 ~~~--~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~-~  160 (372)
                      ...  .++++|||+++|+|.+++.+.++.++|..++.+++||+.||+|||++||+|          |||||+|||++. +
T Consensus        85 ~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH----------~DiK~~NiLl~~~~  154 (313)
T KOG0198|consen   85 SRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVH----------CDIKPANILLDPSN  154 (313)
T ss_pred             cccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEec----------cCcccceEEEeCCC
Confidence            544  699999999999999999986558999999999999999999999999999          999999999999 7


Q ss_pred             CcEEEeecCcccccCC--CCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCC-CCHHH
Q psy11571        161 GHIRLADFGSCLRLGG--DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVE  237 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~-~~~~~  237 (372)
                      +.+||+|||+++....  ..........||+.|||||++..    .....+++|||||||++.||+||++||.. ....+
T Consensus       155 ~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~----g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~  230 (313)
T KOG0198|consen  155 GDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRN----GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAE  230 (313)
T ss_pred             CeEEeccCccccccccccccccccccccCCccccCchhhcC----CCcCCccchhhhcCCEEEeccCCCCcchhhcchHH
Confidence            9999999999987663  11112334789999999999983    11233599999999999999999999987 45555


Q ss_pred             HHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       238 ~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      ....+......+.+|.    .+|+++++||.+|+. +|++||||++++                 .|||.+..
T Consensus       231 ~~~~ig~~~~~P~ip~----~ls~~a~~Fl~~C~~~~p~~Rpta~eLL-----------------~hpf~~~~  282 (313)
T KOG0198|consen  231 ALLLIGREDSLPEIPD----SLSDEAKDFLRKCFKRDPEKRPTAEELL-----------------EHPFLKQN  282 (313)
T ss_pred             HHHHHhccCCCCCCCc----ccCHHHHHHHHHHhhcCcccCcCHHHHh-----------------hChhhhcc
Confidence            5555655544445555    799999999999999 999999988777                 99999854

>KOG0599|consensus

Probab=100.00  E-value=8.2e-50  Score=346.15  Aligned_cols=263  Identities=27%  Similarity=0.410  Sum_probs=224.2

Q ss_pred             CccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCeEEEEEeccCC
Q psy11571         19 KGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLHYAFQDDSNLYLVMDYYCG   97 (372)
Q Consensus        19 ~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv~E~~~g   97 (372)
                      ...|..+....+++.+|+|.+...........  ..+..+..++|+.+|+++. ||+|+++.++|+++..+++|+|.|+.
T Consensus        30 ss~vrRci~k~t~~e~a~kii~~~at~~~~e~--~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~pr  107 (411)
T KOG0599|consen   30 SSVVRRCIHKETGKEFAVKIIDVTATTESGET--PYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPR  107 (411)
T ss_pred             hhhhhhhhhcccccceeEEEEEecccccCCcc--HHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhccc
Confidence            33455555667889999998876554433222  3456677889999999974 99999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCC
Q psy11571         98 GDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD  177 (372)
Q Consensus        98 g~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  177 (372)
                      |.|.+++.. .-.++|.+++.+++|++.|++|||.++|||          |||||+|||++++.++||+|||+|..+..+
T Consensus       108 GELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~IVH----------RDLKpENILlddn~~i~isDFGFa~~l~~G  176 (411)
T KOG0599|consen  108 GELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARNIVH----------RDLKPENILLDDNMNIKISDFGFACQLEPG  176 (411)
T ss_pred             chHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhhhhh----------cccChhheeeccccceEEeccceeeccCCc
Confidence            999999987 578999999999999999999999999999          999999999999999999999999988765


Q ss_pred             CcccccccccCCcccCccccc-ccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCC
Q psy11571        178 GTVQSNVAVGTPDYISPEILT-AMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVG  256 (372)
Q Consensus       178 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  256 (372)
                      ...  ...||||+|+|||.+. ++.++...|+..+|+||+|||+|.|+.|.+||......-++..|+.+...+..|  .|
T Consensus       177 ekL--relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp--eW  252 (411)
T KOG0599|consen  177 EKL--RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP--EW  252 (411)
T ss_pred             hhH--HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc--ch
Confidence            543  3479999999999986 344556779999999999999999999999999999999999999977655544  45


Q ss_pred             CCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccccc
Q psy11571        257 YEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIR  315 (372)
Q Consensus       257 ~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~  315 (372)
                      .++|...+|||++||+ ||.+|+|+++++                 .||||..+-.+..+
T Consensus       253 adis~~~KdLIsrlLqVdp~~Ritake~L-----------------aHpff~q~~~~~~r  295 (411)
T KOG0599|consen  253 ADISATVKDLISRLLQVDPTKRITAKEAL-----------------AHPFFIQIAQQQAR  295 (411)
T ss_pred             hhccccHHHHHHHHHeeCchhcccHHHHh-----------------cChHHHHHHHhccc
Confidence            5899999999999999 999999988777                 99999766544333

>KOG0578|consensus

Probab=100.00  E-value=7.8e-49  Score=370.57  Aligned_cols=254  Identities=26%  Similarity=0.485  Sum_probs=225.0

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|....+.|.|    ..|.||.++...+++.||+|.+......+.          +-+.+|+.+|+..+|+|||++++.
T Consensus       273 ~~y~~~~kigqg----aSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k----------eLilnEi~Vm~~~~H~NiVnfl~S  338 (550)
T KOG0578|consen  273 SKYTDFKKIGQG----ATGGVYVARKISTKQEVAIKRMDLRKQPKK----------ELLLNEILVMRDLHHPNIVNFLDS  338 (550)
T ss_pred             hhhcchhhhccc----cccceeeeeeccCCceEEEEEEEeccCCch----------hhhHHHHHHHHhccchHHHHHHHH
Confidence            356667777776    689999999999999999999988877665          446789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      |.-.+.+|+||||++||+|.+.+..  ..++|.++..++++++.||+|||.+||+|          ||||.+|||++.+|
T Consensus       339 ylv~deLWVVMEym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiH----------rDIKSDnILL~~~g  406 (550)
T KOG0578|consen  339 YLVGDELWVVMEYMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIH----------RDIKSDNILLTMDG  406 (550)
T ss_pred             hcccceeEEEEeecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceee----------eccccceeEeccCC
Confidence            9999999999999999999999987  67999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .+||+|||+|..+..... ...+.+|||.|||||++.     +..|++++||||||+++.||+-|++||...++...+..
T Consensus       407 ~vKltDFGFcaqi~~~~~-KR~TmVGTPYWMAPEVvt-----rk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL  480 (550)
T KOG0578|consen  407 SVKLTDFGFCAQISEEQS-KRSTMVGTPYWMAPEVVT-----RKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL  480 (550)
T ss_pred             cEEEeeeeeeeccccccC-ccccccCCCCccchhhhh-----hcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH
Confidence            999999999998876554 455689999999999998     57899999999999999999999999998877766666


Q ss_pred             Hhhc-cCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        242 IMNH-QNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       242 i~~~-~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      |... ...+..+.    .+|+.++|||.+||+ |+++|++|.+++                 .||||+-
T Consensus       481 Ia~ng~P~lk~~~----klS~~~kdFL~~cL~~dv~~RasA~eLL-----------------~HpFl~~  528 (550)
T KOG0578|consen  481 IATNGTPKLKNPE----KLSPELKDFLDRCLVVDVEQRASAKELL-----------------EHPFLKM  528 (550)
T ss_pred             HhhcCCCCcCCcc----ccCHHHHHHHHHHhhcchhcCCCHHHHh-----------------cChhhhh
Confidence            6543 34444444    799999999999999 999999988877                 9999964

>KOG0659|consensus

Probab=100.00  E-value=9.8e-48  Score=332.16  Aligned_cols=262  Identities=25%  Similarity=0.359  Sum_probs=226.9

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      .||..++.+|.|    .+|.||++.+..+|+.||+|+++.......        .-....+|+..|+.++||||+.+.++
T Consensus         2 ~rY~~~~~lGEG----~~gvVyka~d~~t~~~VAIKKIkl~~~kdG--------i~~talREIK~Lqel~h~nIi~LiD~   69 (318)
T KOG0659|consen    2 DRYEKLEKLGEG----TYGVVYKARDTETGKRVAIKKIKLGNAKDG--------INRTALREIKLLQELKHPNIIELIDV   69 (318)
T ss_pred             chhhhhhhhcCc----ceEEEEEEEecCCCcEEEEEEeeccccccC--------ccHHHHHHHHHHHHccCcchhhhhhh
Confidence            689999999999    699999999999999999999988755433        11235679999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      |.+.+.+.+|+||++ .||...++.....++...++.|+.+++.||+|||++.|+|          |||||.|+|++++|
T Consensus        70 F~~~~~l~lVfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlH----------RDlKPnNLLis~~g  138 (318)
T KOG0659|consen   70 FPHKSNLSLVFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILH----------RDLKPNNLLISSDG  138 (318)
T ss_pred             ccCCCceEEEEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhc----------ccCCccceEEcCCC
Confidence            999999999999995 5999999987778999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .+||+|||+|+............ +-|..|.|||.+.+    .+.|+..+|+||.|||+.||+.|.+-|.|.++.+.+..
T Consensus       139 ~lKiADFGLAr~f~~p~~~~~~~-V~TRWYRAPELLfG----sr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~  213 (318)
T KOG0659|consen  139 QLKIADFGLARFFGSPNRIQTHQ-VVTRWYRAPELLFG----SRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSK  213 (318)
T ss_pred             cEEeecccchhccCCCCcccccc-eeeeeccChHHhcc----chhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHH
Confidence            99999999999987665544332 56999999999995    68899999999999999999999999999999988888


Q ss_pred             HhhccCCcC---CCCC-------------------CCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCC
Q psy11571        242 IMNHQNSFD---LPSD-------------------VGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSI  298 (372)
Q Consensus       242 i~~~~~~~~---~~~~-------------------~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~  298 (372)
                      |.+.-+.+.   +|..                   .....+.++.||+.+||. ||.+|+++.+++              
T Consensus       214 If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL--------------  279 (318)
T KOG0659|consen  214 IFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQAL--------------  279 (318)
T ss_pred             HHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHh--------------
Confidence            765322221   1110                   123567899999999999 999999988877              


Q ss_pred             CCCCCCCcCC
Q psy11571        299 SPRNHPWFQG  308 (372)
Q Consensus       299 ~~~~hp~f~~  308 (372)
                         +|+||+.
T Consensus       280 ---~~~yf~~  286 (318)
T KOG0659|consen  280 ---KHPYFKS  286 (318)
T ss_pred             ---cchhhhc
Confidence               9999984

>KOG0611|consensus

Probab=100.00  E-value=1.4e-47  Score=347.96  Aligned_cols=248  Identities=29%  Similarity=0.452  Sum_probs=222.4

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      .||+..+.+|.|    .+|.|-+++....|+.||+|.+.+.....+.       .+-.+++|+++|+.++||||+++|.+
T Consensus        53 HRyE~~etLGkG----TYGKVk~A~e~~sgR~VAiKsIrKdkIkdeq-------DlvhIRREIeIMSsLNHPhII~IyEV  121 (668)
T KOG0611|consen   53 HRYEITETLGKG----TYGKVKLAYEHKSGREVAIKSIRKDKIKDEQ-------DLVHIRREIEIMSSLNHPHIIQIYEV  121 (668)
T ss_pred             hHHHHHHHhcCC----cccceeehhhccCCcEeehhhhhhhhcccHH-------HHHHHHHHHHHHhhcCCCceeehhhh
Confidence            489999999998    5999999988889999999999888776652       34568999999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      |+..+.+.+||||..+|.|++|+.. .+.++|.+++.+++||+.|+.|||.++++|          ||||.+|||+|.++
T Consensus       122 FENkdKIvivMEYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHknrVvH----------RDLKLENILLD~N~  190 (668)
T KOG0611|consen  122 FENKDKIVIVMEYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKNRVVH----------RDLKLENILLDQNN  190 (668)
T ss_pred             hcCCceEEEEEEecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhcccee----------cccchhheeecCCC
Confidence            9999999999999999999999998 589999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      ++||+|||++.........  .++||+|.|.+||++.+    ...-++.+|.|||||+||.|+.|..||.+.+...+..+
T Consensus       191 NiKIADFGLSNly~~~kfL--qTFCGSPLYASPEIvNG----~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQ  264 (668)
T KOG0611|consen  191 NIKIADFGLSNLYADKKFL--QTFCGSPLYASPEIVNG----TPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQ  264 (668)
T ss_pred             CeeeeccchhhhhccccHH--HHhcCCcccCCccccCC----CCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHH
Confidence            9999999999877654433  45899999999999985    45558899999999999999999999999999999999


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      |.++...  -|     .-+.++.-||+.||. ||++|.|.+++.
T Consensus       265 Is~GaYr--EP-----~~PSdA~gLIRwmLmVNP~RRATieDiA  301 (668)
T KOG0611|consen  265 ISRGAYR--EP-----ETPSDASGLIRWMLMVNPERRATIEDIA  301 (668)
T ss_pred             hhccccc--CC-----CCCchHHHHHHHHHhcCcccchhHHHHh
Confidence            9886533  23     346789999999999 999999977766

>KOG0585|consensus

Probab=100.00  E-value=5.1e-48  Score=357.15  Aligned_cols=268  Identities=28%  Similarity=0.490  Sum_probs=220.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHH----HHHHHHHHHHHHHHhcCCCCceeee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDF----IEFVAKLREERDVLVYGDRRWITNL   78 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~----~~~~~~l~~E~~il~~l~hp~Iv~l   78 (372)
                      +|+.+.++|.|    .+|.|-++++..+++.||+|.+.+....+...+.+.    +..++++++|+.+|+++.|||||+|
T Consensus        98 qy~l~~eiG~G----~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   98 QYELIKEIGSG----QYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             heehhhhhcCC----ccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            46777777777    689999999999999999999988887766444332    2345789999999999999999999


Q ss_pred             eEEEEeC--CeEEEEEeccCCCCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcE
Q psy11571         79 HYAFQDD--SNLYLVMDYYCGGDLLTLLSKFEDR-LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNV  155 (372)
Q Consensus        79 ~~~~~~~--~~~~lv~E~~~gg~L~~~l~~~~~~-l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NI  155 (372)
                      +++..+.  +.+|||+|||..|.+...-..  .. +++.+++.|+++++.||+|||.+||||          |||||.|+
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d--~~els~~~Ar~ylrDvv~GLEYLH~QgiiH----------RDIKPsNL  241 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPD--KPELSEQQARKYLRDVVLGLEYLHYQGIIH----------RDIKPSNL  241 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCCC--cccccHHHHHHHHHHHHHHHHHHHhcCeec----------cccchhhe
Confidence            9999876  579999999998887654332  34 899999999999999999999999999          99999999


Q ss_pred             EeCCCCcEEEeecCcccccCCCC----cccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCC
Q psy11571        156 LLDANGHIRLADFGSCLRLGGDG----TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY  231 (372)
Q Consensus       156 ll~~~~~vkl~Dfg~a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~  231 (372)
                      |++++|+|||+|||.+.......    ...-....|||.|+|||.+.+.. +....+.+.||||+||+||.|+.|+.||.
T Consensus       242 Ll~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~-~~~~~g~a~DiWalGVTLYCllfG~~PF~  320 (576)
T KOG0585|consen  242 LLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGN-SFSYSGFALDIWALGVTLYCLLFGQLPFF  320 (576)
T ss_pred             EEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCC-CccccchhhhhhhhhhhHHHhhhccCCcc
Confidence            99999999999999987652211    11112257999999999998421 12334779999999999999999999999


Q ss_pred             CCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        232 AESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       232 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      ++...+++.+|.+...  .+|...  .+.++++|||.+||+ ||++|++..+   |+              .|||...
T Consensus       321 ~~~~~~l~~KIvn~pL--~fP~~p--e~~e~~kDli~~lL~KdP~~Ri~l~~---ik--------------~Hpwvt~  377 (576)
T KOG0585|consen  321 DDFELELFDKIVNDPL--EFPENP--EINEDLKDLIKRLLEKDPEQRITLPD---IK--------------LHPWVTR  377 (576)
T ss_pred             cchHHHHHHHHhcCcc--cCCCcc--cccHHHHHHHHHHhhcChhheeehhh---he--------------ecceecc
Confidence            9999999999998654  444422  579999999999999 9999997554   44              9999763

>KOG0663|consensus

Probab=100.00  E-value=2.3e-46  Score=332.94  Aligned_cols=262  Identities=21%  Similarity=0.339  Sum_probs=220.9

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.|+.+..|    .+|.||.+++..++..||+|.++...-...-.        -.-.+|+.+|.+++|||||.+-.+
T Consensus        76 ~efe~lnrI~EG----tyGiVYRakdk~t~eIVALKr~kmekek~GFP--------ItsLREIniLl~~~H~NIV~vkEV  143 (419)
T KOG0663|consen   76 EEFEKLNRIEEG----TYGVVYRAKDKKTDEIVALKRLKMEKEKEGFP--------ITSLREINILLKARHPNIVEVKEV  143 (419)
T ss_pred             HHHHHHhhcccC----cceeEEEeccCCcceeEEeeecccccccCCCc--------chhHHHHHHHHhcCCCCeeeeEEE
Confidence            478899998888    69999999999999999999998776332211        113569999999999999999998


Q ss_pred             EEeC--CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC
Q psy11571         82 FQDD--SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA  159 (372)
Q Consensus        82 ~~~~--~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~  159 (372)
                      ....  +.+|+|||||+. ||.+++.+...++...+++.++.|++.|++|||.+.|+|          |||||+|+|++.
T Consensus       144 VvG~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilH----------RDLK~SNLLm~~  212 (419)
T KOG0663|consen  144 VVGSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILH----------RDLKTSNLLLSH  212 (419)
T ss_pred             EeccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEe----------cccchhheeecc
Confidence            7644  579999999955 999999987779999999999999999999999999999          999999999999


Q ss_pred             CCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHH
Q psy11571        160 NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY  239 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~  239 (372)
                      .|.+||+|||+|+..++.... .+..+-|..|.|||++.+    ...|+.++|+||+|||+.||+++++.|.+.++.+.+
T Consensus       213 ~G~lKiaDFGLAR~ygsp~k~-~T~lVVTLWYRaPELLLG----~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl  287 (419)
T KOG0663|consen  213 KGILKIADFGLAREYGSPLKP-YTPLVVTLWYRAPELLLG----AKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQL  287 (419)
T ss_pred             CCcEEecccchhhhhcCCccc-CcceEEEeeecCHHHhcC----CcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHH
Confidence            999999999999998765432 233566999999999996    678999999999999999999999999999999988


Q ss_pred             HHHhhccCCcC-----------------CCCC--------C-CCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhh
Q psy11571        240 GKIMNHQNSFD-----------------LPSD--------V-GYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSAL  292 (372)
Q Consensus       240 ~~i~~~~~~~~-----------------~~~~--------~-~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~  292 (372)
                      .+|.+.-..+.                 ++..        . ...+++...+|+..||. ||.+|.||++.+        
T Consensus       288 ~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L--------  359 (419)
T KOG0663|consen  288 DKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGL--------  359 (419)
T ss_pred             HHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhh--------
Confidence            88864221110                 0100        0 01267999999999999 999999998887        


Q ss_pred             hhccCCCCCCCCCcCC
Q psy11571        293 FVSLSISPRNHPWFQG  308 (372)
Q Consensus       293 ~~~~~~~~~~hp~f~~  308 (372)
                               +|.||..
T Consensus       360 ---------~h~~F~e  366 (419)
T KOG0663|consen  360 ---------KHEYFRE  366 (419)
T ss_pred             ---------ccccccc
Confidence                     9999985

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.8e-46  Score=343.51  Aligned_cols=265  Identities=29%  Similarity=0.542  Sum_probs=215.1

Q ss_pred             ccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         16 IQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        16 ~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      .||+|.||.+.+..+++.+|+|.+........       ...+.+..|+.+++.++||||+++.+++.+...+|+||||+
T Consensus         3 ~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~-------~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~   75 (280)
T cd05608           3 KGGFGEVSACQMRATGKLYACKKLNKKRLKKR-------KGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIM   75 (280)
T ss_pred             CCCceeEEEEEEccCCcEEEEEeeeHHHHhhh-------HHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCC
Confidence            35899999999999999999998765433222       23355678999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCccc
Q psy11571         96 CGGDLLTLLSKF---EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCL  172 (372)
Q Consensus        96 ~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~  172 (372)
                      ++|+|..++...   ...+++..++.++.||+.||.|||++||+|          |||||+||+++.++.++|+|||++.
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H----------~dlkp~Nili~~~~~~~l~dfg~~~  145 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY----------RDLKPENVLLDNDGNVRISDLGLAV  145 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------CCCCHHHEEECCCCCEEEeeCccce
Confidence            999999887532   346899999999999999999999999999          9999999999999999999999997


Q ss_pred             ccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH----HHHHHHhhccCC
Q psy11571        173 RLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV----ETYGKIMNHQNS  248 (372)
Q Consensus       173 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~----~~~~~i~~~~~~  248 (372)
                      ....... ......||+.|+|||++.+     ..++.++|+|||||++|+|++|+.||......    .....+...  .
T Consensus       146 ~~~~~~~-~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~  217 (280)
T cd05608         146 ELKDGQS-KTKGYAGTPGFMAPELLQG-----EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--S  217 (280)
T ss_pred             ecCCCCc-cccccCCCcCccCHHHhcC-----CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--C
Confidence            6543322 2233578999999999983     56889999999999999999999999865432    222233222  1


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCC--ChhhhhhhhhhhhccCCCCCCCCCcCCCCcccccc--CCCCCcC
Q psy11571        249 FDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQN--GIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRD--SNAPYIP  323 (372)
Q Consensus       249 ~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~--~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~~--~~~p~~p  323 (372)
                      ...+.    .++.++.+++.+||+ ||++|++++  .+.+++              +||||++++|+.+..  ..+|+.|
T Consensus       218 ~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l--------------~h~~~~~~~~~~~~~~~~~~~~~~  279 (280)
T cd05608         218 VTYPD----KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLR--------------THPLFRDLNWRQLEAGMLPPPFVP  279 (280)
T ss_pred             CCCcc----cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHh--------------cChhhhcCCHhHHhhccCCCCCCC
Confidence            22232    689999999999999 999999764  356666              999999999998743  4566665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0582|consensus

Probab=100.00  E-value=7.8e-47  Score=347.17  Aligned_cols=264  Identities=25%  Similarity=0.413  Sum_probs=222.3

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+..+++|.|    ..+.||.++....+..||||.++....+.+         ++.+++|+..++.++||||++++.+|.
T Consensus        28 YeL~e~IG~G----~sa~V~~A~c~p~~e~VAIK~inLEkc~~~---------ld~l~kE~~~msl~~HPNIv~~~~sFv   94 (516)
T KOG0582|consen   28 YELQEVIGVG----ASAVVYLARCIPTNEVVAIKIINLEKCNND---------LDALRKEVQTMSLIDHPNIVTYHCSFV   94 (516)
T ss_pred             eeEEEEEecc----ceeEeeeeeecccCCEEEEEEeehhhhhhh---------HHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence            4455555665    347899999999999999998887666543         677899999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+..+|+||.||.+|++.++++.. ...++|..+..++++++.||.|||.+|.||          ||||+.||||+.+|.
T Consensus        95 v~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IH----------RdvKAgnILi~~dG~  164 (516)
T KOG0582|consen   95 VDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIH----------RDVKAGNILIDSDGT  164 (516)
T ss_pred             ecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCcee----------cccccccEEEcCCCc
Confidence            999999999999999999999875 457999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCc--ccc-cccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGT--VQS-NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY  239 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~--~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~  239 (372)
                      |||+|||.+..+-..+.  ... +++.||++|||||+++..   -..|+.|+||||||++..||.+|..||....+.+++
T Consensus       165 VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~---~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL  241 (516)
T KOG0582|consen  165 VKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQ---LHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL  241 (516)
T ss_pred             EEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhc---ccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH
Confidence            99999998766543332  112 567899999999997643   345899999999999999999999999999888877


Q ss_pred             HHHhhccCCc----CCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCC
Q psy11571        240 GKIMNHQNSF----DLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       240 ~~i~~~~~~~----~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~  310 (372)
                      ..-+++.++.    .++.+....++..++.+|..||+ ||.+||||++++                 +|+||+...
T Consensus       242 l~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLl-----------------kh~FFk~~k  300 (516)
T KOG0582|consen  242 LLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLL-----------------KHAFFKKAK  300 (516)
T ss_pred             HHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHh-----------------ccHHHhhcc
Confidence            6666654321    12223334678899999999999 999999988877                 999999764

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=9.3e-46  Score=341.08  Aligned_cols=265  Identities=28%  Similarity=0.488  Sum_probs=213.4

Q ss_pred             ccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         16 IQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        16 ~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      .||+|.||++....+++.+|+|.+........       ...+.+..|+.+++.++||||+++++++.++..+|+||||+
T Consensus         3 ~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-------~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~   75 (277)
T cd05607           3 KGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK-------SGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLM   75 (277)
T ss_pred             CCCceEEEEEEEccCCcEEEEEEEcHHHhhcc-------hhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecC
Confidence            35899999999999999999998865443221       11223456899999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCccccc
Q psy11571         96 CGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL  174 (372)
Q Consensus        96 ~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~  174 (372)
                      +|++|.+++... ...+++..+..++.||+.||+|||+.|++|          |||||+||+++.++.++|+|||++...
T Consensus        76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH----------~dikp~Nili~~~~~~~l~Dfg~~~~~  145 (277)
T cd05607          76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVY----------RDMKPENVLLDDQGNCRLSDLGLAVEL  145 (277)
T ss_pred             CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEE----------ccCChHhEEEcCCCCEEEeeceeeeec
Confidence            999999988653 235889999999999999999999999999          999999999999999999999998776


Q ss_pred             CCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCH----HHHHHHHhhccCCcC
Q psy11571        175 GGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL----VETYGKIMNHQNSFD  250 (372)
Q Consensus       175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~  250 (372)
                      .....  .....|++.|+|||++.+     ..++.++|+|||||++|+|++|..||.....    .+....+.....  .
T Consensus       146 ~~~~~--~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~  216 (277)
T cd05607         146 KDGKT--ITQRAGTNGYMAPEILKE-----EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV--K  216 (277)
T ss_pred             CCCce--eeccCCCCCccCHHHHcc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccc--c
Confidence            44322  223568999999999973     4589999999999999999999999976533    233333333221  1


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCC-hhhhhhhhhhhhccCCCCCCCCCcCCCCccccc--cCCCCCcC
Q psy11571        251 LPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNG-IADFKMWSALFVSLSISPRNHPWFQGIAWDSIR--DSNAPYIP  323 (372)
Q Consensus       251 ~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~-~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~--~~~~p~~p  323 (372)
                      .+   ...+++++++||++||+ ||++||++.+ +.+++              .||||++++|..+.  ...+||.|
T Consensus       217 ~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~--------------~h~~f~~~~~~~~~~~~~~~~~~~  276 (277)
T cd05607         217 FE---HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR--------------KHEFFKTINFPRLEAGLIPPPFVP  276 (277)
T ss_pred             cc---cccCCHHHHHHHHHHhccCHhhCCCCccchhhhh--------------cChhhcCCCHHHHhcCcCCCCCCC
Confidence            11   12579999999999999 9999999865 34555              99999999999885  44667766

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-46  Score=343.19  Aligned_cols=275  Identities=28%  Similarity=0.518  Sum_probs=222.0

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+.++.++.|    ++|.||++....+++.||+|.+........       .....+.+|+.+++.++||||+++++++.
T Consensus         2 y~~~~~lg~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   70 (285)
T cd05605           2 FRHYRVLGKG----GFGEVCACQVRATGKMYACKKLEKKRIKKR-------KGEAMALNEKQILEKVNSRFVVSLAYAYE   70 (285)
T ss_pred             ceEEEEEecC----CCeEEEEEEEcCCCceEEEEEEehhhhhhh-------hhHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4555666666    899999999888999999998865443322       12344667999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      +++.+++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.|++|          |||||+||++++++.
T Consensus        71 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH----------~dlkp~Nil~~~~~~  140 (285)
T cd05605          71 TKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY----------RDLKPENILLDDYGH  140 (285)
T ss_pred             CCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEe----------cCCCHHHEEECCCCC
Confidence            999999999999999999988653 346899999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      ++|+|||++........  .....|++.|+|||++.     ...++.++|+||+||++|+|++|..||.+.+.......+
T Consensus       141 ~~l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~-----~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~  213 (285)
T cd05605         141 IRISDLGLAVEIPEGET--IRGRVGTVGYMAPEVVK-----NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV  213 (285)
T ss_pred             EEEeeCCCceecCCCCc--cccccCCCCccCcHHhc-----CCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH
Confidence            99999999977543322  12357899999999997     356889999999999999999999999887654433333


Q ss_pred             hhcc--CCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCC--ChhhhhhhhhhhhccCCCCCCCCCcCCCCcccccc-
Q psy11571        243 MNHQ--NSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQN--GIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRD-  316 (372)
Q Consensus       243 ~~~~--~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~--~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~~-  316 (372)
                      ....  .....+.    .++..+.+||.+||. ||++||+..  .+.+++              .||||...+|+.+.+ 
T Consensus       214 ~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~--------------~~~~~~~~~~~~~~~~  275 (285)
T cd05605         214 ERRVKEDQEEYSE----KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVK--------------AHPFFRTANFKRLEAG  275 (285)
T ss_pred             HHHhhhcccccCc----ccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHh--------------cCcCccCCCHHHHhhC
Confidence            2211  1112222    589999999999999 999999654  455666              999999999998843 


Q ss_pred             -CCCCCcCC
Q psy11571        317 -SNAPYIPE  324 (372)
Q Consensus       317 -~~~p~~p~  324 (372)
                       .+|||.|.
T Consensus       276 ~~~~~~~~~  284 (285)
T cd05605         276 MLEPPFCPD  284 (285)
T ss_pred             CCCCCCCCC
Confidence             56788873

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0032|consensus

Probab=100.00  E-value=6.1e-46  Score=352.46  Aligned_cols=259  Identities=32%  Similarity=0.493  Sum_probs=227.8

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeeeEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLHYA   81 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~~~   81 (372)
                      .|+....+|.|    .||.||.+....+|+.+|+|.+.+.......       ..+.+.+|+.+|+++. |||||.++++
T Consensus        36 ~Y~l~~~lG~G----~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~-------~~~~v~~Ev~il~~l~~hpniv~l~~~  104 (382)
T KOG0032|consen   36 KYELGRELGRG----QFGVVYLCREKSTGKEVACKVIPKRKLRGKE-------DREDVRREVAILQQLSGHPNIVQLKDA  104 (382)
T ss_pred             cEEehhhhCCC----CceEEEEEEecCCCceeEEEEeehhhccccc-------cHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            34455566666    7999999999999999999999887776542       3456889999999998 9999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC-
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-  160 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~-  160 (372)
                      |++...+++|||+|.||.|.+.+...  .++|..+..++.|++.++.|||+.|++|          |||||+|+|+... 
T Consensus       105 ~e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvH----------rDlKpEN~L~~~~~  172 (382)
T KOG0032|consen  105 FEDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVH----------RDLKPENLLLASKD  172 (382)
T ss_pred             EEcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCcee----------ccCCHHHeeecccc
Confidence            99999999999999999999999874  4999999999999999999999999999          9999999999633 


Q ss_pred             ---CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHH
Q psy11571        161 ---GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE  237 (372)
Q Consensus       161 ---~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~  237 (372)
                         +.+|++|||++.......  .....+||+.|+|||++.     ...|+..+|+||+||++|.|++|.+||.+.+...
T Consensus       173 ~~~~~ik~~DFGla~~~~~~~--~~~~~~Gtp~y~APEvl~-----~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~  245 (382)
T KOG0032|consen  173 EGSGRIKLIDFGLAKFIKPGE--RLHTIVGTPEYVAPEVLG-----GRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE  245 (382)
T ss_pred             CCCCcEEEeeCCCceEccCCc--eEeeecCCccccCchhhc-----CCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH
Confidence               479999999999887622  345589999999999998     3679999999999999999999999999999999


Q ss_pred             HHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCC
Q psy11571        238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       238 ~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~  310 (372)
                      .+.+|..+..  .++...+..+|..+++||++||. ||.+|+++.+++                 +|||+++..
T Consensus       246 ~~~~i~~~~~--~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L-----------------~HpWi~~~~  300 (382)
T KOG0032|consen  246 IFLAILRGDF--DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQAL-----------------QHPWIKSIG  300 (382)
T ss_pred             HHHHHHcCCC--CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHh-----------------cCccccCCc
Confidence            9999998765  45556666899999999999999 999999988777                 899998753

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.7e-45  Score=341.45  Aligned_cols=283  Identities=41%  Similarity=0.757  Sum_probs=239.8

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.++.|    |+|.||.+....+++.+|+|.+.......       .+..+.+.+|+.+++.++||||+++++++
T Consensus         2 ~y~~~~~ig~g----~~~~vy~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   70 (290)
T cd05580           2 DFEFIKTLGTG----SFGRVMLVRHKGSGKYYALKILSKAKIVK-------LKQVEHVLNEKRILQSIRHPFLVNLYGSF   70 (290)
T ss_pred             ceEEEEEeecC----CCeEEEEEEEcCCCCEEEEEEEEHHHhhh-------hhHHHHHHHHHHHHHhCCCCCccceeeEE
Confidence            45556666666    89999999998899999999876543322       12346678899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+...+|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.|++|          +||+|.||+++.++.
T Consensus        71 ~~~~~~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~~i~H----------~dl~p~nili~~~~~  139 (290)
T cd05580          71 QDDSNLYLVMEYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSLDIVY----------RDLKPENLLLDSDGY  139 (290)
T ss_pred             EcCCeEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEec----------CCCCHHHEEECCCCC
Confidence            999999999999999999999987 478999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      ++|+|||++......    .....|++.|+|||.+.+     ...+.++|+||||+++|+|++|..||...+..+...++
T Consensus       140 ~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  210 (290)
T cd05580         140 IKITDFGFAKRVKGR----TYTLCGTPEYLAPEIILS-----KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI  210 (290)
T ss_pred             EEEeeCCCccccCCC----CCCCCCCccccChhhhcC-----CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999876443    223568999999999873     45788999999999999999999999988877777777


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCC--CChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQ--NGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDS  317 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~--~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~  317 (372)
                      ..+.  ..+|.    .++..++++|++||. +|.+|++.  ..+.+++              .||||+.++|..+  ...
T Consensus       211 ~~~~--~~~~~----~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~--------------~~~~~~~~~~~~~~~~~~  270 (290)
T cd05580         211 LEGK--VRFPS----FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK--------------NHPWFAGIDWIALLQRKI  270 (290)
T ss_pred             hcCC--ccCCc----cCCHHHHHHHHHHccCCHHHccCcccCCHHHHH--------------cCcccccCCHHHHhhccC
Confidence            6543  34444    578999999999999 99999953  2566666              9999999999988  456


Q ss_pred             CCCCcCCCCCCCCCCCCCC
Q psy11571        318 NAPYIPEVSSPTDTSHFDV  336 (372)
Q Consensus       318 ~~p~~p~~~~~~~~~~~~~  336 (372)
                      .+|+.|....+.+.+.|++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~  289 (290)
T cd05580         271 EAPFIPKVKGPGDTSNFDD  289 (290)
T ss_pred             CCCccCCCCCccccccccC
Confidence            7899999888888888875

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=5.3e-45  Score=340.60  Aligned_cols=288  Identities=33%  Similarity=0.629  Sum_probs=239.4

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+.++.++.|    ++|.||++.+..+++.|++|.+.......       ....+.+.+|+.+++.++||||+++++.+.
T Consensus         3 y~~~~~l~~g----~~~~v~~~~~~~~~~~v~ik~~~~~~~~~-------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   71 (305)
T cd05609           3 FETIKLISNG----AYGAVYLVRHKETRQRFAMKKINKQNLIL-------RNQIQQVFVERDILTFAENPFVVSMFCSFE   71 (305)
T ss_pred             ceEeeEeecC----CCeeEEEEEECCCCcEEEEEEeehhhhhh-------HHHHHHHHHHHHHHHhCCCCCeeeeEEEEe
Confidence            4455566665    89999999999999999999776543221       123456778999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcE
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI  163 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~v  163 (372)
                      +++.+|+||||++|++|.+++.. .+.+++..+..++.|++.||.|||+.|++|          |||||+||+++.++.+
T Consensus        72 ~~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H----------~dl~p~NIll~~~~~~  140 (305)
T cd05609          72 TKRHLCMVMEYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVH----------RDLKPDNLLITSMGHI  140 (305)
T ss_pred             cCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------cCCchHHEEECCCCCE
Confidence            99999999999999999999987 467999999999999999999999999999          9999999999999999


Q ss_pred             EEeecCcccccCCCC--------------cccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCC
Q psy11571        164 RLADFGSCLRLGGDG--------------TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP  229 (372)
Q Consensus       164 kl~Dfg~a~~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~P  229 (372)
                      +|+|||+++......              ........|+..|+|||.+.     ...++.++|+|||||++|+|++|..|
T Consensus       141 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~vl~el~~g~~p  215 (305)
T cd05609         141 KLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL-----RQGYGKPVDWWAMGIILYEFLVGCVP  215 (305)
T ss_pred             EEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhcc-----CCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            999999886421100              00111245788999999987     35688999999999999999999999


Q ss_pred             CCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        230 FYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       230 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      |.+.+..+....+.......  |... ..++.+++++|++||+ +|++||++.++.+++              .||||.+
T Consensus       216 f~~~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll--------------~~~~~~~  278 (305)
T cd05609         216 FFGDTPEELFGQVISDDIEW--PEGD-EALPADAQDLISRLLRQNPLERLGTGGAFEVK--------------QHRFFLG  278 (305)
T ss_pred             CCCCCHHHHHHHHHhcccCC--CCcc-ccCCHHHHHHHHHHhccChhhccCccCHHHHH--------------hCccccC
Confidence            99888888777776643222  2221 1578999999999999 999999998899988              9999999


Q ss_pred             CCccccccCCCCCcCCCCCCCCCCCCC
Q psy11571        309 IAWDSIRDSNAPYIPEVSSPTDTSHFD  335 (372)
Q Consensus       309 ~~w~~~~~~~~p~~p~~~~~~~~~~~~  335 (372)
                      .+|....+...+++|.+.+..++++||
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (305)
T cd05609         279 LDWNGLLRQKAEFIPQLESEDDTSYFD  305 (305)
T ss_pred             CCHHHHhhcCCCCCCCCCCccccccCC
Confidence            999998777788999998888888875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0580|consensus

Probab=100.00  E-value=9.7e-47  Score=321.56  Aligned_cols=244  Identities=31%  Similarity=0.510  Sum_probs=216.9

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      +-||.||.++...++-.||+|++-++.+...       ..-.++++|++|.+.|+||||+++|++|.+...+|+++||.+
T Consensus        33 gkFG~vYlarekks~~IvalKVlfKsqi~~~-------~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~  105 (281)
T KOG0580|consen   33 GKFGNVYLAREKKSLFIVALKVLFKSQILKT-------QVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAP  105 (281)
T ss_pred             CccccEeEeeeccCCcEEEEeeeeHHHHHHh-------cchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecC
Confidence            3689999999999999999998877665443       344678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccC
Q psy11571         97 GGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG  175 (372)
Q Consensus        97 gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~  175 (372)
                      +|+|...|... ...+++..+..|+.|++.||.|+|..+++|          |||||+|+|++.+|.+||+|||.+....
T Consensus       106 ~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIh----------RdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen  106 RGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIH----------RDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             CchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCccc----------CCCCHHHhccCCCCCeeccCCCceeecC
Confidence            99999999843 457999999999999999999999999999          9999999999999999999999997754


Q ss_pred             CCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCC
Q psy11571        176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDV  255 (372)
Q Consensus       176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  255 (372)
                      ..   ...+.|||..|.+||+..+     ..++..+|+|++|++.||++.|.+||.+.+..+++++|.+..  +.+|+  
T Consensus       176 ~~---kR~tlcgt~dyl~pEmv~~-----~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~--~~~p~--  243 (281)
T KOG0580|consen  176 SN---KRKTLCGTLDYLPPEMVEG-----RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD--LKFPS--  243 (281)
T ss_pred             CC---CceeeecccccCCHhhcCC-----CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc--ccCCc--
Confidence            22   3456899999999999984     678999999999999999999999999999999999998855  44565  


Q ss_pred             CCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        256 GYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       256 ~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                        .++.+++|||.+||. +|.+|+.   +.+++              .|||+..
T Consensus       244 --~is~~a~dlI~~ll~~~p~~r~~---l~~v~--------------~hpwI~a  278 (281)
T KOG0580|consen  244 --TISGGAADLISRLLVKNPIERLA---LTEVM--------------DHPWIVA  278 (281)
T ss_pred             --ccChhHHHHHHHHhccCcccccc---HHHHh--------------hhHHHHh
Confidence              799999999999999 9999996   55555              9999864

>KOG0660|consensus

Probab=100.00  E-value=4.3e-46  Score=335.36  Aligned_cols=262  Identities=23%  Similarity=0.322  Sum_probs=215.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|..++.+|.|    .+|.|.++.+..++..||+|++........        ..++..+|+.+|+.++|+||+.+++++
T Consensus        23 ~y~~~~~iG~G----AyGvVcsA~~~~t~~~VAIKKi~~~F~~~~--------~akRtlRElklLr~~~HeNIi~l~di~   90 (359)
T KOG0660|consen   23 YYVLIEPIGRG----AYGVVCSAKDKRTGEKVAIKKILNPFENQI--------DAKRTLRELKLLRHLRHENIIGLLDIF   90 (359)
T ss_pred             eecccccccCc----ceeeEEEEEEcCCCCEeehhhhhhhhhchH--------HHHHHHHHHHHHHHhcCCCcceEEeec
Confidence            44556666776    789999999999999999998875443322        456778899999999999999999998


Q ss_pred             Ee-----CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe
Q psy11571         83 QD-----DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        83 ~~-----~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      ..     -+.+|+|+|+| +.+|...++. +..++++.+..++.||+.||.|+|+.|++|          |||||.|+++
T Consensus        91 ~p~~~~~f~DvYiV~elM-etDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAnViH----------RDLKPsNll~  158 (359)
T KOG0660|consen   91 RPPSRDKFNDVYLVFELM-ETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSANVIH----------RDLKPSNLLL  158 (359)
T ss_pred             ccccccccceeEEehhHH-hhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcccccc----------cccchhheee
Confidence            76     24699999999 7799999988 456999999999999999999999999999          9999999999


Q ss_pred             CCCCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH
Q psy11571        158 DANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV  236 (372)
Q Consensus       158 ~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~  236 (372)
                      +.+..+||+|||+|+....... ..-+..+-|..|.|||++..    ...|+.++||||+|||+.||++|++.|.|.+..
T Consensus       159 n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~----~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v  234 (359)
T KOG0660|consen  159 NADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLN----SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV  234 (359)
T ss_pred             ccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhc----cccccchhhhhhhhHHHHHHHcCCCCCCCCchH
Confidence            9999999999999998753211 11134677999999999985    578999999999999999999999999998777


Q ss_pred             HHHHHHhhccCCc---------------------CCC----CCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhh
Q psy11571        237 ETYGKIMNHQNSF---------------------DLP----SDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWS  290 (372)
Q Consensus       237 ~~~~~i~~~~~~~---------------------~~~----~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~  290 (372)
                      +.+..|+.--+.+                     ..|    ....++.++.+.||+.+||. ||.+|+|+++++      
T Consensus       235 ~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL------  308 (359)
T KOG0660|consen  235 HQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEAL------  308 (359)
T ss_pred             HHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHh------
Confidence            6665554321111                     011    11124789999999999999 999999988887      


Q ss_pred             hhhhccCCCCCCCCCcCCC
Q psy11571        291 ALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       291 ~~~~~~~~~~~~hp~f~~~  309 (372)
                                 .|||++..
T Consensus       309 -----------~hPYl~~~  316 (359)
T KOG0660|consen  309 -----------AHPYLAPY  316 (359)
T ss_pred             -----------cChhhhhh
Confidence                       99999865

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.6e-45  Score=341.40  Aligned_cols=259  Identities=24%  Similarity=0.347  Sum_probs=209.6

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.++.|    ++|.||++.+..++..||+|.+........         ...+.+|+.+++.++||||++++++
T Consensus         5 ~~y~~~~~lg~G----~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~   71 (288)
T cd07871           5 ETYVKLDKLGEG----TYATVFKGRSKLTENLVALKEIRLEHEEGA---------PCTAIREVSLLKNLKHANIVTLHDI   71 (288)
T ss_pred             ccceEeeEEecC----CCEEEEEEEECCCCCEEEEEEecccccCCc---------chhHHHHHHHHHhCCCCCEeeEEEE
Confidence            357777888877    899999999998999999998765432211         1335679999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+.+..++||||+. ++|.+++......+++..++.++.||+.||+|||++||+|          |||||+|||++.++
T Consensus        72 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH----------~dlkp~Nil~~~~~  140 (288)
T cd07871          72 IHTERCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILH----------RDLKPQNLLINEKG  140 (288)
T ss_pred             EcCCCeEEEEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccc----------CCCCHHHEEECCCC
Confidence            999999999999996 5999999775556899999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .+||+|||+++....... ......|++.|+|||++.+    ...++.++|+|||||++|+|++|++||.+.+..+.+..
T Consensus       141 ~~kl~DfG~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~  215 (288)
T cd07871         141 ELKLADFGLARAKSVPTK-TYSNEVVTLWYRPPDVLLG----STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL  215 (288)
T ss_pred             CEEECcCcceeeccCCCc-cccCceecccccChHHhcC----CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999876533221 1223468999999999873    35688999999999999999999999998887766655


Q ss_pred             HhhccCCc-----------------CCCC-------CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhcc
Q psy11571        242 IMNHQNSF-----------------DLPS-------DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSL  296 (372)
Q Consensus       242 i~~~~~~~-----------------~~~~-------~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~  296 (372)
                      +.......                 .+|.       .....++.++++||++||+ ||.+|+|+++++            
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l------------  283 (288)
T cd07871         216 IFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAAL------------  283 (288)
T ss_pred             HHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHh------------
Confidence            54321100                 0110       0112468899999999999 999999977766            


Q ss_pred             CCCCCCCCCc
Q psy11571        297 SISPRNHPWF  306 (372)
Q Consensus       297 ~~~~~~hp~f  306 (372)
                           +||||
T Consensus       284 -----~hp~f  288 (288)
T cd07871         284 -----RHSYF  288 (288)
T ss_pred             -----cCCCC
Confidence                 99998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0594|consensus

Probab=100.00  E-value=7.2e-45  Score=328.14  Aligned_cols=264  Identities=23%  Similarity=0.354  Sum_probs=220.2

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCc-eeeeeE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRW-ITNLHY   80 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~-Iv~l~~   80 (372)
                      +.|+.++++|.|    .+|.||+++...+|+.||+|++....-. +..       -....+|+.+|+.++|+| |+++++
T Consensus        11 ~~~~~~eklGeG----tyg~Vykar~~~~g~~VALKkirl~~~~-EG~-------P~taiREisllk~L~~~~~iv~L~d   78 (323)
T KOG0594|consen   11 FDYEKVEKLGEG----TYGVVYKARSKRTGKFVALKKIRLEFEE-EGV-------PSTAIREISLLKRLSHANHIVRLHD   78 (323)
T ss_pred             HHHHHHHHhCCC----CceEEEEEEEecCCCEEEEEEEeccccc-cCC-------CchhhHHHHHHHHhCCCcceEEEEe
Confidence            358899999998    6999999999999999999988776543 111       133567999999999999 999999


Q ss_pred             EEEeCC------eEEEEEeccCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCC
Q psy11571         81 AFQDDS------NLYLVMDYYCGGDLLTLLSKFE---DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIK  151 (372)
Q Consensus        81 ~~~~~~------~~~lv~E~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlk  151 (372)
                      ++.+.+      .+++|+||+ ..+|..++....   ..++...++.++.||+.||+|||+++|+|          ||||
T Consensus        79 v~~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlH----------RDLK  147 (323)
T KOG0594|consen   79 VIHTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILH----------RDLK  147 (323)
T ss_pred             eeeecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeec----------ccCC
Confidence            999887      899999998 669999998864   36888999999999999999999999999          9999


Q ss_pred             cCcEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCC
Q psy11571        152 PDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY  231 (372)
Q Consensus       152 p~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~  231 (372)
                      |+||||+++|.+||+|||+|+...-+... .....+|..|.|||++.+    ...|+..+||||+|||++||+++++.|.
T Consensus       148 PQNlLi~~~G~lKlaDFGlAra~~ip~~~-yt~evvTlWYRaPEvLlG----s~~Ys~~vDiWs~GcIfaEm~~~~~LFp  222 (323)
T KOG0594|consen  148 PQNLLISSSGVLKLADFGLARAFSIPMRT-YTPEVVTLWYRAPEVLLG----STSYSTSVDIWSLGCIFAEMFTRRPLFP  222 (323)
T ss_pred             cceEEECCCCcEeeeccchHHHhcCCccc-ccccEEEeeccCHHHhcC----CCcCCCCcchHhHHHHHHHHHhCCCCCC
Confidence            99999999999999999999976543332 233568999999999995    5679999999999999999999999999


Q ss_pred             CCCHHHHHHHHhhccCCc----------------CCCCCC--------CCCCCHHHHHHHHHhcc-CCCCCCCCCChhhh
Q psy11571        232 AESLVETYGKIMNHQNSF----------------DLPSDV--------GYEISDDAKDLMRRLIC-SSDTRLGQNGIADF  286 (372)
Q Consensus       232 ~~~~~~~~~~i~~~~~~~----------------~~~~~~--------~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i  286 (372)
                      +.++.+...+|.+.-..+                .++...        .+..+++..+++.+||+ +|.+|.|++.++  
T Consensus       223 G~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al--  300 (323)
T KOG0594|consen  223 GDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGAL--  300 (323)
T ss_pred             CCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHh--
Confidence            999988888775422111                111111        12344699999999999 999999988777  


Q ss_pred             hhhhhhhhccCCCCCCCCCcCCCC
Q psy11571        287 KMWSALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       287 ~~~~~~~~~~~~~~~~hp~f~~~~  310 (372)
                                     .||||..+.
T Consensus       301 ---------------~h~yf~~~~  309 (323)
T KOG0594|consen  301 ---------------THPYFSELP  309 (323)
T ss_pred             ---------------cChhhcccc
Confidence                           999999873

>KOG4717|consensus

Probab=100.00  E-value=8.3e-46  Score=344.90  Aligned_cols=252  Identities=29%  Similarity=0.474  Sum_probs=219.7

Q ss_pred             CcccCCccEE---EeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEE
Q psy11571         14 GPIQGKGRVF---SIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYL   90 (372)
Q Consensus        14 ~~~~g~G~v~---~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   90 (372)
                      .+.+|.|.+.   .+++..+|..||+|++.+..+..-        .-..+.+|+..|+.++|||||++|++..++..+||
T Consensus        23 ekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~--------st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL   94 (864)
T KOG4717|consen   23 EKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL--------STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL   94 (864)
T ss_pred             hhhhcCCceehhhhhhhhcccceeEEEEecccccchh--------hhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence            3445666544   455677999999999998887654        23557889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC-CCCcEEEeecC
Q psy11571         91 VMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD-ANGHIRLADFG  169 (372)
Q Consensus        91 v~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~-~~~~vkl~Dfg  169 (372)
                      |+|+=.+|+|++||.+....+.|+.++.|++||+.|+.|+|+..+||          |||||+|+.+. +-|-|||.|||
T Consensus        95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVH----------RDLKPENVVFFEKlGlVKLTDFG  164 (864)
T KOG4717|consen   95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVH----------RDLKPENVVFFEKLGLVKLTDFG  164 (864)
T ss_pred             EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhc----------ccCCcceeEEeeecCceEeeecc
Confidence            99999999999999987789999999999999999999999999999          99999999886 56899999999


Q ss_pred             cccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCc
Q psy11571        170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSF  249 (372)
Q Consensus       170 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~  249 (372)
                      ++..+.....  -++.||+..|.|||++.+    ...-.+++||||||||||.|++|++||+..+..+.+..|+.+.  +
T Consensus       165 FSNkf~PG~k--L~TsCGSLAYSAPEILLG----DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK--Y  236 (864)
T KOG4717|consen  165 FSNKFQPGKK--LTTSCGSLAYSAPEILLG----DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK--Y  236 (864)
T ss_pred             ccccCCCcch--hhcccchhhccCchhhhc----CccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc--c
Confidence            9987765443  345899999999999995    3445789999999999999999999999999999999999865  5


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcc
Q psy11571        250 DLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWD  312 (372)
Q Consensus       250 ~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~  312 (372)
                      ..|+    .+|.+++|||..||. ||.+|.+.++|.                 .|+|++.+|-.
T Consensus       237 tvPs----hvS~eCrdLI~sMLvRdPkkRAslEeI~-----------------s~~Wlq~~D~~  279 (864)
T KOG4717|consen  237 TVPS----HVSKECRDLIQSMLVRDPKKRASLEEIV-----------------STSWLQAGDRG  279 (864)
T ss_pred             cCch----hhhHHHHHHHHHHHhcCchhhccHHHHh-----------------ccccccCCCCC
Confidence            5566    789999999999999 999999866555                 99999999853

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.4e-45  Score=341.61  Aligned_cols=264  Identities=22%  Similarity=0.308  Sum_probs=207.6

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    ++|.||.+++..+++.+|+|.+........         ...+.+|+.+++.++||||++++++
T Consensus         5 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~   71 (303)
T cd07869           5 DSYEKLEKLGEG----SYATVYKGKSKVNGKLVALKVIRLQEEEGT---------PFTAIREASLLKGLKHANIVLLHDI   71 (303)
T ss_pred             ccceEeeeEEec----CCEEEEEEEECCCCCEEEEEEecccccccc---------chhHHHHHHHHhhCCCCCcCeEEEE
Confidence            467777888877    899999999998999999998764332111         1235679999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+....|+||||+ +++|.+++....+.+++..++.++.||+.||+|||++||+|          |||||+|||++.++
T Consensus        72 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH----------~dlkp~Nill~~~~  140 (303)
T cd07869          72 IHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILH----------RDLKPQNLLISDTG  140 (303)
T ss_pred             EecCCeEEEEEECC-CcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeec----------CCCCHHHEEECCCC
Confidence            99999999999999 56898888775567999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCH-HHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL-VETYG  240 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-~~~~~  240 (372)
                      .+||+|||++........ ......||+.|+|||++.+    ...++.++|+|||||++|+|++|..||.+... .+...
T Consensus       141 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  215 (303)
T cd07869         141 ELKLADFGLARAKSVPSH-TYSNEVVTLWYRPPDVLLG----STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLE  215 (303)
T ss_pred             CEEECCCCcceeccCCCc-cCCCCcccCCCCChHHHcC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHH
Confidence            999999999875433222 1223568999999999873    34578899999999999999999999987533 23333


Q ss_pred             HHhhccCCc---CC------------------CCC-----CCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhh
Q psy11571        241 KIMNHQNSF---DL------------------PSD-----VGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALF  293 (372)
Q Consensus       241 ~i~~~~~~~---~~------------------~~~-----~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~  293 (372)
                      .+.......   .+                  +..     .....++++++||++||+ ||++|||+++++         
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l---------  286 (303)
T cd07869         216 RIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAAL---------  286 (303)
T ss_pred             HHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHh---------
Confidence            222110000   00                  000     001246789999999999 999999977666         


Q ss_pred             hccCCCCCCCCCcCCCCc
Q psy11571        294 VSLSISPRNHPWFQGIAW  311 (372)
Q Consensus       294 ~~~~~~~~~hp~f~~~~w  311 (372)
                              +||||+++.+
T Consensus       287 --------~h~~f~~~~~  296 (303)
T cd07869         287 --------SHEYFSDLPP  296 (303)
T ss_pred             --------cCcccccCCh
Confidence                    9999998874

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0192|consensus

Probab=100.00  E-value=1.5e-44  Score=340.18  Aligned_cols=243  Identities=23%  Similarity=0.323  Sum_probs=209.4

Q ss_pred             cCCccEEEeeeehhhhh-hhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC-eEEEEEec
Q psy11571         17 QGKGRVFSIETLLDILL-VLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS-NLYLVMDY   94 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~-va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~-~~~lv~E~   94 (372)
                      |++|.||.+.  ..|.. ||+|.+.........        .+.+.+|+.+|..++|||||++++++.+.. .+++||||
T Consensus        52 G~~g~V~~~~--~~g~~~vavK~~~~~~~~~~~--------~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   52 GSFGTVYKGK--WRGTDVVAVKIISDPDFDDES--------RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             CCceeEEEEE--eCCceeEEEEEecchhcChHH--------HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            3788888664  45555 999988776655431        677999999999999999999999999887 79999999


Q ss_pred             cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhcC-ceecCCCCCCCcCCCCCcCcEEeCCCC-cEEEeecCcc
Q psy11571         95 YCGGDLLTLLSK-FEDRLPEDMAKFYIAEMVLAIASIHDLH-YVHRPNHFAFHLCRDIKPDNVLLDANG-HIRLADFGSC  171 (372)
Q Consensus        95 ~~gg~L~~~l~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~~-ivH~~~~~~~~vhrDlkp~NIll~~~~-~vkl~Dfg~a  171 (372)
                      +++|+|.+++.+ .+..++...+..++.||+.|+.|||+++ |||          |||||+|||++.++ ++||+|||++
T Consensus       122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIH----------rDLK~~NiLv~~~~~~~KI~DFGls  191 (362)
T KOG0192|consen  122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIH----------RDLKSDNILVDLKGKTLKIADFGLS  191 (362)
T ss_pred             CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeee----------cccChhhEEEcCCCCEEEECCCccc
Confidence            999999999987 3678999999999999999999999999 999          99999999999997 9999999999


Q ss_pred             cccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCC
Q psy11571        172 LRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDL  251 (372)
Q Consensus       172 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~  251 (372)
                      +...... .......||+.|||||++.+.   ...|+.++||||||+++|||+||+.||.+....+....+.....++.+
T Consensus       192 r~~~~~~-~~~~~~~GT~~wMAPEv~~~~---~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~  267 (362)
T KOG0192|consen  192 REKVISK-TSMTSVAGTYRWMAPEVLRGE---KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPI  267 (362)
T ss_pred             eeecccc-ccccCCCCCccccChhhhcCC---CCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC
Confidence            8765432 122236799999999999842   357999999999999999999999999999888888788777777777


Q ss_pred             CCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        252 PSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       252 ~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      |.    ..++.+..|+.+||. ||.+||++.++...+
T Consensus       268 p~----~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l  300 (362)
T KOG0192|consen  268 PK----ECPPHLSSLMERCWLVDPSRRPSFLEIVSRL  300 (362)
T ss_pred             Cc----cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHH
Confidence            76    589999999999999 999999988776555

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.2e-45  Score=339.79  Aligned_cols=259  Identities=27%  Similarity=0.349  Sum_probs=207.1

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.++.|    |+|.||++.+..+++.+|+|.+........        ..+.+.+|+.+++.++||||+++++++
T Consensus         2 ~y~~~~~lg~g----~~~~v~~~~~~~~~~~~avK~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~iv~~~~~~   69 (287)
T cd07848           2 KFEVLGVVGEG----AYGVVLKCRHKETKEIVAIKKFKDSEENEE--------VKETTLRELKMLRTLKQENIVELKEAF   69 (287)
T ss_pred             CceEEEEeccc----CCEEEEEEEECCCCcEEEEEEEeccccccc--------chhhHHHHHHHHHhCCCccccchhhhE
Confidence            46666777776    899999999988999999998865433221        235567899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+.+.+|+||||++++.|..+... ...+++..++.++.||+.||.|||+.|++|          |||||+||+++.++.
T Consensus        70 ~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H----------~dlkp~Nill~~~~~  138 (287)
T cd07848          70 RRRGKLYLVFEYVEKNMLELLEEM-PNGVPPEKVRSYIYQLIKAIHWCHKNDIVH----------RDIKPENLLISHNDV  138 (287)
T ss_pred             ecCCEEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeec----------CCCCHHHEEEcCCCc
Confidence            999999999999988766655443 567999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||++...............||+.|+|||++.+     ..++.++|+|||||++|+|++|++||.+.+..+....+
T Consensus       139 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~  213 (287)
T cd07848         139 LKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG-----APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTI  213 (287)
T ss_pred             EEEeeccCcccccccccccccccccccccCCcHHHcC-----CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            9999999998764433222234578999999999973     45889999999999999999999999987665544433


Q ss_pred             hhccCC-----------------cCCCCC---------CCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhc
Q psy11571        243 MNHQNS-----------------FDLPSD---------VGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVS  295 (372)
Q Consensus       243 ~~~~~~-----------------~~~~~~---------~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~  295 (372)
                      ......                 ...+..         ....+|.++++||++||+ ||++|||+++++           
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l-----------  282 (287)
T cd07848         214 QKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCL-----------  282 (287)
T ss_pred             HHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHh-----------
Confidence            221110                 001110         012378899999999999 999999977665           


Q ss_pred             cCCCCCCCCCc
Q psy11571        296 LSISPRNHPWF  306 (372)
Q Consensus       296 ~~~~~~~hp~f  306 (372)
                            +||||
T Consensus       283 ------~hp~f  287 (287)
T cd07848         283 ------NHPAF  287 (287)
T ss_pred             ------cCCCC
Confidence                  99998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.4e-44  Score=334.74  Aligned_cols=273  Identities=29%  Similarity=0.555  Sum_probs=218.1

Q ss_pred             HHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe
Q psy11571          5 RELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQD   84 (372)
Q Consensus         5 ~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~   84 (372)
                      +..+.+|.|    |+|.||.+....+++.+|+|.+........       +..+.+.+|+.+++.++|+||+++++.+.+
T Consensus         3 ~~~~~ig~G----~~g~v~~~~~~~~~~~~avK~~~~~~~~~~-------~~~~~~~~E~~il~~l~~~~i~~~~~~~~~   71 (285)
T cd05630           3 RQYRVLGKG----GFGEVCACQVRATGKMYACKKLEKKRIKKR-------KGESMALNEKQILEKVNSRFVVSLAYAYET   71 (285)
T ss_pred             eeeEEeecC----CCeEEEEEEEcCCCceEEEEEEehhhccch-------HHHHHHHHHHHHHHhCCCCCeeeeeEEEec
Confidence            344445555    899999999999999999998765433221       123445679999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcE
Q psy11571         85 DSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI  163 (372)
Q Consensus        85 ~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~v  163 (372)
                      .+.+|+||||++|++|.+++... ...+++..+..++.|++.||.|||+.|++|          |||||+||+++.++.+
T Consensus        72 ~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH----------~dikp~Nil~~~~~~~  141 (285)
T cd05630          72 KDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY----------RDLKPENILLDDHGHI  141 (285)
T ss_pred             CCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEe----------CCCCHHHEEECCCCCE
Confidence            99999999999999999998653 236899999999999999999999999999          9999999999999999


Q ss_pred             EEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH---HHHH
Q psy11571        164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYG  240 (372)
Q Consensus       164 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~---~~~~  240 (372)
                      +|+|||++.........  ....|+..|+|||++.     ...++.++|+||+||++|+|++|+.||......   +...
T Consensus       142 ~l~Dfg~~~~~~~~~~~--~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~  214 (285)
T cd05630         142 RISDLGLAVHVPEGQTI--KGRVGTVGYMAPEVVK-----NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE  214 (285)
T ss_pred             EEeeccceeecCCCccc--cCCCCCccccChHHHc-----CCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH
Confidence            99999998765433221  2347899999999997     356889999999999999999999999875432   2222


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCC--ChhhhhhhhhhhhccCCCCCCCCCcCCCCcccccc-
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQN--GIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRD-  316 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~--~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~~-  316 (372)
                      .+... .....+    ..+++++++||.+||+ ||++|+|++  .+.+++              +||||+.++|..+.. 
T Consensus       215 ~~~~~-~~~~~~----~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~--------------~h~~~~~~~~~~~~~~  275 (285)
T cd05630         215 RLVKE-VQEEYS----EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVK--------------EHPLFKQINFKRLEAG  275 (285)
T ss_pred             hhhhh-hhhhcC----ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHH--------------cChhhhccCHHHHhcC
Confidence            22221 111122    2678999999999999 999999954  255666              999999999998743 


Q ss_pred             -CCCCCcCC
Q psy11571        317 -SNAPYIPE  324 (372)
Q Consensus       317 -~~~p~~p~  324 (372)
                       ..|||.|.
T Consensus       276 ~~~~~~~~~  284 (285)
T cd05630         276 MLEPPFKPD  284 (285)
T ss_pred             CCCCCCCCC
Confidence             66888885

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0201|consensus

Probab=100.00  E-value=5.5e-47  Score=347.87  Aligned_cols=256  Identities=24%  Similarity=0.372  Sum_probs=223.7

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      .|..++.+|+|    .||.||++.+..+++.||+|.++......+         ++.+++|+.+|.++++|||.++|+.|
T Consensus        14 ~~~~~~~IgrG----sfG~Vyk~~d~~t~k~vAiKii~Le~~~de---------Iediqqei~~Ls~~~~~~it~yygsy   80 (467)
T KOG0201|consen   14 LYTKLELIGRG----SFGEVYKAIDNKTKKVVAIKIIDLEEAEDE---------IEDIQQEISVLSQCDSPNITEYYGSY   80 (467)
T ss_pred             ccccchhcccc----ccceeeeeeeccccceEEEEEechhhcchh---------hHHHHHHHHHHHhcCcchHHhhhhhe
Confidence            57777888887    799999999999999999999887665443         56788999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      ..+..++++||||.||++.+.++. +..+.|..+..++++++.||.|||+.+.+|          ||||+.|||+..+|.
T Consensus        81 l~g~~LwiiMey~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiH----------rDIKaanil~s~~g~  149 (467)
T KOG0201|consen   81 LKGTKLWIIMEYCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIH----------RDIKAANILLSESGD  149 (467)
T ss_pred             eecccHHHHHHHhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceec----------ccccccceeEeccCc
Confidence            999999999999999999999987 455699999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||.+..+...... ..+++|||.|||||++.+     ..|+.++||||||++.+||++|.+|+....+...+..|
T Consensus       150 vkl~DfgVa~ql~~~~~r-r~tfvGTPfwMAPEVI~~-----~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI  223 (467)
T KOG0201|consen  150 VKLADFGVAGQLTNTVKR-RKTFVGTPFWMAPEVIKQ-----SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI  223 (467)
T ss_pred             EEEEecceeeeeechhhc-cccccccccccchhhhcc-----ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec
Confidence            999999999887655443 377899999999999983     56999999999999999999999999988875544444


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~  310 (372)
                      -+.     .|+.....+|+.+++|+..||+ ||+.||+|.+++                 +|+|++...
T Consensus       224 pk~-----~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LL-----------------Kh~FIk~a~  270 (467)
T KOG0201|consen  224 PKS-----APPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELL-----------------KHKFIKRAK  270 (467)
T ss_pred             cCC-----CCCccccccCHHHHHHHHHHhhcCcccCcCHHHHh-----------------hhHHHHhcC
Confidence            332     2333444889999999999999 999999988877                 999998744

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-44  Score=335.96  Aligned_cols=280  Identities=36%  Similarity=0.664  Sum_probs=230.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.++.|    ++|.||.+....+++.+++|.+........       ...+.+.+|+.++..++||||+++++.+
T Consensus         2 ~y~~~~~ig~g----~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~   70 (316)
T cd05574           2 HFKKIKLLGKG----DVGRVFLVRLKGTGKLFALKVLDKKEMIKR-------NKVKRVLTEQEILATLDHPFLPTLYASF   70 (316)
T ss_pred             ceEEeeeecCC----ccEEEEEEEEcCCCcEEEEEEEeccccchH-------HHHHHHHHHHHHHHhCCCCCchhheeee
Confidence            45566666666    899999999988899999998876544331       2356688899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      .+....|+||||+.|++|.+++... ...+++..++.++.|++.||+|||+.|++|          +||||+||+++.++
T Consensus        71 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H----------~dlkp~Nili~~~~  140 (316)
T cd05574          71 QTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVY----------RDLKPENILLHESG  140 (316)
T ss_pred             ecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeec----------cCCChHHeEEcCCC
Confidence            9999999999999999999999763 357899999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCc----------------------------ccccccccCCcccCcccccccccCCCCCCCccce
Q psy11571        162 HIRLADFGSCLRLGGDGT----------------------------VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDW  213 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Di  213 (372)
                      .++|+|||++........                            .......||..|+|||++.+     ..++.++||
T Consensus       141 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di  215 (316)
T cd05574         141 HIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-----DGHGSAVDW  215 (316)
T ss_pred             CEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-----CCCCchHHH
Confidence            999999999875432111                            11123468889999999973     557889999


Q ss_pred             eehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCC-CCChhhhhhhhh
Q psy11571        214 WSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLG-QNGIADFKMWSA  291 (372)
Q Consensus       214 wslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s-~~~~~~i~~~~~  291 (372)
                      ||||+++|+|++|..||.+.+....+.++......  ++..  ..++..++++|.+||. +|++||+ .+.+.+++    
T Consensus       216 ~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll----  287 (316)
T cd05574         216 WTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVT--FPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIK----  287 (316)
T ss_pred             HHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCcc--CCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHH----
Confidence            99999999999999999988888777777654332  2321  1379999999999999 9999998 23355555    


Q ss_pred             hhhccCCCCCCCCCcCCCCccccccCCCCCcCCCC
Q psy11571        292 LFVSLSISPRNHPWFQGIAWDSIRDSNAPYIPEVS  326 (372)
Q Consensus       292 ~~~~~~~~~~~hp~f~~~~w~~~~~~~~p~~p~~~  326 (372)
                                .||||++++|..+....+|-+|.+.
T Consensus       288 ----------~~~~~~~~~~~~~~~~~~~~~~~~~  312 (316)
T cd05574         288 ----------QHPFFRGVNWALIRHTTPPIIPRPD  312 (316)
T ss_pred             ----------cCchhhcCChhhcccCCCCCCCCcc
Confidence                      9999999999999887777777653

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=8.6e-44  Score=329.34  Aligned_cols=275  Identities=26%  Similarity=0.488  Sum_probs=220.3

Q ss_pred             HHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC
Q psy11571          6 ELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDD   85 (372)
Q Consensus         6 ~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~   85 (372)
                      .++.+|.|    |+|.||.+....+++.+|+|.+........       ...+.+.+|+.+++.++|+||+++++.+.++
T Consensus         4 ~~~~lg~G----~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~   72 (285)
T cd05632           4 QYRVLGKG----GFGEVCACQVRATGKMYACKRLEKKRIKKR-------KGESMALNEKQILEKVNSQFVVNLAYAYETK   72 (285)
T ss_pred             EEEEEecC----CCeEEEEEEECCCCcEEEEEEeehhhhhhh-------hHHHHHHHHHHHHHHcCCcCceeEEEEEecC
Confidence            34445555    899999999999999999998765443322       1234466799999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEE
Q psy11571         86 SNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIR  164 (372)
Q Consensus        86 ~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vk  164 (372)
                      +..+++|||+++++|.+++... ...+++..+..++.|++.||.|||+.||+|          |||||+||++++++.++
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH----------~dikp~Nili~~~~~~k  142 (285)
T cd05632          73 DALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY----------RDLKPENILLDDYGHIR  142 (285)
T ss_pred             CEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeee----------cCCCHHHEEECCCCCEE
Confidence            9999999999999999988653 246999999999999999999999999999          99999999999999999


Q ss_pred             EeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhh
Q psy11571        165 LADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN  244 (372)
Q Consensus       165 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~  244 (372)
                      |+|||++........  .....|++.|+|||++.+     ..++.++|+|||||++|+|++|..||.+.........+..
T Consensus       143 l~Dfg~~~~~~~~~~--~~~~~g~~~~~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~  215 (285)
T cd05632         143 ISDLGLAVKIPEGES--IRGRVGTVGYMAPEVLNN-----QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR  215 (285)
T ss_pred             EecCCcceecCCCCc--ccCCCCCcCccChHHhcC-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999999876543222  123578999999999973     5688999999999999999999999988766544333332


Q ss_pred             ccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCC--hhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccCCC
Q psy11571        245 HQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNG--IADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNA  319 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~--~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~~~  319 (372)
                      .....  .......++.++.+|+.+||+ +|++||++++  +.+++              .||||+.++|+.+  .+.+|
T Consensus       216 ~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~--------------~~~~~~~~~~~~~~~~~~~~  279 (285)
T cd05632         216 RVLET--EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVK--------------RHPFFRNMNFKRLEAGMLDP  279 (285)
T ss_pred             hhhcc--ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHH--------------cChhhhcCCHHHHhcCcCCC
Confidence            11111  111122678999999999999 9999999542  44555              9999999999987  45678


Q ss_pred             CCcCC
Q psy11571        320 PYIPE  324 (372)
Q Consensus       320 p~~p~  324 (372)
                      ||.|.
T Consensus       280 ~~~~~  284 (285)
T cd05632         280 PFVPD  284 (285)
T ss_pred             CCCCC
Confidence            88885

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=8.4e-44  Score=336.49  Aligned_cols=263  Identities=22%  Similarity=0.334  Sum_probs=212.4

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.+..+|.|    ++|.||++.+..++..+|+|.+......         ...+.+.+|+.+++.++||||++++++
T Consensus         5 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~~a~k~~~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv~~~~~   71 (331)
T cd06649           5 DDFERISELGAG----NGGVVTKVQHKPSGLIMARKLIHLEIKP---------AIRNQIIRELQVLHECNSPYIVGFYGA   71 (331)
T ss_pred             ccceEEEeecCC----CCEEEEEEEECCCCcEEEEEEeecccCH---------HHHHHHHHHHHHHHHCCCCCCCeEEEE
Confidence            567888888887    8999999999999999999987653211         134567889999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDL-HYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      +.+.+.+++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+|          |||||+|||++.+
T Consensus        72 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH----------~dlkp~Nil~~~~  140 (331)
T cd06649          72 FYSDGEISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMH----------RDVKPSNILVNSR  140 (331)
T ss_pred             EEECCEEEEEeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEc----------CCCChhhEEEcCC
Confidence            9999999999999999999999987 46799999999999999999999985 6999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG  240 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~  240 (372)
                      +.++|+|||++.......   .....||+.|+|||++.+     ..++.++|+|||||++|+|++|+.||...+..+...
T Consensus       141 ~~~kl~Dfg~~~~~~~~~---~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~  212 (331)
T cd06649         141 GEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQG-----THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA  212 (331)
T ss_pred             CcEEEccCcccccccccc---cccCCCCcCcCCHhHhcC-----CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999999999987654321   233578999999999973     568899999999999999999999998766544322


Q ss_pred             HHhhcc------------------------------------------CCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCC
Q psy11571        241 KIMNHQ------------------------------------------NSFDLPSDVGYEISDDAKDLMRRLIC-SSDTR  277 (372)
Q Consensus       241 ~i~~~~------------------------------------------~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R  277 (372)
                      .+....                                          .....+......+++++++||.+||+ ||++|
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~R  292 (331)
T cd06649         213 IFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAER  292 (331)
T ss_pred             HhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccC
Confidence            211000                                          00000111112478999999999999 99999


Q ss_pred             CCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccc
Q psy11571        278 LGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDS  313 (372)
Q Consensus       278 ~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~  313 (372)
                      |++++++                 .||||+......
T Consensus       293 pt~~ell-----------------~h~~~~~~~~~~  311 (331)
T cd06649         293 ADLKMLM-----------------NHTFIKRSEVEE  311 (331)
T ss_pred             CCHHHHh-----------------cChHHhhccccc
Confidence            9877665                 999998765543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=8.9e-44  Score=341.61  Aligned_cols=263  Identities=22%  Similarity=0.326  Sum_probs=209.8

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+.++.+|.|    |+|.||++.+..+++.||+|.+.......        ...+++.+|+.+++.++||||+++++++.
T Consensus         2 ~~~~~~lg~G----~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~   69 (372)
T cd07853           2 VEPDRPIGYG----AFGVVWSVTDPRDGKRVALKKMPNVFQNL--------VSCKRVFRELKMLCFFKHDNVLSALDILQ   69 (372)
T ss_pred             CcccceeeeC----CCEEEEEEEECCCCCEEEEEeccccccch--------HHHHHHHHHHHHHHhCCCCCcCCHhheec
Confidence            3455666666    89999999998899999999875432111        12345778999999999999999999998


Q ss_pred             eCC-----eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC
Q psy11571         84 DDS-----NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD  158 (372)
Q Consensus        84 ~~~-----~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~  158 (372)
                      +.+     ..|+||||+. ++|.+.+.. ...+++..++.++.||+.||.|||++|++|          |||||+|||++
T Consensus        70 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH----------~dlkp~Nili~  137 (372)
T cd07853          70 PPHIDPFEEIYVVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILH----------RDIKPGNLLVN  137 (372)
T ss_pred             CCCccccceEEEEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeC----------CCCChHHEEEC
Confidence            876     7899999985 689988876 568999999999999999999999999999          99999999999


Q ss_pred             CCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHH
Q psy11571        159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET  238 (372)
Q Consensus       159 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~  238 (372)
                      .++.+||+|||+++..............+|+.|+|||++.+    ...++.++|||||||++|||++|++||.+.+..+.
T Consensus       138 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  213 (372)
T cd07853         138 SNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMG----SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ  213 (372)
T ss_pred             CCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcC----CCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH
Confidence            99999999999998654332222233467899999999874    34578899999999999999999999998877666


Q ss_pred             HHHHhhccC---------------------CcCCCC-----CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhh
Q psy11571        239 YGKIMNHQN---------------------SFDLPS-----DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSA  291 (372)
Q Consensus       239 ~~~i~~~~~---------------------~~~~~~-----~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~  291 (372)
                      +..+.....                     ....+.     ......++++.+||.+||+ ||.+|||+++++       
T Consensus       214 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l-------  286 (372)
T cd07853         214 LDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL-------  286 (372)
T ss_pred             HHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHh-------
Confidence            555532110                     000000     1122468999999999999 999999876665       


Q ss_pred             hhhccCCCCCCCCCcCCCCc
Q psy11571        292 LFVSLSISPRNHPWFQGIAW  311 (372)
Q Consensus       292 ~~~~~~~~~~~hp~f~~~~w  311 (372)
                                .||||++..+
T Consensus       287 ----------~hp~~~~~~~  296 (372)
T cd07853         287 ----------AHPYLDEGRL  296 (372)
T ss_pred             ----------cCHhhCCCcc
Confidence                      9999998654

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.3e-44  Score=338.19  Aligned_cols=264  Identities=22%  Similarity=0.318  Sum_probs=204.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      ||+..+.++.|    ++|.||.+.+..++..||+|.+.......        .....+.+|+.+++.++||||+++++++
T Consensus         1 ry~i~~~lg~G----~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~~~~~~   68 (338)
T cd07859           1 RYKIQEVIGKG----SYGVVCSAIDTHTGEKVAIKKINDVFEHV--------SDATRILREIKLLRLLRHPDIVEIKHIM   68 (338)
T ss_pred             CeEEEEEEeec----CCeEEEEEEECCCCCEEEEEEechhhccc--------hhHHHHHHHHHHHHhCCCCCEeeecceE
Confidence            35556666666    89999999999999999999776432111        1234567899999999999999999988


Q ss_pred             EeC-----CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe
Q psy11571         83 QDD-----SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        83 ~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      ...     ..+|+||||| +++|.+++.. ...+++..++.++.||+.||.|||++||+|          |||||+|||+
T Consensus        69 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH----------~dlkp~NIll  136 (338)
T cd07859          69 LPPSRREFKDIYVVFELM-ESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFH----------RDLKPKNILA  136 (338)
T ss_pred             eccCCCCCceEEEEEecC-CCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeec----------CCCCHHHeEE
Confidence            643     2589999999 5799999987 567999999999999999999999999999          9999999999


Q ss_pred             CCCCcEEEeecCcccccCCCCc--ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCH
Q psy11571        158 DANGHIRLADFGSCLRLGGDGT--VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL  235 (372)
Q Consensus       158 ~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~  235 (372)
                      +.++.+||+|||+++.......  .......||+.|+|||++.+.   ...++.++|||||||++|+|++|++||.+.+.
T Consensus       137 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~  213 (338)
T cd07859         137 NADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV  213 (338)
T ss_pred             CCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhcc---ccccCchhHHHHHHHHHHHHHcCCCCCCCCCh
Confidence            9999999999999976432211  112235789999999998631   24688899999999999999999999987665


Q ss_pred             HHHHHHHhhc--------------------------cCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhh
Q psy11571        236 VETYGKIMNH--------------------------QNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKM  288 (372)
Q Consensus       236 ~~~~~~i~~~--------------------------~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~  288 (372)
                      ......+...                          .....+. .....+++.+.++|.+||+ +|++||++++++    
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l----  288 (338)
T cd07859         214 VHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFS-QKFPNADPLALRLLERLLAFDPKDRPTAEEAL----  288 (338)
T ss_pred             HHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchH-HhcCCCChHHHHHHHHHcCcCcccCCCHHHHh----
Confidence            4332221110                          0000000 1112468899999999999 999999876665    


Q ss_pred             hhhhhhccCCCCCCCCCcCCCCc
Q psy11571        289 WSALFVSLSISPRNHPWFQGIAW  311 (372)
Q Consensus       289 ~~~~~~~~~~~~~~hp~f~~~~w  311 (372)
                                   +||||+++..
T Consensus       289 -------------~hp~f~~~~~  298 (338)
T cd07859         289 -------------ADPYFKGLAK  298 (338)
T ss_pred             -------------cCchhhhcCc
Confidence                         9999997664

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0589|consensus

Probab=100.00  E-value=3.1e-44  Score=337.17  Aligned_cols=250  Identities=27%  Similarity=0.419  Sum_probs=223.7

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      +.|..+++.|.|    .||.++.+++..+.+.+++|.+.........        .....+|..+++++.|||||.+.+.
T Consensus         4 ~~Ye~~~~iG~G----afG~a~lvrhk~~~~~~vlK~I~l~~~t~~~--------r~~A~~E~~lis~~~hP~iv~y~ds   71 (426)
T KOG0589|consen    4 DNYEVLRQVGRG----AFGSALLVRHKSDDKLYVLKKINLEKLTEPE--------RRSAIQEMDLLSKLLHPNIVEYKDS   71 (426)
T ss_pred             chhhhhhhcCcc----ccchhhhhhhccCCceEEEEEEeccccCchh--------hHHHHHHHHHHHhccCCCeeeeccc
Confidence            468999999999    7999999999999999999999887765431        1246779999999999999999999


Q ss_pred             EEeCCe-EEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC
Q psy11571         82 FQDDSN-LYLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA  159 (372)
Q Consensus        82 ~~~~~~-~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~  159 (372)
                      |..++. ++|||+||+||+|.+.|.+.+ ..++|+.+..|+.|++.|+.|||+++|+|          ||||+.|||++.
T Consensus        72 ~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLH----------RDlK~~Nifltk  141 (426)
T KOG0589|consen   72 FEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLH----------RDLKCANIFLTK  141 (426)
T ss_pred             hhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhc----------ccchhhhhhccc
Confidence            999888 999999999999999998764 56899999999999999999999999999          999999999999


Q ss_pred             CCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHH
Q psy11571        160 NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY  239 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~  239 (372)
                      ++.|+|+|||+|+.+..... ...+..||+.||+||++.+     .+|+.++|||||||++|||++=+++|.+.+...+.
T Consensus       142 ~~~VkLgDfGlaK~l~~~~~-~a~tvvGTp~YmcPEil~d-----~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li  215 (426)
T KOG0589|consen  142 DKKVKLGDFGLAKILNPEDS-LASTVVGTPYYMCPEILSD-----IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELI  215 (426)
T ss_pred             cCceeecchhhhhhcCCchh-hhheecCCCcccCHHHhCC-----CCCCccCcchhhcchHHHHHhcccccCccchHHHH
Confidence            99999999999999876542 3345789999999999995     67999999999999999999999999999999999


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      .+|.+.. ..++|.    ..+.+++.+|+.||. +|..||++.+++
T Consensus       216 ~ki~~~~-~~Plp~----~ys~el~~lv~~~l~~~P~~RPsa~~LL  256 (426)
T KOG0589|consen  216 LKINRGL-YSPLPS----MYSSELRSLVKSMLRKNPEHRPSALELL  256 (426)
T ss_pred             HHHhhcc-CCCCCc----cccHHHHHHHHHHhhcCCccCCCHHHHh
Confidence            9998875 234455    689999999999999 999999987766

>KOG0604|consensus

Probab=100.00  E-value=5.8e-44  Score=313.36  Aligned_cols=241  Identities=27%  Similarity=0.487  Sum_probs=201.5

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeC----CeEEEEE
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYAFQDD----SNLYLVM   92 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~~~~~----~~~~lv~   92 (372)
                      -.|.|..+.+..++..+|+|.+....               +.++|+++--.. .|||||+++++|+..    ..+.+||
T Consensus        74 inGkV~~C~~k~T~ekfALKvL~Ds~---------------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVm  138 (400)
T KOG0604|consen   74 INGKVVQCVHKRTQEKFALKVLLDSP---------------KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVM  138 (400)
T ss_pred             cCCceEEEEeccchhhhHHHHHhcCH---------------HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeee
Confidence            46789999999999999999876533               245677766554 599999999998754    4688999


Q ss_pred             eccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC---CcEEEeec
Q psy11571         93 DYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN---GHIRLADF  168 (372)
Q Consensus        93 E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~---~~vkl~Df  168 (372)
                      |.++||.|.+.++.. ...++|.++..++.||..|+.|||+.+|.|          |||||+|+|...+   -.+||+||
T Consensus       139 E~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAH----------RDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  139 ECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAH----------RDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             ecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhh----------ccCChhheeeecCCCCcceEeccc
Confidence            999999999999874 235999999999999999999999999999          9999999999744   46899999


Q ss_pred             CcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH----HHHHHHhh
Q psy11571        169 GSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV----ETYGKIMN  244 (372)
Q Consensus       169 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~----~~~~~i~~  244 (372)
                      |+|+........  .+.|-||.|.|||++.     ...|+..+|+||+||++|-|++|.+||.+....    .+..+|..
T Consensus       209 GFAK~t~~~~~L--~TPc~TPyYvaPevlg-----~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~  281 (400)
T KOG0604|consen  209 GFAKETQEPGDL--MTPCFTPYYVAPEVLG-----PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT  281 (400)
T ss_pred             ccccccCCCccc--cCCcccccccCHHHhC-----chhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc
Confidence            999886654433  3367899999999997     567999999999999999999999999876432    34567777


Q ss_pred             ccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        245 HQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      ++  +.+|...|..+|++++|+|+.||. +|++|++.+++   +              .|||+.+.
T Consensus       282 gq--y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~---m--------------~hpwi~~~  328 (400)
T KOG0604|consen  282 GQ--YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEV---M--------------DHPWINQY  328 (400)
T ss_pred             cC--ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHh---h--------------cCchhccc
Confidence            55  566777777999999999999999 99999985554   4              99999863

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=6e-43  Score=324.55  Aligned_cols=269  Identities=23%  Similarity=0.345  Sum_probs=220.0

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      +.|+.++.++.|    ++|.||+++...+++.+++|.......          +..+.+.+|+.+++.++||||+++++.
T Consensus        12 ~~y~i~~~lg~g----~~g~vy~~~~~~~~~~~~~k~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~   77 (292)
T cd06644          12 EVWEIIGELGDG----AFGKVYKAKNKETGALAAAKVIETKSE----------EELEDYMVEIEILATCNHPYIVKLLGA   77 (292)
T ss_pred             hhhhhhheecCC----CCeEEEEEEECCCCceEEEEEeccCCH----------HHHHHHHHHHHHHHhCCCCcEeeeEEE
Confidence            568888888887    899999999988999999998765321          134557789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +..++.+|+||||+++++|..++.+....+++..+..++.|++.+|.|||+.|++|          |||||+||+++.++
T Consensus        78 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H----------~dlkp~Nili~~~~  147 (292)
T cd06644          78 FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIH----------RDLKAGNVLLTLDG  147 (292)
T ss_pred             EEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeee----------cCCCcceEEEcCCC
Confidence            99999999999999999999988765567999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .++|+|||++....... .......+++.|+|||++.+.......++.++|+|||||++|+|++|.+||...+......+
T Consensus       148 ~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~  226 (292)
T cd06644         148 DIKLADFGVSAKNVKTL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK  226 (292)
T ss_pred             CEEEccCccceeccccc-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHH
Confidence            99999999886543221 12233568899999999863222234578899999999999999999999988776666655


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccccc
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIR  315 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~  315 (372)
                      +...... ..+  ....++.++.++|.+||. +|++||++++++                 .||||..++|....
T Consensus       227 ~~~~~~~-~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il-----------------~~~~~~~~~~~~~~  281 (292)
T cd06644         227 IAKSEPP-TLS--QPSKWSMEFRDFLKTALDKHPETRPSAAQLL-----------------EHPFVSSVTSNRPL  281 (292)
T ss_pred             HhcCCCc-cCC--CCcccCHHHHHHHHHHhcCCcccCcCHHHHh-----------------cCccccccccchhH
Confidence            5443211 111  112678999999999999 999999866554                 99999999998753

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.4e-43  Score=326.71  Aligned_cols=258  Identities=26%  Similarity=0.352  Sum_probs=201.8

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeeh-hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhc---CCCCceee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLL-DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVY---GDRRWITN   77 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~-~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~---l~hp~Iv~   77 (372)
                      .+|+.++.+|.|    ++|.||++++.. +++.||+|.+.........        ...+.+|..+++.   ++||||++
T Consensus         1 ~~Y~~~~~lg~G----~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~--------~~~~~~e~~~l~~l~~~~hpniv~   68 (290)
T cd07862           1 QQYECVAEIGEG----AYGKVFKARDLKNGGRFVALKRVRVQTGEEGM--------PLSTIREVAVLRHLETFEHPNVVR   68 (290)
T ss_pred             CCcceeeEeccC----CCeEEEEEEEcCCCCeEEEEEEEecccCCCCc--------hHHHHHHHHHHHhhcccCCCCcce
Confidence            367888888887    899999998755 4678999987654332210        1123345555554   47999999


Q ss_pred             eeEEEE-----eCCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCC
Q psy11571         78 LHYAFQ-----DDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIK  151 (372)
Q Consensus        78 l~~~~~-----~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlk  151 (372)
                      +++++.     ....+++||||+. ++|.+++... ...+++..++.++.||+.||.|||++|++|          ||||
T Consensus        69 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH----------~dlk  137 (290)
T cd07862          69 LFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVH----------RDLK  137 (290)
T ss_pred             EEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeee----------CCCC
Confidence            999885     2456899999995 6999998763 245899999999999999999999999999          9999


Q ss_pred             cCcEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCC
Q psy11571        152 PDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY  231 (372)
Q Consensus       152 p~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~  231 (372)
                      |+|||++.++.+||+|||+++......  ......||+.|+|||++.+     ..++.++|+|||||++|||++|.+||.
T Consensus       138 p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~~f~  210 (290)
T cd07862         138 PQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQ-----SSYATPVDLWSVGCIFAEMFRRKPLFR  210 (290)
T ss_pred             HHHEEEcCCCCEEEccccceEeccCCc--ccccccccccccChHHHhC-----CCCCCccchHHHHHHHHHHHcCCCCcC
Confidence            999999999999999999997654332  2234578999999999973     568899999999999999999999999


Q ss_pred             CCCHHHHHHHHhhccCCc---CCCC------------------CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhh
Q psy11571        232 AESLVETYGKIMNHQNSF---DLPS------------------DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMW  289 (372)
Q Consensus       232 ~~~~~~~~~~i~~~~~~~---~~~~------------------~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~  289 (372)
                      +.+..+.+.++.......   .++.                  .....+++.+++||.+||+ ||++||++.+++     
T Consensus       211 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l-----  285 (290)
T cd07862         211 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL-----  285 (290)
T ss_pred             CCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHh-----
Confidence            988877777775432111   0000                  0112578899999999999 999999876665     


Q ss_pred             hhhhhccCCCCCCCCCc
Q psy11571        290 SALFVSLSISPRNHPWF  306 (372)
Q Consensus       290 ~~~~~~~~~~~~~hp~f  306 (372)
                                  +||||
T Consensus       286 ------------~hp~f  290 (290)
T cd07862         286 ------------SHPYF  290 (290)
T ss_pred             ------------cCCCC
Confidence                        99998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-42  Score=317.13  Aligned_cols=252  Identities=37%  Similarity=0.673  Sum_probs=210.0

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHH-HhcCCCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDV-LVYGDRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~i-l~~l~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      +++|.||++.+..+++.+|+|.+........       +....+..|..+ ....+||||+++++++...+.+|+||||+
T Consensus         7 g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   79 (260)
T cd05611           7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAK-------NQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL   79 (260)
T ss_pred             CCCeeEEEEEecCCCCeEEEEEecchhhhHH-------HHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence            3899999999988999999998764433221       112223344444 44568999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccC
Q psy11571         96 CGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG  175 (372)
Q Consensus        96 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~  175 (372)
                      ++++|.+++.. .+.+++..+..++.|++.||.|||+.|++|          |||+|+||+++.++.++|+|||++....
T Consensus        80 ~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H----------~dl~p~nil~~~~~~~~l~dfg~~~~~~  148 (260)
T cd05611          80 NGGDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIH----------RDIKPENLLIDQTGHLKLTDFGLSRNGL  148 (260)
T ss_pred             CCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeec----------CCCCHHHeEECCCCcEEEeecccceecc
Confidence            99999999987 467999999999999999999999999999          9999999999999999999999987643


Q ss_pred             CCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCC
Q psy11571        176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDV  255 (372)
Q Consensus       176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  255 (372)
                      .     .....|+..|+|||.+.+     ..++.++|+||||+++|+|++|..||...+....+..+......  .+...
T Consensus       149 ~-----~~~~~~~~~y~~pe~~~~-----~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~  216 (260)
T cd05611         149 E-----NKKFVGTPDYLAPETILG-----VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN--WPEEV  216 (260)
T ss_pred             c-----cccCCCCcCccChhhhcC-----CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC--CCCcc
Confidence            3     223568899999999873     44789999999999999999999999988888877777654332  23323


Q ss_pred             CCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcc
Q psy11571        256 GYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWD  312 (372)
Q Consensus       256 ~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~  312 (372)
                      ...+++++.++|.+||+ +|++||++.++.+++              .||||++++|+
T Consensus       217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l--------------~~~~~~~~~~~  260 (260)
T cd05611         217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK--------------SHPFFKSINWD  260 (260)
T ss_pred             cccCCHHHHHHHHHHccCCHHHccCCCcHHHHH--------------cChHhhcCCCC
Confidence            33679999999999999 999999999999988              99999999996

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0197|consensus

Probab=100.00  E-value=1.1e-42  Score=327.99  Aligned_cols=250  Identities=21%  Similarity=0.311  Sum_probs=214.2

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      +.++.+.++|.|    -||.|+..+. .....||+|.++...+..+           .+.+|+.+|+.|+|++||+++++
T Consensus       206 ~~l~l~~~LG~G----~FG~V~~g~~-~~~~~vavk~ik~~~m~~~-----------~f~~Ea~iMk~L~H~~lV~l~gV  269 (468)
T KOG0197|consen  206 EELKLIRELGSG----QFGEVWLGKW-NGSTKVAVKTIKEGSMSPE-----------AFLREAQIMKKLRHEKLVKLYGV  269 (468)
T ss_pred             HHHHHHHHhcCC----ccceEEEEEE-cCCCcccceEEeccccChh-----------HHHHHHHHHHhCcccCeEEEEEE
Confidence            356778888888    5999998853 3445899998888755433           35589999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSK-FEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      +..+..+||||||++.|+|.++|+. .+..+...+...++.||++|++||+++++||          |||...||||+++
T Consensus       270 ~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IH----------RDLAARNiLV~~~  339 (468)
T KOG0197|consen  270 CTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIH----------RDLAARNILVDED  339 (468)
T ss_pred             EecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccc----------hhhhhhheeeccC
Confidence            9998899999999999999999987 4567899999999999999999999999999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETY  239 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~  239 (372)
                      +.+||+|||+|+....+.........-...|.|||.+.     .+.++.+||||||||+|+||+| |+.||.+.+..+.+
T Consensus       340 ~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~-----~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~  414 (468)
T KOG0197|consen  340 LVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALN-----YGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL  414 (468)
T ss_pred             ceEEEcccccccccCCCceeecCCCCCCceecCHHHHh-----hCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH
Confidence            99999999999965544332222223355899999998     5789999999999999999998 99999999999999


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ..+.++ .+.+-|.    .+|+++-+++..|+. +|++|||++.+...+
T Consensus       415 ~~le~G-yRlp~P~----~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l  458 (468)
T KOG0197|consen  415 ELLERG-YRLPRPE----GCPDEVYELMKSCWHEDPEDRPTFETLREVL  458 (468)
T ss_pred             HHHhcc-CcCCCCC----CCCHHHHHHHHHHhhCCcccCCCHHHHHHHH
Confidence            999876 4555566    799999999999999 999999988666544

>KOG0607|consensus

Probab=100.00  E-value=9.6e-44  Score=314.37  Aligned_cols=255  Identities=25%  Similarity=0.427  Sum_probs=213.9

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      ++|+|-.+..+.++..+|+|.+.+.....          .+++.+|++++.+++ |+||++++++|+++..+|||||-|.
T Consensus        90 AyasVqtcv~i~t~~EYAVKiidKq~gHs----------R~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~  159 (463)
T KOG0607|consen   90 AYASVQTCVSIQTGKEYAVKIIDKQPGHS----------RSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR  159 (463)
T ss_pred             cceeeeeeeeeccchhhhhhhhhcCCchH----------HHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence            67888888889999999999998765433          356778999999885 9999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC---cEEEeecCcccc
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG---HIRLADFGSCLR  173 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~---~vkl~Dfg~a~~  173 (372)
                      ||.|.++|.+ +..++|.++..++.+|+.||.|||.+||.|          |||||+|||-.+.+   -||||||.+..-
T Consensus       160 GGplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAH----------RDlKPENiLC~~pn~vsPvKiCDfDLgSg  228 (463)
T KOG0607|consen  160 GGPLLSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAH----------RDLKPENILCESPNKVSPVKICDFDLGSG  228 (463)
T ss_pred             CchHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCccc----------ccCCccceeecCCCCcCceeeeccccccc
Confidence            9999999988 578999999999999999999999999999          99999999997655   479999987654


Q ss_pred             cCCC------CcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCC-------------
Q psy11571        174 LGGD------GTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES-------------  234 (372)
Q Consensus       174 ~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~-------------  234 (372)
                      ....      .+..-.+.+|+..|||||++.-..+....|+.++|.||||||+|-|+.|.+||.+.-             
T Consensus       229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr  308 (463)
T KOG0607|consen  229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR  308 (463)
T ss_pred             cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence            3211      111223468999999999976333334578999999999999999999999997631             


Q ss_pred             --HHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCc
Q psy11571        235 --LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAW  311 (372)
Q Consensus       235 --~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w  311 (372)
                        ...++..|..+  .+.+|...|..+|.+++|||+.||. ++.+|+++.+++                 +|||++.+.-
T Consensus       309 ~CQ~~LFesIQEG--kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vl-----------------nhPw~~~~~~  369 (463)
T KOG0607|consen  309 VCQNKLFESIQEG--KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVL-----------------NHPWVQRCAP  369 (463)
T ss_pred             HHHHHHHHHHhcc--CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhcc-----------------CCccccccch
Confidence              23467777664  5677888888999999999999999 999999877766                 9999998765


Q ss_pred             c
Q psy11571        312 D  312 (372)
Q Consensus       312 ~  312 (372)
                      +
T Consensus       370 e  370 (463)
T KOG0607|consen  370 E  370 (463)
T ss_pred             h
Confidence            5

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.8e-43  Score=330.82  Aligned_cols=262  Identities=23%  Similarity=0.360  Sum_probs=209.6

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    |+|.||++.+..++..+|+|.+........         ...+.+|+.+++.++||||++++++
T Consensus         6 ~~y~~~~~lg~G----~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~   72 (309)
T cd07872           6 ETYIKLEKLGEG----TYATVFKGRSKLTENLVALKEIRLEHEEGA---------PCTAIREVSLLKDLKHANIVTLHDI   72 (309)
T ss_pred             CceEEEEEeccc----CCEEEEEEEecCCCCeEEEEEeeccccCCc---------chhHHHHHHHHHhCCCCCcceEEEE
Confidence            356667777777    899999999988999999998765432221         1235579999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+++..|+||||+. ++|.+++...+..+++..++.++.||+.||.|||++||+|          |||||+||+++.++
T Consensus        73 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH----------~dlkp~Nill~~~~  141 (309)
T cd07872          73 VHTDKSLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLH----------RDLKPQNLLINERG  141 (309)
T ss_pred             EeeCCeEEEEEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeec----------CCCCHHHEEECCCC
Confidence            999999999999996 5899988775566899999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .+||+|||++........ ......+|+.|+|||++.+    ...++.++|+|||||++|+|++|++||.+.+..+....
T Consensus       142 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~  216 (309)
T cd07872         142 ELKLADFGLARAKSVPTK-TYSNEVVTLWYRPPDVLLG----SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL  216 (309)
T ss_pred             CEEECccccceecCCCcc-ccccccccccccCCHHHhC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            999999999876533222 1223467899999999873    35678899999999999999999999998876665554


Q ss_pred             HhhccCC-----------------cCCCC-------CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhcc
Q psy11571        242 IMNHQNS-----------------FDLPS-------DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSL  296 (372)
Q Consensus       242 i~~~~~~-----------------~~~~~-------~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~  296 (372)
                      +......                 ...+.       .....+++++++||.+||+ ||.+|+|+++++            
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l------------  284 (309)
T cd07872         217 IFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAM------------  284 (309)
T ss_pred             HHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHh------------
Confidence            4331110                 00111       0112578999999999999 999999876665            


Q ss_pred             CCCCCCCCCcCCC
Q psy11571        297 SISPRNHPWFQGI  309 (372)
Q Consensus       297 ~~~~~~hp~f~~~  309 (372)
                           .||||+++
T Consensus       285 -----~h~~~~~~  292 (309)
T cd07872         285 -----KHAYFRSL  292 (309)
T ss_pred             -----cChhhhhc
Confidence                 99999865

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=5.9e-43  Score=322.14  Aligned_cols=268  Identities=29%  Similarity=0.540  Sum_probs=213.0

Q ss_pred             ccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         16 IQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        16 ~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      .||+|.||.+.+..+++.+++|.+........       ...+.+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus         3 ~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   75 (277)
T cd05577           3 KGGFGEVCACQVKATGKMYACKKLDKKRLKKR-------KGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLM   75 (277)
T ss_pred             CCCceeEEEEEEcCCCcEEEEEEEehhhhhhh-------hhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecC
Confidence            35899999999888999999998765433222       12344567999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCccccc
Q psy11571         96 CGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL  174 (372)
Q Consensus        96 ~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~  174 (372)
                      ++++|.+++.+.. ..+++..+..++.|++.||.|||+.|++|          |||+|+||+++.++.++|+|||.+...
T Consensus        76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H----------~di~p~Nil~~~~~~~~l~dfg~~~~~  145 (277)
T cd05577          76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY----------RDLKPENVLLDDHGNVRISDLGLAVEL  145 (277)
T ss_pred             CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCccc----------CCCCHHHEEECCCCCEEEccCcchhhh
Confidence            9999999997632 26899999999999999999999999999          999999999999999999999998765


Q ss_pred             CCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCC
Q psy11571        175 GGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSD  254 (372)
Q Consensus       175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  254 (372)
                      ....  ......++..|+|||++.+     ..++.++|+|||||++|+|++|+.||...........+.....  ..+..
T Consensus       146 ~~~~--~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~  216 (277)
T cd05577         146 KGGK--KIKGRAGTPGYMAPEVLQG-----EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL--EMAVE  216 (277)
T ss_pred             ccCC--ccccccCCCCcCCHHHhcC-----CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc--ccccc
Confidence            4321  1223457889999999873     4588899999999999999999999987654222222221111  11112


Q ss_pred             CCCCCCHHHHHHHHHhcc-CCCCCCCCCC--hhhhhhhhhhhhccCCCCCCCCCcCCCCccccc--cCCCCCcC
Q psy11571        255 VGYEISDDAKDLMRRLIC-SSDTRLGQNG--IADFKMWSALFVSLSISPRNHPWFQGIAWDSIR--DSNAPYIP  323 (372)
Q Consensus       255 ~~~~~s~~~~~li~~lL~-~p~~R~s~~~--~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~--~~~~p~~p  323 (372)
                      ....+++++.++|++||+ +|.+||+.++  +.+++              .||||..++|+.+.  ..+|||.|
T Consensus       217 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll--------------~h~~~~~~~~~~~~~~~~~~~~~~  276 (277)
T cd05577         217 YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVR--------------EHPLFKDLNWRRLEAGMLEPPFIP  276 (277)
T ss_pred             CCccCCHHHHHHHHHHccCChhHccCCCcccHHHHH--------------hChhhhcCChhhhhcCCCCCCCCC
Confidence            222679999999999999 9999997543  45555              99999999998874  34677776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-43  Score=340.50  Aligned_cols=253  Identities=22%  Similarity=0.310  Sum_probs=198.2

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||.+.+..+++.||+|....                ..+.+|+.+++.++||||++++++|
T Consensus        93 ~y~~~~~lg~G----~~g~V~~~~d~~~~~~vaiK~~~~----------------~~~~~E~~il~~l~HpnIv~~~~~~  152 (391)
T PHA03212         93 GFSILETFTPG----AEGFAFACIDNKTCEHVVIKAGQR----------------GGTATEAHILRAINHPSIIQLKGTF  152 (391)
T ss_pred             CcEEEEEEcCC----CCeEEEEEEECCCCCEEEEechhh----------------hhhHHHHHHHHhCCCCCCCCEeEEE
Confidence            45555566655    899999999999999999995321                2246799999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      ......++|||++ +++|..++.. ...+++..++.++.||+.||.|||++||+|          |||||+|||++.++.
T Consensus       153 ~~~~~~~lv~e~~-~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvH----------rDiKP~NIll~~~~~  220 (391)
T PHA03212        153 TYNKFTCLILPRY-KTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIH----------RDIKAENIFINHPGD  220 (391)
T ss_pred             EECCeeEEEEecC-CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccc----------CCCChHhEEEcCCCC
Confidence            9999999999998 5799999877 467999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCC-------H
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES-------L  235 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~-------~  235 (372)
                      +||+|||+++..............||+.|+|||++.     ...++.++|||||||++|||++|..||....       .
T Consensus       221 vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~  295 (391)
T PHA03212        221 VCLGDFGAACFPVDINANKYYGWAGTIATNAPELLA-----RDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDS  295 (391)
T ss_pred             EEEEeCCcccccccccccccccccCccCCCChhhhc-----CCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCch
Confidence            999999999754322222223457999999999997     3568999999999999999999998875421       1


Q ss_pred             HHHHHHHhhccCCc--C----------------------CCCC-----CCCCCCHHHHHHHHHhcc-CCCCCCCCCChhh
Q psy11571        236 VETYGKIMNHQNSF--D----------------------LPSD-----VGYEISDDAKDLMRRLIC-SSDTRLGQNGIAD  285 (372)
Q Consensus       236 ~~~~~~i~~~~~~~--~----------------------~~~~-----~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~  285 (372)
                      ...+..+.......  .                      .+..     ....++.++.+||.+||+ ||.+|||+++++ 
T Consensus       296 ~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL-  374 (391)
T PHA03212        296 DRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALL-  374 (391)
T ss_pred             hHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHh-
Confidence            11222221110000  0                      0000     001356789999999999 999999977766 


Q ss_pred             hhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        286 FKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       286 i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                                      .||||+.+
T Consensus       375 ----------------~hp~f~~~  382 (391)
T PHA03212        375 ----------------DFAAFQDI  382 (391)
T ss_pred             ----------------cChhhccC
Confidence                            99999863

>KOG0658|consensus

Probab=100.00  E-value=4.2e-44  Score=323.01  Aligned_cols=245  Identities=26%  Similarity=0.409  Sum_probs=202.2

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC-----eEEEEE
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS-----NLYLVM   92 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~-----~~~lv~   92 (372)
                      .||.||.+.-..++..||+|++-....-+              .+|..+|+.++|||||++..+|....     ...+||
T Consensus        36 sFg~Vyq~~~~e~~~~vAIKKv~~d~r~k--------------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl  101 (364)
T KOG0658|consen   36 SFGVVYQAKLRETEEEVAIKKVLQDKRYK--------------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL  101 (364)
T ss_pred             ccceEEEEEEcCCCceeEEEEecCCCCcC--------------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence            79999999988899999999776544322              35899999999999999999987542     356999


Q ss_pred             eccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC-CcEEEeec
Q psy11571         93 DYYCGGDLLTLLSKF---EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADF  168 (372)
Q Consensus        93 E~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~-~~vkl~Df  168 (372)
                      ||++. +|.++++..   +..++.-.++.|+.||+.||+|||+.||+|          |||||+|||+|.+ |.+|||||
T Consensus       102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcH----------RDIKPqNlLvD~~tg~LKicDF  170 (364)
T KOG0658|consen  102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICH----------RDIKPQNLLVDPDTGVLKICDF  170 (364)
T ss_pred             HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCccc----------CCCChheEEEcCCCCeEEeccC
Confidence            99955 999999843   568999999999999999999999999999          9999999999954 99999999


Q ss_pred             CcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccC-
Q psy11571        169 GSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQN-  247 (372)
Q Consensus       169 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-  247 (372)
                      |.|+.+..+...  .++..|..|.|||.+.+    ...|+.+.||||.||++.||+-|++.|.|.+..+.+..|.+--+ 
T Consensus       171 GSAK~L~~~epn--iSYicSRyYRaPELifg----a~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~  244 (364)
T KOG0658|consen  171 GSAKVLVKGEPN--ISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGT  244 (364)
T ss_pred             CcceeeccCCCc--eeEEEeccccCHHHHcC----ccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCC
Confidence            999988655433  33667999999999995    67899999999999999999999999999988877666643111 


Q ss_pred             --------------CcCCCC--------CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCC
Q psy11571        248 --------------SFDLPS--------DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHP  304 (372)
Q Consensus       248 --------------~~~~~~--------~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp  304 (372)
                                    ...+|.        ......++++.+|+.++|. +|.+|.++.+++                 .||
T Consensus       245 Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l-----------------~h~  307 (364)
T KOG0658|consen  245 PTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEAL-----------------AHP  307 (364)
T ss_pred             CCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHh-----------------cch
Confidence                          011111        1234679999999999999 999999876665                 999


Q ss_pred             CcCCCC
Q psy11571        305 WFQGIA  310 (372)
Q Consensus       305 ~f~~~~  310 (372)
                      ||....
T Consensus       308 fFdelr  313 (364)
T KOG0658|consen  308 FFDELR  313 (364)
T ss_pred             hhHHhh
Confidence            998653

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=6.3e-43  Score=333.40  Aligned_cols=256  Identities=22%  Similarity=0.319  Sum_probs=202.1

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      .|+.++.+|.|    ++|.||++.+..+++.||+|.+......         ...+.+.+|+.+++.++||||+++++++
T Consensus        75 ~~~~~~~lg~G----~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv~~~~~~  141 (353)
T PLN00034         75 ELERVNRIGSG----AGGTVYKVIHRPTGRLYALKVIYGNHED---------TVRRQICREIEILRDVNHPNVVKCHDMF  141 (353)
T ss_pred             HHhhhhhccCC----CCeEEEEEEECCCCCEEEEEEEecCCcH---------HHHHHHHHHHHHHHhCCCCCcceeeeEe
Confidence            56777777777    8999999999889999999987543211         1235678899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+.+.+|+||||+.+|+|...     ...++..+..++.||+.||.|||++|++|          |||||+|||++.++.
T Consensus       142 ~~~~~~~lv~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH----------rDlkp~NIll~~~~~  206 (353)
T PLN00034        142 DHNGEIQVLLEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVH----------RDIKPSNLLINSAKN  206 (353)
T ss_pred             ccCCeEEEEEecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEee----------cCCCHHHEEEcCCCC
Confidence            999999999999999998643     34578888999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH---HHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETY  239 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~---~~~  239 (372)
                      +||+|||+++....... ......||..|+|||++..........+.++|||||||++|||++|+.||......   ...
T Consensus       207 ~kL~DfG~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~  285 (353)
T PLN00034        207 VKIADFGVSRILAQTMD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM  285 (353)
T ss_pred             EEEcccccceecccccc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHH
Confidence            99999999976543221 12335789999999998532111233457899999999999999999999743322   222


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      ..+... .....+    ..++.++++||.+||. ||++||++++++                 +||||.+-
T Consensus       286 ~~~~~~-~~~~~~----~~~~~~l~~li~~~l~~~P~~Rpt~~ell-----------------~hp~~~~~  334 (353)
T PLN00034        286 CAICMS-QPPEAP----ATASREFRHFISCCLQREPAKRWSAMQLL-----------------QHPFILRA  334 (353)
T ss_pred             HHHhcc-CCCCCC----CccCHHHHHHHHHHccCChhhCcCHHHHh-----------------cCcccccC
Confidence            222221 112222    2679999999999999 999999866655                 99999974

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-42  Score=316.08  Aligned_cols=252  Identities=27%  Similarity=0.384  Sum_probs=206.5

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+..+.++.|    ++|.||.+.+..+++.+++|.+........     .....+.+.+|+.+++.++||||+++++++.
T Consensus         4 ~~~~~~lg~g----~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   74 (263)
T cd06625           4 WRRGKLLGQG----AFGRVYLCYDVDTGRELAVKQVPFDPDSPE-----TKKEVNALECEIQLLKNLQHERIVQYYGCLR   74 (263)
T ss_pred             ccccceecCC----CceEEEEEEEcCCCcEEEEEEEeecccchh-----hHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc
Confidence            4444455555    789999999888899999997764432221     1233566889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcE
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI  163 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~v  163 (372)
                      ++..+++||||+++++|.+++.. .+.+++..++.++.|++.||.|||+.|++|          |||+|+||+++.++.+
T Consensus        75 ~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H----------~dl~p~nilv~~~~~~  143 (263)
T cd06625          75 DDETLSIFMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVH----------RDIKGANILRDSAGNV  143 (263)
T ss_pred             cCCeEEEEEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeec----------CCCCHHHEEEcCCCCE
Confidence            99999999999999999999987 467899999999999999999999999999          9999999999999999


Q ss_pred             EEeecCcccccCCCCcccc--cccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        164 RLADFGSCLRLGGDGTVQS--NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       164 kl~Dfg~a~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      +|+|||+++..........  ....|+..|+|||++.+     ..++.++|+||||+++|+|++|+.||...+......+
T Consensus       144 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~  218 (263)
T cd06625         144 KLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG-----EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK  218 (263)
T ss_pred             EEeecccceeccccccccccccCCCcCccccCcceecc-----CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHH
Confidence            9999999876543221111  23467889999999984     4588999999999999999999999988776666666


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      +........++.    .++..+.++|++||. +|.+||++++++
T Consensus       219 ~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~ll  258 (263)
T cd06625         219 IATQPTNPQLPS----HVSPDARNFLRRTFVENAKKRPSAEELL  258 (263)
T ss_pred             HhccCCCCCCCc----cCCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence            555444444444    689999999999999 999999866655

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.8e-42  Score=316.02  Aligned_cols=254  Identities=33%  Similarity=0.639  Sum_probs=214.2

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      +++|.||++....+++.+++|.+........       ...+.+.+|+.+++.++||||+++++.+.++..+|++|||++
T Consensus         4 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   76 (262)
T cd05572           4 GGFGRVELVKVKSKNRTFALKCVKKRHIVET-------GQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCL   76 (262)
T ss_pred             CCceEEEEEEECCCCcEEEEEEEehhcchhh-------hHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCC
Confidence            4899999999988899999998875543322       233568889999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCC
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG  176 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  176 (372)
                      +++|.+++.+ ...+++..+..++.||+.||.|||+.|++|          +||+|+||+++.++.++|+|||++.....
T Consensus        77 ~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h----------~dl~~~nilv~~~~~~~l~df~~~~~~~~  145 (262)
T cd05572          77 GGELWTILRD-RGLFDEYTARFYIACVVLAFEYLHNRGIIY----------RDLKPENLLLDSNGYVKLVDFGFAKKLKS  145 (262)
T ss_pred             CCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCccc----------CCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence            9999999987 467899999999999999999999999999          99999999999999999999999987654


Q ss_pred             CCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCC--HHHHHHHHhhccCCcCCCCC
Q psy11571        177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES--LVETYGKIMNHQNSFDLPSD  254 (372)
Q Consensus       177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~  254 (372)
                      ..  ......|++.|+|||.+.+     ..++.++|+||||+++|+|++|..||....  ..+.+.++.........|. 
T Consensus       146 ~~--~~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-  217 (262)
T cd05572         146 GQ--KTWTFCGTPEYVAPEIILN-----KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN-  217 (262)
T ss_pred             cc--ccccccCCcCccChhHhcC-----CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCc-
Confidence            32  2233568899999999873     557889999999999999999999998776  6666777665444444454 


Q ss_pred             CCCCCCHHHHHHHHHhcc-CCCCCCCC--CChhhhhhhhhhhhccCCCCCCCCCcCCCCccc
Q psy11571        255 VGYEISDDAKDLMRRLIC-SSDTRLGQ--NGIADFKMWSALFVSLSISPRNHPWFQGIAWDS  313 (372)
Q Consensus       255 ~~~~~s~~~~~li~~lL~-~p~~R~s~--~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~  313 (372)
                         ..+++++++|.+||. +|++|++.  ..+.+++              +||||++++|+.
T Consensus       218 ---~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~--------------~~~~~~~~~~~~  262 (262)
T cd05572         218 ---YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIK--------------KHKWFNGFDWEG  262 (262)
T ss_pred             ---ccCHHHHHHHHHHccCChhhCcCCcccCHHHHh--------------cChhhhCCCCCC
Confidence               458999999999999 99999982  2355666              999999999973

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=9e-43  Score=333.64  Aligned_cols=257  Identities=20%  Similarity=0.351  Sum_probs=203.8

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    |+|.||.+.+..+++.+|+|.+........        ..+.+.+|+.+++.++||||++++++
T Consensus        24 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~ii~~~~~   91 (364)
T cd07875          24 KRYQNLKPIGSG----AQGIVCAAYDAILERNVAIKKLSRPFQNQT--------HAKRAYRELVLMKCVNHKNIIGLLNV   91 (364)
T ss_pred             cceeEEEEeecC----CCeEEEEEEECCCCcEEEEEEeCccccCch--------hHHHHHHHHHHHHhcCCCCcccccee
Confidence            356666677776    899999999998999999998765432211        23456779999999999999999998


Q ss_pred             EEeC------CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcE
Q psy11571         82 FQDD------SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNV  155 (372)
Q Consensus        82 ~~~~------~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NI  155 (372)
                      +...      ..+|+||||+. ++|.+.+..   .+++..+..++.|++.||.|||++||+|          |||||+||
T Consensus        92 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH----------~Dlkp~NI  157 (364)
T cd07875          92 FTPQKSLEEFQDVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIH----------RDLKPSNI  157 (364)
T ss_pred             ecccccccccCeEEEEEeCCC-CCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeec----------CCCCHHHE
Confidence            8644      35799999995 588887753   4889999999999999999999999999          99999999


Q ss_pred             EeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCH
Q psy11571        156 LLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL  235 (372)
Q Consensus       156 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~  235 (372)
                      |++.++.+||+|||+++.......  .....||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.+.+.
T Consensus       158 ll~~~~~~kL~DfG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  230 (364)
T cd07875         158 VVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMIKGGVLFPGTDH  230 (364)
T ss_pred             EECCCCcEEEEeCCCccccCCCCc--ccCCcccCCcCCHHHHhC-----CCCCchhhHHhHHHHHHHHHhCCCCCCCCCH
Confidence            999999999999999986543322  233578999999999973     5688999999999999999999999998887


Q ss_pred             HHHHHHHhhccCCc------------------------------------CCCCCCCCCCCHHHHHHHHHhcc-CCCCCC
Q psy11571        236 VETYGKIMNHQNSF------------------------------------DLPSDVGYEISDDAKDLMRRLIC-SSDTRL  278 (372)
Q Consensus       236 ~~~~~~i~~~~~~~------------------------------------~~~~~~~~~~s~~~~~li~~lL~-~p~~R~  278 (372)
                      .+.+.+++......                                    +.........+..+++||.+||+ ||.+||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~  310 (364)
T cd07875         231 IDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI  310 (364)
T ss_pred             HHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCC
Confidence            77666654321110                                    00000011235789999999999 999999


Q ss_pred             CCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        279 GQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       279 s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      |+++++                 +||||..
T Consensus       311 t~~e~L-----------------~hp~~~~  323 (364)
T cd07875         311 SVDEAL-----------------QHPYINV  323 (364)
T ss_pred             CHHHHh-----------------cCccccc
Confidence            977666                 9999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-42  Score=318.18  Aligned_cols=264  Identities=23%  Similarity=0.368  Sum_probs=218.9

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.++.|    ++|.||.+....++..+++|.+......          ..+.+.+|+.+++.++||||+++++.
T Consensus         5 ~~~~i~~~l~~g----~~~~v~~~~~~~~~~~~~iK~~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~   70 (280)
T cd06611           5 DIWEIIGELGDG----AFGKVYKAQHKETGLFAAAKIIQIESEE----------ELEDFMVEIDILSECKHPNIVGLYEA   70 (280)
T ss_pred             hHHHHHHHhcCC----CCceEEEEEEcCCCcEEEEEEEeeCCHH----------HHHHHHHHHHHHHhCCCCceeEEEEE
Confidence            689999999998    7999999998888999999987643221          23557789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.++...|+||||+++++|.+++.+....+++..++.++.|++.||.|||+.|++|          +||||+||+++.++
T Consensus        71 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h----------~dl~p~nili~~~~  140 (280)
T cd06611          71 YFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIH----------RDLKAGNILLTLDG  140 (280)
T ss_pred             EecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------CCCChhhEEECCCC
Confidence            99999999999999999999999875567999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .++|+|||++........ ......|++.|+|||.+.........++.++|+|||||++|+|++|++||...+......+
T Consensus       141 ~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~  219 (280)
T cd06611         141 DVKLADFGVSAKNKSTLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLK  219 (280)
T ss_pred             CEEEccCccchhhccccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHH
Confidence            999999998876543222 2233568999999999863222234577899999999999999999999998877776666


Q ss_pred             HhhccC-CcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCc
Q psy11571        242 IMNHQN-SFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAW  311 (372)
Q Consensus       242 i~~~~~-~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w  311 (372)
                      +..... .+..+.    .++.++.++|.+||+ +|.+||++++++                 +||||.+...
T Consensus       220 ~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il-----------------~~~~~~~~~~  270 (280)
T cd06611         220 ILKSEPPTLDQPS----KWSSSFNDFLKSCLVKDPDDRPTAAELL-----------------KHPFVSDQSD  270 (280)
T ss_pred             HhcCCCCCcCCcc----cCCHHHHHHHHHHhccChhhCcCHHHHh-----------------cChhhcccch
Confidence            654322 111222    578999999999999 999999866555                 9999997643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-42  Score=328.91  Aligned_cols=254  Identities=19%  Similarity=0.279  Sum_probs=200.4

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeee-----hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCce
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETL-----LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWI   75 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~-----~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~I   75 (372)
                      +||+..+.+|.|    |+|.||++...     .+++.||+|.+.......         ..+.+.+|+.++..+ +||||
T Consensus         7 ~~~~~~~~lG~G----~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~E~~~l~~l~~h~ni   73 (338)
T cd05102           7 DRLRLGKVLGHG----AFGKVVEASAFGIDKKSSCNTVAVKMLKEGATAS---------EHKALMSELKILIHIGNHLNV   73 (338)
T ss_pred             hHceeeeEeccC----CcceEEEEEEeccCCcccchhhheeccccccchH---------HHHHHHHHHHHHHHhccCcce
Confidence            477777777777    89999999742     345789999876433211         234577899999998 89999


Q ss_pred             eeeeEEEEeC-CeEEEEEeccCCCCHHHHHHhcC----------------------------------------------
Q psy11571         76 TNLHYAFQDD-SNLYLVMDYYCGGDLLTLLSKFE----------------------------------------------  108 (372)
Q Consensus        76 v~l~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~~----------------------------------------------  108 (372)
                      +++++++... ..+++||||+++|+|.+++....                                              
T Consensus        74 v~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (338)
T cd05102          74 VNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPST  153 (338)
T ss_pred             eeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCcccccccccc
Confidence            9999988764 46899999999999999997521                                              


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571        109 ---------------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus       109 ---------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                                     ..+++..+..++.||+.||+|||+.||+|          |||||+|||++.++.+||+|||+++.
T Consensus       154 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH----------rDiKp~Nil~~~~~~~kl~DfG~a~~  223 (338)
T cd05102         154 SGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIH----------RDLAARNILLSENNVVKICDFGLARD  223 (338)
T ss_pred             CcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEEC----------CCCccceEEEcCCCcEEEeecccccc
Confidence                           23778889999999999999999999999          99999999999999999999999976


Q ss_pred             cCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCC
Q psy11571        174 LGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHQNSFDL  251 (372)
Q Consensus       174 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~  251 (372)
                      ...... .......+++.|+|||++.     ...++.++|||||||++|||++ |..||.+....+.+...+........
T Consensus       224 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~  298 (338)
T cd05102         224 IYKDPDYVRKGSARLPLKWMAPESIF-----DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRA  298 (338)
T ss_pred             cccCcchhcccCCCCCccccCcHHhh-----cCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCC
Confidence            533222 1122234567899999997     3568999999999999999997 99999886544444444333333333


Q ss_pred             CCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        252 PSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       252 ~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      |.    ..++++.++|.+||. ||++||++.++.+.+
T Consensus       299 ~~----~~~~~l~~li~~cl~~dp~~RPs~~el~~~l  331 (338)
T cd05102         299 PE----NATPEIYRIMLACWQGDPKERPTFSALVEIL  331 (338)
T ss_pred             CC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            33    678999999999999 999999988877554

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.7e-43  Score=344.88  Aligned_cols=257  Identities=23%  Similarity=0.306  Sum_probs=200.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||++....+++.||+|.+.....              ...+|+.+++.++||||+++++++
T Consensus        67 ~y~~~~~LG~G----~fg~Vy~~~~~~~~~~vAiK~i~~~~~--------------~~~~Ei~il~~l~h~niv~l~~~~  128 (440)
T PTZ00036         67 SYKLGNIIGNG----SFGVVYEAICIDTSEKVAIKKVLQDPQ--------------YKNRELLIMKNLNHINIIFLKDYY  128 (440)
T ss_pred             eEEEeEEEEeC----CCEEEEEEEECCCCCEEEEEEEecCcc--------------hHHHHHHHHHhcCCCCCcceeeeE
Confidence            34455555555    899999999888999999997743221              124689999999999999999887


Q ss_pred             EeC--------CeEEEEEeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCC
Q psy11571         83 QDD--------SNLYLVMDYYCGGDLLTLLSK---FEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIK  151 (372)
Q Consensus        83 ~~~--------~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlk  151 (372)
                      ...        ..+++||||++ ++|.+++..   ....+++..++.++.||+.||.|||++||+|          ||||
T Consensus       129 ~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiH----------rDLK  197 (440)
T PTZ00036        129 YTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICH----------RDLK  197 (440)
T ss_pred             eecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEec----------CCcC
Confidence            532        24779999996 578777653   2467999999999999999999999999999          9999


Q ss_pred             cCcEEeCCCC-cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCC
Q psy11571        152 PDNVLLDANG-HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF  230 (372)
Q Consensus       152 p~NIll~~~~-~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf  230 (372)
                      |+|||++.++ .+||+|||+|+.......  .....||+.|+|||++.+    ...++.++|||||||++|||++|.+||
T Consensus       198 p~NILl~~~~~~vkL~DFGla~~~~~~~~--~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlGvil~elltG~~pf  271 (440)
T PTZ00036        198 PQNLLIDPNTHTLKLCDFGSAKNLLAGQR--SVSYICSRFYRAPELMLG----ATNYTTHIDLWSLGCIIAEMILGYPIF  271 (440)
T ss_pred             HHHEEEcCCCCceeeeccccchhccCCCC--cccCCCCcCccCHHHhcC----CCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            9999998665 799999999987643322  223578999999999873    346899999999999999999999999


Q ss_pred             CCCCHHHHHHHHhhccCC---------------cCCCCC--------CCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhh
Q psy11571        231 YAESLVETYGKIMNHQNS---------------FDLPSD--------VGYEISDDAKDLMRRLIC-SSDTRLGQNGIADF  286 (372)
Q Consensus       231 ~~~~~~~~~~~i~~~~~~---------------~~~~~~--------~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i  286 (372)
                      .+.+..+.+.++......               ..+|..        .....++++++||.+||+ +|.+|+|+.+++  
T Consensus       272 ~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l--  349 (440)
T PTZ00036        272 SGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL--  349 (440)
T ss_pred             CCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh--
Confidence            998777666655432111               111110        112468899999999999 999999877666  


Q ss_pred             hhhhhhhhccCCCCCCCCCcCCCCc
Q psy11571        287 KMWSALFVSLSISPRNHPWFQGIAW  311 (372)
Q Consensus       287 ~~~~~~~~~~~~~~~~hp~f~~~~w  311 (372)
                                     .||||+.+..
T Consensus       350 ---------------~hp~f~~~~~  359 (440)
T PTZ00036        350 ---------------ADPFFDDLRD  359 (440)
T ss_pred             ---------------CChhHHhhhc
Confidence                           9999987654

>KOG0579|consensus

Probab=100.00  E-value=1.8e-43  Score=335.88  Aligned_cols=265  Identities=24%  Similarity=0.360  Sum_probs=228.8

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      +-|+.|+++|.|    +||.||++....++...|-|.+....-          +.++.+.-|++||..++||+||++++.
T Consensus        32 d~WeIiGELGDG----AFGKVyKA~nket~~lAAaKvIetkse----------EELEDylVEIeILa~CdHP~ivkLl~a   97 (1187)
T KOG0579|consen   32 DHWEIIGELGDG----AFGKVYKAVNKETKLLAAAKVIETKSE----------EELEDYLVEIEILAECDHPVIVKLLSA   97 (1187)
T ss_pred             HHHHHHhhhcCc----cchhhhhhhcccchhhhhhhhhcccch----------hHHhhhhhhhhhhhcCCChHHHHHHHH
Confidence            347899999999    799999999887777778777665432          345667789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      |...+.++++.|||.||-...++-..+..+.+.++..+++|++.||.|||+++|||          ||||..|||++-+|
T Consensus        98 yy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIH----------RDLKAGNiL~TldG  167 (1187)
T KOG0579|consen   98 YYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIH----------RDLKAGNILLTLDG  167 (1187)
T ss_pred             HhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhh----------hhccccceEEEecC
Confidence            99999999999999999999988877889999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .++|+|||.+...... .....++.|||.|||||+.....-...+|++++||||||++|.||..+.+|-...++..++-+
T Consensus       168 dirLADFGVSAKn~~t-~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllK  246 (1187)
T KOG0579|consen  168 DIRLADFGVSAKNKST-RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK  246 (1187)
T ss_pred             cEeeecccccccchhH-HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHH
Confidence            9999999988664332 224456899999999999986555567899999999999999999999999999999998888


Q ss_pred             HhhccCC-cCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcc
Q psy11571        242 IMNHQNS-FDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWD  312 (372)
Q Consensus       242 i~~~~~~-~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~  312 (372)
                      |.+..++ +--|+    .++..+.||+++||. ||..||++.+++                 +||||.+++-.
T Consensus       247 iaKSePPTLlqPS----~Ws~~F~DfLk~cL~Knp~~Rp~aaqll-----------------~Hpfv~~~~Sn  298 (1187)
T KOG0579|consen  247 IAKSEPPTLLQPS----HWSRSFSDFLKRCLVKNPRNRPPAAQLL-----------------KHPFVQNAPSN  298 (1187)
T ss_pred             HhhcCCCcccCcc----hhhhHHHHHHHHHHhcCCccCCCHHHHh-----------------hCcccccCCcc
Confidence            8765432 22233    678999999999999 999999987776                 99999987643

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-42  Score=330.28  Aligned_cols=259  Identities=24%  Similarity=0.368  Sum_probs=207.5

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    ++|.||++.+..+++.||+|.+.......        ...+.+.+|+.+++.++||||++++++
T Consensus        15 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~~   82 (343)
T cd07878          15 ERYQNLTPVGSG----AYGSVCSAYDTRLRQKVAVKKLSRPFQSL--------IHARRTYRELRLLKHMKHENVIGLLDV   82 (343)
T ss_pred             hhhhhheecccC----CCeEEEEEEECCCCCEEEEEEeCchhhhh--------HHHHHHHHHHHHHHhcCCCchhhhhhh
Confidence            478888888887    89999999999999999999876533211        123456789999999999999999998


Q ss_pred             EEeC------CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcE
Q psy11571         82 FQDD------SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNV  155 (372)
Q Consensus        82 ~~~~------~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NI  155 (372)
                      +...      ...|++||++ +++|.+++..  ..+++..++.++.||+.||.|||++||+|          |||||+||
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH----------rdikp~Ni  149 (343)
T cd07878          83 FTPATSIENFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIH----------RDLKPSNV  149 (343)
T ss_pred             hcccccccccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeec----------ccCChhhE
Confidence            8643      3579999997 8899988865  67999999999999999999999999999          99999999


Q ss_pred             EeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCH
Q psy11571        156 LLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL  235 (372)
Q Consensus       156 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~  235 (372)
                      +++.++.+||+|||+++.....    .....||+.|+|||++.+    ...++.++|||||||++|+|++|+.||.+.+.
T Consensus       150 l~~~~~~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  221 (343)
T cd07878         150 AVNEDCELRILDFGLARQADDE----MTGYVATRWYRAPEIMLN----WMHYNQTVDIWSVGCIMAELLKGKALFPGNDY  221 (343)
T ss_pred             EECCCCCEEEcCCccceecCCC----cCCccccccccCchHhcC----CccCCchhhhHhHHHHHHHHHHCCCCCCCCCH
Confidence            9999999999999999865432    223578999999999873    34688999999999999999999999988776


Q ss_pred             HHHHHHHhhccCCc---------------------CCCC----CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhh
Q psy11571        236 VETYGKIMNHQNSF---------------------DLPS----DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMW  289 (372)
Q Consensus       236 ~~~~~~i~~~~~~~---------------------~~~~----~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~  289 (372)
                      .+.+..+.......                     ..+.    ......++.+.+||.+||+ ||.+|||+.+++     
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell-----  296 (343)
T cd07878         222 IDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEAL-----  296 (343)
T ss_pred             HHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHh-----
Confidence            65555443211100                     0000    0011457789999999999 999999876665     


Q ss_pred             hhhhhccCCCCCCCCCcCCCC
Q psy11571        290 SALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       290 ~~~~~~~~~~~~~hp~f~~~~  310 (372)
                                  .||||....
T Consensus       297 ------------~hp~~~~~~  305 (343)
T cd07878         297 ------------AHPYFSQYH  305 (343)
T ss_pred             ------------cCcchhccC
Confidence                        999998643

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.4e-42  Score=328.30  Aligned_cols=259  Identities=23%  Similarity=0.336  Sum_probs=207.5

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    ++|.||++.+..++..+|+|.+......         ...+.+.+|+.+++.++||||++++++
T Consensus         5 ~~y~~~~~lg~g----~~g~V~~~~~~~~~~~~a~k~~~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv~~~~~   71 (333)
T cd06650           5 DDFEKISELGAG----NGGVVFKVSHKPSGLIMARKLIHLEIKP---------AIRNQIIRELQVLHECNSPYIVGFYGA   71 (333)
T ss_pred             hhhheeccccCC----CCEEEEEEEECCCCcEEEEEEeecccCH---------HHHHHHHHHHHHHHHCCCCcccceeEE
Confidence            578888888887    8999999999989999999977653211         123457889999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDL-HYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      +.+++.+|+||||+++|+|.+++.. .+.+++..+..++.|++.||.|||+. +++|          |||||+|||++.+
T Consensus        72 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH----------~dlkp~Nili~~~  140 (333)
T cd06650          72 FYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMH----------RDVKPSNILVNSR  140 (333)
T ss_pred             EEECCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEe----------cCCChhhEEEcCC
Confidence            9999999999999999999999987 56789999999999999999999975 7999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG  240 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~  240 (372)
                      +.+||+|||++.......   .....||..|+|||++.+     ..++.++|+|||||++|+|++|+.||......+...
T Consensus       141 ~~~kL~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~  212 (333)
T cd06650         141 GEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQG-----THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL  212 (333)
T ss_pred             CCEEEeeCCcchhhhhhc---cccCCCCccccCHHHhcC-----CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHH
Confidence            999999999987653221   223568999999999973     568889999999999999999999998655433321


Q ss_pred             HHhh---c-------------------------------------cCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCC
Q psy11571        241 KIMN---H-------------------------------------QNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLG  279 (372)
Q Consensus       241 ~i~~---~-------------------------------------~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s  279 (372)
                      .+..   +                                     ...-..+......++.++++||.+||+ ||++||+
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt  292 (333)
T cd06650         213 MFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERAD  292 (333)
T ss_pred             HhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcC
Confidence            1100   0                                     000000111111467899999999999 9999998


Q ss_pred             CCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        280 QNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       280 ~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      +++++                 .||||+..
T Consensus       293 ~~ell-----------------~h~~~~~~  305 (333)
T cd06650         293 LKQLM-----------------VHAFIKRS  305 (333)
T ss_pred             HHHHh-----------------hCHHHhcC
Confidence            66655                 99999854

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.1e-42  Score=324.38  Aligned_cols=263  Identities=23%  Similarity=0.360  Sum_probs=210.1

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.++.|    ++|.||++++..++..||+|.+........         ...+.+|+.+++.++||||++++++
T Consensus         6 ~~y~~~~~lg~g----~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~---------~~~~~~E~~~l~~l~h~nI~~~~~~   72 (301)
T cd07873           6 ETYIKLDKLGEG----TYATVYKGRSKLTDNLVALKEIRLEHEEGA---------PCTAIREVSLLKDLKHANIVTLHDI   72 (301)
T ss_pred             cceEEeeEeccC----cCEEEEEEEEcCCCcEEEEEEEecccccCc---------hhHHHHHHHHHHhcCCCCcceEEEE
Confidence            356677777777    899999999888999999998765432221         1235579999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+.+..|+||||+. ++|.+++......+++..++.++.||+.||+|||+.|++|          +||||+||+++.++
T Consensus        73 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H----------~dlkp~Nil~~~~~  141 (301)
T cd07873          73 IHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLH----------RDLKPQNLLINERG  141 (301)
T ss_pred             EecCCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeC----------CCCCHHHEEECCCC
Confidence            999999999999996 6999998775567899999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .++|+|||++......... .....+++.|+|||++.+    ...++.++|||||||++|+|++|++||.+.+..+....
T Consensus       142 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~----~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~  216 (301)
T cd07873         142 ELKLADFGLARAKSIPTKT-YSNEVVTLWYRPPDILLG----STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHF  216 (301)
T ss_pred             cEEECcCcchhccCCCCCc-ccccceeecccCcHHHhC----CCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999998765432221 122457889999999873    34578899999999999999999999998877665544


Q ss_pred             HhhccCC-----------------cCCCC-------CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhcc
Q psy11571        242 IMNHQNS-----------------FDLPS-------DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSL  296 (372)
Q Consensus       242 i~~~~~~-----------------~~~~~-------~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~  296 (372)
                      +......                 ...+.       .....+++++++||.+||+ ||.+|||+++++            
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil------------  284 (301)
T cd07873         217 IFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAM------------  284 (301)
T ss_pred             HHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHh------------
Confidence            4321110                 01111       1112578999999999999 999999866555            


Q ss_pred             CCCCCCCCCcCCCC
Q psy11571        297 SISPRNHPWFQGIA  310 (372)
Q Consensus       297 ~~~~~~hp~f~~~~  310 (372)
                           +||||+.+-
T Consensus       285 -----~h~~f~~~~  293 (301)
T cd07873         285 -----KHPYFHCLG  293 (301)
T ss_pred             -----cCccccccc
Confidence                 999998764

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.1e-42  Score=330.53  Aligned_cols=256  Identities=21%  Similarity=0.361  Sum_probs=200.3

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||.+.+..+++.+|+|.+........        ....+.+|+.+++.++||||+++++++
T Consensus        22 ~y~~~~~lg~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~   89 (359)
T cd07876          22 RYQQLKPIGSG----AQGIVCAAFDTVLGINVAVKKLSRPFQNQT--------HAKRAYRELVLLKCVNHKNIISLLNVF   89 (359)
T ss_pred             ceEEEEEeecC----CCEEEEEEEEcCCCceeEEEEecccccchh--------HHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence            56666677776    899999999998999999998765432211        234566799999999999999999998


Q ss_pred             EeCC------eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEE
Q psy11571         83 QDDS------NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL  156 (372)
Q Consensus        83 ~~~~------~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIl  156 (372)
                      ....      .+|+||||+. ++|.+.+.   ..+++..+..++.||+.||.|||++||+|          |||||+|||
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH----------rDlkp~NIl  155 (359)
T cd07876          90 TPQKSLEEFQDVYLVMELMD-ANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIH----------RDLKPSNIV  155 (359)
T ss_pred             ccCCCccccceeEEEEeCCC-cCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCccc----------CCCCHHHEE
Confidence            7543      5799999995 57777764   35889999999999999999999999999          999999999


Q ss_pred             eCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH
Q psy11571        157 LDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV  236 (372)
Q Consensus       157 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~  236 (372)
                      ++.++.+||+|||+++.......  .....||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.+.+..
T Consensus       156 ~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~  228 (359)
T cd07876         156 VKSDCTLKILDFGLARTACTNFM--MTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGELVKGSVIFQGTDHI  228 (359)
T ss_pred             ECCCCCEEEecCCCccccccCcc--CCCCcccCCCCCchhccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999999999999976533221  233578999999999973     56889999999999999999999999887655


Q ss_pred             HHHHHHhhccCC--------------------cCC--------------C--CCCCCCCCHHHHHHHHHhcc-CCCCCCC
Q psy11571        237 ETYGKIMNHQNS--------------------FDL--------------P--SDVGYEISDDAKDLMRRLIC-SSDTRLG  279 (372)
Q Consensus       237 ~~~~~i~~~~~~--------------------~~~--------------~--~~~~~~~s~~~~~li~~lL~-~p~~R~s  279 (372)
                      ..+..+......                    ...              +  .......++++++||.+||+ ||++|||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t  308 (359)
T cd07876         229 DQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRIS  308 (359)
T ss_pred             HHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCC
Confidence            443333221100                    000              0  00111346889999999999 9999998


Q ss_pred             CCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        280 QNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       280 ~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      +++++                 .||||..
T Consensus       309 ~~e~l-----------------~hp~~~~  320 (359)
T cd07876         309 VDEAL-----------------RHPYITV  320 (359)
T ss_pred             HHHHh-----------------cCchhhh
Confidence            77665                 9999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1e-42  Score=344.44  Aligned_cols=238  Identities=27%  Similarity=0.389  Sum_probs=200.0

Q ss_pred             cCCccEEEeeeehh-hhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         17 QGKGRVFSIETLLD-ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        17 ~g~G~v~~v~~~~~-~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      +|+|.||.+.+..+ +..|++|.+.....          .....+++|+.+++.++||||+++++++.+++.+|+||||+
T Consensus        78 G~~g~vy~a~~~~~~~~~vv~K~~~~~~~----------~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         78 NPTTAAFVATRGSDPKEKVVAKFVMLNDE----------RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             CCCcEEEEEEEcCCCCeEEEEEEcccCCH----------HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            38999999988877 77888886543221          12345678999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCccc
Q psy11571         96 CGGDLLTLLSKF---EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCL  172 (372)
Q Consensus        96 ~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~  172 (372)
                      +||+|.+++...   ...+++.++..++.||+.||.|||+.||+|          |||||+|||++.++.+||+|||+++
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH----------rDlkp~NIll~~~~~~kL~DFgla~  217 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMH----------RDLKSANIFLMPTGIIKLGDFGFSK  217 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEE----------CCcCHHhEEECCCCcEEEEeCcCce
Confidence            999999988542   346899999999999999999999999999          9999999999999999999999998


Q ss_pred             ccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCC
Q psy11571        173 RLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDL  251 (372)
Q Consensus       173 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~  251 (372)
                      ....... ......+||+.|+|||++.     ...++.++|||||||++|+|++|+.||.+.+..+.+..+..+... +.
T Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-~~  291 (478)
T PTZ00267        218 QYSDSVSLDVASSFCGTPYYLAPELWE-----RKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD-PF  291 (478)
T ss_pred             ecCCccccccccccCCCccccCHhHhC-----CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CC
Confidence            7643221 1233467999999999997     356899999999999999999999999998888888887765432 23


Q ss_pred             CCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        252 PSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       252 ~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      |.    .++.++++||.+||. +|++||++++++
T Consensus       292 ~~----~~s~~~~~li~~~L~~dP~~Rps~~~~l  321 (478)
T PTZ00267        292 PC----PVSSGMKALLDPLLSKNPALRPTTQQLL  321 (478)
T ss_pred             Cc----cCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence            33    678999999999999 999999977665

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.5e-42  Score=317.68  Aligned_cols=241  Identities=19%  Similarity=0.176  Sum_probs=203.2

Q ss_pred             ccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe----CCeEEEE
Q psy11571         16 IQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQD----DSNLYLV   91 (372)
Q Consensus        16 ~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~----~~~~~lv   91 (372)
                      .+|+|.||++..  +++.||+|.+........       ...+.+.+|+.+|+.++||||+++++++.+    ...+++|
T Consensus        30 ~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv  100 (283)
T PHA02988         30 ENDQNSIYKGIF--NNKEVIIRTFKKFHKGHK-------VLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLI  100 (283)
T ss_pred             eCCceEEEEEEE--CCEEEEEEeccccccccH-------HHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEE
Confidence            458888998864  788999998875433221       235668899999999999999999999877    3578999


Q ss_pred             EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCc
Q psy11571         92 MDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD-LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGS  170 (372)
Q Consensus        92 ~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~  170 (372)
                      |||+++|+|.+++.+ ...+++.....++.|++.||.|||+ .+++|          |||||+||+++.++.+||+|||+
T Consensus       101 ~Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~H----------rdlkp~nill~~~~~~kl~dfg~  169 (283)
T PHA02988        101 LEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPY----------KNLTSVSFLVTENYKLKIICHGL  169 (283)
T ss_pred             EEeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCC----------CcCChhhEEECCCCcEEEcccch
Confidence            999999999999987 5678999999999999999999998 48899          99999999999999999999999


Q ss_pred             ccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcC
Q psy11571        171 CLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD  250 (372)
Q Consensus       171 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~  250 (372)
                      ++......    ....|+..|+|||++.+.   ...++.++|||||||++|||++|..||.+.+..+.+..+......+.
T Consensus       170 ~~~~~~~~----~~~~~~~~y~aPE~~~~~---~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~  242 (283)
T PHA02988        170 EKILSSPP----FKNVNFMVYFSYKMLNDI---FSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK  242 (283)
T ss_pred             Hhhhcccc----ccccCcccccCHHHhhhc---cccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence            88654322    224688999999998731   24689999999999999999999999999888888888876655555


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        251 LPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       251 ~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .|.    ..++.+++||.+||+ ||++||+++++.+.+
T Consensus       243 ~~~----~~~~~l~~li~~cl~~dp~~Rps~~ell~~l  276 (283)
T PHA02988        243 LPL----DCPLEIKCIVEACTSHDSIKRPNIKEILYNL  276 (283)
T ss_pred             CCC----cCcHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence            553    578999999999999 999999988887655

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=9.6e-42  Score=314.79  Aligned_cols=262  Identities=24%  Similarity=0.371  Sum_probs=214.4

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      |-|+.++.++.|    ++|.||++....++..+++|.......          ...+.+.+|+.+++.++||||+++++.
T Consensus         5 ~~~~i~~~lg~g----~~g~v~~~~~~~~~~~~~~k~~~~~~~----------~~~~~~~~e~~~l~~l~h~~ii~~~~~   70 (282)
T cd06643           5 EFWEIIGELGDG----AFGKVYKAQNKETGVLAAAKVIDTKSE----------EELEDYMVEIDILASCDHPNIVKLLDA   70 (282)
T ss_pred             HHHHHHhhcccC----CCeEEEEEEECCCCeEEEEEEeCCCCH----------HHHHHHHHHHHHHHHCCCCCeeeEEEE
Confidence            457888888887    799999999888888999887754332          123456779999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +...+..|+||||+++++|..++.+....+++..+..++.|++.||.|||+.|++|          |||||+||+++.++
T Consensus        71 ~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H----------~dlkp~nili~~~~  140 (282)
T cd06643          71 FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIH----------RDLKAGNILFTLDG  140 (282)
T ss_pred             EeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeee----------cCCCcccEEEccCC
Confidence            99999999999999999999988764567999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .++|+|||++........ ......|++.|+|||++.........++.++|+|||||++|+|++|++||...+..+...+
T Consensus       141 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~  219 (282)
T cd06643         141 DIKLADFGVSAKNTRTIQ-RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLK  219 (282)
T ss_pred             CEEEcccccccccccccc-ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHH
Confidence            999999999876533221 2233568999999999853222234578899999999999999999999998877776666


Q ss_pred             HhhccC-CcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        242 IMNHQN-SFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       242 i~~~~~-~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      +..... ....+    ..++.++++||.+||+ +|.+||+++++.                 +||||+..
T Consensus       220 ~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il-----------------~~~~~~~~  268 (282)
T cd06643         220 IAKSEPPTLAQP----SRWSSEFKDFLKKCLEKNVDARWTTTQLL-----------------QHPFVTVN  268 (282)
T ss_pred             HhhcCCCCCCCc----cccCHHHHHHHHHHccCChhhCcCHHHHh-----------------cCCCEecc
Confidence            654322 11122    2578999999999999 999999866555                 99999853

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG0596|consensus

Probab=100.00  E-value=3.7e-42  Score=323.34  Aligned_cols=264  Identities=28%  Similarity=0.432  Sum_probs=214.0

Q ss_pred             ChHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeee
Q psy11571          1 DERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLH   79 (372)
Q Consensus         1 ~~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~   79 (372)
                      +..|+.|+++|.|    |..+||+|.. .+.+.+|+|.+........        .+.-+++|+.+|.+++ |-+||+++
T Consensus       360 g~~Yeilk~iG~G----GSSkV~kV~~-s~~~iyalkkv~~~~~D~q--------tl~gy~nEI~lL~KLkg~~~IIqL~  426 (677)
T KOG0596|consen  360 GREYEILKQIGSG----GSSKVFKVLN-SDKQIYALKKVVLLEADNQ--------TLDGYRNEIALLNKLKGHDKIIQLY  426 (677)
T ss_pred             cchhhHHHhhcCC----Ccceeeeeec-CCCcchhhhHHHHhhcCHH--------HHHHHHHHHHHHHHhcCCceEEEEe
Confidence            3579999999999    7899999954 4667778776655443332        4667889999999885 99999999


Q ss_pred             EEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC
Q psy11571         80 YAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA  159 (372)
Q Consensus        80 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~  159 (372)
                      ++-..++.+|+|||| ...||..+|++.....+...+++|..|++.|+.++|.+||||          .||||.|+|+ -
T Consensus       427 DYEv~d~~lYmvmE~-Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVH----------SDLKPANFLl-V  494 (677)
T KOG0596|consen  427 DYEVTDGYLYMVMEC-GDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVH----------SDLKPANFLL-V  494 (677)
T ss_pred             eeeccCceEEEEeec-ccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceee----------cCCCcccEEE-E
Confidence            999999999999997 467999999985555665799999999999999999999999          9999999999 6


Q ss_pred             CCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccC------CCCCCCccceeehhHHHHHHhhCCCCCCC
Q psy11571        160 NGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEG------RGRYGPECDWWSLGVCMYEMLYGETPFYA  232 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~------~~~~~~~~DiwslGvil~elltG~~Pf~~  232 (372)
                      .|.+||+|||+|..+..+.+ ......+||+.|||||.+..+..+      .-..++++||||||||||+|+.|++||..
T Consensus       495 kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~  574 (677)
T KOG0596|consen  495 KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ  574 (677)
T ss_pred             eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence            78999999999988765432 234457899999999999866533      22367899999999999999999999976


Q ss_pred             CC-HHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        233 ES-LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       233 ~~-~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      .. ....+..|..-...+++|...   -..++.++++.||. ||.+|++..+++                 +|||.+.+
T Consensus       575 ~~n~~aKl~aI~~P~~~Iefp~~~---~~~~li~~mK~CL~rdPkkR~si~eLL-----------------qhpFl~~~  633 (677)
T KOG0596|consen  575 IINQIAKLHAITDPNHEIEFPDIP---ENDELIDVMKCCLARDPKKRWSIPELL-----------------QHPFLQIQ  633 (677)
T ss_pred             HHHHHHHHHhhcCCCccccccCCC---CchHHHHHHHHHHhcCcccCCCcHHHh-----------------cCcccccc
Confidence            53 455556666544445555532   13349999999999 999999977776                 99999864

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=5.6e-42  Score=312.14  Aligned_cols=254  Identities=40%  Similarity=0.712  Sum_probs=215.9

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      +++|.||.+.+..+++.+++|.+.......       ....+.+.+|..+++.++||||+++++.+.+....|++|||++
T Consensus         4 g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~-------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~   76 (265)
T cd05579           4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIR-------KNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLP   76 (265)
T ss_pred             CCceEEEEEEECCCCCEEEEEEecchhhhh-------hhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCC
Confidence            489999999998889999999776544322       1345668889999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCC
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG  176 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  176 (372)
                      +++|.+++.+ .+.+++..+..++.||+.||+|||+.|++|          +||+|+||+++.++.++|+|||++.....
T Consensus        77 ~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H----------~di~~~nil~~~~~~~~l~dfg~~~~~~~  145 (265)
T cd05579          77 GGDLASLLEN-VGSLDEDVARIYIAEIVLALEYLHSNGIIH----------RDLKPDNILIDSNGHLKLTDFGLSKVGLV  145 (265)
T ss_pred             CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCeec----------CCCCHHHeEEcCCCCEEEEecccchhccc
Confidence            9999999987 458999999999999999999999999999          99999999999999999999999876533


Q ss_pred             CCc-------ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCc
Q psy11571        177 DGT-------VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSF  249 (372)
Q Consensus       177 ~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~  249 (372)
                      ...       .......++..|+|||....     ...+.++|+||||+++|+|++|..||......+.+..+..+.  .
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-----~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~  218 (265)
T cd05579         146 RRQINLNDDEKEDKRIVGTPDYIAPEVILG-----QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK--I  218 (265)
T ss_pred             CcccccccccccccCcccCccccCHHHhcC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--c
Confidence            211       12233467889999999873     457889999999999999999999999888888877776633  3


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCc
Q psy11571        250 DLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAW  311 (372)
Q Consensus       250 ~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w  311 (372)
                      ..+...  .++..+.++|.+||+ +|++||++..+.+++              +||||++++|
T Consensus       219 ~~~~~~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l--------------~~~~~~~~~~  265 (265)
T cd05579         219 EWPEDV--EVSDEAIDLISKLLVPDPEKRLGAKSIEEIK--------------NHPFFKGIDW  265 (265)
T ss_pred             CCCccc--cCCHHHHHHHHHHhcCCHhhcCCCccHHHHh--------------cCccccCCCC
Confidence            333321  358999999999999 999999998888888              9999999999

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=7.3e-42  Score=315.51  Aligned_cols=264  Identities=28%  Similarity=0.555  Sum_probs=203.9

Q ss_pred             ccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHH---HHHhcCCCCceeeeeEEEEeCCeEEEEE
Q psy11571         16 IQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREER---DVLVYGDRRWITNLHYAFQDDSNLYLVM   92 (372)
Q Consensus        16 ~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~---~il~~l~hp~Iv~l~~~~~~~~~~~lv~   92 (372)
                      .|++|.||++.+..+++.+|+|.+...........       ....+|.   .++...+||||+++++.+.+.+..++||
T Consensus         4 ~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~   76 (279)
T cd05633           4 RGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE-------TLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFIL   76 (279)
T ss_pred             cCCCeEEEEEEECCCCcEEEEEEEEccccccchHH-------HHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEE
Confidence            34899999999988999999998866544322111       1112232   3344567999999999999999999999


Q ss_pred             eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCccc
Q psy11571         93 DYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCL  172 (372)
Q Consensus        93 E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~  172 (372)
                      ||+++++|.+++.. .+.+++..+..++.|++.||+|||+.|++|          |||||+||++++++.++|+|||++.
T Consensus        77 e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH----------~dikp~Nil~~~~~~~~l~dfg~~~  145 (279)
T cd05633          77 DLMNGGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVY----------RDLKPANILLDEHGHVRISDLGLAC  145 (279)
T ss_pred             ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCC----------CCCCHHHEEECCCCCEEEccCCcce
Confidence            99999999999977 567999999999999999999999999999          9999999999999999999999987


Q ss_pred             ccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH--HHHHHHhhccCCcC
Q psy11571        173 RLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--ETYGKIMNHQNSFD  250 (372)
Q Consensus       173 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--~~~~~i~~~~~~~~  250 (372)
                      ......   .....||+.|+|||.+..    ...++.++|+||+||++|+|++|..||......  ........ .....
T Consensus       146 ~~~~~~---~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~  217 (279)
T cd05633         146 DFSKKK---PHASVGTHGYMAPEVLQK----GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-TVNVE  217 (279)
T ss_pred             eccccC---ccCcCCCcCccCHHHhcC----CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh-cCCcC
Confidence            553322   123468999999999862    245788999999999999999999999754321  12222111 12222


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcc-CCCCCCCC--CChhhhhhhhhhhhccCCCCCCCCCcCCCCccccc--cCCCCCcC
Q psy11571        251 LPSDVGYEISDDAKDLMRRLIC-SSDTRLGQ--NGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIR--DSNAPYIP  323 (372)
Q Consensus       251 ~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~--~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~--~~~~p~~p  323 (372)
                      ++.    .++.+++++|++||. ||++|++.  ..+.+++              +||||++++|....  ...+|.+|
T Consensus       218 ~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~--------------~h~~~~~~~~~~~~~~~~~~~~~~  277 (279)
T cd05633         218 LPD----SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVK--------------EHVFFKGIDWQQVYLQKYPPPLIP  277 (279)
T ss_pred             Ccc----ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH--------------hCccccCCCHhHHhcCCCCCCCCC
Confidence            333    689999999999999 99999962  2456666              99999999998762  33344444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.7e-42  Score=320.45  Aligned_cols=257  Identities=24%  Similarity=0.336  Sum_probs=199.5

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHh---cCCCCceeeee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLV---YGDRRWITNLH   79 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~---~l~hp~Iv~l~   79 (372)
                      +|+.++.+|.|    |+|.||++.+..+++.+|+|.+.........        ...+.+|..+++   .++||||++++
T Consensus         1 ~y~~~~~lg~g----~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~--------~~~~~~e~~~l~~l~~~~h~ni~~~~   68 (288)
T cd07863           1 QYEPVAEIGVG----AYGTVYKARDPHSGHFVALKSVRVQTNEDGL--------PLSTVREVALLKRLEAFDHPNIVRLM   68 (288)
T ss_pred             CceEeeEEeec----CCeEEEEEEECCCCcEEEEEEeccCcCCCCC--------chHHHHHHHHHHHhhhcCCCCeeeee
Confidence            46666777777    8999999999999999999987654322210        011234555554   45799999999


Q ss_pred             EEEEeC-----CeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcC
Q psy11571         80 YAFQDD-----SNLYLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPD  153 (372)
Q Consensus        80 ~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~  153 (372)
                      +++.+.     ..++++|||+. ++|.+++.... ..+++..++.++.|++.||.|||+.|++|          |||||+
T Consensus        69 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH----------~dikp~  137 (288)
T cd07863          69 DVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVH----------RDLKPE  137 (288)
T ss_pred             eeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec----------CCCCHH
Confidence            988653     45899999996 58999887632 35899999999999999999999999999          999999


Q ss_pred             cEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC
Q psy11571        154 NVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE  233 (372)
Q Consensus       154 NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~  233 (372)
                      ||+++.++.+||+|||++........  .....||+.|+|||++.+     ..++.++|||||||++|+|++|.+||.+.
T Consensus       138 Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~~f~~~  210 (288)
T cd07863         138 NILVTSGGQVKLADFGLARIYSCQMA--LTPVVVTLWYRAPEVLLQ-----STYATPVDMWSVGCIFAEMFRRKPLFCGN  210 (288)
T ss_pred             HEEECCCCCEEECccCccccccCccc--CCCccccccccCchHhhC-----CCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence            99999999999999999976643222  223568999999999973     56899999999999999999999999888


Q ss_pred             CHHHHHHHHhhccCC---cCCC------------------CCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhh
Q psy11571        234 SLVETYGKIMNHQNS---FDLP------------------SDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSA  291 (372)
Q Consensus       234 ~~~~~~~~i~~~~~~---~~~~------------------~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~  291 (372)
                      +..+.+.++......   ..++                  ......++..+++||.+||+ ||++|||+++++       
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l-------  283 (288)
T cd07863         211 SEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRAL-------  283 (288)
T ss_pred             CHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHh-------
Confidence            777666655432100   0000                  01112578899999999999 999999876665       


Q ss_pred             hhhccCCCCCCCCCc
Q psy11571        292 LFVSLSISPRNHPWF  306 (372)
Q Consensus       292 ~~~~~~~~~~~hp~f  306 (372)
                                .||||
T Consensus       284 ----------~hp~f  288 (288)
T cd07863         284 ----------QHPFF  288 (288)
T ss_pred             ----------cCCCC
Confidence                      99998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.3e-41  Score=310.96  Aligned_cols=259  Identities=27%  Similarity=0.521  Sum_probs=203.6

Q ss_pred             ccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         16 IQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        16 ~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      .|++|.||.+.+..+++.||+|.+............    ...........+....||+|+++++.+.+.+.+|+||||+
T Consensus         4 ~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (278)
T cd05606           4 RGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET----LALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM   79 (278)
T ss_pred             cCCCeEEEEEEEecCCCEEEEEEeeccccccchhHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecC
Confidence            348999999999889999999988765433221100    0111122334455578999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccC
Q psy11571         96 CGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG  175 (372)
Q Consensus        96 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~  175 (372)
                      +|++|.+++.+ .+.+++..++.++.|++.||.|||+.+++|          |||||+||+++.++.++|+|||++....
T Consensus        80 ~g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H----------~di~p~nili~~~~~~kl~dfg~~~~~~  148 (278)
T cd05606          80 NGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVY----------RDLKPANILLDEHGHVRISDLGLACDFS  148 (278)
T ss_pred             CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEc----------CCCCHHHEEECCCCCEEEccCcCccccC
Confidence            99999999976 567999999999999999999999999999          9999999999999999999999987654


Q ss_pred             CCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC---CHHHHHHHHhhccCCcCCC
Q psy11571        176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYGKIMNHQNSFDLP  252 (372)
Q Consensus       176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~---~~~~~~~~i~~~~~~~~~~  252 (372)
                      ...   .....|+..|+|||++.+    ...++.++|+||+||++|+|++|+.||...   ........+..  ....+|
T Consensus       149 ~~~---~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~  219 (278)
T cd05606         149 KKK---PHASVGTHGYMAPEVLQK----GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELP  219 (278)
T ss_pred             ccC---CcCcCCCcCCcCcHHhcC----CCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc--cCCCCC
Confidence            322   223578999999999873    235788999999999999999999999865   32332222222  223334


Q ss_pred             CCCCCCCCHHHHHHHHHhcc-CCCCCCCCC--ChhhhhhhhhhhhccCCCCCCCCCcCCCCcccccc
Q psy11571        253 SDVGYEISDDAKDLMRRLIC-SSDTRLGQN--GIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRD  316 (372)
Q Consensus       253 ~~~~~~~s~~~~~li~~lL~-~p~~R~s~~--~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~~  316 (372)
                      .    .++.++.++|.+||. +|.+|+...  .+.+++              +||||++++|+.+..
T Consensus       220 ~----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll--------------~~~~~~~~~~~~~~~  268 (278)
T cd05606         220 D----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK--------------EHPFFRSLDWQMVFL  268 (278)
T ss_pred             C----cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHH--------------hCccccCCCchHhhh
Confidence            3    579999999999999 999999544  455555              999999999998743

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0577|consensus

Probab=100.00  E-value=7.5e-43  Score=329.63  Aligned_cols=257  Identities=25%  Similarity=0.358  Sum_probs=225.1

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|..|.++|-|    +||.||-+++..+...||||++....-...       +..+.+..|+..|.++.|||+|.+.++
T Consensus        26 klf~dLrEIGHG----SFGAVYfArd~~n~evVAIKKMsySGKQs~-------EKWqDIlKEVrFL~~l~HPntieYkgC   94 (948)
T KOG0577|consen   26 KLFSDLREIGHG----SFGAVYFARDVRNSEVVAIKKMSYSGKQSN-------EKWQDILKEVRFLRQLRHPNTIEYKGC   94 (948)
T ss_pred             HHHHHHHHhcCC----ccceeEEeeccCccceeeeeeccccccccH-------HHHHHHHHHHHHHHhccCCCcccccce
Confidence            578889999998    799999999999999999999877665443       345667889999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      |..+...||||||| -|+-.+++.-...++.+.++..++.+.+.||+|||+++.||          ||||..|||+++.|
T Consensus        95 yLre~TaWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IH----------RDiKAGNILLse~g  163 (948)
T KOG0577|consen   95 YLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIH----------RDIKAGNILLSEPG  163 (948)
T ss_pred             eeccchHHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHh----------hhccccceEecCCC
Confidence            99999999999999 56888888766678999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .|||+|||.|.....     .++++|||.|||||++..|++  +.|+-++||||||++..||.-.+||..+.+....+..
T Consensus       164 ~VKLaDFGSAsi~~P-----AnsFvGTPywMAPEVILAMDE--GqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH  236 (948)
T KOG0577|consen  164 LVKLADFGSASIMAP-----ANSFVGTPYWMAPEVILAMDE--GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH  236 (948)
T ss_pred             eeeeccccchhhcCc-----hhcccCCccccchhHheeccc--cccCCccceeeccchhhhhhhcCCCccCchHHHHHHH
Confidence            999999999976543     355899999999999998875  5699999999999999999999999999888888888


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      |.... ++.++.   ...|..++.|+..||+ -|.+|||++.++                 .|+|..-
T Consensus       237 IAQNe-sPtLqs---~eWS~~F~~Fvd~CLqKipqeRptse~ll-----------------~H~fv~R  283 (948)
T KOG0577|consen  237 IAQNE-SPTLQS---NEWSDYFRNFVDSCLQKIPQERPTSEELL-----------------KHRFVLR  283 (948)
T ss_pred             HHhcC-CCCCCC---chhHHHHHHHHHHHHhhCcccCCcHHHHh-----------------hcchhcc
Confidence            87653 233333   3679999999999999 799999987776                 9999763

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.3e-41  Score=309.58  Aligned_cols=254  Identities=19%  Similarity=0.296  Sum_probs=204.7

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.++.|    |+|.||.+.+..+++.+++|........          ....+.+|+.+++.++||||+++++.
T Consensus         9 ~~~~~~~~lg~g----~~~~v~~~~~~~~~~~~~ik~~~~~~~~----------~~~~~~~e~~~~~~l~h~~ii~~~~~   74 (267)
T cd06645           9 EDFELIQRIGSG----TYGDVYKARNVNTGELAAIKVIKLEPGE----------DFAVVQQEIIMMKDCKHSNIVAYFGS   74 (267)
T ss_pred             HHHHHHHHhCCC----CCeEEEEEEEcCCCcEEEEEEEecCchh----------HHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence            578889998888    8999999999989999999987654321          12346679999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+.+.+|+||||+++++|.+++.. .+.+++..++.++.|++.||.|||+.|++|          +||||+||+++.++
T Consensus        75 ~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H----------~dlkp~nili~~~~  143 (267)
T cd06645          75 YLRRDKLWICMEFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMH----------RDIKGANILLTDNG  143 (267)
T ss_pred             EEeCCEEEEEEeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeec----------CCCCHHHEEECCCC
Confidence            9999999999999999999999977 568999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .++|+|||++....... .......|++.|+|||++...  ....++.++|+|||||++|+|++|..||...........
T Consensus       144 ~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~  220 (267)
T cd06645         144 HVKLADFGVSAQITATI-AKRKSFIGTPYWMAPEVAAVE--RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL  220 (267)
T ss_pred             CEEECcceeeeEccCcc-cccccccCcccccChhhhccc--cCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh
Confidence            99999999987654321 122335789999999997421  124578899999999999999999999977655444333


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      +........... ....++..+.++|.+||. +|++||++++++
T Consensus       221 ~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll  263 (267)
T cd06645         221 MTKSNFQPPKLK-DKMKWSNSFHHFVKMALTKNPKKRPTAEKLL  263 (267)
T ss_pred             hhccCCCCCccc-ccCCCCHHHHHHHHHHccCCchhCcCHHHHh
Confidence            333222111111 111468899999999999 999999866555

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.4e-41  Score=311.88  Aligned_cols=263  Identities=23%  Similarity=0.339  Sum_probs=210.2

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |...+.+|.|    |+|.||++.+..+++.+|+|.+..................+.+..|+.+++.++||||+++++++.
T Consensus         3 ~~~~~~lg~g----~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   78 (272)
T cd06629           3 WVKGELIGKG----TYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET   78 (272)
T ss_pred             eeecceeccc----CceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec
Confidence            3344455555    899999999888999999998865443333222333445677889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcE
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI  163 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~v  163 (372)
                      ..+..++||||+++++|.+++.+ .+.+++..++.++.||+.||.|||++|++|          |||+|+||+++.++.+
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H----------~dl~~~nil~~~~~~~  147 (272)
T cd06629          79 TEEYLSIFLEYVPGGSIGSCLRT-YGRFEEQLVRFFTEQVLEGLAYLHSKGILH----------RDLKADNLLVDADGIC  147 (272)
T ss_pred             cCCceEEEEecCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhhCCeee----------cCCChhhEEEcCCCeE
Confidence            99999999999999999999987 468999999999999999999999999999          9999999999999999


Q ss_pred             EEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        164 RLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       164 kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +|+|||++........ .......|+..|+|||.+...   ...++.++|+||||+++|+|++|..||...+..+....+
T Consensus       148 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~  224 (272)
T cd06629         148 KISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY---SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKL  224 (272)
T ss_pred             EEeeccccccccccccccccccccCCccccCHHHhccc---cCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHh
Confidence            9999999876532211 112234688899999998741   124788999999999999999999999876665555444


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      ........++......++..++++|.+||. +|++||++++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il  267 (272)
T cd06629         225 GNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELL  267 (272)
T ss_pred             hccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHh
Confidence            443334444444444679999999999999 999999865554

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.7e-42  Score=328.28  Aligned_cols=257  Identities=20%  Similarity=0.365  Sum_probs=201.5

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    |+|.||.+.+..+++.+|+|.+.......        ...+.+.+|+.+++.++||||++++++
T Consensus        17 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~   84 (355)
T cd07874          17 KRYQNLKPIGSG----AQGIVCAAYDAVLDRNVAIKKLSRPFQNQ--------THAKRAYRELVLMKCVNHKNIISLLNV   84 (355)
T ss_pred             hceeEEEEeeec----CCEEEEEEEecCCCceEEEEEeCCcccCh--------HHHHHHHHHHHHHHHhCCCchhceeee
Confidence            356666677776    89999999998899999999876543221        123456779999999999999999999


Q ss_pred             EEeCC------eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcE
Q psy11571         82 FQDDS------NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNV  155 (372)
Q Consensus        82 ~~~~~------~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NI  155 (372)
                      +....      ..|+||||+. ++|.+.+..   .+++..+..++.|++.||.|||++||+|          |||||+||
T Consensus        85 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givH----------rDikp~Ni  150 (355)
T cd07874          85 FTPQKSLEEFQDVYLVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIH----------RDLKPSNI  150 (355)
T ss_pred             eeccccccccceeEEEhhhhc-ccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCccc----------CCCChHHE
Confidence            86543      5799999995 578777753   5889999999999999999999999999          99999999


Q ss_pred             EeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCH
Q psy11571        156 LLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL  235 (372)
Q Consensus       156 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~  235 (372)
                      |++.++.+||+|||+++.......  .....||+.|+|||++.+     ..++.++|+|||||++|+|++|+.||.+.+.
T Consensus       151 ll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~  223 (355)
T cd07874         151 VVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMVRHKILFPGRDY  223 (355)
T ss_pred             EECCCCCEEEeeCcccccCCCccc--cCCccccCCccCHHHHcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999999999999986543322  233578999999999973     5688999999999999999999999998776


Q ss_pred             HHHHHHHhhccCC-------------------------cCCC-----------CCCCCCCCHHHHHHHHHhcc-CCCCCC
Q psy11571        236 VETYGKIMNHQNS-------------------------FDLP-----------SDVGYEISDDAKDLMRRLIC-SSDTRL  278 (372)
Q Consensus       236 ~~~~~~i~~~~~~-------------------------~~~~-----------~~~~~~~s~~~~~li~~lL~-~p~~R~  278 (372)
                      .+.+..+......                         ..++           .......+.++++||.+||+ ||++||
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rp  303 (355)
T cd07874         224 IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI  303 (355)
T ss_pred             HHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcC
Confidence            5544433221100                         0000           01112346789999999999 999999


Q ss_pred             CCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        279 GQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       279 s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      |+++++                 +||||..
T Consensus       304 s~~ell-----------------~hp~~~~  316 (355)
T cd07874         304 SVDEAL-----------------QHPYINV  316 (355)
T ss_pred             CHHHHh-----------------cCcchhc
Confidence            877666                 9999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.7e-42  Score=317.25  Aligned_cols=274  Identities=35%  Similarity=0.631  Sum_probs=216.9

Q ss_pred             HHHhhhcCCcccCCccEEEeeee---hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEE
Q psy11571          6 ELEALFLGGPIQGKGRVFSIETL---LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYA   81 (372)
Q Consensus         6 ~l~~~~~~~~~~g~G~v~~v~~~---~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~   81 (372)
                      .++.++.|    |+|.||.+...   .+++.+|+|.+.......      .....+.+.+|..++..+ +||||+++++.
T Consensus         4 ~~~~ig~G----~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~------~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~   73 (288)
T cd05583           4 LLRVLGTG----AYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQ------KAKTAEHTRTERQVLEAVRRCPFLVTLHYA   73 (288)
T ss_pred             EEEEeccC----CCceEEEEEEeccccCCcEEEEEEEehHHHHh------hhhHHHHHHHHHHHHHhccCCcchhhhhee
Confidence            34444555    88999998754   356789999776443221      123445677899999999 59999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +......|+||||+++++|.+++.. ...+++..++.++.|++.+|.|||+.|++|          |||+|.||+++.++
T Consensus        74 ~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H----------~dl~p~nil~~~~~  142 (288)
T cd05583          74 FQTDTKLHLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIY----------RDIKLENILLDSEG  142 (288)
T ss_pred             eecCCEEEEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeec----------cCCCHHHeEECCCC
Confidence            9999999999999999999999976 467899999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCC----HHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES----LVE  237 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~----~~~  237 (372)
                      .++|+|||++...............|+..|+|||.+.+.   ....+.++|+||||+++|+|++|..||....    ..+
T Consensus       143 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~  219 (288)
T cd05583         143 HVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGG---SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSE  219 (288)
T ss_pred             CEEEEECccccccccccccccccccCCccccCHHHhcCC---CCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHH
Confidence            999999999876544333223335689999999998741   1236789999999999999999999996433    223


Q ss_pred             HHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--
Q psy11571        238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--  314 (372)
Q Consensus       238 ~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--  314 (372)
                      ....+....  ...+.    .++..+.++|.+||+ +|++|||+.++.+++              +||||+.++|+.+  
T Consensus       220 ~~~~~~~~~--~~~~~----~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l--------------~~~~~~~~~~~~~~~  279 (288)
T cd05583         220 ISRRILKSK--PPFPK----TMSAEARDFIQKLLEKDPKKRLGANGADEIK--------------NHPFFQGIDWDDLAA  279 (288)
T ss_pred             HHHHHHccC--CCCCc----ccCHHHHHHHHHHhcCCHhhccCcchHHHHh--------------cCcccccCCHHHHhh
Confidence            333333322  22333    578999999999999 999999999999888              9999999999887  


Q ss_pred             ccCCCCCcC
Q psy11571        315 RDSNAPYIP  323 (372)
Q Consensus       315 ~~~~~p~~p  323 (372)
                      +...+||.|
T Consensus       280 ~~~~~~~~~  288 (288)
T cd05583         280 KRIPAPFKP  288 (288)
T ss_pred             hccCCCCCC
Confidence            344556543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.1e-42  Score=341.69  Aligned_cols=259  Identities=26%  Similarity=0.370  Sum_probs=213.3

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+..+.+|.|    |+|.||.+++..+++.||+|.+........        ....+.+|+.++..++|+||++++..
T Consensus        32 ~rY~i~~~LG~G----~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~--------~~~~~~~Ei~~l~~~~h~~iv~~~~~   99 (496)
T PTZ00283         32 KKYWISRVLGSG----ATGTVLCAKRVSDGEPFAVKVVDMEGMSEA--------DKNRAQAEVCCLLNCDFFSIVKCHED   99 (496)
T ss_pred             CCEEEEEEEecC----CCEEEEEEEEcCCCCEEEEEEEecccCCHH--------HHHHHHHHHHHHhcCCCCcEEEeecc
Confidence            356666666666    899999999999999999998866544322        23456789999999999999999988


Q ss_pred             EEeCC--------eEEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCC
Q psy11571         82 FQDDS--------NLYLVMDYYCGGDLLTLLSKF---EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDI  150 (372)
Q Consensus        82 ~~~~~--------~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDl  150 (372)
                      +...+        .+++||||+++|+|.+++...   ...+++..+..++.|++.||.|||+.||+|          |||
T Consensus       100 ~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiH----------rDL  169 (496)
T PTZ00283        100 FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIH----------RDI  169 (496)
T ss_pred             eecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEec----------CCC
Confidence            75432        378999999999999998653   346899999999999999999999999999          999


Q ss_pred             CcCcEEeCCCCcEEEeecCcccccCCCC-cccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCC
Q psy11571        151 KPDNVLLDANGHIRLADFGSCLRLGGDG-TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP  229 (372)
Q Consensus       151 kp~NIll~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~P  229 (372)
                      ||+|||++.++.+||+|||+++...... .......+||+.|+|||++.+     ..++.++|||||||++|||++|+.|
T Consensus       170 KP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~s~k~DVwSlGvilyeLltG~~P  244 (496)
T PTZ00283        170 KSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-----KPYSKKADMFSLGVLLYELLTLKRP  244 (496)
T ss_pred             CHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCC-----CCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            9999999999999999999997654321 112234679999999999983     5689999999999999999999999


Q ss_pred             CCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        230 FYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       230 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      |.+.+..+.+.++..+... ++|.    .+++++.++|.+||+ +|.+||++.+++                 .|||++.
T Consensus       245 f~~~~~~~~~~~~~~~~~~-~~~~----~~~~~l~~li~~~L~~dP~~RPs~~ell-----------------~~p~~~~  302 (496)
T PTZ00283        245 FDGENMEEVMHKTLAGRYD-PLPP----SISPEMQEIVTALLSSDPKRRPSSSKLL-----------------NMPICKL  302 (496)
T ss_pred             CCCCCHHHHHHHHhcCCCC-CCCC----CCCHHHHHHHHHHcccChhhCcCHHHHH-----------------hCHHHHH
Confidence            9999888888877765432 2333    689999999999999 999999876665                 8888775


Q ss_pred             C
Q psy11571        309 I  309 (372)
Q Consensus       309 ~  309 (372)
                      .
T Consensus       303 ~  303 (496)
T PTZ00283        303 F  303 (496)
T ss_pred             h
Confidence            3

>KOG4236|consensus

Probab=100.00  E-value=5.3e-43  Score=326.92  Aligned_cols=261  Identities=30%  Similarity=0.491  Sum_probs=221.7

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccCC
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCG   97 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~g   97 (372)
                      -||.||-.++..+|+.||+|.+.+......        .-+++++|+.+|+.+.||.||.+...|++.+.+++|||-+.|
T Consensus       576 QFG~VYgg~hRktGrdVAvKvIdKlrFp~k--------qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G  647 (888)
T KOG4236|consen  576 QFGTVYGGKHRKTGRDVAVKVIDKLRFPTK--------QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG  647 (888)
T ss_pred             cceeeecceecccCceeeeeeeecccCCCc--------hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence            689999999999999999999988776654        236789999999999999999999999999999999999955


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC---cEEEeecCccccc
Q psy11571         98 GDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG---HIRLADFGSCLRL  174 (372)
Q Consensus        98 g~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~---~vkl~Dfg~a~~~  174 (372)
                      .-|.-++....+++++...++++.||+.||.|||-+||+|          +||||+|||+.+..   ++||||||+|+.+
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvH----------CDLKPENVLLas~~~FPQvKlCDFGfARiI  717 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVH----------CDLKPENVLLASASPFPQVKLCDFGFARII  717 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceee----------ccCCchheeeccCCCCCceeeccccceeec
Confidence            4444455555789999999999999999999999999999          99999999997543   7999999999998


Q ss_pred             CCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCC
Q psy11571        175 GGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSD  254 (372)
Q Consensus       175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  254 (372)
                      ++....  .+.+|||.|+|||+++     ...|+.+.|+||+|||+|--++|..||..+.  ++-.+|.+.  .+-+|..
T Consensus       718 gEksFR--rsVVGTPAYLaPEVLr-----nkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNA--aFMyPp~  786 (888)
T KOG4236|consen  718 GEKSFR--RSVVGTPAYLAPEVLR-----NKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNA--AFMYPPN  786 (888)
T ss_pred             chhhhh--hhhcCCccccCHHHHh-----hccccccccceeeeEEEEEEecccccCCCcc--chhHHhhcc--ccccCCC
Confidence            765433  3478999999999999     4679999999999999999999999996543  445566553  4566777


Q ss_pred             CCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC-Ccccccc----CCCCCcCC
Q psy11571        255 VGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI-AWDSIRD----SNAPYIPE  324 (372)
Q Consensus       255 ~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~-~w~~~~~----~~~p~~p~  324 (372)
                      .|..+++++.|||..+|+ +-.+|.|.+..+                 .|||+++. -|-+|++    ..+-|+-.
T Consensus       787 PW~eis~~AidlIn~LLqVkm~kRysvdk~l-----------------sh~Wlq~yq~w~DLRelE~~igeRyiTh  845 (888)
T KOG4236|consen  787 PWSEISPEAIDLINNLLQVKMRKRYSVDKSL-----------------SHPWLQDYQTWLDLRELEVRIGERYITH  845 (888)
T ss_pred             chhhcCHHHHHHHHHHHHHHHHHhcchHhhc-----------------cchhhhcchHHHHHHHHHHhhCcceecC
Confidence            788999999999999999 999999877666                 99999997 5888754    33455543

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.7e-41  Score=308.89  Aligned_cols=253  Identities=23%  Similarity=0.347  Sum_probs=201.6

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHY   80 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~   80 (372)
                      .+|+.++.++.|    ++|.||++....+++.+|+|........           ...+..|+.++..+ +||||+++++
T Consensus         6 ~~y~~~~~lg~g----~~g~vy~~~~~~~~~~~aik~~~~~~~~-----------~~~~~~e~~~l~~~~~h~~i~~~~~   70 (272)
T cd06637           6 GIFELVELVGNG----TYGQVYKGRHVKTGQLAAIKVMDVTGDE-----------EEEIKQEINMLKKYSHHRNIATYYG   70 (272)
T ss_pred             hhhhHHHheeec----CCeEEEEEEEcCCCcEEEEEEEEcCCcc-----------HHHHHHHHHHHHHhcCCCCeeeEee
Confidence            468888888777    7999999998889999999987654321           13356788888887 6999999999


Q ss_pred             EEEeC------CeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcC
Q psy11571         81 AFQDD------SNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPD  153 (372)
Q Consensus        81 ~~~~~------~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~  153 (372)
                      .+...      ..+|++|||+.+++|.+++... ...+++..+..++.|++.||+|||+++++|          |||||+
T Consensus        71 ~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh----------~dl~~~  140 (272)
T cd06637          71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIH----------RDIKGQ  140 (272)
T ss_pred             EEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc----------CCCCHH
Confidence            98753      4689999999999999999863 346899999999999999999999999999          999999


Q ss_pred             cEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC
Q psy11571        154 NVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE  233 (372)
Q Consensus       154 NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~  233 (372)
                      ||+++.++.++|+|||++........ ......|++.|+|||++.+.......++.++|+|||||++|+|++|..||...
T Consensus       141 nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~  219 (272)
T cd06637         141 NVLLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM  219 (272)
T ss_pred             HEEECCCCCEEEccCCCceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            99999999999999999876533221 22345789999999998643222345788999999999999999999999876


Q ss_pred             CHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        234 SLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       234 ~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      ........+.....    +......++.++++||.+||. +|.+||++++++
T Consensus       220 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il  267 (272)
T cd06637         220 HPMRALFLIPRNPA----PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLM  267 (272)
T ss_pred             CHHHHHHHHhcCCC----CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence            65554444433221    111122578999999999999 999999866555

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.6e-41  Score=313.07  Aligned_cols=266  Identities=20%  Similarity=0.267  Sum_probs=212.0

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeee-----hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCcee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETL-----LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWIT   76 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~-----~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv   76 (372)
                      +||+.++.++.|    ++|.||++...     ..+..||+|.+.......         ....+.+|..+++.++||||+
T Consensus         6 ~~~~i~~~lg~G----~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~   72 (288)
T cd05061           6 EKITLLRELGQG----SFGMVYEGNARDIIKGEAETRVAVKTVNESASLR---------ERIEFLNEASVMKGFTCHHVV   72 (288)
T ss_pred             HHceeeeeecCC----CCcEEEEEEEeccCCCCcceEEEEEECCCcCCHH---------HHHHHHHHHHHHHhCCCCCee
Confidence            578888888888    89999988643     234578888765432211         123467799999999999999


Q ss_pred             eeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcC
Q psy11571         77 NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE---------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC  147 (372)
Q Consensus        77 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vh  147 (372)
                      ++++++.+....|+||||+++|+|.+++.+..         ..++...+..++.|++.||.|||++|++|          
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H----------  142 (288)
T cd05061          73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVH----------  142 (288)
T ss_pred             eEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcC----------
Confidence            99999999999999999999999999997531         23456788999999999999999999999          


Q ss_pred             CCCCcCcEEeCCCCcEEEeecCcccccCCCCccc-ccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-
Q psy11571        148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ-SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-  225 (372)
Q Consensus       148 rDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-  225 (372)
                      |||||+||+++.++.++|+|||+++......... .....++..|+|||.+.     ...++.++|+|||||++|||++ 
T Consensus       143 ~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~-----~~~~~~~~DvwslG~~l~el~~~  217 (288)
T cd05061         143 RDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK-----DGVFTTSSDMWSFGVVLWEITSL  217 (288)
T ss_pred             CCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhc-----cCCCChHhHHHHHHHHHHHHHhC
Confidence            9999999999999999999999987654322211 12234567899999987     3568899999999999999998 


Q ss_pred             CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCC
Q psy11571        226 GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHP  304 (372)
Q Consensus       226 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp  304 (372)
                      |..||.+.+..+....+.... ....+.    ..++.+++++.+||+ +|++||++.++.+.+.           ...||
T Consensus       218 ~~~p~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~-----------~~~~~  281 (288)
T cd05061         218 AEQPYQGLSNEQVLKFVMDGG-YLDQPD----NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK-----------DDLHP  281 (288)
T ss_pred             CCCCCCCCCHHHHHHHHHcCC-CCCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH-----------hhcCC
Confidence            799999888777776665432 223333    568999999999999 9999999888876651           11499


Q ss_pred             CcCCCCc
Q psy11571        305 WFQGIAW  311 (372)
Q Consensus       305 ~f~~~~w  311 (372)
                      ||++++|
T Consensus       282 ~~~~~~~  288 (288)
T cd05061         282 SFPEVSF  288 (288)
T ss_pred             CCCCCCC
Confidence            9999999

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0667|consensus

Probab=100.00  E-value=5.5e-42  Score=329.74  Aligned_cols=256  Identities=22%  Similarity=0.303  Sum_probs=210.8

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-C-----Ccee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-R-----RWIT   76 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-h-----p~Iv   76 (372)
                      ||.+++-+|.|    .||.|.++.+..+++.||||.+++...           +..+...|+.+|..++ |     -|||
T Consensus       187 rY~V~e~LGkG----tFGQVvk~~d~~T~e~VAIKIiKN~k~-----------f~~Q~~~Ei~iL~~ln~~d~~~~~n~V  251 (586)
T KOG0667|consen  187 RYEVLEVLGKG----SFGQVVKAYDHKTGEIVAIKIIKNKKR-----------FLRQAQIEIRILELLNKHDPDDKYNIV  251 (586)
T ss_pred             EEEEEEEeccc----ccceeEEEEecCCCcEEEEEeeccChH-----------HHHHHHHHHHHHHHHhccCCCCCeeEE
Confidence            56777778887    699999999999999999998877543           4455667888888876 3     4899


Q ss_pred             eeeEEEEeCCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcE
Q psy11571         77 NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNV  155 (372)
Q Consensus        77 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NI  155 (372)
                      +++++|...+++|||+|.+ +.+|+++++.. -.+++...++.++.||+.||.+||+.||||          +|||||||
T Consensus       252 rm~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIH----------cDLKPENI  320 (586)
T KOG0667|consen  252 RMLDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIH----------CDLKPENI  320 (586)
T ss_pred             Eeeeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeee----------ccCChhhe
Confidence            9999999999999999998 77999999874 246899999999999999999999999999          99999999


Q ss_pred             EeCCC--CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC
Q psy11571        156 LLDAN--GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE  233 (372)
Q Consensus       156 ll~~~--~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~  233 (372)
                      |+...  ..|||+|||+|.+....-    .+.+.+..|.|||++.+     .+|+.+.||||||||+.||++|.+.|.+.
T Consensus       321 LL~~~~r~~vKVIDFGSSc~~~q~v----ytYiQSRfYRAPEVILG-----lpY~~~IDmWSLGCIlAEL~tG~PLfpG~  391 (586)
T KOG0667|consen  321 LLKDPKRSRIKVIDFGSSCFESQRV----YTYIQSRFYRAPEVILG-----LPYDTAIDMWSLGCILAELFTGEPLFPGD  391 (586)
T ss_pred             eeccCCcCceeEEecccccccCCcc----eeeeeccccccchhhcc-----CCCCCccceeehhhhHHhHhcCccccCCC
Confidence            99744  379999999998865422    24678999999999995     67999999999999999999999999999


Q ss_pred             CHHHHHHHHhhccCCc--------------------------------------------------CCCCCC-------C
Q psy11571        234 SLVETYGKIMNHQNSF--------------------------------------------------DLPSDV-------G  256 (372)
Q Consensus       234 ~~~~~~~~i~~~~~~~--------------------------------------------------~~~~~~-------~  256 (372)
                      ++.+.+..|+.-.+.+                                                  ..|...       .
T Consensus       392 ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~  471 (586)
T KOG0667|consen  392 NEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLP  471 (586)
T ss_pred             CHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcc
Confidence            9998887775211100                                                  011000       0


Q ss_pred             CCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCC
Q psy11571        257 YEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       257 ~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~  310 (372)
                      ..-...+.|||++||. ||.+|+|+.+++                 +||||.+..
T Consensus       472 ~~~~~~F~dflk~~L~~dP~~R~tp~qal-----------------~Hpfl~~~~  509 (586)
T KOG0667|consen  472 KADDKLFIDFLKRCLEWDPAERITPAQAL-----------------NHPFLTGTS  509 (586)
T ss_pred             cccHHHHHHHHHHHhccCchhcCCHHHHh-----------------cCccccccc
Confidence            0123567899999999 999999988877                 999999643

>KOG0574|consensus

Probab=100.00  E-value=4e-44  Score=314.60  Aligned_cols=256  Identities=22%  Similarity=0.386  Sum_probs=218.6

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      |-+.+++++|.|    .+|+|+++.+..+|+.+|+|.+-...-            ++.+..|+.+++++++|++|++|+.
T Consensus        33 EVFDi~~KLGEG----SYGSV~KAIH~EsG~v~AIK~VPV~sD------------LQEIIKEISIMQQC~S~yVVKYYGS   96 (502)
T KOG0574|consen   33 EVFDIVGKLGEG----SYGSVHKAIHRESGHVLAIKKVPVDTD------------LQEIIKEISIMQQCKSKYVVKYYGS   96 (502)
T ss_pred             HHHHHHHHhcCC----cchHHHHHHHhccCcEEEEEecCccch------------HHHHHHHHHHHHHcCCchhhhhhhh
Confidence            446788888888    799999999999999999997765432            4557889999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      |-....+|+|||||..|+..++++.++..++|.++..+++..+.||+|||...-+|          ||||..|||++.+|
T Consensus        97 YFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIH----------RDIKAGNILLNT~G  166 (502)
T KOG0574|consen   97 YFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIH----------RDIKAGNILLNTDG  166 (502)
T ss_pred             hccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHH----------hhcccccEEEcccc
Confidence            99999999999999999999999987889999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      +.||+|||.|..+... ....++..|||.|||||++..     -.|+.++||||||++..||..|++||.+..+...+..
T Consensus       167 ~AKLADFGVAGQLTDT-MAKRNTVIGTPFWMAPEVI~E-----IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM  240 (502)
T KOG0574|consen  167 IAKLADFGVAGQLTDT-MAKRNTVIGTPFWMAPEVIEE-----IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM  240 (502)
T ss_pred             hhhhhhccccchhhhh-HHhhCccccCcccccHHHHHH-----hccchhhhHhhhcchhhhhhcCCCCcccccccceeEe
Confidence            9999999999776532 334567899999999999983     5589999999999999999999999988776654444


Q ss_pred             Hhhcc-CCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCC
Q psy11571        242 IMNHQ-NSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       242 i~~~~-~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~  310 (372)
                      |-... +.+.-|.    ..|.+..|||++||. +|++|-+|-.+.                 +|||.++..
T Consensus       241 IPT~PPPTF~KPE----~WS~~F~DFi~~CLiK~PE~R~TA~~L~-----------------~H~FiknA~  290 (502)
T KOG0574|consen  241 IPTKPPPTFKKPE----EWSSEFNDFIRSCLIKKPEERKTALRLC-----------------EHTFIKNAP  290 (502)
T ss_pred             ccCCCCCCCCChH----hhhhHHHHHHHHHhcCCHHHHHHHHHHh-----------------hhhhhcCCC
Confidence            43221 1122222    578999999999999 999999866655                 999998753

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.7e-41  Score=318.75  Aligned_cols=255  Identities=20%  Similarity=0.279  Sum_probs=198.7

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccCC
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCG   97 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~g   97 (372)
                      |+|.||++.+..+++.||+|.+........        ..+.+.+|+.+++.++||||+++++++.+++..|+||||+++
T Consensus        12 ~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~   83 (327)
T cd08227          12 DLMTVNLARYKPTGEYVTVRRINLEACTNE--------MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY   83 (327)
T ss_pred             ceEEEEEEeecccCcEEEEEEechhhccHH--------HHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCC
Confidence            678999999999999999998765543222        345577899999999999999999999999999999999999


Q ss_pred             CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCC
Q psy11571         98 GDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG  176 (372)
Q Consensus        98 g~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  176 (372)
                      |+|.+++... ...+++..++.++.|++.||+|||++|++|          |||||+||+++.++.++++||+.+.....
T Consensus        84 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH----------~dlkp~Nil~~~~~~~~l~~~~~~~~~~~  153 (327)
T cd08227          84 GSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVH----------RSVKASHILISVDGKVYLSGLRSNLSMIN  153 (327)
T ss_pred             CcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEec----------CCCChhhEEEecCCcEEEcccchhhcccc
Confidence            9999999753 345899999999999999999999999999          99999999999999999999986544321


Q ss_pred             CCcc------cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcC
Q psy11571        177 DGTV------QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD  250 (372)
Q Consensus       177 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~  250 (372)
                      ....      ......++..|+|||++.+.   ...++.++|||||||++|+|++|+.||....................
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  230 (327)
T cd08227         154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQN---LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL  230 (327)
T ss_pred             ccccccccccccccccceecccChHHhhcc---cCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccc
Confidence            1110      01123467789999999731   13588999999999999999999999987554443333222111000


Q ss_pred             C----------------------------------------CCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhh
Q psy11571        251 L----------------------------------------PSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMW  289 (372)
Q Consensus       251 ~----------------------------------------~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~  289 (372)
                      .                                        .......+++++++||++||+ ||++|||+++++     
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell-----  305 (327)
T cd08227         231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLL-----  305 (327)
T ss_pred             ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHh-----
Confidence            0                                        000112457899999999999 999999987666     


Q ss_pred             hhhhhccCCCCCCCCCcCCCC
Q psy11571        290 SALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       290 ~~~~~~~~~~~~~hp~f~~~~  310 (372)
                                  +||||+.+.
T Consensus       306 ------------~~p~f~~~~  314 (327)
T cd08227         306 ------------NHSFFKQIK  314 (327)
T ss_pred             ------------cChhhhhcc
Confidence                        999998754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-41  Score=308.87  Aligned_cols=257  Identities=26%  Similarity=0.404  Sum_probs=215.0

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      .||+.+..++.|    |+|.||++....++..+++|.+.......         ....+.+|+.+++.++||||+++++.
T Consensus         1 ~~y~~~~~lg~g----~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~   67 (274)
T cd06609           1 ELFTLLECIGKG----SFGEVYKAIDKRTNQVVAIKVIDLEEAED---------EIEDIQQEIQFLSQCRSPYITKYYGS   67 (274)
T ss_pred             ChhhhhhhhcCC----CCeEEEEEEECCCCeEEEEEEeeccccch---------HHHHHHHHHHHHHHcCCCCeeeeeEE
Confidence            478888888887    89999999998899999999876543211         23456789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.++..+|+|+||+++++|.+++..  ..+++..++.++.|++.||.|||+.+++|          +||+|+||++++++
T Consensus        68 ~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~i~h----------~dl~p~ni~i~~~~  135 (274)
T cd06609          68 FLKGSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLHEEGKIH----------RDIKAANILLSEEG  135 (274)
T ss_pred             EEECCeEEEEEEeeCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCccc----------CCCCHHHEEECCCC
Confidence            9999999999999999999999986  48999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .++|+|||+++....... ......|++.|+|||.+.+     ..++.++|+|||||++|+|++|..||...+.......
T Consensus       136 ~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~-----~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~  209 (274)
T cd06609         136 DVKLADFGVSGQLTSTMS-KRNTFVGTPFWMAPEVIKQ-----SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL  209 (274)
T ss_pred             CEEEcccccceeeccccc-ccccccCCccccChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH
Confidence            999999999987654321 2233568889999999984     4588999999999999999999999988776666555


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCC
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~  310 (372)
                      +.... ....+.   ..++.++.++|.+||. +|++||+++++.                 .||||....
T Consensus       210 ~~~~~-~~~~~~---~~~~~~~~~~l~~~l~~~p~~Rpt~~~il-----------------~~~~~~~~~  258 (274)
T cd06609         210 IPKNN-PPSLEG---NKFSKPFKDFVSLCLNKDPKERPSAKELL-----------------KHKFIKKAK  258 (274)
T ss_pred             hhhcC-CCCCcc---cccCHHHHHHHHHHhhCChhhCcCHHHHh-----------------hChhhcCCC
Confidence            54432 222222   1378999999999999 999999866555                 999998754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG4721|consensus

Probab=100.00  E-value=2.8e-42  Score=324.62  Aligned_cols=238  Identities=21%  Similarity=0.308  Sum_probs=206.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      .+.+|+=+|.|    ++|.||..+  ..++.||||+++.-+                 ..+++.|++|+||||+.+.++|
T Consensus       125 ~IsELeWlGSG----aQGAVF~Gr--l~netVAVKKV~elk-----------------ETdIKHLRkLkH~NII~FkGVC  181 (904)
T KOG4721|consen  125 EISELEWLGSG----AQGAVFLGR--LHNETVAVKKVRELK-----------------ETDIKHLRKLKHPNIITFKGVC  181 (904)
T ss_pred             HhhhhhhhccC----cccceeeee--ccCceehhHHHhhhh-----------------hhhHHHHHhccCcceeeEeeee
Confidence            45667777777    799999874  577889999765321                 2377889999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .....+|||||||..|-|..+|+. +..+.......|..+|+.|+.|||.+.|||          ||||.-||||+.+..
T Consensus       182 tqsPcyCIiMEfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIH----------RDLKSPNiLIs~~d~  250 (904)
T KOG4721|consen  182 TQSPCYCIIMEFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIH----------RDLKSPNILISYDDV  250 (904)
T ss_pred             cCCceeEEeeeccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhh----------hccCCCceEeeccce
Confidence            999999999999999999999998 678999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      |||+|||.++......  ..-.++||..|||||+++     ..+.+.++|||||||+||||+||..||.+.+...++.-+
T Consensus       251 VKIsDFGTS~e~~~~S--TkMSFaGTVaWMAPEvIr-----nePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV  323 (904)
T KOG4721|consen  251 VKISDFGTSKELSDKS--TKMSFAGTVAWMAPEVIR-----NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV  323 (904)
T ss_pred             EEeccccchHhhhhhh--hhhhhhhhHhhhCHHHhh-----cCCcccccceehhHHHHHHHHhcCCCccccchheeEEec
Confidence            9999999998776543  334589999999999999     467899999999999999999999999988877766555


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhh
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIAD  285 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~  285 (372)
                      -.....++.|+    .+++.++=||++||+ +|..||++.+++.
T Consensus       324 GsNsL~LpvPs----tcP~GfklL~Kqcw~sKpRNRPSFrqil~  363 (904)
T KOG4721|consen  324 GSNSLHLPVPS----TCPDGFKLLLKQCWNSKPRNRPSFRQILL  363 (904)
T ss_pred             cCCcccccCcc----cCchHHHHHHHHHHhcCCCCCccHHHHHH
Confidence            55555666666    789999999999999 9999999888763

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.8e-42  Score=317.51  Aligned_cols=254  Identities=22%  Similarity=0.337  Sum_probs=198.1

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      ||+.++.++.|    ++|.||++.+..+++.+++|.+........        ....+.+|+.+++.++||||+++++++
T Consensus         1 ~y~~~~~l~~g----~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~--------~~~~~~~ei~~l~~l~h~~i~~~~~~~   68 (284)
T cd07839           1 KYEKLEKIGEG----TYGTVFKAKNRETHEIVALKRVRLDDDDEG--------VPSSALREICLLKELKHKNIVRLYDVL   68 (284)
T ss_pred             CceeEEEeccc----CCeEEEEEEECCCCcEEEEEEeeccccccc--------CccchhHHHHHHHhcCCCCeeeHHHHh
Confidence            45666667666    799999999999999999998765432221        123456799999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+...+|+++||+. ++|.+++.+..+.+++..++.++.||+.||.|||++|++|          |||||+||+++.++.
T Consensus        69 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H----------~dl~~~nil~~~~~~  137 (284)
T cd07839          69 HSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLH----------RDLKPQNLLINKNGE  137 (284)
T ss_pred             ccCCceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEec----------CCCCHHHEEEcCCCc
Confidence            99999999999995 5898888765577999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCC-CCCCHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF-YAESLVETYGK  241 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf-~~~~~~~~~~~  241 (372)
                      ++|+|||+++........ .....+++.|+|||++.+    ...++.++|+|||||++|+|++|..|| .+.+..+.+..
T Consensus       138 ~~l~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~  212 (284)
T cd07839         138 LKLADFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFG----AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR  212 (284)
T ss_pred             EEECccchhhccCCCCCC-cCCCccccCCcChHHHhC----CcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHH
Confidence            999999998765432221 122457889999999874    345788999999999999999998885 44444444444


Q ss_pred             HhhccCC--------------c-CCCC--------CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        242 IMNHQNS--------------F-DLPS--------DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       242 i~~~~~~--------------~-~~~~--------~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      +......              . ..+.        .....+++++++||.+||+ ||.+|||+++++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il  279 (284)
T cd07839         213 IFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEAL  279 (284)
T ss_pred             HHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHh
Confidence            3221100              0 0000        0112578999999999999 999999876665

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.7e-41  Score=313.26  Aligned_cols=260  Identities=26%  Similarity=0.409  Sum_probs=210.0

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+..+.++.|    ++|.||++.+..++..+++|.+........        ..+.+.+|+.+++.++||||+++++++.
T Consensus         2 y~~~~~l~~g----~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~--------~~~~~~~e~~~l~~~~~~~i~~~~~~~~   69 (286)
T cd07832           2 YKILGRIGEG----AHGIVFKAKDRETGETVALKKVALRRLEGG--------IPNQALREIKALQACQHPYVVKLLDVFP   69 (286)
T ss_pred             ceEEeecccC----CCcEEEEEEECCCCceEEEEEEEcccccch--------hhHHHHHHHHHHHhCCCCCCcceeeEEe
Confidence            4555566665    899999999988999999998766543221        2345778999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcE
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI  163 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~v  163 (372)
                      +...+|+||||+ +++|.+++......+++..++.++.||+.||+|||+.|++|          +||||+||+++.++.+
T Consensus        70 ~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H----------~dl~p~ni~~~~~~~~  138 (286)
T cd07832          70 HGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMH----------RDLKPANLLISADGVL  138 (286)
T ss_pred             cCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeec----------CCcCHHHEEEcCCCcE
Confidence            999999999999 99999999775567999999999999999999999999999          9999999999999999


Q ss_pred             EEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHh
Q psy11571        164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM  243 (372)
Q Consensus       164 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~  243 (372)
                      +|+|||++...............|+..|+|||.+.+    ...++.++|||||||++|+|++|.+||.+.+....+..+.
T Consensus       139 ~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~  214 (286)
T cd07832         139 KIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG----ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVF  214 (286)
T ss_pred             EEeeeeecccccCCCCCccccccCcccccCceeeec----cccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHH
Confidence            999999988765433222233568999999999863    3457889999999999999999999998887766665554


Q ss_pred             hccCCc-----------------CCCC-------CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCC
Q psy11571        244 NHQNSF-----------------DLPS-------DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSI  298 (372)
Q Consensus       244 ~~~~~~-----------------~~~~-------~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~  298 (372)
                      ......                 ..+.       ......+..+.+||.+||. +|.+||++++++              
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l--------------  280 (286)
T cd07832         215 RTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEAL--------------  280 (286)
T ss_pred             HHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHh--------------
Confidence            321110                 0000       0112467999999999999 999999877665              


Q ss_pred             CCCCCCCcC
Q psy11571        299 SPRNHPWFQ  307 (372)
Q Consensus       299 ~~~~hp~f~  307 (372)
                         .||||.
T Consensus       281 ---~h~~~~  286 (286)
T cd07832         281 ---RHPYFT  286 (286)
T ss_pred             ---hCcCcC
Confidence               999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.5e-41  Score=306.88  Aligned_cols=246  Identities=23%  Similarity=0.351  Sum_probs=201.5

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      +++|.||.+.+..+++.+++|.+......... .....+..+.+.+|+.+++.++||||+++++++.+....+++|||++
T Consensus        11 g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~-~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   89 (267)
T cd06628          11 GSFGSVYLGMNASSGELMAVKQVELPSVSASS-KDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVP   89 (267)
T ss_pred             CCCeEEEEEEecCCCcEEEEEEecCCCcccch-hHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecC
Confidence            38899999998888999999987655443221 12223456778899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCC
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG  176 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  176 (372)
                      +++|.+++.. .+.+++..+..++.|++.||+|||+.|++|          |||+|+||++++++.++|+|||+++....
T Consensus        90 ~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH----------~di~p~nil~~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06628          90 GGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRGIIH----------RDIKGANILVDNKGGIKISDFGISKKLEA  158 (267)
T ss_pred             CCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcCccc----------ccCCHHHEEEcCCCCEEecccCCCccccc
Confidence            9999999987 467899999999999999999999999999          99999999999999999999999887642


Q ss_pred             CCcc-----cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCC
Q psy11571        177 DGTV-----QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDL  251 (372)
Q Consensus       177 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~  251 (372)
                      ....     ......|+..|+|||.+.+     ..++.++|+|||||++|+|++|+.||...+......++... .....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~-----~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~  232 (267)
T cd06628         159 NSLSTKTNGARPSLQGSVFWMAPEVVKQ-----TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN-ASPEI  232 (267)
T ss_pred             ccccCCccccccccCCCcCccChhHhcc-----CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc-CCCcC
Confidence            2110     1122457889999999873     56788999999999999999999999887665555554432 22223


Q ss_pred             CCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        252 PSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       252 ~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      +.    .++..+.++|++||+ +|.+||++++++
T Consensus       233 ~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il  262 (267)
T cd06628         233 PS----NISSEAIDFLEKTFEIDHNKRPTAAELL  262 (267)
T ss_pred             Cc----ccCHHHHHHHHHHccCCchhCcCHHHHh
Confidence            33    678999999999999 999999866555

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.5e-41  Score=313.56  Aligned_cols=253  Identities=23%  Similarity=0.338  Sum_probs=196.9

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+.++.++.|    ++|.||++....++..|++|.+........        ..+.+.+|+.+++.++||||+++++++.
T Consensus         2 y~~~~~l~~g----~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~   69 (285)
T cd07861           2 YTKIEKIGEG----TYGVVYKGRNKKTGQIVAMKKIRLESEEEG--------VPSTAIREISLLKELQHPNIVCLQDVLM   69 (285)
T ss_pred             ceEeeEeccc----CceEEEEEEECCCCcEEEEEEeccccccCC--------chHHHHHHHHHHHhcCCCCEeeeEEEEe
Confidence            3445555555    799999999888999999998765432211        2244677999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFE--DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      ++..+|+||||++ ++|.+++....  ..+++..++.++.||+.||.|||+.|++|          |||||+||+++.++
T Consensus        70 ~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H----------~dl~p~nil~~~~~  138 (285)
T cd07861          70 QESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLH----------RDLKPQNLLIDNKG  138 (285)
T ss_pred             eCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeee----------cCCCHHHEEEcCCC
Confidence            9999999999996 68999886532  56899999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .++|+|||++........ ......+++.|+|||++.+    ...++.++|+|||||++|+|+||++||.+.+.......
T Consensus       139 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~  213 (285)
T cd07861         139 VIKLADFGLARAFGIPVR-VYTHEVVTLWYRAPEVLLG----SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFR  213 (285)
T ss_pred             cEEECcccceeecCCCcc-cccCCcccccccChHHhcC----CCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            999999999876543221 1122357889999999863    34578899999999999999999999988765544333


Q ss_pred             HhhccCCc----------------CCC-------CCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        242 IMNHQNSF----------------DLP-------SDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       242 i~~~~~~~----------------~~~-------~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      +.......                ..+       ......+++++++||++||+ ||++||++++++
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll  280 (285)
T cd07861         214 IFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKAL  280 (285)
T ss_pred             HHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHh
Confidence            22110000                000       01112578999999999999 999999876655

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.3e-41  Score=311.70  Aligned_cols=267  Identities=35%  Similarity=0.622  Sum_probs=211.8

Q ss_pred             HHHHhhhcCCcccCCccEEEeeee---hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeE
Q psy11571          5 RELEALFLGGPIQGKGRVFSIETL---LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHY   80 (372)
Q Consensus         5 ~~l~~~~~~~~~~g~G~v~~v~~~---~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~   80 (372)
                      +..+.++.|    |+|.||.|+..   .++..||+|.+........      ....+.+.+|+.++..+ +||||+++++
T Consensus         3 ~~~~~lg~G----~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~~i~~~~~   72 (290)
T cd05613           3 ELLKVLGTG----AYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQK------AKTTEHTRTERQVLEHIRQSPFLVTLHY   72 (290)
T ss_pred             eeeeeeccC----CcceEEEEEeccCCCCCceEEEEEeehhhhhhc------chHHHHHHHHHHHHHhcccCCChhceee
Confidence            344455555    89999999875   3788999998765433221      22345567899999998 5999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         81 AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        81 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      +++.+..+|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|          |||+|+|||++.+
T Consensus        73 ~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~i~H----------~dl~p~nil~~~~  141 (290)
T cd05613          73 AFQTDTKLHLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGIIY----------RDIKLENILLDSN  141 (290)
T ss_pred             EeecCCeEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeec----------cCCCHHHeEECCC
Confidence            99999999999999999999999987 467899999999999999999999999999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCC----HH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES----LV  236 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~----~~  236 (372)
                      +.++|+|||++...............|+..|+|||.+...   ...++.++|+||||+++|+|++|..||....    ..
T Consensus       142 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~  218 (290)
T cd05613         142 GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGG---DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQA  218 (290)
T ss_pred             CCEEEeeCccceecccccccccccccCCcccCChhhccCC---CCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHH
Confidence            9999999999876544332223345689999999998731   2346789999999999999999999997533    23


Q ss_pred             HHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCC--CChhhhhhhhhhhhccCCCCCCCCCcCCCCccc
Q psy11571        237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQ--NGIADFKMWSALFVSLSISPRNHPWFQGIAWDS  313 (372)
Q Consensus       237 ~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~--~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~  313 (372)
                      +....+....  .+.+.    .+++.+.+++++||. +|++|++.  ..+.+++              .||||+.++|+.
T Consensus       219 ~~~~~~~~~~--~~~~~----~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~--------------~~~~~~~~~~~~  278 (290)
T cd05613         219 EISRRILKSE--PPYPQ----EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIK--------------KHPFFQKINWDD  278 (290)
T ss_pred             HHHHHhhccC--CCCCc----cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH--------------cCcccccCCHHH
Confidence            3333333322  22233    578999999999999 99999964  3566666              999999999988


Q ss_pred             cc
Q psy11571        314 IR  315 (372)
Q Consensus       314 ~~  315 (372)
                      +.
T Consensus       279 ~~  280 (290)
T cd05613         279 LA  280 (290)
T ss_pred             Hh
Confidence            73

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.7e-41  Score=317.14  Aligned_cols=247  Identities=21%  Similarity=0.304  Sum_probs=185.8

Q ss_pred             ccCCccEEEeeee--hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe--CCeEEEE
Q psy11571         16 IQGKGRVFSIETL--LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQD--DSNLYLV   91 (372)
Q Consensus        16 ~~g~G~v~~v~~~--~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~lv   91 (372)
                      .|++|.||++.+.  .+++.+|+|.+......            ..+.+|+.+++.++||||+++++++.+  ...+|++
T Consensus        11 ~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07868          11 RGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS------------MSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   78 (317)
T ss_pred             cCCCeEEEEEEEccCCCCceEEEEEECCCCCc------------HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence            3489999999864  36688999977654322            225679999999999999999999864  4568999


Q ss_pred             EeccCCCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe----CC
Q psy11571         92 MDYYCGGDLLTLLSKF--------EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL----DA  159 (372)
Q Consensus        92 ~E~~~gg~L~~~l~~~--------~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll----~~  159 (372)
                      |||+ +++|.+++...        ...+++..++.++.||+.||.|||++||+|          |||||+|||+    +.
T Consensus        79 ~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH----------rDlkp~Nil~~~~~~~  147 (317)
T cd07868          79 FDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLH----------RDLKPANILVMGEGPE  147 (317)
T ss_pred             Eecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEc----------CCCCHHHEEEecCCCC
Confidence            9998 56898887632        125899999999999999999999999999          9999999999    45


Q ss_pred             CCcEEEeecCcccccCCCCc--ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH-
Q psy11571        160 NGHIRLADFGSCLRLGGDGT--VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-  236 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-  236 (372)
                      ++.+||+|||+++.......  .......||+.|+|||++.+    ...++.++|+||+||++|+|++|++||.+.... 
T Consensus       148 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~  223 (317)
T cd07868         148 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG----ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI  223 (317)
T ss_pred             cCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcC----CCCcCchhhHHHHHHHHHHHHhCCCCccCCcccc
Confidence            67899999999987543221  11233578999999999974    345889999999999999999999999754321 


Q ss_pred             --------HHHHHHhhccCCc--------------------------------CCCCCCCCCCCHHHHHHHHHhcc-CCC
Q psy11571        237 --------ETYGKIMNHQNSF--------------------------------DLPSDVGYEISDDAKDLMRRLIC-SSD  275 (372)
Q Consensus       237 --------~~~~~i~~~~~~~--------------------------------~~~~~~~~~~s~~~~~li~~lL~-~p~  275 (372)
                              ..+.++.......                                ..........+.++.+||++||+ ||.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~  303 (317)
T cd07868         224 KTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPI  303 (317)
T ss_pred             cccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcc
Confidence                    1122221100000                                00000011246779999999999 999


Q ss_pred             CCCCCCChhhhhhhhhhhhccCCCCCCCCCc
Q psy11571        276 TRLGQNGIADFKMWSALFVSLSISPRNHPWF  306 (372)
Q Consensus       276 ~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f  306 (372)
                      +|+|+++++                 +||||
T Consensus       304 ~R~t~~e~l-----------------~hp~f  317 (317)
T cd07868         304 KRITSEQAM-----------------QDPYF  317 (317)
T ss_pred             cCCCHHHHh-----------------cCCCC
Confidence            999977766                 99998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.5e-41  Score=307.58  Aligned_cols=254  Identities=19%  Similarity=0.284  Sum_probs=203.2

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      .+|+.+..++.|    ++|.||++....+++.+|+|.........          ...+.+|+.+++.++||||++++++
T Consensus         9 ~~y~~~~~lg~g----~~g~vy~~~~~~~~~~~aik~~~~~~~~~----------~~~~~~e~~~l~~~~h~~ii~~~~~   74 (267)
T cd06646           9 HDYELIQRVGSG----TYGDVYKARNLHTGELAAVKIIKLEPGDD----------FSLIQQEIFMVKECKHCNIVAYFGS   74 (267)
T ss_pred             hhcchhheeecC----CCeEEEEEEECCCCeEEEEEEEecCccch----------HHHHHHHHHHHHhcCCCCeeeeeEE
Confidence            467788888777    89999999998899999999876443211          2346779999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +..+..+|+||||+++++|.+++.. .+.+++..+..++.|++.||.|||+.|++|          |||||+||+++.++
T Consensus        75 ~~~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H----------~dl~p~nill~~~~  143 (267)
T cd06646          75 YLSREKLWICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMH----------RDIKGANILLTDNG  143 (267)
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------cCCCHHHEEECCCC
Confidence            9999999999999999999999976 568899999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .++|+|||++........ ......|++.|+|||.+....  ...++.++|+||+||++|+|++|+.||...+.......
T Consensus       144 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~--~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~  220 (267)
T cd06646         144 DVKLADFGVAAKITATIA-KRKSFIGTPYWMAPEVAAVEK--NGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL  220 (267)
T ss_pred             CEEECcCccceeeccccc-ccCccccCccccCHhHccccc--CCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee
Confidence            999999999986543221 123356889999999985311  24467899999999999999999999976654443333


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      +.......+.+. ....++..+.+||++||. +|++||++++++
T Consensus       221 ~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il  263 (267)
T cd06646         221 MSKSNFQPPKLK-DKTKWSSTFHNFVKISLTKNPKKRPTAERLL  263 (267)
T ss_pred             eecCCCCCCCCc-cccccCHHHHHHHHHHhhCChhhCcCHHHHh
Confidence            322221111111 112578999999999999 999999877665

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.6e-41  Score=314.55  Aligned_cols=253  Identities=27%  Similarity=0.449  Sum_probs=207.4

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+.++.++.|    ++|.||++.+..+++.+++|.+.......          .+.+.+|+.+++.++||||+++++.+.
T Consensus        21 y~~~~~lg~g----~~g~vy~~~~~~~~~~v~iK~~~~~~~~~----------~~~~~~e~~~l~~l~h~~iv~~~~~~~   86 (296)
T cd06655          21 YTRYEKIGQG----ASGTVFTAIDVATGQEVAIKQINLQKQPK----------KELIINEILVMKELKNPNIVNFLDSFL   86 (296)
T ss_pred             EEEEEEEecC----CCeEEEEEEEcCCCcEEEEEEEecccCch----------HHHHHHHHHHHHhcCCCceeeeeeeEe
Confidence            3444444444    78999999988899999999876543222          244677999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcE
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI  163 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~v  163 (372)
                      ....+|+|+||+++++|..++..  ..+++.++..++.|++.||.|||+.|++|          |||||+||+++.++.+
T Consensus        87 ~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H----------~dL~p~Nili~~~~~~  154 (296)
T cd06655          87 VGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIH----------RDIKSDNVLLGMDGSV  154 (296)
T ss_pred             cCceEEEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCccc----------CCCCHHHEEECCCCCE
Confidence            99999999999999999999876  57899999999999999999999999999          9999999999999999


Q ss_pred             EEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHh
Q psy11571        164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM  243 (372)
Q Consensus       164 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~  243 (372)
                      +|+|||++........ ......|+..|+|||.+.     ...++.++|+|||||++|+|++|..||.+.+.......+.
T Consensus       155 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~  228 (296)
T cd06655         155 KLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVT-----RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA  228 (296)
T ss_pred             EEccCccchhcccccc-cCCCcCCCccccCcchhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999876543322 122346889999999987     3557889999999999999999999999887766555554


Q ss_pred             hccC-CcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        244 NHQN-SFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       244 ~~~~-~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      .... ....+    ..+++.+++||++||. +|.+||++.++.                 .||||+..
T Consensus       229 ~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rpt~~~il-----------------~~~~~~~~  275 (296)
T cd06655         229 TNGTPELQNP----EKLSPIFRDFLNRCLEMDVEKRGSAKELL-----------------QHPFLKLA  275 (296)
T ss_pred             hcCCcccCCc----ccCCHHHHHHHHHHhhcChhhCCCHHHHh-----------------hChHhhhc
Confidence            3221 11222    2688999999999999 999999876655                 99999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.9e-41  Score=312.62  Aligned_cols=254  Identities=25%  Similarity=0.441  Sum_probs=206.7

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.+..++.|    ++|.||++.+..+++.+++|.+.......          .+.+.+|+.+++.+.||||+++++.+
T Consensus        21 ~y~~~~~lg~g----~~~~v~~~~~~~~~~~v~ik~~~~~~~~~----------~~~~~~e~~~l~~~~h~~v~~~~~~~   86 (296)
T cd06654          21 KYTRFEKIGQG----ASGTVYTAMDVATGQEVAIRQMNLQQQPK----------KELIINEILVMRENKNPNIVNYLDSY   86 (296)
T ss_pred             ceeeEEEecCC----CCeEEEEEEECCCCcEEEEEEEecCCcch----------HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            45555555555    78999999988889999999876544322          24467899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .++...|+||||+++++|.+++.+  ..+++.++..++.|++.||.|||+.|++|          |||||+||+++.++.
T Consensus        87 ~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H----------~dLkp~Nill~~~~~  154 (296)
T cd06654          87 LVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIH----------RDIKSDNILLGMDGS  154 (296)
T ss_pred             EeCCEEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCccc----------CCCCHHHEEEcCCCC
Confidence            999999999999999999999975  56899999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      ++|+|||++........ ......|++.|+|||.+.     ...++.++|+|||||++|+|++|+.||...+.......+
T Consensus       155 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~  228 (296)
T cd06654         155 VKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVT-----RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI  228 (296)
T ss_pred             EEECccccchhcccccc-ccCcccCCccccCHHHHc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHH
Confidence            99999999876543221 122346889999999987     355788999999999999999999999887765443333


Q ss_pred             hhcc-CCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        243 MNHQ-NSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       243 ~~~~-~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      .... .....+    ..++..+.++|.+||. +|++||++++++                 .||||...
T Consensus       229 ~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~eil-----------------~~~~~~~~  276 (296)
T cd06654         229 ATNGTPELQNP----EKLSAIFRDFLNRCLDMDVEKRGSAKELL-----------------QHQFLKIA  276 (296)
T ss_pred             hcCCCCCCCCc----cccCHHHHHHHHHHCcCCcccCcCHHHHh-----------------hChhhhcc
Confidence            3221 111122    2678999999999999 999999866655                 99999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.8e-41  Score=344.75  Aligned_cols=148  Identities=32%  Similarity=0.547  Sum_probs=130.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    ++|.||.+.+..+++.||+|.+........       .....+.+|+.++..++||||+++++++
T Consensus         5 ~y~i~~~LG~G----~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~-------~~~~~~~~E~~~l~~l~hp~Iv~~~~~~   73 (669)
T cd05610           5 EFVIVKPISRG----AFGKVYLGRKKNNSKLYAVKVVKKADMINK-------NMVHQVQAERDALALSKSPFIVHLYYSL   73 (669)
T ss_pred             CEEEEEEEecC----CCeEEEEEEECCCCcEEEEEEEehhhccCH-------HHHHHHHHHHHHHHhcCCCCcCeEEEEE
Confidence            45556666666    899999999998999999998865443222       2345678899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .....+|+||||+.|++|.+++.. .+.+++..++.++.||+.||.|||++||+|          |||||+|||++.++.
T Consensus        74 ~~~~~~~lVmEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiH----------rDLKP~NILl~~~g~  142 (669)
T cd05610          74 QSANNVYLVMEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIH----------RDLKPDNMLISNEGH  142 (669)
T ss_pred             EECCEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEe----------CCccHHHEEEcCCCC
Confidence            999999999999999999999987 467899999999999999999999999999          999999999999999


Q ss_pred             EEEeecCccc
Q psy11571        163 IRLADFGSCL  172 (372)
Q Consensus       163 vkl~Dfg~a~  172 (372)
                      ++|+|||+++
T Consensus       143 vkL~DFGls~  152 (669)
T cd05610         143 IKLTDFGLSK  152 (669)
T ss_pred             EEEEeCCCCc
Confidence            9999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.7e-41  Score=309.26  Aligned_cols=260  Identities=25%  Similarity=0.428  Sum_probs=210.3

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.++.|    ++|.||++....+++.+|+|.+......         .....+.+|+.+++.++||||+++++.
T Consensus         1 ~~~~~~~~ig~g----~~g~v~~~~~~~~~~~~a~k~~~~~~~~---------~~~~~~~~e~~~l~~~~~~~i~~~~~~   67 (286)
T cd06622           1 DEIEVLDELGKG----NYGSVYKVLHRPTGVTMAMKEIRLELDE---------SKFNQIIMELDILHKAVSPYIVDFYGA   67 (286)
T ss_pred             Chhhhhhhhccc----CCeEEEEEEEcCCCcEEEEEEeecccCH---------HHHHHHHHHHHHHHhcCCCcHHhhhhh
Confidence            478899999988    8999999998889999999977543211         123557789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCCcCCCCCcCcEEeC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKF--EDRLPEDMAKFYIAEMVLAIASIHD-LHYVHRPNHFAFHLCRDIKPDNVLLD  158 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~~~~~~~~vhrDlkp~NIll~  158 (372)
                      +...+.+|+||||+++++|.+++...  ...+++..+..++.||+.||.|||+ .|++|          |||||+||+++
T Consensus        68 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H----------~dl~p~nil~~  137 (286)
T cd06622          68 FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIH----------RDVKPTNVLVN  137 (286)
T ss_pred             eecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEee----------CCCCHHHEEEC
Confidence            99999999999999999999998762  2378999999999999999999996 59999          99999999999


Q ss_pred             CCCcEEEeecCcccccCCCCcccccccccCCcccCccccccccc-CCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHH
Q psy11571        159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEE-GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE  237 (372)
Q Consensus       159 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~  237 (372)
                      .++.++|+|||++.......   .....+++.|+|||.+.+... ....++.++|+|||||++|+|++|+.||.......
T Consensus       138 ~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  214 (286)
T cd06622         138 GNGQVKLCDFGVSGNLVASL---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN  214 (286)
T ss_pred             CCCCEEEeecCCcccccCCc---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh
Confidence            99999999999987653321   223467889999999864221 12346889999999999999999999998765544


Q ss_pred             HHHHH---hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        238 TYGKI---MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       238 ~~~~i---~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      ....+   ... .....+.    .++.++.+||.+||+ +|++||+++++.                 .||||...
T Consensus       215 ~~~~~~~~~~~-~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~l~-----------------~~~~~~~~  268 (286)
T cd06622         215 IFAQLSAIVDG-DPPTLPS----GYSDDAQDFVAKCLNKIPNRRPTYAQLL-----------------EHPWLVKY  268 (286)
T ss_pred             HHHHHHHHhhc-CCCCCCc----ccCHHHHHHHHHHcccCcccCCCHHHHh-----------------cChhhhhc
Confidence            44332   222 1222333    589999999999999 999999866555                 99999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4.5e-41  Score=322.89  Aligned_cols=254  Identities=20%  Similarity=0.269  Sum_probs=202.3

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehh-----hhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCce
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLD-----ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWI   75 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~-----~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~I   75 (372)
                      ++|+..+.+|.|    |+|.||++.....     +..||+|.+.......         ..+.+.+|+.+++.+ +||||
T Consensus        38 ~~~~~~~~LG~G----~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~E~~il~~l~~h~nI  104 (374)
T cd05106          38 DNLQFGKTLGAG----AFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD---------EREALMSELKILSHLGQHKNI  104 (374)
T ss_pred             HHceehheecCC----CcccEEEEEEecCCcccccceeEEEeccCCCCHH---------HHHHHHHHHHHHHhhccCCce
Confidence            356667777776    8999999886443     3579999886543222         235577899999998 89999


Q ss_pred             eeeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC-----------------------------------------------
Q psy11571         76 TNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE-----------------------------------------------  108 (372)
Q Consensus        76 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-----------------------------------------------  108 (372)
                      +++++++.+.+.+|+|||||++|+|.+++....                                               
T Consensus       105 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  184 (374)
T cd05106         105 VNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEM  184 (374)
T ss_pred             eeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccccccc
Confidence            999999999999999999999999999986421                                               


Q ss_pred             ----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEe
Q psy11571        109 ----------------------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLA  166 (372)
Q Consensus       109 ----------------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~  166 (372)
                                            ..+++..++.++.||+.||.|||++|++|          |||||+|||++.++.++|+
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiH----------rDLkp~Nil~~~~~~~kL~  254 (374)
T cd05106         185 RPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIH----------RDVAARNVLLTDGRVAKIC  254 (374)
T ss_pred             CCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEe----------ccCchheEEEeCCCeEEEe
Confidence                                  24678889999999999999999999999          9999999999999999999


Q ss_pred             ecCcccccCCCCcc-cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHHhh
Q psy11571        167 DFGSCLRLGGDGTV-QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMN  244 (372)
Q Consensus       167 Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~  244 (372)
                      |||+++........ ......++..|+|||++.     ...++.++|||||||++|+|++ |+.||........+.++..
T Consensus       255 DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~  329 (374)
T cd05106         255 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIF-----DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK  329 (374)
T ss_pred             eceeeeeccCCcceeeccCCCCccceeCHHHhc-----CCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHH
Confidence            99999765432221 112233566899999987     3568999999999999999997 9999988765555555554


Q ss_pred             ccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        245 HQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .......+.    .+++++.++|.+||+ +|++||+++++.+.+
T Consensus       330 ~~~~~~~~~----~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l  369 (374)
T cd05106         330 RGYQMSRPD----FAPPEIYSIMKMCWNLEPTERPTFSQISQLI  369 (374)
T ss_pred             cccCccCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            433333333    578999999999999 999999988877554

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG4279|consensus

Probab=100.00  E-value=8.8e-42  Score=327.30  Aligned_cols=247  Identities=27%  Similarity=0.402  Sum_probs=212.1

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccCC
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCG   97 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~g   97 (372)
                      .+|.||.+++..+..++|+|.+..+..+          ..+-+.+|+.+-+++.|.|||++++++..++++-+.||-++|
T Consensus       587 TYG~VYA~RD~~tqvrIaIKEIpekdsr----------~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  587 TYGTVYAARDMDTQVRIAIKEIPEKDSR----------EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPG  656 (1226)
T ss_pred             ceeEEEeeccccceeEEEeeecccccch----------hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence            5788999999999999999988765543          345678899999999999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC-CCCcEEEeecCccccc
Q psy11571         98 GDLLTLLSKFEDRL--PEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD-ANGHIRLADFGSCLRL  174 (372)
Q Consensus        98 g~L~~~l~~~~~~l--~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~-~~~~vkl~Dfg~a~~~  174 (372)
                      |+|.++++..=+++  .|..+-+|.+||+.||.|||++.|||          ||||-+|+||+ -.|.+||+|||.++.+
T Consensus       657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVH----------RDIKGDNVLvNTySGvlKISDFGTsKRL  726 (1226)
T KOG4279|consen  657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVH----------RDIKGDNVLVNTYSGVLKISDFGTSKRL  726 (1226)
T ss_pred             CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceee----------ccccCCcEEEeeccceEEecccccchhh
Confidence            99999998765677  89999999999999999999999999          99999999997 6789999999999987


Q ss_pred             CCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC-CHHHHHHHHhhccCCcCCCC
Q psy11571        175 GGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE-SLVETYGKIMNHQNSFDLPS  253 (372)
Q Consensus       175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~~  253 (372)
                      ..-.. -+.++.||..|||||++..   |.+.|+.++|||||||++.||.||++||... ++...+.++---...+++|.
T Consensus       727 AginP-~TETFTGTLQYMAPEvIDq---G~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPe  802 (1226)
T KOG4279|consen  727 AGINP-CTETFTGTLQYMAPEVIDQ---GPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPE  802 (1226)
T ss_pred             ccCCc-cccccccchhhhChHhhcc---CCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcH
Confidence            54333 3455789999999999985   5677999999999999999999999999753 34444444443345556666


Q ss_pred             CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        254 DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       254 ~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                          .+|.+++.||.+|+. +|.+||+|.+++                 ..||++.-
T Consensus       803 ----elsaeak~FilrcFepd~~~R~sA~~LL-----------------~DpFlq~~  838 (1226)
T KOG4279|consen  803 ----ELSAEAKNFILRCFEPDPCDRPSAKDLL-----------------QDPFLQHN  838 (1226)
T ss_pred             ----HHHHHHHHHHHHHcCCCcccCccHHHhc-----------------cCcccccC
Confidence                789999999999999 999999998887                 89999865

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=8e-41  Score=303.57  Aligned_cols=238  Identities=28%  Similarity=0.403  Sum_probs=201.1

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccCC
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCG   97 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~g   97 (372)
                      ++|.+|++....+++.+++|.+........        ..+.+.+|+.+++.++||||+++++.+.+.+..|+||||+++
T Consensus        12 ~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd08529          12 SFGVVFKVVRKADKRVYAMKQIDLSKMNRR--------EREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAEN   83 (256)
T ss_pred             CCeEEEEEEEcCCCcEEEEEEeehhhCCHH--------HHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCC
Confidence            889999999988999999998765433321        234577899999999999999999999999999999999999


Q ss_pred             CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCC
Q psy11571         98 GDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG  176 (372)
Q Consensus        98 g~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  176 (372)
                      ++|.+++... ...+++..+..++.|++.||.|||+.|++|          +||||+||+++.++.++|+|||+++....
T Consensus        84 ~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h----------~dl~~~nili~~~~~~~l~df~~~~~~~~  153 (256)
T cd08529          84 GDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILH----------RDIKSLNLFLDAYDNVKIGDLGVAKLLSD  153 (256)
T ss_pred             CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------CCCCcceEEEeCCCCEEEcccccceeccC
Confidence            9999999774 457899999999999999999999999999          99999999999999999999999887654


Q ss_pred             CCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCC
Q psy11571        177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVG  256 (372)
Q Consensus       177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  256 (372)
                      .... .....|++.|+|||++.+     ..++.++|+|||||++|+|++|+.||...+..+...++..+.. ...+.   
T Consensus       154 ~~~~-~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~---  223 (256)
T cd08529         154 NTNF-ANTIVGTPYYLSPELCED-----KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF-PPVSQ---  223 (256)
T ss_pred             ccch-hhccccCccccCHHHhcC-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCcc---
Confidence            3322 233568899999999983     5678899999999999999999999998887777777665432 22222   


Q ss_pred             CCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        257 YEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       257 ~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                       .++.++.++|.+||+ +|++||++.++.
T Consensus       224 -~~~~~~~~~i~~~l~~~p~~Rp~~~~ll  251 (256)
T cd08529         224 -MYSQQLAQLIDQCLTKDYRQRPDTFQLL  251 (256)
T ss_pred             -ccCHHHHHHHHHHccCCcccCcCHHHHh
Confidence             578999999999999 999999876665

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=8.9e-41  Score=305.00  Aligned_cols=254  Identities=22%  Similarity=0.358  Sum_probs=205.9

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+..+.++.|    |+|.||++....++..+++|.........         ..+.+.+|+.+++.++||||+++++.+
T Consensus         2 ~y~~~~~lg~g----~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~   68 (267)
T cd06610           2 DYELIEVIGVG----ATAVVYAAICLPNNEKVAIKRIDLEKCQT---------SVDELRKEVQAMSQCNHPNVVKYYTSF   68 (267)
T ss_pred             cceeeeeecCC----CCeEEEEEEEcCCCcEEEEEEeccCCcch---------HHHHHHHHHHHHHhcCCCCEEEEEEEE
Confidence            45566666666    89999999988888999999775433322         245678899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKF--EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      ......|++||++++++|.+++...  ...+++..++.++.|++.||+|||+.|++|          |||+|+||+++++
T Consensus        69 ~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h----------~~l~p~ni~~~~~  138 (267)
T cd06610          69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIH----------RDIKAGNILLGED  138 (267)
T ss_pred             eeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeec----------CCCCHHhEEEcCC
Confidence            9999999999999999999999763  246899999999999999999999999999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcc---cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTV---QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE  237 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~  237 (372)
                      +.++|+|||++.........   ......|+..|+|||++..    ...++.++|+|||||++|+|++|+.||...+...
T Consensus       139 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~----~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~  214 (267)
T cd06610         139 GSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ----VHGYDFKADIWSFGITAIELATGAAPYSKYPPMK  214 (267)
T ss_pred             CCEEEcccchHHHhccCccccccccccccCChhhcChHHHcc----ccCcCcccchHhHhHHHHHHHhCCCCccccChhh
Confidence            99999999998766543221   1233468899999999874    2367889999999999999999999998887766


Q ss_pred             HHHHHhhccCCcCCCCCC-CCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        238 TYGKIMNHQNSFDLPSDV-GYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       238 ~~~~i~~~~~~~~~~~~~-~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      .+.++...... .++... ...+++.+++++.+||. ||++||++++++
T Consensus       215 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll  262 (267)
T cd06610         215 VLMLTLQNDPP-SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELL  262 (267)
T ss_pred             hHHHHhcCCCC-CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHh
Confidence            66666554221 122111 12578999999999999 999999866555

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=6.8e-41  Score=306.72  Aligned_cols=252  Identities=16%  Similarity=0.206  Sum_probs=203.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeee---hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETL---LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLH   79 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~---~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~   79 (372)
                      +|+..+.+|.|    |+|.||.+...   ..+..+|+|.+.......         ....+.+|+.++..++||||++++
T Consensus         6 ~~~~~~~ig~G----~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~---------~~~~~~~e~~~l~~l~h~~iv~~~   72 (266)
T cd05064           6 SIKIERILGTG----RFGELCRGCLKLPSKRELPVAIHTLRAGCSDK---------QRRGFLAEALTLGQFDHSNIVRLE   72 (266)
T ss_pred             HeEEeeeeccc----CCCeEEEEEEecCCCceeeEEEEecCCCCCHH---------HHHHHHHHHHHHhcCCCCCcCeEE
Confidence            45555566666    89999998654   345688999876543211         224577899999999999999999


Q ss_pred             EEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC
Q psy11571         80 YAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA  159 (372)
Q Consensus        80 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~  159 (372)
                      +++..++..++||||+++|+|.+++......+++..++.++.||+.||+|||++|++|          |||||+||+++.
T Consensus        73 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH----------~dikp~nili~~  142 (266)
T cd05064          73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVH----------KGLAAHKVLVNS  142 (266)
T ss_pred             EEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEee----------ccccHhhEEEcC
Confidence            9999999999999999999999999875567899999999999999999999999999          999999999999


Q ss_pred             CCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHH
Q psy11571        160 NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVET  238 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~  238 (372)
                      ++.++++|||.+...............++..|+|||.+.     ...++.++|||||||++||+++ |..||.+.+..+.
T Consensus       143 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~  217 (266)
T cd05064         143 DLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQ-----YHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV  217 (266)
T ss_pred             CCcEEECCCcccccccccchhcccCCCCceeecCHHHHh-----hCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH
Confidence            999999999987654322222222234567899999987     3568899999999999999775 9999999888877


Q ss_pred             HHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       239 ~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ...+..+. ..+.|.    .++..+.+++.+||+ +|.+||+++++.+.+
T Consensus       218 ~~~~~~~~-~~~~~~----~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l  262 (266)
T cd05064         218 IKAVEDGF-RLPAPR----NCPNLLHQLMLDCWQKERGERPRFSQIHSIL  262 (266)
T ss_pred             HHHHHCCC-CCCCCC----CCCHHHHHHHHHHcCCCchhCCCHHHHHHHH
Confidence            77765442 223333    678999999999999 999999988877654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=9.1e-41  Score=308.00  Aligned_cols=252  Identities=23%  Similarity=0.396  Sum_probs=202.8

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.++.|    ++|.||++.+..+++.+|+|.+......         +..+.+.+|+.+++.++||||+++++.
T Consensus         1 ~~~~~~~~lg~g----~~~~v~~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv~~~~~   67 (279)
T cd06619           1 QDIQYQEILGHG----NGGTVYKAYHLLTRRILAVKVIPLDITV---------ELQKQIMSELEILYKCDSPYIIGFYGA   67 (279)
T ss_pred             CcchheeeeccC----CCeEEEEEEEcCCCcEEEEEEEecCCCh---------HHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence            356777777777    7999999999999999999977543211         123457789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +...+..++||||+++++|..+     ..+++..+..++.|++.||.|||+.|++|          +||||+||+++.++
T Consensus        68 ~~~~~~~~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H----------~dlkp~Nill~~~~  132 (279)
T cd06619          68 FFVENRISICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILH----------RDVKPSNMLVNTRG  132 (279)
T ss_pred             EEECCEEEEEEecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEee----------CCCCHHHEEECCCC
Confidence            9999999999999999999654     35789999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCH------
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL------  235 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~------  235 (372)
                      .++|+|||++.......   .....||..|+|||++.+     ..++.++|+|||||++|+|++|..||.....      
T Consensus       133 ~~~l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~  204 (279)
T cd06619         133 QVKLCDFGVSTQLVNSI---AKTYVGTNAYMAPERISG-----EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM  204 (279)
T ss_pred             CEEEeeCCcceeccccc---ccCCCCChhhcCceeecC-----CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc
Confidence            99999999987654321   233578999999999983     5688999999999999999999999965321      


Q ss_pred             -HHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCC
Q psy11571        236 -VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       236 -~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~  310 (372)
                       ......+... .....+   ....+++++++|.+||+ +|++||+++++.                 .||||...+
T Consensus       205 ~~~~~~~~~~~-~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil-----------------~~~~~~~~~  260 (279)
T cd06619         205 PLQLLQCIVDE-DPPVLP---VGQFSEKFVHFITQCMRKQPKERPAPENLM-----------------DHPFIVQYN  260 (279)
T ss_pred             hHHHHHHHhcc-CCCCCC---CCcCCHHHHHHHHHHhhCChhhCCCHHHHh-----------------cCccccccc
Confidence             1222222221 111111   22578999999999999 999999866555                 999998664

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-41  Score=326.24  Aligned_cols=260  Identities=24%  Similarity=0.371  Sum_probs=202.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeee--hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETL--LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHY   80 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~--~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~   80 (372)
                      +|+.+..++.|    ++|.||.+...  .+++.|++|.+....               ...+|+.+++.++||||+++++
T Consensus        93 ~y~i~~~Lg~G----~~g~Vy~~~~~~~~~~~~v~vK~~~~~~---------------~~~~E~~il~~l~h~~iv~~~~  153 (392)
T PHA03207         93 QYNILSSLTPG----SEGEVFVCTKHGDEQRKKVIVKAVTGGK---------------TPGREIDILKTISHRAIINLIH  153 (392)
T ss_pred             ceEEEEeecCC----CCeEEEEEEEcCCccceeEEEEeccccc---------------cHHHHHHHHHhcCCCCccceee
Confidence            35555666666    78999988643  345678888665321               1346999999999999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         81 AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        81 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      ++.....+|++||++ +++|.+++.. ...+++..++.++.||+.||.|||++||+|          |||||+|||++.+
T Consensus       154 ~~~~~~~~~lv~e~~-~~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givH----------rDlkp~Nill~~~  221 (392)
T PHA03207        154 AYRWKSTVCMVMPKY-KCDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIH----------RDVKTENIFLDEP  221 (392)
T ss_pred             eEeeCCEEEEEehhc-CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------cCCCHHHEEEcCC
Confidence            999999999999998 5799999865 578999999999999999999999999999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCH---H
Q psy11571        161 GHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL---V  236 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~---~  236 (372)
                      +.++|+|||++........ .......||+.|+|||++.+     ..++.++|||||||++|||++|+.||.+...   .
T Consensus       222 ~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~  296 (392)
T PHA03207        222 ENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLAL-----DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS  296 (392)
T ss_pred             CCEEEccCccccccCcccccccccccccccCccCHhHhcC-----CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcH
Confidence            9999999999976543322 12223579999999999973     5688999999999999999999999976532   1


Q ss_pred             HHHHHHhhccC---------------------------CcCCCCC-CCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        237 ETYGKIMNHQN---------------------------SFDLPSD-VGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       237 ~~~~~i~~~~~---------------------------~~~~~~~-~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ..+..+.+...                           .+..+.. ....++.++++||++||. ||++||++.+++   
T Consensus       297 ~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l---  373 (392)
T PHA03207        297 SQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDIL---  373 (392)
T ss_pred             HHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHh---
Confidence            22222221100                           0011110 012457889999999999 999999877766   


Q ss_pred             hhhhhhhccCCCCCCCCCcCCCCccccc
Q psy11571        288 MWSALFVSLSISPRNHPWFQGIAWDSIR  315 (372)
Q Consensus       288 ~~~~~~~~~~~~~~~hp~f~~~~w~~~~  315 (372)
                                    .||||....|+.++
T Consensus       374 --------------~~p~f~~~~~~~~~  387 (392)
T PHA03207        374 --------------SLPLFTKEPINLLN  387 (392)
T ss_pred             --------------hCchhhccchhhhc
Confidence                          99999999888765

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=8.5e-41  Score=312.76  Aligned_cols=257  Identities=25%  Similarity=0.362  Sum_probs=205.2

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.++.|    ++|.||++.+..++..+++|.+......         ...+++.+|+.++..++||||+++++++
T Consensus         2 ~~~~~~~lg~G----~~g~v~~~~~~~~~~~~a~k~~~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv~~~~~~   68 (308)
T cd06615           2 DFEKLGELGAG----NGGVVTKVLHRPSGLIMARKLIHLEIKP---------AIRNQIIRELKVLHECNSPYIVGFYGAF   68 (308)
T ss_pred             CceEEeeccCC----CCeEEEEEEEcCCCeEEEEEEeccccCH---------HHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            45666677766    7999999999889999999877643211         1345577899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD-LHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      .+++.+|+||||+++++|.+++.+ .+.+++..+..++.|++.||.|||+ .+++|          |||||+||+++.++
T Consensus        69 ~~~~~~~lv~ey~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H----------~dl~p~nil~~~~~  137 (308)
T cd06615          69 YSDGEISICMEHMDGGSLDQVLKK-AGRIPENILGKISIAVLRGLTYLREKHKIMH----------RDVKPSNILVNSRG  137 (308)
T ss_pred             eeCCEEEEEeeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEE----------CCCChHHEEEecCC
Confidence            999999999999999999999987 4779999999999999999999997 69999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .++|+|||++.......   .....|++.|+|||.+.+     ..++.++|+|||||++|+|++|..||...+.......
T Consensus       138 ~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~  209 (308)
T cd06615         138 EIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQG-----THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM  209 (308)
T ss_pred             cEEEccCCCcccccccc---cccCCCCcCccChhHhcC-----CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHh
Confidence            99999999987653321   233578999999999873     4578899999999999999999999976554333222


Q ss_pred             HhhccCCcC--------------------------------CCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhh
Q psy11571        242 IMNHQNSFD--------------------------------LPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKM  288 (372)
Q Consensus       242 i~~~~~~~~--------------------------------~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~  288 (372)
                      +........                                .|......++.++++||.+||. +|++||++++++    
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll----  285 (308)
T cd06615         210 FGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELT----  285 (308)
T ss_pred             hcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHh----
Confidence            211100000                                0111111368899999999999 999999876665    


Q ss_pred             hhhhhhccCCCCCCCCCcCC
Q psy11571        289 WSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       289 ~~~~~~~~~~~~~~hp~f~~  308 (372)
                                   .||||.+
T Consensus       286 -------------~~~~~~~  292 (308)
T cd06615         286 -------------KHPFIKR  292 (308)
T ss_pred             -------------cChhhhh
Confidence                         9999975

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1e-40  Score=303.22  Aligned_cols=248  Identities=24%  Similarity=0.385  Sum_probs=202.1

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+.++.++.|    ++|.||.+.+..+++.+++|.+........        ..+.+.+|+.+++.++||||+++++.+.
T Consensus         2 y~~~~~lg~g----~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~~~~~~   69 (257)
T cd08223           2 YCFVRVVGKG----SYGEVSLVRHRTDGKQYVIKKLNLRNASRR--------ERKAAEQEAQLLSQLKHPNIVAYRESWE   69 (257)
T ss_pred             ceEEEEecCC----CCeEEEEEEEcCCCcEEEEEEEehhhcCHH--------HHHHHHHHHHHHHhCCCCCeeeeeeeec
Confidence            4445556655    799999999988899999998765443222        2345678999999999999999999887


Q ss_pred             e-CCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         84 D-DSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        84 ~-~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      . ...+|++|||+++++|.+++... ...+++.++..++.|++.||++||+.|++|          |||||+||+++.++
T Consensus        70 ~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H----------~di~p~nil~~~~~  139 (257)
T cd08223          70 GEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILH----------RDLKTQNVFLTRTN  139 (257)
T ss_pred             CCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeec----------cCCCchhEEEecCC
Confidence            4 44689999999999999999763 345899999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .++|+|||++........ ......|++.|+|||++.+     ..++.++|+|||||++|+|++|+.||...+.......
T Consensus       140 ~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~  213 (257)
T cd08223         140 IIKVGDLGIARVLENQCD-MASTLIGTPYYMSPELFSN-----KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYR  213 (257)
T ss_pred             cEEEecccceEEecccCC-ccccccCCcCccChhHhcC-----CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence            999999999987643322 2233568999999999873     5678899999999999999999999998877666666


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      +..+.. ...+.    .+++++.++|.+||+ +|++||++.+++
T Consensus       214 ~~~~~~-~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~~l  252 (257)
T cd08223         214 IIEGKL-PPMPK----DYSPELGELIATMLSKRPEKRPSVKSIL  252 (257)
T ss_pred             HHhcCC-CCCcc----ccCHHHHHHHHHHhccCcccCCCHHHHh
Confidence            655432 12222    688999999999999 999999866555

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.8e-41  Score=313.53  Aligned_cols=255  Identities=25%  Similarity=0.446  Sum_probs=207.4

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      .+|+.++.++.|    ++|.||++....+++.||+|.+.......          .+.+.+|+.+++.++||||+++++.
T Consensus        19 ~~y~~~~~lg~g----~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----------~~~~~~e~~~l~~~~h~~i~~~~~~   84 (297)
T cd06656          19 KKYTRFEKIGQG----ASGTVYTAIDIATGQEVAIKQMNLQQQPK----------KELIINEILVMRENKNPNIVNYLDS   84 (297)
T ss_pred             hhceeeeeeccC----CCeEEEEEEECCCCCEEEEEEEecCccch----------HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            356666666666    78999999988899999999876543322          2346788999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +..++..|+||||+++++|.+++.+  ..+++..+..++.|++.||.|||+.|++|          |||||+||+++.++
T Consensus        85 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H----------~dL~p~Nili~~~~  152 (297)
T cd06656          85 YLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIH----------RDIKSDNILLGMDG  152 (297)
T ss_pred             EecCCEEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCccc----------CCCCHHHEEECCCC
Confidence            9999999999999999999999976  56899999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .++|+|||++........ ......+++.|+|||.+.+     ..++.++|+|||||++|+|++|..||.+.+.......
T Consensus       153 ~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~  226 (297)
T cd06656         153 SVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTR-----KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL  226 (297)
T ss_pred             CEEECcCccceEccCCcc-CcCcccCCccccCHHHHcC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee
Confidence            999999999876543322 1223568899999999973     5678899999999999999999999987665443332


Q ss_pred             Hhhcc-CCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        242 IMNHQ-NSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       242 i~~~~-~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      +.... .....+    ..++..+++||.+||. +|++||++++++                 .||||+..
T Consensus       227 ~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il-----------------~~~~~~~~  275 (297)
T cd06656         227 IATNGTPELQNP----ERLSAVFRDFLNRCLEMDVDRRGSAKELL-----------------QHPFLKLA  275 (297)
T ss_pred             eccCCCCCCCCc----cccCHHHHHHHHHHccCChhhCcCHHHHh-----------------cCchhccc
Confidence            32221 111122    2578999999999999 999999866555                 99999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0586|consensus

Probab=100.00  E-value=7.4e-42  Score=325.98  Aligned_cols=236  Identities=30%  Similarity=0.462  Sum_probs=209.7

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccCC
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCG   97 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~g   97 (372)
                      -++.|..+++..++..||+|.+.+..+...        .++++.+|+.+++.++|||||+++.+.+.+..+|+||||+.+
T Consensus        68 ~f~~V~La~~~~t~~~VaiK~idkt~ln~~--------~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~  139 (596)
T KOG0586|consen   68 NFAKVKLARHILTGTEVAIKIIDKTQLNPS--------KRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASG  139 (596)
T ss_pred             eeEEEEeeEecCCCceEEEEEehhcccChH--------HHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccC
Confidence            456677777888999999999888877654        445588999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCC
Q psy11571         98 GDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD  177 (372)
Q Consensus        98 g~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  177 (372)
                      |.+.+++.+ .+.+.+..++.++.|++.|++|||+++|+|          ||||.+|||++.+.++||+|||++.++...
T Consensus       140 ge~~~yl~~-~gr~~e~~ar~~F~q~vsaveYcH~k~ivH----------rdLk~eNilL~~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  140 GELFDYLVK-HGRMKEKEARAKFRQIVSAVEYCHSKNIVH----------RDLKAENILLDENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             chhHHHHHh-cccchhhhhhhhhHHHHHHHHHHhhcceec----------cccchhhcccccccceeeeccccceeeccc
Confidence            999999998 688888999999999999999999999999          999999999999999999999999988754


Q ss_pred             CcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCCC
Q psy11571        178 GTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGY  257 (372)
Q Consensus       178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  257 (372)
                      ..  ..++||++.|.|||++.+    ....++.+|+||+|+++|-|+.|..||.+.+..++-.+.+.+...+  |.    
T Consensus       209 ~~--lqt~cgsppyAaPEl~~g----~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rI--p~----  276 (596)
T KOG0586|consen  209 LM--LQTFCGSPPYAAPELFNG----KKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRI--PF----  276 (596)
T ss_pred             cc--ccccCCCCCccChHhhcC----cccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecc--cc----
Confidence            43  345899999999999995    5567899999999999999999999999999888888887765544  33    


Q ss_pred             CCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        258 EISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       258 ~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      .++.+++++|+++|. +|.+|++.+++.
T Consensus       277 ~ms~dce~lLrk~lvl~Pskr~~~dqim  304 (596)
T KOG0586|consen  277 YMSCDCEDLLRKFLVLNPSKRGPCDQIM  304 (596)
T ss_pred             eeechhHHHHHHhhccCccccCCHHHhh
Confidence            679999999999999 999999866554

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6.7e-41  Score=309.24  Aligned_cols=259  Identities=26%  Similarity=0.366  Sum_probs=206.0

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.+..++.|    ++|.||++....+++.+++|.+........        ..+.+.+|+.+++.++||||+++++++
T Consensus         2 ~y~~~~~l~~g----~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~--------~~~~~~~e~~~l~~~~h~~i~~~~~~~   69 (286)
T cd07847           2 KYEKLSKIGEG----SYGVVFKCRNRETGQIVAIKKFVESEDDPV--------IKKIALREIRMLKQLKHPNLVNLIEVF   69 (286)
T ss_pred             ceeeeeeeccc----CCeEEEEEEECCCCcEEEEEEEeecccCcc--------ccHHHHHHHHHHHhCCCCCEeeeeeEE
Confidence            56677777776    799999999888899999997764332111        123356799999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+...+++||||+++++|..++.. ...+++..++.++.||+.||+|||+.|++|          |||||+||+++.++.
T Consensus        70 ~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H----------~dl~p~nil~~~~~~  138 (286)
T cd07847          70 RRKRKLHLVFEYCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKHNCIH----------RDVKPENILITKQGQ  138 (286)
T ss_pred             eeCCEEEEEEeccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcee----------cCCChhhEEEcCCCc
Confidence            999999999999999888887765 467999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      ++|+|||++........ ......++..|+|||.+.+    ...++.++|+|||||++|+|++|.+||.+.+..+....+
T Consensus       139 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~  213 (286)
T cd07847         139 IKLCDFGFARILTGPGD-DYTDYVATRWYRAPELLVG----DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLI  213 (286)
T ss_pred             EEECccccceecCCCcc-cccCcccccccCCHHHHhC----CCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            99999999987654332 1223457889999999873    345788999999999999999999999887665544433


Q ss_pred             hhccCC-----------------cCCCCC--------CCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhcc
Q psy11571        243 MNHQNS-----------------FDLPSD--------VGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSL  296 (372)
Q Consensus       243 ~~~~~~-----------------~~~~~~--------~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~  296 (372)
                      ......                 ...+..        ....++..+.+||.+||+ +|++||++.+++            
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil------------  281 (286)
T cd07847         214 RKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELL------------  281 (286)
T ss_pred             HHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHh------------
Confidence            221000                 000100        012568899999999999 999999876655            


Q ss_pred             CCCCCCCCCc
Q psy11571        297 SISPRNHPWF  306 (372)
Q Consensus       297 ~~~~~~hp~f  306 (372)
                           .||||
T Consensus       282 -----~~~~f  286 (286)
T cd07847         282 -----EHPYF  286 (286)
T ss_pred             -----cCCCC
Confidence                 99998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=5e-42  Score=312.03  Aligned_cols=248  Identities=31%  Similarity=0.508  Sum_probs=198.9

Q ss_pred             HHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC
Q psy11571          7 LEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS   86 (372)
Q Consensus         7 l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~   86 (372)
                      ++.+|.|    |+|.||++++..+++.+|+|.+.........        .....+|..+++.+.||||+++++++.+..
T Consensus         4 ~~~lg~G----~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~--------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~   71 (260)
T PF00069_consen    4 VKKLGSG----GFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE--------REENIREIKILRRLRHPNIVQILDVFQDDN   71 (260)
T ss_dssp             EEEEEEE----SSEEEEEEEETTTTEEEEEEEEESTTHHHHH--------HHHHHHHHHHHHHHTBTTBCHEEEEEEESS
T ss_pred             eEEEEeC----CCEEEEEEEECCCCeEEEEEEeccccccccc--------cchhhhhhhccccccccccccccccccccc
Confidence            3455555    8999999999999999999998877655431        222344899999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEe
Q psy11571         87 NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLA  166 (372)
Q Consensus        87 ~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~  166 (372)
                      ..++||||+.+++|.+++.. ...+++..+..++.||+.||.+||+.|++|          +||||+||+++.++.++|+
T Consensus        72 ~~~~v~~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H----------~dikp~NIl~~~~~~~~l~  140 (260)
T PF00069_consen   72 YLYIVMEYCPGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKGIVH----------RDIKPENILLDENGEVKLI  140 (260)
T ss_dssp             EEEEEEEEETTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTTEEE----------SSBSGGGEEESTTSEEEES
T ss_pred             cccccccccccccccccccc-cccccccccccccccccccccccccccccc----------ccccccccccccccccccc
Confidence            99999999999999999984 478999999999999999999999999999          9999999999999999999


Q ss_pred             ecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCC---HHHHHHHHh
Q psy11571        167 DFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIM  243 (372)
Q Consensus       167 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~---~~~~~~~i~  243 (372)
                      |||.+....... .......++..|+|||++..    ...++.++|+||||+++|+|++|..||...+   ......+..
T Consensus       141 Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~  215 (260)
T PF00069_consen  141 DFGSSVKLSENN-ENFNPFVGTPEYMAPEVLQQ----GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKIL  215 (260)
T ss_dssp             SGTTTEESTSTT-SEBSSSSSSGGGSCHHHHTT----TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHH
T ss_pred             cccccccccccc-cccccccccccccccccccc----cccccccccccccccccccccccccccccccchhhhhhhhhcc
Confidence            999997642222 23334678999999999872    3568899999999999999999999999873   333333333


Q ss_pred             hccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        244 NHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      ..........  ....+..+.++|.+||+ ||++||+++++.
T Consensus       216 ~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~R~~~~~l~  255 (260)
T PF00069_consen  216 KRPLPSSSQQ--SREKSEELRDLIKKMLSKDPEQRPSAEELL  255 (260)
T ss_dssp             HTHHHHHTTS--HTTSHHHHHHHHHHHSSSSGGGSTTHHHHH
T ss_pred             cccccccccc--cchhHHHHHHHHHHHccCChhHCcCHHHHh
Confidence            3211111111  11234899999999999 999999865555

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=9.8e-41  Score=320.75  Aligned_cols=254  Identities=21%  Similarity=0.263  Sum_probs=201.2

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeee-----ehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCce
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIET-----LLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWI   75 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~-----~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~I   75 (372)
                      ++|+..+.+|.|    |+|.||++..     ..++..||+|.+.......         ..+.+.+|+.++..+ +||||
T Consensus        35 ~~~~~~~~LG~G----~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~---------~~~~~~~Ei~il~~l~~HpnI  101 (375)
T cd05104          35 NRLSFGKTLGAG----AFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLT---------EREALMSELKVLSYLGNHINI  101 (375)
T ss_pred             HHeehhheecCC----ccceEEEEEEeccccCccceeEEEEeccCCcCcH---------HHHHHHHHHHHHHHhcCCcce
Confidence            356777777777    8999999864     2346689999876433221         234577899999999 89999


Q ss_pred             eeeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC-----------------------------------------------
Q psy11571         76 TNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE-----------------------------------------------  108 (372)
Q Consensus        76 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-----------------------------------------------  108 (372)
                      +++++++.+.+..++|||||++|+|.+++....                                               
T Consensus       102 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  181 (375)
T cd05104         102 VNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPT  181 (375)
T ss_pred             eeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccc
Confidence            999999999999999999999999999986521                                               


Q ss_pred             ---------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571        109 ---------------------------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus       109 ---------------------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                                                 ..+++..+..++.||+.||.|||+.|++|          |||||+|||++.++
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH----------~Dlkp~Nill~~~~  251 (375)
T cd05104         182 KADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIH----------RDLAARNILLTHGR  251 (375)
T ss_pred             ccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeec----------cCCchhhEEEECCC
Confidence                                       14678889999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCccc-ccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQ-SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETY  239 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~  239 (372)
                      .+||+|||+++......... .....++..|+|||++.     ...++.++|||||||++|||++ |..||.........
T Consensus       252 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~  326 (375)
T cd05104         252 ITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIF-----NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF  326 (375)
T ss_pred             cEEEecCccceeccCcccccccCCCCCCcceeChhHhc-----CCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHH
Confidence            99999999998664332211 12233566899999997     3568999999999999999998 89999876655444


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .+..........|.    ..+.++++||.+||+ ||++||++.++.+.+
T Consensus       327 ~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~eil~~l  371 (375)
T cd05104         327 YKMIKEGYRMLSPE----CAPSEMYDIMKSCWDADPLKRPTFKQIVQLI  371 (375)
T ss_pred             HHHHHhCccCCCCC----CCCHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence            44444333333333    568999999999999 999999988887654

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.8e-40  Score=303.34  Aligned_cols=242  Identities=27%  Similarity=0.372  Sum_probs=196.1

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccCC
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCG   97 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~g   97 (372)
                      ++|.||++.. .++..+|+|.+........    ...+..+.+.+|+.+++.++|+||+++++++.+.+..+++|||+++
T Consensus        12 ~~~~v~~~~~-~~~~~~avk~~~~~~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   86 (265)
T cd06631          12 AYGTVYCGLT-NQGQLIAVKQVELDTSNVL----AAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPG   86 (265)
T ss_pred             CCeEEEEEEE-cCCCeEEEEEeecCccchh----hHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCC
Confidence            7899999864 4788899998765433221    1123456788999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCC
Q psy11571         98 GDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD  177 (372)
Q Consensus        98 g~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  177 (372)
                      ++|.+++.+ .+.+++..+..++.|++.||+|||+.|++|          +||+|+||++++++.++|+|||++......
T Consensus        87 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H----------~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          87 GSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVVH----------RDIKGNNVMLMPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccc----------CCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence            999999987 467899999999999999999999999999          999999999999999999999998765321


Q ss_pred             C-----cccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCC-cCC
Q psy11571        178 G-----TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNS-FDL  251 (372)
Q Consensus       178 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~~  251 (372)
                      .     ........|+..|+|||.+.+     ..++.++|+|||||++|+|++|..||...+.......+...... ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  230 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINE-----SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRL  230 (265)
T ss_pred             cccccccccccccCCCccccChhhhcC-----CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCC
Confidence            1     111123468899999999973     55788999999999999999999999876655544444433211 222


Q ss_pred             CCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        252 PSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       252 ~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      +.    .++.++.++|++||. +|++||++.+++
T Consensus       231 ~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l  260 (265)
T cd06631         231 PD----SFSAAAIDFVTSCLTRDQHERPSALQLL  260 (265)
T ss_pred             CC----CCCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence            22    689999999999999 999999876655

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.8e-40  Score=301.60  Aligned_cols=249  Identities=27%  Similarity=0.378  Sum_probs=209.7

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      ||+.++.++.|    ++|.++.++...+++.+++|.+........        ..+.+.+|+.+++.++|+||+++++++
T Consensus         1 ~y~~~~~ig~g----~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------~~~~~~~e~~~l~~~~h~~i~~~~~~~   68 (256)
T cd08221           1 HYIPIRVLGKG----AFGEATLYRRTEDDSLVVWKEVNLTRLSEK--------ERRDALNEIVILSLLQHPNIIAYYNHF   68 (256)
T ss_pred             CceEeeEeccc----CCceEEEEEEcCCCcEEEEEEEeecccchh--------HHHHHHHHHHHHHhCCCCCeeEEEeEE
Confidence            46667777777    799999999999999999998765543322        234567899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      .+.+.++++|||+++++|.+++.+. ...+++..+..++.|++.+|.|||+.|++|          +||+|+||+++.++
T Consensus        69 ~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h----------~dl~p~ni~~~~~~  138 (256)
T cd08221          69 MDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILH----------RDIKTLNIFLTKAG  138 (256)
T ss_pred             ecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccc----------cCCChHhEEEeCCC
Confidence            9999999999999999999999764 346899999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .+||+|||++........ ......|++.|+|||.+.+     ..++.++|+||||+++|+|++|..||...+..+....
T Consensus       139 ~~kl~d~~~~~~~~~~~~-~~~~~~~~~~y~ape~~~~-----~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~  212 (256)
T cd08221         139 LIKLGDFGISKILGSEYS-MAETVVGTPYYMSPELCQG-----VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVK  212 (256)
T ss_pred             CEEECcCcceEEcccccc-cccccCCCccccCHhhcCC-----CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            999999999876644332 2234568999999999873     4578899999999999999999999999888888877


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      +..+.... .+    ..++.++.++|.+||. +|.+||++++++
T Consensus       213 ~~~~~~~~-~~----~~~~~~~~~~i~~~l~~~p~~R~s~~~ll  251 (256)
T cd08221         213 IVQGNYTP-VV----SVYSSELISLVHSLLQQDPEKRPTADEVL  251 (256)
T ss_pred             HHcCCCCC-Cc----cccCHHHHHHHHHHcccCcccCCCHHHHh
Confidence            76643222 12    2679999999999999 999999876665

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2e-40  Score=303.47  Aligned_cols=256  Identities=27%  Similarity=0.388  Sum_probs=204.2

Q ss_pred             HHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe
Q psy11571          5 RELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQD   84 (372)
Q Consensus         5 ~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~   84 (372)
                      +..+.++.|    ++|.||++.+..+++.+++|.+........     ..+..+.+.+|+.+++.++||||+++++++.+
T Consensus         5 ~~~~~lg~g----~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   75 (266)
T cd06651           5 RRGKLLGQG----AFGRVYLCYDVDTGRELAAKQVQFDPESPE-----TSKEVSALECEIQLLKNLQHERIVQYYGCLRD   75 (266)
T ss_pred             cccceecCC----CCEEEEEEEEcCCCcEEEEEEeecCcCCch-----hHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc
Confidence            344455555    799999999988999999997765432211     11245668889999999999999999999876


Q ss_pred             C--CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         85 D--SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        85 ~--~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .  ..++++|||+++++|.+++.+ ...+++...+.++.|++.||+|||+.+++|          |||||+||+++.++.
T Consensus        76 ~~~~~~~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H----------~~l~p~nil~~~~~~  144 (266)
T cd06651          76 RAEKTLTIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNMIVH----------RDIKGANILRDSAGN  144 (266)
T ss_pred             CCCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeee----------CCCCHHHEEECCCCC
Confidence            3  578999999999999999987 467899999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCc--ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGT--VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG  240 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~  240 (372)
                      ++|+|||++........  .......++..|+|||.+.+     ..++.++|+||+||++|+|++|+.||...+......
T Consensus       145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~  219 (266)
T cd06651         145 VKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG-----EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF  219 (266)
T ss_pred             EEEccCCCccccccccccCCccccCCccccccCHHHhCC-----CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH
Confidence            99999999876532111  11122457889999999973     557889999999999999999999998876666555


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcC
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ  307 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~  307 (372)
                      ++........+|.    .+++.++++| +||. +|++||++++++                 .||||+
T Consensus       220 ~~~~~~~~~~~~~----~~~~~~~~li-~~~~~~p~~Rp~~~eil-----------------~hp~~~  265 (266)
T cd06651         220 KIATQPTNPQLPS----HISEHARDFL-GCIFVEARHRPSAEELL-----------------RHPFAQ  265 (266)
T ss_pred             HHhcCCCCCCCch----hcCHHHHHHH-HHhcCChhhCcCHHHHh-----------------cCcccc
Confidence            5544333333333    5789999999 5666 999999866665                 999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.7e-40  Score=305.83  Aligned_cols=257  Identities=25%  Similarity=0.362  Sum_probs=213.7

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      +.|+.+..++.|    ++|.||.+.+..++..+|+|.+......         ...+.+.+|+.+++.+.||||++++++
T Consensus         4 ~~y~~~~~lg~g----~~~~vy~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~   70 (277)
T cd06640           4 ELFTKLERIGKG----SFGEVFKGIDNRTQQVVAIKIIDLEEAE---------DEIEDIQQEITVLSQCDSPYVTKYYGS   70 (277)
T ss_pred             HhhhhhhhcccC----CCeEEEEEEEccCCEEEEEEEEeccccH---------HHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            578888888888    7999999998888999999987643322         124567889999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.++...|+||||++|++|.+++..  +.+++..+..++.|++.||+|||+.+++|          +||+|+||+++.++
T Consensus        71 ~~~~~~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH----------~dl~p~Nil~~~~~  138 (277)
T cd06640          71 YLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIH----------RDIKAANVLLSEQG  138 (277)
T ss_pred             EEECCEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccC----------cCCChhhEEEcCCC
Confidence            9999999999999999999999976  67899999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .++|+|||++........ ......++..|+|||++.+     ..++.++|+|||||++|+|++|.+||...+.......
T Consensus       139 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~apE~~~~-----~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~  212 (277)
T cd06640         139 DVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIQQ-----SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL  212 (277)
T ss_pred             CEEEcccccceeccCCcc-ccccccCcccccCHhHhcc-----CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh
Confidence            999999999876543322 2233467889999999873     4578899999999999999999999988776655544


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCc
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAW  311 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w  311 (372)
                      +.... ...    ....++..+.++|.+||+ +|++||++++++                 .||||.....
T Consensus       213 ~~~~~-~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il-----------------~~~~~~~~~~  261 (277)
T cd06640         213 IPKNN-PPT----LTGEFSKPFKEFIDACLNKDPSFRPTAKELL-----------------KHKFIVKNAK  261 (277)
T ss_pred             hhcCC-CCC----CchhhhHHHHHHHHHHcccCcccCcCHHHHH-----------------hChHhhhcch
Confidence            43221 112    222578899999999999 999999866555                 9999986654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG0983|consensus

Probab=100.00  E-value=3.3e-41  Score=292.73  Aligned_cols=260  Identities=23%  Similarity=0.395  Sum_probs=216.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYA   81 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~   81 (372)
                      .++.|+.+|.|    ..|.|+++....+|...|+|.+....-..         ..+++.....++... ++|+||+++++
T Consensus        93 dl~~l~dlGsG----tcG~V~k~~~rs~~~iiAVK~M~rt~Nke---------e~kRILmDldvv~~s~dcpyIV~c~Gy  159 (391)
T KOG0983|consen   93 DLENLGDLGSG----TCGQVWKMRFRSTGHIIAVKQMRRTGNKE---------ENKRILMDLDVVLKSHDCPYIVQCFGY  159 (391)
T ss_pred             HhhhHHhhcCC----CccceEEEEEcccceEEEEEeecccCCHH---------HHHHHHHhhhHHhhccCCCeeeeeeeE
Confidence            46778888888    68999999999999999999887655433         355666677766554 59999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD-LHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      |..+..+++.||.| +..+..++++..++++|..+-.+...++.||.||.+ +||+|          ||+||+|||+|..
T Consensus       160 Fi~n~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viH----------RDvKPSNILlDe~  228 (391)
T KOG0983|consen  160 FITNTDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIH----------RDVKPSNILLDER  228 (391)
T ss_pred             EeeCchHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceee----------cccCccceEEccC
Confidence            99999999999998 556777777767889999999999999999999985 79999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC-CHHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE-SLVETY  239 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~-~~~~~~  239 (372)
                      |++||||||++.++......  +...|.+.|||||.+.-  .....|+..+||||||++++||.||+.||.+. .+.+++
T Consensus       229 GniKlCDFGIsGrlvdSkAh--trsAGC~~YMaPERidp--~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~l  304 (391)
T KOG0983|consen  229 GNIKLCDFGISGRLVDSKAH--TRSAGCAAYMAPERIDP--PDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVL  304 (391)
T ss_pred             CCEEeecccccceeeccccc--ccccCCccccCccccCC--CCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHH
Confidence            99999999999887654432  23579999999999973  22567899999999999999999999999985 566788


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCC
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~  310 (372)
                      .+|++..+ +.+|...  .+|++.++|+..||. |+.+||...+++                 +|||+...+
T Consensus       305 tkvln~eP-P~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll-----------------~h~Fi~~ye  356 (391)
T KOG0983|consen  305 TKVLNEEP-PLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLL-----------------EHPFIKRYE  356 (391)
T ss_pred             HHHHhcCC-CCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHh-----------------cCcceeecc
Confidence            88887543 4444432  489999999999999 999999877776                 999998543

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=7.6e-41  Score=310.79  Aligned_cols=255  Identities=23%  Similarity=0.411  Sum_probs=207.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      .|..+..++.|    |+|.||++....++..+++|.+.....          ...+.+.+|+.+++.++||||+++++.+
T Consensus        23 ~~~~~~~lg~g----~~g~v~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~~e~~~l~~l~h~~ii~~~~~~   88 (292)
T cd06658          23 YLDSFIKIGEG----STGIVCIATEKHTGKQVAVKKMDLRKQ----------QRRELLFNEVVIMRDYHHENVVDMYNSY   88 (292)
T ss_pred             HHhhhhcccCC----CCeEEEEEEECCCCCEEEEEEEecchH----------HHHHHHHHHHHHHHhCCCCcHHHHHHhe
Confidence            34445555554    899999999888899999997654321          1234577899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      ...+..|+||||+++++|.+++..  +.+++..+..++.||+.||.|||++|++|          |||||+||+++.++.
T Consensus        89 ~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH----------~dlkp~Nill~~~~~  156 (292)
T cd06658          89 LVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIH----------RDIKSDSILLTSDGR  156 (292)
T ss_pred             ecCCeEEEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEee----------cCCCHHHEEEcCCCC
Confidence            999999999999999999998865  57899999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      ++|+|||++........ ......|+..|+|||.+.     ...++.++|+||||+++|||++|+.||...+....+..+
T Consensus       157 ~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~  230 (292)
T cd06658         157 IKLSDFGFCAQVSKEVP-KRKSLVGTPYWMAPEVIS-----RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI  230 (292)
T ss_pred             EEEccCcchhhcccccc-cCceeecCccccCHHHHc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999876533222 223356899999999987     356888999999999999999999999987776665554


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      .... ....+.  ...++..+.++|.+||. +|.+||++++++                 .||||+..
T Consensus       231 ~~~~-~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il-----------------~~~~~~~~  278 (292)
T cd06658         231 RDNL-PPRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELL-----------------QHPFLKLA  278 (292)
T ss_pred             HhcC-CCcccc--ccccCHHHHHHHHHHccCChhHCcCHHHHh-----------------hChhhhcc
Confidence            4321 111111  12578999999999999 999999876655                 99999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=7.7e-41  Score=304.53  Aligned_cols=253  Identities=34%  Similarity=0.599  Sum_probs=208.2

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+..+.++.|    |+|.||.+.+..++..+++|.+........       ...+.+.+|+.++++++||||+++++.+.
T Consensus         2 y~~~~~i~~g----~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   70 (258)
T cd05578           2 FELLRVIGKG----AFGKVCIVQKRDTKKMFAMKYMNKQKCVEK-------GSVRNVLNERRILQELNHPFLVNLWYSFQ   70 (258)
T ss_pred             ceEEEEeccC----CCceEEEEEEccCCcEEEEEEEehhhhcch-------hHHHHHHHHHHHHHhCCCCChHHHHHhhc
Confidence            3444555555    899999999888899999998875443221       23466888999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcE
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI  163 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~v  163 (372)
                      ++...|+||||+.|++|.+++.. ...+++..+..++.||+.||.|||++|++|          +||+|+||++++++.+
T Consensus        71 ~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h----------~dl~~~nil~~~~~~~  139 (258)
T cd05578          71 DEENMYLVVDLLLGGDLRYHLSQ-KVKFSEEQVKFWICEIVLALEYLHSKGIIH----------RDIKPDNILLDEQGHV  139 (258)
T ss_pred             CCCeEEEEEeCCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHhCCeec----------cCCCHHHeEEcCCCCE
Confidence            99999999999999999999987 368999999999999999999999999999          9999999999999999


Q ss_pred             EEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCH---HHHHH
Q psy11571        164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL---VETYG  240 (372)
Q Consensus       164 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~---~~~~~  240 (372)
                      +|+|||++.......  ......|+..|+|||.+..     ..++.++|+||||+++|+|++|..||...+.   .....
T Consensus       140 ~l~d~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  212 (258)
T cd05578         140 HITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCR-----QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA  212 (258)
T ss_pred             EEeecccccccCCCc--cccccCCChhhcCHHHHcc-----cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH
Confidence            999999987664432  1233568889999999973     4578999999999999999999999988763   33332


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCc
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWF  306 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f  306 (372)
                      ....  .....|.    .++.++.++|.+||. +|.+|+++. +.+++              .||||
T Consensus       213 ~~~~--~~~~~~~----~~~~~~~~~i~~~l~~~p~~R~~~~-~~~l~--------------~~~~~  258 (258)
T cd05578         213 KQET--ADVLYPA----TWSTEAIDAINKLLERDPQKRLGDN-LKDLK--------------NHPYF  258 (258)
T ss_pred             Hhcc--ccccCcc----cCcHHHHHHHHHHccCChhHcCCcc-HHHHh--------------cCCCC
Confidence            2221  2223333    578999999999999 999999984 45555              99998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2e-40  Score=300.99  Aligned_cols=248  Identities=23%  Similarity=0.352  Sum_probs=204.9

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+..+.++.|    ++|.+|++....+++.+++|.+.....            .+.+.+|+.+++.++||||+++++.
T Consensus         3 ~~y~~~~~i~~g----~~~~v~~~~~~~~~~~~~~k~~~~~~~------------~~~~~~e~~~~~~l~~~~i~~~~~~   66 (256)
T cd06612           3 EVFDILEKLGEG----SYGSVYKAIHKETGQVVAIKVVPVEED------------LQEIIKEISILKQCDSPYIVKYYGS   66 (256)
T ss_pred             ccchhhhhhcCC----CCeEEEEEEEcCCCcEEEEEEeecHHH------------HHHHHHHHHHHHhCCCCcEeeeeee
Confidence            578888888887    799999999888889999997654221            3567889999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+...+|+++||+++++|.+++......+++..+..++.|++.||.|||+.|++|          +||+|+||+++.++
T Consensus        67 ~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H----------~dl~~~ni~~~~~~  136 (256)
T cd06612          67 YFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIH----------RDIKAGNILLNEEG  136 (256)
T ss_pred             eecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccc----------CCCCcceEEECCCC
Confidence            99999999999999999999999865668899999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .++|+|||++........ ......|+..|+|||++.+     ..++.++|+||||+++|+|++|+.||...+.......
T Consensus       137 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~  210 (256)
T cd06612         137 QAKLADFGVSGQLTDTMA-KRNTVIGTPFWMAPEVIQE-----IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM  210 (256)
T ss_pred             cEEEcccccchhcccCcc-ccccccCCccccCHHHHhc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh
Confidence            999999999887654322 2233457889999999873     4688899999999999999999999987766554443


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      +..... ..+  .....++.++.++|.+||+ +|++||++++++
T Consensus       211 ~~~~~~-~~~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il  251 (256)
T cd06612         211 IPNKPP-PTL--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLL  251 (256)
T ss_pred             hccCCC-CCC--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHh
Confidence            332211 111  1112578899999999999 999999876665

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.7e-40  Score=301.69  Aligned_cols=249  Identities=29%  Similarity=0.424  Sum_probs=206.8

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.++.|    ++|.+|.+....+++.+++|.+........        ..+.+.+|+.+++.++||||+++++++
T Consensus         1 ~y~~~~~lg~g----~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~~~~~   68 (256)
T cd08218           1 KYVKVKKIGEG----SFGKAILVKSKEDGKQYVIKEINISKMSPK--------EREESRKEVAVLSNMKHPNIVQYQESF   68 (256)
T ss_pred             CceEEEEeccC----CceEEEEEEEcCCCCEEEEEEEEhHhCChH--------HHHHHHHHHHHHHhCCCCCeeeeEeee
Confidence            45666677777    799999999988999999998765332211        234577899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      .+.+..|+||||+++++|.+++... ...+++..+..++.|++.||.|||++|++|          +||+|+||+++.++
T Consensus        69 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h----------~~l~~~nil~~~~~  138 (256)
T cd08218          69 EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILH----------RDIKSQNIFLTKDG  138 (256)
T ss_pred             cCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEec----------CCCCHHHEEEcCCC
Confidence            9999999999999999999999763 236899999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .++|+|||++........ ......|++.|+|||++.+     ..++.++|+|||||++|+|++|..||...+..+....
T Consensus       139 ~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~-----~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~  212 (256)
T cd08218         139 TIKLGDFGIARVLNSTVE-LARTCIGTPYYLSPEICEN-----RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLK  212 (256)
T ss_pred             CEEEeeccceeecCcchh-hhhhccCCccccCHHHhCC-----CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHH
Confidence            999999999976543222 1223458889999999873     5578899999999999999999999998888887777


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      +..+.. ...+.    .++.++.++|.+||+ +|++||++++++
T Consensus       213 ~~~~~~-~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~vl  251 (256)
T cd08218         213 IIRGSY-PPVSS----HYSYDLRNLVSQLFKRNPRDRPSVNSIL  251 (256)
T ss_pred             HhcCCC-CCCcc----cCCHHHHHHHHHHhhCChhhCcCHHHHh
Confidence            765432 22232    679999999999999 999999866655

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.6e-40  Score=305.06  Aligned_cols=253  Identities=24%  Similarity=0.336  Sum_probs=198.8

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHY   80 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~   80 (372)
                      .+|+.++.++.|    ++|.||.+....+++.+++|.......           ....+..|..++..+ +||||+++++
T Consensus        16 ~~~~~~~~lg~g----~~~~v~~~~~~~~~~~~a~K~~~~~~~-----------~~~~~~~e~~~l~~~~~h~~i~~~~~   80 (282)
T cd06636          16 GIFELVEVVGNG----TYGQVYKGRHVKTGQLAAIKVMDVTED-----------EEEEIKLEINMLKKYSHHRNIATYYG   80 (282)
T ss_pred             hhhhhheeeccC----CCeEEEEEEEcCCCcEEEEEEEecChH-----------HHHHHHHHHHHHHHhcCCCcEEEEee
Confidence            356677777776    899999999988999999997654321           123456788888877 6999999999


Q ss_pred             EEEe------CCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcC
Q psy11571         81 AFQD------DSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPD  153 (372)
Q Consensus        81 ~~~~------~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~  153 (372)
                      ++..      ...+|++|||+++|+|.+++... ...+++..+..++.||+.||.|||+.|++|          +||+|+
T Consensus        81 ~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH----------~dl~~~  150 (282)
T cd06636          81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIH----------RDIKGQ  150 (282)
T ss_pred             ehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------CCCCHH
Confidence            9853      45789999999999999999763 345889999999999999999999999999          999999


Q ss_pred             cEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC
Q psy11571        154 NVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE  233 (372)
Q Consensus       154 NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~  233 (372)
                      ||+++.++.++|+|||++........ ......|++.|+|||.+.........++.++|+|||||++|+|++|..||...
T Consensus       151 nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~  229 (282)
T cd06636         151 NVLLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM  229 (282)
T ss_pred             HEEECCCCCEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence            99999999999999999876532211 22335689999999998632222346788999999999999999999999876


Q ss_pred             CHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        234 SLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       234 ~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      ........+.....    +......++.++.+||++||. ||.+||++.+++
T Consensus       230 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell  277 (282)
T cd06636         230 HPMRALFLIPRNPP----PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLL  277 (282)
T ss_pred             CHHhhhhhHhhCCC----CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHh
Confidence            65554444333211    111122578999999999999 999999876655

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.5e-41  Score=320.45  Aligned_cols=251  Identities=20%  Similarity=0.287  Sum_probs=193.4

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+.++.++.|    ++|.||++.+..++..||+|......                ...|+.+++.++||||+++++++.
T Consensus        68 y~~~~~lg~G----~~g~Vy~~~~~~~~~~valK~~~~~~----------------~~~E~~~l~~l~h~~iv~~~~~~~  127 (357)
T PHA03209         68 YTVIKTLTPG----SEGRVFVATKPGQPDPVVLKIGQKGT----------------TLIEAMLLQNVNHPSVIRMKDTLV  127 (357)
T ss_pred             cEEEEEecCC----CCeEEEEEEECCCCceEEEEeCCccc----------------cHHHHHHHHhCCCCCCcChhheEE
Confidence            4555555555    89999999998888999999643221                234888999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcE
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI  163 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~v  163 (372)
                      +....++|||++ .++|.+++......+++..++.++.||+.||.|||++||+|          |||||+|||++.++.+
T Consensus       128 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH----------rDlkp~Nill~~~~~~  196 (357)
T PHA03209        128 SGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIH----------RDVKTENIFINDVDQV  196 (357)
T ss_pred             eCCeeEEEEEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeec----------CCCCHHHEEECCCCCE
Confidence            999999999998 56999998775677999999999999999999999999999          9999999999999999


Q ss_pred             EEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCC-CCCCH-------
Q psy11571        164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF-YAESL-------  235 (372)
Q Consensus       164 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf-~~~~~-------  235 (372)
                      +|+|||+++.......  .....||+.|+|||++.+     ..++.++|||||||++|||+++..|+ .....       
T Consensus       197 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~  269 (357)
T PHA03209        197 CIGDLGAAQFPVVAPA--FLGLAGTVETNAPEVLAR-----DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVK  269 (357)
T ss_pred             EEecCccccccccCcc--cccccccccccCCeecCC-----CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHH
Confidence            9999999875432221  223568999999999973     56899999999999999999865444 33211       


Q ss_pred             --HHHHHHHhhcc--CCcCCC--------------------------CCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        236 --VETYGKIMNHQ--NSFDLP--------------------------SDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       236 --~~~~~~i~~~~--~~~~~~--------------------------~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                        ...+.++....  ....++                          ......++.++.+||.+||+ ||.+|||+++++
T Consensus       270 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l  349 (357)
T PHA03209        270 SCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEIL  349 (357)
T ss_pred             HHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHh
Confidence              01111111110  000111                          00112467788999999999 999999977666


Q ss_pred             hhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        285 DFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       285 ~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                                       +||||+.+
T Consensus       350 -----------------~hp~f~~~  357 (357)
T PHA03209        350 -----------------NYPMFAQL  357 (357)
T ss_pred             -----------------cCchhccC
Confidence                             99999864

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-40  Score=303.70  Aligned_cols=254  Identities=24%  Similarity=0.355  Sum_probs=203.4

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHY   80 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~   80 (372)
                      .+|+.++.++.|    ++|.+|.+....+++.+++|.......           ..+.+.+|+.+++.+ .||||+++++
T Consensus         6 ~~y~~~~~l~~g----~~~~v~~~~~~~~~~~~~~k~~~~~~~-----------~~~~~~~e~~~l~~~~~h~~i~~~~~   70 (275)
T cd06608           6 GIFELVEVIGEG----TYGKVYKARHKKTGQLVAIKIMDIIED-----------EEEEIKEEYNILRKYSNHPNIATFYG   70 (275)
T ss_pred             hheeheeeecCC----CCeEEEEEEECCCCcEEEEEEEecCch-----------hHHHHHHHHHHHHHhcCCCChheEEE
Confidence            467777787777    799999999888889999997764332           124577899999988 6999999999


Q ss_pred             EEEeCC------eEEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCC
Q psy11571         81 AFQDDS------NLYLVMDYYCGGDLLTLLSKF---EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIK  151 (372)
Q Consensus        81 ~~~~~~------~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlk  151 (372)
                      ++.+..      .+|+||||+++++|.+++...   +..+++..++.++.|++.||.|||+.|++|          +||+
T Consensus        71 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H----------~~l~  140 (275)
T cd06608          71 AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIH----------RDIK  140 (275)
T ss_pred             EEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCccc----------CCCC
Confidence            997644      489999999999999998653   357899999999999999999999999999          9999


Q ss_pred             cCcEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCC
Q psy11571        152 PDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY  231 (372)
Q Consensus       152 p~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~  231 (372)
                      |+||+++.++.++|+|||++........ ......|+..|+|||++.........++.++|+|||||++|+|++|.+||.
T Consensus       141 p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~  219 (275)
T cd06608         141 GQNILLTKNAEVKLVDFGVSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC  219 (275)
T ss_pred             HHHEEEccCCeEEECCCccceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcc
Confidence            9999999999999999999876543222 223356899999999986433334557889999999999999999999998


Q ss_pred             CCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        232 AESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       232 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      .........++..... .....  ...++.++++||.+||. ||++||+++++.
T Consensus       220 ~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll  270 (275)
T cd06608         220 DMHPMRALFKIPRNPP-PTLKS--PENWSKKFNDFISECLIKNYEQRPFMEELL  270 (275)
T ss_pred             ccchHHHHHHhhccCC-CCCCc--hhhcCHHHHHHHHHHhhcChhhCcCHHHHh
Confidence            7766665555554321 11111  11468899999999999 999999866655

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.1e-40  Score=302.95  Aligned_cols=258  Identities=25%  Similarity=0.353  Sum_probs=204.8

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+..+.++.|    ++|.||.+.+..+++.|++|.+........     ....++.+.+|+.+++.+.||||+++++++.
T Consensus         4 ~~~~~~l~~g----~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   74 (265)
T cd06652           4 WRLGKLLGQG----AFGRVYLCYDADTGRELAVKQVQFDPESPE-----TSKEVNALECEIQLLKNLLHERIVQYYGCLR   74 (265)
T ss_pred             ceEeeEEecC----CceEEEEEEEcCCCcEEEEEEeecCcCCcc-----cHHHHHHHHHHHHHHHhcCCCCeeeEEeEec
Confidence            3344444554    899999999988999999997754321111     1124567888999999999999999999987


Q ss_pred             eC--CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         84 DD--SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        84 ~~--~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.  ..++++|||+++++|.+++.+ ...+++..+..++.|++.||+|||+.|++|          +||||+||+++.++
T Consensus        75 ~~~~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H----------~dl~p~nil~~~~~  143 (265)
T cd06652          75 DPMERTLSIFMEHMPGGSIKDQLKS-YGALTENVTRKYTRQILEGVSYLHSNMIVH----------RDIKGANILRDSVG  143 (265)
T ss_pred             cCCCceEEEEEEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEec----------CCCCHHHEEecCCC
Confidence            64  468899999999999999987 467899999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCc--ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGT--VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY  239 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~  239 (372)
                      .++|+|||++........  .......|+..|+|||++.+     ..++.++|+|||||++|+|++|+.||...+.....
T Consensus       144 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~  218 (265)
T cd06652         144 NVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG-----EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI  218 (265)
T ss_pred             CEEECcCccccccccccccccccccCCCCccccChhhhcC-----CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH
Confidence            999999999876532111  11122458889999999873     45788999999999999999999999877655555


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcC
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ  307 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~  307 (372)
                      .++.........|.    .++..+.++|++|+.+|++||++++++                 .|||++
T Consensus       219 ~~~~~~~~~~~~~~----~~~~~~~~~i~~~l~~p~~Rp~~~~il-----------------~~~~~~  265 (265)
T cd06652         219 FKIATQPTNPVLPP----HVSDHCRDFLKRIFVEAKLRPSADELL-----------------RHTFVH  265 (265)
T ss_pred             HHHhcCCCCCCCch----hhCHHHHHHHHHHhcChhhCCCHHHHh-----------------cCcccC
Confidence            55443322222332    678999999999999999999866555                 999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=6.9e-41  Score=308.28  Aligned_cols=257  Identities=25%  Similarity=0.356  Sum_probs=213.0

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      +.|+.++.++.|    ++|.||++....++..+|+|.+.......         ..+.+.+|+.+++.++||||+++++.
T Consensus         4 ~~y~~~~~l~~g----~~~~vy~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~   70 (277)
T cd06642           4 ELFTKLERIGKG----SFGEVYKGIDNRTKEVVAIKIIDLEEAED---------EIEDIQQEITVLSQCDSPYITRYYGS   70 (277)
T ss_pred             HHHHHHHHhcCC----CCeeEEEEEEcCCCeEEEEEEeccccchH---------HHHHHHHHHHHHHcCCCCccHhhhcc
Confidence            578888888887    79999999888888999999765433211         23567889999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +..+...|+||||+++++|.+++..  +.+++..++.++.|++.||.|||++|++|          +||+|+||+++.++
T Consensus        71 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH----------~dl~p~ni~i~~~~  138 (277)
T cd06642          71 YLKGTKLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIH----------RDIKAANVLLSEQG  138 (277)
T ss_pred             cccCCceEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeec----------cCCChheEEEeCCC
Confidence            9999999999999999999999875  67899999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .++|+|||++........ ......|+..|+|||.+.+     ..++.++|+|||||++|+|++|..||...........
T Consensus       139 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~  212 (277)
T cd06642         139 DVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQ-----SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL  212 (277)
T ss_pred             CEEEccccccccccCcch-hhhcccCcccccCHHHhCc-----CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh
Confidence            999999999876543322 2223468889999999973     4678899999999999999999999987665555444


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCc
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAW  311 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w  311 (372)
                      +.... ....+    ...+.++.++|.+||. +|++||++.+++                 .||||....+
T Consensus       213 ~~~~~-~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il-----------------~~~~~~~~~~  261 (277)
T cd06642         213 IPKNS-PPTLE----GQYSKPFKEFVEACLNKDPRFRPTAKELL-----------------KHKFITRYTK  261 (277)
T ss_pred             hhcCC-CCCCC----cccCHHHHHHHHHHccCCcccCcCHHHHH-----------------HhHHHHHHhh
Confidence            43321 11222    2578999999999999 999999876665                 9999986554

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.5e-40  Score=303.51  Aligned_cols=253  Identities=20%  Similarity=0.271  Sum_probs=207.2

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhh-----hhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCcee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDI-----LLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWIT   76 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~-----~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv   76 (372)
                      +.|+.++.++.|    |+|.||.+.....+     ..+++|.+......         ...+.+.+|+.++..++||||+
T Consensus         5 ~~~~~~~~lg~G----~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~---------~~~~~~~~ei~~l~~l~h~~i~   71 (283)
T cd05048           5 SAVRFLEELGEG----AFGKVYKGELTGPNERLSATSVAIKTLKENAEP---------KVQQEFRQEAELMSDLQHPNIV   71 (283)
T ss_pred             HHcchhhcccCc----cCCcEEEEEEecCCCCcceeeEEEEecccCCCH---------HHHHHHHHHHHHHHhcCCcccc
Confidence            357778888887    89999999865544     67888876543221         1235578899999999999999


Q ss_pred             eeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCC
Q psy11571         77 NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE---------------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH  141 (372)
Q Consensus        77 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~  141 (372)
                      ++++++.+....|++|||+++++|.+++....               ..+++..+..++.|++.||.|||+.|++|    
T Consensus        72 ~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H----  147 (283)
T cd05048          72 CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVH----  147 (283)
T ss_pred             eEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeec----
Confidence            99999999999999999999999999997631               45788999999999999999999999999    


Q ss_pred             CCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHHH
Q psy11571        142 FAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCM  220 (372)
Q Consensus       142 ~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil  220 (372)
                            |||||+||++++++.++|+|||+++....... .......+++.|+|||.+.     ...++.++|+|||||++
T Consensus       148 ------~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDv~slG~il  216 (283)
T cd05048         148 ------RDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAIL-----YGKFTTESDIWSFGVVL  216 (283)
T ss_pred             ------cccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhc-----cCcCchhhhHHHHHHHH
Confidence                  99999999999999999999999876533221 1122345688999999987     35688999999999999


Q ss_pred             HHHhh-CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        221 YEMLY-GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       221 ~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      |||++ |..||.+.+..+....+..... ...+.    .++.++.+|+.+||+ +|.+||+++++.+.+
T Consensus       217 ~el~~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~----~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l  280 (283)
T cd05048         217 WEIFSYGLQPYYGFSNQEVIEMIRSRQL-LPCPE----DCPARVYALMIECWNEIPARRPRFKDIHTRL  280 (283)
T ss_pred             HHHHcCCCCCCCCCCHHHHHHHHHcCCc-CCCcc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            99998 9999999888887777765432 22333    689999999999999 999999988877544

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.4e-40  Score=305.38  Aligned_cols=255  Identities=22%  Similarity=0.342  Sum_probs=203.6

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      +.|+.+..++.|    ++|.||++....+++.+++|.+........        ....+.+|+.+++.+.||||++++++
T Consensus         5 ~~y~~~~~lg~g----~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~--------~~~~~~~e~~~l~~l~h~ni~~~~~~   72 (293)
T cd07843           5 DEYEKLNRIEEG----TYGVVYRARDKKTGEIVALKKLKMEKEKEG--------FPITSLREINILLKLQHPNIVTVKEV   72 (293)
T ss_pred             hhhhhhhhhcCC----CCeEEEEEEECCCCcEEEEEEEeecccccc--------chhhHHHHHHHHHhcCCCCEEEEEEE
Confidence            367888888888    799999999988899999998865543321        22345679999999999999999999


Q ss_pred             EEeC--CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC
Q psy11571         82 FQDD--SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA  159 (372)
Q Consensus        82 ~~~~--~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~  159 (372)
                      +...  ...|+||||+. ++|.+++......+++..++.++.||+.||+|||+.|++|          +||||+||+++.
T Consensus        73 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H----------~dl~p~nili~~  141 (293)
T cd07843          73 VVGSNLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILH----------RDLKTSNLLLNN  141 (293)
T ss_pred             EEecCCCcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeee----------ccCCHHHEEECC
Confidence            8877  88999999996 5999998774456999999999999999999999999999          999999999999


Q ss_pred             CCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHH
Q psy11571        160 NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY  239 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~  239 (372)
                      ++.++|+|||++........ ......+++.|+|||.+.+    ...++.++|+||||+++|+|++|.+||...+..+..
T Consensus       142 ~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~  216 (293)
T cd07843         142 RGILKICDFGLAREYGSPLK-PYTQLVVTLWYRAPELLLG----AKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL  216 (293)
T ss_pred             CCcEEEeecCceeeccCCcc-ccccccccccccCchhhcC----CccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            99999999999887654322 1223457889999999874    344688999999999999999999999988776666


Q ss_pred             HHHhhccCCc-------------------------CCCCCCCCC-CCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        240 GKIMNHQNSF-------------------------DLPSDVGYE-ISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       240 ~~i~~~~~~~-------------------------~~~~~~~~~-~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      .++.......                         .+....... +++.+.++|++||+ +|++||++++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell  288 (293)
T cd07843         217 NKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDAL  288 (293)
T ss_pred             HHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHh
Confidence            5543321100                         000011112 58899999999999 999999876665

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=5.8e-41  Score=331.35  Aligned_cols=260  Identities=22%  Similarity=0.318  Sum_probs=192.1

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||++.+..+++.||+|.+...... ......++.    +.+++......+|++|++++++|
T Consensus       130 ~y~i~~~lG~G----~fg~V~~a~~~~~~~~vAvK~i~~~~~~-~~~~~~e~~----~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        130 RFKILSLLGEG----TFGKVVEAWDRKRKEYCAVKIVRNVPKY-TRDAKIEIQ----FMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             cEEEEEEEEec----cCEEEEEEEEcCCCeEEEEEEEecchhh-HHHHHHHHH----HHHHHhhcCcccCcceeeeEEEE
Confidence            45555666666    8999999999889999999988542211 111111111    22222223334567799999998


Q ss_pred             EeC-CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         83 QDD-SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD-LHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        83 ~~~-~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      ... .++|+|||++ |++|.+++.+ .+.+++..++.++.||+.||.|||+ .||+|          |||||+|||++.+
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiH----------rDlKP~NILl~~~  268 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMH----------TDLKPENILMETS  268 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeec----------CCCCHHHEEEecC
Confidence            765 4789999997 8899999877 4789999999999999999999998 59999          9999999999866


Q ss_pred             C----------------cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHh
Q psy11571        161 G----------------HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML  224 (372)
Q Consensus       161 ~----------------~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ell  224 (372)
                      +                .+||+|||.+.....    .....+||+.|+|||++.+     ..++.++|||||||++|||+
T Consensus       269 ~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~-----~~~~~~~DiwSlGvil~ell  339 (467)
T PTZ00284        269 DTVVDPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLG-----LGWMYSTDMWSMGCIIYELY  339 (467)
T ss_pred             CcccccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhc-----CCCCcHHHHHHHHHHHHHHH
Confidence            5                499999998764322    2234679999999999984     56899999999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHHhhccCCcC--C--------------------CCC--------------CCCCCCHHHHHHHH
Q psy11571        225 YGETPFYAESLVETYGKIMNHQNSFD--L--------------------PSD--------------VGYEISDDAKDLMR  268 (372)
Q Consensus       225 tG~~Pf~~~~~~~~~~~i~~~~~~~~--~--------------------~~~--------------~~~~~s~~~~~li~  268 (372)
                      +|++||.+.+..+.+..+......++  +                    +..              .....++.+.|||.
T Consensus       340 tG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~  419 (467)
T PTZ00284        340 TGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIY  419 (467)
T ss_pred             hCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHH
Confidence            99999998776655444432211100  0                    000              00012466789999


Q ss_pred             Hhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        269 RLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       269 ~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      +||+ ||++|||+++++                 +||||...
T Consensus       420 ~mL~~dP~~R~ta~e~L-----------------~Hp~~~~~  444 (467)
T PTZ00284        420 GLLHYDRQKRLNARQMT-----------------THPYVLKY  444 (467)
T ss_pred             HhCCcChhhCCCHHHHh-----------------cCcccccc
Confidence            9999 999999977766                 99999853

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.8e-41  Score=344.89  Aligned_cols=260  Identities=23%  Similarity=0.353  Sum_probs=206.5

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.+..+|.|    |+|.||++++..++..+++|.+........        ....+..|+.++..++||||++++++|
T Consensus        14 ~YeIl~kLG~G----gFGtVYLAkdk~tg~~vAlKvIk~~~l~e~--------~~~~~~~EI~IL~~L~HPNIVrl~d~f   81 (1021)
T PTZ00266         14 EYEVIKKIGNG----RFGEVFLVKHKRTQEFFCWKAISYRGLKER--------EKSQLVIEVNVMRELKHKNIVRYIDRF   81 (1021)
T ss_pred             CEEEEEEEecC----CCeEEEEEEECCCCeEEEEEEEeccccCHH--------HHHHHHHHHHHHHHcCCCCcCeEEEEE
Confidence            45666677776    899999999999999999998876544322        235578899999999999999999998


Q ss_pred             EeC--CeEEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhcC-------ceecCCCCCCCcCCCC
Q psy11571         83 QDD--SNLYLVMDYYCGGDLLTLLSKF---EDRLPEDMAKFYIAEMVLAIASIHDLH-------YVHRPNHFAFHLCRDI  150 (372)
Q Consensus        83 ~~~--~~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~-------ivH~~~~~~~~vhrDl  150 (372)
                      .+.  ..+|+||||+++|+|.++|...   ...+++..++.++.||+.||.|||+.+       |+|          |||
T Consensus        82 ~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVH----------RDL  151 (1021)
T PTZ00266         82 LNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLH----------RDL  151 (1021)
T ss_pred             EecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCcee----------ccC
Confidence            654  5689999999999999999753   357999999999999999999999854       888          999


Q ss_pred             CcCcEEeCC-----------------CCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccce
Q psy11571        151 KPDNVLLDA-----------------NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDW  213 (372)
Q Consensus       151 kp~NIll~~-----------------~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Di  213 (372)
                      ||+|||++.                 .+.+||+|||++........  .....||+.|+|||++.+.   ...++.++||
T Consensus       152 KPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge---~~~~s~KSDV  226 (1021)
T PTZ00266        152 KPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHE---TKSYDDKSDM  226 (1021)
T ss_pred             cHHHeEeecCccccccccccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhcc---CCCCCchhHH
Confidence            999999964                 23489999999976643322  2335799999999998631   2457889999


Q ss_pred             eehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhh
Q psy11571        214 WSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSAL  292 (372)
Q Consensus       214 wslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~  292 (372)
                      ||||||+|+|++|..||...+....+...+.....+  +.   ...+.++.+||.+||. +|.+||++.+++        
T Consensus       227 WSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~l--pi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL--------  293 (1021)
T PTZ00266        227 WALGCIIYELCSGKTPFHKANNFSQLISELKRGPDL--PI---KGKSKELNILIKNLLNLSAKERPSALQCL--------  293 (1021)
T ss_pred             HHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCC--Cc---CCCCHHHHHHHHHHhcCChhHCcCHHHHh--------
Confidence            999999999999999998765544444443332222  21   1468999999999999 999999866555        


Q ss_pred             hhccCCCCCCCCCcCCCCc
Q psy11571        293 FVSLSISPRNHPWFQGIAW  311 (372)
Q Consensus       293 ~~~~~~~~~~hp~f~~~~w  311 (372)
                               .|||++.+..
T Consensus       294 ---------~h~~ik~i~~  303 (1021)
T PTZ00266        294 ---------GYQIIKNVGP  303 (1021)
T ss_pred             ---------ccHHHhhcCC
Confidence                     8999987654

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-40  Score=330.20  Aligned_cols=293  Identities=22%  Similarity=0.275  Sum_probs=205.2

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeeh-hhhhhhhhhhcccchh-------hhhhHHHHHHHHHHHHHHHHHHhcCCCCc
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLL-DILLVLYDECCNSSLR-------REKTVSDFIEFVAKLREERDVLVYGDRRW   74 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~-~~~~va~K~~~~~~~~-------~~~~~~~~~~~~~~l~~E~~il~~l~hp~   74 (372)
                      +|+.++.+|.|    |+|.||.+.... ++...+.|.+......       ..+...........+.+|+.+|+.++|||
T Consensus       149 ~Y~ii~~LG~G----~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        149 HFRVIDDLPAG----AFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             ccEEEeEecCC----CCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            56677777777    899999876433 2333333321111100       00111112234566889999999999999


Q ss_pred             eeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCC
Q psy11571         75 ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKF----EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDI  150 (372)
Q Consensus        75 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDl  150 (372)
                      |+++++++.+.+..|+|||++ +++|.+++...    ........++.++.||+.||.|||++||+|          |||
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiH----------rDL  293 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIH----------RDI  293 (501)
T ss_pred             cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeec----------CCC
Confidence            999999999999999999998 56888887542    122346778899999999999999999999          999


Q ss_pred             CcCcEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCC-
Q psy11571        151 KPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP-  229 (372)
Q Consensus       151 kp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~P-  229 (372)
                      ||+|||++.++.+||+|||+++..............||+.|+|||++.+     ..++.++|||||||++|||++|..+ 
T Consensus       294 KP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~ell~~~~~p  368 (501)
T PHA03210        294 KLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-----DGYCEITDIWSCGLILLDMLSHDFCP  368 (501)
T ss_pred             CHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-----CCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            9999999999999999999998765443333334679999999999983     5688999999999999999998764 


Q ss_pred             CCCC--CHHHHHHHHhhccC--CcCCCC-----------------------C-CCCCCCHHHHHHHHHhcc-CCCCCCCC
Q psy11571        230 FYAE--SLVETYGKIMNHQN--SFDLPS-----------------------D-VGYEISDDAKDLMRRLIC-SSDTRLGQ  280 (372)
Q Consensus       230 f~~~--~~~~~~~~i~~~~~--~~~~~~-----------------------~-~~~~~s~~~~~li~~lL~-~p~~R~s~  280 (372)
                      |...  +....+.+++....  ...+|.                       . ....++.++.++|.+||+ ||.+|||+
T Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa  448 (501)
T PHA03210        369 IGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGA  448 (501)
T ss_pred             ccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCH
Confidence            4322  22222222221100  000110                       0 011356788899999999 99999997


Q ss_pred             CChhhhhhhhhhhhccCCCCCCCCCcCCCCcccccc---------CCCCCcCCCCCCCCCC
Q psy11571        281 NGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRD---------SNAPYIPEVSSPTDTS  332 (372)
Q Consensus       281 ~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~~---------~~~p~~p~~~~~~~~~  332 (372)
                      .+++                 .||||.....+.+..         ...|+.|......|+.
T Consensus       449 ~elL-----------------~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  492 (501)
T PHA03210        449 AELL-----------------ALPLFSAEEEEEILFIHGLKSGAAHFKPIKPACRIESDTA  492 (501)
T ss_pred             HHHh-----------------hChhhhcCCchHHHHHHhhhccccccccCCchheeccccc
Confidence            7766                 999999987766511         2346666554444433

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-40  Score=302.90  Aligned_cols=257  Identities=24%  Similarity=0.398  Sum_probs=209.1

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC---CCceeeee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD---RRWITNLH   79 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~---hp~Iv~l~   79 (372)
                      -|+.++.++.|    ++|.||++....+++.+++|.+.......         ..+.+.+|+.+++.+.   ||||++++
T Consensus         2 ~y~~~~~l~~g----~~g~v~~~~~~~~~~~~~iK~~~~~~~~~---------~~~~~~~e~~~l~~l~~~~~~~vi~~~   68 (277)
T cd06917           2 LYQRLELIGRG----AYGAVYRGKHVPTGRVVALKIINLDTPDD---------DVSDIQREVALLSQLRQSQPPNITKYY   68 (277)
T ss_pred             hhhhhhheecc----CCceEEEEEEcCCCcEEEEEEecCCCCch---------hHHHHHHHHHHHHHhccCCCCCeeeEe
Confidence            36777777777    89999999998899999999876432211         2345667888888875   99999999


Q ss_pred             EEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC
Q psy11571         80 YAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA  159 (372)
Q Consensus        80 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~  159 (372)
                      +++.++...|+||||+++++|.+++..  +.+++..+..++.|++.||.|||+.|++|          +||+|+||+++.
T Consensus        69 ~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H----------~dl~p~ni~i~~  136 (277)
T cd06917          69 GSYLKGPRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIH----------RDIKAANILVTN  136 (277)
T ss_pred             eeeeeCCEEEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCccc----------CCcCHHHEEEcC
Confidence            999999999999999999999999876  57999999999999999999999999999          999999999999


Q ss_pred             CCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHH
Q psy11571        160 NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY  239 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~  239 (372)
                      ++.++|+|||++........ ......|+..|+|||.+.+    ...++.++|+|||||++|+|++|..||.+.+.....
T Consensus       137 ~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~  211 (277)
T cd06917         137 TGNVKLCDFGVAALLNQNSS-KRSTFVGTPYWMAPEVITE----GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM  211 (277)
T ss_pred             CCCEEEccCCceeecCCCcc-ccccccCCcceeCHHHhcc----CCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh
Confidence            99999999999987654332 2233568899999999863    345688999999999999999999999887665544


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCC
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~  310 (372)
                      ..+... ....++.   ..++.++.+++.+||+ ||++||++.+++                 .||||+...
T Consensus       212 ~~~~~~-~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il-----------------~~~~~~~~~  262 (277)
T cd06917         212 MLIPKS-KPPRLED---NGYSKLLREFVAACLDEEPKERLSAEELL-----------------KSKWIKAHS  262 (277)
T ss_pred             hccccC-CCCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHh-----------------hChHhhccc
Confidence            333222 1112222   2378999999999999 999999866555                 999998654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-40  Score=301.37  Aligned_cols=255  Identities=21%  Similarity=0.316  Sum_probs=205.0

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+..+.++.|    ++|.||.+....+++.+++|........          ..+.+.+|+.+++.++||||+++++.
T Consensus         3 ~~~~~~~~l~~g----~~~~v~~~~~~~~~~~~~ik~~~~~~~~----------~~~~~~~e~~~l~~~~h~~i~~~~~~   68 (262)
T cd06613           3 EDYELIQRIGSG----TYGDVYKARDIATGELVAIKVIKLEPGD----------DFEIIQQEISMLKECRHPNIVAYFGS   68 (262)
T ss_pred             cceEEEEEecCC----CceEEEEeEecCCCCEEEEEEEEcCchh----------hHHHHHHHHHHHHhCCCCChhceEEE
Confidence            355666666666    8999999998888899999987654322          24567889999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+...+|++|||+++++|.+++......+++..+..++.|++.||.|||++|++|          +||+|+||+++.++
T Consensus        69 ~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h----------~dl~p~ni~i~~~~  138 (262)
T cd06613          69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIH----------RDIKGANILLTEDG  138 (262)
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCcee----------cCCChhhEEECCCC
Confidence            99999999999999999999999874478999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .++|+|||++........ ......++..|+|||.+.+..  ...++.++|+|||||++|+|++|.+||...+.......
T Consensus       139 ~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~--~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~  215 (262)
T cd06613         139 DVKLADFGVSAQLTATIA-KRKSFIGTPYWMAPEVAAVER--KGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL  215 (262)
T ss_pred             CEEECccccchhhhhhhh-ccccccCCccccCchhhcccc--cCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999876543221 122356888999999987421  12678899999999999999999999988776655554


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      +........... ....++.++.++|++||. +|.+||++++++
T Consensus       216 ~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il  258 (262)
T cd06613         216 ISKSNFPPPKLK-DKEKWSPVFHDFIKKCLTKDPKKRPTATKLL  258 (262)
T ss_pred             HHhccCCCcccc-chhhhhHHHHHHHHHHcCCChhhCCCHHHHh
Confidence            444321111111 112467899999999999 999999876665

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3e-40  Score=302.03  Aligned_cols=259  Identities=25%  Similarity=0.434  Sum_probs=205.4

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+....++.|    ++|.||.+....+++.+++|.+........    ...+..+.+.+|+.+++.++||||+++++++.
T Consensus         2 ~~~~~~lg~g----~~~~v~~~~~~~~~~~~alk~~~~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   73 (268)
T cd06630           2 WLKGQQLGTG----AFSSCYQARDVKTGTLMAVKQVTYVRNTSS----EQEEVVEALRKEIRLMARLNHPHIIRMLGATC   73 (268)
T ss_pred             ccccceecCc----CceEEEEEEEcCCCcEEEEEEeecccCCch----hHHHHHHHHHHHHHHHHHcCCCceehhhceec
Confidence            3344445555    899999999888999999998764332111    11234577889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC-c
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG-H  162 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~-~  162 (372)
                      +.+.+++||||+++++|.+++.+ .+.+++..+..++.|++.||.|||++|++|          +||+|+||+++.++ .
T Consensus        74 ~~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H----------~~i~~~nil~~~~~~~  142 (268)
T cd06630          74 EDSHFNLFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIH----------RDVKGANLLIDSTGQR  142 (268)
T ss_pred             cCCeEEEEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeec----------CCCCHHHEEEcCCCCE
Confidence            99999999999999999999987 467899999999999999999999999999          99999999998776 5


Q ss_pred             EEEeecCcccccCCCCc---ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGT---VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY  239 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~  239 (372)
                      ++|+|||.+........   .......|+..|+|||.+.+     ..++.++|+||||+++|+|++|..||...+.....
T Consensus       143 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  217 (268)
T cd06630         143 LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-----EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL  217 (268)
T ss_pred             EEEcccccccccccccccCCccccccccccceeCHhHhcc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH
Confidence            99999999877643211   11123467889999999873     56788999999999999999999999765433222


Q ss_pred             H---HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcC
Q psy11571        240 G---KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ  307 (372)
Q Consensus       240 ~---~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~  307 (372)
                      .   ++.........+.    .+++++.+++.+||. +|++||++.+++                 +||||+
T Consensus       218 ~~~~~~~~~~~~~~~~~----~~~~~~~~~i~~~l~~~p~~R~~~~~ll-----------------~~~~~~  268 (268)
T cd06630         218 ALIFKIASATTAPSIPE----HLSPGLRDVTLRCLELQPEDRPPSRELL-----------------KHPVFR  268 (268)
T ss_pred             HHHHHHhccCCCCCCch----hhCHHHHHHHHHHcCCCcccCcCHHHHh-----------------cCcccC
Confidence            2   2222222222332    678999999999999 999999876665                 999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.4e-40  Score=299.34  Aligned_cols=248  Identities=21%  Similarity=0.277  Sum_probs=202.3

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.++.|    |+|.||.+.. .++..+++|.+......           .+.+.+|+.+++.++||||+++++++
T Consensus         5 ~~~~~~~lg~G----~~~~vy~~~~-~~~~~~a~K~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~   68 (256)
T cd05114           5 ELTFMKELGSG----QFGVVHLGKW-RAQIKVAIKAINEGAMS-----------EEDFIEEAKVMMKLSHPKLVQLYGVC   68 (256)
T ss_pred             HcEEeeEecCC----cCceEEEEEe-ccCceEEEEecccCCcc-----------HHHHHHHHHHHHHCCCCCceeEEEEE
Confidence            44555666666    8999999865 45567888876543321           13467799999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+.+..++||||+++|+|.+++....+.+++..+..++.|++.||+|||++|++|          |||||+||+++.++.
T Consensus        69 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H----------~dl~p~ni~i~~~~~  138 (256)
T cd05114          69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIH----------RDLAARNCLVSSTGV  138 (256)
T ss_pred             ccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccc----------cccCcceEEEcCCCe
Confidence            9999999999999999999999764457899999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGK  241 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~  241 (372)
                      ++|+|||.++..............++..|+|||.+.+     ..++.++|+||||+++|+|++ |+.||...+..+....
T Consensus       139 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~  213 (256)
T cd05114         139 VKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF-----SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEM  213 (256)
T ss_pred             EEECCCCCccccCCCceeccCCCCCchhhCChhhccc-----CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            9999999987654332222222345668999999873     468889999999999999999 9999999888888887


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhh
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADF  286 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i  286 (372)
                      +..+.. ...|.    ..+..+.+++.+||+ +|++||+++++...
T Consensus       214 i~~~~~-~~~~~----~~~~~~~~li~~c~~~~p~~Rps~~~l~~~  254 (256)
T cd05114         214 ISRGFR-LYRPK----LASMTVYEVMYSCWHEKPEGRPTFAELLRA  254 (256)
T ss_pred             HHCCCC-CCCCC----CCCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            766432 22233    468899999999999 99999998877654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-40  Score=325.04  Aligned_cols=243  Identities=24%  Similarity=0.279  Sum_probs=190.5

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      |++|.||++.+..+++.||+|....                ..+.+|+.+|+.++||||+++++++..++..++|||++ 
T Consensus       180 G~~G~Vy~a~~~~~~~~vavK~~~~----------------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-  242 (461)
T PHA03211        180 GSEGCVFESSHPDYPQRVVVKAGWY----------------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-  242 (461)
T ss_pred             CCCeEEEEEEECCCCCEEEEecccc----------------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-
Confidence            3889999999988899999994321                12456999999999999999999999999999999998 


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCC
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG  176 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  176 (372)
                      .++|.+++......+++..++.++.||+.||.|||++||+|          |||||+|||++.++.++|+|||+++....
T Consensus       243 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvH----------rDLKP~NILl~~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        243 RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIH----------RDIKTENVLVNGPEDICLGDFGAACFARG  312 (461)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEE----------CcCCHHHEEECCCCCEEEcccCCceeccc
Confidence            57999998764557999999999999999999999999999          99999999999999999999999976543


Q ss_pred             CCcc-cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCC--------HHHHHHHHhhccC
Q psy11571        177 DGTV-QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIMNHQN  247 (372)
Q Consensus       177 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~--------~~~~~~~i~~~~~  247 (372)
                      .... ......||+.|+|||++.+     ..++.++|||||||++|||++|..|+....        ..++...+.....
T Consensus       313 ~~~~~~~~~~~GT~~Y~APE~~~~-----~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~  387 (461)
T PHA03211        313 SWSTPFHYGIAGTVDTNAPEVLAG-----DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQV  387 (461)
T ss_pred             ccccccccccCCCcCCcCHHHHcC-----CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcc
Confidence            2211 1223579999999999973     568999999999999999999876654321        1222222222111


Q ss_pred             Cc-CCCC------------------------CC---CCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCC
Q psy11571        248 SF-DLPS------------------------DV---GYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSI  298 (372)
Q Consensus       248 ~~-~~~~------------------------~~---~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~  298 (372)
                      .. .++.                        ..   ...++.++.+||.+||+ ||.+|||+.+++              
T Consensus       388 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL--------------  453 (461)
T PHA03211        388 HVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELL--------------  453 (461)
T ss_pred             ccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHh--------------
Confidence            00 0000                        00   01356789999999999 999999877666              


Q ss_pred             CCCCCCCcCC
Q psy11571        299 SPRNHPWFQG  308 (372)
Q Consensus       299 ~~~~hp~f~~  308 (372)
                         +||||++
T Consensus       454 ---~hp~f~~  460 (461)
T PHA03211        454 ---RLPLFQS  460 (461)
T ss_pred             ---hCcccCC
Confidence               9999974

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.3e-40  Score=302.26  Aligned_cols=254  Identities=25%  Similarity=0.431  Sum_probs=209.3

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.++.|    ++|.||++....+++.+++|.+......         ...+.+.+|+.+++.++||||+++++.+
T Consensus         2 ~~~~~~~ig~g----~~~~v~~~~~~~~~~~~~ik~~~~~~~~---------~~~~~~~~e~~~l~~~~~~~i~~~~~~~   68 (265)
T cd06605           2 DLEYLGELGAG----NSGVVSKVLHRPTGKIMAVKTIRLEINE---------AIQKQILRELDILHKCNSPYIVGFYGAF   68 (265)
T ss_pred             cchHHHHhcCC----CCeEEEEEEEcCCCcEEEEEEEecccCh---------HHHHHHHHHHHHHHHCCCCchhhhheee
Confidence            56777888887    7999999999889999999977654322         1235577899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD-LHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      ...+.++++|||+++++|.+++......+++..+..++.|++.||+|||+ .|++|          +||||+||+++.++
T Consensus        69 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H----------~dl~~~ni~~~~~~  138 (265)
T cd06605          69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIH----------RDVKPSNILVNSRG  138 (265)
T ss_pred             ecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeec----------CCCCHHHEEECCCC
Confidence            99999999999999999999998744789999999999999999999999 99999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC-----CHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE-----SLV  236 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~-----~~~  236 (372)
                      .++|+|||.+........   ....++..|+|||.+.+     ..++.++|+||||+++|+|++|..||...     ...
T Consensus       139 ~~~l~d~g~~~~~~~~~~---~~~~~~~~y~~PE~~~~-----~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  210 (265)
T cd06605         139 QIKLCDFGVSGQLVNSLA---KTFVGTSSYMAPERIQG-----NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF  210 (265)
T ss_pred             CEEEeecccchhhHHHHh---hcccCChhccCHHHHcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHH
Confidence            999999999876533221   12568899999999973     46889999999999999999999999764     233


Q ss_pred             HHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       237 ~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      +....+... .....+..   .++.+++++|.+||. +|++||++.++.                 .||||+.
T Consensus       211 ~~~~~~~~~-~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll-----------------~~~~~~~  262 (265)
T cd06605         211 ELLQYIVNE-PPPRLPSG---KFSPDFQDFVNLCLIKDPRERPSYKELL-----------------EHPFIKK  262 (265)
T ss_pred             HHHHHHhcC-CCCCCChh---hcCHHHHHHHHHHcCCCchhCcCHHHHh-----------------hCchhhc
Confidence            344444432 22222221   378999999999999 999999866555                 9999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=8.4e-40  Score=305.77  Aligned_cols=257  Identities=23%  Similarity=0.346  Sum_probs=209.5

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.+..++.|    ++|.||.+....+++.|++|.+........       +..+.+.+|+.+++.++||||++++++
T Consensus        15 ~~y~~~~~lg~g----~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~-------~~~~~~~~Ei~~l~~l~h~niv~~~~~   83 (307)
T cd06607          15 KLFTDLREIGHG----SFGAVYFARDVRTNEVVAIKKMSYSGKQSN-------EKWQDIIKEVRFLQQLRHPNTIEYKGC   83 (307)
T ss_pred             hhhhhheeecCC----CCeEEEEEEEcCCCcEEEEEEEeccccCcH-------HHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            577888887777    799999999888899999998754432221       233557789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+.+..|+||||+. |+|.+++......+++..+..++.|++.||.|||+.|++|          |||+|+||+++.++
T Consensus        84 ~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H----------~dl~p~nIl~~~~~  152 (307)
T cd06607          84 YLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIH----------RDIKAGNILLTEPG  152 (307)
T ss_pred             EEeCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCcee----------cCCCcccEEECCCC
Confidence            999999999999995 6888887654567999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .++|+|||++......     ....+++.|+|||++.+..  ...++.++||||||+++|+|++|.+||.+.+.......
T Consensus       153 ~~kL~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~--~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~  225 (307)
T cd06607         153 TVKLADFGSASLVSPA-----NSFVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH  225 (307)
T ss_pred             CEEEeecCcceecCCC-----CCccCCccccCceeeeccC--CCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH
Confidence            9999999998765432     2246788999999985321  34578899999999999999999999988776665555


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      +..... ...+   ...++..++++|.+||. +|++||++.++.                 .||||..
T Consensus       226 ~~~~~~-~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il-----------------~~~~~~~  272 (307)
T cd06607         226 IAQNDS-PTLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELL-----------------KHRFVLR  272 (307)
T ss_pred             HhcCCC-CCCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHh-----------------cChhhcc
Confidence            543321 1111   12468899999999999 999999866554                 9999985

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.4e-40  Score=311.16  Aligned_cols=261  Identities=22%  Similarity=0.314  Sum_probs=206.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.++.|    ++|.||++....++..||+|.+........        ....+.+|+.+++.++||||+++++++
T Consensus         8 ~y~~~~~ig~g----~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~i~~~~~~~   75 (309)
T cd07845           8 EFEKLNRIGEG----TYGIVYRARDTTSGEIVALKKVRMDNERDG--------IPISSLREITLLLNLRHPNIVELKEVV   75 (309)
T ss_pred             ceeEeeeeeec----CCEEEEEEEECCCCcEEEEEEEEeccCCCC--------CcchhhHHHHHHHhCCCCCCcceEEEE
Confidence            46666666766    799999999988999999998765432221        112245689999999999999999998


Q ss_pred             EeC--CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         83 QDD--SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        83 ~~~--~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      .+.  +.+|+||||+. ++|.+++......+++..+..++.||+.||.|||+.|++|          |||||+||+++.+
T Consensus        76 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H----------~dl~p~nil~~~~  144 (309)
T cd07845          76 VGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIH----------RDLKVSNLLLTDK  144 (309)
T ss_pred             ecCCCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeec----------CCCCHHHEEECCC
Confidence            765  56899999995 5899998765567999999999999999999999999999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG  240 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~  240 (372)
                      +.++|+|||++......... .....+++.|+|||.+.+    ...++.++|+|||||++|+|++|.+||.+.+..+.+.
T Consensus       145 ~~~kL~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~  219 (309)
T cd07845         145 GCLKIADFGLARTYGLPAKP-MTPKVVTLWYRAPELLLG----CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLD  219 (309)
T ss_pred             CCEEECccceeeecCCccCC-CCcccccccccChhhhcC----CCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999876543211 122345788999999873    3457889999999999999999999999888877776


Q ss_pred             HHhhccCC-----------------cCCCCC-------CCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhc
Q psy11571        241 KIMNHQNS-----------------FDLPSD-------VGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVS  295 (372)
Q Consensus       241 ~i~~~~~~-----------------~~~~~~-------~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~  295 (372)
                      .+......                 +..+..       .....++.+.+||.+||+ ||++||++++++           
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il-----------  288 (309)
T cd07845         220 LIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL-----------  288 (309)
T ss_pred             HHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHh-----------
Confidence            66542110                 011100       011358999999999999 999999876655           


Q ss_pred             cCCCCCCCCCcCC
Q psy11571        296 LSISPRNHPWFQG  308 (372)
Q Consensus       296 ~~~~~~~hp~f~~  308 (372)
                            .||||++
T Consensus       289 ------~h~~f~~  295 (309)
T cd07845         289 ------ESSYFKE  295 (309)
T ss_pred             ------cChhhcc
Confidence                  9999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4e-40  Score=304.34  Aligned_cols=253  Identities=22%  Similarity=0.393  Sum_probs=198.3

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHY   80 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~   80 (372)
                      ++|+.++.++.|    ++|.||++.+..+++.+++|........           ...+.+|..+++.+ +||||+++++
T Consensus        18 ~~~~~~~~lg~g----~~~~vy~~~~~~~~~~~~ik~~~~~~~~-----------~~~~~~e~~~l~~l~~h~~i~~~~~   82 (286)
T cd06638          18 DTWEIIETIGKG----TYGKVFKVLNKKNGSKAAVKILDPIHDI-----------DEEIEAEYNILKALSDHPNVVKFYG   82 (286)
T ss_pred             cceeeeeeeccC----CCcEEEEEEECCCCceeEEEeeccccch-----------HHHHHHHHHHHHHHhcCCCeeeeee
Confidence            467777777777    8999999999889999999976532211           13356788888888 6999999999


Q ss_pred             EEE-----eCCeEEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCc
Q psy11571         81 AFQ-----DDSNLYLVMDYYCGGDLLTLLSKF---EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKP  152 (372)
Q Consensus        81 ~~~-----~~~~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp  152 (372)
                      ++.     ++..+++||||+++++|.+++...   ...+++..+..++.|++.||.|||+.+++|          |||||
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H----------~dlkp  152 (286)
T cd06638          83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIH----------RDVKG  152 (286)
T ss_pred             eeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccc----------cCCCH
Confidence            874     445789999999999999987532   356899999999999999999999999999          99999


Q ss_pred             CcEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCC
Q psy11571        153 DNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA  232 (372)
Q Consensus       153 ~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~  232 (372)
                      +||+++.++.++|+|||++........ ......|++.|+|||++.........++.++|+|||||++|+|++|+.||..
T Consensus       153 ~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~  231 (286)
T cd06638         153 NNILLTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD  231 (286)
T ss_pred             HhEEECCCCCEEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCC
Confidence            999999999999999999876543221 2233568999999999863211124578899999999999999999999987


Q ss_pred             CCHHHHHHHHhhccC-CcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        233 ESLVETYGKIMNHQN-SFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       233 ~~~~~~~~~i~~~~~-~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      .+......++..... ....+    ..++.++.+||.+||+ +|++||++.+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~ell  281 (286)
T cd06638         232 LHPMRALFKIPRNPPPTLHQP----ELWSNEFNDFIRKCLTKDYEKRPTVSDLL  281 (286)
T ss_pred             CchhHHHhhccccCCCcccCC----CCcCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            765554444333211 11111    1468899999999999 999999876665

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5.4e-40  Score=299.49  Aligned_cols=250  Identities=19%  Similarity=0.279  Sum_probs=205.1

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++++|.|    |+|.||++.. .++..+++|.+......           .+.+.+|..+++.++||||+++++.
T Consensus         6 ~~~~~~~~lg~g----~~g~v~~~~~-~~~~~v~iK~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~   69 (261)
T cd05072           6 ESIKLVKKLGAG----QFGEVWMGYY-NNSTKVAVKTLKPGTMS-----------VQAFLEEANLMKTLQHDKLVRLYAV   69 (261)
T ss_pred             HHeEEeeecCCc----CCceEEEEEe-cCCceEEEEEccCCchh-----------HHHHHHHHHHHHhCCCCCeeeEEEE
Confidence            356677777777    8999999974 46677899876543221           2457789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      +.+.+..+++|||+++++|.+++... ...+++..+..++.|++.||+|||+.+++|          |||||+||+++.+
T Consensus        70 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H----------~dl~p~nili~~~  139 (261)
T cd05072          70 VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIH----------RDLRAANVLVSES  139 (261)
T ss_pred             EcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeec----------cccchhhEEecCC
Confidence            99999999999999999999999753 356889999999999999999999999999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETY  239 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~  239 (372)
                      +.++|+|||++...............++..|+|||.+.+     ..++.++|+|||||++|+|++ |..||.+.......
T Consensus       140 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~  214 (261)
T cd05072         140 LMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-----GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM  214 (261)
T ss_pred             CcEEECCCccceecCCCceeccCCCccceecCCHHHhcc-----CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH
Confidence            999999999998764432222222345678999999873     567889999999999999998 99999988877777


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ..+.... ..+.+    ..++.++.+++.+||. +|++||+++++.+++
T Consensus       215 ~~~~~~~-~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l  258 (261)
T cd05072         215 SALQRGY-RMPRM----ENCPDELYDIMKTCWKEKAEERPTFDYLQSVL  258 (261)
T ss_pred             HHHHcCC-CCCCC----CCCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence            7665432 22222    2578999999999999 999999998887655

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.4e-40  Score=299.78  Aligned_cols=247  Identities=29%  Similarity=0.444  Sum_probs=205.2

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+..+.++.|    ++|.||.+.+..+++.+++|.+.......         ..+.+.+|..+++.++||||+++++.+.
T Consensus         2 y~~~~~lg~g----~~g~v~~~~~~~~~~~~~iK~~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~   68 (255)
T cd08219           2 YNVLRVVGEG----SFGRALLVQHVNSDQKYAMKEIRLPKSSS---------AVEDSRKEAVLLAKMKHPNIVAFKESFE   68 (255)
T ss_pred             ceEEEEeecc----CCeEEEEEEEcCCCceEEEEEEEcCcchH---------HHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence            4445555666    79999999999999999999875433221         2345677999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      +++.+|++|||+++++|.+++... ...+++..+..++.||+.||.|||++|++|          +||||+||++++++.
T Consensus        69 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H----------~dl~p~nili~~~~~  138 (255)
T cd08219          69 ADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLH----------RDIKSKNIFLTQNGK  138 (255)
T ss_pred             ECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCccc----------CCCCcceEEECCCCc
Confidence            999999999999999999998653 345899999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      ++|+|||.+......... .....|++.|+|||++.+     ..++.++|+||||+++|+|++|..||...+.......+
T Consensus       139 ~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~  212 (255)
T cd08219         139 VKLGDFGSARLLTSPGAY-ACTYVGTPYYVPPEIWEN-----MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV  212 (255)
T ss_pred             EEEcccCcceeecccccc-cccccCCccccCHHHHcc-----CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHH
Confidence            999999998766443221 223568899999999873     55888999999999999999999999988877777776


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      ..+... ..+.    .++..+++||.+||+ +|++||++++++
T Consensus       213 ~~~~~~-~~~~----~~~~~~~~li~~~l~~~P~~Rp~~~~il  250 (255)
T cd08219         213 CQGSYK-PLPS----HYSYELRSLIKQMFKRNPRSRPSATTIL  250 (255)
T ss_pred             hcCCCC-CCCc----ccCHHHHHHHHHHHhCCcccCCCHHHHh
Confidence            654322 2333    578999999999999 999999977665

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5.7e-40  Score=300.97  Aligned_cols=235  Identities=30%  Similarity=0.474  Sum_probs=188.2

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHh-cCCCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLV-YGDRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~-~l~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      |++|.||.+.+..++..+++|..........               |..+.. ..+||||+++++.+...+.+|+||||+
T Consensus        27 g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~---------------e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~   91 (267)
T PHA03390         27 GKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI---------------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYI   91 (267)
T ss_pred             CCceEEEEEEEcCCCcEEEEEEEehhhcchh---------------hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcC
Confidence            3799999999999999999998765433211               111111 127999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC-cEEEeecCccccc
Q psy11571         96 CGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG-HIRLADFGSCLRL  174 (372)
Q Consensus        96 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~-~vkl~Dfg~a~~~  174 (372)
                      ++++|.+++.. ...+++..++.++.|++.||.|||+.|++|          |||||+||+++.++ .++|+|||++...
T Consensus        92 ~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H----------~dl~p~nil~~~~~~~~~l~dfg~~~~~  160 (267)
T PHA03390         92 KDGDLFDLLKK-EGKLSEAEVKKIIRQLVEALNDLHKHNIIH----------NDIKLENVLYDRAKDRIYLCDYGLCKII  160 (267)
T ss_pred             CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeee----------CCCCHHHEEEeCCCCeEEEecCccceec
Confidence            99999999987 458999999999999999999999999999          99999999999888 9999999998765


Q ss_pred             CCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHH-HHHHhhc-cCCcCCC
Q psy11571        175 GGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGKIMNH-QNSFDLP  252 (372)
Q Consensus       175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~-~~~i~~~-~~~~~~~  252 (372)
                      ....     ...|+..|+|||++.+     ..++.++|+||+|+++|+|++|..||........ ...+... ......+
T Consensus       161 ~~~~-----~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  230 (267)
T PHA03390        161 GTPS-----CYDGTLDYFSPEKIKG-----HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFI  230 (267)
T ss_pred             CCCc-----cCCCCCcccChhhhcC-----CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcc
Confidence            4322     2468899999999973     5678899999999999999999999986543322 1111111 1111222


Q ss_pred             CCCCCCCCHHHHHHHHHhcc-CCCCCCCC-CChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        253 SDVGYEISDDAKDLMRRLIC-SSDTRLGQ-NGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       253 ~~~~~~~s~~~~~li~~lL~-~p~~R~s~-~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                          ..+++.+.+||.+||+ +|.+|++. ++++                 +||||.+
T Consensus       231 ----~~~~~~~~~li~~~l~~~p~~R~~~~~~~l-----------------~h~~~~~  267 (267)
T PHA03390        231 ----KNVSKNANDFVQSMLKYNINYRLTNYNEII-----------------KHPFLKI  267 (267)
T ss_pred             ----cccCHHHHHHHHHHhccChhhCCchHHHHh-----------------cCCcccC
Confidence                2689999999999999 99999963 5554                 9999974

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=6e-40  Score=298.00  Aligned_cols=251  Identities=29%  Similarity=0.413  Sum_probs=203.3

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+..+.++.|    |+|.||++....++..+++|.+........     ..+..+.+.+|+.+++.++||||+++++.+.
T Consensus         2 ~~~~~~ig~g----~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~-----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   72 (258)
T cd06632           2 WRKGELLGSG----SFGSVYEGLNLDDGDFFAVKEVSLADDGQT-----GQEAVKQLEQEIALLSKLQHPNIVQYLGTER   72 (258)
T ss_pred             ccccceeeec----CCceEEEEEEcCCCcEEEEEEEEEcccccc-----chHHHHHHHHHHHHHHhcCCCCchheeeeEe
Confidence            4444555555    899999998888899999998754332211     1123456788999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcE
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI  163 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~v  163 (372)
                      +...+|++|||+++++|.+++.+ ...+++..+..++.||+.||.|||+.|++|          +||+|+||+++.++.+
T Consensus        73 ~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H----------~dl~~~ni~~~~~~~~  141 (258)
T cd06632          73 EEDNLYIFLELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDRNTVH----------RDIKGANILVDTNGVV  141 (258)
T ss_pred             cCCeEEEEEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------CCCCHHHEEECCCCCE
Confidence            99999999999999999999987 456899999999999999999999999999          9999999999999999


Q ss_pred             EEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHh
Q psy11571        164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM  243 (372)
Q Consensus       164 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~  243 (372)
                      ||+|||++.......  ......|+..|+|||.+..    ...++.++|+|||||++|+|++|..||..........++.
T Consensus       142 kl~d~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~----~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~  215 (258)
T cd06632         142 KLADFGMAKQVVEFS--FAKSFKGSPYWMAPEVIAQ----QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG  215 (258)
T ss_pred             EEccCccceeccccc--cccccCCCcceeCHHHhcC----CCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHH
Confidence            999999987654332  1233568899999999873    2237889999999999999999999998776555555544


Q ss_pred             hccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        244 NHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      ........+.    .+++++++++.+||. +|.+||++++++
T Consensus       216 ~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~~l  253 (258)
T cd06632         216 RSKELPPIPD----HLSDEAKDFILKCLQRDPSLRPTAAELL  253 (258)
T ss_pred             hcccCCCcCC----CcCHHHHHHHHHHhhcCcccCcCHHHHh
Confidence            4222222332    678999999999999 999999866655

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.6e-40  Score=306.28  Aligned_cols=245  Identities=24%  Similarity=0.429  Sum_probs=202.7

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      +|+|.||++.+..+++.+++|.+......          ..+.+.+|+.++..++||||+++++.+..++..|++|||++
T Consensus        32 g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----------~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~  101 (297)
T cd06659          32 GSTGIVCIAREKHSGRQVAVKMMDLRKQQ----------RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ  101 (297)
T ss_pred             CCceeEEEEEEcCCCCEEEEEEEEecccc----------hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence            48999999998889999999987543221          12346778899999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCC
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG  176 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  176 (372)
                      +++|..++..  ..+++..+..++.|++.||.|||++|++|          |||||+||+++.++.++|+|||++.....
T Consensus       102 ~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH----------~dl~p~Nill~~~~~~kL~dfg~~~~~~~  169 (297)
T cd06659         102 GGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIH----------RDIKSDSILLTLDGRVKLSDFGFCAQISK  169 (297)
T ss_pred             CCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeec----------CCCCHHHeEEccCCcEEEeechhHhhccc
Confidence            9999998865  57899999999999999999999999999          99999999999999999999999875543


Q ss_pred             CCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCC
Q psy11571        177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVG  256 (372)
Q Consensus       177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  256 (372)
                      ... ......|+..|+|||++.+     ..++.++|+|||||++|+|++|+.||...+..+....+..... .  .....
T Consensus       170 ~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~  240 (297)
T cd06659         170 DVP-KRKSLVGTPYWMAPEVISR-----TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-P--KLKNA  240 (297)
T ss_pred             ccc-cccceecCccccCHHHHcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-C--Ccccc
Confidence            222 2233578999999999973     5678999999999999999999999988777666655543221 1  11112


Q ss_pred             CCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        257 YEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       257 ~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      ..++..+.++|.+||+ +|.+||+++++.                 +||||...
T Consensus       241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll-----------------~~~~~~~~  277 (297)
T cd06659         241 HKISPVLRDFLERMLTREPQERATAQELL-----------------DHPFLLQT  277 (297)
T ss_pred             CCCCHHHHHHHHHHhcCCcccCcCHHHHh-----------------hChhhccC
Confidence            2578999999999999 999999866555                 99999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=8.5e-40  Score=298.21  Aligned_cols=254  Identities=26%  Similarity=0.403  Sum_probs=204.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      ||+..+.++.|    ++|.+|.+....+++.+++|........        .+..+.+.+|+.+++.++||||+++++.+
T Consensus         1 ~y~~~~~lg~G----~~~~v~~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~   68 (264)
T cd06626           1 RWQRGNKIGGG----TFGKVYTAVNLDTGELMAVKEIRIQDND--------PKTIKEIADEMKVLELLKHPNLVKYYGVE   68 (264)
T ss_pred             CceeeeEeecC----CCcEEEEEEECCCCcEEEEEEEECcccc--------hHHHHHHHHHHHHHHhCCCCChhheeeeE
Confidence            45666666666    8999999998889999999987655433        12456788999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+.+.+++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|          +||+|+||+++.++.
T Consensus        69 ~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H----------~dl~~~nil~~~~~~  137 (264)
T cd06626          69 VHREKVYIFMEYCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVH----------RDIKPANIFLDHNGV  137 (264)
T ss_pred             ecCCEEEEEEecCCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCccc----------CCCCHHHEEECCCCC
Confidence            999999999999999999999987 456899999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccc---cccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCH-HHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQS---NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL-VET  238 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-~~~  238 (372)
                      +||+|||++...........   ....++..|+|||++.+..  ...++.++|+||||+++|+|++|+.||...+. ...
T Consensus       138 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~  215 (264)
T cd06626         138 IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK--GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI  215 (264)
T ss_pred             EEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCC--CCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH
Confidence            99999999887654332111   1246788999999997411  12378899999999999999999999976533 333


Q ss_pred             HHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       239 ~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      ...+.. .....+|...  .++..+.++|.+||+ +|.+||+++++.
T Consensus       216 ~~~~~~-~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~i~  259 (264)
T cd06626         216 MFHVGA-GHKPPIPDSL--QLSPEGKDFLDRCLESDPKKRPTASELL  259 (264)
T ss_pred             HHHHhc-CCCCCCCccc--ccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            323332 2333344321  458999999999999 999999876655

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.8e-40  Score=306.36  Aligned_cols=258  Identities=24%  Similarity=0.385  Sum_probs=203.3

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+.+..++.|    ++|.||++.+..+++.+++|.+........        ..+.+.+|+.+++.++||||+++++++.
T Consensus         2 y~~~~~l~~g----~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~i~~~~~~~~   69 (284)
T cd07860           2 FQKVEKIGEG----TYGVVYKARNKLTGEVVALKKIRLDTETEG--------VPSTAIREISLLKELNHPNIVKLLDVIH   69 (284)
T ss_pred             ceeeeeecCC----CceEEEEEEECCCCCEEEEEEccccccccc--------cchHHHHHHHHHHhcCCCCCcchhhhcc
Confidence            4455566665    899999999888999999998765432221        2245677999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      +.+..++||||+. ++|.+++... ...+++..+..++.|++.||+|||+.|++|          |||+|+||+++.++.
T Consensus        70 ~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H----------~~l~p~nill~~~~~  138 (284)
T cd07860          70 TENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLH----------RDLKPQNLLINTEGA  138 (284)
T ss_pred             cCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeec----------CCCCHHHEEECCCCC
Confidence            9999999999995 6899988653 356899999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      ++|+|||++........ ......+++.|+|||.+.+    ...++.++|+|||||++|+|+||+.||.+.+......++
T Consensus       139 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~  213 (284)
T cd07860         139 IKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLG----CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI  213 (284)
T ss_pred             EEEeeccchhhcccCcc-ccccccccccccCCeEEec----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            99999999876543222 1122356889999998873    344688999999999999999999999887766555444


Q ss_pred             hhccCCc----------------CCCC-------CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCC
Q psy11571        243 MNHQNSF----------------DLPS-------DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSI  298 (372)
Q Consensus       243 ~~~~~~~----------------~~~~-------~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~  298 (372)
                      .......                .++.       .....++++++++|.+||+ ||++||++++++              
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l--------------  279 (284)
T cd07860         214 FRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAAL--------------  279 (284)
T ss_pred             HHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHh--------------
Confidence            3321110                0000       0112478999999999999 999999876655              


Q ss_pred             CCCCCCCc
Q psy11571        299 SPRNHPWF  306 (372)
Q Consensus       299 ~~~~hp~f  306 (372)
                         .||||
T Consensus       280 ---~~~~f  284 (284)
T cd07860         280 ---AHPFF  284 (284)
T ss_pred             ---cCCCC
Confidence               99998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.9e-40  Score=301.77  Aligned_cols=254  Identities=23%  Similarity=0.401  Sum_probs=208.5

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.++.|    ++|.||++....+++.+|+|.+......         +..+.+.+|+.+++.++||||+++++.
T Consensus         5 ~~~~~~~~ig~g----~~g~v~~~~~~~~~~~~a~k~~~~~~~~---------~~~~~~~~E~~~l~~l~h~~i~~~~~~   71 (284)
T cd06620           5 EDLETISDLGAG----NGGSVSKVKHIPTGTVMAKKVVHIGAKS---------SVRKQILRELQIMHECRSPYIVSFYGA   71 (284)
T ss_pred             HHHHHHHHcCCC----CCeEEEEEEEcCCCcEEEEEEEEecCcc---------hHHHHHHHHHHHHHHcCCCCcceEeee
Confidence            578999999888    7999999999989999999977543211         123557889999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD-LHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      +.+...+|+||||+++++|.+++.+ .+.+++..+..++.+++.||.|||+ .+++|          |||||+||+++.+
T Consensus        72 ~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H----------~dl~p~nil~~~~  140 (284)
T cd06620          72 FLNENNICMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMH----------RDIKPSNILVNSR  140 (284)
T ss_pred             EecCCEEEEEEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeec----------cCCCHHHEEECCC
Confidence            9999999999999999999999887 5679999999999999999999997 68999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH----
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV----  236 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~----  236 (372)
                      +.++|+|||++.......   .....|+..|+|||++.+     ..++.++|+|||||++|+|++|..||......    
T Consensus       141 ~~~~l~d~gl~~~~~~~~---~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~  212 (284)
T cd06620         141 GQIKLCDFGVSGELINSI---ADTFVGTSTYMSPERIQG-----GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ  212 (284)
T ss_pred             CcEEEccCCcccchhhhc---cCccccCcccCCHHHHcc-----CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh
Confidence            999999999986543221   123578999999999873     46888999999999999999999999865542    


Q ss_pred             -------HHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        237 -------ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       237 -------~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                             +....+.... ...++.   ..++.++.+||.+||+ ||++||+++++.                 +||||..
T Consensus       213 ~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~-----------------~~~~~~~  271 (284)
T cd06620         213 DDPMGILDLLQQIVQEP-PPRLPS---SDFPEDLRDFVDACLLKDPTERPTPQQLC-----------------AMPPFIQ  271 (284)
T ss_pred             hhhhHHHHHHHHHhhcc-CCCCCc---hhcCHHHHHHHHHHhcCCcccCcCHHHHh-----------------cCccccc
Confidence                   2333333321 112222   1378899999999999 999999876665                 8998863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3e-40  Score=309.76  Aligned_cols=247  Identities=20%  Similarity=0.307  Sum_probs=184.1

Q ss_pred             ccCCccEEEeeeeh--hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe--CCeEEEE
Q psy11571         16 IQGKGRVFSIETLL--DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQD--DSNLYLV   91 (372)
Q Consensus        16 ~~g~G~v~~v~~~~--~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~lv   91 (372)
                      .||+|.||++....  ++..+|+|.+......            ..+.+|+.+++.++||||+++++++..  +..+++|
T Consensus        11 ~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07867          11 RGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS------------MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL   78 (317)
T ss_pred             cCCCeeEEEEEecCCCccceEEEEEecCCCCc------------HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence            34899999998543  5678999977643321            235679999999999999999999854  4578999


Q ss_pred             EeccCCCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe----CC
Q psy11571         92 MDYYCGGDLLTLLSKF--------EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL----DA  159 (372)
Q Consensus        92 ~E~~~gg~L~~~l~~~--------~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll----~~  159 (372)
                      |||+. ++|.+++...        ...+++..++.++.||+.||.|||+.|++|          |||||+|||+    +.
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH----------~Dlkp~Nil~~~~~~~  147 (317)
T cd07867          79 FDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLH----------RDLKPANILVMGEGPE  147 (317)
T ss_pred             EeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEc----------CCCCHHHEEEccCCCC
Confidence            99984 5888887531        124889999999999999999999999999          9999999999    46


Q ss_pred             CCcEEEeecCcccccCCCCc--ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH-
Q psy11571        160 NGHIRLADFGSCLRLGGDGT--VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-  236 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-  236 (372)
                      ++.+||+|||+++.......  .......||+.|+|||++.+    ...++.++|||||||++|||+||.+||...... 
T Consensus       148 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~  223 (317)
T cd07867         148 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG----ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI  223 (317)
T ss_pred             CCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcC----CCccCcHHHHHhHHHHHHHHHhCCCCcccccccc
Confidence            67899999999987643221  11233568999999999873    345789999999999999999999999754321 


Q ss_pred             --------HHHHHHhhccC--------------C------------cC------CCCCCCCCCCHHHHHHHHHhcc-CCC
Q psy11571        237 --------ETYGKIMNHQN--------------S------------FD------LPSDVGYEISDDAKDLMRRLIC-SSD  275 (372)
Q Consensus       237 --------~~~~~i~~~~~--------------~------------~~------~~~~~~~~~s~~~~~li~~lL~-~p~  275 (372)
                              ....++.....              .            ..      .........+..+.+||.+||+ ||.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~  303 (317)
T cd07867         224 KTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPT  303 (317)
T ss_pred             cccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcc
Confidence                    11111110000              0            00      0000011346779999999999 999


Q ss_pred             CCCCCCChhhhhhhhhhhhccCCCCCCCCCc
Q psy11571        276 TRLGQNGIADFKMWSALFVSLSISPRNHPWF  306 (372)
Q Consensus       276 ~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f  306 (372)
                      +|||+++++                 +||||
T Consensus       304 ~R~t~~e~l-----------------~hp~f  317 (317)
T cd07867         304 KRITSEQAL-----------------QDPYF  317 (317)
T ss_pred             cccCHHHHh-----------------cCCCC
Confidence            999977666                 99998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.1e-39  Score=295.87  Aligned_cols=242  Identities=23%  Similarity=0.311  Sum_probs=196.8

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      +++|.||++....+++.+|+|.+......         +....+.+|+.+++.++||||+++++++.+....|+||||++
T Consensus         6 g~~g~vy~~~~~~~~~~~a~k~~~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   76 (252)
T cd05084           6 GNFGEVFSGRLRADNTPVAVKSCRETLPP---------DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ   76 (252)
T ss_pred             ccCccEEEEEEecCCceEEEEecCccCCH---------HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeecc
Confidence            37999999999889999999977543211         123457789999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCC
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG  176 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  176 (372)
                      +++|.+++......+++..++.++.|++.||.|||+.|++|          |||||+||+++.++.++|+|||++.....
T Consensus        77 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H----------~dl~p~nil~~~~~~~kl~dfg~~~~~~~  146 (252)
T cd05084          77 GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIH----------RDLAARNCLVTEKNVLKISDFGMSREEED  146 (252)
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc----------cccchheEEEcCCCcEEECccccCccccc
Confidence            99999999764456899999999999999999999999999          99999999999999999999999875432


Q ss_pred             CCccc-ccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCCCCC
Q psy11571        177 DGTVQ-SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHQNSFDLPSD  254 (372)
Q Consensus       177 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  254 (372)
                      ..... .....++..|+|||.+.+     ..++.++|+|||||++|+|++ |.+||...+.......+... .....+. 
T Consensus       147 ~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~-  219 (252)
T cd05084         147 GVYASTGGMKQIPVKWTAPEALNY-----GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG-VRLPCPE-  219 (252)
T ss_pred             ccccccCCCCCCceeecCchhhcC-----CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC-CCCCCcc-
Confidence            21111 011122456999999873     568889999999999999997 99999877766655555443 2223333 


Q ss_pred             CCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        255 VGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       255 ~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                         ..+..+.+|+.+||+ +|++||+++++.+.+
T Consensus       220 ---~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l  250 (252)
T cd05084         220 ---LCPDAVYRLMERCWEYDPGQRPSFSTVHQEL  250 (252)
T ss_pred             ---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence               578999999999999 999999988877544

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.6e-40  Score=298.05  Aligned_cols=247  Identities=26%  Similarity=0.384  Sum_probs=204.6

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+.++.++.|    ++|.+|++....+++.+++|.+........        ..+.+.+|+.+++.++||||+++++.+.
T Consensus         2 y~~~~~lg~g----~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~--------~~~~~~~e~~~l~~~~~~~i~~~~~~~~   69 (256)
T cd08220           2 YEKIRVVGRG----AFGIVHLCRRKADQKLVIIKQIPVEQMTKD--------ERLAAQNECQVLKLLSHPNIIEYYENFL   69 (256)
T ss_pred             ceEEEEeccc----CceEEEEEEEcCCCcEEEEEEEeccccccH--------HHHHHHHHHHHHhhCCCCchhheeeeEe
Confidence            4555566666    799999999988999999998865543222        2456788999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC-C
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-G  161 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~-~  161 (372)
                      ..+..++||||+++++|.+++... ...+++..+..++.|++.+|.|||++|++|          +||+|+||+++.+ +
T Consensus        70 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h----------~dl~~~nil~~~~~~  139 (256)
T cd08220          70 EDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILH----------RDLKTQNILLDKHKM  139 (256)
T ss_pred             cCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeec----------CCCCHHHEEEcCCCC
Confidence            999999999999999999999764 235899999999999999999999999999          9999999999855 4


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .++|+|||.+........  .....|+..|+|||.+.+     ..++.++|+||||+++|+|++|..||.+.+.......
T Consensus       140 ~~~l~d~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~  212 (256)
T cd08220         140 VVKIGDFGISKILSSKSK--AYTVVGTPCYISPELCEG-----KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLK  212 (256)
T ss_pred             EEEEccCCCceecCCCcc--ccccccCCcccCchhccC-----CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHH
Confidence            679999999987654322  223568899999999973     5578899999999999999999999998887777666


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      +..... ...+.    .++.+++++|.+||. +|.+||++++++
T Consensus       213 ~~~~~~-~~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~ll  251 (256)
T cd08220         213 IMSGTF-APISD----RYSPDLRQLILSMLNLDPSKRPQLSQIM  251 (256)
T ss_pred             HHhcCC-CCCCC----CcCHHHHHHHHHHccCChhhCCCHHHHh
Confidence            655422 22333    579999999999999 999999877666

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0662|consensus

Probab=100.00  E-value=1.2e-40  Score=273.11  Aligned_cols=262  Identities=22%  Similarity=0.367  Sum_probs=220.2

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      .|..++++|.|    .+|+|++++...++..||+|.+....-...        .-....+|+.+|+.+.|.|||+++++.
T Consensus         3 ~ydkmekigeg----tygtvfkarn~~t~eivalkrvrlddddeg--------vpssalreicllkelkhknivrl~dvl   70 (292)
T KOG0662|consen    3 KYDKMEKIGEG----TYGTVFKARNRETHEIVALKRVRLDDDDEG--------VPSSALREICLLKELKHKNIVRLHDVL   70 (292)
T ss_pred             chHHHHhhcCC----cceeeEecccCCccceEEEEEEeccCCCCC--------CcHHHHHHHHHHHHhhhcceeehhhhh
Confidence            57888999988    599999999999999999998876543322        113356799999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      ..+..+-+|+||| ..+|..+..+.++.++.+.++.++.|++.||.|+|++++.|          |||||+|+||+.+|.
T Consensus        71 hsdkkltlvfe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlh----------rdlkpqnllin~nge  139 (292)
T KOG0662|consen   71 HSDKKLTLVFEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLH----------RDLKPQNLLINRNGE  139 (292)
T ss_pred             ccCceeEEeHHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhh----------ccCCcceEEeccCCc
Confidence            9999999999999 67999999998899999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGK  241 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~  241 (372)
                      +||+|||+++.++..-...+. .+-|..|.+|.++.+    ..-|+.+.|+||.|||+.|+.. |++.|.+.+..+.+.+
T Consensus       140 lkladfglarafgipvrcysa-evvtlwyrppdvlfg----akly~tsidmwsagcifaelanagrplfpg~dvddqlkr  214 (292)
T KOG0662|consen  140 LKLADFGLARAFGIPVRCYSA-EVVTLWYRPPDVLFG----AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR  214 (292)
T ss_pred             EEecccchhhhcCCceEeeec-eeeeeeccCcceeee----eehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHH
Confidence            999999999987654432222 345889999999985    6789999999999999999985 8999999999988888


Q ss_pred             HhhccCCcC---CCCC--------------------CCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccC
Q psy11571        242 IMNHQNSFD---LPSD--------------------VGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLS  297 (372)
Q Consensus       242 i~~~~~~~~---~~~~--------------------~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~  297 (372)
                      |...-..+.   +|+.                    .-+.++..-+||++++|. +|.+|++++.++             
T Consensus       215 if~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaal-------------  281 (292)
T KOG0662|consen  215 IFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAAL-------------  281 (292)
T ss_pred             HHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHh-------------
Confidence            864322211   1110                    012456678999999999 999999988776             


Q ss_pred             CCCCCCCCcCCC
Q psy11571        298 ISPRNHPWFQGI  309 (372)
Q Consensus       298 ~~~~~hp~f~~~  309 (372)
                          +||||.+.
T Consensus       282 ----qhpyf~d~  289 (292)
T KOG0662|consen  282 ----QHPYFSDF  289 (292)
T ss_pred             ----cCcccccc
Confidence                99999865

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=7e-40  Score=305.79  Aligned_cols=257  Identities=21%  Similarity=0.216  Sum_probs=197.1

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeee----------------hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHH
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETL----------------LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDV   66 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~----------------~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~i   66 (372)
                      +|+..+.+|.|    |+|.||.+...                .++..||+|.+......         .....+.+|+.+
T Consensus         6 ~~~~~~~lg~G----~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~E~~~   72 (304)
T cd05096           6 HLLFKEKLGEG----QFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK---------NARNDFLKEVKI   72 (304)
T ss_pred             hCeeeeEeccc----CCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCH---------HHHHHHHHHHHH
Confidence            56666677776    89999998642                13346888877653321         123457789999


Q ss_pred             HhcCCCCceeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC------------------CCCCHHHHHHHHHHHHHHHH
Q psy11571         67 LVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE------------------DRLPEDMAKFYIAEMVLAIA  128 (372)
Q Consensus        67 l~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~------------------~~l~~~~~~~~~~qi~~~L~  128 (372)
                      +..++||||+++++++.+.+..++||||+++|+|.+++....                  ..+++..+..++.||+.||.
T Consensus        73 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~  152 (304)
T cd05096          73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMK  152 (304)
T ss_pred             HhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999999999999986521                  23577889999999999999


Q ss_pred             HHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCcc-cccccccCCcccCcccccccccCCCCC
Q psy11571        129 SIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTV-QSNVAVGTPDYISPEILTAMEEGRGRY  207 (372)
Q Consensus       129 ~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~  207 (372)
                      |||+.|++|          |||||+|||++.++.+||+|||+++........ ......++..|+|||++.+     ..+
T Consensus       153 ~lH~~~ivH----------~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~  217 (304)
T cd05096         153 YLSSLNFVH----------RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-----GKF  217 (304)
T ss_pred             HHHHCCccc----------cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-----CCC
Confidence            999999999          999999999999999999999999765432221 1222345788999999873     568


Q ss_pred             CCccceeehhHHHHHHhh--CCCCCCCCCHHHHHHHHhhcc--CCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCC
Q psy11571        208 GPECDWWSLGVCMYEMLY--GETPFYAESLVETYGKIMNHQ--NSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNG  282 (372)
Q Consensus       208 ~~~~DiwslGvil~ellt--G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~  282 (372)
                      +.++|||||||++|+|++  +..||.+.+..+....+....  ............++..+.+||.+||. +|++||++++
T Consensus       218 ~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~  297 (304)
T cd05096         218 TTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSD  297 (304)
T ss_pred             CchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHH
Confidence            999999999999999986  678898777666554432210  00000011112578999999999999 9999999888


Q ss_pred             hhhhh
Q psy11571        283 IADFK  287 (372)
Q Consensus       283 ~~~i~  287 (372)
                      +..++
T Consensus       298 i~~~l  302 (304)
T cd05096         298 IHAFL  302 (304)
T ss_pred             HHHHH
Confidence            76544

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.2e-40  Score=313.93  Aligned_cols=255  Identities=21%  Similarity=0.370  Sum_probs=201.0

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.++.|    |+|.||.+.+..+++.+|+|.+.......        ...+.+.+|+.+++.++||||++++++|
T Consensus        17 ~y~~~~~lg~g----~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~~~   84 (353)
T cd07850          17 RYQNLKPIGSG----AQGIVCAAYDTVTGQNVAIKKLSRPFQNV--------THAKRAYRELVLMKLVNHKNIIGLLNVF   84 (353)
T ss_pred             ceEEEEEeccC----CCEEEEEEEECCCCCEEEEEecCccccCh--------hHHHHHHHHHHHHHhcCCCCCcceeeee
Confidence            45666666666    89999999999999999999875432211        1234466799999999999999999998


Q ss_pred             EeC------CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEE
Q psy11571         83 QDD------SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL  156 (372)
Q Consensus        83 ~~~------~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIl  156 (372)
                      ...      ...|+||||+ .++|.+.+..   .+++..+..++.|++.||+|||++|++|          |||||+||+
T Consensus        85 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H----------~dlkp~Nil  150 (353)
T cd07850          85 TPQKSLEEFQDVYLVMELM-DANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIH----------RDLKPSNIV  150 (353)
T ss_pred             ccCCCccccCcEEEEEecc-CCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeee----------CCCCHHHEE
Confidence            654      3579999999 4589998865   2899999999999999999999999999          999999999


Q ss_pred             eCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH
Q psy11571        157 LDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV  236 (372)
Q Consensus       157 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~  236 (372)
                      ++.++.++|+|||+++.......  .....+++.|+|||.+.+     ..++.++|+|||||++|+|++|+.||...+..
T Consensus       151 ~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~  223 (353)
T cd07850         151 VKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI  223 (353)
T ss_pred             ECCCCCEEEccCccceeCCCCCC--CCCCcccccccCHHHHhC-----CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH
Confidence            99999999999999987643322  223467899999999973     56889999999999999999999999887765


Q ss_pred             HHHHHHhhccCCc----------------------------------CCCC---CCCCCCCHHHHHHHHHhcc-CCCCCC
Q psy11571        237 ETYGKIMNHQNSF----------------------------------DLPS---DVGYEISDDAKDLMRRLIC-SSDTRL  278 (372)
Q Consensus       237 ~~~~~i~~~~~~~----------------------------------~~~~---~~~~~~s~~~~~li~~lL~-~p~~R~  278 (372)
                      ..+.++.......                                  ..+.   ......++.+++||.+||+ ||++||
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  303 (353)
T cd07850         224 DQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRI  303 (353)
T ss_pred             HHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCc
Confidence            5555443211100                                  0000   0011346779999999999 999999


Q ss_pred             CCCChhhhhhhhhhhhccCCCCCCCCCcC
Q psy11571        279 GQNGIADFKMWSALFVSLSISPRNHPWFQ  307 (372)
Q Consensus       279 s~~~~~~i~~~~~~~~~~~~~~~~hp~f~  307 (372)
                      ++++++                 .||||+
T Consensus       304 t~~eiL-----------------~~~~~~  315 (353)
T cd07850         304 SVDDAL-----------------QHPYIN  315 (353)
T ss_pred             CHHHHh-----------------cChhHh
Confidence            877666                 999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-39  Score=296.34  Aligned_cols=248  Identities=19%  Similarity=0.253  Sum_probs=202.3

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+..+.++.|    ++|.||.+... ++..+++|.+.......           ..+.+|+.+++.++||||+++++++
T Consensus         5 ~~~~~~~lg~G----~~~~v~~~~~~-~~~~~~iK~~~~~~~~~-----------~~~~~e~~~l~~l~~~~i~~~~~~~   68 (256)
T cd05059           5 ELTFLKELGSG----QFGVVHLGKWR-GKIDVAIKMIREGAMSE-----------DDFIEEAKVMMKLSHPNLVQLYGVC   68 (256)
T ss_pred             HcchhhhhccC----CCceEEEeEec-CCccEEEEEeccCCCCH-----------HHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            56777777777    79999999754 56688999775433221           2356789999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+.+..|+||||+++++|.+++......+++..+..++.|++.||+|||+.|++|          |||||+||+++.++.
T Consensus        69 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H----------~dl~p~ni~i~~~~~  138 (256)
T cd05059          69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIH----------RDLAARNCLVGEDNV  138 (256)
T ss_pred             cCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCccc----------ccccHhhEEECCCCc
Confidence            9999999999999999999999865557899999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGK  241 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~  241 (372)
                      +||+|||+++..............++..|+|||.+.+     ..++.++|+||||+++|+|++ |..||...+..+....
T Consensus       139 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-----~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~  213 (256)
T cd05059         139 VKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDY-----SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES  213 (256)
T ss_pred             EEECCcccceecccccccccCCCCCCccccCHHHhcc-----CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Confidence            9999999987654322211111223457999999873     568889999999999999999 8999988877777776


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhh
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADF  286 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i  286 (372)
                      +... .....+.    ..+..+.+++.+||+ +|++||+++++++.
T Consensus       214 ~~~~-~~~~~~~----~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         214 VSAG-YRLYRPK----LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHcC-CcCCCCC----CCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            6543 2223333    579999999999999 99999998777643

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.2e-39  Score=301.55  Aligned_cols=255  Identities=24%  Similarity=0.410  Sum_probs=207.9

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|.....++.|    ++|.||.+....+++.+++|.+......          ..+.+.+|+.+++.++||||+++++++
T Consensus        20 ~~~~~~~lg~g----~~g~v~~~~~~~~~~~~~iK~~~~~~~~----------~~~~~~~e~~~l~~~~h~~vv~~~~~~   85 (285)
T cd06648          20 YLDNFVKIGEG----STGIVCIATDKSTGRQVAVKKMDLRKQQ----------RRELLFNEVVIMRDYQHPNIVEMYSSY   85 (285)
T ss_pred             hhhcceEeccC----CCeEEEEEEECCCCCEEEEEEEeccchh----------HHHHHHHHHHHHHHcCCCChheEEEEE
Confidence            34444444444    7899999988888999999976433221          124467899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      ...+..++++||+++++|.+++..  ..+++..+..++.|++.||+|||++|++|          |||+|+||+++.++.
T Consensus        86 ~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H----------~dl~p~Nil~~~~~~  153 (285)
T cd06648          86 LVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIH----------RDIKSDSILLTSDGR  153 (285)
T ss_pred             EcCCeEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeec----------CCCChhhEEEcCCCc
Confidence            999999999999999999999987  67899999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      ++|+|||++........ ......|++.|+|||.+.+     ..++.++|+|||||++|+|++|+.||...+..+...++
T Consensus       154 ~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~  227 (285)
T cd06648         154 VKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPEVISR-----LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI  227 (285)
T ss_pred             EEEcccccchhhccCCc-ccccccCCccccCHHHhcC-----CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH
Confidence            99999998876543222 2233568999999999873     55888999999999999999999999888877777666


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      .... ......  ...++..+.++|.+||. +|++||++.+++                 .||||+..
T Consensus       228 ~~~~-~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~il-----------------~~~~~~~~  275 (285)
T cd06648         228 RDNL-PPKLKN--LHKVSPRLRSFLDRMLVRDPAQRATAAELL-----------------NHPFLAKA  275 (285)
T ss_pred             HhcC-CCCCcc--cccCCHHHHHHHHHHcccChhhCcCHHHHc-----------------cCcccccC
Confidence            5542 111111  11478999999999999 999999877665                 99999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.3e-40  Score=307.38  Aligned_cols=255  Identities=25%  Similarity=0.340  Sum_probs=201.9

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.++.|    |+|.||++....+++.+|+|.+.......        ...+.+.+|+.+++.++||||++++++
T Consensus         1 ~~y~~~~~lg~g----~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~   68 (286)
T cd07846           1 EKYENLGLVGEG----SYGMVMKCKHKETGQIVAIKKFLESEDDK--------MVKKIAMREIRMLKQLRHENLVNLIEV   68 (286)
T ss_pred             CceeEeeeeccC----CCeEEEEEEECCCCCEEEEEeHhhccCcc--------hhhHHHHHHHHHHHhcCCcchhhHHHh
Confidence            356667777777    89999999988889999999876543222        123446779999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.++...|+||||+++++|..+... ...+++..+..++.||+.||+|||+.|++|          +||+|+||++++++
T Consensus        69 ~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h----------~~l~p~ni~~~~~~  137 (286)
T cd07846          69 FRRKKRLYLVFEFVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHNIIH----------RDIKPENILVSQSG  137 (286)
T ss_pred             cccCCeEEEEEecCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------cCCCHHHEEECCCC
Confidence            9999999999999999988887765 456999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .++|+|||++........ ......++..|+|||++.+    ...++.++|+|||||++|+|++|++||.+.+..+....
T Consensus       138 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~  212 (286)
T cd07846         138 VVKLCDFGFARTLAAPGE-VYTDYVATRWYRAPELLVG----DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYH  212 (286)
T ss_pred             cEEEEeeeeeeeccCCcc-ccCcccceeeccCcHHhcc----ccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHH
Confidence            999999999876543322 2223467889999999873    34577899999999999999999999987766554444


Q ss_pred             HhhccCCc-----------------CCCC--------CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        242 IMNHQNSF-----------------DLPS--------DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       242 i~~~~~~~-----------------~~~~--------~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      +......+                 ..+.        .....++..+.+|+.+||+ +|++||++++++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il  281 (286)
T cd07846         213 IIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLL  281 (286)
T ss_pred             HHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHh
Confidence            43211110                 0000        0112578999999999999 999999876555

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.2e-40  Score=308.00  Aligned_cols=264  Identities=25%  Similarity=0.329  Sum_probs=208.7

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+.++.++.|    ++|.||++....+++.|++|.+..........     .....+.+|+.+++.++||||+++++++.
T Consensus         2 y~~~~~lg~g----~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~-----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   72 (298)
T cd07841           2 YEKGKKLGEG----TYAVVYKARDKETGRIVAIKKIKLGERKEAKD-----GINFTALREIKLLQELKHPNIIGLLDVFG   72 (298)
T ss_pred             ceeeeeeeec----cccEEEEEEECCCCcEEEEEEEeccccccccc-----hhhHHHHHHHHHHhhcCCCCChhhhheee
Confidence            4555566665    79999999988889999999887655442111     12344667999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcE
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI  163 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~v  163 (372)
                      +.+..++||||+ +++|.+++......+++..+..++.||+.||.|||++|++|          +||||+||+++.++.+
T Consensus        73 ~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H----------~dl~p~nill~~~~~~  141 (298)
T cd07841          73 HKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILH----------RDLKPNNLLIASDGVL  141 (298)
T ss_pred             cCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeee----------cCCChhhEEEcCCCCE
Confidence            999999999999 99999999873337999999999999999999999999999          9999999999999999


Q ss_pred             EEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHh
Q psy11571        164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM  243 (372)
Q Consensus       164 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~  243 (372)
                      +|+|||++......... .....+++.|+|||.+.+    ...++.++|+|||||++|+|++|.+||.+.+..+.+.++.
T Consensus       142 ~l~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~  216 (298)
T cd07841         142 KLADFGLARSFGSPNRK-MTHQVVTRWYRAPELLFG----ARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIF  216 (298)
T ss_pred             EEccceeeeeccCCCcc-ccccccceeeeCHHHHhC----CCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHH
Confidence            99999999876543221 122356788999999863    3567889999999999999999999998877666555554


Q ss_pred             hccCCcC---------------------CC-CCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCC
Q psy11571        244 NHQNSFD---------------------LP-SDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISP  300 (372)
Q Consensus       244 ~~~~~~~---------------------~~-~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~  300 (372)
                      .......                     .+ .......+..+.++|.+||. +|++||++++++                
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l----------------  280 (298)
T cd07841         217 EALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQAL----------------  280 (298)
T ss_pred             HHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHh----------------
Confidence            3210000                     00 00112457899999999999 999999866665                


Q ss_pred             CCCCCcCCC
Q psy11571        301 RNHPWFQGI  309 (372)
Q Consensus       301 ~~hp~f~~~  309 (372)
                       .||||++.
T Consensus       281 -~~~~~~~~  288 (298)
T cd07841         281 -EHPYFSND  288 (298)
T ss_pred             -hCccccCC
Confidence             99999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=9.1e-40  Score=302.96  Aligned_cols=258  Identities=23%  Similarity=0.405  Sum_probs=201.7

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYA   81 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~   81 (372)
                      +|+.++.++.|    ++|.||++....+++.+++|.+......           .+.+.+|+.++..+ +||||++++++
T Consensus        23 ~y~~~~~l~~g----~~~~vy~~~~~~~~~~~aik~~~~~~~~-----------~~~~~~e~~~l~~l~~h~ni~~~~~~   87 (291)
T cd06639          23 TWEIIETIGKG----TYGKVYKVTNKKDGSLAAVKILDPISDV-----------DEEIEAEYNILQSLPNHPNVVKFYGM   87 (291)
T ss_pred             CeEEEEEeecC----CCeEEEEEEECCCCCEEEEEEecccccH-----------HHHHHHHHHHHHHhcCCCCeEEEEEE
Confidence            34445555555    7899999999889999999987543211           13356788888887 79999999999


Q ss_pred             EEeC-----CeEEEEEeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcC
Q psy11571         82 FQDD-----SNLYLVMDYYCGGDLLTLLSK---FEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPD  153 (372)
Q Consensus        82 ~~~~-----~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~  153 (372)
                      +...     +.+|+||||+++++|.++++.   ....+++..++.++.|++.||.|||+.|++|          |||||+
T Consensus        88 ~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH----------~dlkp~  157 (291)
T cd06639          88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIH----------RDVKGN  157 (291)
T ss_pred             EEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeec----------cCCCHH
Confidence            8754     358999999999999998863   2457899999999999999999999999999          999999


Q ss_pred             cEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC
Q psy11571        154 NVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE  233 (372)
Q Consensus       154 NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~  233 (372)
                      ||+++.++.++|+|||++........ ......|+..|+|||++.........++.++|+|||||++|+|++|++||...
T Consensus       158 nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~  236 (291)
T cd06639         158 NILLTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM  236 (291)
T ss_pred             HEEEcCCCCEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence            99999999999999999876543221 12335688999999998642111223688999999999999999999999887


Q ss_pred             CHHHHHHHHhhccC-CcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcC
Q psy11571        234 SLVETYGKIMNHQN-SFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ  307 (372)
Q Consensus       234 ~~~~~~~~i~~~~~-~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~  307 (372)
                      +.......+..... ....+.    ..+..+.+||.+||+ +|++||++.+++                 +||||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~il-----------------~~~~~~  291 (291)
T cd06639         237 HPVKTLFKIPRNPPPTLLHPE----KWCRSFNHFISQCLIKDFEARPSVTHLL-----------------EHPFIK  291 (291)
T ss_pred             cHHHHHHHHhcCCCCCCCccc----ccCHHHHHHHHHHhhcChhhCcCHHHHh-----------------cCcccC
Confidence            76665555544321 111121    467899999999999 999999866555                 999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.2e-39  Score=301.62  Aligned_cols=266  Identities=21%  Similarity=0.336  Sum_probs=205.8

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeeeEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLHYA   81 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~~~   81 (372)
                      .|+.++.++.|    ++|.||.+.+..+++.+|+|.+......         .....+.+|+.++.++. ||||++++++
T Consensus         5 ~~~~~~~lg~G----~~g~vy~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~~~e~~~l~~~~~~~~iv~~~~~   71 (288)
T cd06616           5 DLKDLGEIGRG----AFGTVNKMLHKPSGTIMAVKRIRSTVDE---------KEQKRLLMDLDVVMRSSDCPYIVKFYGA   71 (288)
T ss_pred             HhHHHHHhCCC----CceEEEEEEECCCCCEEEEEEehhccCh---------HHHHHHHHHHHHHHHhcCCCCEeeeeeE
Confidence            56777777777    8999999999999999999987654322         12345677888888886 9999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHH---h-cCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCCcCCCCCcCcEE
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLS---K-FEDRLPEDMAKFYIAEMVLAIASIHD-LHYVHRPNHFAFHLCRDIKPDNVL  156 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~---~-~~~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~~~~~~~~vhrDlkp~NIl  156 (372)
                      +.++...+++|||+. ++|.++..   . ....+++..+..++.|++.||+|||+ .|++|          |||||+||+
T Consensus        72 ~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H----------~dlkp~Nil  140 (288)
T cd06616          72 LFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIH----------RDVKPSNIL  140 (288)
T ss_pred             EecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeec----------cCCCHHHEE
Confidence            999999999999984 46555432   2 13579999999999999999999997 49999          999999999


Q ss_pred             eCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCH-
Q psy11571        157 LDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL-  235 (372)
Q Consensus       157 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-  235 (372)
                      ++.++.++|+|||++........  .....|++.|+|||++.+..  ...++.++|+|||||++|+|++|++||..... 
T Consensus       141 ~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~--~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~  216 (288)
T cd06616         141 LDRNGNIKLCDFGISGQLVDSIA--KTRDAGCRPYMAPERIDPSA--RDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV  216 (288)
T ss_pred             EccCCcEEEeecchhHHhccCCc--cccccCccCccCHHHhcccc--ccCCcchhhhhHHHHHHHHHHhCCCCchhcchH
Confidence            99999999999999976543222  12246889999999987411  13688899999999999999999999976542 


Q ss_pred             HHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc
Q psy11571        236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI  314 (372)
Q Consensus       236 ~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~  314 (372)
                      .+...++... ....++......++.++.+||.+||+ +|++||+++++.                 .||||+...|+..
T Consensus       217 ~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~-----------------~~~~~~~~~~~~~  278 (288)
T cd06616         217 FDQLTQVVKG-DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELL-----------------EHPFIKDYEERNV  278 (288)
T ss_pred             HHHHhhhcCC-CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHh-----------------cChhhhchhhcch
Confidence            1222333222 11222332223589999999999999 999999876665                 9999998776543

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.8e-39  Score=298.89  Aligned_cols=253  Identities=19%  Similarity=0.265  Sum_probs=206.8

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeee-----hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCcee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETL-----LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWIT   76 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~-----~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv   76 (372)
                      .+|..++.++.|    |+|.||++...     .+++.+|+|.+......         +..+.+.+|+.+++.+.||||+
T Consensus         5 ~~~~~~~~lg~g----~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~   71 (280)
T cd05049           5 DTIVLKRELGEG----AFGKVFLGECYHLEPENDKELVAVKTLKETASN---------DARKDFEREAELLTNFQHENIV   71 (280)
T ss_pred             HHhhHHhhcccc----CCceEeeeeeccccCcCCcceEEEEeecccCCH---------HHHHHHHHHHHHHHhcCCCCch
Confidence            367788888887    89999998764     34578999977644322         1235678899999999999999


Q ss_pred             eeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCC
Q psy11571         77 NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE-------------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFA  143 (372)
Q Consensus        77 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~  143 (372)
                      ++++++......++||||+++++|.+++...+             ..+++..+..++.|++.||.|||++|++|      
T Consensus        72 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h------  145 (280)
T cd05049          72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVH------  145 (280)
T ss_pred             heeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeec------
Confidence            99999999999999999999999999997631             34788899999999999999999999999      


Q ss_pred             CCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHH
Q psy11571        144 FHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYE  222 (372)
Q Consensus       144 ~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~e  222 (372)
                          |||||+||+++.++.++|+|||++........ .......+++.|+|||++.+     ..++.++|||||||++|+
T Consensus       146 ----~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~e  216 (280)
T cd05049         146 ----RDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-----RKFTTESDVWSFGVVLWE  216 (280)
T ss_pred             ----cccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhcc-----CCcchhhhHHHHHHHHHH
Confidence                99999999999999999999999876533221 11122345788999999973     568899999999999999


Q ss_pred             Hhh-CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        223 MLY-GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       223 llt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      |++ |..||.+.+..+....+..+... ..+.    .++..++++|.+||+ ||++||+++++++.+
T Consensus       217 ~~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l  278 (280)
T cd05049         217 IFTYGKQPWYGLSNEEVIECITQGRLL-QRPR----TCPSEVYDIMLGCWKRDPQQRINIKDIHERL  278 (280)
T ss_pred             HHhcCCCCCCCCCHHHHHHHHHcCCcC-CCCC----CCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence            998 99999988888777777654321 2222    678999999999999 999999988877654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=9.4e-40  Score=298.46  Aligned_cols=239  Identities=19%  Similarity=0.288  Sum_probs=199.3

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccCC
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCG   97 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~g   97 (372)
                      ++|.||++....+++.+++|.......           ..+.+.+|+.+++.++||||+++++++...+.++++|||+++
T Consensus        18 ~~~~v~~~~~~~~~~~~~~K~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (263)
T cd05052          18 QYGEVYEGVWKKYSLTVAVKTLKEDTM-----------EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY   86 (263)
T ss_pred             ccceEEEEEEecCCceEEEEEecCCch-----------HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCC
Confidence            789999999888899999997764321           124467899999999999999999999999999999999999


Q ss_pred             CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCC
Q psy11571         98 GDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG  176 (372)
Q Consensus        98 g~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  176 (372)
                      ++|.+++... ...+++..++.++.|++.||+|||+.|++|          |||||+||++++++.+||+|||++.....
T Consensus        87 ~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H----------~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          87 GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH----------RDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             CcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEee----------cccCcceEEEcCCCcEEeCCCcccccccc
Confidence            9999999763 245899999999999999999999999999          99999999999999999999999987654


Q ss_pred             CCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCCCCCC
Q psy11571        177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHQNSFDLPSDV  255 (372)
Q Consensus       177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  255 (372)
                      ..........++..|+|||.+.+     ..++.++|||||||++|+|++ |..||.+.+..+....+... .....+.  
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~--  228 (263)
T cd05052         157 DTYTAHAGAKFPIKWTAPESLAY-----NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG-YRMERPE--  228 (263)
T ss_pred             ceeeccCCCCCccccCCHHHhcc-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CCCCCCC--
Confidence            32222222234568999999873     568889999999999999998 99999988887777766543 2233333  


Q ss_pred             CCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        256 GYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       256 ~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                        .++.++.++|.+||+ +|++||++.++.+.+
T Consensus       229 --~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l  259 (263)
T cd05052         229 --GCPPKVYELMRACWQWNPSDRPSFAEIHQAF  259 (263)
T ss_pred             --CCCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence              679999999999999 999999988887654

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-40  Score=304.86  Aligned_cols=253  Identities=22%  Similarity=0.332  Sum_probs=194.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.++.|    ++|.||++.+..+++.|++|.+........         ...+.+|+.+++.++||||+++++++
T Consensus         6 ~y~~~~~lg~g----~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~   72 (291)
T cd07844           6 TYKKLDKLGEG----SYATVYKGRSKLTGQLVALKEIRLEHEEGA---------PFTAIREASLLKDLKHANIVTLHDII   72 (291)
T ss_pred             ceeEEEEEeec----CCeEEEEEEEcCCCcEEEEEEEecccccCC---------chhHHHHHHHHhhCCCcceeeEEEEE
Confidence            45666666666    799999999888999999998765432211         12245699999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+++..|+||||+. ++|.+++......+++..++.++.|++.||.|||+.|++|          |||||+||+++.++.
T Consensus        73 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H----------~dl~p~nil~~~~~~  141 (291)
T cd07844          73 HTKKTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLH----------RDLKPQNLLISERGE  141 (291)
T ss_pred             ecCCeEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec----------ccCCHHHEEEcCCCC
Confidence            99999999999996 5999998775567899999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCC-HHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGK  241 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~-~~~~~~~  241 (372)
                      ++|+|||+++........ .....++..|+|||++.+    ...++.++|+||+||++|+|++|+.||.+.. ..+....
T Consensus       142 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~----~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~  216 (291)
T cd07844         142 LKLADFGLARAKSVPSKT-YSNEVVTLWYRPPDVLLG----STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHK  216 (291)
T ss_pred             EEECccccccccCCCCcc-ccccccccccCCcHHhhc----CcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHH
Confidence            999999998764322211 122346889999999873    3457889999999999999999999997655 2232222


Q ss_pred             HhhccCC-------------------cCC--CC---CCCCCCC--HHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        242 IMNHQNS-------------------FDL--PS---DVGYEIS--DDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       242 i~~~~~~-------------------~~~--~~---~~~~~~s--~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      +......                   ...  +.   .....++  .++.++|.+||+ +|++||++++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l  286 (291)
T cd07844         217 IFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAM  286 (291)
T ss_pred             HHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHh
Confidence            2110000                   000  00   0001234  889999999999 999999876655

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-40  Score=303.26  Aligned_cols=255  Identities=27%  Similarity=0.360  Sum_probs=200.7

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+..+.++.|    ++|.||++....+++.|++|.+.......        ...+.+.+|+.+++.++||||+++++++
T Consensus         2 ~y~~~~~i~~g----~~~~v~~~~~~~~~~~v~vK~~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~   69 (288)
T cd07833           2 KYEVLGVVGEG----AYGVVLKCRNKATGEIVAIKKFKESEDDE--------DVKKTALREVKVLRQLRHENIVNLKEAF   69 (288)
T ss_pred             ceeEEEEeccc----CCeeEEEEEeCCCCcEEEEehhhhhcccc--------cchhHHHHHHHHHHhcCCCCeeehhheE
Confidence            45556666666    79999999988889999999886543322        1345678899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+++..+++|||++++.|..+..+ ...+++..+..++.||+.||.|||+.|++|          +||+|+||+++.++.
T Consensus        70 ~~~~~~~iv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H----------~dl~~~ni~~~~~~~  138 (288)
T cd07833          70 RRKGRLYLVFEYVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSHNIIH----------RDIKPENILVSESGV  138 (288)
T ss_pred             EECCEEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeec----------CCCCHHHeEECCCCC
Confidence            999999999999988766666554 567999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      ++|+|||++...............++..|+|||++.+    ...++.++|+||||+++|+|++|++||.+.+..+....+
T Consensus       139 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~----~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~  214 (288)
T cd07833         139 LKLCDFGFARALRARPASPLTDYVATRWYRAPELLVG----DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLI  214 (288)
T ss_pred             EEEEeeecccccCCCccccccCcccccCCcCCchhcC----CCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            9999999988765443222233567889999999984    226789999999999999999999999877655444333


Q ss_pred             hhccCCc-----------------CCCC---------CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        243 MNHQNSF-----------------DLPS---------DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       243 ~~~~~~~-----------------~~~~---------~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      .......                 ..+.         .....++.++++||++||. +|++||+++++.
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il  283 (288)
T cd07833         215 QKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELL  283 (288)
T ss_pred             HHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHh
Confidence            2110000                 0000         0111358999999999999 999999866555

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.4e-39  Score=295.01  Aligned_cols=250  Identities=19%  Similarity=0.252  Sum_probs=209.2

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      +.|+.++.++.|    |+|.||.+.... +..+++|.+......          ....+.+|+.+++.++||||++++++
T Consensus         6 ~~y~~~~~ig~g----~~~~vy~~~~~~-~~~~~~k~~~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~   70 (261)
T cd05148           6 EEFTLERKLGSG----YFGEVWEGLWKN-RVRVAIKILKSDDLL----------KQQDFQKEVQALKRLRHKHLISLFAV   70 (261)
T ss_pred             HHHHHhhhhccC----CCccEEEeEecC-CCcEEEEeccccchh----------hHHHHHHHHHHHhcCCCcchhheeee
Confidence            468888888888    899999998766 888999987654321          12346789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      +.+....++||||+++++|.+++.+. ...+++..+..++.||+.||.|||+.|++|          |||||+||+++.+
T Consensus        71 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h----------~dl~~~nilv~~~  140 (261)
T cd05148          71 CSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIH----------RDLAARNILVGED  140 (261)
T ss_pred             EecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeec----------cccCcceEEEcCC
Confidence            99999999999999999999999763 346899999999999999999999999999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETY  239 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~  239 (372)
                      +.++|+|||++......... .....++..|+|||.+.     ...++.++|+||||+++|+|++ |..||.+.+..+.+
T Consensus       141 ~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~PE~~~-----~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~  214 (261)
T cd05148         141 LVCKVADFGLARLIKEDVYL-SSDKKIPYKWTAPEAAS-----HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY  214 (261)
T ss_pred             ceEEEccccchhhcCCcccc-ccCCCCceEecCHHHHc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence            99999999999776433221 22334567899999987     3568889999999999999998 89999988888887


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ..+... ...+.+.    ..++.+.+++.+||+ +|.+||+++++.+.+
T Consensus       215 ~~~~~~-~~~~~~~----~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L  258 (261)
T cd05148         215 DQITAG-YRMPCPA----KCPQEIYKIMLECWAAEPEDRPSFKALREEL  258 (261)
T ss_pred             HHHHhC-CcCCCCC----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            777643 2223333    678999999999999 999999998887655

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.5e-39  Score=299.52  Aligned_cols=255  Identities=25%  Similarity=0.388  Sum_probs=210.7

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      +-|+.+..++.|    |+|.||++....++..+|+|........         ...+.+.+|+.++..++||||+++++.
T Consensus         4 ~~~~~~~~ig~G----~~~~vy~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~~~e~~~l~~l~h~~iv~~~~~   70 (277)
T cd06641           4 ELFTKLEKIGKG----SFGEVFKGIDNRTQKVVAIKIIDLEEAE---------DEIEDIQQEITVLSQCDSPYVTKYYGS   70 (277)
T ss_pred             HhhhhheeEeec----CCeEEEEEEECCCCcEEEEEEeccccch---------HHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            456677777776    8999999988888999999976543221         123567889999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.++...|+||||+++++|.+++..  ..+++..+..++.|++.++.+||+.|++|          +||+|+||+++.++
T Consensus        71 ~~~~~~~~lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h----------~dl~p~Ni~i~~~~  138 (277)
T cd06641          71 YLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIH----------RDIKAANVLLSEHG  138 (277)
T ss_pred             EEeCCeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeec----------CCCCHHhEEECCCC
Confidence            9999999999999999999999975  57899999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .++|+|||++........ ......|+..|+|||.+.+     ..++.++|+|||||++|+|++|..||...+.......
T Consensus       139 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~-----~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  212 (277)
T cd06641         139 EVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQ-----SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL  212 (277)
T ss_pred             CEEEeecccceecccchh-hhccccCCccccChhhhcc-----CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH
Confidence            999999999876543221 2233467889999999873     4578899999999999999999999988776665555


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      +.... ...++    ..++.++.++|.+||. +|.+||++.+++                 .||||...
T Consensus       213 ~~~~~-~~~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l-----------------~~~~~~~~  259 (277)
T cd06641         213 IPKNN-PPTLE----GNYSKPLKEFVEACLNKEPSFRPTAKELL-----------------KHKFIVRF  259 (277)
T ss_pred             HhcCC-CCCCC----cccCHHHHHHHHHHccCChhhCcCHHHHH-----------------hCHHHhhh
Confidence            54322 22222    2578999999999999 999999866655                 99999853

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.8e-40  Score=304.74  Aligned_cols=263  Identities=22%  Similarity=0.317  Sum_probs=204.7

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.++.|    ++|.||++.+..+++.+++|.+........        ..+.+.+|+.+++.++||||+++++++
T Consensus         3 ~y~~~~~l~~g----~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~   70 (294)
T PLN00009          3 QYEKVEKIGEG----TYGVVYKARDRVTNETIALKKIRLEQEDEG--------VPSTAIREISLLKEMQHGNIVRLQDVV   70 (294)
T ss_pred             ceEEEEEecCC----CCEEEEEEEecCCCcEEEEEehhhcccccc--------chHHHHHHHHHHHhccCCCEeeEEEEE
Confidence            45666666666    799999999988999999998765433211        234567799999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC-C
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA-N  160 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~-~  160 (372)
                      .+....|+||||++ ++|.+++.... ..+++..++.++.||+.||+|||++|++|          |||+|+||+++. +
T Consensus        71 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H----------~dl~p~nill~~~~  139 (294)
T PLN00009         71 HSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLH----------RDLKPQNLLIDRRT  139 (294)
T ss_pred             ecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeC----------CCCCcceEEEECCC
Confidence            99999999999995 58888886532 23688899999999999999999999999          999999999985 5


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG  240 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~  240 (372)
                      +.+||+|||++........ ......+++.|+|||.+.+    ...++.++|+|||||++|+|+||.+||...+..+...
T Consensus       140 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~----~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~  214 (294)
T PLN00009        140 NALKLADFGLARAFGIPVR-TFTHEVVTLWYRAPEILLG----SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF  214 (294)
T ss_pred             CEEEEcccccccccCCCcc-ccccCceeecccCHHHHhC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            6799999999976543221 1122457889999999863    3457889999999999999999999998877666555


Q ss_pred             HHhhccCCcC----------------CC---C----CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhcc
Q psy11571        241 KIMNHQNSFD----------------LP---S----DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSL  296 (372)
Q Consensus       241 ~i~~~~~~~~----------------~~---~----~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~  296 (372)
                      ++........                .+   .    .....+++++.++|.+||+ +|++||++++++            
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l------------  282 (294)
T PLN00009        215 KIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAAL------------  282 (294)
T ss_pred             HHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHh------------
Confidence            5432111000                00   0    0112578999999999999 999999866655            


Q ss_pred             CCCCCCCCCcCCCC
Q psy11571        297 SISPRNHPWFQGIA  310 (372)
Q Consensus       297 ~~~~~~hp~f~~~~  310 (372)
                           .||||++++
T Consensus       283 -----~~~~~~~~~  291 (294)
T PLN00009        283 -----EHEYFKDLG  291 (294)
T ss_pred             -----cCchHhHHh
Confidence                 999998754

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.2e-39  Score=300.34  Aligned_cols=249  Identities=24%  Similarity=0.329  Sum_probs=193.2

Q ss_pred             HHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeeeEEEE
Q psy11571          5 RELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLHYAFQ   83 (372)
Q Consensus         5 ~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~~~~~   83 (372)
                      +.++.++.|    ++|.||++....+++.+|+|..........        ... ..+|..++..+. ||||+++++++.
T Consensus         2 ~~~~~lg~g----~~~~v~~~~~~~~~~~~aik~~~~~~~~~~--------~~~-~~~e~~~l~~l~~h~~i~~~~~~~~   68 (282)
T cd07831           2 KILGKIGEG----TFSEVLKAQSRKTGKYYAIKCMKKHFKSLE--------QVN-NLREIQALRRLSPHPNILRLIEVLF   68 (282)
T ss_pred             ceEeecccc----ccceEEEEEEcCCCcEEEEEEehhccCCch--------hhh-HHHHHHHHhhcCCCCCccceEEEEe
Confidence            344555555    799999999988999999997765322111        111 235777777774 999999999999


Q ss_pred             eC--CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         84 DD--SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        84 ~~--~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.  +.+++||||++ ++|.+.+......+++..++.++.|++.||+|||+.|++|          |||+|+||+++. +
T Consensus        69 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H----------~dl~p~ni~l~~-~  136 (282)
T cd07831          69 DRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFH----------RDIKPENILIKD-D  136 (282)
T ss_pred             cCCCCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcee----------cccCHHHEEEcC-C
Confidence            88  88999999996 5888888764567899999999999999999999999999          999999999999 9


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .+||+|||++.........  ....++..|+|||.+..    ...++.++|+|||||++|||++|.+||.+.+..+....
T Consensus       137 ~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~  210 (282)
T cd07831         137 ILKLADFGSCRGIYSKPPY--TEYISTRWYRAPECLLT----DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAK  210 (282)
T ss_pred             CeEEEecccccccccCCCc--CCCCCCcccCChhHhhc----CCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHH
Confidence            9999999999876433222  22457899999998753    34578899999999999999999999998876665554


Q ss_pred             Hhhcc----------------CCcCCCCCC-------CCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        242 IMNHQ----------------NSFDLPSDV-------GYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       242 i~~~~----------------~~~~~~~~~-------~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      +....                ..+.++...       ...++.+++++|.+||. +|++||++++++
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l  277 (282)
T cd07831         211 IHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQAL  277 (282)
T ss_pred             HHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHh
Confidence            43211                111111110       12468999999999999 999999876655

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.3e-39  Score=296.55  Aligned_cols=248  Identities=28%  Similarity=0.451  Sum_probs=204.0

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+.++.++.|    |+|.||++.+..++..+++|.+........        ..+.+.+|+.+++.++||||+++++.+.
T Consensus         2 y~~~~~lg~g----~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~~~~~~   69 (265)
T cd08217           2 YEVLETIGKG----SFGTVRKVRRKSDGKILVWKEIDYGNMTEK--------EKQQLVSEVNILRELKHPNIVRYYDRII   69 (265)
T ss_pred             ceeeeeeccC----CCeEEEEeeecCCCCEEEEEEEecccCCHH--------HHHHHHHHHHHHHhcCCCccceeeeeee
Confidence            5566666666    899999999999999999998765443222        2355778999999999999999999876


Q ss_pred             e--CCeEEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH-----hcCceecCCCCCCCcCCCCCcC
Q psy11571         84 D--DSNLYLVMDYYCGGDLLTLLSKF---EDRLPEDMAKFYIAEMVLAIASIH-----DLHYVHRPNHFAFHLCRDIKPD  153 (372)
Q Consensus        84 ~--~~~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~LH-----~~~ivH~~~~~~~~vhrDlkp~  153 (372)
                      .  ....|++|||+++++|.+++...   ...+++..++.++.||+.||.|||     +.+++|          +||+|+
T Consensus        70 ~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h----------~dl~p~  139 (265)
T cd08217          70 DRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLH----------RDLKPA  139 (265)
T ss_pred             cCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCccee----------cCCCHH
Confidence            4  45689999999999999999763   457899999999999999999999     899999          999999


Q ss_pred             cEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC
Q psy11571        154 NVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE  233 (372)
Q Consensus       154 NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~  233 (372)
                      ||+++.++.++|+|||++......... .....|++.|+|||++.+     ..++.++|+||||+++|+|++|..||...
T Consensus       140 nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~pE~~~~-----~~~~~~~Dv~slG~il~~l~~g~~p~~~~  213 (265)
T cd08217         140 NIFLDANNNVKLGDFGLAKILGHDSSF-AKTYVGTPYYMSPEQLNH-----MSYDEKSDIWSLGCLIYELCALSPPFTAR  213 (265)
T ss_pred             HEEEecCCCEEEecccccccccCCccc-ccccccCCCccChhhhcC-----CCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence            999999999999999999876543321 223568999999999973     55788999999999999999999999988


Q ss_pred             CHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        234 SLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       234 ~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      +..+....+..... ..++.    .++..+.+++.+||. +|++||++++++
T Consensus       214 ~~~~~~~~~~~~~~-~~~~~----~~~~~~~~l~~~~l~~~p~~Rp~~~~il  260 (265)
T cd08217         214 NQLQLASKIKEGKF-RRIPY----RYSSELNEVIKSMLNVDPDKRPSTEELL  260 (265)
T ss_pred             CHHHHHHHHhcCCC-CCCcc----ccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            86666666654322 22333    678999999999999 999999866655

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.9e-39  Score=313.53  Aligned_cols=254  Identities=20%  Similarity=0.257  Sum_probs=200.3

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehh-----hhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCce
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLD-----ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWI   75 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~-----~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~I   75 (372)
                      .+|+..+.+|.|    |+|.||++.....     +..||+|.+.......         ..+.+.+|+.++..+. ||||
T Consensus        37 ~~~~~~~~LG~G----~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~---------~~~~~~~Ei~~l~~l~~HpnI  103 (400)
T cd05105          37 DGLVLGRILGSG----AFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSS---------EKQALMSELKIMTHLGPHLNI  103 (400)
T ss_pred             cceehhheecCC----CCceEEEEEEcccCCCCCceEEEEEecCCCCChH---------HHHHHHHHHHHHHhcCCCCCe
Confidence            356677777777    8999999875432     3468999775433221         2355788999999996 9999


Q ss_pred             eeeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC-----------------------------------------------
Q psy11571         76 TNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE-----------------------------------------------  108 (372)
Q Consensus        76 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-----------------------------------------------  108 (372)
                      +++++++.+...+|+|||||++|+|.+++....                                               
T Consensus       104 v~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  183 (400)
T cd05105         104 VNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQA  183 (400)
T ss_pred             eeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccc
Confidence            999999999999999999999999999886521                                               


Q ss_pred             ------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCC
Q psy11571        109 ------------------------------------------------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN  140 (372)
Q Consensus       109 ------------------------------------------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~  140 (372)
                                                                      ..+++..+..++.||+.||.|||+.|++|   
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH---  260 (400)
T cd05105         184 DTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVH---  260 (400)
T ss_pred             cccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeC---
Confidence                                                            23677888999999999999999999999   


Q ss_pred             CCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHH
Q psy11571        141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVC  219 (372)
Q Consensus       141 ~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvi  219 (372)
                             |||||+|||++.++.+||+|||+++....... .......+++.|+|||.+.+     ..++.++|||||||+
T Consensus       261 -------~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwSlGvi  328 (400)
T cd05105         261 -------RDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-----NLYTTLSDVWSYGIL  328 (400)
T ss_pred             -------CCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-----CCCCchhhHHHHHHH
Confidence                   99999999999999999999999976543221 11223456788999999873     568899999999999


Q ss_pred             HHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        220 MYEMLY-GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       220 l~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      +|+|++ |..||.....................+.    .++.++.++|.+||+ +|++||++.++.+++
T Consensus       329 l~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l  394 (400)
T cd05105         329 LWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPD----HATQEVYDIMVKCWNSEPEKRPSFLHLSDIV  394 (400)
T ss_pred             HHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCc----cCCHHHHHHHHHHCccCHhHCcCHHHHHHHH
Confidence            999997 9999987654444433333333333333    678999999999999 999999988877655

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.9e-39  Score=295.88  Aligned_cols=241  Identities=27%  Similarity=0.417  Sum_probs=191.0

Q ss_pred             ccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         16 IQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        16 ~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      .+|+|.||++.+..++..+++|.+......          ..+.+.+|+.+++.++||||+++++++.+++..+++|||+
T Consensus        18 ~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~----------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   87 (268)
T cd06624          18 KGTYGIVYAARDLSTQVRIAIKEIPERDSR----------YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV   87 (268)
T ss_pred             cCCceEEEEeEecCCCcEEEEEEecCCCHH----------HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence            348899999988888899999977654322          2345778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC-CCcEEEeecCccc
Q psy11571         96 CGGDLLTLLSKFEDRL--PEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA-NGHIRLADFGSCL  172 (372)
Q Consensus        96 ~gg~L~~~l~~~~~~l--~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~-~~~vkl~Dfg~a~  172 (372)
                      ++++|.+++......+  ++..+..++.||+.||+|||+.|++|          |||||+||+++. ++.++|+|||++.
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h----------~dl~p~nil~~~~~~~~~l~dfg~~~  157 (268)
T cd06624          88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH----------RDIKGDNVLVNTYSGVVKISDFGTSK  157 (268)
T ss_pred             CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEee----------cCCCHHHEEEcCCCCeEEEecchhhe
Confidence            9999999998643455  88899999999999999999999999          999999999976 6799999999987


Q ss_pred             ccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH-HHHHHHhhccCCcCC
Q psy11571        173 RLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKIMNHQNSFDL  251 (372)
Q Consensus       173 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~  251 (372)
                      ....... ......|++.|+|||.+...   ...++.++|+||||+++|+|++|.+||...... .....+........+
T Consensus       158 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~---~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  233 (268)
T cd06624         158 RLAGINP-CTETFTGTLQYMAPEVIDKG---PRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEI  233 (268)
T ss_pred             ecccCCC-ccccCCCCccccChhhhccc---cccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCC
Confidence            6543222 12224578999999998631   234788999999999999999999999754322 222122111112223


Q ss_pred             CCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        252 PSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       252 ~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      |.    .+++++++|+++||. +|.+||+++++.
T Consensus       234 ~~----~~~~~~~~li~~~l~~~p~~Rpt~~~ll  263 (268)
T cd06624         234 PE----SLSAEAKNFILRCFEPDPDKRASAHDLL  263 (268)
T ss_pred             Cc----ccCHHHHHHHHHHcCCCchhCCCHHHHH
Confidence            33    678999999999999 999999876665

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=8.5e-40  Score=303.51  Aligned_cols=260  Identities=23%  Similarity=0.338  Sum_probs=201.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeeeEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLHYA   81 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~~~   81 (372)
                      +|+....++.|    ++|.||++....+++.|++|..........        ....+.+|+.+++.+. ||||++++++
T Consensus         2 ~y~~~~~lg~g----~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~--------~~~~~~~E~~~l~~l~~~~~i~~~~~~   69 (295)
T cd07837           2 AYEKLEKIGEG----TYGKVYKARDKNTGKLVALKKTRLEMDEEG--------IPPTALREISLLQMLSESIYIVRLLDV   69 (295)
T ss_pred             CceEeeEeccc----CCeEEEEEEECCCCcEEEEEeehhhccccC--------CchHHHHHHHHHHHccCCCCccceeee
Confidence            46666667666    799999999988999999997655432211        2234677999999985 6999999999


Q ss_pred             EEeCCe-----EEEEEeccCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCc
Q psy11571         82 FQDDSN-----LYLVMDYYCGGDLLTLLSKFE----DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKP  152 (372)
Q Consensus        82 ~~~~~~-----~~lv~E~~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp  152 (372)
                      +.....     .|+||||+++ +|.+++....    ..+++..++.++.||+.||.|||++|++|          |||||
T Consensus        70 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H----------~dl~~  138 (295)
T cd07837          70 EHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMH----------RDLKP  138 (295)
T ss_pred             EeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeee----------cCCCh
Confidence            987665     8999999975 8998886532    35799999999999999999999999999          99999


Q ss_pred             CcEEeCC-CCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCC
Q psy11571        153 DNVLLDA-NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY  231 (372)
Q Consensus       153 ~NIll~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~  231 (372)
                      +||+++. ++.++|+|||++........ ......+++.|+|||++.+    ...++.++|+||||+++|+|++|.+||.
T Consensus       139 ~nil~~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~~~~  213 (295)
T cd07837         139 QNLLVDKQKGLLKIADLGLGRAFSIPVK-SYTHEIVTLWYRAPEVLLG----STHYSTPVDIWSVGCIFAEMSRKQPLFP  213 (295)
T ss_pred             HHEEEecCCCeEEEeecccceecCCCcc-ccCCcccccCCCChHHhhC----CCCCCchHHHHHHHHHHHHHHcCCCCCC
Confidence            9999998 88999999999876533211 1122356889999999863    3457889999999999999999999999


Q ss_pred             CCCHHHHHHHHhhccCCcC---------------CC-------CCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhh
Q psy11571        232 AESLVETYGKIMNHQNSFD---------------LP-------SDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKM  288 (372)
Q Consensus       232 ~~~~~~~~~~i~~~~~~~~---------------~~-------~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~  288 (372)
                      +.+..+...++........               .+       ......++..+.+||.+||. +|.+||++++++    
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil----  289 (295)
T cd07837         214 GDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAAL----  289 (295)
T ss_pred             CCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHh----
Confidence            8776665555433210000               00       00112578999999999999 999999866555    


Q ss_pred             hhhhhhccCCCCCCCCCcC
Q psy11571        289 WSALFVSLSISPRNHPWFQ  307 (372)
Q Consensus       289 ~~~~~~~~~~~~~~hp~f~  307 (372)
                                   .||||+
T Consensus       290 -------------~~~~~~  295 (295)
T cd07837         290 -------------THPYFD  295 (295)
T ss_pred             -------------cCCCcC
Confidence                         999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.3e-39  Score=306.92  Aligned_cols=254  Identities=19%  Similarity=0.271  Sum_probs=202.0

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeeh-----hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCce
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLL-----DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWI   75 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~-----~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~I   75 (372)
                      +||+.++.+|.|    |+|.||.+....     +++.||+|.+.......         ..+.+.+|+.++..+ +||||
T Consensus         7 ~~~~i~~~lG~G----~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~---------~~~~~~~E~~~~~~l~~h~ni   73 (337)
T cd05054           7 DRLKLGKPLGRG----AFGKVIQASAFGIEKSASCRTVAVKMLKEGATAS---------EYKALMTELKILIHIGHHLNV   73 (337)
T ss_pred             HHhhhhcccccC----cCceEEeccccccccccccceeeeeeccCCCCHH---------HHHHHHHHHHHHHhhccCcch
Confidence            589999999888    899999997543     34789999876433221         234567799999988 79999


Q ss_pred             eeeeEEEEeC-CeEEEEEeccCCCCHHHHHHhcC----------------------------------------------
Q psy11571         76 TNLHYAFQDD-SNLYLVMDYYCGGDLLTLLSKFE----------------------------------------------  108 (372)
Q Consensus        76 v~l~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~~----------------------------------------------  108 (372)
                      +++++++... ..++++|||+++++|.+++....                                              
T Consensus        74 v~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (337)
T cd05054          74 VNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSL  153 (337)
T ss_pred             hheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcch
Confidence            9999987654 57899999999999999986421                                              


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCccccc
Q psy11571        109 --------------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL  174 (372)
Q Consensus       109 --------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~  174 (372)
                                    ..+++..+..++.||+.||+|||++||+|          |||||+|||++.++.++|+|||++...
T Consensus       154 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH----------rDikp~Nill~~~~~vkL~DfG~a~~~  223 (337)
T cd05054         154 SDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIH----------RDLAARNILLSENNVVKICDFGLARDI  223 (337)
T ss_pred             hhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeec----------CCCCcceEEEeCCCcEEEeccccchhc
Confidence                          25788999999999999999999999999          999999999999999999999999875


Q ss_pred             CCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCCC
Q psy11571        175 GGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHQNSFDLP  252 (372)
Q Consensus       175 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~  252 (372)
                      ..... .......++..|+|||++.     ...++.++|||||||++|||++ |..||.+....+.+...+........+
T Consensus       224 ~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~  298 (337)
T cd05054         224 YKDPDYVRKGDARLPLKWMAPESIF-----DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAP  298 (337)
T ss_pred             ccCcchhhccCCCCCccccCcHHhc-----CCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCC
Confidence            43222 1222345567899999987     3668999999999999999998 999998765444444444433333333


Q ss_pred             CCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        253 SDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       253 ~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .    ..++++.+++.+||+ +|++||+++++.+.+
T Consensus       299 ~----~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l  330 (337)
T cd05054         299 E----YATPEIYSIMLDCWHNNPEDRPTFSELVEIL  330 (337)
T ss_pred             c----cCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            3    578999999999999 999999988887655

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-39  Score=294.90  Aligned_cols=252  Identities=18%  Similarity=0.247  Sum_probs=204.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehh---hhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLD---ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLH   79 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~---~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~   79 (372)
                      +|+..+.++.|    |+|.||++....+   ...+++|.........         ....+.+|+.+++.++||||++++
T Consensus         5 ~~~~~~~lg~g----~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~   71 (266)
T cd05033           5 YVTIEKVIGGG----EFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDK---------QRLDFLTEASIMGQFDHPNIIRLE   71 (266)
T ss_pred             HceeeeEecCC----ccceEEEEEEccCCCCcceEEEEEcCCCCChH---------HHHHHHHHHHHHHhCCCCCcceEe
Confidence            45566666666    8999999876543   4578888765433211         234567799999999999999999


Q ss_pred             EEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC
Q psy11571         80 YAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA  159 (372)
Q Consensus        80 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~  159 (372)
                      +.+.+.+..+++|||+++++|.+++....+.+++..+..++.|++.||.|||++|++|          |||||+||+++.
T Consensus        72 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H----------~di~p~nili~~  141 (266)
T cd05033          72 GVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVH----------RDLAARNILVNS  141 (266)
T ss_pred             EEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccc----------CCCCcceEEEcC
Confidence            9999999999999999999999999875567999999999999999999999999999          999999999999


Q ss_pred             CCcEEEeecCcccccCC-CCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHH
Q psy11571        160 NGHIRLADFGSCLRLGG-DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVE  237 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~  237 (372)
                      ++.++|+|||++..... ..........++..|+|||.+.+     ..++.++|+||||+++|+|++ |..||......+
T Consensus       142 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-----~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~  216 (266)
T cd05033         142 NLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY-----RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD  216 (266)
T ss_pred             CCCEEECccchhhcccccccceeccCCCCCccccChhhhcc-----CCCccccchHHHHHHHHHHHccCCCCCCCCCHHH
Confidence            99999999999987642 12212222334678999999873     568899999999999999998 999998888777


Q ss_pred             HHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       238 ~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ....+.... ..+.+.    ..++.+.+++.+||+ +|++||+++++.+.+
T Consensus       217 ~~~~~~~~~-~~~~~~----~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l  262 (266)
T cd05033         217 VIKAVEDGY-RLPPPM----DCPSALYQLMLDCWQKDRNERPTFSQIVSTL  262 (266)
T ss_pred             HHHHHHcCC-CCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            777665532 222232    578999999999999 999999988887655

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3e-39  Score=295.36  Aligned_cols=255  Identities=26%  Similarity=0.394  Sum_probs=206.5

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      .+|+..+.++.|    ++|.||++....+++.+++|.+........       ...+.+.+|+.+++.++||||++++++
T Consensus         2 ~~y~~~~~ig~g----~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~-------~~~~~~~~e~~~l~~~~h~~i~~~~~~   70 (267)
T cd08229           2 ANFRIEKKIGRG----QFSEVYRATCLLDGVPVALKKVQIFDLMDA-------KARADCIKEIDLLKQLNHPNVIKYYAS   70 (267)
T ss_pred             chhhhhhhhccc----CCeEEEEEeecCCCceEEEEeeeehhhhhH-------HHHHHHHHHHHHHHHccCCchhhhhhe
Confidence            357778888887    799999999988999999997765433222       233567789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKF---EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD  158 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~  158 (372)
                      +.+++..+++|||+++++|.+++...   ...+++..++.++.||+.||.|||++|++|          +||||+||+++
T Consensus        71 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H----------~dl~p~nili~  140 (267)
T cd08229          71 FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMH----------RDIKPANVFIT  140 (267)
T ss_pred             eEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeec----------CCCCHHHEEEc
Confidence            99999999999999999999998642   346899999999999999999999999999          99999999999


Q ss_pred             CCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCH--H
Q psy11571        159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL--V  236 (372)
Q Consensus       159 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~--~  236 (372)
                      .++.++|+|||++........ ......|+..|+|||.+.+     ..++.++|+||||+++|+|++|..||.+...  .
T Consensus       141 ~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~ape~~~~-----~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~  214 (267)
T cd08229         141 ATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHE-----NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY  214 (267)
T ss_pred             CCCCEEECcchhhhccccCCc-ccccccCCcCccCHHHhcC-----CCccchhhHHHHHHHHHHHHhCCCCcccccchHH
Confidence            999999999999876543322 1223568899999999973     5578899999999999999999999976543  2


Q ss_pred             HHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       237 ~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      +....+....    .+......+++.++++|.+||+ +|++||+++++.++.
T Consensus       215 ~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~  262 (267)
T cd08229         215 SLCKKIEQCD----YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVA  262 (267)
T ss_pred             HHhhhhhcCC----CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHH
Confidence            3333343321    1222222578999999999999 999999988776654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=5.2e-40  Score=302.02  Aligned_cols=257  Identities=33%  Similarity=0.570  Sum_probs=212.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeeeEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLHYA   81 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~~~   81 (372)
                      +|+..+.++.|    |+|.||.+....+++.+++|.+........       ...+.+.+|..+++.+. ||||++++++
T Consensus         2 ~y~~~~~lg~g----~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~-------~~~~~~~~e~~~~~~l~~~~~i~~~~~~   70 (280)
T cd05581           2 DFKFGKIIGEG----SFSTVVLAKEKETNKEYAIKILDKRQLIKE-------KKVKYVKIEKEVLTRLNGHPGIIKLYYT   70 (280)
T ss_pred             CceEeeeecCC----CceEEEEEEEcCCCCEEEEEEechHhccch-------HHHHHHHHHHHHHHhcccCCCchhHHHH
Confidence            45555666666    899999999988999999998776444322       12355778999999998 9999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+.+..++|||++++++|.+++.+ .+.+++..+..++.|++.||.+||+.|++|          +||+|+||+++.++
T Consensus        71 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H----------~dl~~~ni~i~~~~  139 (280)
T cd05581          71 FQDEENLYFVLEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHSKGIIH----------RDLKPENILLDKDM  139 (280)
T ss_pred             hcCCceEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeee----------cCCCHHHeEECCCC
Confidence            9999999999999999999999987 468999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCc-------------------ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGT-------------------VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYE  222 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~e  222 (372)
                      .++|+|||++........                   .......|+..|+|||+...     ..++.++|+||||+++++
T Consensus       140 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-----~~~~~~~Di~slG~~l~~  214 (280)
T cd05581         140 HIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-----KPAGKSSDLWALGCIIYQ  214 (280)
T ss_pred             CEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC-----CCCChhhhHHHHHHHHHH
Confidence            999999999876643321                   12233467889999999873     557889999999999999


Q ss_pred             HhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCC-ChhhhhhhhhhhhccCCCC
Q psy11571        223 MLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQN-GIADFKMWSALFVSLSISP  300 (372)
Q Consensus       223 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~-~~~~i~~~~~~~~~~~~~~  300 (372)
                      +++|..||...+....+..+....  ..+|.    .+++.+.+||.+||+ +|.+||++. ...+++             
T Consensus       215 l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll-------------  275 (280)
T cd05581         215 MLTGKPPFRGSNEYLTFQKILKLE--YSFPP----NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK-------------  275 (280)
T ss_pred             HHhCCCCCCCccHHHHHHHHHhcC--CCCCC----ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh-------------
Confidence            999999999888777776665432  33343    679999999999999 999999982 123444             


Q ss_pred             CCCCCc
Q psy11571        301 RNHPWF  306 (372)
Q Consensus       301 ~~hp~f  306 (372)
                       +||||
T Consensus       276 -~~~~~  280 (280)
T cd05581         276 -AHPFF  280 (280)
T ss_pred             -cCCCC
Confidence             99998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7.4e-40  Score=304.25  Aligned_cols=255  Identities=25%  Similarity=0.426  Sum_probs=206.2

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.++.|    ++|.||++.+..+++.+++|.+......          ..+.+.+|+.+++.++||||+++++.+
T Consensus        20 ~~~~~~~lg~g----~~g~v~~~~~~~~~~~v~iK~~~~~~~~----------~~~~~~~e~~~l~~l~hp~i~~~~~~~   85 (293)
T cd06647          20 KYTRFEKIGQG----ASGTVYTAIDVATGQEVAIKQMNLQQQP----------KKELIINEILVMRENKHPNIVNYLDSY   85 (293)
T ss_pred             hceeeeEecCC----CCeEEEEEEEcCCCCEEEEEEeccccch----------HHHHHHHHHHHHhhcCCCCeeehhhee
Confidence            55666666665    7999999988888999999977533221          124467788999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      ...+..|+|+||+++++|.+++.+  ..+++..+..++.|++.||.|||++|++|          |||||+||+++.++.
T Consensus        86 ~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H----------~dL~p~Nili~~~~~  153 (293)
T cd06647          86 LVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIH----------RDIKSDNILLGMDGS  153 (293)
T ss_pred             eeCCcEEEEEecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEee----------ccCCHHHEEEcCCCC
Confidence            999999999999999999999976  56889999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      ++|+|||++........ ......|++.|+|||.+..     ..++.++|+|||||++|+|++|..||...+.......+
T Consensus       154 ~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~-----~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~  227 (293)
T cd06647         154 VKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTR-----KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI  227 (293)
T ss_pred             EEEccCcceeccccccc-ccccccCChhhcCchhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh
Confidence            99999998876543322 2223468889999999873     56788999999999999999999999887655443333


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      .... ...++  ....++..++++|++||. +|++||+++++.                 .||||+..
T Consensus       228 ~~~~-~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il-----------------~h~~~~~~  275 (293)
T cd06647         228 ATNG-TPELQ--NPEKLSAIFRDFLNRCLEMDVEKRGSAKELL-----------------QHPFLKIA  275 (293)
T ss_pred             hcCC-CCCCC--CccccCHHHHHHHHHHccCChhhCcCHHHHh-----------------cCHHHhcC
Confidence            3221 11111  122578899999999999 999999866555                 99999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.1e-39  Score=295.21  Aligned_cols=247  Identities=21%  Similarity=0.267  Sum_probs=200.7

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||.++.. .+..+|+|.+......           .+.+.+|+.+++.++||||+++++++
T Consensus         5 ~~~~~~~lg~G----~~~~vy~~~~~-~~~~~aik~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~   68 (256)
T cd05113           5 DLTFLKELGTG----QFGVVKYGKWR-GQYDVAIKMIKEGSMS-----------EDEFIEEAKVMMKLSHEKLVQLYGVC   68 (256)
T ss_pred             HeEEeeEecCc----ccceEEEEEec-CCCcEEEEEcCCCccc-----------HHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence            45555666665    79999998643 4456899977644321           13367799999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+....|++|||+.+|+|.+++......+++..+..++.||+.||.|||+.|++|          +||||+||+++.++.
T Consensus        69 ~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H----------~dl~p~nili~~~~~  138 (256)
T cd05113          69 TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIH----------RDLAARNCLVDDQGC  138 (256)
T ss_pred             ccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeec----------cccCcceEEEcCCCC
Confidence            9999999999999999999999874457899999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGK  241 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~  241 (372)
                      +||+|||.++..............++..|+|||.+.+     ..++.++|+|||||++|+|++ |..||...+..+....
T Consensus       139 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-----~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~  213 (256)
T cd05113         139 VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLY-----SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK  213 (256)
T ss_pred             EEECCCccceecCCCceeecCCCccChhhCCHHHHhc-----CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH
Confidence            9999999987654332222222335678999999973     458889999999999999998 9999998887777777


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhh
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIAD  285 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~  285 (372)
                      +..... ...+.    ..+..+++++.+||+ +|.+||++.++++
T Consensus       214 ~~~~~~-~~~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~ll~  253 (256)
T cd05113         214 VSQGLR-LYRPH----LASEKVYAIMYSCWHEKAEERPTFQQLLS  253 (256)
T ss_pred             HhcCCC-CCCCC----CCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            766432 22232    468999999999999 9999999877764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6.3e-39  Score=292.30  Aligned_cols=241  Identities=20%  Similarity=0.284  Sum_probs=194.9

Q ss_pred             cCCccEEEeeee--hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEec
Q psy11571         17 QGKGRVFSIETL--LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDY   94 (372)
Q Consensus        17 ~g~G~v~~v~~~--~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~   94 (372)
                      ||+|.||.+...  .++..+|+|.+......         ...+.+.+|+.+++.++||||++++++++. ...++||||
T Consensus         6 G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~---------~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~   75 (257)
T cd05115           6 GNFGCVKKGVYKMRKKQIDVAIKVLKNENEK---------SVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEM   75 (257)
T ss_pred             CCcccEEEEEEecCCCceeEEEEEcccccCh---------HHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEe
Confidence            489999987643  34556888877654321         123567889999999999999999998864 578999999


Q ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCccccc
Q psy11571         95 YCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL  174 (372)
Q Consensus        95 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~  174 (372)
                      +++++|.+++......+++..+..++.||+.||.|||++|++|          |||||+||+++.++.+||+|||++...
T Consensus        76 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H----------~dlkp~nil~~~~~~~kl~dfg~~~~~  145 (257)
T cd05115          76 ASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVH----------RDLAARNVLLVNQHYAKISDFGLSKAL  145 (257)
T ss_pred             CCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeee----------cccchheEEEcCCCcEEeccCCccccc
Confidence            9999999999765567999999999999999999999999999          999999999999999999999999765


Q ss_pred             CCCCcccc--cccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCC
Q psy11571        175 GGDGTVQS--NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHQNSFDL  251 (372)
Q Consensus       175 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~  251 (372)
                      ........  ....++..|+|||.+.     ...++.++|+|||||++|+|++ |..||.+....+....+..+. ....
T Consensus       146 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~  219 (257)
T cd05115         146 GADDSYYKARSAGKWPLKWYAPECIN-----FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK-RLDC  219 (257)
T ss_pred             cCCccceeccCCCCCCcccCCHHHHc-----cCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-CCCC
Confidence            43322111  1122356899999987     3558889999999999999996 999999888777766665542 3333


Q ss_pred             CCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        252 PSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       252 ~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      +.    ..++++.++|.+||. +|++||++.++.+.+
T Consensus       220 ~~----~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l  252 (257)
T cd05115         220 PA----ECPPEMYALMKDCWIYKWEDRPNFAKVEERM  252 (257)
T ss_pred             CC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            43    678999999999999 999999988887665

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG0584|consensus

Probab=100.00  E-value=6.4e-40  Score=313.15  Aligned_cols=247  Identities=18%  Similarity=0.350  Sum_probs=204.9

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCe--EEEEEecc
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSN--LYLVMDYY   95 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~--~~lv~E~~   95 (372)
                      .+-+||++.+-.+|..||=-.++...+.+      ..+.++++..|+.+|+.|+||||+++|+++.+..+  +-+|+|.+
T Consensus        52 afKtVYka~De~~giEVAWnqvk~~d~~q------~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~  125 (632)
T KOG0584|consen   52 AFKTVYKAFDEEEGIEVAWNQVKIRDVTQ------SPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF  125 (632)
T ss_pred             cceeeeeccccccchhhHHHHHhHHHhhc------ChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence            45567888777777777754444333332      24567889999999999999999999999987765  88999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC-CCCcEEEeecCccccc
Q psy11571         96 CGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD-ANGHIRLADFGSCLRL  174 (372)
Q Consensus        96 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~-~~~~vkl~Dfg~a~~~  174 (372)
                      ..|+|+.|+++ .+.++...++.|++||+.||.|||++.        .||+|||||.+||+|+ ..|.|||+|+|+|...
T Consensus       126 TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~~--------PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~  196 (632)
T KOG0584|consen  126 TSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQD--------PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL  196 (632)
T ss_pred             cCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcCC--------CCccccccccceEEEcCCcCceeecchhHHHHh
Confidence            99999999998 578999999999999999999999853        2455599999999998 5689999999999887


Q ss_pred             CCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCC-CCHHHHHHHHhhccCCcCCCC
Q psy11571        175 GGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHQNSFDLPS  253 (372)
Q Consensus       175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~  253 (372)
                      .....   ....|||.|||||++-      ..|+..+||||||+++.||+|+..||.- .+..++|+++..+..+-.+..
T Consensus       197 r~s~a---ksvIGTPEFMAPEmYE------E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~k  267 (632)
T KOG0584|consen  197 RKSHA---KSVIGTPEFMAPEMYE------ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSK  267 (632)
T ss_pred             hcccc---ceeccCccccChHHHh------hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhc
Confidence            65432   2368999999999996      5699999999999999999999999974 678889999988754333332


Q ss_pred             CCCCCCCHHHHHHHHHhccCCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        254 DVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       254 ~~~~~~s~~~~~li~~lL~~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                          --.+++++||.+||...++|+|+.+++                 .||||+.-
T Consensus       268 ----V~dPevr~fIekCl~~~~~R~sa~eLL-----------------~d~Ff~~d  302 (632)
T KOG0584|consen  268 ----VKDPEVREFIEKCLATKSERLSAKELL-----------------KDPFFDED  302 (632)
T ss_pred             ----cCCHHHHHHHHHHhcCchhccCHHHHh-----------------hChhhccc
Confidence                448999999999999999999977776                 99999863

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.3e-39  Score=306.46  Aligned_cols=271  Identities=24%  Similarity=0.346  Sum_probs=210.3

Q ss_pred             hHHHHHHh-hhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhh----HHHHHHHHHHHHHHHHHHhcCCCCcee
Q psy11571          2 ERLRELEA-LFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKT----VSDFIEFVAKLREERDVLVYGDRRWIT   76 (372)
Q Consensus         2 ~~~~~l~~-~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~----~~~~~~~~~~l~~E~~il~~l~hp~Iv   76 (372)
                      .||..+.. ++.|    |+|.||++.+..+++.||+|.+..........    ..........+.+|+.+++.++||||+
T Consensus         8 ~ry~~~~~~ig~G----~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   83 (335)
T PTZ00024          8 ERYIQKGAHLGEG----TYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIM   83 (335)
T ss_pred             cchhhhhhcccCC----CceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCccee
Confidence            57777755 5555    89999999998899999999886544332110    000001122467899999999999999


Q ss_pred             eeeEEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEE
Q psy11571         77 NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL  156 (372)
Q Consensus        77 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIl  156 (372)
                      ++++++...+..++||||+. |+|.+++.. ...+++..+..++.|++.||.|||+.|++|          +||+|+||+
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H----------~dl~~~nil  151 (335)
T PTZ00024         84 GLVDVYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMH----------RDLSPANIF  151 (335)
T ss_pred             eeeEEEecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeec----------ccccHHHeE
Confidence            99999999999999999995 699999976 567999999999999999999999999999          999999999


Q ss_pred             eCCCCcEEEeecCcccccCCCC-------------cccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHH
Q psy11571        157 LDANGHIRLADFGSCLRLGGDG-------------TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM  223 (372)
Q Consensus       157 l~~~~~vkl~Dfg~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~el  223 (372)
                      ++.++.++|+|||++.......             ........+++.|+|||.+.+    ...++.++|+|||||++|+|
T Consensus       152 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~~l~el  227 (335)
T PTZ00024        152 INSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG----AEKYHFAVDMWSVGCIFAEL  227 (335)
T ss_pred             ECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhccc----CCCCCcHHHHHHHHHHHHHH
Confidence            9999999999999987654111             111122346788999999873    34578899999999999999


Q ss_pred             hhCCCCCCCCCHHHHHHHHhhccCCcC---CCC-------------------CCCCCCCHHHHHHHHHhcc-CCCCCCCC
Q psy11571        224 LYGETPFYAESLVETYGKIMNHQNSFD---LPS-------------------DVGYEISDDAKDLMRRLIC-SSDTRLGQ  280 (372)
Q Consensus       224 ltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~~-------------------~~~~~~s~~~~~li~~lL~-~p~~R~s~  280 (372)
                      ++|.+||.+.+..+.+..+........   ++.                   ......+.++.++|.+||+ +|++||++
T Consensus       228 ~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~  307 (335)
T PTZ00024        228 LTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISA  307 (335)
T ss_pred             HhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCH
Confidence            999999998887776665543211110   000                   0012458899999999999 99999986


Q ss_pred             CChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        281 NGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       281 ~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      ++++                 .||||++.
T Consensus       308 ~~~l-----------------~~~~~~~~  319 (335)
T PTZ00024        308 KEAL-----------------KHEYFKSD  319 (335)
T ss_pred             HHHh-----------------cCcccCCC
Confidence            6555                 99999854

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=6e-39  Score=300.99  Aligned_cols=258  Identities=23%  Similarity=0.344  Sum_probs=207.5

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      .|..+++++.|    ++|.||++.+..++..+++|.+........       ...+.+.+|..+++.++|||++++++++
T Consensus        22 ~~~~~~~lg~g----~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~   90 (313)
T cd06633          22 IFVGLHEIGHG----SFGAVYFATNSHTNEVVAVKKMSYSGKQTN-------EKWQDIIKEVKFLQQLKHPNTIEYKGCY   90 (313)
T ss_pred             HhhcceeeccC----CCeEEEEEEECCCCcEEEEEEEeccccCch-------HHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence            34444455555    899999999888999999998765443222       2235577899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+....|+||||+. |+|.+++......+++..+..++.||+.||.|||++|++|          +||+|+||+++.++.
T Consensus        91 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H----------~dl~p~nili~~~~~  159 (313)
T cd06633          91 LKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIH----------RDIKAGNILLTEPGQ  159 (313)
T ss_pred             EeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeec----------CCCChhhEEECCCCC
Confidence            99999999999995 6888888765567899999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      ++|+|||++.....     .....|+..|+|||++....  ...++.++|+|||||++|+|++|.+||...+......++
T Consensus       160 ~kL~dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~--~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~  232 (313)
T cd06633         160 VKLADFGSASKSSP-----ANSFVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI  232 (313)
T ss_pred             EEEeecCCCcccCC-----CCCccccccccChhhccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            99999998865322     22356889999999985321  245788999999999999999999999887766666555


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~  310 (372)
                      .....    +......++..+++||.+||+ +|.+||++.+++                 .||||+..+
T Consensus       233 ~~~~~----~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l-----------------~~~~~~~~~  280 (313)
T cd06633         233 AQNDS----PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELL-----------------RHDFVRRDR  280 (313)
T ss_pred             HhcCC----CCCCccccCHHHHHHHHHHccCChhhCcCHHHHh-----------------cCcccCCCc
Confidence            44322    222222578899999999999 999999866555                 999998654

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=5.2e-39  Score=292.58  Aligned_cols=241  Identities=21%  Similarity=0.265  Sum_probs=196.2

Q ss_pred             cCCccEEEee--eehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEec
Q psy11571         17 QGKGRVFSIE--TLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDY   94 (372)
Q Consensus        17 ~g~G~v~~v~--~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~   94 (372)
                      ||+|.||++.  ...++..+|+|.+.......        ...+.+.+|+.+++.++||||+++++++.. ...++||||
T Consensus         6 G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~   76 (257)
T cd05116           6 GNFGTVKKGMYKMKKSEKTVAVKILKNDNNDP--------ALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMEL   76 (257)
T ss_pred             cCCcceEEeEEecCCCceEEEEEEccCCCCcH--------HHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEec
Confidence            3899999874  34567889999876443221        234567889999999999999999998764 567899999


Q ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCccccc
Q psy11571         95 YCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL  174 (372)
Q Consensus        95 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~  174 (372)
                      +++++|.+++.. ...+++..+..++.|++.||+|||++|++|          |||||.||+++.++.++|+|||++...
T Consensus        77 ~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H----------~dlkp~nill~~~~~~kl~Dfg~~~~~  145 (257)
T cd05116          77 AELGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVH----------RDLAARNVLLVTQHYAKISDFGLSKAL  145 (257)
T ss_pred             CCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEee----------cccchhhEEEcCCCeEEECCCcccccc
Confidence            999999999977 467999999999999999999999999999          999999999999999999999999876


Q ss_pred             CCCCccc--ccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCC
Q psy11571        175 GGDGTVQ--SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHQNSFDL  251 (372)
Q Consensus       175 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~  251 (372)
                      .......  .....++..|+|||.+.     ...++.++|+|||||++|||++ |.+||.+.+..+....+.++. ..+.
T Consensus       146 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~-~~~~  219 (257)
T cd05116         146 GADENYYKAKTHGKWPVKWYAPECMN-----YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE-RMEC  219 (257)
T ss_pred             CCCCCeeeecCCCCCCccccCHhHhc-----cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-CCCC
Confidence            4432211  11123457899999987     3568889999999999999998 999999888877777776543 3344


Q ss_pred             CCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        252 PSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       252 ~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      |.    .++++++++|.+||+ ||++||+++++.+.+
T Consensus       220 ~~----~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l  252 (257)
T cd05116         220 PQ----RCPPEMYDLMKLCWTYGVDERPGFAVVELRL  252 (257)
T ss_pred             CC----CCCHHHHHHHHHHhccCchhCcCHHHHHHHH
Confidence            44    689999999999999 999999987776444

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-39  Score=291.09  Aligned_cols=246  Identities=41%  Similarity=0.753  Sum_probs=208.8

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      ||+|.+|.+....+++.+++|.+........       .....+.+|+.+++.++||||+++++.+.++...|++|||++
T Consensus         4 G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   76 (250)
T cd05123           4 GSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR-------KEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAP   76 (250)
T ss_pred             CCceEEEEEEECCCCcEEEEEEeehhhhcch-------HHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCC
Confidence            4899999999888899999998766543322       234567889999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCC
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG  176 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  176 (372)
                      +++|.+++.. ...+++..+..++.|++.||.|||+.+++|          +||+|+||+++.++.++|+|||++.....
T Consensus        77 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H----------~~l~p~ni~~~~~~~~~l~d~~~~~~~~~  145 (250)
T cd05123          77 GGELFSHLSK-EGRFSEERARFYAAEIVLALEYLHSLGIIY----------RDLKPENILLDADGHIKLTDFGLAKELSS  145 (250)
T ss_pred             CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcee----------cCCCcceEEEcCCCcEEEeecCcceeccc
Confidence            9999999987 457899999999999999999999999999          99999999999999999999999877544


Q ss_pred             CCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCC
Q psy11571        177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVG  256 (372)
Q Consensus       177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  256 (372)
                      ... ......++..|+|||.+.+     ...+.++|+||||+++|+|++|..||...+..+....+...  .+.++.   
T Consensus       146 ~~~-~~~~~~~~~~~~~Pe~~~~-----~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~---  214 (250)
T cd05123         146 EGS-RTNTFCGTPEYLAPEVLLG-----KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD--PLRFPE---  214 (250)
T ss_pred             CCC-cccCCcCCccccChHHhCC-----CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC--CCCCCC---
Confidence            321 2233568889999999873     45788999999999999999999999888877777776652  344444   


Q ss_pred             CCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCc
Q psy11571        257 YEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWF  306 (372)
Q Consensus       257 ~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f  306 (372)
                       .++..+.++|++||. ||++||++.++.+++              +||||
T Consensus       215 -~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~--------------~~~~f  250 (250)
T cd05123         215 -FLSPEARDLISGLLQKDPTKRLGSGGAEEIK--------------AHPFF  250 (250)
T ss_pred             -CCCHHHHHHHHHHhcCCHhhCCCcccHHHHH--------------hCCCC
Confidence             568999999999999 999999985556666              99998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=6e-39  Score=296.75  Aligned_cols=259  Identities=25%  Similarity=0.402  Sum_probs=212.1

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      .|+....++.|    ++|.||.+.+..++..+++|.+.....           ..+.+.+|+.+++.++||||+++++.+
T Consensus        20 ~~~~~~~l~~g----~~~~v~~~~~~~~~~~~~iK~~~~~~~-----------~~~~~~~e~~~l~~l~~~~i~~~~~~~   84 (286)
T cd06614          20 LYKNLEKIGEG----ASGEVYKATDRATGKEVAIKKMRLRKQ-----------NKELIINEILIMKDCKHPNIVDYYDSY   84 (286)
T ss_pred             cchHhHhccCC----CCeEEEEEEEccCCcEEEEEEEecCch-----------hHHHHHHHHHHHHHCCCCCeeEEEEEE
Confidence            35555555555    799999999888899999998764332           234467799999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      ......|+++||+++++|.+++......+++..+..++.|++.||.|||+.|++|          +||+|+||+++.++.
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H----------~dl~p~ni~i~~~~~  154 (286)
T cd06614          85 LVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIH----------RDIKSDNILLSKDGS  154 (286)
T ss_pred             EECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeee----------CCCChhhEEEcCCCC
Confidence            9999999999999999999999884338999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      ++|+|||++........ ......++..|+|||.+.+     ..++.++|+|||||++|+|++|..||...+.......+
T Consensus       155 ~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~-----~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~  228 (286)
T cd06614         155 VKLADFGFAAQLTKEKS-KRNSVVGTPYWMAPEVIKR-----KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI  228 (286)
T ss_pred             EEECccchhhhhccchh-hhccccCCcccCCHhHhcC-----CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999998876543221 1223457889999999873     45789999999999999999999999987776665555


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcc
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWD  312 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~  312 (372)
                      ..... ...+.  ...++..++++|.+||+ +|.+||++.+++                 .||||...+|.
T Consensus       229 ~~~~~-~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~il-----------------~~~~~~~~~~~  279 (286)
T cd06614         229 TTKGI-PPLKN--PEKWSPEFKDFLNKCLVKDPEKRPSAEELL-----------------QHPFLKKACPK  279 (286)
T ss_pred             HhcCC-CCCcc--hhhCCHHHHHHHHHHhccChhhCcCHHHHh-----------------hChHhhccCch
Confidence            44322 11111  11478999999999999 999999876655                 99999997764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.4e-39  Score=295.07  Aligned_cols=255  Identities=26%  Similarity=0.458  Sum_probs=211.3

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+.++.++.|    |+|.+|++....+++.+++|.+......         ...+.+.+|+..+..++||||+++++++.
T Consensus         3 ~~~~~~i~~g----~~~~v~~~~~~~~~~~~~vk~~~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   69 (264)
T cd06623           3 LERVKVLGQG----SSGVVYKVRHKPTGKIYALKKIHVDGDE---------EFRKQLLRELKTLRSCESPYVVKCYGAFY   69 (264)
T ss_pred             ceeeeeeeec----CCeEEEEEEEcCCCcEEEEEEeccCcch---------HHHHHHHHHHHHHHhcCCCCeeeEEEEEc
Confidence            4555566666    8999999999989999999987654432         12355788999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD-LHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      ....+++||||+++++|.+++.. ...+++..+..++.|++.||.|||+ .|++|          |||+|+||+++.++.
T Consensus        70 ~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H----------~~l~~~ni~~~~~~~  138 (264)
T cd06623          70 KEGEISIVLEYMDGGSLADLLKK-VGKIPEPVLAYIARQILKGLDYLHTKRHIIH----------RDIKPSNLLINSKGE  138 (264)
T ss_pred             cCCeEEEEEEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhccCCCcc----------CCCCHHHEEECCCCC
Confidence            99999999999999999999987 4789999999999999999999999 99999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC---CHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETY  239 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~---~~~~~~  239 (372)
                      ++|+|||++......... .....++..|+|||.+..     ..++.++|+||||+++|+|++|..||...   ...+..
T Consensus       139 ~~l~df~~~~~~~~~~~~-~~~~~~~~~y~~pE~~~~-----~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~  212 (264)
T cd06623         139 VKIADFGISKVLENTLDQ-CNTFVGTVTYMSPERIQG-----ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM  212 (264)
T ss_pred             EEEccCccceecccCCCc-ccceeecccccCHhhhCC-----CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH
Confidence            999999998876543322 223567899999999873     56888999999999999999999999877   444555


Q ss_pred             HHHhhccCCcCCCCCCCCC-CCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCC
Q psy11571        240 GKIMNHQNSFDLPSDVGYE-ISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~-~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~  310 (372)
                      ..+... .....+.    . ++..+.++|.+||. +|++||++++++                 .||||+.++
T Consensus       213 ~~~~~~-~~~~~~~----~~~~~~l~~li~~~l~~~p~~R~~~~~ll-----------------~~~~~~~~~  263 (264)
T cd06623         213 QAICDG-PPPSLPA----EEFSPEFRDFISACLQKDPKKRPSAAELL-----------------QHPFIKKAD  263 (264)
T ss_pred             HHHhcC-CCCCCCc----ccCCHHHHHHHHHHccCChhhCCCHHHHH-----------------hCHHHHhcc
Confidence            555432 2222222    4 78999999999999 999999876665                 999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.1e-39  Score=298.91  Aligned_cols=261  Identities=22%  Similarity=0.346  Sum_probs=200.7

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHH-HHhcCCCCceeeeeEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERD-VLVYGDRRWITNLHYAF   82 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~-il~~l~hp~Iv~l~~~~   82 (372)
                      |+.++.++.|    ++|.||++.+..+++.||+|.+........        . .++..|.. .++.++||||+++++++
T Consensus         3 ~~~~~~ig~g----~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--------~-~~~~~e~~~~~~~~~~~~iv~~~~~~   69 (283)
T cd06617           3 LEVIEELGRG----AYGVVDKMRHVPTGTIMAVKRIRATVNSQE--------Q-KRLLMDLDISMRSVDCPYTVTFYGAL   69 (283)
T ss_pred             ceEEEEeccc----CCeEEEEEEEcCCCcEEEEEEEecCCCcHH--------H-HHHHHHHHHHHHHcCCCCeeeeeEEE
Confidence            4555666666    899999999999999999998765432211        1 12233444 46678999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCCCcCCCCCcCcEEeC
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKF---EDRLPEDMAKFYIAEMVLAIASIHDL-HYVHRPNHFAFHLCRDIKPDNVLLD  158 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~~~~~~~~vhrDlkp~NIll~  158 (372)
                      ..++..|++|||++ |+|.+++...   ...+++..+..++.||+.||.|||++ +++|          |||||+||+++
T Consensus        70 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h----------~dlkp~nil~~  138 (283)
T cd06617          70 FREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIH----------RDVKPSNVLIN  138 (283)
T ss_pred             ecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeec----------CCCCHHHEEEC
Confidence            99999999999995 6888887642   34689999999999999999999997 9999          99999999999


Q ss_pred             CCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC-CHHH
Q psy11571        159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE-SLVE  237 (372)
Q Consensus       159 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~-~~~~  237 (372)
                      .++.+||+|||++........  .....|+..|+|||.+.+.. ....++.++|+|||||++|+|++|+.||... ...+
T Consensus       139 ~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  215 (283)
T cd06617         139 RNGQVKLCDFGISGYLVDSVA--KTIDAGCKPYMAPERINPEL-NQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ  215 (283)
T ss_pred             CCCCEEEeecccccccccccc--cccccCCccccChhhcCCcc-cccccCccccchhhHHHHHHHHhCCCCCCccccCHH
Confidence            999999999999876543221  12246888999999886321 1134688999999999999999999999753 2333


Q ss_pred             HHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcc
Q psy11571        238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWD  312 (372)
Q Consensus       238 ~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~  312 (372)
                      ....+... .....+.   ..+|.++.++|.+||. +|.+||+++++.                 .||||+....+
T Consensus       216 ~~~~~~~~-~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il-----------------~~~~~~~~~~~  270 (283)
T cd06617         216 QLKQVVEE-PSPQLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELL-----------------QHPFFELHLSK  270 (283)
T ss_pred             HHHHHHhc-CCCCCCc---cccCHHHHHHHHHHccCChhhCcCHHHHh-----------------cCchhhhcccc
Confidence            34444332 2222222   2578999999999999 999999876555                 99999987654

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.8e-39  Score=299.97  Aligned_cols=272  Identities=21%  Similarity=0.268  Sum_probs=206.7

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhh--hhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDIL--LVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLH   79 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~--~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~   79 (372)
                      +|+..+.++.|    |+|.||++....++.  .+++|........         ...+.+.+|+.++.++ +||||++++
T Consensus         3 ~~~~~~~lg~g----~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~---------~~~~~~~~E~~~l~~l~~hp~iv~~~   69 (297)
T cd05089           3 DIKFEDVIGEG----NFGQVIRAMIKKDGLKMNAAIKMLKEFASE---------NDHRDFAGELEVLCKLGHHPNIINLL   69 (297)
T ss_pred             cceeeeeecCC----CcceEEEEEecCCCCcceeEEEEccccCCH---------HHHHHHHHHHHHHHhhcCCCchhheE
Confidence            45556666666    899999998766654  3566655432211         1234577899999888 799999999


Q ss_pred             EEEEeCCeEEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCC
Q psy11571         80 YAFQDDSNLYLVMDYYCGGDLLTLLSKFE---------------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAF  144 (372)
Q Consensus        80 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~  144 (372)
                      +++.+.+.+|++|||+++++|.+++....               ..+++..++.++.|++.||+|||++|++|       
T Consensus        70 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH-------  142 (297)
T cd05089          70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIH-------  142 (297)
T ss_pred             EEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCccc-------
Confidence            99999999999999999999999997521               24788999999999999999999999999       


Q ss_pred             CcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHh
Q psy11571        145 HLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML  224 (372)
Q Consensus       145 ~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ell  224 (372)
                         |||||+|||++.++.+||+|||++.......  .......+..|+|||++.     ...++.++|||||||++|||+
T Consensus       143 ---~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlG~il~el~  212 (297)
T cd05089         143 ---RDLAARNVLVGENLASKIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLN-----YSVYTTKSDVWSFGVLLWEIV  212 (297)
T ss_pred             ---CcCCcceEEECCCCeEEECCcCCCcccccee--ccCCCCcCccccCchhhc-----cCCCCchhhHHHHHHHHHHHH
Confidence               9999999999999999999999986432111  111122345799999987     356889999999999999999


Q ss_pred             h-CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCC
Q psy11571        225 Y-GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRN  302 (372)
Q Consensus       225 t-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~  302 (372)
                      + |..||.+.+..+...++... .....+.    .++..+++||.+||+ +|.+||+++++...+  ........... .
T Consensus       213 t~g~~pf~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l--~~~~~~~~~~~-~  284 (297)
T cd05089         213 SLGGTPYCGMTCAELYEKLPQG-YRMEKPR----NCDDEVYELMRQCWRDRPYERPPFAQISVQL--SRMLEARKAYV-N  284 (297)
T ss_pred             cCCCCCCCCCCHHHHHHHHhcC-CCCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHH--HHHHHhhcccc-c
Confidence            7 99999998888877776553 2223333    688999999999999 999999988875443  22222222222 4


Q ss_pred             CCCcCCCCcc
Q psy11571        303 HPWFQGIAWD  312 (372)
Q Consensus       303 hp~f~~~~w~  312 (372)
                      +.+|+++.|.
T Consensus       285 ~~~~~~~~~~  294 (297)
T cd05089         285 MALFENFTYA  294 (297)
T ss_pred             chhhhhhccc
Confidence            5666666554

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-39  Score=309.58  Aligned_cols=258  Identities=24%  Similarity=0.380  Sum_probs=205.7

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      ||+.++.+|.|    ++|.||.+.+..++..||+|.+.......        ...+.+.+|+.+++.++||||+++++++
T Consensus        16 ~y~~~~~lg~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~~~   83 (343)
T cd07880          16 RYRDLKQVGSG----AYGTVCSALDRRTGAKVAIKKLYRPFQSE--------LFAKRAYRELRLLKHMKHENVIGLLDVF   83 (343)
T ss_pred             ceEEEEEeeec----CCeEEEEEEECCCCcEEEEEEecccccch--------HHHHHHHHHHHHHHhcCCCCccceeeee
Confidence            56666777766    79999999998899999999875432111        1234577899999999999999999999


Q ss_pred             EeCC------eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEE
Q psy11571         83 QDDS------NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL  156 (372)
Q Consensus        83 ~~~~------~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIl  156 (372)
                      ....      .+++||||+ +++|.+++..  ..+++..++.++.||+.||+|||+.|++|          |||||+||+
T Consensus        84 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H----------~dlkp~Nil  150 (343)
T cd07880          84 TPDLSLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIH----------RDLKPGNLA  150 (343)
T ss_pred             cCCccccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeec----------CCCCHHHEE
Confidence            7654      468999998 8899998875  67999999999999999999999999999          999999999


Q ss_pred             eCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH
Q psy11571        157 LDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV  236 (372)
Q Consensus       157 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~  236 (372)
                      ++.++.++|+|||++.......    ....+++.|+|||.+.+    ...++.++|+|||||++|+|++|.+||.+.+..
T Consensus       151 l~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~  222 (343)
T cd07880         151 VNEDCELKILDFGLARQTDSEM----TGYVVTRWYRAPEVILN----WMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL  222 (343)
T ss_pred             EcCCCCEEEeecccccccccCc----cccccCCcccCHHHHhC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999999999999987654321    22467889999999873    235788999999999999999999999887765


Q ss_pred             HHHHHHhhccCCcC------------------CC-------CCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhh
Q psy11571        237 ETYGKIMNHQNSFD------------------LP-------SDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWS  290 (372)
Q Consensus       237 ~~~~~i~~~~~~~~------------------~~-------~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~  290 (372)
                      ..+.+++.......                  .+       ......+++.+.++|.+||+ ||++||++.+++      
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l------  296 (343)
T cd07880         223 DQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL------  296 (343)
T ss_pred             HHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh------
Confidence            55555443211100                  00       01112578899999999999 999999876655      


Q ss_pred             hhhhccCCCCCCCCCcCCCC
Q psy11571        291 ALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       291 ~~~~~~~~~~~~hp~f~~~~  310 (372)
                                 .||||+.+.
T Consensus       297 -----------~~~~~~~~~  305 (343)
T cd07880         297 -----------AHPYFEEFH  305 (343)
T ss_pred             -----------cCccHhhhc
Confidence                       999999753

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.2e-39  Score=298.27  Aligned_cols=250  Identities=22%  Similarity=0.317  Sum_probs=201.4

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeee-----hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeee
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETL-----LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNL   78 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~-----~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l   78 (372)
                      |...+.++.|    |+|.||.+...     .++..+++|.+.....          ...+.+.+|+.+++.++||||+++
T Consensus         7 ~~~~~~lg~G----~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~   72 (288)
T cd05093           7 IVLKRELGEG----AFGKVFLAECYNLCPEQDKILVAVKTLKDASD----------NARKDFHREAELLTNLQHEHIVKF   72 (288)
T ss_pred             eeeccccCCc----CCeeEEeeEeccCCCCCcceEEEEEecCCcCH----------HHHHHHHHHHHHHHhCCCCCcceE
Confidence            3444555555    89999998742     2455688887754321          123457789999999999999999


Q ss_pred             eEEEEeCCeEEEEEeccCCCCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCc
Q psy11571         79 HYAFQDDSNLYLVMDYYCGGDLLTLLSKFE------------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL  146 (372)
Q Consensus        79 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~v  146 (372)
                      ++++...+.+++||||+++++|.+++....            ..+++..+..++.|++.||+|||++|++|         
T Consensus        73 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H---------  143 (288)
T cd05093          73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVH---------  143 (288)
T ss_pred             EEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeee---------
Confidence            999999999999999999999999997532            24899999999999999999999999999         


Q ss_pred             CCCCCcCcEEeCCCCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh
Q psy11571        147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY  225 (372)
Q Consensus       147 hrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt  225 (372)
                       |||||+||++++++.++|+|||++........ .......++..|+|||++.+     ..++.++|+|||||++|+|++
T Consensus       144 -~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~il~~l~t  217 (288)
T cd05093         144 -RDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-----RKFTTESDVWSLGVVLWEIFT  217 (288)
T ss_pred             -cccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-----CCCCchhhHHHHHHHHHHHHh
Confidence             99999999999999999999999976543221 11122345778999999873     568889999999999999998


Q ss_pred             -CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        226 -GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       226 -G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                       |.+||...+..+....+..+.. ...+.    .++.++.+|+.+||+ ||.+||+++++.+.+
T Consensus       218 ~g~~p~~~~~~~~~~~~i~~~~~-~~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l  276 (288)
T cd05093         218 YGKQPWYQLSNNEVIECITQGRV-LQRPR----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLL  276 (288)
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCc-CCCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence             9999998888887777766532 22232    578999999999999 999999988876554

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.7e-39  Score=302.70  Aligned_cols=252  Identities=18%  Similarity=0.249  Sum_probs=201.7

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhh----hhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILL----VLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITN   77 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~----va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~   77 (372)
                      .+|+.++.+|.|    |+|.||++....++..    ||+|.+......         ...+.+.+|+.+++.++||||++
T Consensus         7 ~~f~~~~~lg~G----~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~e~~~l~~l~h~niv~   73 (316)
T cd05108           7 TEFKKIKVLGSG----AFGTVYKGLWIPEGEKVKIPVAIKELREATSP---------KANKEILDEAYVMASVDNPHVCR   73 (316)
T ss_pred             hhceeeeeeecC----CCceEEEEEEecCCCccceeEEEEeccccCCH---------HHHHHHHHHHHHHHhCCCCCCCe
Confidence            467778888888    7999999987666554    788877543211         12345778999999999999999


Q ss_pred             eeEEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe
Q psy11571         78 LHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        78 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      +++++... ..++++||+++|+|.+++......+++..+..++.||+.||+|||+.|++|          |||||+|||+
T Consensus        74 ~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH----------~dlkp~Nill  142 (316)
T cd05108          74 LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVH----------RDLAARNVLV  142 (316)
T ss_pred             EEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeec----------cccchhheEe
Confidence            99998765 578999999999999999875567899999999999999999999999999          9999999999


Q ss_pred             CCCCcEEEeecCcccccCCCCcc-cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCH
Q psy11571        158 DANGHIRLADFGSCLRLGGDGTV-QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESL  235 (372)
Q Consensus       158 ~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~  235 (372)
                      +.++.+||+|||+++........ ......++..|+|||.+.     ...++.++|||||||++|||++ |..||.+...
T Consensus       143 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~-----~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~  217 (316)
T cd05108         143 KTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL-----HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA  217 (316)
T ss_pred             cCCCcEEEccccccccccCCCcceeccCCccceeecChHHhc-----cCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence            99999999999999876533221 112223467899999997     3568899999999999999997 9999988776


Q ss_pred             HHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       236 ~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .+... +......++.+.    ..+.++.+++.+||. +|++||++.++...+
T Consensus       218 ~~~~~-~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l  265 (316)
T cd05108         218 SEISS-ILEKGERLPQPP----ICTIDVYMIMVKCWMIDADSRPKFRELIIEF  265 (316)
T ss_pred             HHHHH-HHhCCCCCCCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            66543 434333333333    578999999999999 999999988776543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.2e-39  Score=295.17  Aligned_cols=254  Identities=26%  Similarity=0.382  Sum_probs=203.7

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+..+.++.|    ++|.||++....+++.+|+|.+........       +....+.+|+.+++.++||||+++++.+
T Consensus         3 ~~~i~~~l~~g----~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~   71 (267)
T cd08228           3 NFQIEKKIGRG----QFSEVYRATCLLDRKPVALKKVQIFEMMDA-------KARQDCVKEIDLLKQLNHPNVIKYLDSF   71 (267)
T ss_pred             ceeeeeeeccC----CCeeEEEEEEeCCCCEEEEEEeeccccCCH-------HHHHHHHHHHHHHHhCCCcceeeeeeeE
Confidence            45666677766    799999999999999999997765332222       2335567899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKF---EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA  159 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~  159 (372)
                      .+.+..+++|||+++++|.+++...   ...+++..+..++.||+.||.|||++|++|          +||||+||+++.
T Consensus        72 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H----------~dl~~~nil~~~  141 (267)
T cd08228          72 IEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMH----------RDIKPANVFITA  141 (267)
T ss_pred             EECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeC----------CCCCHHHEEEcC
Confidence            9999999999999999999988532   345899999999999999999999999999          999999999999


Q ss_pred             CCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCC--HHH
Q psy11571        160 NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES--LVE  237 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~--~~~  237 (372)
                      ++.++|+|||++........ ......|++.|+|||.+.+     ..++.++|+||+|+++|+|++|..||....  ...
T Consensus       142 ~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~  215 (267)
T cd08228         142 TGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHE-----NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS  215 (267)
T ss_pred             CCCEEECccccceeccchhH-HHhcCCCCccccChhhhcc-----CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHH
Confidence            99999999999887643322 1223468889999999873     457889999999999999999999997653  234


Q ss_pred             HHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       238 ~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ....+....    .++......+..+.++|.+||+ +|++||+++++++.+
T Consensus       216 ~~~~~~~~~----~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~  262 (267)
T cd08228         216 LCQKIEQCD----YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIA  262 (267)
T ss_pred             HHHHHhcCC----CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHH
Confidence            444443322    1222222578999999999999 999999988887654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.4e-40  Score=310.69  Aligned_cols=262  Identities=21%  Similarity=0.310  Sum_probs=205.1

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      .+|+.+..++.|    |+|.||.+.+..+++.|++|.+........        ....+.+|+.+++.++||||++++++
T Consensus         5 ~~y~~~~~lg~G----~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~ni~~~~~~   72 (337)
T cd07858           5 TKYVPIKPIGRG----AYGIVCSAKNSETNEKVAIKKIANAFDNRI--------DAKRTLREIKLLRHLDHENVIAIKDI   72 (337)
T ss_pred             cceeEEEEeccC----CCeEEEEEEecCCCCeEEEEEecccccccc--------hhHHHHHHHHHHHhcCCCCccchHHh
Confidence            466777777776    799999999999999999998765332211        12345679999999999999999998


Q ss_pred             EEeC-----CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEE
Q psy11571         82 FQDD-----SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL  156 (372)
Q Consensus        82 ~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIl  156 (372)
                      +...     ...|++|||+ +++|.+++.. .+.+++..+..++.|++.||.|||++|++|          |||||+||+
T Consensus        73 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H----------~dlkp~Nil  140 (337)
T cd07858          73 MPPPHREAFNDVYIVYELM-DTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLH----------RDLKPSNLL  140 (337)
T ss_pred             eecccccccCcEEEEEeCC-CCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEec----------CCCCHHHEE
Confidence            8654     3589999999 5799999877 578999999999999999999999999999          999999999


Q ss_pred             eCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH
Q psy11571        157 LDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV  236 (372)
Q Consensus       157 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~  236 (372)
                      ++.++.+||+|||++........ ......++..|+|||.+.+    ...++.++|+|||||++|+|++|++||.+.+..
T Consensus       141 ~~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~  215 (337)
T cd07858         141 LNANCDLKICDFGLARTTSEKGD-FMTEYVVTRWYRAPELLLN----CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV  215 (337)
T ss_pred             EcCCCCEEECcCccccccCCCcc-cccccccccCccChHHHhc----CCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH
Confidence            99999999999999987643321 2233467889999999863    235888999999999999999999999876654


Q ss_pred             HHHHHHhhccCC-----------------------cCCC--CCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhh
Q psy11571        237 ETYGKIMNHQNS-----------------------FDLP--SDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWS  290 (372)
Q Consensus       237 ~~~~~i~~~~~~-----------------------~~~~--~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~  290 (372)
                      .....+......                       ...+  ......+++++++||++||+ +|++||++++++      
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell------  289 (337)
T cd07858         216 HQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEAL------  289 (337)
T ss_pred             HHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHH------
Confidence            433322211000                       0000  00112578999999999999 999999866655      


Q ss_pred             hhhhccCCCCCCCCCcCCC
Q psy11571        291 ALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       291 ~~~~~~~~~~~~hp~f~~~  309 (372)
                                 +||||+.+
T Consensus       290 -----------~h~~~~~~  297 (337)
T cd07858         290 -----------AHPYLASL  297 (337)
T ss_pred             -----------cCcchhhh
Confidence                       99999865

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=6.8e-39  Score=292.15  Aligned_cols=249  Identities=20%  Similarity=0.265  Sum_probs=203.3

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.++.|    |+|.||.+... ++..+++|.+.......           +.+.+|+.+++.++||||+++++.
T Consensus         6 ~~~~~~~~ig~g----~~~~v~~~~~~-~~~~~~~k~~~~~~~~~-----------~~~~~E~~~l~~l~~~~i~~~~~~   69 (260)
T cd05070           6 ESLQLIKKLGNG----QFGEVWMGTWN-GNTKVAVKTLKPGTMSP-----------ESFLEEAQIMKKLRHDKLVQLYAV   69 (260)
T ss_pred             HHhhhhheeccc----cCceEEEEEec-CCceeEEEEecCCCCCH-----------HHHHHHHHHHHhcCCCceEEEEeE
Confidence            578888888887    89999999644 66678988876543321           236789999999999999999998


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      +.. ...|++|||+++++|.+++... ...+++..++.++.|++.||.|||+.|++|          |||||+||+++++
T Consensus        70 ~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H----------~di~p~Nili~~~  138 (260)
T cd05070          70 VSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIH----------RDLRSANILVGDG  138 (260)
T ss_pred             ECC-CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------CCCccceEEEeCC
Confidence            754 5689999999999999999763 245899999999999999999999999999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETY  239 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~  239 (372)
                      +.++|+|||++...............++..|+|||.+.     ...++.++|+||||+++|+|++ |.+||.+.+..+..
T Consensus       139 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~  213 (260)
T cd05070         139 LVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL-----YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL  213 (260)
T ss_pred             ceEEeCCceeeeeccCcccccccCCCCCccccChHHHh-----cCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            99999999999765443222222234566899999987     3568899999999999999999 99999988877777


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ..+... ...+.+.    ..+..+++|+.+||. +|.+|||++++.+.+
T Consensus       214 ~~~~~~-~~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l  257 (260)
T cd05070         214 EQVERG-YRMPCPQ----DCPISLHELMLQCWKKDPEERPTFEYLQSFL  257 (260)
T ss_pred             HHHHcC-CCCCCCC----cCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence            776543 2233333    678999999999999 999999988776554

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=5e-39  Score=296.56  Aligned_cols=252  Identities=20%  Similarity=0.299  Sum_probs=203.1

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeee-----ehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCcee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIET-----LLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWIT   76 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~-----~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv   76 (372)
                      ++++..++++.|    |+|.||.+..     ..++..+++|.+......          ..+.+.+|+.+++.++||||+
T Consensus         5 ~~~~~~~~lg~g----~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~   70 (280)
T cd05092           5 RDIVLKWELGEG----AFGKVFLAECHNLLPEQDKMLVAVKALKEASES----------ARQDFQREAELLTVLQHQHIV   70 (280)
T ss_pred             HhceeccccCCc----cCCeEEEeEEecCCCCCCceEEEEEecCcCCHH----------HHHHHHHHHHHHhcCCCCCCc
Confidence            456667777776    8999999863     234667888866543221          234578899999999999999


Q ss_pred             eeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCC
Q psy11571         77 NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE--------------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHF  142 (372)
Q Consensus        77 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~  142 (372)
                      ++++++.+....+++|||+++++|.+++....              ..+++..+..++.||+.||+|||+.|++|     
T Consensus        71 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H-----  145 (280)
T cd05092          71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVH-----  145 (280)
T ss_pred             eEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeec-----
Confidence            99999999999999999999999999997632              24789999999999999999999999999     


Q ss_pred             CCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCcc-cccccccCCcccCcccccccccCCCCCCCccceeehhHHHH
Q psy11571        143 AFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTV-QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMY  221 (372)
Q Consensus       143 ~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~  221 (372)
                           |||||+|||+++++.++|+|||++......... ......+++.|+|||.+.+     ..++.++|+|||||++|
T Consensus       146 -----~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~  215 (280)
T cd05092         146 -----RDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-----RKFTTESDIWSFGVVLW  215 (280)
T ss_pred             -----ccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-----CCcCchhhHHHHHHHHH
Confidence                 999999999999999999999998755332211 1122345678999999873     56889999999999999


Q ss_pred             HHhh-CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        222 EMLY-GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       222 ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      +|++ |.+||......+....+.... ....+.    .+++.+.++|.+||+ +|.+||+++++.+.+
T Consensus       216 el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l  278 (280)
T cd05092         216 EIFTYGKQPWYQLSNTEAIECITQGR-ELERPR----TCPPEVYAIMQGCWQREPQQRMVIKDIHSRL  278 (280)
T ss_pred             HHHcCCCCCCccCCHHHHHHHHHcCc-cCCCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence            9998 999998887777776665542 222233    678999999999999 999999988877544

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-39  Score=293.47  Aligned_cols=253  Identities=23%  Similarity=0.332  Sum_probs=202.5

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      .|+..+.++.|    ++|.||.+.+..+++.+++|..........     ..+....+.+|+.+++.++||||+++++.+
T Consensus         3 ~~~~~~~lg~g----~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-----~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~   73 (264)
T cd06653           3 NWRLGKLLGRG----AFGEVYLCYDADTGRELAVKQVPFDPDSQE-----TSKEVNALECEIQLLKNLRHDRIVQYYGCL   73 (264)
T ss_pred             ceeeeeeEccC----CCeEEEEEEEcCCCCEEEEEEEecCcccch-----hhHHHHHHHHHHHHHHHcCCCCcceEEEEE
Confidence            34445555555    899999999988999999997643221110     122456788999999999999999999998


Q ss_pred             EeC--CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         83 QDD--SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        83 ~~~--~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      .+.  ..++++|||+++++|.+++.+ .+.+++..++.++.|++.||.|||+.|++|          +||||+||+++.+
T Consensus        74 ~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~i~H----------~dl~p~ni~i~~~  142 (264)
T cd06653          74 RDPEEKKLSIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHSNMIVH----------RDIKGANILRDSA  142 (264)
T ss_pred             EcCCCCEEEEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEec----------CCCCHHHEEEcCC
Confidence            764  468999999999999999987 466899999999999999999999999999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCc--ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGT--VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET  238 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~  238 (372)
                      +.++|+|||+++.......  .......|+..|+|||.+.+     ..++.++|+|||||++|+|++|+.||......+.
T Consensus       143 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~  217 (264)
T cd06653         143 GNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG-----EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA  217 (264)
T ss_pred             CCEEECccccccccccccccCccccccCCcccccCHhhhcC-----CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH
Confidence            9999999999976532110  11123468899999999973     4578899999999999999999999988776666


Q ss_pred             HHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCCChh
Q psy11571        239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIA  284 (372)
Q Consensus       239 ~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~~p~~R~s~~~~~  284 (372)
                      ..++........+|.    .+++.+.++|.+||++|.+||++.+++
T Consensus       218 ~~~~~~~~~~~~~p~----~~~~~~~~~i~~~l~~~~~r~~~~~~~  259 (264)
T cd06653         218 IFKIATQPTKPMLPD----GVSDACRDFLKQIFVEEKRRPTAEFLL  259 (264)
T ss_pred             HHHHHcCCCCCCCCc----ccCHHHHHHHHHHhcCcccCccHHHHh
Confidence            655554333333343    789999999999999889999877655

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.1e-38  Score=294.46  Aligned_cols=253  Identities=18%  Similarity=0.212  Sum_probs=206.6

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeeh-----hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCcee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLL-----DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWIT   76 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~-----~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv   76 (372)
                      ..|+.++++|.|    |+|.||++....     +++.+|+|.+......         ...+.+.+|..++..++||||+
T Consensus         5 ~~~~~~~~lg~G----~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~e~~~~~~l~h~~iv   71 (283)
T cd05091           5 STVRFMEELGED----RFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG---------PLREEFKHEAMMRSRLQHPNIV   71 (283)
T ss_pred             HHHHHHHHhCCC----CCCeEEEEEEecCCCCCceeEEEEEEccCCCCH---------HHHHHHHHHHHHHhcCCCCCcC
Confidence            367888888888    899999997654     3578999987643321         1235577899999999999999


Q ss_pred             eeeEEEEeCCeEEEEEeccCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCC
Q psy11571         77 NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKF---------------EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH  141 (372)
Q Consensus        77 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~---------------~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~  141 (372)
                      ++++++.+....++++||+.+++|.+++...               ...+++..+..++.|++.||.|||++|++|    
T Consensus        72 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H----  147 (283)
T cd05091          72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVH----  147 (283)
T ss_pred             eEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccc----
Confidence            9999999999999999999999999998531               134788889999999999999999999999    


Q ss_pred             CCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHHH
Q psy11571        142 FAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCM  220 (372)
Q Consensus       142 ~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil  220 (372)
                            |||||+||+++.++.+||+|||+++....... .......+++.|+|||.+.     ...++.++|||||||++
T Consensus       148 ------~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l  216 (283)
T cd05091         148 ------KDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIM-----YGKFSIDSDIWSYGVVL  216 (283)
T ss_pred             ------cccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHh-----cCCCCcchhHHHHHHHH
Confidence                  99999999999999999999999876543221 1122334678999999987     35688999999999999


Q ss_pred             HHHhh-CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        221 YEMLY-GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       221 ~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      |||++ |..||.+.+..+....+..... ...+.    .++..+.+|+.+||+ +|.+||+++++...+
T Consensus       217 ~el~~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~----~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l  280 (283)
T cd05091         217 WEVFSYGLQPYCGYSNQDVIEMIRNRQV-LPCPD----DCPAWVYTLMLECWNEFPSRRPRFKDIHSRL  280 (283)
T ss_pred             HHHHcCCCCCCCCCCHHHHHHHHHcCCc-CCCCC----CCCHHHHHHHHHHhCCCcccCCCHHHHHHHh
Confidence            99998 8999998888888877766532 22333    689999999999999 999999988776433

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.9e-39  Score=292.02  Aligned_cols=248  Identities=29%  Similarity=0.440  Sum_probs=207.6

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+.++.++.|    |+|.||.+....++..+++|.+.......        +..+.+.+|+.+++.++|||++++.+.+.
T Consensus         2 y~~~~~l~~g----~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~   69 (258)
T cd08215           2 YEIIKQIGKG----SFGKVYLVRRKSDGKLYVLKEIDLSNMSE--------KEREDALNEVKILKKLNHPNIIKYYESFE   69 (258)
T ss_pred             ceEEeeeccC----CCeEEEEEEEcCCCcEEEEEEeecccCCh--------HHHHHHHHHHHHHHhcCCCChhheEEEEe
Confidence            4445555555    89999999998889999999886654432        13445778999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKF---EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      .....++|+||+++++|.+++...   ...+++..+..++.+++.||.+||+.|++|          +||+|+||+++.+
T Consensus        70 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H----------~dl~~~nil~~~~  139 (258)
T cd08215          70 EKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILH----------RDIKPQNIFLTSN  139 (258)
T ss_pred             cCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEec----------ccCChHHeEEcCC
Confidence            999999999999999999999874   267999999999999999999999999999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG  240 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~  240 (372)
                      +.++|+|||.+........ ......|++.|+|||.+.+     ..++.++|+||+|+++|+|++|..||...+..+...
T Consensus       140 ~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~-----~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~  213 (258)
T cd08215         140 GLVKLGDFGISKVLSSTVD-LAKTVVGTPYYLSPELCQN-----KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELAL  213 (258)
T ss_pred             CcEEECCccceeecccCcc-eecceeeeecccChhHhcc-----CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHH
Confidence            9999999999977654331 2233578899999999873     557889999999999999999999998888777776


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      .+.... ...++.    .++.++.+++.+||. +|++||++++++
T Consensus       214 ~~~~~~-~~~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll  253 (258)
T cd08215         214 KILKGQ-YPPIPS----QYSSELRNLVSSLLQKDPEERPSIAQIL  253 (258)
T ss_pred             HHhcCC-CCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence            665543 223333    678999999999999 999999877666

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-39  Score=295.46  Aligned_cols=253  Identities=20%  Similarity=0.241  Sum_probs=203.4

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehh-----hhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCcee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLD-----ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWIT   76 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~-----~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv   76 (372)
                      ++|+.++.+|.|    |+|.||++.....     +..+++|.........         ....+.+|+.+++.++||||+
T Consensus         6 ~~~~~~~~lg~g----~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~---------~~~~~~~e~~~l~~~~~~~i~   72 (277)
T cd05032           6 EKITLIRELGQG----SFGMVYEGLAKGVVKGEPETRVAIKTVNENASMR---------ERIEFLNEASVMKEFNCHHVV   72 (277)
T ss_pred             HHeeEEeEecCC----CCceEEEEEEeccCCCCcceeEEEEecCCccCHH---------HHHHHHHHHHHHHhCCCCcee
Confidence            355666666666    8999999876543     3789999865432111         124467799999999999999


Q ss_pred             eeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcC
Q psy11571         77 NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE---------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC  147 (372)
Q Consensus        77 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vh  147 (372)
                      ++++++.+....|+||||+++|+|.+++....         ..+++..+..++.|++.||.|||+.|++|          
T Consensus        73 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H----------  142 (277)
T cd05032          73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVH----------  142 (277)
T ss_pred             EEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc----------
Confidence            99999999999999999999999999997521         23678899999999999999999999999          


Q ss_pred             CCCCcCcEEeCCCCcEEEeecCcccccCCCCcc-cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-
Q psy11571        148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTV-QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-  225 (372)
Q Consensus       148 rDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-  225 (372)
                      |||||+||+++.++.++|+|||+++........ ......++..|+|||.+.     ...++.++|+|||||++|+|++ 
T Consensus       143 ~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~t~  217 (277)
T cd05032         143 RDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK-----DGVFTTKSDVWSFGVVLWEMATL  217 (277)
T ss_pred             cccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHh-----cCCCCcccchHHHHHHHHHhhcc
Confidence            999999999999999999999998765433221 122345678899999987     3568899999999999999998 


Q ss_pred             CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        226 GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       226 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      |..||.+.+..+....+... .....|.    ..+.++.++|.+||+ +|++||++.++.+.+
T Consensus       218 g~~p~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l  275 (277)
T cd05032         218 AEQPYQGLSNEEVLKFVIDG-GHLDLPE----NCPDKLLELMRMCWQYNPKMRPTFLEIVSSL  275 (277)
T ss_pred             CCCCCccCCHHHHHHHHhcC-CCCCCCC----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHh
Confidence            99999988887777766633 3334444    568999999999999 999999988877544

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=6.2e-39  Score=298.00  Aligned_cols=253  Identities=25%  Similarity=0.434  Sum_probs=205.6

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |..+..++.|    ++|.||++....++..+++|.+......          ....+.+|+.+++.++||||+++++.+.
T Consensus        22 ~~~~~~lg~g----~~g~v~~~~~~~~~~~v~iK~~~~~~~~----------~~~~~~~e~~~l~~l~h~~iv~~~~~~~   87 (292)
T cd06657          22 LDNFIKIGEG----STGIVCIATVKSSGKLVAVKKMDLRKQQ----------RRELLFNEVVIMRDYQHENVVEMYNSYL   87 (292)
T ss_pred             hhhHHHcCCC----CCeEEEEEEEcCCCeEEEEEEecccchh----------HHHHHHHHHHHHHhcCCcchhheeeEEE
Confidence            3444455555    7999999988889999999976432211          2345778999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcE
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI  163 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~v  163 (372)
                      ..+..|++|||+++++|.+++..  ..+++..++.++.|++.||+|||+.|++|          +||+|+||+++.++.+
T Consensus        88 ~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH----------~dl~p~Nilv~~~~~~  155 (292)
T cd06657          88 VGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIH----------RDIKSDSILLTHDGRV  155 (292)
T ss_pred             eCCEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeec----------CCCCHHHEEECCCCCE
Confidence            99999999999999999998865  57899999999999999999999999999          9999999999999999


Q ss_pred             EEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHh
Q psy11571        164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM  243 (372)
Q Consensus       164 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~  243 (372)
                      +|+|||++........ ......|++.|+|||.+.     ...++.++|+||+|+++|+|++|..||.+.+..+....+.
T Consensus       156 ~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~pE~~~-----~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~  229 (292)
T cd06657         156 KLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPELIS-----RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR  229 (292)
T ss_pred             EEcccccceecccccc-cccccccCccccCHHHhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999998876543221 223356889999999986     3557889999999999999999999999877666555543


Q ss_pred             hccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        244 NHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      ... ...+..  ...++..+.++|.+||. +|.+||++++++                 .||||..
T Consensus       230 ~~~-~~~~~~--~~~~~~~l~~li~~~l~~~P~~R~~~~~ll-----------------~~~~~~~  275 (292)
T cd06657         230 DNL-PPKLKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELL-----------------KHPFLAK  275 (292)
T ss_pred             hhC-CcccCC--cccCCHHHHHHHHHHHhCCcccCcCHHHHh-----------------cChHHhc
Confidence            321 111111  12578999999999999 999999876655                 9999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.6e-39  Score=299.92  Aligned_cols=257  Identities=25%  Similarity=0.355  Sum_probs=203.4

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+.++.++.|    ++|.||++.+..++..+++|.+.......         ..+.+.+|+.+++.++||||+++++.+.
T Consensus         2 y~~~~~l~~g----~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~~   68 (284)
T cd07836           2 FKQLEKLGEG----TYATVYKGRNRTTGEIVALKEIHLDAEEG---------TPSTAIREISLMKELKHENIVRLHDVIH   68 (284)
T ss_pred             ceEeeeeccC----CceEEEEEEECCCCeEEEEEEeccccccc---------chHHHHHHHHHHHhhcCCCEeeeeeeEe
Confidence            5556666666    79999999998899999999876543221         1234567999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFE--DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+..++||||++ ++|.+++....  ..+++..+..++.|++.||.|||+.|++|          |||||+||++++++
T Consensus        69 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h----------~dl~p~ni~~~~~~  137 (284)
T cd07836          69 TENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLH----------RDLKPQNLLINKRG  137 (284)
T ss_pred             eCCcEEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeee----------CCCCHHHEEECCCC
Confidence            9999999999997 48999887633  46899999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .++|+|||++........ ......++..|+|||++.+    ...++.++|+|||||++|+|++|++||.+.+..+...+
T Consensus       138 ~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~----~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~  212 (284)
T cd07836         138 ELKLADFGLARAFGIPVN-TFSNEVVTLWYRAPDVLLG----SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLK  212 (284)
T ss_pred             cEEEeecchhhhhcCCcc-ccccccccccccChHHhcC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence            999999999976543221 1122457889999999863    34578899999999999999999999998877666555


Q ss_pred             HhhccCCc----------------CCCC-------CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccC
Q psy11571        242 IMNHQNSF----------------DLPS-------DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLS  297 (372)
Q Consensus       242 i~~~~~~~----------------~~~~-------~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~  297 (372)
                      +.......                ..+.       .....++..++++|.+||+ +|.+||++++++             
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l-------------  279 (284)
T cd07836         213 IFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDAL-------------  279 (284)
T ss_pred             HHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHh-------------
Confidence            44321000                0000       0011457899999999999 999999866555             


Q ss_pred             CCCCCCCCc
Q psy11571        298 ISPRNHPWF  306 (372)
Q Consensus       298 ~~~~~hp~f  306 (372)
                          .||||
T Consensus       280 ----~~~~f  284 (284)
T cd07836         280 ----QHPWF  284 (284)
T ss_pred             ----cCCCC
Confidence                99998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-39  Score=299.07  Aligned_cols=253  Identities=24%  Similarity=0.336  Sum_probs=197.9

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+.++.++.|    ++|.||++.+..+++.|++|.+........        ..+.+.+|+.+++.++||||+++++++.
T Consensus         1 y~~~~~l~~g----~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~--------~~~~~~~E~~~l~~l~~~~iv~~~~~~~   68 (283)
T cd07835           1 YQKVEKIGEG----TYGVVYKARDKLTGEIVALKKIRLETEDEG--------VPSTAIREISLLKELNHPNIVRLLDVVH   68 (283)
T ss_pred             CchheEecCC----CCeEEEEEEEcCCCCEEEEEEeeccccccc--------chhHHHHHHHHHHhcCCCCccCHhheec
Confidence            3455666666    799999999888999999998765432221        1234667999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      +.+..|++|||+ +++|.+++.... ..+++..+..++.|++.||+|||+++++|          |||+|+||+++.++.
T Consensus        69 ~~~~~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H----------~dl~p~nil~~~~~~  137 (283)
T cd07835          69 SENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLH----------RDLKPQNLLIDREGA  137 (283)
T ss_pred             cCCeEEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeC----------CCCCHHHEEEcCCCc
Confidence            999999999999 569999987632 36899999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      ++|+|||++......... .....+++.|+|||++.+    ...++.++|+||||+++|+|++|++||...+......++
T Consensus       138 ~~l~df~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  212 (283)
T cd07835         138 LKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLG----SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRI  212 (283)
T ss_pred             EEEeecccccccCCCccc-cCccccccCCCCCceeec----CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999998765432211 122356889999998863    345788999999999999999999999887765544443


Q ss_pred             hhccCC-----------------------cCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        243 MNHQNS-----------------------FDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       243 ~~~~~~-----------------------~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      ......                       ..........++..+.++|.+||+ +|.+||+++++.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il  278 (283)
T cd07835         213 FRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAAL  278 (283)
T ss_pred             HHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence            321100                       000111123678999999999999 999999865555

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.7e-39  Score=295.09  Aligned_cols=247  Identities=27%  Similarity=0.407  Sum_probs=200.1

Q ss_pred             HHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe
Q psy11571          5 RELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQD   84 (372)
Q Consensus         5 ~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~   84 (372)
                      +.++.++.|    |+|.||++....++..+++|.+........        ..+.+.+|+.+++.++||||+++++.+.+
T Consensus         3 ~~~~~l~~g----~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~--------~~~~~~~E~~~l~~~~h~~i~~~~~~~~~   70 (257)
T cd08225           3 EIIKKIGEG----SFGKIYLAKAKSDSEHCVIKEIDLTKMPVK--------EKEASKKEVILLAKMKHPNIVTFFASFQE   70 (257)
T ss_pred             eEEEEecCC----CcceEEEEEEcCCCceEEEEEeeHhhccch--------hhHHHHHHHHHHHhCCCCChhhhhheecc
Confidence            334444444    899999999988999999998765432211        23456789999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC-c
Q psy11571         85 DSNLYLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG-H  162 (372)
Q Consensus        85 ~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~-~  162 (372)
                      ....|+|+||+++++|.+++.... ..+++..+..++.|++.||.|||+.+++|          +||||+||++++++ .
T Consensus        71 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H----------~dl~~~nil~~~~~~~  140 (257)
T cd08225          71 NGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILH----------RDIKSQNIFLSKNGMV  140 (257)
T ss_pred             CCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------ccCCHHHEEEcCCCCe
Confidence            999999999999999999997632 35799999999999999999999999999          99999999999876 4


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      ++|+|||.+........ ......|++.|+|||.+.+     ..++.++|+||||+++|+|++|..||...+..+....+
T Consensus       141 ~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~-----~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~  214 (257)
T cd08225         141 AKLGDFGIARQLNDSME-LAYTCVGTPYYLSPEICQN-----RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKI  214 (257)
T ss_pred             EEecccccchhccCCcc-cccccCCCccccCHHHHcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence            69999999876653322 2223468899999999873     56888999999999999999999999887776666665


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      ...... ..+    ..++.+++++|.+||. +|++||++++++
T Consensus       215 ~~~~~~-~~~----~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll  252 (257)
T cd08225         215 CQGYFA-PIS----PNFSRDLRSLISQLFKVSPRDRPSITSIL  252 (257)
T ss_pred             hcccCC-CCC----CCCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence            543221 112    2578999999999999 999999876665

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG4645|consensus

Probab=100.00  E-value=3.5e-41  Score=342.17  Aligned_cols=242  Identities=25%  Similarity=0.404  Sum_probs=205.4

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      |-+|.||.+....+|...|+|.+...... .       +....+.+|..++..++|||+|++|++-.+.+.++|.||||.
T Consensus      1246 G~fG~VYtavN~~tGellAvKEI~iq~~~-~-------k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~ 1317 (1509)
T KOG4645|consen 1246 GTFGKVYTAVNLDTGELLAVKEIKIQDSD-H-------KTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCE 1317 (1509)
T ss_pred             cceeeeEEeecCCccchhhhhhhhcCccc-c-------ccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhc
Confidence            35788999999999999999988776554 2       245567889999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCC
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG  176 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  176 (372)
                      ||+|.+++.. ++..+|...+.|..|++.|++|||++||||          |||||.||+++.+|.+|++|||.|..+..
T Consensus      1318 ~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~gIVH----------RDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1318 GGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHGIVH----------RDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             cCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcCcee----------cCCCccceeeecCCcEEeecccceeEecC
Confidence            9999999987 566788899999999999999999999999          99999999999999999999999988765


Q ss_pred             CCcc---cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCC-CCHHHHHHHHhhccCCcCCC
Q psy11571        177 DGTV---QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHQNSFDLP  252 (372)
Q Consensus       177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~  252 (372)
                      ....   .-....||+.|||||++.+..  ......++|||||||++.||+||+.||.. +++-.++.++..+. .+++|
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~--~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh-~Pq~P 1463 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTK--GKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGH-KPQIP 1463 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhcccc--cCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccC-CCCCc
Confidence            4211   113468999999999998643  12356689999999999999999999976 45556666666553 45566


Q ss_pred             CCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        253 SDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       253 ~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      .    .+|.+.+|||.+||+ ||++|.++.+++
T Consensus      1464 ~----~ls~~g~dFle~Cl~~dP~~Rw~~~qll 1492 (1509)
T KOG4645|consen 1464 E----RLSSEGRDFLEHCLEQDPKMRWTASQLL 1492 (1509)
T ss_pred             h----hhhHhHHHHHHHHHhcCchhhhHHHHHH
Confidence            6    589999999999999 999999877666

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.4e-38  Score=298.99  Aligned_cols=256  Identities=23%  Similarity=0.339  Sum_probs=209.2

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      .|+.++.++.|    ++|.||+++...++..+++|.+........       +..+.+.+|+.+++.++|||++++++++
T Consensus        26 ~f~~~~~lg~G----~~~~v~~~~~~~~~~~valK~~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~   94 (317)
T cd06635          26 LFTDLREIGHG----SFGAVYFARDVRTNEVVAIKKMSYSGKQSN-------EKWQDIIKEVKFLQRIKHPNSIEYKGCY   94 (317)
T ss_pred             hhhhhheeccC----CCeEEEEEEEcCCCcEEEEEEEecCCCCch-------HHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            46677777776    899999999888999999998765433222       2345577899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .++...|+||||+. |+|.+++......+++..+..++.|++.||.|||+.|++|          |||+|+||+++.++.
T Consensus        95 ~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H----------~dL~p~Nil~~~~~~  163 (317)
T cd06635          95 LREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIH----------RDIKAGNILLTEPGQ  163 (317)
T ss_pred             eeCCeEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------CCCCcccEEECCCCC
Confidence            99999999999996 5888887654567999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      ++|+|||++......     ....|++.|+|||.+....  .+.++.++|+|||||++|+|++|.+||...+.......+
T Consensus       164 ~kl~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~--~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~  236 (317)
T cd06635         164 VKLADFGSASIASPA-----NSFVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI  236 (317)
T ss_pred             EEEecCCCccccCCc-----ccccCCccccChhhhhcCC--CCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence            999999988654322     2346889999999985211  245788999999999999999999999887776666666


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      ........ +   ...+++.++++|.+||+ +|.+||+++++.                 .|+|+..
T Consensus       237 ~~~~~~~~-~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il-----------------~~~~~~~  282 (317)
T cd06635         237 AQNESPTL-Q---SNEWSDYFRNFVDSCLQKIPQDRPTSEELL-----------------KHMFVLR  282 (317)
T ss_pred             HhccCCCC-C---CccccHHHHHHHHHHccCCcccCcCHHHHH-----------------hChhhhc
Confidence            55432221 1   12578999999999999 999999866655                 9999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.3e-39  Score=302.43  Aligned_cols=260  Identities=24%  Similarity=0.332  Sum_probs=199.0

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.+..++.|    ++|.||++.+..+++.||+|.+........        ....+.+|+.+++.++||||+++++++
T Consensus        13 ~y~~~~~lg~g----~~~~v~~~~~~~~~~~~aik~~~~~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~~~~~   80 (310)
T cd07865          13 KYEKLAKIGQG----TFGEVFKARHKKTKQIVALKKVLMENEKEG--------FPITALREIKILQLLKHENVVNLIEIC   80 (310)
T ss_pred             heEEEEEeecC----CCEEEEEEEECCCCcEEEEEEEeccCCcCC--------chhHHHHHHHHHHhCCCCCccceEEEE
Confidence            45666666666    799999999988999999998754332211        112345689999999999999999998


Q ss_pred             EeCC--------eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCc
Q psy11571         83 QDDS--------NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDN  154 (372)
Q Consensus        83 ~~~~--------~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~N  154 (372)
                      .+..        ..++||||+. ++|.+++......+++.+++.++.||+.||.|||++|++|          +||||+|
T Consensus        81 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H----------~dl~p~n  149 (310)
T cd07865          81 RTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILH----------RDMKAAN  149 (310)
T ss_pred             ecccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeec----------cCCCHHH
Confidence            7653        4599999985 5899888774457899999999999999999999999999          9999999


Q ss_pred             EEeCCCCcEEEeecCcccccCCCCcc---cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCC
Q psy11571        155 VLLDANGHIRLADFGSCLRLGGDGTV---QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY  231 (372)
Q Consensus       155 Ill~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~  231 (372)
                      |+++.++.++|+|||++.........   ......++..|+|||.+.+    ...++.++|+||||+++|+|++|.+||.
T Consensus       150 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~~l~el~t~~~~~~  225 (310)
T cd07865         150 ILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLG----ERDYGPPIDMWGAGCIMAEMWTRSPIMQ  225 (310)
T ss_pred             EEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcC----CcccCchhhhHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999765432211   1123457889999999863    3446889999999999999999999998


Q ss_pred             CCCHHHHHHHHhhccCCc-----------------CCCCCC---------CCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        232 AESLVETYGKIMNHQNSF-----------------DLPSDV---------GYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       232 ~~~~~~~~~~i~~~~~~~-----------------~~~~~~---------~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      +.+.......+......+                 ..+...         ....+..+++||.+||. ||.+||++++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l  305 (310)
T cd07865         226 GNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTAL  305 (310)
T ss_pred             CCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHh
Confidence            877655443332211100                 001000         01236788999999999 999999876665


Q ss_pred             hhhhhhhhhhccCCCCCCCCCc
Q psy11571        285 DFKMWSALFVSLSISPRNHPWF  306 (372)
Q Consensus       285 ~i~~~~~~~~~~~~~~~~hp~f  306 (372)
                                       .||||
T Consensus       306 -----------------~h~~f  310 (310)
T cd07865         306 -----------------NHDFF  310 (310)
T ss_pred             -----------------cCCCC
Confidence                             99998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5.5e-39  Score=295.59  Aligned_cols=253  Identities=19%  Similarity=0.223  Sum_probs=200.6

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeee-----hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCcee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETL-----LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWIT   76 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~-----~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv   76 (372)
                      ++|+..+.++.|    |+|.||.+...     .++..+|+|.+.......         ....+.+|+.+++.++||||+
T Consensus         6 ~~~~~~~~ig~G----~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~---------~~~~~~~e~~~l~~l~~~~iv   72 (277)
T cd05062           6 EKITMSRELGQG----SFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMR---------ERIEFLNEASVMKEFNCHHVV   72 (277)
T ss_pred             HHceeeeeeccc----cCCeEEEEEeccCCCCCceeEEEEEeccccCCHH---------HHHHHHHHHHHHHhCCCCCee
Confidence            567777777777    89999987643     235678988765322111         123467899999999999999


Q ss_pred             eeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcC
Q psy11571         77 NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE---------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC  147 (372)
Q Consensus        77 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vh  147 (372)
                      ++++++.+....++||||+++++|.+++.+..         ..++...+..++.|++.||.|||+.|++|          
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH----------  142 (277)
T cd05062          73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVH----------  142 (277)
T ss_pred             eEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCccc----------
Confidence            99999999999999999999999999997532         12567788999999999999999999999          


Q ss_pred             CCCCcCcEEeCCCCcEEEeecCcccccCCCCccc-ccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-
Q psy11571        148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ-SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-  225 (372)
Q Consensus       148 rDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-  225 (372)
                      |||||+||++++++.++|+|||+++......... .....+++.|+|||++.     ...++.++|+|||||++|||++ 
T Consensus       143 ~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~~  217 (277)
T cd05062         143 RDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK-----DGVFTTYSDVWSFGVVLWEIATL  217 (277)
T ss_pred             CCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhh-----cCCcCchhHHHHHHHHHHHHHcC
Confidence            9999999999999999999999987654322211 11234577899999987     3568899999999999999999 


Q ss_pred             CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        226 GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       226 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      |..||.+.+..+....+.... ....+.    ..+..+++++.+||+ +|++||++.++.+.+
T Consensus       218 ~~~p~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  275 (277)
T cd05062         218 AEQPYQGMSNEQVLRFVMEGG-LLDKPD----NCPDMLFELMRMCWQYNPKMRPSFLEIISSI  275 (277)
T ss_pred             CCCCCCCCCHHHHHHHHHcCC-cCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHh
Confidence            799999888777776665542 222333    578999999999999 999999987776543

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.5e-39  Score=294.02  Aligned_cols=249  Identities=21%  Similarity=0.263  Sum_probs=201.4

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.++.|    |+|.||++....+ ..+++|.+.......           +.+.+|+.+++.++||||+++++.
T Consensus         6 ~~~~~~~~lg~g----~~~~v~~~~~~~~-~~valK~~~~~~~~~-----------~~~~~E~~~l~~l~~~~i~~~~~~   69 (262)
T cd05071           6 ESLRLEVKLGQG----CFGEVWMGTWNGT-TRVAIKTLKPGTMSP-----------EAFLQEAQVMKKLRHEKLVQLYAV   69 (262)
T ss_pred             HHeeEeeecCCC----CCCcEEEEEecCC-ceEEEEecccCccCH-----------HHHHHHHHHHHhCCCCCcceEEEE
Confidence            467777777776    8999999976544 468998876533211           346779999999999999999998


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      +.+ ...|+||||+++|+|.+++.+. ...+++..+..++.|++.||+|||+.|++|          |||||+||+++.+
T Consensus        70 ~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H----------~dl~p~Nill~~~  138 (262)
T cd05071          70 VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH----------RDLRAANILVGEN  138 (262)
T ss_pred             ECC-CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccc----------cccCcccEEEcCC
Confidence            754 5689999999999999999763 245789999999999999999999999999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETY  239 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~  239 (372)
                      +.++|+|||.+...............++..|+|||...     ...++.++|+|||||++|+|++ |..||.+....+..
T Consensus       139 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~  213 (262)
T cd05071         139 LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL-----YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL  213 (262)
T ss_pred             CcEEeccCCceeeccccccccccCCcccceecCHhHhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH
Confidence            99999999999766443322222234667899999887     3568999999999999999999 89999888777777


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ..+.... ....+.    .++..+.++|.+||+ +|++||+++++.+.+
T Consensus       214 ~~~~~~~-~~~~~~----~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l  257 (262)
T cd05071         214 DQVERGY-RMPCPP----ECPESLHDLMCQCWRKEPEERPTFEYLQAFL  257 (262)
T ss_pred             HHHhcCC-CCCCcc----ccCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence            7665432 222222    578999999999999 999999988877655

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.3e-39  Score=305.68  Aligned_cols=256  Identities=17%  Similarity=0.249  Sum_probs=198.5

Q ss_pred             ccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         16 IQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        16 ~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      .+++|.||.+++..+++.||+|.........        +..+.+.+|+.+++.++||||++++++|..++..++||||+
T Consensus        10 ~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~   81 (328)
T cd08226          10 FCNLTSVYLARHTPTGTLVTVRITDLENCTE--------EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM   81 (328)
T ss_pred             ccCceeEEEEEEcCCCcEEEEEEeccccCCH--------HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecc
Confidence            3478899999999999999999876543322        13466888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCccccc
Q psy11571         96 CGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL  174 (372)
Q Consensus        96 ~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~  174 (372)
                      .+++|.+++.+. ...+++..+..++.|++.||+|||+.|++|          |||||+||+++.++.++++||+.+...
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH----------rDlkp~Nill~~~~~~~~~~~~~~~~~  151 (328)
T cd08226          82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIH----------RNIKASHILISGDGLVSLSGLSHLYSL  151 (328)
T ss_pred             cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeec----------CCCCHHHEEEeCCCcEEEechHHHhhh
Confidence            999999998763 235899999999999999999999999999          999999999999999999999865433


Q ss_pred             CCCCccc------ccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCC
Q psy11571        175 GGDGTVQ------SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNS  248 (372)
Q Consensus       175 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~  248 (372)
                      .......      .....++..|+|||++.+.   ...++.++|+|||||++|+|++|.+||.+.........+......
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  228 (328)
T cd08226         152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQD---LYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPY  228 (328)
T ss_pred             hccCccccccccccccccCccCccChhhhcCC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCC
Confidence            2111100      0112346679999998741   234788999999999999999999999877655444333322110


Q ss_pred             cC-----------------------------------------CCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhh
Q psy11571        249 FD-----------------------------------------LPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADF  286 (372)
Q Consensus       249 ~~-----------------------------------------~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i  286 (372)
                      .+                                         ........+++.+.+||++||+ ||++|||+++++  
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l--  306 (328)
T cd08226         229 SPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL--  306 (328)
T ss_pred             CCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHh--
Confidence            00                                         0000012357789999999999 999999977766  


Q ss_pred             hhhhhhhhccCCCCCCCCCcCCC
Q psy11571        287 KMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       287 ~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                                     +||||+.+
T Consensus       307 ---------------~~~~~~~~  314 (328)
T cd08226         307 ---------------SHAFFKQV  314 (328)
T ss_pred             ---------------hCHHHHHH
Confidence                           99999764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.1e-38  Score=298.37  Aligned_cols=258  Identities=22%  Similarity=0.337  Sum_probs=209.3

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|..++.++.|    ++|.||.+....++..+++|.+........       ...+.+.+|+.+++.++|||+++++++
T Consensus        15 ~~~~~~~~lg~g----~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~   83 (308)
T cd06634          15 KLFSDLREIGHG----SFGAVYFARDVRNSEVVAIKKMSYSGKQSN-------EKWQDIIKEVRFLQKLRHPNTIQYRGC   83 (308)
T ss_pred             HHHHHHHheeeC----CCEEEEEEEEcCCCcEEEEEEEecccccCh-------HHHHHHHHHHHHHHhCCCCCcccEEEE
Confidence            467888888777    899999999988899999997764332222       123456779999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +......++||||+. |+|.+++......+++..+..++.|++.||.|||+.+++|          |||+|+||+++.++
T Consensus        84 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H----------~dl~p~nil~~~~~  152 (308)
T cd06634          84 YLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH----------RDVKAGNILLSEPG  152 (308)
T ss_pred             EEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccc----------CCCCHHhEEECCCC
Confidence            999999999999995 6888887654567899999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .++|+|||++......     ....|++.|+|||.+.+..  ...++.++|||||||++|+|++|..||...+..+....
T Consensus       153 ~~kl~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~--~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~  225 (308)
T cd06634         153 LVKLGDFGSASIMAPA-----NXFVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH  225 (308)
T ss_pred             cEEECCcccceeecCc-----ccccCCccccCHHHHhhcc--cCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHH
Confidence            9999999998765432     2246889999999985321  23478899999999999999999999987766555555


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      +.....    +......++..+.+||++||. +|++||+++++.                 .|||+...
T Consensus       226 ~~~~~~----~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll-----------------~~~~~~~~  273 (308)
T cd06634         226 IAQNES----PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL-----------------KHRFVLRE  273 (308)
T ss_pred             HhhcCC----CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHh-----------------hCcccccc
Confidence            544322    111122578999999999999 999999866655                 99999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-39  Score=292.58  Aligned_cols=249  Identities=19%  Similarity=0.201  Sum_probs=201.5

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+..+.++.|    |+|.||++... +++.||+|.+......           .+.+.+|+.+++.++||||+++++++
T Consensus         7 ~~~~~~~lg~g----~~~~v~~~~~~-~~~~v~iK~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~   70 (261)
T cd05068           7 SIQLLRKLGAG----QFGEVWEGLWN-NTTPVAVKTLKPGTMD-----------PKDFLAEAQIMKKLRHPKLIQLYAVC   70 (261)
T ss_pred             heeeEEEeccc----CCccEEEEEec-CCeEEEEEeeCCCccc-----------HHHHHHHHHHHHHCCCCCccceeEEE
Confidence            45555666666    79999998753 5577999987654322           13367799999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      ...+..|++|||+++++|.+++.... ..+++..+..++.|++.||.+||+.|++|          |||||+||+++.++
T Consensus        71 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H----------~dl~p~Nil~~~~~  140 (261)
T cd05068          71 TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIH----------RDLAARNVLVGENN  140 (261)
T ss_pred             ecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeee----------ccCCcceEEEcCCC
Confidence            99999999999999999999997632 36899999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYG  240 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~  240 (372)
                      .++|+|||+++...............+..|+|||.+.     ...++.++|+||||+++|+|++ |+.||.+.+......
T Consensus       141 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~  215 (261)
T cd05068         141 ICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAAL-----YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ  215 (261)
T ss_pred             CEEECCcceEEEccCCcccccCCCcCceeccCccccc-----cCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            9999999999876532221111122345799999987     3568889999999999999999 999999888777777


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .+.... ....+.    ..+..+.+++.+||+ +|.+||+++++...+
T Consensus       216 ~~~~~~-~~~~~~----~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l  258 (261)
T cd05068         216 QVDQGY-RMPCPP----GCPKELYDIMLDCWKEDPDDRPTFETLQWKL  258 (261)
T ss_pred             HHHcCC-CCCCCC----cCCHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence            765432 222222    578999999999999 999999988877554

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=7.8e-39  Score=295.53  Aligned_cols=251  Identities=17%  Similarity=0.252  Sum_probs=200.4

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeee----hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeee
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETL----LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLH   79 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~----~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~   79 (372)
                      ++.++.++.|    |+|.||++...    .++..+++|.+......         .....+.+|+.+++.++||||++++
T Consensus         7 ~~~~~~lg~g----~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~~~   73 (283)
T cd05090           7 VRFMEELGEC----AFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP---------QQWGEFQQEASLMAELHHPNIVCLL   73 (283)
T ss_pred             ceeeeecccc----CCcceEEEEEecCCCCCcceEEEEeccCCCCH---------HHHHHHHHHHHHHhhCCCCCeeeEE
Confidence            4445556655    89999998753    34578888877643221         1234577899999999999999999


Q ss_pred             EEEEeCCeEEEEEeccCCCCHHHHHHhc----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCC
Q psy11571         80 YAFQDDSNLYLVMDYYCGGDLLTLLSKF----------------EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFA  143 (372)
Q Consensus        80 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~----------------~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~  143 (372)
                      +++......|++|||+++++|.+++...                ...+++..+..++.|++.||.|||++|++|      
T Consensus        74 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H------  147 (283)
T cd05090          74 GVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVH------  147 (283)
T ss_pred             EEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeeh------
Confidence            9999999999999999999999998532                124788899999999999999999999999      


Q ss_pred             CCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHH
Q psy11571        144 FHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYE  222 (372)
Q Consensus       144 ~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~e  222 (372)
                          |||||+||+++.++.+||+|||+++....... .......++..|+|||.+.+     ..++.++|+|||||++||
T Consensus       148 ----~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~e  218 (283)
T cd05090         148 ----KDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-----GKFSSDSDIWSFGVVLWE  218 (283)
T ss_pred             ----hccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhcc-----CCCCchhhhHHHHHHHHH
Confidence                99999999999999999999999976543221 11223345678999999873     568899999999999999


Q ss_pred             Hhh-CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        223 MLY-GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       223 llt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      |++ |.+||.+.+..+....+.... .+..+.    .+++.+++++.+||+ +|++||++.++.+.+
T Consensus       219 l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l  280 (283)
T cd05090         219 IFSFGLQPYYGFSNQEVIEMVRKRQ-LLPCSE----DCPPRMYSLMTECWQEGPSRRPRFKDIHTRL  280 (283)
T ss_pred             HHcCCCCCCCCCCHHHHHHHHHcCC-cCCCCC----CCCHHHHHHHHHHcccCcccCcCHHHHHHHh
Confidence            998 999998887766666665432 233333    678999999999999 999999988877544

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=8e-39  Score=292.96  Aligned_cols=253  Identities=19%  Similarity=0.248  Sum_probs=204.4

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhh---hhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDI---LLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNL   78 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~---~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l   78 (372)
                      .+|+..+.++.|    ++|.||.+....++   ..+++|.+.......         ..+.+.+|+.+++.++||||+++
T Consensus         4 ~~~~~~~~lg~g----~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~   70 (267)
T cd05066           4 SCIKIEKVIGAG----EFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK---------QRRDFLSEASIMGQFDHPNIIHL   70 (267)
T ss_pred             HHeEeeeeeccc----CCCceEEEEEecCCCCceEEEEEECCCCCCHH---------HHHHHHHHHHHHHhCCCCCcceE
Confidence            356666666666    89999999876443   368888775433211         23457789999999999999999


Q ss_pred             eEEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC
Q psy11571         79 HYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD  158 (372)
Q Consensus        79 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~  158 (372)
                      ++++.+++..|+||||+++++|.+++....+.++..++..++.|++.||+|||+.|++|          |||||+||+++
T Consensus        71 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h----------~dlkp~nili~  140 (267)
T cd05066          71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVH----------RDLAARNILVN  140 (267)
T ss_pred             EEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEee----------hhhchhcEEEC
Confidence            99999999999999999999999999875567899999999999999999999999999          99999999999


Q ss_pred             CCCcEEEeecCcccccCCCCcccc--cccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCH
Q psy11571        159 ANGHIRLADFGSCLRLGGDGTVQS--NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESL  235 (372)
Q Consensus       159 ~~~~vkl~Dfg~a~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~  235 (372)
                      .++.++|+|||++...........  ....++..|+|||.+.+     ..++.++|+|||||++|++++ |..||...+.
T Consensus       141 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-----~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~  215 (267)
T cd05066         141 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY-----RKFTSASDVWSYGIVMWEVMSYGERPYWEMSN  215 (267)
T ss_pred             CCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhcc-----CccCchhhhHHHHHHHHHHhcCCCCCcccCCH
Confidence            999999999999987644322111  11223568999999973     568899999999999999886 9999998877


Q ss_pred             HHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       236 ~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .+....+... ...+.+.    .+++.+.+++.+||+ +|.+||+++++.+.+
T Consensus       216 ~~~~~~~~~~-~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l  263 (267)
T cd05066         216 QDVIKAIEEG-YRLPAPM----DCPAALHQLMLDCWQKDRNERPKFEQIVSIL  263 (267)
T ss_pred             HHHHHHHhCC-CcCCCCC----CCCHHHHHHHHHHcccCchhCCCHHHHHHHH
Confidence            7777766654 2222222    578999999999999 999999988877655

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-38  Score=289.37  Aligned_cols=241  Identities=20%  Similarity=0.279  Sum_probs=203.4

Q ss_pred             cCCccEEEeeeehh---hhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEe
Q psy11571         17 QGKGRVFSIETLLD---ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMD   93 (372)
Q Consensus        17 ~g~G~v~~v~~~~~---~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E   93 (372)
                      +|+|.||.+.....   +..+++|.........         ..+.+.+|+.++..++||||+++++++.+...++++||
T Consensus         6 g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~---------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   76 (262)
T cd00192           6 GAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE---------ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE   76 (262)
T ss_pred             CCceEEEEEEEecCCCCCceEEeEeeccccchh---------HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence            48999999988866   8899999876544322         24567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEE
Q psy11571         94 YYCGGDLLTLLSKF--------EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRL  165 (372)
Q Consensus        94 ~~~gg~L~~~l~~~--------~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl  165 (372)
                      |+++++|.+++...        ...+++..+..++.|++.||.|||++|++|          |||||+||+++.++.++|
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H----------~di~p~nili~~~~~~~l  146 (262)
T cd00192          77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVH----------RDLAARNCLVGEDLVVKI  146 (262)
T ss_pred             eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCccc----------CccCcceEEECCCCcEEE
Confidence            99999999999874        367999999999999999999999999999          999999999999999999


Q ss_pred             eecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHHh
Q psy11571        166 ADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIM  243 (372)
Q Consensus       166 ~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i~  243 (372)
                      +|||.+........ .......++..|+|||.+..     ..++.++|+|||||++|+|++ |..||...+..+....+.
T Consensus       147 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~  221 (262)
T cd00192         147 SDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKD-----GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR  221 (262)
T ss_pred             cccccccccccccccccccCCCcCccccCHHHhcc-----CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            99999987654321 11223457889999999873     468899999999999999999 699999988888777776


Q ss_pred             hccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhh
Q psy11571        244 NHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADF  286 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i  286 (372)
                      .. .....+.    .++.++.+++.+||+ +|.+||+++++.+.
T Consensus       222 ~~-~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         222 KG-YRLPKPE----YCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             cC-CCCCCCc----cCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            53 2333343    679999999999999 99999998877643

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=5.9e-39  Score=299.50  Aligned_cols=252  Identities=20%  Similarity=0.270  Sum_probs=198.9

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeee-----hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceee
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETL-----LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITN   77 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~-----~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~   77 (372)
                      |+..+.++.|    |+|.||.+...     .++..+|+|.+.......         ..+.+.+|+.+++.+ +||||++
T Consensus        37 ~~~~~~ig~G----~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~E~~~l~~l~~h~~iv~  103 (302)
T cd05055          37 LSFGKTLGAG----AFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSS---------EREALMSELKIMSHLGNHENIVN  103 (302)
T ss_pred             eEEcceeecc----CCeeEEEEEEecCCCCCceeEEEEEecCccCChH---------HHHHHHHHHHHHHhccCCCCcce
Confidence            3334444444    78999988642     245578888766433211         235678899999999 7999999


Q ss_pred             eeEEEEeCCeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEE
Q psy11571         78 LHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL  156 (372)
Q Consensus        78 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIl  156 (372)
                      +++.+...+..|++|||+++|+|.+++.... ..+++..+..++.|++.||.|||++|++|          +||||+||+
T Consensus       104 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH----------~dlkp~Nil  173 (302)
T cd05055         104 LLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIH----------RDLAARNVL  173 (302)
T ss_pred             EEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeh----------hhhccceEE
Confidence            9999999999999999999999999997632 24899999999999999999999999999          999999999


Q ss_pred             eCCCCcEEEeecCcccccCCCCcc-cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCC
Q psy11571        157 LDANGHIRLADFGSCLRLGGDGTV-QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAES  234 (372)
Q Consensus       157 l~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~  234 (372)
                      ++.++.++|+|||+++........ ......++..|+|||.+.+     ..++.++|||||||++|+|++ |..||.+..
T Consensus       174 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslGvil~el~t~g~~p~~~~~  248 (302)
T cd05055         174 LTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFN-----CVYTFESDVWSYGILLWEIFSLGSNPYPGMP  248 (302)
T ss_pred             EcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhcc-----CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC
Confidence            999999999999999865433221 1222345778999999873     568889999999999999998 999998877


Q ss_pred             HHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        235 LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       235 ~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ..+.+.+..........+.    ..++++.+++.+||. +|++||++.++.+.+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l  298 (302)
T cd05055         249 VDSKFYKLIKEGYRMAQPE----HAPAEIYDIMKTCWDADPLKRPTFKQIVQLI  298 (302)
T ss_pred             chHHHHHHHHcCCcCCCCC----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            6665555544333222222    578999999999999 999999988877544

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.6e-38  Score=287.79  Aligned_cols=240  Identities=23%  Similarity=0.344  Sum_probs=196.3

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      +|+|.||++. ..+++.+|+|.+.......         ....+.+|+.+++.++||||+++++++...+..++||||++
T Consensus         6 g~~g~vy~~~-~~~~~~~a~K~~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   75 (250)
T cd05085           6 GNFGEVFKGT-LKDKTPVAVKTCKEDLPQE---------LKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVP   75 (250)
T ss_pred             CCCceEEEEE-ecCCcEEEEEecCCcCCHH---------HHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCC
Confidence            4899999996 4578899999876543221         12346789999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCC
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG  176 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  176 (372)
                      +++|.+++......+++..+..++.|++.+|.|||+.|++|          |||||+||+++.++.++|+|||++.....
T Consensus        76 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H----------~dl~p~nili~~~~~~~l~d~g~~~~~~~  145 (250)
T cd05085          76 GGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIH----------RDLAARNCLVGENNVLKISDFGMSRQEDD  145 (250)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeee----------cccChheEEEcCCCeEEECCCccceeccc
Confidence            99999999765567899999999999999999999999999          99999999999999999999999875433


Q ss_pred             CCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCCCCCC
Q psy11571        177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHQNSFDLPSDV  255 (372)
Q Consensus       177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  255 (372)
                      ..........++..|+|||++.     ...++.++|+||||+++|+|++ |..||.+.........+... .....+.  
T Consensus       146 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~--  217 (250)
T cd05085         146 GIYSSSGLKQIPIKWTAPEALN-----YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG-YRMSCPQ--  217 (250)
T ss_pred             cccccCCCCCCcccccCHHHhc-----cCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CCCCCCC--
Confidence            2221122234466799999987     3568889999999999999998 99999988777766666543 2222232  


Q ss_pred             CCCCCHHHHHHHHHhcc-CCCCCCCCCChhhh
Q psy11571        256 GYEISDDAKDLMRRLIC-SSDTRLGQNGIADF  286 (372)
Q Consensus       256 ~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i  286 (372)
                        .++..+.+++.+||. +|++||+++++.+.
T Consensus       218 --~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  247 (250)
T cd05085         218 --KCPDDVYKVMQRCWDYKPENRPKFSELQKE  247 (250)
T ss_pred             --CCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence              678999999999999 99999998777643

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.4e-39  Score=298.36  Aligned_cols=253  Identities=23%  Similarity=0.282  Sum_probs=193.1

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.++.|    ++|.||++....++..+++|.+........         ...+.+|+.+++.++|+||+++++++
T Consensus         6 ~y~~~~~ig~g----~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~---------~~~~~~e~~~l~~l~h~ni~~~~~~~   72 (291)
T cd07870           6 SYLNLEKLGEG----SYATVYKGISRINGQLVALKVISMKTEEGV---------PFTAIREASLLKGLKHANIVLLHDII   72 (291)
T ss_pred             eeEEEEEEEec----CCEEEEEEEEcCCCcEEEEEEecccCcCCC---------cHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            45566666666    799999999988999999998765432221         12345788999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .++...|+||||+. ++|.+.+......+++..++.++.|++.||.|||+.|++|          +||||+||+++.++.
T Consensus        73 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H----------~dlkp~Nil~~~~~~  141 (291)
T cd07870          73 HTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH----------RDLKPQNLLISYLGE  141 (291)
T ss_pred             ecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc----------CCCChHHEEEcCCCc
Confidence            99999999999995 7888877654567889999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH-HHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGK  241 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-~~~~~  241 (372)
                      ++|+|||+++....... ......+++.|+|||.+.+    ...++.++|+|||||++|+|++|..||.+.+.. +.+.+
T Consensus       142 ~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~  216 (291)
T cd07870         142 LKLADFGLARAKSIPSQ-TYSSEVVTLWYRPPDVLLG----ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEK  216 (291)
T ss_pred             EEEeccccccccCCCCC-CCCCccccccccCCceeec----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHH
Confidence            99999999876433222 1223457899999999873    345778999999999999999999999765432 22222


Q ss_pred             HhhccCC---------------------cCCCCC-----CCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        242 IMNHQNS---------------------FDLPSD-----VGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       242 i~~~~~~---------------------~~~~~~-----~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      +......                     ...+..     .....+.++.+++.+||+ ||++|||+++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l  286 (291)
T cd07870         217 IWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL  286 (291)
T ss_pred             HHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHh
Confidence            2110000                     000000     001236789999999999 999999877665

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.2e-38  Score=301.82  Aligned_cols=262  Identities=26%  Similarity=0.359  Sum_probs=206.6

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHY   80 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~   80 (372)
                      .+|+..+.++.|    |+|.||++.+..++..+++|.+........        ....+.+|+.+++++ +||||+++++
T Consensus         7 ~~y~~~~~lg~g----~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~--------~~~~~~~E~~~l~~l~~h~ni~~~~~   74 (337)
T cd07852           7 RKYEILQKLGKG----AYGIVWKAIDRRTKEVVALKKIFDAFRNAT--------DAQRTFREIMFLQELGDHPNIVKLLN   74 (337)
T ss_pred             hHHHHhHhhcCC----CCeeEEEEEEcCCCeEEEEEeeccccCcch--------hhhhhhHHHHHHHHhcCCCCccceee
Confidence            478888888887    899999999888899999997754321111        224466799999999 9999999999


Q ss_pred             EEEeC--CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC
Q psy11571         81 AFQDD--SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD  158 (372)
Q Consensus        81 ~~~~~--~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~  158 (372)
                      ++...  ..+|+||||+. ++|.+++..  +.+++..++.++.||+.||.|||+.|++|          |||||+||+++
T Consensus        75 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~i~H----------~dl~p~nill~  141 (337)
T cd07852          75 VIKAENDKDIYLVFEYME-TDLHAVIRA--NILEDVHKRYIMYQLLKALKYIHSGNVIH----------RDLKPSNILLN  141 (337)
T ss_pred             eeccCCCceEEEEecccc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeec----------CCCCHHHEEEc
Confidence            98654  36899999996 599999976  47899999999999999999999999999          99999999999


Q ss_pred             CCCcEEEeecCcccccCCCCc----ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCC
Q psy11571        159 ANGHIRLADFGSCLRLGGDGT----VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES  234 (372)
Q Consensus       159 ~~~~vkl~Dfg~a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~  234 (372)
                      .++.++|+|||++........    .......||..|+|||.+.+    ...++.++|+||||+++|+|++|++||.+..
T Consensus       142 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~sDi~slG~~l~el~tg~~pf~~~~  217 (337)
T cd07852         142 SDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLG----STRYTKGVDMWSVGCILGEMLLGKPLFPGTS  217 (337)
T ss_pred             CCCcEEEeeccchhccccccccccCcchhcccccccccCceeeec----cccccccchHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999976543221    12223568899999998863    3457889999999999999999999998776


Q ss_pred             HHHHHHHHhhccCCc-------------------------CCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhh
Q psy11571        235 LVETYGKIMNHQNSF-------------------------DLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKM  288 (372)
Q Consensus       235 ~~~~~~~i~~~~~~~-------------------------~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~  288 (372)
                      ..+...++.......                         .........++.++.++|.+||+ +|++||++.+++    
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il----  293 (337)
T cd07852         218 TLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEAL----  293 (337)
T ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHh----
Confidence            655444433221100                         00011112478999999999999 999999866655    


Q ss_pred             hhhhhhccCCCCCCCCCcCCC
Q psy11571        289 WSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       289 ~~~~~~~~~~~~~~hp~f~~~  309 (372)
                                   .||||+.+
T Consensus       294 -------------~~~~~~~~  301 (337)
T cd07852         294 -------------EHPYVAQF  301 (337)
T ss_pred             -------------hChhhhhh
Confidence                         99999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=9e-39  Score=291.35  Aligned_cols=249  Identities=18%  Similarity=0.259  Sum_probs=201.8

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      +.|+.++.++.|    |+|.||++. ..+++.+|+|.+......           .+.+.+|+.+++.++||||++++++
T Consensus         6 ~~~~~~~~ig~G----~~g~v~~~~-~~~~~~~a~K~~~~~~~~-----------~~~~~~E~~~l~~l~h~~i~~~~~~   69 (260)
T cd05067           6 ETLKLVKKLGAG----QFGEVWMGY-YNGHTKVAIKSLKQGSMS-----------PEAFLAEANLMKQLQHPRLVRLYAV   69 (260)
T ss_pred             HHceeeeeeccC----ccceEEeee-cCCCceEEEEEecCCCCc-----------HHHHHHHHHHHHhcCCcCeeeEEEE
Confidence            456677777777    899999997 446788999987644332           1346779999999999999999998


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      +. .+..+++|||+.+++|.+++... ...+++..+..++.|++.||+|||+.|++|          |||||+||+++.+
T Consensus        70 ~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H----------~dl~p~ni~i~~~  138 (260)
T cd05067          70 VT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIH----------RDLRAANILVSET  138 (260)
T ss_pred             Ec-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeec----------ccccHHhEEEcCC
Confidence            74 45789999999999999998753 346899999999999999999999999999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETY  239 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~  239 (372)
                      +.++|+|||++...............++..|+|||++.     ...++.++|+||||+++|+|++ |++||.+.+..+..
T Consensus       139 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~-----~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~  213 (260)
T cd05067         139 LCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN-----YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI  213 (260)
T ss_pred             CCEEEccCcceeecCCCCcccccCCcccccccCHHHhc-----cCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHH
Confidence            99999999999766532222222234567899999987     3567889999999999999999 99999988877776


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ..+... ...+.+.    ..+.++.++|.+||+ +|++||+++++..++
T Consensus       214 ~~~~~~-~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l  257 (260)
T cd05067         214 QNLERG-YRMPRPD----NCPEELYELMRLCWKEKPEERPTFEYLRSVL  257 (260)
T ss_pred             HHHHcC-CCCCCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHh
Confidence            665443 2223333    578999999999999 999999988887654

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=7.4e-39  Score=294.19  Aligned_cols=254  Identities=20%  Similarity=0.306  Sum_probs=204.8

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeeh-----hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCcee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLL-----DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWIT   76 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~-----~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv   76 (372)
                      ++|+.+..+|.|    |+|.||.++...     +.+.+++|.+......         ...+.+.+|+.+++.++||||+
T Consensus         5 ~~~~~~~~lg~g----~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv   71 (275)
T cd05046           5 SNLQEITTLGRG----EFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE---------NLQSEFRRELDMFRKLSHKNVV   71 (275)
T ss_pred             Hhceeeeeeccc----ceeEEEEEEeccCCcCCCcceEEEEccCCccch---------HHHHHHHHHHHHHHhcCCccee
Confidence            467777777777    899999998543     3456777766543221         2345678899999999999999


Q ss_pred             eeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCC
Q psy11571         77 NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE--------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCR  148 (372)
Q Consensus        77 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhr  148 (372)
                      ++++++.+.+..|+||||+++|+|.+++....        ..+++..+..++.|++.||+|||+.|++|          |
T Consensus        72 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H----------~  141 (275)
T cd05046          72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVH----------R  141 (275)
T ss_pred             eeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCccc----------C
Confidence            99999999899999999999999999997632        15899999999999999999999999999          9


Q ss_pred             CCCcCcEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CC
Q psy11571        149 DIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GE  227 (372)
Q Consensus       149 Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~  227 (372)
                      ||||+||+++.++.++|+|||++...............++..|+|||.+.+     ..++.++|+||||+++|+|++ |.
T Consensus       142 dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~slG~~l~~l~~~~~  216 (275)
T cd05046         142 DLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-----DDFSTKSDVWSFGVLMWEVFTQGE  216 (275)
T ss_pred             cCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCC
Confidence            999999999999999999999987543322222233456778999999873     457889999999999999998 88


Q ss_pred             CCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        228 TPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       228 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .||...........+..+......+.    .++..+.+++.+||+ +|++||++.+++..+
T Consensus       217 ~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l  273 (275)
T cd05046         217 LPFYGLSDEEVLNRLQAGKLELPVPE----GCPSRLYKLMTRCWAVNPKDRPSFSELVSAL  273 (275)
T ss_pred             CCccccchHHHHHHHHcCCcCCCCCC----CCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence            99988777777766655443333332    678999999999999 999999988776543

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=6e-39  Score=288.96  Aligned_cols=232  Identities=28%  Similarity=0.479  Sum_probs=188.7

Q ss_pred             ccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         16 IQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        16 ~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      .|.+|.||.|.+..+++.+|+|.+.....               ..+|...+....||||+++++++.+....|++|||+
T Consensus         3 ~g~~~~v~~~~~~~~~~~~~~K~i~~~~~---------------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   67 (237)
T cd05576           3 LGVIDKVLLVMDTRTQQTFILKGLRKSSE---------------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHA   67 (237)
T ss_pred             ccccceEEEEEEccCCcEEEEEeecchhh---------------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecC
Confidence            35789999999999999999998765321               122334444557999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccC
Q psy11571         96 CGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG  175 (372)
Q Consensus        96 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~  175 (372)
                      +||+|.+++.+ ...+++..+..++.|++.||.|||+.|++|          |||||+||+++.++.++++|||.+....
T Consensus        68 ~~~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H----------~dlkp~Nil~~~~~~~~l~df~~~~~~~  136 (237)
T cd05576          68 EGGKLWSHISK-FLNIPEECVKRWAAEMVVALDALHREGIVC----------RDLNPNNILLDDRGHIQLTYFSRWSEVE  136 (237)
T ss_pred             CCCCHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCeec----------cCCCHHHEEEcCCCCEEEecccchhccc
Confidence            99999999977 467999999999999999999999999999          9999999999999999999999876654


Q ss_pred             CCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCC
Q psy11571        176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDV  255 (372)
Q Consensus       176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  255 (372)
                      ...    ....++..|+|||.+.     ...++.++|+||+|+++|+|++|..||......     + .......+|.  
T Consensus       137 ~~~----~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-~~~~~~~~~~--  199 (237)
T cd05576         137 DSC----DGEAVENMYCAPEVGG-----ISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I-NTHTTLNIPE--  199 (237)
T ss_pred             ccc----ccCCcCccccCCcccC-----CCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-ccccccCCcc--
Confidence            321    2235677899999986     355788999999999999999999988643211     1 1112223343  


Q ss_pred             CCCCCHHHHHHHHHhcc-CCCCCCCCC--ChhhhhhhhhhhhccCCCCCCCCCc
Q psy11571        256 GYEISDDAKDLMRRLIC-SSDTRLGQN--GIADFKMWSALFVSLSISPRNHPWF  306 (372)
Q Consensus       256 ~~~~s~~~~~li~~lL~-~p~~R~s~~--~~~~i~~~~~~~~~~~~~~~~hp~f  306 (372)
                        .+++.++++|.+||+ ||++|+++.  .+.+++              +||||
T Consensus       200 --~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~--------------~h~~~  237 (237)
T cd05576         200 --WVSEEARSLLQQLLQFNPTERLGAGVAGVEDIK--------------SHPFF  237 (237)
T ss_pred             --cCCHHHHHHHHHHccCCHHHhcCCCccchHHHH--------------cCCCC
Confidence              679999999999999 999999963  356777              99998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-39  Score=297.20  Aligned_cols=252  Identities=25%  Similarity=0.368  Sum_probs=199.6

Q ss_pred             HHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC
Q psy11571          6 ELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDD   85 (372)
Q Consensus         6 ~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~   85 (372)
                      .++.++.|    |+|.||++....+++.+++|.+.......        ...+.+.+|+.+++.++||||+++++++.+.
T Consensus         3 ~~~~l~~g----~~~~vy~~~~~~~~~~~~~K~~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   70 (287)
T cd07840           3 KIAQIGEG----TYGQVYKARNKKTGELVALKKIRMENEKE--------GFPITAIREIKLLQKLRHPNIVRLKEIVTSK   70 (287)
T ss_pred             eeEEeccC----CCeEEEEEEECCCCeEEEEEEEecccccc--------cchHHHHHHHHHHHhccCCCeeeheeeEecC
Confidence            34555555    79999999998889999999887654111        1224467799999999999999999999988


Q ss_pred             --CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcE
Q psy11571         86 --SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI  163 (372)
Q Consensus        86 --~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~v  163 (372)
                        +..++||||++ ++|.+++......+++..++.++.||+.||+|||+.|++|          +||+|+||++++++.+
T Consensus        71 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h----------~dl~p~nil~~~~~~~  139 (287)
T cd07840          71 GKGSIYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILH----------RDIKGSNILINNDGVL  139 (287)
T ss_pred             CCCcEEEEecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcee----------ccCcHHHeEEcCCCCE
Confidence              88999999996 5999998774457999999999999999999999999999          9999999999999999


Q ss_pred             EEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHh
Q psy11571        164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM  243 (372)
Q Consensus       164 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~  243 (372)
                      +|+|||++...............++..|+|||.+.+    ...++.++|+||||+++|+|++|+.||...+.......+.
T Consensus       140 ~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~  215 (287)
T cd07840         140 KLADFGLARPYTKRNSADYTNRVITLWYRPPELLLG----ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIF  215 (287)
T ss_pred             EEccccceeeccCCCcccccccccccccCCceeeEc----cccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            999999998765443212223456888999998763    3457889999999999999999999999888776666554


Q ss_pred             hccCCcC---CCC----------------------CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        244 NHQNSFD---LPS----------------------DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       244 ~~~~~~~---~~~----------------------~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      .......   ++.                      .....+++.+.++|++||. +|.+||+++++.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l  282 (287)
T cd07840         216 ELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQAL  282 (287)
T ss_pred             HHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence            3211110   000                      0011138899999999999 999999876655

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG1989|consensus

Probab=100.00  E-value=7e-39  Score=317.29  Aligned_cols=238  Identities=27%  Similarity=0.393  Sum_probs=191.4

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeeeEEEE-e------CCeE
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLHYAFQ-D------DSNL   88 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~~~~~-~------~~~~   88 (372)
                      |||+.||.|.....+..||+|.+....          .+.++.+++|+.+|++|. |+|||.+++... .      .-.+
T Consensus        48 GGFa~VYla~~~~~~~~~AlKrm~~~d----------e~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   48 GGFAQVYLAQDVKGGKKYALKRMYVND----------EEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             CCcEEEEEEEecCCCceeeeeeeecCC----------HHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            499999999988888999999776542          135677899999999997 999999999422 1      1257


Q ss_pred             EEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCCCcCCCCCcCcEEeCCCCcEEE
Q psy11571         89 YLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLH--YVHRPNHFAFHLCRDIKPDNVLLDANGHIRL  165 (372)
Q Consensus        89 ~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl  165 (372)
                      +|+||||.||.|.++|..+ ...|+|.+++.|+++++.|+++||...  |||          ||||-|||||+.+|+.||
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIH----------RDLKiENvLls~~g~~KL  187 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIH----------RDLKIENVLLSADGNYKL  187 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccch----------hhhhhhheEEcCCCCEEe
Confidence            8999999999999999854 456999999999999999999999987  888          999999999999999999


Q ss_pred             eecCcccccCCCCccc--------ccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHH
Q psy11571        166 ADFGSCLRLGGDGTVQ--------SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE  237 (372)
Q Consensus       166 ~Dfg~a~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~  237 (372)
                      ||||.|..........        .-....|+.|+|||++.-.  +....+.|+|||||||+||.|+....||...... 
T Consensus       188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDly--sg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-  264 (738)
T KOG1989|consen  188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLY--SGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-  264 (738)
T ss_pred             CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhh--cCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-
Confidence            9999986543221100        0012469999999998632  2456799999999999999999999999876433 


Q ss_pred             HHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       238 ~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                         .|+++...+  |..  ..++..+++||+.||+ ||.+||++-+++
T Consensus       265 ---aIlng~Y~~--P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~  305 (738)
T KOG1989|consen  265 ---AILNGNYSF--PPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVL  305 (738)
T ss_pred             ---eEEeccccC--CCC--ccHHHHHHHHHHHHhccCcccCCCHHHHH
Confidence               466655444  442  2689999999999999 999999755444

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.3e-39  Score=308.19  Aligned_cols=263  Identities=23%  Similarity=0.343  Sum_probs=203.9

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      .+|+..+.++.|    |+|.||.+.+..+++.|++|.+.......        ...+.+.+|+.+++.++||||++++++
T Consensus         5 ~~y~~~~~lg~g----~~g~v~~~~~~~~~~~valK~~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~   72 (334)
T cd07855           5 SRYKPIENIGSG----AYGVVCSAIDTRSGKKVAIKKIPHAFDVP--------TLAKRTLRELKILRHFKHDNIIAIRDI   72 (334)
T ss_pred             hceeeeeeeecC----CCeEEEEEEEcCCCCEEEEEEeccccccc--------cchHHHHHHHHHHHhcCCCCccCHHHh
Confidence            356666666665    79999999999999999999876533221        134556779999999999999999998


Q ss_pred             EEe----CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe
Q psy11571         82 FQD----DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        82 ~~~----~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      +..    ...+|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||+.|++|          |||||+||++
T Consensus        73 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH----------~dlkp~Nil~  140 (334)
T cd07855          73 LRPPGADFKDVYVVMDLM-ESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIH----------RDLKPSNLLV  140 (334)
T ss_pred             ccccCCCCceEEEEEehh-hhhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeec----------CCCCHHHEEE
Confidence            763    34689999999 4699999876 467999999999999999999999999999          9999999999


Q ss_pred             CCCCcEEEeecCcccccCCCCcc---cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCC
Q psy11571        158 DANGHIRLADFGSCLRLGGDGTV---QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES  234 (372)
Q Consensus       158 ~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~  234 (372)
                      +.++.+||+|||++.........   ......|+..|+|||.+.+    ...++.++|+|||||++|+|++|++||.+.+
T Consensus       141 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~~l~el~~g~~pf~~~~  216 (334)
T cd07855         141 NEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLS----LPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN  216 (334)
T ss_pred             cCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcC----CcccccccchHHHHHHHHHHHcCCCccCCCC
Confidence            99999999999998765332211   1123468899999999863    2457899999999999999999999998776


Q ss_pred             HHHHHHHHhhccCC--------------------c----CCC-CCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhh
Q psy11571        235 LVETYGKIMNHQNS--------------------F----DLP-SDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKM  288 (372)
Q Consensus       235 ~~~~~~~i~~~~~~--------------------~----~~~-~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~  288 (372)
                      ....+..+......                    +    ..+ .......+.+++++|++||+ +|.+||++++++    
T Consensus       217 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l----  292 (334)
T cd07855         217 YVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQAL----  292 (334)
T ss_pred             hHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHH----
Confidence            54443332221000                    0    000 00112568999999999999 999999866555    


Q ss_pred             hhhhhhccCCCCCCCCCcCCC
Q psy11571        289 WSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       289 ~~~~~~~~~~~~~~hp~f~~~  309 (372)
                                   .||||+..
T Consensus       293 -------------~~~~~~~~  300 (334)
T cd07855         293 -------------QHPFLAQY  300 (334)
T ss_pred             -------------hChhhhhc
Confidence                         99999854

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=9.5e-39  Score=296.31  Aligned_cols=248  Identities=22%  Similarity=0.317  Sum_probs=199.3

Q ss_pred             HHHhhhcCCcccCCccEEEeeee-----hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeE
Q psy11571          6 ELEALFLGGPIQGKGRVFSIETL-----LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHY   80 (372)
Q Consensus         6 ~l~~~~~~~~~~g~G~v~~v~~~-----~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~   80 (372)
                      ..+.++.|    |+|.||.++..     .++..+++|........          ..+.+.+|+.+++.++||||+++++
T Consensus         9 ~~~~lg~g----~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~   74 (291)
T cd05094           9 LKRELGEG----AFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA----------ARKDFQREAELLTNLQHEHIVKFYG   74 (291)
T ss_pred             Eeeeeccc----CCCeEEEeEeeccCCCCcceeeEEEecCCccHH----------HHHHHHHHHHHHhcCCCCCcceEEE
Confidence            33444444    89999998753     34556777776543332          2345778999999999999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCC
Q psy11571         81 AFQDDSNLYLVMDYYCGGDLLTLLSKFE---------------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH  145 (372)
Q Consensus        81 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~  145 (372)
                      ++.+....++||||+++++|.+++....               +.+++..++.++.||+.||+|||++|++|        
T Consensus        75 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H--------  146 (291)
T cd05094          75 VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVH--------  146 (291)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeee--------
Confidence            9999999999999999999999997521               34789999999999999999999999999        


Q ss_pred             cCCCCCcCcEEeCCCCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHh
Q psy11571        146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML  224 (372)
Q Consensus       146 vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ell  224 (372)
                        |||||+||+++.++.++|+|||++........ .......++..|+|||.+.+     ..++.++|+|||||++|+|+
T Consensus       147 --~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~  219 (291)
T cd05094         147 --RDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-----RKFTTESDVWSFGVILWEIF  219 (291)
T ss_pred             --cccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-----CCCCchhhHHHHHHHHHHHH
Confidence              99999999999999999999999976543221 11223456788999999873     56888999999999999999


Q ss_pred             h-CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        225 Y-GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       225 t-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      + |..||...+..+....+..+.. ...+.    ..+..+.+++.+||+ +|++||+++++.+.+
T Consensus       220 t~g~~p~~~~~~~~~~~~~~~~~~-~~~~~----~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l  279 (291)
T cd05094         220 TYGKQPWFQLSNTEVIECITQGRV-LERPR----VCPKEVYDIMLGCWQREPQQRLNIKEIYKIL  279 (291)
T ss_pred             hCCCCCCCCCCHHHHHHHHhCCCC-CCCCc----cCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence            8 9999988887777766654322 22222    578999999999999 999999988877655

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.8e-39  Score=301.34  Aligned_cols=255  Identities=20%  Similarity=0.254  Sum_probs=196.8

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccCC
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCG   97 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~g   97 (372)
                      |.|.++.++...+++.+|+|.+.......        +..+.+.+|+.+++.++||||+++++++.+.+..|++|||+++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~--------~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSK--------EDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccch--------hHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            45667777777799999999887543222        1356688899999999999999999999999999999999999


Q ss_pred             CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCC
Q psy11571         98 GDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG  176 (372)
Q Consensus        98 g~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  176 (372)
                      |+|.+++... ...+++..+..++.|++.||.|||++||+|          |||||+||+++.++.++|+|||.+.....
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH----------~dlk~~Nili~~~~~~kl~d~~~~~~~~~  153 (314)
T cd08216          84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIH----------RSVKASHILLSGDGKVVLSGLRYSVSMIK  153 (314)
T ss_pred             CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeec----------CCCCcceEEEecCCceEEecCccceeecc
Confidence            9999999763 346899999999999999999999999999          99999999999999999999998865432


Q ss_pred             CCc------ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCc-
Q psy11571        177 DGT------VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSF-  249 (372)
Q Consensus       177 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-  249 (372)
                      ...      .......++..|+|||++...   ...++.++|+||+||++|+|++|..||..............+.... 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  230 (314)
T cd08216         154 HGKRQRVVHDFPKSSVKNLPWLSPEVLQQN---LQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCL  230 (314)
T ss_pred             ccccccccccccccccccccccCHHHhcCC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccc
Confidence            211      011224567789999998731   1347889999999999999999999998765443322111110000 


Q ss_pred             ---------------------------CCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCC
Q psy11571        250 ---------------------------DLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPR  301 (372)
Q Consensus       250 ---------------------------~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~  301 (372)
                                                 ..+......++.++.+|+.+||+ ||++||++++++                 
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll-----------------  293 (314)
T cd08216         231 LDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLL-----------------  293 (314)
T ss_pred             cccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHh-----------------
Confidence                                       00001111345789999999999 999999977666                 


Q ss_pred             CCCCcCCCC
Q psy11571        302 NHPWFQGIA  310 (372)
Q Consensus       302 ~hp~f~~~~  310 (372)
                      .||||+.+.
T Consensus       294 ~~p~~~~~~  302 (314)
T cd08216         294 NHSFFKQCK  302 (314)
T ss_pred             cCchHhhhc
Confidence            999998653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-39  Score=306.28  Aligned_cols=262  Identities=21%  Similarity=0.309  Sum_probs=210.5

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      ||+..+.++.|    ++|.||++....+++.+++|.+.......        ...+.+.+|+.+++.++||||+++++++
T Consensus         1 ~y~i~~~ig~g----~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~   68 (330)
T cd07834           1 RYELLKPIGSG----AYGVVCSAVDKRTGRKVAIKKISNVFDDL--------IDAKRILREIKLLRHLRHENIIGLLDIL   68 (330)
T ss_pred             CceeeeeecCC----CCeEEEEEEeCCCCcEEEEEeeccccccc--------hhhhhHHHHHHHHHhcCCcchhhhhhhh
Confidence            45556666666    89999999988889999999876543211        2345678899999999999999999999


Q ss_pred             EeCC-----eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe
Q psy11571         83 QDDS-----NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        83 ~~~~-----~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      .+..     .+|++|||++ ++|.+++.+ ...+++..++.++.||+.||+|||+.|++|          |||||+||++
T Consensus        69 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H----------~dlkp~nili  136 (330)
T cd07834          69 RPPSPEDFNDVYIVTELME-TDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIH----------RDLKPSNILV  136 (330)
T ss_pred             cccCcccccceEEEecchh-hhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeec----------CCCCHHHEEE
Confidence            8775     7899999996 589999977 458999999999999999999999999999          9999999999


Q ss_pred             CCCCcEEEeecCcccccCCCCc--ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCH
Q psy11571        158 DANGHIRLADFGSCLRLGGDGT--VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL  235 (372)
Q Consensus       158 ~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~  235 (372)
                      +.++.++|+|||++........  .......+++.|+|||++.+    ...++.++|+||||+++|+|++|.+||.+.+.
T Consensus       137 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~  212 (330)
T cd07834         137 NSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS----SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY  212 (330)
T ss_pred             cCCCCEEEcccCceEeecccccccccccccccccCcCCceeeec----ccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH
Confidence            9999999999999987654321  11223467889999999984    22688999999999999999999999998887


Q ss_pred             HHHHHHHhhccCCcCCC-------------------------CCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhh
Q psy11571        236 VETYGKIMNHQNSFDLP-------------------------SDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMW  289 (372)
Q Consensus       236 ~~~~~~i~~~~~~~~~~-------------------------~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~  289 (372)
                      .+.+..+..........                         ......++.++.+||.+||+ +|.+||++++++     
T Consensus       213 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll-----  287 (330)
T cd07834         213 IDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEAL-----  287 (330)
T ss_pred             HHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHH-----
Confidence            77666665432211100                         00012468899999999999 999999866655     


Q ss_pred             hhhhhccCCCCCCCCCcCCC
Q psy11571        290 SALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       290 ~~~~~~~~~~~~~hp~f~~~  309 (372)
                                  .||||+++
T Consensus       288 ------------~~~~~~~~  295 (330)
T cd07834         288 ------------AHPYLAQL  295 (330)
T ss_pred             ------------hCccHHhh
Confidence                        99999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-39  Score=303.45  Aligned_cols=260  Identities=21%  Similarity=0.295  Sum_probs=198.1

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeeh--hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLL--DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~--~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      |+.++.++.|    |+|.||++.+..  +++.||+|.+........       ...+.+.+|+.+++.++||||++++++
T Consensus         2 y~~~~~ig~g----~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~   70 (316)
T cd07842           2 YEIEGCIGRG----TYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYT-------GISQSACREIALLRELKHENVVSLVEV   70 (316)
T ss_pred             ceEEEEeccC----CcEEEEEEEecCCCCCCeEEEEEecccccccc-------CccHHHHHHHHHHHhcCCCCccceEEE
Confidence            4555666666    899999999988  789999998876442211       122345679999999999999999999


Q ss_pred             EEeC--CeEEEEEeccCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcE
Q psy11571         82 FQDD--SNLYLVMDYYCGGDLLTLLSKF----EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNV  155 (372)
Q Consensus        82 ~~~~--~~~~lv~E~~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NI  155 (372)
                      +.+.  ..+|+||||++ ++|.+++...    ...+++..++.++.||+.||.|||+.+++|          |||||+||
T Consensus        71 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h----------~dlkp~Ni  139 (316)
T cd07842          71 FLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLH----------RDLKPANI  139 (316)
T ss_pred             EeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEee----------CCCCHHHE
Confidence            9988  78999999985 5787776532    136899999999999999999999999999          99999999


Q ss_pred             EeCC----CCcEEEeecCcccccCCCCc--ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCC
Q psy11571        156 LLDA----NGHIRLADFGSCLRLGGDGT--VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP  229 (372)
Q Consensus       156 ll~~----~~~vkl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~P  229 (372)
                      +++.    ++.+||+|||++........  .......+++.|+|||++.+    ...++.++|+|||||++|+|++|++|
T Consensus       140 l~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~~~~~~  215 (316)
T cd07842         140 LVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLG----ARHYTKAIDIWAIGCIFAELLTLEPI  215 (316)
T ss_pred             EEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhC----CCCCCcHHHHHHHHHHHHHHHhcCCC
Confidence            9999    89999999999886543222  12233567899999999873    34578899999999999999999999


Q ss_pred             CCCCCHHH---------HHHHHhh------------------------ccCCcCCCC-C------CCCCCCHHHHHHHHH
Q psy11571        230 FYAESLVE---------TYGKIMN------------------------HQNSFDLPS-D------VGYEISDDAKDLMRR  269 (372)
Q Consensus       230 f~~~~~~~---------~~~~i~~------------------------~~~~~~~~~-~------~~~~~s~~~~~li~~  269 (372)
                      |.+.....         .+..+..                        .......+. .      .....+.++.++|.+
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  295 (316)
T cd07842         216 FKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRK  295 (316)
T ss_pred             CcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHH
Confidence            98654322         1111110                        000001110 0      001467889999999


Q ss_pred             hcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCc
Q psy11571        270 LIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWF  306 (372)
Q Consensus       270 lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f  306 (372)
                      ||. ||++|||++++.                 .||||
T Consensus       296 ~l~~~P~~Rps~~eil-----------------~~~~f  316 (316)
T cd07842         296 LLEYDPTKRITAEEAL-----------------EHPYF  316 (316)
T ss_pred             HhcCCcccCcCHHHHh-----------------cCCCC
Confidence            999 999999876665                 99998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.5e-38  Score=294.90  Aligned_cols=252  Identities=20%  Similarity=0.283  Sum_probs=200.7

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehh-----hhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCcee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLD-----ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWIT   76 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~-----~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv   76 (372)
                      +|+.++.+|.|    |+|.||++.....     ...+++|.........         ....+.+|+.+++.+ +||||+
T Consensus        13 ~~~~~~~ig~g----~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~---------~~~~~~~E~~~l~~l~~h~~i~   79 (293)
T cd05053          13 RLTLGKPLGEG----AFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK---------DLSDLVSEMEMMKMIGKHKNII   79 (293)
T ss_pred             HeEEeeEeccc----ccccEEEEEEecCCCCCCceeEEEEEccCCCCHH---------HHHHHHHHHHHHHhhcCCCCee
Confidence            45555556665    8999999876543     3678888776432211         234477899999999 799999


Q ss_pred             eeeEEEEeCCeEEEEEeccCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCC
Q psy11571         77 NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKF---------------EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH  141 (372)
Q Consensus        77 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~---------------~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~  141 (372)
                      ++++++..++.++++|||+++|+|.+++...               ...+++..+..++.|++.||+|||+.|++|    
T Consensus        80 ~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH----  155 (293)
T cd05053          80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIH----  155 (293)
T ss_pred             eEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccc----
Confidence            9999999999999999999999999999642               246889999999999999999999999999    


Q ss_pred             CCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCccc-ccccccCCcccCcccccccccCCCCCCCccceeehhHHH
Q psy11571        142 FAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ-SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCM  220 (372)
Q Consensus       142 ~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil  220 (372)
                            |||||+||+++.++.++|+|||+++......... .....++..|+|||++.     ...++.++|||||||++
T Consensus       156 ------~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il  224 (293)
T cd05053         156 ------RDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLL  224 (293)
T ss_pred             ------cccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhc-----cCCcCcccceeehhhHH
Confidence                  9999999999999999999999998654322111 11123456899999987     35688999999999999


Q ss_pred             HHHhh-CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        221 YEMLY-GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       221 ~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      |+|++ |..||.+.+..+.+..+... .....+.    ..+..+.+|+.+||. +|++|||++++++.+
T Consensus       225 ~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~eil~~l  288 (293)
T cd05053         225 WEIFTLGGSPYPGIPVEELFKLLKEG-YRMEKPQ----NCTQELYHLMRDCWHEVPSQRPTFKQLVEDL  288 (293)
T ss_pred             HHHhcCCCCCCCCCCHHHHHHHHHcC-CcCCCCC----CCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence            99997 99999988877777666543 2233333    578999999999999 999999988876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-38  Score=290.59  Aligned_cols=243  Identities=19%  Similarity=0.272  Sum_probs=196.0

Q ss_pred             cCCccEEEeeeehhh---hhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCe------
Q psy11571         17 QGKGRVFSIETLLDI---LLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSN------   87 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~---~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~------   87 (372)
                      ||+|.||.+....++   ..+|+|.+.......        ...+.+.+|+.+++.++||||+++++++.....      
T Consensus        10 G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   81 (273)
T cd05035          10 GEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY--------SEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK   81 (273)
T ss_pred             CCCceEEEEEEecCCCCcceEEEEEeccCcCCH--------HHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence            389999999876544   789999876533222        124557889999999999999999998765543      


Q ss_pred             EEEEEeccCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         88 LYLVMDYYCGGDLLTLLSKF-----EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        88 ~~lv~E~~~gg~L~~~l~~~-----~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+++|||+++|+|..++...     ...+++..+..++.|++.||.|||+.|++|          |||||+||++++++.
T Consensus        82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H----------~dlkp~Nil~~~~~~  151 (273)
T cd05035          82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIH----------RDLAARNCMLREDMT  151 (273)
T ss_pred             cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeec----------cccchheEEECCCCe
Confidence            79999999999999998542     236899999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCccc-ccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQ-SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYG  240 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~  240 (372)
                      +||+|||+++......... .....++..|+|||.+.     ...++.++|||||||++|||++ |.+||.+.+..+.+.
T Consensus       152 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~  226 (273)
T cd05035         152 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA-----DRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYD  226 (273)
T ss_pred             EEECCccceeeccccccccccccccCCccccCHhhcc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999999998764332211 11233567899999987     3568899999999999999999 999999888877777


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .+..+. ....+.    .++..+.++|.+||+ ||.+||++.++...+
T Consensus       227 ~~~~~~-~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l  269 (273)
T cd05035         227 YLRHGN-RLKQPE----DCLDELYDLMYSCWRADPKDRPTFTKLREVL  269 (273)
T ss_pred             HHHcCC-CCCCCc----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            666542 233333    679999999999999 999999988776544

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=287.64  Aligned_cols=247  Identities=24%  Similarity=0.407  Sum_probs=205.3

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+..+.++.|    ++|.+|.+.+..+++.+++|.........        ...+.+.+|+.+++.+.||||+++++++.
T Consensus         2 y~~~~~l~~g----~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   69 (254)
T cd06627           2 YQLGDLIGRG----AFGVVYKGLNLETGDFVAIKQISLEKIKE--------EALKSIMQEIDLLKNLKHPNIVKYIGSIE   69 (254)
T ss_pred             ceeeeEEccc----CCeEEEEEEEcCCCcEEEEEEecccccCH--------HHHHHHHHHHHHHHhCCCCCccEEEEEEE
Confidence            4455555555    79999999988889999999887655431        23466888999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcE
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI  163 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~v  163 (372)
                      +++..+++|||+++++|.+++.. ...+++..+..++.|++.||.+||+.|++|          |||+|+||+++.++.+
T Consensus        70 ~~~~~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H----------~dl~p~ni~i~~~~~~  138 (254)
T cd06627          70 TSDSLYIILEYAENGSLRQIIKK-FGPFPESLVAVYVYQVLQGLAYLHEQGVIH----------RDIKAANILTTKDGVV  138 (254)
T ss_pred             eCCEEEEEEecCCCCcHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHhhCCccc----------CCCCHHHEEECCCCCE
Confidence            99999999999999999999987 478999999999999999999999999999          9999999999999999


Q ss_pred             EEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHh
Q psy11571        164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM  243 (372)
Q Consensus       164 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~  243 (372)
                      +|+|||++......... .....++..|+|||...+     ..++.++|+||||+++|+|++|..||...+......++.
T Consensus       139 ~l~d~~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~-----~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~  212 (254)
T cd06627         139 KLADFGVATKLNDVSKD-DASVVGTPYWMAPEVIEM-----SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV  212 (254)
T ss_pred             EEeccccceecCCCccc-ccccccchhhcCHhhhcC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence            99999999876543321 233568899999999873     347889999999999999999999998777655555544


Q ss_pred             hccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        244 NHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      .. .....+.    .++..++++|.+||. +|++||+++++.
T Consensus       213 ~~-~~~~~~~----~~~~~~~~~i~~~l~~~p~~R~~~~~~l  249 (254)
T cd06627         213 QD-DHPPLPE----GISPELKDFLMQCFQKDPNLRPTAKQLL  249 (254)
T ss_pred             cc-CCCCCCC----CCCHHHHHHHHHHHhCChhhCcCHHHHh
Confidence            32 2223333    679999999999999 999999866655

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1e-38  Score=297.97  Aligned_cols=248  Identities=23%  Similarity=0.308  Sum_probs=194.4

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhh--hhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLV--LYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHY   80 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~v--a~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~   80 (372)
                      |+..+.+|.|    |+|.||++.+..++..+  ++|........         ...+.+.+|+.++..+ +||||+++++
T Consensus         9 ~~~~~~lg~G----~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~---------~~~~~~~~Ei~~l~~l~~h~~iv~~~~   75 (303)
T cd05088           9 IKFQDVIGEG----NFGQVLKARIKKDGLRMDAAIKRMKEYASK---------DDHRDFAGELEVLCKLGHHPNIINLLG   75 (303)
T ss_pred             ceeeeeecCC----CCceEEEEEEccCCceeeEEEEEecccCCH---------HHHHHHHHHHHHHHHhcCCCCcceEEE
Confidence            3344455555    89999999887776544  55544321111         1235577899999998 8999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCC
Q psy11571         81 AFQDDSNLYLVMDYYCGGDLLTLLSKFE---------------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH  145 (372)
Q Consensus        81 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~  145 (372)
                      ++.+.+.+|+||||+++++|.+++....               ..+++..++.++.||+.||+|||++|++|        
T Consensus        76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H--------  147 (303)
T cd05088          76 ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIH--------  147 (303)
T ss_pred             EECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccc--------
Confidence            9999999999999999999999997531               25789999999999999999999999999        


Q ss_pred             cCCCCCcCcEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh
Q psy11571        146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY  225 (372)
Q Consensus       146 vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt  225 (372)
                        |||||+|||++.++.++|+|||++......  .......++..|+|||.+.+     ..++.++|||||||++|+|+|
T Consensus       148 --~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~ellt  218 (303)
T cd05088         148 --RDLAARNILVGENYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNY-----SVYTTNSDVWSYGVLLWEIVS  218 (303)
T ss_pred             --cccchheEEecCCCcEEeCccccCcccchh--hhcccCCCcccccCHHHHhc-----cCCcccccchhhhhHHHHHHh
Confidence              999999999999999999999998643211  11111234567999998873     557899999999999999998


Q ss_pred             -CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhh
Q psy11571        226 -GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADF  286 (372)
Q Consensus       226 -G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i  286 (372)
                       |.+||.+.+..+....+... .....+.    .+++++.+||.+||+ +|++||++++++..
T Consensus       219 ~g~~p~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         219 LGGTPYCGMTCAELYEKLPQG-YRLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             cCCCCcccCChHHHHHHHhcC-CcCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             99999888777776665432 2222222    578999999999999 99999998877643

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=7.1e-39  Score=298.31  Aligned_cols=255  Identities=25%  Similarity=0.326  Sum_probs=198.1

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+..+.++.|    ++|.||++....+++.|++|.+........        ....+.+|+.+++.++||||+++++++
T Consensus         8 ~~~~~~~lg~g----~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~--------~~~~~~~e~~~~~~l~h~~i~~~~~~~   75 (302)
T cd07864           8 KFDIIGQIGEG----TYGQVYKARDKDTGELVALKKVRLDNEKEG--------FPITAIREIKILRQLNHRNIVNLKEIV   75 (302)
T ss_pred             hhheeeeeccc----CCEEEEEEEECCCCcEEEEEEEeecccccC--------chHHHHHHHHHHHhCCCCCeeeeehee
Confidence            56666666666    799999999988899999998765432211        123456789999999999999999998


Q ss_pred             EeCC----------eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCc
Q psy11571         83 QDDS----------NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKP  152 (372)
Q Consensus        83 ~~~~----------~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp  152 (372)
                      .+..          .+++||||+++ +|...+.+....+++..++.++.||+.||+|||+.|++|          +||||
T Consensus        76 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H----------~dl~p  144 (302)
T cd07864          76 TDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLH----------RDIKC  144 (302)
T ss_pred             cCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec----------CCCCH
Confidence            7654          79999999965 788887764457999999999999999999999999999          99999


Q ss_pred             CcEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCC
Q psy11571        153 DNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA  232 (372)
Q Consensus       153 ~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~  232 (372)
                      +||++++++.+||+|||++...............++..|+|||.+.+    ...++.++|+|||||++|+|++|++||..
T Consensus       145 ~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~~~~el~~g~~~~~~  220 (302)
T cd07864         145 SNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLG----EERYGPAIDVWSCGCILGELFTKKPIFQA  220 (302)
T ss_pred             HHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcC----CCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999987664332211122346788999998863    34578899999999999999999999988


Q ss_pred             CCHHHHHHHHhhccCCc---CCCC---------------------CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        233 ESLVETYGKIMNHQNSF---DLPS---------------------DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       233 ~~~~~~~~~i~~~~~~~---~~~~---------------------~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      .+..+.+..+.......   .+|.                     .....++..+.++|.+||. +|.+||++++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il  297 (302)
T cd07864         221 NQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEAL  297 (302)
T ss_pred             CChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence            77666555544321110   0000                     0112468999999999999 999999876555

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.2e-38  Score=294.17  Aligned_cols=256  Identities=22%  Similarity=0.245  Sum_probs=203.7

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhh----------------hhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHH
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDI----------------LLVLYDECCNSSLRREKTVSDFIEFVAKLREERD   65 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~----------------~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~   65 (372)
                      .+|+.++.+|.|    |+|.||.+.....+                ..+|+|.+......         ...+.+.+|+.
T Consensus         5 ~~~~~~~~lg~G----~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~---------~~~~~~~~e~~   71 (296)
T cd05051           5 QPLNFVEKLGEG----QFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD---------NAREDFLKEVK   71 (296)
T ss_pred             hhCcccccccCC----CCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH---------HHHHHHHHHHH
Confidence            478888888888    89999998765433                45677766544322         23456788999


Q ss_pred             HHhcCCCCceeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhcCc
Q psy11571         66 VLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE----------DRLPEDMAKFYIAEMVLAIASIHDLHY  135 (372)
Q Consensus        66 il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------~~l~~~~~~~~~~qi~~~L~~LH~~~i  135 (372)
                      ++..++||||+++++++..+...+++|||+++++|.+++....          ..+++..++.++.|++.||+|||++|+
T Consensus        72 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i  151 (296)
T cd05051          72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNF  151 (296)
T ss_pred             HHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCc
Confidence            9999999999999999999999999999999999999997632          168999999999999999999999999


Q ss_pred             eecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCcccee
Q psy11571        136 VHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWW  214 (372)
Q Consensus       136 vH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diw  214 (372)
                      +|          |||||+||+++.++.++|+|||+++....... .......+++.|+|||.+.+     ..++.++|||
T Consensus       152 ~H----------~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~  216 (296)
T cd05051         152 VH----------RDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-----GKFTTKSDVW  216 (296)
T ss_pred             cc----------cccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-----CCCCccchhh
Confidence            99          99999999999999999999999876543221 11223456778999999873     5688999999


Q ss_pred             ehhHHHHHHhh--CCCCCCCCCHHHHHHHHhhc----cCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        215 SLGVCMYEMLY--GETPFYAESLVETYGKIMNH----QNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       215 slGvil~ellt--G~~Pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ||||++|+|++  |..||...+..+.+..+...    ......+.  ....+.++.++|.+||+ +|++||++.++.+.+
T Consensus       217 slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L  294 (296)
T cd05051         217 AFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPR--PPNCPKDIYELMLECWRRDEEDRPTFREIHLFL  294 (296)
T ss_pred             hhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCC--ccCCCHHHHHHHHHHhccChhcCCCHHHHHHHh
Confidence            99999999998  78899887776666655432    11111111  12568999999999999 999999988876544

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.3e-39  Score=296.12  Aligned_cols=259  Identities=24%  Similarity=0.393  Sum_probs=202.7

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    ++|.||.+....+++.+++|.+......         .....+.+|+.+++.++||||+++++++
T Consensus         2 ~~~~~~~lg~g----~~~~v~~~~~~~~~~~~~~k~~~~~~~~---------~~~~~~~~e~~~l~~l~h~~iv~~~~~~   68 (287)
T cd06621           2 KIVELSRLGEG----AGGSVTKCRLKNTGMIFALKTITTDPNP---------DLQKQILRELEINKSCKSPYIVKYYGAF   68 (287)
T ss_pred             ceEEEEEeccC----CceEEEEEEECCCCeEEEEEEEecCCch---------HHHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence            34555666666    7899999999888999999977653221         1235577899999999999999999988


Q ss_pred             EeC--CeEEEEEeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe
Q psy11571         83 QDD--SNLYLVMDYYCGGDLLTLLSK---FEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        83 ~~~--~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      .+.  +.+|+||||+++++|.+++..   ....+++..+..++.||+.||.|||+.|++|          +||+|+||++
T Consensus        69 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H----------~dl~~~nil~  138 (287)
T cd06621          69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIH----------RDIKPSNILL  138 (287)
T ss_pred             EccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------CCCCHHHEEE
Confidence            654  478999999999999988753   2356899999999999999999999999999          9999999999


Q ss_pred             CCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC----
Q psy11571        158 DANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE----  233 (372)
Q Consensus       158 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~----  233 (372)
                      +.++.++|+|||++........   ....++..|+|||.+.     ...++.++|+|||||++|+|++|..||...    
T Consensus       139 ~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~y~~pE~~~-----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  210 (287)
T cd06621         139 TRKGQVKLCDFGVSGELVNSLA---GTFTGTSFYMAPERIQ-----GKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP  210 (287)
T ss_pred             ecCCeEEEeecccccccccccc---ccccCCccccCHHHhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC
Confidence            9999999999999876533221   2245788999999987     356889999999999999999999999865    


Q ss_pred             -CHHHHHHHHhhccCCcCCCCCC--CCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        234 -SLVETYGKIMNHQNSFDLPSDV--GYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       234 -~~~~~~~~i~~~~~~~~~~~~~--~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                       ...+....+.... ...++...  ....++.+.++|.+||. +|++|||+.++.                 .||||+..
T Consensus       211 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil-----------------~~~~~~~~  272 (287)
T cd06621         211 LGPIELLSYIVNMP-NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDML-----------------EHPWIKAQ  272 (287)
T ss_pred             CChHHHHHHHhcCC-chhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHH-----------------hCcccccc
Confidence             2234444443321 11222111  12357899999999999 999999866555                 99999765


Q ss_pred             C
Q psy11571        310 A  310 (372)
Q Consensus       310 ~  310 (372)
                      .
T Consensus       273 ~  273 (287)
T cd06621         273 M  273 (287)
T ss_pred             c
Confidence            4

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.5e-38  Score=292.90  Aligned_cols=251  Identities=20%  Similarity=0.259  Sum_probs=199.3

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeeh-----hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLL-----DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITN   77 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~-----~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~   77 (372)
                      .|+.++.++.|    |+|.||.+....     ....|++|.........         ....+.+|+.+++.++||||++
T Consensus         7 ~~~~~~~lg~g----~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~   73 (277)
T cd05036           7 SITLLRALGHG----AFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQ---------DESDFLMEALIMSKFNHQNIVR   73 (277)
T ss_pred             HcEeeeECCCC----CCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHH---------HHHHHHHHHHHHHhCCCCCEee
Confidence            45555666666    899999998776     66788888765433221         1234677999999999999999


Q ss_pred             eeEEEEeCCeEEEEEeccCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCC
Q psy11571         78 LHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIK  151 (372)
Q Consensus        78 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlk  151 (372)
                      +++++.+....++||||++|++|.+++....      ..+++..+..++.||+.||+|||+++++|          ||||
T Consensus        74 ~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH----------~dlk  143 (277)
T cd05036          74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIH----------RDIA  143 (277)
T ss_pred             EEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEee----------cccc
Confidence            9999999999999999999999999997632      25889999999999999999999999999          9999


Q ss_pred             cCcEEeCCCC---cEEEeecCcccccCCCCccc-ccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-C
Q psy11571        152 PDNVLLDANG---HIRLADFGSCLRLGGDGTVQ-SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-G  226 (372)
Q Consensus       152 p~NIll~~~~---~vkl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G  226 (372)
                      |+||+++.++   .+||+|||+++......... .....++..|+|||++.     ...++.++|||||||++|+|++ |
T Consensus       144 p~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~~g  218 (277)
T cd05036         144 ARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFL-----DGIFTSKTDVWSFGVLLWEIFSLG  218 (277)
T ss_pred             hheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHh-----cCCcCchhHHHHHHHHHHHHHcCC
Confidence            9999998654   58999999998763322111 11223356899999997     3568999999999999999997 9


Q ss_pred             CCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhh
Q psy11571        227 ETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADF  286 (372)
Q Consensus       227 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i  286 (372)
                      ..||.+.+..+....+... .....|.    .++..+.+++.+||+ +|++||++.++++.
T Consensus       219 ~~pf~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         219 YMPYPGRTNQEVMEFVTGG-GRLDPPK----GCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CCCCCCCCHHHHHHHHHcC-CcCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            9999988877766665543 2233333    678999999999999 99999998877643

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-39  Score=306.96  Aligned_cols=261  Identities=21%  Similarity=0.329  Sum_probs=200.5

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      .+|+.++.++.|    |+|.||.+.+..+++.||+|.+......         .....+.+|+.+++.++||||++++++
T Consensus         5 ~~y~i~~~lg~G----~~g~vy~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~~~~~   71 (336)
T cd07849           5 PRYQNLSYIGEG----AYGMVCSATHKPTGVKVAIKKISPFEHQ---------TFCQRTLREIKILRRFKHENIIGILDI   71 (336)
T ss_pred             cceEEEEEEEec----CCeEEEEEEEcCCCCeEEEEEecccccc---------hhHHHHHHHHHHHHhCCCCCcCchhhe
Confidence            356666667776    8999999999999999999987532211         123446679999999999999999988


Q ss_pred             EEeC-----CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEE
Q psy11571         82 FQDD-----SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL  156 (372)
Q Consensus        82 ~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIl  156 (372)
                      +...     ...|++|||+. ++|.+++..  ..+++..++.++.|++.||.|||+.|++|          |||||+||+
T Consensus        72 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH----------~dlkp~Nil  138 (336)
T cd07849          72 IRPPSFESFNDVYIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLH----------RDLKPSNLL  138 (336)
T ss_pred             eecccccccceEEEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeec----------cCCCHHHEE
Confidence            7654     35899999985 599988865  67999999999999999999999999999          999999999


Q ss_pred             eCCCCcEEEeecCcccccCCCCcc--cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCC
Q psy11571        157 LDANGHIRLADFGSCLRLGGDGTV--QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES  234 (372)
Q Consensus       157 l~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~  234 (372)
                      ++.++.++|+|||++.........  ......||+.|+|||.+.+    ...++.++|+|||||++|+|++|++||.+.+
T Consensus       139 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslGvil~el~~G~~~f~~~~  214 (336)
T cd07849         139 LNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLN----SKGYTKAIDIWSVGCILAEMLSNRPLFPGKD  214 (336)
T ss_pred             ECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999998765432211  1122468899999998763    3457889999999999999999999998765


Q ss_pred             HHHHHHHHhhccC------------------------CcCCC-CCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhh
Q psy11571        235 LVETYGKIMNHQN------------------------SFDLP-SDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKM  288 (372)
Q Consensus       235 ~~~~~~~i~~~~~------------------------~~~~~-~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~  288 (372)
                      .......+.....                        ....+ .......++++.+||.+||+ +|++||++.+++    
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l----  290 (336)
T cd07849         215 YLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEAL----  290 (336)
T ss_pred             HHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHh----
Confidence            4433322211000                        00000 00012468889999999999 999999876655    


Q ss_pred             hhhhhhccCCCCCCCCCcCCC
Q psy11571        289 WSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       289 ~~~~~~~~~~~~~~hp~f~~~  309 (372)
                                   .||||+..
T Consensus       291 -------------~hp~~~~~  298 (336)
T cd07849         291 -------------AHPYLEQY  298 (336)
T ss_pred             -------------cCcccccc
Confidence                         99999854

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.5e-38  Score=291.82  Aligned_cols=252  Identities=20%  Similarity=0.216  Sum_probs=198.4

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhh----hhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILL----VLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITN   77 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~----va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~   77 (372)
                      .+|+.++.+|.|    |+|.||++....++..    +++|.......         ......+..|...+..++||||++
T Consensus         7 ~~~~~~~~lg~G----~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~---------~~~~~~~~~~~~~l~~l~h~~iv~   73 (279)
T cd05111           7 TELRKLKLLGSG----VFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG---------RQTFQEITDHMLAMGSLDHAYIVR   73 (279)
T ss_pred             hhceeccccCcc----CCcceEEEEEcCCCCceeeEEEEeecccccc---------hHHHHHHHHHHHHHhcCCCCCcce
Confidence            356667777776    8999999988777764    55555432211         122345677888889999999999


Q ss_pred             eeEEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe
Q psy11571         78 LHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        78 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      +++++. ....++++||+++|+|.+++......+++..+..++.||+.||+|||+.|++|          |||||+||++
T Consensus        74 ~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH----------~dlkp~nili  142 (279)
T cd05111          74 LLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVH----------RNLAARNILL  142 (279)
T ss_pred             EEEEEC-CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEec----------cccCcceEEE
Confidence            999875 45678999999999999999875567899999999999999999999999999          9999999999


Q ss_pred             CCCCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCH
Q psy11571        158 DANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESL  235 (372)
Q Consensus       158 ~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~  235 (372)
                      +.++.+||+|||+++....... .......++..|+|||.+.+     ..++.++|+|||||++|||++ |..||.+...
T Consensus       143 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-----~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~  217 (279)
T cd05111         143 KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF-----GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP  217 (279)
T ss_pred             cCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhcc-----CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            9999999999999986543221 11223456778999999973     568999999999999999998 9999988776


Q ss_pred             HHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       236 ~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ......+..+ .....+.    ..+.++.+++.+|+. +|++||++.++.+.+
T Consensus       218 ~~~~~~~~~~-~~~~~~~----~~~~~~~~li~~c~~~~p~~Rps~~el~~~l  265 (279)
T cd05111         218 HEVPDLLEKG-ERLAQPQ----ICTIDVYMVMVKCWMIDENVRPTFKELANEF  265 (279)
T ss_pred             HHHHHHHHCC-CcCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            6554444332 3333333    467899999999999 999999988876543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.3e-38  Score=290.13  Aligned_cols=251  Identities=17%  Similarity=0.209  Sum_probs=190.3

Q ss_pred             cCCccEEEeeeeh--hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEec
Q psy11571         17 QGKGRVFSIETLL--DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDY   94 (372)
Q Consensus        17 ~g~G~v~~v~~~~--~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~   94 (372)
                      |++|.||.+....  ....+++|.........         ....+.+|+.+++.++||||+++++.+.+...+|+||||
T Consensus         6 G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~---------~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~   76 (269)
T cd05042           6 GWFGKVLLGEAHRGMSKARVVVKELRASATPD---------EQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEF   76 (269)
T ss_pred             cCCceEEEEEEecCCCCeEEEEeecCccCChH---------HHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEe
Confidence            3899999885332  33456777554332111         224467788999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCc
Q psy11571         95 YCGGDLLTLLSKFED----RLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGS  170 (372)
Q Consensus        95 ~~gg~L~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~  170 (372)
                      +++|+|.+++.....    ..++..+..++.||+.||+|||++|++|          |||||+|||++.++.+||+|||+
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH----------~dlkp~Nill~~~~~~kl~dfg~  146 (269)
T cd05042          77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIH----------SDLALRNCQLTADLSVKIGDYGL  146 (269)
T ss_pred             CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEec----------ccccHhheEecCCCcEEEecccc
Confidence            999999999976322    2467888999999999999999999999          99999999999999999999999


Q ss_pred             ccccCCCCcc-cccccccCCcccCccccccccc--CCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHHhhcc
Q psy11571        171 CLRLGGDGTV-QSNVAVGTPDYISPEILTAMEE--GRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHQ  246 (372)
Q Consensus       171 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~  246 (372)
                      +......... ......+++.|+|||++.....  ....++.++|||||||++|||++ |..||......+....+....
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~  226 (269)
T cd05042         147 ALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQ  226 (269)
T ss_pred             ccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhcc
Confidence            8654322211 1122345678999999853110  12356789999999999999999 889998877766666554432


Q ss_pred             C-CcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCCChhhhh
Q psy11571        247 N-SFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFK  287 (372)
Q Consensus       247 ~-~~~~~~~~~~~~s~~~~~li~~lL~~p~~R~s~~~~~~i~  287 (372)
                      . .+..| .....++..+.+++..|+.||++||+++++.+++
T Consensus       227 ~~~~~~~-~~~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         227 DIKLPKP-QLDLKYSDRWYEVMQFCWLDPETRPTAEEVHELL  267 (269)
T ss_pred             CccCCCC-cccccCCHHHHHHHHHHhcCcccccCHHHHHHHh
Confidence            2 22212 2223678999999999988999999999888766

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.4e-38  Score=286.78  Aligned_cols=242  Identities=19%  Similarity=0.244  Sum_probs=199.4

Q ss_pred             cCCccEEEeeeeh-hh--hhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEe
Q psy11571         17 QGKGRVFSIETLL-DI--LLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMD   93 (372)
Q Consensus        17 ~g~G~v~~v~~~~-~~--~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E   93 (372)
                      +|+|.||++.... .+  ..+|+|.+......         +..+.+.+|+.+++.++||||+++++.+.+ ..++++||
T Consensus         6 g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e   75 (257)
T cd05040           6 GSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS---------DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTE   75 (257)
T ss_pred             cCcccEEeeeEecCCCCceEEEEeecCCcccH---------HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEE
Confidence            4899999998755 22  35899977665543         245668889999999999999999999988 88999999


Q ss_pred             ccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCccc
Q psy11571         94 YYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCL  172 (372)
Q Consensus        94 ~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~  172 (372)
                      |+++++|.+++.+.. ..+++..+..++.|++.||.|||+.|++|          +||||+||+++.++.+||+|||++.
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H----------~di~p~nil~~~~~~~kl~dfg~~~  145 (257)
T cd05040          76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIH----------RDLAARNILLASDDKVKIGDFGLMR  145 (257)
T ss_pred             ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccc----------cccCcccEEEecCCEEEeccccccc
Confidence            999999999998743 46899999999999999999999999999          9999999999999999999999998


Q ss_pred             ccCCCCcc--cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHHhhccCCc
Q psy11571        173 RLGGDGTV--QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHQNSF  249 (372)
Q Consensus       173 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~  249 (372)
                      ........  ......++..|+|||.+.+     ..++.++|+|||||++|+|++ |..||...+..+....+.......
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-----~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~  220 (257)
T cd05040         146 ALPQNEDHYVMEEHLKVPFAWCAPESLRT-----RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL  220 (257)
T ss_pred             cccccccceecccCCCCCceecCHHHhcc-----cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcC
Confidence            76442211  1112456788999999873     568889999999999999998 999998888887777776533333


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        250 DLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       250 ~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ..+.    ..+..+.+++.+||+ +|++||++.++.+.+
T Consensus       221 ~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l  255 (257)
T cd05040         221 ERPE----ACPQDIYNVMLQCWAHNPADRPTFAALREFL  255 (257)
T ss_pred             CCCc----cCCHHHHHHHHHHCCCCcccCCCHHHHHHHh
Confidence            3333    578999999999999 999999988776543

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-38  Score=287.03  Aligned_cols=240  Identities=21%  Similarity=0.290  Sum_probs=195.8

Q ss_pred             cCCccEEEeeeehhh---hhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEe
Q psy11571         17 QGKGRVFSIETLLDI---LLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMD   93 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~---~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E   93 (372)
                      ||+|.||++.....+   ..+++|.+.......         ..+.+.+|+.+++.++||||+++++++. .+..++|||
T Consensus         6 G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~---------~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e   75 (257)
T cd05060           6 GNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAA---------GKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVME   75 (257)
T ss_pred             cCceeEEEeEeeccCCCcceEEEEecccccchH---------HHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEE
Confidence            489999998765554   788999776554431         2345778999999999999999999876 456899999


Q ss_pred             ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571         94 YYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus        94 ~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                      |+++++|.+++.+ ...+++..+..++.|++.||+|||+.|++|          +||||+||+++.++.++|+|||+++.
T Consensus        76 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H----------~di~p~nili~~~~~~kl~df~~~~~  144 (257)
T cd05060          76 LAPLGPLLKYLKK-RREIPVSDLKELAHQVAMGMAYLESKHFVH----------RDLAARNVLLVNRHQAKISDFGMSRA  144 (257)
T ss_pred             eCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCeec----------cCcccceEEEcCCCcEEeccccccce
Confidence            9999999999987 457999999999999999999999999999          99999999999999999999999986


Q ss_pred             cCCCCccccc--ccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHHhhccCCcC
Q psy11571        174 LGGDGTVQSN--VAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHQNSFD  250 (372)
Q Consensus       174 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~  250 (372)
                      ..........  ...++..|+|||.+.     ...++.++|+|||||++|+|++ |.+||...+..+....+.... ...
T Consensus       145 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~-~~~  218 (257)
T cd05060         145 LGAGSDYYRATTAGRWPLKWYAPECIN-----YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE-RLP  218 (257)
T ss_pred             eecCCcccccccCccccccccCHHHhc-----CCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-cCC
Confidence            6443322111  112346799999987     3568899999999999999998 999998888777766665442 223


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        251 LPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       251 ~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .+.    .++..++++|.+||. +|++||++.++.+++
T Consensus       219 ~~~----~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l  252 (257)
T cd05060         219 RPE----ECPQEIYSIMLSCWKYRPEDRPTFSELESTF  252 (257)
T ss_pred             CCC----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence            333    678999999999999 999999988887665

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG0193|consensus

Probab=100.00  E-value=1.2e-39  Score=309.54  Aligned_cols=246  Identities=17%  Similarity=0.197  Sum_probs=202.8

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccCC
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCG   97 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~g   97 (372)
                      |.|++..|.+...--.||||.++......+        .++.|++|+.++++-.|-||+-+.+++..... .||+.+|+|
T Consensus       401 GsGsFGtV~Rg~whGdVAVK~Lnv~~pt~~--------qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeG  471 (678)
T KOG0193|consen  401 GSGSFGTVYRGRWHGDVAVKLLNVDDPTPE--------QLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEG  471 (678)
T ss_pred             ccccccceeecccccceEEEEEecCCCCHH--------HHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccC
Confidence            444444444444555699999988777664        67889999999999999999999999988876 899999999


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCC-
Q psy11571         98 GDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG-  176 (372)
Q Consensus        98 g~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~-  176 (372)
                      .+|+.+++....+|.....+.|++||++|+.|||.++|||          ||||..||++.+++.|||+|||++..... 
T Consensus       472 sSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIH----------rDLKSnNIFl~~~~kVkIgDFGLatvk~~w  541 (678)
T KOG0193|consen  472 SSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIH----------RDLKSNNIFLHEDLKVKIGDFGLATVKTRW  541 (678)
T ss_pred             chhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhh----------hhccccceEEccCCcEEEecccceeeeeee
Confidence            9999999876678999999999999999999999999999          99999999999999999999999865321 


Q ss_pred             CCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCC
Q psy11571        177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVG  256 (372)
Q Consensus       177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  256 (372)
                      .+........|...|||||+++..+  ..+|++.+|||||||++|||++|..||...+.++++..+-++...+... ...
T Consensus       542 ~g~~q~~qp~gsilwmAPEvIRmqd--~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s-~~~  618 (678)
T KOG0193|consen  542 SGEQQLEQPHGSLLWMAPEVIRMQD--DNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLS-KIR  618 (678)
T ss_pred             ccccccCCCccchhhhcHHHHhhcc--cCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccch-hhh
Confidence            1112223356888999999998443  5679999999999999999999999999888887777776663333222 222


Q ss_pred             CCCCHHHHHHHHHhcc-CCCCCCCCCChhh
Q psy11571        257 YEISDDAKDLMRRLIC-SSDTRLGQNGIAD  285 (372)
Q Consensus       257 ~~~s~~~~~li~~lL~-~p~~R~s~~~~~~  285 (372)
                      .+.+.++++|+..|+. ++++||.+.++++
T Consensus       619 s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  619 SNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             ccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            3677899999999999 9999999888776

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.1e-38  Score=292.10  Aligned_cols=251  Identities=19%  Similarity=0.245  Sum_probs=200.0

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhh----hhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILL----VLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITN   77 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~----va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~   77 (372)
                      .+|+.++.++.|    |+|.||++....++..    ||+|.+.......         ..+.+.+|..++..++||||++
T Consensus         7 ~~~~~~~~lg~G----~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~---------~~~~~~~e~~~l~~~~~~~i~~   73 (279)
T cd05109           7 TELKKVKVLGSG----AFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK---------ANKEILDEAYVMAGVGSPYVCR   73 (279)
T ss_pred             hheeeeeecCCC----CCceEEEEEEecCCCccceEEEEEEecCCCCHH---------HHHHHHHHHHHHHhcCCCCCce
Confidence            356667777776    8999999987777664    6888765433221         2345777889999999999999


Q ss_pred             eeEEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe
Q psy11571         78 LHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        78 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      +++++... ..+++|||+++|+|.+++....+.+++..+..++.|++.||+|||+.|++|          |||||+|||+
T Consensus        74 ~~~~~~~~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH----------~dlkp~Nil~  142 (279)
T cd05109          74 LLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVH----------RDLAARNVLV  142 (279)
T ss_pred             EEEEEcCC-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeec----------cccccceEEE
Confidence            99998754 578999999999999999875567999999999999999999999999999          9999999999


Q ss_pred             CCCCcEEEeecCcccccCCCCcc-cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCH
Q psy11571        158 DANGHIRLADFGSCLRLGGDGTV-QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESL  235 (372)
Q Consensus       158 ~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~  235 (372)
                      +.++.+||+|||+++........ ......+++.|+|||.+.+     ..++.++|||||||++|||++ |..||.....
T Consensus       143 ~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~  217 (279)
T cd05109         143 KSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH-----RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA  217 (279)
T ss_pred             cCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhcc-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            99999999999999876432221 1111234678999999873     568899999999999999998 9999988776


Q ss_pred             HHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhh
Q psy11571        236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADF  286 (372)
Q Consensus       236 ~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i  286 (372)
                      ......+... ...+.+.    ..+.++.++|.+||+ ||++||++.++.+.
T Consensus       218 ~~~~~~~~~~-~~~~~~~----~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~  264 (279)
T cd05109         218 REIPDLLEKG-ERLPQPP----ICTIDVYMIMVKCWMIDSECRPRFRELVDE  264 (279)
T ss_pred             HHHHHHHHCC-CcCCCCc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            6665554443 2233333    578999999999999 99999998887643

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.6e-38  Score=296.74  Aligned_cols=253  Identities=20%  Similarity=0.285  Sum_probs=200.5

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeeh-------hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCC
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLL-------DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRR   73 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~-------~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp   73 (372)
                      ++|...+.++.|    |+|.||.+....       +...+|+|.+......         +....+.+|+.+++.+ +||
T Consensus        12 ~~~~~~~~lg~G----~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~~~E~~~l~~l~~h~   78 (314)
T cd05099          12 DRLVLGKPLGEG----CFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD---------KDLADLISEMELMKLIGKHK   78 (314)
T ss_pred             HHeeeeeeecCC----CcccEEEeeecccCCccCCcceEEEEEecCCCCCh---------HHHHHHHHHHHHHHhccCCC
Confidence            355555666666    899999987532       3456888876543221         1234577899999988 699


Q ss_pred             ceeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCceec
Q psy11571         74 WITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE---------------DRLPEDMAKFYIAEMVLAIASIHDLHYVHR  138 (372)
Q Consensus        74 ~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~  138 (372)
                      ||+++++++.+.+.+|++|||+++|+|.+++....               ..++...+..++.||+.||.|||++|++| 
T Consensus        79 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H-  157 (314)
T cd05099          79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIH-  157 (314)
T ss_pred             CeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeee-
Confidence            99999999999999999999999999999997631               34788899999999999999999999999 


Q ss_pred             CCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCcc-cccccccCCcccCcccccccccCCCCCCCccceeehh
Q psy11571        139 PNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTV-QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLG  217 (372)
Q Consensus       139 ~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG  217 (372)
                               |||||+||+++.++.+||+|||+++........ ......++..|+|||++.     ...++.++|+||||
T Consensus       158 ---------~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG  223 (314)
T cd05099         158 ---------RDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF-----DRVYTHQSDVWSFG  223 (314)
T ss_pred             ---------ccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHc-----cCCcCccchhhHHH
Confidence                     999999999999999999999999765432211 111123456799999987     35688999999999


Q ss_pred             HHHHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        218 VCMYEMLY-GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       218 vil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      |++|+|++ |..||.+.+..+.+..+.... ....+.    .++.+++++|.+||. +|++||++.++.+.+
T Consensus       224 ~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l  290 (314)
T cd05099         224 ILMWEIFTLGGSPYPGIPVEELFKLLREGH-RMDKPS----NCTHELYMLMRECWHAVPTQRPTFKQLVEAL  290 (314)
T ss_pred             HHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            99999999 899999888877777765532 223333    678999999999999 999999988877655

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2e-38  Score=287.18  Aligned_cols=240  Identities=28%  Similarity=0.431  Sum_probs=199.0

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC--CeEEEEEec
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDD--SNLYLVMDY   94 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~lv~E~   94 (372)
                      +|+|.+|.+....+++.+++|........        ....+.+.+|+.+++.++||||+++++.+.+.  ..++++|||
T Consensus        11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~   82 (260)
T cd06606          11 GSFGSVYLALDKDTGELMAVKSVELSGDS--------EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY   82 (260)
T ss_pred             cCceEEEEEEECCCCcEEEEEEeeccccc--------hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEe
Confidence            38999999998888999999987665433        12456788899999999999999999999988  899999999


Q ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCccccc
Q psy11571         95 YCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL  174 (372)
Q Consensus        95 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~  174 (372)
                      +++++|.+++.+ ...+++..+..++.|++.||+|||+.|++|          +||+|+||+++.++.++|+|||.+...
T Consensus        83 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h----------~dl~p~ni~i~~~~~~~l~d~~~~~~~  151 (260)
T cd06606          83 VSGGSLSSLLKK-FGKLPEPVIRKYTRQILEGLAYLHSNGIVH----------RDIKGANILVDSDGVVKLADFGCAKRL  151 (260)
T ss_pred             cCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------cCCCHHHEEEcCCCCEEEcccccEEec
Confidence            999999999987 358999999999999999999999999999          999999999999999999999999876


Q ss_pred             CCCCcc-cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCC-HHHHHHHHhhccCCcCCC
Q psy11571        175 GGDGTV-QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKIMNHQNSFDLP  252 (372)
Q Consensus       175 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~  252 (372)
                      ...... ......++..|+|||.+..     ...+.++|+||||+++|+|++|..||...+ .......+.........|
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~pE~~~~-----~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  226 (260)
T cd06606         152 GDIETGEGTGSVRGTPYWMAPEVIRG-----EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIP  226 (260)
T ss_pred             ccccccccccCCCCCccccCHhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCC
Confidence            544320 1223568899999999873     448899999999999999999999998765 333333443322333333


Q ss_pred             CCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        253 SDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       253 ~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      .    .++..++++|.+||+ +|.+||++.++.
T Consensus       227 ~----~~~~~l~~~i~~~l~~~p~~Rp~~~~ll  255 (260)
T cd06606         227 E----HLSEEAKDFLRKCLRRDPKKRPTADELL  255 (260)
T ss_pred             c----ccCHHHHHHHHHhCcCChhhCCCHHHHh
Confidence            3    679999999999999 999999866655

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.8e-38  Score=289.48  Aligned_cols=249  Identities=20%  Similarity=0.251  Sum_probs=198.9

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+..+.++.|    |+|.||.+....+ ..+++|........           .+.+.+|+.+++.++||||++++++
T Consensus         6 ~~~~~~~~ig~g----~~~~v~~~~~~~~-~~~~lK~~~~~~~~-----------~~~~~~E~~~l~~l~h~~i~~~~~~   69 (260)
T cd05069           6 ESLRLDVKLGQG----CFGEVWMGTWNGT-TKVAIKTLKPGTMM-----------PEAFLQEAQIMKKLRHDKLVPLYAV   69 (260)
T ss_pred             HHeeeeeeecCc----CCCeEEEEEEcCC-ceEEEEEcccCCcc-----------HHHHHHHHHHHHhCCCCCeeeEEEE
Confidence            456666777776    7999999965433 45888876543221           1346779999999999999999998


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      +.. +..+++|||+++++|.+++... ...+++..+..++.|++.||.|||+.|++|          +||||+||+++++
T Consensus        70 ~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H----------~dl~~~Nill~~~  138 (260)
T cd05069          70 VSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIH----------RDLRAANILVGDN  138 (260)
T ss_pred             EcC-CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEee----------cccCcceEEEcCC
Confidence            754 5689999999999999999763 234789999999999999999999999999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETY  239 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~  239 (372)
                      +.++|+|||++...............++..|+|||...     ...++.++|+||||+++|+|++ |..||.+....+..
T Consensus       139 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~-----~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~  213 (260)
T cd05069         139 LVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL-----YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL  213 (260)
T ss_pred             CeEEECCCccceEccCCcccccCCCccchhhCCHHHhc-----cCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999766433222222234567899999887     3568889999999999999999 99999988877777


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ..+... .....+.    ..+..+++++++||. +|++||+++++.+.+
T Consensus       214 ~~~~~~-~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l  257 (260)
T cd05069         214 EQVERG-YRMPCPQ----GCPESLHELMKLCWKKDPDERPTFEYIQSFL  257 (260)
T ss_pred             HHHHcC-CCCCCCc----ccCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence            666543 2222232    678999999999999 999999988777554

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.3e-38  Score=287.39  Aligned_cols=239  Identities=21%  Similarity=0.309  Sum_probs=200.2

Q ss_pred             CCccEEEeeeehhh----hhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEe
Q psy11571         18 GKGRVFSIETLLDI----LLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMD   93 (372)
Q Consensus        18 g~G~v~~v~~~~~~----~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E   93 (372)
                      |+|.||.+....++    ..+|+|.........         ..+.+.+|+.++..++||||+++++.+.+.+..+++||
T Consensus        11 ~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219       11 AFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ---------QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             CCcceEEEEecCCCCCCCceEEEEEccCCCChH---------HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            89999999988766    889999886543321         34567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCccc
Q psy11571         94 YYCGGDLLTLLSKFEDR-LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCL  172 (372)
Q Consensus        94 ~~~gg~L~~~l~~~~~~-l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~  172 (372)
                      |+++++|.+++...... +++..+..++.|++.||.+||+.|++|          +||||+||+++.++.++|+|||++.
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h----------~dl~~~nil~~~~~~~~l~dfg~~~  151 (258)
T smart00219       82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIH----------RDLAARNCLVGENLVVKISDFGLSR  151 (258)
T ss_pred             ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeee----------cccccceEEEccCCeEEEcccCCce
Confidence            99999999999763333 999999999999999999999999999          9999999999999999999999998


Q ss_pred             ccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCC
Q psy11571        173 RLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHQNSFDL  251 (372)
Q Consensus       173 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~  251 (372)
                      ..............+++.|+|||.+.     ...++.++|+||||+++|+|++ |.+||...+.......+.... ....
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~~Pe~~~-----~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~  225 (258)
T smart00219      152 DLYDDDYYKKKGGKLPIRWMAPESLK-----DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY-RLPK  225 (258)
T ss_pred             ecccccccccccCCCcccccChHHhc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCCC
Confidence            76544222221233678999999986     3668899999999999999998 899999888887777776543 2223


Q ss_pred             CCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhh
Q psy11571        252 PSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIAD  285 (372)
Q Consensus       252 ~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~  285 (372)
                      +.    ..+.++.+++.+||. +|++|||+.++++
T Consensus       226 ~~----~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      226 PE----NCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             CC----cCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence            33    579999999999999 9999999877663

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3e-38  Score=291.59  Aligned_cols=252  Identities=19%  Similarity=0.234  Sum_probs=194.2

Q ss_pred             hHH-HHHHhhhcCCcccCCccEEEee----eehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCcee
Q psy11571          2 ERL-RELEALFLGGPIQGKGRVFSIE----TLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWIT   76 (372)
Q Consensus         2 ~~~-~~l~~~~~~~~~~g~G~v~~v~----~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv   76 (372)
                      .|| +.++.++.|    |+|.||.+.    ...++..+|+|.+.......         ..+.+.+|+.+++.++||||+
T Consensus         3 ~~~~~~~~~lg~g----~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~   69 (283)
T cd05080           3 KRYLKKIRVLGEG----HFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQ---------NTSGWKKEINILKTLYHENIV   69 (283)
T ss_pred             hhhceeceecccC----CCcEEEEeeEccccCCCCceEEEEEeccccChH---------HHHHHHHHHHHHHhCCCCCEe
Confidence            455 778888877    799997653    34567889999776542211         234567899999999999999


Q ss_pred             eeeEEEEeC--CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCc
Q psy11571         77 NLHYAFQDD--SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDN  154 (372)
Q Consensus        77 ~l~~~~~~~--~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~N  154 (372)
                      ++++++...  ..++++|||+++++|.+++..  ..+++..++.++.|++.||.|||++|++|          |||||+|
T Consensus        70 ~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H----------~dlkp~N  137 (283)
T cd05080          70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIH----------RDLAARN  137 (283)
T ss_pred             eEEEEEecCCCceEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeec----------cccChhe
Confidence            999987653  468999999999999999976  56999999999999999999999999999          9999999


Q ss_pred             EEeCCCCcEEEeecCcccccCCCCccc--ccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCC
Q psy11571        155 VLLDANGHIRLADFGSCLRLGGDGTVQ--SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA  232 (372)
Q Consensus       155 Ill~~~~~vkl~Dfg~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~  232 (372)
                      |+++.++.++|+|||+++.........  .....++..|+|||.+.+     ..++.++||||||+++|+|++|..||..
T Consensus       138 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slG~~l~el~tg~~p~~~  212 (283)
T cd05080         138 VLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE-----NKFSYASDVWSFGVTLYELLTHCDSKQS  212 (283)
T ss_pred             EEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcc-----cCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999998664322111  111235667999999873     5688999999999999999999999865


Q ss_pred             CCHH--HH------------HHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        233 ESLV--ET------------YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       233 ~~~~--~~------------~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ....  +.            ...........+.+    ..++..+.+++.+||+ +|++||+++++.+.+
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l  278 (283)
T cd05080         213 PPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCP----KNCPQEVYILMKNCWETEAKFRPTFRSLIPIL  278 (283)
T ss_pred             CcchhhhhhcccccccchhhhhhhhhcCCCCCCC----CCCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence            3211  00            11111111111122    2578999999999999 999999988887654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-38  Score=289.05  Aligned_cols=250  Identities=20%  Similarity=0.277  Sum_probs=203.3

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+..+.++.|    |+|.||++.. .+++.+++|.+......           .+.+.+|+.+++.++||||++++++
T Consensus         6 ~~~~i~~~ig~g----~~~~v~~~~~-~~~~~~~vK~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~   69 (261)
T cd05034           6 ESLKLERKLGAG----QFGEVWMGTW-NGTTKVAVKTLKPGTMS-----------PEAFLQEAQIMKKLRHDKLVQLYAV   69 (261)
T ss_pred             hheeeeeeeccC----cceEEEEEEE-cCCceEEEEEecCCccC-----------HHHHHHHHHHHhhCCCCCEeeeeee
Confidence            456666666666    7999999875 35677899877654332           1346779999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      +.+....+++|||+++++|.+++.... ..+++..+..++.|++.||.|||++|++|          +||||+||+++++
T Consensus        70 ~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h----------~di~p~nili~~~  139 (261)
T cd05034          70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIH----------RDLAARNILVGEN  139 (261)
T ss_pred             eecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCccc----------CCcchheEEEcCC
Confidence            999889999999999999999997632 46899999999999999999999999999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETY  239 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~  239 (372)
                      +.++|+|||++...............++..|+|||.+.+     ..++.++|+||||+++|+|++ |+.||.+.+.....
T Consensus       140 ~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~  214 (261)
T cd05034         140 LVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANY-----GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVL  214 (261)
T ss_pred             CCEEECccccceeccchhhhhhhccCCCccccCHHHhcc-----CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            999999999987764322211122234568999999873     568889999999999999998 99999988877777


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .++.... ....+.    ..+.++.+++.+||+ +|.+||+++++.+.+
T Consensus       215 ~~~~~~~-~~~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l  258 (261)
T cd05034         215 EQVERGY-RMPRPP----NCPEELYDLMLQCWDKDPEERPTFEYLQSFL  258 (261)
T ss_pred             HHHHcCC-CCCCCC----CCCHHHHHHHHHHcccCcccCCCHHHHHHHH
Confidence            7775532 222232    568999999999999 999999988877554

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.7e-39  Score=305.40  Aligned_cols=258  Identities=24%  Similarity=0.354  Sum_probs=200.0

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+.++.++.|    ++|.||++.+..+++.+|+|.+........        ....+.+|+.+++.+.||||+++++++.
T Consensus        17 y~~~~~ig~g----~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~   84 (342)
T cd07879          17 YTSLKQVGSG----AYGSVCSAIDKRTGEKVAIKKLSRPFQSEI--------FAKRAYRELTLLKHMQHENVIGLLDVFT   84 (342)
T ss_pred             eEEEEEeeec----CCeEEEEEEeCCCCcEEEEEEecCcccccc--------chhHHHHHHHHHHhcCCCCccchhheec
Confidence            4444444444    789999999888999999998765322111        2344677999999999999999999987


Q ss_pred             eCC------eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe
Q psy11571         84 DDS------NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        84 ~~~------~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      ...      .+|+||||+. .+|..++.   ..+++..+..++.|++.||+|||+.|++|          |||||+||++
T Consensus        85 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~i~H----------~dlkp~NIll  150 (342)
T cd07879          85 SAVSGDEFQDFYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAGIIH----------RDLKPGNLAV  150 (342)
T ss_pred             ccccCCCCceEEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCccc----------CCCCHHHEEE
Confidence            553      4699999985 57877652   46899999999999999999999999999          9999999999


Q ss_pred             CCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHH
Q psy11571        158 DANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE  237 (372)
Q Consensus       158 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~  237 (372)
                      +.++.++|+|||+++......    ....+++.|+|||.+.+    ...++.++|+|||||++|+|++|+.||.+.+...
T Consensus       151 ~~~~~~kL~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~  222 (342)
T cd07879         151 NEDCELKILDFGLARHADAEM----TGYVVTRWYRAPEVILN----WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD  222 (342)
T ss_pred             CCCCCEEEeeCCCCcCCCCCC----CCceeeecccChhhhcC----ccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999999999999987653221    22467889999999873    3457889999999999999999999999887666


Q ss_pred             HHHHHhhccCCc---------------------CCCC----CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhh
Q psy11571        238 TYGKIMNHQNSF---------------------DLPS----DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSA  291 (372)
Q Consensus       238 ~~~~i~~~~~~~---------------------~~~~----~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~  291 (372)
                      .+..+.......                     ..+.    ......+.++.+||.+||+ ||++||++++++       
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l-------  295 (342)
T cd07879         223 QLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEAL-------  295 (342)
T ss_pred             HHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHh-------
Confidence            555544321100                     0000    0012467889999999999 999999876665       


Q ss_pred             hhhccCCCCCCCCCcCCCCcc
Q psy11571        292 LFVSLSISPRNHPWFQGIAWD  312 (372)
Q Consensus       292 ~~~~~~~~~~~hp~f~~~~w~  312 (372)
                                .||||+.+.+.
T Consensus       296 ----------~h~~f~~~~~~  306 (342)
T cd07879         296 ----------EHPYFDSFRDA  306 (342)
T ss_pred             ----------cCcchhhcccc
Confidence                      99999987653

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.7e-38  Score=289.81  Aligned_cols=250  Identities=22%  Similarity=0.321  Sum_probs=198.6

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehh---hhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLD---ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHY   80 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~---~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~   80 (372)
                      |...+.++.|    |+|.||++.....   ...+++|.+......         +..+.+.+|+.+++.++||||+++++
T Consensus         8 ~~~~~~lg~g----~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~---------~~~~~~~~e~~~l~~~~h~~i~~~~~   74 (270)
T cd05056           8 ITLGRCIGEG----QFGDVYQGVYMSPENEKIAVAVKTCKNCTSP---------SVREKFLQEAYIMRQFDHPHIVKLIG   74 (270)
T ss_pred             ceeeeeeCCc----cceeEEEEEEecCCCCCcceEEEecCCcCCH---------HHHHHHHHHHHHHHhCCCCchhceeE
Confidence            3333444444    8999999876543   346788876544321         12355778999999999999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         81 AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        81 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      ++.+. ..|+||||+++++|.+++.+....+++..+..++.|++.||+|||+.|++|          |||||+||+++.+
T Consensus        75 ~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H----------~dl~p~nili~~~  143 (270)
T cd05056          75 VITEN-PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVH----------RDIAARNVLVSSP  143 (270)
T ss_pred             EEcCC-CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec----------cccChheEEEecC
Confidence            98764 578999999999999999875456899999999999999999999999999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETY  239 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~  239 (372)
                      +.++|+|||+++..............++..|+|||.+.     ...++.++|+||||+++|+|++ |..||.+.+..+..
T Consensus       144 ~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~  218 (270)
T cd05056         144 DCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN-----FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI  218 (270)
T ss_pred             CCeEEccCceeeecccccceecCCCCccccccChhhhc-----cCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence            99999999998876543322222233456899999987     3568899999999999999986 99999988877777


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ..+..+. ....+.    .++..+.++|.+|+. +|.+||++.++.+.+
T Consensus       219 ~~~~~~~-~~~~~~----~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l  262 (270)
T cd05056         219 GRIENGE-RLPMPP----NCPPTLYSLMTKCWAYDPSKRPRFTELKAQL  262 (270)
T ss_pred             HHHHcCC-cCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            6665543 233333    678999999999999 999999987776543

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=4.2e-38  Score=283.99  Aligned_cols=244  Identities=26%  Similarity=0.409  Sum_probs=200.4

Q ss_pred             HHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC
Q psy11571          7 LEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS   86 (372)
Q Consensus         7 l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~   86 (372)
                      .+.++.|    ++|.||.+....+++.+++|.......          ...+.+.+|+.+++.++||||+++++.+....
T Consensus         5 ~~~l~~g----~~~~v~~~~~~~~~~~~~~k~~~~~~~----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   70 (253)
T cd05122           5 LEKIGKG----GFGEVYKARHKRTGKEVAIKVIKLESK----------EKKEKIINEIQILKKCKHPNIVKYYGSYLKKD   70 (253)
T ss_pred             eeeeccC----CceEEEEEEECCCCcEEEEEEecccch----------hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence            3444444    789999999888899999998866443          13456778999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEe
Q psy11571         87 NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLA  166 (372)
Q Consensus        87 ~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~  166 (372)
                      ..++++||+++++|.+++......+++..+..++.|++.||.+||+.|++|          +||+|+||+++.++.++|+
T Consensus        71 ~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h----------~dl~p~ni~i~~~~~~~l~  140 (253)
T cd05122          71 ELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIH----------RDIKAANILLTSDGEVKLI  140 (253)
T ss_pred             eEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEec----------CCCCHHHEEEccCCeEEEe
Confidence            999999999999999999874457999999999999999999999999999          9999999999999999999


Q ss_pred             ecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhcc
Q psy11571        167 DFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQ  246 (372)
Q Consensus       167 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~  246 (372)
                      |||.+........  .....++..|+|||.+.+     ..++.++|+||||+++|+|++|..||...+.......+... 
T Consensus       141 d~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~-----~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-  212 (253)
T cd05122         141 DFGLSAQLSDTKA--RNTMVGTPYWMAPEVING-----KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-  212 (253)
T ss_pred             ecccccccccccc--ccceecCCcccCHHHHcC-----CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-
Confidence            9999877654332  234578899999999974     44788999999999999999999999887555544444332 


Q ss_pred             CCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        247 NSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       247 ~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      .....+..  ..++..+.++|.+||+ ||++||++.+++
T Consensus       213 ~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~t~~~~l  249 (253)
T cd05122         213 GPPGLRNP--EKWSDEFKDFLKKCLQKNPEKRPTAEQLL  249 (253)
T ss_pred             CCCCcCcc--cccCHHHHHHHHHHccCChhhCCCHHHHh
Confidence            12222221  1348999999999999 999999876665

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.9e-38  Score=288.56  Aligned_cols=254  Identities=26%  Similarity=0.398  Sum_probs=203.9

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+..+.++.|    ++|.||++....+++.+++|.+........       ...+.+.+|+.+++.++|+||+++++.+
T Consensus         3 ~y~~~~~lg~g----~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-------~~~~~~~~ei~~l~~~~~~~i~~~~~~~   71 (267)
T cd08224           3 NFKIEKKIGKG----QFSVVYKAICLLDGRVVALKKVQIFEMMDA-------KARQDCLKEIDLLKQLDHPNVIKYLASF   71 (267)
T ss_pred             ceeeeeeeccC----CceEEEEEEEcCCCCEEEEEEeecccccch-------hhHHHHHHHHHHHHhCCCCCeeeeeeee
Confidence            34555566666    799999999988999999998765333222       1345678899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKF---EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA  159 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~  159 (372)
                      .+.+..++||||+++++|.+++...   ...+++..+..++.|++.||.|||+.|++|          |||+|+||+++.
T Consensus        72 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h----------~dl~p~nil~~~  141 (267)
T cd08224          72 IENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMH----------RDIKPANVFITA  141 (267)
T ss_pred             ecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEec----------CCcChhhEEECC
Confidence            9999999999999999999998642   345899999999999999999999999999          999999999999


Q ss_pred             CCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCC--HHH
Q psy11571        160 NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES--LVE  237 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~--~~~  237 (372)
                      ++.++|+|||++........ ......|++.|+|||.+.+     ..++.++|+|||||++|+|++|+.||....  ..+
T Consensus       142 ~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~  215 (267)
T cd08224         142 TGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHE-----NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS  215 (267)
T ss_pred             CCcEEEeccceeeeccCCCc-ccceecCCccccCHHHhcc-----CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHH
Confidence            99999999999876543221 1223568899999999873     558889999999999999999999996543  233


Q ss_pred             HHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       238 ~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ....+..+.. .+.|.   ..++..+.++|.+||. +|++||++.++.+.+
T Consensus       216 ~~~~~~~~~~-~~~~~---~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~  262 (267)
T cd08224         216 LCKKIEKCDY-PPLPA---DHYSEELRDLVSRCINPDPEKRPDISYVLQVA  262 (267)
T ss_pred             HHhhhhcCCC-CCCCh---hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence            4444433221 11221   2578899999999999 999999988887665

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=7.6e-38  Score=286.79  Aligned_cols=251  Identities=18%  Similarity=0.196  Sum_probs=190.0

Q ss_pred             cCCccEEEeeee--hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEec
Q psy11571         17 QGKGRVFSIETL--LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDY   94 (372)
Q Consensus        17 ~g~G~v~~v~~~--~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~   94 (372)
                      ||+|.||++...  .++..+++|.+.......         ....+.+|+.+++.++||||+++++++.+....++||||
T Consensus         6 G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~---------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   76 (269)
T cd05087           6 GWFGKVILGEVNSGYTPAQVVVKELRVSASVQ---------EQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF   76 (269)
T ss_pred             cCCceEEEEEEcCCCCceEEEEEecCCCCChH---------HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence            489999998643  345678888765443211         123467799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCc
Q psy11571         95 YCGGDLLTLLSKFE----DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGS  170 (372)
Q Consensus        95 ~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~  170 (372)
                      +++|+|.+++....    ...++..+..++.|++.||.|||+.|++|          |||||+||+++.++.++|+|||+
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H----------~dlkp~nil~~~~~~~kL~dfg~  146 (269)
T cd05087          77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIH----------SDLALRNCLLTADLTVKIGDYGL  146 (269)
T ss_pred             CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEec----------cccCcceEEEcCCCcEEECCccc
Confidence            99999999997521    24567788899999999999999999999          99999999999999999999999


Q ss_pred             ccccCCCCcc-cccccccCCcccCcccccccccC--CCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHHhhc-
Q psy11571        171 CLRLGGDGTV-QSNVAVGTPDYISPEILTAMEEG--RGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNH-  245 (372)
Q Consensus       171 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-  245 (372)
                      +......... ......|+..|+|||++.+....  ...++.++|+||||+++|||++ |..||......+........ 
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~  226 (269)
T cd05087         147 SHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQ  226 (269)
T ss_pred             cccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcc
Confidence            8754332221 12234577889999998632100  1235789999999999999996 99999877666554433322 


Q ss_pred             cCCcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCCChhhhh
Q psy11571        246 QNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFK  287 (372)
Q Consensus       246 ~~~~~~~~~~~~~~s~~~~~li~~lL~~p~~R~s~~~~~~i~  287 (372)
                      ...+..|. .....++.+.+++++|+.+|++||+++++...+
T Consensus       227 ~~~~~~~~-~~~~~~~~~~~l~~~c~~~P~~Rpt~~~l~~~l  267 (269)
T cd05087         227 QLKLPKPR-LKLPLSDRWYEVMQFCWLQPEQRPSAEEVHLLL  267 (269)
T ss_pred             cCCCCCCc-cCCCCChHHHHHHHHHhcCcccCCCHHHHHHHh
Confidence            22222221 122568899999999988999999998887544

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.2e-39  Score=305.83  Aligned_cols=257  Identities=25%  Similarity=0.374  Sum_probs=203.8

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.+..++.|    ++|.||.++...+++.|++|.+.......        ...+.+.+|+.+++.+.||||+++++++
T Consensus        16 ~y~~~~~ig~g----~~g~vy~~~~~~~~~~~aiK~~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~~~   83 (343)
T cd07851          16 RYQNLSPVGSG----AYGQVCSAFDTKTGRKVAIKKLSRPFQSA--------IHAKRTYRELRLLKHMDHENVIGLLDVF   83 (343)
T ss_pred             ceEEEEEeccC----CceEEEEEEECCCCcEEEEEecccccchh--------hHHHHHHHHHHHHHhccCCCHHHHHHHh
Confidence            34444555555    78999999998899999999876432211        1234567799999999999999999988


Q ss_pred             EeCCe------EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEE
Q psy11571         83 QDDSN------LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL  156 (372)
Q Consensus        83 ~~~~~------~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIl  156 (372)
                      .....      .++|+||+ +++|.+++..  ..+++..++.++.|++.||.|||+.|++|          |||||+||+
T Consensus        84 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H----------~dlkp~Nil  150 (343)
T cd07851          84 TPASSLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIH----------RDLKPSNIA  150 (343)
T ss_pred             hccccccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeec----------CCCCHHHeE
Confidence            76654      89999998 7799999976  67999999999999999999999999999          999999999


Q ss_pred             eCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH
Q psy11571        157 LDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV  236 (372)
Q Consensus       157 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~  236 (372)
                      ++.++.++|+|||++......    .....++..|+|||.+.+    ...++.++|+|||||++|+|++|+.||.+.+..
T Consensus       151 l~~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~  222 (343)
T cd07851         151 VNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLN----WMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI  222 (343)
T ss_pred             ECCCCCEEEcccccccccccc----ccCCcccccccCHHHHhC----CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH
Confidence            999999999999999765432    223467889999999863    235788999999999999999999999888777


Q ss_pred             HHHHHHhhccCCcC------------------CCC-------CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhh
Q psy11571        237 ETYGKIMNHQNSFD------------------LPS-------DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWS  290 (372)
Q Consensus       237 ~~~~~i~~~~~~~~------------------~~~-------~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~  290 (372)
                      +.+..+........                  .+.       ......++.+.+||.+||+ +|++|||+.+++      
T Consensus       223 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell------  296 (343)
T cd07851         223 DQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEAL------  296 (343)
T ss_pred             HHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHh------
Confidence            66666544211100                  000       0011458999999999999 999999876655      


Q ss_pred             hhhhccCCCCCCCCCcCCC
Q psy11571        291 ALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       291 ~~~~~~~~~~~~hp~f~~~  309 (372)
                                 .||||+..
T Consensus       297 -----------~h~~~~~~  304 (343)
T cd07851         297 -----------AHPYLAEY  304 (343)
T ss_pred             -----------cCCCcccc
Confidence                       99999853

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG2345|consensus

Probab=100.00  E-value=6e-40  Score=281.29  Aligned_cols=255  Identities=22%  Similarity=0.287  Sum_probs=202.7

Q ss_pred             ChHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeE
Q psy11571          1 DERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHY   80 (372)
Q Consensus         1 ~~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~   80 (372)
                      |+||+....++.|    |+.-|+.|+.+.+++.+|+|++......          ..+...+|++..++++||||+++++
T Consensus        20 ~~Ryri~~~LgeG----Gfsfv~LV~~~s~~~~YAlKkI~c~~~~----------~~e~~~rEid~~rkf~s~~vl~l~d   85 (302)
T KOG2345|consen   20 NKRYRIQRLLGEG----GFSFVDLVKGLSTGHLYALKKILCHSQE----------DIEEALREIDNHRKFNSPNVLRLVD   85 (302)
T ss_pred             CceEEEeeeecCC----CceeeeeecccCcccchhhheeeccchH----------HHHHHHHHHHHHHhhCCcchHHHHH
Confidence            5789999999998    8999999999999999999998876633          3466788999999999999999997


Q ss_pred             EEEeC-----CeEEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCCCcCCCC
Q psy11571         81 AFQDD-----SNLYLVMDYYCGGDLLTLLSKF---EDRLPEDMAKFYIAEMVLAIASIHDLH--YVHRPNHFAFHLCRDI  150 (372)
Q Consensus        81 ~~~~~-----~~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~~~~~~~~vhrDl  150 (372)
                      +...+     ...|+++.|...|+|.+.+...   +..++|.++..++.+|+.||++||+..  ++|          |||
T Consensus        86 h~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH----------~Di  155 (302)
T KOG2345|consen   86 HQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAH----------RDI  155 (302)
T ss_pred             HHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccc----------cCC
Confidence            75433     3489999999999999998764   346899999999999999999999998  999          999


Q ss_pred             CcCcEEeCCCCcEEEeecCcccccCCCCcc--------cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHH
Q psy11571        151 KPDNVLLDANGHIRLADFGSCLRLGGDGTV--------QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYE  222 (372)
Q Consensus       151 kp~NIll~~~~~vkl~Dfg~a~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~e  222 (372)
                      ||.|||+++.+.++|.|||.+......-..        ....-..|..|.|||.+.-..  ....+.++|||||||++|.
T Consensus       156 KP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~--~~ti~ertDIWSLGCtLYa  233 (302)
T KOG2345|consen  156 KPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKS--HCTITERTDIWSLGCTLYA  233 (302)
T ss_pred             CcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheeccc--CcccccccchhhhhHHHHH
Confidence            999999999999999999998765321100        001123588999999997421  3456889999999999999


Q ss_pred             HhhCCCCCCCCCH--HHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhh
Q psy11571        223 MLYGETPFYAESL--VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIAD  285 (372)
Q Consensus       223 lltG~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~  285 (372)
                      |+.|..||...-.  ..+--.+.+  ..+.+|...  .+|+.+.+||+.||+ ||.+||++.+++.
T Consensus       234 ~mf~~sPfe~~~~~GgSlaLAv~n--~q~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~  295 (302)
T KOG2345|consen  234 MMFGESPFERIYQQGGSLALAVQN--AQISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLS  295 (302)
T ss_pred             HHHcCCcchHHhhcCCeEEEeeec--cccccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            9999999953211  001111222  233445433  589999999999999 9999999877653

>KOG0603|consensus

Probab=100.00  E-value=5.5e-39  Score=307.83  Aligned_cols=229  Identities=33%  Similarity=0.521  Sum_probs=190.6

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHH-hcCCCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVL-VYGDRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il-~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      .++.+-.+.+..+++..++|.+.......              .+|..++ ...+||||+++++.+.++.+.|+|||.+.
T Consensus       334 s~s~~~~~~~~~t~~~~~vkii~~~~~~~--------------~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~  399 (612)
T KOG0603|consen  334 SFSAVKYCESSPTDQEPAVKIISKRADDN--------------QDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD  399 (612)
T ss_pred             Cccceeeeeccccccchhheecccccccc--------------ccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence            55667777778889999999888763222              2355444 44579999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe-CCCCcEEEeecCcccccC
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL-DANGHIRLADFGSCLRLG  175 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll-~~~~~vkl~Dfg~a~~~~  175 (372)
                      |+-|.+.+..  .+....++..|+++|+.|+.|||++|+||          |||||+|||+ ++.|+++|+|||.++...
T Consensus       400 g~ell~ri~~--~~~~~~e~~~w~~~lv~Av~~LH~~gvvh----------RDLkp~NIL~~~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  400 GGELLRRIRS--KPEFCSEASQWAAELVSAVDYLHEQGVVH----------RDLKPGNILLDGSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             ccHHHHHHHh--cchhHHHHHHHHHHHHHHHHHHHhcCeee----------cCCChhheeecCCCCcEEEEEechhhhCc
Confidence            9999888876  33334888899999999999999999999          9999999999 689999999999998765


Q ss_pred             CCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH-HHHHHHhhccCCcCCCCC
Q psy11571        176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKIMNHQNSFDLPSD  254 (372)
Q Consensus       176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~  254 (372)
                      ..    ..+.+-|..|.|||++.     ...|+.++||||||++||+|++|+.||...... ++..+|....    +.  
T Consensus       468 ~~----~~tp~~t~~y~APEvl~-----~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~----~s--  532 (612)
T KOG0603|consen  468 RS----CDTPALTLQYVAPEVLA-----IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPK----FS--  532 (612)
T ss_pred             hh----hcccchhhcccChhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCc----cc--
Confidence            44    22346688999999998     467999999999999999999999999887655 5555554422    22  


Q ss_pred             CCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCc
Q psy11571        255 VGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWF  306 (372)
Q Consensus       255 ~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f  306 (372)
                        ..+|..+++||++||+ ||.+|+++.++.                 .||||
T Consensus       533 --~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~-----------------~h~w~  566 (612)
T KOG0603|consen  533 --ECVSDEAKDLLQQLLQVDPALRLGADEIG-----------------AHPWF  566 (612)
T ss_pred             --cccCHHHHHHHHHhccCChhhCcChhhhc-----------------cCcch
Confidence              2799999999999999 999999988877                 99999

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=8.9e-39  Score=327.44  Aligned_cols=249  Identities=20%  Similarity=0.249  Sum_probs=197.0

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      ||+.++.+|.|    |+|.||++.+..+++.||+|.+.......+       ...+++.+|+.+++.++||||+++++++
T Consensus         3 rYeIi~~LGkG----gfG~VYlA~d~~tg~~VAIK~I~~~l~~~e-------~~~~rflrEi~ILs~L~HPNIVkl~~v~   71 (932)
T PRK13184          3 RYDIIRLIGKG----GMGEVYLAYDPVCSRRVALKKIREDLSENP-------LLKKRFLREAKIAADLIHPGIVPVYSIC   71 (932)
T ss_pred             CeEEEEEEecC----CCEEEEEEEECCCCcEEEEEEECcccccCH-------HHHHHHHHHHHHHHhCCCcCcCeEEEEE
Confidence            56677777777    899999999998999999998865432221       2335678899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKF----------EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKP  152 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~----------~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp  152 (372)
                      .+++..|++|||++||+|.+++.+.          ...++...+..++.||+.||+|||++||+|          |||||
T Consensus        72 ~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIH----------RDLKP  141 (932)
T PRK13184         72 SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLH----------RDLKP  141 (932)
T ss_pred             eeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccc----------cCCch
Confidence            9999999999999999999998642          123456678899999999999999999999          99999


Q ss_pred             CcEEeCCCCcEEEeecCcccccCCCC-----------------cccccccccCCcccCcccccccccCCCCCCCccceee
Q psy11571        153 DNVLLDANGHIRLADFGSCLRLGGDG-----------------TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWS  215 (372)
Q Consensus       153 ~NIll~~~~~vkl~Dfg~a~~~~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diws  215 (372)
                      +||+++.++.++|+|||+++......                 .......+||+.|+|||++.+     ..++.++||||
T Consensus       142 eNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-----~~~S~kSDIWS  216 (932)
T PRK13184        142 DNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-----VPASESTDIYA  216 (932)
T ss_pred             heEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-----CCCCcHhHHHH
Confidence            99999999999999999998652110                 011123469999999999873     56889999999


Q ss_pred             hhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCC
Q psy11571        216 LGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQ  280 (372)
Q Consensus       216 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~  280 (372)
                      |||++|||+||..||...+........... ......  ....+++.+.+++.+||. ||++|++.
T Consensus       217 LGVILyELLTG~~PF~~~~~~ki~~~~~i~-~P~~~~--p~~~iP~~L~~LI~rcL~~DP~kR~ss  279 (932)
T PRK13184        217 LGVILYQMLTLSFPYRRKKGRKISYRDVIL-SPIEVA--PYREIPPFLSQIAMKALAVDPAERYSS  279 (932)
T ss_pred             HHHHHHHHHHCCCCCCCcchhhhhhhhhcc-Chhhcc--ccccCCHHHHHHHHHHccCChhhCcCH
Confidence            999999999999999876554433221111 111111  112678999999999999 99999874

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.8e-38  Score=287.16  Aligned_cols=248  Identities=20%  Similarity=0.252  Sum_probs=200.7

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.++.|    |+|.||++... ++..+++|.........           ..+.+|+.+++.++||||+++++++
T Consensus         5 ~~~~~~~ig~g----~~g~v~~~~~~-~~~~~~~k~~~~~~~~~-----------~~~~~e~~~l~~l~~~~i~~~~~~~   68 (256)
T cd05112           5 ELTLVQEIGSG----QFGLVWLGYWL-EKRKVAIKTIREGAMSE-----------EDFIEEAQVMMKLSHPKLVQLYGVC   68 (256)
T ss_pred             HeEEEeeecCc----ccceEEEEEEe-CCCeEEEEECCCCCCCH-----------HHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            34445556665    89999999764 46788999776443321           2366799999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      ......+++|||+++++|.+++....+.++++.++.++.|++.+|++||+.|++|          |||||+||+++.++.
T Consensus        69 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h----------~dl~p~ni~i~~~~~  138 (256)
T cd05112          69 TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIH----------RDLAARNCLVGENQV  138 (256)
T ss_pred             ccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccc----------cccccceEEEcCCCe
Confidence            9999999999999999999999875567899999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGK  241 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~  241 (372)
                      ++|+|||++...............++..|+|||.+.+     ..++.++|+||||+++|+|++ |..||......+....
T Consensus       139 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~-----~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  213 (256)
T cd05112         139 VKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF-----SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVET  213 (256)
T ss_pred             EEECCCcceeecccCcccccCCCccchhhcCHhHhcc-----CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence            9999999987654322211122334678999999873     568889999999999999998 9999998887777777


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhh
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADF  286 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i  286 (372)
                      +..+.. ...+.    ..+..+.+|+.+||+ +|++||+++++++.
T Consensus       214 ~~~~~~-~~~~~----~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         214 INAGFR-LYKPR----LASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HhCCCC-CCCCC----CCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence            655422 22232    468999999999999 99999998877643

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.5e-38  Score=283.95  Aligned_cols=241  Identities=23%  Similarity=0.312  Sum_probs=197.5

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      +|+|.||.+.... ++.+++|.+......         +..+.+.+|+.+++.++||||+++++++.+....++||||++
T Consensus         6 g~~g~v~~~~~~~-~~~v~~K~~~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   75 (251)
T cd05041           6 GNFGDVYKGVLKG-NTEVAVKTCRSTLPP---------DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVP   75 (251)
T ss_pred             CCCceEEEEEEeC-CCcEEEEeccccCCH---------HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCC
Confidence            4899999998766 999999977654432         123457889999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCC
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG  176 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  176 (372)
                      +++|.+++......+++..+..++.+++.+|.|||++|++|          |||||+||+++.++.++|+|||++.....
T Consensus        76 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h----------~di~p~nili~~~~~~~l~d~g~~~~~~~  145 (251)
T cd05041          76 GGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIH----------RDLAARNCLVGENNVLKISDFGMSREEEG  145 (251)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeh----------hhcCcceEEEcCCCcEEEeeccccccccC
Confidence            99999999765567899999999999999999999999999          99999999999999999999999876542


Q ss_pred             CCccc-ccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCCCCC
Q psy11571        177 DGTVQ-SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHQNSFDLPSD  254 (372)
Q Consensus       177 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  254 (372)
                      ..... .....++..|+|||.+.+     ..++.++|+|||||++|+|++ |..||...........+... .....+. 
T Consensus       146 ~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~-~~~~~~~-  218 (251)
T cd05041         146 GIYTVSDGLKQIPIKWTAPEALNY-----GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG-YRMPAPQ-  218 (251)
T ss_pred             CcceeccccCcceeccCChHhhcc-----CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC-CCCCCCc-
Confidence            21111 111233567999999873     568899999999999999999 89999888776666665443 2233333 


Q ss_pred             CCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        255 VGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       255 ~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                         ..+.++.+++.+||+ +|.+||+++++++.+
T Consensus       219 ---~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l  249 (251)
T cd05041         219 ---LCPEEIYRLMLQCWAYDPENRPSFSEIYNEL  249 (251)
T ss_pred             ---cCCHHHHHHHHHHhccChhhCcCHHHHHHHh
Confidence               678999999999999 999999988877543

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG1026|consensus

Probab=100.00  E-value=1e-38  Score=314.88  Aligned_cols=249  Identities=22%  Similarity=0.310  Sum_probs=213.0

Q ss_pred             HHHhhhcCCcccCCccEEEeeeeh-----hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeE
Q psy11571          6 ELEALFLGGPIQGKGRVFSIETLL-----DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHY   80 (372)
Q Consensus         6 ~l~~~~~~~~~~g~G~v~~v~~~~-----~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~   80 (372)
                      ..+++|.|    .||+||+++-..     +...||||.++......         ..+.|++|++++..++|||||++++
T Consensus       490 ~~~eLGeg----aFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~---------~~~dF~REaeLla~l~H~nIVrLlG  556 (774)
T KOG1026|consen  490 FKEELGEG----AFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQ---------ARQDFRREAELLAELQHPNIVRLLG  556 (774)
T ss_pred             ehhhhcCc----hhhhhhhhhccCCCCCccceehhHhhhcccccHH---------HHHHHHHHHHHHHhccCCCeEEEEE
Confidence            34556666    788999887532     45789999988766543         3567999999999999999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHhcC---------CC----CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcC
Q psy11571         81 AFQDDSNLYLVMDYYCGGDLLTLLSKFE---------DR----LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC  147 (372)
Q Consensus        81 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~---------~~----l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vh  147 (372)
                      ++..++.+|+|+|||..|||.++|+...         ..    ++..+...++.||+.|+.||-++.+||          
T Consensus       557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVH----------  626 (774)
T KOG1026|consen  557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVH----------  626 (774)
T ss_pred             EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccc----------
Confidence            9999999999999999999999997531         12    788999999999999999999999999          


Q ss_pred             CCCCcCcEEeCCCCcEEEeecCcccccCCCCccccc-ccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-
Q psy11571        148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSN-VAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-  225 (372)
Q Consensus       148 rDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-  225 (372)
                      |||-..|+||.++-.|||+|||+++.+-..+.++.. ...-..+|||||.+.     .+.|+.+|||||+||+|||+++ 
T Consensus       627 RDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl-----y~kFTteSDVWs~GVvLWEIFsy  701 (774)
T KOG1026|consen  627 RDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL-----YGKFTTESDVWSFGVVLWEIFSY  701 (774)
T ss_pred             cchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhh-----cCcccchhhhhhhhhhhhhhhcc
Confidence            999999999999999999999999876443333221 123356999999999     6889999999999999999996 


Q ss_pred             CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        226 GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       226 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      |..||.+.+..+.++.|.++.. +.-|.    +.+.++.+|+..|++ +|++||++.+|-..+
T Consensus       702 G~QPy~glSn~EVIe~i~~g~l-L~~Pe----~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L  759 (774)
T KOG1026|consen  702 GKQPYYGLSNQEVIECIRAGQL-LSCPE----NCPTEVYSLMLECWNENPKRRPSFKEIHSRL  759 (774)
T ss_pred             ccCcccccchHHHHHHHHcCCc-ccCCC----CCCHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence            9999999999999999988765 66666    799999999999999 999999998887554

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=7.4e-39  Score=304.06  Aligned_cols=259  Identities=22%  Similarity=0.323  Sum_probs=201.9

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      ||+.++.+|.|    |+|.||++.+..+++.|++|.+......          ..+.+.+|+.+++.++||||+++++++
T Consensus         6 ~y~~~~~Lg~g----~~g~vy~~~~~~~~~~v~iK~i~~~~~~----------~~~~~~~Ei~~l~~l~h~~i~~~~~~~   71 (342)
T cd07854           6 RYMDLRPLGCG----SNGLVFSAVDSDCDKRVAVKKIVLTDPQ----------SVKHALREIKIIRRLDHDNIVKVYEVL   71 (342)
T ss_pred             ceEEEEEecCC----CCEEEEEEEECCCCcEEEEEEEecCCCc----------hHHHHHHHHHHHHhcCCCcchhhHhhh
Confidence            56667777776    8999999999999999999987654431          235567799999999999999999876


Q ss_pred             EeC--------------CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCC
Q psy11571         83 QDD--------------SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCR  148 (372)
Q Consensus        83 ~~~--------------~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhr  148 (372)
                      ...              ...|+||||+. ++|.+++..  +.+++..++.++.||+.||.|||+.|++|          |
T Consensus        72 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH----------~  138 (342)
T cd07854          72 GPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLH----------R  138 (342)
T ss_pred             cccccccccccccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCccc----------C
Confidence            654              35799999996 699998865  57999999999999999999999999999          9


Q ss_pred             CCCcCcEEeC-CCCcEEEeecCcccccCCCCcc--cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh
Q psy11571        149 DIKPDNVLLD-ANGHIRLADFGSCLRLGGDGTV--QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY  225 (372)
Q Consensus       149 Dlkp~NIll~-~~~~vkl~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt  225 (372)
                      ||||+||+++ .++.++|+|||++.........  ......++..|+|||.+.+    ...++.++|+|||||++|+|++
T Consensus       139 dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwSlGvil~el~~  214 (342)
T cd07854         139 DLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS----PNNYTKAIDMWAAGCIFAEMLT  214 (342)
T ss_pred             CCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhC----ccccCchhhHHHHHHHHHHHHh
Confidence            9999999998 4567899999998765322111  1112357889999998763    3457889999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHhhccCC-----------------------cCCC-CCCCCCCCHHHHHHHHHhcc-CCCCCCCC
Q psy11571        226 GETPFYAESLVETYGKIMNHQNS-----------------------FDLP-SDVGYEISDDAKDLMRRLIC-SSDTRLGQ  280 (372)
Q Consensus       226 G~~Pf~~~~~~~~~~~i~~~~~~-----------------------~~~~-~~~~~~~s~~~~~li~~lL~-~p~~R~s~  280 (372)
                      |+.||.+.+..+....+......                       ...+ ......++.++++||.+||+ ||.+||++
T Consensus       215 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  294 (342)
T cd07854         215 GKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA  294 (342)
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCH
Confidence            99999887766555544332100                       0000 00112578999999999999 99999987


Q ss_pred             CChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        281 NGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       281 ~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      ++++                 .||||+.+
T Consensus       295 ~ell-----------------~h~~~~~~  306 (342)
T cd07854         295 EEAL-----------------MHPYMSCY  306 (342)
T ss_pred             HHHh-----------------CCCccccc
Confidence            6665                 99999854

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.8e-38  Score=304.46  Aligned_cols=253  Identities=19%  Similarity=0.260  Sum_probs=200.0

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeee-----hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCcee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETL-----LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWIT   76 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~-----~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv   76 (372)
                      +|...+.+|.|    ++|.||++...     ..++.||+|.+.......         ..+.+.+|+.++..+. ||||+
T Consensus        38 ~~~~~~~lG~G----~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~---------~~~~~~~E~~~l~~l~~H~niv  104 (401)
T cd05107          38 NLVLGRTLGSG----AFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSS---------EKQALMSELKIMSHLGPHLNIV  104 (401)
T ss_pred             HeehhhhccCC----CceeEEEEEEcCCCCCCCceEEEEEecCCCCChh---------HHHHHHHHHHHHHhcCCCCCeE
Confidence            45555666666    89999999742     345689999886543221         1245778999999997 99999


Q ss_pred             eeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC------------------------------------------------
Q psy11571         77 NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE------------------------------------------------  108 (372)
Q Consensus        77 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~------------------------------------------------  108 (372)
                      ++++++.+.+..++|||||++|+|.+++....                                                
T Consensus       105 ~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  184 (401)
T cd05107         105 NLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKD  184 (401)
T ss_pred             EEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCc
Confidence            99999999999999999999999999996521                                                


Q ss_pred             -------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecC
Q psy11571        109 -------------------------------------------------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRP  139 (372)
Q Consensus       109 -------------------------------------------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~  139 (372)
                                                                       ..++...+..++.||+.||.|||+.+++|  
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH--  262 (401)
T cd05107         185 ESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVH--  262 (401)
T ss_pred             cccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCc--
Confidence                                                             12566778889999999999999999999  


Q ss_pred             CCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhH
Q psy11571        140 NHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGV  218 (372)
Q Consensus       140 ~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGv  218 (372)
                              |||||+|||++.++.++|+|||+++....... .......+++.|+|||.+.+     ..++.++|+|||||
T Consensus       263 --------rdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslGv  329 (401)
T cd05107         263 --------RDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-----NLYTTLSDVWSFGI  329 (401)
T ss_pred             --------ccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-----CCCCcHhHHHHHHH
Confidence                    99999999999999999999999976532221 11223456789999999973     56888999999999


Q ss_pred             HHHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        219 CMYEMLY-GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       219 il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ++|||++ |..||......+...........+..|.    .++.++.+|+.+||. +|.+||++++++..+
T Consensus       330 il~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~----~~~~~l~~li~~cl~~~P~~RPs~~ell~~L  396 (401)
T cd05107         330 LLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPA----HASDEIYEIMQKCWEEKFEIRPDFSQLVHLV  396 (401)
T ss_pred             HHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            9999998 8999987665555444444333333343    578999999999999 999999988877554

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=5e-38  Score=287.58  Aligned_cols=251  Identities=18%  Similarity=0.237  Sum_probs=200.6

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhh---hhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDIL---LVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHY   80 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~---~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~   80 (372)
                      |...+.++.|    |+|.||++....++.   .+++|.+.......         ..+.+..|+.+++.++||||+++.+
T Consensus         7 ~~~~~~lg~g----~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~   73 (268)
T cd05063           7 ITKQKVIGAG----EFGEVFRGILKMPGRKEVAVAIKTLKPGYTEK---------QRQDFLSEASIMGQFSHHNIIRLEG   73 (268)
T ss_pred             ceEeeEecCC----CCccEEEEEEecCCCCceEEEEEeccccCCHH---------HHHHHHHHHHHHhcCCCCCeeEEEE
Confidence            3334445555    799999998766554   68888775432211         2345678999999999999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         81 AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        81 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      ++.+.+..|+||||+++++|.+++....+.+++..+..++.|++.||.|||+.|++|          |||||+||+++.+
T Consensus        74 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H----------~dlkp~Nili~~~  143 (268)
T cd05063          74 VVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVH----------RDLAARNILVNSN  143 (268)
T ss_pred             EEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeec----------cccchhhEEEcCC
Confidence            999999999999999999999999875567899999999999999999999999999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCccccc--ccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSN--VAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVE  237 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~  237 (372)
                      +.++|+|||++............  ....+..|+|||++.     ...++.++|+|||||++|+|++ |..||...+..+
T Consensus       144 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~  218 (268)
T cd05063         144 LECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA-----YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE  218 (268)
T ss_pred             CcEEECCCccceecccccccceeccCCCcCceecCHHHhh-----cCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH
Confidence            99999999998765432211111  112345799999987     3567899999999999999997 999998888777


Q ss_pred             HHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       238 ~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ....+.... ..+.+.    ..+..+.+++.+||. +|++||++.++.+.+
T Consensus       219 ~~~~i~~~~-~~~~~~----~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l  264 (268)
T cd05063         219 VMKAINDGF-RLPAPM----DCPSAVYQLMLQCWQQDRARRPRFVDIVNLL  264 (268)
T ss_pred             HHHHHhcCC-CCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            777775532 222222    578999999999999 999999988877554

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.9e-38  Score=287.08  Aligned_cols=233  Identities=17%  Similarity=0.187  Sum_probs=185.5

Q ss_pred             cCCccEEEeeeehhh-------hhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEE
Q psy11571         17 QGKGRVFSIETLLDI-------LLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLY   89 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~-------~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   89 (372)
                      ||+|.||++.+...+       ..+++|......          ....+.+.+|..+++.++||||+++++++..+...+
T Consensus         6 G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~----------~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~   75 (258)
T cd05078           6 GTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH----------RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESI   75 (258)
T ss_pred             ccchhheeeeecccccccccccchhhHHhhcchh----------HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcE
Confidence            389999999875433       347777664322          123455777999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc-------
Q psy11571         90 LVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH-------  162 (372)
Q Consensus        90 lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~-------  162 (372)
                      +||||+++|+|.+++......+++..+..++.||+.||+|||++|++|          |||||+||+++.++.       
T Consensus        76 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH----------~dlkp~nili~~~~~~~~~~~~  145 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTH----------GNVCAKNVLLIREEDRKTGNPP  145 (258)
T ss_pred             EEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeec----------CCCccceEEEecccccccCCCc
Confidence            999999999999999875556899999999999999999999999999          999999999987664       


Q ss_pred             -EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhC-CCCCCCCCHHHHHH
Q psy11571        163 -IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYG-ETPFYAESLVETYG  240 (372)
Q Consensus       163 -vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG-~~Pf~~~~~~~~~~  240 (372)
                       ++++|||++......     ....+++.|+|||++.+    ...++.++|+|||||++|+|++| .+||...+......
T Consensus       146 ~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~  216 (258)
T cd05078         146 FIKLSDPGISITVLPK-----EILLERIPWVPPECIEN----PQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ  216 (258)
T ss_pred             eEEecccccccccCCc-----hhccccCCccCchhccC----CCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH
Confidence             699999988654322     22467889999999973    34578899999999999999998 56776655544332


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhh
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIAD  285 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~  285 (372)
                       +...  ...+|.    ..+.++.+||.+||+ +|++||+++++.+
T Consensus       217 -~~~~--~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~  255 (258)
T cd05078         217 -FYED--RHQLPA----PKWTELANLINQCMDYEPDFRPSFRAIIR  255 (258)
T ss_pred             -HHHc--cccCCC----CCcHHHHHHHHHHhccChhhCCCHHHHHH
Confidence             2222  223343    457899999999999 9999999877664

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=4e-38  Score=291.48  Aligned_cols=253  Identities=20%  Similarity=0.279  Sum_probs=204.0

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeee-----hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCcee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETL-----LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWIT   76 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~-----~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv   76 (372)
                      .+|+.+..++.|    |+|.||++...     .++..+|+|.+......         ...+.+.+|+.+++.++||||+
T Consensus         5 ~~~~~~~~lg~g----~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~~~ei~~l~~l~h~~iv   71 (288)
T cd05050           5 NNIEYVRDIGQG----AFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA---------DMQADFQREAALMAEFDHPNIV   71 (288)
T ss_pred             Hhceeccccccc----ccccEEEEEEcccCCCCcceeEEEEecCCCcCH---------HHHHHHHHHHHHHHhcCCCchh
Confidence            356777777777    89999999763     35778999977643321         1235577899999999999999


Q ss_pred             eeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCc
Q psy11571         77 NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE---------------------DRLPEDMAKFYIAEMVLAIASIHDLHY  135 (372)
Q Consensus        77 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---------------------~~l~~~~~~~~~~qi~~~L~~LH~~~i  135 (372)
                      ++++++.++...+++|||+++|+|.+++....                     ..+++..+..++.|++.||.|||+.|+
T Consensus        72 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i  151 (288)
T cd05050          72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKF  151 (288)
T ss_pred             eEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            99999999999999999999999999997521                     246788899999999999999999999


Q ss_pred             eecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCcc-cccccccCCcccCcccccccccCCCCCCCcccee
Q psy11571        136 VHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTV-QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWW  214 (372)
Q Consensus       136 vH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diw  214 (372)
                      +|          |||||+||+++.++.++|+|||++......... ......++..|+|||.+.+     ..++.++|+|
T Consensus       152 ~H----------~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~  216 (288)
T cd05050         152 VH----------RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-----NRYTTESDVW  216 (288)
T ss_pred             ec----------ccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-----CCCCchhHHH
Confidence            99          999999999999999999999998765332211 1112234667999999873     5688999999


Q ss_pred             ehhHHHHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        215 SLGVCMYEMLY-GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       215 slGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ||||++|+|++ |..||.+.+..+....+..+.. ...+.    .++.++.+||.+||+ +|++||+++++...+
T Consensus       217 slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l  286 (288)
T cd05050         217 AYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNV-LSCPD----NCPLELYNLMRLCWSKLPSDRPSFASINRIL  286 (288)
T ss_pred             HHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-CCCCC----CCCHHHHHHHHHHcccCcccCCCHHHHHHHh
Confidence            99999999997 8899988887777776655432 22233    578999999999999 999999998887655

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.4e-38  Score=288.24  Aligned_cols=250  Identities=18%  Similarity=0.245  Sum_probs=199.9

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhh---hhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDIL---LVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHY   80 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~---~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~   80 (372)
                      |+..+.++.|    |+|.||++....+++   .|++|.+......         ...+.+..|+.+++.++||||+++++
T Consensus         6 ~~~~~~lg~g----~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~e~~~l~~l~h~ni~~~~~   72 (269)
T cd05065           6 VKIEEVIGAG----EFGEVCRGRLKLPGKREIFVAIKTLKSGYTE---------KQRRDFLSEASIMGQFDHPNIIHLEG   72 (269)
T ss_pred             eEEEeEecCC----CCCeEEEEEEecCCCCceeEEEEEcCCCCCH---------HHHHHHHHHHHHHHhCCCcCcceEEE
Confidence            3334445555    899999998776664   5899977643211         12355788999999999999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         81 AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        81 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      ++.++...++||||+++++|.+++....+.+++..++.++.|++.||+|||++|++|          +||||+||+++.+
T Consensus        73 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H----------~dl~p~nili~~~  142 (269)
T cd05065          73 VVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVH----------RDLAARNILVNSN  142 (269)
T ss_pred             EECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEee----------cccChheEEEcCC
Confidence            999999999999999999999999875567899999999999999999999999999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcccc--cccc--cCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQS--NVAV--GTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESL  235 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~--~~~~--gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~  235 (372)
                      +.++|+|||++...........  ....  .+..|+|||.+.     ...++.++|+|||||++|||++ |..||...+.
T Consensus       143 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~  217 (269)
T cd05065         143 LVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA-----YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN  217 (269)
T ss_pred             CcEEECCCccccccccCccccccccccCCCcceeecCHhHhc-----cCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH
Confidence            9999999999876543221111  1111  235799999987     3568899999999999999886 9999998887


Q ss_pred             HHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhh
Q psy11571        236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADF  286 (372)
Q Consensus       236 ~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i  286 (372)
                      .+....+... ...+.+.    .++..+.+++.+||. +|.+||+++++...
T Consensus       218 ~~~~~~i~~~-~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  264 (269)
T cd05065         218 QDVINAIEQD-YRLPPPM----DCPTALHQLMLDCWQKDRNARPKFGQIVST  264 (269)
T ss_pred             HHHHHHHHcC-CcCCCcc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7777766443 2223232    578999999999999 99999998777644

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG0666|consensus

Probab=100.00  E-value=8e-39  Score=282.33  Aligned_cols=263  Identities=20%  Similarity=0.286  Sum_probs=200.5

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehh----hhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLD----ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNL   78 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~----~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l   78 (372)
                      .|+.++.++.|    .+|.||++.+..+    .+.+|+|+++...-...        .-....+|+.+++.++||||+.+
T Consensus        25 ~ye~ig~Ig~G----TYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG--------iS~SAcREiaL~REl~h~nvi~L   92 (438)
T KOG0666|consen   25 EYEGIGKIGRG----TYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG--------ISMSACREIALLRELKHPNVISL   92 (438)
T ss_pred             Hhhccceeccc----ccceeeEeeeccCCcccchhhHHHHHhccCCCCC--------cCHHHHHHHHHHHHhcCCcchhH
Confidence            34555555555    5788888865543    34899999887643222        12335789999999999999999


Q ss_pred             eEEEEe-CCeEEEEEeccCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcC
Q psy11571         79 HYAFQD-DSNLYLVMDYYCGGDLLTLLSKF----EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPD  153 (372)
Q Consensus        79 ~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~  153 (372)
                      ..+|.+ +..+++++||.+. ||.++|+-.    ...++...++.++.||+.|+.|||++=|+|          |||||.
T Consensus        93 v~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlH----------RDLKPa  161 (438)
T KOG0666|consen   93 VKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLH----------RDLKPA  161 (438)
T ss_pred             HHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheee----------ccCCcc
Confidence            999987 7789999999855 999998642    246899999999999999999999999999          999999


Q ss_pred             cEEeCCC----CcEEEeecCcccccCCCCc--ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCC
Q psy11571        154 NVLLDAN----GHIRLADFGSCLRLGGDGT--VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGE  227 (372)
Q Consensus       154 NIll~~~----~~vkl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~  227 (372)
                      |||+..+    |.|||+|||+++.....-.  ......+-|..|.|||.+.+    ...|+++.|+||+|||+.||+|-.
T Consensus       162 NIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLG----a~hYT~AiDvWAiGCIfaElLtl~  237 (438)
T KOG0666|consen  162 NILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLG----ARHYTKAIDVWAIGCIFAELLTLE  237 (438)
T ss_pred             eEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcc----cccccchhhhHHHHHHHHHHHccC
Confidence            9999877    8999999999998754321  12233566899999999995    788999999999999999999999


Q ss_pred             CCCCCCCHH---------HHHHHHhhccCCcC---------CCCC----------C------------CCCCCHHHHHHH
Q psy11571        228 TPFYAESLV---------ETYGKIMNHQNSFD---------LPSD----------V------------GYEISDDAKDLM  267 (372)
Q Consensus       228 ~Pf~~~~~~---------~~~~~i~~~~~~~~---------~~~~----------~------------~~~~s~~~~~li  267 (372)
                      +.|.+....         +.+.+|.+--+.+.         .|..          .            ...-++.+.+|+
T Consensus       238 PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL  317 (438)
T KOG0666|consen  238 PLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLL  317 (438)
T ss_pred             ccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHH
Confidence            888764322         23334432111110         1110          0            012456699999


Q ss_pred             HHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        268 RRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       268 ~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      .+||+ ||.+|+++++++                 +|+||..-
T Consensus       318 ~klL~yDP~kRIta~qAl-----------------eh~yF~~d  343 (438)
T KOG0666|consen  318 QKLLTYDPIKRITAEQAL-----------------EHPYFTED  343 (438)
T ss_pred             HHHhccCchhhccHHHHh-----------------cccccccC
Confidence            99999 999999998887                 99999853

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.2e-38  Score=288.94  Aligned_cols=250  Identities=19%  Similarity=0.266  Sum_probs=194.4

Q ss_pred             HHHHHhhhcCCcccCCccEEEeee----ehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeee
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIET----LLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLH   79 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~----~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~   79 (372)
                      |+.++.++.|    |+|.||.++.    ..++..|++|.+......         ...+.+.+|+.+++.+.||||++++
T Consensus         6 ~~~~~~lg~g----~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~   72 (284)
T cd05079           6 LKRIRDLGEG----HFGKVELCRYDPEGDNTGEQVAVKSLKPESGG---------NHIADLKKEIEILRNLYHENIVKYK   72 (284)
T ss_pred             hhhceecCCC----CceeEEEEEEccCCCCccceEEEEEcCccccH---------HHHHHHHHHHHHHHhCCCCCeeeee
Confidence            5777787777    8999999863    456889999987644321         1235578899999999999999999


Q ss_pred             EEEEeC--CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe
Q psy11571         80 YAFQDD--SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        80 ~~~~~~--~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      +++.+.  ...++||||++|++|.+++.+....+++..+..++.|++.||+|||+.|++|          |||||+||++
T Consensus        73 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H----------~dlkp~Nil~  142 (284)
T cd05079          73 GICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVH----------RDLAARNVLV  142 (284)
T ss_pred             eEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeee----------cccchheEEE
Confidence            998875  5689999999999999999764456899999999999999999999999999          9999999999


Q ss_pred             CCCCcEEEeecCcccccCCCCcc--cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCC-
Q psy11571        158 DANGHIRLADFGSCLRLGGDGTV--QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES-  234 (372)
Q Consensus       158 ~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~-  234 (372)
                      +.++.++|+|||++.........  ......++..|+|||++.+     ..++.++|+|||||++|+|+++..|+.... 
T Consensus       143 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-----~~~~~~~Di~slG~il~ellt~~~~~~~~~~  217 (284)
T cd05079         143 ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ-----SKFYIASDVWSFGVTLYELLTYCDSESSPMT  217 (284)
T ss_pred             cCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhcc-----CCCCccccchhhhhhhhhhhcCCCCCccccc
Confidence            99999999999998865432211  1123456778999999873     568889999999999999999877653211 


Q ss_pred             -------------HHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhh
Q psy11571        235 -------------LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIAD  285 (372)
Q Consensus       235 -------------~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~  285 (372)
                                   ...............+.+    ..++..+.+||.+||+ +|.+||+++++.+
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  278 (284)
T cd05079         218 LFLKMIGPTHGQMTVTRLVRVLEEGKRLPRP----PNCPEEVYQLMRKCWEFQPSKRTTFQNLIE  278 (284)
T ss_pred             hhhhhcccccccccHHHHHHHHHcCccCCCC----CCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                         001111112222222222    2689999999999999 9999999887764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1e-38  Score=294.01  Aligned_cols=252  Identities=25%  Similarity=0.349  Sum_probs=200.3

Q ss_pred             HHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe
Q psy11571          5 RELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQD   84 (372)
Q Consensus         5 ~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~   84 (372)
                      +.++.++.|    ++|.||++....+++.+++|.+.......        .....+.+|+.+++.++||||+++++.+.+
T Consensus         2 ~~~~~i~~g----~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   69 (283)
T cd05118           2 QKLGKIGEG----TYGVVYKARDKLTGEIVAIKKIKLRFESE--------GIPKTALREIKLLKELNHPNIIKLLDVFRH   69 (283)
T ss_pred             ccceeeecC----CCceEEEEEcCCCCcEEEEEEeccccccc--------hhHHHHHHHHHHHHHhcCCCcchHHHhhcc
Confidence            344555555    79999999988899999999876544332        123456779999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEE
Q psy11571         85 DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIR  164 (372)
Q Consensus        85 ~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vk  164 (372)
                      ++..++||||++ ++|.+++......+++..+..++.||+.||.|||+.|++|          +||||+||+++.++.++
T Consensus        70 ~~~~~~v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H----------~dl~p~nili~~~~~~~  138 (283)
T cd05118          70 KGDLYLVFEFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILH----------RDLKPENLLINTEGVLK  138 (283)
T ss_pred             CCCEEEEEeccC-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeee----------cCcCHHHEEECCCCcEE
Confidence            999999999996 4999988775568999999999999999999999999999          99999999999999999


Q ss_pred             EeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhh
Q psy11571        165 LADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN  244 (372)
Q Consensus       165 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~  244 (372)
                      |+|||.+........ ......++..|+|||.+.+    ...++.++|+||||+++|+|++|+.||.+.+..+.+.++..
T Consensus       139 l~df~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~  213 (283)
T cd05118         139 LADFGLARSFGSPVR-PYTHYVVTRWYRAPELLLG----DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFR  213 (283)
T ss_pred             EeeeeeeEecCCCcc-cccCccCcccccCcHHHhc----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999999877654331 1122457889999999874    33688999999999999999999999988777665555433


Q ss_pred             ccCCc-----------------CCC-------CCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        245 HQNSF-----------------DLP-------SDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       245 ~~~~~-----------------~~~-------~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      .....                 .++       ......++.+++++|.+||+ +|.+||+++++.
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll  278 (283)
T cd05118         214 TLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQAL  278 (283)
T ss_pred             HcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHh
Confidence            21110                 000       00112468899999999999 999999866555

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.7e-38  Score=285.95  Aligned_cols=243  Identities=19%  Similarity=0.289  Sum_probs=196.0

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+..+.++.|    |+|.||++..  .+..+++|.......            .+.+.+|+.+++.++||||+++++++
T Consensus         7 ~~~~~~~lg~g----~~~~v~~~~~--~~~~~~~k~~~~~~~------------~~~~~~e~~~l~~l~~~~i~~~~~~~   68 (256)
T cd05082           7 ELKLLQTIGKG----EFGDVMLGDY--RGNKVAVKCIKNDAT------------AQAFLAEASVMTQLRHSNLVQLLGVI   68 (256)
T ss_pred             hCeeeeeeccc----CCCeEEEEEE--cCCcEEEEEeCCCch------------HHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            45555666666    7899998854  477888887653221            23467899999999999999999875


Q ss_pred             -EeCCeEEEEEeccCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         83 -QDDSNLYLVMDYYCGGDLLTLLSKFED-RLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        83 -~~~~~~~lv~E~~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                       .+++..|++|||+++++|.+++.+... .+++..+..++.|++.||+|||++|++|          |||||+||+++.+
T Consensus        69 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H----------~dlkp~nil~~~~  138 (256)
T cd05082          69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVH----------RDLAARNVLVSED  138 (256)
T ss_pred             EcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEec----------cccchheEEEcCC
Confidence             455678999999999999999976432 4789999999999999999999999999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETY  239 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~  239 (372)
                      +.+||+|||++.......    ....++..|+|||++.+     ..++.++|+|||||++|+|++ |+.||...+..+..
T Consensus       139 ~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~  209 (256)
T cd05082         139 NVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALRE-----KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV  209 (256)
T ss_pred             CcEEecCCccceeccccC----CCCccceeecCHHHHcc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            999999999987653322    12345668999999873     568889999999999999997 99999988777776


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ..+.... ....+.    .+++.+.++|.+||+ +|++||+++++.+.+
T Consensus       210 ~~~~~~~-~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l  253 (256)
T cd05082         210 PRVEKGY-KMDAPD----GCPPVVYDVMKQCWHLDAATRPSFLQLREQL  253 (256)
T ss_pred             HHHhcCC-CCCCCC----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence            6665432 222232    679999999999999 999999988876544

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-38  Score=301.17  Aligned_cols=256  Identities=23%  Similarity=0.354  Sum_probs=199.5

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.++.|    ++|.||.+.+..+++.||+|.+.......        ...+.+.+|+.+++.++||||+++++++
T Consensus        18 ~y~~~~~lg~G----~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~~Ei~~l~~l~h~~iv~~~~~~   85 (345)
T cd07877          18 RYQNLSPVGSG----AYGSVCAAFDTKTGLRVAVKKLSRPFQSI--------IHAKRTYRELRLLKHMKHENVIGLLDVF   85 (345)
T ss_pred             ceEEEEEeeec----CCeEEEEEEEcCCCeEEEEEEecCcchhh--------HHHHHHHHHHHHHHHcCCCcccceeeee
Confidence            44445555555    89999999988899999999776532211        1234567899999999999999999988


Q ss_pred             EeC------CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEE
Q psy11571         83 QDD------SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL  156 (372)
Q Consensus        83 ~~~------~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIl  156 (372)
                      ...      ...|++++++ +++|.+++..  ..+++..++.++.|++.||.|||+.|++|          |||||+||+
T Consensus        86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH----------~dlkp~NIl  152 (345)
T cd07877          86 TPARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIH----------RDLKPSNLA  152 (345)
T ss_pred             eecccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeee----------cCCChHHEE
Confidence            653      3478888886 8899988865  57999999999999999999999999999          999999999


Q ss_pred             eCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH
Q psy11571        157 LDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV  236 (372)
Q Consensus       157 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~  236 (372)
                      +++++.++|+|||++......    .....|+..|+|||.+.+    ...++.++|+|||||++|+|++|++||...+..
T Consensus       153 l~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~  224 (345)
T cd07877         153 VNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLN----WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI  224 (345)
T ss_pred             EcCCCCEEEeccccccccccc----ccccccCCCccCHHHHhC----ccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            999999999999998765322    123467899999999863    345788999999999999999999999877665


Q ss_pred             HHHHHHhhccCCc---------------------CCCC----CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhh
Q psy11571        237 ETYGKIMNHQNSF---------------------DLPS----DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWS  290 (372)
Q Consensus       237 ~~~~~i~~~~~~~---------------------~~~~----~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~  290 (372)
                      .....+.......                     ..+.    ......++++++||.+||+ +|.+|+++.+++      
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l------  298 (345)
T cd07877         225 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL------  298 (345)
T ss_pred             HHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHh------
Confidence            5544443211100                     0000    0011358899999999999 999999866555      


Q ss_pred             hhhhccCCCCCCCCCcCC
Q psy11571        291 ALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       291 ~~~~~~~~~~~~hp~f~~  308 (372)
                                 .||||+.
T Consensus       299 -----------~h~~f~~  305 (345)
T cd07877         299 -----------AHAYFAQ  305 (345)
T ss_pred             -----------cChhhhh
Confidence                       9999985

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=8.1e-39  Score=298.86  Aligned_cols=255  Identities=23%  Similarity=0.312  Sum_probs=194.7

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.++.|    ++|.||++....+++.+++|.+........        ....+.+|+.+++.++||||+++++++
T Consensus         9 ~y~~~~~lg~g----~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~   76 (311)
T cd07866           9 DYEILGKLGEG----TFGEVYKARQIKTGRVVALKKILMHNEKDG--------FPITALREIKILKKLKHPNVVPLIDMA   76 (311)
T ss_pred             cEEEEEEeccC----CCEEEEEEEECCCCcEEEEEEEEeccCCCC--------cchhHHHHHHHHHhcCCCCccchhhhe
Confidence            45555666666    899999999988999999998765443221        112346799999999999999999887


Q ss_pred             EeC--------CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCc
Q psy11571         83 QDD--------SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDN  154 (372)
Q Consensus        83 ~~~--------~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~N  154 (372)
                      .+.        ..+|+||||+. ++|...+......+++..++.++.|++.||.|||++|++|          +||||+|
T Consensus        77 ~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H----------~dl~p~n  145 (311)
T cd07866          77 VERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILH----------RDIKAAN  145 (311)
T ss_pred             ecccccccccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeec----------CCCCHHH
Confidence            543        34799999985 5788887664567999999999999999999999999999          9999999


Q ss_pred             EEeCCCCcEEEeecCcccccCCCCcc----------cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHh
Q psy11571        155 VLLDANGHIRLADFGSCLRLGGDGTV----------QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML  224 (372)
Q Consensus       155 Ill~~~~~vkl~Dfg~a~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ell  224 (372)
                      |++++++.++|+|||++.........          ......+++.|+|||.+.+    ...++.++|+|||||++|+|+
T Consensus       146 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~el~  221 (311)
T cd07866         146 ILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG----ERRYTTAVDIWGIGCVFAEMF  221 (311)
T ss_pred             EEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhC----CCccCchhHhHHHHHHHHHHH
Confidence            99999999999999999765432111          1122356888999999863    345788999999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHHhhccCCcC---------------------CCC---CCCCCCCHHHHHHHHHhcc-CCCCCCC
Q psy11571        225 YGETPFYAESLVETYGKIMNHQNSFD---------------------LPS---DVGYEISDDAKDLMRRLIC-SSDTRLG  279 (372)
Q Consensus       225 tG~~Pf~~~~~~~~~~~i~~~~~~~~---------------------~~~---~~~~~~s~~~~~li~~lL~-~p~~R~s  279 (372)
                      +|++||.+.+.......+........                     .+.   .....+++.+.++|.+||+ +|++||+
T Consensus       222 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t  301 (311)
T cd07866         222 TRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT  301 (311)
T ss_pred             hCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcC
Confidence            99999998877666555443211100                     000   0012355789999999999 9999998


Q ss_pred             CCChh
Q psy11571        280 QNGIA  284 (372)
Q Consensus       280 ~~~~~  284 (372)
                      +.+++
T Consensus       302 ~~ell  306 (311)
T cd07866         302 ASDAL  306 (311)
T ss_pred             HHHHh
Confidence            66555

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=8.7e-38  Score=286.49  Aligned_cols=244  Identities=19%  Similarity=0.241  Sum_probs=193.7

Q ss_pred             ccCCccEEEeeeehhhh--hhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC------Ce
Q psy11571         16 IQGKGRVFSIETLLDIL--LVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDD------SN   87 (372)
Q Consensus        16 ~~g~G~v~~v~~~~~~~--~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~------~~   87 (372)
                      .||+|.||.+....++.  .+|+|.+........        ..+.+.+|..+++.++||||+++++.+...      ..
T Consensus         9 ~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           9 EGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRS--------EMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             cccCceEEEeEEccCCCeeeEEEEecccCcCCHH--------HHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            34899999998766654  588887765432221        245677899999999999999999876432      24


Q ss_pred             EEEEEeccCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         88 LYLVMDYYCGGDLLTLLSKF-----EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        88 ~~lv~E~~~gg~L~~~l~~~-----~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+++|||+++|+|.+++...     ...+++..+..++.|++.||+|||++||+|          |||||+|||++.++.
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H----------~dlkp~Nil~~~~~~  150 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIH----------RDLAARNCMLNENMN  150 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeec----------cccchhheEEcCCCC
Confidence            68999999999999987431     234789999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCccc-ccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQ-SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYG  240 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~  240 (372)
                      ++|+|||+++......... .....+++.|+|||.+.     ...++.++|+|||||++|+|++ |..||.+....+...
T Consensus       151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  225 (272)
T cd05075         151 VCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLA-----DRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYD  225 (272)
T ss_pred             EEECCCCcccccCcccceecCCcccCCcccCCHHHcc-----CCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            9999999998764332211 12234567899999987     3568899999999999999999 899999888777777


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .+..+. ....+.    .++..+.++|.+||+ +|++||+++++.+.+
T Consensus       226 ~~~~~~-~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l  268 (272)
T cd05075         226 YLRQGN-RLKQPP----DCLDGLYSLMSSCWLLNPKDRPSFETLRCEL  268 (272)
T ss_pred             HHHcCC-CCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            766543 222233    678999999999999 999999988776543

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=6.1e-38  Score=285.98  Aligned_cols=249  Identities=20%  Similarity=0.290  Sum_probs=200.0

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+..+.++.|    |+|.||.+. ..++..+++|.+.....           ..+.+.+|+.+++.++|+||+++++.
T Consensus         6 ~~~~~~~~lg~g----~~~~vy~~~-~~~~~~~~iK~~~~~~~-----------~~~~~~~e~~~l~~l~~~~i~~~~~~   69 (260)
T cd05073           6 ESLKLEKKLGAG----QFGEVWMAT-YNKHTKVAVKTMKPGSM-----------SVEAFLAEANVMKTLQHDKLVKLHAV   69 (260)
T ss_pred             cceeEEeEecCc----cceEEEEEE-ecCCccEEEEecCCChh-----------HHHHHHHHHHHHHhcCCCCcceEEEE
Confidence            455666666666    799999996 44566788887664321           13457789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      +.+ ...+++|||+++++|.+++.+. ...++...+..++.|++.||.|||+.|++|          |||||+||+++.+
T Consensus        70 ~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H----------~dl~p~ni~i~~~  138 (260)
T cd05073          70 VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH----------RDLRAANILVSAS  138 (260)
T ss_pred             EcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccc----------cccCcceEEEcCC
Confidence            887 7789999999999999999763 345788899999999999999999999999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETY  239 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~  239 (372)
                      +.++|+|||.+...............++..|+|||++.     ...++.++|+|||||++|++++ |..||.+.+.....
T Consensus       139 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~  213 (260)
T cd05073         139 LVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN-----FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI  213 (260)
T ss_pred             CcEEECCCcceeeccCCCcccccCCcccccccCHhHhc-----cCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            99999999998765433222222234567899999987     3568889999999999999998 99999988777766


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ..+... ...+.+.    ..+.++.+++.+||+ +|++||+++++.+.+
T Consensus       214 ~~~~~~-~~~~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L  257 (260)
T cd05073         214 RALERG-YRMPRPE----NCPEELYNIMMRCWKNRPEERPTFEYIQSVL  257 (260)
T ss_pred             HHHhCC-CCCCCcc----cCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence            666543 2222222    678999999999999 999999988776554

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=5.3e-38  Score=293.60  Aligned_cols=252  Identities=20%  Similarity=0.277  Sum_probs=198.0

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeeh-------hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCc
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLL-------DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRW   74 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~-------~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~   74 (372)
                      +|...+.+|.|    |+|.||.++...       +...+|+|.+......         .....+.+|+.+++.+ +|||
T Consensus        19 ~~~i~~~lg~G----~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~~~e~~~l~~l~~h~~   85 (307)
T cd05098          19 RLVLGKPLGEG----CFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATE---------KDLSDLISEMEMMKMIGKHKN   85 (307)
T ss_pred             HeEEeeeeccC----CCeeEEEeEEeccCCcccCccceEEEEeccCCCCh---------HHHHHHHHHHHHHHHhcCCCC
Confidence            44455556555    799999987543       2346888877643211         1234577789999988 7999


Q ss_pred             eeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecC
Q psy11571         75 ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE---------------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRP  139 (372)
Q Consensus        75 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~  139 (372)
                      |+++++++...+..|+||||+++|+|.+++....               ..++...++.++.|++.||+|||++|++|  
T Consensus        86 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H--  163 (307)
T cd05098          86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIH--  163 (307)
T ss_pred             EeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCccc--
Confidence            9999999999999999999999999999997632               24788999999999999999999999999  


Q ss_pred             CCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCccc-ccccccCCcccCcccccccccCCCCCCCccceeehhH
Q psy11571        140 NHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ-SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGV  218 (372)
Q Consensus       140 ~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGv  218 (372)
                              |||||+||+++.++.++|+|||++.......... .....+++.|+|||++.+     ..++.++|+|||||
T Consensus       164 --------~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~  230 (307)
T cd05098         164 --------RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-----RIYTHQSDVWSFGV  230 (307)
T ss_pred             --------ccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-----CCCCcHHHHHHHHH
Confidence                    9999999999999999999999987654322111 111234568999999873     56889999999999


Q ss_pred             HHHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        219 CMYEMLY-GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       219 il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ++|+|++ |..||.+.+..+....+... .....+.    ..+.++++||.+||. +|++||++.++.+.+
T Consensus       231 ~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~evl~~l  296 (307)
T cd05098         231 LLWEIFTLGGSPYPGVPVEELFKLLKEG-HRMDKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  296 (307)
T ss_pred             HHHHHHcCCCCCCCcCCHHHHHHHHHcC-CCCCCCC----cCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence            9999998 89999888777766665443 2233333    678999999999999 999999988776544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=6e-38  Score=292.76  Aligned_cols=252  Identities=20%  Similarity=0.291  Sum_probs=199.9

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeee-------hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCc
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETL-------LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRW   74 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~-------~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~   74 (372)
                      +|.....++.|    |+|.||.++..       .++..+++|........         +..+.+.+|+.+++.+ +|||
T Consensus        16 ~~~~~~~lg~G----~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~---------~~~~~~~~E~~~l~~l~~h~~   82 (304)
T cd05101          16 KLTLGKPLGEG----CFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE---------KDLSDLVSEMEMMKMIGKHKN   82 (304)
T ss_pred             Heeecceeecc----CCceEEEEEEeccCCCCCCcceeEEeeecccccch---------HHHHHHHHHHHHHHhhccCCC
Confidence            34444455555    89999998643       23457888876543221         1235578899999998 7999


Q ss_pred             eeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecC
Q psy11571         75 ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE---------------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRP  139 (372)
Q Consensus        75 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~  139 (372)
                      |+++++.+......|++|||+++|+|.+++.+..               ..++...+..++.||+.||.|||++|++|  
T Consensus        83 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH--  160 (304)
T cd05101          83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIH--  160 (304)
T ss_pred             chheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeee--
Confidence            9999999999999999999999999999997631               24677889999999999999999999999  


Q ss_pred             CCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCcc-cccccccCCcccCcccccccccCCCCCCCccceeehhH
Q psy11571        140 NHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTV-QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGV  218 (372)
Q Consensus       140 ~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGv  218 (372)
                              |||||+||+++.++.+||+|||+++........ ......+++.|+|||++.+     ..++.++||||||+
T Consensus       161 --------~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~  227 (304)
T cd05101         161 --------RDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-----RVYTHQSDVWSFGV  227 (304)
T ss_pred             --------cccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-----CCCCchhhHHHHHH
Confidence                    999999999999999999999999876432221 1222345678999999973     56889999999999


Q ss_pred             HHHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        219 CMYEMLY-GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       219 il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ++|+|++ |..||.+.+..+....+.... ....+.    .++..+++||.+||. +|.+||++.++++.+
T Consensus       228 ~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l  293 (304)
T cd05101         228 LMWEIFTLGGSPYPGIPVEELFKLLKEGH-RMDKPA----NCTNELYMMMRDCWHAIPSHRPTFKQLVEDL  293 (304)
T ss_pred             HHHHHHcCCCCCcccCCHHHHHHHHHcCC-cCCCCC----CCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence            9999998 889999888888777765442 222332    678999999999999 999999988776544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=7.2e-38  Score=291.13  Aligned_cols=256  Identities=23%  Similarity=0.253  Sum_probs=197.6

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeeh----------------hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHH
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLL----------------DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERD   65 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~----------------~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~   65 (372)
                      ++|+..+.++.|    |+|.||.+....                +...+|+|........         ...+.+.+|+.
T Consensus         5 ~~~~~~~~lg~G----~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~---------~~~~~~~~E~~   71 (296)
T cd05095           5 KRLTFKEKLGEG----QFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK---------NARNDFLKEIK   71 (296)
T ss_pred             hhceeeeeccCC----CCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCH---------HHHHHHHHHHH
Confidence            467777777777    899999885322                2346777766543211         12356788999


Q ss_pred             HHhcCCCCceeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhcCc
Q psy11571         66 VLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE----------DRLPEDMAKFYIAEMVLAIASIHDLHY  135 (372)
Q Consensus        66 il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------~~l~~~~~~~~~~qi~~~L~~LH~~~i  135 (372)
                      +++.++||||+++++++.+.+..+++|||+++++|.+++....          ..+++..+..++.|++.||+|||+.|+
T Consensus        72 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i  151 (296)
T cd05095          72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNF  151 (296)
T ss_pred             HHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            9999999999999999999999999999999999999997631          236678899999999999999999999


Q ss_pred             eecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCcc-cccccccCCcccCcccccccccCCCCCCCcccee
Q psy11571        136 VHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTV-QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWW  214 (372)
Q Consensus       136 vH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diw  214 (372)
                      +|          |||||+||+++.++.++|+|||+++........ ......+++.|+|||...+     +.++.++|+|
T Consensus       152 ~H----------~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~Diw  216 (296)
T cd05095         152 VH----------RDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-----GKFTTASDVW  216 (296)
T ss_pred             ec----------ccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-----CCccchhhhh
Confidence            99          999999999999999999999998765432211 1122334678999998773     5689999999


Q ss_pred             ehhHHHHHHhh--CCCCCCCCCHHHHHHHHhh---cc-CCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        215 SLGVCMYEMLY--GETPFYAESLVETYGKIMN---HQ-NSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       215 slGvil~ellt--G~~Pf~~~~~~~~~~~i~~---~~-~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ||||++|||++  |..||...+..+.......   .. .....+.  ...+++.+.+|+.+||+ ||.+||++.++.+++
T Consensus       217 SlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l  294 (296)
T cd05095         217 AFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPK--PALCPDSLYKLMLSCWRRNAKERPSFQEIHATL  294 (296)
T ss_pred             HHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence            99999999998  7899987766665443321   10 1111111  12578999999999999 999999988887655

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=8e-38  Score=289.87  Aligned_cols=251  Identities=19%  Similarity=0.241  Sum_probs=198.2

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeeh-----hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeee
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLL-----DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNL   78 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~-----~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l   78 (372)
                      |+..+.+|.|    |+|.||++....     ....+++|.+.......         ..+.+.+|+.+++.++||||+++
T Consensus         2 ~~~~~~lg~g----~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~---------~~~~~~~E~~~l~~l~h~~iv~~   68 (290)
T cd05045           2 LVLGKTLGEG----EFGKVVKATAFRLKGRAGYTTVAVKMLKENASSS---------ELRDLLSEFNLLKQVNHPHVIKL   68 (290)
T ss_pred             ccccccccCc----CCcceEEEEEecCCCCCcceeEEEEecCCCCCHH---------HHHHHHHHHHHHhhCCCCCEeeE
Confidence            3444555555    899999987643     22457777665433211         23567889999999999999999


Q ss_pred             eEEEEeCCeEEEEEeccCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCc
Q psy11571         79 HYAFQDDSNLYLVMDYYCGGDLLTLLSKFE-----------------------DRLPEDMAKFYIAEMVLAIASIHDLHY  135 (372)
Q Consensus        79 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-----------------------~~l~~~~~~~~~~qi~~~L~~LH~~~i  135 (372)
                      ++.+...+..+++|||+.+++|.+++....                       ..+++..+..++.|++.||.|||+.|+
T Consensus        69 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i  148 (290)
T cd05045          69 YGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKL  148 (290)
T ss_pred             EEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            999999999999999999999999986521                       247788999999999999999999999


Q ss_pred             eecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCcc-cccccccCCcccCcccccccccCCCCCCCcccee
Q psy11571        136 VHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTV-QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWW  214 (372)
Q Consensus       136 vH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diw  214 (372)
                      +|          |||||+||++++++.++|+|||+++........ ......++..|+|||.+.     ...++.++|+|
T Consensus       149 vH----------~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~-----~~~~~~~~Di~  213 (290)
T cd05045         149 VH----------RDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF-----DHIYTTQSDVW  213 (290)
T ss_pred             eh----------hhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHc-----cCCcchHhHHH
Confidence            99          999999999999999999999998765332221 122234567899999987     35688999999


Q ss_pred             ehhHHHHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        215 SLGVCMYEMLY-GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       215 slGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      |||+++|+|++ |..||.+....+....+... .....+.    .++.++.+++.+||+ +|++||++.++.+.+
T Consensus       214 slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l  283 (290)
T cd05045         214 SFGVLLWEIVTLGGNPYPGIAPERLFNLLKTG-YRMERPE----NCSEEMYNLMLTCWKQEPDKRPTFADISKEL  283 (290)
T ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-CCCCCCC----CCCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence            99999999998 99999988877766655432 2233333    678999999999999 999999988776544

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.8e-38  Score=298.36  Aligned_cols=256  Identities=24%  Similarity=0.368  Sum_probs=199.5

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.+..++.|    ++|.||++.+..+++.+++|.+.......        ...+.+.+|+.+++.++||||+++++++
T Consensus        11 ~y~~~~~ig~g----~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~~~~~~   78 (328)
T cd07856          11 RYVDLQPVGMG----AFGLVCSARDQLTGQNVAIKKIMKPFSTP--------VLAKRTYRELKLLKHLRHENIISLSDIF   78 (328)
T ss_pred             ceEEEEeeccc----CCeEEEEEEECCCCCEEEEEEeccccccc--------chhHHHHHHHHHHHhcCCCCeeeEeeeE
Confidence            55666666665    89999999999999999999775432211        1234567899999999999999999998


Q ss_pred             Ee-CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         83 QD-DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        83 ~~-~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      .. ....|++|||+ +++|.++++.  ..+++..+..++.|++.||.|||+.|++|          |||+|.||+++.++
T Consensus        79 ~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH----------~dl~p~Nili~~~~  145 (328)
T cd07856          79 ISPLEDIYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVH----------RDLKPSNILINENC  145 (328)
T ss_pred             ecCCCcEEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccc----------CCCCHHHEeECCCC
Confidence            76 45789999998 6799998875  57899999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .++|+|||.+.......    ....+++.|+|||.+.+    ...++.++|+|||||++|+|++|++||.+.+....+..
T Consensus       146 ~~~l~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~  217 (328)
T cd07856         146 DLKICDFGLARIQDPQM----TGYVSTRYYRAPEIMLT----WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSI  217 (328)
T ss_pred             CEEeCccccccccCCCc----CCCcccccccCceeeec----cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999987543221    22457889999998763    34578999999999999999999999987665333222


Q ss_pred             Hhhcc------------------------CCcCCC-CCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhc
Q psy11571        242 IMNHQ------------------------NSFDLP-SDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVS  295 (372)
Q Consensus       242 i~~~~------------------------~~~~~~-~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~  295 (372)
                      +.+..                        .....| ......++..+.++|++||+ +|++||++++++           
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell-----------  286 (328)
T cd07856         218 ITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEAL-----------  286 (328)
T ss_pred             HHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHh-----------
Confidence            11100                        000001 01112568999999999999 999999866554           


Q ss_pred             cCCCCCCCCCcCC
Q psy11571        296 LSISPRNHPWFQG  308 (372)
Q Consensus       296 ~~~~~~~hp~f~~  308 (372)
                            .||||..
T Consensus       287 ------~~~~~~~  293 (328)
T cd07856         287 ------AHPYLAP  293 (328)
T ss_pred             ------cCCcccc
Confidence                  9999973

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0194|consensus

Probab=100.00  E-value=2.1e-38  Score=303.03  Aligned_cols=249  Identities=22%  Similarity=0.275  Sum_probs=207.5

Q ss_pred             HhhhcCCcccCCccEEEeeeehhhh---h-hhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          8 EALFLGGPIQGKGRVFSIETLLDIL---L-VLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         8 ~~~~~~~~~~g~G~v~~v~~~~~~~---~-va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      .++|.|    .||.||.+.-...+.   . ||+|.........       .+.++.+.+|..++++++|||||++||+..
T Consensus       163 kkLGeG----aFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~-------~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  163 KKLGEG----AFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELT-------KEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             ceeecc----cccEEEEEEEEecCCceeeeeEEEeeccccccc-------HHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            455555    799999887655322   3 8888877633211       135677899999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcE
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI  163 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~v  163 (372)
                      ....+|+|||+|+||+|.++|++..+.++..+...++.+.+.||+|||+++++|          |||-..|+|++.++.+
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IH----------RDIAARNcL~~~~~~v  301 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIH----------RDIAARNCLYSKKGVV  301 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcc----------hhHhHHHheecCCCeE
Confidence            999999999999999999999996557999999999999999999999999999          9999999999999999


Q ss_pred             EEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHH
Q psy11571        164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKI  242 (372)
Q Consensus       164 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i  242 (372)
                      ||+|||+++....-.. ......-...|+|||.+.     ...|+.++||||+||++||+++ |..||.+....++..+|
T Consensus       302 KISDFGLs~~~~~~~~-~~~~~klPirWLAPEtl~-----~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI  375 (474)
T KOG0194|consen  302 KISDFGLSRAGSQYVM-KKFLKKLPIRWLAPETLN-----TGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI  375 (474)
T ss_pred             EeCccccccCCcceee-ccccccCcceecChhhhc-----cCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH
Confidence            9999999876531111 111112356899999998     4689999999999999999998 89999999999999999


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .....+.+.|.    ..+.++..++.+|+. +|++|+++.++...+
T Consensus       376 ~~~~~r~~~~~----~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l  417 (474)
T KOG0194|consen  376 VKNGYRMPIPS----KTPKELAKVMKQCWKKDPEDRPTMSTIKKKL  417 (474)
T ss_pred             HhcCccCCCCC----CCHHHHHHHHHHhccCChhhccCHHHHHHHH
Confidence            77666666666    678999999999999 999999987765433

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.9e-38  Score=290.06  Aligned_cols=258  Identities=21%  Similarity=0.223  Sum_probs=199.5

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhh--------------hhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHH
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDI--------------LLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVL   67 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~--------------~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il   67 (372)
                      .||+..+.++.|    |+|.||.+.....+              ..||+|.+......         ...+.+.+|+.++
T Consensus         5 ~~~~~~~~lg~G----~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~ei~~l   71 (295)
T cd05097           5 QQLRLKEKLGEG----QFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK---------TARNDFLKEIKIM   71 (295)
T ss_pred             HhCeehhccCCC----CCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCH---------HHHHHHHHHHHHH
Confidence            478888888888    89999998764322              24788877643221         1234578899999


Q ss_pred             hcCCCCceeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCce
Q psy11571         68 VYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE-----------DRLPEDMAKFYIAEMVLAIASIHDLHYV  136 (372)
Q Consensus        68 ~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-----------~~l~~~~~~~~~~qi~~~L~~LH~~~iv  136 (372)
                      +.++||||+++++++...+..++||||+++++|.+++....           ..+++..+..++.|++.||.|||++|++
T Consensus        72 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~  151 (295)
T cd05097          72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFV  151 (295)
T ss_pred             HhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCee
Confidence            99999999999999999999999999999999999986521           1367889999999999999999999999


Q ss_pred             ecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCcc-cccccccCCcccCcccccccccCCCCCCCccceee
Q psy11571        137 HRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTV-QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWS  215 (372)
Q Consensus       137 H~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diws  215 (372)
                      |          |||||+||+++.++.+||+|||++......... ......++..|+|||++.+     ..++.++|+||
T Consensus       152 H----------~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwS  216 (295)
T cd05097         152 H----------RDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-----GKFTTASDVWA  216 (295)
T ss_pred             c----------cccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-----CCcCchhhHHH
Confidence            9          999999999999999999999998765332211 1122345678999999873     56899999999


Q ss_pred             hhHHHHHHhh--CCCCCCCCCHHHHHHHHhhccC--CcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        216 LGVCMYEMLY--GETPFYAESLVETYGKIMNHQN--SFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       216 lGvil~ellt--G~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      |||++|+|++  |..||...+..+....+.....  ............++.+.+||.+||. +|++||+++++.+.+
T Consensus       217 lG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l  293 (295)
T cd05097         217 FGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFL  293 (295)
T ss_pred             HHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            9999999988  7789988776665554432100  0000011122578999999999999 999999988876544

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=6e-38  Score=297.94  Aligned_cols=254  Identities=19%  Similarity=0.256  Sum_probs=198.7

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeee-----ehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCce
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIET-----LLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWI   75 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~-----~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~I   75 (372)
                      +||+..+.+|.|    |+|.||.+.+     ..+++.||+|.+.......         ....+.+|+.++..+ +||||
T Consensus         7 ~~~~~~~~lG~G----~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~E~~~l~~l~~h~ni   73 (343)
T cd05103           7 DRLKLGKPLGRG----AFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS---------EHRALMSELKILIHIGHHLNV   73 (343)
T ss_pred             hHhcccccccCC----ccceEEEEeeccCCccccceeEEEEEeccCCChH---------HHHHHHHHHHHHHhccCCccH
Confidence            588899999888    8999999974     3467889999876433221         234577899999998 68999


Q ss_pred             eeeeEEEEeC-CeEEEEEeccCCCCHHHHHHhcC----------------------------------------------
Q psy11571         76 TNLHYAFQDD-SNLYLVMDYYCGGDLLTLLSKFE----------------------------------------------  108 (372)
Q Consensus        76 v~l~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~~----------------------------------------------  108 (372)
                      +++++++... ..++++||||++|+|.+++....                                              
T Consensus        74 v~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (343)
T cd05103          74 VNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFV  153 (343)
T ss_pred             hhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccccccccccccc
Confidence            9999987654 46899999999999999986521                                              


Q ss_pred             --------------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeec
Q psy11571        109 --------------------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADF  168 (372)
Q Consensus       109 --------------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Df  168 (372)
                                          ..++...+..++.||+.||+|||++|++|          |||||+||+++.++.++|+||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H----------~dikp~Nil~~~~~~~kl~df  223 (343)
T cd05103         154 EEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIH----------RDLAARNILLSENNVVKICDF  223 (343)
T ss_pred             CCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeec----------CCCccCeEEEcCCCcEEEEec
Confidence                                13577788899999999999999999999          999999999999999999999


Q ss_pred             CcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHHhhcc
Q psy11571        169 GSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHQ  246 (372)
Q Consensus       169 g~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~  246 (372)
                      |++........ .......++..|+|||.+.+     ..++.++|+||||+++|+|++ |..||................
T Consensus       224 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~  298 (343)
T cd05103         224 GLARDIYKDPDYVRKGDARLPLKWMAPETIFD-----RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG  298 (343)
T ss_pred             ccccccccCcchhhcCCCCCCcceECcHHhcC-----CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhcc
Confidence            99876533221 11122345678999999873     568899999999999999997 999998765443333333333


Q ss_pred             CCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        247 NSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       247 ~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .....|.    ..++++.+++.+||+ +|++||++.++++.+
T Consensus       299 ~~~~~~~----~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l  336 (343)
T cd05103         299 TRMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL  336 (343)
T ss_pred             CCCCCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            3333333    468899999999999 999999988877544

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-38  Score=290.41  Aligned_cols=249  Identities=24%  Similarity=0.325  Sum_probs=192.5

Q ss_pred             HHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhc---CCCCceeeeeEEE
Q psy11571          6 ELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVY---GDRRWITNLHYAF   82 (372)
Q Consensus         6 ~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~---l~hp~Iv~l~~~~   82 (372)
                      .++.++.|    ++|.||.++...+++.+|+|.+........        ....+.+|+.+++.   ++||||+++++++
T Consensus         3 ~~~~l~~g----~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~--------~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~   70 (287)
T cd07838           3 ELAEIGEG----AYGTVYKARDLNTGRFVALKKVRVPLSEEG--------IPLSTLREIALLKQLESFEHPNIVRLLDVC   70 (287)
T ss_pred             EEEEeccc----CceEEEEEEECCCCCEEEEEEeccccccch--------hhhhHHHHHHHHHHhhccCCCCcceEEEEE
Confidence            34445555    799999999888899999998865433211        11223456666554   4699999999999


Q ss_pred             EeCCe-----EEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEE
Q psy11571         83 QDDSN-----LYLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL  156 (372)
Q Consensus        83 ~~~~~-----~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIl  156 (372)
                      .+...     ++++|||+. ++|.+++.... ..+++..++.++.|++.||.|||+.|++|          +||+|+||+
T Consensus        71 ~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h----------~~l~~~nil  139 (287)
T cd07838          71 HGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVH----------RDLKPQNIL  139 (287)
T ss_pred             eeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeee----------ccCChhhEE
Confidence            98876     999999996 58999887632 35899999999999999999999999999          999999999


Q ss_pred             eCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH
Q psy11571        157 LDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV  236 (372)
Q Consensus       157 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~  236 (372)
                      ++.++.++|+|||++.........  ....++..|+|||++.+     ..++.++|+|||||++|+|++|.+||.+.+..
T Consensus       140 i~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~PE~~~~-----~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~  212 (287)
T cd07838         140 VTSDGQVKIADFGLARIYSFEMAL--TSVVVTLWYRAPEVLLQ-----SSYATPVDMWSVGCIFAELFRRRPLFRGTSEA  212 (287)
T ss_pred             EccCCCEEEeccCcceeccCCccc--ccccccccccChHHhcc-----CCCCCcchhhhHHHHHHHHHhCCCcccCCChH
Confidence            999999999999998776433221  22357889999999973     55788999999999999999999999998887


Q ss_pred             HHHHHHhhccCC---cCCC------------------CCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        237 ETYGKIMNHQNS---FDLP------------------SDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       237 ~~~~~i~~~~~~---~~~~------------------~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      +.+.++......   ..++                  ......+++.+.++|.+||+ ||.+||++++++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il  282 (287)
T cd07838         213 DQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEAL  282 (287)
T ss_pred             HHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHh
Confidence            777666542110   0000                  00011356889999999999 999999866555

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.4e-37  Score=284.60  Aligned_cols=242  Identities=19%  Similarity=0.302  Sum_probs=194.2

Q ss_pred             cCCccEEEeeeehhh------hhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEE
Q psy11571         17 QGKGRVFSIETLLDI------LLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYL   90 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~------~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   90 (372)
                      +|+|.||.++.....      +.+++|.+......         .....+.+|+.+++.++||||+++++++.+....++
T Consensus         6 g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   76 (269)
T cd05044           6 GAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD---------QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYI   76 (269)
T ss_pred             ccceeEEeeeecccccCcccceeehhhhhhcccch---------hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEE
Confidence            478999998765433      67899977543211         123457779999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC---
Q psy11571         91 VMDYYCGGDLLTLLSKF------EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG---  161 (372)
Q Consensus        91 v~E~~~gg~L~~~l~~~------~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~---  161 (372)
                      ||||+++++|.+++.+.      ...+++..+..++.|++.||.|||+.+++|          +||||+||+++.++   
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H----------~dl~p~nil~~~~~~~~  146 (269)
T cd05044          77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIH----------RDLAARNCLVSEKGYDA  146 (269)
T ss_pred             EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCccc----------CCCChheEEEecCCCCC
Confidence            99999999999999752      134788999999999999999999999999          99999999999877   


Q ss_pred             --cEEEeecCcccccCCCCcc-cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHH
Q psy11571        162 --HIRLADFGSCLRLGGDGTV-QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVE  237 (372)
Q Consensus       162 --~vkl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~  237 (372)
                        .++|+|||++......... ......++..|+|||.+.     ...++.++|+|||||++|+|++ |..||...+..+
T Consensus       147 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~  221 (269)
T cd05044         147 DRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLL-----DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE  221 (269)
T ss_pred             CcceEECCcccccccccccccccCcccCCCccccCHHHHc-----cCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH
Confidence              8999999998765332211 112234567899999997     3568999999999999999998 999998877777


Q ss_pred             HHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       238 ~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ....+... ..+..+.    .++..+.++|.+||. +|.+||+++++.+.+
T Consensus       222 ~~~~~~~~-~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l  267 (269)
T cd05044         222 VLQHVTAG-GRLQKPE----NCPDKIYQLMTNCWAQDPSERPTFDRIQEIL  267 (269)
T ss_pred             HHHHHhcC-CccCCcc----cchHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence            66665443 2233333    678999999999999 999999988877654

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.4e-38  Score=286.10  Aligned_cols=246  Identities=26%  Similarity=0.403  Sum_probs=203.3

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+.++.++.|    ++|.+|++.+..+++.+++|..........        ....+.+|+.+++.++||||+++++++.
T Consensus         2 y~~~~~i~~g----~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~~~~~~   69 (256)
T cd08530           2 FKVLKKLGKG----SYGSVYKVKRLSDNQFYALKEVDLGSMSQK--------EREDAVNEIRILASVNHPNIISYKEAFL   69 (256)
T ss_pred             ceEeeeecCC----CceeEEEEEECCCCCEEEEEEEehhhccHH--------HHHHHHHHHHHHHhCCCCCchhhhhhhc
Confidence            4555566665    799999999888999999998765443221        2344567899999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKF---EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      +....|+||||+++++|.+++.+.   ...+++..+..++.|++.||+|||+.|++|          +||+|+||+++.+
T Consensus        70 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h----------~~l~~~ni~~~~~  139 (256)
T cd08530          70 DGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILH----------RDLKSANILLVAN  139 (256)
T ss_pred             cCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCccc----------CCCCcceEEEecC
Confidence            999999999999999999998652   246899999999999999999999999999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG  240 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~  240 (372)
                      +.++|+|||++......   ......+++.|+|||.+.+     ..++.++|+||||+++|+|++|+.||...+..+...
T Consensus       140 ~~~kl~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~-----~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~  211 (256)
T cd08530         140 DLVKIGDLGISKVLKKN---MAKTQIGTPHYMAPEVWKG-----RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY  211 (256)
T ss_pred             CcEEEeeccchhhhccC---CcccccCCccccCHHHHCC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999776543   1222467899999999973     567889999999999999999999999888777666


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      .+..... ...+.    ..+.+++++|.+||. +|++||++.+++
T Consensus       212 ~~~~~~~-~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~~l  251 (256)
T cd08530         212 KVQRGKY-PPIPP----IYSQDLQNFIRSMLQVKPKLRPNCDKIL  251 (256)
T ss_pred             HHhcCCC-CCCch----hhCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            6654321 12222    678999999999999 999999876665

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-37  Score=286.33  Aligned_cols=252  Identities=17%  Similarity=0.229  Sum_probs=203.5

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhh----hhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDIL----LVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITN   77 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~----~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~   77 (372)
                      .+|+.++.++.|    |+|.||++....++.    .+++|........         .....+.+|+.++..++||||++
T Consensus         7 ~~~~~~~~ig~g----~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~   73 (279)
T cd05057           7 TELEKIKVLGSG----AFGTVYKGVWIPEGEKVKIPVAIKVLREETSP---------KANKEILDEAYVMASVDHPHVVR   73 (279)
T ss_pred             HHcEEcceecCC----CCccEEEEEEecCCCCcceEEEEEeccCCCCH---------HHHHHHHHHHHHHHhCCCCCcce
Confidence            356666777776    899999998766554    4777766544321         23455778999999999999999


Q ss_pred             eeEEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe
Q psy11571         78 LHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        78 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      +++++.+ ...++||||+++|+|.+++.+....+++..+..++.||+.||+|||+.|++|          |||||+||++
T Consensus        74 ~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H----------~di~p~nil~  142 (279)
T cd05057          74 LLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVH----------RDLAARNVLV  142 (279)
T ss_pred             EEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEe----------cccCcceEEE
Confidence            9999887 7889999999999999999875567999999999999999999999999999          9999999999


Q ss_pred             CCCCcEEEeecCcccccCCCCcc-cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCH
Q psy11571        158 DANGHIRLADFGSCLRLGGDGTV-QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESL  235 (372)
Q Consensus       158 ~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~  235 (372)
                      +.++.++|+|||+++........ ......++..|+|||.+.     ...++.++|+|||||++||+++ |..||.+...
T Consensus       143 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  217 (279)
T cd05057         143 KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL-----HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA  217 (279)
T ss_pred             cCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhh-----cCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH
Confidence            99999999999999876432221 111122356899999986     3568889999999999999998 9999999888


Q ss_pred             HHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       236 ~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .+....+..+. ....|.    ..+.++.+++.+||. +|.+||++.++.+.+
T Consensus       218 ~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l  265 (279)
T cd05057         218 VEIPDLLEKGE-RLPQPP----ICTIDVYMVLVKCWMIDAESRPTFKELINEF  265 (279)
T ss_pred             HHHHHHHhCCC-CCCCCC----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence            77776666542 233333    568999999999999 999999988776544

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-37  Score=285.53  Aligned_cols=240  Identities=23%  Similarity=0.304  Sum_probs=191.0

Q ss_pred             cCCccEEEeeeehhhh--hhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCeEEEEEe
Q psy11571         17 QGKGRVFSIETLLDIL--LVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYAFQDDSNLYLVMD   93 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~--~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~E   93 (372)
                      +|+|.||++....++.  .+++|........         +..+.+.+|+.++..+ +||||+++++++...+.+|++||
T Consensus         6 g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~---------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e   76 (270)
T cd05047           6 GNFGQVLKARIKKDGLRMDAAIKRMKEYASK---------DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   76 (270)
T ss_pred             CCCceEEEEEEcCCCCeeEEEEEEccccCCH---------HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence            4899999998777665  3566766532211         1234567799999888 79999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC
Q psy11571         94 YYCGGDLLTLLSKFE---------------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD  158 (372)
Q Consensus        94 ~~~gg~L~~~l~~~~---------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~  158 (372)
                      |+++|+|.+++....               ..+++..++.++.|++.||+|||+.|++|          |||||+||+++
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H----------~dikp~nili~  146 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIH----------RDLAARNILVG  146 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEee----------cccccceEEEc
Confidence            999999999997521               24789999999999999999999999999          99999999999


Q ss_pred             CCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHH
Q psy11571        159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVE  237 (372)
Q Consensus       159 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~  237 (372)
                      .++.+||+|||++......  ........+..|+|||++.     ...++.++|+|||||++|||++ |..||.+.+..+
T Consensus       147 ~~~~~kl~dfgl~~~~~~~--~~~~~~~~~~~y~apE~~~-----~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~  219 (270)
T cd05047         147 ENYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLN-----YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE  219 (270)
T ss_pred             CCCeEEECCCCCccccchh--hhccCCCCccccCChHHHc-----cCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH
Confidence            9999999999998532211  1111123356799999987     3568899999999999999997 999998887777


Q ss_pred             HHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       238 ~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .+..+... .....+.    .++.++.+++.+||. +|.+||++.+++..+
T Consensus       220 ~~~~~~~~-~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  265 (270)
T cd05047         220 LYEKLPQG-YRLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSL  265 (270)
T ss_pred             HHHHHhCC-CCCCCCC----cCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence            77666443 2222232    578999999999999 999999988776543

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-38  Score=291.04  Aligned_cols=239  Identities=24%  Similarity=0.348  Sum_probs=190.9

Q ss_pred             CCccEEEeeee----hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEe
Q psy11571         18 GKGRVFSIETL----LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMD   93 (372)
Q Consensus        18 g~G~v~~v~~~----~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E   93 (372)
                      .+|.||.+...    ..+..|++|.+.......         ..+.+.+|+..++.++||||+++++++...+..++|||
T Consensus        11 ~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~---------~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen   11 SFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEE---------EEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             SSEEEEEEEEESTTTSSEEEEEEEEESTTSSHH---------HHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             CCcEEEEEEEEcccCCCCEEEEEEEeccccccc---------cceeeeeccccccccccccccccccccccccccccccc
Confidence            78999998776    346788998885432221         24567789999999999999999999998888999999


Q ss_pred             ccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCccc
Q psy11571         94 YYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCL  172 (372)
Q Consensus        94 ~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~  172 (372)
                      ||++|+|.+++... ...+++.....++.||+.||.|||+++++|          +||++.||+++.++.+||+|||++.
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH----------~~l~~~nill~~~~~~Kl~~f~~~~  151 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIH----------GNLSPSNILLDSNGQVKLSDFGLSR  151 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEE----------ST-SGGGEEEETTTEEEEESTTTGE
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccc----------ccccccccccccccccccccccccc
Confidence            99999999999984 467999999999999999999999999999          9999999999999999999999998


Q ss_pred             ccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHHhhccCCcC
Q psy11571        173 RLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHQNSFD  250 (372)
Q Consensus       173 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~  250 (372)
                      ....... .......+...|+|||.+..     ..++.++||||||+++|||++ |+.||...+..+...++... ....
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~-~~~~  225 (259)
T PF07714_consen  152 PISEKSKYKNDSSQQLPLRYLAPEVLKD-----GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQG-QRLP  225 (259)
T ss_dssp             ETTTSSSEEESTTSESGGGGS-HHHHHH-----SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTT-EETT
T ss_pred             cccccccccccccccccccccccccccc-----cccccccccccccccccccccccccccccccccccccccccc-ccce
Confidence            7632221 12222346678999999984     458999999999999999999 78999998888888888544 3333


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhh
Q psy11571        251 LPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIAD  285 (372)
Q Consensus       251 ~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~  285 (372)
                      .+.    .++..+.++|.+||. +|++||++.++.+
T Consensus       226 ~~~----~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  226 IPD----NCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             SBT----TSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             ecc----chhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            333    679999999999999 9999999777654

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.8e-37  Score=284.32  Aligned_cols=252  Identities=15%  Similarity=0.203  Sum_probs=189.2

Q ss_pred             cCCccEEEeeeehhh--hhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEec
Q psy11571         17 QGKGRVFSIETLLDI--LLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDY   94 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~--~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~   94 (372)
                      ||+|.||+++...+.  ..+++|.+......         ...+.+.+|+.+++.++||||+++++.+.+....|+||||
T Consensus         6 G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~---------~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~   76 (268)
T cd05086           6 GWFGKVLLSEIYTDTGVARVVVKELKANASS---------KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEY   76 (268)
T ss_pred             CcCceEEEEEEEcCCCcceEEEEEecCCCCh---------HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEec
Confidence            389999998644322  23444443332211         1235577889999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcc
Q psy11571         95 YCGGDLLTLLSKF---EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSC  171 (372)
Q Consensus        95 ~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a  171 (372)
                      +++|+|.+++.+.   ....++..+..++.||+.||+|||+.+++|          |||||+|||++.++.++|+|||++
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H----------~dikp~nil~~~~~~~~l~Dfg~~  146 (268)
T cd05086          77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLH----------SDLALRNCFLTSDLTVKVGDYGIG  146 (268)
T ss_pred             CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeec----------cCCccceEEEcCCccEEecccccc
Confidence            9999999999763   134567788899999999999999999999          999999999999999999999998


Q ss_pred             cccCCCC-cccccccccCCcccCcccccccccC--CCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHHhhccC
Q psy11571        172 LRLGGDG-TVQSNVAVGTPDYISPEILTAMEEG--RGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHQN  247 (372)
Q Consensus       172 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~  247 (372)
                      ....... ........++..|+|||++.....+  ...++.++|||||||++|||++ |..||...+..+.+..+.....
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~  226 (268)
T cd05086         147 PSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQ  226 (268)
T ss_pred             cccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcc
Confidence            6432211 1122235678899999998531110  1245789999999999999996 5789988777777776655432


Q ss_pred             CcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCCChhhhh
Q psy11571        248 SFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFK  287 (372)
Q Consensus       248 ~~~~~~~~~~~~s~~~~~li~~lL~~p~~R~s~~~~~~i~  287 (372)
                      .....+.....+++.+.+++..|+.+|++||+++++.+.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~l~~~c~~~P~~Rp~~~~i~~~l  266 (268)
T cd05086         227 VKLFKPQLELPYSERWYEVLQFCWLSPEKRATAEEVHRLL  266 (268)
T ss_pred             cccCCCccCCCCcHHHHHHHHHHhhCcccCCCHHHHHHHh
Confidence            1111122223578999999999999999999988877544

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.2e-37  Score=287.58  Aligned_cols=253  Identities=20%  Similarity=0.269  Sum_probs=194.9

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEee----eehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIE----TLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITN   77 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~----~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~   77 (372)
                      .+|+.++.++.|    |+|.||.+.    ...++..|++|.+.....          ...+.+.+|+.+++.++||||++
T Consensus         4 ~~~~~~~~lg~g----~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~----------~~~~~~~~e~~~l~~l~h~~iv~   69 (284)
T cd05081           4 RHLKFIQQLGKG----NFGSVELCRYDPLQDNTGEVVAVKKLQHSTA----------EHLRDFEREIEILKSLQHDNIVK   69 (284)
T ss_pred             ccceeeeeccCC----CCceEEEEEecCCcCCCCcEEEEEEeccCCH----------HHHHHHHHHHHHHHhCCCCCeeE
Confidence            466777777777    899999986    345688999998765432          12355788999999999999999


Q ss_pred             eeEEEEe--CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcE
Q psy11571         78 LHYAFQD--DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNV  155 (372)
Q Consensus        78 l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NI  155 (372)
                      +++++..  ...+++||||+++++|.+++.+....+++..+..++.|++.||+|||++|++|          |||||+||
T Consensus        70 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H----------~dlkp~ni  139 (284)
T cd05081          70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVH----------RDLATRNI  139 (284)
T ss_pred             EEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCcee----------ccCCHhhE
Confidence            9998654  34689999999999999999764567899999999999999999999999999          99999999


Q ss_pred             EeCCCCcEEEeecCcccccCCCCccc--ccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC
Q psy11571        156 LLDANGHIRLADFGSCLRLGGDGTVQ--SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE  233 (372)
Q Consensus       156 ll~~~~~vkl~Dfg~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~  233 (372)
                      +++.++.++|+|||++..........  .....++..|+|||++.+     ..++.++|+|||||++|||++|..|+...
T Consensus       140 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~~~~~~~~~  214 (284)
T cd05081         140 LVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE-----SKFSVASDVWSFGVVLYELFTYSDKSCSP  214 (284)
T ss_pred             EECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhcc-----CCcChHHHHHHHHHHHHHHhhcCCcCCCc
Confidence            99999999999999998764332211  111223456999999873     56888999999999999999988776433


Q ss_pred             CHHH---------------HHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        234 SLVE---------------TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       234 ~~~~---------------~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ....               .+..++.....++.+.    .++.++.+||.+||. +|++|||++++.+.+
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l  280 (284)
T cd05081         215 PAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPP----GCPAEIYAIMKECWNNDPSQRPSFSELALQV  280 (284)
T ss_pred             chhhhhhcccccccccchHHHHHHHhcCCcCCCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence            2110               0111222222222222    678999999999999 999999988877544

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-37  Score=282.69  Aligned_cols=244  Identities=16%  Similarity=0.234  Sum_probs=200.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      .|+..+.++.|    ++|.||.+..  .++.+++|.+.....           ..+++.+|+.+++.++||||+++++++
T Consensus         7 ~~~~~~~ig~g----~~g~v~~~~~--~~~~v~iK~~~~~~~-----------~~~~~~~e~~~l~~l~~~~i~~~~~~~   69 (256)
T cd05039           7 ELKLGATIGKG----EFGDVMLGDY--RGQKVAVKCLKDDST-----------AAQAFLAEASVMTTLRHPNLVQLLGVV   69 (256)
T ss_pred             hccceeeeecC----CCceEEEEEe--cCcEEEEEEeccchh-----------HHHHHHHHHHHHHhcCCcceeeeEEEE
Confidence            34555555555    7899999864  478899998765432           235577899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      .+.+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++|          |||||+||+++.++
T Consensus        70 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H----------~di~p~Nili~~~~  139 (256)
T cd05039          70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVH----------RDLAARNVLVSEDL  139 (256)
T ss_pred             cCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc----------hhcccceEEEeCCC
Confidence            99999999999999999999997632 26899999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYG  240 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~  240 (372)
                      .++|+|||.++.......    ...++..|+|||.+.     ...++.++|+||||+++|+|++ |..||...+..+...
T Consensus       140 ~~~l~d~g~~~~~~~~~~----~~~~~~~~~ape~~~-----~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~  210 (256)
T cd05039         140 VAKVSDFGLAKEASQGQD----SGKLPVKWTAPEALR-----EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP  210 (256)
T ss_pred             CEEEcccccccccccccc----cCCCcccccCchhhc-----CCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            999999999987633221    123456799999987     3567889999999999999997 999999888777766


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .+... .....+.    .+++.+.++|.+||. +|++||+++++++.+
T Consensus       211 ~~~~~-~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l  253 (256)
T cd05039         211 HVEKG-YRMEAPE----GCPPEVYKVMKDCWELDPAKRPTFKQLREQL  253 (256)
T ss_pred             HHhcC-CCCCCcc----CCCHHHHHHHHHHhccChhhCcCHHHHHHHH
Confidence            66543 2223333    578999999999999 999999988877554

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2e-37  Score=283.80  Aligned_cols=258  Identities=24%  Similarity=0.360  Sum_probs=205.3

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeeh-hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHh-cCCCCceeeeeEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLL-DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLV-YGDRRWITNLHYA   81 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~-~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~-~l~hp~Iv~l~~~   81 (372)
                      |+.++.++.|    ++|.||.+.... .++.+++|.+........+...........+.+|..++. .++||||+++++.
T Consensus         2 y~~~~~ig~G----~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~   77 (269)
T cd08528           2 YAVLEHLGSG----AFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKT   77 (269)
T ss_pred             chhhhhhcCC----CCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEee
Confidence            5667777777    799999998877 678899998765443322111111234455667888776 4799999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCCcCCCCCcCcEEe
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSK---FEDRLPEDMAKFYIAEMVLAIASIHD-LHYVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      +.+++..+++|||+++++|.+++..   ....+++..++.++.|++.||.|||+ .|++|          +||+|+||++
T Consensus        78 ~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H----------~dl~~~nil~  147 (269)
T cd08528          78 FLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVH----------RDLTPNNIML  147 (269)
T ss_pred             EccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceee----------cCCCHHHEEE
Confidence            9999999999999999999998743   24568999999999999999999996 78999          9999999999


Q ss_pred             CCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHH
Q psy11571        158 DANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE  237 (372)
Q Consensus       158 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~  237 (372)
                      +.++.++|+|||.+.......  ......|+..|+|||.+.+     ..++.++|+||||+++|+|++|++||...+...
T Consensus       148 ~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~-----~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~  220 (269)
T cd08528         148 GEDDKVTITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKN-----EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS  220 (269)
T ss_pred             CCCCcEEEecccceeeccccc--ccccccCcccCcChhhhcC-----CCCchHHHHHHHHHHHHHHHhCCCcccccCHHH
Confidence            999999999999997654432  2233568899999999973     558899999999999999999999998877766


Q ss_pred             HHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhh
Q psy11571        238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADF  286 (372)
Q Consensus       238 ~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i  286 (372)
                      ....+....... .+.   ..+++.+.++|.+||+ ||++||++.++.+.
T Consensus       221 ~~~~~~~~~~~~-~~~---~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         221 LATKIVEAVYEP-LPE---GMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             HHHHHhhccCCc-CCc---ccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            666665543221 111   2578999999999999 99999998777644

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-38  Score=289.22  Aligned_cols=251  Identities=25%  Similarity=0.334  Sum_probs=198.9

Q ss_pred             HHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC
Q psy11571          6 ELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDD   85 (372)
Q Consensus         6 ~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~   85 (372)
                      .++.++.|    ++|.||.+....+++.+++|.+........        ..+.+..|+.+++.++||||+++++++.+.
T Consensus         3 ~~~~ig~g----~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~--------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   70 (282)
T cd07829           3 KLEKLGEG----TYGVVYKARDKKTGEIVALKKIRLDNEEEG--------IPSTALREISLLKELKHPNIVKLLDVIHTE   70 (282)
T ss_pred             eehccccc----CcceEEEeeecCCCcEEEEEEecccccccc--------ccHHHHHHHHHHHhcCCCCHHHHHhhhhcC
Confidence            34455555    789999999998999999998876542111        234456789999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEE
Q psy11571         86 SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRL  165 (372)
Q Consensus        86 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl  165 (372)
                      ...++||||++ ++|.+++.+....+++..+..++.|++.||.+||+.|++|          |||+|+||++++++.++|
T Consensus        71 ~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H----------~~l~~~ni~~~~~~~~~l  139 (282)
T cd07829          71 RKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILH----------RDLKPQNILINRDGVLKL  139 (282)
T ss_pred             CceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCccc----------CCCChheEEEcCCCCEEE
Confidence            99999999996 5999999874357999999999999999999999999999          999999999999999999


Q ss_pred             eecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhc
Q psy11571        166 ADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH  245 (372)
Q Consensus       166 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~  245 (372)
                      +|||.+........ ......++..|+|||.+.+    ...++.++|+|||||++|+|++|.+||.+.+..+.+.++...
T Consensus       140 ~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~  214 (282)
T cd07829         140 ADFGLARAFGIPLR-TYTHEVVTLWYRAPEILLG----SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQI  214 (282)
T ss_pred             ecCCcccccCCCcc-ccCccccCcCcCChHHhcC----CcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHH
Confidence            99999877644322 1122346778999999873    336889999999999999999999999988766665554331


Q ss_pred             cC----------------CcCCCC-------CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        246 QN----------------SFDLPS-------DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       246 ~~----------------~~~~~~-------~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      ..                ...++.       .....++..+.++|++||. +|++||+++++.
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l  277 (282)
T cd07829         215 LGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEAL  277 (282)
T ss_pred             hCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHh
Confidence            10                000000       1112357899999999999 999999866655

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG1151|consensus

Probab=100.00  E-value=8.8e-38  Score=286.96  Aligned_cols=269  Identities=24%  Similarity=0.371  Sum_probs=217.2

Q ss_pred             ChHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeE
Q psy11571          1 DERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHY   80 (372)
Q Consensus         1 ~~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~   80 (372)
                      ++||-.|+-+|.|    ||..||++.++...+.||+|.-..   .+.....+..++.+...+|..+-+.++||-||++|+
T Consensus       462 n~RYLlLhLLGrG----GFSEVyKAFDl~EqRYvAvKIHql---NK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD  534 (775)
T KOG1151|consen  462 NDRYLLLHLLGRG----GFSEVYKAFDLTEQRYVAVKIHQL---NKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD  534 (775)
T ss_pred             HHHHHHHHHhccc----cHHHHHHhcccchhheeeEeeehh---ccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence            4789999999998    899999999999999999995443   333333445567888999999999999999999999


Q ss_pred             EEE-eCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhc--CceecCCCCCCCcCCCCCcCcEEe
Q psy11571         81 AFQ-DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDL--HYVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        81 ~~~-~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~--~ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      +|. +.+.+|-|+|||+|.+|.-||+. ...++|.+++.|+.||+.||.||.+.  -|||          -||||.|||+
T Consensus       535 yfslDtdsFCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEikpPIIH----------YDLKPgNILL  603 (775)
T KOG1151|consen  535 YFSLDTDSFCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEIKPPIIH----------YDLKPGNILL  603 (775)
T ss_pred             eeeeccccceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhccCCCeee----------eccCCccEEE
Confidence            986 45678999999999999999988 57899999999999999999999975  4677          9999999999


Q ss_pred             C---CCCcEEEeecCcccccCCCC------cccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCC
Q psy11571        158 D---ANGHIRLADFGSCLRLGGDG------TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGET  228 (372)
Q Consensus       158 ~---~~~~vkl~Dfg~a~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~  228 (372)
                      -   ..|.+||+|||+++.+..+.      ...+....||..|++||.+.-.. .....+.++||||+|||+|.++.|+.
T Consensus       604 v~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgk-ePPKIsnKVDVWSvGVIFyQClYGrK  682 (775)
T KOG1151|consen  604 VNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGK-EPPKISNKVDVWSVGVIFYQCLYGRK  682 (775)
T ss_pred             ecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCC-CCCccccceeeEeeehhhhhhhccCC
Confidence            4   44789999999999876432      22344568999999999987321 13567899999999999999999999


Q ss_pred             CCCCCCH-HHHHH--HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCC
Q psy11571        229 PFYAESL-VETYG--KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHP  304 (372)
Q Consensus       229 Pf~~~~~-~~~~~--~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp  304 (372)
                      ||..+.. .+++.  .|++. ....+|...  .++.++++||++||. .-++|....++.                 .||
T Consensus       683 PFGhnqsQQdILqeNTIlkA-tEVqFP~KP--vVsseAkaFIRRCLaYRKeDR~DV~qLA-----------------~dp  742 (775)
T KOG1151|consen  683 PFGHNQSQQDILQENTILKA-TEVQFPPKP--VVSSEAKAFIRRCLAYRKEDRIDVQQLA-----------------CDP  742 (775)
T ss_pred             CCCCchhHHHHHhhhchhcc-eeccCCCCC--ccCHHHHHHHHHHHHhhhhhhhhHHHHc-----------------cCc
Confidence            9976532 23322  24333 334455533  789999999999999 889999654444                 899


Q ss_pred             CcCC
Q psy11571        305 WFQG  308 (372)
Q Consensus       305 ~f~~  308 (372)
                      +|..
T Consensus       743 yllP  746 (775)
T KOG1151|consen  743 YLLP  746 (775)
T ss_pred             cccc
Confidence            9974

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.4e-37  Score=281.00  Aligned_cols=242  Identities=15%  Similarity=0.176  Sum_probs=190.1

Q ss_pred             cCCccEEEeeeeh---hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE-eCCeEEEEE
Q psy11571         17 QGKGRVFSIETLL---DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ-DDSNLYLVM   92 (372)
Q Consensus        17 ~g~G~v~~v~~~~---~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~-~~~~~~lv~   92 (372)
                      ||+|.||++....   +...+|+|.+......         ...+.+.+|..+++.++||||+++++++. .++..+++|
T Consensus         6 g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   76 (262)
T cd05058           6 GHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL---------EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL   76 (262)
T ss_pred             cCCceEEEEEEecCCCceEEEEEEecCccCCH---------HHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence            4899999987643   3457888876432211         12456778999999999999999999765 455689999


Q ss_pred             eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCccc
Q psy11571         93 DYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCL  172 (372)
Q Consensus        93 E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~  172 (372)
                      ||+.+|+|.+++.+.....++..+..++.|++.||.|||+.+++|          |||||+|||++.++.+||+|||+++
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H----------~dlk~~nili~~~~~~kl~dfg~~~  146 (262)
T cd05058          77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVH----------RDLAARNCMLDESFTVKVADFGLAR  146 (262)
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccc----------cccCcceEEEcCCCcEEECCccccc
Confidence            999999999999875456788888999999999999999999999          9999999999999999999999987


Q ss_pred             ccCCCCc---ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHHhhccCC
Q psy11571        173 RLGGDGT---VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHQNS  248 (372)
Q Consensus       173 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~  248 (372)
                      .......   .......++..|+|||.+.+     ..++.++|||||||++|||++ |.+||...+..+....+..+. .
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~-~  220 (262)
T cd05058         147 DIYDKEYYSVHNHTGAKLPVKWMALESLQT-----QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR-R  220 (262)
T ss_pred             cccCCcceeecccccCcCCccccChhHhcc-----CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-C
Confidence            6533211   01112345678999999873     568889999999999999999 577787777766666655432 2


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        249 FDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       249 ~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ...+.    .+++.+.+++.+||. +|++||++.+++..+
T Consensus       221 ~~~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l  256 (262)
T cd05058         221 LLQPE----YCPDPLYEVMLSCWHPKPEMRPTFSELVSRI  256 (262)
T ss_pred             CCCCC----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence            22232    578999999999999 999999988776543

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG1035|consensus

Probab=100.00  E-value=7.9e-38  Score=316.49  Aligned_cols=250  Identities=26%  Similarity=0.400  Sum_probs=198.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      .+++|.-+|.|    |||.||+|+...||+.||+|++.... ..        +...++.+|+.+|.+++|||||++|..+
T Consensus       480 DFEEL~lLGkG----GFG~VvkVRNKlDGr~YAIKKIpl~~-s~--------~~~skI~rEVk~LArLnHpNVVRYysAW  546 (1351)
T KOG1035|consen  480 DFEELELLGKG----GFGSVVKVRNKLDGREYAIKKIPLKA-SD--------KLYSKILREVKLLARLNHPNVVRYYSAW  546 (1351)
T ss_pred             hhHHHHHhcCC----CCceEEEEeecccchhhhhhhccCch-HH--------HHHHHHHHHHHHHhhcCCcceeeeehhh
Confidence            56788888888    89999999999999999999998876 22        2456788999999999999999999643


Q ss_pred             Ee------------------------------------------------------------------------------
Q psy11571         83 QD------------------------------------------------------------------------------   84 (372)
Q Consensus        83 ~~------------------------------------------------------------------------------   84 (372)
                      .+                                                                              
T Consensus       547 VEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~ded  626 (1351)
T KOG1035|consen  547 VESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDED  626 (1351)
T ss_pred             hccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccc
Confidence            10                                                                              


Q ss_pred             ---------------------------------C--------CeEEEEEeccCCCCHHHHHHhcCCCC--CHHHHHHHHH
Q psy11571         85 ---------------------------------D--------SNLYLVMDYYCGGDLLTLLSKFEDRL--PEDMAKFYIA  121 (372)
Q Consensus        85 ---------------------------------~--------~~~~lv~E~~~gg~L~~~l~~~~~~l--~~~~~~~~~~  121 (372)
                                                       +        ..+||-||||+..+|.+++..  +.+  ....++++++
T Consensus       627 g~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~--N~~~~~~d~~wrLFr  704 (1351)
T KOG1035|consen  627 GRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR--NHFNSQRDEAWRLFR  704 (1351)
T ss_pred             ccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh--cccchhhHHHHHHHH
Confidence                                             0        136899999999888888877  334  4789999999


Q ss_pred             HHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccC-----------------CCCcccccc
Q psy11571        122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG-----------------GDGTVQSNV  184 (372)
Q Consensus       122 qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~-----------------~~~~~~~~~  184 (372)
                      ||+.||.|+|++||||          |||||.||++++++.|||+|||+|....                 .......+.
T Consensus       705 eIlEGLaYIH~~giIH----------RDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts  774 (1351)
T KOG1035|consen  705 EILEGLAYIHDQGIIH----------RDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTS  774 (1351)
T ss_pred             HHHHHHHHHHhCceee----------ccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCccccc
Confidence            9999999999999999          9999999999999999999999998721                 011112345


Q ss_pred             cccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHH-HHHHHhhccCCcCCCCCCCCCCCHHH
Q psy11571        185 AVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKIMNHQNSFDLPSDVGYEISDDA  263 (372)
Q Consensus       185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~s~~~  263 (372)
                      .+||.-|+|||++.+..  ...|+.|+|+||||+|++||+.   ||....+.. ++.++.+  +.++.+......--+.-
T Consensus       775 ~VGTalYvAPEll~~~~--~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~--g~iP~~~~f~~~~~~~e  847 (1351)
T KOG1035|consen  775 QVGTALYVAPELLSDTS--SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRK--GSIPEPADFFDPEHPEE  847 (1351)
T ss_pred             ccceeeeecHHHhcccc--cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhccc--CCCCCCcccccccchHH
Confidence            68999999999998632  1369999999999999999984   676554433 3334432  34444433333555678


Q ss_pred             HHHHHHhcc-CCCCCCCCCChh
Q psy11571        264 KDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       264 ~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      ..+|+.||+ ||++||||.+++
T Consensus       848 ~slI~~Ll~hdP~kRPtA~eLL  869 (1351)
T KOG1035|consen  848 ASLIRWLLSHDPSKRPTATELL  869 (1351)
T ss_pred             HHHHHHHhcCCCccCCCHHHHh
Confidence            899999999 999999988776

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.5e-37  Score=292.56  Aligned_cols=252  Identities=20%  Similarity=0.270  Sum_probs=199.5

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehh-------hhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCc
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLD-------ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRW   74 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~-------~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~   74 (372)
                      +|+....++.|    |+|.||.+.+...       ...+|+|.+......         ...+.+.+|+.+++++ .|||
T Consensus        13 ~~~i~~~ig~G----~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~E~~~l~~l~~h~~   79 (334)
T cd05100          13 RLTLGKPLGEG----CFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD---------KDLSDLVSEMEMMKMIGKHKN   79 (334)
T ss_pred             Heeecceeccc----cCCcEEEEEEeccCCccCCcceeEEEEEcccccCH---------HHHHHHHHHHHHHHhhcCCCC
Confidence            45555666666    8999999976432       235788866543211         1345677899999998 7999


Q ss_pred             eeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecC
Q psy11571         75 ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE---------------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRP  139 (372)
Q Consensus        75 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~  139 (372)
                      |+++++++...+..|++|||+++|+|.+++.+..               ..++...+..++.|++.||.|||++|++|  
T Consensus        80 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH--  157 (334)
T cd05100          80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIH--  157 (334)
T ss_pred             eeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeec--
Confidence            9999999999999999999999999999997521               23677888999999999999999999999  


Q ss_pred             CCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCccc-ccccccCCcccCcccccccccCCCCCCCccceeehhH
Q psy11571        140 NHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ-SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGV  218 (372)
Q Consensus       140 ~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGv  218 (372)
                              |||||+||+++.++.+||+|||+++......... .....++..|+|||++.     ...++.++|||||||
T Consensus       158 --------~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~  224 (334)
T cd05100         158 --------RDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGV  224 (334)
T ss_pred             --------cccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhc-----cCCcCchhhhHHHHH
Confidence                    9999999999999999999999997654322111 11123456799999997     356888999999999


Q ss_pred             HHHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        219 CMYEMLY-GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       219 il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ++|||++ |..||.+.+..+....+.... ....+.    ..+.++.++|.+||+ +|++||++.++++.+
T Consensus       225 il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~l~~li~~cl~~~p~~Rps~~ell~~l  290 (334)
T cd05100         225 LLWEIFTLGGSPYPGIPVEELFKLLKEGH-RMDKPA----NCTHELYMIMRECWHAVPSQRPTFKQLVEDL  290 (334)
T ss_pred             HHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCC----CCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence            9999998 899999888888777765432 223333    578999999999999 999999988877554

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.4e-37  Score=282.70  Aligned_cols=233  Identities=19%  Similarity=0.227  Sum_probs=182.0

Q ss_pred             cCCccEEEeeeeh------------hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe
Q psy11571         17 QGKGRVFSIETLL------------DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQD   84 (372)
Q Consensus        17 ~g~G~v~~v~~~~------------~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~   84 (372)
                      |++|.||+++...            ....+++|.......          .....+.+|..++..++||||+++++++.+
T Consensus         6 G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----------~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~   75 (262)
T cd05077           6 GTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR----------DISLAFFETASMMRQVSHKHIVLLYGVCVR   75 (262)
T ss_pred             CCcceEeeeecccCCCccccccchhhceeEEEeecChhhh----------hHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            3789999886422            122466665443211          123457778899999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc--
Q psy11571         85 DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH--  162 (372)
Q Consensus        85 ~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~--  162 (372)
                      +...+++|||+++|+|..++......+++..+..++.||+.||+|||++|++|          |||||+|||++.++.  
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH----------~dlkp~Nill~~~~~~~  145 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVH----------GNVCTKNILLAREGIDG  145 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeEC----------CCCCcccEEEecCCccC
Confidence            98999999999999999998765567999999999999999999999999999          999999999986664  


Q ss_pred             -----EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHh-hCCCCCCCCCHH
Q psy11571        163 -----IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLV  236 (372)
Q Consensus       163 -----vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ell-tG~~Pf~~~~~~  236 (372)
                           ++++|||++......     ....++..|+|||.+..    ...++.++|||||||++|+|+ +|..||......
T Consensus       146 ~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~  216 (262)
T cd05077         146 ECGPFIKLSDPGIPITVLSR-----QECVERIPWIAPECVED----SKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA  216 (262)
T ss_pred             CCCceeEeCCCCCCccccCc-----ccccccccccChhhhcC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh
Confidence                 899999998655322     22457889999998863    356888999999999999998 589998876544


Q ss_pred             HHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhh
Q psy11571        237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIAD  285 (372)
Q Consensus       237 ~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~  285 (372)
                      +.. .+.....  ....    ..++++.+||.+||+ ||.+||++.++++
T Consensus       217 ~~~-~~~~~~~--~~~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~  259 (262)
T cd05077         217 EKE-RFYEGQC--MLVT----PSCKELADLMTHCMNYDPNQRPFFRAIMR  259 (262)
T ss_pred             HHH-HHHhcCc--cCCC----CChHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            432 2222221  1111    346889999999999 9999999877663

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=8.3e-38  Score=295.60  Aligned_cols=258  Identities=21%  Similarity=0.279  Sum_probs=197.4

Q ss_pred             HHHHhhhcCCcccCCccEEEeeeehh--hhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEE
Q psy11571          5 RELEALFLGGPIQGKGRVFSIETLLD--ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYA   81 (372)
Q Consensus         5 ~~l~~~~~~~~~~g~G~v~~v~~~~~--~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~   81 (372)
                      +..+.++.|    ++|.||.+....+  +..+|+|.+.......        ...+.+.+|+.+++.+ +||||+++++.
T Consensus         3 ~~~~~lg~G----~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~--------~~~~~~~~E~~~l~~l~~h~~iv~~~~~   70 (332)
T cd07857           3 ELIKELGQG----AYGIVCSARNAETSEEETVAIKKITNVFSKK--------ILAKRALRELKLLRHFRGHKNITCLYDM   70 (332)
T ss_pred             eEEEEcccc----CCeEEEEEEeCCCCcCceEEEEEeccccccc--------hhHHHHHHHHHHHHHhcCCCChheeeee
Confidence            334445554    8999999998877  8899999875432111        1234466788889888 59999999987


Q ss_pred             EEeC----CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe
Q psy11571         82 FQDD----SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        82 ~~~~----~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      ....    ..+|++|||+ +++|.+.+.. ...+++..++.++.||+.||+|||+.|++|          |||||+||++
T Consensus        71 ~~~~~~~~~~~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH----------~dlkp~Nili  138 (332)
T cd07857          71 DIVFPGNFNELYLYEELM-EADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLH----------RDLKPGNLLV  138 (332)
T ss_pred             eeeccccCCcEEEEEecc-cCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccc----------CCCCHHHeEE
Confidence            5432    4578999998 5799999976 568999999999999999999999999999          9999999999


Q ss_pred             CCCCcEEEeecCcccccCCCCcc---cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCC
Q psy11571        158 DANGHIRLADFGSCLRLGGDGTV---QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES  234 (372)
Q Consensus       158 ~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~  234 (372)
                      +.++.++|+|||+++........   ......||+.|+|||.+.+    ...++.++|+|||||++|+|++|.+||.+.+
T Consensus       139 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~  214 (332)
T cd07857         139 NADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLS----FQSYTKAIDVWSVGCILAELLGRKPVFKGKD  214 (332)
T ss_pred             cCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhC----CCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence            99999999999999765432211   1123468999999998863    3457889999999999999999999998876


Q ss_pred             HHHHHHHHhhccC--------------------------CcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        235 LVETYGKIMNHQN--------------------------SFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       235 ~~~~~~~i~~~~~--------------------------~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ....+..+.....                          ...++ ......+..+++||.+||+ +|.+||++++++   
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll---  290 (332)
T cd07857         215 YVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEAL---  290 (332)
T ss_pred             HHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHh---
Confidence            5554443332110                          00111 1122468899999999999 999999876665   


Q ss_pred             hhhhhhhccCCCCCCCCCcCC
Q psy11571        288 MWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       288 ~~~~~~~~~~~~~~~hp~f~~  308 (372)
                                    .||||+.
T Consensus       291 --------------~~~~~~~  297 (332)
T cd07857         291 --------------EHPYLAI  297 (332)
T ss_pred             --------------cChhhhh
Confidence                          9999964

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=7.9e-38  Score=285.01  Aligned_cols=251  Identities=22%  Similarity=0.351  Sum_probs=197.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      ||...+.++.|    |+|.||++.....+..+++|.++.........     .....+.+|..+++.++||||+++++++
T Consensus         1 ~y~i~~~ig~g----~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~   71 (260)
T cd08222           1 RYILQQRLGKG----SFGTVYLVKDKKAVAEERLKVLKEIPVGELNP-----NETVQANQEAQLLSKLDHPAIVKFHASF   71 (260)
T ss_pred             CceeeeeecCC----CCceEEEEEecCCCCcceEEEeccccccccCc-----chHHHHHHHHHHHHhCCCCcHHHHHHHH
Confidence            45556666666    89999999887776666666655433321110     0122355688899999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSK---FEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA  159 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~  159 (372)
                      .+....++||||+++++|.+++..   ....+++..++.++.|++.||.|||+.|++|          +||+|+||+++.
T Consensus        72 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h----------~~l~~~nili~~  141 (260)
T cd08222          72 LERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILH----------RDLKAKNIFLKN  141 (260)
T ss_pred             hcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccc----------cCCChhheEeec
Confidence            999999999999999999998864   2457899999999999999999999999999          999999999975


Q ss_pred             CCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHH
Q psy11571        160 NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY  239 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~  239 (372)
                       +.++|+|||++........ ......|++.|+|||.+.+     ..++.++|+||||+++|+|++|..||...+.....
T Consensus       142 -~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~-----~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~  214 (260)
T cd08222         142 -NLLKIGDFGVSRLLMGSCD-LATTFTGTPYYMSPEALKH-----QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVV  214 (260)
T ss_pred             -CCEeecccCceeecCCCcc-cccCCCCCcCccCHHHHcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence             6799999999876543322 2233567889999999863     45788999999999999999999999887776666


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      ..+.... ....+.    .++.++.++|.+||. +|++||++++++
T Consensus       215 ~~~~~~~-~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il  255 (260)
T cd08222         215 LRIVEGP-TPSLPE----TYSRQLNSIMQSMLNKDPSLRPSAAEIL  255 (260)
T ss_pred             HHHHcCC-CCCCcc----hhcHHHHHHHHHHhcCChhhCcCHHHHh
Confidence            6665432 222222    678999999999999 999999866665

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=286.93  Aligned_cols=249  Identities=24%  Similarity=0.326  Sum_probs=194.0

Q ss_pred             HHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEe
Q psy11571          6 ELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLHYAFQD   84 (372)
Q Consensus         6 ~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~~~~~~   84 (372)
                      ..+.++.|    |+|.||++....+++.+++|.+........         .....+|+..+..+. ||||+++++++.+
T Consensus         3 ~~~~ig~g----~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~---------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   69 (283)
T cd07830           3 VIKQLGDG----TFGSVYLARNKETGELVAIKKMKKKFYSWE---------ECMNLREVKSLRKLNEHPNIVKLKEVFRE   69 (283)
T ss_pred             eheeeccC----CceEEEEEEECCCCcEEEEEEehhhccchh---------HHHHHHHHHHHHhccCCCCchhHHHHhhc
Confidence            34455555    899999999888889999997765432211         111235778888888 9999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcE
Q psy11571         85 DSNLYLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI  163 (372)
Q Consensus        85 ~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~v  163 (372)
                      ++..|+||||+ +|+|.+++.... ..+++..+..++.|++.+|.|||++|++|          +||+|+||+++.++.+
T Consensus        70 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H----------~dl~~~ni~i~~~~~~  138 (283)
T cd07830          70 NDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFH----------RDLKPENLLVSGPEVV  138 (283)
T ss_pred             CCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCccc----------CCCChhhEEEcCCCCE
Confidence            99999999999 889999987743 47899999999999999999999999999          9999999999999999


Q ss_pred             EEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHh
Q psy11571        164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM  243 (372)
Q Consensus       164 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~  243 (372)
                      +|+|||++.........  ....++..|+|||++..    ...++.++|+||||+++++|++|++||...+..+.+.++.
T Consensus       139 ~l~d~~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~----~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~  212 (283)
T cd07830         139 KIADFGLAREIRSRPPY--TDYVSTRWYRAPEILLR----STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKIC  212 (283)
T ss_pred             EEeecccceeccCCCCc--CCCCCcccccCceeeec----CcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHH
Confidence            99999999766443221  22467889999999863    3457889999999999999999999998877665554443


Q ss_pred             hccCCc-----------------CCCC-------CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        244 NHQNSF-----------------DLPS-------DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       244 ~~~~~~-----------------~~~~-------~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      ......                 ..+.       ......+.++.++|++||+ +|++||+++++.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~  278 (283)
T cd07830         213 SVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQAL  278 (283)
T ss_pred             HhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHh
Confidence            211110                 0000       0011236889999999999 999999866555

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.4e-37  Score=287.62  Aligned_cols=259  Identities=24%  Similarity=0.396  Sum_probs=198.5

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYA   81 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~   81 (372)
                      .|+.++.++.|    ++|.||++....+++.+|+|.+.......         ....+.+|..++... .||||++++++
T Consensus        16 ~~~~~~~lg~g----~~~~v~~~~~~~~~~~~avK~~~~~~~~~---------~~~~~~~e~~~~~~~~~~~~i~~~~~~   82 (296)
T cd06618          16 DLENLGEIGSG----TCGQVYKMRFKKTGHVMAVKQMRRTGNKE---------ENKRILMDLDVVLKSHDCPYIVKCYGY   82 (296)
T ss_pred             hheeeeEeecc----CCeEEEEEEECCCCeEEEEEEEeccCChH---------HHHHHHHHHHHHHhccCCCchHhhhee
Confidence            34555666666    78999999988889999999876543221         112334455555544 59999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD-LHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      +.+....|++|||+ +++|.+++......+++..+..++.||+.||+|||+ .|++|          |||+|+||+++++
T Consensus        83 ~~~~~~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H----------~dl~p~nill~~~  151 (296)
T cd06618          83 FITDSDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIH----------RDVKPSNILLDAS  151 (296)
T ss_pred             eecCCeEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEec----------CCCcHHHEEEcCC
Confidence            99999999999998 558888877655679999999999999999999997 69999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCH-HHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL-VETY  239 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-~~~~  239 (372)
                      +.++|+|||++.........  ....++..|+|||.+.+... ...++.++|+||||+++|+|++|+.||..... .+.+
T Consensus       152 ~~~kL~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~  228 (296)
T cd06618         152 GNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPERIDPPDP-NPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL  228 (296)
T ss_pred             CCEEECccccchhccCCCcc--cCCCCCccccCHhhcCCCCC-ccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHH
Confidence            99999999998765432221  22357889999999874211 13478899999999999999999999976432 3444


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      ..+..... ...+..  ..++.++.+||.+||. +|.+||+++++.                 .||||..
T Consensus       229 ~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il-----------------~~~~~~~  278 (296)
T cd06618         229 TKILQEEP-PSLPPN--EGFSPDFCSFVDLCLTKDHRKRPKYRELL-----------------QHPFIRR  278 (296)
T ss_pred             HHHhcCCC-CCCCCC--CCCCHHHHHHHHHHccCChhhCCCHHHHh-----------------cChhhhc
Confidence            45544321 222221  1478999999999999 999999876665                 9999984

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4e-37  Score=279.49  Aligned_cols=241  Identities=20%  Similarity=0.243  Sum_probs=194.1

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+..+.++.|    |+|.||.+.  .+++.+++|.......            .+.+.+|+.+++.++||||+++++++.
T Consensus         8 ~~~~~~lg~g----~~g~v~~~~--~~~~~~~iK~~~~~~~------------~~~~~~e~~~l~~~~~~~i~~~~~~~~   69 (254)
T cd05083           8 LTLGEIIGEG----EFGAVLQGE--YTGQKVAVKNIKCDVT------------AQAFLEETAVMTKLHHKNLVRLLGVIL   69 (254)
T ss_pred             ceeeeeeccC----CCCceEecc--cCCCceEEEeecCcch------------HHHHHHHHHHHHhCCCCCcCeEEEEEc
Confidence            4444455555    899999875  4678899997654221            234678999999999999999999987


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .. ..+++|||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++|          |||||+||+++.++.
T Consensus        70 ~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H----------~dl~p~nili~~~~~  138 (254)
T cd05083          70 HN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVH----------RDLAARNILVSEDGV  138 (254)
T ss_pred             CC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeec----------cccCcceEEEcCCCc
Confidence            65 5799999999999999997642 35899999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGK  241 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~  241 (372)
                      ++|+|||++.......    .....+..|+|||.+.     ...++.++|+|||||++|+|++ |.+||...+..+....
T Consensus       139 ~kl~Dfg~~~~~~~~~----~~~~~~~~y~~pe~~~-----~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  209 (254)
T cd05083         139 AKVSDFGLARVGSMGV----DNSKLPVKWTAPEALK-----HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC  209 (254)
T ss_pred             EEECCCccceeccccC----CCCCCCceecCHHHhc-----cCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence            9999999987643211    1123456899999987     3568889999999999999997 9999998887776666


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      +..+ .....+.    .++..+.+++.+||+ +|++||+++++.+.+
T Consensus       210 ~~~~-~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l  251 (254)
T cd05083         210 VEKG-YRMEPPE----GCPADVYVLMTSCWETEPKKRPSFHKLREKL  251 (254)
T ss_pred             HhCC-CCCCCCC----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            6543 2222222    678999999999999 999999988877544

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.4e-37  Score=283.25  Aligned_cols=253  Identities=17%  Similarity=0.208  Sum_probs=200.0

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeeh----hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLL----DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITN   77 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~----~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~   77 (372)
                      ++|+..+.++.|    |+|.||.+....    .+..|++|.+......         ...+.+.+|..+++.++||||++
T Consensus         6 ~~~~~~~~i~~g----~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~---------~~~~~~~~e~~~l~~l~h~ni~~   72 (280)
T cd05043           6 DRVTLSDLLQEG----TFGRIFYGILIDEKPGKEEEVFVKTVKDHASE---------IQVTLLLQESCLLYGLSHQNILP   72 (280)
T ss_pred             hheEEeeeeccc----CCceEEEEEEecCCCCceeEEEEEEccCCCCH---------HHHHHHHHHHHHHHhCCCCCCCe
Confidence            355555556665    899999998765    2577888876532211         23455778999999999999999


Q ss_pred             eeEEEEe-CCeEEEEEeccCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCC
Q psy11571         78 LHYAFQD-DSNLYLVMDYYCGGDLLTLLSKFE-------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRD  149 (372)
Q Consensus        78 l~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrD  149 (372)
                      +++++.. +...++++||+++++|.+++....       ..+++..+..++.|++.||+|||+++++|          ||
T Consensus        73 ~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H----------~d  142 (280)
T cd05043          73 ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIH----------KD  142 (280)
T ss_pred             EEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEee----------cc
Confidence            9998665 467899999999999999997632       35889999999999999999999999999          99


Q ss_pred             CCcCcEEeCCCCcEEEeecCcccccCCCCcc-cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CC
Q psy11571        150 IKPDNVLLDANGHIRLADFGSCLRLGGDGTV-QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GE  227 (372)
Q Consensus       150 lkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~  227 (372)
                      |||+||+++.++.+||+|||+++........ ......++..|+|||++.+     ..++.++|||||||++|++++ |+
T Consensus       143 i~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-----~~~~~~~Di~slG~~l~el~~~g~  217 (280)
T cd05043         143 IAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN-----KEYSSASDVWSFGVLLWELMTLGQ  217 (280)
T ss_pred             cCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhc-----CCCCchhhHHHhHHHHHHHhcCCC
Confidence            9999999999999999999999765332211 1122345678999999973     568899999999999999998 99


Q ss_pred             CCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        228 TPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       228 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      +||...+..+....+... ..+..+.    .+++++.+++.+||. +|++||++.++.+.+
T Consensus       218 ~p~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l  273 (280)
T cd05043         218 TPYVEIDPFEMAAYLKDG-YRLAQPI----NCPDELFAVMACCWALDPEERPSFSQLVQCL  273 (280)
T ss_pred             CCcCcCCHHHHHHHHHcC-CCCCCCC----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence            999988877766655543 2222222    578999999999999 999999988877554

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=6.1e-37  Score=285.96  Aligned_cols=252  Identities=18%  Similarity=0.250  Sum_probs=198.3

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhh----hhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILL----VLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITN   77 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~----va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~   77 (372)
                      ++|+.++.++.|    |+|.||++....++..    +++|.+.......         ....+.+|..+++.++||||++
T Consensus         7 ~~~~~~~~lg~G----~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~~e~~~~~~l~h~niv~   73 (303)
T cd05110           7 TELKRVKVLGSG----AFGTVYKGIWVPEGETVKIPVAIKILNETTGPK---------ANVEFMDEALIMASMDHPHLVR   73 (303)
T ss_pred             hhceeccccccC----CCccEEEEEEecCCCcceeeEEEEeccccCCHH---------HHHHHHHHHHHHHhCCCCCccc
Confidence            356667777777    8999999988777764    5666654332211         1234678999999999999999


Q ss_pred             eeEEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe
Q psy11571         78 LHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        78 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      +++++... ..++++||+++|+|.+++......+++..+..++.|++.||.|||++|++|          |||||+||++
T Consensus        74 ~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH----------~dikp~Nill  142 (303)
T cd05110          74 LLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVH----------RDLAARNVLV  142 (303)
T ss_pred             EEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeec----------cccccceeee
Confidence            99998764 467999999999999999875557899999999999999999999999999          9999999999


Q ss_pred             CCCCcEEEeecCcccccCCCCcc-cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCH
Q psy11571        158 DANGHIRLADFGSCLRLGGDGTV-QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESL  235 (372)
Q Consensus       158 ~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~  235 (372)
                      +.++.+||+|||+++........ ......++..|+|||.+.     ...++.++|||||||++|||++ |..||.+...
T Consensus       143 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~  217 (303)
T cd05110         143 KSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH-----YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT  217 (303)
T ss_pred             cCCCceEEccccccccccCcccccccCCCccccccCCHHHhc-----cCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999865432211 122234567899999987     3568899999999999999997 9999988766


Q ss_pred             HHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       236 ~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .+....+ .....+..+.    ..+.++.+++.+|+. +|++||+++++...+
T Consensus       218 ~~~~~~~-~~~~~~~~~~----~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l  265 (303)
T cd05110         218 REIPDLL-EKGERLPQPP----ICTIDVYMVMVKCWMIDADSRPKFKELAAEF  265 (303)
T ss_pred             HHHHHHH-HCCCCCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            5544444 3333333332    568899999999999 999999988876544

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7.3e-37  Score=281.81  Aligned_cols=254  Identities=19%  Similarity=0.274  Sum_probs=200.0

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeee----hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETL----LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITN   77 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~----~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~   77 (372)
                      +.|+.++.++.|    |+|.||++...    .++..+|+|.+......         ...+.+.+|+.+++.+.||||++
T Consensus         4 ~~~~~~~~ig~g----~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~---------~~~~~~~~ei~~l~~l~~~~i~~   70 (284)
T cd05038           4 RHLKFIKQLGEG----HFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE---------QHRSDFEREIEILRTLDHENIVK   70 (284)
T ss_pred             hhchhheeeccC----CCeeEEEeeecCCCCCCceEEEEEEeccccch---------HHHHHHHHHHHHHHhCCCCChhe
Confidence            456777777777    89999999753    34788999987654432         13456788999999999999999


Q ss_pred             eeEEEEe--CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcE
Q psy11571         78 LHYAFQD--DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNV  155 (372)
Q Consensus        78 l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NI  155 (372)
                      +++++..  ....+++|||+++++|.+++......+++..+..++.|++.||+|||+.|++|          +||||+||
T Consensus        71 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H----------~dl~p~ni  140 (284)
T cd05038          71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIH----------RDLAARNI  140 (284)
T ss_pred             EEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeec----------CCCCHHhE
Confidence            9999887  55789999999999999999875456999999999999999999999999999          99999999


Q ss_pred             EeCCCCcEEEeecCcccccCCCCccc--ccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC
Q psy11571        156 LLDANGHIRLADFGSCLRLGGDGTVQ--SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE  233 (372)
Q Consensus       156 ll~~~~~vkl~Dfg~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~  233 (372)
                      +++.++.++|+|||++..........  .....++..|+|||.+.+     ..++.++|+||||+++|+|++|..||...
T Consensus       141 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-----~~~~~~~Di~slG~~l~el~tg~~p~~~~  215 (284)
T cd05038         141 LVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT-----SKFSSASDVWSFGVTLYELFTYGDPSQSP  215 (284)
T ss_pred             EEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHcc-----CCCCcccchHHHhhhhheeeccCCCcccc
Confidence            99999999999999998765322111  111234567999999873     56888999999999999999999998654


Q ss_pred             CHH--------------HHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        234 SLV--------------ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       234 ~~~--------------~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ...              ......+........+.    ..+.++.+++.+||+ +|++||++.++.+.+
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l  280 (284)
T cd05038         216 PAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPP----SCPDEVYDLMKLCWEAEPQDRPSFADLILIV  280 (284)
T ss_pred             cchhccccccccccccHHHHHHHHHcCCcCCCCc----cCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence            221              11222233222222222    567899999999999 999999988887655

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.5e-37  Score=281.33  Aligned_cols=203  Identities=20%  Similarity=0.268  Sum_probs=166.3

Q ss_pred             HHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCce
Q psy11571         57 VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYV  136 (372)
Q Consensus        57 ~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~iv  136 (372)
                      ...+.+|..+++.++||||+++++++.+....++||||+++|+|..++.+..+.+++..+..++.||+.||+|||++|++
T Consensus        60 ~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ii  139 (274)
T cd05076          60 ALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLV  139 (274)
T ss_pred             HHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCcc
Confidence            34577788999999999999999999999999999999999999999976556789999999999999999999999999


Q ss_pred             ecCCCCCCCcCCCCCcCcEEeCCCC-------cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCC
Q psy11571        137 HRPNHFAFHLCRDIKPDNVLLDANG-------HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGP  209 (372)
Q Consensus       137 H~~~~~~~~vhrDlkp~NIll~~~~-------~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~  209 (372)
                      |          |||||+||+++..+       .++++|||++......     ....++..|+|||.+.+    ...++.
T Consensus       140 H----------~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~----~~~~~~  200 (274)
T cd05076         140 H----------GNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPG----GNSLST  200 (274)
T ss_pred             C----------CCCCcccEEEeccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcC----CCCCCc
Confidence            9          99999999997543       4899999987654321     12357888999999873    345789


Q ss_pred             ccceeehhHHHHHHh-hCCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhh
Q psy11571        210 ECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIAD  285 (372)
Q Consensus       210 ~~DiwslGvil~ell-tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~  285 (372)
                      ++|+|||||++|||+ +|..||......+....+ ...  ...|.    ..++.+.++|.+||+ +|++||+++++++
T Consensus       201 ~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~--~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~  271 (274)
T cd05076         201 AADKWSFGTTLLEICFDGEVPLKERTPSEKERFY-EKK--HRLPE----PSCKELATLISQCLTYEPTQRPSFRTILR  271 (274)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH-Hhc--cCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHH
Confidence            999999999999995 799999877655443322 221  12232    356789999999999 9999999877764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG1095|consensus

Probab=100.00  E-value=4.1e-37  Score=313.57  Aligned_cols=241  Identities=22%  Similarity=0.301  Sum_probs=203.1

Q ss_pred             ccCCccEEEeeeeh-hhh----hhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEE
Q psy11571         16 IQGKGRVFSIETLL-DIL----LVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYL   90 (372)
Q Consensus        16 ~~g~G~v~~v~~~~-~~~----~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   90 (372)
                      .|.||.||.+.-.. ++.    .||+|.+.......         ....|.+|..+|+.++|||||++++++.+....++
T Consensus       702 ~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~---------~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  702 KGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQ---------EVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             cccccceEEEEEecCCCCccceEEEEEeccccCCHH---------HHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            34789999886433 232    37777666544332         34568889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEE
Q psy11571         91 VMDYYCGGDLLTLLSKF------EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIR  164 (372)
Q Consensus        91 v~E~~~gg~L~~~l~~~------~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vk  164 (372)
                      ++|||+||||..+|++.      ...++..+...++.+|+.|+.||+++++||          |||...|+|++....||
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvH----------RDLAaRNCLL~~~r~VK  842 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVH----------RDLAARNCLLDERRVVK  842 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcC----------cchhhhheeecccCcEE
Confidence            99999999999999986      456899999999999999999999999999          99999999999999999


Q ss_pred             EeecCcccccCCCCccccccc-ccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHH
Q psy11571        165 LADFGSCLRLGGDGTVQSNVA-VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKI  242 (372)
Q Consensus       165 l~Dfg~a~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i  242 (372)
                      |+|||+|+.+-....+..... .-...|||||.+.     .+.++.++|||||||++||++| |..||.+.+..+++...
T Consensus       843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~-----d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~  917 (1025)
T KOG1095|consen  843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLK-----DGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV  917 (1025)
T ss_pred             EcccchhHhhhhchheeccCccccceecCCHHHHh-----hcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH
Confidence            999999995543333332222 2346899999998     4789999999999999999998 99999999999999878


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhh
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIAD  285 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~  285 (372)
                      +++. +++.|.    .++..+-+++.+|++ +|++||++..+.+
T Consensus       918 ~~gg-RL~~P~----~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  918 LEGG-RLDPPS----YCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             HhCC-ccCCCC----CCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            7775 677676    789999999999999 9999999766653

>KOG1187|consensus

Probab=100.00  E-value=3.1e-36  Score=285.46  Aligned_cols=244  Identities=21%  Similarity=0.247  Sum_probs=183.7

Q ss_pred             ccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC-eEEEEEec
Q psy11571         16 IQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS-NLYLVMDY   94 (372)
Q Consensus        16 ~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~-~~~lv~E~   94 (372)
                      .+|+|.||++. +.++..||+|.........          ..++.+|+.++.+++|||+|+++++|.+.+ ..+||+||
T Consensus        85 ~Ggfg~VYkG~-l~~~~~vAVK~~~~~~~~~----------~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEy  153 (361)
T KOG1187|consen   85 EGGFGTVYKGV-LSDGTVVAVKRLSSNSGQG----------EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEY  153 (361)
T ss_pred             cCCCeEEEEEE-ECCCCEEEEEEecCCCCcc----------hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEc
Confidence            44788888873 5566899999666544321          123788999999999999999999999998 59999999


Q ss_pred             cCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhcC---ceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCc
Q psy11571         95 YCGGDLLTLLSKFED-RLPEDMAKFYIAEMVLAIASIHDLH---YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGS  170 (372)
Q Consensus        95 ~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~  170 (372)
                      +++|+|.+++..... .+++.....|+.+++.||+|||+..   |||          |||||.|||+|++.++||+|||+
T Consensus       154 m~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiH----------rDiKssNILLD~~~~aKlsDFGL  223 (361)
T KOG1187|consen  154 MPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIH----------RDIKSSNILLDEDFNAKLSDFGL  223 (361)
T ss_pred             cCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEec----------CCCCHHHeeECCCCCEEccCccC
Confidence            999999999987544 8899999999999999999999843   778          99999999999999999999999


Q ss_pred             ccccCC-CCccccccc-ccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCC---H---HHHHHHH
Q psy11571        171 CLRLGG-DGTVQSNVA-VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES---L---VETYGKI  242 (372)
Q Consensus       171 a~~~~~-~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~---~---~~~~~~i  242 (372)
                      |+.... ....  ... .||.+|+|||.+.     .+..+.++|||||||++.|++||+.+.....   .   .+-....
T Consensus       224 a~~~~~~~~~~--~~~~~gt~gY~~PEy~~-----~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~  296 (361)
T KOG1187|consen  224 AKLGPEGDTSV--STTVMGTFGYLAPEYAS-----TGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL  296 (361)
T ss_pred             cccCCccccce--eeecCCCCccCChhhhc-----cCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence            976543 2221  112 7999999999998     4678999999999999999999998887432   1   1111111


Q ss_pred             hhccCCcCCC-CCCC-CCCC--HH---HHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        243 MNHQNSFDLP-SDVG-YEIS--DD---AKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       243 ~~~~~~~~~~-~~~~-~~~s--~~---~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .....-..+. +... ...+  ..   +..+..+|++ +|.+||+..++.+.+
T Consensus       297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L  349 (361)
T KOG1187|consen  297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL  349 (361)
T ss_pred             HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence            1111001111 1111 1223  23   4566788999 899999977654433

>KOG1006|consensus

Probab=100.00  E-value=1.8e-38  Score=274.69  Aligned_cols=263  Identities=22%  Similarity=0.363  Sum_probs=211.7

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHH-hcCCCCceeeeeE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVL-VYGDRRWITNLHY   80 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il-~~l~hp~Iv~l~~   80 (372)
                      +.++.|+++|.|    .+|+|.+..+...|+..|+|.+......++         .+++..|.++. +.-+.||||++|+
T Consensus        64 ~~Lqdlg~iG~G----~fG~V~KM~hk~sg~~mAVKrIr~~n~~ke---------q~rll~e~d~~mks~~cp~IVkfyG  130 (361)
T KOG1006|consen   64 DNLQDLGEIGNG----AFGTVNKMLHKPSGKLMAVKRIRSNNIEKE---------QKRLLMEHDTVMKSSNCPNIVKFYG  130 (361)
T ss_pred             chHHHHHHhcCC----cchhhhhhhcCccCcEEEEEEeeeccchHH---------HHHHHHHHHHHHhhcCCcHHHHHhh
Confidence            357889999998    799999999999999999999887665332         35566666655 4557999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCCcCCCCCcCcE
Q psy11571         81 AFQDDSNLYLVMDYYCGGDLLTLLSK----FEDRLPEDMAKFYIAEMVLAIASIHD-LHYVHRPNHFAFHLCRDIKPDNV  155 (372)
Q Consensus        81 ~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~~~~~~~~vhrDlkp~NI  155 (372)
                      +.-.++..|+.||+| ..+|..+.+.    .+..++|..+-.++...+.||.||.. ..|||          ||+||+||
T Consensus       131 a~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIH----------RDvKPSNI  199 (361)
T KOG1006|consen  131 ALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIH----------RDVKPSNI  199 (361)
T ss_pred             hhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhh----------ccCChhhe
Confidence            999999999999998 5576554332    14679999999999999999999985 68999          99999999


Q ss_pred             EeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCC-
Q psy11571        156 LLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES-  234 (372)
Q Consensus       156 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~-  234 (372)
                      |++..|.+||||||++..+..+-  ..+.-.|...|||||.+..+.   ..|+-+||+||||++|||+.||..|+.+-+ 
T Consensus       200 Lldr~G~vKLCDFGIcGqLv~Si--AkT~daGCrpYmAPERi~p~~---~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s  274 (361)
T KOG1006|consen  200 LLDRHGDVKLCDFGICGQLVDSI--AKTVDAGCRPYMAPERIDPSD---KGYDIRSDVWSLGITLYEVATGNFPYRKWDS  274 (361)
T ss_pred             EEecCCCEeeecccchHhHHHHH--HhhhccCCccccChhccCCcc---CCcchhhhhhhhcceEeeeecCCCCcchHHH
Confidence            99999999999999997765432  223357889999999998543   248899999999999999999999998754 


Q ss_pred             HHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCC
Q psy11571        235 LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       235 ~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~  310 (372)
                      ..+.+.++..+..+.-.++.....++..++.+|.-||. |-..||...++.                 ++||++...
T Consensus       275 vfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk-----------------~~~fyr~y~  334 (361)
T KOG1006|consen  275 VFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLK-----------------KFPFYRMYA  334 (361)
T ss_pred             HHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhh-----------------cCchhhhhh
Confidence            44555566666554444443334689999999999999 899999887776                 999998644

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.9e-36  Score=274.10  Aligned_cols=232  Identities=16%  Similarity=0.176  Sum_probs=182.5

Q ss_pred             cCCccEEEeeeehhh----------hhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC
Q psy11571         17 QGKGRVFSIETLLDI----------LLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS   86 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~----------~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~   86 (372)
                      ||+|.||++....++          ..+++|.......           ....+.+|..+++.++||||+++++++.. .
T Consensus         6 G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   73 (259)
T cd05037           6 GTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR-----------DSLAFFETASLMSQLSHKHLVKLYGVCVR-D   73 (259)
T ss_pred             cccceEEEEEEeccCCccccCCccceeeeeeccccchh-----------hHHHHHHHHHHHHcCCCcchhheeeEEec-C
Confidence            489999999887665          2355554433221           13456788999999999999999999888 7


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC-----
Q psy11571         87 NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG-----  161 (372)
Q Consensus        87 ~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~-----  161 (372)
                      ..++||||+++|+|.+++......+++..+..++.||+.||+|||++|++|          |||||+||+++.++     
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H----------~dlkp~Nill~~~~~~~~~  143 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVH----------GNVCGKNILVARYGLNEGY  143 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeec----------ccCccceEEEecCccccCC
Confidence            789999999999999999874447899999999999999999999999999          99999999999887     


Q ss_pred             --cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHH
Q psy11571        162 --HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVET  238 (372)
Q Consensus       162 --~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~  238 (372)
                        .++|+|||++......     ....++..|+|||++.+.   ...++.++|+|||||++|+|++ |..||...+..+.
T Consensus       144 ~~~~kl~Dfg~a~~~~~~-----~~~~~~~~y~aPE~~~~~---~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~  215 (259)
T cd05037         144 VPFIKLSDPGIPITVLSR-----EERVERIPWIAPECIRNG---QASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK  215 (259)
T ss_pred             ceeEEeCCCCcccccccc-----cccccCCCccChhhhcCC---CCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH
Confidence              7999999998765431     224567889999998741   1368889999999999999999 6888877654443


Q ss_pred             HHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhh
Q psy11571        239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIAD  285 (372)
Q Consensus       239 ~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~  285 (372)
                      ..... .....  +.    .....+.++|.+||. +|.+||++.++++
T Consensus       216 ~~~~~-~~~~~--~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         216 ERFYQ-DQHRL--PM----PDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             HHHHh-cCCCC--CC----CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            33322 11111  11    224899999999999 9999999777653

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0671|consensus

Probab=100.00  E-value=7.7e-37  Score=276.66  Aligned_cols=256  Identities=23%  Similarity=0.317  Sum_probs=202.5

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCC--C----ce
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDR--R----WI   75 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~h--p----~I   75 (372)
                      .||..+..+|.|    .+|.|..+.+..++..||+|.++...--+           +..+-|+.+|.++.+  |    -+
T Consensus        89 ~Ry~i~~~lGeG----tFGkV~ec~D~~~~~~vAlKIik~V~kYr-----------eAa~iEi~vLqki~~~DP~g~~rc  153 (415)
T KOG0671|consen   89 NRYEIVDLLGEG----TFGKVVECWDRETKEHVALKIIKNVDKYR-----------EAALIEIEVLQKINESDPNGKFRC  153 (415)
T ss_pred             cceehhhhhcCC----cccceEEEeecCCCceehHHHHHHHHHHh-----------hHHHHHHHHHHHHHhcCCCCceEE
Confidence            478889998888    69999999998889999999877544333           334568888888732  2    37


Q ss_pred             eeeeEEEEeCCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCc
Q psy11571         76 TNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDN  154 (372)
Q Consensus        76 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~N  154 (372)
                      |++.++|.-.++.|+|+|.+ |-++.++|... -.+++...++.+++|++.+++|||+.+++|          .||||+|
T Consensus       154 v~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~H----------TDLKPEN  222 (415)
T KOG0671|consen  154 VQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTH----------TDLKPEN  222 (415)
T ss_pred             EeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceee----------cCCChhe
Confidence            88889999999999999997 88999999873 236899999999999999999999999999          9999999


Q ss_pred             EEeCC--------------------CCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCcccee
Q psy11571        155 VLLDA--------------------NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWW  214 (372)
Q Consensus       155 Ill~~--------------------~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diw  214 (372)
                      ||+.+                    +..|+++|||.|.+.....    ...+.|..|.|||++.+     ..++.++|||
T Consensus       223 ILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLg-----LGwS~pCDvW  293 (415)
T KOG0671|consen  223 ILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILG-----LGWSQPCDVW  293 (415)
T ss_pred             EEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheec-----cCcCCccCce
Confidence            99832                    2248999999998865443    34678999999999995     5699999999


Q ss_pred             ehhHHHHHHhhCCCCCCCCCHHH---HHHHHhhcc----------------CCcCCCCCCC-------------------
Q psy11571        215 SLGVCMYEMLYGETPFYAESLVE---TYGKIMNHQ----------------NSFDLPSDVG-------------------  256 (372)
Q Consensus       215 slGvil~elltG~~Pf~~~~~~~---~~~~i~~~~----------------~~~~~~~~~~-------------------  256 (372)
                      |+||||+|+.||...|+..+..+   ++++|+...                ..+.++....                   
T Consensus       294 SiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~  373 (415)
T KOG0671|consen  294 SIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYML  373 (415)
T ss_pred             eeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhc
Confidence            99999999999999999876554   455553210                0111111100                   


Q ss_pred             --CCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        257 --YEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       257 --~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                        ..-..++.|||++||. ||.+|+|+.+++                 .||||+..
T Consensus       374 ~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL-----------------~HpFF~~~  412 (415)
T KOG0671|consen  374 QDDLEHVQLFDLLRRMLEFDPARRITLREAL-----------------SHPFFARL  412 (415)
T ss_pred             cCcHHHhHHHHHHHHHHccCccccccHHHHh-----------------cCHHhhcC
Confidence              0122468899999999 999999988877                 99999853

>KOG0669|consensus

Probab=100.00  E-value=1.2e-37  Score=267.67  Aligned_cols=262  Identities=26%  Similarity=0.330  Sum_probs=207.0

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      .|+.+...+.|    .+|.|++++...+++.||+|++-...-...        +-....+|+.+|..+.|+|++.+++.+
T Consensus        18 ~yek~~kigqG----tfgeVFkAr~~n~~kkvalkkvlmeneKeG--------fpitalreikiL~~lkHenv~nliEic   85 (376)
T KOG0669|consen   18 KYEKLAKIGQG----TFGEVFKARSKNTGKKVALKKVLMENEKEG--------FPITALREIKILQLLKHENVVNLIEIC   85 (376)
T ss_pred             HHHHHHhcCCc----hHHHHHHHhhcCccchhHHHHHHHhccccC--------CcHHHHHHHHHHHHhcchhHHHHHHHH
Confidence            56777777777    589999999999999999997644322211        112245699999999999999998876


Q ss_pred             EeC--------CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCc
Q psy11571         83 QDD--------SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDN  154 (372)
Q Consensus        83 ~~~--------~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~N  154 (372)
                      .+.        ..+|+||.+|+. +|..++.+...+++..++..++.++..||.|+|...|+|          ||+||+|
T Consensus        86 ~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilH----------RDmKaaN  154 (376)
T KOG0669|consen   86 RTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILH----------RDMKAAN  154 (376)
T ss_pred             hhccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHh----------hcccHhh
Confidence            532        358999999955 999999886678999999999999999999999999999          9999999


Q ss_pred             EEeCCCCcEEEeecCcccccCCCCccc---ccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCC
Q psy11571        155 VLLDANGHIRLADFGSCLRLGGDGTVQ---SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY  231 (372)
Q Consensus       155 Ill~~~~~vkl~Dfg~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~  231 (372)
                      +||+.+|.+||+|||+++.+.......   .+..+-|..|.+||.+.+    .+.|+++.|+|+.|||+.||.||.+-|.
T Consensus       155 vLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG----~r~yg~~iDiWgAgCimaeMwtrspimq  230 (376)
T KOG0669|consen  155 VLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLG----DREYGPPIDIWGAGCIMAEMWTRSPIMQ  230 (376)
T ss_pred             EEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhc----ccccCCcchhHhHHHHHHHHHccCcccc
Confidence            999999999999999997654322211   122455899999999995    7889999999999999999999999999


Q ss_pred             CCCHHHHHHHHhhccCCc---C-----------------CCCCC---------CCCCCHHHHHHHHHhcc-CCCCCCCCC
Q psy11571        232 AESLVETYGKIMNHQNSF---D-----------------LPSDV---------GYEISDDAKDLMRRLIC-SSDTRLGQN  281 (372)
Q Consensus       232 ~~~~~~~~~~i~~~~~~~---~-----------------~~~~~---------~~~~s~~~~~li~~lL~-~p~~R~s~~  281 (372)
                      ++++...+..|..--..+   .                 +|...         ...-++++.||+.+||. ||.+|+.++
T Consensus       231 gnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad  310 (376)
T KOG0669|consen  231 GNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDAD  310 (376)
T ss_pred             CChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchH
Confidence            998887766553211111   0                 11100         01235689999999999 999999988


Q ss_pred             ChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        282 GIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       282 ~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      +++                 +|.||..
T Consensus       311 ~al-----------------nh~~F~k  320 (376)
T KOG0669|consen  311 QAL-----------------NHDFFWK  320 (376)
T ss_pred             hhh-----------------chhhhhc
Confidence            887                 9999963

>KOG4250|consensus

Probab=100.00  E-value=6.9e-37  Score=295.85  Aligned_cols=265  Identities=23%  Similarity=0.363  Sum_probs=200.3

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC------eEEE
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS------NLYL   90 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~------~~~l   90 (372)
                      ||+|.||..++..+|+.||+|.++.....+.         .+...+|+++|++++|||||+++++-++..      ...+
T Consensus        24 Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~---------~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   24 GAFGNVYRGRNKETGRLVAVKTFNKESSLRP---------RERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             CccceeeeecccccccchhHHhhhhhcccch---------HHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            4899999999999999999999988764443         456788999999999999999999876554      4689


Q ss_pred             EEeccCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC--CCC--cEE
Q psy11571         91 VMDYYCGGDLLTLLSKF--EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD--ANG--HIR  164 (372)
Q Consensus        91 v~E~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~--~~~--~vk  164 (372)
                      |||||.||||+.++++.  ..+++|.+.+.++..++.||.|||++||+|          |||||+||++-  .+|  ..|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvH----------RDlKP~NIvl~~Gedgq~IyK  164 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVH----------RDLKPGNIVLQIGEDGQSIYK  164 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCcee----------ccCCCCcEEEeecCCCceEEe
Confidence            99999999999999864  347999999999999999999999999999          99999999984  334  369


Q ss_pred             EeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCC----HHHHHH
Q psy11571        165 LADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES----LVETYG  240 (372)
Q Consensus       165 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~----~~~~~~  240 (372)
                      |+|||.|+.+..+..  ..+..||+.|.+||++-.    .+.|+..+|.|||||++|+++||..||....    ..++..
T Consensus       165 LtDfG~Arel~d~s~--~~S~vGT~~YLhPel~E~----q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~  238 (732)
T KOG4250|consen  165 LTDFGAARELDDNSL--FTSLVGTEEYLHPELYER----QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMW  238 (732)
T ss_pred             eecccccccCCCCCe--eeeecCchhhcChHHHhh----ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhh
Confidence            999999998876653  345899999999999973    3679999999999999999999999997532    223333


Q ss_pred             HHhhc-------------------cCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCC--CC----CChhhhhhhhhhhh
Q psy11571        241 KIMNH-------------------QNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRL--GQ----NGIADFKMWSALFV  294 (372)
Q Consensus       241 ~i~~~-------------------~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~--s~----~~~~~i~~~~~~~~  294 (372)
                      .+...                   ...++.|......+-..+-..+..+|+ +|.+|-  +.    .++.+|+..+..+.
T Consensus       239 ~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~vvhi  318 (732)
T KOG4250|consen  239 HIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKVVHI  318 (732)
T ss_pred             hhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhheeEE
Confidence            33221                   112222222111222334456777888 899998  43    35667776555433


Q ss_pred             ccCCCCCCCCCc
Q psy11571        295 SLSISPRNHPWF  306 (372)
Q Consensus       295 ~~~~~~~~hp~f  306 (372)
                      -...+...|-++
T Consensus       319 Fs~~~~~~~~~~  330 (732)
T KOG4250|consen  319 FSMVQATSHEYY  330 (732)
T ss_pred             EeeccceEEEEe
Confidence            333333344443

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=6.9e-36  Score=274.03  Aligned_cols=250  Identities=18%  Similarity=0.239  Sum_probs=195.7

Q ss_pred             HHHhhhcCCcccCCccEEEeeeeh---hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          6 ELEALFLGGPIQGKGRVFSIETLL---DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         6 ~l~~~~~~~~~~g~G~v~~v~~~~---~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      ..+.++.|    |+|.||.+....   +++.+|+|.+........        ..+.+.+|+.+++.++||||+++++++
T Consensus         3 ~~~~ig~g----~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~i~~~~~~~   70 (273)
T cd05074           3 LGRMLGKG----EFGSVREAQLKSEDGSFQKVAVKMLKADIFSSS--------DIEEFLREAACMKEFDHPNVIKLIGVS   70 (273)
T ss_pred             chhcccCC----CCCCEEeeEeeccCCCceEEEEEEeccccCChH--------HHHHHHHHHHHHhcCCCCCcceEEEEE
Confidence            34445555    899999997654   467899998765443222        235577899999999999999999988


Q ss_pred             EeCC------eEEEEEeccCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCC
Q psy11571         83 QDDS------NLYLVMDYYCGGDLLTLLSKF-----EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIK  151 (372)
Q Consensus        83 ~~~~------~~~lv~E~~~gg~L~~~l~~~-----~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlk  151 (372)
                      ....      ..++++||+.+|+|.+++...     ...++...+..++.||+.||+|||+.|++|          ||||
T Consensus        71 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H----------~dik  140 (273)
T cd05074          71 LRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIH----------RDLA  140 (273)
T ss_pred             ccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEee----------cccc
Confidence            6542      247899999999999887532     124788999999999999999999999999          9999


Q ss_pred             cCcEEeCCCCcEEEeecCcccccCCCCcc-cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCC
Q psy11571        152 PDNVLLDANGHIRLADFGSCLRLGGDGTV-QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETP  229 (372)
Q Consensus       152 p~NIll~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~P  229 (372)
                      |+||+++.++.++|+|||+++........ ......+++.|++||.+.     ...++.++|||||||++|+|++ |.+|
T Consensus       141 p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~sDi~slG~il~el~~~g~~p  215 (273)
T cd05074         141 ARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLA-----DNVYTTHSDVWAFGVTMWEIMTRGQTP  215 (273)
T ss_pred             hhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHh-----cCccchhhhhHHHHHHHHHHhhCCCCC
Confidence            99999999999999999998865432211 112234567899999987     3567889999999999999999 8999


Q ss_pred             CCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        230 FYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       230 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      |.+.+..+....+.... ....+.    ..+..+.+++.+||. +|++||++.++.+.+
T Consensus       216 ~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l  269 (273)
T cd05074         216 YAGVENSEIYNYLIKGN-RLKQPP----DCLEDVYELMCQCWSPEPKCRPSFQHLRDQL  269 (273)
T ss_pred             CCCCCHHHHHHHHHcCC-cCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            99888777776665542 222222    578999999999999 999999988776544

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=8.4e-36  Score=277.18  Aligned_cols=256  Identities=15%  Similarity=0.119  Sum_probs=184.3

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehh---hhhhhhhhhcccch--hhhhhHHHHHHHHHHHHHHHHHHhcCCCCcee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLD---ILLVLYDECCNSSL--RREKTVSDFIEFVAKLREERDVLVYGDRRWIT   76 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~---~~~va~K~~~~~~~--~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv   76 (372)
                      ++|+..+.+|.|    |+|.||++....+   +..+++|.......  ..+....+.... .....+...+..+.|++|+
T Consensus        12 ~~y~i~~~LG~G----~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~-~~~~~~~~~~~~~~h~~i~   86 (294)
T PHA02882         12 KEWKIDKLIGCG----GFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYD-IDKIALWKNIHNIDHLGIP   86 (294)
T ss_pred             CceEEeeEEecC----CCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhh-HHHHHHHHHhccCCCCCCC
Confidence            456666777777    8999999987766   55666664322211  111111111111 1122334455678899999


Q ss_pred             eeeEEEEeCC----eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCc
Q psy11571         77 NLHYAFQDDS----NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKP  152 (372)
Q Consensus        77 ~l~~~~~~~~----~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp  152 (372)
                      +++++.....    ..+++||++ ..++.+.+.. ....++..++.++.|++.||+|||+.+++|          |||||
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH----------rDiKp  154 (294)
T PHA02882         87 KYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISH----------GDIKP  154 (294)
T ss_pred             cEEEeeeEecCCceEEEEEEehh-ccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeec----------CCCCH
Confidence            9998866543    357888987 5578777765 345788999999999999999999999999          99999


Q ss_pred             CcEEeCCCCcEEEeecCcccccCCCCc------ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhC
Q psy11571        153 DNVLLDANGHIRLADFGSCLRLGGDGT------VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYG  226 (372)
Q Consensus       153 ~NIll~~~~~vkl~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG  226 (372)
                      +|||++.++.++|+|||+|+.......      .......||+.|+|||+..+     ..++.++|||||||++|||++|
T Consensus       155 ~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-----~~~~~~~DiwSlG~~l~el~~g  229 (294)
T PHA02882        155 ENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-----ACVTRRGDLESLGYCMLKWAGI  229 (294)
T ss_pred             HHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-----CCCCcHHHHHHHHHHHHHHHhC
Confidence            999999999999999999976542211      11223469999999999873     5689999999999999999999


Q ss_pred             CCCCCCCCH-HH--------HHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhh
Q psy11571        227 ETPFYAESL-VE--------TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADF  286 (372)
Q Consensus       227 ~~Pf~~~~~-~~--------~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i  286 (372)
                      .+||.+.+. ..        ...++....  ...+     ..++.+.++++.|+. +|++||+++++.++
T Consensus       230 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-----~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~  292 (294)
T PHA02882        230 KLPWKGFGHNGNLIHAAKCDFIKRLHEGK--IKIK-----NANKFIYDFIECVTKLSYEEKPDYDALIKI  292 (294)
T ss_pred             CCCCCccccchHHHHHhHHHHHHHhhhhh--hccC-----CCCHHHHHHHHHHHhCCCCCCCCHHHHHHh
Confidence            999987632 22        122222211  1111     468999999999999 99999998877654

>KOG4257|consensus

Probab=100.00  E-value=2.4e-36  Score=287.18  Aligned_cols=241  Identities=23%  Similarity=0.354  Sum_probs=206.9

Q ss_pred             cCCccEEEeeeehh----hhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEE
Q psy11571         17 QGKGRVFSIETLLD----ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVM   92 (372)
Q Consensus        17 ~g~G~v~~v~~~~~----~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   92 (372)
                      |-||.||.+.....    ...||+|.|+.......         .++|..|..+++.++||||+++++++.+. ..|+||
T Consensus       400 GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~---------tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm  469 (974)
T KOG4257|consen  400 GQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD---------TEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM  469 (974)
T ss_pred             CcccceeeeEecccccCcceeeeeehhccCCChhh---------HHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence            35788887764332    34789999988665433         35678899999999999999999999875 689999


Q ss_pred             eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCccc
Q psy11571         93 DYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCL  172 (372)
Q Consensus        93 E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~  172 (372)
                      |+++-|.|..|++.....++......|+.||+.||+|||+.++||          |||...|||+.+..-|||+|||+++
T Consensus       470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVH----------RDIAaRNiLVsSp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVH----------RDIAARNILVSSPQCVKLADFGLSR  539 (974)
T ss_pred             ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhh----------hhhhhhheeecCcceeeecccchhh
Confidence            999999999999987788999999999999999999999999999          9999999999999999999999999


Q ss_pred             ccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCC
Q psy11571        173 RLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHQNSFDL  251 (372)
Q Consensus       173 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~  251 (372)
                      .+..+..+......-...|||||.+.     .+.++.++|||-|||++||++. |..||.+-...+.+..|.++ .+++.
T Consensus       540 ~~ed~~yYkaS~~kLPIKWmaPESIN-----fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnG-eRlP~  613 (974)
T KOG4257|consen  540 YLEDDAYYKASRGKLPIKWMAPESIN-----FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENG-ERLPC  613 (974)
T ss_pred             hccccchhhccccccceeecCccccc-----hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCC-CCCCC
Confidence            98876665554444456899999998     6889999999999999999885 99999998888888777766 45666


Q ss_pred             CCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        252 PSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       252 ~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      |+    ++++.+-.|+.+|+. +|.+||.+.++..++
T Consensus       614 P~----nCPp~LYslmskcWayeP~kRPrftei~~~l  646 (974)
T KOG4257|consen  614 PP----NCPPALYSLMSKCWAYEPSKRPRFTEIKAIL  646 (974)
T ss_pred             CC----CCChHHHHHHHHHhccCcccCCcHHHHHHHH
Confidence            76    789999999999999 999999987665443

>KOG0665|consensus

Probab=100.00  E-value=7e-37  Score=271.18  Aligned_cols=268  Identities=21%  Similarity=0.379  Sum_probs=208.7

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      ||..|.-.+.|.    . .|..+.+...++.|++|+.........        ..++..+|..++..++|+||++++.+|
T Consensus        18 Ry~nL~p~~~g~----~-~v~~a~D~v~~~~v~ikk~~~pf~n~~--------~akra~rel~l~~~v~~~nii~l~n~f   84 (369)
T KOG0665|consen   18 RYVNLKPIGSGA----Q-IVVAAFDQVLGRPVAIKKLSRPFQNQT--------HAKRAYRELKLMKCVNHKNIISLLNVF   84 (369)
T ss_pred             eeeeecccCCCC----c-eEEecchhhccCceehhhhcCccccCc--------cchhhhhhhhhhhhhcccceeeeeecc
Confidence            444444444442    2 577788888999999998877633322        345678899999999999999999999


Q ss_pred             EeCC------eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEE
Q psy11571         83 QDDS------NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL  156 (372)
Q Consensus        83 ~~~~------~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIl  156 (372)
                      .-..      .+|+|||++ ..+|.+.+..   .++-+.+..++.|++.|++|||+.||+|          |||||+||+
T Consensus        85 tP~~~l~~~~e~y~v~e~m-~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~Iih----------RdLkPsniv  150 (369)
T KOG0665|consen   85 TPQKTLEEFQEVYLVMELM-DANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIH----------RDLKPSNIV  150 (369)
T ss_pred             CccccHHHHHhHHHHHHhh-hhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceee----------cccCcccce
Confidence            7553      589999998 6799999863   5788899999999999999999999999          999999999


Q ss_pred             eCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH
Q psy11571        157 LDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV  236 (372)
Q Consensus       157 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~  236 (372)
                      +..++.+||.|||+|+.....  ..-+..+.|..|.|||++.++    + |...+||||+||++.||++|+..|.+.+..
T Consensus       151 v~~~~~lKi~dfg~ar~e~~~--~~mtpyVvtRyyrapevil~~----~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~i  223 (369)
T KOG0665|consen  151 VNSDCTLKILDFGLARTEDTD--FMMTPYVVTRYYRAPEVILGM----G-YKENVDIWSVGCIMGELILGTVLFPGKDHI  223 (369)
T ss_pred             ecchhheeeccchhhcccCcc--cccCchhheeeccCchheecc----C-CcccchhhhhhhHHHHHhhceEEecCchHH
Confidence            999999999999999875543  233456789999999999963    3 889999999999999999999999998877


Q ss_pred             HHHHHHhhccCCc-----------------------------CCCCCC-------CCCCCHHHHHHHHHhcc-CCCCCCC
Q psy11571        237 ETYGKIMNHQNSF-----------------------------DLPSDV-------GYEISDDAKDLMRRLIC-SSDTRLG  279 (372)
Q Consensus       237 ~~~~~i~~~~~~~-----------------------------~~~~~~-------~~~~s~~~~~li~~lL~-~p~~R~s  279 (372)
                      +.+.++...-+.+                             .+|...       ...-+..++||+.+||. ||++|.+
T Consensus       224 dQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Ris  303 (369)
T KOG0665|consen  224 DQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRIS  303 (369)
T ss_pred             HHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhccc
Confidence            7776664221110                             011111       11234679999999999 9999998


Q ss_pred             CCChhhhhhhhhhhhccCCCCCCCCCcCCCCccccccCCCCCcC
Q psy11571        280 QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIP  323 (372)
Q Consensus       280 ~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~~~~~p~~p  323 (372)
                      +++++                 .||||+  -|-.-.+..+|..|
T Consensus       304 v~daL-----------------~HPY~~--vw~~~~ev~ap~pe  328 (369)
T KOG0665|consen  304 VDDAL-----------------RHPYIK--VWYDPDEVEAPPPE  328 (369)
T ss_pred             HHHHh-----------------cCCeee--eecccccccCCCCc
Confidence            77666                 999999  46444444444444

>KOG0603|consensus

Probab=100.00  E-value=6.3e-37  Score=293.70  Aligned_cols=294  Identities=34%  Similarity=0.607  Sum_probs=245.5

Q ss_pred             CCccEEEeeee---hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCeEEEEEe
Q psy11571         18 GKGRVFSIETL---LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLHYAFQDDSNLYLVMD   93 (372)
Q Consensus        18 g~G~v~~v~~~---~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv~E   93 (372)
                      .+|.|+.|++.   ..+..+|+|..++.........        .-..|..++..++ ||++++++..|+.+..++++++
T Consensus         6 ~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--------~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld   77 (612)
T KOG0603|consen    6 SYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--------HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD   77 (612)
T ss_pred             CCcchHHHHHhccccccchhhhhccccccccccccc--------ccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence            56666666543   3578999998887776544222        3456788888887 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571         94 YYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus        94 ~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                      +..||+|...+.+ ...+.+...+.+...++.+++++|+.+++|          ||+|++||+++.+|++++.|||+++.
T Consensus        78 ~~rgg~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l~iiy----------rd~k~enilld~~Ghi~~tdfglske  146 (612)
T KOG0603|consen   78 FLRGGDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKLGIAY----------RDYKLENVLLLLEGHIKLTDFGLSKE  146 (612)
T ss_pred             hcccchhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchhHHHH----------hcccccceeecccCccccCCchhhhH
Confidence            9999999999987 577899999999999999999999999999          99999999999999999999999987


Q ss_pred             cCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCC
Q psy11571        174 LGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPS  253 (372)
Q Consensus       174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~  253 (372)
                      .-....     .|||..|||||++.+       ...++|+||+|++++||+||..||.+    ++..+|.+..  +..|.
T Consensus       147 ~v~~~~-----~cgt~eymApEI~~g-------h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~--~~~p~  208 (612)
T KOG0603|consen  147 AVKEKI-----ACGTYEYRAPEIING-------HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE--LEMPR  208 (612)
T ss_pred             hHhhhh-----cccchhhhhhHhhhc-------cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc--cCCch
Confidence            644322     289999999999973       67899999999999999999999988    6777777643  44555


Q ss_pred             CCCCCCCHHHHHHHHHhcc-CCCCCCCC--CChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccCCCCCcCCCCCC
Q psy11571        254 DVGYEISDDAKDLMRRLIC-SSDTRLGQ--NGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSP  328 (372)
Q Consensus       254 ~~~~~~s~~~~~li~~lL~-~p~~R~s~--~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~~~p~~p~~~~~  328 (372)
                          .++..+++++.+++. +|.+|+++  ..+.+|+              +|+||..++|+.+  ++..|||+|.+..+
T Consensus       209 ----~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik--------------~h~f~~~i~~~~l~~r~~~~~fkp~~~~e  270 (612)
T KOG0603|consen  209 ----ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK--------------QHEFFQSIDWNELEARSRPPPFKPGSITE  270 (612)
T ss_pred             ----hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh--------------ccchheeeeHhhHhhcCCCCCCCCcccch
Confidence                689999999999999 99999986  6889998              9999999999987  67889999999999


Q ss_pred             CCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceeeC
Q psy11571        329 TDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQ  370 (372)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (372)
                      .++.+||.+.+...+.+.    ....+....|..|.||+|.+
T Consensus       271 ~~~~~fd~eft~~~P~ds----p~~~~~~s~~~if~g~sfva  308 (612)
T KOG0603|consen  271 RDVAQFDPEFTSQVPADS----PLLSASGSDHTIFSGPSFVA  308 (612)
T ss_pred             hhhhhcCchhccCCcccC----CCCCCCccccchhcCCCccC
Confidence            999999988775433321    11223345678899999876

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=6e-35  Score=261.45  Aligned_cols=237  Identities=37%  Similarity=0.648  Sum_probs=195.4

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccCC
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCG   97 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~g   97 (372)
                      |+|.||.+....+++.+++|..........         .+.+.+|+..++.++|+||+++++.+......++++||+.+
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~---------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   71 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK---------RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDG   71 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH---------HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCC
Confidence            689999999888899999998776544321         35678899999999999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCC
Q psy11571         98 GDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD  177 (372)
Q Consensus        98 g~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  177 (372)
                      ++|.+++.. ...++...+..++.+++.++.+||+.|++|          +||+|.||+++.++.++|+|||.+......
T Consensus        72 ~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h----------~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~  140 (244)
T smart00220       72 GDLFDLLKK-RGRLSEDEARFYARQILSALEYLHSNGIIH----------RDLKPENILLDEDGHVKLADFGLARQLDPG  140 (244)
T ss_pred             CCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHcCeec----------CCcCHHHeEECCCCcEEEccccceeeeccc
Confidence            999999987 344899999999999999999999999999          999999999999999999999999876543


Q ss_pred             CcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCC-CCHHHHHHHHhhccCCcCCCCCCC
Q psy11571        178 GTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHQNSFDLPSDVG  256 (372)
Q Consensus       178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~  256 (372)
                      .  ......++..|+|||...     ...++.++|+||||+++++|++|..||.. .+.......+..........   .
T Consensus       141 ~--~~~~~~~~~~~~~pE~~~-----~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---~  210 (244)
T smart00220      141 G--LLTTFVGTPEYMAPEVLL-----GKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPP---E  210 (244)
T ss_pred             c--ccccccCCcCCCCHHHHc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccc---c
Confidence            2  223356788999999987     35678899999999999999999999987 55555555444332221111   1


Q ss_pred             CCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        257 YEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       257 ~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      ..++.++.+++.+||. +|++||++.++.
T Consensus       211 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~  239 (244)
T smart00220      211 WKISPEAKDLIRKLLVKDPEKRLTAEEAL  239 (244)
T ss_pred             ccCCHHHHHHHHHHccCCchhccCHHHHh
Confidence            1278999999999999 999999866665

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.4e-35  Score=297.11  Aligned_cols=264  Identities=16%  Similarity=0.223  Sum_probs=173.7

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehh----hhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeee
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLD----ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLH   79 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~----~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~   79 (372)
                      |+..+.+|.|    |+|.||++....+    +..||+|.+.......       ....+++.       ...+.++..+.
T Consensus       134 y~l~~~LG~G----~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e-------~~~~e~l~-------~~~~~~~~~~~  195 (566)
T PLN03225        134 FVLGKKLGEG----AFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE-------IWMNERVR-------RACPNSCADFV  195 (566)
T ss_pred             eEEeEEEeeC----CCeEEEEEEEcCCccccCcEEEEEEecccchhH-------HHHHHHHH-------hhchhhHHHHH
Confidence            3444455555    8999999998888    8999999765432111       01111111       11112222221


Q ss_pred             EE------EEeCCeEEEEEeccCCCCHHHHHHhcCCC-------------------CCHHHHHHHHHHHHHHHHHHHhcC
Q psy11571         80 YA------FQDDSNLYLVMDYYCGGDLLTLLSKFEDR-------------------LPEDMAKFYIAEMVLAIASIHDLH  134 (372)
Q Consensus        80 ~~------~~~~~~~~lv~E~~~gg~L~~~l~~~~~~-------------------l~~~~~~~~~~qi~~~L~~LH~~~  134 (372)
                      ..      ..+...+++||||+.+++|.+++......                   ..+..+..++.||+.||.|||++|
T Consensus       196 ~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g  275 (566)
T PLN03225        196 YGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG  275 (566)
T ss_pred             HhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC
Confidence            11      24556799999999999999998752211                   123456789999999999999999


Q ss_pred             ceecCCCCCCCcCCCCCcCcEEeCC-CCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCC---------
Q psy11571        135 YVHRPNHFAFHLCRDIKPDNVLLDA-NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR---------  204 (372)
Q Consensus       135 ivH~~~~~~~~vhrDlkp~NIll~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---------  204 (372)
                      |+|          |||||+|||++. ++.+||+|||+|+..............+|+.|+|||.+.......         
T Consensus       276 IiH----------RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~  345 (566)
T PLN03225        276 IVH----------RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAT  345 (566)
T ss_pred             EEe----------CcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccc
Confidence            999          999999999985 579999999999866544333444578999999999764221100         


Q ss_pred             --------CCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhc-cCCc-----CCCCC----------CCCCCC
Q psy11571        205 --------GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH-QNSF-----DLPSD----------VGYEIS  260 (372)
Q Consensus       205 --------~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~-----~~~~~----------~~~~~s  260 (372)
                              ..++.++|||||||++|||+++..++.  +....+.+++.. ....     ..+..          .....+
T Consensus       346 ~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  423 (566)
T PLN03225        346 ALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSD--SNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDG  423 (566)
T ss_pred             cccchhccccCCCCcccHHHHHHHHHHHhCcCCCc--hHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccc
Confidence                    124456799999999999999776643  222222222111 0000     00000          001123


Q ss_pred             HHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc
Q psy11571        261 DDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI  314 (372)
Q Consensus       261 ~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~  314 (372)
                      ....+||++||+ ||.+|||+++++                 +||||++.++..+
T Consensus       424 ~~~~dLi~~mL~~dP~kR~ta~e~L-----------------~Hpff~~~~~~~~  461 (566)
T PLN03225        424 GAGWELLKSMMRFKGRQRISAKAAL-----------------AHPYFDREGLLGL  461 (566)
T ss_pred             hHHHHHHHHHccCCcccCCCHHHHh-----------------CCcCcCCCCcccc
Confidence            456699999999 999999977766                 9999999888643

>KOG0587|consensus

Probab=100.00  E-value=3.8e-35  Score=288.92  Aligned_cols=249  Identities=24%  Similarity=0.394  Sum_probs=209.1

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEe-----CCeEEEE
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYAFQD-----DSNLYLV   91 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~~~~-----~~~~~lv   91 (372)
                      -+|.||+++...+++..|+|.........+           .+..|..+|+.. +|||++.+|++|..     ++.+|||
T Consensus        31 tygkv~k~k~~~~~~~aa~kI~~~~~d~de-----------EiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLV   99 (953)
T KOG0587|consen   31 TYGKVYKGRHVKTGQLAAIKIMDPTEDEEE-----------EIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLV   99 (953)
T ss_pred             cceeEEEEeeeecCceeeeEeecCCccccH-----------HHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEE
Confidence            578899999999999999997776554332           355688888776 69999999999864     3579999


Q ss_pred             EeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCc
Q psy11571         92 MDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGS  170 (372)
Q Consensus        92 ~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~  170 (372)
                      ||||.||+.-+++++. +.++.|+.+..|++.++.||.+||.+.++|          ||||-.|||++.++.|||+|||.
T Consensus       100 MEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviH----------RDikG~NiLLT~e~~VKLvDFGv  169 (953)
T KOG0587|consen  100 MEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIH----------RDIKGQNVLLTENAEVKLVDFGV  169 (953)
T ss_pred             eeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceee----------ecccCceEEEeccCcEEEeeeee
Confidence            9999999999999875 457999999999999999999999999999          99999999999999999999999


Q ss_pred             ccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcC
Q psy11571        171 CLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD  250 (372)
Q Consensus       171 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~  250 (372)
                      +..+... ....++..|||.|||||++..++.....|+..+|+||||++..||.-|.+|+.+..+...+..|-... ++.
T Consensus       170 SaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNP-PPk  247 (953)
T KOG0587|consen  170 SAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-PPK  247 (953)
T ss_pred             eeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCC-Ccc
Confidence            9876543 23456789999999999999877767778999999999999999999999999888777766665432 121


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        251 LPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       251 ~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      +  ..+...+.++.+||..||. |-++||+..+++                 .|||+..
T Consensus       248 L--krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll-----------------~hpFi~e  287 (953)
T KOG0587|consen  248 L--KRPKKWSKKFNDFISTCLVKDYEQRPSTEELL-----------------KHPFITE  287 (953)
T ss_pred             c--cchhhHHHHHHHHHHHHHhhccccCcchhhhc-----------------cCCcccc
Confidence            1  1133679999999999999 899999866655                 9999984

>KOG0668|consensus

Probab=100.00  E-value=2.1e-35  Score=250.72  Aligned_cols=254  Identities=23%  Similarity=0.349  Sum_probs=203.2

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeeeE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLHY   80 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~~   80 (372)
                      +.|+.+.++|+|    -++.|+.+....++..+.+|.++...             .+++++|+.+|..+. ||||+++++
T Consensus        38 ddYeivrk~GRG----KYSEVFeg~~~~~~eK~ViKiLKPVk-------------kkKIkREikIL~nL~gg~NIi~L~D  100 (338)
T KOG0668|consen   38 DDYEIVRKVGRG----KYSEVFEGINITNNEKCVIKILKPVK-------------KKKIKREIKILQNLRGGPNIIKLLD  100 (338)
T ss_pred             chHHHHHHHcCc----cHhhHhcccccCCCceEEEeeechHH-------------HHHHHHHHHHHHhccCCCCeeehhh
Confidence            468899999998    48889999888999999999876533             245789999999987 999999999


Q ss_pred             EEEeCC--eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC
Q psy11571         81 AFQDDS--NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD  158 (372)
Q Consensus        81 ~~~~~~--~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~  158 (372)
                      +..+..  ...+|+||+++.+...+.    ..++..+++.++.+++.||.|||++||+|          ||+||.|++||
T Consensus       101 iV~Dp~SktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImH----------RDVKPhNvmId  166 (338)
T KOG0668|consen  101 IVKDPESKTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMH----------RDVKPHNVMID  166 (338)
T ss_pred             hhcCccccCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCccc----------ccCCcceeeec
Confidence            998764  468999999999888876    45888999999999999999999999999          99999999999


Q ss_pred             CC-CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCC-CCCHH
Q psy11571        159 AN-GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY-AESLV  236 (372)
Q Consensus       159 ~~-~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~-~~~~~  236 (372)
                      .. -.++|+|+|+|.+.......  +..+.+..|.-||.+..    ...|+.+.|+|||||++..|+..+-||. +.+..
T Consensus       167 h~~rkLrlIDWGLAEFYHp~~eY--nVRVASRyfKGPELLVd----y~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~  240 (338)
T KOG0668|consen  167 HELRKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVD----YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY  240 (338)
T ss_pred             hhhceeeeeecchHhhcCCCcee--eeeeehhhcCCchheee----chhccccHHHHHHHHHHHHHHhccCcccCCCCCH
Confidence            54 47999999999987654432  33566788999999985    5678999999999999999999988875 44444


Q ss_pred             HHHHHHh---------------------------hccCCc----CCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        237 ETYGKIM---------------------------NHQNSF----DLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       237 ~~~~~i~---------------------------~~~~~~----~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      +.+-+|.                           ....+-    -.++....-+++++.|||.++|. |-.+|+||.++.
T Consensus       241 DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam  320 (338)
T KOG0668|consen  241 DQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM  320 (338)
T ss_pred             HHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHh
Confidence            3333331                           110000    01112223467999999999999 999999988776


Q ss_pred             hhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        285 DFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       285 ~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                                       .||||..+
T Consensus       321 -----------------~HpyF~~~  328 (338)
T KOG0668|consen  321 -----------------AHPYFAPV  328 (338)
T ss_pred             -----------------cCchHHHH
Confidence                             99999854

>KOG4278|consensus

Probab=100.00  E-value=1.4e-34  Score=274.98  Aligned_cols=239  Identities=21%  Similarity=0.333  Sum_probs=203.2

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccCC
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCG   97 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~g   97 (372)
                      -+|.||......-.-.||+|.++.....           ++.|..|..+|+.+.|||+|+++++|..+..+|||+|||..
T Consensus       279 QYGeVYeGvWKkyslTvAVKtLKEDtMe-----------veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y  347 (1157)
T KOG4278|consen  279 QYGEVYEGVWKKYSLTVAVKTLKEDTME-----------VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY  347 (1157)
T ss_pred             cccceeeeeeeccceeeehhhhhhcchh-----------HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence            4789998888877788999988876653           45577899999999999999999999999999999999999


Q ss_pred             CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCC
Q psy11571         98 GDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG  176 (372)
Q Consensus        98 g~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  176 (372)
                      |+|.+||+.++ ..++.-....++.||..|++||..+++||          |||...|+|+.++..||++|||+++.+..
T Consensus       348 GNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIH----------RDLAARNCLVgEnhiVKvADFGLsRlMtg  417 (1157)
T KOG4278|consen  348 GNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIH----------RDLAARNCLVGENHIVKVADFGLSRLMTG  417 (1157)
T ss_pred             ccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhh----------hhhhhhhccccccceEEeeccchhhhhcC
Confidence            99999999863 34677778888999999999999999999          99999999999999999999999998876


Q ss_pred             CCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCCCCCC
Q psy11571        177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHQNSFDLPSDV  255 (372)
Q Consensus       177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  255 (372)
                      +.........-...|.|||-+.     ...++.++|||+|||+|||+.| |-.||.+.+..+++.-+.+ ..+..-|.  
T Consensus       418 DTYTAHAGAKFPIKWTAPEsLA-----yNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk-gyRM~~Pe--  489 (1157)
T KOG4278|consen  418 DTYTAHAGAKFPIKWTAPESLA-----YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK-GYRMDGPE--  489 (1157)
T ss_pred             CceecccCccCcccccCccccc-----ccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc-cccccCCC--
Confidence            5332211112245799999998     5778999999999999999997 9999999998888876654 45556565  


Q ss_pred             CCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        256 GYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       256 ~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                        .+++.+-+|++.|++ +|.+||++.++-+-+
T Consensus       490 --GCPpkVYeLMraCW~WsPsDRPsFaeiHqaf  520 (1157)
T KOG4278|consen  490 --GCPPKVYELMRACWNWSPSDRPSFAEIHQAF  520 (1157)
T ss_pred             --CCCHHHHHHHHHHhcCCcccCccHHHHHHHH
Confidence              899999999999999 999999987765433

>KOG1027|consensus

Probab=100.00  E-value=1e-34  Score=284.61  Aligned_cols=229  Identities=23%  Similarity=0.353  Sum_probs=180.8

Q ss_pred             ehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCeEEEEEeccCCCCHHHHHHh
Q psy11571         28 LLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSK  106 (372)
Q Consensus        28 ~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~  106 (372)
                      ...++.||+|.+.....             ....+|+..|+.-+ |||||++|+.-++....|+..|.| ..+|.+++..
T Consensus       530 ~ye~R~VAVKrll~e~~-------------~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~dlie~  595 (903)
T KOG1027|consen  530 VYEGREVAVKRLLEEFF-------------DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQDLIES  595 (903)
T ss_pred             eeCCceehHHHHhhHhH-------------HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHHHHHhc
Confidence            56889999998776443             33578999998774 999999999999999999999999 6699999987


Q ss_pred             c--CCC-CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC---CC--cEEEeecCcccccCCCC
Q psy11571        107 F--EDR-LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA---NG--HIRLADFGSCLRLGGDG  178 (372)
Q Consensus       107 ~--~~~-l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~---~~--~vkl~Dfg~a~~~~~~~  178 (372)
                      .  ... ......+..+.|++.||++||+.+|||          |||||+||||+.   ++  +++|+|||+++++..+.
T Consensus       596 ~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVH----------RDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  596 SGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVH----------RDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             cccchhhcccccHHHHHHHHHHHHHHHHhccccc----------ccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            2  111 112456888999999999999999999          999999999975   33  68999999999986543


Q ss_pred             cc--cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhC-CCCCCCCCHHHHHHHHhhccCCcCCCCCC
Q psy11571        179 TV--QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYG-ETPFYAESLVETYGKIMNHQNSFDLPSDV  255 (372)
Q Consensus       179 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  255 (372)
                      ..  ......||-+|+|||++..     ..-+.++||+||||++|+.++| .+||.+.-..+  .+|+.+...+..-.. 
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~-----~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~~-  737 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLRE-----DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLEP-  737 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhc-----cccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeecc-
Confidence            32  2345679999999999984     4456799999999999999986 99997654433  467666544322211 


Q ss_pred             CCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcC
Q psy11571        256 GYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ  307 (372)
Q Consensus       256 ~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~  307 (372)
                        ....+++|||.+||+ +|..||+|.+++                 .||||=
T Consensus       738 --~~d~eA~dLI~~ml~~dP~~RPsa~~VL-----------------~HPlFW  771 (903)
T KOG1027|consen  738 --LPDCEAKDLISRMLNPDPQLRPSATDVL-----------------NHPLFW  771 (903)
T ss_pred             --CchHHHHHHHHHhcCCCcccCCCHHHHh-----------------CCCccC
Confidence              122389999999999 999999977766                 999993

>KOG0670|consensus

Probab=100.00  E-value=1.2e-35  Score=277.54  Aligned_cols=254  Identities=22%  Similarity=0.308  Sum_probs=198.3

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC------CCce
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD------RRWI   75 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~------hp~I   75 (372)
                      .||.+.+-.|.|    =|+.|..+.+...+..||||.+.+..+...           .=..|+++|+.|+      --++
T Consensus       432 ~RY~V~~~~GkG----vFs~Vvra~D~~r~~~vAiKIIRnNE~M~K-----------tGl~EleiLkKL~~AD~Edk~Hc  496 (752)
T KOG0670|consen  432 SRYEVQGYTGKG----VFSTVVRARDQARGQEVAIKIIRNNEVMHK-----------TGLKELEILKKLNDADPEDKFHC  496 (752)
T ss_pred             ceeEEEeccccc----eeeeeeeccccCCCCeeEEEEeecchHHhh-----------hhhHHHHHHHHhhccCchhhhHH
Confidence            345544444444    356666666666788999999987666543           2235778888774      3589


Q ss_pred             eeeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcC
Q psy11571         76 TNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE--DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPD  153 (372)
Q Consensus        76 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~  153 (372)
                      ++++..|...+++|||+|-+ ..+|.++|++.+  -.|....++.|+.|+..||..|..+||+|          .||||+
T Consensus       497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlH----------aDIKPD  565 (752)
T KOG0670|consen  497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLH----------ADIKPD  565 (752)
T ss_pred             HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeee----------cccCcc
Confidence            99999999999999999998 679999999863  36888999999999999999999999999          999999


Q ss_pred             cEEeCCC-CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCC
Q psy11571        154 NVLLDAN-GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA  232 (372)
Q Consensus       154 NIll~~~-~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~  232 (372)
                      |||+++. ..+||||||.|.+.......   .+.-+..|.|||++.+     ..|+...|+||+||+||||.||+..|.+
T Consensus       566 NiLVNE~k~iLKLCDfGSA~~~~eneit---PYLVSRFYRaPEIiLG-----~~yd~~iD~WSvgctLYElYtGkIlFpG  637 (752)
T KOG0670|consen  566 NILVNESKNILKLCDFGSASFASENEIT---PYLVSRFYRAPEIILG-----LPYDYPIDTWSVGCTLYELYTGKILFPG  637 (752)
T ss_pred             ceEeccCcceeeeccCcccccccccccc---HHHHHHhccCcceeec-----CcccCCccceeeceeeEEeeccceecCC
Confidence            9999865 56799999999887655432   2445678999999995     6799999999999999999999999999


Q ss_pred             CCHHHHHHHHhhccCCcCCCCCC--------------------------------------------------------C
Q psy11571        233 ESLVETYGKIMNHQNSFDLPSDV--------------------------------------------------------G  256 (372)
Q Consensus       233 ~~~~~~~~~i~~~~~~~~~~~~~--------------------------------------------------------~  256 (372)
                      .+...++.-.+...+.+  |..+                                                        .
T Consensus       638 ~TNN~MLrl~me~KGk~--p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq  715 (752)
T KOG0670|consen  638 RTNNQMLRLFMELKGKF--PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQ  715 (752)
T ss_pred             CCcHHHHHHHHHhcCCC--cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchh
Confidence            87776655443322211  1100                                                        0


Q ss_pred             CCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        257 YEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       257 ~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      ..+-..+++||.+||. ||++|++.++++                 +||||.+
T Consensus       716 ~~~~~~~rdLLdkml~LdP~KRit~nqAL-----------------~HpFi~~  751 (752)
T KOG0670|consen  716 PKIVQQLRDLLDKMLILDPEKRITVNQAL-----------------KHPFITE  751 (752)
T ss_pred             HHHHHHHHHHHHHHhccChhhcCCHHHHh-----------------cCCcccC
Confidence            0122478899999999 999999988887                 9999974

>KOG0199|consensus

Probab=100.00  E-value=3.8e-34  Score=275.26  Aligned_cols=249  Identities=21%  Similarity=0.247  Sum_probs=207.0

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeeh---hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLL---DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNL   78 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~---~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l   78 (372)
                      +.++..+.+|.|    .||.|+......   +...||+|.+.......         .+..|.+|+.+|..++|||+++|
T Consensus       110 e~i~l~e~LG~G----sFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~---------~mddflrEas~M~~L~H~hliRL  176 (1039)
T KOG0199|consen  110 EQIKLYELLGEG----SFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA---------IMDDFLREASHMLKLQHPHLIRL  176 (1039)
T ss_pred             HHHHHHHHhcCc----ceeeEeeccccCCCCcEEeEEEEeccCCccch---------hHHHHHHHHHHHHhccCcceeEE
Confidence            455566666666    577776665433   23478888777665543         46778999999999999999999


Q ss_pred             eEEEEeCCeEEEEEeccCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe
Q psy11571         79 HYAFQDDSNLYLVMDYYCGGDLLTLLSK-FEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        79 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      |++..+ ..+.+|||+++.|+|.+.|++ .+..|.......|+.||+.|+.||.++++||          |||...|+|+
T Consensus       177 yGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvH----------RDLAARNlll  245 (1039)
T KOG0199|consen  177 YGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVH----------RDLAARNLLL  245 (1039)
T ss_pred             eeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhh----------hhhhhhhhee
Confidence            999988 578899999999999999987 3567889999999999999999999999999          9999999999


Q ss_pred             CCCCcEEEeecCcccccCCCCcccc--cccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCC
Q psy11571        158 DANGHIRLADFGSCLRLGGDGTVQS--NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAES  234 (372)
Q Consensus       158 ~~~~~vkl~Dfg~a~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~  234 (372)
                      .....|||+|||+.+.++.......  ....-...|+|||.+.     .+.++.++|+|++||++|||+| |..||.+..
T Consensus       246 asprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLr-----h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~  320 (1039)
T KOG0199|consen  246 ASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLR-----HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR  320 (1039)
T ss_pred             cccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhc-----cccccccchhhhhhhhHHhhhccCCCCCCCCC
Confidence            9988999999999998876543221  1112245799999998     5889999999999999999997 899999999


Q ss_pred             HHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        235 LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       235 ~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      ..+++++|-. ...++-|.    .+++++-+++++||. +|++||++..|.
T Consensus       321 g~qIL~~iD~-~erLpRPk----~csedIY~imk~cWah~paDRptFsair  366 (1039)
T KOG0199|consen  321 GIQILKNIDA-GERLPRPK----YCSEDIYQIMKNCWAHNPADRPTFSAIR  366 (1039)
T ss_pred             HHHHHHhccc-cccCCCCC----CChHHHHHHHHHhccCCccccccHHHHH
Confidence            9999999984 34555555    789999999999999 999999987663

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.2e-33  Score=277.17  Aligned_cols=271  Identities=18%  Similarity=0.195  Sum_probs=181.9

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeee----------------hhhhhhhhhhhcccchhhhhhHHHHHH----HHHHHHH
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETL----------------LDILLVLYDECCNSSLRREKTVSDFIE----FVAKLRE   62 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~----------------~~~~~va~K~~~~~~~~~~~~~~~~~~----~~~~l~~   62 (372)
                      +|+..+.+|.|    |||.||++...                .+++.||+|.+..........+.++..    ..+....
T Consensus       146 ~F~i~~~LG~G----gFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        146 DFQLRDKLGGG----NFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             CceEeeEeecC----CCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            45556666666    89999988542                234578999876543322222221111    1122334


Q ss_pred             HHHHHhcCCCCc-----eeeeeEEEEe--------CCeEEEEEeccCCCCHHHHHHhcCC--------------------
Q psy11571         63 ERDVLVYGDRRW-----ITNLHYAFQD--------DSNLYLVMDYYCGGDLLTLLSKFED--------------------  109 (372)
Q Consensus        63 E~~il~~l~hp~-----Iv~l~~~~~~--------~~~~~lv~E~~~gg~L~~~l~~~~~--------------------  109 (372)
                      |..++..+.|.+     +++++++|..        .+..++||||+++++|.+++....+                    
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            666666666554     4666666542        3568999999999999999864211                    


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCcccccccc
Q psy11571        110 ---RLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAV  186 (372)
Q Consensus       110 ---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~  186 (372)
                         .+++..++.++.|++.+|.|||+.+++|          |||||+|||++.++.+||+|||++...............
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivH----------rDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~  371 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVH----------RDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGM  371 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCeec----------CCCchHhEEECCCCcEEEEeCcCccccccCCccCccccC
Confidence               2355678899999999999999999999          999999999999999999999999765433222222234


Q ss_pred             cCCcccCcccccccccCCC-----------------CCCCccceeehhHHHHHHhhCCC-CCCCCCH-----------HH
Q psy11571        187 GTPDYISPEILTAMEEGRG-----------------RYGPECDWWSLGVCMYEMLYGET-PFYAESL-----------VE  237 (372)
Q Consensus       187 gt~~y~aPE~~~~~~~~~~-----------------~~~~~~DiwslGvil~elltG~~-Pf~~~~~-----------~~  237 (372)
                      +|+.|+|||.+........                 ....+.|+||+||++|+|++|.. ||.+...           ..
T Consensus       372 ~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~  451 (507)
T PLN03224        372 LDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLN  451 (507)
T ss_pred             CCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHH
Confidence            5889999999863210000                 11234799999999999999975 7754211           11


Q ss_pred             HHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CC---CCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SS---DTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       238 ~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p---~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      .+..+...  .+.++  .....++.++||+.+||. +|   .+|+|+++++                 +||||..
T Consensus       452 ~~r~~~~~--~~~~~--~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL-----------------~Hp~f~~  505 (507)
T PLN03224        452 RWRMYKGQ--KYDFS--LLDRNKEAGWDLACKLITKRDQANRGRLSVGQAL-----------------SHRFFLP  505 (507)
T ss_pred             HHHhhccc--CCCcc--cccccChHHHHHHHHHhccCCCCcccCCCHHHHh-----------------CCCCcCC
Confidence            11112122  22222  223679999999999998 65   6899877766                 9999964

>KOG0196|consensus

Probab=100.00  E-value=2.8e-34  Score=279.33  Aligned_cols=241  Identities=20%  Similarity=0.278  Sum_probs=207.3

Q ss_pred             CCccEEEeeeehhh---hhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEec
Q psy11571         18 GKGRVFSIETLLDI---LLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDY   94 (372)
Q Consensus        18 g~G~v~~v~~~~~~---~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~   94 (372)
                      -||.|+..+-...+   ..||||.++.....+.         ...|..|..||-+.+||||++|.++......++||+||
T Consensus       641 EFGEVc~GrLk~pgkre~~VAIKTLK~Gytekq---------rrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy  711 (996)
T KOG0196|consen  641 EFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQ---------RRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY  711 (996)
T ss_pred             cccceecccccCCCCcceeEEEeeeccCccHHH---------HhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence            57888887665544   5889998876655433         34578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCccccc
Q psy11571         95 YCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL  174 (372)
Q Consensus        95 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~  174 (372)
                      |++|+|..+|+...+.++..+...+++.|+.|+.||-++|+||          |||...|||++.+-.+|++|||+++.+
T Consensus       712 MENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVH----------RDLAARNILVNsnLvCKVsDFGLSRvl  781 (996)
T KOG0196|consen  712 MENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVH----------RDLAARNILVNSNLVCKVSDFGLSRVL  781 (996)
T ss_pred             hhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchh----------hhhhhhheeeccceEEEeccccceeec
Confidence            9999999999998889999999999999999999999999999          999999999999999999999999987


Q ss_pred             CCCCccccccccc--CCcccCcccccccccCCCCCCCccceeehhHHHHHHh-hCCCCCCCCCHHHHHHHHhhccCCcCC
Q psy11571        175 GGDGTVQSNVAVG--TPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMNHQNSFDL  251 (372)
Q Consensus       175 ~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ell-tG~~Pf~~~~~~~~~~~i~~~~~~~~~  251 (372)
                      .++.....++.-|  ..+|.|||.+.     .+.++.++||||+|++|||.+ .|..||...+..+.++.|..+ .+++.
T Consensus       782 edd~~~~ytt~GGKIPiRWTAPEAIa-----~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~g-yRLPp  855 (996)
T KOG0196|consen  782 EDDPEAAYTTLGGKIPIRWTAPEAIA-----YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQG-YRLPP  855 (996)
T ss_pred             ccCCCccccccCCccceeecChhHhh-----hcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhc-cCCCC
Confidence            6554222222222  35899999998     688999999999999999987 499999999999999999876 44444


Q ss_pred             CCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        252 PSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       252 ~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      |.    .++..+-.|+..|++ |-.+||.+.++..++
T Consensus       856 Pm----DCP~aL~qLMldCWqkdR~~RP~F~qiV~~l  888 (996)
T KOG0196|consen  856 PM----DCPAALYQLMLDCWQKDRNRRPKFAQIVSTL  888 (996)
T ss_pred             CC----CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHH
Confidence            44    689999999999999 899999998887666

>KOG0664|consensus

Probab=100.00  E-value=1.1e-34  Score=252.14  Aligned_cols=245  Identities=22%  Similarity=0.339  Sum_probs=196.3

Q ss_pred             ccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC-----eEEE
Q psy11571         16 IQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS-----NLYL   90 (372)
Q Consensus        16 ~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~-----~~~l   90 (372)
                      +|+||.||.|.+-.+|++|++|++-+...+        +...+++-+|..+|....|.|++..++..+...     .+|+
T Consensus        63 YGAFGVVWsVTDPRdgrrvalkK~pnvfq~--------L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   63 YGAFGVVWSVTDPRSGKRVALKKMPNVFQN--------LASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             ccceeEEEeccCCCCccchhHhhcchHHHH--------HHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            447899999999999999999987653322        234567888999999999999999999887654     4788


Q ss_pred             EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCc
Q psy11571         91 VMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGS  170 (372)
Q Consensus        91 v~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~  170 (372)
                      ++|++ ..+|..+|-+ ...++.+.++.+++||+.||.|||+.||+|          |||||.|+|++++..+||||||+
T Consensus       135 ~TELm-QSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILH----------RDIKPGNLLVNSNCvLKICDFGL  202 (449)
T KOG0664|consen  135 LTELM-QSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILH----------RDIKPGNLLVNSNCILKICDFGL  202 (449)
T ss_pred             HHHHH-Hhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhh----------ccCCCccEEeccCceEEeccccc
Confidence            99998 5689888876 578999999999999999999999999999          99999999999999999999999


Q ss_pred             ccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhcc----
Q psy11571        171 CLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQ----  246 (372)
Q Consensus       171 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~----  246 (372)
                      ++....+....-+..+-|..|.|||++++    .+.|+.++||||+|||+.|++..+..|...++.+.++.|..--    
T Consensus       203 ARvee~d~~~hMTqEVVTQYYRAPEiLMG----aRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs  278 (449)
T KOG0664|consen  203 ARTWDQRDRLNMTHEVVTQYYRAPELLMG----ARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPS  278 (449)
T ss_pred             ccccchhhhhhhHHHHHHHHhccHHHhhc----chhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCc
Confidence            98766554433334456889999999995    7889999999999999999999999999888776665553210    


Q ss_pred             -----------------CCcCCCCC--C-----CCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        247 -----------------NSFDLPSD--V-----GYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       247 -----------------~~~~~~~~--~-----~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                                       .....|+.  .     ...-..+..+++.++|. +|.+|.+.++++
T Consensus       279 ~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~  341 (449)
T KOG0664|consen  279 QEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEAL  341 (449)
T ss_pred             HHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhc
Confidence                             00111110  0     01234578899999999 999999876665

>KOG0984|consensus

Probab=100.00  E-value=2e-33  Score=235.24  Aligned_cols=222  Identities=22%  Similarity=0.363  Sum_probs=178.0

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhc-CCCCceeeeeEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVY-GDRRWITNLHYAF   82 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~-l~hp~Iv~l~~~~   82 (372)
                      +..+.++|.|    ++|.|-+.++..+|...|+|.+...--..         ..+++.+|..+... ..+|++|.+|+.+
T Consensus        48 L~~i~elGrG----ayG~vekmrh~~sg~imAvKri~~tvn~q---------~q~r~L~dldi~~r~~~CPf~V~FyGa~  114 (282)
T KOG0984|consen   48 LVGIEELGRG----AYGVVEKMRHIQSGTIMAVKRIRATVNSQ---------EQKRLLMDLDIIMRTVDCPFTVHFYGAL  114 (282)
T ss_pred             hhhhhhhcCC----ccchhhheeeccCCeEEEEeeehhhcChH---------HHHHHHHhhhhhccCCCCCeEEEeehhh
Confidence            4556667776    78999999999999999999876644322         34556667777654 5799999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCCcCCCCCcCcEEeC
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSK---FEDRLPEDMAKFYIAEMVLAIASIHD-LHYVHRPNHFAFHLCRDIKPDNVLLD  158 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~~~~~~~~vhrDlkp~NIll~  158 (372)
                      .....+++.||.| ..+|..+-++   .++.++|..+-+++..++.||.|||+ ..++|          ||+||.|||++
T Consensus       115 ~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIH----------RDvKPsNiLIn  183 (282)
T KOG0984|consen  115 FREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIH----------RDVKPSNILIN  183 (282)
T ss_pred             hccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhh----------ccCCcceEEEc
Confidence            9999999999998 5577665432   26789999999999999999999997 58999          99999999999


Q ss_pred             CCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCC-CCHHH
Q psy11571        159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVE  237 (372)
Q Consensus       159 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~-~~~~~  237 (372)
                      ..|+||+||||++..+..+-.  .+.-.|...|||||.+..... ...|+-++||||||+++.||.+++.||.. .++.+
T Consensus       184 ~~GqVKiCDFGIsG~L~dSiA--kt~daGCkpYmaPEri~~e~n-~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~  260 (282)
T KOG0984|consen  184 YDGQVKICDFGISGYLVDSIA--KTMDAGCKPYMAPERINPELN-QKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQ  260 (282)
T ss_pred             cCCcEEEcccccceeehhhhH--HHHhcCCCccCChhhcCcccC-cccceeehhhhhhhhhhhhhhhccccccccCCHHH
Confidence            999999999999987754322  222467889999999974332 33689999999999999999999999986 46777


Q ss_pred             HHHHHhhccCCcCCCC
Q psy11571        238 TYGKIMNHQNSFDLPS  253 (372)
Q Consensus       238 ~~~~i~~~~~~~~~~~  253 (372)
                      .+.++... +.+.+|.
T Consensus       261 qLkqvVee-p~P~Lp~  275 (282)
T KOG0984|consen  261 QLKQVVEE-PSPQLPA  275 (282)
T ss_pred             HHHHHhcC-CCCCCcc
Confidence            88888764 3444454

>KOG1094|consensus

Probab=100.00  E-value=2.1e-33  Score=265.70  Aligned_cols=250  Identities=22%  Similarity=0.237  Sum_probs=195.3

Q ss_pred             HHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe
Q psy11571          5 RELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQD   84 (372)
Q Consensus         5 ~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~   84 (372)
                      ...+++|.|    -||.|-.+. ......||+|..+.......         ...|.+|+++|.+++||||++++++|..
T Consensus       541 ~~~ekiGeG----qFGEVhLCe-veg~lkVAVK~Lr~~a~~~~---------r~~F~kEIkiLsqLkhPNIveLvGVC~~  606 (807)
T KOG1094|consen  541 RFKEKIGEG----QFGEVHLCE-VEGPLKVAVKILRPDATKNA---------RNDFLKEIKILSRLKHPNIVELLGVCVQ  606 (807)
T ss_pred             ehhhhhcCc----ccceeEEEE-ecCceEEEEeecCcccchhH---------HHHHHHHHHHHhccCCCCeeEEEeeeec
Confidence            344445544    355555553 33358999998877665443         3558889999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcE
Q psy11571         85 DSNLYLVMDYYCGGDLLTLLSKFEDR-LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI  163 (372)
Q Consensus        85 ~~~~~lv~E~~~gg~L~~~l~~~~~~-l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~v  163 (372)
                      ++.+++||||++.|+|.+++.....+ +.-.....++.||+.|++||.+.++||          |||.+.|+|++.++++
T Consensus       607 DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVH----------rd~a~rNcLv~~e~~i  676 (807)
T KOG1094|consen  607 DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVH----------RDLATRNCLVDGEFTI  676 (807)
T ss_pred             CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhh----------ccccccceeecCcccE
Confidence            99999999999999999999884323 345666779999999999999999999          9999999999999999


Q ss_pred             EEeecCcccccCCCCccc-ccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh--CCCCCCCCCHHHHHH
Q psy11571        164 RLADFGSCLRLGGDGTVQ-SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY--GETPFYAESLVETYG  240 (372)
Q Consensus       164 kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt--G~~Pf~~~~~~~~~~  240 (372)
                      ||+|||+++.+-...... ....+-...|||||.+.     .+.++.++|+|+||+++||+++  ...||...+.++...
T Consensus       677 KiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsil-----lgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vve  751 (807)
T KOG1094|consen  677 KIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESIL-----LGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVE  751 (807)
T ss_pred             EecCcccccccccCCceeeecceeeeeeehhHHHHH-----hccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHH
Confidence            999999998654433322 22234567999999998     4789999999999999999874  789999888777766


Q ss_pred             HHh---hccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        241 KIM---NHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       241 ~i~---~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      +..   ..+..-..++ ...-++..+-+|+.+|+. +-++||+++++-
T Consensus       752 n~~~~~~~~~~~~~l~-~P~~cp~~lyelml~Cw~~es~~RPsFe~lh  798 (807)
T KOG1094|consen  752 NAGEFFRDQGRQVVLS-RPPACPQGLYELMLRCWRRESEQRPSFEQLH  798 (807)
T ss_pred             hhhhhcCCCCcceecc-CCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence            543   2222221121 122678999999999999 999999987754

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.98  E-value=2.2e-32  Score=292.70  Aligned_cols=232  Identities=16%  Similarity=0.194  Sum_probs=174.5

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      |++|.||+++...++..||+|.+.......              ..|+.+++.++|||||++++++.+....|+||||++
T Consensus       701 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~  766 (968)
T PLN00113        701 GKKGASYKGKSIKNGMQFVVKEINDVNSIP--------------SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE  766 (968)
T ss_pred             CCCeeEEEEEECCCCcEEEEEEccCCcccc--------------HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence            488999999988899999999775432111              235677889999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIH---DLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                      +|+|.++++.    +++..+..++.|++.||+|||   +.+++|          |||||+||+++.++..++. ||.+..
T Consensus       767 ~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH----------~dlkp~Nil~~~~~~~~~~-~~~~~~  831 (968)
T PLN00113        767 GKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVV----------GNLSPEKIIIDGKDEPHLR-LSLPGL  831 (968)
T ss_pred             CCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeec----------CCCCHHhEEECCCCceEEE-eccccc
Confidence            9999999953    788999999999999999999   669999          9999999999988887775 665443


Q ss_pred             cCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCH----HHHHHHHhhccC--
Q psy11571        174 LGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL----VETYGKIMNHQN--  247 (372)
Q Consensus       174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~--  247 (372)
                      ....     ....||+.|+|||++.     ...++.++|||||||++|||+||+.||.....    ...+.+......  
T Consensus       832 ~~~~-----~~~~~t~~y~aPE~~~-----~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  901 (968)
T PLN00113        832 LCTD-----TKCFISSAYVAPETRE-----TKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHL  901 (968)
T ss_pred             cccC-----CCccccccccCccccc-----CCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccch
Confidence            2211     2236789999999987     35689999999999999999999999854211    011111100000  


Q ss_pred             ----CcCCCCC--CCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        248 ----SFDLPSD--VGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       248 ----~~~~~~~--~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                          .......  .......++.+++.+|++ +|++||+++++.+.+
T Consensus       902 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  948 (968)
T PLN00113        902 DMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL  948 (968)
T ss_pred             hheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHH
Confidence                0000000  000122357789999999 999999988877554

>KOG0200|consensus

Probab=99.97  E-value=3.7e-31  Score=267.64  Aligned_cols=242  Identities=24%  Similarity=0.331  Sum_probs=196.9

Q ss_pred             cCCccEEEeeeeh-------hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCeE
Q psy11571         17 QGKGRVFSIETLL-------DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYAFQDDSNL   88 (372)
Q Consensus        17 ~g~G~v~~v~~~~-------~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~~~~~~~~   88 (372)
                      +.+|.|+++.-..       ....||+|..+......+         .+.+..|+.+|+.+ .||||+.+.+++...+.+
T Consensus       307 g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~---------~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~  377 (609)
T KOG0200|consen  307 GAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSE---------KKDLMSELNVLKELGKHPNIVNLLGACTQDGPL  377 (609)
T ss_pred             ccccceEeEEEeecccccccceEEEEEEecccccCcHH---------HHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence            3677777665221       145788888776665533         45688899999876 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcC
Q psy11571         89 YLVMDYYCGGDLLTLLSKFE---------------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPD  153 (372)
Q Consensus        89 ~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~  153 (372)
                      ++|+||+..|+|.++++..+               ..++..+...++.||+.|++||++..+||          |||-..
T Consensus       378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vH----------RDLAaR  447 (609)
T KOG0200|consen  378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVH----------RDLAAR  447 (609)
T ss_pred             EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccc----------hhhhhh
Confidence            99999999999999999854               23889999999999999999999999999          999999


Q ss_pred             cEEeCCCCcEEEeecCcccccCCCCccccccccc--CCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCC
Q psy11571        154 NVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVG--TPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPF  230 (372)
Q Consensus       154 NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf  230 (372)
                      |||+..+..+||+|||+|+..............|  ...|||||.+.     ...|+.++||||+||+|||++| |..||
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~-----~~~ft~kSDVWSfGI~L~EifsLG~~PY  522 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLF-----DRVFTSKSDVWSFGILLWEIFTLGGTPY  522 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhc-----cCcccccchhhHHHHHHHHHhhCCCCCC
Confidence            9999999999999999999765544433222222  33599999998     4679999999999999999997 89999


Q ss_pred             CCCC-HHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        231 YAES-LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       231 ~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .+.. ..+++..+.. ..+...|.    ..++++-++++.|++ +|++||++.++.+.+
T Consensus       523 p~~~~~~~l~~~l~~-G~r~~~P~----~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~  576 (609)
T KOG0200|consen  523 PGIPPTEELLEFLKE-GNRMEQPE----HCSDEIYDLMKSCWNADPEDRPTFSECVEFF  576 (609)
T ss_pred             CCCCcHHHHHHHHhc-CCCCCCCC----CCCHHHHHHHHHHhCCCcccCCCHHHHHHHH
Confidence            9865 5566654444 45556666    679999999999999 999999988776554

>KOG1025|consensus

Probab=99.97  E-value=6.5e-32  Score=263.91  Aligned_cols=249  Identities=19%  Similarity=0.225  Sum_probs=206.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhh----hhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDIL----LVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNL   78 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~----~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l   78 (372)
                      +.+...++|.|    ++|+||+....-.+.    +||+|++........         -..+.+|+.+|..++|||++++
T Consensus       697 elkk~kvLGsg----AfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~---------s~e~LdeAl~masldHpnl~RL  763 (1177)
T KOG1025|consen  697 ELKKDKVLGSG----AFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKA---------SIELLDEALRMASLDHPNLLRL  763 (1177)
T ss_pred             hhhhhceeccc----cceeEEeeeEecCCceecceeEEEEeeccCCchh---------hHHHHHHHHHHhcCCCchHHHH
Confidence            45566666766    799999988777664    566666555444322         2447779999999999999999


Q ss_pred             eEEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC
Q psy11571         79 HYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD  158 (372)
Q Consensus        79 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~  158 (372)
                      ++++.... +.||++|+++|+|.++++..+..+.......|..||++|+.|||+++++|          |||-..||||.
T Consensus       764 Lgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVH----------rdLaaRNVLVk  832 (1177)
T KOG1025|consen  764 LGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVH----------RDLAARNVLVK  832 (1177)
T ss_pred             hhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhh----------hhhhhhheeec
Confidence            99998775 88999999999999999988889999999999999999999999999999          99999999999


Q ss_pred             CCCcEEEeecCcccccCCCCcccc-cccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHH
Q psy11571        159 ANGHIRLADFGSCLRLGGDGTVQS-NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLV  236 (372)
Q Consensus       159 ~~~~vkl~Dfg~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~  236 (372)
                      +-.++||.|||+++....+..... ....-.+.|||-|.+.     .+.|+.++||||+||++||++| |..|+.+...+
T Consensus       833 sP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~-----~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~  907 (1177)
T KOG1025|consen  833 SPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIR-----IRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE  907 (1177)
T ss_pred             CCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhh-----ccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH
Confidence            999999999999998765443221 1122346799999998     5889999999999999999997 99999999988


Q ss_pred             HHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhh
Q psy11571        237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIAD  285 (372)
Q Consensus       237 ~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~  285 (372)
                      ++-.-+..+ .++.-|+    ..+-++..++.+||. |+..||+++++.+
T Consensus       908 eI~dlle~g-eRLsqPp----iCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  908 EIPDLLEKG-ERLSQPP----ICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HhhHHHhcc-ccCCCCC----CccHHHHHHHHHHhccCcccCccHHHHHH
Confidence            876655554 4466666    689999999999999 9999999876643

>KOG0576|consensus

Probab=99.97  E-value=3.4e-32  Score=260.97  Aligned_cols=261  Identities=20%  Similarity=0.315  Sum_probs=216.9

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      .+|+.+..+|.|    .+|.||++++..+++..|+|.++......          .+-++.|+-+++.++|||||.+++.
T Consensus        15 ddyellqrvgsg----TygdvyKaRd~~s~elaavkvVkLep~dd----------~~~iqqei~~~~dc~h~nivay~gs   80 (829)
T KOG0576|consen   15 DDYELLQRVGSG----TYGDVYKARDKRSGELAAVKVVKLEPGDD----------FSGIQQEIGMLRDCRHPNIVAYFGS   80 (829)
T ss_pred             cchhheeeecCC----cccchhhhcccccCchhhheeeeccCCcc----------ccccccceeeeecCCCcChHHHHhh
Confidence            356777777777    69999999999999999999998877554          2446779999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +...+.+++.||||.||+|.+.-.- .+.++|.++....++.+.||+|||++|-+|          ||||-.||++++.|
T Consensus        81 ylr~dklwicMEycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~gk~h----------RdiKGanilltd~g  149 (829)
T KOG0576|consen   81 YLRRDKLWICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQGKIH----------RDIKGANILLTDEG  149 (829)
T ss_pred             hhhhcCcEEEEEecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCCccc----------ccccccceeecccC
Confidence            9999999999999999999998766 689999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .+|+.|||.+..+...-. +...+.||+.|||||+-.-..  .+.|+..+|+|++|+...|+---++|.....+......
T Consensus       150 DvklaDfgvsaqitati~-KrksfiGtpywmapEvaaver--kggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L  226 (829)
T KOG0576|consen  150 DVKLADFGVSAQITATIA-KRKSFIGTPYWMAPEVAAVER--KGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL  226 (829)
T ss_pred             ceeecccCchhhhhhhhh-hhhcccCCccccchhHHHHHh--cccccccccccccccchhhhhhcCCcccccchHHHHHH
Confidence            999999998876643222 334578999999999976322  45689999999999999999988888777666655444


Q ss_pred             HhhccC-CcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        242 IMNHQN-SFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       242 i~~~~~-~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      ..+... ++.+..  ....++.+-+|++.+|. +|++||+++.++                 .|||...-
T Consensus       227 mTkS~~qpp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL-----------------~h~fvs~~  277 (829)
T KOG0576|consen  227 MTKSGFQPPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLL-----------------QHPFVSQT  277 (829)
T ss_pred             hhccCCCCCcccC--CccchHHHHHHHHHHhcCCCccCCChhhhe-----------------eceeeccc
Confidence            433222 222222  22678999999999999 999999998877                 89988754

>KOG3653|consensus

Probab=99.97  E-value=9.2e-31  Score=242.82  Aligned_cols=260  Identities=20%  Similarity=0.239  Sum_probs=192.5

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhc--CCCCceeeeeEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVY--GDRRWITNLHYA   81 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~--l~hp~Iv~l~~~   81 (372)
                      ++.++.++.|    +||.||++.  .+++.||||++....             .+.+..|.+|.+.  +.|+||+++++.
T Consensus       212 l~l~eli~~G----rfg~V~Kaq--L~~~~VAVKifp~~~-------------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~  272 (534)
T KOG3653|consen  212 LQLLELIGRG----RFGCVWKAQ--LDNRLVAVKIFPEQE-------------KQSFQNEKNIYSLPGMKHENILQFIGA  272 (534)
T ss_pred             hhhHHHhhcC----ccceeehhh--ccCceeEEEecCHHH-------------HHHHHhHHHHHhccCccchhHHHhhch
Confidence            4455666666    788888874  467999999776532             3446777777765  679999999998


Q ss_pred             EEeCC----eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe
Q psy11571         82 FQDDS----NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        82 ~~~~~----~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      -....    .++||+||.+.|+|.++|+.  ..+++.+..+++..++.||+|||+--- -......+|+|||||..||||
T Consensus       273 ekr~t~~~~eywLVt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p-~~d~~Kp~IaHRDlkSkNVLv  349 (534)
T KOG3653|consen  273 EKRGTADRMEYWLVTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELP-RGDHHKPPIAHRDLKSKNVLV  349 (534)
T ss_pred             hccCCccccceeEEeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCC-cCCCCCCccccccccccceEE
Confidence            76555    79999999999999999997  789999999999999999999997422 112245556669999999999


Q ss_pred             CCCCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCC-CCCCCccceeehhHHHHHHhhCCC-------
Q psy11571        158 DANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGR-GRYGPECDWWSLGVCMYEMLYGET-------  228 (372)
Q Consensus       158 ~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~DiwslGvil~elltG~~-------  228 (372)
                      .+++...|+|||+|..+..... ......+||.+|||||++.+.-.-. ...-.+.||||+|.+|+||++...       
T Consensus       350 K~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~v  429 (534)
T KOG3653|consen  350 KNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPV  429 (534)
T ss_pred             ccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCC
Confidence            9999999999999988753221 1222368999999999997421101 111136899999999999997533       


Q ss_pred             -----CCC-----CCCHHHHHHHHhhccCCcCCCCCCC-CCCCHHHHHHHHHhcc-CCCCCCCCCChhh
Q psy11571        229 -----PFY-----AESLVETYGKIMNHQNSFDLPSDVG-YEISDDAKDLMRRLIC-SSDTRLGQNGIAD  285 (372)
Q Consensus       229 -----Pf~-----~~~~~~~~~~i~~~~~~~~~~~~~~-~~~s~~~~~li~~lL~-~p~~R~s~~~~~~  285 (372)
                           ||.     ..+.+++...+.+...++.+|+... ..--..+++.+..|+. ||+-|+||.-+.+
T Consensus       430 p~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~e  498 (534)
T KOG3653|consen  430 PEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEE  498 (534)
T ss_pred             CcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHH
Confidence                 332     1234455556666667777665322 2234678899999999 9999999876554

>KOG0606|consensus

Probab=99.97  E-value=4.9e-31  Score=264.65  Aligned_cols=243  Identities=33%  Similarity=0.625  Sum_probs=199.1

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      +++|.||.|++..+.+++|+|..+...+.+                  .++....+|++|                    
T Consensus        94 gAygavylvrh~~trqrfa~kiNkq~lilR------------------nilt~a~npfvv--------------------  135 (1205)
T KOG0606|consen   94 GAYGAVYLVRHKETRQRFAMKINKQNLILR------------------NILTFAGNPFVV--------------------  135 (1205)
T ss_pred             CCCCceeeeeccccccchhhcccccchhhh------------------ccccccCCccee--------------------
Confidence            489999999999999999995433322211                  145555666666                    


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCC
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG  176 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  176 (372)
                       ||=...++. -+.++.+.        +.+++|||+.||+|          ||+||+|.+|+.-|++|+.|||+++....
T Consensus       136 -gDc~tllk~-~g~lPvdm--------vla~Eylh~ygivh----------rdlkpdnllIT~mGhiKlTDfgLsk~GLm  195 (1205)
T KOG0606|consen  136 -GDCATLLKN-IGPLPVDM--------VLAVEYLHSYGIVH----------RDLKPDNLLITSMGHIKLTDFGLSKKGLM  195 (1205)
T ss_pred             -chhhhhccc-CCCCcchh--------hHHhHhhccCCeec----------CCCCCCcceeeecccccccchhhhhhhhh
Confidence             555555655 35555544        78999999999999          99999999999999999999999876432


Q ss_pred             CC--------------cccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        177 DG--------------TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       177 ~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      ..              .......||||.|.|||++.     ...|+..+|||++|+|+||.+.|..||.++++++++.++
T Consensus       196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil-----rqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v  270 (1205)
T KOG0606|consen  196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL-----RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV  270 (1205)
T ss_pred             hccchhhhcchHHHHHHhhhccccCCccccChhhhh-----hhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh
Confidence            11              11223468999999999998     467999999999999999999999999999999999999


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccccccCCCCC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPY  321 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~~~~~p~  321 (372)
                      +.....  +|.. ...+.++++++|.+||+ +|..|.+..+..+++              +|+||+.+||..|.+.+++|
T Consensus       271 isd~i~--wpE~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk--------------~h~ff~~LDw~~llRqkaef  333 (1205)
T KOG0606|consen  271 ISDDIE--WPEE-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVK--------------QHGFFQLLDWKSLLRQKAEF  333 (1205)
T ss_pred             hhhhcc--cccc-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhh--------------hccceeecccchhhhhhccc
Confidence            886543  3443 34789999999999999 999999988888888              99999999999999999999


Q ss_pred             cCCCCCCCCCCCCCCCcc
Q psy11571        322 IPEVSSPTDTSHFDVDEA  339 (372)
Q Consensus       322 ~p~~~~~~~~~~~~~~~~  339 (372)
                      +|.+.+..|+++||....
T Consensus       334 vpql~~eddtsyfdTRs~  351 (1205)
T KOG0606|consen  334 VPQLESEDDTSYFDTRSD  351 (1205)
T ss_pred             cccccccccchhhcccch
Confidence            999999999999987544

>KOG1290|consensus

Probab=99.97  E-value=7.3e-31  Score=244.11  Aligned_cols=129  Identities=20%  Similarity=0.242  Sum_probs=106.0

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-----C---Cc
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-----R---RW   74 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-----h---p~   74 (372)
                      ||-++.++|.|    -|.+||.+++....+.||+|+.+....-.           +....|+.+|+++.     |   .+
T Consensus        79 RY~v~rKLGWG----HFSTVWLawDtq~~r~VAlKVvKSAqhYt-----------EaAlDEIklL~~v~~~Dp~~~~~~~  143 (590)
T KOG1290|consen   79 RYHVQRKLGWG----HFSTVWLAWDTQNKRYVALKVVKSAQHYT-----------EAALDEIKLLQQVREGDPNDPGKKC  143 (590)
T ss_pred             eEEEEEecccc----ccceeEEEeeccCCeEEEEEEEehhhHHH-----------HHHHHHHHHHHHHHhcCCCCCCCce
Confidence            55555666666    68899999999999999999887655443           33456777776642     3   47


Q ss_pred             eeeeeEEEEeC----CeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCCcCC
Q psy11571         75 ITNLHYAFQDD----SNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHD-LHYVHRPNHFAFHLCR  148 (372)
Q Consensus        75 Iv~l~~~~~~~----~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~~~~~~~~vhr  148 (372)
                      ||+|++.|...    .++|+|+|++ |.+|..+|... -..++...++.|++||+.||.|||. .||||          .
T Consensus       144 VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIH----------T  212 (590)
T KOG1290|consen  144 VVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIH----------T  212 (590)
T ss_pred             eeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccc----------c
Confidence            99999999854    4899999998 88999999875 3579999999999999999999995 79999          9


Q ss_pred             CCCcCcEEe
Q psy11571        149 DIKPDNVLL  157 (372)
Q Consensus       149 Dlkp~NIll  157 (372)
                      ||||+|||+
T Consensus       213 DlKPENvLl  221 (590)
T KOG1290|consen  213 DLKPENVLL  221 (590)
T ss_pred             CCCcceeee
Confidence            999999998

>KOG1167|consensus

Probab=99.97  E-value=7.8e-31  Score=240.65  Aligned_cols=257  Identities=21%  Similarity=0.339  Sum_probs=195.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeeh---hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLL---DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNL   78 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~---~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l   78 (372)
                      .|..++..|.|    .|++||++....   ..+.||+|.+.......            ++..|.++|..+ .+.||+++
T Consensus        37 ~~~~v~kigeG----sFssv~~a~~~~~~~~~~~valk~i~~ts~p~------------ri~~El~~L~~~gG~~ni~~~  100 (418)
T KOG1167|consen   37 AYKVVNKIGEG----SFSSVYKATDIEQDTKRRYVALKAIYRTSSPS------------RILNELEMLYRLGGSDNIIKL  100 (418)
T ss_pred             hhhhhcccccc----chhhhhhhhHhhhccccceEeeeecccccCch------------HHHHHHHHHHHhccchhhhcc
Confidence            34555566655    688888887776   67889999887766543            377899999876 59999999


Q ss_pred             eEEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC
Q psy11571         79 HYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD  158 (372)
Q Consensus        79 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~  158 (372)
                      .+++..++...+||||++..+..++...    ++-.+++.|++.++.||+++|.+||||          |||||.|+|.+
T Consensus       101 ~~~~rnnd~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvH----------RDiKpsNFL~n  166 (418)
T KOG1167|consen  101 NGCFRNNDQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVH----------RDIKPSNFLYN  166 (418)
T ss_pred             hhhhccCCeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccc----------cCCCccccccc
Confidence            9999999999999999999999999865    678899999999999999999999999          99999999998


Q ss_pred             -CCCcEEEeecCcccccCCC-------C------c------------------------------ccccccccCCcccCc
Q psy11571        159 -ANGHIRLADFGSCLRLGGD-------G------T------------------------------VQSNVAVGTPDYISP  194 (372)
Q Consensus       159 -~~~~vkl~Dfg~a~~~~~~-------~------~------------------------------~~~~~~~gt~~y~aP  194 (372)
                       ..++-.|+|||+|......       .      .                              .......||++|.||
T Consensus       167 ~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaP  246 (418)
T KOG1167|consen  167 RRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAP  246 (418)
T ss_pred             cccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCch
Confidence             5578899999999721100       0      0                              001124699999999


Q ss_pred             ccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH-HHHHHH--------------hhcc-------------
Q psy11571        195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKI--------------MNHQ-------------  246 (372)
Q Consensus       195 E~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-~~~~~i--------------~~~~-------------  246 (372)
                      |++..    ....++++||||.|||+..++++..||.....+ ..+..|              ..+.             
T Consensus       247 EvL~k----~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~  322 (418)
T KOG1167|consen  247 EVLFR----CPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIP  322 (418)
T ss_pred             HHHhh----ccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccH
Confidence            99985    556788999999999999999999999542111 100000              0000             


Q ss_pred             ------CCc------------CCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcC
Q psy11571        247 ------NSF------------DLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ  307 (372)
Q Consensus       247 ------~~~------------~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~  307 (372)
                            ..+            ..........+..+.||+.+||. ||.+|+||++++                 +||||.
T Consensus       323 e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeAL-----------------kHpFF~  385 (418)
T KOG1167|consen  323 ELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDAL-----------------KHPFFD  385 (418)
T ss_pred             HHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHh-----------------cCcCCc
Confidence                  000            00011112456689999999999 999999999888                 999999


Q ss_pred             CCC
Q psy11571        308 GIA  310 (372)
Q Consensus       308 ~~~  310 (372)
                      ..+
T Consensus       386 ~~~  388 (418)
T KOG1167|consen  386 EAD  388 (418)
T ss_pred             chh
Confidence            553

>KOG1152|consensus

Probab=99.97  E-value=1.9e-31  Score=252.27  Aligned_cols=205  Identities=30%  Similarity=0.448  Sum_probs=174.0

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC---CCceeeeeE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD---RRWITNLHY   80 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~---hp~Iv~l~~   80 (372)
                      |..+..+|.|    ++|.|..+.+..+...|.+|.+.+...-..--+.  -..+-.+-.|+.+|..++   |+||+++++
T Consensus       563 yttlq~lG~G----AyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvr--DrkLGtVp~EIqIla~l~~~sH~NIlKlLd  636 (772)
T KOG1152|consen  563 YTTLQPLGEG----AYGKVNLAIHKENNYEVVIKMIFKERILVDTWVR--DRKLGTVPSEIQILATLNKHSHENILKLLD  636 (772)
T ss_pred             ceeeeecccc----ccceEEEeeecccceEEEeeehhhhhhhhhhhhc--ccccCccchhHHHHHHhhhcCccchhhhhh
Confidence            4456667776    7999999999999999999988776654331111  123455677999999887   999999999


Q ss_pred             EEEeCCeEEEEEecc-CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC
Q psy11571         81 AFQDDSNLYLVMDYY-CGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA  159 (372)
Q Consensus        81 ~~~~~~~~~lv~E~~-~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~  159 (372)
                      +|++++++||+||-- +|-+|.++|.. +..++|.+++.++.|++.|+++||+.||||          ||||-+|+.++.
T Consensus       637 fFEddd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivh----------rdikdenvivd~  705 (772)
T KOG1152|consen  637 FFEDDDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVH----------RDIKDENVIVDS  705 (772)
T ss_pred             eeecCCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCcee----------cccccccEEEec
Confidence            999999999999975 45699999987 688999999999999999999999999999          999999999999


Q ss_pred             CCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCC
Q psy11571        160 NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA  232 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~  232 (372)
                      +|-+||+|||.|.......   -..+.||..|.|||++.+    ....+..-|||+||++||.++....||..
T Consensus       706 ~g~~klidfgsaa~~ksgp---fd~f~gtv~~aapevl~g----~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  706 NGFVKLIDFGSAAYTKSGP---FDVFVGTVDYAAPEVLGG----EKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             CCeEEEeeccchhhhcCCC---cceeeeeccccchhhhCC----CccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            9999999999997765432   244789999999999985    55668889999999999999999999864

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=2.5e-30  Score=270.66  Aligned_cols=199  Identities=14%  Similarity=0.160  Sum_probs=144.2

Q ss_pred             CC-CceeeeeEEE-------EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCC
Q psy11571         71 DR-RWITNLHYAF-------QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHF  142 (372)
Q Consensus        71 ~h-p~Iv~l~~~~-------~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~  142 (372)
                      .| +||.+++++|       .....++++||++ +++|.+++......+++.+++.++.||+.||.|||++||+|     
T Consensus        30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvH-----  103 (793)
T PLN00181         30 SHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVV-----  103 (793)
T ss_pred             hHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeee-----
Confidence            44 5777777776       2334678889987 77999999764556999999999999999999999999999     


Q ss_pred             CCCcCCCCCcCcEEeCCCC-------------------cEEEeecCcccccCCCC---------------cccccccccC
Q psy11571        143 AFHLCRDIKPDNVLLDANG-------------------HIRLADFGSCLRLGGDG---------------TVQSNVAVGT  188 (372)
Q Consensus       143 ~~~vhrDlkp~NIll~~~~-------------------~vkl~Dfg~a~~~~~~~---------------~~~~~~~~gt  188 (372)
                           |||||+|||++..|                   .+|++|||+++......               ........||
T Consensus       104 -----rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt  178 (793)
T PLN00181        104 -----HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM  178 (793)
T ss_pred             -----ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence                 99999999996544                   45555666554321100               0001124588


Q ss_pred             CcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHH
Q psy11571        189 PDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMR  268 (372)
Q Consensus       189 ~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~  268 (372)
                      +.|||||++.+     ..++.++|||||||+||||++|.+|+....  ..+..+.....    |.... ...+...+++.
T Consensus       179 ~~Y~APE~~~~-----~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~----~~~~~-~~~~~~~~~~~  246 (793)
T PLN00181        179 SWYTSPEEDNG-----SSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL----PPQIL-LNWPKEASFCL  246 (793)
T ss_pred             cceEChhhhcc-----CCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc----Chhhh-hcCHHHHHHHH
Confidence            99999999983     568999999999999999999999875432  22222222111    11100 22456789999


Q ss_pred             Hhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        269 RLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       269 ~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      +||+ +|.+||++.+++                 +||||...
T Consensus       247 ~~L~~~P~~Rps~~eil-----------------~h~~~~~~  271 (793)
T PLN00181        247 WLLHPEPSCRPSMSELL-----------------QSEFINEP  271 (793)
T ss_pred             HhCCCChhhCcChHHHh-----------------hchhhhhh
Confidence            9999 999999877666                 99999753

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=1.1e-28  Score=218.94  Aligned_cols=205  Identities=33%  Similarity=0.490  Sum_probs=172.0

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      +++|.+|++....+++.+++|........         ...+.+.+|+..+..++|+|++++++.+......++++|+++
T Consensus        10 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221       10 GAFGKVYLARDKGTGELVAVKVLKKEKTE---------KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CCCeEEEEEEEcCCCcEEEEEeeccccch---------HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            47899999988878899999988765543         134567889999999999999999999999899999999999


Q ss_pred             CCCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccC
Q psy11571         97 GGDLLTLLSKFEDR-LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG  175 (372)
Q Consensus        97 gg~L~~~l~~~~~~-l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~  175 (372)
                      +++|.+++... .. +++..+..++.+++.++.+||+.+++|          +||+|.||+++.++.++|+|||.+....
T Consensus        81 ~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h----------~di~~~ni~v~~~~~~~l~d~g~~~~~~  149 (225)
T smart00221       81 GGDLFDYLRKK-GGKLSEEEARFYLRQILEALEYLHSLGIVH----------RDLKPENILLGMDGLVKLADFGLARFIH  149 (225)
T ss_pred             CCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeec----------CCCCHHHEEEcCCCCEEEeeCceeeEec
Confidence            99999999873 34 899999999999999999999999999          9999999999999999999999988765


Q ss_pred             CCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCC--CCHHHHHHHHhhc
Q psy11571        176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA--ESLVETYGKIMNH  245 (372)
Q Consensus       176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~--~~~~~~~~~i~~~  245 (372)
                      ...........++..|++||.+..    ...++.++|+||||+++++|++|+.||..  .+...+.+.|..+
T Consensus       150 ~~~~~~~~~~~~~~~~~~pe~~~~----~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~  217 (225)
T smart00221      150 RDLAALLKTVKGTPFYLAPEVLLG----GKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFG  217 (225)
T ss_pred             CcccccccceeccCCcCCHhHhcC----CCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcC
Confidence            432112233567889999999841    45677899999999999999999999987  3444566666554

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=3.5e-28  Score=212.17  Aligned_cols=208  Identities=33%  Similarity=0.546  Sum_probs=177.0

Q ss_pred             ccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         16 IQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        16 ~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      .+++|.+|++....+++.+++|.........         ..+.+.+|+..++.+.|++|+++++++......+++||++
T Consensus         3 ~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~---------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~   73 (215)
T cd00180           3 EGGFGTVYLARDKKTGKKVAIKIIKKEDSSS---------LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYC   73 (215)
T ss_pred             cCCceEEEEEEecCCCcEEEEEEeccccchh---------HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecC
Confidence            3478999999887779999999877655432         2355788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC-CCcEEEeecCccccc
Q psy11571         96 CGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA-NGHIRLADFGSCLRL  174 (372)
Q Consensus        96 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~-~~~vkl~Dfg~a~~~  174 (372)
                      .|++|.+++......++...+..++.+++.++.+||+.|++|          +||+|.||+++. ++.++|+|||.+...
T Consensus        74 ~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H----------~dl~~~ni~~~~~~~~~~l~d~~~~~~~  143 (215)
T cd00180          74 EGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIH----------RDLKPENILLDSDNGKVKLADFGLSKLL  143 (215)
T ss_pred             CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeec----------cCCCHhhEEEeCCCCcEEEecCCceEEc
Confidence            989999999873347899999999999999999999999999          999999999998 899999999999876


Q ss_pred             CCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCC
Q psy11571        175 GGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSD  254 (372)
Q Consensus       175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  254 (372)
                      ..... ......+...|++||.+..    ...++.++|+|++|+++++|                               
T Consensus       144 ~~~~~-~~~~~~~~~~~~~pe~~~~----~~~~~~~~D~~~lg~~~~~l-------------------------------  187 (215)
T cd00180         144 TSDKS-LLKTIVGTPAYMAPEVLLG----KGYYSEKSDIWSLGVILYEL-------------------------------  187 (215)
T ss_pred             cCCcc-hhhcccCCCCccChhHhcc----cCCCCchhhhHHHHHHHHHH-------------------------------
Confidence            44321 1222457889999999873    12678899999999999999                               


Q ss_pred             CCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        255 VGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       255 ~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                            ..+.+++.+|+. +|++||++.++.
T Consensus       188 ------~~~~~~l~~~l~~~p~~R~~~~~l~  212 (215)
T cd00180         188 ------PELKDLIRKMLQKDPEKRPSAKEIL  212 (215)
T ss_pred             ------HHHHHHHHHHhhCCcccCcCHHHHh
Confidence                  678999999999 999999876654

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345|consensus

Probab=99.96  E-value=2.7e-29  Score=218.39  Aligned_cols=244  Identities=20%  Similarity=0.292  Sum_probs=189.9

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHY   80 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~   80 (372)
                      +.|.....+|.|    -||.+-.+++..++..+++|.+......           ++.+.+|..---.| .|.||+.-|+
T Consensus        24 d~y~I~k~lgeG----~FgkIlL~eHr~s~t~ivlKavp~p~tt-----------~~dF~rEfhY~~~Ls~H~hIi~tY~   88 (378)
T KOG1345|consen   24 DVYTINKQLGEG----RFGKILLAEHRQSKTRIVLKAVPRPQTT-----------QADFVREFHYSFFLSPHQHIIDTYE   88 (378)
T ss_pred             hhhhHHHHhccc----ceeeEEeeeccCCceEEEeeccCcchhh-----------HHHHHHHhccceeeccchhhhHHHH
Confidence            456777777777    5888899999999999999987765543           34466777655445 4899998875


Q ss_pred             -EEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC-
Q psy11571         81 -AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD-  158 (372)
Q Consensus        81 -~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~-  158 (372)
                       .|++.+.++++|||++-|+|.+-+..  .++.|...+.++.|+++||.|+|+.++||          ||||.+||||- 
T Consensus        89 vaFqt~d~YvF~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVH----------RdlK~eNiLif~  156 (378)
T KOG1345|consen   89 VAFQTSDAYVFVQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVH----------RDLKAENILIFD  156 (378)
T ss_pred             HHhhcCceEEEeeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhh----------cccccceEEEec
Confidence             48888999999999999999998876  67999999999999999999999999999          99999999995 


Q ss_pred             -CCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH-
Q psy11571        159 -ANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-  236 (372)
Q Consensus       159 -~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-  236 (372)
                       +..+|||||||..+..+..-..    .--+..|.+||+......+.....+.+|+|.||+++|.++||.+||+..... 
T Consensus       157 ~df~rvKlcDFG~t~k~g~tV~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d  232 (378)
T KOG1345|consen  157 ADFYRVKLCDFGLTRKVGTTVKY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD  232 (378)
T ss_pred             CCccEEEeeecccccccCceehh----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC
Confidence             3348999999998765432111    2235679999998766656666789999999999999999999999854322 


Q ss_pred             ---HHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCC
Q psy11571        237 ---ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRL  278 (372)
Q Consensus       237 ---~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~  278 (372)
                         -.+.+...+ .....|... ..+|+.+..+.++-|. ++++|-
T Consensus       233 ~~Y~~~~~w~~r-k~~~~P~~F-~~fs~~a~r~Fkk~lt~~~~drc  276 (378)
T KOG1345|consen  233 KPYWEWEQWLKR-KNPALPKKF-NPFSEKALRLFKKSLTPRFKDRC  276 (378)
T ss_pred             chHHHHHHHhcc-cCccCchhh-cccCHHHHHHHHHhcCCcccccc
Confidence               222333322 223444433 3689999999999999 888884

>KOG2052|consensus

Probab=99.96  E-value=2.9e-29  Score=231.37  Aligned_cols=247  Identities=22%  Similarity=0.276  Sum_probs=175.2

Q ss_pred             ccCCccEEEeeeeh-hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHh--cCCCCceeeeeEEEEeCC----eE
Q psy11571         16 IQGKGRVFSIETLL-DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLV--YGDRRWITNLHYAFQDDS----NL   88 (372)
Q Consensus        16 ~~g~G~v~~v~~~~-~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~--~l~hp~Iv~l~~~~~~~~----~~   88 (372)
                      .+|+|++..|++.. .|..||+|.+....-.             ...+|.++.+  .++|+||+.+++.=..+.    .+
T Consensus       218 ~IGkGRyGEVwrG~wrGe~VAVKiF~srdE~-------------SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  218 IIGKGRFGEVWRGRWRGEDVAVKIFSSRDER-------------SWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             EecCccccceeeccccCCceEEEEecccchh-------------hhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence            35777777776644 7899999987653321             2345666664  479999999998754432    68


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeec
Q psy11571         89 YLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADF  168 (372)
Q Consensus        89 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Df  168 (372)
                      |||++|.+.|+|++||.+  ..++.+...+++..++.||++||.. |+-++ +..-|-|||||..||||.++|...|+|+
T Consensus       285 wLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~e-I~GTq-gKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHME-IVGTQ-GKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             EEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHH-HhcCC-CCchhhccccccccEEEccCCcEEEeec
Confidence            999999999999999987  7899999999999999999999963 11111 2222233999999999999999999999


Q ss_pred             CcccccCCCC---cccccccccCCcccCcccccccccCCCCC--CCccceeehhHHHHHHhhC----------CCCCCC-
Q psy11571        169 GSCLRLGGDG---TVQSNVAVGTPDYISPEILTAMEEGRGRY--GPECDWWSLGVCMYEMLYG----------ETPFYA-  232 (372)
Q Consensus       169 g~a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~--~~~~DiwslGvil~elltG----------~~Pf~~-  232 (372)
                      |+|.......   ....+..+||.+|||||++...-. ...+  -..+||||||.++||++..          ++||.+ 
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin-~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~  439 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETIN-MKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV  439 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhhhcC-hhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence            9998765432   123456799999999999973111 0111  1358999999999999842          578864 


Q ss_pred             ---C-CHHHHHHHHhhccCCcCCCCCCC-CCCCHHHHHHHHHhcc-CCCCCCCC
Q psy11571        233 ---E-SLVETYGKIMNHQNSFDLPSDVG-YEISDDAKDLMRRLIC-SSDTRLGQ  280 (372)
Q Consensus       233 ---~-~~~~~~~~i~~~~~~~~~~~~~~-~~~s~~~~~li~~lL~-~p~~R~s~  280 (372)
                         + +.+++..-+.-...++.+|.... ...-..+..+++.|+. ||.-|++|
T Consensus       440 Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltA  493 (513)
T KOG2052|consen  440 VPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTA  493 (513)
T ss_pred             CCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHH
Confidence               2 33344444444445555554321 1122345577899999 99999984

>KOG1024|consensus

Probab=99.95  E-value=1.8e-27  Score=216.25  Aligned_cols=242  Identities=17%  Similarity=0.209  Sum_probs=196.3

Q ss_pred             cCCccEEEee-----eehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC-CeEEE
Q psy11571         17 QGKGRVFSIE-----TLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDD-SNLYL   90 (372)
Q Consensus        17 ~g~G~v~~v~-----~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~-~~~~l   90 (372)
                      |.||+||.+.     ...+.+.|-+|.++.....-         .+..+..|.-++....|||+..+.++.... ...++
T Consensus       295 GtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~i---------Qv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V  365 (563)
T KOG1024|consen  295 GTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQI---------QVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFV  365 (563)
T ss_pred             CchhheeeeeecccCCcchHHHHHHHHHHhcccHH---------HHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceE
Confidence            3688888873     23356778888777665443         355677899999999999999999887544 56788


Q ss_pred             EEeccCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcE
Q psy11571         91 VMDYYCGGDLLTLLSKFE-------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI  163 (372)
Q Consensus        91 v~E~~~gg~L~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~v  163 (372)
                      ++.+..-|+|..++..++       ..++..+...++.|++.|++|||++|+||          .||...|++||+.-++
T Consensus       366 ~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViH----------kDiAaRNCvIdd~LqV  435 (563)
T KOG1024|consen  366 LYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIH----------KDIAARNCVIDDQLQV  435 (563)
T ss_pred             EEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCccc----------chhhhhcceehhheeE
Confidence            889998899999998432       24677788899999999999999999999          9999999999999999


Q ss_pred             EEeecCcccccCCCC-cccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHH
Q psy11571        164 RLADFGSCLRLGGDG-TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGK  241 (372)
Q Consensus       164 kl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~  241 (372)
                      ||+|-.+++.+-..+ ......--....|||||.+.     ...|+.++|+|||||+||||+| |+.|+...++.++..-
T Consensus       436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~-----n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y  510 (563)
T KOG1024|consen  436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQ-----NSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY  510 (563)
T ss_pred             EeccchhccccCcccccccCCCCCCcccccCHHHHh-----hhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH
Confidence            999999998653221 11111122356899999998     4789999999999999999997 9999999999998877


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      +..+ .++..|.    ++++++..++.-|+. .|++||+.+++...+
T Consensus       511 lkdG-yRlaQP~----NCPDeLf~vMacCWallpeeRPsf~Qlv~cL  552 (563)
T KOG1024|consen  511 LKDG-YRLAQPF----NCPDELFTVMACCWALLPEERPSFSQLVICL  552 (563)
T ss_pred             Hhcc-ceecCCC----CCcHHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence            7665 5566566    899999999999999 999999998876554

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=3.5e-28  Score=208.54  Aligned_cols=158  Identities=23%  Similarity=0.273  Sum_probs=121.8

Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCC
Q psy11571         98 GDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD  177 (372)
Q Consensus        98 g~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  177 (372)
                      |+|.+++...+..+++..++.++.||+.||.|||+.              +  ||+|||++.++.+++  ||+++.....
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~--------------~--kp~Nil~~~~~~~~~--fG~~~~~~~~   62 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ--------------A--KSGNILLTWDGLLKL--DGSVAFKTPE   62 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc--------------C--CcccEeEcCccceee--ccceEeeccc
Confidence            789999987556799999999999999999999984              2  999999999999999  9998765432


Q ss_pred             CcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH-HHHHHHhhccCCcCCCC-CC
Q psy11571        178 GTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKIMNHQNSFDLPS-DV  255 (372)
Q Consensus       178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~-~~  255 (372)
                      .      ..||+.|+|||++.+     ..++.++|||||||++|||++|+.||...... ..+..+........... ..
T Consensus        63 ~------~~g~~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  131 (176)
T smart00750       63 Q------SRVDPYFMAPEVIQG-----QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSN  131 (176)
T ss_pred             c------CCCcccccChHHhcC-----CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcccccc
Confidence            1      258999999999983     56889999999999999999999999765432 33333333221111000 01


Q ss_pred             CCCCCH--HHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        256 GYEISD--DAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       256 ~~~~s~--~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      ...++.  +++++|.+||. +|.+||++.++.
T Consensus       132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll  163 (176)
T smart00750      132 LESVSAARSFADFMRVCASRLPQRREAANHYL  163 (176)
T ss_pred             HHHHHhhhhHHHHHHHHHhcccccccCHHHHH
Confidence            112334  69999999999 999999877666

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590|consensus

Probab=99.94  E-value=1.5e-28  Score=246.14  Aligned_cols=256  Identities=20%  Similarity=0.313  Sum_probs=195.2

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccCC
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCG   97 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~g   97 (372)
                      .+|.++.+.+.......+.|..... ..   ....+......+..|..+-..+.|||++.....+.+....+-.||||++
T Consensus       330 a~g~~~~~~~~~~~~~~~~~~~r~~-~~---~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~  405 (601)
T KOG0590|consen  330 AYGSVRIAKRRSDLKSFPEKEFRVR-VK---PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY  405 (601)
T ss_pred             ccCceEEEEecCCCccchhhhhhcc-cC---CcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhcccH
Confidence            4556778888878888888876633 11   1111122333377888888899999998888877777666666999999


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCC
Q psy11571         98 GDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD  177 (372)
Q Consensus        98 g~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  177 (372)
                       +|..++.. .+.+...++..++.|++.|+.|+|++|+.|          ||+||+|++++.+|.+||+|||.+......
T Consensus       406 -Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~Giah----------rdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  406 -DLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAH----------RDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             -HHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCcee----------ccCccccEEEecCCceEEeecCcceeeccC
Confidence             99999987 468999999999999999999999999999          999999999999999999999988765433


Q ss_pred             Cc---ccccccccCCcccCcccccccccCCCCC-CCccceeehhHHHHHHhhCCCCCCCCCHHHHH--H-HHhhccCCcC
Q psy11571        178 GT---VQSNVAVGTPDYISPEILTAMEEGRGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETY--G-KIMNHQNSFD  250 (372)
Q Consensus       178 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~--~-~i~~~~~~~~  250 (372)
                      ..   ......+|+..|+|||++.+     ..| ...+||||.|++++.|.+|+.||......+..  . .-..+.....
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~-----~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~  548 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTG-----KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFE  548 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccc-----cccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccccccccc
Confidence            22   33455789999999999984     344 45799999999999999999999765433221  1 1111111112


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCc
Q psy11571        251 LPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAW  311 (372)
Q Consensus       251 ~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w  311 (372)
                      -+......++...+.+|.+||+ +|.+|.++++|+                 +.+||+.++=
T Consensus       549 ~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~-----------------~d~W~~~i~~  593 (601)
T KOG0590|consen  549 GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQIL-----------------NDEWIRSIEC  593 (601)
T ss_pred             ChHHHHHhchhhHHHHHHHHccCChhheecHHHHh-----------------hChHhhhcce
Confidence            2233334688999999999999 999999866665                 9999998763

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=4.9e-23  Score=190.99  Aligned_cols=245  Identities=32%  Similarity=0.510  Sum_probs=187.5

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCC-ceeeeeEEEEeCCeEEEEEecc
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRR-WITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp-~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      +++|.||.+.+.   ..+++|.+........       .....+.+|..++..+.|+ +|+++++.+......+++++++
T Consensus        11 g~~~~v~~~~~~---~~~~~k~~~~~~~~~~-------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~   80 (384)
T COG0515          11 GSFGEVYLARDR---KLVALKVLAKKLESKS-------KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV   80 (384)
T ss_pred             CCCeEEEEEEec---cEEEEEeechhhccch-------hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence            378888888766   5666666655444332       3456678899999999988 7999999998888889999999


Q ss_pred             CCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC-cEEEeecCccc
Q psy11571         96 CGGDLLTLLSKFE--DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG-HIRLADFGSCL  172 (372)
Q Consensus        96 ~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~-~vkl~Dfg~a~  172 (372)
                      .+++|.+++....  ..+++..+..++.|++.++.++|+.+++|          ||+||+||+++..+ .++++|||.+.
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~h----------rd~kp~nil~~~~~~~~~l~dfg~~~  150 (384)
T COG0515          81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIH----------RDIKPENILLDRDGRVVKLIDFGLAK  150 (384)
T ss_pred             CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeec----------cCCCHHHeeecCCCCeEEEeccCcce
Confidence            9999998877632  27999999999999999999999999999          99999999999888 79999999998


Q ss_pred             ccCCCCcc-----cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCH----HHHHHHHh
Q psy11571        173 RLGGDGTV-----QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL----VETYGKIM  243 (372)
Q Consensus       173 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~----~~~~~~i~  243 (372)
                      ........     ......||..|+|||.+.+..  ...++...|+||+|++++++++|..||.....    ......+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~--~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  228 (384)
T COG0515         151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS--LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL  228 (384)
T ss_pred             ecCCCCccccccccccccccccccCCHHHhcCCC--CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHH
Confidence            65443321     234578999999999997310  04678899999999999999999999887763    44444444


Q ss_pred             hccCCcCCCCCCCCCC----CHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        244 NHQNSFDLPSDVGYEI----SDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~----s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      ..... ..........    ...+.+++.+++. +|..|.+.....
T Consensus       229 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~  273 (384)
T COG0515         229 ELPTP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL  273 (384)
T ss_pred             hcCCc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHh
Confidence            43222 0111111011    2689999999999 999999865433

>KOG1164|consensus

Probab=99.90  E-value=5e-23  Score=193.74  Aligned_cols=253  Identities=19%  Similarity=0.202  Sum_probs=183.7

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhh-hhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC----CCceee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDI-LLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD----RRWITN   77 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~-~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~----hp~Iv~   77 (372)
                      +|+....+|.|    |+|.||.|.+..++ ..+|+|..........          ..+..|..++..+.    .+++.+
T Consensus        19 ~~~i~~~iG~G----~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~----------~~l~~E~~vl~~l~~~~~~~~~~~   84 (322)
T KOG1164|consen   19 RYKLGKKIGEG----GFGAVYLVSDKSEKNKEYAKKLEKKELGSKP----------SVLKIEIQVLKKLEKKNGPSHFPK   84 (322)
T ss_pred             ceEEeeecccc----CCceEEEEEecCCCCeeEEEEEEEecccCCC----------ccchhHHHHHHHHhhhcCCCCCCE
Confidence            45555666666    89999999987774 5777776655433221          12556777777665    368999


Q ss_pred             eeEEE-EeCCeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcE
Q psy11571         78 LHYAF-QDDSNLYLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNV  155 (372)
Q Consensus        78 l~~~~-~~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NI  155 (372)
                      +++.. ..+..-|+||+.+ |.+|.++..... +.++...+..++.|++.+|++||+.|++|          |||||+|+
T Consensus        85 ~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iH----------RDiKp~N~  153 (322)
T KOG1164|consen   85 LLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIH----------RDIKPENF  153 (322)
T ss_pred             EEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCccc----------CCcCHHHe
Confidence            99999 5777889999997 999999886654 68999999999999999999999999999          99999999


Q ss_pred             EeCCC-----CcEEEeecCccc--ccC-CCCc------ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHH
Q psy11571        156 LLDAN-----GHIRLADFGSCL--RLG-GDGT------VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMY  221 (372)
Q Consensus       156 ll~~~-----~~vkl~Dfg~a~--~~~-~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~  221 (372)
                      ++...     ..+.|.|||+++  ... ..+.      .....+.||..|+++.+..+     ...+.+.|+||++.++.
T Consensus       154 ~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-----~e~~r~DDles~~Y~l~  228 (322)
T KOG1164|consen  154 VVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-----IEQGRRDDLESLFYMLL  228 (322)
T ss_pred             eecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCC-----CccCCchhhhhHHHHHH
Confidence            99855     358999999998  321 1111      11233569999999999884     56788999999999999


Q ss_pred             HHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhh
Q psy11571        222 EMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADF  286 (372)
Q Consensus       222 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i  286 (372)
                      +++.|..||.+........++........... .....+.+..++...+-. +...+|....+..+
T Consensus       229 el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  229 ELLKGSLPWEALEMTDLKSKFEKDPRKLLTDR-FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             HHhcCCCCCccccccchHHHHHHHhhhhcccc-ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            99999999977653322333222211111111 111345667777776666 78888876555443

>KOG1163|consensus

Probab=99.90  E-value=9.1e-24  Score=181.24  Aligned_cols=274  Identities=20%  Similarity=0.190  Sum_probs=211.0

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCC-CceeeeeEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDR-RWITNLHYAF   82 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~h-p~Iv~l~~~~   82 (372)
                      |+.+.++|.|    +||.+|.+..+.+|..||+|.-........            +..|..+...+.+ ..|..+..++
T Consensus        17 y~lvrkiGsG----SFGdIy~~~~i~~ge~VAiK~Es~~a~hpq------------L~yEskvY~iL~~g~GiP~i~~y~   80 (341)
T KOG1163|consen   17 YKLVRKIGSG----SFGDIYLGISITSGEEVAIKLESSKAKHPQ------------LLYESKVYRILQGGVGIPHIRHYG   80 (341)
T ss_pred             eEEEEeecCC----chhheeeeeeccCCceEEEEeecccCCCcc------------hhHHHHHHHHhccCCCCchhhhhc
Confidence            4445556666    799999999999999999997666554433            5668888888764 7888888888


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC---
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA---  159 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~---  159 (372)
                      .+..+-.+||+.+ |.+|.+++.-+...++...+..++-|++.-++|+|.++++|          |||||+|.|..-   
T Consensus        81 ~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiH----------RDIKPdNFLMGlgrh  149 (341)
T KOG1163|consen   81 TEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIH----------RDIKPDNFLMGLGRH  149 (341)
T ss_pred             cccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhcccc----------ccCCccceeeccccc
Confidence            8888899999998 99999999887788999999999999999999999999999          999999999963   


Q ss_pred             CCcEEEeecCcccccCCCCcc------cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC
Q psy11571        160 NGHIRLADFGSCLRLGGDGTV------QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE  233 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~  233 (372)
                      ...+.|+|||+|+...+..+.      ......||..|.+--...+     ...+...|+=|+|.+|..+..|..||++.
T Consensus       150 ~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g-----~eqSRRDDmeSvgYvLmYfnrG~LPWQgl  224 (341)
T KOG1163|consen  150 CNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLG-----IEQSRRDDMESVGYVLMYFNRGSLPWQGL  224 (341)
T ss_pred             cceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhh-----hhhhhhhhhhhhcceeeeeecCCCccccc
Confidence            357899999999876542221      1233579999998877764     34567889999999999999999999985


Q ss_pred             ---CHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCC
Q psy11571        234 ---SLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       234 ---~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~  310 (372)
                         +..+.+++|.+...+.+ +......++.+..-.+.-|-.     +++++--+..+++.+++++.... +|.+=--.|
T Consensus       225 ka~tk~QKyEkI~EkK~s~~-ie~LC~G~P~EF~myl~Y~R~-----L~F~E~Pdy~ylrqlFriLfr~l-n~~~d~iyD  297 (341)
T KOG1163|consen  225 KAATKKQKYEKISEKKMSTP-IEVLCKGFPAEFAMYLNYCRG-----LGFEEKPDYMYLRQLFRILFRTL-NHQYDYIYD  297 (341)
T ss_pred             chhhHHHHHHHHHHhhcCCC-HHHHhCCCcHHHHHHHHHHhh-----cCCCCCCcHHHHHHHHHHHHhhc-cccCCeEee
Confidence               34456677776544332 223334778888888887744     33333346667777778777766 666655689


Q ss_pred             cccccc
Q psy11571        311 WDSIRD  316 (372)
Q Consensus       311 w~~~~~  316 (372)
                      |+.+++
T Consensus       298 W~~lkq  303 (341)
T KOG1163|consen  298 WTMLKQ  303 (341)
T ss_pred             HHHHHH
Confidence            998854

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=5.6e-23  Score=193.99  Aligned_cols=166  Identities=16%  Similarity=0.034  Sum_probs=122.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeeh-hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceee-eeE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLL-DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITN-LHY   80 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~-~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~-l~~   80 (372)
                      +|+..+.+|.|    |+|.||++.... +++.+|+|...........     ....+.+.+|+.+|+.++|+||+. +++
T Consensus        19 ~Y~~~~~IG~G----~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~-----~~~~~~~~~E~~iL~~L~h~~iv~~l~~   89 (365)
T PRK09188         19 RFVETAVLKRD----VFSTVERGYFAGDPGTARAVRRRVSEVPWWSK-----PLARHLAAREIRALKTVRGIGVVPQLLA   89 (365)
T ss_pred             CceEccEEeec----CcEEEEEEEEcCCCCeEEEEEEeccccccccc-----HHHHHHHHHHHHHHHhccCCCCCcEEEE
Confidence            45555666666    899999997765 6777899875422110000     112355889999999999999985 443


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCC-CcCcEEeCC
Q psy11571         81 AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDI-KPDNVLLDA  159 (372)
Q Consensus        81 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDl-kp~NIll~~  159 (372)
                      .    +..|+|||||+|++|.. +..    ..   ...++.|++.+|.|||++||+|          ||| ||+|||++.
T Consensus        90 ~----~~~~LVmE~~~G~~L~~-~~~----~~---~~~~~~~i~~aL~~lH~~gIiH----------rDL~KP~NILv~~  147 (365)
T PRK09188         90 T----GKDGLVRGWTEGVPLHL-ARP----HG---DPAWFRSAHRALRDLHRAGITH----------NDLAKPQNWLMGP  147 (365)
T ss_pred             c----CCcEEEEEccCCCCHHH-hCc----cc---hHHHHHHHHHHHHHHHHCCCee----------CCCCCcceEEEcC
Confidence            2    45799999999999963 211    11   1467899999999999999999          999 999999999


Q ss_pred             CCcEEEeecCcccccCCCCcccc-------cccccCCcccCcccccc
Q psy11571        160 NGHIRLADFGSCLRLGGDGTVQS-------NVAVGTPDYISPEILTA  199 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~  199 (372)
                      ++.++|+|||+|+.....+....       ....+++.|+|||.+..
T Consensus       148 ~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        148 DGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             CCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            99999999999987654332111       24568889999999873

>KOG4158|consensus

Probab=99.88  E-value=1.5e-22  Score=185.02  Aligned_cols=200  Identities=27%  Similarity=0.412  Sum_probs=151.8

Q ss_pred             CCCceeeeeEEEEe---------------------------CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHH
Q psy11571         71 DRRWITNLHYAFQD---------------------------DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEM  123 (372)
Q Consensus        71 ~hp~Iv~l~~~~~~---------------------------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi  123 (372)
                      .|||||++..+|.+                           +..+|+||.-+ ..+|.+++-.  ...+....+.++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~--~~~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT--RHRSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc--CCCchHHHHHHHHHH
Confidence            59999999988854                           23589999987 5699999986  567888899999999


Q ss_pred             HHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC--CCC--cEEEeecCcccccCCCCc-----ccccccccCCcccCc
Q psy11571        124 VLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD--ANG--HIRLADFGSCLRLGGDGT-----VQSNVAVGTPDYISP  194 (372)
Q Consensus       124 ~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~--~~~--~vkl~Dfg~a~~~~~~~~-----~~~~~~~gt~~y~aP  194 (372)
                      ++|+.|||.+|+.|          ||+|.+|||+.  +++  .+.|+|||.+---...+.     ...-..-|...-|||
T Consensus       351 LEav~hL~~hgvAh----------RDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAP  420 (598)
T KOG4158|consen  351 LEAVTHLHKHGVAH----------RDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAP  420 (598)
T ss_pred             HHHHHHHHHccchh----------hcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecch
Confidence            99999999999999          99999999994  443  578999998754322111     111223577789999


Q ss_pred             ccccccccCCCCCC-CccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-
Q psy11571        195 EILTAMEEGRGRYG-PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-  272 (372)
Q Consensus       195 E~~~~~~~~~~~~~-~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-  272 (372)
                      |+...++......+ .++|.|+.|.+.||+++...||.+..+..+-.+-.+...-+.+|+    .+++.+++|+..+|+ 
T Consensus       421 Ei~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~----~vpp~~rqlV~~lL~r  496 (598)
T KOG4158|consen  421 EIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPS----RVPPVARQLVFDLLKR  496 (598)
T ss_pred             hhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcc----cCChHHHHHHHHHhcC
Confidence            99986654332222 479999999999999999999998554433222223333344555    789999999999999 


Q ss_pred             CCCCCCCCCChhhhh
Q psy11571        273 SSDTRLGQNGIADFK  287 (372)
Q Consensus       273 ~p~~R~s~~~~~~i~  287 (372)
                      ||++|++++-+..++
T Consensus       497 ~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  497 DPSKRVSPNIAANVL  511 (598)
T ss_pred             CccccCCccHHHhHH
Confidence            999999976555544

>KOG1165|consensus

Probab=99.87  E-value=3.2e-22  Score=178.99  Aligned_cols=201  Identities=25%  Similarity=0.286  Sum_probs=167.8

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      .||..+..+.+.++..||||.--.+.-.            -+++.|....+.|. .+.|...|++.+.+.+-.||||++ 
T Consensus        40 sFG~lf~G~Nl~nne~VAIKfEPrkS~A------------PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-  106 (449)
T KOG1165|consen   40 SFGVLFLGKNLYNNEPVAIKFEPRKSEA------------PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-  106 (449)
T ss_pred             cceeeecccccccCceEEEEeccccCCc------------chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence            5777778888889999999965443322            34777888888775 799999999999998999999998 


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC-----cEEEeecCcc
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG-----HIRLADFGSC  171 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~-----~vkl~Dfg~a  171 (372)
                      |.+|.++..-++.+++...+..++.|++.-++++|++.+|.          |||||+|.||...+     .|.++|||+|
T Consensus       107 GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIY----------RDIKPdNFLIGrp~~k~~n~IhiiDFGmA  176 (449)
T KOG1165|consen  107 GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIY----------RDIKPDNFLIGRPGTKDANVIHIIDFGMA  176 (449)
T ss_pred             CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceee----------cccCccceeecCCCCCCCceEEEEeccch
Confidence            99999999988889999999999999999999999999999          99999999997443     5899999999


Q ss_pred             cccCCCCccc------ccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCC---CCHHHHHHHH
Q psy11571        172 LRLGGDGTVQ------SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA---ESLVETYGKI  242 (372)
Q Consensus       172 ~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~---~~~~~~~~~i  242 (372)
                      +......+..      .....||..||+--...+     +..+...|+=|||-++...+.|..||.+   .+..+.+++|
T Consensus       177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG-----rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI  251 (449)
T KOG1165|consen  177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLG-----REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI  251 (449)
T ss_pred             hhhcCccccccCccccccccccceeeeEeecccc-----chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence            9876554321      223579999999888874     5678889999999999999999999987   4566777777


Q ss_pred             hhcc
Q psy11571        243 MNHQ  246 (372)
Q Consensus       243 ~~~~  246 (372)
                      -...
T Consensus       252 Ge~K  255 (449)
T KOG1165|consen  252 GETK  255 (449)
T ss_pred             cccc
Confidence            6543

>KOG0606|consensus

Probab=99.87  E-value=1.1e-22  Score=204.90  Aligned_cols=281  Identities=32%  Similarity=0.504  Sum_probs=223.8

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccCC
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCG   97 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~g   97 (372)
                      ..|+++.+...-.+...+.|.......-..       ...+.++.+..++....||.+++....+.-....+++|+|+.+
T Consensus       816 sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~-------~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~  888 (1205)
T KOG0606|consen  816 SPSSSFPASPAGSGHTRPSKVHGLAPKIRT-------NDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNG  888 (1205)
T ss_pred             CCcccccCCccccccccchhhhccchhhcc-------ccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhcc
Confidence            556666666555565555554443332222       1234455666666667789999888887777889999999999


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCC
Q psy11571         98 GDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD  177 (372)
Q Consensus        98 g~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  177 (372)
                      ++|...+++ .+..+++.++.++..+.+++++||+..+.|          ||++|.|+++..+|+.++.|||.....+.-
T Consensus       889 ~~~~Skl~~-~~~~saepaRs~i~~~vqs~e~L~s~~r~h----------~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  889 GDLPSKLHN-SGCLSAEPARSPILERVQSLESLHSSLRKH----------RDLKPDSLLIAYDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             CCchhhhhc-CCCcccccccchhHHHHhhhhccccchhhc----------ccccccchhhcccCCcccCccccccccccc
Confidence            999999988 467888999999999999999999998999          999999999999999999999844332110


Q ss_pred             ------------------------------CcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCC
Q psy11571        178 ------------------------------GTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGE  227 (372)
Q Consensus       178 ------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~  227 (372)
                                                    .........||+.|.+||.+.+     ......+|||++|++++|.++|.
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-----~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-----RRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-----ccCCCcchhhhhhhhhhhhhcCC
Confidence                                          0011233568999999999985     55778899999999999999999


Q ss_pred             CCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCc
Q psy11571        228 TPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWF  306 (372)
Q Consensus       228 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f  306 (372)
                      +||.......++.+|.......+.-.   ...+..+++++.++|. +|.+|.++....+++              .||||
T Consensus      1033 pp~na~tpq~~f~ni~~~~~~~p~g~---~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k--------------~~~~~ 1095 (1205)
T KOG0606|consen 1033 PPFNAETPQQIFENILNRDIPWPEGP---EEGSYEAQDLINRLLTEEPTQRLGAKGAAEVK--------------GHPFF 1095 (1205)
T ss_pred             CCCCCcchhhhhhccccCCCCCCCCc---cccChhhhhhhhhhhccCchhccCcccccccc--------------cCCcc
Confidence            99999999999999988664433222   2679999999999999 999999988777766              99999


Q ss_pred             CCCCccccccCCCCCcCCCCCCCCCCCCCCCc
Q psy11571        307 QGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDE  338 (372)
Q Consensus       307 ~~~~w~~~~~~~~p~~p~~~~~~~~~~~~~~~  338 (372)
                      ++++|+.+.....+|+|...+..|+++|....
T Consensus      1096 ~~~~~~~l~~q~~~~~p~~~s~~dtS~~~~r~ 1127 (1205)
T KOG0606|consen 1096 QDVDWENLALQKAEFVPQPESTQDTSYFESRF 1127 (1205)
T ss_pred             CCCCccccccccCccCCCCCCCCccchhhccc
Confidence            99999999988999999999999999885533

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.86  E-value=3.6e-22  Score=176.01  Aligned_cols=177  Identities=16%  Similarity=0.176  Sum_probs=131.0

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      ||+.+..++.|    |+|.||.+..  ++..+++|.+.......+.....+.. .+.+.+|+..+.++.||+|.....++
T Consensus        32 ~y~~~~~l~~~----~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~-g~~~e~Ea~~l~rL~~~GI~~~~d~~  104 (232)
T PRK10359         32 NIKTIKVFRNI----DDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVK-GDYYENLIVQTDRVRSEGLASLNDFY  104 (232)
T ss_pred             ceEEEEEecCC----CceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhh-hHHHHHHHHHHHHHHHCCCCcceEee
Confidence            44445555544    8999999755  46789999887766555433333222 34478899999999999999999887


Q ss_pred             EeC--------CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCc
Q psy11571         83 QDD--------SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDN  154 (372)
Q Consensus        83 ~~~--------~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~N  154 (372)
                      ...        ...+++|||++|.+|.++..     +++.    ...+++.+|..+|+.|++|          ||+||.|
T Consensus       105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~~----~~~~i~~~l~~lH~~gi~H----------~Dikp~N  165 (232)
T PRK10359        105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISED----VKAKIKASIESLHQHGMVS----------GDPHKGN  165 (232)
T ss_pred             eecccccccccCCeEEEEEEECCccHHHhhh-----ccHH----HHHHHHHHHHHHHHcCCcc----------CCCChHH
Confidence            644        35789999999999988732     2332    4569999999999999999          9999999


Q ss_pred             EEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHh
Q psy11571        155 VLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML  224 (372)
Q Consensus       155 Ill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ell  224 (372)
                      |+++.+| ++|+|||...........             ..++.     ...++.++|+||||+++..+.
T Consensus       166 ili~~~g-i~liDfg~~~~~~e~~a~-------------d~~vl-----er~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        166 FIVSKNG-LRIIDLSGKRCTAQRKAK-------------DRIDL-----ERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEeCCC-EEEEECCCcccccchhhH-------------HHHHH-----HhHhcccccccceeEeehHHH
Confidence            9999888 999999987654322111             01233     245668999999999987554

>KOG0195|consensus

Probab=99.85  E-value=1.5e-21  Score=170.34  Aligned_cols=207  Identities=21%  Similarity=0.240  Sum_probs=168.0

Q ss_pred             HHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhcC-c
Q psy11571         58 AKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFED-RLPEDMAKFYIAEMVLAIASIHDLH-Y  135 (372)
Q Consensus        58 ~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~~L~~LH~~~-i  135 (372)
                      ..+.+|.--|+...||||+.+++.+....++.++..|++.|+|+..+....+ ..+..++.+++.+++.|++|||+.. +
T Consensus       232 rdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~  311 (448)
T KOG0195|consen  232 RDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPM  311 (448)
T ss_pred             chhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchh
Confidence            4578899999999999999999999999999999999999999999987322 3577899999999999999999864 2


Q ss_pred             eecCCCCCCCcCCCCCcCcEEeCCCCcEEEe--ecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccce
Q psy11571        136 VHRPNHFAFHLCRDIKPDNVLLDANGHIRLA--DFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDW  213 (372)
Q Consensus       136 vH~~~~~~~~vhrDlkp~NIll~~~~~vkl~--Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Di  213 (372)
                      +-       .  --|....+++|++-+.+|.  |--++..        .....-.|.||+||.++..++  ...-.++|+
T Consensus       312 ip-------r--~~lns~hvmidedltarismad~kfsfq--------e~gr~y~pawmspealqrkpe--d~n~raadm  372 (448)
T KOG0195|consen  312 IP-------R--FYLNSKHVMIDEDLTARISMADTKFSFQ--------EVGRAYSPAWMSPEALQRKPE--DLNIRAADM  372 (448)
T ss_pred             hh-------h--hhcccceEEecchhhhheecccceeeee--------ccccccCcccCCHHHHhcCch--hcchhhhhH
Confidence            22       1  3488899999988766653  4332211        111234789999999985432  223458999


Q ss_pred             eehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        214 WSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       214 wslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      |||+++++|+.|...||...++.+.-.+|.-...+..+|+    .++.....|++-|++ ||.+||.++.+.-|+
T Consensus       373 wsfaillwel~trevpfadlspmecgmkialeglrv~ipp----gis~hm~klm~icmnedpgkrpkfdmivpil  443 (448)
T KOG0195|consen  373 WSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPP----GISRHMNKLMNICMNEDPGKRPKFDMIVPIL  443 (448)
T ss_pred             HHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCC----CccHHHHHHHHHHhcCCCCcCCCcceehhhH
Confidence            9999999999999999999999998888877777788887    899999999999999 999999988776554

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=1.3e-20  Score=162.96  Aligned_cols=185  Identities=15%  Similarity=0.141  Sum_probs=135.8

Q ss_pred             ccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCeEEEEEec
Q psy11571         16 IQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLHYAFQDDSNLYLVMDY   94 (372)
Q Consensus        16 ~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv~E~   94 (372)
                      .+|||+|+.+.+  .+..++.+.+.....-...      -....+.+|+.+|+++. |++|++++++    +..|++|||
T Consensus        12 ~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~------~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274         12 SDTFGRILLVRG--GERKFVRRDLSAAPWWLRG------VAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             CCCcceEEEeec--CCceeeecccccchhhhhh------HHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            458999997755  6667776655554432211      01235788999999995 5889999886    346999999


Q ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCC-CcCcEEeCCCCcEEEeecCcccc
Q psy11571         95 YCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDI-KPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus        95 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDl-kp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                      +.|.+|.+.+..  +      ...++.|++.+|.++|++||+|          ||| ||+|||++.+|.++|+|||+|..
T Consensus        80 I~G~~L~~~~~~--~------~~~~~~qi~~~L~~lH~~GIvH----------rDL~kp~NILv~~~g~i~LIDFG~A~~  141 (218)
T PRK12274         80 LAGAAMYQRPPR--G------DLAYFRAARRLLQQLHRCGVAH----------NDLAKEANWLVQEDGSPAVIDFQLAVR  141 (218)
T ss_pred             ecCccHHhhhhh--h------hHHHHHHHHHHHHHHHHCcCcc----------CCCCCcceEEEcCCCCEEEEECCCcee
Confidence            999999765422  1      1347789999999999999999          999 79999999999999999999986


Q ss_pred             cCCCCcc----c--------ccccccCCcccCcccccccccCCCCCC-CccceeehhHHHHHHhhCCCCCCCCC
Q psy11571        174 LGGDGTV----Q--------SNVAVGTPDYISPEILTAMEEGRGRYG-PECDWWSLGVCMYEMLYGETPFYAES  234 (372)
Q Consensus       174 ~~~~~~~----~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~DiwslGvil~elltG~~Pf~~~~  234 (372)
                      .......    .        ......++.|++|+.....    ...+ ...+|++.|+-+|.++||..++.+++
T Consensus       142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l----~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVL----KRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhh----ccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            5443310    0        1112357888888865421    1222 46789999999999999999987665

>KOG1240|consensus

Probab=99.84  E-value=3.1e-22  Score=202.08  Aligned_cols=236  Identities=21%  Similarity=0.256  Sum_probs=171.4

Q ss_pred             cccCCccEEEeeeehhh-hhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEe
Q psy11571         15 PIQGKGRVFSIETLLDI-LLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMD   93 (372)
Q Consensus        15 ~~~g~G~v~~v~~~~~~-~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E   93 (372)
                      ..+|.+++.++-+.++. -.|.+|++.+..-.-  ....   +.+++. |+. ...+++||++.+..+..+....|+|-+
T Consensus        29 ~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~--sL~~---~~qrL~-~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   29 ENLGSTRFLKVARAKDREGLVVVKVFVKQDPTI--SLRP---FKQRLE-EIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             cccCchhhhhhhhccCCCceEEEEEEeccCCCC--CchH---HHHHHH-HHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            45688888888776653 357778775544221  1111   223333 333 667789999999999888888899999


Q ss_pred             ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571         94 YYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus        94 ~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                      |. .-+|++.+.. +.-+..-+.+.|+-|++.||..+|..||+|          +|||.+||||++-+-+.|+||..-+.
T Consensus       102 yv-khnLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~gVcH----------GDIKsENILiTSWNW~~LtDFAsFKP  169 (1431)
T KOG1240|consen  102 YV-KHNLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKLGVCH----------GDIKSENILITSWNWLYLTDFASFKP  169 (1431)
T ss_pred             HH-hhhhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHcCccc----------cccccceEEEeeechhhhhcccccCC
Confidence            98 5599999987 566788999999999999999999999999          99999999999999999999987653


Q ss_pred             c--CCCCccccc----ccccCCcccCcccccccc------cCCCCCCCccceeehhHHHHHHhh-CCCCCCC--------
Q psy11571        174 L--GGDGTVQSN----VAVGTPDYISPEILTAME------EGRGRYGPECDWWSLGVCMYEMLY-GETPFYA--------  232 (372)
Q Consensus       174 ~--~~~~~~~~~----~~~gt~~y~aPE~~~~~~------~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~--------  232 (372)
                      .  ..++....+    +...-.+|.|||.+....      +.....+++.||||+||++.||++ |++||.-        
T Consensus       170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~  249 (1431)
T KOG1240|consen  170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRS  249 (1431)
T ss_pred             ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhc
Confidence            2  222221111    112335899999986411      111236789999999999999997 7899841        


Q ss_pred             ---CCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhh
Q psy11571        233 ---ESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIAD  285 (372)
Q Consensus       233 ---~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~  285 (372)
                         .+.+..+++|                -+..++.||..|++ ||++|++|++.++
T Consensus       250 ~~~~~~e~~Le~I----------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~  290 (1431)
T KOG1240|consen  250 GNADDPEQLLEKI----------------EDVSLRNLILSMIQRDPSKRLSAEDYLQ  290 (1431)
T ss_pred             cCccCHHHHHHhC----------------cCccHHHHHHHHHccCchhccCHHHHHH
Confidence               1111121111                24579999999999 9999999887764

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.83  E-value=2.3e-20  Score=162.04  Aligned_cols=143  Identities=16%  Similarity=0.088  Sum_probs=105.5

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhh---------hHHH-------HHHHHHHHHHHHHHHhcCCCCceeeeeE
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREK---------TVSD-------FIEFVAKLREERDVLVYGDRRWITNLHY   80 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~---------~~~~-------~~~~~~~l~~E~~il~~l~hp~Iv~l~~   80 (372)
                      ||+|.||.+.+. +|+.||+|.+.........         .+.+       ..........|..++..+.++++.....
T Consensus         8 G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~p~~   86 (190)
T cd05147           8 GKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPCPEP   86 (190)
T ss_pred             ccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCcE
Confidence            389999999876 8999999998765332111         0000       0001123456888998887777644332


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HhcCceecCCCCCCCcCCCCCcCcEEeCC
Q psy11571         81 AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASI-HDLHYVHRPNHFAFHLCRDIKPDNVLLDA  159 (372)
Q Consensus        81 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~L-H~~~ivH~~~~~~~~vhrDlkp~NIll~~  159 (372)
                      .. ... .++||||++|++|...+.. ...+++..+..++.|++.+|.++ |+.||+|          |||||+|||++ 
T Consensus        87 ~~-~~~-~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiH----------rDlkP~NIli~-  152 (190)
T cd05147          87 IL-LKS-HVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVH----------ADLSEYNLLYH-  152 (190)
T ss_pred             EE-ecC-CEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCccc----------CCCCHHHEEEE-
Confidence            22 222 3899999998887665433 36799999999999999999999 7999999          99999999998 


Q ss_pred             CCcEEEeecCccccc
Q psy11571        160 NGHIRLADFGSCLRL  174 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~  174 (372)
                      ++.++|+|||+|...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            578999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.81  E-value=1.3e-19  Score=157.49  Aligned_cols=145  Identities=17%  Similarity=0.080  Sum_probs=108.1

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhh---------hH-------HHHHHHHHHHHHHHHHHhcCCCCceeeeeE
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREK---------TV-------SDFIEFVAKLREERDVLVYGDRRWITNLHY   80 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~---------~~-------~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~   80 (372)
                      |++|.||.+.+. +|+.||+|...........         .+       .........+.+|...+..+.|++|.....
T Consensus         8 G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~   86 (190)
T cd05145           8 GKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPVPEP   86 (190)
T ss_pred             CCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCCceE
Confidence            389999999876 8999999988765321110         00       000111234568899999999988754444


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCCcCCCCCcCcEEeCC
Q psy11571         81 AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD-LHYVHRPNHFAFHLCRDIKPDNVLLDA  159 (372)
Q Consensus        81 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~~~~~~~~vhrDlkp~NIll~~  159 (372)
                      +....  .|+||||++|+++...... ...+++..+..++.|++.++.++|+ .||+|          |||||+||+++ 
T Consensus        87 ~~~~~--~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givH----------rDlkP~NIll~-  152 (190)
T cd05145          87 ILLKK--NVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVH----------GDLSEYNILYH-  152 (190)
T ss_pred             EEecC--CEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEec----------CCCChhhEEEE-
Confidence            33332  4899999988865443222 3678899999999999999999999 99999          99999999998 


Q ss_pred             CCcEEEeecCcccccCC
Q psy11571        160 NGHIRLADFGSCLRLGG  176 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~  176 (372)
                      ++.++|+|||++.....
T Consensus       153 ~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCEEEEEcccceecCC
Confidence            88999999999977643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023|consensus

Probab=99.80  E-value=3.1e-19  Score=171.95  Aligned_cols=211  Identities=21%  Similarity=0.236  Sum_probs=161.5

Q ss_pred             HhcCCCCceeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCc-eecCCCCCCC
Q psy11571         67 LVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHY-VHRPNHFAFH  145 (372)
Q Consensus        67 l~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i-vH~~~~~~~~  145 (372)
                      |+.+.|.|+.++++.+.++...+.|.+||..|+|.+.+......++.-....++++|+.||+|||+.-| .|        
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~h--------   72 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYH--------   72 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceee--------
Confidence            356789999999999999999999999999999999998866678888899999999999999998655 77        


Q ss_pred             cCCCCCcCcEEeCCCCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCC--CCCCCccceeehhHHHHH
Q psy11571        146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGR--GRYGPECDWWSLGVCMYE  222 (372)
Q Consensus       146 vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~--~~~~~~~DiwslGvil~e  222 (372)
                        +.|+..|++++....+||+|||+......... .......-...|.|||.+.+.....  ...+.+.|+||+|++++|
T Consensus        73 --g~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e  150 (484)
T KOG1023|consen   73 --GALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE  150 (484)
T ss_pred             --eeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence              99999999999999999999999876642100 0001112245689999998532111  125778999999999999


Q ss_pred             HhhCCCCCCCC----CHHHHHHHHhhccCCcCCCCCCCC-CCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        223 MLYGETPFYAE----SLVETYGKIMNHQNSFDLPSDVGY-EISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       223 lltG~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~-~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      +++...||...    +..++..++.+.......|..... ...+++..++++|+. +|.+||+.+.+...+
T Consensus       151 i~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~  221 (484)
T KOG1023|consen  151 ILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKL  221 (484)
T ss_pred             HHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhh
Confidence            99999999762    334566666552333333332211 456689999999999 999999977765433

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.80  E-value=7.2e-20  Score=166.17  Aligned_cols=230  Identities=23%  Similarity=0.298  Sum_probs=139.6

Q ss_pred             ccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCC----------CceeeeeEEE---
Q psy11571         16 IQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDR----------RWITNLHYAF---   82 (372)
Q Consensus        16 ~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~h----------p~Iv~l~~~~---   82 (372)
                      .+|+|.||.|.+..+++.+|+|...........       .++++++|.-....+.+          -.++..++..   
T Consensus        22 ~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~-------~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~   94 (288)
T PF14531_consen   22 KGGFSIVFEVTDVETGEEFAVKVFLLPADASAN-------EYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP   94 (288)
T ss_dssp             EETTEEEEEEEETTTTEEEEEEEEEESSTTHTT-------HHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred             cCCceEEEEEEEccCCceEEEEEEecccccchH-------HHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence            457889999999999999999988766632222       23444444433322211          1112222221   


Q ss_pred             ------EeC---C-----eEEEEEeccCCCCHHHHHHh---cCCC---CCHHHHHHHHHHHHHHHHHHHhcCceecCCCC
Q psy11571         83 ------QDD---S-----NLYLVMDYYCGGDLLTLLSK---FEDR---LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHF  142 (372)
Q Consensus        83 ------~~~---~-----~~~lv~E~~~gg~L~~~l~~---~~~~---l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~  142 (372)
                            ...   .     +.+++|+-+ .+||.+++..   ....   +.......++.|++..+++||+.|++|     
T Consensus        95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVH-----  168 (288)
T PF14531_consen   95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVH-----  168 (288)
T ss_dssp             TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEE-----
T ss_pred             CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEe-----
Confidence                  111   1     347788876 6688887642   1111   112223445689999999999999999     


Q ss_pred             CCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccc---cCCCCCCCccceeehhHH
Q psy11571        143 AFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAME---EGRGRYGPECDWWSLGVC  219 (372)
Q Consensus       143 ~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~DiwslGvi  219 (372)
                           +||+|+|++++.+|.+.|+||+.....+.....    ...+..|.+||......   ...-.++.+.|.|+||++
T Consensus       169 -----gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~  239 (288)
T PF14531_consen  169 -----GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT  239 (288)
T ss_dssp             -----ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred             -----cccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence                 999999999999999999999987665432211    23457899999875310   012347889999999999


Q ss_pred             HHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCC
Q psy11571        220 MYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTR  277 (372)
Q Consensus       220 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R  277 (372)
                      +|.|.+|..||..........        ..+.. .. .+++.+++||.+||+ ||.+|
T Consensus       240 ly~lWC~~lPf~~~~~~~~~~--------~~f~~-C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  240 LYSLWCGRLPFGLSSPEADPE--------WDFSR-CR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHSS-STCCCGGGSTSG--------GGGTT-SS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHccCCCCCCCcccccc--------ccchh-cC-CcCHHHHHHHHHHccCCcccC
Confidence            999999999998654322111        01111 11 689999999999999 99987

>PRK10345 hypothetical protein; Provisional

Probab=99.78  E-value=2.1e-18  Score=151.37  Aligned_cols=127  Identities=15%  Similarity=0.095  Sum_probs=94.0

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-----CCCceeeeeEEEEeCC---eEE
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-----DRRWITNLHYAFQDDS---NLY   89 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-----~hp~Iv~l~~~~~~~~---~~~   89 (372)
                      ++|.||.  +..+... ++|++......          ..+.+.+|+.+++.+     +||||++++++++++.   .++
T Consensus        14 ~~~~Vy~--hp~~~~k-~IKv~~~~~~~----------~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345         14 RHRKCYA--HPEDAQR-CIKIVYHRGDG----------GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             CceEEEE--CCCCcCe-EEEEEeccccc----------hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            5666663  3334333 56665443221          124578899999888     6799999999999874   434


Q ss_pred             -EEEec--cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC----C
Q psy11571         90 -LVMDY--YCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAI-ASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN----G  161 (372)
Q Consensus        90 -lv~E~--~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L-~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~----~  161 (372)
                       +||||  +.+++|.+++++  +.+++.  ..++.|++.++ +|||+++|+|          |||||+|||++..    +
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~Ivh----------rDlKp~NILl~~~~~~~~  146 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVT----------MELKPQNILCQRISESEV  146 (210)
T ss_pred             EEEecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEee----------cCCCHHHEEEeccCCCCC
Confidence             78999  557999999976  456666  35678888887 9999999999          9999999999743    3


Q ss_pred             cEEEeecCcc
Q psy11571        162 HIRLADFGSC  171 (372)
Q Consensus       162 ~vkl~Dfg~a  171 (372)
                      .++|+||+.+
T Consensus       147 ~~~LiDg~G~  156 (210)
T PRK10345        147 IPVVCDNIGE  156 (210)
T ss_pred             cEEEEECCCC
Confidence            7999995433

>KOG0590|consensus

Probab=99.75  E-value=8.1e-20  Score=183.36  Aligned_cols=250  Identities=22%  Similarity=0.338  Sum_probs=189.4

Q ss_pred             CCccEEEeeeeh-hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCeEEEEEecc
Q psy11571         18 GKGRVFSIETLL-DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        18 g~G~v~~v~~~~-~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      .++.+..+.... ....+|.|.+......        ....+.+..|..+-..+. |+|++++++...+....+++++|.
T Consensus        32 s~~~~~~~~~~~~~~~~~a~~~~s~~~~~--------~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s  103 (601)
T KOG0590|consen   32 SFSSSALASNSRDPESSSATKPISIPPKS--------EDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYS  103 (601)
T ss_pred             ccchhhhhhhcCCCcceeeccCCCCCCCc--------cchhhhcCccccccccccccccccccCCccCCCcccccccCcc
Confidence            344444444322 2345566655554411        123455667888888887 999999999999999999999999


Q ss_pred             CCCCHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHH-hcCceecCCCCCCCcCCCCCcCcEEeCCCC-cEEEeecCccc
Q psy11571         96 CGGDLLTLL-SKFEDRLPEDMAKFYIAEMVLAIASIH-DLHYVHRPNHFAFHLCRDIKPDNVLLDANG-HIRLADFGSCL  172 (372)
Q Consensus        96 ~gg~L~~~l-~~~~~~l~~~~~~~~~~qi~~~L~~LH-~~~ivH~~~~~~~~vhrDlkp~NIll~~~~-~vkl~Dfg~a~  172 (372)
                      .|+++...+ .......+...+..++.|+..++.|+| ..++.|          ||+||+|.+++..+ .+++.|||+|.
T Consensus       104 ~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h----------~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen  104 DGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTH----------RDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             cccccccccccCCccCCCCcchhhhhhhhccCccccCccccccc----------CCCCCccchhccCCCcccCCCchhhc
Confidence            999999998 442226788899999999999999999 999999          99999999999999 99999999998


Q ss_pred             ccCC-CC-ccccccccc-CCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHH-HHHHhhccCC
Q psy11571        173 RLGG-DG-TVQSNVAVG-TPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGKIMNHQNS  248 (372)
Q Consensus       173 ~~~~-~~-~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~-~~~i~~~~~~  248 (372)
                      .... .+ .......+| ++.|+|||...+    .....+..|+||+|+++.-+++|..|+........ +.........
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~----~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~  249 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSG----KAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGR  249 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccc----hhhcCCCcccccccccccccccCCCCccccccccccceeecccccc
Confidence            7655 22 223344678 999999999984    34568899999999999999999999976543321 1222222111


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        249 FDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       249 ~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      +  -...+..++....+++.++|. +|..|.+.+++.                 .+||+..
T Consensus       250 ~--~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~-----------------~d~~~~~  291 (601)
T KOG0590|consen  250 F--TQLPWNSISDQAHDLLHKILKENPSNRLSIEELK-----------------LDNWLSS  291 (601)
T ss_pred             c--ccCccccCChhhhhcccccccCCchhcccccccc-----------------ccccccc
Confidence            1  122234789999999999998 999999877766                 8999987

>KOG1033|consensus

Probab=99.74  E-value=3.3e-19  Score=168.99  Aligned_cols=168  Identities=22%  Similarity=0.381  Sum_probs=128.9

Q ss_pred             eEEEEEeccCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEE
Q psy11571         87 NLYLVMDYYCGGDLLTLLSKF--EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIR  164 (372)
Q Consensus        87 ~~~lv~E~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vk  164 (372)
                      ++|+.|++|.-.+|.++|...  ....+......++.|++.|+.|   ++.+|          ||+||.||+...+..+|
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ih----------rdlkp~nif~~~d~q~k  396 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIH----------RDLKPSNIFFSDDDQLK  396 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchh----------hhccccccccccchhhh
Confidence            589999999999999999742  3356778889999999999999   99999          99999999999999999


Q ss_pred             EeecCcccccCCCC-----cccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCH-HHH
Q psy11571        165 LADFGSCLRLGGDG-----TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL-VET  238 (372)
Q Consensus       165 l~Dfg~a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-~~~  238 (372)
                      |.|||+........     ....+...||..||+||.+.+     ..|+.++||||||+||+|+++   +|....+ ...
T Consensus       397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-----~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t  468 (516)
T KOG1033|consen  397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG-----QQYSEKVDIYALGLILAELLI---QFSTQFERIAT  468 (516)
T ss_pred             hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhh-----hhhhhhcchhhHHHHHHHHHH---HhccHHHHHHh
Confidence            99999988765544     222344579999999999994     679999999999999999997   3332221 122


Q ss_pred             HHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCC
Q psy11571        239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQ  280 (372)
Q Consensus       239 ~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~  280 (372)
                      +..+..+.    +|+... .-.++-.+|+.+||. .|.+||++
T Consensus       469 ~~d~r~g~----ip~~~~-~d~p~e~~ll~~lls~~p~~RP~~  506 (516)
T KOG1033|consen  469 LTDIRDGI----IPPEFL-QDYPEEYTLLQQLLSPSPEERPSA  506 (516)
T ss_pred             hhhhhcCC----CChHHh-hcCcHHHHHHHHhcCCCcccCchH
Confidence            23333332    232111 113556789999999 99999953

>smart00090 RIO RIO-like kinase

Probab=99.71  E-value=2.7e-17  Score=147.58  Aligned_cols=143  Identities=13%  Similarity=0.036  Sum_probs=105.0

Q ss_pred             cCCccEEEee-eehhhhhhhhhhhcccchhhhh---------hH-----HHHHHHHHHHHHHHHHHhcCCCC--ceeeee
Q psy11571         17 QGKGRVFSIE-TLLDILLVLYDECCNSSLRREK---------TV-----SDFIEFVAKLREERDVLVYGDRR--WITNLH   79 (372)
Q Consensus        17 ~g~G~v~~v~-~~~~~~~va~K~~~~~~~~~~~---------~~-----~~~~~~~~~l~~E~~il~~l~hp--~Iv~l~   79 (372)
                      +++|.||.+. +..+++.||+|.+.........         .+     .........+.+|..++..+.+.  .+.+++
T Consensus        39 G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~~p~~~  118 (237)
T smart00090       39 GKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVPVPKPI  118 (237)
T ss_pred             CcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCeee
Confidence            4788999997 6778999999988754321100         00     00001123467899999988753  334444


Q ss_pred             EEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-ceecCCCCCCCcCCCCCcCcEEeC
Q psy11571         80 YAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH-YVHRPNHFAFHLCRDIKPDNVLLD  158 (372)
Q Consensus        80 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~-ivH~~~~~~~~vhrDlkp~NIll~  158 (372)
                      ..   . ..++||||++|.+|...... ...+....+..++.||+.+|.+||+.| ++|          |||||+||+++
T Consensus       119 ~~---~-~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH----------~Dikp~NIli~  183 (237)
T smart00090      119 AW---R-RNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVH----------GDLSEYNILVH  183 (237)
T ss_pred             Ee---c-CceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEe----------CCCChhhEEEE
Confidence            32   2 34899999999888776533 345677778899999999999999999 999          99999999998


Q ss_pred             CCCcEEEeecCcccccC
Q psy11571        159 ANGHIRLADFGSCLRLG  175 (372)
Q Consensus       159 ~~~~vkl~Dfg~a~~~~  175 (372)
                       ++.++|+|||.+....
T Consensus       184 -~~~i~LiDFg~a~~~~  199 (237)
T smart00090      184 -DGKVVIIDVSQSVELD  199 (237)
T ss_pred             -CCCEEEEEChhhhccC
Confidence             8899999999987543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.69  E-value=1.6e-16  Score=140.26  Aligned_cols=137  Identities=18%  Similarity=0.198  Sum_probs=108.2

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      |++|.||.+..  ++..+++|.......... ... .......+.+|..++..+.|++|.....++.+....+++|||++
T Consensus         7 G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~-~~~-~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~   82 (211)
T PRK14879          7 GAEAEIYLGDF--LGIKAVIKWRIPKRYRHP-ELD-ERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIE   82 (211)
T ss_pred             CceEEEEEEee--CCCceEEEEeCCcCCcCh-HHH-HHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeC
Confidence            37888998865  667788886554332221 111 11123557789999999999988777777777778899999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                      |++|.+++... .   . ....++.+++.+|.++|+.|++|          +|++|.|||++ ++.++|+|||.+..
T Consensus        83 G~~L~~~~~~~-~---~-~~~~i~~~i~~~l~~lH~~~i~H----------~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         83 GEPLKDLINSN-G---M-EELELSREIGRLVGKLHSAGIIH----------GDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CcCHHHHHHhc-c---H-HHHHHHHHHHHHHHHHHhCCccc----------CCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999998652 1   2 78889999999999999999999          99999999998 78899999998865

>KOG1166|consensus

Probab=99.68  E-value=3e-17  Score=168.74  Aligned_cols=184  Identities=22%  Similarity=0.288  Sum_probs=142.9

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      ||+|+||.+.... ++.||+|.-+......   +.-..+..++|+     +..  -+-|..+..++.-.+..++|+||.+
T Consensus       709 g~y~~vy~a~~~~-~~~~alK~e~P~~~WE---fYI~~q~~~RLk-----~~~--~~~~~~~~~a~~~~~~S~lv~ey~~  777 (974)
T KOG1166|consen  709 GSYGSVYVATHSN-GKLVALKVEKPPNPWE---FYICLQVMERLK-----PQM--LPSIMHISSAHVFQNASVLVSEYSP  777 (974)
T ss_pred             ccceEEEEeecCC-CcEEEEEeecCCCcee---eeehHHHHHhhc-----hhh--hcchHHHHHHHccCCcceeeeeccc
Confidence            3889999998776 9999999776655433   222222333333     111  2445666666666677899999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC-------CCcEEEeecC
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA-------NGHIRLADFG  169 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~-------~~~vkl~Dfg  169 (372)
                      .|+|.+++.. .+.+++..+..++.|++..++.||.++|||          +||||+|.|+..       .--++|+|||
T Consensus       778 ~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~lH~~~IIH----------gDiKPDNfll~~~~~~~~~~~~l~lIDfG  846 (974)
T KOG1166|consen  778 YGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLHAMGIIH----------GDIKPDNFLLRREICADSDSKGLYLIDFG  846 (974)
T ss_pred             cccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHHhcceec----------ccCCcceeEeecccCCCCcccceEEEecc
Confidence            9999999986 678999999999999999999999999999          999999999942       2248999999


Q ss_pred             cccccCC--CCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCC
Q psy11571        170 SCLRLGG--DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGET  228 (372)
Q Consensus       170 ~a~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~  228 (372)
                      .+..+.-  ++ ..-...++|-.+-.+|+..+     +.+++.+|.|.|+.++|-||.|+.
T Consensus       847 ~siDm~lfp~~-~~F~~~~~td~f~C~EM~~g-----rpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  847 RSIDMKLFPDG-TKFKAVWHTDLFDCIEMREG-----RPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cceeeeEcCCC-cEEeeeeccccchhHHHhcC-----CCCchhhhhHHHHHHHHHHHHHHH
Confidence            8865432  22 22334678889999999984     789999999999999999999974

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.68  E-value=2.7e-16  Score=137.55  Aligned_cols=135  Identities=19%  Similarity=0.210  Sum_probs=103.7

Q ss_pred             ccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         16 IQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        16 ~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      .|++|.||.+.  .++..+++|........... . +.....+++.+|..++..+.|+++.....++.+....++||||+
T Consensus         4 ~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~-~-~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         4 KGAEAIIYLGD--FLGLKAVIKERVPKSYRHPE-L-DERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCceEEEEEee--cCCccEEEEEecCCcCcCch-H-HHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            34788899986  46788888875543322211 1 11223466888999999998876555444455666779999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571         96 CGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus        96 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                      +|++|.+.+... ..       .++.+++.+|.+||+.|++|          +|++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~-~~-------~~~~~i~~~l~~lH~~gi~H----------~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEG-ND-------ELLREIGRLVGKLHKAGIVH----------GDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhc-HH-------HHHHHHHHHHHHHHHCCeec----------CCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999988651 11       78899999999999999999          99999999998 88999999998865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.66  E-value=6.2e-16  Score=139.04  Aligned_cols=141  Identities=20%  Similarity=0.167  Sum_probs=103.1

Q ss_pred             cccCCccEEEeeeehhhhhhhhhhhcccchhhh---hhHHHHHHHHHHHHHHHHHHhcCCCCce--eeeeEEEEeCC---
Q psy11571         15 PIQGKGRVFSIETLLDILLVLYDECCNSSLRRE---KTVSDFIEFVAKLREERDVLVYGDRRWI--TNLHYAFQDDS---   86 (372)
Q Consensus        15 ~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~---~~~~~~~~~~~~l~~E~~il~~l~hp~I--v~l~~~~~~~~---   86 (372)
                      +.+|.|++|.|+..  +..+++|......+-..   ....-......++.+|..++..+.|++|  ++.+++.....   
T Consensus        41 ~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~  118 (239)
T PRK01723         41 SAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLF  118 (239)
T ss_pred             cCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcc
Confidence            35699999999653  66778876654322111   0000001234567889999999988774  66666644322   


Q ss_pred             -eEEEEEeccCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEE
Q psy11571         87 -NLYLVMDYYCG-GDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIR  164 (372)
Q Consensus        87 -~~~lv~E~~~g-g~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vk  164 (372)
                       ..++|||+++| .+|.+++..  ..+++..    +.+|+.+|.+||+.||+|          |||||.|||++.++.++
T Consensus       119 ~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~H----------rDlkp~NILv~~~~~v~  182 (239)
T PRK01723        119 YRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYH----------ADLNAHNILLDPDGKFW  182 (239)
T ss_pred             eeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCC----------CCCCchhEEEcCCCCEE
Confidence             23599999997 699998865  4566553    568999999999999999          99999999999889999


Q ss_pred             EeecCcccc
Q psy11571        165 LADFGSCLR  173 (372)
Q Consensus       165 l~Dfg~a~~  173 (372)
                      |+|||.+..
T Consensus       183 LIDfg~~~~  191 (239)
T PRK01723        183 LIDFDRGEL  191 (239)
T ss_pred             EEECCCccc
Confidence            999998865

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.63  E-value=1.1e-15  Score=133.71  Aligned_cols=138  Identities=14%  Similarity=0.061  Sum_probs=99.0

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhh--hh---------HHHHH-HHHHHHHHHHHHHhcCCCC--ceeeeeEEE
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRRE--KT---------VSDFI-EFVAKLREERDVLVYGDRR--WITNLHYAF   82 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~--~~---------~~~~~-~~~~~l~~E~~il~~l~hp--~Iv~l~~~~   82 (372)
                      +++|.||++.. .+++.+|+|.+........  ..         ..... .......+|..++..+.|+  .+++.++  
T Consensus        26 G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~~~--  102 (198)
T cd05144          26 GKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPID--  102 (198)
T ss_pred             CcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCceee--
Confidence            37788888865 3799999997654331100  00         00001 1122366788888888776  4444443  


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                        ....++||||++|++|......       .....++.+++.++.++|+.|++|          |||||+||+++.++.
T Consensus       103 --~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H----------~Dl~p~Nill~~~~~  163 (198)
T cd05144         103 --WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIH----------GDLSEFNILVDDDEK  163 (198)
T ss_pred             --cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCc----------CCCCcccEEEcCCCc
Confidence              2345899999999999765421       345678899999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCC
Q psy11571        163 IRLADFGSCLRLGG  176 (372)
Q Consensus       163 vkl~Dfg~a~~~~~  176 (372)
                      ++|+|||++.....
T Consensus       164 ~~liDfg~~~~~~~  177 (198)
T cd05144         164 IYIIDWPQMVSTDH  177 (198)
T ss_pred             EEEEECCccccCCC
Confidence            99999999866543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.62  E-value=3.3e-15  Score=150.07  Aligned_cols=134  Identities=19%  Similarity=0.174  Sum_probs=101.2

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      |++|.||++...  +..+++|......... +... .....+++.+|..++..+.|++|+....+..+....++||||++
T Consensus       344 G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~-~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~  419 (535)
T PRK09605        344 GAEADIKKGEYL--GRDAVIKERVPKGYRH-PELD-ERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIG  419 (535)
T ss_pred             CCcEEEEEEeec--CccceeEEEecccccc-hhHH-HHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecC
Confidence            377888886532  3334444332221111 1111 11234568899999999999999888777777777899999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCccccc
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL  174 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~  174 (372)
                      |++|.+++.         ....++.+++.+|.+||+.|++|          |||||+|||+ .++.++|+|||+++..
T Consensus       420 g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiH----------rDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        420 GKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVH----------GDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCcc----------CCCChHHEEE-ECCcEEEEeCcccccC
Confidence            999999885         34678999999999999999999          9999999999 6788999999998653

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.51  E-value=4.8e-14  Score=121.96  Aligned_cols=139  Identities=15%  Similarity=0.093  Sum_probs=93.3

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHH--------------H-HHHHHHHHHHHHhcCCCC--ceeeee
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFI--------------E-FVAKLREERDVLVYGDRR--WITNLH   79 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~--------------~-~~~~l~~E~~il~~l~hp--~Iv~l~   79 (372)
                      +++|.||.+.+. +++.||+|.+........... ...              . .......|...+..+.+.  .+.+.+
T Consensus         8 G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~   85 (187)
T cd05119           8 GKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRK-RYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPKPI   85 (187)
T ss_pred             ccceeEEEEECC-CCCEEEEEEEecCccchhhhh-hhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCceE
Confidence            489999999876 889999998765432211100 000              0 001123455555555433  345555


Q ss_pred             EEEEeCCeEEEEEeccCCCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCCcCCCCCcCcEEe
Q psy11571         80 YAFQDDSNLYLVMDYYCGGDLLT-LLSKFEDRLPEDMAKFYIAEMVLAIASIHD-LHYVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        80 ~~~~~~~~~~lv~E~~~gg~L~~-~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      ++    ...++||||++++++.. .+..  ... ...+..++.+++.++.++|. .|++|          |||||+||++
T Consensus        86 ~~----~~~~lv~e~~~g~~~~~~~l~~--~~~-~~~~~~~~~~~~~~l~~lh~~~~ivH----------~Dl~p~Nili  148 (187)
T cd05119          86 DL----NRHVLVMEFIGGDGIPAPRLKD--VRL-LEDPEELYDQILELMRKLYREAGLVH----------GDLSEYNILV  148 (187)
T ss_pred             ec----CCCEEEEEEeCCCCccChhhhh--hhh-cccHHHHHHHHHHHHHHHhhccCcCc----------CCCChhhEEE
Confidence            43    23589999999854432 1221  111 16788999999999999999 99999          9999999999


Q ss_pred             CCCCcEEEeecCcccccC
Q psy11571        158 DANGHIRLADFGSCLRLG  175 (372)
Q Consensus       158 ~~~~~vkl~Dfg~a~~~~  175 (372)
                      + ++.++|+|||.+....
T Consensus       149 ~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         149 D-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             E-CCcEEEEECccccccc
Confidence            9 8899999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601|consensus

Probab=99.50  E-value=1.7e-14  Score=139.46  Aligned_cols=238  Identities=16%  Similarity=0.176  Sum_probs=176.1

Q ss_pred             cCCccEEEeee--ehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCeEEEEEe
Q psy11571         17 QGKGRVFSIET--LLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYAFQDDSNLYLVMD   93 (372)
Q Consensus        17 ~g~G~v~~v~~--~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~E   93 (372)
                      |++|.+|....  -.+...+|+|.-+..........       . =.+|......+ .|++.++.+..++..+..|+-+|
T Consensus       127 g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~-------~-k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE  198 (524)
T KOG0601|consen  127 GSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSK-------R-KLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTE  198 (524)
T ss_pred             CCCceeecccCCcccCCcccccccccCCCCCccccc-------c-ccchhhcccccCccccccccCcccccCCcceeeec
Confidence            57899998887  67788888886433222111011       0 12344444444 49999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHH----HHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC-CcEEEeec
Q psy11571         94 YYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVL----AIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADF  168 (372)
Q Consensus        94 ~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~----~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~-~~vkl~Df  168 (372)
                      +| +.+|.++.......+++..++..+.+...    ||.++|+.+++|          -|+||+||++..+ ...+++||
T Consensus       199 ~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~----------~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  199 LC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVH----------DDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             cc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccc----------cccchhheecccccceeecCCc
Confidence            98 68999998875556899999999999999    999999999999          9999999999988 78899999


Q ss_pred             CcccccCCCCccc----ccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhh
Q psy11571        169 GSCLRLGGDGTVQ----SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN  244 (372)
Q Consensus       169 g~a~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~  244 (372)
                      |+...+.......    .....|...|++||...      +.++.+.|++|||.++.+..+|..+....-. ..+..+-.
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~------~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-~~W~~~r~  340 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN------GLATFASDIFSLGEVILEAILGSHLPSVGKN-SSWSQLRQ  340 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhhc------cccchHhhhcchhhhhHhhHhhcccccCCCC-CCcccccc
Confidence            9998876543211    11125778899999997      5689999999999999999998776654310 01111211


Q ss_pred             ccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        245 HQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      .    .+|.......+..+...+.+|+. +|-.|++++.+.
T Consensus       341 ~----~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  341 G----YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             c----cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence            1    13433333667788889999999 899999876554

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.44  E-value=2.9e-13  Score=111.94  Aligned_cols=124  Identities=19%  Similarity=0.198  Sum_probs=99.0

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCC--CceeeeeEEEEeCCeEEEEEecc
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDR--RWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~h--p~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      +.+.||++...  +..+++|.......            ...+.+|..++..+.|  +++++++..+...+..+++|||+
T Consensus        10 ~~~~v~~~~~~--~~~~~iK~~~~~~~------------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~   75 (155)
T cd05120          10 LTNRVYLLGTK--DEDYVLKINPSREK------------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI   75 (155)
T ss_pred             cccceEEEEec--CCeEEEEecCCCCc------------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence            67889988753  36788887655432            1235667777777765  58999999888888899999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhc---CceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCccc
Q psy11571         96 CGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDL---HYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCL  172 (372)
Q Consensus        96 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~  172 (372)
                      +|+++..+        +......++.+++.+|+.+|..   +++|          +|++|.||+++..+.++++|||.+.
T Consensus        76 ~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H----------~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          76 EGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCH----------GDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             CCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEe----------cCCCcceEEEECCcEEEEEeccccc
Confidence            88777543        4456677889999999999985   6999          9999999999998999999999886


Q ss_pred             c
Q psy11571        173 R  173 (372)
Q Consensus       173 ~  173 (372)
                      .
T Consensus       138 ~  138 (155)
T cd05120         138 Y  138 (155)
T ss_pred             C
Confidence            5

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1266|consensus

Probab=99.42  E-value=1.5e-13  Score=123.57  Aligned_cols=198  Identities=18%  Similarity=0.257  Sum_probs=135.4

Q ss_pred             HHHHHhcCCCCceeeeeEEEEeCC-----eEEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhcC
Q psy11571         63 ERDVLVYGDRRWITNLHYAFQDDS-----NLYLVMDYYCGGDLLTLLSKF---EDRLPEDMAKFYIAEMVLAIASIHDLH  134 (372)
Q Consensus        63 E~~il~~l~hp~Iv~l~~~~~~~~-----~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~  134 (372)
                      -..-|.++.|.|||+++.++.+..     ...+++||+..|+|.++|++.   +..+....-++|+.||+.||.|||+..
T Consensus       117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~  196 (458)
T KOG1266|consen  117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence            344456678999999998876543     578999999999999999753   346888899999999999999999864


Q ss_pred             --ceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccC---CCCcccccccccCCcccCcccccccccCCCCCCC
Q psy11571        135 --YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG---GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGP  209 (372)
Q Consensus       135 --ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~  209 (372)
                        |+|          +++..+-|++..+|-+|+.--.-.....   ......+..-.+-++|.|||.=.     ....+.
T Consensus       197 Ppiih----------gnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~-----~tn~~~  261 (458)
T KOG1266|consen  197 PPIIH----------GNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT-----TTNTTG  261 (458)
T ss_pred             Ccccc----------CCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc-----cccccc
Confidence              555          9999999999999988875221110000   00011111223567899999754     234567


Q ss_pred             ccceeehhHHHHHHhhCCCC-CCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        210 ECDWWSLGVCMYEMLYGETP-FYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       210 ~~DiwslGvil~elltG~~P-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      ++|||++|....+|..+..- -.+.+..+.-..|.+.....         -..--+++|.+||+ .|..||+++.++
T Consensus       262 a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~l---------en~lqr~~i~kcl~~eP~~rp~ar~ll  329 (458)
T KOG1266|consen  262 ASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGL---------ENGLQRGSITKCLEGEPNGRPDARLLL  329 (458)
T ss_pred             chhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeec---------cCccccCcCcccccCCCCCCcchhhhh
Confidence            89999999999999887653 22222222222222211111         12334678999999 999999987665

>KOG1243|consensus

Probab=99.36  E-value=4.3e-12  Score=124.28  Aligned_cols=168  Identities=18%  Similarity=0.188  Sum_probs=127.5

Q ss_pred             eeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccCCCCHHHHH
Q psy11571         25 IETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLL  104 (372)
Q Consensus        25 v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l  104 (372)
                      +....++..|.+...+...-  +        ..+.+.+-+.-|+.++||||++++..++.++.+|+|+|-+  ..|..++
T Consensus        31 ~t~k~~~~~vsVF~~~~~~~--~--------~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~l   98 (690)
T KOG1243|consen   31 GTRKADGGPVSVFVYKRSNG--E--------VTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVL   98 (690)
T ss_pred             cceeccCCceEEEEEeCCCc--h--------hhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHH
Confidence            34455677777776665543  1        2344566778889999999999999999999999999986  4788888


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHH-hcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCccccc
Q psy11571        105 SKFEDRLPEDMAKFYIAEMVLAIASIH-DLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSN  183 (372)
Q Consensus       105 ~~~~~~l~~~~~~~~~~qi~~~L~~LH-~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~  183 (372)
                      ++    +....+..-+.||+.||.||| +.+++|          ++|.-+.|+|+..|..||++|-++........ ...
T Consensus        99 k~----l~~~~v~~Gl~qIl~AL~FL~~d~~lvH----------gNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~  163 (690)
T KOG1243|consen   99 KE----LGKEEVCLGLFQILAALSFLNDDCNLVH----------GNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAK  163 (690)
T ss_pred             HH----hHHHHHHHHHHHHHHHHHHHhccCCeee----------ccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccc
Confidence            76    347888889999999999998 688999          99999999999999999999988765433221 001


Q ss_pred             ccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhC
Q psy11571        184 VAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYG  226 (372)
Q Consensus       184 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG  226 (372)
                      ...---.|..|+.+..       -....|.|-|||++++++.|
T Consensus       164 ~~~~~~s~~~P~~~~~-------s~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  164 SLYLIESFDDPEEIDP-------SEWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cchhhhcccChhhcCc-------cccchhhhhHHHHHHHHhCc
Confidence            1111224667776541       12467999999999999998

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.26  E-value=3.2e-11  Score=117.73  Aligned_cols=78  Identities=24%  Similarity=0.321  Sum_probs=60.8

Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHH-HHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEE
Q psy11571         86 SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVL-AIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIR  164 (372)
Q Consensus        86 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~-~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vk  164 (372)
                      +..++||||++|++|.++.........   ...++.+++. .+..+|..|++|          +|++|.||+++.+|+++
T Consensus       231 ~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~H----------~D~hPgNilv~~~g~i~  297 (437)
T TIGR01982       231 SERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFFH----------ADLHPGNIFVLKDGKII  297 (437)
T ss_pred             CCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCcee----------CCCCcccEEECCCCcEE
Confidence            346899999999999887654212222   2345555555 467899999999          99999999999999999


Q ss_pred             EeecCcccccCC
Q psy11571        165 LADFGSCLRLGG  176 (372)
Q Consensus       165 l~Dfg~a~~~~~  176 (372)
                      ++|||++.....
T Consensus       298 liDfG~~~~l~~  309 (437)
T TIGR01982       298 ALDFGIVGRLSE  309 (437)
T ss_pred             EEeCCCeeECCH
Confidence            999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.22  E-value=1.2e-11  Score=122.36  Aligned_cols=141  Identities=17%  Similarity=0.164  Sum_probs=85.7

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhh------------------------hHHHHHHHHHHHHHHHHHHhcC---
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREK------------------------TVSDFIEFVAKLREERDVLVYG---   70 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~------------------------~~~~~~~~~~~l~~E~~il~~l---   70 (372)
                      +.|.|+.+....+|+.||+|+........-.                        ...-..+..+.+.+|.+.....   
T Consensus       131 SiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~Ea~N~  210 (537)
T PRK04750        131 SIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMREAANA  210 (537)
T ss_pred             CccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHHHHHH
Confidence            6677888866555999999988754321100                        0000012223333444433222   


Q ss_pred             -------CCCceeeeeEEEEe-CCeEEEEEeccCCCCHHHH--HHhcCC----CCCHHHHHHHHHHHHHHHHHHHhcCce
Q psy11571         71 -------DRRWITNLHYAFQD-DSNLYLVMDYYCGGDLLTL--LSKFED----RLPEDMAKFYIAEMVLAIASIHDLHYV  136 (372)
Q Consensus        71 -------~hp~Iv~l~~~~~~-~~~~~lv~E~~~gg~L~~~--l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~iv  136 (372)
                             .+...+.+-.++.+ ...-++||||+.|++|.++  +.. .+    .+.+..+..++.|++       ..|++
T Consensus       211 ~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~-~g~d~~~la~~~v~~~~~Qif-------~~Gff  282 (537)
T PRK04750        211 SQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA-AGTDMKLLAERGVEVFFTQVF-------RDGFF  282 (537)
T ss_pred             HHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh-cCCCHHHHHHHHHHHHHHHHH-------hCCee
Confidence                   23322333333322 2345799999999999875  333 12    244444555555544       58999


Q ss_pred             ecCCCCCCCcCCCCCcCcEEeCCCC----cEEEeecCcccccCC
Q psy11571        137 HRPNHFAFHLCRDIKPDNVLLDANG----HIRLADFGSCLRLGG  176 (372)
Q Consensus       137 H~~~~~~~~vhrDlkp~NIll~~~~----~vkl~Dfg~a~~~~~  176 (372)
                      |          +|+||.||+++.+|    +++++|||++..+..
T Consensus       283 H----------aDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        283 H----------ADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             e----------CCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            9          99999999999888    999999999987754

>KOG0601|consensus

Probab=99.17  E-value=1.3e-11  Score=119.68  Aligned_cols=231  Identities=19%  Similarity=0.142  Sum_probs=161.3

Q ss_pred             CCccEEEeeee-hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         18 GKGRVFSIETL-LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        18 g~G~v~~v~~~-~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      +++.++.+... .++..+++|...+........+    ..    ..|+.+...+ .|.++++++..+....+.|+-.|||
T Consensus       277 ~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di----~s----l~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~  348 (524)
T KOG0601|consen  277 NFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI----FS----LGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFC  348 (524)
T ss_pred             ccccceeeeecCCCCceEeChhhhccccchHhhh----cc----hhhhhHhhHhhcccccCCCCCCccccccccCchhhh
Confidence            56667765533 5778889888776555433211    11    1244444433 5899999888888778888999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC-CcEEEeecCccccc
Q psy11571         96 CGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFGSCLRL  174 (372)
Q Consensus        96 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~-~~vkl~Dfg~a~~~  174 (372)
                      +++++...+.. ...+.+...+.+..|++.++.++|+..++|          +|+||+||++..+ +..++.|||....+
T Consensus       349 ~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~----------~d~~psni~i~~~~~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  349 EGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIHSKLFVH----------LDVKPSNILISNDGFFSKLGDFGCWTRL  417 (524)
T ss_pred             cCcchhhhhHH-HHhcCcchhhhhHHHHHhccccccchhhhc----------ccccccceeeccchhhhhcccccccccc
Confidence            99988777643 457889999999999999999999999999          9999999999876 67799999988643


Q ss_pred             CCCCcccccccccCCccc-CcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCC
Q psy11571        175 GGDGTVQSNVAVGTPDYI-SPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPS  253 (372)
Q Consensus       175 ~~~~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~  253 (372)
                      ...    .....++-.+. .+|++..    ...+..++|++|||..+.+.++|.+.=.....   ...|..+.  .+...
T Consensus       418 ~~~----~~~~~~~~r~~p~~~~~~e----~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~--~p~~~  484 (524)
T KOG0601|consen  418 AFS----SGVFHHIDRLYPIAEILLE----DYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGD--TPNLP  484 (524)
T ss_pred             cee----cccccccccccccchhhcc----ccccccccccccccccccccccCcccCccccc---ceeeeccc--ccCCC
Confidence            211    11123344455 3555553    45678899999999999999998754332221   12233321  11111


Q ss_pred             CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        254 DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       254 ~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                          ....++..+.+.++. ++..|+.+.++.
T Consensus       485 ----~~~~~~q~~~kv~~~~~~~~~~l~~~l~  512 (524)
T KOG0601|consen  485 ----GLKLQLQVLLKVMINPDRKRRPSAVELS  512 (524)
T ss_pred             ----chHHhhhhhhhhhcCCccccchhhhhhc
Confidence                345888888999988 888898866554

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.15  E-value=8.2e-11  Score=99.86  Aligned_cols=121  Identities=17%  Similarity=0.163  Sum_probs=83.4

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCc-eeeeeEEEEeCCeEEEEEeccC
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRW-ITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~-Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      ..+.+|.+..  .+..+++|........ .          .....|..++..+.+.+ +.+++....  ...++|||+++
T Consensus        10 ~~~~vy~~~~--~~~~~~lK~~~~~~~~-~----------~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~   74 (170)
T cd05151          10 MTNKNYRVEV--ANKKYVVRIPGNGTEL-L----------INRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE   74 (170)
T ss_pred             ccCceEEEEE--CCeEEEEEeCCCCccc-c----------cCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence            4678888864  3678899876543311 0          11345666666654333 445555433  23479999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCc-----eecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcc
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHY-----VHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSC  171 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i-----vH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a  171 (372)
                      |.++...  .       ......+.+++.+|+.||+.++     +|          +|++|.||+++ ++.++++||+.+
T Consensus        75 G~~l~~~--~-------~~~~~~~~~l~~~l~~LH~~~~~~~~~~H----------gD~~~~Nil~~-~~~~~liDf~~a  134 (170)
T cd05151          75 GSELLTE--D-------FSDPENLEKIAKLLKKLHSSPLPDLVPCH----------NDLLPGNFLLD-DGRLWLIDWEYA  134 (170)
T ss_pred             CCccccc--c-------ccCHHHHHHHHHHHHHHhCCCCCCceeec----------CCCCcCcEEEE-CCeEEEEecccc
Confidence            9887543  0       1123456799999999999885     78          99999999998 678999999987


Q ss_pred             cc
Q psy11571        172 LR  173 (372)
Q Consensus       172 ~~  173 (372)
                      ..
T Consensus       135 ~~  136 (170)
T cd05151         135 GM  136 (170)
T ss_pred             cC
Confidence            54

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.10  E-value=4.8e-10  Score=97.00  Aligned_cols=98  Identities=15%  Similarity=0.208  Sum_probs=74.6

Q ss_pred             HHHHHHHhcCCC--CceeeeeEEEEeCCeEEEEEeccCCCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHH-HhcCce
Q psy11571         61 REERDVLVYGDR--RWITNLHYAFQDDSNLYLVMDYYCGGDLLT-LLSKFEDRLPEDMAKFYIAEMVLAIASI-HDLHYV  136 (372)
Q Consensus        61 ~~E~~il~~l~h--p~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~-~l~~~~~~l~~~~~~~~~~qi~~~L~~L-H~~~iv  136 (372)
                      ++|...|+++..  -.+.+.+.+    ..-++||||+.+..+.. .++.  ..++++.+..+..+++.+|..+ |+.|++
T Consensus        74 ~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glV  147 (197)
T cd05146          74 EKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLV  147 (197)
T ss_pred             HHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCee
Confidence            378888887742  456666654    34579999996654432 2332  3466667788889999999998 899999


Q ss_pred             ecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccC
Q psy11571        137 HRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG  175 (372)
Q Consensus       137 H~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~  175 (372)
                      |          +||++.||+++ ++.+.|+|||.+....
T Consensus       148 H----------GDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         148 H----------ADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             c----------CCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            9          99999999996 5789999999886543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.05  E-value=2.4e-09  Score=89.99  Aligned_cols=134  Identities=19%  Similarity=0.182  Sum_probs=88.3

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccCC
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCG   97 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~g   97 (372)
                      +...++.+.-  -+..+.+|.=.. +.-+.+.+...+. .++..+|..++..+.--.|.--.-++.+.+...++|||++|
T Consensus         8 AEa~i~~~~~--~g~~av~K~Ri~-K~YR~p~LD~klr-r~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G   83 (204)
T COG3642           8 AEAIIYLTDF--LGLPAVVKERIP-KRYRHPELDEKLR-RERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEG   83 (204)
T ss_pred             cceeEEeeec--cCcceEEEeecC-cccCChHHHHHHH-HHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCC
Confidence            4444555521  233344443333 3333333433333 35567788888876433333222334466677899999999


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCccccc
Q psy11571         98 GDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL  174 (372)
Q Consensus        98 g~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~  174 (372)
                      ..|.+.+...        ...++..+-.-+.-||..||+|          +||.++||++...+ +.++|||++...
T Consensus        84 ~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givH----------GDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          84 ELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVH----------GDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             hhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeec----------CCCccceEEEeCCc-EEEEECCccccc
Confidence            9999999772        1445667777788899999999          99999999996554 999999998653

>KOG2137|consensus

Probab=98.99  E-value=3.3e-10  Score=111.67  Aligned_cols=159  Identities=21%  Similarity=0.404  Sum_probs=113.8

Q ss_pred             HHHHHHHHHHHh-cCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCcccc--------cccccCCcc
Q psy11571        121 AEMVLAIASIHD-LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQS--------NVAVGTPDY  191 (372)
Q Consensus       121 ~qi~~~L~~LH~-~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~--------~~~~gt~~y  191 (372)
                      .+.+.|+.|+|. .++||          ++|.|++|.++.+|..||+.|+++...........        ....-...|
T Consensus       106 ~~v~dgl~flh~sAk~VH----------~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f  175 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVH----------GNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNF  175 (700)
T ss_pred             hcccchhhhhccCcceee----------cccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCccc
Confidence            345589999995 68999          99999999999999999999998876544211111        011234579


Q ss_pred             cCcccccccccCCCCCCCccceeehhHHHHHHh-hCCCCCCCCCHHHHHHHHh--hccCCcCCCCCCCCCCCHHHHHHHH
Q psy11571        192 ISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIM--NHQNSFDLPSDVGYEISDDAKDLMR  268 (372)
Q Consensus       192 ~aPE~~~~~~~~~~~~~~~~DiwslGvil~ell-tG~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~s~~~~~li~  268 (372)
                      .|||.+..     ...+.++|++|+||++|.+. .|+.-+...+....+..-.  .+-..+...    .+++.++++=|.
T Consensus       176 ~apE~~~~-----~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s----~~~p~el~~~l~  246 (700)
T KOG2137|consen  176 LAPEYLLG-----TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYS----NNLPSELRESLK  246 (700)
T ss_pred             ccchhhcc-----ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccccccccc----ccCcHHHHHHHH
Confidence            99999983     56788999999999999999 5666665554333222211  111222222    378999999999


Q ss_pred             Hhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccccc
Q psy11571        269 RLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIR  315 (372)
Q Consensus       269 ~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~  315 (372)
                      ++|. ++.-||+...+.                 .-|||.+..-..|+
T Consensus       247 k~l~~~~~~rp~~~~l~-----------------~~~ff~D~~~~aLr  277 (700)
T KOG2137|consen  247 KLLNGDSAVRPTLDLLL-----------------SIPFFSDPGLKALR  277 (700)
T ss_pred             HHhcCCcccCcchhhhh-----------------cccccCCchhhhhh
Confidence            9999 999999655444                 78999887665554

>KOG3741|consensus

Probab=98.97  E-value=3.1e-09  Score=101.58  Aligned_cols=201  Identities=18%  Similarity=0.185  Sum_probs=145.7

Q ss_pred             ccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe----CCeEEEEEecc
Q psy11571         20 GRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQD----DSNLYLVMDYY   95 (372)
Q Consensus        20 G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~----~~~~~lv~E~~   95 (372)
                      -+.|++....||..|.+|.+.........+          ...-++.++++.|+|||++.++|.+    +..+++|++|.
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk----------~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYy  359 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNK----------DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYY  359 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCccc----------chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecC
Confidence            458899999999999999884444333211          2234567788999999999999884    34789999998


Q ss_pred             CC-CCHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         96 CG-GDLLTLLSKF--------------EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        96 ~g-g~L~~~l~~~--------------~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      ++ ++|.++.-..              +.+.+|..+|.|+.|+..||.++|+.|+.-          +-|.|.+|+++.+
T Consensus       360 P~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAc----------k~L~~~kIlv~G~  429 (655)
T KOG3741|consen  360 PSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLAC----------KTLDLKKILVTGK  429 (655)
T ss_pred             CCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCcee----------ecccHhHeEeeCc
Confidence            77 5888764221              234788999999999999999999999998          9999999999988


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCC-CCCCCHHHH-
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP-FYAESLVET-  238 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~P-f~~~~~~~~-  238 (372)
                      .+++|...|+...+..+.        +       |-+.        --.+-|.=.||.++..|.||..- +..+...+. 
T Consensus       430 ~RIriS~C~i~Dvl~~d~--------~-------~~le--------~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~  486 (655)
T KOG3741|consen  430 MRIRISGCGIMDVLQEDP--------T-------EPLE--------SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSH  486 (655)
T ss_pred             ceEEEecccceeeecCCC--------C-------cchh--------HHhhhhHHHHHHHHHHHhhcccccccccchHHHH
Confidence            899998888765443322        0       1111        11356888999999999999643 222222222 


Q ss_pred             HHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCC
Q psy11571        239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDT  276 (372)
Q Consensus       239 ~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~  276 (372)
                      ...|..             .+|.+++++|.-+.. ++.+
T Consensus       487 ~~~I~~-------------~yS~D~rn~v~yl~s~~~~~  512 (655)
T KOG3741|consen  487 LTRITT-------------TYSTDLRNVVEYLESLNFRE  512 (655)
T ss_pred             HHHhhh-------------hhhHHHHHHHHHHHhcCccc
Confidence            222221             578999999998888 6764

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.94  E-value=1.9e-09  Score=95.41  Aligned_cols=144  Identities=13%  Similarity=0.063  Sum_probs=103.1

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCC--CceeeeeEEEEeC---CeEEEEE
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDR--RWITNLHYAFQDD---SNLYLVM   92 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~h--p~Iv~l~~~~~~~---~~~~lv~   92 (372)
                      ..+.+|++... ++..+++|.........         ....+..|..++..+.+  ..+.+++.+....   +..++||
T Consensus        10 ~~n~~~~v~~~-~g~~~ilK~~~~~~~~~---------~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~   79 (223)
T cd05154          10 QSNLTYLLTAG-GGRRLVLRRPPPGALLP---------SAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM   79 (223)
T ss_pred             ccceEEEEEec-CCcceEEEeCCCcccCc---------ccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence            46778888653 35788888765433210         12346678888888764  4467777776553   2568999


Q ss_pred             eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceec----------------------------------
Q psy11571         93 DYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHR----------------------------------  138 (372)
Q Consensus        93 E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~----------------------------------  138 (372)
                      ||++|.+|.+.+..  ..+++.....++.+++.+|..||+...-..                                  
T Consensus        80 e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          80 ERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             EEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            99999988776532  457888888999999999999997532100                                  


Q ss_pred             ------------CCCCCCCcCCCCCcCcEEeCC--CCcEEEeecCcccc
Q psy11571        139 ------------PNHFAFHLCRDIKPDNVLLDA--NGHIRLADFGSCLR  173 (372)
Q Consensus       139 ------------~~~~~~~vhrDlkp~NIll~~--~~~vkl~Dfg~a~~  173 (372)
                                  ...+..++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                        002567799999999999998  56789999998754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087|consensus

Probab=98.94  E-value=9.2e-09  Score=86.27  Aligned_cols=143  Identities=18%  Similarity=0.185  Sum_probs=93.6

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      |+.++|+.+  ...|+.+.+|.--.+..+.. .... .-..++..+|...|.++.--.|.--.-+|.+...-.++|||++
T Consensus        18 GAEArv~~~--~~~Ge~~iIK~Rf~K~YRHP-~LD~-kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~   93 (229)
T KOG3087|consen   18 GAEARVPRG--SFSGEAAIIKERFSKRYRHP-ALDQ-KLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFID   93 (229)
T ss_pred             cceeeEeee--ccCCceeEEeecccccccch-HHHH-HHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEecc
Confidence            344544444  34566666664333333322 2222 2234567778888877643233222234556666689999997


Q ss_pred             C-CCHHHHHHhcCCCCCHHH-HHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC---cEEEeecCcc
Q psy11571         97 G-GDLLTLLSKFEDRLPEDM-AKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG---HIRLADFGSC  171 (372)
Q Consensus        97 g-g~L~~~l~~~~~~l~~~~-~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~---~vkl~Dfg~a  171 (372)
                      | .++.+++...-..-.++. ...++.+|-..+.-||..+|+|          +||..+||++.++|   .+.++|||++
T Consensus        94 g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiH----------GDLTTSNill~~~~~~~~~~lIdfgls  163 (229)
T KOG3087|consen   94 GASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIH----------GDLTTSNILLRSDGNQITPILIDFGLS  163 (229)
T ss_pred             chhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeec----------ccccccceEEecCCCcCceEEEeecch
Confidence            6 488888876433333333 3788899999999999999999          99999999997655   3589999987


Q ss_pred             cc
Q psy11571        172 LR  173 (372)
Q Consensus       172 ~~  173 (372)
                      ..
T Consensus       164 ~~  165 (229)
T KOG3087|consen  164 SV  165 (229)
T ss_pred             hc
Confidence            54

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.92  E-value=2.9e-08  Score=92.92  Aligned_cols=181  Identities=19%  Similarity=0.233  Sum_probs=122.5

Q ss_pred             EEEEEeccCCC-CHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         88 LYLVMDYYCGG-DLLTLLSKF-----EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        88 ~~lv~E~~~gg-~L~~~l~~~-----~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +-+.|..++|. ....+++..     -..+.+..+.+.++.++.+.+.||+.|.+-          +|++++|+|+++++
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~v----------GDVn~~~~lVsd~~  154 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVV----------GDVNQNSFLVSDDS  154 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcc----------cccCccceeeecCc
Confidence            67888888775 222222210     123677899999999999999999999988          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhC-CCCCCCCC------
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYG-ETPFYAES------  234 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG-~~Pf~~~~------  234 (372)
                      .|.|+|-..-.... .+. .....+|.+.|.+||.-.-..-..-..+...|.|.||+++++++.| ++||.+..      
T Consensus       155 ~V~LVdsDsfqi~~-ng~-~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap  232 (637)
T COG4248         155 KVVLVDSDSFQINA-NGT-LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAP  232 (637)
T ss_pred             eEEEEcccceeecc-CCc-eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCC
Confidence            99999865433221 222 2233578999999997651100112346689999999999999987 99997631      


Q ss_pred             -HHHHHHHHhh---------ccCCcCCC-CCCCCCCCHHHHHHHHHhccC---CCCCCCCCC
Q psy11571        235 -LVETYGKIMN---------HQNSFDLP-SDVGYEISDDAKDLMRRLICS---SDTRLGQNG  282 (372)
Q Consensus       235 -~~~~~~~i~~---------~~~~~~~~-~~~~~~~s~~~~~li~~lL~~---p~~R~s~~~  282 (372)
                       ..+.  .|..         +....+-| +..+.-+++++..|..+|+.+   +.-||+++.
T Consensus       233 ~p~E~--~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         233 NPLET--DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             Ccchh--hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence             1110  1211         11111111 122235789999999999983   568999764

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.81  E-value=4e-08  Score=89.60  Aligned_cols=104  Identities=10%  Similarity=0.057  Sum_probs=76.7

Q ss_pred             HHHHHHHHhcCCCC--ceeeeeEEEEe-----CCeEEEEEeccCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHH
Q psy11571         60 LREERDVLVYGDRR--WITNLHYAFQD-----DSNLYLVMDYYCGG-DLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASI  130 (372)
Q Consensus        60 l~~E~~il~~l~hp--~Iv~l~~~~~~-----~~~~~lv~E~~~gg-~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~L  130 (372)
                      ..+|...+..+..-  ..+....+.+.     ....++|||++++. +|.+++... ....++.....++.+++..+.-|
T Consensus        75 a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~L  154 (268)
T PRK15123         75 ADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDM  154 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence            45676666555321  12233333332     23578999999876 899998642 24456778889999999999999


Q ss_pred             HhcCceecCCCCCCCcCCCCCcCcEEeCC-------CCcEEEeecCcccc
Q psy11571        131 HDLHYVHRPNHFAFHLCRDIKPDNVLLDA-------NGHIRLADFGSCLR  173 (372)
Q Consensus       131 H~~~ivH~~~~~~~~vhrDlkp~NIll~~-------~~~vkl~Dfg~a~~  173 (372)
                      |..|++|          +|+++.|||++.       ++.+.|+||+.+..
T Consensus       155 H~~Gi~H----------gDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        155 HAAGINH----------RDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHCcCcc----------CCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            9999999          999999999975       46789999998754

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.78  E-value=1.3e-08  Score=87.78  Aligned_cols=101  Identities=22%  Similarity=0.222  Sum_probs=68.2

Q ss_pred             HHHHHHHHHHHhcCCCC--ceeeeeEEEEeCCeEEEEEeccC--CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH-HH
Q psy11571         57 VAKLREERDVLVYGDRR--WITNLHYAFQDDSNLYLVMDYYC--GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS-IH  131 (372)
Q Consensus        57 ~~~l~~E~~il~~l~hp--~Iv~l~~~~~~~~~~~lv~E~~~--gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~-LH  131 (372)
                      ....++|...|..+..-  ++.+.+.+.    .-++||||+.  |..+..+. .  ..++.+....++.+++..+.. +|
T Consensus        52 ~~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~-~--~~~~~~~~~~~~~~il~~~~~~~~  124 (188)
T PF01163_consen   52 REWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLK-D--VDLSPEEPKELLEEILEEIIKMLH  124 (188)
T ss_dssp             HHHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHH-H--CGGGGSTHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHH-h--ccccchhHHHHHHHHHHHHHHHHH
Confidence            45678899999998754  567776552    2369999998  55554433 3  222245567777888885554 68


Q ss_pred             hcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccC
Q psy11571        132 DLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG  175 (372)
Q Consensus       132 ~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~  175 (372)
                      +.|++|          +||.+.||+++.+ .+.|+|||.+....
T Consensus       125 ~~givH----------GDLs~~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  125 KAGIVH----------GDLSEYNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             CTTEEE----------SS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred             hcCcee----------cCCChhhEEeecc-eEEEEecCcceecC
Confidence            999999          9999999999776 89999999886643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.71  E-value=1.4e-07  Score=82.87  Aligned_cols=105  Identities=21%  Similarity=0.256  Sum_probs=79.1

Q ss_pred             HHHHHHHHHhcCCC--CceeeeeEEEEeC----CeEEEEEeccCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Q psy11571         59 KLREERDVLVYGDR--RWITNLHYAFQDD----SNLYLVMDYYCGG-DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIH  131 (372)
Q Consensus        59 ~l~~E~~il~~l~h--p~Iv~l~~~~~~~----~~~~lv~E~~~gg-~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH  131 (372)
                      +..+|...+..+..  =.+++.+.+.+..    ...++|||++++. +|.+++... ...+......++.+++..++-||
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~-~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW-EQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh-cccchhhHHHHHHHHHHHHHHHH
Confidence            34556665554421  1234444444432    2468999999884 899999863 34777788899999999999999


Q ss_pred             hcCceecCCCCCCCcCCCCCcCcEEeCCCC---cEEEeecCccccc
Q psy11571        132 DLHYVHRPNHFAFHLCRDIKPDNVLLDANG---HIRLADFGSCLRL  174 (372)
Q Consensus       132 ~~~ivH~~~~~~~~vhrDlkp~NIll~~~~---~vkl~Dfg~a~~~  174 (372)
                      +.|++|          +|+++.|||++.++   .+.++||+-++..
T Consensus       136 ~~gi~H----------~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  136 DAGIYH----------GDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HCcCCC----------CCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999999          99999999999877   8999999977653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.54  E-value=6.4e-07  Score=79.98  Aligned_cols=146  Identities=17%  Similarity=0.116  Sum_probs=95.0

Q ss_pred             HHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccch--hhhhhHHHH----------HHHHHHHHHHHHHHhcCCCC-
Q psy11571          7 LEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSL--RREKTVSDF----------IEFVAKLREERDVLVYGDRR-   73 (372)
Q Consensus         7 l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~--~~~~~~~~~----------~~~~~~l~~E~~il~~l~hp-   73 (372)
                      ++.+|.-.+.|-.+.||.+.+- .+..+++|.-.....  .+.+...+.          .-.....++|...|..+... 
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G  170 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG  170 (304)
T ss_pred             HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence            3344433333334558877654 578888885432211  111111111          11223467899999988644 


Q ss_pred             -ceeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCc
Q psy11571         74 -WITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKP  152 (372)
Q Consensus        74 -~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp  152 (372)
                       .|.+-+++    +.-.+||||++|-.|...      +++.+.+..++..|+.-+.-+-..|+||          +|+++
T Consensus       171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~GiVH----------GDlSe  230 (304)
T COG0478         171 VKVPKPIAW----NRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRGIVH----------GDLSE  230 (304)
T ss_pred             CCCCCcccc----ccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcCccc----------cCCch
Confidence             56666655    455799999988666432      2245556667777777777777899999          99999


Q ss_pred             CcEEeCCCCcEEEeecCcccc
Q psy11571        153 DNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus       153 ~NIll~~~~~vkl~Dfg~a~~  173 (372)
                      -||+++++|.+.++||--+..
T Consensus       231 fNIlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         231 FNILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             heEEEecCCCEEEEeCccccc
Confidence            999999999999999986644

>KOG0576|consensus

Probab=98.51  E-value=1.7e-08  Score=98.93  Aligned_cols=199  Identities=20%  Similarity=0.177  Sum_probs=131.4

Q ss_pred             HHHHHHHHhcCCCCc-eeeeeEEEEeCCeEEEEEeccCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCcee
Q psy11571         60 LREERDVLVYGDRRW-ITNLHYAFQDDSNLYLVMDYYCGG-DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVH  137 (372)
Q Consensus        60 l~~E~~il~~l~hp~-Iv~l~~~~~~~~~~~lv~E~~~gg-~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH  137 (372)
                      .+-++++|.+++||| .+..++-++.+...+++|+++.++ +-...+......+.+-+.....+.-..+++++|+.--+|
T Consensus       280 ~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~  359 (829)
T KOG0576|consen  280 RRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVH  359 (829)
T ss_pred             hHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccC
Confidence            456889999999999 778788888888999999999777 222221111123444455556667778899999876677


Q ss_pred             cCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehh
Q psy11571        138 RPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLG  217 (372)
Q Consensus       138 ~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG  217 (372)
                                ||    ||+..+ +..+..||+....+....  ..++..+|+.++|||+..     ...+....|.||+|
T Consensus       360 ----------~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~~~~~~~~pev~~-----~~~~~~~p~~~~~~  417 (829)
T KOG0576|consen  360 ----------RD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAIGTPEPLAPEVIQ-----ENTIDGCPDSGSLA  417 (829)
T ss_pred             ----------cc----cccccc-cccccccccCCcccCccc--ccccCCCCCCCCCchhhc-----ccccccCCCccCCC
Confidence                      88    777754 678999999887665432  345578999999999987     46688899999999


Q ss_pred             HHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCC-CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        218 VCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPS-DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       218 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      +-..+|.-|.+|-...  ......+-.+...+.+.. ..+  -...-+++...|+. .|..|+...++.
T Consensus       418 ~~~~~~ap~~pPr~~P--~~~~~~~g~~p~s~~L~~~~aw--~~~~~~~~~~~~~~g~P~~pkv~mgac  482 (829)
T KOG0576|consen  418 VSAIQMAPGLPPRSSP--PAVLPMIGNGPNSPMLTDKSAW--SPVFHRDFPAPCLNGLPPTPKVHMGAC  482 (829)
T ss_pred             cchhhcCCCCCCCCCC--ccccCCCCCCCCccccchhhhc--CcccccCCcccccCCCCCCCcchhhHH
Confidence            9888888887775431  111111111111111111 000  01111246677888 788887765554

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.51  E-value=2.9e-06  Score=74.20  Aligned_cols=125  Identities=24%  Similarity=0.289  Sum_probs=78.9

Q ss_pred             hhhhhhhhhhhcccchhhhhhHHHHHH--HHHHHHHHHHHHhcCCCCceeeeeEEEE-----eCCeEEEEEeccCCCCHH
Q psy11571         29 LDILLVLYDECCNSSLRREKTVSDFIE--FVAKLREERDVLVYGDRRWITNLHYAFQ-----DDSNLYLVMDYYCGGDLL  101 (372)
Q Consensus        29 ~~~~~va~K~~~~~~~~~~~~~~~~~~--~~~~l~~E~~il~~l~hp~Iv~l~~~~~-----~~~~~~lv~E~~~gg~L~  101 (372)
                      .+++.+.+|.........++.+..+..  ...++......+....--....++.+.+     -....+++|||++|..|.
T Consensus        52 i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~  131 (229)
T PF06176_consen   52 IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELN  131 (229)
T ss_pred             ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEecCeecc
Confidence            467888888887776666655554432  1222222233332222222222222222     223467899999998887


Q ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571        102 TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus       102 ~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                      ++..     +++.    +...+.+++.-||+.|++|          +|..|.|++++.++ ++++||+..+.
T Consensus       132 d~~~-----i~e~----~~~ki~~~ikqlH~~G~~H----------GD~hpgNFlv~~~~-i~iID~~~k~~  183 (229)
T PF06176_consen  132 DIED-----IDED----LAEKIVEAIKQLHKHGFYH----------GDPHPGNFLVSNNG-IRIIDTQGKRM  183 (229)
T ss_pred             cchh-----cCHH----HHHHHHHHHHHHHHcCCcc----------CCCCcCcEEEECCc-EEEEECccccc
Confidence            6532     2332    4456778899999999999          99999999997554 99999986543

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1035|consensus

Probab=98.25  E-value=3.9e-06  Score=87.76  Aligned_cols=199  Identities=15%  Similarity=0.156  Sum_probs=135.2

Q ss_pred             HHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCe----EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Q psy11571         55 EFVAKLREERDVLVYGDRRWITNLHYAFQDDSN----LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASI  130 (372)
Q Consensus        55 ~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~----~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~L  130 (372)
                      ..+....-|...+....|+|++.++.+......    ..+..|+|..-++.+.+.. .+..+.+.++.+..++..||+++
T Consensus       224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHH
Confidence            445556667888888999999999988654432    2355689999999999988 57899999999999999999999


Q ss_pred             HhcCceecCCCCCCCcCCCCCcC---cEEeCCCCcEEEe--ecCcccccCCCCcccccccccCCcccCcccccccccCCC
Q psy11571        131 HDLHYVHRPNHFAFHLCRDIKPD---NVLLDANGHIRLA--DFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRG  205 (372)
Q Consensus       131 H~~~ivH~~~~~~~~vhrDlkp~---NIll~~~~~vkl~--Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  205 (372)
                      |+....|          .-|...   +--.+..+.+.+.  ||+.++.........  ...-+..+.+||.....   ..
T Consensus       303 h~~~l~~----------v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~---~~  367 (1351)
T KOG1035|consen  303 HSLSLEH----------VVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKEN---TA  367 (1351)
T ss_pred             HHhccce----------eEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccc---cc
Confidence            9986666          333333   3334455556665  898887765433221  12335567788877631   12


Q ss_pred             CCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        206 RYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       206 ~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      ..+...|+|.+|.....+..|..+-.-..   ....++        +.    .......+++.+|+. ++++|+++.+++
T Consensus       368 ~~~r~~dL~~lgll~~~~~~~~~i~~~~~---~~~~~l--------~~----~~~~~~~d~~~~~~~~~~~~Rl~~~~ll  432 (1351)
T KOG1035|consen  368 KKSRLTDLWCLGLLLLQLSQGEDISEKSA---VPVSLL--------DV----LSTSELLDALPKCLDEDSEERLSALELL  432 (1351)
T ss_pred             hhhhhhHHHHHHHHHhhhhhcCccccccc---chhhhh--------cc----ccchhhhhhhhhhcchhhhhccchhhhh
Confidence            22334699999999999988765431111   111111        11    112278889999998 899999988777

>PRK09902 hypothetical protein; Provisional

Probab=98.22  E-value=1e-05  Score=70.48  Aligned_cols=140  Identities=11%  Similarity=0.152  Sum_probs=90.4

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhh-hHHHHHHHHHHHHHHHHHHhcCCC--CceeeeeEEEEe--C--CeEE
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREK-TVSDFIEFVAKLREERDVLVYGDR--RWITNLHYAFQD--D--SNLY   89 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~-~~~~~~~~~~~l~~E~~il~~l~h--p~Iv~l~~~~~~--~--~~~~   89 (372)
                      +|.+.|+.+..  .|+.+=+|.-.+.....-. .+     -...+.+|...|..+..  -.+.+....-..  +  ...+
T Consensus        29 gG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~-----g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~  101 (216)
T PRK09902         29 NGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPF-----GRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRAL  101 (216)
T ss_pred             CCcceEEEEEe--CCcEEEEEeccCcccccccCCC-----CchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEE
Confidence            36777777642  2234555654322211110 00     12335667777665531  114444422212  1  2468


Q ss_pred             EEEeccCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc--EEE
Q psy11571         90 LVMDYYCG-GDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH--IRL  165 (372)
Q Consensus        90 lv~E~~~g-g~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~--vkl  165 (372)
                      ||+|-+.| .||.+++... -.+.++.....++.+++.+++-||+.|+.|          +|+.+.||+++.+|.  +++
T Consensus       102 LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~H----------gdly~khIll~~~g~~~v~l  171 (216)
T PRK09902        102 LVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQH----------GCCYVRHIYVKTEGKAEAGF  171 (216)
T ss_pred             EEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcC----------CCCCHhheeecCCCCeeEEE
Confidence            99997754 5999888652 124577777899999999999999999999          999999999986676  999


Q ss_pred             eecCcccc
Q psy11571        166 ADFGSCLR  173 (372)
Q Consensus       166 ~Dfg~a~~  173 (372)
                      +||--++.
T Consensus       172 IDlEk~r~  179 (216)
T PRK09902        172 LDLEKSRR  179 (216)
T ss_pred             EEhhccch
Confidence            99986554

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.18  E-value=1.2e-05  Score=79.62  Aligned_cols=78  Identities=21%  Similarity=0.307  Sum_probs=56.4

Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEe
Q psy11571         87 NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLA  166 (372)
Q Consensus        87 ~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~  166 (372)
                      .-.++|||+.|-.+.+.........+...+.....++.  +..+-..|++|          .|..|.||+++.+|++.+.
T Consensus       240 ~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgffH----------aDpHpGNi~v~~~g~i~~l  307 (517)
T COG0661         240 RRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFFH----------ADPHPGNILVRSDGRIVLL  307 (517)
T ss_pred             CcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCccc----------cCCCccceEEecCCcEEEE
Confidence            45799999999988888433234555443333322222  23344589999          9999999999999999999


Q ss_pred             ecCcccccCC
Q psy11571        167 DFGSCLRLGG  176 (372)
Q Consensus       167 Dfg~a~~~~~  176 (372)
                      |||+......
T Consensus       308 DfGi~g~l~~  317 (517)
T COG0661         308 DFGIVGRLDP  317 (517)
T ss_pred             cCcceecCCH
Confidence            9999877654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.17  E-value=1.8e-05  Score=70.57  Aligned_cols=134  Identities=13%  Similarity=0.060  Sum_probs=78.0

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCC--ceeeeeEEEEeCCeEEEEEecc
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRR--WITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp--~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      ..+.+|+.    .+..+++|.......            ...+.+|..+++.+..-  -+.+.+.+..+.+...+|||++
T Consensus        13 ~t~~~y~~----~~~~~VlR~~~~~~~------------~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i   76 (226)
T TIGR02172        13 GNGESYTH----KTGKWMLKLYNPGFD------------KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELI   76 (226)
T ss_pred             CCcceeEe----cCCCEEEEeCCCCCC------------HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeec
Confidence            45667763    244555665543221            12246688888776532  2567777777777888999999


Q ss_pred             CCCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCc---------------------e------------ecCCC
Q psy11571         96 CGGD-LLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHY---------------------V------------HRPNH  141 (372)
Q Consensus        96 ~gg~-L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i---------------------v------------H~~~~  141 (372)
                      +|.+ +...+.     .+......++.+++..+.-||+...                     .            .....
T Consensus        77 ~G~~~~~~~~~-----~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~  151 (226)
T TIGR02172        77 VGKRSFSRIIS-----DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPD  151 (226)
T ss_pred             CCccchhhhhc-----CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCC
Confidence            8864 222221     1222223334444444444443211                     0            00112


Q ss_pred             CCCCcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571        142 FAFHLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus       142 ~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                      ...++|+|+.|.||+++.++ +.++||+.+..
T Consensus       152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            23447899999999999888 99999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>smart00133 S_TK_X Extension to Ser/Thr-type protein kinases

Probab=98.08  E-value=2.8e-06  Score=59.65  Aligned_cols=60  Identities=35%  Similarity=0.762  Sum_probs=40.9

Q ss_pred             CCCCcccc--ccCCCCCcCCCCCCCCCCCCCCCccccCCCCCCCCCCCCccccc-CCCCccCceee
Q psy11571        307 QGIAWDSI--RDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSA-LHLPFVGFTFT  369 (372)
Q Consensus       307 ~~~~w~~~--~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  369 (372)
                      +++||+.|  ++..|||+|.+.+..+.++|+...........  +... ...+. .+..|.||||.
T Consensus         1 ~~idW~~l~~r~~~pP~~P~~~~~~d~s~fd~~~~~~~~~~s--~~~~-~~~~~~~~~~F~gfsy~   63 (64)
T smart00133        1 RGIDWDKLENKEIEPPFVPKIKSPTDTSNFDDEFTEETPVLT--PVDS-PASGGSQQEPFRGFSYV   63 (64)
T ss_pred             CCCCHHHHHhCCCCCCcccccCCccHHhHcCCcCCCCCCCCC--CCCc-cccccccccccCCCccc
Confidence            47999999  67899999999999999999975443332211  1111 11111 14789999996

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.87  E-value=0.00027  Score=61.45  Aligned_cols=140  Identities=18%  Similarity=0.134  Sum_probs=85.0

Q ss_pred             cccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHH------HHHHHHHHHHHHHHh------cCCCCceeeeeEEE
Q psy11571         15 PIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDF------IEFVAKLREERDVLV------YGDRRWITNLHYAF   82 (372)
Q Consensus        15 ~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~------~~~~~~l~~E~~il~------~l~hp~Iv~l~~~~   82 (372)
                      ..+|.|.--.|..-.+.....+|+...............      ....++..+|..-..      ...+.+|.+++++.
T Consensus         7 ~~i~~G~~R~cy~HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~v   86 (199)
T PF10707_consen    7 DLIAQGGERDCYQHPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFV   86 (199)
T ss_pred             cccccCCCceEEECCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEEE
Confidence            345666655555555556666776665551100000000      001122233333322      23488999999999


Q ss_pred             EeCCeEEEEEeccCC------CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEE
Q psy11571         83 QDDSNLYLVMDYYCG------GDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL  156 (372)
Q Consensus        83 ~~~~~~~lv~E~~~g------g~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIl  156 (372)
                      +++...-+|+|.+.+      .+|.+++..  +.+++ .....   +-.-..+|-+.+|+.          +|++|.||+
T Consensus        87 eT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~~~~~---L~~f~~~l~~~~Iv~----------~dl~~~NIv  150 (199)
T PF10707_consen   87 ETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE-ELRQA---LDEFKRYLLDHHIVI----------RDLNPHNIV  150 (199)
T ss_pred             ecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH-HHHHH---HHHHHHHHHHcCCee----------cCCCcccEE
Confidence            999999999998643      378999965  56666 33333   334456778899999          999999999


Q ss_pred             eCCC--C--cEEEee-cCc
Q psy11571        157 LDAN--G--HIRLAD-FGS  170 (372)
Q Consensus       157 l~~~--~--~vkl~D-fg~  170 (372)
                      +...  +  .+.|+| ||.
T Consensus       151 ~~~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  151 VQRRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             EEecCCCceEEEEEeCCCC
Confidence            9633  2  467776 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.72  E-value=0.00012  Score=63.21  Aligned_cols=100  Identities=17%  Similarity=0.237  Sum_probs=76.7

Q ss_pred             HHHHHHHhcCCC-CceeeeeEEEEeCCeEEEEEeccCCCCHHHH---HHhcCCCCCHHHHHHHHHHHHHHHHHHHhc--C
Q psy11571         61 REERDVLVYGDR-RWITNLHYAFQDDSNLYLVMDYYCGGDLLTL---LSKFEDRLPEDMAKFYIAEMVLAIASIHDL--H  134 (372)
Q Consensus        61 ~~E~~il~~l~h-p~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~---l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~--~  134 (372)
                      ..|..+++.+.+ +++++++|++-+    ++++||...+++...   +.. -...++.....++.+++..+.+++..  |
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            357888888875 699999999843    578899977766421   111 12457889999999999999999862  2


Q ss_pred             ceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCccccc
Q psy11571        135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL  174 (372)
Q Consensus       135 ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~  174 (372)
                      .+|         -.|++|+|+-++++|++|++|...+...
T Consensus        82 ~~~---------lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   82 FFY---------LCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             cEE---------EeecchHHeEEeCCCcEEEEechhcchh
Confidence            233         1999999999999999999999977543

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1235|consensus

Probab=97.62  E-value=0.00021  Score=70.75  Aligned_cols=86  Identities=21%  Similarity=0.324  Sum_probs=59.1

Q ss_pred             eeeeeEEEEeCCeEEEEEeccCCCCHHHH--HHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCc
Q psy11571         75 ITNLHYAFQDDSNLYLVMDYYCGGDLLTL--LSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKP  152 (372)
Q Consensus        75 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~--l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp  152 (372)
                      |.++|..+.+  .-.|+||||+|..+.+.  |.+  ..++...+...+.+...  .-+=..|++|          +|-.|
T Consensus       266 VP~Vy~~~st--~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~i~~~l~~~~~--~qIf~~GffH----------aDPHP  329 (538)
T KOG1235|consen  266 VPKVYWDLST--KRVLTMEYVDGIKINDLDAIDK--RGISPHDILNKLVEAYL--EQIFKTGFFH----------ADPHP  329 (538)
T ss_pred             CCeehhhcCc--ceEEEEEecCCccCCCHHHHHH--cCCCHHHHHHHHHHHHH--HHHHhcCCcc----------CCCCC
Confidence            6666665543  35899999999755443  444  55666655444443332  2233568999          99999


Q ss_pred             CcEEeCC----CCcEEEeecCcccccCC
Q psy11571        153 DNVLLDA----NGHIRLADFGSCLRLGG  176 (372)
Q Consensus       153 ~NIll~~----~~~vkl~Dfg~a~~~~~  176 (372)
                      .||+++.    ++.+.+.|||+......
T Consensus       330 GNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  330 GNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CcEEEecCCCCCccEEEEcccccccccH
Confidence            9999984    56899999999876643

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.53  E-value=0.00078  Score=59.89  Aligned_cols=140  Identities=17%  Similarity=0.122  Sum_probs=86.8

Q ss_pred             CCccEEEeeee--hhhhhhhhhhhcccchhhhhhHHHHH---------------HHHHHHHHHHHHHhcCC--CCceeee
Q psy11571         18 GKGRVFSIETL--LDILLVLYDECCNSSLRREKTVSDFI---------------EFVAKLREERDVLVYGD--RRWITNL   78 (372)
Q Consensus        18 g~G~v~~v~~~--~~~~~va~K~~~~~~~~~~~~~~~~~---------------~~~~~l~~E~~il~~l~--hp~Iv~l   78 (372)
                      +.|.-.+|...  .++..+|+|..........+ ..+.+               ....=.+.|..-|.++.  +=.+.+-
T Consensus        57 stGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~-~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~P  135 (268)
T COG1718          57 STGKEANVYLAETGDGRYVAVKIYRTSTSEFKR-IRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEP  135 (268)
T ss_pred             cCCcceEEEeeccCCCceEEEEEEehhhhhhhh-HHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCc
Confidence            44554444432  35788999987766554332 11110               01111345666665542  3344444


Q ss_pred             eEEEEeCCeEEEEEeccCCCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCCcCCCCCcCcEE
Q psy11571         79 HYAFQDDSNLYLVMDYYCGGD-LLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD-LHYVHRPNHFAFHLCRDIKPDNVL  156 (372)
Q Consensus        79 ~~~~~~~~~~~lv~E~~~gg~-L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~~~~~~~~vhrDlkp~NIl  156 (372)
                      +.+.    .-.|||||+.... =.-.|+.  -.+..+++..+..+++..+.-|-. .|+||          +||+.-|||
T Consensus       136 i~~~----~nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~a~LVH----------gDLSEyNiL  199 (268)
T COG1718         136 IAFR----NNVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKEAGLVH----------GDLSEYNIL  199 (268)
T ss_pred             eeec----CCeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHhcCccc----------ccchhhheE
Confidence            4443    2369999984431 1111221  234444788889999999988876 99999          999999999


Q ss_pred             eCCCCcEEEeecCcccccC
Q psy11571        157 LDANGHIRLADFGSCLRLG  175 (372)
Q Consensus       157 l~~~~~vkl~Dfg~a~~~~  175 (372)
                      +. ++.+.++|+|-|....
T Consensus       200 ~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         200 VH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             EE-CCeEEEEECccccccC
Confidence            98 8889999999886543

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.52  E-value=0.00047  Score=61.81  Aligned_cols=30  Identities=23%  Similarity=0.361  Sum_probs=24.4

Q ss_pred             CCcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571        144 FHLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus       144 ~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                      .++|+|+.|.||+++.++..-|+||+.+..
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            367799999999998665567999998743

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PLN02876 acyl-CoA dehydrogenase

Probab=97.52  E-value=0.00058  Score=72.48  Aligned_cols=112  Identities=13%  Similarity=0.161  Sum_probs=69.5

Q ss_pred             HHHHHHHHHhcCC-CCce--eeeeEEEEeC---CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy11571         59 KLREERDVLVYGD-RRWI--TNLHYAFQDD---SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD  132 (372)
Q Consensus        59 ~l~~E~~il~~l~-hp~I--v~l~~~~~~~---~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~  132 (372)
                      .+.+|..+++.+. |++|  .+++.++.+.   +..|+||||++|..+.+..   -..++..+...+..+++.+|..||+
T Consensus        84 ~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~~~~~---~~~~~~~~r~~l~~~l~~~La~LH~  160 (822)
T PLN02876         84 AVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIFVDPK---LPGVAPERRRAIYRATAKVLAALHS  160 (822)
T ss_pred             HHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcccCCcc---CCCCCHHHHHHHHHHHHHHHHHHhC
Confidence            3667999998885 6654  7888877664   4678999999886433210   0123344444455555555555554


Q ss_pred             cCc-------------------------------------------------eecCCC-----CCCCcCCCCCcCcEEeC
Q psy11571        133 LHY-------------------------------------------------VHRPNH-----FAFHLCRDIKPDNVLLD  158 (372)
Q Consensus       133 ~~i-------------------------------------------------vH~~~~-----~~~~vhrDlkp~NIll~  158 (372)
                      ...                                                 -|.+..     ...+||+|+++.||+++
T Consensus       161 vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~  240 (822)
T PLN02876        161 ADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFH  240 (822)
T ss_pred             CCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEc
Confidence            110                                                 001111     23578999999999998


Q ss_pred             C-CCc-EEEeecCcccc
Q psy11571        159 A-NGH-IRLADFGSCLR  173 (372)
Q Consensus       159 ~-~~~-vkl~Dfg~a~~  173 (372)
                      . ++. +-|.||.++..
T Consensus       241 ~~~~~v~aVLDWE~a~~  257 (822)
T PLN02876        241 PTEDRVIGILDWELSTL  257 (822)
T ss_pred             CCCCeEEEEEeeecccc
Confidence            5 334 57999998764

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.50  E-value=0.00062  Score=61.26  Aligned_cols=132  Identities=14%  Similarity=0.106  Sum_probs=77.3

Q ss_pred             ccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCeEEEEEeccCCC
Q psy11571         20 GRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLHYAFQDDSNLYLVMDYYCGG   98 (372)
Q Consensus        20 G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv~E~~~gg   98 (372)
                      ..||.+..  ++..+.+|......   .          ..+.+|..++..+. +--+.+++.+....+..++|||+++|.
T Consensus        13 ~~v~~~~~--~~~~~~vk~~~~~~---~----------~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~   77 (244)
T cd05150          13 ATVYRLDG--KNPGLYLKIAPSGP---T----------YELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV   77 (244)
T ss_pred             CeEEEEcC--CCCcEEEEecCCCc---c----------cchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence            45777753  23456666554332   1          12345666666553 344667777777666789999999998


Q ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCc-------------------------------------------
Q psy11571         99 DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHY-------------------------------------------  135 (372)
Q Consensus        99 ~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i-------------------------------------------  135 (372)
                      +|......    .   ....++.++...+..||+...                                           
T Consensus        78 ~l~~~~~~----~---~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (244)
T cd05150          78 PAAALWEE----L---EPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELY  150 (244)
T ss_pred             cHhHhhcc----c---CHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHH
Confidence            87644210    0   111233344444444443210                                           


Q ss_pred             ---eec--CCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571        136 ---VHR--PNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus       136 ---vH~--~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                         ...  ...+..++|+|+.|.|||++.++.+.|+||+.+..
T Consensus       151 ~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         151 AELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             HHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence               000  01223467899999999999877788999997743

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1826|consensus

Probab=97.48  E-value=2.2e-05  Score=84.28  Aligned_cols=161  Identities=16%  Similarity=0.098  Sum_probs=113.9

Q ss_pred             HHHHHHHHHhcCCCCceeeeeEEEEeC--CeEEEEEeccCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhc
Q psy11571         59 KLREERDVLVYGDRRWITNLHYAFQDD--SNLYLVMDYYCGGDLLTLLSKFE---DRLPEDMAKFYIAEMVLAIASIHDL  133 (372)
Q Consensus        59 ~l~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~lv~E~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~  133 (372)
                      .+..|+..++...|+++...+.-....  ...|..++|+.+|++.+.|-+..   ..+.+..+.....+.+.+..-+|+.
T Consensus      1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred             hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence            344566666677899988877665433  34689999999999999987632   2233344444444435555555542


Q ss_pred             -CceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccc
Q psy11571        134 -HYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECD  212 (372)
Q Consensus       134 -~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~D  212 (372)
                       ++-      .-.||++||+-|.+|..+..+++.++|+.+.... .....+...+++.|++|++...     -.++.++|
T Consensus      1355 tnlg------~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~-----ik~t~rsd 1422 (2724)
T KOG1826|consen 1355 TNLG------NTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNE-----IKFTKRSD 1422 (2724)
T ss_pred             ccCC------ccchhhhhhhhccceecCCcccccccccccccCc-hHhhhhhhhCCHHHHHHHHHHH-----HhhhhHHH
Confidence             222      2335599999999999999999999999983322 2223344667888999998873     45677799


Q ss_pred             eeehhHHHHHHhhCCCCCC
Q psy11571        213 WWSLGVCMYEMLYGETPFY  231 (372)
Q Consensus       213 iwslGvil~elltG~~Pf~  231 (372)
                      +|..|+.+|+...|..+|.
T Consensus      1423 ilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1423 ILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred             HHHHHHHHHHHhcccHHHH
Confidence            9999999999999988874

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.40  E-value=0.00053  Score=60.70  Aligned_cols=70  Identities=20%  Similarity=0.107  Sum_probs=41.8

Q ss_pred             CccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCC--ceeeeeEEEE---eCCeEEEEEe
Q psy11571         19 KGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRR--WITNLHYAFQ---DDSNLYLVMD   93 (372)
Q Consensus        19 ~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp--~Iv~l~~~~~---~~~~~~lv~E   93 (372)
                      .+.+|.+....  ..+++|.....  .          ....+.+|..+++.+...  -+.+++....   .....+++|+
T Consensus        10 ~n~~~~v~~~~--~~~vlK~~~~~--~----------~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~   75 (239)
T PF01636_consen   10 SNRVYRVTTDD--GRYVLKFYRPP--D----------AAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME   75 (239)
T ss_dssp             SSEEEEEEETT--SEEEEEEESSH--H----------HHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred             eeeEEEEEECC--cEEEEEEeCCC--C----------CHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence            45688886443  47888875544  1          123345666666655322  3556665432   2345799999


Q ss_pred             ccCCCCHHH
Q psy11571         94 YYCGGDLLT  102 (372)
Q Consensus        94 ~~~gg~L~~  102 (372)
                      +++|.++..
T Consensus        76 ~i~g~~~~~   84 (239)
T PF01636_consen   76 YIPGRPLDD   84 (239)
T ss_dssp             EESSEEHHH
T ss_pred             Eeccccccc
Confidence            999988877

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PRK10593 hypothetical protein; Provisional

Probab=97.36  E-value=0.0019  Score=60.10  Aligned_cols=73  Identities=11%  Similarity=-0.051  Sum_probs=43.5

Q ss_pred             ccCCccEEEeeeehhh-hhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCC---CceeeeeEEEEeC---CeE
Q psy11571         16 IQGKGRVFSIETLLDI-LLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDR---RWITNLHYAFQDD---SNL   88 (372)
Q Consensus        16 ~~g~G~v~~v~~~~~~-~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~h---p~Iv~l~~~~~~~---~~~   88 (372)
                      .+|.|.+..+..+.+. ..+.+|..+.....            ..+..|...|+.+.-   -.+.++++++.+.   +..
T Consensus        21 ~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~~------------~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~   88 (297)
T PRK10593         21 CISEQPYAALWALYDSQGNPMPLMARSFSTP------------GVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPD   88 (297)
T ss_pred             ecCCccceeEEEEEcCCCCEEEEEecccccc------------hHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCe
Confidence            4566666666665432 23444543221011            235667777776642   3677888776543   568


Q ss_pred             EEEEeccCCCCH
Q psy11571         89 YLVMDYYCGGDL  100 (372)
Q Consensus        89 ~lv~E~~~gg~L  100 (372)
                      ++|||+++|+++
T Consensus        89 ~LVmE~i~G~~~  100 (297)
T PRK10593         89 VLLLERLRGVSV  100 (297)
T ss_pred             EEEEeccCCEec
Confidence            999999998765

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.03  E-value=0.0041  Score=52.55  Aligned_cols=121  Identities=18%  Similarity=0.141  Sum_probs=76.5

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCcee-eeeEEEEeCCeEEEEEeccC
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWIT-NLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv-~l~~~~~~~~~~~lv~E~~~   96 (372)
                      +.|.||.+.  ..+..+|+|.-.......            .+..|.++|..+..-++. ++|.+-.    .++.|||+.
T Consensus        34 ~~s~Vyl~~--~~~~~~a~Kvrr~ds~r~------------~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~   95 (201)
T COG2112          34 TTSVVYLGE--WRGGEVALKVRRRDSPRR------------NLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYID   95 (201)
T ss_pred             cccEEEEee--ccCceEEEEEecCCcchh------------hHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhc
Confidence            567777764  345678888655544433            367788988888765554 4444422    246699999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCC-cCcEEeCCCCcEEEeecCccccc
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIK-PDNVLLDANGHIRLADFGSCLRL  174 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlk-p~NIll~~~~~vkl~Dfg~a~~~  174 (372)
                      |-.|.+.-..  .  +..    -+..++..---|-..||-|          +.|. |..+++..++.+-|+||..|+..
T Consensus        96 G~~L~~~~~~--~--~rk----~l~~vlE~a~~LD~~GI~H----------~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          96 GRPLGKLEIG--G--DRK----HLLRVLEKAYKLDRLGIEH----------GELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             Ccchhhhhhc--c--cHH----HHHHHHHHHHHHHHhccch----------hhhcCCceeEEecCCcEEEEEccchhhc
Confidence            9888776542  1  222    2334444444566788888          6664 44444445668999999988754

>PF00433 Pkinase_C: Protein kinase C terminal domain; InterPro: IPR017892 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=96.84  E-value=0.00026  Score=46.50  Aligned_cols=45  Identities=36%  Similarity=0.469  Sum_probs=26.6

Q ss_pred             CCCCCCCCCCCCCccccCCCCCCCCC-CCCcccccCCCCccCceeeCC
Q psy11571        325 VSSPTDTSHFDVDEAGVRASDALPPA-AASPALSALHLPFVGFTFTQG  371 (372)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  371 (372)
                      ++++.|++|||.+.......  +++. ......+..+..|.||||++.
T Consensus         2 v~~~~DtsnFD~eFt~~~~~--~t~~~~~~~~~~~~~~~F~GFTy~~~   47 (48)
T PF00433_consen    2 VKSETDTSNFDPEFTEEPPV--DTPPSDPSPLSSSMQENFQGFTYVNP   47 (48)
T ss_dssp             -SSTT-GTTSCHHHHTSSSS--S--S--HHHHCTSSGGGGTT-CEETC
T ss_pred             CCchhhhhhcCcccccCCCC--CCCcccCCcccccccCcCCCCeecCC
Confidence            67899999999977755433  3332 222334455566999999874

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This domain is found in a large variety of protein kinases with different functions and dependencies. Protein kinase C, for example, is a calcium-activated, phospholipid-dependent serine- and threonine-specific enzyme. It is activated by diacylglycerol which, in turn, phosphorylates a range of cellular proteins. This domain is most often found associated with IPR000719 from INTERPRO.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3E8D_A 1MRV_A 3E88_A 1GZO_A 1GZK_A 2JDO_A 2JDR_A 1MRY_A 1GZN_A 1O6L_A ....

>TIGR02721 ycfN_thiK thiamine kinase

Probab=96.77  E-value=0.0072  Score=54.80  Aligned_cols=31  Identities=19%  Similarity=0.299  Sum_probs=25.5

Q ss_pred             CCCCcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571        142 FAFHLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus       142 ~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                      +..++|+|+.|.||+++.++ +.|+||..|..
T Consensus       145 ~~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       145 PLAPLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CCeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            34457799999999998877 78999998754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG1093|consensus

Probab=96.68  E-value=0.0035  Score=61.17  Aligned_cols=153  Identities=16%  Similarity=0.162  Sum_probs=91.9

Q ss_pred             HHHHHHHhcCCCCceeeeeEEEEeC-CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecC
Q psy11571         61 REERDVLVYGDRRWITNLHYAFQDD-SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRP  139 (372)
Q Consensus        61 ~~E~~il~~l~hp~Iv~l~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~  139 (372)
                      .-....++.+.|+|...++++-... ....+|||++ +.+|.+++... . +.....          +    .+|+.|  
T Consensus        30 lgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~-~-l~~~s~----------~----~~~~~~--   90 (725)
T KOG1093|consen   30 LGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG-N-LKDESL----------L----AHGVLH--   90 (725)
T ss_pred             hhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc-c-cchhhh----------c----ccccce--
Confidence            3345678889999999999887644 3588999998 77999998762 2 211111          1    233333  


Q ss_pred             CCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHH
Q psy11571        140 NHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVC  219 (372)
Q Consensus       140 ~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvi  219 (372)
                                   .||+       ..+| .++                |. |  |-          ..++++||||+|.+
T Consensus        91 -------------~~~~-------~~td-~~~----------------t~-~--~~----------~~~pKsdVwsl~~i  120 (725)
T KOG1093|consen   91 -------------LNII-------YITD-HFL----------------TK-Y--PS----------PIGPKSDVWSLGFI  120 (725)
T ss_pred             -------------ehhh-------hccc-ccc----------------cc-C--CC----------CCCcchhhhhHHHH
Confidence                         2222       2233 000                00 0  11          12258999999999


Q ss_pred             HHHHhhCCCCCCCCCHHHHHHHHhhccCCcCC------CCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCC
Q psy11571        220 MYEMLYGETPFYAESLVETYGKIMNHQNSFDL------PSDVGYEISDDAKDLMRRLIC-SSDTRLGQNG  282 (372)
Q Consensus       220 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~------~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~  282 (372)
                      +.++..|...+......+....|.+-.....-      ........+.-..++..+|+- .|..||...+
T Consensus       121 ~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~  190 (725)
T KOG1093|consen  121 ILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPME  190 (725)
T ss_pred             HHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhH
Confidence            99999998888766655555444332110000      000011356677788899998 8999996443

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=96.64  E-value=0.006  Score=56.52  Aligned_cols=29  Identities=28%  Similarity=0.308  Sum_probs=24.3

Q ss_pred             CcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571        145 HLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus       145 ~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                      ++|+|+.|.||++++++.+.|+||+.+..
T Consensus       177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         177 VIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            45599999999999877778999997743

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=96.58  E-value=0.013  Score=52.32  Aligned_cols=29  Identities=10%  Similarity=0.306  Sum_probs=24.3

Q ss_pred             CCcCCCCCcCcEEeCC-CCcEEEeecCccc
Q psy11571        144 FHLCRDIKPDNVLLDA-NGHIRLADFGSCL  172 (372)
Q Consensus       144 ~~vhrDlkp~NIll~~-~~~vkl~Dfg~a~  172 (372)
                      .++|+|+.+.|||++. ++.+.|+||..|.
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            3455999999999997 5789999998764

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=96.52  E-value=0.0052  Score=53.29  Aligned_cols=131  Identities=23%  Similarity=0.206  Sum_probs=80.0

Q ss_pred             HHHhhhcCCcccCC-ccEEEeeeehhhhhhhhhhhcccchhhh-----------hhHHHHHHHHHHHHHHHHHHhcC---
Q psy11571          6 ELEALFLGGPIQGK-GRVFSIETLLDILLVLYDECCNSSLRRE-----------KTVSDFIEFVAKLREERDVLVYG---   70 (372)
Q Consensus         6 ~l~~~~~~~~~~g~-G~v~~v~~~~~~~~va~K~~~~~~~~~~-----------~~~~~~~~~~~~l~~E~~il~~l---   70 (372)
                      .|+-++.|    .. |.|++++  .+|+.+|+|....-.....           ..+........-+..|.....++   
T Consensus        41 flefLg~g----~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   41 FLEFLGHG----SHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             eeeecCCC----CceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            34444444    34 6777763  4778999998322111111           01111123445566676665544   


Q ss_pred             CCCce--eeeeEEEEeC------------------CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Q psy11571         71 DRRWI--TNLHYAFQDD------------------SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASI  130 (372)
Q Consensus        71 ~hp~I--v~l~~~~~~~------------------~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~L  130 (372)
                      .+..+  |+++++..-.                  ...-||.||.+...          .+....    +.+|..-+..+
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~~----~~~~~~dl~~~  180 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIRD----IPQMLRDLKIL  180 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchhH----HHHHHHHHHHH
Confidence            45566  9999987321                  12357888776533          223333    45677778889


Q ss_pred             HhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcc
Q psy11571        131 HDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSC  171 (372)
Q Consensus       131 H~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a  171 (372)
                      |..||+-          +|+++.|..   +  -+|+|||.+
T Consensus       181 ~k~gI~~----------~Dv~~~ny~---~--G~lvDfs~~  206 (207)
T PF13095_consen  181 HKLGIVP----------RDVKPRNYR---G--GKLVDFSSS  206 (207)
T ss_pred             HHCCeee----------ccCcccccc---C--CEEEecccC
Confidence            9999999          999999985   3  489999964

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.39  E-value=0.01  Score=55.33  Aligned_cols=112  Identities=13%  Similarity=0.129  Sum_probs=70.2

Q ss_pred             HHHHHHHHHHHHhcCCC--CceeeeeEEEEeCC--eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHH-HHHHHHHHH
Q psy11571         56 FVAKLREERDVLVYGDR--RWITNLHYAFQDDS--NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA-EMVLAIASI  130 (372)
Q Consensus        56 ~~~~l~~E~~il~~l~h--p~Iv~l~~~~~~~~--~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~-qi~~~L~~L  130 (372)
                      ......+|..++..+.-  --+...++.+.++.  ..|.||++++|..+.+.+..      ......++. .+...|+-|
T Consensus        64 ~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~------~~~~~~~~~~~l~~~La~L  137 (321)
T COG3173          64 SAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPP------ESLGRQFALDALADFLAEL  137 (321)
T ss_pred             hhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCc------ccchHHHHHHHHHHHHHHH
Confidence            34556778888877642  23444556666555  67999999988533322211      111112222 445555555


Q ss_pred             HhcC------------------------------------------------ceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571        131 HDLH------------------------------------------------YVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus       131 H~~~------------------------------------------------ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      |+..                                                ..+....+.++||+|+.+.||+++..+-
T Consensus       138 H~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~  217 (321)
T COG3173         138 HSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRP  217 (321)
T ss_pred             hCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCe
Confidence            5410                                                0111557778899999999999998888


Q ss_pred             EEEeecCcccc
Q psy11571        163 IRLADFGSCLR  173 (372)
Q Consensus       163 vkl~Dfg~a~~  173 (372)
                      +-++||+++..
T Consensus       218 ~gVlDwe~~~l  228 (321)
T COG3173         218 TGVLDWELATL  228 (321)
T ss_pred             eEEEecccccc
Confidence            99999999865

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=96.19  E-value=0.033  Score=53.79  Aligned_cols=29  Identities=10%  Similarity=0.186  Sum_probs=23.4

Q ss_pred             CCcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571        144 FHLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus       144 ~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                      .++|+|+.+.|||+..+ .++++||-++..
T Consensus       224 ~l~HgDl~~gni~~~~~-~~~viD~E~a~~  252 (401)
T PRK09550        224 ALLHGDLHTGSIFVTEE-ETKVIDPEFAFY  252 (401)
T ss_pred             ceeeccCCcccEEeeCC-CcEEEecccccc
Confidence            34669999999999765 589999987643

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.17  E-value=0.02  Score=52.68  Aligned_cols=31  Identities=19%  Similarity=0.416  Sum_probs=25.1

Q ss_pred             CCCcCCCCCcCcEEeCCCCc-EEEeecCcccc
Q psy11571        143 AFHLCRDIKPDNVLLDANGH-IRLADFGSCLR  173 (372)
Q Consensus       143 ~~~vhrDlkp~NIll~~~~~-vkl~Dfg~a~~  173 (372)
                      ..++|+|++|.|||++.++. .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45688999999999987565 46999998754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=95.98  E-value=0.029  Score=53.36  Aligned_cols=31  Identities=16%  Similarity=0.247  Sum_probs=25.0

Q ss_pred             CCCcCCCCCcCcEEeCC-CCcEEEeecCcccc
Q psy11571        143 AFHLCRDIKPDNVLLDA-NGHIRLADFGSCLR  173 (372)
Q Consensus       143 ~~~vhrDlkp~NIll~~-~~~vkl~Dfg~a~~  173 (372)
                      ..+.|+|+++.|||+++ ++.+.++||..|..
T Consensus       200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            34455999999999986 46899999998754

>KOG2268|consensus

Probab=95.58  E-value=0.043  Score=51.01  Aligned_cols=92  Identities=14%  Similarity=0.145  Sum_probs=64.0

Q ss_pred             HHHHHHHhcCC-CCc-eeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceec
Q psy11571         61 REERDVLVYGD-RRW-ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHR  138 (372)
Q Consensus        61 ~~E~~il~~l~-hp~-Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~  138 (372)
                      .+|...|+.+. |-+ |.+.+++    +.-++|||++.|-.|.+.-.-    .   .+..+...+..-+--|-.+|+|| 
T Consensus       158 ~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v----~---d~~~ly~~lm~~Iv~la~~GlIH-  225 (465)
T KOG2268|consen  158 TKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV----E---DPPTLYDDLMGLIVRLANHGLIH-  225 (465)
T ss_pred             HHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec----C---ChHHHHHHHHHHHHHHHHcCcee-
Confidence            46777777764 322 3333333    456899999999888665322    1   22334444555566677899999 


Q ss_pred             CCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571        139 PNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus       139 ~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                               +|.+-=||++++++.++++||--+..
T Consensus       226 ---------gDFNEFNimv~dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  226 ---------GDFNEFNIMVKDDDKIVVIDFPQMVS  251 (465)
T ss_pred             ---------cccchheeEEecCCCEEEeechHhhc
Confidence                     99999999999999999999976543

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.06  E-value=0.083  Score=49.86  Aligned_cols=72  Identities=19%  Similarity=0.305  Sum_probs=52.7

Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCCCcCCCCCcCcEEeCCCCcEE
Q psy11571         86 SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDL-HYVHRPNHFAFHLCRDIKPDNVLLDANGHIR  164 (372)
Q Consensus        86 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~~~~~~~~vhrDlkp~NIll~~~~~vk  164 (372)
                      .+.|++|++- |++|.- ++    .-..+++..++.+.+..+.-+... ..-|          ||+.-.||||+ +|+|.
T Consensus       299 ~y~yl~~kdh-gt~is~-ik----~~~~~e~lsff~s~~sil~~lekkf~feh----------rnlt~~niLId-~Gnvt  361 (488)
T COG5072         299 LYLYLHFKDH-GTPISI-IK----ADRSEEELSFFWSCISILDILEKKFPFEH----------RNLTLDNILID-EGNVT  361 (488)
T ss_pred             eEEEEEEecC-Cceeee-ee----cccHHHHHHHHHHHHHHHhhhhhcCCccc----------ccccccceeee-cCceE
Confidence            4678999984 666543 21    234566777777777666655543 4567          99999999999 99999


Q ss_pred             EeecCccccc
Q psy11571        165 LADFGSCLRL  174 (372)
Q Consensus       165 l~Dfg~a~~~  174 (372)
                      |+||-+++..
T Consensus       362 LIDfklsRl~  371 (488)
T COG5072         362 LIDFKLSRLS  371 (488)
T ss_pred             EEEeeeeecc
Confidence            9999999843

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=94.46  E-value=0.11  Score=48.10  Aligned_cols=139  Identities=15%  Similarity=0.116  Sum_probs=61.9

Q ss_pred             CCccEEEeeee-hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC---CCCceeeeeEEEEeCCeEEEEEe
Q psy11571         18 GKGRVFSIETL-LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG---DRRWITNLHYAFQDDSNLYLVMD   93 (372)
Q Consensus        18 g~G~v~~v~~~-~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l---~hp~Iv~l~~~~~~~~~~~lv~E   93 (372)
                      +.|.+-.+..+ .+++.+-+|.......             ..+..|..-|+.+   ..-.+++.+.+...++..|||||
T Consensus        26 ~GG~i~~a~~~~~~~~~~FvK~~~~~~~-------------~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle   92 (288)
T PF03881_consen   26 SGGDINEAYRLDTDGGSYFVKVNSESGR-------------DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLE   92 (288)
T ss_dssp             --SSSSEEEEEETTS-EEEEEEEEGGGC-------------CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE
T ss_pred             CCCChhheEEEECCCccEEEEecChhhH-------------HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEE
Confidence            34544444333 4567777776652211             1244565555555   34567888888887777899999


Q ss_pred             ccCCC--------CHHHH---HHh-c-CCC-----------------CCHHHHHHHHHH-HHHHHHHHHhcC--------
Q psy11571         94 YYCGG--------DLLTL---LSK-F-EDR-----------------LPEDMAKFYIAE-MVLAIASIHDLH--------  134 (372)
Q Consensus        94 ~~~gg--------~L~~~---l~~-~-~~~-----------------l~~~~~~~~~~q-i~~~L~~LH~~~--------  134 (372)
                      |++.+        .|...   |.+ . .+.                 ....-..+++.+ |.--++.+-+.|        
T Consensus        93 ~l~~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~  172 (288)
T PF03881_consen   93 FLEMGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELER  172 (288)
T ss_dssp             --------CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHH
T ss_pred             eecCCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHH
Confidence            98776        11111   112 1 111                 112223333332 222222222221        


Q ss_pred             -------ceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecC
Q psy11571        135 -------YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG  169 (372)
Q Consensus       135 -------ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg  169 (372)
                             .++...+...+||+||-+.|++++.+|.+.|.|=.
T Consensus       173 l~~~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa  214 (288)
T PF03881_consen  173 LVERLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA  214 (288)
T ss_dssp             HHHHHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred             HHHHHHHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence                   12333455677889999999999999989998865

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=93.88  E-value=0.43  Score=42.13  Aligned_cols=84  Identities=19%  Similarity=0.245  Sum_probs=55.6

Q ss_pred             HHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--cCcee
Q psy11571         60 LREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD--LHYVH  137 (372)
Q Consensus        60 l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~--~~ivH  137 (372)
                      ++.+..++.++.  .|+++..-  +...+-+++|.|-....          ..   .-.+.+ =+.+|.-.|+  .+.+|
T Consensus       105 y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i----------~~---~N~i~a-gi~~L~~fH~~~~~~lH  166 (308)
T PF07387_consen  105 YFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI----------NF---SNFITA-GIKDLMDFHSENQHCLH  166 (308)
T ss_pred             hhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc----------ch---hHHHHH-hHHHHHHhhccCCCeec
Confidence            455677777763  47777632  34457799999843211          11   111111 1356777783  46888


Q ss_pred             cCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcc
Q psy11571        138 RPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSC  171 (372)
Q Consensus       138 ~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a  171 (372)
                                +|..|+|||-|+.|.+||.|-+..
T Consensus       167 ----------GD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  167 ----------GDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             ----------CCCChhheeecCCCCEEecChhhh
Confidence                      999999999999999999998753

The function of this family is unknown.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=93.85  E-value=0.15  Score=48.23  Aligned_cols=30  Identities=20%  Similarity=0.354  Sum_probs=24.3

Q ss_pred             CCcCCCCCcCcEEeCC-CCcEEEeecCcccc
Q psy11571        144 FHLCRDIKPDNVLLDA-NGHIRLADFGSCLR  173 (372)
Q Consensus       144 ~~vhrDlkp~NIll~~-~~~vkl~Dfg~a~~  173 (372)
                      .+-|.|+.+.|||+++ ++.++++||..|..
T Consensus       183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            3345999999999974 57899999998754

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=92.59  E-value=0.59  Score=44.50  Aligned_cols=28  Identities=11%  Similarity=0.218  Sum_probs=22.4

Q ss_pred             CcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571        145 HLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus       145 ~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                      ++|+|+.+.||+++.++ ++++|+.++..
T Consensus       194 llHGDl~~gNi~~~~~~-~~~iD~e~~~~  221 (370)
T TIGR01767       194 LLHGDLHSGSIFVSEHE-TKVIDPEFAFY  221 (370)
T ss_pred             eeeccCCcccEEEcCCC-CEEEcCccccc
Confidence            34599999999997654 78999987644

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PRK10271 thiK thiamine kinase; Provisional

Probab=92.58  E-value=0.11  Score=44.56  Aligned_cols=28  Identities=29%  Similarity=0.438  Sum_probs=23.7

Q ss_pred             CcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571        145 HLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus       145 ~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                      ..|+|+.|.||+++++| ++|+||+.+..
T Consensus        79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            34599999999998777 89999998754

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=91.85  E-value=0.38  Score=44.67  Aligned_cols=25  Identities=28%  Similarity=0.511  Sum_probs=21.8

Q ss_pred             CCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571        148 RDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus       148 rDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                      +|+.+.||+++. +.+.|+||+.+..
T Consensus       192 gD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       192 QDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CCCCcccEEEeC-CcEEEEECccccc
Confidence            999999999987 6789999997643

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=91.77  E-value=0.29  Score=45.56  Aligned_cols=28  Identities=32%  Similarity=0.432  Sum_probs=23.7

Q ss_pred             CcCCCCCcCcEEeCCCCcEEEeecCccc
Q psy11571        145 HLCRDIKPDNVLLDANGHIRLADFGSCL  172 (372)
Q Consensus       145 ~vhrDlkp~NIll~~~~~vkl~Dfg~a~  172 (372)
                      ++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       189 l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       189 VIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCCCCcCcEEEECCceEEEeeccccc
Confidence            3449999999999988767899999764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=91.62  E-value=0.35  Score=45.21  Aligned_cols=29  Identities=24%  Similarity=0.291  Sum_probs=23.3

Q ss_pred             CcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571        145 HLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus       145 ~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                      ++|+|+.|.||+++.+...-|+||+.+..
T Consensus       189 liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        189 VIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cCCCCCCCCcEEEECCceEEEEecccccC
Confidence            45599999999998665558999998743

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=91.29  E-value=0.36  Score=45.49  Aligned_cols=52  Identities=25%  Similarity=0.320  Sum_probs=32.0

Q ss_pred             HHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc-EEEeecCccc
Q psy11571        121 AEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH-IRLADFGSCL  172 (372)
Q Consensus       121 ~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~-vkl~Dfg~a~  172 (372)
                      .++...+..+.+.=-.|-+.....+||+|+.|.||+++.+.. +.++||+-+.
T Consensus       175 a~~~~~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         175 AALLAALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             HHHHHHHHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            344445555554321221111122333999999999998874 8999999764

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=90.81  E-value=0.42  Score=44.29  Aligned_cols=32  Identities=22%  Similarity=0.223  Sum_probs=25.7

Q ss_pred             CCCCcCCCCCcCcEEeCCC----CcEEEeecCcccc
Q psy11571        142 FAFHLCRDIKPDNVLLDAN----GHIRLADFGSCLR  173 (372)
Q Consensus       142 ~~~~vhrDlkp~NIll~~~----~~vkl~Dfg~a~~  173 (372)
                      +..+.|+|+.|.||+++.+    +.+.++||..|..
T Consensus       178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            3344559999999999874    8899999998743

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PTZ00384 choline kinase; Provisional

Probab=90.05  E-value=1.6  Score=42.20  Aligned_cols=25  Identities=24%  Similarity=0.103  Sum_probs=20.7

Q ss_pred             CCCCCcCcEEeCCCCcEEEeecCccc
Q psy11571        147 CRDIKPDNVLLDANGHIRLADFGSCL  172 (372)
Q Consensus       147 hrDlkp~NIll~~~~~vkl~Dfg~a~  172 (372)
                      |.|+-+.||+.++ +.+.++||-.|.
T Consensus       231 HNDL~~gNIL~~~-~~l~lID~EYA~  255 (383)
T PTZ00384        231 HNDLFFTNILDFN-QGIYFIDFDFAG  255 (383)
T ss_pred             eccCCcccEEecC-CCEEEEEecccc
Confidence            3999999999854 459999998764

>KOG2270|consensus

Probab=89.83  E-value=0.95  Score=43.08  Aligned_cols=73  Identities=21%  Similarity=0.290  Sum_probs=56.0

Q ss_pred             EEEEEeccCCCCHHH--HHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hcCceecCCCCCCCcCCCCCcCcEEeCCCCcEE
Q psy11571         88 LYLVMDYYCGGDLLT--LLSKFEDRLPEDMAKFYIAEMVLAIASIH-DLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIR  164 (372)
Q Consensus        88 ~~lv~E~~~gg~L~~--~l~~~~~~l~~~~~~~~~~qi~~~L~~LH-~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vk  164 (372)
                      -.|||+|+. .+=+-  .|+  ...++...+..+-.|++.-+.-|. .+++||          .||.--|+|+ .+|.+.
T Consensus       239 hVLVM~FlG-rdgw~aPkLK--d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVH----------ADLSEfN~Ly-hdG~ly  304 (520)
T KOG2270|consen  239 HVLVMEFLG-RDGWAAPKLK--DASLSTSKARELYQQCVRIMRRLYQKCRLVH----------ADLSEFNLLY-HDGKLY  304 (520)
T ss_pred             ceEeeeecc-CCCCcCcccc--cccCChHHHHHHHHHHHHHHHHHHHHhceec----------cchhhhhheE-ECCEEE
Confidence            379999984 33222  233  356888889998888888887775 578999          9999999999 678899


Q ss_pred             EeecCccccc
Q psy11571        165 LADFGSCLRL  174 (372)
Q Consensus       165 l~Dfg~a~~~  174 (372)
                      ++|-+-+...
T Consensus       305 iIDVSQSVE~  314 (520)
T KOG2270|consen  305 IIDVSQSVEH  314 (520)
T ss_pred             EEEccccccC
Confidence            9999877543

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=89.42  E-value=0.31  Score=45.68  Aligned_cols=52  Identities=27%  Similarity=0.399  Sum_probs=32.7

Q ss_pred             HHHHHHHHHHHHHHHHHHH----hcCceecCCCCCCCcCCCCCcCcEEeCCCC------------------cEEEeecCc
Q psy11571        113 EDMAKFYIAEMVLAIASIH----DLHYVHRPNHFAFHLCRDIKPDNVLLDANG------------------HIRLADFGS  170 (372)
Q Consensus       113 ~~~~~~~~~qi~~~L~~LH----~~~ivH~~~~~~~~vhrDlkp~NIll~~~~------------------~vkl~Dfg~  170 (372)
                      .+-++.++.||+.-.--+-    -.+.+|          -||||+|||+-+..                  .++|.||.+
T Consensus       274 ~~YvkfifLQiaLLyikIYelp~c~nF~H----------~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDf  343 (434)
T PF05445_consen  274 VEYVKFIFLQIALLYIKIYELPCCTNFLH----------VDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDF  343 (434)
T ss_pred             HHHHHHHHHHHHHHHeeeecCCCcceeee----------cccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCH
Confidence            3456667777765331121    235677          99999999994322                  356778877


Q ss_pred             cccc
Q psy11571        171 CLRL  174 (372)
Q Consensus       171 a~~~  174 (372)
                      |+..
T Consensus       344 Sqv~  347 (434)
T PF05445_consen  344 SQVA  347 (434)
T ss_pred             HHhc
Confidence            7654

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>PLN02756 S-methyl-5-thioribose kinase

Probab=88.77  E-value=1.8  Score=41.96  Aligned_cols=26  Identities=12%  Similarity=0.275  Sum_probs=21.4

Q ss_pred             cCCCCCcCcEEeCCCCcEEEeecCccc
Q psy11571        146 LCRDIKPDNVLLDANGHIRLADFGSCL  172 (372)
Q Consensus       146 vhrDlkp~NIll~~~~~vkl~Dfg~a~  172 (372)
                      +|+||.|.|||++.++ .+++|.-++.
T Consensus       233 ~HGDl~~g~i~~~~~~-~~~id~ef~~  258 (418)
T PLN02756        233 VHGDLHTGSVMVTPDS-TQVIDPEFAF  258 (418)
T ss_pred             eecCCCCCcEEEcCCC-ceEecchhhc
Confidence            5699999999998765 8888877654

>COG4499 Predicted membrane protein [Function unknown]

Probab=88.30  E-value=4.5  Score=38.22  Aligned_cols=123  Identities=12%  Similarity=0.099  Sum_probs=74.8

Q ss_pred             HHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCC
Q psy11571         63 ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHF  142 (372)
Q Consensus        63 E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~  142 (372)
                      +..++.. ..|+|+.-+..  +.+.+.|-.+-.  .....+-.-  ..+.....++++.|.+..|.-+-... .|     
T Consensus        41 ~~~lld~-~~~f~~~eit~--~~Ds~vIsy~i~--~~~~~F~~~--k~~~k~~Klr~a~~~I~~l~e~~~tr-~~-----  107 (434)
T COG4499          41 LAELLDK-SPPFIVAEITE--DNDSFVISYPIP--EAAKSFASA--KRKEKTRKLRLALQNIATLSELNNTR-YT-----  107 (434)
T ss_pred             HHHHhcc-CCCccceeecc--cCceeEEEecCc--cccchHHHH--HHHHHHHHHHHHHHHHHHHHHhhccc-ee-----
Confidence            4556666 56777665543  344444444433  233222211  23556666777778777776544322 23     


Q ss_pred             CCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHH
Q psy11571        143 AFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYE  222 (372)
Q Consensus       143 ~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~e  222 (372)
                           -=|.|+||+++.++.+.+.-+|+-..+             .|.=+.||.+..               ++-+++..
T Consensus       108 -----~~laPeNilf~~~l~p~~vH~Glk~~l-------------pPye~tee~f~~---------------~ykA~~~~  154 (434)
T COG4499         108 -----FFLAPENILFDGGLTPFFVHRGLKNSL-------------PPYEMTEERFLK---------------EYKALAIY  154 (434)
T ss_pred             -----EEecchheEEcCCCceEEEecchhccC-------------CCCCCCHHHHHH---------------HHHHHHHH
Confidence                 346799999999999999999975332             222355665542               35577888


Q ss_pred             HhhCCCCCC
Q psy11571        223 MLYGETPFY  231 (372)
Q Consensus       223 lltG~~Pf~  231 (372)
                      ++.|..+|.
T Consensus       155 ~fn~k~~Fe  163 (434)
T COG4499         155 AFNGKFSFE  163 (434)
T ss_pred             HHcCCccHH
Confidence            889999985

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=88.03  E-value=0.89  Score=41.60  Aligned_cols=28  Identities=29%  Similarity=0.419  Sum_probs=24.7

Q ss_pred             cCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571        146 LCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus       146 vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                      +|.|+.|+|++.++.+.++|+||-.|..
T Consensus       156 cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         156 CHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             ecCCCCccceEEcCCCcEEEEecccCCC
Confidence            3499999999999989999999987754

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=87.39  E-value=0.99  Score=39.42  Aligned_cols=26  Identities=31%  Similarity=0.683  Sum_probs=19.1

Q ss_pred             CCCCcCcEEe-CCCCcEEEeecCcccc
Q psy11571        148 RDIKPDNVLL-DANGHIRLADFGSCLR  173 (372)
Q Consensus       148 rDlkp~NIll-~~~~~vkl~Dfg~a~~  173 (372)
                      .|+.|.|||+ +.++.++|+||..|..
T Consensus       148 nDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  148 NDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             ccCccccEEeccCCCeEEEecHHHHhh
Confidence            9999999999 7889999999998754

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	372
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-120
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-117
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-117
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		5e-87
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-72
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-72
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-72
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-69
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-40
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-40
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-40
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-40
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-40
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-40
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-40
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-40
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-40
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-40
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-40
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-40
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-40
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-40
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-40
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-40
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-40
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-40
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-40
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-40
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-40
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-40
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-40
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		6e-40
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-40
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-40
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		7e-40
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-40
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		7e-40
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		8e-40
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		9e-40
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-39
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-39
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-39
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-39
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-39
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-39
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-39
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-39
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-39
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-39
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-39
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-39
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-39
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-39
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-39
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-39
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-39
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-39
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-39
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-39
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-39
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-39
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-36
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-36
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-36
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		9e-36
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-34
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-34
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-34
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-33
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-33
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-33
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-33
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-32
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-32
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-32
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-32
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-32
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-31
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-31
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		8e-31
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		9e-31
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-30
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-30
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-30
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-30
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-30
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-30
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-30
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		6e-30
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		7e-30
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-29
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-27
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-27
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-27
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-27
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-27
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-27
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		6e-27
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-27
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-27
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-27
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		7e-27
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-27
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		7e-27
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		7e-27
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		8e-27
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		8e-27
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		8e-27
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-27
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		9e-27
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-26
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-26
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		9e-25
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		9e-25
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		8e-23
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-22
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		5e-22
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-22
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-21
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-21
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-21
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-21
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-21
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-21
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		5e-20
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-20
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-20
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-20
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-20
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-19
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-19
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-19
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-19
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-19
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-19
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-19
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-19
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-19
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-19
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-19
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-19
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-19
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-19
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-19
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-19
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-19
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-19
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-19
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-19
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-19
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-19
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-19
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-19
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-19
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-19
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		6e-19
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-19
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		7e-19
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		7e-19
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-19
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		7e-19
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-19
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-19
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		8e-19
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		8e-19
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-18
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-18
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-18
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-18
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-18
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-18
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-18
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-18
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-18
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-18
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-18
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-18
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-18
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-18
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-18
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-18
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-18
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-18
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-18
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-18
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-18
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-18
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-18
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-18
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-18
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-18
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-18
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-18
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-18
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		6e-18
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-18
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-18
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		8e-18
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-18
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-18
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-18
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		9e-18
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-17
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-17
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-17
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-17
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-17
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-17
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-17
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-17
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-17
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-17
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-17
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-17
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-17
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-17
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-17
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-17
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-17
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-17
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-17
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-17
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-17
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-17
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-17
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-17
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-17
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-17
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-17
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-17
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-17
3soa_A	444	Full-Length Human Camkii Length = 444		7e-17
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-17
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-17
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		9e-17
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-16
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-16
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-16
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-16
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-16
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-16
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-16
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-16
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-16
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-16
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-16
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-16
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-16
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-16
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-16
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-16
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-16
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-16
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		6e-16
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-16
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		7e-16
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		8e-16
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		9e-16
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		9e-16
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-15
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-15
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-15
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-15
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-15
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-15
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-15
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-15
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-15
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-15
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-15
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-15
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-15
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-15
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-15
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-15
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-15
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-15
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		6e-15
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		8e-15
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-14
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-14
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-14
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-14
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-14
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-14
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-14
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-14
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-14
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-14
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-14
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-14
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-14
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-14
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-14
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-14
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-14
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		4e-14
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-14
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-14
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		6e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		7e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		7e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		8e-14
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		9e-14
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-13
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-13
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-13
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-13
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-13
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-13
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-13
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-13
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		4e-13
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		4e-13
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		5e-13
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-13
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-13
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		7e-13
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		8e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-12
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-12
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-12
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-12
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		9e-12
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-11
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-11
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-11
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-11
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-11
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-11
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-11
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-11
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-11
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		6e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		9e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		9e-11
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		9e-11
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-10
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-10
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-10
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-10
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-10
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-10
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-10
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		1e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-09
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-09
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-09
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-09
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-09
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-09
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		8e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		8e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		8e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		9e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-08
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-08
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		2e-08
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-08
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-08
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-08
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-08
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-08
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		6e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-08
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-08
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-08
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		7e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		7e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		8e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		9e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		9e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		9e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		9e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		9e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		9e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		9e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		9e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		9e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		9e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-07
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-07
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-07
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-07
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-07
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-07
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-07
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-07
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-07
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-07
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-07
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-07
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-07
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-07
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-07
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-07
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-07
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-07
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-07
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		6e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		7e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		7e-07
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		9e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-06
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-06
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-06
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-06
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-06
3gni_B	389	Structure Of Strad And Mo25 Length = 389		2e-06
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-06
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-06
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-06
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-06
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-06
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-06
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-06
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-06
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-06
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-06
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-06
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-06
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-06
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-06
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-06
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-06
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-06
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-06
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-06
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-06
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-06
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-06
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-06
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-06
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-06
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-06
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-06
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-06
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-06
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-06
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-06
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-06
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-06
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-06
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-06
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-06
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-06
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-06
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-06
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		5e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		5e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		5e-06
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-06
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-06
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		5e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		5e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		5e-06
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		5e-06
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		5e-06
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		5e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-06
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		5e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-06
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		5e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-06
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-06
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-06
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-06
3a4o_X	286	Lyn Kinase Domain Length = 286		7e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-06
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		7e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		7e-06
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		8e-06
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-06
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		8e-06
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		8e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-06
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		8e-06
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		8e-06
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		8e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-06
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		8e-06
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		9e-06
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		9e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-06
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		9e-06
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		9e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		9e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		9e-06
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		9e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		9e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		9e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		9e-06
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		9e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		9e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		9e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		9e-06
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		9e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		9e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		9e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		9e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		9e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		9e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-05
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-05
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-05
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-05
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-05
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-05
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-05
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-05
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-05
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-05
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-05
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-05
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-05
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-05
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-05
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-05
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-05
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-05
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-05
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-05
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-05
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-05
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		1e-05
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-05
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-05
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-05
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-05
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-05
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-05
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-05
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-05
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-05
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-05
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-05
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-05
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-05
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-05
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		2e-05
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-05
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-05
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-05
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-05
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-05
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-05
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-05
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-05
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-05
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-05
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-05
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-05
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-05
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-05
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-05
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-05
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-05
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-05
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-05
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-05
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-05
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-05
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-05
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-05
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-05
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		4e-05
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-05
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-05
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-05
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-05
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-05
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-05
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		7e-05
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		7e-05
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		7e-05
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		7e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-05
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		7e-05
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		7e-05
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		7e-05
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		7e-05
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		7e-05
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		7e-05
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		7e-05
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		7e-05
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-05
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		7e-05
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		7e-05
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-05
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-05
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		8e-05
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		8e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		8e-05
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		9e-05
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-05
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		9e-05
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		9e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		9e-05
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-04
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-04
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-04
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-04
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-04
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-04
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-04
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-04
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-04
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-04
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-04
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-04
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-04
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-04
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-04
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-04
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-04
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-04
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-04
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-04
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-04
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-04
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-04
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-04
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-04
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-04
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-04
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-04
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-04
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-04
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-04
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-04
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-04
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-04
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-04
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		2e-04
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-04
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-04
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-04
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-04
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-04
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-04
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-04
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-04
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-04
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		2e-04
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-04
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-04
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-04
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-04
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-04
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-04
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-04
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-04
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-04
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-04
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-04
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-04
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-04
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-04
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-04
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-04
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-04
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-04
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-04
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-04
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-04
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-04
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-04
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-04
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-04
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-04
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-04
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-04
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-04
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-04
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-04
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-04
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-04
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-04
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		4e-04
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-04
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-04
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-04
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-04
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		5e-04
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-04
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-04
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-04
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-04
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-04
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-04
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-04
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-04
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		6e-04
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-04
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		6e-04
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-04
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		7e-04
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		7e-04
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		7e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		7e-04
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		8e-04
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		8e-04
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-04
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-04
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-04
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		8e-04
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		9e-04
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		9e-04

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  428 bits (1101), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 213/313 (68%), Positives = 241/313 (76%), Gaps = 26/313 (8%)
Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
            A  REERDVLV GD +WIT LHYAFQDD+NLYLVMDYY GGDLLTLLSKFEDRLPE+MA
Sbjct: 118 TACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA 177
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FY+AEMV+AI S+H LHYVHR          DIKPDN+L+D NGHIRLADFGSCL+L  
Sbjct: 178 RFYLAEMVIAIDSVHQLHYVHR----------DIKPDNILMDMNGHIRLADFGSCLKLME 227
Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
           DGTVQS+VAVGTPDYISPEIL AME G+GRYGPECDWWSLGVCMYEMLYGETPFYAESLV
Sbjct: 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 287
Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSL 296
           ETYGKIMNH+  F  P+ V  ++S++AKDL+RRLICS + RLGQNGI DFK         
Sbjct: 288 ETYGKIMNHKERFQFPTQVT-DVSENAKDLIRRLICSREHRLGQNGIEDFK--------- 337
Query: 297 SISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRXXXXXXXXXXXXXX 356
                 HP+F GI WD+IR+  APYIPEVSSPTDTS+FDVD+  ++              
Sbjct: 338 -----KHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLK-NSETMPPPTHTAF 391
Query: 357 XXXHLPFVGFTFT 369
              HLPFVGFT+T
Sbjct: 392 SGHHLPFVGFTYT 404

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score =  417 bits (1072), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 209/313 (66%), Positives = 240/313 (76%), Gaps = 26/313 (8%)
Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
            A  REERDVLV GD +WIT LHYAFQD+++LYLVMDYY GGDLLTLLSKFED+LPEDMA
Sbjct: 134 TACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMA 193
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FYI EMVLAI SIH LHYVHR          DIKPDNVLLD NGHIRLADFGSCL++  
Sbjct: 194 RFYIGEMVLAIDSIHQLHYVHR----------DIKPDNVLLDVNGHIRLADFGSCLKMND 243
Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
           DGTVQS+VAVGTPDYISPEIL AME+G G+YGPECDWWSLGVCMYEMLYGETPFYAESLV
Sbjct: 244 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 303
Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSL 296
           ETYGKIMNH+  F  PS V  ++S++AKDL++RLICS + RLGQNGI DFK         
Sbjct: 304 ETYGKIMNHEERFQFPSHVT-DVSEEAKDLIQRLICSRERRLGQNGIEDFK--------- 353
Query: 297 SISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRXXXXXXXXXXXXXX 356
                 H +F+G+ W++IR+  APYIP+VSSP+DTS+FDVD+  +R              
Sbjct: 354 -----KHAFFEGLNWENIRNLEAPYIPDVSSPSDTSNFDVDDDVLR-NTEILPPGSHTGF 407
Query: 357 XXXHLPFVGFTFT 369
              HLPF+GFTFT
Sbjct: 408 SGLHLPFIGFTFT 420

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score =  417 bits (1071), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 209/313 (66%), Positives = 240/313 (76%), Gaps = 26/313 (8%)
Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
            A  REERDVLV GD +WIT LHYAFQD+++LYLVMDYY GGDLLTLLSKFED+LPEDMA
Sbjct: 118 TACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMA 177
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FYI EMVLAI SIH LHYVHR          DIKPDNVLLD NGHIRLADFGSCL++  
Sbjct: 178 RFYIGEMVLAIDSIHQLHYVHR----------DIKPDNVLLDVNGHIRLADFGSCLKMND 227
Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
           DGTVQS+VAVGTPDYISPEIL AME+G G+YGPECDWWSLGVCMYEMLYGETPFYAESLV
Sbjct: 228 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 287
Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSL 296
           ETYGKIMNH+  F  PS V  ++S++AKDL++RLICS + RLGQNGI DFK         
Sbjct: 288 ETYGKIMNHEERFQFPSHVT-DVSEEAKDLIQRLICSRERRLGQNGIEDFK--------- 337
Query: 297 SISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRXXXXXXXXXXXXXX 356
                 H +F+G+ W++IR+  APYIP+VSSP+DTS+FDVD+  +R              
Sbjct: 338 -----KHAFFEGLNWENIRNLEAPYIPDVSSPSDTSNFDVDDDVLR-NTEILPPGSHTGF 391
Query: 357 XXXHLPFVGFTFT 369
              HLPF+GFTFT
Sbjct: 392 SGLHLPFIGFTFT 404

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score =  317 bits (813), Expect = 5e-87,   Method: Compositional matrix adjust.
 Identities = 170/319 (53%), Positives = 215/319 (67%), Gaps = 31/319 (9%)
Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           V+  REERDVLV GDRRWIT LH+AFQD++ LYLVM+YY GGDLLTLLSKF +R+P +MA
Sbjct: 105 VSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA 164
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FY+AE+V+AI S+H L YVH          RDIKPDN+LLD  GHIRLADFGSCL+L  
Sbjct: 165 RFYLAEIVMAIDSVHRLGYVH----------RDIKPDNILLDRCGHIRLADFGSCLKLRA 214
Query: 177 DGTVQSNVAVGTPDYISPEILTAM--EEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES 234
           DGTV+S VAVGTPDY+SPEIL A+    G G YGPECDWW+LGV  YEM YG+TPFYA+S
Sbjct: 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274
Query: 235 LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFV 294
             ETYGKI++++    LP  V   + ++A+D ++RL+C  +TRLG+ G  DF        
Sbjct: 275 TAETYGKIVHYKEHLSLPL-VDEGVPEEARDFIQRLLCPPETRLGRGGAGDF-------- 325
Query: 295 SLSISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAG----VRXXXXXXXX 350
                 R HP+F G+ WD +RDS  P+ P+    TDT +FD+ E G    V         
Sbjct: 326 ------RTHPFFFGLDWDGLRDSVPPFTPDFEGATDTCNFDLVEDGLTAMVSGGGETLSD 379
Query: 351 XXXXXXXXXHLPFVGFTFT 369
                    HLPFVG++++
Sbjct: 380 IREGAPLGVHLPFVGYSYS 398

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  268 bits (685), Expect = 3e-72,   Method: Compositional matrix adjust.
 Identities = 140/307 (45%), Positives = 198/307 (64%), Gaps = 30/307 (9%)
Query: 62  EERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA 121
           EERD++ + +  W+  L YAFQDD  LY+VM+Y  GGDL+ L+S ++  +PE  A+FY A
Sbjct: 123 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTA 180
Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ 181
           E+VLA+ +IH + ++HR          D+KPDN+LLD +GH++LADFG+C+++  +G V+
Sbjct: 181 EVVLALDAIHSMGFIHR----------DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 230
Query: 182 SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 241
            + AVGTPDYISPE+L + + G G YG ECDWWS+GV +YEML G+TPFYA+SLV TY K
Sbjct: 231 CDTAVGTPDYISPEVLKS-QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK 289
Query: 242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPR 301
           IMNH+NS   P D   +IS +AK+L+   +   + RLG+NG+ + K    LF       +
Sbjct: 290 IMNHKNSLTFPDD--NDISKEAKNLICAFLTDREVRLGRNGVEEIK--RHLFF------K 339
Query: 302 NHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRXXXXXXXXXXXXXXXXXHL 361
           N  W    AW+++RD+ AP +P++SS  DTS+FD  E                      L
Sbjct: 340 NDQW----AWETLRDTVAPVVPDLSSDIDTSNFDDLE---EDKGEEETFPIPKAFVGNQL 392
Query: 362 PFVGFTF 368
           PFVGFT+
Sbjct: 393 PFVGFTY 399

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  268 bits (685), Expect = 4e-72,   Method: Compositional matrix adjust.
 Identities = 140/307 (45%), Positives = 198/307 (64%), Gaps = 30/307 (9%)
Query: 62  EERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA 121
           EERD++ + +  W+  L YAFQDD  LY+VM+Y  GGDL+ L+S ++  +PE  A+FY A
Sbjct: 118 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTA 175
Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ 181
           E+VLA+ +IH + ++HR          D+KPDN+LLD +GH++LADFG+C+++  +G V+
Sbjct: 176 EVVLALDAIHSMGFIHR----------DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225
Query: 182 SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 241
            + AVGTPDYISPE+L + + G G YG ECDWWS+GV +YEML G+TPFYA+SLV TY K
Sbjct: 226 CDTAVGTPDYISPEVLKS-QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK 284
Query: 242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPR 301
           IMNH+NS   P D   +IS +AK+L+   +   + RLG+NG+ + K    LF       +
Sbjct: 285 IMNHKNSLTFPDD--NDISKEAKNLICAFLTDREVRLGRNGVEEIK--RHLFF------K 334
Query: 302 NHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRXXXXXXXXXXXXXXXXXHL 361
           N  W    AW+++RD+ AP +P++SS  DTS+FD  E                      L
Sbjct: 335 NDQW----AWETLRDTVAPVVPDLSSDIDTSNFDDLE---EDKGEEETFPIPKAFVGNQL 387
Query: 362 PFVGFTF 368
           PFVGFT+
Sbjct: 388 PFVGFTY 394

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  268 bits (685), Expect = 4e-72,   Method: Compositional matrix adjust.
 Identities = 140/307 (45%), Positives = 198/307 (64%), Gaps = 30/307 (9%)
Query: 62  EERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA 121
           EERD++ + +  W+  L YAFQDD  LY+VM+Y  GGDL+ L+S ++  +PE  A+FY A
Sbjct: 123 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTA 180
Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ 181
           E+VLA+ +IH + ++HR          D+KPDN+LLD +GH++LADFG+C+++  +G V+
Sbjct: 181 EVVLALDAIHSMGFIHR----------DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 230
Query: 182 SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 241
            + AVGTPDYISPE+L + + G G YG ECDWWS+GV +YEML G+TPFYA+SLV TY K
Sbjct: 231 CDTAVGTPDYISPEVLKS-QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK 289
Query: 242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPR 301
           IMNH+NS   P D   +IS +AK+L+   +   + RLG+NG+ + K    LF       +
Sbjct: 290 IMNHKNSLTFPDD--NDISKEAKNLICAFLTDREVRLGRNGVEEIK--RHLFF------K 339
Query: 302 NHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRXXXXXXXXXXXXXXXXXHL 361
           N  W    AW+++RD+ AP +P++SS  DTS+FD  E                      L
Sbjct: 340 NDQW----AWETLRDTVAPVVPDLSSDIDTSNFDDLE---EDKGEEETFPIPKAFVGNQL 392
Query: 362 PFVGFTF 368
           PFVGFT+
Sbjct: 393 PFVGFTY 399

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  260 bits (664), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 138/311 (44%), Positives = 194/311 (62%), Gaps = 38/311 (12%)
Query: 62  EERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA 121
           EERD++ + +  W+  L  AFQDD  LY+VM+Y  GGDL+ L+S ++  +PE  AKFY A
Sbjct: 124 EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWAKFYTA 181
Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ 181
           E+VLA+ +IH +  +HR          D+KPDN+LLD +GH++LADFG+C+++   G V 
Sbjct: 182 EVVLALDAIHSMGLIHR----------DVKPDNMLLDKHGHLKLADFGTCMKMDETGMVH 231
Query: 182 SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 241
            + AVGTPDYISPE+L + + G G YG ECDWWS+GV ++EML G+TPFYA+SLV TY K
Sbjct: 232 CDTAVGTPDYISPEVLKS-QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSK 290
Query: 242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPR 301
           IM+H+NS   P D   EIS  AK+L+   +   + RLG+NG+ + K              
Sbjct: 291 IMDHKNSLCFPEDA--EISKHAKNLICAFLTDREVRLGRNGVEEIK-------------- 334
Query: 302 NHPWFQGIA--WDSIRDSNAPYIPEVSSPTDTSHFD--VDEAGVRXXXXXXXXXXXXXXX 357
            HP+F+     WD+IR++ AP +PE+SS  D+S+FD   D+ G                 
Sbjct: 335 QHPFFKNDQWNWDNIRETAAPVVPELSSDIDSSNFDDIEDDKG-----DVETFPIPKAFV 389
Query: 358 XXHLPFVGFTF 368
              LPF+GFT+
Sbjct: 390 GNQLPFIGFTY 400

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 107/314 (34%), Positives = 168/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 57  VMLVKHMETGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GGD+ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 115 NLYMVMEYMPGGDMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 165
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ADFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 166 --DLKPENLLIDQQGYIKVADFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 214
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 268
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 314
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 315 IPKFKGPGDTSNFD 328

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 107/314 (34%), Positives = 168/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 57  VMLVKHMETGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GGD+ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 115 NLYMVMEYMPGGDMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 165
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ADFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 166 --DLKPENLLIDQQGYIKVADFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 214
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 268
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 314
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 315 IPKFKGPGDTSNFD 328

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 57  VMLVKHKESGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 165
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 166 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLAGTPEYLAPEIILS----KG- 214
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 268
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 314
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 315 IPKFKGPGDTSNFD 328

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 108/298 (36%), Positives = 154/298 (51%), Gaps = 48/298 (16%)
Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTL 103
           L++E  V   ++ V    +ER +L      +I  +   FQD   ++++MDY  GG+L +L
Sbjct: 39  LKKEIVVR--LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL 96
Query: 104 LSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI 163
           L K   R P  +AKFY AE+ LA+  +H    ++R          D+KP+N+LLD NGHI
Sbjct: 97  LRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYR----------DLKPENILLDKNGHI 145
Query: 164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM 223
           ++ DFG   +   D T       GTPDYI+PE+++        Y    DWWS G+ +YEM
Sbjct: 146 KITDFGFA-KYVPDVTYX---LCGTPDYIAPEVVSTKP-----YNKSIDWWSFGILIYEM 196
Query: 224 LYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLG--Q 280
           L G TPFY  + ++TY KI+N +  F  P       ++D KDL+ RLI      RLG  Q
Sbjct: 197 LAGYTPFYDSNTMKTYEKILNAELRFP-PF-----FNEDVKDLLSRLITRDLSQRLGNLQ 250
Query: 281 NGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPT-DTSHFD 335
           NG  D K              NHPWF+ + W+ +  R+   PY P +     DTS FD
Sbjct: 251 NGTEDVK--------------NHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFD 294

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 57  VMLVKHKESGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 165
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 166 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLXGTPEYLAPEIILS----KG- 214
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 268
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 314
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 315 IPKFKGPGDTSNFD 328

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 58  VMLVKHKESGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 115
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 116 NLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 166
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 167 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 215
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 269
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 315
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 316 IPKFKGPGDTSNFD 329

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 106/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L Y+F+D+S
Sbjct: 57  VMLVKHKETGNHFAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNS 114
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 115 NLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 165
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 166 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 214
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 268
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 314
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 315 IPKFKGPGDTSNFD 328

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 57  VMLVKHKESGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRI-GRFAEPHARFYAAQIVLTFEYLHSLDLIYR-------- 165
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+  + +G   
Sbjct: 166 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEII--LSKG--- 214
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 268
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 314
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 315 IPKFKGPGDTSNFD 328

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 57  VMLVKHKESGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 165
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 166 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 214
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 268
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 314
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 315 IPKFKGPGDTSNFD 328

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 106/314 (33%), Positives = 168/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 57  VMLVKHMETGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 115 NLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 165
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ADFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 166 --DLKPENLLIDQQGYIKVADFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 214
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 268
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 314
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 315 IPKFKGPGDTSNFD 328

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 57  VMLVKHKESGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 165
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 166 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 214
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 268
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 314
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 315 IPKFKGPGDTSNFD 328

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 52  VMLVKHKESGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 109
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 110 NLYMVMEYVAGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYR-------- 160
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 161 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 209
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 210 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 263
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 264 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 309
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 310 IPKFKGPGDTSNFD 323

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 44  VMLVKHKESGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 101
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 102 NLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 152
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 153 --DLKPENLLIDEQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 201
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 202 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 255
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 256 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 301
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 302 IPKFKGPGDTSNFD 315

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 78  VMLVKHKESGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 135
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 136 NLYMVMEYVAGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYR-------- 186
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 187 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 235
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 236 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 289
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 290 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 335
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 336 IPKFKGPGDTSNFD 349

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 57  VMLVKHKESGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYR-------- 165
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 166 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 214
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 268
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 314
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 315 IPKFKGPGDTSNFD 328

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 166/314 (52%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 78  VMLVKHKESGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 135
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 136 NLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 186
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G     +    GTP+Y++PEI+ +    +G 
Sbjct: 187 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----ATWTLCGTPEYLAPEIILS----KG- 235
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 236 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 289
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 290 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 335
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 336 IPKFKGPGDTSNFD 349

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 57  VMLVKHKESGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 165
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 166 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 214
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRF--PS----HFSSDLKDL 268
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 314
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 315 IPKFKGPGDTSNFD 328

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 57  VMLVKHKESGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYR-------- 165
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 166 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 214
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 268
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 314
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 315 IPKFKGPGDTSNFD 328

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 104/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 57  VMLVKHKESGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 165
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+++D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 166 --DLKPENLIIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIIIS----KG- 214
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 268
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 314
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 315 IPKFKGPGDTSNFD 328

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 168/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++T L ++F+D+S
Sbjct: 58  VMLVKHMETGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNS 115
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 116 NLYMVMEYAPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 166
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+++D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 167 --DLKPENLMIDQQGYIKVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 215
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 269
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 315
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 316 IPKFKGPGDTSNFD 329

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 168/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++T L ++F+D+S
Sbjct: 58  VMLVKHMETGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNS 115
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 116 NLYMVMEYAPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 166
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+++D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 167 --DLKPENLMIDQQGYIKVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 215
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 269
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 315
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 316 IPKFKGPGDTSNFD 329

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 57  VMLVKHKESGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYR-------- 165
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 166 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 214
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 268
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 314
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 315 IPKFKGPGDTSNFD 328

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 78  VMLVKHKETGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 135
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 136 NLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 186
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 187 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 235
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 236 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 289
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 290 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 335
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 336 IPKFKGPGDTSNFD 349

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 168/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++T L ++F+D+S
Sbjct: 58  VMLVKHMETGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNS 115
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 116 NLYMVMEYAPGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYR-------- 166
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+++D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 167 --DLKPENLMIDQQGYIKVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 215
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 269
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 315
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 316 IPKFKGPGDTSNFD 329

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 58  VMLVKHKETGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 115
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 116 NLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 166
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 167 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 215
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 269
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 315
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 316 IPKFKGPGDTSNFD 329

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  161 bits (407), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 58  VMLVKHKETGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 115
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 116 NLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 166
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 167 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 215
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 269
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 315
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 316 IPKFKGPGDTSNFD 329

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  161 bits (407), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 104/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 57  VMLVKHKESGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 165
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+  + +G   
Sbjct: 166 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEII--LSKG--- 214
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +Y+M  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 215 YNKAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 268
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 314
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 315 IPKFKGPGDTSNFD 328

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  161 bits (407), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 50  VMLVKHKETGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 107
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 108 NLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 158
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 159 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 207
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 208 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 261
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 262 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 307
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 308 IPKFKGPGDTSNFD 321

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  161 bits (407), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 103/314 (32%), Positives = 166/314 (52%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 57  VMLVKHKESGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 165
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 166 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 214
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 268
Query: 267 MRRLICSSDTRLG---QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T+     +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 269 LRNLLQVDLTKAFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 314
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 315 IPKFKGPGDTSNFD 328

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  160 bits (406), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 104/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 58  VMLVKHKETGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 115
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 116 NLYMVMEYAPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 166
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+++D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 167 --DLKPENLMIDQQGYIKVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 215
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 269
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 315
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 316 IPKFKGPGDTSNFD 329

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  160 bits (406), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 58  VMLVKHMETGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 115
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 116 NLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 166
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 167 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEYLAPEIILS----KG- 215
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 269
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 315
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 316 IPKFKGPGDTSNFD 329

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 50  VMLVKHKETGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 107
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 108 NLYMVMEYVPGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYR-------- 158
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 159 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 207
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 208 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 261
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 262 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 307
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 308 IPKFKGPGDTSNFD 321

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L Y+F+D+S
Sbjct: 57  VMLVKHKETGNHFAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNS 114
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 115 NLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 165
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 166 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 214
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 268
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  ++G+ D K              NH WF    W +I  R   AP+
Sbjct: 269 LRNLLQVDLTKRFGNLKDGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 314
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 315 IPKFKGPGDTSNFD 328

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L Y+F+D+S
Sbjct: 57  VMLVKHKETGNHFAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNS 114
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 115 NLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 165
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 166 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 214
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 268
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  ++G+ D K              NH WF    W +I  R   AP+
Sbjct: 269 LRNLLQVDLTKRFGNLKDGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 314
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 315 IPKFKGPGDTSNFD 328

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 58  VMLVKHMETGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 115
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 116 NLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 166
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 167 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 215
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 269
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 315
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 316 IPKFKGPGDTSNFD 329

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 101/290 (34%), Positives = 157/290 (54%), Gaps = 51/290 (17%)
Query: 57  VAKLRE------ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR 110
           V KL+E      E+ +L   +  ++  L ++F+D+SNLY+VM+Y  GG++ + L +   R
Sbjct: 79  VVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI-GR 137
Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGS 170
             E  A+FY A++VL    +H L  ++R          D+KP+N+++D  G+I++ DFG 
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYR----------DLKPENLMIDQQGYIKVTDFGL 187
Query: 171 CLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
             R+ G    ++    GTP+Y++PEI+ +    +G Y    DWW+LGV +YEM  G  PF
Sbjct: 188 AKRVKG----RTWXLCGTPEYLAPEIILS----KG-YNKAVDWWALGVLIYEMAAGYPPF 238
Query: 231 YAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT-RLG--QNGIADFK 287
           +A+  ++ Y KI++ +  F  PS      S D KDL+R L+    T R G  +NG+ D K
Sbjct: 239 FADQPIQIYEKIVSGKVRF--PS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIK 292
Query: 288 MWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFD 335
                         NH WF    W +I  R   AP+IP+   P DTS+FD
Sbjct: 293 --------------NHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 104/314 (33%), Positives = 166/314 (52%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 57  VMLVKHKESGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 165
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++P I+  + +G   
Sbjct: 166 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPAII--LSKG--- 214
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 268
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 314
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 315 IPKFKGPGDTSNFD 328

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 57  VMLVKHMETGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 115 NLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 165
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 166 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 214
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 268
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 314
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 315 IPKFKGPGDTSNFD 328

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 57  VMLVKHMETGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 115 NLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 165
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 166 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 214
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 268
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 314
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 315 IPKFKGPGDTSNFD 328

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  160 bits (404), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 57  VMLVKHMETGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 115 NLYMVMEYVPGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYR-------- 165
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 166 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 214
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 268
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 314
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 315 IPKFKGPGDTSNFD 328

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 57  VMLVKHMETGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 115 NLYMVMEYVPGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYR-------- 165
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 166 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 214
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 268
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 314
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 315 IPKFKGPGDTSNFD 328

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 58  VMLVKHMETGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 115
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 116 NLYMVMEYVPGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYR-------- 166
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 167 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 215
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 269
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 315
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 316 IPKFKGPGDTSNFD 329

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 104/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 57  VMLVKHMETGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 115 NLYMVMEYAPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 165
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+++D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 166 --DLKPENLMIDQQGYIKVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 214
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 268
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 314
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 315 IPKFKGPGDTSNFD 328

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 104/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +    +  ++  L ++F+D+S
Sbjct: 58  VMLVKHKETGNHYAMKILDKQKVVK--LKQIEHTLNEKRIQQAVNFPFLVKLEFSFKDNS 115
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+V++Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 116 NLYMVLEYAPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 166
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ADFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 167 --DLKPENLLIDQQGYIKVADFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 215
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 269
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 315
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 316 IPKFKGPGDTSNFD 329

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 101/290 (34%), Positives = 157/290 (54%), Gaps = 51/290 (17%)
Query: 57  VAKLRE------ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR 110
           V KL+E      E+ +L   +  ++  L ++F+D+SNLY+VM+Y  GG++ + L +   R
Sbjct: 79  VVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI-GR 137
Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGS 170
             E  A+FY A++VL    +H L  ++R          D+KP+N+++D  G+I++ DFG 
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYR----------DLKPENLMIDQQGYIQVTDFGL 187
Query: 171 CLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
             R+ G    ++    GTP+Y++PEI+ +    +G Y    DWW+LGV +YEM  G  PF
Sbjct: 188 AKRVKG----RTWXLCGTPEYLAPEIILS----KG-YNKAVDWWALGVLIYEMAAGYPPF 238
Query: 231 YAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT-RLG--QNGIADFK 287
           +A+  ++ Y KI++ +  F  PS      S D KDL+R L+    T R G  +NG+ D K
Sbjct: 239 FADQPIQIYEKIVSGKVRF--PS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIK 292
Query: 288 MWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFD 335
                         NH WF    W +I  R   AP+IP+   P DTS+FD
Sbjct: 293 --------------NHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 104/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 57  VMLVKHMETGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 115 NLYMVMEYAPGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYR-------- 165
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+++D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 166 --DLKPENLMIDQQGYIKVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 214
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 268
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 314
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 315 IPKFKGPGDTSNFD 328

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 104/314 (33%), Positives = 166/314 (52%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 58  VMLVKHKETGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 115
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 116 NLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 166
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 167 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 215
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 269
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D                NH WF    W +I  R   AP+
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDI--------------XNHKWFATTDWIAIYQRKVEAPF 315
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 316 IPKFKGPGDTSNFD 329

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 104/314 (33%), Positives = 166/314 (52%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 57  VMLVKHKESGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 165
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+ ++PEI+  + +G   
Sbjct: 166 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEALAPEII--LSKG--- 214
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 268
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 314
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 315 IPKFKGPGDTSNFD 328

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 104/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 57  VMLVKHMETGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 115 NLYMVMEYAPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 165
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+++D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 166 --DLKPENLMIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 214
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 268
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  +NG+ D K              NH WF    W +I  R   AP+
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 314
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 315 IPKFKGPGDTSNFD 328

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 104/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 57  VMLVKHMETGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 165
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 166 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 214
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 268
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  ++G+ D K              NH WF    W +I  R   AP+
Sbjct: 269 LRNLLQVDLTKRFGNLKDGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 314
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 315 IPKFKGPGDTSNFD 328

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  158 bits (399), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 104/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 43  VMLVKHMETGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 100
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 101 NLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 151
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 152 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEYLAPEIILS----KG- 200
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 201 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 254
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  ++G+ D K              NH WF    W +I  R   AP+
Sbjct: 255 LRNLLQVDLTKRFGNLKDGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 300
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 301 IPKFKGPGDTSNFD 314

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  158 bits (399), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 104/314 (33%), Positives = 165/314 (52%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 57  VMLVKHKESGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 165
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+  + +G   
Sbjct: 166 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEII--LSKG--- 214
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 268
Query: 267 MRRLICSSDT-RLGQ--NGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G   NG+ D K              NH WF    W +I  R   AP+
Sbjct: 269 LRNLLQVDLTKRFGNLPNGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 314
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+ D
Sbjct: 315 IPKFKGPGDTSNAD 328

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  158 bits (399), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 104/314 (33%), Positives = 167/314 (53%), Gaps = 51/314 (16%)
Query: 31  ILLVLYDECCN----SSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS 86
           ++LV + E  N      L ++K V   ++ +     E+ +L   +  ++  L ++F+D+S
Sbjct: 57  VMLVKHMETGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NLY+VM+Y  GG++ + L +   R  E  A+FY A++VL    +H L  ++R        
Sbjct: 115 NLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 165
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP+N+L+D  G+I++ DFG   R+ G    ++    GTP+Y++PEI+ +    +G 
Sbjct: 166 --DLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILS----KG- 214
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
           Y    DWW+LGV +YEM  G  PF+A+  ++ Y KI++ +  F  PS      S D KDL
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PS----HFSSDLKDL 268
Query: 267 MRRLICSSDT-RLG--QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPY 321
           +R L+    T R G  ++G+ D K              NH WF    W +I  R   AP+
Sbjct: 269 LRNLLQVDLTKRFGNLKDGVNDIK--------------NHKWFATTDWIAIYQRKVEAPF 314
Query: 322 IPEVSSPTDTSHFD 335
           IP+   P DTS+FD
Sbjct: 315 IPKFKGPGDTSNFD 328

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 145/283 (51%), Gaps = 42/283 (14%)
Query: 58  AKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAK 117
            + + ERD+LV  +  +I  LHYAFQ +  LYL++D+  GGDL T LSK E    E+  K
Sbjct: 71  VRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVK 129
Query: 118 FYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD 177
           FY+AE+ LA+  +H L  ++          RD+KP+N+LLD  GHI+L DFG   +   D
Sbjct: 130 FYLAELALALDHLHSLGIIY----------RDLKPENILLDEEGHIKLTDFGLS-KESID 178
Query: 178 GTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 237
              ++    GT +Y++PE++      R  +    DWWS GV M+EML G  PF  +   E
Sbjct: 179 HEKKAYSFCGTVEYMAPEVVN-----RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE 233
Query: 238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT-RLGQ--NGIADFKMWSALFV 294
           T   I+  +    +P      +S +A+ L+R L   +   RLG   +G+ + K       
Sbjct: 234 TMTMIL--KAKLGMPQF----LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIK------- 280
Query: 295 SLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFD 335
                   H +F  I W+ +  R+ + P+ P    P DT +FD
Sbjct: 281 -------RHSFFSTIDWNKLYRREIHPPFKPATGRPEDTFYFD 316

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 98/281 (34%), Positives = 145/281 (51%), Gaps = 36/281 (12%)
Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
            A  + ER++L      +I +L YAFQ    LYL+++Y  GG+L   L + E    ED A
Sbjct: 65  TAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER-EGIFMEDTA 123
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
            FY+AE+ +A+  +H    ++R          D+KP+N++L+  GH++L DFG C     
Sbjct: 124 CFYLAEISMALGHLHQKGIIYR----------DLKPENIMLNHQGHVKLTDFGLCKESIH 173
Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
           DGTV ++   GT +Y++PEIL  M  G  R     DWWSLG  MY+ML G  PF  E+  
Sbjct: 174 DGTV-THTFCGTIEYMAPEIL--MRSGHNR---AVDWWSLGALMYDMLTGAPPFTGENRK 227
Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSL 296
           +T  KI+  +   +LP  +  E  D  K L++R   ++ +RLG  G  D     A     
Sbjct: 228 KTIDKIL--KCKLNLPPYLTQEARDLLKKLLKR---NAASRLGA-GPGDAGEVQA----- 276
Query: 297 SISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFD 335
                 HP+F+ I W+ +  R    P+ P + S  D S FD
Sbjct: 277 ------HPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFD 311

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  148 bits (373), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 98/281 (34%), Positives = 145/281 (51%), Gaps = 36/281 (12%)
Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
            A  + ER++L      +I +L YAFQ    LYL+++Y  GG+L   L + E    ED A
Sbjct: 65  TAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER-EGIFMEDTA 123
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
            FY+AE+ +A+  +H    ++R          D+KP+N++L+  GH++L DFG C     
Sbjct: 124 CFYLAEISMALGHLHQKGIIYR----------DLKPENIMLNHQGHVKLTDFGLCKESIH 173
Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
           DGTV ++   GT +Y++PEIL  M  G  R     DWWSLG  MY+ML G  PF  E+  
Sbjct: 174 DGTV-THXFCGTIEYMAPEIL--MRSGHNR---AVDWWSLGALMYDMLTGAPPFTGENRK 227
Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSL 296
           +T  KI+  +   +LP  +  E  D  K L++R   ++ +RLG  G  D     A     
Sbjct: 228 KTIDKIL--KCKLNLPPYLTQEARDLLKKLLKR---NAASRLGA-GPGDAGEVQA----- 276
Query: 297 SISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFD 335
                 HP+F+ I W+ +  R    P+ P + S  D S FD
Sbjct: 277 ------HPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFD 311

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  147 bits (371), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 95/277 (34%), Positives = 141/277 (50%), Gaps = 40/277 (14%)
Query: 63  ERDVLVYGDRR-WITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA 121
           ER+VL+   +  ++  LH++FQ    LY V+DY  GG+L   L + E    E  A+FY A
Sbjct: 88  ERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR-ERCFLEPRARFYAA 146
Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ 181
           E+  A+  +H L+ V+R          D+KP+N+LLD+ GHI L DFG C +   +    
Sbjct: 147 EIASALGYLHSLNIVYR----------DLKPENILLDSQGHIVLTDFGLC-KENIEHNST 195
Query: 182 SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 241
           ++   GTP+Y++PE+L      +  Y    DWW LG  +YEMLYG  PFY+ +  E Y  
Sbjct: 196 TSTFCGTPEYLAPEVL-----HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN 250
Query: 242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT-RLGQNGIADFKMWSALFVSLSISP 300
           I+N       P  +   I++ A+ L+  L+    T RLG     DF           +  
Sbjct: 251 ILNK------PLQLKPNITNSARHLLEGLLQKDRTKRLGAKD--DF-----------MEI 291
Query: 301 RNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFD 335
           ++H +F  I WD +  +    P+ P VS P D  HFD
Sbjct: 292 KSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHFD 328

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 92/277 (33%), Positives = 142/277 (51%), Gaps = 42/277 (15%)
Query: 62  EERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA 121
           E+R + +  +  ++T++   FQ   NL+ VM+Y  GGDL+  +     +     A FY A
Sbjct: 67  EKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAA 125
Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ 181
           E++L +  +H    V+R          D+K DN+LLD +GHI++ADFG C +    G  +
Sbjct: 126 EIILGLQFLHSKGIVYR----------DLKLDNILLDKDGHIKIADFGMC-KENMLGDAK 174
Query: 182 SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 241
           +N   GTPDYI+PEIL        +Y    DWWS GV +YEML G++PF+ +   E +  
Sbjct: 175 TNXFCGTPDYIAPEILLGQ-----KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF-- 227
Query: 242 IMNHQNSFDLPSDVGYEISDDAKDLMRRL-ICSSDTRLGQNGIADFKMWSALFVSLSISP 300
              H    D P    + +  +AKDL+ +L +   + RLG  G                  
Sbjct: 228 ---HSIRMDNPFYPRW-LEKEAKDLLVKLFVREPEKRLGVRG----------------DI 267
Query: 301 RNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFD 335
           R HP F+ I W+ +  ++ + P+ P+V SP D S+FD
Sbjct: 268 RQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFD 304

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 92/277 (33%), Positives = 142/277 (51%), Gaps = 42/277 (15%)
Query: 62  EERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA 121
           E+R + +  +  ++T++   FQ   NL+ VM+Y  GGDL+  +     +     A FY A
Sbjct: 68  EKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAA 126
Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ 181
           E++L +  +H    V+R          D+K DN+LLD +GHI++ADFG C +    G  +
Sbjct: 127 EIILGLQFLHSKGIVYR----------DLKLDNILLDKDGHIKIADFGMC-KENMLGDAK 175
Query: 182 SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 241
           +N   GTPDYI+PEIL        +Y    DWWS GV +YEML G++PF+ +   E +  
Sbjct: 176 TNEFCGTPDYIAPEILLGQ-----KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF-- 228
Query: 242 IMNHQNSFDLPSDVGYEISDDAKDLMRRL-ICSSDTRLGQNGIADFKMWSALFVSLSISP 300
              H    D P    + +  +AKDL+ +L +   + RLG  G                  
Sbjct: 229 ---HSIRMDNPFYPRW-LEKEAKDLLVKLFVREPEKRLGVRG----------------DI 268
Query: 301 RNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFD 335
           R HP F+ I W+ +  ++ + P+ P+V SP D S+FD
Sbjct: 269 RQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFD 305

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 93/284 (32%), Positives = 143/284 (50%), Gaps = 42/284 (14%)
Query: 58  AKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAK 117
            + + ERD+L   +  ++  LHYAFQ +  LYL++D+  GGDL T LSK E    E+  K
Sbjct: 75  VRTKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVK 133
Query: 118 FYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD 177
           FY+AE+ L +  +H L  ++          RD+KP+N+LLD  GHI+L DFG   +   D
Sbjct: 134 FYLAELALGLDHLHSLGIIY----------RDLKPENILLDEEGHIKLTDFGLS-KEAID 182
Query: 178 GTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 237
              ++    GT +Y++PE++      R  +    DWWS GV M+EML G  PF  +   E
Sbjct: 183 HEKKAYSFCGTVEYMAPEVVN-----RQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKE 237
Query: 238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT-RLGQ--NGIADFKMWSALFV 294
           T   I+  +    +P      +S +A+ L+R L   +   RLG   +G  + K       
Sbjct: 238 TMTLIL--KAKLGMPQ----FLSTEAQSLLRALFKRNPANRLGSGPDGAEEIK------- 284
Query: 295 SLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFDV 336
                   H ++  I W+ +  R+   P+ P V+ P DT +FD 
Sbjct: 285 -------RHVFYSTIDWNKLYRREIKPPFKPAVAQPDDTFYFDT 321

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 95/281 (33%), Positives = 144/281 (51%), Gaps = 37/281 (13%)
Query: 60  LREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFY 119
           + E+R + +  +  ++T L   FQ    L+ VM++  GGDL+  + K   R  E  A+FY
Sbjct: 71  MTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEARARFY 129
Query: 120 IAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT 179
            AE++ A+  +HD   ++R          D+K DNVLLD  GH +LADFG C + G    
Sbjct: 130 AAEIISALMFLHDKGIIYR----------DLKLDNVLLDHEGHCKLADFGMC-KEGICNG 178
Query: 180 VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 239
           V +    GTPDYI+PEIL  M      YGP  DWW++GV +YEML G  PF AE+  + +
Sbjct: 179 VTTATFCGTPDYIAPEILQEM-----LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF 233
Query: 240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT-RLGQNGIADFKMWSALFVSLSI 298
             I+N +  +  P+     + +DA  +++  +  + T RLG           +L      
Sbjct: 234 EAILNDEVVY--PT----WLHEDATGILKSFMTKNPTMRLG-----------SLTQGGEH 276
Query: 299 SPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFDVD 337
           +   HP+F+ I W  +  R    P+ P + S  D S+FD D
Sbjct: 277 AILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPD 317

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 93/292 (31%), Positives = 147/292 (50%), Gaps = 30/292 (10%)
Query: 46  REKTVSDFIEFVAKLREERDVLVYGDRR-WITNLHYAFQDDSNLYLVMDYYCGGDLLTLL 104
           ++ T+    +     R ER VL +  +  ++  LHYAFQ ++ L+L++DY  GG+L T L
Sbjct: 91  KKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL 150
Query: 105 SKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIR 164
           S+ E R  E   + Y+ E+VLA+  +H L  ++R          DIK +N+LLD+NGH+ 
Sbjct: 151 SQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYR----------DIKLENILLDSNGHVV 199
Query: 165 LADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML 224
           L DFG       D T ++    GT +Y++P+I+   + G  +     DWWSLGV MYE+L
Sbjct: 200 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDK---AVDWWSLGVLMYELL 256
Query: 225 YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIA 284
            G +PF  +    +  +I       + P     E+S  AKDL++RL+     +    G  
Sbjct: 257 TGASPFTVDGEKNSQAEISRRILKSEPPYP--QEMSALAKDLIQRLLMKDPKKRLGCGPR 314
Query: 285 DFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHF 334
           D           +   + H +FQ I WD +  +   AP+ P +    D S+F
Sbjct: 315 D-----------ADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELDVSNF 355

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 91/271 (33%), Positives = 139/271 (51%), Gaps = 42/271 (15%)
Query: 58  AKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAK 117
            + + ERD+LV  +  +I  LHYAFQ +  LYL++D+  GGDL T LSK E    E+  K
Sbjct: 71  VRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVK 129
Query: 118 FYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD 177
           FY+AE+ LA+  +H L  ++          RD+KP+N+LLD  GHI+L DFG   +   D
Sbjct: 130 FYLAELALALDHLHSLGIIY----------RDLKPENILLDEEGHIKLTDFGLS-KESID 178
Query: 178 GTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 237
              ++    GT +Y++PE++      R  +    DWWS GV M+EML G  PF  +   E
Sbjct: 179 HEKKAYSFCGTVEYMAPEVVN-----RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE 233
Query: 238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT-RLGQ--NGIADFKMWSALFV 294
           T   I+  +    +P      +S +A+ L+R L   +   RLG   +G+ + K       
Sbjct: 234 TMTMIL--KAKLGMPQF----LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIK------- 280
Query: 295 SLSISPRNHPWFQGIAWDSI--RDSNAPYIP 323
                   H +F  I W+ +  R+ + P+ P
Sbjct: 281 -------RHSFFSTIDWNKLYRREIHPPFKP 304

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 91/271 (33%), Positives = 139/271 (51%), Gaps = 42/271 (15%)
Query: 58  AKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAK 117
            + + ERD+LV  +  +I  LHYAFQ +  LYL++D+  GGDL T LSK E    E+  K
Sbjct: 72  VRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVK 130
Query: 118 FYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD 177
           FY+AE+ LA+  +H L  ++          RD+KP+N+LLD  GHI+L DFG   +   D
Sbjct: 131 FYLAELALALDHLHSLGIIY----------RDLKPENILLDEEGHIKLTDFGLS-KESID 179
Query: 178 GTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 237
              ++    GT +Y++PE++      R  +    DWWS GV M+EML G  PF  +   E
Sbjct: 180 HEKKAYSFCGTVEYMAPEVVN-----RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE 234
Query: 238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT-RLGQ--NGIADFKMWSALFV 294
           T   I+  +    +P      +S +A+ L+R L   +   RLG   +G+ + K       
Sbjct: 235 TMTMIL--KAKLGMPQF----LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIK------- 281
Query: 295 SLSISPRNHPWFQGIAWDSI--RDSNAPYIP 323
                   H +F  I W+ +  R+ + P+ P
Sbjct: 282 -------RHSFFSTIDWNKLYRREIHPPFKP 305

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 102/321 (31%), Positives = 150/321 (46%), Gaps = 53/321 (16%)
Query: 17  QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWIT 76
           +  GR ++++ L   ++V  DE                  VA    E  VL      ++T
Sbjct: 170 KATGRYYAMKILKKEVIVAKDE------------------VAHTLTENRVLQNSRHPFLT 211
Query: 77  NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYV 136
            L Y+FQ    L  VM+Y  GG+L   LS+ E    ED A+FY AE+V A      L Y+
Sbjct: 212 ALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSA------LDYL 264
Query: 137 HRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEI 196
           H   +  +   RD+K +N++LD +GHI++ DFG C     DG        GTP+Y++PE+
Sbjct: 265 HSEKNVVY---RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEV 320
Query: 197 LTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVG 256
           L   +     YG   DWW LGV MYEM+ G  PFY +   + +  I+  +  F  P  +G
Sbjct: 321 LEDND-----YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF--PRTLG 373
Query: 257 YEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRD 316
            E    AK L+  L+     +    G  D K               H +F GI W  + +
Sbjct: 374 PE----AKSLLSGLLKKDPKQRLGGGSEDAK-----------EIMQHRFFAGIVWQHVYE 418
Query: 317 S--NAPYIPEVSSPTDTSHFD 335
              + P+ P+V+S TDT +FD
Sbjct: 419 KKLSPPFKPQVTSETDTRYFD 439

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 102/321 (31%), Positives = 150/321 (46%), Gaps = 53/321 (16%)
Query: 17  QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWIT 76
           +  GR ++++ L   ++V  DE                  VA    E  VL      ++T
Sbjct: 30  KATGRYYAMKILKKEVIVAKDE------------------VAHTLTENRVLQNSRHPFLT 71
Query: 77  NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYV 136
            L Y+FQ    L  VM+Y  GG+L   LS+ E    ED A+FY AE+V A      L Y+
Sbjct: 72  ALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSA------LDYL 124
Query: 137 HRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEI 196
           H   +  +   RD+K +N++LD +GHI++ DFG C     DG        GTP+Y++PE+
Sbjct: 125 HSEKNVVY---RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFC-GTPEYLAPEV 180
Query: 197 LTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVG 256
           L   + GR       DWW LGV MYEM+ G  PFY +   + +  I+  +  F  P  +G
Sbjct: 181 LEDNDYGRA-----VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF--PRTLG 233
Query: 257 YEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRD 316
            E    AK L+  L+     +    G  D K               H +F GI W  + +
Sbjct: 234 PE----AKSLLSGLLKKDPKQRLGGGSEDAK-----------EIMQHRFFAGIVWQHVYE 278
Query: 317 S--NAPYIPEVSSPTDTSHFD 335
              + P+ P+V+S TDT +FD
Sbjct: 279 KKLSPPFKPQVTSETDTRYFD 299

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 102/321 (31%), Positives = 150/321 (46%), Gaps = 53/321 (16%)
Query: 17  QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWIT 76
           +  GR ++++ L   ++V  DE                  VA    E  VL      ++T
Sbjct: 173 KATGRYYAMKILKKEVIVAKDE------------------VAHTLTENRVLQNSRHPFLT 214
Query: 77  NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYV 136
            L Y+FQ    L  VM+Y  GG+L   LS+ E    ED A+FY AE+V A      L Y+
Sbjct: 215 ALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSA------LDYL 267
Query: 137 HRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEI 196
           H   +  +   RD+K +N++LD +GHI++ DFG C     DG        GTP+Y++PE+
Sbjct: 268 HSEKNVVY---RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEV 323
Query: 197 LTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVG 256
           L   +     YG   DWW LGV MYEM+ G  PFY +   + +  I+  +  F  P  +G
Sbjct: 324 LEDND-----YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF--PRTLG 376
Query: 257 YEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRD 316
            E    AK L+  L+     +    G  D K               H +F GI W  + +
Sbjct: 377 PE----AKSLLSGLLKKDPKQRLGGGSEDAK-----------EIMQHRFFAGIVWQHVYE 421
Query: 317 S--NAPYIPEVSSPTDTSHFD 335
              + P+ P+V+S TDT +FD
Sbjct: 422 KKLSPPFKPQVTSETDTRYFD 442

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 102/321 (31%), Positives = 150/321 (46%), Gaps = 53/321 (16%)
Query: 17  QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWIT 76
           +  GR ++++ L   ++V  DE                  VA    E  VL      ++T
Sbjct: 31  KATGRYYAMKILKKEVIVAKDE------------------VAHTLTENRVLQNSRHPFLT 72
Query: 77  NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYV 136
            L Y+FQ    L  VM+Y  GG+L   LS+ E    ED A+FY AE+V A      L Y+
Sbjct: 73  ALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSA------LDYL 125
Query: 137 HRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEI 196
           H   +  +   RD+K +N++LD +GHI++ DFG C     DG        GTP+Y++PE+
Sbjct: 126 HSEKNVVY---RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFC-GTPEYLAPEV 181
Query: 197 LTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVG 256
           L   + GR       DWW LGV MYEM+ G  PFY +   + +  I+  +  F  P  +G
Sbjct: 182 LEDNDYGRA-----VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF--PRTLG 234
Query: 257 YEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRD 316
            E    AK L+  L+     +    G  D K               H +F GI W  + +
Sbjct: 235 PE----AKSLLSGLLKKDPKQRLGGGSEDAK-----------EIMQHRFFAGIVWQHVYE 279
Query: 317 S--NAPYIPEVSSPTDTSHFD 335
              + P+ P+V+S TDT +FD
Sbjct: 280 KKLSPPFKPQVTSETDTRYFD 300

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 102/321 (31%), Positives = 150/321 (46%), Gaps = 53/321 (16%)
Query: 17  QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWIT 76
           +  GR ++++ L   ++V  DE                  VA    E  VL      ++T
Sbjct: 32  KATGRYYAMKILKKEVIVAKDE------------------VAHTLTENRVLQNSRHPFLT 73
Query: 77  NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYV 136
            L Y+FQ    L  VM+Y  GG+L   LS+ E    ED A+FY AE+V A      L Y+
Sbjct: 74  ALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSA------LDYL 126
Query: 137 HRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEI 196
           H   +  +   RD+K +N++LD +GHI++ DFG C     DG        GTP+Y++PE+
Sbjct: 127 HSEKNVVY---RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFC-GTPEYLAPEV 182
Query: 197 LTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVG 256
           L   + GR       DWW LGV MYEM+ G  PFY +   + +  I+  +  F  P  +G
Sbjct: 183 LEDNDYGRA-----VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF--PRTLG 235
Query: 257 YEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRD 316
            E    AK L+  L+     +    G  D K               H +F GI W  + +
Sbjct: 236 PE----AKSLLSGLLKKDPKQRLGGGSEDAK-----------EIMQHRFFAGIVWQHVYE 280
Query: 317 S--NAPYIPEVSSPTDTSHFD 335
              + P+ P+V+S TDT +FD
Sbjct: 281 KKLSPPFKPQVTSETDTRYFD 301

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 93/281 (33%), Positives = 133/281 (47%), Gaps = 47/281 (16%)
Query: 62  EERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA 121
           E+R + + G   ++T LH  FQ    LY VM+Y  GGDL+  + +   R  E  A FY A
Sbjct: 391 EKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAA 449
Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ 181
           E+ + +  +     ++R          D+K DNV+LD+ GHI++ADFG C     DG V 
Sbjct: 450 EIAIGLFFLQSKGIIYR----------DLKLDNVMLDSEGHIKIADFGMCKENIWDG-VT 498
Query: 182 SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 241
           +    GTPDYI+PEI+         YG   DWW+ GV +YEML G+ PF  E   E +  
Sbjct: 499 TKXFCGTPDYIAPEIIAYQP-----YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS 553
Query: 242 IMNHQNSFDLPSDVGYEISDDAKDLM-----RRLICSSDTRLGQNGIADFKMWSALFVSL 296
           IM H  ++  P  +  E     K LM     +RL C      G  G  D K         
Sbjct: 554 IMEHNVAY--PKSMSKEAVAICKGLMTKHPGKRLGC------GPEGERDIK--------- 596
Query: 297 SISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFD 335
                 H +F+ I W+ +  ++   PY P+ S   +  +FD
Sbjct: 597 -----EHAFFRYIDWEKLERKEIQPPYKPKASG-RNAENFD 631

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  131 bits (330), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 93/271 (34%), Positives = 130/271 (47%), Gaps = 47/271 (17%)
Query: 63  ERDVLVYGDRR-WITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA 121
           E+ VL   D+  ++T LH  FQ    LY VM+Y  GGDL+  + +   +  E  A FY A
Sbjct: 69  EKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAA 127
Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ 181
           E+ + +  +H    ++          RD+K DNV+LD+ GHI++ADFG C     DG V 
Sbjct: 128 EISIGLFFLHKRGIIY----------RDLKLDNVMLDSEGHIKIADFGMCKEHMMDG-VT 176
Query: 182 SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 241
           +    GTPDYI+PEI+         YG   DWW+ GV +YEML G+ PF  E   E +  
Sbjct: 177 TREFCGTPDYIAPEIIAYQP-----YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS 231
Query: 242 IMNHQNSFDLPSDVGYEISDDAKDLM-----RRLICSSDTRLGQNGIADFKMWSALFVSL 296
           IM H  S+  P  +  E     K LM     +RL C      G  G  D           
Sbjct: 232 IMEHNVSY--PKSLSKEAVSICKGLMTKHPAKRLGC------GPEGERDV---------- 273
Query: 297 SISPRNHPWFQGIAWDSI--RDSNAPYIPEV 325
               R H +F+ I W+ +  R+   P+ P+V
Sbjct: 274 ----REHAFFRRIDWEKLENREIQPPFKPKV 300

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  130 bits (328), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 95/294 (32%), Positives = 138/294 (46%), Gaps = 38/294 (12%)
Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTL 103
           LR+E  ++   + VA    E  VL      ++T L YAFQ    L  VM+Y  GG+L   
Sbjct: 41  LRKEVIIAK--DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFH 98
Query: 104 LSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI 163
           LS+ E    E+ A+FY AE+V A+  +H    V+R          DIK +N++LD +GHI
Sbjct: 99  LSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYR----------DIKLENLMLDKDGHI 147
Query: 164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM 223
           ++ DFG C     DG        GTP+Y++PE+L   + GR       DWW LGV MYEM
Sbjct: 148 KITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGRA-----VDWWGLGVVMYEM 201
Query: 224 LYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGI 283
           + G  PFY +     +  I+  +  F         +S +AK L+  L+     +    G 
Sbjct: 202 MCGRLPFYNQDHERLFELILMEEIRFP------RTLSPEAKSLLAGLLKKDPKQRLGGGP 255
Query: 284 ADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSN--APYIPEVSSPTDTSHFD 335
           +D K               H +F  I W  +       P+ P+V+S  DT +FD
Sbjct: 256 SDAK-----------EVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD 298

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 95/294 (32%), Positives = 138/294 (46%), Gaps = 38/294 (12%)
Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTL 103
           LR+E  ++   + VA    E  VL      ++T L YAFQ    L  VM+Y  GG+L   
Sbjct: 38  LRKEVIIAK--DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFH 95
Query: 104 LSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI 163
           LS+ E    E+ A+FY AE+V A+  +H    V+R          DIK +N++LD +GHI
Sbjct: 96  LSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYR----------DIKLENLMLDKDGHI 144
Query: 164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM 223
           ++ DFG C     DG        GTP+Y++PE+L   + GR       DWW LGV MYEM
Sbjct: 145 KITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGRA-----VDWWGLGVVMYEM 198
Query: 224 LYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGI 283
           + G  PFY +     +  I+  +  F         +S +AK L+  L+     +    G 
Sbjct: 199 MCGRLPFYNQDHERLFELILMEEIRFP------RTLSPEAKSLLAGLLKKDPKQRLGGGP 252
Query: 284 ADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSN--APYIPEVSSPTDTSHFD 335
           +D K               H +F  I W  +       P+ P+V+S  DT +FD
Sbjct: 253 SDAK-----------EVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD 295

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 95/294 (32%), Positives = 138/294 (46%), Gaps = 38/294 (12%)
Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTL 103
           LR+E  ++   + VA    E  VL      ++T L YAFQ    L  VM+Y  GG+L   
Sbjct: 38  LRKEVIIAK--DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFH 95
Query: 104 LSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI 163
           LS+ E    E+ A+FY AE+V A+  +H    V+R          DIK +N++LD +GHI
Sbjct: 96  LSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYR----------DIKLENLMLDKDGHI 144
Query: 164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM 223
           ++ DFG C     DG        GTP+Y++PE+L   + GR       DWW LGV MYEM
Sbjct: 145 KITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGRA-----VDWWGLGVVMYEM 198
Query: 224 LYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGI 283
           + G  PFY +     +  I+  +  F         +S +AK L+  L+     +    G 
Sbjct: 199 MCGRLPFYNQDHERLFELILMEEIRFP------RTLSPEAKSLLAGLLKKDPKQRLGGGP 252
Query: 284 ADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSN--APYIPEVSSPTDTSHFD 335
           +D K               H +F  I W  +       P+ P+V+S  DT +FD
Sbjct: 253 SDAK-----------EVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD 295

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 95/294 (32%), Positives = 138/294 (46%), Gaps = 38/294 (12%)
Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTL 103
           LR+E  ++   + VA    E  VL      ++T L YAFQ    L  VM+Y  GG+L   
Sbjct: 38  LRKEVIIAK--DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFH 95
Query: 104 LSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI 163
           LS+ E    E+ A+FY AE+V A+  +H    V+R          DIK +N++LD +GHI
Sbjct: 96  LSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYR----------DIKLENLMLDKDGHI 144
Query: 164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM 223
           ++ DFG C     DG        GTP+Y++PE+L   + GR       DWW LGV MYEM
Sbjct: 145 KITDFGLCKEGISDGATMKXFC-GTPEYLAPEVLEDNDYGRA-----VDWWGLGVVMYEM 198
Query: 224 LYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGI 283
           + G  PFY +     +  I+  +  F         +S +AK L+  L+     +    G 
Sbjct: 199 MCGRLPFYNQDHERLFELILMEEIRFP------RTLSPEAKSLLAGLLKKDPKQRLGGGP 252
Query: 284 ADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSN--APYIPEVSSPTDTSHFD 335
           +D K               H +F  I W  +       P+ P+V+S  DT +FD
Sbjct: 253 SDAK-----------EVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD 295

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 92/281 (32%), Positives = 132/281 (46%), Gaps = 47/281 (16%)
Query: 62  EERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA 121
           E+R + + G   ++T LH  FQ    LY VM+Y  GGDL+  + +   R  E  A FY A
Sbjct: 70  EKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAA 128
Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ 181
           E+ + +  +     ++R          D+K DNV+LD+ GHI++ADFG C     DG V 
Sbjct: 129 EIAIGLFFLQSKGIIYR----------DLKLDNVMLDSEGHIKIADFGMCKENIWDG-VT 177
Query: 182 SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 241
           +    GTPDYI+PEI+         YG   DWW+ GV +YEML G+ PF  E   E +  
Sbjct: 178 TKXFCGTPDYIAPEIIAYQP-----YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS 232
Query: 242 IMNHQNSFDLPSDVGYEISDDAKDLM-----RRLICSSDTRLGQNGIADFKMWSALFVSL 296
           IM H  ++  P  +  E     K LM     +RL C      G  G  D K         
Sbjct: 233 IMEHNVAY--PKSMSKEAVAICKGLMTKHPGKRLGC------GPEGERDIK--------- 275
Query: 297 SISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFD 335
                 H +F+ I W+ +  ++   PY P+     +  +FD
Sbjct: 276 -----EHAFFRYIDWEKLERKEIQPPYKPKACG-RNAENFD 310

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 95/294 (32%), Positives = 138/294 (46%), Gaps = 38/294 (12%)
Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTL 103
           LR+E  ++   + VA    E  VL      ++T L YAFQ    L  VM+Y  GG+L   
Sbjct: 38  LRKEVIIAK--DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFH 95
Query: 104 LSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI 163
           LS+ E    E+ A+FY AE+V A+  +H    V+R          DIK +N++LD +GHI
Sbjct: 96  LSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYR----------DIKLENLMLDKDGHI 144
Query: 164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM 223
           ++ DFG C     DG        GTP+Y++PE+L   + GR       DWW LGV MYEM
Sbjct: 145 KITDFGLCKEGISDGATMKXFC-GTPEYLAPEVLEDNDYGRA-----VDWWGLGVVMYEM 198
Query: 224 LYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGI 283
           + G  PFY +     +  I+  +  F         +S +AK L+  L+     +    G 
Sbjct: 199 MCGRLPFYNQDHERLFELILMEEIRFP------RTLSPEAKSLLAGLLKKDPKQRLGGGP 252
Query: 284 ADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSN--APYIPEVSSPTDTSHFD 335
           +D K               H +F  I W  +       P+ P+V+S  DT +FD
Sbjct: 253 SDAK-----------EVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD 295

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 95/294 (32%), Positives = 138/294 (46%), Gaps = 38/294 (12%)
Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTL 103
           LR+E  ++   + VA    E  VL      ++T L YAFQ    L  VM+Y  GG+L   
Sbjct: 38  LRKEVIIAK--DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFH 95
Query: 104 LSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI 163
           LS+ E    E+ A+FY AE+V A+  +H    V+R          DIK +N++LD +GHI
Sbjct: 96  LSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYR----------DIKLENLMLDKDGHI 144
Query: 164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM 223
           ++ DFG C     DG        GTP+Y++PE+L   + GR       DWW LGV MYEM
Sbjct: 145 KITDFGLCKEGISDGATMKXFC-GTPEYLAPEVLEDNDYGRA-----VDWWGLGVVMYEM 198
Query: 224 LYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGI 283
           + G  PFY +     +  I+  +  F         +S +AK L+  L+     +    G 
Sbjct: 199 MCGRLPFYNQDHERLFELILMEEIRFPRT------LSPEAKSLLAGLLKKDPKQRLGGGP 252
Query: 284 ADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSN--APYIPEVSSPTDTSHFD 335
           +D K               H +F  I W  +       P+ P+V+S  DT +FD
Sbjct: 253 SDAK-----------EVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD 295

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 95/294 (32%), Positives = 138/294 (46%), Gaps = 38/294 (12%)
Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTL 103
           LR+E  ++   + VA    E  VL      ++T L YAFQ    L  VM+Y  GG+L   
Sbjct: 43  LRKEVIIAK--DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFH 100
Query: 104 LSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI 163
           LS+ E    E+ A+FY AE+V A+  +H    V+R          DIK +N++LD +GHI
Sbjct: 101 LSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYR----------DIKLENLMLDKDGHI 149
Query: 164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM 223
           ++ DFG C     DG        GTP+Y++PE+L   + GR       DWW LGV MYEM
Sbjct: 150 KITDFGLCKEGISDGATMKXFC-GTPEYLAPEVLEDNDYGRA-----VDWWGLGVVMYEM 203
Query: 224 LYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGI 283
           + G  PFY +     +  I+  +  F         +S +AK L+  L+     +    G 
Sbjct: 204 MCGRLPFYNQDHERLFELILMEEIRFP------RTLSPEAKSLLAGLLKKDPKQRLGGGP 257
Query: 284 ADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSN--APYIPEVSSPTDTSHFD 335
           +D K               H +F  I W  +       P+ P+V+S  DT +FD
Sbjct: 258 SDAK-----------EVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD 300

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  128 bits (321), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 87/275 (31%), Positives = 133/275 (48%), Gaps = 48/275 (17%)
Query: 74  WITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDL 133
           ++  LH  FQ +S L+ V++Y  GGDL+  + + + +LPE+ A+FY AE+ LA+  +H+ 
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHER 172
Query: 134 HYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYIS 193
             ++R          D+K DNVLLD+ GHI+L D+G C      G   S    GTP+YI+
Sbjct: 173 GIIYR----------DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIA 221
Query: 194 PEILTAMEEGRGR-YGPECDWWSLGVCMYEMLYGETPF-------YAESLVETYGKIMNH 245
           PEIL      RG  YG   DWW+LGV M+EM+ G +PF         +   E Y   +  
Sbjct: 222 PEIL------RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 275
Query: 246 QNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLG---QNGIADFKMWSALFVSLSISPRN 302
           +    +P  +  + +   K  + +       RLG   Q G AD +               
Sbjct: 276 EKQIRIPRSLSVKAASVLKSFLNK---DPKERLGCHPQTGFADIQ--------------G 318
Query: 303 HPWFQGIAWDSIRDSNA--PYIPEVSSPTDTSHFD 335
           HP+F+ + WD +       P+ P +S      +FD
Sbjct: 319 HPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFD 353

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 132/274 (48%), Gaps = 46/274 (16%)
Query: 74  WITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDL 133
           ++  LH  FQ +S L+ V++Y  GGDL+  + + + +LPE+ A+FY AE+ LA+  +H+ 
Sbjct: 82  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHER 140
Query: 134 HYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYIS 193
             ++R          D+K DNVLLD+ GHI+L D+G C      G   S    GTP+YI+
Sbjct: 141 GIIYR----------DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC-GTPNYIA 189
Query: 194 PEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF-------YAESLVETYGKIMNHQ 246
           PEIL   +     YG   DWW+LGV M+EM+ G +PF         +   E Y   +  +
Sbjct: 190 PEILRGED-----YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 244
Query: 247 NSFDLPSDVGYEISDDAKDLMRRLICSSDTRLG---QNGIADFKMWSALFVSLSISPRNH 303
               +P  +  + +   K  + +       RLG   Q G AD +               H
Sbjct: 245 KQIRIPRSMSVKAASVLKSFLNK---DPKERLGCLPQTGFADIQ--------------GH 287
Query: 304 PWFQGIAWDSIRDSNA--PYIPEVSSPTDTSHFD 335
           P+F+ + WD +       P+ P +S      +FD
Sbjct: 288 PFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFD 321

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  127 bits (320), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 132/274 (48%), Gaps = 46/274 (16%)
Query: 74  WITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDL 133
           ++  LH  FQ +S L+ V++Y  GGDL+  + + + +LPE+ A+FY AE+ LA+  +H+ 
Sbjct: 67  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHER 125
Query: 134 HYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYIS 193
             ++R          D+K DNVLLD+ GHI+L D+G C      G   S    GTP+YI+
Sbjct: 126 GIIYR----------DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC-GTPNYIA 174
Query: 194 PEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF-------YAESLVETYGKIMNHQ 246
           PEIL   +     YG   DWW+LGV M+EM+ G +PF         +   E Y   +  +
Sbjct: 175 PEILRGED-----YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 229
Query: 247 NSFDLPSDVGYEISDDAKDLMRRLICSSDTRLG---QNGIADFKMWSALFVSLSISPRNH 303
               +P  +  + +   K  + +       RLG   Q G AD +               H
Sbjct: 230 KQIRIPRSLSVKAASVLKSFLNK---DPKERLGCHPQTGFADIQ--------------GH 272
Query: 304 PWFQGIAWDSIRDSNA--PYIPEVSSPTDTSHFD 335
           P+F+ + WD +       P+ P +S      +FD
Sbjct: 273 PFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFD 306

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 132/274 (48%), Gaps = 46/274 (16%)
Query: 74  WITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDL 133
           ++  LH  FQ +S L+ V++Y  GGDL+  + + + +LPE+ A+FY AE+ LA+  +H+ 
Sbjct: 71  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHER 129
Query: 134 HYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYIS 193
             ++R          D+K DNVLLD+ GHI+L D+G C      G   S    GTP+YI+
Sbjct: 130 GIIYR----------DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC-GTPNYIA 178
Query: 194 PEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF-------YAESLVETYGKIMNHQ 246
           PEIL   +     YG   DWW+LGV M+EM+ G +PF         +   E Y   +  +
Sbjct: 179 PEILRGED-----YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 233
Query: 247 NSFDLPSDVGYEISDDAKDLMRRLICSSDTRLG---QNGIADFKMWSALFVSLSISPRNH 303
               +P  +  + +   K  + +       RLG   Q G AD +               H
Sbjct: 234 KQIRIPRSLSVKAASVLKSFLNK---DPKERLGCHPQTGFADIQ--------------GH 276
Query: 304 PWFQGIAWDSIRDSNA--PYIPEVSSPTDTSHFD 335
           P+F+ + WD +       P+ P +S      +FD
Sbjct: 277 PFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFD 310

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 85/313 (27%), Positives = 146/313 (46%), Gaps = 37/313 (11%)
Query: 11  FLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG 70
           F  G I G+G  FS   L   L    +       +R     + + +V +   ERDV+   
Sbjct: 32  FKFGKILGEGS-FSTTVLARELATSREYAIKILEKRHIIKENKVPYVTR---ERDVMSRL 87
Query: 71  DRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASI 130
           D  +   L++ FQDD  LY  + Y   G+LL  + K      E   +FY AE+V A+  +
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYL 146
Query: 131 HDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTP 189
           H    +H          RD+KP+N+LL+ + HI++ DFG+   L  +    ++N  VGT 
Sbjct: 147 HGKGIIH----------RDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSF 249
            Y+SPE+LT     +       D W+LG  +Y+++ G  PF A +    + KI+  +  +
Sbjct: 197 QYVSPELLTEKSACKS-----SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--Y 249
Query: 250 DLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI 309
           D P     +    A+DL+ +L+    T+  + G  + + +  L        + HP+F+ +
Sbjct: 250 DFPE----KFFPKARDLVEKLLVLDATK--RLGCEEMEGYGPL--------KAHPFFESV 295
Query: 310 AWDSIRDSNAPYI 322
            W+++     P +
Sbjct: 296 TWENLHQQTPPKL 308

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 85/313 (27%), Positives = 146/313 (46%), Gaps = 37/313 (11%)
Query: 11  FLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG 70
           F  G I G+G  FS   L   L    +       +R     + + +V +   ERDV+   
Sbjct: 34  FKFGKILGEGS-FSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR---ERDVMSRL 89
Query: 71  DRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASI 130
           D  +   L++ FQDD  LY  + Y   G+LL  + K      E   +FY AE+V A+  +
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYL 148
Query: 131 HDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTP 189
           H    +H          RD+KP+N+LL+ + HI++ DFG+   L  +    ++N  VGT 
Sbjct: 149 HGKGIIH----------RDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSF 249
            Y+SPE+LT     +       D W+LG  +Y+++ G  PF A +    + KI+  +  +
Sbjct: 199 QYVSPELLTEKSAXKS-----SDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE--Y 251
Query: 250 DLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI 309
           D P     +    A+DL+ +L+    T+  + G  + + +  L        + HP+F+ +
Sbjct: 252 DFPE----KFFPKARDLVEKLLVLDATK--RLGCEEMEGYGPL--------KAHPFFESV 297
Query: 310 AWDSIRDSNAPYI 322
            W+++     P +
Sbjct: 298 TWENLHQQTPPKL 310

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 130/267 (48%), Gaps = 33/267 (12%)
Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           V  +  ERDV+   D  +   L++ FQDD  LY  + Y   G+LL  + K      E   
Sbjct: 54  VPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCT 112
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FY AE+V A+  +H    +H          RD+KP+N+LL+ + HI++ DFG+   L  
Sbjct: 113 RFYTAEIVSALEYLHGKGIIH----------RDLKPENILLNEDMHIQITDFGTAKVLSP 162
Query: 177 DGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
           +    ++N  VGT  Y+SPE+LT     +       D W+LG  +Y+++ G  PF A + 
Sbjct: 163 ESKQARANXFVGTAQYVSPELLTEKSACKS-----SDLWALGCIIYQLVAGLPPFRAGNE 217
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVS 295
              + KI+  +  +D P     +    A+DL+ +L+    T+  + G  + + +  L   
Sbjct: 218 YLIFQKIIKLE--YDFPE----KFFPKARDLVEKLLVLDATK--RLGCEEMEGYGPL--- 266
Query: 296 LSISPRNHPWFQGIAWDSIRDSNAPYI 322
                + HP+F+ + W+++     P +
Sbjct: 267 -----KAHPFFESVTWENLHQQTPPKL 288

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 130/267 (48%), Gaps = 33/267 (12%)
Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           V  +  ERDV+   D  +   L++ FQDD  LY  + Y   G+LL  + K      E   
Sbjct: 52  VPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCT 110
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FY AE+V A+  +H    +H          RD+KP+N+LL+ + HI++ DFG+   L  
Sbjct: 111 RFYTAEIVSALEYLHGKGIIH----------RDLKPENILLNEDMHIQITDFGTAKVLSP 160
Query: 177 DGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
           +    ++N  VGT  Y+SPE+LT     +       D W+LG  +Y+++ G  PF A + 
Sbjct: 161 ESKQARANXFVGTAQYVSPELLTEKSACKS-----SDLWALGCIIYQLVAGLPPFRAGNE 215
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVS 295
              + KI+  +  +D P     +    A+DL+ +L+    T+  + G  + + +  L   
Sbjct: 216 YLIFQKIIKLE--YDFPE----KFFPKARDLVEKLLVLDATK--RLGCEEMEGYGPL--- 264
Query: 296 LSISPRNHPWFQGIAWDSIRDSNAPYI 322
                + HP+F+ + W+++     P +
Sbjct: 265 -----KAHPFFESVTWENLHQQTPPKL 286

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 129/265 (48%), Gaps = 33/265 (12%)
Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           V  +  ERDV+   D  +   L++ FQDD  LY  + Y   G+LL  + K      E   
Sbjct: 53  VPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCT 111
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FY AE+V A+  +H    +H          RD+KP+N+LL+ + HI++ DFG+   L  
Sbjct: 112 RFYTAEIVSALEYLHGKGIIH----------RDLKPENILLNEDMHIQITDFGTAKVLSP 161
Query: 177 DGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
           +    ++N  VGT  Y+SPE+LT     +       D W+LG  +Y+++ G  PF A + 
Sbjct: 162 ESKQARANXFVGTAQYVSPELLTEKSACKS-----SDLWALGCIIYQLVAGLPPFRAGNE 216
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVS 295
              + KI+  +  +D P     +    A+DL+ +L+    T+  + G  + + +  L   
Sbjct: 217 YLIFQKIIKLE--YDFPE----KFFPKARDLVEKLLVLDATK--RLGCEEMEGYGPL--- 265
Query: 296 LSISPRNHPWFQGIAWDSIRDSNAP 320
                + HP+F+ + W+++     P
Sbjct: 266 -----KAHPFFESVTWENLHQQTPP 285

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 130/267 (48%), Gaps = 33/267 (12%)
Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           V  +  ERDV+   D  +   L++ FQDD  LY  + Y   G+LL  + K      E   
Sbjct: 51  VPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCT 109
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FY AE+V A+  +H    +H          RD+KP+N+LL+ + HI++ DFG+   L  
Sbjct: 110 RFYTAEIVSALEYLHGKGIIH----------RDLKPENILLNEDMHIQITDFGTAKVLSP 159
Query: 177 DGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
           +    ++N  VGT  Y+SPE+LT     +       D W+LG  +Y+++ G  PF A + 
Sbjct: 160 ESKQARANXFVGTAQYVSPELLTEKSACKS-----SDLWALGCIIYQLVAGLPPFRAGNE 214
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVS 295
              + KI+  +  +D P     +    A+DL+ +L+    T+  + G  + + +  L   
Sbjct: 215 YLIFQKIIKLE--YDFPE----KFFPKARDLVEKLLVLDATK--RLGCEEMEGYGPL--- 263
Query: 296 LSISPRNHPWFQGIAWDSIRDSNAPYI 322
                + HP+F+ + W+++     P +
Sbjct: 264 -----KAHPFFESVTWENLHQQTPPKL 285

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 85/313 (27%), Positives = 146/313 (46%), Gaps = 37/313 (11%)
Query: 11  FLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG 70
           F  G I G+G  FS   L   L    +       +R     + + +V +   ERDV+   
Sbjct: 32  FKFGKILGEGS-FSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR---ERDVMSRL 87
Query: 71  DRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASI 130
           D  +   L++ FQDD  LY  + Y   G+LL  + K      E   +FY AE+V A+  +
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYL 146
Query: 131 HDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTP 189
           H    +H          RD+KP+N+LL+ + HI++ DFG+   L  +    ++N  VGT 
Sbjct: 147 HGKGIIH----------RDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTA 196
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSF 249
            Y+SPE+LT     +       D W+LG  +Y+++ G  PF A +    + KI+  +  +
Sbjct: 197 QYVSPELLTEKSACKS-----SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--Y 249
Query: 250 DLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI 309
           D P     +    A+DL+ +L+    T+  + G  + + +  L        + HP+F+ +
Sbjct: 250 DFPE----KFFPKARDLVEKLLVLDATK--RLGCEEMEGYGPL--------KAHPFFESV 295
Query: 310 AWDSIRDSNAPYI 322
            W+++     P +
Sbjct: 296 TWENLHQQTPPKL 308

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 129/265 (48%), Gaps = 33/265 (12%)
Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           V  +  ERDV+   D  +   L++ FQDD  LY  + Y   G+LL  + K      E   
Sbjct: 58  VPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCT 116
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FY AE+V A+  +H    +H          RD+KP+N+LL+ + HI++ DFG+   L  
Sbjct: 117 RFYTAEIVSALEYLHGKGIIH----------RDLKPENILLNEDMHIQITDFGTAKVLSP 166
Query: 177 DGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
           +    ++N  VGT  Y+SPE+LT     +       D W+LG  +Y+++ G  PF A + 
Sbjct: 167 ESKQARANXFVGTAQYVSPELLTEKSACKS-----SDLWALGCIIYQLVAGLPPFRAGNE 221
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVS 295
              + KI+  +  +D P     +    A+DL+ +L+    T+  + G  + + +  L   
Sbjct: 222 YLIFQKIIKLE--YDFPE----KFFPKARDLVEKLLVLDATK--RLGCEEMEGYGPL--- 270
Query: 296 LSISPRNHPWFQGIAWDSIRDSNAP 320
                + HP+F+ + W+++     P
Sbjct: 271 -----KAHPFFESVTWENLHQQTPP 290

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 129/265 (48%), Gaps = 33/265 (12%)
Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           V  +  ERDV+   D  +   L++ FQDD  LY  + Y   G+LL  + K      E   
Sbjct: 73  VPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCT 131
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FY AE+V A+  +H    +H          RD+KP+N+LL+ + HI++ DFG+   L  
Sbjct: 132 RFYTAEIVSALEYLHGKGIIH----------RDLKPENILLNEDMHIQITDFGTAKVLSP 181
Query: 177 DGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
           +    ++N  VGT  Y+SPE+LT     +       D W+LG  +Y+++ G  PF A + 
Sbjct: 182 ESKQARANXFVGTAQYVSPELLTEKSACKS-----SDLWALGCIIYQLVAGLPPFRAGNE 236
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVS 295
              + KI+  +  +D P     +    A+DL+ +L+    T+  + G  + + +  L   
Sbjct: 237 YLIFQKIIKLE--YDFPE----KFFPKARDLVEKLLVLDATK--RLGCEEMEGYGPL--- 285
Query: 296 LSISPRNHPWFQGIAWDSIRDSNAP 320
                + HP+F+ + W+++     P
Sbjct: 286 -----KAHPFFESVTWENLHQQTPP 305

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 130/267 (48%), Gaps = 33/267 (12%)
Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           V  +  ERDV+   D  +   L++ FQDD  LY  + Y   G+LL  + K      E   
Sbjct: 74  VPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCT 132
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FY AE+V A+  +H    +H          RD+KP+N+LL+ + HI++ DFG+   L  
Sbjct: 133 RFYTAEIVSALEYLHGKGIIH----------RDLKPENILLNEDMHIQITDFGTAKVLSP 182
Query: 177 DGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
           +    ++N  VGT  Y+SPE+LT     +       D W+LG  +Y+++ G  PF A + 
Sbjct: 183 ESKQARANXFVGTAQYVSPELLTEKSACKS-----SDLWALGCIIYQLVAGLPPFRAGNE 237
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVS 295
              + KI+  +  +D P     +    A+DL+ +L+    T+  + G  + + +  L   
Sbjct: 238 YLIFQKIIKLE--YDFPE----KFFPKARDLVEKLLVLDATK--RLGCEEMEGYGPL--- 286
Query: 296 LSISPRNHPWFQGIAWDSIRDSNAPYI 322
                + HP+F+ + W+++     P +
Sbjct: 287 -----KAHPFFESVTWENLHQQTPPKL 308

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  117 bits (294), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 130/267 (48%), Gaps = 33/267 (12%)
Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           V  +  ERDV+   D  +   L++ FQDD  LY  + Y   G+LL  + K      E   
Sbjct: 76  VPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCT 134
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FY AE+V A+  +H    +H          RD+KP+N+LL+ + HI++ DFG+   L  
Sbjct: 135 RFYTAEIVSALEYLHGKGIIH----------RDLKPENILLNEDMHIQITDFGTAKVLSP 184
Query: 177 DGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
           +    ++N  VGT  Y+SPE+LT     +       D W+LG  +Y+++ G  PF A + 
Sbjct: 185 ESKQARANXFVGTAQYVSPELLTEKSACKS-----SDLWALGCIIYQLVAGLPPFRAGNE 239
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVS 295
              + KI+  +  +D P     +    A+DL+ +L+    T+  + G  + + +  L   
Sbjct: 240 YLIFQKIIKLE--YDFPE----KFFPKARDLVEKLLVLDATK--RLGCEEMEGYGPL--- 288
Query: 296 LSISPRNHPWFQGIAWDSIRDSNAPYI 322
                + HP+F+ + W+++     P +
Sbjct: 289 -----KAHPFFESVTWENLHQQTPPKL 310

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  117 bits (294), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 130/267 (48%), Gaps = 33/267 (12%)
Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           V  +  ERDV+   D  +   L++ FQDD  LY  + Y   G+LL  + K      E   
Sbjct: 74  VPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCT 132
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FY AE+V A+  +H    +H          RD+KP+N+LL+ + HI++ DFG+   L  
Sbjct: 133 RFYTAEIVSALEYLHGKGIIH----------RDLKPENILLNEDMHIQITDFGTAKVLSP 182
Query: 177 DGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
           +    ++N  VGT  Y+SPE+LT     +       D W+LG  +Y+++ G  PF A + 
Sbjct: 183 ESKQARANXFVGTAQYVSPELLTEKSACKS-----SDLWALGCIIYQLVAGLPPFRAGNE 237
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVS 295
              + KI+  +  +D P     +    A+DL+ +L+    T+  + G  + + +  L   
Sbjct: 238 YLIFQKIIKLE--YDFPE----KFFPKARDLVEKLLVLDATK--RLGCEEMEGYGPL--- 286
Query: 296 LSISPRNHPWFQGIAWDSIRDSNAPYI 322
                + HP+F+ + W+++     P +
Sbjct: 287 -----KAHPFFESVTWENLHQQTPPKL 308

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  117 bits (294), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 130/267 (48%), Gaps = 33/267 (12%)
Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           V  +  ERDV+   D  +   L++ FQDD  LY  + Y   G+LL  + K      E   
Sbjct: 76  VPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCT 134
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FY AE+V A+  +H    +H          RD+KP+N+LL+ + HI++ DFG+   L  
Sbjct: 135 RFYTAEIVSALEYLHGKGIIH----------RDLKPENILLNEDMHIQITDFGTAKVLSP 184
Query: 177 DGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
           +    ++N  VGT  Y+SPE+LT     +       D W+LG  +Y+++ G  PF A + 
Sbjct: 185 ESKQARANXFVGTAQYVSPELLTEKSACKS-----SDLWALGCIIYQLVAGLPPFRAGNE 239
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVS 295
              + KI+  +  +D P     +    A+DL+ +L+    T+  + G  + + +  L   
Sbjct: 240 YLIFQKIIKLE--YDFPE----KFFPKARDLVEKLLVLDATK--RLGCEEMEGYGPL--- 288
Query: 296 LSISPRNHPWFQGIAWDSIRDSNAPYI 322
                + HP+F+ + W+++     P +
Sbjct: 289 -----KAHPFFESVTWENLHQQTPPKL 310

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  117 bits (294), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 130/267 (48%), Gaps = 33/267 (12%)
Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           V  +  ERDV+   D  +   L++ FQDD  LY  + Y   G+LL  + K      E   
Sbjct: 76  VPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCT 134
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FY AE+V A+  +H    +H          RD+KP+N+LL+ + HI++ DFG+   L  
Sbjct: 135 RFYTAEIVSALEYLHGKGIIH----------RDLKPENILLNEDMHIQITDFGTAKVLSP 184
Query: 177 DGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
           +    ++N  VGT  Y+SPE+LT     +       D W+LG  +Y+++ G  PF A + 
Sbjct: 185 ESKQARANXFVGTAQYVSPELLTEKSACKS-----SDLWALGCIIYQLVAGLPPFRAGNE 239
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVS 295
              + KI+  +  +D P     +    A+DL+ +L+    T+  + G  + + +  L   
Sbjct: 240 GLIFAKIIKLE--YDFPE----KFFPKARDLVEKLLVLDATK--RLGCEEMEGYGPL--- 288
Query: 296 LSISPRNHPWFQGIAWDSIRDSNAPYI 322
                + HP+F+ + W+++     P +
Sbjct: 289 -----KAHPFFESVTWENLHQQTPPKL 310

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 85/313 (27%), Positives = 146/313 (46%), Gaps = 37/313 (11%)
Query: 11  FLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG 70
           F  G I G+G  FS   L   L    +       +R     + + +V +   ERDV+   
Sbjct: 35  FKFGKILGEGS-FSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR---ERDVMSRL 90
Query: 71  DRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASI 130
           D  +   L++ FQDD  LY  + Y   G+LL  + K      E   +FY AE+V A+  +
Sbjct: 91  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYL 149
Query: 131 HDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTP 189
           H    +H          RD+KP+N+LL+ + HI++ DFG+   L  +    ++N  VGT 
Sbjct: 150 HGKGIIH----------RDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 199
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSF 249
            Y+SPE+LT     +       D W+LG  +Y+++ G  PF A +    + KI+  +  +
Sbjct: 200 QYVSPELLTEKSACKS-----SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--Y 252
Query: 250 DLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI 309
           D P     +    A+DL+ +L+    T+  + G  + + +  L        + HP+F+ +
Sbjct: 253 DFPE----KFFPKARDLVEKLLVLDATK--RLGCEEMEGYGPL--------KAHPFFESV 298
Query: 310 AWDSIRDSNAPYI 322
            W+++     P +
Sbjct: 299 TWENLHQQTPPKL 311

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 130/267 (48%), Gaps = 33/267 (12%)
Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           V  +  ERDV+   D  +   L++ FQDD  LY  + Y   G+LL  + K      E   
Sbjct: 76  VPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCT 134
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FY AE+V A+  +H    +H          RD+KP+N+LL+ + HI++ DFG+   L  
Sbjct: 135 RFYTAEIVSALEYLHGKGIIH----------RDLKPENILLNEDMHIQITDFGTAKVLSP 184
Query: 177 DGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
           +    ++N  VGT  Y+SPE+LT     +       D W+LG  +Y+++ G  PF A + 
Sbjct: 185 ESKQARANXFVGTAQYVSPELLTEKSACKS-----SDLWALGCIIYQLVAGLPPFRAGNE 239
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVS 295
              + KI+  +  +D P     +    A+DL+ +L+    T+  + G  + + +  L   
Sbjct: 240 YLIFQKIIKLE--YDFPE----KFFPKARDLVEKLLVLDATK--RLGCEEMEGYGPL--- 288
Query: 296 LSISPRNHPWFQGIAWDSIRDSNAPYI 322
                + HP+F+ + W+++     P +
Sbjct: 289 -----KAHPFFESVTWENLHQQTPPKL 310

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 130/267 (48%), Gaps = 33/267 (12%)
Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           V  +  ERDV+   D  +   L++ FQDD  LY  + Y   G+LL  + K      E   
Sbjct: 81  VPYVTRERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCT 139
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FY AE+V A+  +H    +H          RD+KP+N+LL+ + HI++ DFG+   L  
Sbjct: 140 RFYTAEIVSALEYLHGKGIIH----------RDLKPENILLNEDMHIQITDFGTAKVLSP 189
Query: 177 DGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
           +    ++N  VGT  Y+SPE+LT     +       D W+LG  +Y+++ G  PF A + 
Sbjct: 190 ESKQARANXFVGTAQYVSPELLTEKSACKS-----SDLWALGCIIYQLVAGLPPFRAGNE 244
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVS 295
              + KI+  +  +D P     +    A+DL+ +L+    T+  + G  + + +  L   
Sbjct: 245 YLIFQKIIKLE--YDFPE----KFFPKARDLVEKLLVLDATK--RLGCEEMEGYGPL--- 293
Query: 296 LSISPRNHPWFQGIAWDSIRDSNAPYI 322
                + HP+F+ + W+++     P +
Sbjct: 294 -----KAHPFFESVTWENLHQQTPPKL 315

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 130/267 (48%), Gaps = 33/267 (12%)
Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           V  +  ERDV+   D  +   L++ FQDD  LY  + Y   G+LL  + K      E   
Sbjct: 79  VPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCT 137
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FY AE+V A+  +H    +H          RD+KP+N+LL+ + HI++ DFG+   L  
Sbjct: 138 RFYTAEIVSALEYLHGKGIIH----------RDLKPENILLNEDMHIQITDFGTAKVLSP 187
Query: 177 DGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
           +    ++N  VGT  Y+SPE+LT     +       D W+LG  +Y+++ G  PF A + 
Sbjct: 188 ESKQARANXFVGTAQYVSPELLTEKSACKS-----SDLWALGCIIYQLVAGLPPFRAGNE 242
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVS 295
              + KI+  +  +D P+         A+DL+ +L+    T+  + G  + + +  L   
Sbjct: 243 YLIFQKIIKLE--YDFPA----AFFPKARDLVEKLLVLDATK--RLGCEEMEGYGPL--- 291
Query: 296 LSISPRNHPWFQGIAWDSIRDSNAPYI 322
                + HP+F+ + W+++     P +
Sbjct: 292 -----KAHPFFESVTWENLHQQTPPKL 313

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 129/265 (48%), Gaps = 33/265 (12%)
Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           V  +  ERDV+   D  +   L++ FQDD  LY  + Y   G+LL  + K      E   
Sbjct: 73  VPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCT 131
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FY AE+V A+  +H    +H          RD+KP+N+LL+ + HI++ DFG+   L  
Sbjct: 132 RFYTAEIVSALEYLHGKGIIH----------RDLKPENILLNEDMHIQITDFGTAKVLSP 181
Query: 177 DGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
           +    ++N  VGT  Y+SPE+LT     +       D W+LG  +Y+++ G  PF A + 
Sbjct: 182 ESKQARANSFVGTAQYVSPELLTEKSACKS-----SDLWALGCIIYQLVAGLPPFRAGNE 236
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVS 295
              + KI+  +  +D P     +    A+DL+ +L+    T+  + G  + + +  L   
Sbjct: 237 YLIFQKIIKLE--YDFPE----KFFPKARDLVEKLLVLDATK--RLGCEEMEGYGPL--- 285
Query: 296 LSISPRNHPWFQGIAWDSIRDSNAP 320
                + HP+F+ + W+++     P
Sbjct: 286 -----KAHPFFESVTWENLHQQTPP 305

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 85/313 (27%), Positives = 146/313 (46%), Gaps = 37/313 (11%)
Query: 11  FLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG 70
           F  G I G+G  FS   L   L    +       +R     + + +V +   ERDV+   
Sbjct: 35  FKFGKILGEGS-FSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR---ERDVMSRL 90
Query: 71  DRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASI 130
           D  +   L++ FQDD  LY  + Y   G+LL  + K      E   +FY AE+V A+  +
Sbjct: 91  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYL 149
Query: 131 HDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTP 189
           H    +H          RD+KP+N+LL+ + HI++ DFG+   L  +    ++N  VGT 
Sbjct: 150 HGKGIIH----------RDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 199
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSF 249
            Y+SPE+LT     +       D W+LG  +Y+++ G  PF A +    + KI+  +  +
Sbjct: 200 QYVSPELLTEKSACKS-----SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--Y 252
Query: 250 DLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI 309
           D P     +    A+DL+ +L+    T+  + G  + + +  L        + HP+F+ +
Sbjct: 253 DFPE----KFFPKARDLVEKLLVLDATK--RLGCEEMEGYGPL--------KAHPFFESV 298
Query: 310 AWDSIRDSNAPYI 322
            W+++     P +
Sbjct: 299 TWENLHQQTPPKL 311

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 129/267 (48%), Gaps = 33/267 (12%)
Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           V  +  ERDV+   D  +   L++ FQDD  LY  + Y   G LL  + K      E   
Sbjct: 76  VPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKI-GSFDETCT 134
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FY AE+V A+  +H    +H          RD+KP+N+LL+ + HI++ DFG+   L  
Sbjct: 135 RFYTAEIVSALEYLHGKGIIH----------RDLKPENILLNEDMHIQITDFGTAKVLSP 184
Query: 177 DGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
           +    ++N  VGT  Y+SPE+LT     +       D W+LG  +Y+++ G  PF A + 
Sbjct: 185 ESKQARANSFVGTAQYVSPELLTEKSASKS-----SDLWALGCIIYQLVAGLPPFRAGNE 239
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVS 295
              + KI+  +  +D P     +    A+DL+ +L+    T+  + G  + + +  L   
Sbjct: 240 YLIFQKIIKLE--YDFPE----KFFPKARDLVEKLLVLDATK--RLGCEEMEGYGPL--- 288
Query: 296 LSISPRNHPWFQGIAWDSIRDSNAPYI 322
                + HP+F+ + W+++     P +
Sbjct: 289 -----KAHPFFESVTWENLHQQTPPKL 310

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 83/266 (31%), Positives = 130/266 (48%), Gaps = 28/266 (10%)
Query: 42  SSLRR--EKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGD 99
           + +RR  +K    F+E V + ++E +++   D   I  L+  F+D++++YLVM+   GG+
Sbjct: 33  TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGE 92
Query: 100 LLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL-- 157
           L   +         D A+  + +++ A+A  H L+  HR          D+KP+N L   
Sbjct: 93  LFERVVHKRVFRESDAARI-MKDVLSAVAYCHKLNVAHR----------DLKPENFLFLT 141
Query: 158 -DANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSL 216
              +  ++L DFG   R      +++ V  GTP Y+SP++L       G YGPECD WS 
Sbjct: 142 DSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSPQVL------EGLYGPECDEWSA 193
Query: 217 GVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT 276
           GV MY +L G  PF A +  E   KI   + +F  P      +S  A+ L+RRL+  S  
Sbjct: 194 GVMMYVLLCGYPPFSAPTDXEVMLKI--REGTFTFPEKDWLNVSPQAESLIRRLLTKSPK 251
Query: 277 RLGQNGIADFKMWSALFVSLSISPRN 302
           +   +  A    W      LS SPRN
Sbjct: 252 QRITSLQALEHEW--FEKQLSSSPRN 275

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 83/266 (31%), Positives = 130/266 (48%), Gaps = 28/266 (10%)
Query: 42  SSLRR--EKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGD 99
           + +RR  +K    F+E V + ++E +++   D   I  L+  F+D++++YLVM+   GG+
Sbjct: 50  TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGE 109
Query: 100 LLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL-- 157
           L   +         D A+  + +++ A+A  H L+  HR          D+KP+N L   
Sbjct: 110 LFERVVHKRVFRESDAARI-MKDVLSAVAYCHKLNVAHR----------DLKPENFLFLT 158
Query: 158 -DANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSL 216
              +  ++L DFG   R      +++ V  GTP Y+SP++L       G YGPECD WS 
Sbjct: 159 DSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSPQVL------EGLYGPECDEWSA 210
Query: 217 GVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT 276
           GV MY +L G  PF A +  E   KI   + +F  P      +S  A+ L+RRL+  S  
Sbjct: 211 GVMMYVLLCGYPPFSAPTDXEVMLKI--REGTFTFPEKDWLNVSPQAESLIRRLLTKSPK 268
Query: 277 RLGQNGIADFKMWSALFVSLSISPRN 302
           +   +  A    W      LS SPRN
Sbjct: 269 QRITSLQALEHEW--FEKQLSSSPRN 292

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 116/242 (47%), Gaps = 35/242 (14%)
Query: 74  WITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDL 133
           ++ NL Y+FQD+ ++++V+D   GGDL   L +      E+  K +I E+V+A+  + + 
Sbjct: 76  FLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQ 134
Query: 134 HYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYIS 193
             +HR          D+KPDN+LLD +GH+ + DF     L  +   Q     GT  Y++
Sbjct: 135 RIIHR----------DMKPDNILLDEHGHVHITDFNIAAMLPRE--TQITTMAGTKPYMA 182
Query: 194 PEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNS-FDLP 252
           PE+ ++  +G G Y    DWWSLGV  YE+L G  P++  S   +   +   + +    P
Sbjct: 183 PEMFSS-RKGAG-YSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP 240
Query: 253 SDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWD 312
           S    E+    K L+     + D R  Q  ++D +              N P+   I WD
Sbjct: 241 SAWSQEMVSLLKKLLE---PNPDQRFSQ--LSDVQ--------------NFPYMNDINWD 281
Query: 313 SI 314
           ++
Sbjct: 282 AV 283

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 110/225 (48%), Gaps = 27/225 (12%)
Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDL-LTLLSKFEDRLPEDMAKFYIA 121
           E+ +L   + R++ +L YA++    L LV+    GGDL   +    +   PE  A FY A
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ 181
           E+   +  +H    V+R          D+KP+N+LLD +GHIR++D G  + +    T++
Sbjct: 294 EICCGLEDLHRERIVYR----------DLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 343
Query: 182 SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 241
               VGT  Y++PE++        RY    DWW+LG  +YEM+ G++PF      +   K
Sbjct: 344 GR--VGTVGYMAPEVVK-----NERYTFSPDWWALGCLLYEMIAGQSPFQ-----QRKKK 391
Query: 242 IMNHQNS---FDLPSDVGYEISDDAKDLMRRLICSSDT-RLGQNG 282
           I   +      ++P +     S  A+ L  +L+C     RLG  G
Sbjct: 392 IKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRG 436

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 110/225 (48%), Gaps = 27/225 (12%)
Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDL-LTLLSKFEDRLPEDMAKFYIA 121
           E+ +L   + R++ +L YA++    L LV+    GGDL   +    +   PE  A FY A
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ 181
           E+   +  +H    V+R          D+KP+N+LLD +GHIR++D G  + +    T++
Sbjct: 294 EICCGLEDLHRERIVYR----------DLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 343
Query: 182 SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 241
               VGT  Y++PE++        RY    DWW+LG  +YEM+ G++PF      +   K
Sbjct: 344 GR--VGTVGYMAPEVVK-----NERYTFSPDWWALGCLLYEMIAGQSPFQ-----QRKKK 391
Query: 242 IMNHQNSF---DLPSDVGYEISDDAKDLMRRLICSSDT-RLGQNG 282
           I   +      ++P +     S  A+ L  +L+C     RLG  G
Sbjct: 392 IKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRG 436

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 130/284 (45%), Gaps = 52/284 (18%)
Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE 122
           E ++L   D   I  L    +D S+ Y+V + Y GG+L   + K   R  E  A   I +
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQ 129
Query: 123 MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH---IRLADFG--SCLRLGGD 177
           +   I  +H  + VHR          D+KP+N+LL++      I++ DFG  +C +    
Sbjct: 130 VFSGITYMHKHNIVHR----------DLKPENILLESKEKDCDIKIIDFGLSTCFQ---- 175
Query: 178 GTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 237
              +    +GT  YI+PE+L      RG Y  +CD WS GV +Y +L G  PFY ++  +
Sbjct: 176 QNTKMKDRIGTAYYIAPEVL------RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYD 229
Query: 238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLS 297
              ++   + +FDLP      ISDDAKDL+R+++                       SL 
Sbjct: 230 ILKRVETGKYAFDLPQ--WRTISDDAKDLIRKML-------------------TFHPSLR 268
Query: 298 ISPRN---HPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDE 338
           I+      HPW Q  + ++   S+ P +   S+ T+   F  ++
Sbjct: 269 ITATQCLEHPWIQKYSSETPTISDLPSLE--SAMTNIRQFQAEK 310

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 129/272 (47%), Gaps = 44/272 (16%)
Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLP---EDMAKFY 119
           E+ +L     R+I +L YAF+  ++L LVM    GGD+   +   ++  P   E  A FY
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 120 IAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT 179
            A++V  +  +H  + ++R          D+KP+NVLLD +G++R++D G  + L   G 
Sbjct: 295 TAQIVSGLEHLHQRNIIYR----------DLKPENVLLDDDGNVRISDLGLAVELKA-GQ 343
Query: 180 VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 239
            ++    GTP +++PE+L   E     Y    D+++LGV +YEM+    PF A       
Sbjct: 344 TKTKGYAGTPGFMAPELLLGEE-----YDFSVDYFALGVTLYEMIAARGPFRARG----- 393
Query: 240 GKIMNHQ-NSFDLPSDVGY--EISDDAKDLMRRLICS-SDTRLG-QNGIADFKMWSALFV 294
            K+ N +     L   V Y  + S  +KD    L+    + RLG ++G  D         
Sbjct: 394 EKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCD--------- 444
Query: 295 SLSISPRNHPWFQGIAWDSIRDS--NAPYIPE 324
                 R HP F+ I+W  +       P++P+
Sbjct: 445 ----GLRTHPLFRDISWRQLEAGMLTPPFVPD 472

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 129/272 (47%), Gaps = 44/272 (16%)
Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLP---EDMAKFY 119
           E+ +L     R+I +L YAF+  ++L LVM    GGD+   +   ++  P   E  A FY
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 120 IAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT 179
            A++V  +  +H  + ++R          D+KP+NVLLD +G++R++D G  + L   G 
Sbjct: 295 TAQIVSGLEHLHQRNIIYR----------DLKPENVLLDDDGNVRISDLGLAVELKA-GQ 343
Query: 180 VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 239
            ++    GTP +++PE+L   E     Y    D+++LGV +YEM+    PF A       
Sbjct: 344 TKTKGYAGTPGFMAPELLLGEE-----YDFSVDYFALGVTLYEMIAARGPFRARG----- 393
Query: 240 GKIMNHQ-NSFDLPSDVGY--EISDDAKDLMRRLICS-SDTRLG-QNGIADFKMWSALFV 294
            K+ N +     L   V Y  + S  +KD    L+    + RLG ++G  D         
Sbjct: 394 EKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCD--------- 444
Query: 295 SLSISPRNHPWFQGIAWDSIRDS--NAPYIPE 324
                 R HP F+ I+W  +       P++P+
Sbjct: 445 ----GLRTHPLFRDISWRQLEAGMLTPPFVPD 472

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 108/214 (50%), Gaps = 28/214 (13%)
Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE 122
           E ++L   D   I  L    +D S+ Y+V + Y GG+L   + K   R  E  A   I +
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQ 129
Query: 123 MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH---IRLADFG--SCLRLGGD 177
           +   I  +H  + VHR          D+KP+N+LL++      I++ DFG  +C +    
Sbjct: 130 VFSGITYMHKHNIVHR----------DLKPENILLESKEKDCDIKIIDFGLSTCFQ---- 175
Query: 178 GTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 237
              +    +GT  YI+PE+L      RG Y  +CD WS GV +Y +L G  PFY ++  +
Sbjct: 176 QNTKMKDRIGTAYYIAPEVL------RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYD 229
Query: 238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
              ++   + +FDLP      ISDDAKDL+R+++
Sbjct: 230 ILKRVETGKYAFDLPQ--WRTISDDAKDLIRKML 261

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 129/272 (47%), Gaps = 44/272 (16%)
Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLP---EDMAKFY 119
           E+ +L     R+I +L YAF+  ++L LVM    GGD+   +   ++  P   E  A FY
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 120 IAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT 179
            A++V  +  +H  + ++R          D+KP+NVLLD +G++R++D G  + L   G 
Sbjct: 295 TAQIVSGLEHLHQRNIIYR----------DLKPENVLLDDDGNVRISDLGLAVELKA-GQ 343
Query: 180 VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 239
            ++    GTP +++PE+L   E     Y    D+++LGV +YEM+    PF A       
Sbjct: 344 TKTKGYAGTPGFMAPELLLGEE-----YDFSVDYFALGVTLYEMIAARGPFRARG----- 393
Query: 240 GKIMNHQ-NSFDLPSDVGY--EISDDAKDLMRRLICS-SDTRLG-QNGIADFKMWSALFV 294
            K+ N +     L   V Y  + S  +KD    L+    + RLG ++G  D         
Sbjct: 394 EKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCD--------- 444
Query: 295 SLSISPRNHPWFQGIAWDSIRDS--NAPYIPE 324
                 R HP F+ I+W  +       P++P+
Sbjct: 445 ----GLRTHPLFRDISWRQLEAGMLTPPFVPD 472

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 129/272 (47%), Gaps = 44/272 (16%)
Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLP---EDMAKFY 119
           E+ +L     R+I +L YAF+  ++L LVM    GGD+   +   ++  P   E  A FY
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 120 IAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT 179
            A++V  +  +H  + ++R          D+KP+NVLLD +G++R++D G  + L   G 
Sbjct: 295 TAQIVSGLEHLHQRNIIYR----------DLKPENVLLDDDGNVRISDLGLAVELKA-GQ 343
Query: 180 VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 239
            ++    GTP +++PE+L   E     Y    D+++LGV +YEM+    PF A       
Sbjct: 344 TKTKGYAGTPGFMAPELLLGEE-----YDFSVDYFALGVTLYEMIAARGPFRARG----- 393
Query: 240 GKIMNHQ-NSFDLPSDVGY--EISDDAKDLMRRLICS-SDTRLG-QNGIADFKMWSALFV 294
            K+ N +     L   V Y  + S  +KD    L+    + RLG ++G  D         
Sbjct: 394 EKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCD--------- 444
Query: 295 SLSISPRNHPWFQGIAWDSIRDS--NAPYIPE 324
                 R HP F+ I+W  +       P++P+
Sbjct: 445 ----GLRTHPLFRDISWRQLEAGMLTPPFVPD 472

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 108/214 (50%), Gaps = 28/214 (13%)
Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE 122
           E ++L   D   I  L    +D S+ Y+V + Y GG+L   + K   R  E  A   I +
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQ 129
Query: 123 MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH---IRLADFG--SCLRLGGD 177
           +   I  +H  + VHR          D+KP+N+LL++      I++ DFG  +C +    
Sbjct: 130 VFSGITYMHKHNIVHR----------DLKPENILLESKEKDCDIKIIDFGLSTCFQ---- 175
Query: 178 GTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 237
              +    +GT  YI+PE+L      RG Y  +CD WS GV +Y +L G  PFY ++  +
Sbjct: 176 QNTKMKDRIGTAYYIAPEVL------RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYD 229
Query: 238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
              ++   + +FDLP      ISDDAKDL+R+++
Sbjct: 230 ILKRVETGKYAFDLPQ--WRTISDDAKDLIRKML 261

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 106/213 (49%), Gaps = 25/213 (11%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           +LR E ++  +     I  L+  F D + +YL+++Y   G +   L K   R  E     
Sbjct: 58  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SRFDEQRTAT 116
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
           YI E+  A++  H    +HR          DIKP+N+LL +NG +++ADFG  +      
Sbjct: 117 YITELANALSYCHSKRVIHR----------DIKPENLLLGSNGELKIADFGWSVHAPSS- 165
Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 238
             + +   GT DY+ PE++    EGR  +  + D WSLGV  YE L G  PF A +  ET
Sbjct: 166 --RRDTLCGTLDYLPPEMI----EGR-MHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQET 218
Query: 239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           Y +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 219 YRRIS--RVEFTFPDFV----TEGARDLISRLL 245

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 105/213 (49%), Gaps = 25/213 (11%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           +LR E ++  +     I  L+  F D + +YL+++Y   G +   L K   R  E     
Sbjct: 58  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SRFDEQRTAT 116
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
           YI E+  A++  H    +HR          DIKP+N+LL +NG +++ADFG  +      
Sbjct: 117 YITELANALSYCHSKRVIHR----------DIKPENLLLGSNGELKIADFGWSVHAPSS- 165
Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 238
             +     GT DY+ PE++    EGR  +  + D WSLGV  YE L G  PF A +  ET
Sbjct: 166 --RRTTLCGTLDYLPPEMI----EGR-MHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQET 218
Query: 239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           Y +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 219 YRRI--SRVEFTFPDFV----TEGARDLISRLL 245

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 106/213 (49%), Gaps = 25/213 (11%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           +LR E ++  +     I  L+  F D + +YL+++Y   G++   L K   +  E     
Sbjct: 59  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKL-SKFDEQRTAT 117
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
           YI E+  A++  H    +HR          DIKP+N+LL + G +++ADFG  +      
Sbjct: 118 YITELANALSYCHSKRVIHR----------DIKPENLLLGSAGELKIADFGWSVHAPSS- 166
Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 238
             +     GT DY+ PE++    EGR  +  + D WSLGV  YE L G+ PF A +  ET
Sbjct: 167 --RRTTLCGTLDYLPPEMI----EGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 219
Query: 239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           Y +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 220 YKRISRVE--FTFPDFV----TEGARDLISRLL 246

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 74/217 (34%), Positives = 110/217 (50%), Gaps = 33/217 (15%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDL---LTLLSKFEDRLPEDM 115
           +LR E ++  +     I  L+  F D + +YL+++Y   G +   L  LSKF+    E  
Sbjct: 55  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD----EQR 110
Query: 116 AKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG-SCLRL 174
              YI E+  A++  H    +HR          DIKP+N+LL + G +++ADFG SC   
Sbjct: 111 TATYITELANALSYCHSKRVIHR----------DIKPENLLLGSAGELKIADFGWSCHAP 160
Query: 175 GGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES 234
               T  S    GT DY+ PE++    EGR  +  + D WSLGV  YE L G+ PF A +
Sbjct: 161 SSRRTTLS----GTLDYLPPEMI----EGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANT 211
Query: 235 LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
             ETY +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 212 YQETYKRISRVE--FTFPDFV----TEGARDLISRLL 242

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 107/213 (50%), Gaps = 25/213 (11%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           +LR E ++  +     I  L+  F D + +YL+++Y   G++   L K   +  E     
Sbjct: 59  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKL-SKFDEQRTAT 117
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
           YI E+  A++  H    +HR          DIKP+N+LL + G +++ADFG  +      
Sbjct: 118 YITELANALSYCHSKRVIHR----------DIKPENLLLGSAGELKIADFGWSVHAP--- 164
Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 238
           + +     GT DY+ PE++    EGR  +  + D WSLGV  YE L G+ PF A +  ET
Sbjct: 165 SSRRXXLXGTLDYLPPEMI----EGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 219
Query: 239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           Y +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 220 YKRISRVE--FTFPDFV----TEGARDLISRLL 246

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 31/216 (14%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDL---LTLLSKFEDRLPEDM 115
           +LR E ++  +     I  L+  F D + +YL+++Y   G +   L  LSKF+    E  
Sbjct: 80  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD----EQR 135
Query: 116 AKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG 175
              YI E+  A++  H    +HR          DIKP+N+LL + G +++ADFG  +   
Sbjct: 136 TATYITELANALSYCHSKRVIHR----------DIKPENLLLGSAGELKIADFGWSVHAP 185
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
                +     GT DY+ PE++    EGR  +  + D WSLGV  YE L G+ PF A + 
Sbjct: 186 SS---RRTTLCGTLDYLPPEMI----EGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTY 237
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
            ETY +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 238 QETYKRISRVE--FTFPDFV----TEGARDLISRLL 267

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 25/213 (11%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           +LR E ++  +     I  L+  F D + +YL+++Y   G +   L K   +  E     
Sbjct: 59  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTAT 117
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
           YI E+  A++  H    +HR          DIKP+N+LL + G +++ADFG  +      
Sbjct: 118 YITELANALSYCHSKRVIHR----------DIKPENLLLGSAGELKIADFGWSVHAPSS- 166
Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 238
             +     GT DY+ PE++    EGR  +  + D WSLGV  YE L G+ PF A +  ET
Sbjct: 167 --RRTTLCGTLDYLPPEMI----EGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 219
Query: 239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           Y +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 220 YKRISRVE--FTFPDFV----TEGARDLISRLL 246

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 31/216 (14%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDL---LTLLSKFEDRLPEDM 115
           +LR E ++  +     I  L+  F D + +YL+++Y   G +   L  LSKF+    E  
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD----EQR 109
Query: 116 AKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG 175
              YI E+  A++  H    +HR          DIKP+N+LL + G +++ADFG  +   
Sbjct: 110 TATYITELANALSYCHSKRVIHR----------DIKPENLLLGSAGELKIADFGWSVHAP 159
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
                +     GT DY+ PE++    EGR  +  + D WSLGV  YE L G+ PF A + 
Sbjct: 160 SS---RRTTLCGTLDYLPPEMI----EGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTY 211
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
            ETY +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 212 QETYKRISRVE--FTFPDFV----TEGARDLISRLL 241

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 23/205 (11%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L    + +  LYL+M+Y  GG++   L     R+ E  A+    ++V A+   H   
Sbjct: 73  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKR 131
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            VHR          D+K +N+LLDA+ +I++ADFG        G +  +   G+P Y +P
Sbjct: 132 IVHR----------DLKAENLLLDADMNIKIADFGFSNEFTVGGKL--DTFCGSPPYAAP 179
Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSD 254
           E+     +G+   GPE D WSLGV +Y ++ G  PF  ++L E   +++  +  + +P  
Sbjct: 180 ELF----QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL--RGKYRIP-- 231
Query: 255 VGYEISDDAKDLMRRLICSSDTRLG 279
             + +S D ++L++R +  +  + G
Sbjct: 232 --FYMSTDCENLLKRFLVLNPIKRG 254

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 31/216 (14%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDL---LTLLSKFEDRLPEDM 115
           +LR E ++  +     I  L+  F D + +YL+++Y   G +   L  LSKF+    E  
Sbjct: 71  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD----EQR 126
Query: 116 AKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG 175
              YI E+  A++  H    +HR          DIKP+N+LL + G +++ADFG  +   
Sbjct: 127 TATYITELANALSYCHSKRVIHR----------DIKPENLLLGSAGELKIADFGWSVHAP 176
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
                +     GT DY+ PE++    EGR  +  + D WSLGV  YE L G+ PF A + 
Sbjct: 177 SS---RRTTLCGTLDYLPPEMI----EGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTY 228
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
            ETY +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 229 QETYKRISRVE--FTFPDFV----TEGARDLISRLL 258

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 109/216 (50%), Gaps = 31/216 (14%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDL---LTLLSKFEDRLPEDM 115
           +LR E ++  +     I  L+  F D + +YL+++Y   G +   L  LSKF+    E  
Sbjct: 55  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD----EQR 110
Query: 116 AKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG 175
              YI E+  A++  H    +HR          DIKP+N+LL + G +++ADFG  +   
Sbjct: 111 TATYITELANALSYCHSKRVIHR----------DIKPENLLLGSAGELKIADFGWSVHAP 160
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
                + +   GT DY+ PE++    EGR  +  + D WSLGV  YE L G+ PF A + 
Sbjct: 161 SS---RRDTLCGTLDYLPPEMI----EGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTY 212
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
            ETY +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 213 QETYKRISRVE--FTFPDFV----TEGARDLISRLL 242

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 25/213 (11%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           +LR E ++  +     I  L+  F D + +YL+++Y   G +   L K   +  E     
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTAT 115
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
           YI E+  A++  H    +HR          DIKP+N+LL + G +++ADFG  +      
Sbjct: 116 YITELANALSYCHSKRVIHR----------DIKPENLLLGSAGELKIADFGWSVHAPSS- 164
Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 238
             +     GT DY+ PE++    EGR  +  + D WSLGV  YE L G+ PF A +  ET
Sbjct: 165 --RRTTLCGTLDYLPPEMI----EGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 217
Query: 239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           Y +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 218 YKRISRVE--FTFPDFV----TEGARDLISRLL 244

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 109/216 (50%), Gaps = 31/216 (14%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDL---LTLLSKFEDRLPEDM 115
           +LR E ++  +     I  L+  F D + +YL+++Y   G +   L  LSKF+    E  
Sbjct: 58  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD----EQR 113
Query: 116 AKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG 175
              YI E+  A++  H    +HR          DIKP+N+LL + G +++ADFG  +   
Sbjct: 114 TATYITELANALSYCHSKRVIHR----------DIKPENLLLGSAGELKIADFGWSVH-- 161
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
              + +     GT DY+ PE++    EGR  +  + D WSLGV  YE L G+ PF A + 
Sbjct: 162 -APSSRRTTLCGTLDYLPPEMI----EGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTY 215
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
            ETY +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 216 QETYKRI--SRVEFTFPDFV----TEGARDLISRLL 245

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 25/213 (11%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           +LR E ++  +     I  L+  F D + +YL+++Y   G +   L K   +  E     
Sbjct: 53  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTAT 111
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
           YI E+  A++  H    +HR          DIKP+N+LL + G +++ADFG  +      
Sbjct: 112 YITELANALSYCHSKRVIHR----------DIKPENLLLGSAGELKIADFGWSVHAPSS- 160
Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 238
             +     GT DY+ PE++    EGR  +  + D WSLGV  YE L G+ PF A +  ET
Sbjct: 161 --RRTTLCGTLDYLPPEMI----EGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 213
Query: 239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           Y +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 214 YKRI--SRVEFTFPDFV----TEGARDLISRLL 240

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 25/213 (11%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           +LR E ++  +     I  L+  F D + +YL+++Y   G +   L K   +  E     
Sbjct: 51  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTAT 109
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
           YI E+  A++  H    +HR          DIKP+N+LL + G +++ADFG  +      
Sbjct: 110 YITELANALSYCHSKRVIHR----------DIKPENLLLGSAGELKIADFGWSVHAPSS- 158
Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 238
             +     GT DY+ PE++    EGR  +  + D WSLGV  YE L G+ PF A +  ET
Sbjct: 159 --RRTTLCGTLDYLPPEMI----EGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 211
Query: 239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           Y +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 212 YKRI--SRVEFTFPDFV----TEGARDLISRLL 238

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 25/213 (11%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           +LR E ++  +     I  L+  F D + +YL+++Y   G +   L K   +  E     
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTAT 115
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
           YI E+  A++  H    +HR          DIKP+N+LL + G +++ADFG  +      
Sbjct: 116 YITELANALSYCHSKRVIHR----------DIKPENLLLGSAGELKIADFGWSVHAPSS- 164
Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 238
             +     GT DY+ PE++    EGR  +  + D WSLGV  YE L G+ PF A +  ET
Sbjct: 165 --RRTTLCGTLDYLPPEMI----EGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 217
Query: 239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           Y +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 218 YKRI--SRVEFTFPDFV----TEGARDLISRLL 244

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 103/205 (50%), Gaps = 23/205 (11%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L    + +  LYL+M+Y  GG++   L     R+ E  A+    ++V A+   H   
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            VHR          D+K +N+LLDA+ +I++ADFG        G +  +   G P Y +P
Sbjct: 135 IVHR----------DLKAENLLLDADMNIKIADFGFSNEFTVGGKL--DAFCGAPPYAAP 182
Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSD 254
           E+     +G+   GPE D WSLGV +Y ++ G  PF  ++L E   +++  +  + +P  
Sbjct: 183 ELF----QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL--RGKYRIP-- 234
Query: 255 VGYEISDDAKDLMRRLICSSDTRLG 279
             + +S D ++L++R +  +  + G
Sbjct: 235 --FYMSTDCENLLKRFLVLNPIKRG 257

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           +LR E ++  +     I  L+  F D + +YL+++Y   G +   L K   +  E     
Sbjct: 59  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTAT 117
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
           YI E+  A++  H    +HR          DIKP+N+LL + G +++ADFG  +      
Sbjct: 118 YITELANALSYCHSKRVIHR----------DIKPENLLLGSAGELKIADFGWSVHAPSS- 166
Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 238
             +     GT DY+ PE +    EGR  +  + D WSLGV  YE L G+ PF A +  ET
Sbjct: 167 --RRTTLCGTLDYLPPEXI----EGRX-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 219
Query: 239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           Y +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 220 YKRIS--RVEFTFPDFV----TEGARDLISRLL 246

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 111/242 (45%), Gaps = 32/242 (13%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L   ++ ++  +LV D    G+L   L++ +  L E   +  +  ++  I ++H L+
Sbjct: 86  IIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLN 144
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            VHR          D+KP+N+LLD + +I+L DFG   +L     ++S    GTP Y++P
Sbjct: 145 IVHR----------DLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRS--VCGTPSYLAP 192
Query: 195 EIL-TAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPS 253
           EI+  +M +    YG E D WS GV MY +L G  PF+    +     IM+    F  P 
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 252
Query: 254 DVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDS 313
              Y  SD  KDL+ R +     +        +    AL          HP+FQ    + 
Sbjct: 253 WDDY--SDTVKDLVSRFLVVQPQK-------RYTAEEAL---------AHPFFQQYVVEE 294
Query: 314 IR 315
           +R
Sbjct: 295 VR 296

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 106/213 (49%), Gaps = 25/213 (11%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           +LR E ++  +     I  L+  F D + +YL+++Y   G +   L K   +  E     
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTAT 115
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
           YI E+  A++  H    +HR          DIKP+N+LL + G +++ADFG  +      
Sbjct: 116 YITELANALSYCHSKRVIHR----------DIKPENLLLGSAGELKIADFGWSVH---AP 162
Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 238
           + +     GT DY+ PE++    EGR  +  + D WSLGV  YE L G+ PF A +  ET
Sbjct: 163 SSRRAALCGTLDYLPPEMI----EGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 217
Query: 239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           Y +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 218 YKRISRVE--FTFPDFV----TEGARDLISRLL 244

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 25/213 (11%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           +LR E ++  +     I  L+  F D + +YL+++Y   G +   L K   +  E     
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTAT 112
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
           YI E+  A++  H    +HR          DIKP+N+LL + G +++ADFG  +      
Sbjct: 113 YITELANALSYCHSKRVIHR----------DIKPENLLLGSAGELKIADFGWSVHAPSSR 162
Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 238
             +     GT DY+ PE++    EGR  +  + D WSLGV  YE L G+ PF A +  ET
Sbjct: 163 RTE---LCGTLDYLPPEMI----EGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214
Query: 239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           Y +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 215 YKRISRVE--FTFPDFV----TEGARDLISRLL 241

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 25/213 (11%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           +LR E ++  +     I  L+  F D + +YL+++Y   G +   L K   +  E     
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTAT 112
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
           YI E+  A++  H    +HR          DIKP+N+LL + G +++ADFG  +      
Sbjct: 113 YITELANALSYCHSKRVIHR----------DIKPENLLLGSAGELKIADFGWSVHAPSS- 161
Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 238
             +     GT DY+ PE++    EGR  +  + D WSLGV  YE L G+ PF A +  ET
Sbjct: 162 --RRTXLCGTLDYLPPEMI----EGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214
Query: 239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           Y +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 215 YKRI--SRVEFTFPDFV----TEGARDLISRLL 241

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 31/216 (14%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDL---LTLLSKFEDRLPEDM 115
           +LR E ++  +     I  L+  F D + +YL+++Y   G +   L  LSKF+    E  
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD----EQR 109
Query: 116 AKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG 175
              YI E+  A++  H    +HR          DIKP+N+LL + G +++ADFG  +   
Sbjct: 110 TATYITELANALSYCHSKRVIHR----------DIKPENLLLGSAGELKIADFGWSVHAP 159
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
                +     GT DY+ PE++    EGR  +  + D WSLGV  YE L G+ PF A + 
Sbjct: 160 SS---RRAALCGTLDYLPPEMI----EGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTY 211
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
            ETY +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 212 QETYKRI--SRVEFTFPDFV----TEGARDLISRLL 241

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 101/189 (53%), Gaps = 21/189 (11%)
Query: 84  DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFA 143
           ++ +LY+V +    G ++ + +     L ED A+FY  +++  I  +H    +HR     
Sbjct: 109 NEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQKIIHR----- 161
Query: 144 FHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEG 203
                DIKP N+L+  +GHI++ADFG      G   + SN  VGTP +++PE L+  E  
Sbjct: 162 -----DIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSN-TVGTPAFMAPESLS--ETR 213
Query: 204 RGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSF-DLPSDVGYEISDD 262
           +   G   D W++GV +Y  ++G+ PF  E ++  + KI +    F D P     +I++D
Sbjct: 214 KIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQP-----DIAED 268
Query: 263 AKDLMRRLI 271
            KDL+ R++
Sbjct: 269 LKDLITRML 277

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 25/213 (11%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           +LR E ++  +     I  L+  F D + +YL+++Y   G +   L K   +  E     
Sbjct: 56  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTAT 114
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
           YI E+  A++  H    +HR          DIKP+N+LL + G +++ADFG  +      
Sbjct: 115 YITELANALSYCHSKRVIHR----------DIKPENLLLGSAGELKIADFGWSVHAPSS- 163
Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 238
             +     GT DY+ PE++    EGR  +  + D WSLGV  YE L G+ PF A +  ET
Sbjct: 164 --RRXXLCGTLDYLPPEMI----EGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 216
Query: 239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           Y +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 217 YKRISRVE--FTFPDFV----TEGARDLISRLL 243

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 25/213 (11%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           +LR E ++  +     I  L+  F D + +YL+++Y   G +   L K   +  E     
Sbjct: 56  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTAT 114
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
           YI E+  A++  H    +HR          DIKP+N+LL + G +++A+FG  +      
Sbjct: 115 YITELANALSYCHSKRVIHR----------DIKPENLLLGSAGELKIANFGWSVHAPSS- 163
Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 238
             +     GT DY+ PE++    EGR  +  + D WSLGV  YE L G+ PF A +  ET
Sbjct: 164 --RRTTLCGTLDYLPPEMI----EGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 216
Query: 239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           Y +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 217 YKRISRVE--FTFPDFV----TEGARDLISRLL 243

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 109/216 (50%), Gaps = 31/216 (14%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDL---LTLLSKFEDRLPEDM 115
           +LR E ++  +     I  L+  F D + +YL+++Y   G +   L  LSKF+    E  
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD----EQR 109
Query: 116 AKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG 175
              YI E+  A++  H    +HR          DIKP+N+LL + G +++ADFG  +   
Sbjct: 110 TATYITELANALSYCHSKRVIHR----------DIKPENLLLGSAGELKIADFGWSVH-- 157
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
              + +     GT DY+ PE++    EGR  +  + D WSLGV  YE L G+ PF A + 
Sbjct: 158 -APSSRRXXLCGTLDYLPPEMI----EGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTY 211
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
            ETY +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 212 QETYKRI--SRVEFTFPDFV----TEGARDLISRLL 241

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 25/213 (11%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           +LR E ++  +     I  L+  F D + +YL+++Y   G +   L K   +  E     
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTAT 115
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
           YI E+  A++  H    +HR          DIKP+N+LL + G +++ADFG  +      
Sbjct: 116 YITELANALSYCHSKRVIHR----------DIKPENLLLGSAGELKIADFGWSVHAPSS- 164
Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 238
             +     GT DY+ PE++    EGR  +  + D WSLGV  YE L G+ PF A +  ET
Sbjct: 165 --RRXXLCGTLDYLPPEMI----EGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 217
Query: 239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           Y +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 218 YKRI--SRVEFTFPDFV----TEGARDLISRLL 244

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 110/216 (50%), Gaps = 31/216 (14%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDL---LTLLSKFEDRLPEDM 115
           +LR E ++  +     I  L+  F D + +YL+++Y   G +   L  LSKF+    E  
Sbjct: 80  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD----EQR 135
Query: 116 AKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG 175
              YI E+  A++  H    +HR          DIKP+N+LL + G +++ADFG  +   
Sbjct: 136 TATYITELANALSYCHSKRVIHR----------DIKPENLLLGSAGELKIADFGWSVHAP 185
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
              + + +   GT DY+ PE++    EGR  +  + D WSLGV  YE L G+ PF A + 
Sbjct: 186 ---SSRRDDLCGTLDYLPPEMI----EGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTY 237
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
            ETY +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 238 QETYKRISRVE--FTFPDFV----TEGARDLISRLL 267

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 108/216 (50%), Gaps = 31/216 (14%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDL---LTLLSKFEDRLPEDM 115
           +LR E ++  +     I  L+  F D + +YL+++Y   G +   L  LSKF+    E  
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD----EQR 112
Query: 116 AKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG 175
              YI E+  A++  H    +HR          DIKP+N+LL + G +++A+FG  +   
Sbjct: 113 TATYITELANALSYCHSKRVIHR----------DIKPENLLLGSAGELKIANFGWSVHAP 162
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
                +     GT DY+ PE++    EGR  +  + D WSLGV  YE L G+ PF A + 
Sbjct: 163 SS---RRTTLCGTLDYLPPEMI----EGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTY 214
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
            ETY +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 215 QETYKRI--SRVEFTFPDFV----TEGARDLISRLL 244

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 112/218 (51%), Gaps = 26/218 (11%)
Query: 58  AKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLL-TLLSKFEDRLPEDMA 116
           +KL EE  VL   D   I  L+  F+D  N YLVM+ Y GG+L   ++ +   +  E  A
Sbjct: 81  SKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM--KFNEVDA 138
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA---NGHIRLADFGSCLR 173
              I +++  +  +H  + VHR          D+KP+N+LL++   +  I++ DFG    
Sbjct: 139 AVIIKQVLSGVTYLHKHNIVHR----------DLKPENLLLESKEKDALIKIVDFGLSAV 188
Query: 174 LGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE 233
                 ++  +  GT  YI+PE+L      R +Y  +CD WS+GV ++ +L G  PF  +
Sbjct: 189 FENQKKMKERL--GTAYYIAPEVL------RKKYDEKCDVWSIGVILFILLAGYPPFGGQ 240
Query: 234 SLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           +  E   K+   + +FD P      +S+ AKDL+++++
Sbjct: 241 TDQEILRKVEKGKYTFDSPE--WKNVSEGAKDLIKQML 276

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 109/213 (51%), Gaps = 25/213 (11%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           +LR E ++  +     I  L+  F D + +YL+++Y   G +   L K   +  E     
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTAT 112
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
           YI E+  A++  H    +HR          DIKP+N+LL + G +++ADFG  +      
Sbjct: 113 YITELANALSYCHSKRVIHR----------DIKPENLLLGSAGELKIADFGWSVH--APS 160
Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 238
           + ++++  GT DY+ PE++    EGR  +  + D WSLGV  YE L G+ PF A +  ET
Sbjct: 161 SRRTDLC-GTLDYLPPEMI----EGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214
Query: 239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           Y +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 215 YKRI--SRVEFTFPDFV----TEGARDLISRLL 241

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 112/216 (51%), Gaps = 31/216 (14%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDL---LTLLSKFEDRLPEDM 115
           +LR E ++  +     I  L+  F D + +YL+++Y   G +   L  LSKF+    E  
Sbjct: 55  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD----EQR 110
Query: 116 AKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG 175
              YI E+  A++  H    +HR          DIKP+N+LL + G +++ADFG  +   
Sbjct: 111 TATYITELANALSYCHSKRVIHR----------DIKPENLLLGSAGELKIADFGWSVH-- 158
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
              + ++++  GT DY+ PE++    EGR  +  + D WSLGV  YE L G+ PF A + 
Sbjct: 159 APSSRRTDLC-GTLDYLPPEMI----EGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTY 212
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
            ETY +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 213 QETYKRISRVE--FTFPDFV----TEGARDLISRLL 242

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 16/198 (8%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L   ++ ++  +LV D    G+L   L++ +  L E   +  +  ++  I ++H L+
Sbjct: 73  IIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLN 131
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            VHR          D+KP+N+LLD + +I+L DFG   +L  D   +     GTP Y++P
Sbjct: 132 IVHR----------DLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYLAP 179
Query: 195 EIL-TAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPS 253
           EI+  +M +    YG E D WS GV MY +L G  PF+    +     IM+    F  P 
Sbjct: 180 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 239
Query: 254 DVGYEISDDAKDLMRRLI 271
              Y  SD  KDL+ R +
Sbjct: 240 WDDY--SDTVKDLVSRFL 255

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 109/213 (51%), Gaps = 25/213 (11%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           +LR E ++  +     I  L+  F D + +YL+++Y   G +   L K   +  E     
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTAT 112
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
           YI E+  A++  H    +HR          DIKP+N+LL + G +++ADFG  +      
Sbjct: 113 YITELANALSYCHSKRVIHR----------DIKPENLLLGSAGELKIADFGWSVH--APS 160
Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 238
           + ++++  GT DY+ PE++    EGR  +  + D WSLGV  YE L G+ PF A +  ET
Sbjct: 161 SRRTDLC-GTLDYLPPEMI----EGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214
Query: 239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           Y +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 215 YKRI--SRVEFTFPDFV----TEGARDLISRLL 241

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 110/242 (45%), Gaps = 32/242 (13%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L   ++ ++  +LV D    G+L   L++ +  L E   +  +  ++  I ++H L+
Sbjct: 86  IIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLN 144
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            VHR          D+KP+N+LLD + +I+L DFG   +L  D   +     GTP Y++P
Sbjct: 145 IVHR----------DLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYLAP 192
Query: 195 EIL-TAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPS 253
           EI+  +M +    YG E D WS GV MY +L G  PF+    +     IM+    F  P 
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 252
Query: 254 DVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDS 313
              Y  SD  KDL+ R +     +        +    AL          HP+FQ    + 
Sbjct: 253 WDDY--SDTVKDLVSRFLVVQPQK-------RYTAEEAL---------AHPFFQQYVVEE 294
Query: 314 IR 315
           +R
Sbjct: 295 VR 296

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 109/213 (51%), Gaps = 25/213 (11%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           +LR E ++  +     I  L+  F D + +YL+++Y   G +   L K   +  E     
Sbjct: 59  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTAT 117
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
           YI E+  A++  H    +HR          DIKP+N+LL + G +++ADFG  +      
Sbjct: 118 YITELANALSYCHSKRVIHR----------DIKPENLLLGSAGELKIADFGWSVH--APS 165
Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 238
           + ++++  GT DY+ PE++    EGR  +  + D WSLGV  YE L G+ PF A +  ET
Sbjct: 166 SRRTDLC-GTLDYLPPEMI----EGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 219
Query: 239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           Y +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 220 YKRIS--RVEFTFPDFV----TEGARDLISRLL 246

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 110/216 (50%), Gaps = 31/216 (14%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDL---LTLLSKFEDRLPEDM 115
           +LR E ++  +     I  L+  F D + +YL+++Y   G +   L  LSKF+    E  
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD----EQR 112
Query: 116 AKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG 175
              YI E+  A++  H    +HR          DIKP+N+LL + G +++ADFG  +   
Sbjct: 113 TATYITELANALSYCHSKRVIHR----------DIKPENLLLGSAGELKIADFGWSVH-- 160
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
              + + +   GT DY+ PE++    EGR  +  + D WSLGV  YE L G+ PF A + 
Sbjct: 161 -APSSRRDDLCGTLDYLPPEMI----EGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTY 214
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
            ETY +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 215 QETYKRI--SRVEFTFPDFV----TEGARDLISRLL 244

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 125/271 (46%), Gaps = 38/271 (14%)
Query: 70  GDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS 129
           GD  +I  + YAF     L  ++D   GGDL   LS+       DM +FY AE++L +  
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-RFYAAEIILGLEH 307
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD-GTVQSNVAVGT 188
           +H+   V+R          D+KP N+LLD +GH+R++D G    L  D    + + +VGT
Sbjct: 308 MHNRFVVYR----------DLKPANILLDEHGHVRISDLG----LACDFSKKKPHASVGT 353
Query: 189 PDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG-KIMNHQN 247
             Y++PE+L   ++G   Y    DW+SLG  ++++L G +PF      + +    M    
Sbjct: 354 HGYMAPEVL---QKGVA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 409
Query: 248 SFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ 307
           + +LP     E+    + L++R +   + RLG  G    ++            +  P+F+
Sbjct: 410 AVELPDSFSPELRSLLEGLLQRDV---NRRLGCLGRGAQEV------------KESPFFR 454
Query: 308 GIAWDSI--RDSNAPYIPEVSSPTDTSHFDV 336
            + W  +  +    P IP          FD+
Sbjct: 455 SLDWQMVFLQKYPPPLIPPRGEVNAADAFDI 485

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 125/271 (46%), Gaps = 38/271 (14%)
Query: 70  GDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS 129
           GD  +I  + YAF     L  ++D   GGDL   LS+       DM +FY AE++L +  
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-RFYAAEIILGLEH 307
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD-GTVQSNVAVGT 188
           +H+   V+R          D+KP N+LLD +GH+R++D G    L  D    + + +VGT
Sbjct: 308 MHNRFVVYR----------DLKPANILLDEHGHVRISDLG----LACDFSKKKPHASVGT 353
Query: 189 PDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG-KIMNHQN 247
             Y++PE+L   ++G   Y    DW+SLG  ++++L G +PF      + +    M    
Sbjct: 354 HGYMAPEVL---QKGVA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 409
Query: 248 SFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ 307
           + +LP     E+    + L++R +   + RLG  G    ++            +  P+F+
Sbjct: 410 AVELPDSFSPELRSLLEGLLQRDV---NRRLGCLGRGAQEV------------KESPFFR 454
Query: 308 GIAWDSI--RDSNAPYIPEVSSPTDTSHFDV 336
            + W  +  +    P IP          FD+
Sbjct: 455 SLDWQMVFLQKYPPPLIPPRGEVNAADAFDI 485

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 125/271 (46%), Gaps = 38/271 (14%)
Query: 70  GDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS 129
           GD  +I  + YAF     L  ++D   GGDL   LS+       DM +FY AE++L +  
Sbjct: 248 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-RFYAAEIILGLEH 306
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD-GTVQSNVAVGT 188
           +H+   V+R          D+KP N+LLD +GH+R++D G    L  D    + + +VGT
Sbjct: 307 MHNRFVVYR----------DLKPANILLDEHGHVRISDLG----LACDFSKKKPHASVGT 352
Query: 189 PDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG-KIMNHQN 247
             Y++PE+L   ++G   Y    DW+SLG  ++++L G +PF      + +    M    
Sbjct: 353 HGYMAPEVL---QKGVA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 408
Query: 248 SFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ 307
           + +LP     E+    + L++R +   + RLG  G    ++            +  P+F+
Sbjct: 409 AVELPDSFSPELRSLLEGLLQRDV---NRRLGCLGRGAQEV------------KESPFFR 453
Query: 308 GIAWDSI--RDSNAPYIPEVSSPTDTSHFDV 336
            + W  +  +    P IP          FD+
Sbjct: 454 SLDWQMVFLQKYPPPLIPPRGEVNAADAFDI 484

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 125/271 (46%), Gaps = 38/271 (14%)
Query: 70  GDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS 129
           GD  +I  + YAF     L  ++D   GGDL   LS+       DM +FY AE++L +  
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-RFYAAEIILGLEH 307
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD-GTVQSNVAVGT 188
           +H+   V+R          D+KP N+LLD +GH+R++D G    L  D    + + +VGT
Sbjct: 308 MHNRFVVYR----------DLKPANILLDEHGHVRISDLG----LACDFSKKKPHASVGT 353
Query: 189 PDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG-KIMNHQN 247
             Y++PE+L   ++G   Y    DW+SLG  ++++L G +PF      + +    M    
Sbjct: 354 HGYMAPEVL---QKGVA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 409
Query: 248 SFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ 307
           + +LP     E+    + L++R +   + RLG  G    ++            +  P+F+
Sbjct: 410 AVELPDSFSPELRSLLEGLLQRDV---NRRLGCLGRGAQEV------------KESPFFR 454
Query: 308 GIAWDSI--RDSNAPYIPEVSSPTDTSHFDV 336
            + W  +  +    P IP          FD+
Sbjct: 455 SLDWQMVFLQKYPPPLIPPRGEVNAADAFDI 485

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 108/216 (50%), Gaps = 31/216 (14%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDL---LTLLSKFEDRLPEDM 115
           +LR E ++  +     I  L+  F D + +YL+++Y   G +   L  LSKF+    E  
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFD----EQR 109
Query: 116 AKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG 175
              YI E+  A++  H    +HR          DIKP+N+LL + G +++ADFG  +   
Sbjct: 110 TATYITELANALSYCHSKKVIHR----------DIKPENLLLGSAGELKIADFGWSVHAP 159
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
                +     GT DY+ PE++    EGR  +  + D WSLGV  YE L G+ PF A + 
Sbjct: 160 SS---RRAALCGTLDYLPPEMI----EGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTY 211
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
            +TY +I   +  F  P  V    ++ A+DL+ RL+
Sbjct: 212 QDTYKRI--SRVEFTFPDFV----TEGARDLISRLL 241

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 102/199 (51%), Gaps = 19/199 (9%)
Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTL 103
           L R+K  S  ++ V K+R E   L       I  L+      S++++VM+Y  GG+L   
Sbjct: 49  LNRQKIRS--LDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDY 106
Query: 104 LSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI 163
           + K   RL E  ++    +++  +       Y HR  H   H  RD+KP+NVLLDA+ + 
Sbjct: 107 ICK-NGRLDEKESRRLFQQILSGVD------YCHR--HMVVH--RDLKPENVLLDAHMNA 155
Query: 164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM 223
           ++ADFG    +  DG      + G+P+Y +PE+++    GR   GPE D WS GV +Y +
Sbjct: 156 KIADFGLS-NMMSDGEFL-RXSCGSPNYAAPEVIS----GRLYAGPEVDIWSSGVILYAL 209
Query: 224 LYGETPFYAESLVETYGKI 242
           L G  PF  + +   + KI
Sbjct: 210 LCGTLPFDDDHVPTLFKKI 228

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 111/223 (49%), Gaps = 23/223 (10%)
Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           + KL  E  ++   +   I  L    + +  LYLVM+Y  GG++   L     R+ E  A
Sbjct: 57  LQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVA-HGRMKEKEA 115
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +    ++V A+   H    VHR          D+K +N+LLDA+ +I++ADFG       
Sbjct: 116 RAKFRQIVSAVQYCHQKFIVHR----------DLKAENLLLDADMNIKIADFGFSNEFTF 165
Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
              +  +   G+P Y +PE+     +G+   GPE D WSLGV +Y ++ G  PF  ++L 
Sbjct: 166 GNKL--DTFCGSPPYAAPELF----QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK 219
Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLG 279
           E   +++  +  + +P    + +S D ++L+++ +  + ++ G
Sbjct: 220 ELRERVL--RGKYRIP----FYMSTDCENLLKKFLILNPSKRG 256

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 111/223 (49%), Gaps = 23/223 (10%)
Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           + KL  E  ++   +   I  L    + +  LYLVM+Y  GG++   L     R+ E  A
Sbjct: 57  LQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVA-HGRMKEKEA 115
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +    ++V A+   H    VHR          D+K +N+LLDA+ +I++ADFG       
Sbjct: 116 RAKFRQIVSAVQYCHQKFIVHR----------DLKAENLLLDADMNIKIADFGFSNEFTF 165
Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
              +  +   G+P Y +PE+     +G+   GPE D WSLGV +Y ++ G  PF  ++L 
Sbjct: 166 GNKL--DTFCGSPPYAAPELF----QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK 219
Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLG 279
           E   +++  +  + +P    + +S D ++L+++ +  + ++ G
Sbjct: 220 ELRERVL--RGKYRIP----FYMSTDCENLLKKFLILNPSKRG 256

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 101/199 (50%), Gaps = 18/199 (9%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L  +++  S ++LV D    G+L   L++ +  L E   +  +  ++ A++ +H  +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANN 220
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG-SCLRLGGDGTVQSNVAVGTPDYIS 193
            VHR          D+KP+N+LLD N  IRL+DFG SC    G+   +     GTP Y++
Sbjct: 221 IVHR----------DLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE---LCGTPGYLA 267
Query: 194 PEILT-AMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLP 252
           PEIL  +M+E    YG E D W+ GV ++ +L G  PF+    +     IM  Q  F  P
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSP 327
Query: 253 SDVGYEISDDAKDLMRRLI 271
                + S   KDL+ RL+
Sbjct: 328 E--WDDRSSTVKDLISRLL 344

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 111/223 (49%), Gaps = 23/223 (10%)
Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           + KL  E  ++   +   I  L    + +  LYLVM+Y  GG++   L     R+ E  A
Sbjct: 57  LQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVA-HGRMKEKEA 115
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +    ++V A+   H    VHR          D+K +N+LLDA+ +I++ADFG       
Sbjct: 116 RAKFRQIVSAVQYCHQKFIVHR----------DLKAENLLLDADMNIKIADFGFSNEFTF 165
Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
              +  +   G+P Y +PE+     +G+   GPE D WSLGV +Y ++ G  PF  ++L 
Sbjct: 166 GNKL--DTFCGSPPYAAPELF----QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK 219
Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLG 279
           E   +++  +  + +P    + +S D ++L+++ +  + ++ G
Sbjct: 220 ELRERVL--RGKYRIP----FYMSTDCENLLKKFLILNPSKRG 256

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTL 103
           L R+K  S  ++ V K++ E   L       I  L+      ++ ++VM+Y  GG+L   
Sbjct: 44  LNRQKIRS--LDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDY 101
Query: 104 LSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI 163
           + K   R+ E  A+    +++ A+       Y HR  H   H  RD+KP+NVLLDA+ + 
Sbjct: 102 ICK-HGRVEEMEARRLFQQILSAVD------YCHR--HMVVH--RDLKPENVLLDAHMNA 150
Query: 164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM 223
           ++ADFG    +  DG    + + G+P+Y +PE+++    GR   GPE D WS GV +Y +
Sbjct: 151 KIADFGLS-NMMSDGEFLRD-SCGSPNYAAPEVIS----GRLYAGPEVDIWSCGVILYAL 204
Query: 224 LYGETPFYAESLVETYGKI 242
           L G  PF  E +   + KI
Sbjct: 205 LCGTLPFDDEHVPTLFKKI 223

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 24/215 (11%)
Query: 60  LREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFY 119
           L +E  VL   D   I  L+  F+D  N YLVM+ Y GG+L   +     +  E  A   
Sbjct: 68  LLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEII-LRQKFSEVDAAVI 126
Query: 120 IAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH---IRLADFGSCLRLGG 176
           + +++     +H  + VHR          D+KP+N+LL++      I++ DFG       
Sbjct: 127 MKQVLSGTTYLHKHNIVHR----------DLKPENLLLESKSRDALIKIVDFGLSAHFEV 176
Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
            G ++  +  GT  YI+PE+L      R +Y  +CD WS GV +Y +L G  PF  ++  
Sbjct: 177 GGKMKERL--GTAYYIAPEVL------RKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQ 228
Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           E   ++   + SFD P     ++SD+AK L++ ++
Sbjct: 229 EILKRVEKGKFSFDPPD--WTQVSDEAKQLVKLML 261

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 102/199 (51%), Gaps = 19/199 (9%)
Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTL 103
           L R+K  S  ++ V K++ E   L       I  L+      ++ ++VM+Y  GG+L   
Sbjct: 44  LNRQKIRS--LDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDY 101
Query: 104 LSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI 163
           + K   R+ E  A+    +++ A+       Y HR  H   H  RD+KP+NVLLDA+ + 
Sbjct: 102 ICK-HGRVEEMEARRLFQQILSAVD------YCHR--HMVVH--RDLKPENVLLDAHMNA 150
Query: 164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM 223
           ++ADFG    +  DG      + G+P+Y +PE+++    GR   GPE D WS GV +Y +
Sbjct: 151 KIADFGLS-NMMSDGEFLRT-SCGSPNYAAPEVIS----GRLYAGPEVDIWSCGVILYAL 204
Query: 224 LYGETPFYAESLVETYGKI 242
           L G  PF  E +   + KI
Sbjct: 205 LCGTLPFDDEHVPTLFKKI 223

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 109/217 (50%), Gaps = 26/217 (11%)
Query: 60  LREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLL-TLLSKFEDRLPEDMAKF 118
           L  E  +L   D   I  L+  F+D    YLV + Y GG+L   ++S+   R  E  A  
Sbjct: 79  LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAAR 136
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA---NGHIRLADFGSCLRLG 175
            I +++  I  +H    VHR          D+KP+N+LL++   + +IR+ DFG  L   
Sbjct: 137 IIRQVLSGITYMHKNKIVHR----------DLKPENLLLESKSKDANIRIIDFG--LSTH 184
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
            + + +    +GT  YI+PE+L       G Y  +CD WS GV +Y +L G  PF   + 
Sbjct: 185 FEASKKMKDKIGTAYYIAPEVL------HGTYDEKCDVWSTGVILYILLSGCPPFNGANE 238
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC 272
            +   K+   + +F+LP     ++S+ AKDL+R+++ 
Sbjct: 239 YDILKKVEKGKYTFELPQ--WKKVSESAKDLIRKMLT 273

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 116/229 (50%), Gaps = 30/229 (13%)
Query: 57  VAKLREERDVLVYGDRRW--ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPED 114
           V++   ER+V +  + R   I  LH  F++ +++ L+++   GG+L   L++ E  L ED
Sbjct: 57  VSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES-LTED 115
Query: 115 MAKFYIAEMVLAIASIHDLHYVH--RPNHFAFHLCRDIKPDNV-LLDAN---GHIRLADF 168
            A  ++ +++  +      HY+H  R  HF      D+KP+N+ LLD N     I+L DF
Sbjct: 116 EATQFLKQILDGV------HYLHSKRIAHF------DLKPENIMLLDKNVPNPRIKLIDF 163
Query: 169 GSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGET 228
           G   ++   G    N+  GTP++++PEI+          G E D WS+GV  Y +L G +
Sbjct: 164 GIAHKIEA-GNEFKNI-FGTPEFVAPEIVNYEP-----LGLEADMWSIGVITYILLSGAS 216
Query: 229 PFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTR 277
           PF  E+  ET   I     ++D   +     S+ AKD +RRL+     R
Sbjct: 217 PFLGETKQETLTNI--SAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKR 263

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 110/223 (49%), Gaps = 23/223 (10%)
Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           + KL  E  ++   +   I  L    + +  LYLVM+Y  GG++   L     R+ E  A
Sbjct: 57  LQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVA-HGRMKEKEA 115
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +    ++V A+   H    VHR          D+K +N+LLDA+ +I++ADFG       
Sbjct: 116 RAKFRQIVSAVQYCHQKFIVHR----------DLKAENLLLDADMNIKIADFGFSNEFTF 165
Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
              +  +   G P Y +PE+     +G+   GPE D WSLGV +Y ++ G  PF  ++L 
Sbjct: 166 GNKL--DAFCGAPPYAAPELF----QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK 219
Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLG 279
           E   +++  +  + +P    + +S D ++L+++ +  + ++ G
Sbjct: 220 ELRERVL--RGKYRIP----FYMSTDCENLLKKFLILNPSKRG 256

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 130/271 (47%), Gaps = 46/271 (16%)
Query: 57  VAKLREERDVLVYGDRRW--ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPED 114
           V++   ER+V +  + R   I  LH  F++ +++ L+++   GG+L   L++ E  L ED
Sbjct: 50  VSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES-LTED 108
Query: 115 MAKFYIAEMVLAIASIHDLHYVH--RPNHFAFHLCRDIKPDNV-LLDAN---GHIRLADF 168
            A  ++ +++  +      HY+H  R  HF      D+KP+N+ LLD N     I+L DF
Sbjct: 109 EATQFLKQILDGV------HYLHSKRIAHF------DLKPENIMLLDKNVPNPRIKLIDF 156
Query: 169 GSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGET 228
           G   ++   G    N+  GTP++++PEI+          G E D WS+GV  Y +L G +
Sbjct: 157 GIAHKIEA-GNEFKNI-FGTPEFVAPEIVNYEP-----LGLEADMWSIGVITYILLSGAS 209
Query: 229 PFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKM 288
           PF  E+  ET   I     ++D   +     S+ AKD +RRL+           + D K 
Sbjct: 210 PFLGETKQETLTNI--SAVNYDFDEEYFSNTSELAKDFIRRLL-----------VKDPKR 256
Query: 289 WSALFVSLSISPRNHPWFQGIAWDSIRDSNA 319
              +  SL      H W + I   ++R  ++
Sbjct: 257 RMTIAQSLE-----HSWIKAIRRRNVRGEDS 282

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 130/271 (47%), Gaps = 46/271 (16%)
Query: 57  VAKLREERDVLVYGDRRW--ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPED 114
           V++   ER+V +  + R   I  LH  F++ +++ L+++   GG+L   L++ E  L ED
Sbjct: 71  VSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES-LTED 129
Query: 115 MAKFYIAEMVLAIASIHDLHYVH--RPNHFAFHLCRDIKPDNV-LLDAN---GHIRLADF 168
            A  ++ +++  +      HY+H  R  HF      D+KP+N+ LLD N     I+L DF
Sbjct: 130 EATQFLKQILDGV------HYLHSKRIAHF------DLKPENIMLLDKNVPNPRIKLIDF 177
Query: 169 GSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGET 228
           G   ++   G    N+  GTP++++PEI+          G E D WS+GV  Y +L G +
Sbjct: 178 GIAHKIEA-GNEFKNI-FGTPEFVAPEIVNYEP-----LGLEADMWSIGVITYILLSGAS 230
Query: 229 PFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKM 288
           PF  E+  ET   I     ++D   +     S+ AKD +RRL+     R           
Sbjct: 231 PFLGETKQETLTNI--SAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKR----------- 277
Query: 289 WSALFVSLSISPRNHPWFQGIAWDSIRDSNA 319
              + ++ S+    H W + I   ++R  ++
Sbjct: 278 --RMXIAQSLE---HSWIKAIRRRNVRGEDS 303

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 110/241 (45%), Gaps = 31/241 (12%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  LH  F D  + +LVM+   GG+L   + K +    E  A + + ++V A++ +HD+ 
Sbjct: 68  IVKLHEVFHDQLHTFLVMELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVG 126
Query: 135 YVHRPNHFAFHLCRDIKPDNVLL---DANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDY 191
            VHR          D+KP+N+L    + N  I++ DFG   RL             T  Y
Sbjct: 127 VVHR----------DLKPENLLFTDENDNLEIKIIDFGFA-RLKPPDNQPLKTPCFTLHY 175
Query: 192 ISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE-------SLVETYGKIMN 244
            +PE+L      +  Y   CD WSLGV +Y ML G+ PF +        S VE   KI  
Sbjct: 176 AAPELLN-----QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI-- 228
Query: 245 HQNSFDLPSDVGYEISDDAKDLMRRLI-CSSDTRLGQNGIADFKMWSALFVSLSISPRNH 303
            +  F    +    +S +AKDL++ L+    + RL  +G+  +  W      LS +P   
Sbjct: 229 KKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR-YNEWLQDGSQLSSNPLMT 287
Query: 304 P 304
           P
Sbjct: 288 P 288

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 110/223 (49%), Gaps = 23/223 (10%)
Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           + KL  E  ++   +   I  L    + +  LYLVM+Y  GG++   L     R+ E  A
Sbjct: 57  LQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVA-HGRMKEKEA 115
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +    ++V A+   H    VHR          D+K +N+LLDA+ +I++ADFG       
Sbjct: 116 RAKFRQIVSAVQYCHQKFIVHR----------DLKAENLLLDADMNIKIADFGFSNEFTF 165
Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
              +      G+P Y +PE+     +G+   GPE D WSLGV +Y ++ G  PF  ++L 
Sbjct: 166 GNKLDE--FCGSPPYAAPELF----QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK 219
Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLG 279
           E   +++  +  + +P    + +S D ++L+++ +  + ++ G
Sbjct: 220 ELRERVL--RGKYRIP----FYMSTDCENLLKKFLILNPSKRG 256

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 24/215 (11%)
Query: 60  LREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFY 119
           L +E  VL   D   I  L+  F+D  N YLVM+ Y GG+L   +     +  E  A   
Sbjct: 51  LLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEII-LRQKFSEVDAAVI 109
Query: 120 IAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH---IRLADFGSCLRLGG 176
           + +++     +H  + VHR          D+KP+N+LL++      I++ DFG       
Sbjct: 110 MKQVLSGTTYLHKHNIVHR----------DLKPENLLLESKSRDALIKIVDFGLSAHFEV 159
Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
            G ++  +  GT  YI+PE+L      R +Y  +CD WS GV +Y +L G  PF  ++  
Sbjct: 160 GGKMKERL--GTAYYIAPEVL------RKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQ 211
Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           E   ++   + SFD P     ++SD+AK L++ ++
Sbjct: 212 EILKRVEKGKFSFDPPD--WTQVSDEAKQLVKLML 244

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 26/217 (11%)
Query: 60  LREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLL-TLLSKFEDRLPEDMAKF 118
           L  E  +L   D   I  L+  F+D    YLV + Y GG+L   ++S+   R  E  A  
Sbjct: 73  LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAAR 130
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA---NGHIRLADFGSCLRLG 175
            I +++  I  +H    VHR          D+KP+N+LL++   + +IR+ DFG      
Sbjct: 131 IIRQVLSGITYMHKNKIVHR----------DLKPENLLLESKSKDANIRIIDFGLSTHFE 180
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
               ++  +  GT  YI+PE+L       G Y  +CD WS GV +Y +L G  PF   + 
Sbjct: 181 ASKKMKDKI--GTAYYIAPEVL------HGTYDEKCDVWSTGVILYILLSGCPPFNGANE 232
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC 272
            +   K+   + +F+LP     ++S+ AKDL+R+++ 
Sbjct: 233 YDILKKVEKGKYTFELPQ--WKKVSESAKDLIRKMLT 267

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/247 (30%), Positives = 116/247 (46%), Gaps = 42/247 (17%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L   ++   +LYL+M    GG+L   + +       D ++  I +++ A+  +HDL 
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL-IFQVLDAVKYLHDLG 136
Query: 135 YVHRPNHFAFHLCRDIKPDNVL---LDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDY 191
            VHR          D+KP+N+L   LD +  I ++DFG   ++   G+V S  A GTP Y
Sbjct: 137 IVHR----------DLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGSVLST-ACGTPGY 184
Query: 192 ISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDL 251
           ++PE+L      +  Y    D WS+GV  Y +L G  PFY E+  + + +I+  +  FD 
Sbjct: 185 VAPEVL-----AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS 239
Query: 252 PSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAW 311
           P     +ISD AKD +R L+     +        F    AL          HPW   IA 
Sbjct: 240 P--YWDDISDSAKDFIRHLMEKDPEK-------RFTCEQAL---------QHPW---IAG 278
Query: 312 DSIRDSN 318
           D+  D N
Sbjct: 279 DTALDKN 285

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/247 (30%), Positives = 116/247 (46%), Gaps = 42/247 (17%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L   ++   +LYL+M    GG+L   + +       D ++  I +++ A+  +HDL 
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL-IFQVLDAVKYLHDLG 136
Query: 135 YVHRPNHFAFHLCRDIKPDNVL---LDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDY 191
            VHR          D+KP+N+L   LD +  I ++DFG   ++   G+V S  A GTP Y
Sbjct: 137 IVHR----------DLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGSVLST-ACGTPGY 184
Query: 192 ISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDL 251
           ++PE+L      +  Y    D WS+GV  Y +L G  PFY E+  + + +I+  +  FD 
Sbjct: 185 VAPEVL-----AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS 239
Query: 252 PSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAW 311
           P     +ISD AKD +R L+     +        F    AL          HPW   IA 
Sbjct: 240 P--YWDDISDSAKDFIRHLMEKDPEKR-------FTCEQAL---------QHPW---IAG 278
Query: 312 DSIRDSN 318
           D+  D N
Sbjct: 279 DTALDKN 285

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/247 (30%), Positives = 116/247 (46%), Gaps = 42/247 (17%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L   ++   +LYL+M    GG+L   + +       D ++  I +++ A+  +HDL 
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL-IFQVLDAVKYLHDLG 136
Query: 135 YVHRPNHFAFHLCRDIKPDNVL---LDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDY 191
            VHR          D+KP+N+L   LD +  I ++DFG   ++   G+V S  A GTP Y
Sbjct: 137 IVHR----------DLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGSVLST-ACGTPGY 184
Query: 192 ISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDL 251
           ++PE+L      +  Y    D WS+GV  Y +L G  PFY E+  + + +I+  +  FD 
Sbjct: 185 VAPEVL-----AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS 239
Query: 252 PSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAW 311
           P     +ISD AKD +R L+     +        F    AL          HPW   IA 
Sbjct: 240 P--YWDDISDSAKDFIRHLMEKDPEK-------RFTCEQAL---------QHPW---IAG 278
Query: 312 DSIRDSN 318
           D+  D N
Sbjct: 279 DTALDKN 285

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 26/217 (11%)
Query: 60  LREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLL-TLLSKFEDRLPEDMAKF 118
           L  E  +L   D   I  L+  F+D    YLV + Y GG+L   ++S+   R  E  A  
Sbjct: 96  LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAAR 153
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA---NGHIRLADFGSCLRLG 175
            I +++  I  +H    VHR          D+KP+N+LL++   + +IR+ DFG      
Sbjct: 154 IIRQVLSGITYMHKNKIVHR----------DLKPENLLLESKSKDANIRIIDFGLSTHFE 203
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
               ++  +  GT  YI+PE+L       G Y  +CD WS GV +Y +L G  PF   + 
Sbjct: 204 ASKKMKDKI--GTAYYIAPEVL------HGTYDEKCDVWSTGVILYILLSGCPPFNGANE 255
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC 272
            +   K+   + +F+LP     ++S+ AKDL+R+++ 
Sbjct: 256 YDILKKVEKGKYTFELPQ--WKKVSESAKDLIRKMLT 290

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 26/217 (11%)
Query: 60  LREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLL-TLLSKFEDRLPEDMAKF 118
           L  E  +L   D   I  L+  F+D    YLV + Y GG+L   ++S+   R  E  A  
Sbjct: 97  LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAAR 154
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA---NGHIRLADFGSCLRLG 175
            I +++  I  +H    VHR          D+KP+N+LL++   + +IR+ DFG      
Sbjct: 155 IIRQVLSGITYMHKNKIVHR----------DLKPENLLLESKSKDANIRIIDFGLSTHFE 204
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
               ++  +  GT  YI+PE+L       G Y  +CD WS GV +Y +L G  PF   + 
Sbjct: 205 ASKKMKDKI--GTAYYIAPEVL------HGTYDEKCDVWSTGVILYILLSGCPPFNGANE 256
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC 272
            +   K+   + +F+LP     ++S+ AKDL+R+++ 
Sbjct: 257 YDILKKVEKGKYTFELPQ--WKKVSESAKDLIRKMLT 291

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/247 (30%), Positives = 116/247 (46%), Gaps = 42/247 (17%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L   ++   +LYL+M    GG+L   + +       D ++  I +++ A+  +HDL 
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL-IFQVLDAVKYLHDLG 136
Query: 135 YVHRPNHFAFHLCRDIKPDNVL---LDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDY 191
            VHR          D+KP+N+L   LD +  I ++DFG   ++   G+V S  A GTP Y
Sbjct: 137 IVHR----------DLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGSVLST-ACGTPGY 184
Query: 192 ISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDL 251
           ++PE+L      +  Y    D WS+GV  Y +L G  PFY E+  + + +I+  +  FD 
Sbjct: 185 VAPEVL-----AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS 239
Query: 252 PSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAW 311
           P     +ISD AKD +R L+     +        F    AL          HPW   IA 
Sbjct: 240 P--YWDDISDSAKDFIRHLMEKDPEKR-------FTCEQAL---------QHPW---IAG 278
Query: 312 DSIRDSN 318
           D+  D N
Sbjct: 279 DTALDKN 285

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 123/249 (49%), Gaps = 26/249 (10%)
Query: 73  RWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD 132
           + +   H  F+D+  +++V++  C    L  L K    L E  A++Y+ ++VL    +H 
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLEL-CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 159
Query: 133 LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYI 192
              +HR          D+K  N+ L+ +  +++ DFG   ++  DG  +  V  GTP+YI
Sbjct: 160 NRVIHR----------DLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RKKVLCGTPNYI 208
Query: 193 SPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLP 252
           +PE+L+     +  +  E D WS+G  MY +L G+ PF    L ETY +I   +N + +P
Sbjct: 209 APEVLS-----KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIP 261
Query: 253 SDVGYEISDDAKDLMRRLICSSDT-RLGQNGIADFKMWSALFVS--LSISPRNHPWFQGI 309
                 I+  A  L+++++ +  T R   N + + + +++ ++   L I+    P    I
Sbjct: 262 K----HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSI 317
Query: 310 AWDSIRDSN 318
           A  S+  SN
Sbjct: 318 APSSLDPSN 326

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 123/249 (49%), Gaps = 26/249 (10%)
Query: 73  RWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD 132
           + +   H  F+D+  +++V++  C    L  L K    L E  A++Y+ ++VL    +H 
Sbjct: 99  QHVVGFHGFFEDNDFVFVVLEL-CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 157
Query: 133 LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYI 192
              +HR          D+K  N+ L+ +  +++ DFG   ++  DG  +  V  GTP+YI
Sbjct: 158 NRVIHR----------DLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RKKVLCGTPNYI 206
Query: 193 SPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLP 252
           +PE+L+     +  +  E D WS+G  MY +L G+ PF    L ETY +I   +N + +P
Sbjct: 207 APEVLS-----KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIP 259
Query: 253 SDVGYEISDDAKDLMRRLICSSDT-RLGQNGIADFKMWSALFVS--LSISPRNHPWFQGI 309
                 I+  A  L+++++ +  T R   N + + + +++ ++   L I+    P    I
Sbjct: 260 K----HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSI 315
Query: 310 AWDSIRDSN 318
           A  S+  SN
Sbjct: 316 APSSLDPSN 324

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 112/229 (48%), Gaps = 33/229 (14%)
Query: 46  REKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLS 105
           +E ++ + I  + K++ E           I  L   ++  ++LYLVM    GG+L   + 
Sbjct: 63  KESSIENEIAVLRKIKHEN----------IVALEDIYESPNHLYLVMQLVSGGELFDRIV 112
Query: 106 KFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL---DANGH 162
           + +    E  A   I +++ A+  +H +  VHR          D+KP+N+L    D    
Sbjct: 113 E-KGFYTEKDASTLIRQVLDAVYYLHRMGIVHR----------DLKPENLLYYSQDEESK 161
Query: 163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYE 222
           I ++DFG   ++ G G V S  A GTP Y++PE+L      +  Y    D WS+GV  Y 
Sbjct: 162 IMISDFG-LSKMEGKGDVMS-TACGTPGYVAPEVL-----AQKPYSKAVDCWSIGVIAYI 214
Query: 223 MLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           +L G  PFY E+  + + +I+  +  FD P     +ISD AKD +R L+
Sbjct: 215 LLCGYPPFYDENDSKLFEQILKAEYEFDSP--YWDDISDSAKDFIRNLM 261

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 109/210 (51%), Gaps = 31/210 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  LH  +++ +++ L+++   GG+L   L++ E  L E+ A  +I +++  +  +H   
Sbjct: 77  IITLHDVYENRTDVVLILELVSGGELFDFLAQKES-LSEEEATSFIKQILDGVNYLH--- 132
Query: 135 YVHRPNHFAFHLCRDIKPDNV-LLDAN---GHIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
              +  HF      D+KP+N+ LLD N    HI+L DFG    +  DG    N+  GTP+
Sbjct: 133 -TKKIAHF------DLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNI-FGTPE 183
Query: 191 YISPEILTAMEEGRGRYGP---ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQN 247
           +++PEI+         Y P   E D WS+GV  Y +L G +PF  ++  ET   I     
Sbjct: 184 FVAPEIVN--------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT--AV 233
Query: 248 SFDLPSDVGYEISDDAKDLMRRLICSSDTR 277
           S+D   +   + S+ AKD +R+L+   +TR
Sbjct: 234 SYDFDEEFFSQTSELAKDFIRKLLV-KETR 262

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 118/237 (49%), Gaps = 31/237 (13%)
Query: 73  RWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD 132
           + +   H  F+D+  +++V++  C    L  L K    L E  A++Y+ ++VL    +H 
Sbjct: 75  QHVVGFHGFFEDNDFVFVVLEL-CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133
Query: 133 LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYI 192
              +HR          D+K  N+ L+ +  +++ DFG   ++  DG  +  V  GTP+YI
Sbjct: 134 NRVIHR----------DLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RKKVLCGTPNYI 182
Query: 193 SPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLP 252
           +PE+L+     +  +  E D WS+G  MY +L G+ PF    L ETY +I   +N + +P
Sbjct: 183 APEVLS-----KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIP 235
Query: 253 SDVGYEISDDAKDLMRRLICSSDT-RLGQNGIADFKMWSALFVS-------LSISPR 301
                 I+  A  L+++++ +  T R   N + + + +++ ++        L+I PR
Sbjct: 236 K----HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPR 288

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 108/207 (52%), Gaps = 25/207 (12%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +  LH  +++ +++ L+++   GG+L   L++ E  L E+ A  +I +++  +  +H   
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKES-LSEEEATSFIKQILDGVNYLH--- 132
Query: 135 YVHRPNHFAFHLCRDIKPDNV-LLDAN---GHIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
              +  HF      D+KP+N+ LLD N    HI+L DFG    +  DG    N+  GTP+
Sbjct: 133 -TKKIAHF------DLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNI-FGTPE 183
Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD 250
           +++PEI+          G E D WS+GV  Y +L G +PF  ++  ET   I     S+D
Sbjct: 184 FVAPEIVNYEP-----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT--AVSYD 236
Query: 251 LPSDVGYEISDDAKDLMRRLICSSDTR 277
              +   + S+ AKD +R+L+   +TR
Sbjct: 237 FDEEFFSQTSELAKDFIRKLLV-KETR 262

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 108/207 (52%), Gaps = 25/207 (12%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +  LH  +++ +++ L+++   GG+L   L++ E  L E+ A  +I +++  +  +H   
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKES-LSEEEATSFIKQILDGVNYLH--- 132
Query: 135 YVHRPNHFAFHLCRDIKPDNV-LLDAN---GHIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
              +  HF      D+KP+N+ LLD N    HI+L DFG    +  DG    N+  GTP+
Sbjct: 133 -TKKIAHF------DLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNI-FGTPE 183
Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD 250
           +++PEI+          G E D WS+GV  Y +L G +PF  ++  ET   I     S+D
Sbjct: 184 FVAPEIVNYEP-----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT--AVSYD 236
Query: 251 LPSDVGYEISDDAKDLMRRLICSSDTR 277
              +   + S+ AKD +R+L+   +TR
Sbjct: 237 FDEEFFSQTSELAKDFIRKLLV-KETR 262

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 110/207 (53%), Gaps = 22/207 (10%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           + NLH AF+DD+ + ++ ++  GG+L   ++   +++ ED A  Y+ ++   +  +H+ +
Sbjct: 110 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 169
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDA--NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYI 192
           YVH           D+KP+N++     +  ++L DFG    L    +V+  V  GT ++ 
Sbjct: 170 YVH----------LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK--VTTGTAEFA 217
Query: 193 SPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLP 252
           +PE+     EG+   G   D WS+GV  Y +L G +PF  E+  ET   + +   + D  
Sbjct: 218 APEVA----EGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS 272
Query: 253 SDVGYEISDDAKDLMRRLICS-SDTRL 278
           +  G  IS+D KD +R+L+ +  +TR+
Sbjct: 273 AFSG--ISEDGKDFIRKLLLADPNTRM 297

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 123/249 (49%), Gaps = 26/249 (10%)
Query: 73  RWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD 132
           + +   H  F+D+  +++V++  C    L  L K    L E  A++Y+ ++VL    +H 
Sbjct: 77  QHVVGFHGFFEDNDFVFVVLEL-CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 135
Query: 133 LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYI 192
              +HR          D+K  N+ L+ +  +++ DFG   ++  DG  +  +  GTP+YI
Sbjct: 136 NRVIHR----------DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC-GTPNYI 184
Query: 193 SPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLP 252
           +PE+L+     +  +  E D WS+G  MY +L G+ PF    L ETY +I   +N + +P
Sbjct: 185 APEVLS-----KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIP 237
Query: 253 SDVGYEISDDAKDLMRRLICSSDT-RLGQNGIADFKMWSALFVS--LSISPRNHPWFQGI 309
                 I+  A  L+++++ +  T R   N + + + +++ ++   L I+    P    I
Sbjct: 238 K----HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPXFSI 293
Query: 310 AWDSIRDSN 318
           A  S+  SN
Sbjct: 294 APSSLDPSN 302

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 26/202 (12%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLL-TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDL 133
           I  L+  F+D    YLV + Y GG+L   ++S+   R  E  A   I +++  I   H  
Sbjct: 88  IXKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYXHKN 145
Query: 134 HYVHRPNHFAFHLCRDIKPDNVLLDA---NGHIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
             VHR          D+KP+N+LL++   + +IR+ DFG  L    + + +    +GT  
Sbjct: 146 KIVHR----------DLKPENLLLESKSKDANIRIIDFG--LSTHFEASKKXKDKIGTAY 193
Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD 250
           YI+PE+L       G Y  +CD WS GV +Y +L G  PF   +  +   K+   + +F+
Sbjct: 194 YIAPEVL------HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE 247
Query: 251 LPSDVGYEISDDAKDLMRRLIC 272
           LP     ++S+ AKDL+R+ + 
Sbjct: 248 LPQ--WKKVSESAKDLIRKXLT 267

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 110/207 (53%), Gaps = 22/207 (10%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           + NLH AF+DD+ + ++ ++  GG+L   ++   +++ ED A  Y+ ++   +  +H+ +
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDA--NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYI 192
           YVH           D+KP+N++     +  ++L DFG    L    +V+  V  GT ++ 
Sbjct: 276 YVH----------LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK--VTTGTAEFA 323
Query: 193 SPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLP 252
           +PE+     EG+   G   D WS+GV  Y +L G +PF  E+  ET   + +   + D  
Sbjct: 324 APEVA----EGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS 378
Query: 253 SDVGYEISDDAKDLMRRLICS-SDTRL 278
           +  G  IS+D KD +R+L+ +  +TR+
Sbjct: 379 AFSG--ISEDGKDFIRKLLLADPNTRM 403

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 108/207 (52%), Gaps = 25/207 (12%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +  LH  +++ +++ L+++   GG+L   L++ E  L E+ A  +I +++  +  +H   
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKES-LSEEEATSFIKQILDGVNYLH--- 132
Query: 135 YVHRPNHFAFHLCRDIKPDNV-LLDAN---GHIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
              +  HF      D+KP+N+ LLD N    HI+L DFG    +  DG    N+  GTP+
Sbjct: 133 -TKKIAHF------DLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNI-FGTPE 183
Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD 250
           +++PEI+          G E D WS+GV  Y +L G +PF  ++  ET   I +   S+D
Sbjct: 184 FVAPEIVNYEP-----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITS--VSYD 236
Query: 251 LPSDVGYEISDDAKDLMRRLICSSDTR 277
              +     S+ AKD +R+L+   +TR
Sbjct: 237 FDEEFFSHTSELAKDFIRKLLV-KETR 262

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 108/207 (52%), Gaps = 25/207 (12%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +  LH  +++ +++ L+++   GG+L   L++ E  L E+ A  +I +++  +  +H   
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKES-LSEEEATSFIKQILDGVNYLH--- 132
Query: 135 YVHRPNHFAFHLCRDIKPDNV-LLDAN---GHIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
              +  HF      D+KP+N+ LLD N    HI+L DFG    +  DG    N+  GTP+
Sbjct: 133 -TKKIAHF------DLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNI-FGTPE 183
Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD 250
           +++PEI+          G E D WS+GV  Y +L G +PF  ++  ET   I +   S+D
Sbjct: 184 FVAPEIVNYEP-----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITS--VSYD 236
Query: 251 LPSDVGYEISDDAKDLMRRLICSSDTR 277
              +     S+ AKD +R+L+   +TR
Sbjct: 237 FDEEFFSHTSELAKDFIRKLLV-KETR 262

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 108/207 (52%), Gaps = 25/207 (12%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +  LH  +++ +++ L+++   GG+L   L++ E  L E+ A  +I +++  +  +H   
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKES-LSEEEATSFIKQILDGVNYLH--- 132
Query: 135 YVHRPNHFAFHLCRDIKPDNV-LLDAN---GHIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
              +  HF      D+KP+N+ LLD N    HI+L DFG    +  DG    N+  GTP+
Sbjct: 133 -TKKIAHF------DLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNI-FGTPE 183
Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD 250
           +++PEI+          G E D WS+GV  Y +L G +PF  ++  ET   I +   S+D
Sbjct: 184 FVAPEIVNYEP-----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITS--VSYD 236
Query: 251 LPSDVGYEISDDAKDLMRRLICSSDTR 277
              +     S+ AKD +R+L+   +TR
Sbjct: 237 FDEEFFSHTSELAKDFIRKLLV-KETR 262

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 123/249 (49%), Gaps = 26/249 (10%)
Query: 73  RWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD 132
           + +   H  F+D+  +++V++  C    L  L K    L E  A++Y+ ++VL    +H 
Sbjct: 77  QHVVGFHGFFEDNDFVFVVLEL-CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 135
Query: 133 LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYI 192
              +HR          D+K  N+ L+ +  +++ DFG   ++  DG  +  +  GTP+YI
Sbjct: 136 NRVIHR----------DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC-GTPNYI 184
Query: 193 SPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLP 252
           +PE+L+     +  +  E D WS+G  MY +L G+ PF    L ETY +I   +N + +P
Sbjct: 185 APEVLS-----KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIP 237
Query: 253 SDVGYEISDDAKDLMRRLICSSDT-RLGQNGIADFKMWSALFVS--LSISPRNHPWFQGI 309
                 I+  A  L+++++ +  T R   N + + + +++ ++   L I+    P    I
Sbjct: 238 K----HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSI 293
Query: 310 AWDSIRDSN 318
           A  S+  SN
Sbjct: 294 APSSLDPSN 302

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 81/147 (55%), Gaps = 18/147 (12%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           L++VM+Y  GG L  +++  E  + E        E + A+  +H    +HR         
Sbjct: 92  LWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHR--------- 140
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
            DIK DN+LL  +G ++L DFG C ++  + + +S + VGTP +++PE++T     R  Y
Sbjct: 141 -DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVT-----RKAY 193
Query: 208 GPECDWWSLGVCMYEMLYGETPFYAES 234
           GP+ D WSLG+   EM+ GE P+  E+
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNEN 220

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 123/249 (49%), Gaps = 26/249 (10%)
Query: 73  RWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD 132
           + +   H  F+D+  +++V++  C    L  L K    L E  A++Y+ ++VL    +H 
Sbjct: 81  QHVVGFHGFFEDNDFVFVVLEL-CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 139
Query: 133 LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYI 192
              +HR          D+K  N+ L+ +  +++ DFG   ++  DG  +  +  GTP+YI
Sbjct: 140 NRVIHR----------DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC-GTPNYI 188
Query: 193 SPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLP 252
           +PE+L+     +  +  E D WS+G  MY +L G+ PF    L ETY +I   +N + +P
Sbjct: 189 APEVLS-----KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIP 241
Query: 253 SDVGYEISDDAKDLMRRLICSSDT-RLGQNGIADFKMWSALFVS--LSISPRNHPWFQGI 309
                 I+  A  L+++++ +  T R   N + + + +++ ++   L I+    P    I
Sbjct: 242 K----HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSI 297
Query: 310 AWDSIRDSN 318
           A  S+  SN
Sbjct: 298 APSSLDPSN 306

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 81/147 (55%), Gaps = 18/147 (12%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           L++VM+Y  GG L  +++  E  + E        E + A+  +H    +HR         
Sbjct: 92  LWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHR--------- 140
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
            DIK DN+LL  +G ++L DFG C ++  + + +S + VGTP +++PE++T     R  Y
Sbjct: 141 -DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEM-VGTPYWMAPEVVT-----RKAY 193
Query: 208 GPECDWWSLGVCMYEMLYGETPFYAES 234
           GP+ D WSLG+   EM+ GE P+  E+
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNEN 220

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 105/229 (45%), Gaps = 35/229 (15%)
Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH 141
           F D  + Y+V++   GG+L   +     RL E   K Y  +M+LA+  +H+   +H    
Sbjct: 83  FFDAEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIH---- 137
Query: 142 FAFHLCRDIKPDNVLLDANGH---IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILT 198
                 RD+KP+NVLL +      I++ DFG    LG    +++    GTP Y++PE+L 
Sbjct: 138 ------RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPEVLV 189
Query: 199 AMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYE 258
           ++  G   Y    D WSLGV ++  L G  PF +E   +   K       ++   +V  E
Sbjct: 190 SV--GTAGYNRAVDCWSLGVILFICLSGYPPF-SEHRTQVSLKDQITSGKYNFIPEVWAE 246
Query: 259 ISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ 307
           +S+ A DL+++L+            A F    AL          HPW Q
Sbjct: 247 VSEKALDLVKKLLVVDPK-------ARFTTEEAL---------RHPWLQ 279

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 81/147 (55%), Gaps = 18/147 (12%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           L++VM+Y  GG L  +++  E  + E        E + A+  +H    +HR         
Sbjct: 93  LWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHR--------- 141
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
            DIK DN+LL  +G ++L DFG C ++  + + +S + VGTP +++PE++T     R  Y
Sbjct: 142 -DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXM-VGTPYWMAPEVVT-----RKAY 194
Query: 208 GPECDWWSLGVCMYEMLYGETPFYAES 234
           GP+ D WSLG+   EM+ GE P+  E+
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPPYLNEN 221

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 81/147 (55%), Gaps = 18/147 (12%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           L++VM+Y  GG L  +++  E  + E        E + A+  +H    +HR         
Sbjct: 92  LWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHR--------- 140
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
            DIK DN+LL  +G ++L DFG C ++  + + +S + VGTP +++PE++T     R  Y
Sbjct: 141 -DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXM-VGTPYWMAPEVVT-----RKAY 193
Query: 208 GPECDWWSLGVCMYEMLYGETPFYAES 234
           GP+ D WSLG+   EM+ GE P+  E+
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNEN 220

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 105/229 (45%), Gaps = 35/229 (15%)
Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH 141
           F D  + Y+V++   GG+L   +     RL E   K Y  +M+LA+  +H+   +H    
Sbjct: 83  FFDAEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIH---- 137
Query: 142 FAFHLCRDIKPDNVLLDANGH---IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILT 198
                 RD+KP+NVLL +      I++ DFG    LG    +++    GTP Y++PE+L 
Sbjct: 138 ------RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPEVLV 189
Query: 199 AMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYE 258
           ++  G   Y    D WSLGV ++  L G  PF +E   +   K       ++   +V  E
Sbjct: 190 SV--GTAGYNRAVDCWSLGVILFICLSGYPPF-SEHRTQVSLKDQITSGKYNFIPEVWAE 246
Query: 259 ISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ 307
           +S+ A DL+++L+            A F    AL          HPW Q
Sbjct: 247 VSEKALDLVKKLLVVDPK-------ARFTTEEAL---------RHPWLQ 279

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 105/229 (45%), Gaps = 35/229 (15%)
Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH 141
           F D  + Y+V++   GG+L   +     RL E   K Y  +M+LA+  +H+   +H    
Sbjct: 82  FFDAEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIH---- 136
Query: 142 FAFHLCRDIKPDNVLLDANGH---IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILT 198
                 RD+KP+NVLL +      I++ DFG    LG    +++    GTP Y++PE+L 
Sbjct: 137 ------RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPEVLV 188
Query: 199 AMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYE 258
           ++  G   Y    D WSLGV ++  L G  PF +E   +   K       ++   +V  E
Sbjct: 189 SV--GTAGYNRAVDCWSLGVILFICLSGYPPF-SEHRTQVSLKDQITSGKYNFIPEVWAE 245
Query: 259 ISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ 307
           +S+ A DL+++L+            A F    AL          HPW Q
Sbjct: 246 VSEKALDLVKKLLVVDPK-------ARFTTEEAL---------RHPWLQ 278

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 105/229 (45%), Gaps = 35/229 (15%)
Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH 141
           F D  + Y+V++   GG+L   +     RL E   K Y  +M+LA+  +H+   +H    
Sbjct: 83  FFDAEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIH---- 137
Query: 142 FAFHLCRDIKPDNVLLDANGH---IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILT 198
                 RD+KP+NVLL +      I++ DFG    LG    +++    GTP Y++PE+L 
Sbjct: 138 ------RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPEVLV 189
Query: 199 AMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYE 258
           ++  G   Y    D WSLGV ++  L G  PF +E   +   K       ++   +V  E
Sbjct: 190 SV--GTAGYNRAVDCWSLGVILFICLSGYPPF-SEHRTQVSLKDQITSGKYNFIPEVWAE 246
Query: 259 ISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ 307
           +S+ A DL+++L+            A F    AL          HPW Q
Sbjct: 247 VSEKALDLVKKLLVVDPK-------ARFTTEEAL---------RHPWLQ 279

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/193 (31%), Positives = 93/193 (48%), Gaps = 13/193 (6%)
Query: 83  QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHF 142
           + ++ LY+VM+Y  GGDL ++++K          +F +  M     ++ + H      H 
Sbjct: 77  RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT 136
Query: 143 AFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEE 202
             H  RD+KP NV LD   +++L DFG    L  D T  +   VGTP Y+SPE +  M  
Sbjct: 137 VLH--RDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKTFVGTPYYMSPEQMNRMS- 192
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDD 262
               Y  + D WSLG  +YE+     PF A S  E  GKI   +  F     + Y  SD+
Sbjct: 193 ----YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI--REGKF---RRIPYRYSDE 243
Query: 263 AKDLMRRLICSSD 275
             +++ R++   D
Sbjct: 244 LNEIITRMLNLKD 256

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 105/229 (45%), Gaps = 35/229 (15%)
Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH 141
           F D  + Y+V++   GG+L   +     RL E   K Y  +M+LA+  +H+   +H    
Sbjct: 89  FFDAEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIH---- 143
Query: 142 FAFHLCRDIKPDNVLLDANGH---IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILT 198
                 RD+KP+NVLL +      I++ DFG    LG    +++    GTP Y++PE+L 
Sbjct: 144 ------RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPEVLV 195
Query: 199 AMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYE 258
           ++  G   Y    D WSLGV ++  L G  PF +E   +   K       ++   +V  E
Sbjct: 196 SV--GTAGYNRAVDCWSLGVILFICLSGYPPF-SEHRTQVSLKDQITSGKYNFIPEVWAE 252
Query: 259 ISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ 307
           +S+ A DL+++L+            A F    AL          HPW Q
Sbjct: 253 VSEKALDLVKKLLVVDPK-------ARFTTEEAL---------RHPWLQ 285

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/193 (31%), Positives = 93/193 (48%), Gaps = 13/193 (6%)
Query: 83  QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHF 142
           + ++ LY+VM+Y  GGDL ++++K          +F +  M     ++ + H      H 
Sbjct: 77  RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT 136
Query: 143 AFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEE 202
             H  RD+KP NV LD   +++L DFG    L  D T  +   VGTP Y+SPE +  M  
Sbjct: 137 VLH--RDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMSPEQMNRMS- 192
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDD 262
               Y  + D WSLG  +YE+     PF A S  E  GKI   +  F     + Y  SD+
Sbjct: 193 ----YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI--REGKF---RRIPYRYSDE 243
Query: 263 AKDLMRRLICSSD 275
             +++ R++   D
Sbjct: 244 LNEIITRMLNLKD 256

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 108/239 (45%), Gaps = 41/239 (17%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR---LPEDMAKFYIAEMVLAIASIH 131
           I  L   +  D  LY+V ++  G DL   + K  D      E +A  Y+ +++ A+   H
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 132 DLHYVHRPNHFAFHLCRDIKPDNVLL---DANGHIRLADFGSCLRLGGDGTVQSNVAVGT 188
           D + +HR          D+KP+NVLL   + +  ++L DFG  ++LG  G V     VGT
Sbjct: 148 DNNIIHR----------DVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGG-RVGT 196
Query: 189 PDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNS 248
           P +++PE++      R  YG   D W  GV ++ +L G  PFY        G I   +  
Sbjct: 197 PHFMAPEVVK-----REPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGII---KGK 248
Query: 249 FDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ 307
           + +       IS+ AKDL+RR+       L  +      ++ AL         NHPW +
Sbjct: 249 YKMNPRQWSHISESAKDLVRRM-------LMLDPAERITVYEAL---------NHPWLK 291

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 105/229 (45%), Gaps = 35/229 (15%)
Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH 141
           F D  + Y+V++   GG+L   +     RL E   K Y  +M+LA+  +H+   +H    
Sbjct: 222 FFDAEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIH---- 276
Query: 142 FAFHLCRDIKPDNVLLDANGH---IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILT 198
                 RD+KP+NVLL +      I++ DFG    LG    +++    GTP Y++PE+L 
Sbjct: 277 ------RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPEVLV 328
Query: 199 AMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYE 258
           ++  G   Y    D WSLGV ++  L G  PF +E   +   K       ++   +V  E
Sbjct: 329 SV--GTAGYNRAVDCWSLGVILFICLSGYPPF-SEHRTQVSLKDQITSGKYNFIPEVWAE 385
Query: 259 ISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ 307
           +S+ A DL+++L+            A F    AL          HPW Q
Sbjct: 386 VSEKALDLVKKLLVVDPK-------ARFTTEEAL---------RHPWLQ 418

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 120/265 (45%), Gaps = 34/265 (12%)
Query: 11  FLGGPIQGKG------RVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREER 64
           F  G + GKG      R  SI T L++ + + D+         + V + ++   +L+   
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 65  DVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMV 124
                     I  L+  F+D + +YLV++    G++   L        E+ A+ ++ +++
Sbjct: 73  ----------ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII 122
Query: 125 LAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNV 184
             +  +H    +HR          D+   N+LL  N +I++ADFG   +L         +
Sbjct: 123 TGMLYLHSHGILHR----------DLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL 172
Query: 185 AVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
             GTP+YISPEI T     R  +G E D WSLG   Y +L G  PF  +++  T  K++ 
Sbjct: 173 C-GTPNYISPEIAT-----RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV- 225
Query: 245 HQNSFDLPSDVGYEISDDAKDLMRR 269
               +++PS +  E  D    L+RR
Sbjct: 226 -LADYEMPSFLSIEAKDLIHQLLRR 249

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 105/229 (45%), Gaps = 35/229 (15%)
Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH 141
           F D  + Y+V++   GG+L   +     RL E   K Y  +M+LA+  +H+   +H    
Sbjct: 208 FFDAEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIH---- 262
Query: 142 FAFHLCRDIKPDNVLLDANGH---IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILT 198
                 RD+KP+NVLL +      I++ DFG    LG    +++    GTP Y++PE+L 
Sbjct: 263 ------RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPEVLV 314
Query: 199 AMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYE 258
           ++  G   Y    D WSLGV ++  L G  PF +E   +   K       ++   +V  E
Sbjct: 315 SV--GTAGYNRAVDCWSLGVILFICLSGYPPF-SEHRTQVSLKDQITSGKYNFIPEVWAE 371
Query: 259 ISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ 307
           +S+ A DL+++L+            A F    AL          HPW Q
Sbjct: 372 VSEKALDLVKKLLVVDPK-------ARFTTEEAL---------RHPWLQ 404

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 103/206 (50%), Gaps = 23/206 (11%)
Query: 71  DRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASI 130
           D   +   H  F+DD  +Y+V++  C    L  L K    + E  A++++ + +  +  +
Sbjct: 84  DNPHVVGFHGFFEDDDFVYVVLEI-CRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 142
Query: 131 HDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
           H+   +HR          D+K  N+ L+ +  +++ DFG   ++  DG  + ++  GTP+
Sbjct: 143 HNNRVIHR----------DLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLC-GTPN 191
Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD 250
           YI+PE+L      +  +  E D WSLG  +Y +L G+ PF    L ETY +I   +N + 
Sbjct: 192 YIAPEVLC-----KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI--KKNEYS 244
Query: 251 LPSDVGYEISDDAKDLMRRLICSSDT 276
           +P      I+  A  L+RR++ +  T
Sbjct: 245 VPR----HINPVASALIRRMLHADPT 266

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 92/168 (54%), Gaps = 18/168 (10%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +  ++ ++     L+++M++  GG L  ++S+   RL E+        ++ A+A +H   
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQG 161
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          DIK D++LL  +G ++L+DFG C ++  D   +    VGTP +++P
Sbjct: 162 VIHR----------DIKSDSILLTLDGRVKLSDFGFCAQISKD-VPKRKXLVGTPYWMAP 210
Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
           E+++     R  Y  E D WSLG+ + EM+ GE P++++S V+   ++
Sbjct: 211 EVIS-----RSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL 253

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 88/171 (51%), Gaps = 21/171 (12%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L    + +  LYLVM+Y  GG++   L     R+ E  A+    ++V A+   H  +
Sbjct: 76  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVA-HGRMKEKEARAKFRQIVSAVQYCHQKY 134
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAV--GTPDYI 192
            VHR          D+K +N+LLD + +I++ADFG       + TV + +    G+P Y 
Sbjct: 135 IVHR----------DLKAENLLLDGDMNIKIADFG----FSNEFTVGNKLDTFCGSPPYA 180
Query: 193 SPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
           +PE+     +G+   GPE D WSLGV +Y ++ G  PF  ++L E   +++
Sbjct: 181 APELF----QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL 227

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 110/223 (49%), Gaps = 23/223 (10%)
Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           + KL  E  ++   +   I  L    + +  LYLVM+Y  GG++   L      + E  A
Sbjct: 50  LQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVA-HGWMKEKEA 108
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +    ++V A+   H    VHR          D+K +N+LLDA+ +I++ADFG       
Sbjct: 109 RAKFRQIVSAVQYCHQKFIVHR----------DLKAENLLLDADMNIKIADFGFSNEFTF 158
Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
              +  +   G+P Y +PE+     +G+   GPE D WSLGV +Y ++ G  PF  ++L 
Sbjct: 159 GNKL--DTFCGSPPYAAPELF----QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK 212
Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLG 279
           E   +++  +  + +P    + +S D ++L+++ +  + ++ G
Sbjct: 213 ELRERVL--RGKYRIP----FYMSTDCENLLKKFLILNPSKRG 249

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 32/211 (15%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDM-----AKFYIAEMVLAIAS 129
           I  LH +  ++ + YL+ D   GG+L      FED +  +      A   I +++ A+  
Sbjct: 83  IVRLHDSISEEGHHYLIFDLVTGGEL------FEDIVAREYYSEADASHCIQQILEAVLH 136
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN---GHIRLADFGSCLRLGGDGTVQSNVAV 186
            H +  VHR          D+KP+N+LL +      ++LADFG  + + G+       A 
Sbjct: 137 CHQMGVVHR----------DLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA- 185
Query: 187 GTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQ 246
           GTP Y+SPE+L      +  YG   D W+ GV +Y +L G  PF+ E     Y +I    
Sbjct: 186 GTPGYLSPEVLR-----KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI--KA 238
Query: 247 NSFDLPSDVGYEISDDAKDLMRRLICSSDTR 277
            ++D PS     ++ +AKDL+ +++  + ++
Sbjct: 239 GAYDFPSPEWDTVTPEAKDLINKMLTINPSK 269

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 103/206 (50%), Gaps = 23/206 (11%)
Query: 71  DRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASI 130
           D   +   H  F+DD  +Y+V++  C    L  L K    + E  A++++ + +  +  +
Sbjct: 100 DNPHVVGFHGFFEDDDFVYVVLEI-CRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 131 HDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
           H+   +HR          D+K  N+ L+ +  +++ DFG   ++  DG  + ++  GTP+
Sbjct: 159 HNNRVIHR----------DLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLC-GTPN 207
Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD 250
           YI+PE+L      +  +  E D WSLG  +Y +L G+ PF    L ETY +I   +N + 
Sbjct: 208 YIAPEVLC-----KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI--KKNEYS 260
Query: 251 LPSDVGYEISDDAKDLMRRLICSSDT 276
           +P      I+  A  L+RR++ +  T
Sbjct: 261 VPR----HINPVASALIRRMLHADPT 282

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 23/206 (11%)
Query: 71  DRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASI 130
           D   +   H  F+DD  +Y+V++  C    L  L K    + E  A++++ + +  +  +
Sbjct: 100 DNPHVVGFHGFFEDDDFVYVVLEI-CRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 131 HDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
           H+   +HR          D+K  N+ L+ +  +++ DFG   ++  DG  +  +  GTP+
Sbjct: 159 HNNRVIHR----------DLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLC-GTPN 207
Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD 250
           YI+PE+L      +  +  E D WSLG  +Y +L G+ PF    L ETY +I   +N + 
Sbjct: 208 YIAPEVLC-----KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI--KKNEYS 260
Query: 251 LPSDVGYEISDDAKDLMRRLICSSDT 276
           +P      I+  A  L+RR++ +  T
Sbjct: 261 VPR----HINPVASALIRRMLHADPT 282

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 49/147 (33%), Positives = 81/147 (55%), Gaps = 18/147 (12%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           L++VM+Y  GG L  +++  E  + E        E + A+  +H    +HR         
Sbjct: 93  LWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHR--------- 141
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
            +IK DN+LL  +G ++L DFG C ++  + + +S + VGTP +++PE++T     R  Y
Sbjct: 142 -NIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVT-----RKAY 194
Query: 208 GPECDWWSLGVCMYEMLYGETPFYAES 234
           GP+ D WSLG+   EM+ GE P+  E+
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPPYLNEN 221

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L    + +  LYLV +Y  GG++   L     R  E  A+    ++V A+   H   
Sbjct: 75  IVKLFEVIETEKTLYLVXEYASGGEVFDYLVA-HGRXKEKEARAKFRQIVSAVQYCHQKF 133
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            VHR          D+K +N+LLDA+ +I++ADFG          +  +   G P Y +P
Sbjct: 134 IVHR----------DLKAENLLLDADXNIKIADFGFSNEFTFGNKL--DAFCGAPPYAAP 181
Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSD 254
           E+     +G+   GPE D WSLGV +Y ++ G  PF  ++L E   +++  +  + +P  
Sbjct: 182 ELF----QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL--RGKYRIP-- 233
Query: 255 VGYEISDDAKDLMRRLICSSDTRLG 279
             +  S D ++L+++ +  + ++ G
Sbjct: 234 --FYXSTDCENLLKKFLILNPSKRG 256

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 23/206 (11%)
Query: 71  DRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASI 130
           D   +   H  F+DD  +Y+V++  C    L  L K    + E  A++++ + +  +  +
Sbjct: 100 DNPHVVGFHGFFEDDDFVYVVLEI-CRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 131 HDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
           H+   +HR          D+K  N+ L+ +  +++ DFG   ++  DG  +  +  GTP+
Sbjct: 159 HNNRVIHR----------DLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLC-GTPN 207
Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD 250
           YI+PE+L      +  +  E D WSLG  +Y +L G+ PF    L ETY +I   +N + 
Sbjct: 208 YIAPEVLC-----KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI--KKNEYS 260
Query: 251 LPSDVGYEISDDAKDLMRRLICSSDT 276
           +P      I+  A  L+RR++ +  T
Sbjct: 261 VPR----HINPVASALIRRMLHADPT 282

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 53/155 (34%), Positives = 77/155 (49%), Gaps = 18/155 (11%)
Query: 83  QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHF 142
           ++D   YLVM+Y  G  L   +      L  D A  +  +++  I   HD+  VHR    
Sbjct: 81  EEDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHR---- 135
Query: 143 AFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEE 202
                 DIKP N+L+D+N  +++ DFG    L      Q+N  +GT  Y SP      E+
Sbjct: 136 ------DIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSP------EQ 183
Query: 203 GRGRYGPEC-DWWSLGVCMYEMLYGETPFYAESLV 236
            +G    EC D +S+G+ +YEML GE PF  E+ V
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV 218

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 32/211 (15%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDM-----AKFYIAEMVLAIAS 129
           I  LH +  ++ + YL+ D   GG+L      FED +  +      A   I +++ A+  
Sbjct: 72  IVRLHDSISEEGHHYLIFDLVTGGEL------FEDIVAREYYSEADASHCIQQILEAVLH 125
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN---GHIRLADFGSCLRLGGDGTVQSNVAV 186
            H +  VHR          ++KP+N+LL +      ++LADFG  + + G+       A 
Sbjct: 126 CHQMGVVHR----------NLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA- 174
Query: 187 GTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQ 246
           GTP Y+SPE+L      +  YG   D W+ GV +Y +L G  PF+ E     Y +I    
Sbjct: 175 GTPGYLSPEVLR-----KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK--A 227
Query: 247 NSFDLPSDVGYEISDDAKDLMRRLICSSDTR 277
            ++D PS     ++ +AKDL+ +++  + ++
Sbjct: 228 GAYDFPSPEWDTVTPEAKDLINKMLTINPSK 258

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 104/221 (47%), Gaps = 32/221 (14%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDM--- 115
           KL  E  +        I  LH +  ++   YLV D   GG+L      FED +  +    
Sbjct: 49  KLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGEL------FEDIVAREYYSE 102
Query: 116 --AKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN---GHIRLADFGS 170
             A   I +++ A+   H +  VHR          D+KP+N+LL +      ++LADFG 
Sbjct: 103 ADASHCIQQILEAVLHCHQMGVVHR----------DLKPENLLLASKCKGAAVKLADFGL 152
Query: 171 CLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
            + + GD       A GTP Y+SPE+L      +  YG   D W+ GV +Y +L G  PF
Sbjct: 153 AIEVQGDQQAWFGFA-GTPGYLSPEVLR-----KEAYGKPVDIWACGVILYILLVGYPPF 206
Query: 231 YAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           + E   + Y +I     ++D PS     ++ +AK+L+ +++
Sbjct: 207 WDEDQHKLYQQIK--AGAYDFPSPEWDTVTPEAKNLINQML 245

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 91/193 (47%), Gaps = 13/193 (6%)
Query: 83  QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHF 142
           + ++ LY+VM+Y  GGDL ++++K          +F +  M     ++ + H      H 
Sbjct: 77  RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT 136
Query: 143 AFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEE 202
             H  RD+KP NV LD   +++L DFG    L  D        VGTP Y+SPE +  M  
Sbjct: 137 VLH--RDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEF-VGTPYYMSPEQMNRMS- 192
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDD 262
               Y  + D WSLG  +YE+     PF A S  E  GKI   +  F     + Y  SD+
Sbjct: 193 ----YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI--REGKF---RRIPYRYSDE 243
Query: 263 AKDLMRRLICSSD 275
             +++ R++   D
Sbjct: 244 LNEIITRMLNLKD 256

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 103/199 (51%), Gaps = 24/199 (12%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L+      +++ +V++Y  GG+L   + + + R+ ED  + +  +++ AI   H   
Sbjct: 71  IIKLYDVITTPTDIVMVIEY-AGGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            VHR          D+KP+N+LLD N ++++ADFG    +  DG      + G+P+Y +P
Sbjct: 129 IVHR----------DLKPENLLLDDNLNVKIADFGLS-NIMTDGNFLKT-SCGSPNYAAP 176
Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSD 254
           E++     G+   GPE D WS G+ +Y ML G  PF  E +   + K+  +   + +P  
Sbjct: 177 EVIN----GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDF 230
Query: 255 VGYEISDDAKDLMRRLICS 273
               +S  A+ L+RR+I +
Sbjct: 231 ----LSPGAQSLIRRMIVA 245

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 88/169 (52%), Gaps = 18/169 (10%)
Query: 61  REERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYI 120
           ++E  VL   D  ++T  + ++  D+ L+++M+Y  GG  L LL       P  + +  I
Sbjct: 73  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE------PGPLDETQI 126
Query: 121 AEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTV 180
           A ++  I  +  L Y+H        + RDIK  NVLL  +G ++LADFG   +L  D  +
Sbjct: 127 ATILREI--LKGLDYLHSEKK----IHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQI 179
Query: 181 QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           + N  VGTP +++PE++      +  Y  + D WSLG+   E+  GE P
Sbjct: 180 KRNTFVGTPFWMAPEVIK-----QSAYDSKADIWSLGITAIELARGEPP 223

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/169 (33%), Positives = 87/169 (51%), Gaps = 18/169 (10%)
Query: 61  REERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYI 120
           ++E  VL   D  ++T  + ++   S L+++M+Y  GG  L LL       P D  +F I
Sbjct: 69  QQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAG----PFD--EFQI 122
Query: 121 AEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTV 180
           A M+  I  +  L Y+H        + RDIK  NVLL   G ++LADFG   +L  D  +
Sbjct: 123 ATMLKEI--LKGLDYLHSEKK----IHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQI 175
Query: 181 QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           + N  VGTP +++PE++      +  Y  + D WSLG+   E+  GE P
Sbjct: 176 KRNTFVGTPFWMAPEVIQ-----QSAYDSKADIWSLGITAIELAKGEPP 219

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 88/169 (52%), Gaps = 18/169 (10%)
Query: 61  REERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYI 120
           ++E  VL   D  ++T  + ++  D+ L+++M+Y  GG  L LL       P  + +  I
Sbjct: 53  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE------PGPLDETQI 106
Query: 121 AEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTV 180
           A ++  I  +  L Y+H        + RDIK  NVLL  +G ++LADFG   +L  D  +
Sbjct: 107 ATILREI--LKGLDYLHSEKK----IHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQI 159
Query: 181 QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           + N  VGTP +++PE++      +  Y  + D WSLG+   E+  GE P
Sbjct: 160 KRNTFVGTPFWMAPEVIK-----QSAYDSKADIWSLGITAIELARGEPP 203

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 104/200 (52%), Gaps = 25/200 (12%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +  ++ ++     L++VM++  GG L  +++    R+ E+        ++ A++ +H   
Sbjct: 210 VVEMYNSYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLQALSVLHAQG 267
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          DIK D++LL  +G ++L+DFG C ++  +   +    VGTP +++P
Sbjct: 268 VIHR----------DIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPRRKXLVGTPYWMAP 316
Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSD 254
           E+++ +      YGPE D WSLG+ + EM+ GE P++ E  ++    I +     +LP  
Sbjct: 317 ELISRLP-----YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-----NLPPR 366
Query: 255 VG--YEISDDAKDLMRRLIC 272
           +   +++S   K  + RL+ 
Sbjct: 367 LKNLHKVSPSLKGFLDRLLV 386

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 88/169 (52%), Gaps = 18/169 (10%)
Query: 61  REERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYI 120
           ++E  VL   D  ++T  + ++  D+ L+++M+Y  GG  L LL       P  + +  I
Sbjct: 53  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE------PGPLDETQI 106
Query: 121 AEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTV 180
           A ++  I  +  L Y+H        + RDIK  NVLL  +G ++LADFG   +L  D  +
Sbjct: 107 ATILREI--LKGLDYLHSEKK----IHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQI 159
Query: 181 QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           + N  VGTP +++PE++      +  Y  + D WSLG+   E+  GE P
Sbjct: 160 KRNXFVGTPFWMAPEVIK-----QSAYDSKADIWSLGITAIELARGEPP 203

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 88/169 (52%), Gaps = 18/169 (10%)
Query: 61  REERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYI 120
           ++E  VL   D  ++T  + ++  D+ L+++M+Y  GG  L LL       P  + +  I
Sbjct: 68  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE------PGPLDETQI 121
Query: 121 AEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTV 180
           A ++  I  +  L Y+H        + RDIK  NVLL  +G ++LADFG   +L  D  +
Sbjct: 122 ATILREI--LKGLDYLHSEKK----IHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQI 174
Query: 181 QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           + N  VGTP +++PE++      +  Y  + D WSLG+   E+  GE P
Sbjct: 175 KRNXFVGTPFWMAPEVIK-----QSAYDSKADIWSLGITAIELARGEPP 218

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 93/168 (55%), Gaps = 18/168 (10%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           + +++ ++     L++VM++  GG L  +++    R+ E+        ++ A++ +H+  
Sbjct: 104 VVDMYSSYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHNQG 161
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          DIK D++LL ++G I+L+DFG C ++  +   +    VGTP +++P
Sbjct: 162 VIHR----------DIKSDSILLTSDGRIKLSDFGFCAQVSKE-VPKRKXLVGTPYWMAP 210
Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
           E+++     R  YG E D WSLG+ + EM+ GE P++ E  ++   +I
Sbjct: 211 EVIS-----RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI 253

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 104/200 (52%), Gaps = 25/200 (12%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +  ++ ++     L++VM++  GG L  +++    R+ E+        ++ A++ +H   
Sbjct: 133 VVEMYNSYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLQALSVLHAQG 190
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          DIK D++LL  +G ++L+DFG C ++  +   +    VGTP +++P
Sbjct: 191 VIHR----------DIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPRRKXLVGTPYWMAP 239
Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSD 254
           E+++ +      YGPE D WSLG+ + EM+ GE P++ E  ++    I +     +LP  
Sbjct: 240 ELISRLP-----YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-----NLPPR 289
Query: 255 VG--YEISDDAKDLMRRLIC 272
           +   +++S   K  + RL+ 
Sbjct: 290 LKNLHKVSPSLKGFLDRLLV 309

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 104/200 (52%), Gaps = 25/200 (12%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +  ++ ++     L++VM++  GG L  +++    R+ E+        ++ A++ +H   
Sbjct: 88  VVEMYNSYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLQALSVLHAQG 145
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          DIK D++LL  +G ++L+DFG C ++  +   +    VGTP +++P
Sbjct: 146 VIHR----------DIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPRRKXLVGTPYWMAP 194
Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSD 254
           E+++     R  YGPE D WSLG+ + EM+ GE P++ E  ++    I +     +LP  
Sbjct: 195 ELIS-----RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-----NLPPR 244
Query: 255 VG--YEISDDAKDLMRRLIC 272
           +   +++S   K  + RL+ 
Sbjct: 245 LKNLHKVSPSLKGFLDRLLV 264

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 104/200 (52%), Gaps = 25/200 (12%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +  ++ ++     L++VM++  GG L  +++    R+ E+        ++ A++ +H   
Sbjct: 90  VVEMYNSYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLQALSVLHAQG 147
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          DIK D++LL  +G ++L+DFG C ++  +   +    VGTP +++P
Sbjct: 148 VIHR----------DIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPRRKXLVGTPYWMAP 196
Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSD 254
           E+++     R  YGPE D WSLG+ + EM+ GE P++ E  ++    I +     +LP  
Sbjct: 197 ELIS-----RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-----NLPPR 246
Query: 255 VG--YEISDDAKDLMRRLIC 272
           +   +++S   K  + RL+ 
Sbjct: 247 LKNLHKVSPSLKGFLDRLLV 266

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 104/200 (52%), Gaps = 25/200 (12%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +  ++ ++     L++VM++  GG L  +++    R+ E+        ++ A++ +H   
Sbjct: 79  VVEMYNSYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLQALSVLHAQG 136
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          DIK D++LL  +G ++L+DFG C ++  +   +    VGTP +++P
Sbjct: 137 VIHR----------DIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPRRKXLVGTPYWMAP 185
Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSD 254
           E+++     R  YGPE D WSLG+ + EM+ GE P++ E  ++    I +     +LP  
Sbjct: 186 ELIS-----RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-----NLPPR 235
Query: 255 VG--YEISDDAKDLMRRLIC 272
           +   +++S   K  + RL+ 
Sbjct: 236 LKNLHKVSPSLKGFLDRLLV 255

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/193 (31%), Positives = 98/193 (50%), Gaps = 23/193 (11%)
Query: 58  AKLREE--RDVLVYGDRRWITNLHY--AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRL-P 112
           +K REE  R+V V  + +    + Y  +F+++ +LY+VMDY  GGDL   ++  +  L  
Sbjct: 64  SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ 123
Query: 113 EDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCL 172
           ED    +  ++ LA+  +HD   +H          RDIK  N+ L  +G ++L DFG   
Sbjct: 124 EDQILDWFVQICLALKHVHDRKILH----------RDIKSQNIFLTKDGTVQLGDFGIAR 173
Query: 173 RLGGDGTVQ-SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
            L  + TV+ +   +GTP Y+SPEI          Y  + D W+LG  +YE+   +  F 
Sbjct: 174 VL--NSTVELARACIGTPYYLSPEICENKP-----YNNKSDIWALGCVLYELCTLKHAFE 226
Query: 232 AESLVETYGKIMN 244
           A S+     KI++
Sbjct: 227 AGSMKNLVLKIIS 239

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 104/200 (52%), Gaps = 25/200 (12%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +  ++ ++     L++VM++  GG L  +++    R+ E+        ++ A++ +H   
Sbjct: 83  VVEMYNSYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLQALSVLHAQG 140
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          DIK D++LL  +G ++L+DFG C ++  +   +    VGTP +++P
Sbjct: 141 VIHR----------DIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPRRKXLVGTPYWMAP 189
Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSD 254
           E+++     R  YGPE D WSLG+ + EM+ GE P++ E  ++    I +     +LP  
Sbjct: 190 ELIS-----RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-----NLPPR 239
Query: 255 VG--YEISDDAKDLMRRLIC 272
           +   +++S   K  + RL+ 
Sbjct: 240 LKNLHKVSPSLKGFLDRLLV 259

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 120/259 (46%), Gaps = 48/259 (18%)
Query: 60  LREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSK---FEDRLPEDMA 116
           +R E  VL+      I  L   F+  + + LV++   GG+L   + +   + +R   D  
Sbjct: 95  VRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAV 154
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA---NGHIRLADFGSCLR 173
           K    +++ A+A +H+   VHR          D+KP+N+L      +  +++ADFG  L 
Sbjct: 155 K----QILEAVAYLHENGIVHR----------DLKPENLLYATPAPDAPLKIADFG--LS 198
Query: 174 LGGDGTVQSNVAVGTPDYISPEILTAMEEGRG-RYGPECDWWSLGVCMYEMLYGETPFYA 232
              +  V      GTP Y +PEIL      RG  YGPE D WS+G+  Y +L G  PFY 
Sbjct: 199 KIVEHQVLMKTVCGTPGYCAPEIL------RGCAYGPEVDMWSVGIITYILLCGFEPFYD 252
Query: 233 ESLVE-TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSA 291
           E   +  + +I+N +  F  P     E+S +AKDL+R+LI           + D K    
Sbjct: 253 ERGDQFMFRRILNCEYYFISPW--WDEVSLNAKDLVRKLI-----------VLDPKKRLT 299
Query: 292 LFVSLSISPRNHPWFQGIA 310
            F +L      HPW  G A
Sbjct: 300 TFQAL-----QHPWVTGKA 313

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 32/205 (15%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDM-----AKFYIAEMVLAIAS 129
           I  LH +  ++   YLV D   GG+L      FED +  +      A   I +++ ++  
Sbjct: 65  IVRLHDSISEEGFHYLVFDLVTGGEL------FEDIVAREYYSEADASHCIQQILESVNH 118
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH---IRLADFGSCLRLGGDGTVQSNVAV 186
            H    VHR          D+KP+N+LL +      ++LADFG  + + GD       A 
Sbjct: 119 CHLNGIVHR----------DLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA- 167
Query: 187 GTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQ 246
           GTP Y+SPE+L      +  YG   D W+ GV +Y +L G  PF+ E     Y +I    
Sbjct: 168 GTPGYLSPEVLR-----KDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQI--KA 220
Query: 247 NSFDLPSDVGYEISDDAKDLMRRLI 271
            ++D PS     ++ +AKDL+ +++
Sbjct: 221 GAYDFPSPEWDTVTPEAKDLINKML 245

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 32/205 (15%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDM-----AKFYIAEMVLAIAS 129
           I  LH +  ++   YLV D   GG+L      FED +  +      A   I +++ ++  
Sbjct: 65  IVRLHDSISEEGFHYLVFDLVTGGEL------FEDIVAREYYSEADASHCIQQILESVNH 118
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH---IRLADFGSCLRLGGDGTVQSNVAV 186
            H    VHR          D+KP+N+LL +      ++LADFG  + + GD       A 
Sbjct: 119 CHLNGIVHR----------DLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA- 167
Query: 187 GTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQ 246
           GTP Y+SPE+L      +  YG   D W+ GV +Y +L G  PF+ E     Y +I    
Sbjct: 168 GTPGYLSPEVLR-----KDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQI--KA 220
Query: 247 NSFDLPSDVGYEISDDAKDLMRRLI 271
            ++D PS     ++ +AKDL+ +++
Sbjct: 221 GAYDFPSPEWDTVTPEAKDLINKML 245

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 32/205 (15%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDM-----AKFYIAEMVLAIAS 129
           I  LH +  ++   YLV D   GG+L      FED +  +      A   I +++ ++  
Sbjct: 92  IVRLHDSISEEGFHYLVFDLVTGGEL------FEDIVAREYYSEADASHCIHQILESVNH 145
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN---GHIRLADFGSCLRLGGDGTVQSNVAV 186
           IH    VHR          D+KP+N+LL +      ++LADFG  + + G+       A 
Sbjct: 146 IHQHDIVHR----------DLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFA- 194
Query: 187 GTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQ 246
           GTP Y+SPE+L      +  YG   D W+ GV +Y +L G  PF+ E   + Y +I    
Sbjct: 195 GTPGYLSPEVLR-----KDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQI--KA 247
Query: 247 NSFDLPSDVGYEISDDAKDLMRRLI 271
            ++D PS     ++ +AK+L+ +++
Sbjct: 248 GAYDFPSPEWDTVTPEAKNLINQML 272

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 86/169 (50%), Gaps = 18/169 (10%)
Query: 61  REERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYI 120
           ++E  VL   D  +IT    ++   + L+++M+Y  GG  L LL       P  + + YI
Sbjct: 65  QQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLK------PGPLEETYI 118
Query: 121 AEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTV 180
           A ++  I  +  L Y+H        + RDIK  NVLL   G ++LADFG   +L  D  +
Sbjct: 119 ATILREI--LKGLDYLHSERK----IHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQI 171
Query: 181 QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           + N  VGTP +++PE++      +  Y  + D WSLG+   E+  GE P
Sbjct: 172 KRNXFVGTPFWMAPEVIK-----QSAYDFKADIWSLGITAIELAKGEPP 215

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 111/230 (48%), Gaps = 30/230 (13%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           +LR E ++  +     I  ++  F D   +YL++++   G+L   L K   R  E  +  
Sbjct: 60  QLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK-HGRFDEQRSAT 118
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
           ++ E+  A+   H+   +HR          DIKP+N+L+   G +++ADFG  +      
Sbjct: 119 FMEELADALHYCHERKVIHR----------DIKPENLLMGYKGELKIADFGWSVHA---P 165
Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 238
           +++     GT DY+ PE++    EG+  +  + D W  GV  YE L G  PF + S  ET
Sbjct: 166 SLRRRXMCGTLDYLPPEMI----EGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET 220
Query: 239 YGKIMNHQNSFDLPSDVGYE--ISDDAKDLMRRLI-CSSDTRLGQNGIAD 285
           + +I+N         D+ +   +SD +KDL+ +L+      RL   G+ +
Sbjct: 221 HRRIVN--------VDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 111/230 (48%), Gaps = 30/230 (13%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           +LR E ++  +     I  ++  F D   +YL++++   G+L   L K   R  E  +  
Sbjct: 61  QLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK-HGRFDEQRSAT 119
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
           ++ E+  A+   H+   +HR          DIKP+N+L+   G +++ADFG  +      
Sbjct: 120 FMEELADALHYCHERKVIHR----------DIKPENLLMGYKGELKIADFGWSVHA---P 166
Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 238
           +++     GT DY+ PE++    EG+  +  + D W  GV  YE L G  PF + S  ET
Sbjct: 167 SLRRRXMCGTLDYLPPEMI----EGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET 221
Query: 239 YGKIMNHQNSFDLPSDVGYE--ISDDAKDLMRRLI-CSSDTRLGQNGIAD 285
           + +I+N         D+ +   +SD +KDL+ +L+      RL   G+ +
Sbjct: 222 HRRIVN--------VDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 263

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 46/214 (21%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +  LH  +++ +++ L+++   GG+L   L++ E  L E+ A  ++ +++  +  +H L 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHSLQ 134
Query: 135 YVHRPNHFAFHLCRDIKPDNV-LLDAN---GHIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
             H           D+KP+N+ LLD N     I++ DFG   ++   G    N+  GTP+
Sbjct: 135 IAHF----------DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNI-FGTPE 182
Query: 191 YISPEILTAMEEGRGRYGP---ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQN 247
           +++PEI+         Y P   E D WS+GV  Y +L G +PF  ++  ET   +     
Sbjct: 183 FVAPEIVN--------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV----- 229
Query: 248 SFDLPSDVGYEISDD--------AKDLMRRLICS 273
                S V YE  D+        AKD +RRL+  
Sbjct: 230 -----SAVNYEFEDEYFSNTSALAKDFIRRLLVK 258

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 40/211 (18%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +  LH  +++ +++ L+++   GG+L   L++ E  L E+ A  ++ +++  +  +H L 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHSLQ 134
Query: 135 YVHRPNHFAFHLCRDIKPDNV-LLDAN---GHIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
             H           D+KP+N+ LLD N     I++ DFG   ++   G    N+  GTP+
Sbjct: 135 IAHF----------DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNI-FGTPE 182
Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD 250
           +++PEI+          G E D WS+GV  Y +L G +PF  ++  ET   +        
Sbjct: 183 FVAPEIVNYEP-----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-------- 229
Query: 251 LPSDVGYEISDD--------AKDLMRRLICS 273
             S V YE  D+        AKD +RRL+  
Sbjct: 230 --SAVNYEFEDEYFSNTSALAKDFIRRLLVK 258

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 40/211 (18%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +  LH  +++ +++ L+++   GG+L   L++ E  L E+ A  ++ +++  +  +H L 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHSLQ 134
Query: 135 YVHRPNHFAFHLCRDIKPDNV-LLDAN---GHIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
             H           D+KP+N+ LLD N     I++ DFG   ++   G    N+  GTP+
Sbjct: 135 IAHF----------DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNI-FGTPE 182
Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD 250
           +++PEI+          G E D WS+GV  Y +L G +PF  ++  ET   +        
Sbjct: 183 FVAPEIVNYEP-----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-------- 229
Query: 251 LPSDVGYEISDD--------AKDLMRRLICS 273
             S V YE  D+        AKD +RRL+  
Sbjct: 230 --SAVNYEFEDEYFSNTSALAKDFIRRLLVK 258

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 40/211 (18%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +  LH  +++ +++ L+++   GG+L   L++ E  L E+ A  ++ +++  +  +H L 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHSLQ 134
Query: 135 YVHRPNHFAFHLCRDIKPDNV-LLDAN---GHIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
             H           D+KP+N+ LLD N     I++ DFG   ++   G    N+  GTP+
Sbjct: 135 IAHF----------DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNI-FGTPE 182
Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD 250
           +++PEI+          G E D WS+GV  Y +L G +PF  ++  ET   +        
Sbjct: 183 FVAPEIVNYEP-----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-------- 229
Query: 251 LPSDVGYEISDD--------AKDLMRRLICS 273
             S V YE  D+        AKD +RRL+  
Sbjct: 230 --SAVNYEFEDEYFSNTSALAKDFIRRLLVK 258

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 40/211 (18%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +  LH  +++ +++ L+++   GG+L   L++ E  L E+ A  ++ +++  +  +H L 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHSLQ 134
Query: 135 YVHRPNHFAFHLCRDIKPDNV-LLDAN---GHIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
             H           D+KP+N+ LLD N     I++ DFG   ++   G    N+  GTP+
Sbjct: 135 IAHF----------DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNI-FGTPE 182
Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD 250
           +++PEI+          G E D WS+GV  Y +L G +PF  ++  ET   +        
Sbjct: 183 FVAPEIVNYEP-----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-------- 229
Query: 251 LPSDVGYEISDD--------AKDLMRRLICS 273
             S V YE  D+        AKD +RRL+  
Sbjct: 230 --SAVNYEFEDEYFSNTSALAKDFIRRLLVK 258

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 40/211 (18%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +  LH  +++ +++ L+++   GG+L   L++ E  L E+ A  ++ +++  +  +H L 
Sbjct: 75  VITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHSLQ 133
Query: 135 YVHRPNHFAFHLCRDIKPDNV-LLDAN---GHIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
             H           D+KP+N+ LLD N     I++ DFG   ++   G    N+  GTP+
Sbjct: 134 IAHF----------DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNI-FGTPE 181
Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD 250
           +++PEI+          G E D WS+GV  Y +L G +PF  ++  ET   +        
Sbjct: 182 FVAPEIVNYEP-----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-------- 228
Query: 251 LPSDVGYEISDD--------AKDLMRRLICS 273
             S V YE  D+        AKD +RRL+  
Sbjct: 229 --SAVNYEFEDEYFSNTSALAKDFIRRLLVK 257

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 40/211 (18%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +  LH  +++ +++ L+++   GG+L   L++ E  L E+ A  ++ +++  +  +H L 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHSLQ 134
Query: 135 YVHRPNHFAFHLCRDIKPDNV-LLDAN---GHIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
             H           D+KP+N+ LLD N     I++ DFG   ++   G    N+  GTP+
Sbjct: 135 IAHF----------DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNI-FGTPE 182
Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD 250
           +++PEI+          G E D WS+GV  Y +L G +PF  ++  ET   +        
Sbjct: 183 FVAPEIVNYEP-----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-------- 229
Query: 251 LPSDVGYEISDD--------AKDLMRRLICS 273
             S V YE  D+        AKD +RRL+  
Sbjct: 230 --SAVNYEFEDEYFSNTSALAKDFIRRLLVK 258

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 40/211 (18%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +  LH  +++ +++ L+++   GG+L   L++ E  L E+ A  ++ +++  +  +H L 
Sbjct: 75  VITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHSLQ 133
Query: 135 YVHRPNHFAFHLCRDIKPDNV-LLDAN---GHIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
             H           D+KP+N+ LLD N     I++ DFG   ++   G    N+  GTP+
Sbjct: 134 IAHF----------DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNI-FGTPE 181
Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD 250
           +++PEI+          G E D WS+GV  Y +L G +PF  ++  ET   +        
Sbjct: 182 FVAPEIVNYEP-----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-------- 228
Query: 251 LPSDVGYEISDD--------AKDLMRRLICS 273
             S V YE  D+        AKD +RRL+  
Sbjct: 229 --SAVNYEFEDEYFSNTSALAKDFIRRLLVK 257

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 40/211 (18%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +  LH  +++ +++ L+++   GG+L   L++ E  L E+ A  ++ +++  +  +H L 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHSLQ 134
Query: 135 YVHRPNHFAFHLCRDIKPDNV-LLDAN---GHIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
             H           D+KP+N+ LLD N     I++ DFG   ++   G    N+  GTP+
Sbjct: 135 IAHF----------DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNI-FGTPE 182
Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD 250
           +++PEI+          G E D WS+GV  Y +L G +PF  ++  ET   +        
Sbjct: 183 FVAPEIVNYEP-----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-------- 229
Query: 251 LPSDVGYEISDD--------AKDLMRRLICS 273
             S V YE  D+        AKD +RRL+  
Sbjct: 230 --SAVNYEFEDEYFSNTSALAKDFIRRLLVK 258

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 40/211 (18%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +  LH  +++ +++ L+++   GG+L   L++ E  L E+ A  ++ +++  +  +H L 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHSLQ 134
Query: 135 YVHRPNHFAFHLCRDIKPDNV-LLDAN---GHIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
             H           D+KP+N+ LLD N     I++ DFG   ++   G    N+  GTP+
Sbjct: 135 IAHF----------DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNI-FGTPE 182
Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD 250
           +++PEI+          G E D WS+GV  Y +L G +PF  ++  ET   +        
Sbjct: 183 FVAPEIVNYEP-----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-------- 229
Query: 251 LPSDVGYEISDD--------AKDLMRRLICS 273
             S V YE  D+        AKD +RRL+  
Sbjct: 230 --SAVNYEFEDEYFSNTSALAKDFIRRLLVK 258

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 40/211 (18%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +  LH  +++ +++ L+++   GG+L   L++ E  L E+ A  ++ +++  +  +H L 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHSLQ 134
Query: 135 YVHRPNHFAFHLCRDIKPDNV-LLDAN---GHIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
             H           D+KP+N+ LLD N     I++ DFG   ++   G    N+  GTP+
Sbjct: 135 IAHF----------DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNI-FGTPE 182
Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD 250
           +++PEI+          G E D WS+GV  Y +L G +PF  ++  ET   +        
Sbjct: 183 FVAPEIVNYEP-----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-------- 229
Query: 251 LPSDVGYEISDD--------AKDLMRRLICS 273
             S V YE  D+        AKD +RRL+  
Sbjct: 230 --SAVNYEFEDEYFSNTSALAKDFIRRLLVK 258

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 40/211 (18%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +  LH  +++ +++ L+++   GG+L   L++ E  L E+ A  ++ +++  +  +H L 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHSLQ 134
Query: 135 YVHRPNHFAFHLCRDIKPDNV-LLDAN---GHIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
             H           D+KP+N+ LLD N     I++ DFG   ++   G    N+  GTP+
Sbjct: 135 IAHF----------DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNI-FGTPE 182
Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD 250
           +++PEI+          G E D WS+GV  Y +L G +PF  ++  ET   +        
Sbjct: 183 FVAPEIVNYEP-----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-------- 229
Query: 251 LPSDVGYEISDD--------AKDLMRRLICS 273
             S V YE  D+        AKD +RRL+  
Sbjct: 230 --SAVNYEFEDEYFSNTSALAKDFIRRLLVK 258

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 24/200 (12%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L   F+D    YLV ++Y GG+L   +     +  E  A   + +++  I  +H  +
Sbjct: 108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHN 166
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANG---HIRLADFGSCLRLGGDGTVQSNVAVGTPDY 191
            VHR          DIKP+N+LL+      +I++ DFG       D  ++    +GT  Y
Sbjct: 167 IVHR----------DIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD--RLGTAYY 214
Query: 192 ISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDL 251
           I+PE+L      + +Y  +CD WS GV MY +L G  PF  ++  +   K+   +  FD 
Sbjct: 215 IAPEVL------KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF 268
Query: 252 PSDVGYEISDDAKDLMRRLI 271
                  ISD+AK+L++ ++
Sbjct: 269 ND--WKNISDEAKELIKLML 286

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 105/216 (48%), Gaps = 41/216 (18%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMV-------LAI 127
           + NLH  +++ S + L+++Y  GG++ +L       LPE      +AEMV       L  
Sbjct: 91  VINLHEVYENTSEIILILEYAAGGEIFSLC------LPE------LAEMVSENDVIRLIK 138
Query: 128 ASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN---GHIRLADFGSCLRLGGDGTVQSNV 184
             +  ++Y+H+ N    HL  D+KP N+LL +    G I++ DFG   ++G    ++   
Sbjct: 139 QILEGVYYLHQNN--IVHL--DLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE-- 192
Query: 185 AVGTPDYISPEILTAMEEGRGRYGP---ECDWWSLGVCMYEMLYGETPFYAESLVETYGK 241
            +GTP+Y++PEIL         Y P     D W++G+  Y +L   +PF  E   ETY  
Sbjct: 193 IMGTPEYLAPEILN--------YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN 244
Query: 242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTR 277
           I   Q + D   +    +S  A D ++ L+  +  +
Sbjct: 245 I--SQVNVDYSEETFSSVSQLATDFIQSLLVKNPEK 278

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 105/239 (43%), Gaps = 41/239 (17%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR---LPEDMAKFYIAEMVLAIASIH 131
           I  L   +  D  LY+V ++  G DL   + K  D      E +A  Y+ +++ A+   H
Sbjct: 90  IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 149
Query: 132 DLHYVHRPNHFAFHLCRDIKPDNVLL---DANGHIRLADFGSCLRLGGDGTVQSNVAVGT 188
           D + +HR          D+KP  VLL   + +  ++L  FG  ++LG  G V     VGT
Sbjct: 150 DNNIIHR----------DVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG-RVGT 198
Query: 189 PDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNS 248
           P +++PE++      R  YG   D W  GV ++ +L G  PFY        G I   +  
Sbjct: 199 PHFMAPEVVK-----REPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGII---KGK 250
Query: 249 FDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ 307
           + +       IS+ AKDL+RR+       L  +      ++ AL         NHPW +
Sbjct: 251 YKMNPRQWSHISESAKDLVRRM-------LMLDPAERITVYEAL---------NHPWLK 293

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 105/239 (43%), Gaps = 41/239 (17%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR---LPEDMAKFYIAEMVLAIASIH 131
           I  L   +  D  LY+V ++  G DL   + K  D      E +A  Y+ +++ A+   H
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 132 DLHYVHRPNHFAFHLCRDIKPDNVLL---DANGHIRLADFGSCLRLGGDGTVQSNVAVGT 188
           D + +HR          D+KP  VLL   + +  ++L  FG  ++LG  G V     VGT
Sbjct: 148 DNNIIHR----------DVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG-RVGT 196
Query: 189 PDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNS 248
           P +++PE++      R  YG   D W  GV ++ +L G  PFY        G I   +  
Sbjct: 197 PHFMAPEVVK-----REPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGII---KGK 248
Query: 249 FDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ 307
           + +       IS+ AKDL+RR+       L  +      ++ AL         NHPW +
Sbjct: 249 YKMNPRQWSHISESAKDLVRRM-------LMLDPAERITVYEAL---------NHPWLK 291

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 40/211 (18%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +  LH  +++ +++ L+++   GG+L   L++ E  L E+ A  ++ +++  +  +H L 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHSLQ 134
Query: 135 YVHRPNHFAFHLCRDIKPDNV-LLDAN---GHIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
             H           D+KP+N+ LLD N     I++ DFG   ++   G    N+  GTP 
Sbjct: 135 IAHF----------DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNI-FGTPA 182
Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD 250
           +++PEI+          G E D WS+GV  Y +L G +PF  ++  ET   +        
Sbjct: 183 FVAPEIVNYEP-----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-------- 229
Query: 251 LPSDVGYEISDD--------AKDLMRRLICS 273
             S V YE  D+        AKD +RRL+  
Sbjct: 230 --SAVNYEFEDEYFSNTSALAKDFIRRLLVK 258

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 107/226 (47%), Gaps = 29/226 (12%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           ++  E +VL   D   I  +   F+D  N+Y+VM+   GG+LL  +   + R  + +++ 
Sbjct: 66  QIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQAR-GKALSEG 124
Query: 119 YIAE----MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL-DANGH--IRLADFGSC 171
           Y+AE    M+ A+A  H  H VH+          D+KP+N+L  D + H  I++ DFG  
Sbjct: 125 YVAELMKQMMNALAYFHSQHVVHK----------DLKPENILFQDTSPHSPIKIIDFGLA 174
Query: 172 LRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
                D    S  A GT  Y++PE+       +     +CD WS GV MY +L G  PF 
Sbjct: 175 ELFKSDE--HSTNAAGTALYMAPEVF------KRDVTFKCDIWSAGVVMYFLLTGCLPFT 226
Query: 232 AESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTR 277
             SL E   K    + ++ +       ++  A DL+++++     R
Sbjct: 227 GTSLEEVQQKATYKEPNYAVECR---PLTPQAVDLLKQMLTKDPER 269

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 40/211 (18%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +  LH  +++ +++ L+ +   GG+L   L++ E  L E+ A  ++ +++  +  +H L 
Sbjct: 76  VITLHEVYENKTDVILIGELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHSLQ 134
Query: 135 YVHRPNHFAFHLCRDIKPDNV-LLDAN---GHIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
             H           D+KP+N+ LLD N     I++ DFG   ++   G    N+  GTP+
Sbjct: 135 IAHF----------DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNI-FGTPE 182
Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD 250
           +++PEI+          G E D WS+GV  Y +L G +PF  ++  ET   +        
Sbjct: 183 FVAPEIVNYEP-----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-------- 229
Query: 251 LPSDVGYEISDD--------AKDLMRRLICS 273
             S V YE  D+        AKD +RRL+  
Sbjct: 230 --SAVNYEFEDEYFSNTSALAKDFIRRLLVK 258

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 36/223 (16%)
Query: 58  AKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRL------ 111
           + L  E  VL       I  L   ++  ++ YLVM    GG+L        DR+      
Sbjct: 51  SSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELF-------DRILERGVY 103
Query: 112 PEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL---DANGHIRLADF 168
            E  A   I +++ A+  +H+   VHR          D+KP+N+L    + N  I + DF
Sbjct: 104 TEKDASLVIQQVLSAVKYLHENGIVHR----------DLKPENLLYLTPEENSKIMITDF 153
Query: 169 GSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGET 228
           G   ++  +G + +  A GTP Y++PE+L      +  Y    D WS+GV  Y +L G  
Sbjct: 154 GLS-KMEQNGIMST--ACGTPGYVAPEVL-----AQKPYSKAVDCWSIGVITYILLCGYP 205
Query: 229 PFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           PFY E+  + + KI      F+ P     +IS+ AKD +  L+
Sbjct: 206 PFYEETESKLFEKIKEGYYEFESP--FWDDISESAKDFICHLL 246

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 24/215 (11%)
Query: 48  KTVSDFIEFVAKLR----EERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTL 103
           K V  F    AK R    +E D+L   +   +   + +F +D+ L +V++    GDL  +
Sbjct: 63  KKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRM 122
Query: 104 LSKFEDR---LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN 160
           +  F+ +   +PE     Y  ++  A+  +H    +HR          DIKP NV + A 
Sbjct: 123 IKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHR----------DIKPANVFITAT 172
Query: 161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCM 220
           G ++L D G   R     T  ++  VGTP Y+SPE +   E G   Y  + D WSLG  +
Sbjct: 173 GVVKLGDLG-LGRFFSSKTTAAHSLVGTPYYMSPERIH--ENG---YNFKSDIWSLGCLL 226
Query: 221 YEMLYGETPFYAESL-VETYGKIMNHQNSFDLPSD 254
           YEM   ++PFY + + + +  K +   +   LPSD
Sbjct: 227 YEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD 261

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 51/231 (22%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
           ++L +VM+Y  GG+L   +     R  ED A+F+  +++  ++  H +   HR       
Sbjct: 88  THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYAHAMQVAHR------- 139
Query: 146 LCRDIKPDNVLLDANG--HIRLADFGSCLRLGGDGTV---QSNVAVGTPDYISPEILTAM 200
              D+K +N LLD +    +++ADFG         +V   Q   AVGTP YI+PE+L   
Sbjct: 140 ---DLKLENTLLDGSPAPRLKIADFGY-----SKASVLHSQPKSAVGTPAYIAPEVLLKK 191
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF----YAESLVETYGKIMNHQNSFDLPSDVG 256
           E      G   D WS GV +Y ML G  PF      ++  +T  +I+N Q  + +P  V 
Sbjct: 192 EYD----GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQ--YAIPDYV- 244
Query: 257 YEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISP-RNHPWF 306
             IS + + L+ R+  +   +                  +SI   RNH WF
Sbjct: 245 -HISPECRHLISRIFVADPAK-----------------RISIPEIRNHEWF 277

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 96/199 (48%), Gaps = 21/199 (10%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           + NLH AF+D   + L++++  GG+L   ++  + ++ E     Y+ +    +  +H+  
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE-- 167
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDAN--GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYI 192
                 H   HL  DIKP+N++ +      +++ DFG   +L  D  V+  V   T ++ 
Sbjct: 168 ------HSIVHL--DIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK--VTTATAEFA 217
Query: 193 SPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLP 252
           +PEI+      R   G   D W++GV  Y +L G +PF  E  +ET   +      FD  
Sbjct: 218 APEIV-----DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD-- 270
Query: 253 SDVGYEISDDAKDLMRRLI 271
            D    +S +AKD ++ L+
Sbjct: 271 EDAFSSVSPEAKDFIKNLL 289

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 93/193 (48%), Gaps = 19/193 (9%)
Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE 122
           E  VL   +  +I   + AF  D  + + M++  GG L  +L K   R+PE +       
Sbjct: 57  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILG----- 110
Query: 123 MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQS 182
             ++IA I  L Y+ R  H   H  RD+KP N+L+++ G I+L DFG   +L  +    +
Sbjct: 111 -KVSIAVIKGLTYL-REKHKIMH--RDVKPSNILVNSRGEIKLCDFGVSGQLIDE---MA 163
Query: 183 NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
           N  VGT  Y+SPE L         Y  + D WS+G+ + EM  G  P    ++ E    I
Sbjct: 164 NEFVGTRSYMSPERLQGT-----HYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYI 218
Query: 243 MNHQNSFDLPSDV 255
           +N +    LPS V
Sbjct: 219 VN-EPPPKLPSAV 230

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 24/197 (12%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L+   +    + +V++Y  G +L   + +  D++ E  A+ +  +++ A+   H   
Sbjct: 75  IIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHK 132
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            VHR          D+KP+N+LLD + ++++ADFG    +  DG      + G+P+Y +P
Sbjct: 133 IVHR----------DLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKT-SCGSPNYAAP 180
Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSD 254
           E+++    G+   GPE D WS GV +Y ML    PF  ES+   +  I N    + LP  
Sbjct: 181 EVIS----GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN--GVYTLPK- 233
Query: 255 VGYEISDDAKDLMRRLI 271
               +S  A  L++R++
Sbjct: 234 ---FLSPGAAGLIKRML 247

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 24/197 (12%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L+   +    + +V++Y  G +L   + +  D++ E  A+ +  +++ A+   H   
Sbjct: 66  IIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHK 123
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            VHR          D+KP+N+LLD + ++++ADFG    +  DG      + G+P+Y +P
Sbjct: 124 IVHR----------DLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKT-SCGSPNYAAP 171
Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSD 254
           E+++    G+   GPE D WS GV +Y ML    PF  ES+   +  I N    + LP  
Sbjct: 172 EVIS----GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN--GVYTLPK- 224
Query: 255 VGYEISDDAKDLMRRLI 271
               +S  A  L++R++
Sbjct: 225 ---FLSPGAAGLIKRML 238

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 24/197 (12%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L+   +    + +V++Y  G +L   + +  D++ E  A+ +  +++ A+   H   
Sbjct: 76  IIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHK 133
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            VHR          D+KP+N+LLD + ++++ADFG    +  DG      + G+P+Y +P
Sbjct: 134 IVHR----------DLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKT-SCGSPNYAAP 181
Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSD 254
           E+++    G+   GPE D WS GV +Y ML    PF  ES+   +  I N    + LP  
Sbjct: 182 EVIS----GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN--GVYTLPK- 234
Query: 255 VGYEISDDAKDLMRRLI 271
               +S  A  L++R++
Sbjct: 235 ---FLSPGAAGLIKRML 248

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 24/197 (12%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L+   +    + +V++Y  G +L   + +  D++ E  A+ +  +++ A+   H   
Sbjct: 70  IIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHK 127
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            VHR          D+KP+N+LLD + ++++ADFG    +  DG      + G+P+Y +P
Sbjct: 128 IVHR----------DLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKT-SCGSPNYAAP 175
Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSD 254
           E+++    G+   GPE D WS GV +Y ML    PF  ES+   +  I N    + LP  
Sbjct: 176 EVIS----GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN--GVYTLPK- 228
Query: 255 VGYEISDDAKDLMRRLI 271
               +S  A  L++R++
Sbjct: 229 ---FLSPGAAGLIKRML 242

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 33/205 (16%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDM-----AKFYIAEMVLAIAS 129
           I  LH + Q++S  YLV D   GG+L      FED +  +      A   I +++ +IA 
Sbjct: 67  IVRLHDSIQEESFHYLVFDLVTGGEL------FEDIVAREFYSEADASHCIQQILESIAY 120
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH---IRLADFGSCLRLGGDGTVQSNVAV 186
            H    VHR          ++KP+N+LL +      ++LADFG  + +  D       A 
Sbjct: 121 CHSNGIVHR----------NLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFA- 168
Query: 187 GTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQ 246
           GTP Y+SPE+L      +  Y    D W+ GV +Y +L G  PF+ E     Y +I    
Sbjct: 169 GTPGYLSPEVLK-----KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KA 221
Query: 247 NSFDLPSDVGYEISDDAKDLMRRLI 271
            ++D PS     ++ +AK L+  ++
Sbjct: 222 GAYDYPSPEWDTVTPEAKSLIDSML 246

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 33/205 (16%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDM-----AKFYIAEMVLAIAS 129
           I  LH + Q++S  YLV D   GG+L      FED +  +      A   I +++ +IA 
Sbjct: 67  IVRLHDSIQEESFHYLVFDLVTGGEL------FEDIVAREFYSEADASHCIQQILESIAY 120
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH---IRLADFGSCLRLGGDGTVQSNVAV 186
            H    VHR          ++KP+N+LL +      ++LADFG  + +  D       A 
Sbjct: 121 CHSNGIVHR----------NLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFA- 168
Query: 187 GTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQ 246
           GTP Y+SPE+L      +  Y    D W+ GV +Y +L G  PF+ E     Y +I    
Sbjct: 169 GTPGYLSPEVLK-----KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KA 221
Query: 247 NSFDLPSDVGYEISDDAKDLMRRLI 271
            ++D PS     ++ +AK L+  ++
Sbjct: 222 GAYDYPSPEWDTVTPEAKSLIDSML 246

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 33/205 (16%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDM-----AKFYIAEMVLAIAS 129
           I  LH + Q++S  YLV D   GG+L      FED +  +      A   I +++ +IA 
Sbjct: 90  IVRLHDSIQEESFHYLVFDLVTGGEL------FEDIVAREFYSEADASHCIQQILESIAY 143
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH---IRLADFGSCLRLGGDGTVQSNVAV 186
            H    VHR          ++KP+N+LL +      ++LADFG  + +  D       A 
Sbjct: 144 CHSNGIVHR----------NLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFA- 191
Query: 187 GTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQ 246
           GTP Y+SPE+L      +  Y    D W+ GV +Y +L G  PF+ E     Y +I    
Sbjct: 192 GTPGYLSPEVLK-----KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KA 244
Query: 247 NSFDLPSDVGYEISDDAKDLMRRLI 271
            ++D PS     ++ +AK L+  ++
Sbjct: 245 GAYDYPSPEWDTVTPEAKSLIDSML 269

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 33/205 (16%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDM-----AKFYIAEMVLAIAS 129
           I  LH + Q++S  YLV D   GG+L      FED +  +      A   I +++ +IA 
Sbjct: 66  IVRLHDSIQEESFHYLVFDLVTGGEL------FEDIVAREFYSEADASHCIQQILESIAY 119
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH---IRLADFGSCLRLGGDGTVQSNVAV 186
            H    VHR          ++KP+N+LL +      ++LADFG  + +  D       A 
Sbjct: 120 CHSNGIVHR----------NLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFA- 167
Query: 187 GTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQ 246
           GTP Y+SPE+L      +  Y    D W+ GV +Y +L G  PF+ E     Y +I    
Sbjct: 168 GTPGYLSPEVLK-----KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KA 220
Query: 247 NSFDLPSDVGYEISDDAKDLMRRLI 271
            ++D PS     ++ +AK L+  ++
Sbjct: 221 GAYDYPSPEWDTVTPEAKSLIDSML 245

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 108/226 (47%), Gaps = 41/226 (18%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           L +VM+   GG+L    S+ +DR  +   +   +E++ +I     + Y+H  N    H  
Sbjct: 134 LLIVMECLDGGELF---SRIQDRGDQAFTEREASEIMKSIGEA--IQYLHSIN--IAH-- 184
Query: 148 RDIKPDNVLLDA---NGHIRLADFGSCLRLGGDGTVQSNVAVG--TPDYISPEILTAMEE 202
           RD+KP+N+L  +   N  ++L DFG       + T  +++     TP Y++PE+L     
Sbjct: 185 RDVKPENLLYTSKRPNAILKLTDFG----FAKETTSHNSLTTPCYTPYYVAPEVL----- 235
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAE-SLVETYG-KIMNHQNSFDLPSDVGYEIS 260
           G  +Y   CD WSLGV MY +L G  PFY+   L  + G K       ++ P+    E+S
Sbjct: 236 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 295
Query: 261 DDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWF 306
           ++ K L+R L+ +  T+  +  I +F               NHPW 
Sbjct: 296 EEVKMLIRNLLKTEPTQ--RMTITEF--------------MNHPWI 325

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 108/226 (47%), Gaps = 41/226 (18%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           L +VM+   GG+L    S+ +DR  +   +   +E++ +I     + Y+H  N    H  
Sbjct: 95  LLIVMECLDGGELF---SRIQDRGDQAFTEREASEIMKSIGEA--IQYLHSIN--IAH-- 145
Query: 148 RDIKPDNVLLDA---NGHIRLADFGSCLRLGGDGTVQSNVAVG--TPDYISPEILTAMEE 202
           RD+KP+N+L  +   N  ++L DFG       + T  +++     TP Y++PE+L     
Sbjct: 146 RDVKPENLLYTSKRPNAILKLTDFG----FAKETTSHNSLTTPCYTPYYVAPEVL----- 196
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAE-SLVETYG-KIMNHQNSFDLPSDVGYEIS 260
           G  +Y   CD WSLGV MY +L G  PFY+   L  + G K       ++ P+    E+S
Sbjct: 197 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 256
Query: 261 DDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWF 306
           ++ K L+R L+ +  T+  +  I +F               NHPW 
Sbjct: 257 EEVKMLIRNLLKTEPTQ--RMTITEF--------------MNHPWI 286

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 37/224 (16%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           L +VM+   GG+L    S+ +DR  +   +   +E++ +I     + Y+H  N    H  
Sbjct: 94  LLIVMECLDGGELF---SRIQDRGDQAFTEREASEIMKSIGEA--IQYLHSIN--IAH-- 144
Query: 148 RDIKPDNVLLDA---NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR 204
           RD+KP+N+L  +   N  ++L DFG         ++ +     TP Y++PE+L     G 
Sbjct: 145 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVL-----GP 197
Query: 205 GRYGPECDWWSLGVCMYEMLYGETPFYAE-SLVETYG-KIMNHQNSFDLPSDVGYEISDD 262
            +Y   CD WSLGV MY +L G  PFY+   L  + G K       ++ P+    E+S++
Sbjct: 198 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 257
Query: 263 AKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWF 306
            K L+R L+ +  T+  +  I +F               NHPW 
Sbjct: 258 VKMLIRNLLKTEPTQ--RMTITEF--------------MNHPWI 285

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 37/224 (16%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           L +VM+   GG+L    S+ +DR  +   +   +E++ +I     + Y+H  N    H  
Sbjct: 88  LLIVMECLDGGELF---SRIQDRGDQAFTEREASEIMKSIGEA--IQYLHSIN--IAH-- 138
Query: 148 RDIKPDNVLLDA---NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR 204
           RD+KP+N+L  +   N  ++L DFG         ++ +     TP Y++PE+L     G 
Sbjct: 139 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVL-----GP 191
Query: 205 GRYGPECDWWSLGVCMYEMLYGETPFYAE-SLVETYG-KIMNHQNSFDLPSDVGYEISDD 262
            +Y   CD WSLGV MY +L G  PFY+   L  + G K       ++ P+    E+S++
Sbjct: 192 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 251
Query: 263 AKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWF 306
            K L+R L+ +  T+  +  I +F               NHPW 
Sbjct: 252 VKMLIRNLLKTEPTQ--RMTITEF--------------MNHPWI 279

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 37/224 (16%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           L +VM+   GG+L    S+ +DR  +   +   +E++ +I     + Y+H  N    H  
Sbjct: 90  LLIVMECLDGGELF---SRIQDRGDQAFTEREASEIMKSIGEA--IQYLHSIN--IAH-- 140
Query: 148 RDIKPDNVLLDA---NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR 204
           RD+KP+N+L  +   N  ++L DFG         ++ +     TP Y++PE+L     G 
Sbjct: 141 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVL-----GP 193
Query: 205 GRYGPECDWWSLGVCMYEMLYGETPFYAE-SLVETYG-KIMNHQNSFDLPSDVGYEISDD 262
            +Y   CD WSLGV MY +L G  PFY+   L  + G K       ++ P+    E+S++
Sbjct: 194 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 253
Query: 263 AKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWF 306
            K L+R L+ +  T+  +  I +F               NHPW 
Sbjct: 254 VKMLIRNLLKTEPTQ--RMTITEF--------------MNHPWI 281

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 108/226 (47%), Gaps = 41/226 (18%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           L +VM+   GG+L    S+ +DR  +   +   +E++ +I     + Y+H  N    H  
Sbjct: 90  LLIVMECLDGGELF---SRIQDRGDQAFTEREASEIMKSIGEA--IQYLHSIN--IAH-- 140
Query: 148 RDIKPDNVLLDA---NGHIRLADFGSCLRLGGDGTVQSNVAVG--TPDYISPEILTAMEE 202
           RD+KP+N+L  +   N  ++L DFG       + T  +++     TP Y++PE+L     
Sbjct: 141 RDVKPENLLYTSKRPNAILKLTDFG----FAKETTSHNSLTTPCYTPYYVAPEVL----- 191
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAE-SLVETYG-KIMNHQNSFDLPSDVGYEIS 260
           G  +Y   CD WSLGV MY +L G  PFY+   L  + G K       ++ P+    E+S
Sbjct: 192 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 251
Query: 261 DDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWF 306
           ++ K L+R L+ +  T+  +  I +F               NHPW 
Sbjct: 252 EEVKMLIRNLLKTEPTQ--RMTITEF--------------MNHPWI 281

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 37/224 (16%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           L +VM+   GG+L    S+ +DR  +   +   +E++ +I     + Y+H  N    H  
Sbjct: 96  LLIVMECLDGGELF---SRIQDRGDQAFTEREASEIMKSIGEA--IQYLHSIN--IAH-- 146
Query: 148 RDIKPDNVLLDA---NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR 204
           RD+KP+N+L  +   N  ++L DFG         ++ +     TP Y++PE+L     G 
Sbjct: 147 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVL-----GP 199
Query: 205 GRYGPECDWWSLGVCMYEMLYGETPFYAE-SLVETYG-KIMNHQNSFDLPSDVGYEISDD 262
            +Y   CD WSLGV MY +L G  PFY+   L  + G K       ++ P+    E+S++
Sbjct: 200 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 259
Query: 263 AKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWF 306
            K L+R L+ +  T+  +  I +F               NHPW 
Sbjct: 260 VKMLIRNLLKTEPTQ--RMTITEF--------------MNHPWI 287

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 108/226 (47%), Gaps = 41/226 (18%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           L +VM+   GG+L    S+ +DR  +   +   +E++ +I     + Y+H  N    H  
Sbjct: 140 LLIVMECLDGGELF---SRIQDRGDQAFTEREASEIMKSIGEA--IQYLHSIN--IAH-- 190
Query: 148 RDIKPDNVLLDA---NGHIRLADFGSCLRLGGDGTVQSNVAVG--TPDYISPEILTAMEE 202
           RD+KP+N+L  +   N  ++L DFG       + T  +++     TP Y++PE+L     
Sbjct: 191 RDVKPENLLYTSKRPNAILKLTDFG----FAKETTSHNSLTTPCYTPYYVAPEVL----- 241
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAE-SLVETYG-KIMNHQNSFDLPSDVGYEIS 260
           G  +Y   CD WSLGV MY +L G  PFY+   L  + G K       ++ P+    E+S
Sbjct: 242 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 301
Query: 261 DDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWF 306
           ++ K L+R L+ +  T+  +  I +F               NHPW 
Sbjct: 302 EEVKMLIRNLLKTEPTQ--RMTITEF--------------MNHPWI 331

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 37/224 (16%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           L +VM+   GG+L    S+ +DR  +   +   +E++ +I     + Y+H  N    H  
Sbjct: 89  LLIVMECLDGGELF---SRIQDRGDQAFTEREASEIMKSIGEA--IQYLHSIN--IAH-- 139
Query: 148 RDIKPDNVLLDA---NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR 204
           RD+KP+N+L  +   N  ++L DFG         ++ +     TP Y++PE+L     G 
Sbjct: 140 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVL-----GP 192
Query: 205 GRYGPECDWWSLGVCMYEMLYGETPFYAE-SLVETYG-KIMNHQNSFDLPSDVGYEISDD 262
            +Y   CD WSLGV MY +L G  PFY+   L  + G K       ++ P+    E+S++
Sbjct: 193 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 252
Query: 263 AKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWF 306
            K L+R L+ +  T+  +  I +F               NHPW 
Sbjct: 253 VKMLIRNLLKTEPTQ--RMTITEF--------------MNHPWI 280

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/172 (32%), Positives = 83/172 (48%), Gaps = 18/172 (10%)
Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE 122
           E  VL   +  +I   + AF  D  + + M++  GG L  +L K   R+PE +       
Sbjct: 73  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILG----- 126
Query: 123 MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQS 182
             ++IA I  L Y+ R  H   H  RD+KP N+L+++ G I+L DFG   +L       +
Sbjct: 127 -KVSIAVIKGLTYL-REKHKIMH--RDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA 179
Query: 183 NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES 234
           N  VGT  Y+SPE L         Y  + D WS+G+ + EM  G  P  + S
Sbjct: 180 NSFVGTRSYMSPERLQGTH-----YSVQSDIWSMGLSLVEMAVGRYPIGSGS 226

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 37/224 (16%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           L +VM+   GG+L    S+ +DR  +   +   +E++ +I     + Y+H  N    H  
Sbjct: 104 LLIVMECLDGGELF---SRIQDRGDQAFTEREASEIMKSIGEA--IQYLHSIN--IAH-- 154
Query: 148 RDIKPDNVLLDA---NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR 204
           RD+KP+N+L  +   N  ++L DFG         ++ +     TP Y++PE+L     G 
Sbjct: 155 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVL-----GP 207
Query: 205 GRYGPECDWWSLGVCMYEMLYGETPFYAE-SLVETYG-KIMNHQNSFDLPSDVGYEISDD 262
            +Y   CD WSLGV MY +L G  PFY+   L  + G K       ++ P+    E+S++
Sbjct: 208 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 267
Query: 263 AKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWF 306
            K L+R L+ +  T+  +  I +F               NHPW 
Sbjct: 268 VKMLIRNLLKTEPTQ--RMTITEF--------------MNHPWI 295

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 104/237 (43%), Gaps = 51/237 (21%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFED----RLPEDMAKFYIA------EMV 124
           I  L+  ++D+  + LVM+   GG LL  L+ F D    +   D+ K  I       E  
Sbjct: 90  IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 125 LAIASIHD------------------------LHYVHRPNHFAFHLCRDIKPDNVLLDAN 160
           +   SIH                         LHY+H  N    H  RDIKP+N L   N
Sbjct: 150 IN-GSIHGFRESLDFVQREKLISNIMRQIFSALHYLH--NQGICH--RDIKPENFLFSTN 204
Query: 161 G--HIRLADFG---SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWS 215
               I+L DFG      +L            GTP +++PE+L    E    YGP+CD WS
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES---YGPKCDAWS 261
Query: 216 LGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEI-SDDAKDLMRRLI 271
            GV ++ +L G  PF   +  +T  +++N +  F+ P+   Y + S  A+DL+  L+
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPN---YNVLSPLARDLLSNLL 315

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/251 (25%), Positives = 107/251 (42%), Gaps = 49/251 (19%)
Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH 141
           F+DD+  YLV +   GG +L  + K +    E  A   + ++  A+  +H     HR   
Sbjct: 80  FEDDTRFYLVFEKLQGGSILAHIQK-QKHFNEREASRVVRDVAAALDFLHTKGIAHR--- 135
Query: 142 FAFHLCRDIKPDNVLLDANGHI---RLADF--GSCLRLGGDGTVQSNVAVGTP----DYI 192
                  D+KP+N+L ++   +   ++ DF  GS ++L    T  +   + TP    +Y+
Sbjct: 136 -------DLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYM 188
Query: 193 SPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YGKIMN----- 244
           +PE++    +    Y   CD WSLGV +Y ML G  PF      +     G++       
Sbjct: 189 APEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNK 248
Query: 245 -----HQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSIS 299
                 +  ++ P      IS +AKDL+ +L+            A  ++ +A  +     
Sbjct: 249 LFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRD---------AKQRLSAAQVL----- 294
Query: 300 PRNHPWFQGIA 310
              HPW QG A
Sbjct: 295 --QHPWVQGQA 303

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 105/224 (46%), Gaps = 37/224 (16%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           L +VM+   GG+L    S+ +DR  +   +   +E++ +I     + Y+H  N    H  
Sbjct: 88  LLIVMECLDGGELF---SRIQDRGDQAFTEREASEIMKSIGEA--IQYLHSIN--IAH-- 138
Query: 148 RDIKPDNVLLDA---NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR 204
           RD+KP+N+L  +   N  ++L DFG         ++       TP Y++PE+L     G 
Sbjct: 139 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTE--PCYTPYYVAPEVL-----GP 191
Query: 205 GRYGPECDWWSLGVCMYEMLYGETPFYAE-SLVETYG-KIMNHQNSFDLPSDVGYEISDD 262
            +Y   CD WSLGV MY +L G  PFY+   L  + G K       ++ P+    E+S++
Sbjct: 192 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 251
Query: 263 AKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWF 306
            K L+R L+ +  T+  +  I +F               NHPW 
Sbjct: 252 VKMLIRNLLKTEPTQ--RMTITEF--------------MNHPWI 279

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 105/219 (47%), Gaps = 29/219 (13%)
Query: 62  EERDVLV-YGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLL--TLLSKFEDRLPEDMAKF 118
           EE ++L+ YG    I  L   + D  ++YLV +   GG+LL   L  KF     E  A F
Sbjct: 69  EEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF---FSEREASF 125
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL-LDANGH---IRLADFGSCLRL 174
            +  +   +  +H    VHR          D+KP N+L +D +G+   +R+ DFG   +L
Sbjct: 126 VLHTIGKTVEYLHSQGVVHR----------DLKPSNILYVDESGNPECLRICDFGFAKQL 175
Query: 175 GGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES 234
             +  +       T ++++PE+L      R  Y   CD WSLG+ +Y ML G TPF A  
Sbjct: 176 RAENGLLMTPCY-TANFVAPEVLK-----RQGYDEGCDIWSLGILLYTMLAGYTPF-ANG 228
Query: 235 LVETYGKIMNHQNS--FDLPSDVGYEISDDAKDLMRRLI 271
             +T  +I+    S  F L       +S+ AKDL+ +++
Sbjct: 229 PSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKML 267

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 105/219 (47%), Gaps = 29/219 (13%)
Query: 62  EERDVLV-YGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLL--TLLSKFEDRLPEDMAKF 118
           EE ++L+ YG    I  L   + D  ++YLV +   GG+LL   L  KF     E  A F
Sbjct: 69  EEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF---FSEREASF 125
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL-LDANGH---IRLADFGSCLRL 174
            +  +   +  +H    VHR          D+KP N+L +D +G+   +R+ DFG   +L
Sbjct: 126 VLHTIGKTVEYLHSQGVVHR----------DLKPSNILYVDESGNPECLRICDFGFAKQL 175
Query: 175 GGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES 234
             +  +       T ++++PE+L      R  Y   CD WSLG+ +Y ML G TPF A  
Sbjct: 176 RAENGLLMTPCY-TANFVAPEVLK-----RQGYDEGCDIWSLGILLYTMLAGYTPF-ANG 228
Query: 235 LVETYGKIMNHQNS--FDLPSDVGYEISDDAKDLMRRLI 271
             +T  +I+    S  F L       +S+ AKDL+ +++
Sbjct: 229 PSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKML 267

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 81/168 (48%), Gaps = 18/168 (10%)
Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE 122
           E  VL   +  +I   + AF  D  + + M++  GG L  +L K   R+PE +       
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILG----- 134
Query: 123 MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQS 182
             ++IA I  L Y+ R  H   H  RD+KP N+L+++ G I+L DFG   +L       +
Sbjct: 135 -KVSIAVIKGLTYL-REKHKIMH--RDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA 187
Query: 183 NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
           N  VGT  Y+SPE L         Y  + D WS+G+ + EM  G  P 
Sbjct: 188 NSFVGTRSYMSPERLQGT-----HYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 122/278 (43%), Gaps = 55/278 (19%)
Query: 54  IEFVAKL--REERD-------VLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLL--T 102
           +EF  K+  + +RD       +L YG    I  L   + D   +Y+V +   GG+LL   
Sbjct: 48  MEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKI 107
Query: 103 LLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL-LDANG 161
           L  KF     E  A   +  +   +  +H    VHR          D+KP N+L +D +G
Sbjct: 108 LRQKF---FSEREASAVLFTITKTVEYLHAQGVVHR----------DLKPSNILYVDESG 154
Query: 162 H---IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGV 218
           +   IR+ DFG   +L  +  +       T ++++PE+L      R  Y   CD WSLGV
Sbjct: 155 NPESIRICDFGFAKQLRAENGLLMTPCY-TANFVAPEVLE-----RQGYDAACDIWSLGV 208
Query: 219 CMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGY--EISDDAKDLMRRLICSSDT 276
            +Y ML G TPF A    +T  +I+    S       GY   +SD AKDL+ +++     
Sbjct: 209 LLYTMLTGYTPF-ANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPH 267
Query: 277 RLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI 314
           +         ++ +AL +        HPW   + WD +
Sbjct: 268 Q---------RLTAALVL-------RHPWI--VHWDQL 287

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 81/168 (48%), Gaps = 18/168 (10%)
Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE 122
           E  VL   +  +I   + AF  D  + + M++  GG L  +L K   R+PE +       
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILG----- 169
Query: 123 MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQS 182
             ++IA I  L Y+ R  H   H  RD+KP N+L+++ G I+L DFG   +L       +
Sbjct: 170 -KVSIAVIKGLTYL-REKHKIMH--RDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA 222
Query: 183 NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
           N  VGT  Y+SPE L         Y  + D WS+G+ + EM  G  P 
Sbjct: 223 NSFVGTRSYMSPERLQGT-----HYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 83/172 (48%), Gaps = 18/172 (10%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           ++  E  VL   +  +I   + AF  D  + + M++  GG L  +L K   R+PE +   
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILG- 107
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
                 ++IA I  L Y+ R  H   H  RD+KP N+L+++ G I+L DFG   +L    
Sbjct: 108 -----KVSIAVIKGLTYL-REKHKIMH--RDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158
Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
              +N  VGT  Y+SPE L         Y  + D WS+G+ + EM  G  P 
Sbjct: 159 --MANSFVGTRSYMSPERLQGT-----HYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 83/172 (48%), Gaps = 18/172 (10%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           ++  E  VL   +  +I   + AF  D  + + M++  GG L  +L K   R+PE +   
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILG- 107
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
                 ++IA I  L Y+ R  H   H  RD+KP N+L+++ G I+L DFG   +L    
Sbjct: 108 -----KVSIAVIKGLTYL-REKHKIMH--RDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158
Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
              +N  VGT  Y+SPE L         Y  + D WS+G+ + EM  G  P 
Sbjct: 159 --MANSFVGTRSYMSPERLQGT-----HYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 83/172 (48%), Gaps = 18/172 (10%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           ++  E  VL   +  +I   + AF  D  + + M++  GG L  +L K   R+PE +   
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILG- 107
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
                 ++IA I  L Y+ R  H   H  RD+KP N+L+++ G I+L DFG   +L    
Sbjct: 108 -----KVSIAVIKGLTYL-REKHKIMH--RDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158
Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
              +N  VGT  Y+SPE L         Y  + D WS+G+ + EM  G  P 
Sbjct: 159 --MANSFVGTRSYMSPERLQGT-----HYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 83/172 (48%), Gaps = 18/172 (10%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           ++  E  VL   +  +I   + AF  D  + + M++  GG L  +L K   R+PE +   
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILG- 107
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
                 ++IA I  L Y+ R  H   H  RD+KP N+L+++ G I+L DFG   +L    
Sbjct: 108 -----KVSIAVIKGLTYL-REKHKIMH--RDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158
Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
              +N  VGT  Y+SPE L         Y  + D WS+G+ + EM  G  P 
Sbjct: 159 --MANSFVGTRSYMSPERLQGT-----HYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 83/172 (48%), Gaps = 18/172 (10%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           ++  E  VL   +  +I   + AF  D  + + M++  GG L  +L K   R+PE +   
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILG- 107
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
                 ++IA I  L Y+ R  H   H  RD+KP N+L+++ G I+L DFG   +L    
Sbjct: 108 -----KVSIAVIKGLTYL-REKHKIMH--RDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158
Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
              +N  VGT  Y+SPE L         Y  + D WS+G+ + EM  G  P 
Sbjct: 159 --MANSFVGTRSYMSPERLQGT-----HYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 94/188 (50%), Gaps = 20/188 (10%)
Query: 43  SLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLT 102
           ++++    SD  E +    +E  ++   D   +   + ++  +++L++VM+Y   G +  
Sbjct: 58  AIKQVPVESDLQEII----KEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD 113
Query: 103 LLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH 162
           ++      L ED     IA ++ +  ++  L Y+H    F   + RDIK  N+LL+  GH
Sbjct: 114 IIRLRNKTLTED----EIATILQS--TLKGLEYLH----FMRKIHRDIKAGNILLNTEGH 163
Query: 163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYE 222
            +LADFG   +L  D   + N  +GTP +++PE++  +      Y    D WSLG+   E
Sbjct: 164 AKLADFGVAGQL-TDXMAKRNXVIGTPFWMAPEVIQEI-----GYNCVADIWSLGITAIE 217
Query: 223 MLYGETPF 230
           M  G+ P+
Sbjct: 218 MAEGKPPY 225

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 103/232 (44%), Gaps = 53/232 (22%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
           ++L +VM+Y  GG+L   +     R  ED A+F+  +++  ++  H +   HR       
Sbjct: 87  THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHR------- 138
Query: 146 LCRDIKPDNVLLDANG--HIRLADFG----SCLRLGGDGTVQSNVAVGTPDYISPEILTA 199
              D+K +N LLD +    +++ DFG    S L        Q    VGTP YI+PE+L  
Sbjct: 139 ---DLKLENTLLDGSPAPRLKICDFGYSKSSVLH------SQPKSTVGTPAYIAPEVLLK 189
Query: 200 MEEGRGRYGPECDWWSLGVCMYEMLYGETPF----YAESLVETYGKIMNHQNSFDLPSDV 255
            E      G   D WS GV +Y ML G  PF      ++  +T  +I+N Q  + +P  V
Sbjct: 190 KEYD----GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQ--YAIPDYV 243
Query: 256 GYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISP-RNHPWF 306
              IS + + L+ R+  +   +                  +SI   RNH WF
Sbjct: 244 --HISPECRHLISRIFVADPAK-----------------RISIPEIRNHEWF 276

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 102/232 (43%), Gaps = 53/232 (22%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
           ++L +VM+Y  GG+L   +     R  ED A+F+  +++  ++  H +   HR       
Sbjct: 88  THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHR------- 139
Query: 146 LCRDIKPDNVLLDANGHIRLA--DFG----SCLRLGGDGTVQSNVAVGTPDYISPEILTA 199
              D+K +N LLD +   RL   DFG    S L        Q    VGTP YI+PE+L  
Sbjct: 140 ---DLKLENTLLDGSPAPRLKICDFGYSKSSVLH------SQPKSTVGTPAYIAPEVLLK 190
Query: 200 MEEGRGRYGPECDWWSLGVCMYEMLYGETPF----YAESLVETYGKIMNHQNSFDLPSDV 255
            E      G   D WS GV +Y ML G  PF      ++  +T  +I+N Q  + +P  V
Sbjct: 191 KEYD----GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQ--YAIPDYV 244
Query: 256 GYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISP-RNHPWF 306
              IS + + L+ R+  +   +                  +SI   RNH WF
Sbjct: 245 --HISPECRHLISRIFVADPAK-----------------RISIPEIRNHEWF 277

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 77/154 (50%), Gaps = 17/154 (11%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLP--EDMAKFYIAEMVLAIASIHDLHYVHR 138
           +F ++  + + M+   GG L  LL      L   E    FY  +++  +  +HD   VHR
Sbjct: 87  SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 139 PNHFAFHLCRDIKPDNVLLDA-NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEIL 197
                     DIK DNVL++  +G ++++DFG+  RL G     +    GT  Y++PEI+
Sbjct: 147 ----------DIKGDNVLINTYSGVLKISDFGTSKRLAGINPC-TETFTGTLQYMAPEII 195
Query: 198 TAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
              ++G   YG   D WSLG  + EM  G+ PFY
Sbjct: 196 ---DKGPRGYGKAADIWSLGCTIIEMATGKPPFY 226

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 73/148 (49%), Gaps = 14/148 (9%)
Query: 85  DSNLYLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFA 143
           D  L+LVM++   G +  L+   + + L E+   +   E++  ++ +H    +HR     
Sbjct: 99  DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHR----- 153
Query: 144 FHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTV-QSNVAVGTPDYISPEILTAMEE 202
                DIK  NVLL  N  ++L DFG   +L  D TV + N  +GTP +++PE++   E 
Sbjct: 154 -----DIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDEN 206
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPF 230
               Y  + D WSLG+   EM  G  P 
Sbjct: 207 PDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 84/175 (48%), Gaps = 17/175 (9%)
Query: 60  LREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLP--EDMAK 117
           L EE  +  +   + I     +F ++  + + M+   GG L  LL      L   E    
Sbjct: 52  LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG 111
Query: 118 FYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA-NGHIRLADFGSCLRLGG 176
           FY  +++  +  +HD   VHR          DIK DNVL++  +G ++++DFG+  RL G
Sbjct: 112 FYTKQILEGLKYLHDNQIVHR----------DIKGDNVLINTYSGVLKISDFGTSKRLAG 161
Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
                +    GT  Y++PEI+   ++G   YG   D WSLG  + EM  G+ PFY
Sbjct: 162 INPC-TETFTGTLQYMAPEII---DKGPRGYGKAADIWSLGCTIIEMATGKPPFY 212

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 84/170 (49%), Gaps = 13/170 (7%)
Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE 122
           E D+L   D   I  L  AF  ++NL++++++  GG +  ++ + E  L E   +    +
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 143
Query: 123 MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQS 182
            + A+  +HD   +H          RD+K  N+L   +G I+LADFG   +     T+Q 
Sbjct: 144 TLDALNYLHDNKIIH----------RDLKAGNILFTLDGDIKLADFGVSAK--NTRTIQR 191
Query: 183 NVA-VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
             + +GTP +++PE++         Y  + D WSLG+ + EM   E P +
Sbjct: 192 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH 241

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 120/290 (41%), Gaps = 52/290 (17%)
Query: 43  SLRREKTVSDFIEFVAKLRE--ERDVLVYGDRRW--ITNLHYAFQDDSNLYLVMDYYCGG 98
            L +E     +IE  A + E  +R+++ +   R   I          ++L ++M+Y  GG
Sbjct: 42  KLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGG 101
Query: 99  DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD 158
           +L   +     R  ED A+F+  +++  ++  H +   HR          D+K +N LLD
Sbjct: 102 ELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHR----------DLKLENTLLD 150
Query: 159 ANGHIRL--ADFGSCLRLGGDGTV---QSNVAVGTPDYISPEILTAMEEGRGRYGPECDW 213
            +   RL   DFG         +V   Q    VGTP YI+PE+L   E      G   D 
Sbjct: 151 GSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEVLLRQEYD----GKIADV 201
Query: 214 WSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNS--FDLPSDVGYEISDDAKDLMRRL- 270
           WS GV +Y ML G  PF        Y K +    S  + +P D+   IS +   L+ R+ 
Sbjct: 202 WSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDI--RISPECCHLISRIF 259
Query: 271 ICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWF-QGIAWDSIRDSNA 319
           +    TR+    I                 + H WF + +  D + +SN 
Sbjct: 260 VADPATRISIPEI-----------------KTHSWFLKNLPADLMNESNT 292

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 41/226 (18%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
           ++L +VM+Y  GG+L   +     R  ED A+F+  +++  ++  H +   HR       
Sbjct: 88  THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHR------- 139
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRG 205
              D+K +N LLD +   RL               Q    VGTP YI+PE+L   E    
Sbjct: 140 ---DLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD-- 194
Query: 206 RYGPECDWWSLGVCMYEMLYGETPF----YAESLVETYGKIMNHQNSFDLPSDVGYEISD 261
             G   D WS GV +Y ML G  PF      ++  +T  +I+N Q  + +P  V   IS 
Sbjct: 195 --GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQ--YAIPDYV--HISP 248
Query: 262 DAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISP-RNHPWF 306
           + + L+ R+  +   +                  +SI   RNH WF
Sbjct: 249 ECRHLISRIFVADPAK-----------------RISIPEIRNHEWF 277

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 23/217 (10%)
Query: 60  LREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFY 119
           +++E  +L     R I +LH +F+    L ++ ++  G D+   ++     L E     Y
Sbjct: 48  VKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY 107
Query: 120 IAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA--NGHIRLADFGSCLRLG-G 176
           + ++  A+  +H     H   HF      DI+P+N++     +  I++ +FG   +L  G
Sbjct: 108 VHQVCEALQFLHS----HNIGHF------DIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157
Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
           D      +    P+Y +PE+               D WSLG  +Y +L G  PF AE+  
Sbjct: 158 DNF---RLLFTAPEYYAPEV-----HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ 209
Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICS 273
           +    IMN + +FD   +   EIS +A D + RL+  
Sbjct: 210 QIIENIMNAEYTFD--EEAFKEISIEAMDFVDRLLVK 244

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 41/226 (18%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           L +V +   GG+L    S+ +DR  +   +   +E+  +I     + Y+H  N    H  
Sbjct: 134 LLIVXECLDGGELF---SRIQDRGDQAFTEREASEIXKSIGEA--IQYLHSIN--IAH-- 184
Query: 148 RDIKPDNVLLDA---NGHIRLADFGSCLRLGGDGTVQSNVAVG--TPDYISPEILTAMEE 202
           RD+KP+N+L  +   N  ++L DFG       + T  +++     TP Y++PE+L     
Sbjct: 185 RDVKPENLLYTSKRPNAILKLTDFG----FAKETTSHNSLTTPCYTPYYVAPEVL----- 235
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAES--LVETYGKIMNHQNSFDLPSDVGYEIS 260
           G  +Y   CD WSLGV  Y +L G  PFY+     +    K       ++ P+    E+S
Sbjct: 236 GPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWSEVS 295
Query: 261 DDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWF 306
           ++ K L+R L+ +  T+  +  I +F               NHPW 
Sbjct: 296 EEVKXLIRNLLKTEPTQ--RXTITEFX--------------NHPWI 325

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 106/238 (44%), Gaps = 47/238 (19%)
Query: 77  NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYV 136
           N+H+       L ++M+   GG+L    S+ ++R  +   +   AE++  I +     + 
Sbjct: 93  NMHHG---KRCLLIIMECMEGGELF---SRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 146
Query: 137 HRPNHFAFHLCRDIKPDNVLL---DANGHIRLADFGSCLRLGGDGTVQSNVAVG--TPDY 191
           H   H      RD+KP+N+L    + +  ++L DFG         T Q+ +     TP Y
Sbjct: 147 HNIAH------RDVKPENLLYTSKEKDAVLKLTDFGF-----AKETTQNALQTPCYTPYY 195
Query: 192 ISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES--LVETYGKIMNHQNSF 249
           ++PE+L     G  +Y   CD WSLGV MY +L G  PFY+ +   +    K       +
Sbjct: 196 VAPEVL-----GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY 250
Query: 250 DLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISP-RNHPWF 306
             P+    E+S+DAK L+R L+ +  T                   L+I+   NHPW 
Sbjct: 251 GFPNPEWSEVSEDAKQLIRLLLKTDPTE-----------------RLTITQFMNHPWI 291

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 29/207 (14%)
Query: 77  NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYV 136
           N+H+       L ++M+   GG+L    S+ ++R  +   +   AE++  I +     + 
Sbjct: 74  NMHHG---KRCLLIIMECMEGGELF---SRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 127
Query: 137 HRPNHFAFHLCRDIKPDNVLL---DANGHIRLADFGSCLRLGGDGTVQSNVAVG--TPDY 191
           H   H      RD+KP+N+L    + +  ++L DFG         T Q+ +     TP Y
Sbjct: 128 HNIAH------RDVKPENLLYTSKEKDAVLKLTDFGF-----AKETTQNALQTPCYTPYY 176
Query: 192 ISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES--LVETYGKIMNHQNSF 249
           ++PE+L     G  +Y   CD WSLGV MY +L G  PFY+ +   +    K       +
Sbjct: 177 VAPEVL-----GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY 231
Query: 250 DLPSDVGYEISDDAKDLMRRLICSSDT 276
             P+    E+S+DAK L+R L+ +  T
Sbjct: 232 GFPNPEWSEVSEDAKQLIRLLLKTDPT 258

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 41/226 (18%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
           ++L +VM+Y  GG+L   +     R  ED A+F+  +++  ++  H +   HR       
Sbjct: 88  THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHR------- 139
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRG 205
              D+K +N LLD +   RL               Q    VGTP YI+PE+L   E    
Sbjct: 140 ---DLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYD-- 194
Query: 206 RYGPECDWWSLGVCMYEMLYGETPF----YAESLVETYGKIMNHQNSFDLPSDVGYEISD 261
             G   D WS GV +Y ML G  PF      ++  +T  +I+N Q  + +P  V   IS 
Sbjct: 195 --GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQ--YAIPDYV--HISP 248
Query: 262 DAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISP-RNHPWF 306
           + + L+ R+  +   +                  +SI   RNH WF
Sbjct: 249 ECRHLISRIFVADPAK-----------------RISIPEIRNHEWF 277

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 107/221 (48%), Gaps = 23/221 (10%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           +++ E  V+   D   +  L+ AF+  +++ LVM+Y  GG+L   +      L E     
Sbjct: 132 EVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL 191
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL---DANGHIRLADFGSCLRLG 175
           ++ ++   I  +H ++ +H           D+KP+N+L    DA   I++ DFG   R  
Sbjct: 192 FMKQICEGIRHMHQMYILH----------LDLKPENILCVNRDAK-QIKIIDFGLARRYK 240
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
               ++ N   GTP++++PE++              D WS+GV  Y +L G +PF  ++ 
Sbjct: 241 PREKLKVN--FGTPEFLAPEVVNY-----DFVSFPTDMWSVGVIAYMLLSGLSPFLGDND 293
Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT 276
            ET   I+  +  +DL  +   +IS++AK+ + +L+    +
Sbjct: 294 AETLNNILACR--WDLEDEEFQDISEEAKEFISKLLIKEKS 332

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 11/169 (6%)
Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE 122
           E D+L   D   I  L  AF  ++NL++++++  GG +  ++ + E  L E   +    +
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 143
Query: 123 MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQS 182
            + A+  +HD   +H          RD+K  N+L   +G I+LADFG   +       + 
Sbjct: 144 TLDALNYLHDNKIIH----------RDLKAGNILFTLDGDIKLADFGVSAK-NTRXIQRR 192
Query: 183 NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
           +  +GTP +++PE++         Y  + D WSLG+ + EM   E P +
Sbjct: 193 DXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH 241

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 11/169 (6%)
Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE 122
           E D+L   D   I  L  AF  ++NL++++++  GG +  ++ + E  L E   +    +
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 143
Query: 123 MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQS 182
            + A+  +HD   +H          RD+K  N+L   +G I+LADFG   +       + 
Sbjct: 144 TLDALNYLHDNKIIH----------RDLKAGNILFTLDGDIKLADFGVSAK-NTRXIQRR 192
Query: 183 NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
           +  +GTP +++PE++         Y  + D WSLG+ + EM   E P +
Sbjct: 193 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH 241

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 119/277 (42%), Gaps = 55/277 (19%)
Query: 55  EFVAKL--REERD-------VLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLL--TL 103
           EF  K+  + +RD       +L YG    I  L   + D   +Y+V +   GG+LL   L
Sbjct: 49  EFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKIL 108
Query: 104 LSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL-LDANGH 162
             KF     E  A   +  +   +  +H    VHR          D+KP N+L +D +G+
Sbjct: 109 RQKF---FSEREASAVLFTITKTVEYLHAQGVVHR----------DLKPSNILYVDESGN 155
Query: 163 ---IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVC 219
              IR+ DFG   +L  +  +       T ++++PE+L      R  Y   CD WSLGV 
Sbjct: 156 PESIRICDFGFAKQLRAENGLLXTPCY-TANFVAPEVLE-----RQGYDAACDIWSLGVL 209
Query: 220 MYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGY--EISDDAKDLMRRLICSSDTR 277
           +Y  L G TPF A    +T  +I+    S       GY   +SD AKDL+ + +     +
Sbjct: 210 LYTXLTGYTPF-ANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKXLHVDPHQ 268
Query: 278 LGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI 314
                    ++ +AL +        HPW   + WD +
Sbjct: 269 ---------RLTAALVL-------RHPWI--VHWDQL 287

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 14/193 (7%)
Query: 66  VLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVL 125
           VL   D  +I      F  ++++++ M+      + T   K + R+   + +  + +M +
Sbjct: 77  VLKSHDCPYIVQCFGTFITNTDVFIAMEL-----MGTCAEKLKKRMQGPIPERILGKMTV 131
Query: 126 AIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVA 185
           AI  +  L+Y+ +  H   H  RD+KP N+LLD  G I+L DFG   RL  D     + +
Sbjct: 132 AI--VKALYYL-KEKHGVIH--RDVKPSNILLDERGQIKLCDFGISGRLVDDKA--KDRS 184
Query: 186 VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMN 244
            G   Y++PE +   +  +  Y    D WSLG+ + E+  G+ P+   ++  E   K++ 
Sbjct: 185 AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ 244
Query: 245 HQNSFDLPSDVGY 257
            +    LP  +G+
Sbjct: 245 EEPPL-LPGHMGF 256

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 88/182 (48%), Gaps = 21/182 (11%)
Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE 122
           E  VL   +  +I   + AF  D  + + M++  GG L  +L K   R+PE++       
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KEAKRIPEEILG----- 117
Query: 123 MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQS 182
             ++IA +  L Y+ R  H   H  RD+KP N+L+++ G I+L DFG   +L       +
Sbjct: 118 -KVSIAVLRGLAYL-REKHQIMH--RDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA 170
Query: 183 NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY---AESLVETY 239
           N  VGT  Y++PE L         Y  + D WS+G+ + E+  G  P     A+ L   +
Sbjct: 171 NSFVGTRSYMAPERLQGT-----HYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIF 225
Query: 240 GK 241
           G+
Sbjct: 226 GR 227

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 83/170 (48%), Gaps = 13/170 (7%)
Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE 122
           E ++L   D  +I  L  A+  D  L++++++  GG +  ++ + +  L E   +    +
Sbjct: 58  EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQ 117
Query: 123 MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQS 182
           M+ A+  +H    +HR          D+K  NVL+   G IRLADFG   +     T+Q 
Sbjct: 118 MLEALNFLHSKRIIHR----------DLKAGNVLMTLEGDIRLADFGVSAK--NLKTLQK 165
Query: 183 NVA-VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
             + +GTP +++PE++         Y  + D WSLG+ + EM   E P +
Sbjct: 166 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH 215

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 83/170 (48%), Gaps = 13/170 (7%)
Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE 122
           E ++L   D  +I  L  A+  D  L++++++  GG +  ++ + +  L E   +    +
Sbjct: 66  EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQ 125
Query: 123 MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQS 182
           M+ A+  +H    +HR          D+K  NVL+   G IRLADFG   +     T+Q 
Sbjct: 126 MLEALNFLHSKRIIHR----------DLKAGNVLMTLEGDIRLADFGVSAK--NLKTLQK 173
Query: 183 NVA-VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
             + +GTP +++PE++         Y  + D WSLG+ + EM   E P +
Sbjct: 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH 223

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 25/213 (11%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           +LR E ++  +     I  L+  F D   +YL+++Y   G+L   L K      E     
Sbjct: 69  QLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQK-SCTFDEQRTAT 127
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
            + E+  A+   H    +HR          DIKP+N+LL   G +++ADFG  +      
Sbjct: 128 IMEELADALMYCHGKKVIHR----------DIKPENLLLGLKGELKIADFGWSVHAP--- 174
Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 238
           +++     GT DY+ PE++    EGR  +  + D W +GV  YE+L G  PF + S  ET
Sbjct: 175 SLRRKTMCGTLDYLPPEMI----EGR-MHNEKVDLWCIGVLCYELLVGNPPFESASHNET 229
Query: 239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           Y +I+     F      G      A+DL+ +L+
Sbjct: 230 YRRIVKVDLKFPASVPTG------AQDLISKLL 256

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 101/245 (41%), Gaps = 49/245 (20%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
            YLV +   GG +L+ + K      E  A   + ++  A+  +H+    HR         
Sbjct: 86  FYLVFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHR--------- 135
Query: 148 RDIKPDNVLLDANGHI---RLADF--GSCLRLGGDGTVQSNVAVGTP----DYISPEILT 198
            D+KP+N+L +    +   ++ DF  GS ++L GD +  S   + TP    +Y++PE++ 
Sbjct: 136 -DLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 199 AMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES-------LVETYGKIMN------H 245
           A  E    Y   CD WSLGV +Y +L G  PF             E      N       
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQ 254
Query: 246 QNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPW 305
           +  ++ P      IS  AKDL+ +L+           + D K   +    L      HPW
Sbjct: 255 EGKYEFPDKDWAHISCAAKDLISKLL-----------VRDAKQRLSAAQVL-----QHPW 298
Query: 306 FQGIA 310
            QG A
Sbjct: 299 VQGCA 303

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 101/245 (41%), Gaps = 49/245 (20%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
            YLV +   GG +L+ + K      E  A   + ++  A+  +H+    HR         
Sbjct: 86  FYLVFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHR--------- 135
Query: 148 RDIKPDNVLLDANGHI---RLADFG--SCLRLGGDGTVQSNVAVGTP----DYISPEILT 198
            D+KP+N+L +    +   ++ DFG  S ++L GD +  S   + TP    +Y++PE++ 
Sbjct: 136 -DLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 199 AMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES-------LVETYGKIMN------H 245
           A  E    Y   CD WSLGV +Y +L G  PF             E      N       
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQ 254
Query: 246 QNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPW 305
           +  ++ P      IS  AKDL+ +L+           + D K   +    L      HPW
Sbjct: 255 EGKYEFPDKDWAHISCAAKDLISKLL-----------VRDAKQRLSAAQVL-----QHPW 298
Query: 306 FQGIA 310
            QG A
Sbjct: 299 VQGCA 303

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 101/224 (45%), Gaps = 28/224 (12%)
Query: 47  EKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSK 106
           E  V   I+ + +LR +  +        + ++ Y  ++   +Y+VM+Y   G    L S 
Sbjct: 50  EANVKKEIQLLRRLRHKNVI-------QLVDVLYN-EEKQKMYMVMEYCVCGMQEMLDSV 101
Query: 107 FEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLA 166
            E R P   A  Y  +++  +  +H    VH          +DIKP N+LL   G ++++
Sbjct: 102 PEKRFPVCQAHGYFCQLIDGLEYLHSQGIVH----------KDIKPGNLLLTTGGTLKIS 151
Query: 167 DFGSCLRL---GGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM 223
             G    L     D T ++  + G+P +  PEI   ++   G    + D WS GV +Y +
Sbjct: 152 ALGVAEALHPFAADDTCRT--SQGSPAFQPPEIANGLDTFSGF---KVDIWSAGVTLYNI 206
Query: 224 LYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLM 267
             G  PF  +++ + +  I   + S+ +P D G  +SD  K ++
Sbjct: 207 TTGLYPFEGDNIYKLFENI--GKGSYAIPGDCGPPLSDLLKGML 248

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 39/118 (33%), Positives = 64/118 (54%), Gaps = 14/118 (11%)
Query: 128 ASIHDLHYVHRPNHFAFHLC-RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAV 186
           + ++   Y+H   +    +C RD+KP N+L+D NG ++L+DFG    +  D  ++   + 
Sbjct: 159 SVLNSFSYIHNEKN----ICHRDVKPSNILMDKNGRVKLSDFGESEYM-VDKKIKG--SR 211
Query: 187 GTPDYISPEILTAMEEGRGRY-GPECDWWSLGVCMYEMLYGETPFYAE-SLVETYGKI 242
           GT +++ PE  +        Y G + D WSLG+C+Y M Y   PF  + SLVE +  I
Sbjct: 212 GTYEFMPPEFFS----NESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI 265

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           + NL   F+    L+LV +Y C   +L  L +++  +PE + K    + + A+   H  +
Sbjct: 64  LVNLLEVFRRKRRLHLVFEY-CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          D+KP+N+L+  +  I+L DFG    L G      +  V T  Y SP
Sbjct: 123 CIHR----------DVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD-EVATRWYRSP 171
Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYG 226
           E+L     G  +YGP  D W++G    E+L G
Sbjct: 172 ELLV----GDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 133/304 (43%), Gaps = 56/304 (18%)
Query: 18  GKGRVFSI----ETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRR 73
           G  +VF +    + +  I  V  +E  N +L    +  + I ++ KL++  D ++     
Sbjct: 40  GSSKVFQVLNEKKQIYAIKYVNLEEADNQTL---DSYRNEIAYLNKLQQHSDKIIRLYDY 96
Query: 74  WITNLHYAFQDDSNLYLVMDYYCGG-DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD 132
            IT        D  +Y+VM+  CG  DL + L K +   P +  K Y   M+ A+ +IH 
Sbjct: 97  EIT--------DQYIYMVME--CGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQ 145
Query: 133 LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDY 191
              VH           D+KP N L+  +G ++L DFG   ++  D T V  +  VGT +Y
Sbjct: 146 HGIVHS----------DLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 194
Query: 192 ISPEILTAMEEGRGR------YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM-- 243
           + PE +  M   R          P+ D WSLG  +Y M YG+TPF  + ++    K+   
Sbjct: 195 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAI 252
Query: 244 ---NHQNSF-DLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSIS 299
              NH+  F D+P           KDL   L C    R  +  I+  ++ +  +V +   
Sbjct: 253 IDPNHEIEFPDIPE----------KDLQDVLKCCL-KRDPKQRISIPELLAHPYVQIQTH 301
Query: 300 PRNH 303
           P N 
Sbjct: 302 PVNQ 305

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 133/304 (43%), Gaps = 56/304 (18%)
Query: 18  GKGRVFSI----ETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRR 73
           G  +VF +    + +  I  V  +E  N +L    +  + I ++ KL++  D ++     
Sbjct: 68  GSSKVFQVLNEKKQIYAIKYVNLEEADNQTL---DSYRNEIAYLNKLQQHSDKIIRLYDY 124
Query: 74  WITNLHYAFQDDSNLYLVMDYYCGG-DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD 132
            IT        D  +Y+VM+  CG  DL + L K +   P +  K Y   M+ A+ +IH 
Sbjct: 125 EIT--------DQYIYMVME--CGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQ 173
Query: 133 LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDY 191
              VH           D+KP N L+  +G ++L DFG   ++  D T V  +  VGT +Y
Sbjct: 174 HGIVHS----------DLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 222
Query: 192 ISPEILTAMEEGRGR------YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM-- 243
           + PE +  M   R          P+ D WSLG  +Y M YG+TPF  + ++    K+   
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAI 280
Query: 244 ---NHQNSF-DLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSIS 299
              NH+  F D+P           KDL   L C    R  +  I+  ++ +  +V +   
Sbjct: 281 IDPNHEIEFPDIPE----------KDLQDVLKCCL-KRDPKQRISIPELLAHPYVQIQTH 329
Query: 300 PRNH 303
           P N 
Sbjct: 330 PVNQ 333

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 69/154 (44%), Gaps = 19/154 (12%)
Query: 70  GDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS 129
           G       L  A+++   LYL  +  CG  L      +   LPE     Y+ + +LA+A 
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
           +H    VH           D+KP N+ L   G  +L DFG  + LG  G     V  G P
Sbjct: 173 LHSQGLVHL----------DVKPANIFLGPRGRCKLGDFGLLVELGTAGA--GEVQEGDP 220
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM 223
            Y++PE+L      +G YG   D +SLG+ + E+
Sbjct: 221 RYMAPELL------QGSYGTAADVFSLGLTILEV 248

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 133/304 (43%), Gaps = 56/304 (18%)
Query: 18  GKGRVFSI----ETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRR 73
           G  +VF +    + +  I  V  +E  N +L    +  + I ++ KL++  D ++     
Sbjct: 24  GSSKVFQVLNEKKQIYAIKYVNLEEADNQTL---DSYRNEIAYLNKLQQHSDKIIRLYDY 80
Query: 74  WITNLHYAFQDDSNLYLVMDYYCGG-DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD 132
            IT        D  +Y+VM+  CG  DL + L K +   P +  K Y   M+ A+ +IH 
Sbjct: 81  EIT--------DQYIYMVME--CGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQ 129
Query: 133 LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDY 191
              VH           D+KP N L+  +G ++L DFG   ++  D T V  +  VGT +Y
Sbjct: 130 HGIVHS----------DLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 178
Query: 192 ISPEILTAMEEGRGR------YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM-- 243
           + PE +  M   R          P+ D WSLG  +Y M YG+TPF  + ++    K+   
Sbjct: 179 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAI 236
Query: 244 ---NHQNSF-DLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSIS 299
              NH+  F D+P           KDL   L C    R  +  I+  ++ +  +V +   
Sbjct: 237 IDPNHEIEFPDIPE----------KDLQDVLKCCL-KRDPKQRISIPELLAHPYVQIQTH 285
Query: 300 PRNH 303
           P N 
Sbjct: 286 PVNQ 289

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/253 (28%), Positives = 116/253 (45%), Gaps = 45/253 (17%)
Query: 18  GKGRVFSI----ETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRR 73
           G  +VF +    + +  I  V  +E  N +L    +  + I ++ KL++  D ++     
Sbjct: 21  GSSKVFQVLNEKKQIYAIKYVNLEEADNQTL---DSYRNEIAYLNKLQQHSDKIIRLYDY 77
Query: 74  WITNLHYAFQDDSNLYLVMDYYCGG-DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD 132
            IT        D  +Y+VM+  CG  DL + L K +   P +  K Y   M+ A+ +IH 
Sbjct: 78  EIT--------DQYIYMVME--CGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQ 126
Query: 133 LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDY 191
              VH           D+KP N L+  +G ++L DFG   ++  D T V  +  VGT +Y
Sbjct: 127 HGIVHS----------DLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 175
Query: 192 ISPEILTAMEEGRGR------YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM-- 243
           + PE +  M   R          P+ D WSLG  +Y M YG+TPF  + ++    K+   
Sbjct: 176 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAI 233
Query: 244 ---NHQNSF-DLP 252
              NH+  F D+P
Sbjct: 234 IDPNHEIEFPDIP 246

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 28/178 (15%)
Query: 54  IEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPE 113
           + F+ KLR    +   G           +  +   +LVM+Y C G    LL   +  L E
Sbjct: 105 VRFLQKLRHPNTIQYRG----------CYLREHTAWLVMEY-CLGSASDLLEVHKKPLQE 153
Query: 114 DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR 173
                 +    +   ++  L Y+H  +H   H  RD+K  N+LL   G ++L DFGS   
Sbjct: 154 ------VEIAAVTHGALQGLAYLH--SHNMIH--RDVKAGNILLSEPGLVKLGDFGSASI 203
Query: 174 LGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
           +       +N  VGTP +++PE++ AM+E  G+Y  + D WSLG+   E+   + P +
Sbjct: 204 MA-----PANXFVGTPYWMAPEVILAMDE--GQYDGKVDVWSLGITCIELAERKPPLF 254

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 133/304 (43%), Gaps = 56/304 (18%)
Query: 18  GKGRVFSI----ETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRR 73
           G  +VF +    + +  I  V  +E  N +L    +  + I ++ KL++  D ++     
Sbjct: 20  GSSKVFQVLNEKKQIYAIKYVNLEEADNQTL---DSYRNEIAYLNKLQQHSDKIIRLYDY 76
Query: 74  WITNLHYAFQDDSNLYLVMDYYCGG-DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD 132
            IT        D  +Y+VM+  CG  DL + L K +   P +  K Y   M+ A+ +IH 
Sbjct: 77  EIT--------DQYIYMVME--CGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQ 125
Query: 133 LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDY 191
              VH           D+KP N L+  +G ++L DFG   ++  D T V  +  VGT +Y
Sbjct: 126 HGIVHS----------DLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 174
Query: 192 ISPEILTAMEEGRGR------YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM-- 243
           + PE +  M   R          P+ D WSLG  +Y M YG+TPF  + ++    K+   
Sbjct: 175 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAI 232
Query: 244 ---NHQNSF-DLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSIS 299
              NH+  F D+P           KDL   L C    R  +  I+  ++ +  +V +   
Sbjct: 233 IDPNHEIEFPDIPE----------KDLQDVLKCCL-KRDPKQRISIPELLAHPYVQIQTH 281
Query: 300 PRNH 303
           P N 
Sbjct: 282 PVNQ 285

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 78/273 (28%), Positives = 121/273 (44%), Gaps = 55/273 (20%)
Query: 18  GKGRVFSI----ETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRR 73
           G  +VF +    + +  I  V  +E  N +L    +  + I ++ KL++  D ++     
Sbjct: 68  GSSKVFQVLNEKKQIYAIKYVNLEEADNQTL---DSYRNEIAYLNKLQQHSDKIIRLYDY 124
Query: 74  WITNLHYAFQDDSNLYLVMDYYCGG-DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD 132
            IT        D  +Y+VM+  CG  DL + L K +   P +  K Y   M+ A+ +IH 
Sbjct: 125 EIT--------DQYIYMVME--CGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQ 173
Query: 133 LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDY 191
              VH           D+KP N L+  +G ++L DFG   ++  D T V  +  VGT +Y
Sbjct: 174 HGIVHS----------DLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 222
Query: 192 ISPEILTAMEEGRGR------YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM-- 243
           + PE +  M   R          P+ D WSLG  +Y M YG+TPF  + ++    K+   
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAI 280
Query: 244 ---NHQNSF-DLPSDVGYEISDDAKDLMRRLIC 272
              NH+  F D+P           KDL   L C
Sbjct: 281 IDPNHEIEFPDIPE----------KDLQDVLKC 303

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 28/178 (15%)
Query: 54  IEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPE 113
           + F+ KLR    +   G           +  +   +LVM+Y C G    LL   +  L E
Sbjct: 66  VRFLQKLRHPNTIQYRG----------CYLREHTAWLVMEY-CLGSASDLLEVHKKPLQE 114
Query: 114 DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR 173
                 +    +   ++  L Y+H  +H   H  RD+K  N+LL   G ++L DFGS   
Sbjct: 115 ------VEIAAVTHGALQGLAYLH--SHNMIH--RDVKAGNILLSEPGLVKLGDFGSASI 164
Query: 174 LGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
           +       +N  VGTP +++PE++ AM+E  G+Y  + D WSLG+   E+   + P +
Sbjct: 165 MA-----PANXFVGTPYWMAPEVILAMDE--GQYDGKVDVWSLGITCIELAERKPPLF 215

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 80/168 (47%), Gaps = 25/168 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLL----SKFEDR---LPEDMAKFYIAEMVLAI 127
           I + + +F     L+LVM    GG +L ++    +K E +   L E      + E++  +
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 128 ASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVA-- 185
             +H    +HR          D+K  N+LL  +G +++ADFG    L   G +  N    
Sbjct: 135 EYLHKNGQIHR----------DVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 184
Query: 186 --VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
             VGTP +++PE+   ME+ RG Y  + D WS G+   E+  G  P++
Sbjct: 185 TFVGTPCWMAPEV---MEQVRG-YDFKADIWSFGITAIELATGAAPYH 228

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 80/168 (47%), Gaps = 25/168 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLL----SKFEDR---LPEDMAKFYIAEMVLAI 127
           I + + +F     L+LVM    GG +L ++    +K E +   L E      + E++  +
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 128 ASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVA-- 185
             +H    +HR          D+K  N+LL  +G +++ADFG    L   G +  N    
Sbjct: 130 EYLHKNGQIHR----------DVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 179
Query: 186 --VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
             VGTP +++PE+   ME+ RG Y  + D WS G+   E+  G  P++
Sbjct: 180 TFVGTPCWMAPEV---MEQVRG-YDFKADIWSFGITAIELATGAAPYH 223

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 92/191 (48%), Gaps = 21/191 (10%)
Query: 44  LRREKTVSD-FIE--FVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGG-D 99
           +++EK + D +IE   + K+  E  +L   +   I  +   F++     LVM+ +  G D
Sbjct: 57  IKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLD 116
Query: 100 LLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA 159
           L   + +   RL E +A +   ++V A+  +     +HR          DIK +N+++  
Sbjct: 117 LFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHR----------DIKDENIVIAE 165
Query: 160 NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVC 219
           +  I+L DFGS   L       +    GT +Y +PE+L     G    GPE + WSLGV 
Sbjct: 166 DFTIKLIDFGSAAYLERGKLFYT--FCGTIEYCAPEVLM----GNPYRGPELEMWSLGVT 219
Query: 220 MYEMLYGETPF 230
           +Y +++ E PF
Sbjct: 220 LYTLVFEENPF 230

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 22/212 (10%)
Query: 38  ECCNSSLRREKTVSDFIE-----FVAKL-REERDVLVYGDRRWITNLHYAFQDDSNLYLV 91
           +C N    R   +  F+E      V K+   E  +L       + NL    +     YLV
Sbjct: 43  KCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102
Query: 92  MDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIK 151
            ++     +L  L  F + L   + + Y+ +++  I   H  + +HR          DIK
Sbjct: 103 FEF-VDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHR----------DIK 151
Query: 152 PDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPEC 211
           P+N+L+  +G ++L DFG    L   G V  +  V T  Y +PE+L     G  +YG   
Sbjct: 152 PENILVSQSGVVKLCDFGFARTLAAPGEVYDD-EVATRWYRAPELLV----GDVKYGKAV 206
Query: 212 DWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
           D W++G  + EM  GE  F  +S ++    IM
Sbjct: 207 DVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM 238

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 70/151 (46%), Gaps = 20/151 (13%)
Query: 89  YLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCR 148
           Y+VM+Y  G  L  ++   E  +    A   IA+   A+   H    +HR          
Sbjct: 92  YIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSHQNGIIHR---------- 140
Query: 149 DIKPDNVLLDANGHIRLADFGSCLRLG--GDGTVQSNVAVGTPDYISPEILTAMEEGRG- 205
           D+KP N+L+ A   +++ DFG    +   G+   Q+   +GT  Y+SP      E+ RG 
Sbjct: 141 DVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSP------EQARGD 194
Query: 206 RYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
                 D +SLG  +YE+L GE PF  +S V
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 132/304 (43%), Gaps = 56/304 (18%)
Query: 18  GKGRVFSI----ETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRR 73
           G  +VF +    + +  I  V  +E  N +L    +  + I ++ KL++  D ++     
Sbjct: 40  GSSKVFQVLNEKKQIYAIKYVNLEEADNQTL---DSYRNEIAYLNKLQQHSDKIIRLYDY 96
Query: 74  WITNLHYAFQDDSNLYLVMDYYCGG-DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD 132
            IT        D  +Y+VM+  CG  DL + L K +   P +  K Y   M+ A+ +IH 
Sbjct: 97  EIT--------DQYIYMVME--CGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQ 145
Query: 133 LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDY 191
              VH           D+KP N L+  +G ++L DFG   ++  D   V  +  VGT +Y
Sbjct: 146 HGIVHS----------DLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNY 194
Query: 192 ISPEILTAMEEGRGR------YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM-- 243
           + PE +  M   R          P+ D WSLG  +Y M YG+TPF  + ++    K+   
Sbjct: 195 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAI 252
Query: 244 ---NHQNSF-DLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSIS 299
              NH+  F D+P           KDL   L C    R  +  I+  ++ +  +V +   
Sbjct: 253 IDPNHEIEFPDIPE----------KDLQDVLKCCL-KRDPKQRISIPELLAHPYVQIQTH 301
Query: 300 PRNH 303
           P N 
Sbjct: 302 PVNQ 305

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 120/273 (43%), Gaps = 55/273 (20%)
Query: 18  GKGRVFSI----ETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRR 73
           G  +VF +    + +  I  V  +E  N +L    +  + I ++ KL++  D ++     
Sbjct: 68  GSSKVFQVLNEKKQIYAIKYVNLEEADNQTL---DSYRNEIAYLNKLQQHSDKIIRLYDY 124
Query: 74  WITNLHYAFQDDSNLYLVMDYYCGG-DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD 132
            IT        D  +Y+VM+  CG  DL + L K +   P +  K Y   M+ A+ +IH 
Sbjct: 125 EIT--------DQYIYMVME--CGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQ 173
Query: 133 LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDY 191
              VH           D+KP N L+  +G ++L DFG   ++  D T V  +  VG  +Y
Sbjct: 174 HGIVHS----------DLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNY 222
Query: 192 ISPEILTAMEEGRGR------YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM-- 243
           + PE +  M   R          P+ D WSLG  +Y M YG+TPF  + ++    K+   
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAI 280
Query: 244 ---NHQNSF-DLPSDVGYEISDDAKDLMRRLIC 272
              NH+  F D+P           KDL   L C
Sbjct: 281 IDPNHEIEFPDIPE----------KDLQDVLKC 303

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 91/194 (46%), Gaps = 36/194 (18%)
Query: 40  CNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNL-YLVMDYYCGG 98
           C  ++++E  ++      A L  E  V  YG RR           + N+ YL ++Y  GG
Sbjct: 48  CPENIKKEICIN------AMLNHENVVKFYGHRR-----------EGNIQYLFLEYCSGG 90
Query: 99  DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD 158
           +L   +   +  +PE  A+ +  +++  +  +H +   HR          DIKP+N+LLD
Sbjct: 91  ELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR----------DIKPENLLLD 139
Query: 159 ANGHIRLADFG--SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSL 216
              +++++DFG  +  R      +  N   GT  Y++PE+L    + R  +    D WS 
Sbjct: 140 ERDNLKISDFGLATVFRYNNRERL-LNKMCGTLPYVAPELL----KRREFHAEPVDVWSC 194
Query: 217 GVCMYEMLYGETPF 230
           G+ +  ML GE P+
Sbjct: 195 GIVLTAMLAGELPW 208

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 70/151 (46%), Gaps = 20/151 (13%)
Query: 89  YLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCR 148
           Y+VM+Y  G  L  ++   E  +    A   IA+   A+   H    +HR          
Sbjct: 92  YIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSHQNGIIHR---------- 140
Query: 149 DIKPDNVLLDANGHIRLADFGSCLRLG--GDGTVQSNVAVGTPDYISPEILTAMEEGRG- 205
           D+KP N+++ A   +++ DFG    +   G+   Q+   +GT  Y+SP      E+ RG 
Sbjct: 141 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP------EQARGD 194
Query: 206 RYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
                 D +SLG  +YE+L GE PF  +S V
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 70/151 (46%), Gaps = 20/151 (13%)
Query: 89  YLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCR 148
           Y+VM+Y  G  L  ++   E  +    A   IA+   A+   H    +HR          
Sbjct: 92  YIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHR---------- 140
Query: 149 DIKPDNVLLDANGHIRLADFGSCLRLG--GDGTVQSNVAVGTPDYISPEILTAMEEGRG- 205
           D+KP N+++ A   +++ DFG    +   G+   Q+   +GT  Y+SP      E+ RG 
Sbjct: 141 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP------EQARGD 194
Query: 206 RYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
                 D +SLG  +YE+L GE PF  +S V
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 70/151 (46%), Gaps = 20/151 (13%)
Query: 89  YLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCR 148
           Y+VM+Y  G  L  ++   E  +    A   IA+   A+   H    +HR          
Sbjct: 92  YIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSHQNGIIHR---------- 140
Query: 149 DIKPDNVLLDANGHIRLADFGSCLRLG--GDGTVQSNVAVGTPDYISPEILTAMEEGRG- 205
           D+KP N+++ A   +++ DFG    +   G+   Q+   +GT  Y+SP      E+ RG 
Sbjct: 141 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP------EQARGD 194
Query: 206 RYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
                 D +SLG  +YE+L GE PF  +S V
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 36/194 (18%)
Query: 40  CNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNL-YLVMDYYCGG 98
           C  ++++E  ++        L  E  V  YG RR           + N+ YL ++Y  GG
Sbjct: 48  CPENIKKEIXINKM------LNHENVVKFYGHRR-----------EGNIQYLFLEYCSGG 90
Query: 99  DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD 158
           +L   +   +  +PE  A+ +  +++  +  +H +   HR          DIKP+N+LLD
Sbjct: 91  ELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR----------DIKPENLLLD 139
Query: 159 ANGHIRLADFG--SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSL 216
              +++++DFG  +  R      +  N   GT  Y++PE+L    + R  +    D WS 
Sbjct: 140 ERDNLKISDFGLATVFRYNNRERL-LNKMXGTLPYVAPELL----KRREFHAEPVDVWSC 194
Query: 217 GVCMYEMLYGETPF 230
           G+ +  ML GE P+
Sbjct: 195 GIVLTAMLAGELPW 208

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 36/194 (18%)
Query: 40  CNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNL-YLVMDYYCGG 98
           C  ++++E  ++        L  E  V  YG RR           + N+ YL ++Y  GG
Sbjct: 47  CPENIKKEICINKM------LNHENVVKFYGHRR-----------EGNIQYLFLEYCSGG 89
Query: 99  DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD 158
           +L   +   +  +PE  A+ +  +++  +  +H +   HR          DIKP+N+LLD
Sbjct: 90  ELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR----------DIKPENLLLD 138
Query: 159 ANGHIRLADFG--SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSL 216
              +++++DFG  +  R      +  N   GT  Y++PE+L    + R  +    D WS 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERLL-NKMCGTLPYVAPELL----KRREFHAEPVDVWSC 193
Query: 217 GVCMYEMLYGETPF 230
           G+ +  ML GE P+
Sbjct: 194 GIVLTAMLAGELPW 207

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 36/194 (18%)
Query: 40  CNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNL-YLVMDYYCGG 98
           C  ++++E  ++        L  E  V  YG RR           + N+ YL ++Y  GG
Sbjct: 47  CPENIKKEICINKM------LNHENVVKFYGHRR-----------EGNIQYLFLEYCSGG 89
Query: 99  DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD 158
           +L   +   +  +PE  A+ +  +++  +  +H +   HR          DIKP+N+LLD
Sbjct: 90  ELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR----------DIKPENLLLD 138
Query: 159 ANGHIRLADFG--SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSL 216
              +++++DFG  +  R      +  N   GT  Y++PE+L    + R  +    D WS 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERL-LNKMCGTLPYVAPELL----KRREFHAEPVDVWSC 193
Query: 217 GVCMYEMLYGETPF 230
           G+ +  ML GE P+
Sbjct: 194 GIVLTAMLAGELPW 207

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 36/194 (18%)
Query: 40  CNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNL-YLVMDYYCGG 98
           C  ++++E  ++        L  E  V  YG RR           + N+ YL ++Y  GG
Sbjct: 48  CPENIKKEICINKM------LNHENVVKFYGHRR-----------EGNIQYLFLEYCSGG 90
Query: 99  DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD 158
           +L   +   +  +PE  A+ +  +++  +  +H +   HR          DIKP+N+LLD
Sbjct: 91  ELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR----------DIKPENLLLD 139
Query: 159 ANGHIRLADFG--SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSL 216
              +++++DFG  +  R      +  N   GT  Y++PE+L    + R  +    D WS 
Sbjct: 140 ERDNLKISDFGLATVFRYNNRERLL-NKMCGTLPYVAPELL----KRREFHAEPVDVWSC 194
Query: 217 GVCMYEMLYGETPF 230
           G+ +  ML GE P+
Sbjct: 195 GIVLTAMLAGELPW 208

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 36/194 (18%)
Query: 40  CNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNL-YLVMDYYCGG 98
           C  ++++E  ++        L  E  V  YG RR           + N+ YL ++Y  GG
Sbjct: 47  CPENIKKEIXINKM------LNHENVVKFYGHRR-----------EGNIQYLFLEYCSGG 89
Query: 99  DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD 158
           +L   +   +  +PE  A+ +  +++  +  +H +   HR          DIKP+N+LLD
Sbjct: 90  ELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR----------DIKPENLLLD 138
Query: 159 ANGHIRLADFG--SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSL 216
              +++++DFG  +  R      +  N   GT  Y++PE+L    + R  +    D WS 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERL-LNKMCGTLPYVAPELL----KRREFHAEPVDVWSC 193
Query: 217 GVCMYEMLYGETPF 230
           G+ +  ML GE P+
Sbjct: 194 GIVLTAMLAGELPW 207

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 70/151 (46%), Gaps = 20/151 (13%)
Query: 89  YLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCR 148
           Y+VM+Y  G  L  ++   E  +    A   IA+   A+   H    +HR          
Sbjct: 109 YIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHR---------- 157
Query: 149 DIKPDNVLLDANGHIRLADFGSCLRLG--GDGTVQSNVAVGTPDYISPEILTAMEEGRG- 205
           D+KP N+++ A   +++ DFG    +   G+   Q+   +GT  Y+SP      E+ RG 
Sbjct: 158 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP------EQARGD 211
Query: 206 RYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
                 D +SLG  +YE+L GE PF  +S V
Sbjct: 212 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 242

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 36/194 (18%)
Query: 40  CNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNL-YLVMDYYCGG 98
           C  ++++E  ++        L  E  V  YG RR           + N+ YL ++Y  GG
Sbjct: 47  CPENIKKEIXINKM------LNHENVVKFYGHRR-----------EGNIQYLFLEYCSGG 89
Query: 99  DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD 158
           +L   +   +  +PE  A+ +  +++  +  +H +   HR          DIKP+N+LLD
Sbjct: 90  ELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR----------DIKPENLLLD 138
Query: 159 ANGHIRLADFG--SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSL 216
              +++++DFG  +  R      +  N   GT  Y++PE+L    + R  +    D WS 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERL-LNKMXGTLPYVAPELL----KRREFHAEPVDVWSC 193
Query: 217 GVCMYEMLYGETPF 230
           G+ +  ML GE P+
Sbjct: 194 GIVLTAMLAGELPW 207

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 36/194 (18%)
Query: 40  CNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNL-YLVMDYYCGG 98
           C  ++++E  ++        L  E  V  YG RR           + N+ YL ++Y  GG
Sbjct: 48  CPENIKKEICINKM------LNHENVVKFYGHRR-----------EGNIQYLFLEYCSGG 90
Query: 99  DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD 158
           +L   +   +  +PE  A+ +  +++  +  +H +   HR          DIKP+N+LLD
Sbjct: 91  ELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR----------DIKPENLLLD 139
Query: 159 ANGHIRLADFG--SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSL 216
              +++++DFG  +  R      +  N   GT  Y++PE+L    + R  +    D WS 
Sbjct: 140 ERDNLKISDFGLATVFRYNNRERL-LNKMCGTLPYVAPELL----KRREFHAEPVDVWSC 194
Query: 217 GVCMYEMLYGETPF 230
           G+ +  ML GE P+
Sbjct: 195 GIVLTAMLAGELPW 208

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 36/194 (18%)
Query: 40  CNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNL-YLVMDYYCGG 98
           C  ++++E  ++        L  E  V  YG RR           + N+ YL ++Y  GG
Sbjct: 48  CPENIKKEICINKM------LNHENVVKFYGHRR-----------EGNIQYLFLEYCSGG 90
Query: 99  DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD 158
           +L   +   +  +PE  A+ +  +++  +  +H +   HR          DIKP+N+LLD
Sbjct: 91  ELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR----------DIKPENLLLD 139
Query: 159 ANGHIRLADFG--SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSL 216
              +++++DFG  +  R      +  N   GT  Y++PE+L    + R  +    D WS 
Sbjct: 140 ERDNLKISDFGLATVFRYNNRERL-LNKMCGTLPYVAPELL----KRREFHAEPVDVWSC 194
Query: 217 GVCMYEMLYGETPF 230
           G+ +  ML GE P+
Sbjct: 195 GIVLTAMLAGELPW 208

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 36/194 (18%)
Query: 40  CNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNL-YLVMDYYCGG 98
           C  ++++E  ++        L  E  V  YG RR           + N+ YL ++Y  GG
Sbjct: 46  CPENIKKEICINKM------LNHENVVKFYGHRR-----------EGNIQYLFLEYCSGG 88
Query: 99  DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD 158
           +L   +   +  +PE  A+ +  +++  +  +H +   HR          DIKP+N+LLD
Sbjct: 89  ELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR----------DIKPENLLLD 137
Query: 159 ANGHIRLADFG--SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSL 216
              +++++DFG  +  R      +  N   GT  Y++PE+L    + R  +    D WS 
Sbjct: 138 ERDNLKISDFGLATVFRYNNRERL-LNKMCGTLPYVAPELL----KRREFHAEPVDVWSC 192
Query: 217 GVCMYEMLYGETPF 230
           G+ +  ML GE P+
Sbjct: 193 GIVLTAMLAGELPW 206

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 36/194 (18%)
Query: 40  CNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNL-YLVMDYYCGG 98
           C  ++++E  ++        L  E  V  YG RR           + N+ YL ++Y  GG
Sbjct: 47  CPENIKKEICINKM------LNHENVVKFYGHRR-----------EGNIQYLFLEYCSGG 89
Query: 99  DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD 158
           +L   +   +  +PE  A+ +  +++  +  +H +   HR          DIKP+N+LLD
Sbjct: 90  ELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR----------DIKPENLLLD 138
Query: 159 ANGHIRLADFG--SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSL 216
              +++++DFG  +  R      +  N   GT  Y++PE+L    + R  +    D WS 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERL-LNKMXGTLPYVAPELL----KRREFHAEPVDVWSC 193
Query: 217 GVCMYEMLYGETPF 230
           G+ +  ML GE P+
Sbjct: 194 GIVLTAMLAGELPW 207

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 36/194 (18%)
Query: 40  CNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNL-YLVMDYYCGG 98
           C  ++++E  ++        L  E  V  YG RR           + N+ YL ++Y  GG
Sbjct: 47  CPENIKKEICINKM------LNHENVVKFYGHRR-----------EGNIQYLFLEYCSGG 89
Query: 99  DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD 158
           +L   +   +  +PE  A+ +  +++  +  +H +   HR          DIKP+N+LLD
Sbjct: 90  ELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR----------DIKPENLLLD 138
Query: 159 ANGHIRLADFG--SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSL 216
              +++++DFG  +  R      +  N   GT  Y++PE+L    + R  +    D WS 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERL-LNKMCGTLPYVAPELL----KRREFHAEPVDVWSC 193
Query: 217 GVCMYEMLYGETPF 230
           G+ +  ML GE P+
Sbjct: 194 GIVLTAMLAGELPW 207

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 36/194 (18%)
Query: 40  CNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNL-YLVMDYYCGG 98
           C  ++++E  ++        L  E  V  YG RR           + N+ YL ++Y  GG
Sbjct: 47  CPENIKKEICINKM------LNHENVVKFYGHRR-----------EGNIQYLFLEYCSGG 89
Query: 99  DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD 158
           +L   +   +  +PE  A+ +  +++  +  +H +   HR          DIKP+N+LLD
Sbjct: 90  ELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR----------DIKPENLLLD 138
Query: 159 ANGHIRLADFG--SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSL 216
              +++++DFG  +  R      +  N   GT  Y++PE+L    + R  +    D WS 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERL-LNKMXGTLPYVAPELL----KRREFHAEPVDVWSC 193
Query: 217 GVCMYEMLYGETPF 230
           G+ +  ML GE P+
Sbjct: 194 GIVLTAMLAGELPW 207

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 36/194 (18%)
Query: 40  CNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNL-YLVMDYYCGG 98
           C  ++++E  ++        L  E  V  YG RR           + N+ YL ++Y  GG
Sbjct: 47  CPENIKKEICINKM------LNHENVVKFYGHRR-----------EGNIQYLFLEYCSGG 89
Query: 99  DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD 158
           +L   +   +  +PE  A+ +  +++  +  +H +   HR          DIKP+N+LLD
Sbjct: 90  ELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR----------DIKPENLLLD 138
Query: 159 ANGHIRLADFG--SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSL 216
              +++++DFG  +  R      +  N   GT  Y++PE+L    + R  +    D WS 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERLL-NKMCGTLPYVAPELL----KRREFHAEPVDVWSC 193
Query: 217 GVCMYEMLYGETPF 230
           G+ +  ML GE P+
Sbjct: 194 GIVLTAMLAGELPW 207

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 36/194 (18%)
Query: 40  CNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNL-YLVMDYYCGG 98
           C  ++++E  ++        L  E  V  YG RR           + N+ YL ++Y  GG
Sbjct: 47  CPENIKKEICINKM------LNHENVVKFYGHRR-----------EGNIQYLFLEYCSGG 89
Query: 99  DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD 158
           +L   +   +  +PE  A+ +  +++  +  +H +   HR          DIKP+N+LLD
Sbjct: 90  ELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR----------DIKPENLLLD 138
Query: 159 ANGHIRLADFG--SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSL 216
              +++++DFG  +  R      +  N   GT  Y++PE+L    + R  +    D WS 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERL-LNKMXGTLPYVAPELL----KRREFHAEPVDVWSC 193
Query: 217 GVCMYEMLYGETPF 230
           G+ +  ML GE P+
Sbjct: 194 GIVLTAMLAGELPW 207

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 36/194 (18%)
Query: 40  CNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNL-YLVMDYYCGG 98
           C  ++++E  ++        L  E  V  YG RR           + N+ YL ++Y  GG
Sbjct: 47  CPENIKKEICINKM------LNHENVVKFYGHRR-----------EGNIQYLFLEYCSGG 89
Query: 99  DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD 158
           +L   +   +  +PE  A+ +  +++  +  +H +   HR          DIKP+N+LLD
Sbjct: 90  ELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR----------DIKPENLLLD 138
Query: 159 ANGHIRLADFG--SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSL 216
              +++++DFG  +  R      +  N   GT  Y++PE+L    + R  +    D WS 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERL-LNKMCGTLPYVAPELL----KRREFHAEPVDVWSC 193
Query: 217 GVCMYEMLYGETPF 230
           G+ +  ML GE P+
Sbjct: 194 GIVLTAMLAGELPW 207

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 36/194 (18%)
Query: 40  CNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNL-YLVMDYYCGG 98
           C  ++++E  ++        L  E  V  YG RR           + N+ YL ++Y  GG
Sbjct: 47  CPENIKKEICINKM------LNHENVVKFYGHRR-----------EGNIQYLFLEYCSGG 89
Query: 99  DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD 158
           +L   +   +  +PE  A+ +  +++  +  +H +   HR          DIKP+N+LLD
Sbjct: 90  ELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR----------DIKPENLLLD 138
Query: 159 ANGHIRLADFG--SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSL 216
              +++++DFG  +  R      +  N   GT  Y++PE+L    + R  +    D WS 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERL-LNKMCGTLPYVAPELL----KRREFHAEPVDVWSC 193
Query: 217 GVCMYEMLYGETPF 230
           G+ +  ML GE P+
Sbjct: 194 GIVLTAMLAGELPW 207

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 36/194 (18%)
Query: 40  CNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNL-YLVMDYYCGG 98
           C  ++++E  ++        L  E  V  YG RR           + N+ YL ++Y  GG
Sbjct: 47  CPENIKKEICINKM------LNHENVVKFYGHRR-----------EGNIQYLFLEYCSGG 89
Query: 99  DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD 158
           +L   +   +  +PE  A+ +  +++  +  +H +   HR          DIKP+N+LLD
Sbjct: 90  ELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR----------DIKPENLLLD 138
Query: 159 ANGHIRLADFG--SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSL 216
              +++++DFG  +  R      +  N   GT  Y++PE+L    + R  +    D WS 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERL-LNKMCGTLPYVAPELL----KRREFHAEPVDVWSC 193
Query: 217 GVCMYEMLYGETPF 230
           G+ +  ML GE P+
Sbjct: 194 GIVLTAMLAGELPW 207

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 36/194 (18%)
Query: 40  CNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNL-YLVMDYYCGG 98
           C  ++++E  ++        L  E  V  YG RR           + N+ YL ++Y  GG
Sbjct: 48  CPENIKKEICINKM------LNHENVVKFYGHRR-----------EGNIQYLFLEYCSGG 90
Query: 99  DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD 158
           +L   +   +  +PE  A+ +  +++  +  +H +   HR          DIKP+N+LLD
Sbjct: 91  ELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR----------DIKPENLLLD 139
Query: 159 ANGHIRLADFG--SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSL 216
              +++++DFG  +  R      +  N   GT  Y++PE+L    + R  +    D WS 
Sbjct: 140 ERDNLKISDFGLATVFRYNNRERLL-NKMCGTLPYVAPELL----KRREFHAEPVDVWSC 194
Query: 217 GVCMYEMLYGETPF 230
           G+ +  ML GE P+
Sbjct: 195 GIVLTAMLAGELPW 208

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 36/194 (18%)
Query: 40  CNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNL-YLVMDYYCGG 98
           C  ++++E  ++        L  E  V  YG RR           + N+ YL ++Y  GG
Sbjct: 48  CPENIKKEICINKM------LNHENVVKFYGHRR-----------EGNIQYLFLEYCSGG 90
Query: 99  DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD 158
           +L   +   +  +PE  A+ +  +++  +  +H +   HR          DIKP+N+LLD
Sbjct: 91  ELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR----------DIKPENLLLD 139
Query: 159 ANGHIRLADFG--SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSL 216
              +++++DFG  +  R      +  N   GT  Y++PE+L    + R  +    D WS 
Sbjct: 140 ERDNLKISDFGLATVFRYNNRERLL-NKMCGTLPYVAPELL----KRREFHAEPVDVWSC 194
Query: 217 GVCMYEMLYGETPF 230
           G+ +  ML GE P+
Sbjct: 195 GIVLTAMLAGELPW 208

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 36/194 (18%)
Query: 40  CNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNL-YLVMDYYCGG 98
           C  ++++E  ++        L  E  V  YG RR           + N+ YL ++Y  GG
Sbjct: 48  CPENIKKEICINKM------LNHENVVKFYGHRR-----------EGNIQYLFLEYCSGG 90
Query: 99  DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD 158
           +L   +   +  +PE  A+ +  +++  +  +H +   HR          DIKP+N+LLD
Sbjct: 91  ELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR----------DIKPENLLLD 139
Query: 159 ANGHIRLADFG--SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSL 216
              +++++DFG  +  R      +  N   GT  Y++PE+L    + R  +    D WS 
Sbjct: 140 ERDNLKISDFGLATVFRYNNRERLL-NKMCGTLPYVAPELL----KRREFHAEPVDVWSC 194
Query: 217 GVCMYEMLYGETPF 230
           G+ +  ML GE P+
Sbjct: 195 GIVLTAMLAGELPW 208

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 69/149 (46%), Gaps = 20/149 (13%)
Query: 89  YLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCR 148
           Y+VM+Y  G  L  ++   E  +    A   IA+   A+   H    +HR          
Sbjct: 92  YIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSHQNGIIHR---------- 140
Query: 149 DIKPDNVLLDANGHIRLADFGSCLRLG--GDGTVQSNVAVGTPDYISPEILTAMEEGRG- 205
           D+KP N+++ A   +++ DFG    +   G+   Q+   +GT  Y+SP      E+ RG 
Sbjct: 141 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP------EQARGD 194
Query: 206 RYGPECDWWSLGVCMYEMLYGETPFYAES 234
                 D +SLG  +YE+L GE PF  +S
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 100/241 (41%), Gaps = 65/241 (26%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           L +VM+   GG+L    S+ +DR  +   +   +E++ +I     + Y+H  N    H  
Sbjct: 90  LLIVMECLDGGELF---SRIQDRGDQAFTEREASEIMKSIGEA--IQYLHSIN--IAH-- 140
Query: 148 RDIKPDNVLLDA---NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR 204
           RD+KP+N+L  +   N  ++L DFG      G+                           
Sbjct: 141 RDVKPENLLYTSKRPNAILKLTDFGFAKETTGE--------------------------- 173
Query: 205 GRYGPECDWWSLGVCMYEMLYGETPFYAE-SLVETYG-KIMNHQNSFDLPSDVGYEISDD 262
            +Y   CD WSLGV MY +L G  PFY+   L  + G K       ++ P+    E+S++
Sbjct: 174 -KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 232
Query: 263 AKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPYI 322
            K L+R L+ +  T+  +  I +F               NHPW        ++ +  P  
Sbjct: 233 VKMLIRNLLKTEPTQ--RMTITEF--------------MNHPWI-------MQSTKVPQT 269
Query: 323 P 323
           P
Sbjct: 270 P 270

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 90/189 (47%), Gaps = 26/189 (13%)
Query: 84  DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFA 143
           D ++ YLVM +  G DL  L+    ++L ED  +F + +M+  +  IH    +HR     
Sbjct: 101 DFTDFYLVMPF-MGTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHR----- 152
Query: 144 FHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPE-ILTAMEE 202
                D+KP N+ ++ +  +++ DFG    L      +    V T  Y +PE IL  M  
Sbjct: 153 -----DLKPGNLAVNEDCELKILDFG----LARQADSEMXGXVVTRWYRAPEVILNWM-- 201
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEI-SD 261
              RY    D WS+G  M EM+ G+T F     ++   +IM    +   P++    + SD
Sbjct: 202 ---RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT--PPAEFVQRLQSD 256
Query: 262 DAKDLMRRL 270
           +AK+ M+ L
Sbjct: 257 EAKNYMKGL 265

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 74/156 (47%), Gaps = 17/156 (10%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L  AF   SN+ LV D+    DL  ++      L     K Y+      + ++  L 
Sbjct: 74  IIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYM------LMTLQGLE 126
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
           Y+H+  H+  H  RD+KP+N+LLD NG ++LADFG     G       +  V T  Y +P
Sbjct: 127 YLHQ--HWILH--RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV-TRWYRAP 181
Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
           E+L     G   YG   D W++G  + E+L    PF
Sbjct: 182 ELLF----GARMYGVGVDMWAVGCILAELLL-RVPF 212

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 84/184 (45%), Gaps = 23/184 (12%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L+        L LV ++    DL  LL   E  L    AK ++ +++  IA  HD  
Sbjct: 62  IVKLYDVIHTKKRLVLVFEH-LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          D+KP N+L++  G +++ADFG   R  G    +    V T  Y +P
Sbjct: 121 VLHR----------DLKPQNLLINREGELKIADFGLA-RAFGIPVRKYTHEVVTLWYRAP 169
Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY-----AESLVETYGKIMNHQNSF 249
           ++L     G  +Y    D WS+G    EM+ G TP +     A+ L+  + +I+   NS 
Sbjct: 170 DVLM----GSKKYSTTIDIWSVGCIFAEMVNG-TPLFPGVSEADQLMRIF-RILGTPNSK 223
Query: 250 DLPS 253
           + P+
Sbjct: 224 NWPN 227

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 25/214 (11%)
Query: 50  VSDFIEFVA---KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSK 106
           V++F+  VA   +LR    VL  G          A     NL +V +Y   G L  LL K
Sbjct: 78  VNEFLREVAIMKRLRHPNIVLFMG----------AVTQPPNLSIVTEYLSRGSLYRLLHK 127
Query: 107 FEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLA 166
              R   D  +     + +A      ++Y+H  N    H  RD+K  N+L+D    +++ 
Sbjct: 128 SGAREQLDERR----RLSMAYDVAKGMNYLHNRNPPIVH--RDLKSPNLLVDKKYTVKVC 181
Query: 167 DFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYG 226
           DFG   RL     + S  A GTP++++PE+L            + D +S GV ++E+   
Sbjct: 182 DFGLS-RLKASXFLXSKXAAGTPEWMAPEVLRDEPSNE-----KSDVYSFGVILWELATL 235
Query: 227 ETPFYAESLVETYGKIMNHQNSFDLPSDVGYEIS 260
           + P+   +  +    +       ++P ++  +++
Sbjct: 236 QQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA 269

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 71/142 (50%), Gaps = 19/142 (13%)
Query: 105 SKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD-ANGHI 163
           +K +  +P  + K Y+ +++ ++A IH +   H          RDIKP N+LLD  +G +
Sbjct: 132 AKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICH----------RDIKPQNLLLDPPSGVL 181
Query: 164 RLADFGSC-LRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYE 222
           +L DFGS  + + G+  V     + +  Y +PE++     G   Y    D WS G  M E
Sbjct: 182 KLIDFGSAKILIAGEPNVS---XICSRYYRAPELIF----GATNYTTNIDIWSTGCVMAE 234
Query: 223 MLYGETPFYAESLVETYGKIMN 244
           ++ G+  F  ES ++   +I+ 
Sbjct: 235 LMQGQPLFPGESGIDQLVEIIK 256

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 84/184 (45%), Gaps = 23/184 (12%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L+        L LV ++    DL  LL   E  L    AK ++ +++  IA  HD  
Sbjct: 62  IVKLYDVIHTKKRLVLVFEH-LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          D+KP N+L++  G +++ADFG   R  G    +    + T  Y +P
Sbjct: 121 VLHR----------DLKPQNLLINREGELKIADFGLA-RAFGIPVRKYTHEIVTLWYRAP 169
Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY-----AESLVETYGKIMNHQNSF 249
           ++L     G  +Y    D WS+G    EM+ G TP +     A+ L+  + +I+   NS 
Sbjct: 170 DVLM----GSKKYSTTIDIWSVGCIFAEMVNG-TPLFPGVSEADQLMRIF-RILGTPNSK 223
Query: 250 DLPS 253
           + P+
Sbjct: 224 NWPN 227

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 100/241 (41%), Gaps = 47/241 (19%)
Query: 84  DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA-EMVLAIASIHDLHYVHRPNHF 142
           +D ++YLV DY    DL  ++      + E + K Y+  +++  I  +H    +HR    
Sbjct: 82  NDRDVYLVFDY-METDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHR---- 133
Query: 143 AFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVA----------------- 185
                 D+KP N+LL+A  H+++ADFG          V +N+                  
Sbjct: 134 ------DMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 186 ---VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
              V T  Y +PEIL     G  +Y    D WSLG  + E+L G+  F   S +    +I
Sbjct: 188 TDYVATRWYRAPEILL----GSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243
Query: 243 MNHQNSFDLPS--DVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISP 300
           +      D PS  DV    S  AK ++  L    + R   N    F  W  L   L I+P
Sbjct: 244 I---GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIR-QSNKRDIFTKWKNLL--LKINP 297
Query: 301 R 301
           +
Sbjct: 298 K 298

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 33/198 (16%)
Query: 49  TVSDFIEFVAKLREERDVLVYG---DRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLS 105
           T+   +  +A L  +  V  Y    +RR       A +  S L++ M+Y   G L  L+ 
Sbjct: 48  TILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH 107
Query: 106 KFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRL 165
                   D       +++ A++ IH    +HR          D+KP N+ +D + ++++
Sbjct: 108 SENLNQQRDEYWRLFRQILEALSYIHSQGIIHR----------DLKPMNIFIDESRNVKI 157
Query: 166 ADFG---------SCLRLGGDGTVQSN----VAVGTPDYISPEILTAMEEGRGRYGPECD 212
            DFG           L+L       S+     A+GT  Y++ E+L    +G G Y  + D
Sbjct: 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVL----DGTGHYNEKID 213
Query: 213 WWSLGVCMYEMLYGETPF 230
            +SLG+  +EM+Y   PF
Sbjct: 214 MYSLGIIFFEMIY---PF 228

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 99/226 (43%), Gaps = 28/226 (12%)
Query: 37  DECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC 96
           DE    + R +    D  + +  +R+E  +        I  L      + NL LVM++  
Sbjct: 31  DEVAVKAARHDPD-EDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFAR 89
Query: 97  GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL 156
           GG L  +LS    R+P D+   +  ++   +  +HD   V         + RD+K  N+L
Sbjct: 90  GGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVP-------IIHRDLKSSNIL 140
Query: 157 LD--------ANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYG 208
           +         +N  +++ DFG   R     T  S  A G   +++PE++ A    +G   
Sbjct: 141 ILQKVENGDLSNKILKITDFGLA-REWHRTTKMS--AAGAYAWMAPEVIRASMFSKG--- 194
Query: 209 PECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHQNSFDLPS 253
              D WS GV ++E+L GE PF   + L   YG  MN + +  +PS
Sbjct: 195 --SDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN-KLALPIPS 237

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 25/214 (11%)
Query: 50  VSDFIEFVA---KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSK 106
           V++F+  VA   +LR    VL  G          A     NL +V +Y   G L  LL K
Sbjct: 78  VNEFLREVAIMKRLRHPNIVLFMG----------AVTQPPNLSIVTEYLSRGSLYRLLHK 127
Query: 107 FEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLA 166
              R   D  +     + +A      ++Y+H  N    H  R++K  N+L+D    +++ 
Sbjct: 128 SGAREQLDERR----RLSMAYDVAKGMNYLHNRNPPIVH--RNLKSPNLLVDKKYTVKVC 181
Query: 167 DFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYG 226
           DFG   RL     + S  A GTP++++PE+L            + D +S GV ++E+   
Sbjct: 182 DFGLS-RLKASTFLSSKSAAGTPEWMAPEVLRDEPSNE-----KSDVYSFGVILWELATL 235
Query: 227 ETPFYAESLVETYGKIMNHQNSFDLPSDVGYEIS 260
           + P+   +  +    +       ++P ++  +++
Sbjct: 236 QQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA 269

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 21/213 (9%)
Query: 104 LSKFEDRLPED-MAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH 162
           L+ + D++PE  +    I +M+  +    D  + HR  H      RD+KP N+L+ ++G 
Sbjct: 105 LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVH------RDLKPQNILVTSSGQ 158
Query: 163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYE 222
           I+LADFG   R+       ++V V T  Y +PE+L      +  Y    D WS+G    E
Sbjct: 159 IKLADFGLA-RIYSFQMALTSVVV-TLWYRAPEVLL-----QSSYATPVDLWSVGCIFAE 211
Query: 223 MLYGETPFYAESLVETYGKIMN---HQNSFDLPSDVGY---EISDDAKDLMRRLICSSDT 276
           M   +  F   S V+  GKI++        D P DV          +   + + +   D 
Sbjct: 212 MFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID- 270
Query: 277 RLGQNGIADFKMWSALFVSLSISPRNHPWFQGI 309
            LG++ +     ++      + S  +HP+FQ +
Sbjct: 271 ELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 14/142 (9%)
Query: 104 LSKFEDRLPED-MAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH 162
           L+ + D++PE  +    I +M+  +    D  + HR  H      RD+KP N+L+ ++G 
Sbjct: 105 LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVH------RDLKPQNILVTSSGQ 158
Query: 163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYE 222
           I+LADFG   R+       ++V V T  Y +PE+L      +  Y    D WS+G    E
Sbjct: 159 IKLADFGLA-RIYSFQMALTSVVV-TLWYRAPEVLL-----QSSYATPVDLWSVGCIFAE 211
Query: 223 MLYGETPFYAESLVETYGKIMN 244
           M   +  F   S V+  GKI++
Sbjct: 212 MFRRKPLFRGSSDVDQLGKILD 233

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 82/183 (44%), Gaps = 21/183 (11%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L+        L LV ++    DL  LL   E  L    AK ++ +++  IA  HD  
Sbjct: 62  IVKLYDVIHTKKRLVLVFEH-LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          D+KP N+L++  G +++ADFG   R  G    +    V T  Y +P
Sbjct: 121 VLHR----------DLKPQNLLINREGELKIADFGLA-RAFGIPVRKYTHEVVTLWYRAP 169
Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF----YAESLVETYGKIMNHQNSFD 250
           ++L     G  +Y    D WS+G    EM+ G   F     A+ L+  + +I+   NS +
Sbjct: 170 DVLM----GSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIF-RILGTPNSKN 224
Query: 251 LPS 253
            P+
Sbjct: 225 WPN 227

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 66/126 (52%), Gaps = 12/126 (9%)
Query: 105 SKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIR 164
           S  +D +PE++         + +A++  L+++ + N    H  RDIKP N+LLD +G+I+
Sbjct: 116 SVLDDVIPEEILG------KITLATVKALNHL-KENLKIIH--RDIKPSNILLDRSGNIK 166
Query: 165 LADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML 224
           L DFG   +L    ++      G   Y++PE +      +G Y    D WSLG+ +YE+ 
Sbjct: 167 LCDFGISGQLV--DSIAKTRDAGCRPYMAPERIDPSASRQG-YDVRSDVWSLGITLYELA 223
Query: 225 YGETPF 230
            G  P+
Sbjct: 224 TGRFPY 229

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 14/142 (9%)
Query: 104 LSKFEDRLPED-MAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH 162
           L+ + D++PE  +    I +M+  +    D  + HR  H      RD+KP N+L+ ++G 
Sbjct: 105 LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVH------RDLKPQNILVTSSGQ 158
Query: 163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYE 222
           I+LADFG   R+       ++V V T  Y +PE+L      +  Y    D WS+G    E
Sbjct: 159 IKLADFG-LARIYSFQMALTSVVV-TLWYRAPEVLL-----QSSYATPVDLWSVGCIFAE 211
Query: 223 MLYGETPFYAESLVETYGKIMN 244
           M   +  F   S V+  GKI++
Sbjct: 212 MFRRKPLFRGSSDVDQLGKILD 233

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 68/145 (46%), Gaps = 14/145 (9%)
Query: 111 LPEDMAKFYIAEMVLAIASIHD-LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG 169
           +PED+       +V A+  +H  L  +HR          D+KP NVL++A G +++ DFG
Sbjct: 106 IPEDILGKIAVSIVKALEHLHSKLSVIHR----------DVKPSNVLINALGQVKMCDFG 155
Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
               L  D  V  ++  G   Y++PE +      +G Y  + D WSLG+ M E+     P
Sbjct: 156 ISGYLVDD--VAKDIDAGCKPYMAPERINPELNQKG-YSVKSDIWSLGITMIELAILRFP 212
Query: 230 FYAESLVETYGKIMNHQNSFDLPSD 254
           + +        K +  + S  LP+D
Sbjct: 213 YDSWGTPFQQLKQVVEEPSPQLPAD 237

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 23/164 (14%)
Query: 90  LVMDYYCGGDLLTLLSKFED--RLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           L M+Y  GGDL   L++FE+   L E   +  ++++  A+  +H+   +HR         
Sbjct: 95  LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHR--------- 145
Query: 148 RDIKPDNVLLDANGHI---RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR 204
            D+KP+N++L         ++ D G    L  D        VGT  Y++PE+L      +
Sbjct: 146 -DLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYLAPELLE-----Q 197
Query: 205 GRYGPECDWWSLGVCMYEMLYGETPFYAE-SLVETYGKIMNHQN 247
            +Y    D+WS G   +E + G  PF      V+ +GK+    N
Sbjct: 198 KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN 241

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 23/164 (14%)
Query: 90  LVMDYYCGGDLLTLLSKFED--RLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           L M+Y  GGDL   L++FE+   L E   +  ++++  A+  +H+   +HR         
Sbjct: 96  LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHR--------- 146
Query: 148 RDIKPDNVLLDANGHI---RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR 204
            D+KP+N++L         ++ D G    L  D        VGT  Y++PE+L      +
Sbjct: 147 -DLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYLAPELLE-----Q 198
Query: 205 GRYGPECDWWSLGVCMYEMLYGETPFYAE-SLVETYGKIMNHQN 247
            +Y    D+WS G   +E + G  PF      V+ +GK+    N
Sbjct: 199 KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN 242

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 81/181 (44%), Gaps = 23/181 (12%)
Query: 70  GDRRWITNLHYAF--QDDSNLYL-VMDYYCGGDLLTLLSKF---EDRLPEDMAKFYIAEM 123
           G    + N H +       N YL V+  Y    L  +L  F      +P ++   YI ++
Sbjct: 91  GKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQL 150
Query: 124 VLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH-IRLADFGSCLRLGGDGTVQS 182
             A+  IH L   HR          DIKP N+L+++  + ++L DFGS  +L    +  S
Sbjct: 151 FRAVGFIHSLGICHR----------DIKPQNLLVNSKDNTLKLCDFGSAKKL--IPSEPS 198
Query: 183 NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
              + +  Y +PE++    E    Y P  D WS+G    E++ G+  F  E+ ++   +I
Sbjct: 199 VAXICSRFYRAPELMLGATE----YTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRI 254
Query: 243 M 243
           +
Sbjct: 255 I 255

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 75/173 (43%), Gaps = 25/173 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L KF D      +P  + K Y+ +++  +A 
Sbjct: 71  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H    +HR          D+KP N+L++  G I+LADFG     G      ++  V T 
Sbjct: 126 CHSHRVLHR----------DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TL 174
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 175 WYRAPEILL----GXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 223

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 76/173 (43%), Gaps = 25/173 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L KF D      +P  + K Y+ +++  +A 
Sbjct: 64  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H     HR  H      RD+KP N+L++  G I+LADFG     G      ++  V T 
Sbjct: 119 CHS----HRVLH------RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TL 167
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 168 WYRAPEILL----GXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 16/156 (10%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I +L      +  L LV ++    DL  +L + +  L +   K Y+ +++  +A  H   
Sbjct: 81  IVSLIDVIHSERCLTLVFEF-MEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR 139
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          D+KP N+L++++G ++LADFG   R  G         V T  Y +P
Sbjct: 140 ILHR----------DLKPQNLLINSDGALKLADFGLA-RAFGIPVRSYTHEVVTLWYRAP 188
Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
           ++L     G  +Y    D WS+G    EM+ G+  F
Sbjct: 189 DVLM----GSKKYSTSVDIWSIGCIFAEMITGKPLF 220

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 16/156 (10%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I +L      +  L LV ++    DL  +L + +  L +   K Y+ +++  +A  H   
Sbjct: 81  IVSLIDVIHSERCLTLVFEF-MEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR 139
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          D+KP N+L++++G ++LADFG   R  G         V T  Y +P
Sbjct: 140 ILHR----------DLKPQNLLINSDGALKLADFGLA-RAFGIPVRSYTHEVVTLWYRAP 188
Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
           ++L     G  +Y    D WS+G    EM+ G+  F
Sbjct: 189 DVLM----GSKKYSTSVDIWSIGCIFAEMITGKPLF 220

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/142 (34%), Positives = 68/142 (47%), Gaps = 20/142 (14%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASI-HDLHYVHRPNHFAF 144
           +++YLV D+ C  DL  LLS         + KF ++E+   +  + + L+Y+HR N    
Sbjct: 98  ASIYLVFDF-CEHDLAGLLSNV-------LVKFTLSEIKRVMQMLLNGLYYIHR-NKI-- 146
Query: 145 HLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNV---AVGTPDYISPEILTAME 201
            L RD+K  NVL+  +G ++LADFG           Q N     V T  Y  PE+L    
Sbjct: 147 -LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLL--- 202
Query: 202 EGRGRYGPECDWWSLGVCMYEM 223
            G   YGP  D W  G  M EM
Sbjct: 203 -GERDYGPPIDLWGAGCIMAEM 223

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/141 (34%), Positives = 67/141 (47%), Gaps = 20/141 (14%)
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASI-HDLHYVHRPNHFAFH 145
           ++YLV D+ C  DL  LLS         + KF ++E+   +  + + L+Y+HR N     
Sbjct: 99  SIYLVFDF-CEHDLAGLLSNV-------LVKFTLSEIKRVMQMLLNGLYYIHR-NKI--- 146
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNV---AVGTPDYISPEILTAMEE 202
           L RD+K  NVL+  +G ++LADFG           Q N     V T  Y  PE+L     
Sbjct: 147 LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLL---- 202
Query: 203 GRGRYGPECDWWSLGVCMYEM 223
           G   YGP  D W  G  M EM
Sbjct: 203 GERDYGPPIDLWGAGCIMAEM 223

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 67/145 (46%), Gaps = 14/145 (9%)
Query: 111 LPEDMAKFYIAEMVLAIASIHD-LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG 169
           +PED+       +V A+  +H  L  +HR          D+KP NVL++A G +++ DFG
Sbjct: 150 IPEDILGKIAVSIVKALEHLHSKLSVIHR----------DVKPSNVLINALGQVKMCDFG 199
Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
               L    +V   +  G   Y++PE +      +G Y  + D WSLG+ M E+     P
Sbjct: 200 ISGYLV--DSVAKTIDAGCKPYMAPERINPELNQKG-YSVKSDIWSLGITMIELAILRFP 256
Query: 230 FYAESLVETYGKIMNHQNSFDLPSD 254
           + +        K +  + S  LP+D
Sbjct: 257 YDSWGTPFQQLKQVVEEPSPQLPAD 281

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 85/198 (42%), Gaps = 33/198 (16%)
Query: 49  TVSDFIEFVAKLREERDVLVYG---DRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLS 105
           T+   +  +A L  +  V  Y    +RR       A +  S L++ M+Y     L  L+ 
Sbjct: 48  TILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIH 107
Query: 106 KFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRL 165
                   D       +++ A++ IH    +HR          D+KP N+ +D + ++++
Sbjct: 108 SENLNQQRDEYWRLFRQILEALSYIHSQGIIHR----------DLKPMNIFIDESRNVKI 157
Query: 166 ADFG---------SCLRLGGDGTVQSN----VAVGTPDYISPEILTAMEEGRGRYGPECD 212
            DFG           L+L       S+     A+GT  Y++ E+L    +G G Y  + D
Sbjct: 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVL----DGTGHYNEKID 213
Query: 213 WWSLGVCMYEMLYGETPF 230
            +SLG+  +EM+Y   PF
Sbjct: 214 MYSLGIIFFEMIY---PF 228

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/141 (34%), Positives = 67/141 (47%), Gaps = 20/141 (14%)
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASI-HDLHYVHRPNHFAFH 145
           ++YLV D+ C  DL  LLS         + KF ++E+   +  + + L+Y+HR N     
Sbjct: 98  SIYLVFDF-CEHDLAGLLSNV-------LVKFTLSEIKRVMQMLLNGLYYIHR-NKI--- 145
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNV---AVGTPDYISPEILTAMEE 202
           L RD+K  NVL+  +G ++LADFG           Q N     V T  Y  PE+L     
Sbjct: 146 LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLL---- 201
Query: 203 GRGRYGPECDWWSLGVCMYEM 223
           G   YGP  D W  G  M EM
Sbjct: 202 GERDYGPPIDLWGAGCIMAEM 222

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 70/163 (42%), Gaps = 17/163 (10%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  LH     + +L LV +Y    DL   L    + +     K ++ +++  +A  H   
Sbjct: 62  IVTLHDIIHTEKSLTLVFEY-LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK 120
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          D+KP N+L++  G ++LADFG   R     T   +  V T  Y  P
Sbjct: 121 VLHR----------DLKPQNLLINERGELKLADFGLA-RAKSIPTKTYDNEVVTLWYRPP 169
Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 237
           +IL     G   Y  + D W +G   YEM  G  P +  S VE
Sbjct: 170 DILL----GSTDYSTQIDMWGVGCIFYEMATGR-PLFPGSTVE 207

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 75/173 (43%), Gaps = 25/173 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L KF D      +P  + K Y+ +++  +A 
Sbjct: 65  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H    +HR          D+KP N+L++  G I+LADFG     G      ++  V T 
Sbjct: 120 CHSHRVLHR----------DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TL 168
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 169 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 217

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 75/173 (43%), Gaps = 25/173 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L KF D      +P  + K Y+ +++  +A 
Sbjct: 71  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H    +HR          D+KP N+L++  G I+LADFG     G      ++  V T 
Sbjct: 126 CHSHRVLHR----------DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TL 174
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 175 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 223

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/141 (34%), Positives = 67/141 (47%), Gaps = 20/141 (14%)
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASI-HDLHYVHRPNHFAFH 145
           ++YLV D+ C  DL  LLS         + KF ++E+   +  + + L+Y+HR N     
Sbjct: 99  SIYLVFDF-CEHDLAGLLSNV-------LVKFTLSEIKRVMQMLLNGLYYIHR-NKI--- 146
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNV---AVGTPDYISPEILTAMEE 202
           L RD+K  NVL+  +G ++LADFG           Q N     V T  Y  PE+L     
Sbjct: 147 LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLL---- 202
Query: 203 GRGRYGPECDWWSLGVCMYEM 223
           G   YGP  D W  G  M EM
Sbjct: 203 GERDYGPPIDLWGAGCIMAEM 223

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 76/173 (43%), Gaps = 25/173 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L KF D      +P  + K Y+ +++  +A 
Sbjct: 64  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H     HR  H      RD+KP N+L++  G I+LADFG     G      ++  V T 
Sbjct: 119 CHS----HRVLH------RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TL 167
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 168 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 75/173 (43%), Gaps = 25/173 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L KF D      +P  + K Y+ +++  +A 
Sbjct: 63  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H    +HR          D+KP N+L++  G I+LADFG     G      ++  V T 
Sbjct: 118 CHSHRVLHR----------DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TL 166
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 167 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 76/173 (43%), Gaps = 25/173 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L KF D      +P  + K Y+ +++  +A 
Sbjct: 63  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H     HR  H      RD+KP N+L++  G I+LADFG     G      ++  V T 
Sbjct: 118 CHS----HRVLH------RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TL 166
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 167 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 66/138 (47%), Gaps = 16/138 (11%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           L++ M++   G   TL    E R  E + K    E+   I    D  Y+H        + 
Sbjct: 95  LFIQMEFCDKG---TLEQWIEKRRGEKLDKVLALELFEQITKGVD--YIHSKKL----IN 145
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
           RD+KP N+ L     +++ DFG    L  DG  +   + GT  Y+SPE +++ +     Y
Sbjct: 146 RDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG--KRXRSKGTLRYMSPEQISSQD-----Y 198
Query: 208 GPECDWWSLGVCMYEMLY 225
           G E D ++LG+ + E+L+
Sbjct: 199 GKEVDLYALGLILAELLH 216

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 75/173 (43%), Gaps = 25/173 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L KF D      +P  + K Y+ +++  +A 
Sbjct: 68  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H    +HR          D+KP N+L++  G I+LADFG     G      ++  V T 
Sbjct: 123 CHSHRVLHR----------DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TL 171
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 172 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 220

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 76/173 (43%), Gaps = 25/173 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L KF D      +P  + K Y+ +++  +A 
Sbjct: 64  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H     HR  H      RD+KP N+L++  G I+LADFG     G      ++  V T 
Sbjct: 119 CHS----HRVLH------RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TL 167
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 168 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 81/180 (45%), Gaps = 27/180 (15%)
Query: 75  ITNLHYAF------QDDSNLYLVMDYYCGG--DLLTLLSKFEDRLPEDMAKFYIAEMVLA 126
           I  L Y F      +D+  L LV+DY       +    S+ +  LP    K Y+ ++  +
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 127 IASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI-RLADFGSCLRL-GGDGTVQSNV 184
           +A IH     HR          DIKP N+LLD +  + +L DFGS  +L  G+  V    
Sbjct: 135 LAYIHSFGICHR----------DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-- 182
Query: 185 AVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
            + +  Y +PE++     G   Y    D WS G  + E+L G+  F  +S V+   +I+ 
Sbjct: 183 -ICSRYYRAPELIF----GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 76/173 (43%), Gaps = 25/173 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L KF D      +P  + K Y+ +++  +A 
Sbjct: 63  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H     HR  H      RD+KP N+L++  G I+LADFG     G      ++  V T 
Sbjct: 118 CHS----HRVLH------RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TL 166
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 167 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 76/173 (43%), Gaps = 25/173 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L KF D      +P  + K Y+ +++  +A 
Sbjct: 64  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H     HR  H      RD+KP N+L++  G I+LADFG     G      ++  V T 
Sbjct: 119 CHS----HRVLH------RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TL 167
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 168 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 77/181 (42%), Gaps = 25/181 (13%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L KF D      +P  + K Y+ +++  +A 
Sbjct: 67  IVKLLDVIHTENKLYLVFEF-----LSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H    +HR          D+KP+N+L++  G I+LADFG     G       +  V T 
Sbjct: 122 CHSHRVLHR----------DLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 170
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSF 249
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I     + 
Sbjct: 171 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 226
Query: 250 D 250
           D
Sbjct: 227 D 227

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 65/142 (45%), Gaps = 24/142 (16%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRPNHFA 143
           L++ M++   G   TL    E R  E + K    E+   I      IH    +HR     
Sbjct: 109 LFIQMEFCDKG---TLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHR----- 160
Query: 144 FHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEG 203
                D+KP N+ L     +++ DFG    L  DG  +   + GT  Y+SPE +++ +  
Sbjct: 161 -----DLKPSNIFLVDTKQVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQD-- 211
Query: 204 RGRYGPECDWWSLGVCMYEMLY 225
              YG E D ++LG+ + E+L+
Sbjct: 212 ---YGKEVDLYALGLILAELLH 230

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 76/173 (43%), Gaps = 25/173 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L KF D      +P  + K Y+ +++  +A 
Sbjct: 65  IVKLLDVIHTENKLYLVFEF-----LSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H     HR  H      RD+KP+N+L++  G I+LADFG     G       +  V T 
Sbjct: 120 CHS----HRVLH------RDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 168
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 169 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 217

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 75/173 (43%), Gaps = 25/173 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L KF D      +P  + K Y+ +++  +A 
Sbjct: 65  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H    +HR          D+KP+N+L++  G I+LADFG     G       +  V T 
Sbjct: 120 CHSHRVLHR----------DLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 168
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 169 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 217

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 75/173 (43%), Gaps = 25/173 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L KF D      +P  + K Y+ +++  +A 
Sbjct: 66  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H    +HR          D+KP+N+L++  G I+LADFG     G       +  V T 
Sbjct: 121 CHSHRVLHR----------DLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 169
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 170 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 218

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 92/219 (42%), Gaps = 21/219 (9%)
Query: 31  ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG--DRRWITNLHYAFQDDSNL 88
           I++  YD     ++  +K    F       R  R++++    + + I  L   F    +L
Sbjct: 39  IVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSL 98
Query: 89  YLVMDYYCGGDLL--TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
               D Y   +L+   L    +  L  +   + + +M++ I  +H    +HR        
Sbjct: 99  EEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHR-------- 150
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+++ ++  +++ DFG   R  G   + +   V T  Y +PE++  M      
Sbjct: 151 --DLKPSNIVVKSDATLKILDFG-LARTAGTSFMMTPYVV-TRYYRAPEVILGMG----- 201
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           Y    D WS+GV M EM+ G   F     ++ + K++  
Sbjct: 202 YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 65/157 (41%), Gaps = 16/157 (10%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  LH     D  L LV ++ C  DL          L  ++ K ++ +++  +   H  +
Sbjct: 63  IVRLHDVLHSDKKLTLVFEF-CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          D+KP N+L++ NG ++LADFG   R  G      +  V T  Y  P
Sbjct: 122 VLHR----------DLKPQNLLINRNGELKLADFGLA-RAFGIPVRCYSAEVVTLWYRPP 170
Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
           ++L     G   Y    D WS G    E+     P +
Sbjct: 171 DVLF----GAKLYSTSIDMWSAGCIFAELANAARPLF 203

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 75/173 (43%), Gaps = 25/173 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L KF D      +P  + K Y+ +++  +A 
Sbjct: 64  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H     HR  H      RD+KP N+L++  G I+LADFG     G       +  V T 
Sbjct: 119 CHS----HRVLH------RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 167
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 168 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 75/169 (44%), Gaps = 17/169 (10%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLL-SKFEDRLPEDMAKFYIAEMVLAIASIHDL 133
           I  L      ++ LYLV ++    DL T + +     +P  + K Y+ +++  +A  H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEH-VHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 134 HYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYIS 193
             +HR          D+KP N+L++  G I+LADFG     G      ++  V T  Y +
Sbjct: 122 RVLHR----------DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 170
Query: 194 PEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
           PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 171 PEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 81/180 (45%), Gaps = 27/180 (15%)
Query: 75  ITNLHYAF------QDDSNLYLVMDYYCGG--DLLTLLSKFEDRLPEDMAKFYIAEMVLA 126
           I  L Y F      +D+  L LV+DY       +    S+ +  LP    K Y+ ++  +
Sbjct: 94  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 153
Query: 127 IASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI-RLADFGSCLRL-GGDGTVQSNV 184
           +A IH     HR          DIKP N+LLD +  + +L DFGS  +L  G+  V    
Sbjct: 154 LAYIHSFGICHR----------DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-- 201
Query: 185 AVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
            + +  Y +PE++     G   Y    D WS G  + E+L G+  F  +S V+   +I+ 
Sbjct: 202 -ICSRYYRAPELIF----GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 256

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 75/173 (43%), Gaps = 25/173 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L KF D      +P  + K Y+ +++  +A 
Sbjct: 64  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H     HR  H      RD+KP N+L++  G I+LADFG     G       +  V T 
Sbjct: 119 CHS----HRVLH------RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 167
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 168 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 88/198 (44%), Gaps = 31/198 (15%)
Query: 38  ECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCG 97
           +C    +R E   ++ +   A L   R V +YG          A ++   + + M+   G
Sbjct: 120 QCAVKKVRLEVFRAEELMACAGLTSPRIVPLYG----------AVREGPWVNIFMELLEG 169
Query: 98  GDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL 157
           G L  L+ K +  LPED A +Y+ + +  +  +H    +H           D+K DNVLL
Sbjct: 170 GSLGQLV-KEQGCLPEDRALYYLGQALEGLEYLHSRRILH----------GDVKADNVLL 218
Query: 158 DANG-HIRLADFGSCLRLGGDGTVQS----NVAVGTPDYISPEILTAMEEGRGRYGPECD 212
            ++G H  L DFG  + L  DG  +S    +   GT  +++PE++     GR     + D
Sbjct: 219 SSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVL----GRS-CDAKVD 273
Query: 213 WWSLGVCMYEMLYGETPF 230
            WS    M  ML G  P+
Sbjct: 274 VWSSCCMMLHMLNGCHPW 291

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 81/180 (45%), Gaps = 27/180 (15%)
Query: 75  ITNLHYAF------QDDSNLYLVMDYYCGG--DLLTLLSKFEDRLPEDMAKFYIAEMVLA 126
           I  L Y F      +D+  L LV+DY       +    S+ +  LP    K Y+ ++  +
Sbjct: 83  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 142
Query: 127 IASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI-RLADFGSCLRL-GGDGTVQSNV 184
           +A IH     HR          DIKP N+LLD +  + +L DFGS  +L  G+  V    
Sbjct: 143 LAYIHSFGICHR----------DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-- 190
Query: 185 AVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
            + +  Y +PE++     G   Y    D WS G  + E+L G+  F  +S V+   +I+ 
Sbjct: 191 -ICSRYYRAPELIF----GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 245

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 81/180 (45%), Gaps = 27/180 (15%)
Query: 75  ITNLHYAF------QDDSNLYLVMDYYCGG--DLLTLLSKFEDRLPEDMAKFYIAEMVLA 126
           I  L Y F      +D+  L LV+DY       +    S+ +  LP    K Y+ ++  +
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 127 IASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI-RLADFGSCLRL-GGDGTVQSNV 184
           +A IH     HR          DIKP N+LLD +  + +L DFGS  +L  G+  V    
Sbjct: 147 LAYIHSFGICHR----------DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-- 194
Query: 185 AVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
            + +  Y +PE++     G   Y    D WS G  + E+L G+  F  +S V+   +I+ 
Sbjct: 195 -ICSRYYRAPELIF----GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 249

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 74/173 (42%), Gaps = 25/173 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L KF D      +P  + K Y+ +++  +A 
Sbjct: 67  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H    +HR          D+KP N+L++  G I+LADFG     G       +  V T 
Sbjct: 122 CHSHRVLHR----------DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 170
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 171 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 219

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 74/173 (42%), Gaps = 25/173 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L KF D      +P  + K Y+ +++  +A 
Sbjct: 66  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H    +HR          D+KP N+L++  G I+LADFG     G       +  V T 
Sbjct: 121 CHSHRVLHR----------DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 169
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 170 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 218

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 75/173 (43%), Gaps = 25/173 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L KF D      +P  + K Y+ +++  +A 
Sbjct: 63  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H     HR  H      RD+KP N+L++  G I+LADFG     G       +  V T 
Sbjct: 118 CHS----HRVLH------RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 166
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 167 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 81/180 (45%), Gaps = 27/180 (15%)
Query: 75  ITNLHYAF------QDDSNLYLVMDYYCGG--DLLTLLSKFEDRLPEDMAKFYIAEMVLA 126
           I  L Y F      +D+  L LV+DY       +    S+ +  LP    K Y+ ++  +
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 127 IASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI-RLADFGSCLRL-GGDGTVQSNV 184
           +A IH     HR          DIKP N+LLD +  + +L DFGS  +L  G+  V    
Sbjct: 135 LAYIHSFGICHR----------DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-- 182
Query: 185 AVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
            + +  Y +PE++     G   Y    D WS G  + E+L G+  F  +S V+   +I+ 
Sbjct: 183 -ICSRYYRAPELIF----GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 81/180 (45%), Gaps = 27/180 (15%)
Query: 75  ITNLHYAF------QDDSNLYLVMDYYCGG--DLLTLLSKFEDRLPEDMAKFYIAEMVLA 126
           I  L Y F      +D+  L LV+DY       +    S+ +  LP    K Y+ ++  +
Sbjct: 76  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 135
Query: 127 IASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI-RLADFGSCLRL-GGDGTVQSNV 184
           +A IH     HR          DIKP N+LLD +  + +L DFGS  +L  G+  V    
Sbjct: 136 LAYIHSFGICHR----------DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-- 183
Query: 185 AVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
            + +  Y +PE++     G   Y    D WS G  + E+L G+  F  +S V+   +I+ 
Sbjct: 184 -ICSRYYRAPELIF----GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 238

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 81/180 (45%), Gaps = 27/180 (15%)
Query: 75  ITNLHYAF------QDDSNLYLVMDYYCGG--DLLTLLSKFEDRLPEDMAKFYIAEMVLA 126
           I  L Y F      +D+  L LV+DY       +    S+ +  LP    K Y+ ++  +
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 127 IASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI-RLADFGSCLRL-GGDGTVQSNV 184
           +A IH     HR          DIKP N+LLD +  + +L DFGS  +L  G+  V    
Sbjct: 147 LAYIHSFGICHR----------DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-- 194
Query: 185 AVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
            + +  Y +PE++     G   Y    D WS G  + E+L G+  F  +S V+   +I+ 
Sbjct: 195 -ICSRYYRAPELIF----GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 249

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 75/173 (43%), Gaps = 25/173 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L KF D      +P  + K Y+ +++  +A 
Sbjct: 63  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H     HR  H      RD+KP N+L++  G I+LADFG     G       +  V T 
Sbjct: 118 CHS----HRVLH------RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 166
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 167 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 74/173 (42%), Gaps = 25/173 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L KF D      +P  + K Y+ +++  +A 
Sbjct: 67  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H    +HR          D+KP N+L++  G I+LADFG     G       +  V T 
Sbjct: 122 CHSHRVLHR----------DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 170
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 171 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 219

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 74/173 (42%), Gaps = 25/173 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L KF D      +P  + K Y+ +++  +A 
Sbjct: 66  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H    +HR          D+KP N+L++  G I+LADFG     G       +  V T 
Sbjct: 121 CHSHRVLHR----------DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 169
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 170 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 218

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 74/173 (42%), Gaps = 25/173 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L KF D      +P  + K Y+ +++  +A 
Sbjct: 65  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H    +HR          D+KP N+L++  G I+LADFG     G       +  V T 
Sbjct: 120 CHSHRVLHR----------DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 168
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 169 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 217

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 81/180 (45%), Gaps = 27/180 (15%)
Query: 75  ITNLHYAF------QDDSNLYLVMDYYCGG--DLLTLLSKFEDRLPEDMAKFYIAEMVLA 126
           I  L Y F      +D+  L LV+DY       +    S+ +  LP    K Y+ ++  +
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 127 IASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI-RLADFGSCLRL-GGDGTVQSNV 184
           +A IH     HR          DIKP N+LLD +  + +L DFGS  +L  G+  V    
Sbjct: 135 LAYIHSFGICHR----------DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-- 182
Query: 185 AVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
            + +  Y +PE++     G   Y    D WS G  + E+L G+  F  +S V+   +I+ 
Sbjct: 183 -ICSRYYRAPELIF----GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 74/173 (42%), Gaps = 25/173 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L KF D      +P  + K Y+ +++  +A 
Sbjct: 65  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H    +HR          D+KP N+L++  G I+LADFG     G       +  V T 
Sbjct: 120 CHSHRVLHR----------DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 168
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 169 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 217

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 74/173 (42%), Gaps = 25/173 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L KF D      +P  + K Y+ +++  +A 
Sbjct: 64  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H    +HR          D+KP N+L++  G I+LADFG     G       +  V T 
Sbjct: 119 CHSHRVLHR----------DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 167
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 168 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 76/181 (41%), Gaps = 25/181 (13%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L KF D      +P  + K Y+ +++  +A 
Sbjct: 68  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H    +HR          D+KP N+L++  G I+LADFG     G       +  V T 
Sbjct: 123 CHSHRVLHR----------DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 171
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSF 249
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I     + 
Sbjct: 172 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 227
Query: 250 D 250
           D
Sbjct: 228 D 228

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 75/173 (43%), Gaps = 25/173 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L KF D      +P  + K Y+ +++  +A 
Sbjct: 64  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H     HR  H      RD+KP N+L++  G I+LADFG     G       +  V T 
Sbjct: 119 CHS----HRVLH------RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 167
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 168 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 81/180 (45%), Gaps = 27/180 (15%)
Query: 75  ITNLHYAF------QDDSNLYLVMDYYCGG--DLLTLLSKFEDRLPEDMAKFYIAEMVLA 126
           I  L Y F      +D+  L LV+DY       +    S+ +  LP    K Y+ ++  +
Sbjct: 79  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 138
Query: 127 IASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI-RLADFGSCLRL-GGDGTVQSNV 184
           +A IH     HR          DIKP N+LLD +  + +L DFGS  +L  G+  V    
Sbjct: 139 LAYIHSFGICHR----------DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-- 186
Query: 185 AVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
            + +  Y +PE++     G   Y    D WS G  + E+L G+  F  +S V+   +I+ 
Sbjct: 187 -ICSRYYRAPELIF----GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 241

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 81/180 (45%), Gaps = 27/180 (15%)
Query: 75  ITNLHYAF------QDDSNLYLVMDYYCGG--DLLTLLSKFEDRLPEDMAKFYIAEMVLA 126
           I  L Y F      +D+  L LV+DY       +    S+ +  LP    K Y+ ++  +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 127 IASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI-RLADFGSCLRL-GGDGTVQSNV 184
           +A IH     HR          DIKP N+LLD +  + +L DFGS  +L  G+  V    
Sbjct: 169 LAYIHSFGICHR----------DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-- 216
Query: 185 AVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
            + +  Y +PE++     G   Y    D WS G  + E+L G+  F  +S V+   +I+ 
Sbjct: 217 -ICSRYYRAPELIF----GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 271

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 75/173 (43%), Gaps = 25/173 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L KF D      +P  + K Y+ +++  ++ 
Sbjct: 64  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSF 118
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H    +HR          D+KP N+L++  G I+LADFG     G      ++  V T 
Sbjct: 119 CHSHRVLHR----------DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TL 167
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 168 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 82/180 (45%), Gaps = 27/180 (15%)
Query: 75  ITNLHYAF------QDDSNLYLVMDYYCGG--DLLTLLSKFEDRLPEDMAKFYIAEMVLA 126
           I  L Y F      +D+  L LV+DY       +    S+ +  LP    K Y+ ++  +
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 127 IASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI-RLADFGSCLRLGGDGTVQSNVA 185
           +A IH     HR          DIKP N+LLD +  + +L DFGS  +L      + NV+
Sbjct: 135 LAYIHSFGICHR----------DIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVS 181
Query: 186 -VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
            + +  Y +PE++     G   Y    D WS G  + E+L G+  F  +S V+   +I+ 
Sbjct: 182 YICSRYYRAPELIF----GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 82/180 (45%), Gaps = 27/180 (15%)
Query: 75  ITNLHYAF------QDDSNLYLVMDYYCGG--DLLTLLSKFEDRLPEDMAKFYIAEMVLA 126
           I  L Y F      +D+  L LV+DY       +    S+ +  LP    K Y+ ++  +
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 127 IASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI-RLADFGSCLRLGGDGTVQSNVA 185
           +A IH     HR          DIKP N+LLD +  + +L DFGS  +L      + NV+
Sbjct: 135 LAYIHSFGICHR----------DIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVS 181
Query: 186 -VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
            + +  Y +PE++     G   Y    D WS G  + E+L G+  F  +S V+   +I+ 
Sbjct: 182 YICSRYYRAPELIF----GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 82/180 (45%), Gaps = 27/180 (15%)
Query: 75  ITNLHYAF------QDDSNLYLVMDYYCGG--DLLTLLSKFEDRLPEDMAKFYIAEMVLA 126
           I  L Y F      +D+  L LV+DY       +    S+ +  LP    K Y+ ++  +
Sbjct: 88  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 147
Query: 127 IASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI-RLADFGSCLRLGGDGTVQSNVA 185
           +A IH     HR          DIKP N+LLD +  + +L DFGS  +L      + NV+
Sbjct: 148 LAYIHSFGICHR----------DIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVS 194
Query: 186 -VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
            + +  Y +PE++     G   Y    D WS G  + E+L G+  F  +S V+   +I+ 
Sbjct: 195 YICSRYYRAPELIF----GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 250

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 82/180 (45%), Gaps = 27/180 (15%)
Query: 75  ITNLHYAF------QDDSNLYLVMDYYCGG--DLLTLLSKFEDRLPEDMAKFYIAEMVLA 126
           I  L Y F      +D+  L LV+DY       +    S+ +  LP    K Y+ ++  +
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 127 IASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI-RLADFGSCLRLGGDGTVQSNVA 185
           +A IH     HR          DIKP N+LLD +  + +L DFGS  +L      + NV+
Sbjct: 135 LAYIHSFGICHR----------DIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVS 181
Query: 186 -VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
            + +  Y +PE++     G   Y    D WS G  + E+L G+  F  +S V+   +I+ 
Sbjct: 182 YICSRYYRAPELIF----GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 82/180 (45%), Gaps = 27/180 (15%)
Query: 75  ITNLHYAF------QDDSNLYLVMDYYCGG--DLLTLLSKFEDRLPEDMAKFYIAEMVLA 126
           I  L Y F      +D+  L LV+DY       +    S+ +  LP    K Y+ ++  +
Sbjct: 103 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 162
Query: 127 IASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI-RLADFGSCLRLGGDGTVQSNVA 185
           +A IH     HR          DIKP N+LLD +  + +L DFGS  +L      + NV+
Sbjct: 163 LAYIHSFGICHR----------DIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVS 209
Query: 186 -VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
            + +  Y +PE++     G   Y    D WS G  + E+L G+  F  +S V+   +I+ 
Sbjct: 210 YICSRYYRAPELIF----GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 265

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 74/169 (43%), Gaps = 17/169 (10%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLL-SKFEDRLPEDMAKFYIAEMVLAIASIHDL 133
           I  L      ++ LYLV ++    DL T + +     +P  + K Y+ +++  +A  H  
Sbjct: 67  IVKLLDVIHTENKLYLVFEF-LHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 134 HYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYIS 193
             +HR          D+KP N+L++  G I+LADFG     G       +  V T  Y +
Sbjct: 126 RVLHR----------DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 174
Query: 194 PEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
           PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 175 PEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 219

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 82/180 (45%), Gaps = 27/180 (15%)
Query: 75  ITNLHYAF------QDDSNLYLVMDYYCGG--DLLTLLSKFEDRLPEDMAKFYIAEMVLA 126
           I  L Y F      +D+  L LV+DY       +    S+ +  LP    K Y+ ++  +
Sbjct: 113 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 172
Query: 127 IASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI-RLADFGSCLRLGGDGTVQSNVA 185
           +A IH     HR          DIKP N+LLD +  + +L DFGS  +L      + NV+
Sbjct: 173 LAYIHSFGICHR----------DIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVS 219
Query: 186 -VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
            + +  Y +PE++     G   Y    D WS G  + E+L G+  F  +S V+   +I+ 
Sbjct: 220 YICSRYYRAPELIF----GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 275

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 82/180 (45%), Gaps = 27/180 (15%)
Query: 75  ITNLHYAF------QDDSNLYLVMDYYCGG--DLLTLLSKFEDRLPEDMAKFYIAEMVLA 126
           I  L Y F      +D+  L LV+DY       +    S+ +  LP    K Y+ ++  +
Sbjct: 111 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 170
Query: 127 IASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI-RLADFGSCLRLGGDGTVQSNVA 185
           +A IH     HR          DIKP N+LLD +  + +L DFGS  +L      + NV+
Sbjct: 171 LAYIHSFGICHR----------DIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVS 217
Query: 186 -VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
            + +  Y +PE++     G   Y    D WS G  + E+L G+  F  +S V+   +I+ 
Sbjct: 218 YICSRYYRAPELIF----GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 273

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 82/180 (45%), Gaps = 27/180 (15%)
Query: 75  ITNLHYAF------QDDSNLYLVMDYYCGG--DLLTLLSKFEDRLPEDMAKFYIAEMVLA 126
           I  L Y F      +D+  L LV+DY       +    S+ +  LP    K Y+ ++  +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 127 IASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI-RLADFGSCLRLGGDGTVQSNVA 185
           +A IH     HR          DIKP N+LLD +  + +L DFGS  +L      + NV+
Sbjct: 169 LAYIHSFGICHR----------DIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVS 215
Query: 186 -VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
            + +  Y +PE++     G   Y    D WS G  + E+L G+  F  +S V+   +I+ 
Sbjct: 216 YICSRYYRAPELIF----GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 271

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 82/180 (45%), Gaps = 27/180 (15%)
Query: 75  ITNLHYAF------QDDSNLYLVMDYYCGG--DLLTLLSKFEDRLPEDMAKFYIAEMVLA 126
           I  L Y F      +D+  L LV+DY       +    S+ +  LP    K Y+ ++  +
Sbjct: 80  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 139
Query: 127 IASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI-RLADFGSCLRLGGDGTVQSNVA 185
           +A IH     HR          DIKP N+LLD +  + +L DFGS  +L      + NV+
Sbjct: 140 LAYIHSFGICHR----------DIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVS 186
Query: 186 -VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
            + +  Y +PE++     G   Y    D WS G  + E+L G+  F  +S V+   +I+ 
Sbjct: 187 YICSRYYRAPELIF----GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 242

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 82/180 (45%), Gaps = 27/180 (15%)
Query: 75  ITNLHYAF------QDDSNLYLVMDYYCGG--DLLTLLSKFEDRLPEDMAKFYIAEMVLA 126
           I  L Y F      +D+  L LV+DY       +    S+ +  LP    K Y+ ++  +
Sbjct: 154 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 213
Query: 127 IASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI-RLADFGSCLRLGGDGTVQSNVA 185
           +A IH     HR          DIKP N+LLD +  + +L DFGS  +L      + NV+
Sbjct: 214 LAYIHSFGICHR----------DIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVS 260
Query: 186 -VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
            + +  Y +PE++     G   Y    D WS G  + E+L G+  F  +S V+   +I+ 
Sbjct: 261 YICSRYYRAPELIF----GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 316

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 91/219 (41%), Gaps = 21/219 (9%)
Query: 31  ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG--DRRWITNLHYAFQDDSNL 88
           I+   YD     ++  +K    F       R  R++++    + + I  L   F    +L
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSL 98
Query: 89  YLVMDYYCGGDLL--TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
               D Y   +L+   L    +  L  +   + + +M++ I  +H    +HR        
Sbjct: 99  EEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHR-------- 150
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+++ ++  +++ DFG   R  G   + +   V T  Y +PE++  M      
Sbjct: 151 --DLKPSNIVVKSDATLKILDFG-LARTAGTSFMMTPYVV-TRYYRAPEVILGMG----- 201
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           Y    D WS+GV M EM+ G   F     ++ + K++  
Sbjct: 202 YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 87/198 (43%), Gaps = 31/198 (15%)
Query: 38  ECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCG 97
           +C    +R E   ++ +   A L   R V +YG          A ++   + + M+   G
Sbjct: 101 QCAVKKVRLEVFRAEELMACAGLTSPRIVPLYG----------AVREGPWVNIFMELLEG 150
Query: 98  GDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL 157
           G L  L+ K +  LPED A +Y+ + +  +  +H    +H           D+K DNVLL
Sbjct: 151 GSLGQLV-KEQGCLPEDRALYYLGQALEGLEYLHSRRILH----------GDVKADNVLL 199
Query: 158 DANG-HIRLADFGSCLRLGGDG----TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECD 212
            ++G H  L DFG  + L  DG     +  +   GT  +++PE++     GR     + D
Sbjct: 200 SSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVL----GRS-CDAKVD 254
Query: 213 WWSLGVCMYEMLYGETPF 230
            WS    M  ML G  P+
Sbjct: 255 VWSSCCMMLHMLNGCHPW 272

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 78/175 (44%), Gaps = 19/175 (10%)
Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPED 114
           E   +  +E  V+       +  L     D  +L LV  Y   G LL  LS  +   P  
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 115 MAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL 174
               +     +A  + + ++++H  NH   H+ RDIK  N+LLD     +++DFG  L  
Sbjct: 132 ----WHMRCKIAQGAANGINFLHE-NH---HIHRDIKSANILLDEAFTAKISDFG--LAR 181
Query: 175 GGDG---TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYG 226
             +    TV  +  VGT  Y++PE L      RG   P+ D +S GV + E++ G
Sbjct: 182 ASEKFAQTVMXSRIVGTTAYMAPEAL------RGEITPKSDIYSFGVVLLEIITG 230

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 95  SLEEFNDVYLVT-HLMGADLNNIVKS--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 149
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG C     + T      V T  Y +PEI+   
Sbjct: 150 --------DLKPSNLAVNEDSELKILDFGLCRHTDDEMTGY----VATRWYRAPEIML-- 195
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 65/145 (44%), Gaps = 14/145 (9%)
Query: 111 LPEDMAKFYIAEMVLAIASIHD-LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG 169
           +PED+       +V A+  +H  L  +HR          D+KP NVL++A G ++  DFG
Sbjct: 133 IPEDILGKIAVSIVKALEHLHSKLSVIHR----------DVKPSNVLINALGQVKXCDFG 182
Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
               L  D  V  ++  G   Y +PE +      +G Y  + D WSLG+   E+     P
Sbjct: 183 ISGYLVDD--VAKDIDAGCKPYXAPERINPELNQKG-YSVKSDIWSLGITXIELAILRFP 239
Query: 230 FYAESLVETYGKIMNHQNSFDLPSD 254
           + +        K +  + S  LP+D
Sbjct: 240 YDSWGTPFQQLKQVVEEPSPQLPAD 264

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 71/164 (43%), Gaps = 21/164 (12%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + +D S +YLV     G DL  ++      L ++  +F + +++  +  IH    +HR  
Sbjct: 101 SIEDFSEVYLVTTL-MGADLNNIVKS--QALSDEHVQFLVYQLLRGLKYIHSAGIIHR-- 155
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP NV ++ +  +R+ DFG    L      +    V T  Y +PEI+   
Sbjct: 156 --------DLKPSNVAVNEDSELRILDFG----LARQADEEMTGYVATRWYRAPEIML-- 201
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
                 Y    D WS+G  M E+L G+  F     ++   +IM 
Sbjct: 202 --NWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIME 243

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 67/155 (43%), Gaps = 23/155 (14%)
Query: 89  YLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAI--ASIHDLHYVHRPNHFAFHL 146
           +L++   C G L+  L K E R P         + VL I   +   + ++HR      H 
Sbjct: 109 FLLLTELCKGQLVEFLKKMESRGP------LSCDTVLKIFYQTCRAVQHMHRQKPPIIH- 161
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLG----------GDGTVQSNVAVG-TPDYISPE 195
            RD+K +N+LL   G I+L DFGS   +               V+  +    TP Y +PE
Sbjct: 162 -RDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPE 220
Query: 196 ILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
           I+          G + D W+LG  +Y + + + PF
Sbjct: 221 IIDLY--SNFPIGEKQDIWALGCILYLLCFRQHPF 253

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 73/173 (42%), Gaps = 25/173 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++         L KF D      +P  + K Y+ +++  +A 
Sbjct: 67  IVKLLDVIHTENKLYLVFEHVDQD-----LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H    +HR          D+KP N+L++  G I+LADFG     G       +  V T 
Sbjct: 122 CHSHRVLHR----------DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 170
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 171 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 219

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 65/157 (41%), Gaps = 16/157 (10%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  LH     D  L LV ++ C  DL          L  ++ K ++ +++  +   H  +
Sbjct: 63  IVRLHDVLHSDKKLTLVFEF-CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          D+KP N+L++ NG ++LA+FG   R  G      +  V T  Y  P
Sbjct: 122 VLHR----------DLKPQNLLINRNGELKLANFGLA-RAFGIPVRCYSAEVVTLWYRPP 170
Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
           ++L     G   Y    D WS G    E+     P +
Sbjct: 171 DVLF----GAKLYSTSIDMWSAGCIFAELANAGRPLF 203

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 80/180 (44%), Gaps = 27/180 (15%)
Query: 75  ITNLHYAF------QDDSNLYLVMDYYCGG--DLLTLLSKFEDRLPEDMAKFYIAEMVLA 126
           I  L Y F      +D   L LV+DY       +    S+ +  LP    K Y+ ++  +
Sbjct: 75  IVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 127 IASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI-RLADFGSCLRL-GGDGTVQSNV 184
           +A IH     HR          DIKP N+LLD +  + +L DFGS  +L  G+  V    
Sbjct: 135 LAYIHSFGICHR----------DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-- 182
Query: 185 AVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
            + +  Y +PE++     G   Y    D WS G  + E+L G+  F  +S V+   +I+ 
Sbjct: 183 -ICSRYYRAPELIF----GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 77/175 (44%), Gaps = 19/175 (10%)
Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPED 114
           E   +  +E  V+       +  L     D  +L LV  Y   G LL  LS  +   P  
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 115 MAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL 174
               +     +A  + + ++++H  NH   H+ RDIK  N+LLD     +++DFG  L  
Sbjct: 132 ----WHMRCKIAQGAANGINFLHE-NH---HIHRDIKSANILLDEAFTAKISDFG--LAR 181
Query: 175 GGDG---TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYG 226
             +    TV     VGT  Y++PE L      RG   P+ D +S GV + E++ G
Sbjct: 182 ASEKFAQTVMXXRIVGTTAYMAPEAL------RGEITPKSDIYSFGVVLLEIITG 230

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 74/173 (42%), Gaps = 25/173 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L  F D      +P  + K Y+ +++  +A 
Sbjct: 64  IVKLLDVIHTENKLYLVFEF-----LHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H    +HR          D+KP+N+L++  G I+LADFG     G       +  V T 
Sbjct: 119 CHSHRVLHR----------DLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 167
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 168 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 69/153 (45%), Gaps = 23/153 (15%)
Query: 89  YLVMDYYCGGDLLTLLSKFEDR---LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
           +L++ ++  G L   + + +D+   L ED   + +  +   + +IH   Y HR       
Sbjct: 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHR------- 158
Query: 146 LCRDIKPDNVLLDANGHIRLADFGS----CLRLGGDG---TVQSNVAVG-TPDYISPEIL 197
              D+KP N+LL   G   L D GS    C+ + G     T+Q   A   T  Y +PE+ 
Sbjct: 159 ---DLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELF 215
Query: 198 TAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
           +   +         D WSLG  +Y M++GE P+
Sbjct: 216 SV--QSHCVIDERTDVWSLGCVLYAMMFGEGPY 246

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 71/164 (43%), Gaps = 21/164 (12%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + +D S +YLV     G DL  ++      L ++  +F + +++  +  IH    +HR  
Sbjct: 101 SIEDFSEVYLVTTL-MGADLNNIVKC--QALSDEHVQFLVYQLLRGLKYIHSAGIIHR-- 155
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP NV ++ +  +R+ DFG    L      +    V T  Y +PEI+   
Sbjct: 156 --------DLKPSNVAVNEDSELRILDFG----LARQADEEMTGYVATRWYRAPEIML-- 201
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
                 Y    D WS+G  M E+L G+  F     ++   +IM 
Sbjct: 202 --NWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIME 243

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 75/181 (41%), Gaps = 25/181 (13%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L  F D      +P  + K Y+ +++  +A 
Sbjct: 67  IVKLLDVIHTENKLYLVFEF-----LSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H    +HR          D+KP N+L++  G I+LADFG     G       +  V T 
Sbjct: 122 CHSHRVLHR----------DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 170
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSF 249
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I     + 
Sbjct: 171 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 226
Query: 250 D 250
           D
Sbjct: 227 D 227

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 73/173 (42%), Gaps = 25/173 (14%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L      ++ LYLV ++     L   L  F D      +P  + K Y+ +++  +A 
Sbjct: 66  IVKLLDVIHTENKLYLVFEF-----LSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H    +HR          D+KP N+L++  G I+LADFG     G       +  V T 
Sbjct: 121 CHSHRVLHR----------DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 169
Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y +PEIL     G   Y    D WSLG    EM+     F  +S ++   +I
Sbjct: 170 WYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 218

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 64/125 (51%), Gaps = 17/125 (13%)
Query: 112 PEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL-DANGHIRLADFGS 170
           P  + K ++ +++ +I  +H       P+    H  RDIKP NVL+ +A+G ++L DFGS
Sbjct: 127 PPILIKVFLFQLIRSIGCLH------LPSVNVCH--RDIKPHNVLVNEADGTLKLCDFGS 178
Query: 171 CLRLGGDGTVQSNVA-VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
             +L      + NVA + +  Y +PE++     G   Y    D WS+G    EM+ GE  
Sbjct: 179 AKKLSPS---EPNVAYICSRYYRAPELIF----GNQHYTTAVDIWSVGCIFAEMMLGEPI 231
Query: 230 FYAES 234
           F  ++
Sbjct: 232 FRGDN 236

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/219 (21%), Positives = 90/219 (41%), Gaps = 21/219 (9%)
Query: 31  ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG--DRRWITNLHYAFQDDSNL 88
           I+   YD     ++  +K    F       R  R++++    + + I  L   F    +L
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSL 98
Query: 89  YLVMDYYCGGDLL--TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
               D Y   +L+   L    +  L  +   + + +M++ I  +H    +HR        
Sbjct: 99  EEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHR-------- 150
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+++ ++  +++ DFG   R  G   + +   V T  Y +PE++  M      
Sbjct: 151 --DLKPSNIVVKSDATLKILDFG-LARTAGTSFMMTPYVV-TRYYRAPEVILGM-----G 201
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           Y    D WS+G  M EM+ G   F     ++ + K++  
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 71/164 (43%), Gaps = 21/164 (12%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + +D S +YLV     G DL  ++      L ++  +F + +++  +  IH    +HR  
Sbjct: 93  SIEDFSEVYLVTTL-MGADLNNIVKC--QALSDEHVQFLVYQLLRGLKYIHSAGIIHR-- 147
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP NV ++ +  +R+ DFG    L      +    V T  Y +PEI+   
Sbjct: 148 --------DLKPSNVAVNEDCELRILDFG----LARQADEEMTGYVATRWYRAPEIML-- 193
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
                 Y    D WS+G  M E+L G+  F     ++   +IM 
Sbjct: 194 --NWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIME 235

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 77/175 (44%), Gaps = 19/175 (10%)
Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPED 114
           E   +  +E  V+       +  L     D  +L LV  Y   G LL  LS  +   P  
Sbjct: 66  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 125
Query: 115 MAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL 174
               +     +A  + + ++++H  NH   H+ RDIK  N+LLD     +++DFG  L  
Sbjct: 126 ----WHMRCKIAQGAANGINFLHE-NH---HIHRDIKSANILLDEAFTAKISDFG--LAR 175
Query: 175 GGDGTVQSNVA---VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYG 226
             +   Q  +    VGT  Y++PE L      RG   P+ D +S GV + E++ G
Sbjct: 176 ASEKFAQXVMXXRIVGTTAYMAPEAL------RGEITPKSDIYSFGVVLLEIITG 224

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 83/198 (41%), Gaps = 33/198 (16%)
Query: 49  TVSDFIEFVAKLREERDVLVYG---DRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLS 105
           T+   +  +A L  +  V  Y    +RR       A +  S L++  +Y     L  L+ 
Sbjct: 48  TILSEVXLLASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIH 107
Query: 106 KFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRL 165
                   D       +++ A++ IH    +HR          ++KP N+ +D + ++++
Sbjct: 108 SENLNQQRDEYWRLFRQILEALSYIHSQGIIHR----------NLKPXNIFIDESRNVKI 157
Query: 166 ADFG---------SCLRLGGDGTVQSN----VAVGTPDYISPEILTAMEEGRGRYGPECD 212
            DFG           L+L       S+     A+GT  Y++ E+L    +G G Y  + D
Sbjct: 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVL----DGTGHYNEKID 213
Query: 213 WWSLGVCMYEMLYGETPF 230
            +SLG+  +E +Y   PF
Sbjct: 214 XYSLGIIFFEXIY---PF 228

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 73/165 (44%), Gaps = 29/165 (17%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L+ A ++   + + M+   GG L  L+ +    LPED A +Y+ + +  +  +H   
Sbjct: 126 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRR 184
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANG-HIRLADFGSCLRLGGDGTVQS----NVAVGTP 189
            +H           D+K DNVLL ++G    L DFG  L L  DG  +S    +   GT 
Sbjct: 185 ILH----------GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 234
Query: 190 DYISPEILTAMEEGRGRYGPECDW----WSLGVCMYEMLYGETPF 230
            +++PE++          G  CD     WS    M  ML G  P+
Sbjct: 235 THMAPEVVM---------GKPCDAKVDIWSSCCMMLHMLNGCHPW 270

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 73/165 (44%), Gaps = 29/165 (17%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L+ A ++   + + M+   GG L  L+ +    LPED A +Y+ + +  +  +H   
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRR 170
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANG-HIRLADFGSCLRLGGDGTVQS----NVAVGTP 189
            +H           D+K DNVLL ++G    L DFG  L L  DG  +S    +   GT 
Sbjct: 171 ILH----------GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 220
Query: 190 DYISPEILTAMEEGRGRYGPECDW----WSLGVCMYEMLYGETPF 230
            +++PE++          G  CD     WS    M  ML G  P+
Sbjct: 221 THMAPEVV---------MGKPCDAKVDIWSSCCMMLHMLNGCHPW 256

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 73/165 (44%), Gaps = 29/165 (17%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L+ A ++   + + M+   GG L  L+ +    LPED A +Y+ + +  +  +H   
Sbjct: 128 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRR 186
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANG-HIRLADFGSCLRLGGDGTVQS----NVAVGTP 189
            +H           D+K DNVLL ++G    L DFG  L L  DG  +S    +   GT 
Sbjct: 187 ILH----------GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 236
Query: 190 DYISPEILTAMEEGRGRYGPECDW----WSLGVCMYEMLYGETPF 230
            +++PE++          G  CD     WS    M  ML G  P+
Sbjct: 237 THMAPEVV---------MGKPCDAKVDIWSSCCMMLHMLNGCHPW 272

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 68/157 (43%), Gaps = 25/157 (15%)
Query: 69  YGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIA 128
           + D R    L Y + ++ NL     +  G DL T+   +E RL             + I 
Sbjct: 103 FCDERNEMILIYKYMENGNL---KRHLYGSDLPTMSMSWEQRLE------------ICIG 147
Query: 129 SIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR-LGGDGTVQSNVAVG 187
           +   LHY+H       H  RD+K  N+LLD N   ++ DFG   +    D T    V  G
Sbjct: 148 AARGLHYLH--TRAIIH--RDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKG 203
Query: 188 TPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML 224
           T  YI PE        +GR   + D +S GV ++E+L
Sbjct: 204 TLGYIDPEYFI-----KGRLTEKSDVYSFGVVLFEVL 235

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 68/146 (46%), Gaps = 19/146 (13%)
Query: 84  DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFA 143
           D  +L LV  Y   G LL  LS  +   P      +     +A  + + ++++H  NH  
Sbjct: 92  DGDDLCLVYVYXPNGSLLDRLSCLDGTPPLS----WHXRCKIAQGAANGINFLHE-NH-- 144
Query: 144 FHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ---SNVAVGTPDYISPEILTAM 200
            H+ RDIK  N+LLD     +++DFG  L    +   Q    +  VGT  Y +PE L   
Sbjct: 145 -HIHRDIKSANILLDEAFTAKISDFG--LARASEKFAQXVXXSRIVGTTAYXAPEAL--- 198
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYG 226
              RG   P+ D +S GV + E++ G
Sbjct: 199 ---RGEITPKSDIYSFGVVLLEIITG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/219 (21%), Positives = 89/219 (40%), Gaps = 21/219 (9%)
Query: 31  ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG--DRRWITNLHYAFQDDSNL 88
           I+   YD     ++  +K    F       R  R++++    + + I  L   F    +L
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 89  YLVMDYYCGGDLL--TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
               D Y   +L+   L    +  L  +   + + +M+  I  +H    +HR        
Sbjct: 99  EEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR-------- 150
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+++ ++  +++ DFG   R  G   + +   V T  Y +PE++  M      
Sbjct: 151 --DLKPSNIVVKSDATLKILDFG-LARTAGTSFMMTPYVV-TRYYRAPEVILGMG----- 201
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           Y    D WS+G  M EM+ G   F     ++ + K++  
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/219 (21%), Positives = 89/219 (40%), Gaps = 21/219 (9%)
Query: 31  ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG--DRRWITNLHYAFQDDSNL 88
           I+   YD     ++  +K    F       R  R++++    + + I  L   F    +L
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSL 98
Query: 89  YLVMDYYCGGDLL--TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
               D Y   +L+   L    +  L  +   + + +M+  I  +H    +HR        
Sbjct: 99  EEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR-------- 150
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+++ ++  +++ DFG   R  G   + +   V T  Y +PE++  M      
Sbjct: 151 --DLKPSNIVVKSDATLKILDFG-LARTAGTSFMMTPYVV-TRYYRAPEVILGM-----G 201
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           Y    D WS+G  M EM+ G   F     ++ + K++  
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 67/157 (42%), Gaps = 25/157 (15%)
Query: 69  YGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIA 128
           + D R    L Y + ++ NL     +  G DL T+   +E RL             + I 
Sbjct: 103 FCDERNEMILIYKYMENGNL---KRHLYGSDLPTMSMSWEQRLE------------ICIG 147
Query: 129 SIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ-SNVAVG 187
           +   LHY+H       H  RD+K  N+LLD N   ++ DFG   +    G      V  G
Sbjct: 148 AARGLHYLH--TRAIIH--RDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKG 203
Query: 188 TPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML 224
           T  YI PE        +GR   + D +S GV ++E+L
Sbjct: 204 TLGYIDPEYFI-----KGRLTEKSDVYSFGVVLFEVL 235

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 18/121 (14%)
Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFG 169
           L E++A+ +  +++ A+   H+   +HR          DIK +N+L+D N G ++L DFG
Sbjct: 107 LQEELARSFFWQVLEAVRHCHNXGVLHR----------DIKDENILIDLNRGELKLIDFG 156
Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           S   L    TV ++   GT  Y  PE +         +G     WSLG+ +Y+M+ G+ P
Sbjct: 157 SGALL--KDTVYTDFD-GTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIP 209
Query: 230 F 230
           F
Sbjct: 210 F 210

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 71/161 (44%), Gaps = 16/161 (9%)
Query: 85  DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAF 144
           ++ ++++M+    G+L + L   +  L       Y  ++  A+A +    +VHR      
Sbjct: 82  ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHR------ 135
Query: 145 HLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR 204
               DI   NVL+ +N  ++L DFG    +      +++       +++PE +       
Sbjct: 136 ----DIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFR---- 187
Query: 205 GRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
            R+    D W  GVCM+E+L +G  PF      +  G+I N
Sbjct: 188 -RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 227

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 96/224 (42%), Gaps = 27/224 (12%)
Query: 16  IQGKGRVFSIETLLDILLVLYDECCN-SSLRREKTVSDFIEFVAKLREERDVLVYGDRRW 74
           + GKG     E L+ + L  Y       ++RR    +   E V  L+ E  V    +   
Sbjct: 32  VIGKG----FEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPN 87
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLL-SKFEDRLPEDMAKFYIAEMVL-AIASIHD 132
           I      F  D+ L++V  +   G    L+ + F D + E +A  YI + VL A+  IH 
Sbjct: 88  IVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNE-LAIAYILQGVLKALDYIHH 146
Query: 133 LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNV------AV 186
           + YVH          R +K  ++L+  +G + L+   S L +   G  Q  V      +V
Sbjct: 147 MGYVH----------RSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196
Query: 187 GTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
               ++SPE+L    +G   Y  + D +S+G+   E+  G  PF
Sbjct: 197 KVLPWLSPEVLQQNLQG---YDAKSDIYSVGITACELANGHVPF 237

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 96/224 (42%), Gaps = 27/224 (12%)
Query: 16  IQGKGRVFSIETLLDILLVLYDECCN-SSLRREKTVSDFIEFVAKLREERDVLVYGDRRW 74
           + GKG     E L+ + L  Y       ++RR    +   E V  L+ E  V    +   
Sbjct: 16  VIGKG----FEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPN 71
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLL-SKFEDRLPEDMAKFYIAEMVL-AIASIHD 132
           I      F  D+ L++V  +   G    L+ + F D + E +A  YI + VL A+  IH 
Sbjct: 72  IVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNE-LAIAYILQGVLKALDYIHH 130
Query: 133 LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNV------AV 186
           + YVH          R +K  ++L+  +G + L+   S L +   G  Q  V      +V
Sbjct: 131 MGYVH----------RSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 180
Query: 187 GTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
               ++SPE+L    +G   Y  + D +S+G+   E+  G  PF
Sbjct: 181 KVLPWLSPEVLQQNLQG---YDAKSDIYSVGITACELANGHVPF 221

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 18/121 (14%)
Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFG 169
           L E++A+ +  +++ A+   H+   +HR          DIK +N+L+D N G ++L DFG
Sbjct: 110 LQEELARSFFWQVLEAVRHCHNCGVLHR----------DIKDENILIDLNRGELKLIDFG 159
Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           S   L    TV ++   GT  Y  PE +         +G     WSLG+ +Y+M+ G+ P
Sbjct: 160 SGALL--KDTVYTDFD-GTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIP 212
Query: 230 F 230
           F
Sbjct: 213 F 213

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 18/121 (14%)
Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFG 169
           L E++A+ +  +++ A+   H+   +HR          DIK +N+L+D N G ++L DFG
Sbjct: 111 LQEELARSFFWQVLEAVRHCHNCGVLHR----------DIKDENILIDLNRGELKLIDFG 160
Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           S   L    TV ++   GT  Y  PE +         +G     WSLG+ +Y+M+ G+ P
Sbjct: 161 SGALL--KDTVYTDFD-GTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIP 213
Query: 230 F 230
           F
Sbjct: 214 F 214

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 18/121 (14%)
Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFG 169
           L E++A+ +  +++ A+   H+   +HR          DIK +N+L+D N G ++L DFG
Sbjct: 107 LQEELARSFFWQVLEAVRHCHNCGVLHR----------DIKDENILIDLNRGELKLIDFG 156
Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           S   L    TV ++   GT  Y  PE +         +G     WSLG+ +Y+M+ G+ P
Sbjct: 157 SGALL--KDTVYTDFD-GTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIP 209
Query: 230 F 230
           F
Sbjct: 210 F 210

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/219 (21%), Positives = 87/219 (39%), Gaps = 21/219 (9%)
Query: 31  ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG--DRRWITNLHYAFQDDSNL 88
           I+   YD     ++  +K    F       R  R++++    + + I  L   F    +L
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 89  YLVMDYYCGGDLL--TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
               D Y   +L+   L    +  L  +   + + +M+  I  +H    +HR        
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR-------- 150
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+++ ++  +++ DFG     G    +   V   T  Y +PE++  M      
Sbjct: 151 --DLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVV--TRYYRAPEVILGMG----- 201
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           Y    D WS+G  M EM+ G   F     ++ + K++  
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 18/121 (14%)
Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFG 169
           L E++A+ +  +++ A+   H+   +HR          DIK +N+L+D N G ++L DFG
Sbjct: 107 LQEELARSFFWQVLEAVRHCHNCGVLHR----------DIKDENILIDLNRGELKLIDFG 156
Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           S   L    TV ++   GT  Y  PE +         +G     WSLG+ +Y+M+ G+ P
Sbjct: 157 SGALL--KDTVYTDFD-GTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIP 209
Query: 230 F 230
           F
Sbjct: 210 F 210

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 18/121 (14%)
Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFG 169
           L E++A+ +  +++ A+   H+   +HR          DIK +N+L+D N G ++L DFG
Sbjct: 111 LQEELARSFFWQVLEAVRHCHNCGVLHR----------DIKDENILIDLNRGELKLIDFG 160
Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           S   L    TV ++   GT  Y  PE +         +G     WSLG+ +Y+M+ G+ P
Sbjct: 161 SGALL--KDTVYTDFD-GTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIP 213
Query: 230 F 230
           F
Sbjct: 214 F 214

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 71/151 (47%), Gaps = 23/151 (15%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 95  SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 149
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEI-LTA 199
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI L A
Sbjct: 150 --------DLKPSNLAVNEDCELKILDFGLARHTDDEMTGY----VATRWYRAPEIMLNA 197
Query: 200 MEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
           M      Y    D WS+G  M E+L G T F
Sbjct: 198 MH-----YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/219 (21%), Positives = 89/219 (40%), Gaps = 21/219 (9%)
Query: 31  ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG--DRRWITNLHYAFQDDSNL 88
           I+   YD     ++  +K    F       R  R++++    + + I  L   F    +L
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 89  YLVMDYYCGGDLL--TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
               D Y   +L+   L    +  L  +   + + +M+  I  +H    +HR        
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR-------- 150
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+++ ++  +++ DFG   R  G   + +   V T  Y +PE++  M      
Sbjct: 151 --DLKPSNIVVKSDCTLKILDFG-LARTAGTSFMMTPYVV-TRYYRAPEVILGMG----- 201
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           Y    D WS+G  M EM+ G   F     ++ + K++  
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 18/121 (14%)
Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFG 169
           L E++A+ +  +++ A+   H+   +HR          DIK +N+L+D N G ++L DFG
Sbjct: 112 LQEELARSFFWQVLEAVRHCHNCGVLHR----------DIKDENILIDLNRGELKLIDFG 161
Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           S   L    TV ++   GT  Y  PE +         +G     WSLG+ +Y+M+ G+ P
Sbjct: 162 SGALL--KDTVYTDFD-GTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIP 214
Query: 230 F 230
           F
Sbjct: 215 F 215

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 18/121 (14%)
Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFG 169
           L E++A+ +  +++ A+   H+   +HR          DIK +N+L+D N G ++L DFG
Sbjct: 112 LQEELARSFFWQVLEAVRHCHNCGVLHR----------DIKDENILIDLNRGELKLIDFG 161
Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           S   L    TV ++   GT  Y  PE +         +G     WSLG+ +Y+M+ G+ P
Sbjct: 162 SGALL--KDTVYTDFD-GTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIP 214
Query: 230 F 230
           F
Sbjct: 215 F 215

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 76/185 (41%), Gaps = 29/185 (15%)
Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR--LP 112
           E + KL  +  V ++      T  H          L+M++   G L T+L +  +   LP
Sbjct: 59  EVLKKLNHKNIVKLFAIEEETTTRHKV--------LIMEFCPCGSLYTVLEEPSNAYGLP 110
Query: 113 EDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL----DANGHIRLADF 168
           E      + ++V  +  + +   VHR          +IKP N++     D     +L DF
Sbjct: 111 ESEFLIVLRDVVGGMNHLRENGIVHR----------NIKPGNIMRVIGEDGQSVYKLTDF 160
Query: 169 GSCLRLGGDGTVQSNVAVGTPDYISPEI---LTAMEEGRGRYGPECDWWSLGVCMYEMLY 225
           G+   L  D    S    GT +Y+ P++       ++ + +YG   D WS+GV  Y    
Sbjct: 161 GAARELEDDEQFVS--LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
Query: 226 GETPF 230
           G  PF
Sbjct: 219 GSLPF 223

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/219 (21%), Positives = 89/219 (40%), Gaps = 21/219 (9%)
Query: 31  ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG--DRRWITNLHYAFQDDSNL 88
           I+   YD     ++  +K    F       R  R++++    + + I  L   F    +L
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 89  YLVMDYYCGGDLL--TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
               D Y   +L+   L    +  L  +   + + +M+  I  +H    +HR        
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR-------- 150
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+++ ++  +++ DFG   R  G   + +   V T  Y +PE++  M      
Sbjct: 151 --DLKPSNIVVKSDCTLKILDFG-LARTAGTSFMMTPYVV-TRYYRAPEVILGMG----- 201
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           Y    D WS+G  M EM+ G   F     ++ + K++  
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/180 (23%), Positives = 81/180 (45%), Gaps = 23/180 (12%)
Query: 53  FIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLP 112
           F   VA LR+ R V +         L   +    NL +V  +  G  L   L   E    
Sbjct: 79  FRNEVAVLRKTRHVNIL--------LFMGYMTKDNLAIVTQWCEGSSLYKHLHVQE---- 126
Query: 113 EDMAKFYIAEMV-LAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG-S 170
               KF + +++ +A  +   + Y+H  N     + RD+K +N+ L     +++ DFG +
Sbjct: 127 ---TKFQMFQLIDIARQTAQGMDYLHAKNI----IHRDMKSNNIFLHEGLTVKIGDFGLA 179
Query: 171 CLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
            ++    G+ Q     G+  +++PE++   +     +  + D +S G+ +YE++ GE P+
Sbjct: 180 TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNP--FSFQSDVYSYGIVLYELMTGELPY 237

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 71/158 (44%), Gaps = 22/158 (13%)
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           + YLVM +    DL  ++     +  E+  ++ + +M+  +  IH    VHR        
Sbjct: 103 DFYLVMPF-MQTDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAGVVHR-------- 150
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+ ++ +  +++ DFG    L      +    V T  Y +PE++ +       
Sbjct: 151 --DLKPGNLAVNEDCELKILDFG----LARHADAEMTGYVVTRWYRAPEVILSW----MH 200
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
           Y    D WS+G  M EML G+T F  +  ++   +I+ 
Sbjct: 201 YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 238

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/219 (21%), Positives = 90/219 (41%), Gaps = 21/219 (9%)
Query: 31  ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG--DRRWITNLHYAFQDDSNL 88
           I+   YD   + ++  +K    F       R  R++++    + + I +L   F     L
Sbjct: 39  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTL 98
Query: 89  YLVMDYYCGGDLL--TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
               D Y   +L+   L    +  L  +   + + +M+  I  +H    +HR        
Sbjct: 99  EEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR-------- 150
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+++ ++  +++ DFG   R  G   + +   V T  Y +PE++  M      
Sbjct: 151 --DLKPSNIVVKSDXTLKILDFGLA-RTAGTSFMMTPYVV-TRYYRAPEVILGMG----- 201
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           Y    D WS+G  M EM+  +  F     ++ + K++  
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/219 (21%), Positives = 89/219 (40%), Gaps = 21/219 (9%)
Query: 31  ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG--DRRWITNLHYAFQDDSNL 88
           I+   YD     ++  +K    F       R  R++++    + + I  L   F    +L
Sbjct: 40  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 99
Query: 89  YLVMDYYCGGDLL--TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
               D Y   +L+   L    +  L  +   + + +M+  I  +H    +HR        
Sbjct: 100 EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR-------- 151
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+++ ++  +++ DFG   R  G   + +   V T  Y +PE++  M      
Sbjct: 152 --DLKPSNIVVKSDCTLKILDFG-LARTAGTSFMMTPYVV-TRYYRAPEVILGM-----G 202
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           Y    D WS+G  M EM+ G   F     ++ + K++  
Sbjct: 203 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 241

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 18/121 (14%)
Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFG 169
           L E++A+ +  +++ A+   H+   +HR          DIK +N+L+D N G ++L DFG
Sbjct: 134 LQEELARSFFWQVLEAVRHCHNCGVLHR----------DIKDENILIDLNRGELKLIDFG 183
Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           S   L    TV ++   GT  Y  PE +         +G     WSLG+ +Y+M+ G+ P
Sbjct: 184 SGALL--KDTVYTDFD-GTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIP 236
Query: 230 F 230
           F
Sbjct: 237 F 237

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/219 (21%), Positives = 90/219 (41%), Gaps = 21/219 (9%)
Query: 31  ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG--DRRWITNLHYAFQDDSNL 88
           I+   YD   + ++  +K    F       R  R++++    + + I +L   F     L
Sbjct: 39  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTL 98
Query: 89  YLVMDYYCGGDLL--TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
               D Y   +L+   L    +  L  +   + + +M+  I  +H    +HR        
Sbjct: 99  EEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHR-------- 150
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+++ ++  +++ DFG   R  G   + +   V T  Y +PE++  M      
Sbjct: 151 --DLKPSNIVVKSDXTLKILDFGLA-RTAGTSFMMTPYVV-TRYYRAPEVILGMG----- 201
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           Y    D WS+G  M EM+  +  F     ++ + K++  
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/219 (21%), Positives = 90/219 (41%), Gaps = 21/219 (9%)
Query: 31  ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG--DRRWITNLHYAFQDDSNL 88
           I+   YD   + ++  +K    F       R  R++++    + + I +L   F     L
Sbjct: 32  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 91
Query: 89  YLVMDYYCGGDLL--TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
               D Y   +L+   L    +  L  +   + + +M+  I  +H    +HR        
Sbjct: 92  EEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHR-------- 143
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+++ ++  +++ DFG   R  G   + +   V T  Y +PE++  M      
Sbjct: 144 --DLKPSNIVVKSDXTLKILDFGLA-RTAGTSFMMTPYVV-TRYYRAPEVILGMG----- 194
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           Y    D WS+G  M EM+  +  F     ++ + K++  
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 18/121 (14%)
Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFG 169
           L E++A+ +  +++ A+   H+   +HR          DIK +N+L+D N G ++L DFG
Sbjct: 154 LQEELARSFFWQVLEAVRHCHNCGVLHR----------DIKDENILIDLNRGELKLIDFG 203
Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           S   L    TV ++   GT  Y  PE +         +G     WSLG+ +Y+M+ G+ P
Sbjct: 204 SGALL--KDTVYTDFD-GTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIP 256
Query: 230 F 230
           F
Sbjct: 257 F 257

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 18/121 (14%)
Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFG 169
           L E++A+ +  +++ A+   H+   +HR          DIK +N+L+D N G ++L DFG
Sbjct: 112 LQEELARSFFWQVLEAVRHCHNCGVLHR----------DIKDENILIDLNRGELKLIDFG 161
Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           S   L    TV ++   GT  Y  PE +         +G     WSLG+ +Y+M+ G+ P
Sbjct: 162 SGALL--KDTVYTDFD-GTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIP 214
Query: 230 F 230
           F
Sbjct: 215 F 215

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/219 (21%), Positives = 90/219 (41%), Gaps = 21/219 (9%)
Query: 31  ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG--DRRWITNLHYAFQDDSNL 88
           I+   YD   + ++  +K    F       R  R++++    + + I +L   F     L
Sbjct: 39  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 98
Query: 89  YLVMDYYCGGDLL--TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
               D Y   +L+   L    +  L  +   + + +M+  I  +H    +HR        
Sbjct: 99  EEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHR-------- 150
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+++ ++  +++ DFG   R  G   + +   V T  Y +PE++  M      
Sbjct: 151 --DLKPSNIVVKSDXTLKILDFG-LARTAGTSFMMTPYVV-TRYYRAPEVILGMG----- 201
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           Y    D WS+G  M EM+  +  F     ++ + K++  
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 18/121 (14%)
Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFG 169
           L E++A+ +  +++ A+   H+   +HR          DIK +N+L+D N G ++L DFG
Sbjct: 140 LQEELARSFFWQVLEAVRHCHNCGVLHR----------DIKDENILIDLNRGELKLIDFG 189
Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           S   L    TV ++   GT  Y  PE +         +G     WSLG+ +Y+M+ G+ P
Sbjct: 190 SGALL--KDTVYTDFD-GTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIP 242
Query: 230 F 230
           F
Sbjct: 243 F 243

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 18/121 (14%)
Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFG 169
           L E++A+ +  +++ A+   H+   +HR          DIK +N+L+D N G ++L DFG
Sbjct: 154 LQEELARSFFWQVLEAVRHCHNCGVLHR----------DIKDENILIDLNRGELKLIDFG 203
Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           S   L    TV ++   GT  Y  PE +         +G     WSLG+ +Y+M+ G+ P
Sbjct: 204 SGALL--KDTVYTDFD-GTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIP 256
Query: 230 F 230
           F
Sbjct: 257 F 257

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 18/121 (14%)
Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFG 169
           L E++A+ +  +++ A+   H+   +HR          DIK +N+L+D N G ++L DFG
Sbjct: 139 LQEELARSFFWQVLEAVRHCHNCGVLHR----------DIKDENILIDLNRGELKLIDFG 188
Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           S   L    TV ++   GT  Y  PE +         +G     WSLG+ +Y+M+ G+ P
Sbjct: 189 SGALL--KDTVYTDFD-GTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIP 241
Query: 230 F 230
           F
Sbjct: 242 F 242

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 95  SLEEFNDVYLVT-HLMGADLNNIVKX--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 149
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 150 --------DLKPSNLAVNEDXELKILDFGLARHTDDEMTGY----VATRWYRAPEIML-- 195
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 18/121 (14%)
Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFG 169
           L E++A+ +  +++ A+   H+   +HR          DIK +N+L+D N G ++L DFG
Sbjct: 126 LQEELARSFFWQVLEAVRHCHNCGVLHR----------DIKDENILIDLNRGELKLIDFG 175
Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           S   L    TV ++   GT  Y  PE +         +G     WSLG+ +Y+M+ G+ P
Sbjct: 176 SGALL--KDTVYTDFD-GTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIP 228
Query: 230 F 230
           F
Sbjct: 229 F 229

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 18/121 (14%)
Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFG 169
           L E++A+ +  +++ A+   H+   +HR          DIK +N+L+D N G ++L DFG
Sbjct: 127 LQEELARSFFWQVLEAVRHCHNCGVLHR----------DIKDENILIDLNRGELKLIDFG 176
Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           S   L    TV ++   GT  Y  PE +         +G     WSLG+ +Y+M+ G+ P
Sbjct: 177 SGALL--KDTVYTDFD-GTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIP 229
Query: 230 F 230
           F
Sbjct: 230 F 230

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 18/121 (14%)
Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFG 169
           L E++A+ +  +++ A+   H+   +HR          DIK +N+L+D N G ++L DFG
Sbjct: 140 LQEELARSFFWQVLEAVRHCHNCGVLHR----------DIKDENILIDLNRGELKLIDFG 189
Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           S   L    TV ++   GT  Y  PE +         +G     WSLG+ +Y+M+ G+ P
Sbjct: 190 SGALL--KDTVYTDFD-GTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIP 242
Query: 230 F 230
           F
Sbjct: 243 F 243

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 18/121 (14%)
Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFG 169
           L E++A+ +  +++ A+   H+   +HR          DIK +N+L+D N G ++L DFG
Sbjct: 139 LQEELARSFFWQVLEAVRHCHNCGVLHR----------DIKDENILIDLNRGELKLIDFG 188
Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           S   L    TV ++   GT  Y  PE +         +G     WSLG+ +Y+M+ G+ P
Sbjct: 189 SGALL--KDTVYTDFD-GTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIP 241
Query: 230 F 230
           F
Sbjct: 242 F 242

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 18/121 (14%)
Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFG 169
           L E++A+ +  +++ A+   H+   +HR          DIK +N+L+D N G ++L DFG
Sbjct: 127 LQEELARSFFWQVLEAVRHCHNCGVLHR----------DIKDENILIDLNRGELKLIDFG 176
Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           S   L    TV ++   GT  Y  PE +         +G     WSLG+ +Y+M+ G+ P
Sbjct: 177 SGALL--KDTVYTDFD-GTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIP 229
Query: 230 F 230
           F
Sbjct: 230 F 230

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 18/121 (14%)
Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFG 169
           L E++A+ +  +++ A+   H+   +HR          DIK +N+L+D N G ++L DFG
Sbjct: 127 LQEELARSFFWQVLEAVRHCHNCGVLHR----------DIKDENILIDLNRGELKLIDFG 176
Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           S   L    TV ++   GT  Y  PE +         +G     WSLG+ +Y+M+ G+ P
Sbjct: 177 SGALL--KDTVYTDFD-GTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIP 229
Query: 230 F 230
           F
Sbjct: 230 F 230

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 18/121 (14%)
Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFG 169
           L E++A+ +  +++ A+   H+   +HR          DIK +N+L+D N G ++L DFG
Sbjct: 139 LQEELARSFFWQVLEAVRHCHNCGVLHR----------DIKDENILIDLNRGELKLIDFG 188
Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           S   L    TV ++   GT  Y  PE +         +G     WSLG+ +Y+M+ G+ P
Sbjct: 189 SGALL--KDTVYTDFD-GTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIP 241
Query: 230 F 230
           F
Sbjct: 242 F 242

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 18/121 (14%)
Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFG 169
           L E++A+ +  +++ A+   H+   +HR          DIK +N+L+D N G ++L DFG
Sbjct: 139 LQEELARSFFWQVLEAVRHCHNCGVLHR----------DIKDENILIDLNRGELKLIDFG 188
Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           S   L    TV ++   GT  Y  PE +         +G     WSLG+ +Y+M+ G+ P
Sbjct: 189 SGALL--KDTVYTDFD-GTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIP 241
Query: 230 F 230
           F
Sbjct: 242 F 242

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 18/121 (14%)
Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFG 169
           L E++A+ +  +++ A+   H+   +HR          DIK +N+L+D N G ++L DFG
Sbjct: 126 LQEELARSFFWQVLEAVRHCHNCGVLHR----------DIKDENILIDLNRGELKLIDFG 175
Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           S   L    TV ++   GT  Y  PE +         +G     WSLG+ +Y+M+ G+ P
Sbjct: 176 SGALL--KDTVYTDFD-GTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIP 228
Query: 230 F 230
           F
Sbjct: 229 F 229

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 18/121 (14%)
Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFG 169
           L E++A+ +  +++ A+   H+   +HR          DIK +N+L+D N G ++L DFG
Sbjct: 140 LQEELARSFFWQVLEAVRHCHNCGVLHR----------DIKDENILIDLNRGELKLIDFG 189
Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           S   L    TV ++   GT  Y  PE +         +G     WSLG+ +Y+M+ G+ P
Sbjct: 190 SGALL--KDTVYTDFD-GTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIP 242
Query: 230 F 230
           F
Sbjct: 243 F 243

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 18/121 (14%)
Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFG 169
           L E++A+ +  +++ A+   H+   +HR          DIK +N+L+D N G ++L DFG
Sbjct: 140 LQEELARSFFWQVLEAVRHCHNCGVLHR----------DIKDENILIDLNRGELKLIDFG 189
Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           S   L    TV ++   GT  Y  PE +         +G     WSLG+ +Y+M+ G+ P
Sbjct: 190 SGALL--KDTVYTDFD-GTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIP 242
Query: 230 F 230
           F
Sbjct: 243 F 243

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/219 (21%), Positives = 89/219 (40%), Gaps = 21/219 (9%)
Query: 31  ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG--DRRWITNLHYAFQDDSNL 88
           I+   YD     ++  +K    F       R  R++++    + + I  L   F    +L
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 89  YLVMDYYCGGDLL--TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
               D Y   +L+   L    +  L  +   + + +M+  I  +H    +HR        
Sbjct: 99  EEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR-------- 150
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+++ ++  +++ DFG   R  G   + +   V T  Y +PE++  M      
Sbjct: 151 --DLKPSNIVVKSDCTLKILDFG-LARTAGTSFMMTPYVV-TRYYRAPEVILGM-----G 201
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           Y    D WS+G  M EM+ G   F     ++ + K++  
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 18/121 (14%)
Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFG 169
           L E++A+ +  +++ A+   H+   +HR          DIK +N+L+D N G ++L DFG
Sbjct: 146 LQEELARSFFWQVLEAVRHCHNCGVLHR----------DIKDENILIDLNRGELKLIDFG 195
Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           S   L    TV ++   GT  Y  PE +         +G     WSLG+ +Y+M+ G+ P
Sbjct: 196 SGALL--KDTVYTDFD-GTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIP 248
Query: 230 F 230
           F
Sbjct: 249 F 249

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/219 (21%), Positives = 90/219 (41%), Gaps = 21/219 (9%)
Query: 31  ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG--DRRWITNLHYAFQDDSNL 88
           I+   YD   + ++  +K    F       R  R++++    + + I +L   F     L
Sbjct: 39  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTL 98
Query: 89  YLVMDYYCGGDLL--TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
               D Y   +L+   L    +  L  +   + + +M+  I  +H    +HR        
Sbjct: 99  EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR-------- 150
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+++ ++  +++ DFG   R  G   + +   V T  Y +PE++  M      
Sbjct: 151 --DLKPSNIVVKSDXTLKILDFGLA-RTAGTSFMMTPYVV-TRYYRAPEVILGMG----- 201
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           Y    D WS+G  M EM+  +  F     ++ + K++  
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 18/121 (14%)
Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFG 169
           L E++A+ +  +++ A+   H+   +HR          DIK +N+L+D N G ++L DFG
Sbjct: 154 LQEELARSFFWQVLEAVRHCHNCGVLHR----------DIKDENILIDLNRGELKLIDFG 203
Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           S   L    TV ++   GT  Y  PE +         +G     WSLG+ +Y+M+ G+ P
Sbjct: 204 SGALL--KDTVYTDFD-GTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIP 256
Query: 230 F 230
           F
Sbjct: 257 F 257

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 18/121 (14%)
Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFG 169
           L E++A+ +  +++ A+   H+   +HR          DIK +N+L+D N G ++L DFG
Sbjct: 159 LQEELARSFFWQVLEAVRHCHNCGVLHR----------DIKDENILIDLNRGELKLIDFG 208
Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
           S   L    TV ++   GT  Y  PE +         +G     WSLG+ +Y+M+ G+ P
Sbjct: 209 SGALL--KDTVYTDFD-GTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIP 261
Query: 230 F 230
           F
Sbjct: 262 F 262

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/219 (21%), Positives = 88/219 (40%), Gaps = 21/219 (9%)
Query: 31  ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG--DRRWITNLHYAFQDDSNL 88
           I+   YD     ++  +K    F       R  R++++    + + I  L   F    +L
Sbjct: 41  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 100
Query: 89  YLVMDYYCGGDLL--TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
               D Y   +L+   L    +  L  +   + + +M+  I  +H    +HR        
Sbjct: 101 EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR-------- 152
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+++ ++  +++ DFG   R  G   +     V T  Y +PE++  M      
Sbjct: 153 --DLKPSNIVVKSDCTLKILDFG-LARTAGTSFMMVPFVV-TRYYRAPEVILGMG----- 203
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           Y    D WS+G  M EM+ G   F     ++ + K++  
Sbjct: 204 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 242

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/175 (24%), Positives = 77/175 (44%), Gaps = 19/175 (10%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           ++  E  ++   D  +I  L    Q ++ L LVM+   GG L   L    + +P      
Sbjct: 56  EMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAE 114
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
            + ++ + +  + + ++VHR          D+   NVLL    + +++DFG    LG D 
Sbjct: 115 LLHQVSMGMKYLEEKNFVHR----------DLAARNVLLVNRHYAKISDFGLSKALGADD 164
Query: 179 TVQSNVAVGT--PDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPF 230
           +  +  + G     + +PE +        ++    D WS GV M+E L YG+ P+
Sbjct: 165 SYYTARSAGKWPLKWYAPECINFR-----KFSSRSDVWSYGVTMWEALSYGQKPY 214

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 71/161 (44%), Gaps = 16/161 (9%)
Query: 85  DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAF 144
           ++ ++++M+    G+L + L   +  L       Y  ++  A+A +    +VHR      
Sbjct: 82  ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR------ 135
Query: 145 HLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR 204
               DI   NVL+ +N  ++L DFG    +      +++       +++PE +       
Sbjct: 136 ----DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR---- 187
Query: 205 GRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
            R+    D W  GVCM+E+L +G  PF      +  G+I N
Sbjct: 188 -RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 227

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 71/161 (44%), Gaps = 16/161 (9%)
Query: 85  DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAF 144
           ++ ++++M+    G+L + L   +  L       Y  ++  A+A +    +VHR      
Sbjct: 85  ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR------ 138
Query: 145 HLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR 204
               DI   NVL+ +N  ++L DFG    +      +++       +++PE +       
Sbjct: 139 ----DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR---- 190
Query: 205 GRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
            R+    D W  GVCM+E+L +G  PF      +  G+I N
Sbjct: 191 -RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 230

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 79/183 (43%), Gaps = 38/183 (20%)
Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFED---RL 111
           + + KLR E+ V +Y           A   +  +Y+V +Y   G LL  L        RL
Sbjct: 231 QVMKKLRHEKLVQLY-----------AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRL 279
Query: 112 PE--DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG 169
           P+  DMA    A++   +A +  ++YVHR          D++  N+L+  N   ++ADFG
Sbjct: 280 PQLVDMA----AQIASGMAYVERMNYVHR----------DLRAANILVGENLVCKVADFG 325
Query: 170 SCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM-LYGE 227
              RL  D    +      P  + +PE         GR+  + D WS G+ + E+   G 
Sbjct: 326 -LARLIEDNEYTARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELTTKGR 379
Query: 228 TPF 230
            P+
Sbjct: 380 VPY 382

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 71/161 (44%), Gaps = 16/161 (9%)
Query: 85  DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAF 144
           ++ ++++M+    G+L + L   +  L       Y  ++  A+A +    +VHR      
Sbjct: 79  ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR------ 132
Query: 145 HLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR 204
               DI   NVL+ +N  ++L DFG    +      +++       +++PE +       
Sbjct: 133 ----DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR---- 184
Query: 205 GRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
            R+    D W  GVCM+E+L +G  PF      +  G+I N
Sbjct: 185 -RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 224

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 18/162 (11%)
Query: 85  DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAF 144
           ++ ++++M+    G+L + L   +  L       Y  ++  A+A +    +VHR      
Sbjct: 462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHR------ 515
Query: 145 HLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEG 203
               DI   NVL+ +N  ++L DFG   R   D T         P  +++PE +      
Sbjct: 516 ----DIAARNVLVSSNDCVKLGDFGLS-RYMEDSTYYKASKGKLPIKWMAPESINFR--- 567
Query: 204 RGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
             R+    D W  GVCM+E+L +G  PF      +  G+I N
Sbjct: 568 --RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 607

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 71/161 (44%), Gaps = 16/161 (9%)
Query: 85  DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAF 144
           ++ ++++M+    G+L + L   +  L       Y  ++  A+A +    +VHR      
Sbjct: 82  ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR------ 135
Query: 145 HLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR 204
               DI   NVL+ +N  ++L DFG    +      +++       +++PE +       
Sbjct: 136 ----DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR---- 187
Query: 205 GRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
            R+    D W  GVCM+E+L +G  PF      +  G+I N
Sbjct: 188 -RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 227

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 79/183 (43%), Gaps = 38/183 (20%)
Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFED---RL 111
           + + KLR E+ V +Y           A   +  +Y+V +Y   G LL  L        RL
Sbjct: 231 QVMKKLRHEKLVQLY-----------AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRL 279
Query: 112 PE--DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG 169
           P+  DMA    A++   +A +  ++YVHR          D++  N+L+  N   ++ADFG
Sbjct: 280 PQLVDMA----AQIASGMAYVERMNYVHR----------DLRAANILVGENLVCKVADFG 325
Query: 170 SCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM-LYGE 227
              RL  D    +      P  + +PE         GR+  + D WS G+ + E+   G 
Sbjct: 326 -LARLIEDNEYTARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELTTKGR 379
Query: 228 TPF 230
            P+
Sbjct: 380 VPY 382

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/219 (21%), Positives = 90/219 (41%), Gaps = 21/219 (9%)
Query: 31  ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG--DRRWITNLHYAFQDDSNL 88
           I+   YD   + ++  +K    F       R  R++++    + + I +L   F     L
Sbjct: 38  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 97
Query: 89  YLVMDYYCGGDLL--TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
               D Y   +L+   L    +  L  +   + + +M+  I  +H    +HR        
Sbjct: 98  EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR-------- 149
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+++ ++  +++ DFG   R  G   + +   V T  Y +PE++  M      
Sbjct: 150 --DLKPSNIVVKSDCTLKILDFG-LARTAGTSFMMTPYVV-TRYYRAPEVILGMG----- 200
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           Y    D WS+G  M EM+  +  F     ++ + K++  
Sbjct: 201 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 239

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/219 (21%), Positives = 90/219 (41%), Gaps = 21/219 (9%)
Query: 31  ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG--DRRWITNLHYAFQDDSNL 88
           I+   YD   + ++  +K    F       R  R++++    + + I +L   F     L
Sbjct: 33  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 92
Query: 89  YLVMDYYCGGDLL--TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
               D Y   +L+   L    +  L  +   + + +M+  I  +H    +HR        
Sbjct: 93  EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR-------- 144
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+++ ++  +++ DFG   R  G   + +   V T  Y +PE++  M      
Sbjct: 145 --DLKPSNIVVKSDCTLKILDFGLA-RTAGTSFMMTPYVV-TRYYRAPEVILGMG----- 195
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           Y    D WS+G  M EM+  +  F     ++ + K++  
Sbjct: 196 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 234

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/219 (21%), Positives = 90/219 (41%), Gaps = 21/219 (9%)
Query: 31  ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG--DRRWITNLHYAFQDDSNL 88
           I+   YD   + ++  +K    F       R  R++++    + + I +L   F     L
Sbjct: 40  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 99
Query: 89  YLVMDYYCGGDLL--TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
               D Y   +L+   L    +  L  +   + + +M+  I  +H    +HR        
Sbjct: 100 EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR-------- 151
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+++ ++  +++ DFG   R  G   + +   V T  Y +PE++  M      
Sbjct: 152 --DLKPSNIVVKSDCTLKILDFGLA-RTAGTSFMMTPYVV-TRYYRAPEVILGMG----- 202
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           Y    D WS+G  M EM+  +  F     ++ + K++  
Sbjct: 203 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 241

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/219 (20%), Positives = 88/219 (40%), Gaps = 21/219 (9%)
Query: 31  ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG--DRRWITNLHYAFQDDSNL 88
           I+   YD     ++  +K    F       R  R++++    + + I  L   F    +L
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 89  YLVMDYYCGGDLL--TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
               D Y   +L+   L    +  L  +   + + +M+  I  +H    +HR        
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR-------- 150
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+++ ++  +++ DFG     G    ++  V   T  Y +PE++  M      
Sbjct: 151 --DLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV--TRYYRAPEVILGM-----G 201
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           Y    D WS+G  M EM+  +  F     ++ + K++  
Sbjct: 202 YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 240

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 71/161 (44%), Gaps = 16/161 (9%)
Query: 85  DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAF 144
           ++ ++++M+    G+L + L   +  L       Y  ++  A+A +    +VHR      
Sbjct: 87  ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR------ 140
Query: 145 HLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR 204
               DI   NVL+ +N  ++L DFG    +      +++       +++PE +       
Sbjct: 141 ----DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR---- 192
Query: 205 GRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
            R+    D W  GVCM+E+L +G  PF      +  G+I N
Sbjct: 193 -RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 232

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 81/184 (44%), Gaps = 40/184 (21%)
Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFED----R 110
           + + KLR E+ V +Y           A   +  +Y+V +Y   G LL  L K E     R
Sbjct: 314 QVMKKLRHEKLVQLY-----------AVVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLR 361
Query: 111 LPE--DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADF 168
           LP+  DMA    A++   +A +  ++YVHR          D++  N+L+  N   ++ADF
Sbjct: 362 LPQLVDMA----AQIASGMAYVERMNYVHR----------DLRAANILVGENLVCKVADF 407
Query: 169 GSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM-LYG 226
           G   RL  D    +      P  + +PE         GR+  + D WS G+ + E+   G
Sbjct: 408 G-LARLIEDNEYTARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELTTKG 461
Query: 227 ETPF 230
             P+
Sbjct: 462 RVPY 465

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 71/161 (44%), Gaps = 16/161 (9%)
Query: 85  DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAF 144
           ++ ++++M+    G+L + L   +  L       Y  ++  A+A +    +VHR      
Sbjct: 84  ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR------ 137
Query: 145 HLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR 204
               DI   NVL+ +N  ++L DFG    +      +++       +++PE +       
Sbjct: 138 ----DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR---- 189
Query: 205 GRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
            R+    D W  GVCM+E+L +G  PF      +  G+I N
Sbjct: 190 -RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 229

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/219 (21%), Positives = 90/219 (41%), Gaps = 21/219 (9%)
Query: 31  ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG--DRRWITNLHYAFQDDSNL 88
           I+   YD   + ++  +K    F       R  R++++    + + I +L   F     L
Sbjct: 32  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 91
Query: 89  YLVMDYYCGGDLL--TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
               D Y   +L+   L    +  L  +   + + +M+  I  +H    +HR        
Sbjct: 92  EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR-------- 143
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+++ ++  +++ DFG   R  G   + +   V T  Y +PE++  M      
Sbjct: 144 --DLKPSNIVVKSDCTLKILDFGLA-RTAGTSFMMTPYVV-TRYYRAPEVILGMG----- 194
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           Y    D WS+G  M EM+  +  F     ++ + K++  
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 95  SLEEFNDVYLVT-HLMGADLNNIVKX--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 149
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 150 --------DLKPSNLAVNEDCELKILDFGLARHTDDEMTGY----VATRWYRAPEIML-- 195
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/219 (21%), Positives = 90/219 (41%), Gaps = 21/219 (9%)
Query: 31  ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG--DRRWITNLHYAFQDDSNL 88
           I+   YD   + ++  +K    F       R  R++++    + + I +L   F     L
Sbjct: 33  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 92
Query: 89  YLVMDYYCGGDLL--TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
               D Y   +L+   L    +  L  +   + + +M+  I  +H    +HR        
Sbjct: 93  EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR-------- 144
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+++ ++  +++ DFG   R  G   + +   V T  Y +PE++  M      
Sbjct: 145 --DLKPSNIVVKSDCTLKILDFGLA-RTAGTSFMMTPYVV-TRYYRAPEVILGMG----- 195
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           Y    D WS+G  M EM+  +  F     ++ + K++  
Sbjct: 196 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 234

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/219 (21%), Positives = 90/219 (41%), Gaps = 21/219 (9%)
Query: 31  ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG--DRRWITNLHYAFQDDSNL 88
           I+   YD   + ++  +K    F       R  R++++    + + I +L   F     L
Sbjct: 40  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 99
Query: 89  YLVMDYYCGGDLL--TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
               D Y   +L+   L    +  L  +   + + +M+  I  +H    +HR        
Sbjct: 100 EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR-------- 151
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+++ ++  +++ DFG   R  G   + +   V T  Y +PE++  M      
Sbjct: 152 --DLKPSNIVVKSDCTLKILDFG-LARTAGTSFMMTPYVV-TRYYRAPEVILGMG----- 202
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           Y    D WS+G  M EM+  +  F     ++ + K++  
Sbjct: 203 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 241

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/219 (21%), Positives = 90/219 (41%), Gaps = 21/219 (9%)
Query: 31  ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG--DRRWITNLHYAFQDDSNL 88
           I+   YD   + ++  +K    F       R  R++++    + + I +L   F     L
Sbjct: 39  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 98
Query: 89  YLVMDYYCGGDLL--TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
               D Y   +L+   L    +  L  +   + + +M+  I  +H    +HR        
Sbjct: 99  EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR-------- 150
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+++ ++  +++ DFG   R  G   + +   V T  Y +PE++  M      
Sbjct: 151 --DLKPSNIVVKSDCTLKILDFG-LARTAGTSFMMTPYVV-TRYYRAPEVILGMG----- 201
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           Y    D WS+G  M EM+  +  F     ++ + K++  
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/219 (21%), Positives = 90/219 (41%), Gaps = 21/219 (9%)
Query: 31  ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG--DRRWITNLHYAFQDDSNL 88
           I+   YD   + ++  +K    F       R  R++++    + + I +L   F     L
Sbjct: 39  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 98
Query: 89  YLVMDYYCGGDLL--TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
               D Y   +L+   L    +  L  +   + + +M+  I  +H    +HR        
Sbjct: 99  EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR-------- 150
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+++ ++  +++ DFG   R  G   + +   V T  Y +PE++  M      
Sbjct: 151 --DLKPSNIVVKSDCTLKILDFGLA-RTAGTSFMMTPYVV-TRYYRAPEVILGMG----- 201
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           Y    D WS+G  M EM+  +  F     ++ + K++  
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 91/223 (40%), Gaps = 25/223 (11%)
Query: 47  EKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSK 106
           EK +SD +  +  ++      + G  + I NL  A   D  LY++++Y   G+L   L  
Sbjct: 81  EKDLSDLVSEMEMMK------MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA 134
Query: 107 FEDRLPEDMAKFY----IAEMVLAIASIHDLHY--VHRPNHFAFHLC--RDIKPDNVLLD 158
              R P  M   Y    + E  +    +    Y       + A   C  RD+   NVL+ 
Sbjct: 135 ---RRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 191
Query: 159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLG 217
            N  +++ADFG    +      +       P  +++PE L         Y  + D WS G
Sbjct: 192 ENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDR-----VYTHQSDVWSFG 246
Query: 218 VCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEI 259
           V M+E+   G +P Y    VE   K++   +  D P++   E+
Sbjct: 247 VLMWEIFTLGGSP-YPGIPVEELFKLLKEGHRMDKPANCTNEL 288

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 76/185 (41%), Gaps = 29/185 (15%)
Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR--LP 112
           E + KL  +  V ++      T  H          L+M++   G L T+L +  +   LP
Sbjct: 59  EVLKKLNHKNIVKLFAIEEETTTRHKV--------LIMEFCPCGSLYTVLEEPSNAYGLP 110
Query: 113 EDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL----DANGHIRLADF 168
           E      + ++V  +  + +   VHR          +IKP N++     D     +L DF
Sbjct: 111 ESEFLIVLRDVVGGMNHLRENGIVHR----------NIKPGNIMRVIGEDGQSVYKLTDF 160
Query: 169 GSCLRLGGDGTVQSNVAVGTPDYISPEI---LTAMEEGRGRYGPECDWWSLGVCMYEMLY 225
           G+   L  D   Q     GT +Y+ P++       ++ + +YG   D WS+GV  Y    
Sbjct: 161 GAARELEDDE--QFVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
Query: 226 GETPF 230
           G  PF
Sbjct: 219 GSLPF 223

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 101 SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 155
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 156 --------DLKPSNLAVNEDSELKILDFGLARHTDDEMTGY----VATRWYRAPEIML-- 201
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 202 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 71/161 (44%), Gaps = 16/161 (9%)
Query: 85  DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAF 144
           ++ ++++M+    G+L + L   +  L       Y  ++  A+A +    +VHR      
Sbjct: 110 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR------ 163
Query: 145 HLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR 204
               DI   NVL+ +N  ++L DFG    +      +++       +++PE +       
Sbjct: 164 ----DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR---- 215
Query: 205 GRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
            R+    D W  GVCM+E+L +G  PF      +  G+I N
Sbjct: 216 -RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 255

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/219 (20%), Positives = 88/219 (40%), Gaps = 21/219 (9%)
Query: 31  ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG--DRRWITNLHYAFQDDSNL 88
           I+   YD     ++  +K    F       R  R++++    + + I  L   F    +L
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 89  YLVMDYYCGGDLL--TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
               D Y   +L+   L    +  L  +   + + +M+  I  +H    +HR        
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR-------- 150
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+++ ++  +++ DFG     G    ++  V   T  Y +PE++  M      
Sbjct: 151 --DLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV--TRYYRAPEVILGMG----- 201
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           Y    D WS+G  M EM+  +  F     ++ + K++  
Sbjct: 202 YKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 240

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/219 (21%), Positives = 90/219 (41%), Gaps = 21/219 (9%)
Query: 31  ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG--DRRWITNLHYAFQDDSNL 88
           I+   YD   + ++  +K    F       R  R++++    + + I +L   F     L
Sbjct: 77  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136
Query: 89  YLVMDYYCGGDLL--TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
               D Y   +L+   L    +  L  +   + + +M+  I  +H    +HR        
Sbjct: 137 EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR-------- 188
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+++ ++  +++ DFG   R  G   + +   V T  Y +PE++  M      
Sbjct: 189 --DLKPSNIVVKSDCTLKILDFG-LARTAGTSFMMTPYVV-TRYYRAPEVILGMG----- 239
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           Y    D WS+G  M EM+  +  F     ++ + K++  
Sbjct: 240 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 102 SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 156
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 157 --------DLKPSNLAVNEDCELKILDFGLARHTADEMTGY----VATRWYRAPEIML-- 202
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 203 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 70/158 (44%), Gaps = 22/158 (13%)
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           + YLVM +    DL  ++        E+  ++ + +M+  +  IH    VHR        
Sbjct: 121 DFYLVMPF-MQTDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIHSAGVVHR-------- 168
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+ ++ +  +++ DFG    L      +    V T  Y +PE++ +       
Sbjct: 169 --DLKPGNLAVNEDCELKILDFG----LARHADAEMTGYVVTRWYRAPEVILSW----MH 218
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
           Y    D WS+G  M EML G+T F  +  ++   +I+ 
Sbjct: 219 YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 256

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/219 (21%), Positives = 90/219 (41%), Gaps = 21/219 (9%)
Query: 31  ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG--DRRWITNLHYAFQDDSNL 88
           I+   YD   + ++  +K    F       R  R++++    + + I +L   F     L
Sbjct: 77  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136
Query: 89  YLVMDYYCGGDLL--TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
               D Y   +L+   L    +  L  +   + + +M+  I  +H    +HR        
Sbjct: 137 EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR-------- 188
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+++ ++  +++ DFG   R  G   + +   V T  Y +PE++  M      
Sbjct: 189 --DLKPSNIVVKSDCTLKILDFG-LARTAGTSFMMTPYVV-TRYYRAPEVILGMG----- 239
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           Y    D WS+G  M EM+  +  F     ++ + K++  
Sbjct: 240 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 97  SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 151
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 152 --------DLKPSNLAVNEDSELKILDFGLARHTDDEMTGY----VATRWYRAPEIML-- 197
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 198 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 22/164 (13%)
Query: 90  LVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVH----RPNHFAFH 145
           LVM+YY  G L   LS             +++   LA +    L Y+H    R +H+   
Sbjct: 89  LVMEYYPNGSLXKYLSLH--------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA 140
Query: 146 LC-RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTV----QSNVA---VGTPDYISPEIL 197
           +  RD+   NVL+  +G   ++DFG  +RL G+  V    + N A   VGT  Y++PE+L
Sbjct: 141 ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVL 200
Query: 198 TAMEEGRGRYG--PECDWWSLGVCMYEMLYGETPFYAESLVETY 239
                 R       + D ++LG+  +E+    T  +    V  Y
Sbjct: 201 EGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 102 SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 156
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 157 --------DLKPSNLAVNEDCELKILDFGLARHTADEMTGY----VATRWYRAPEIML-- 202
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 203 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 102 SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 156
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 157 --------DLKPSNLAVNEDCELKILDFGLARHTADEMTGY----VATRWYRAPEIML-- 202
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 203 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 80/183 (43%), Gaps = 38/183 (20%)
Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFED---RL 111
           + + KLR E+ V +Y           A   +  +Y+VM+Y   G LL  L        RL
Sbjct: 65  QVMKKLRHEKLVQLY-----------AVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRL 113
Query: 112 PE--DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG 169
           P+  DMA    A++   +A +  ++YVH          RD++  N+L+  N   ++ADFG
Sbjct: 114 PQLVDMA----AQIASGMAYVERMNYVH----------RDLRAANILVGENLVCKVADFG 159
Query: 170 SCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM-LYGE 227
              RL  D    +      P  + +PE         GR+  + D WS G+ + E+   G 
Sbjct: 160 LA-RLIEDNEYTARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELTTKGR 213
Query: 228 TPF 230
            P+
Sbjct: 214 VPY 216

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 80/183 (43%), Gaps = 38/183 (20%)
Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFED---RL 111
           + + KLR E+ V +Y           A   +  +Y+V++Y   G LL  L        RL
Sbjct: 65  QVMKKLRHEKLVQLY-----------AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRL 113
Query: 112 PE--DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG 169
           P+  DMA    A++   +A +  ++YVHR          D++  N+L+  N   ++ADFG
Sbjct: 114 PQLVDMA----AQIASGMAYVERMNYVHR----------DLRAANILVGENLVCKVADFG 159
Query: 170 SCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM-LYGE 227
              RL  D    +      P  + +PE         GR+  + D WS G+ + E+   G 
Sbjct: 160 -LARLIEDNEXTARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELTTKGR 213
Query: 228 TPF 230
            P+
Sbjct: 214 VPY 216

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 73/163 (44%), Gaps = 21/163 (12%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 124 SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 178
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG    L      +    V T  Y +PEI+   
Sbjct: 179 --------DLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIML-- 224
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
                 Y    D WS+G  M E+L G T F     +    +IM
Sbjct: 225 --NWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIM 265

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 100 SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 154
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 155 --------DLKPSNLAVNEDXELKILDFGLARHTDDEMTGY----VATRWYRAPEIML-- 200
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 201 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/193 (23%), Positives = 85/193 (44%), Gaps = 19/193 (9%)
Query: 41  NSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDL 100
           NS+    KT+      V    EE +++       +  L+     +  +Y++ +Y   G L
Sbjct: 36  NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSL 95
Query: 101 LTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD-LHYVHRPNHFAFHLCRDIKPDNVLLDA 159
           L  L   E        K  + +++   A I + + Y+ R N+    + RD++  NVL+  
Sbjct: 96  LDFLKSDEG------GKVLLPKLIDFSAQIAEGMAYIERKNY----IHRDLRAANVLVSE 145
Query: 160 NGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLGV 218
           +   ++ADFG   R+  D    +      P  + +PE +       G +  + D WS G+
Sbjct: 146 SLMCKIADFG-LARVIEDNEYTAREGAKFPIKWTAPEAINF-----GCFTIKSDVWSFGI 199
Query: 219 CMYEML-YGETPF 230
            +YE++ YG+ P+
Sbjct: 200 LLYEIVTYGKIPY 212

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 95  SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 149
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG    L      +    V T  Y +PEI+   
Sbjct: 150 --------DLKPSNLAVNEDCELKILDFG----LARHTDDEMTGXVATRWYRAPEIML-- 195
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 25/223 (11%)
Query: 47  EKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSK 106
           EK +SD +  +  ++      + G  + I NL  A   D  LY++++Y   G+L   L  
Sbjct: 81  EKDLSDLVSEMEMMK------MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA 134
Query: 107 FEDRLPEDMAKFY----IAEMVLAIASIHDLHY--VHRPNHFAFHLC--RDIKPDNVLLD 158
              R P  M   Y    + E  +    +    Y       + A   C  RD+   NVL+ 
Sbjct: 135 ---RRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 191
Query: 159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLG 217
            N  +R+ADFG    +      +       P  +++PE L         Y  + D WS G
Sbjct: 192 ENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-----VYTHQSDVWSFG 246
Query: 218 VCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEI 259
           V M+E+   G +P Y    VE   K++   +  D P++   E+
Sbjct: 247 VLMWEIFTLGGSP-YPGIPVEELFKLLKEGHRMDKPANCTNEL 288

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 100 SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 154
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 155 --------DLKPSNLAVNEDXELKILDFGLARHTDDEMTGY----VATRWYRAPEIML-- 200
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 201 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/219 (21%), Positives = 89/219 (40%), Gaps = 21/219 (9%)
Query: 31  ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG--DRRWITNLHYAFQDDSNL 88
           I+   YD     ++  +K    F       R  R++++    + + I  L   F    +L
Sbjct: 44  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 103
Query: 89  YLVMDYYCGGDLL--TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
               D Y   +L+   L    +  L  +   + + +M+  I  +H    +HR        
Sbjct: 104 EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR-------- 155
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+++ ++  +++ DFG   R  G   + +   V T  Y +PE++  M      
Sbjct: 156 --DLKPSNIVVKSDCTLKILDFG-LARTAGTSFMMTPYVV-TRYYRAPEVILGMG----- 206
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           Y    D WS+G  M EM+  +  F     ++ + K++  
Sbjct: 207 YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 245

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 80/183 (43%), Gaps = 38/183 (20%)
Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFED---RL 111
           + + KLR E+ V +Y           A   +  +Y+V++Y   G LL  L        RL
Sbjct: 65  QVMKKLRHEKLVQLY-----------AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRL 113
Query: 112 PE--DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG 169
           P+  DMA    A++   +A +  ++YVHR          D++  N+L+  N   ++ADFG
Sbjct: 114 PQLVDMA----AQIASGMAYVERMNYVHR----------DLRAANILVGENLVCKVADFG 159
Query: 170 SCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM-LYGE 227
              RL  D    +      P  + +PE         GR+  + D WS G+ + E+   G 
Sbjct: 160 -LARLIEDNEYTARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELTTKGR 213
Query: 228 TPF 230
            P+
Sbjct: 214 VPY 216

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 73/159 (45%), Gaps = 29/159 (18%)
Query: 80  YAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR---LPE--DMAKFYIAEMVLAIASIHDLH 134
           YA   +  +Y+V +Y   G LL  L   E R   LP   DMA    A++   +A I  ++
Sbjct: 70  YAVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMA----AQVAAGMAYIERMN 125
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHI-RLADFGSCLRLGGDGTVQSNVAVGTP-DYI 192
           Y+HR          D++  N+L+  NG I ++ADFG   RL  D    +      P  + 
Sbjct: 126 YIHR----------DLRSANILV-GNGLICKIADFGLA-RLIEDNEXTARQGAKFPIKWT 173
Query: 193 SPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPF 230
           +PE         GR+  + D WS G+ + E++  G  P+
Sbjct: 174 APEAALY-----GRFTIKSDVWSFGILLTELVTKGRVPY 207

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/149 (23%), Positives = 70/149 (46%), Gaps = 16/149 (10%)
Query: 84  DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFA 143
           ++   +++M+ Y  G+L   L + ++ L       Y  ++  A+A +  ++ VH      
Sbjct: 95  EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVH------ 148
Query: 144 FHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEG 203
               RDI   N+L+ +   ++L DFG    +  +   +++V      ++SPE +      
Sbjct: 149 ----RDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR--- 201
Query: 204 RGRYGPECDWWSLGVCMYEML-YGETPFY 231
             R+    D W   VCM+E+L +G+ PF+
Sbjct: 202 --RFTTASDVWMFAVCMWEILSFGKQPFF 228

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/149 (23%), Positives = 70/149 (46%), Gaps = 16/149 (10%)
Query: 84  DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFA 143
           ++   +++M+ Y  G+L   L + ++ L       Y  ++  A+A +  ++ VH      
Sbjct: 79  EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVH------ 132
Query: 144 FHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEG 203
               RDI   N+L+ +   ++L DFG    +  +   +++V      ++SPE +      
Sbjct: 133 ----RDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR--- 185
Query: 204 RGRYGPECDWWSLGVCMYEML-YGETPFY 231
             R+    D W   VCM+E+L +G+ PF+
Sbjct: 186 --RFTTASDVWMFAVCMWEILSFGKQPFF 212

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 106 SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 160
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 161 --------DLKPSNLAVNEDXELKILDFGLARHTDDEMTGY----VATRWYRAPEIML-- 206
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 207 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 234

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 79/183 (43%), Gaps = 38/183 (20%)
Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFED---RL 111
           + + KLR E+ V +Y           A   +  +Y+V +Y   G LL  L        RL
Sbjct: 231 QVMKKLRHEKLVQLY-----------AVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRL 279
Query: 112 PE--DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG 169
           P+  DMA    A++   +A +  ++YVHR          D++  N+L+  N   ++ADFG
Sbjct: 280 PQLVDMA----AQIASGMAYVERMNYVHR----------DLRAANILVGENLVCKVADFG 325
Query: 170 SCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM-LYGE 227
              RL  D    +      P  + +PE         GR+  + D WS G+ + E+   G 
Sbjct: 326 -LARLIEDNEYTARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELTTKGR 379
Query: 228 TPF 230
            P+
Sbjct: 380 VPY 382

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 79/183 (43%), Gaps = 38/183 (20%)
Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFED---RL 111
           + + KLR E+ V +Y           A   +  +Y+V +Y   G LL  L        RL
Sbjct: 58  QVMKKLRHEKLVQLY-----------AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRL 106
Query: 112 PE--DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG 169
           P+  DMA    A++   +A +  ++YVHR          D++  N+L+  N   ++ADFG
Sbjct: 107 PQLVDMA----AQIASGMAYVERMNYVHR----------DLRAANILVGENLVCKVADFG 152
Query: 170 SCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM-LYGE 227
              RL  D    +      P  + +PE         GR+  + D WS G+ + E+   G 
Sbjct: 153 -LARLIEDNEYTARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELTTKGR 206
Query: 228 TPF 230
            P+
Sbjct: 207 VPY 209

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 91/191 (47%), Gaps = 25/191 (13%)
Query: 43  SLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLT 102
           ++++ ++ S+   F+ +LR+   V    +   I  L+ A  +   + LVM+Y  GG L  
Sbjct: 36  AIKQIESESERKAFIVELRQLSRV----NHPNIVKLYGACLNP--VCLVMEYAEGGSLYN 89
Query: 103 LLSKFEDRLPEDMAKFYIAE--MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN 160
           +L   E  LP     +Y A   M   +     + Y+H     A  + RD+KP N+LL A 
Sbjct: 90  VLHGAEP-LP-----YYTAAHAMSWCLQCSQGVAYLHSMQPKAL-IHRDLKPPNLLLVAG 142
Query: 161 GHI-RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVC 219
           G + ++ DFG+   +    T       G+  +++PE+     EG   Y  +CD +S G+ 
Sbjct: 143 GTVLKICDFGTACDIQTHMTNNK----GSAAWMAPEVF----EG-SNYSEKCDVFSWGII 193
Query: 220 MYEMLYGETPF 230
           ++E++    PF
Sbjct: 194 LWEVITRRKPF 204

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 71/150 (47%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 115 SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 169
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG  L    D  +   VA  T  Y +PEI+   
Sbjct: 170 --------DLKPSNLAVNEDCELKILDFG--LARHTDDEMXGXVA--TRWYRAPEIML-- 215
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 216 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/117 (27%), Positives = 55/117 (47%), Gaps = 15/117 (12%)
Query: 114 DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR 173
           ++ K++  +++  +A  H+   +HR          D+KP N+L++  G ++L DFG    
Sbjct: 108 NLVKYFQWQLLQGLAFCHENKILHR----------DLKPQNLLINKRGQLKLGDFGLARA 157
Query: 174 LGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
            G      S+  V T  Y +P++L     G   Y    D WS G  + EM+ G+  F
Sbjct: 158 FGIPVNTFSSEVV-TLWYRAPDVLM----GSRTYSTSIDIWSCGCILAEMITGKPLF 209

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 91/223 (40%), Gaps = 25/223 (11%)
Query: 47  EKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSK 106
           EK +SD +  +  ++      + G  + I NL  A   D  LY++++Y   G+L   L  
Sbjct: 81  EKDLSDLVSEMEMMK------MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA 134
Query: 107 FEDRLPEDMAKFY----IAEMVLAIASIHDLHY--VHRPNHFAFHLC--RDIKPDNVLLD 158
              R P  M   Y    + E  +    +    Y       + A   C  RD+   NVL+ 
Sbjct: 135 ---RRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 191
Query: 159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLG 217
            N  +++ADFG    +      +       P  +++PE L         Y  + D WS G
Sbjct: 192 ENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDR-----VYTHQSDVWSFG 246
Query: 218 VCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEI 259
           V M+E+   G +P Y    VE   K++   +  D P++   E+
Sbjct: 247 VLMWEIFTLGGSP-YPGIPVEELFKLLKEGHRMDKPANCTNEL 288

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 80/214 (37%), Gaps = 28/214 (13%)
Query: 20  GRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLH 79
           G VFS     D  LV    C      RE    D     AK  +E  +L       I  L 
Sbjct: 128 GEVFSGRLRADNTLVAVKSC------RETLPPDL---KAKFLQEARILKQYSHPNIVRLI 178
Query: 80  YAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRP 139
                   +Y+VM+   GGD LT L     RL        + +    +  +     +HR 
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHR- 237
Query: 140 NHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAV-GTP-DYISPEIL 197
                    D+   N L+     ++++DFG   R   DG   ++  +   P  + +PE L
Sbjct: 238 ---------DLAARNCLVTEKNVLKISDFGMS-REEADGVXAASGGLRQVPVKWTAPEAL 287
Query: 198 TAMEEGRGRYGPECDWWSLGVCMYEML-YGETPF 230
                  GRY  E D WS G+ ++E    G +P+
Sbjct: 288 NY-----GRYSSESDVWSFGILLWETFSLGASPY 316

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 95  SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 149
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG    L      +    V T  Y +PEI+   
Sbjct: 150 --------DLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIML-- 195
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 96/225 (42%), Gaps = 21/225 (9%)
Query: 43  SLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLT 102
           +++  K  +D  E  A + E + +   G    I NL  A      +YL+ +Y C GDLL 
Sbjct: 79  AVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN 138
Query: 103 LLSKFEDRLPEDMAKFYIAEMV-----LAIASIHDL----HYVHRPNHF-AFHLC--RDI 150
            L    ++  ED  ++   + +     L + +  DL    + V +   F  F  C  RD+
Sbjct: 139 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 198
Query: 151 KPDNVLLDANGHIRLADFGSCLRLGGDG--TVQSNVAVGTPDYISPEILTAMEEGRGRYG 208
              NVL+     +++ DFG    +  D    V+ N  +    +++PE L       G Y 
Sbjct: 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPV-KWMAPESLF-----EGIYT 252
Query: 209 PECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLP 252
            + D WS G+ ++E+   G  P+    +   + K++ +    D P
Sbjct: 253 IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQP 297

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 91/191 (47%), Gaps = 25/191 (13%)
Query: 43  SLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLT 102
           ++++ ++ S+   F+ +LR+   V    +   I  L+ A  +   + LVM+Y  GG L  
Sbjct: 35  AIKQIESESERKAFIVELRQLSRV----NHPNIVKLYGACLNP--VCLVMEYAEGGSLYN 88
Query: 103 LLSKFEDRLPEDMAKFYIAE--MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN 160
           +L   E  LP     +Y A   M   +     + Y+H     A  + RD+KP N+LL A 
Sbjct: 89  VLHGAEP-LP-----YYTAAHAMSWCLQCSQGVAYLHSMQPKAL-IHRDLKPPNLLLVAG 141
Query: 161 GHI-RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVC 219
           G + ++ DFG+   +    T       G+  +++PE+     EG   Y  +CD +S G+ 
Sbjct: 142 GTVLKICDFGTACDIQTHMTNNK----GSAAWMAPEVF----EG-SNYSEKCDVFSWGII 192
Query: 220 MYEMLYGETPF 230
           ++E++    PF
Sbjct: 193 LWEVITRRKPF 203

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 95  SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 149
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG    L      +    V T  Y +PEI+   
Sbjct: 150 --------DLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIML-- 195
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 95  SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 149
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 150 --------DLKPSNLAVNEDCELKILDFGLARHTDDEMTGY----VATRWYRAPEIML-- 195
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 35/149 (23%), Positives = 70/149 (46%), Gaps = 16/149 (10%)
Query: 84  DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFA 143
           ++   +++M+ Y  G+L   L + ++ L       Y  ++  A+A +  ++ VH      
Sbjct: 83  EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVH------ 136
Query: 144 FHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEG 203
               RDI   N+L+ +   ++L DFG    +  +   +++V      ++SPE +      
Sbjct: 137 ----RDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR--- 189
Query: 204 RGRYGPECDWWSLGVCMYEML-YGETPFY 231
             R+    D W   VCM+E+L +G+ PF+
Sbjct: 190 --RFTTASDVWMFAVCMWEILSFGKQPFF 216

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 95  SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 149
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 150 --------DLKPSNLAVNEDCELKILDFGLARHTDDEMT----GYVATRWYRAPEIML-- 195
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 101 SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 155
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 156 --------DLKPSNLAVNEDCELKILDFGLARHTDDEMTGY----VATRWYRAPEIML-- 201
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 202 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/219 (21%), Positives = 89/219 (40%), Gaps = 21/219 (9%)
Query: 31  ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG--DRRWITNLHYAFQDDSNL 88
           I+   YD     ++  +K    F       R  R++++    + + I  L   F    +L
Sbjct: 33  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 92
Query: 89  YLVMDYYCGGDLL--TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
               D Y   +L+   L    +  L  +   + + +M+  I  +H    +HR        
Sbjct: 93  EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR-------- 144
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
             D+KP N+++ ++  +++ DFG   R  G   + +   V T  Y +PE++  M      
Sbjct: 145 --DLKPSNIVVKSDCTLKILDFGLA-RTAGTSFMMTPYVV-TRYYRAPEVILGM-----G 195
Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
           Y    D WS+G  M EM+  +  F     ++ + K++  
Sbjct: 196 YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 234

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 70/161 (43%), Gaps = 16/161 (9%)
Query: 85  DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAF 144
           ++ ++++M+    G+L + L   +  L       Y  ++  A+A +    +VHR      
Sbjct: 82  ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHR------ 135
Query: 145 HLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR 204
               DI   NVL+ A   ++L DFG    +      +++       +++PE +       
Sbjct: 136 ----DIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR---- 187
Query: 205 GRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
            R+    D W  GVCM+E+L +G  PF      +  G+I N
Sbjct: 188 -RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 227

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 102 SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 156
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 157 --------DLKPSNLAVNEDCELKILDFGLARHTDDEMTGY----VATRWYRAPEIML-- 202
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 203 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 95  SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 149
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG    L      +    V T  Y +PEI+   
Sbjct: 150 --------DLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIML-- 195
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 95  SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 149
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 150 --------DLKPSNLAVNEDCELKILDFGLARHTDDEMTGY----VATRWYRAPEIML-- 195
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 105 SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 159
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 160 --------DLKPSNLAVNEDCELKILDFGLARHTDDEMTGY----VATRWYRAPEIML-- 205
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 206 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 233

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 70/161 (43%), Gaps = 16/161 (9%)
Query: 85  DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAF 144
           ++ ++++M+    G+L + L   +  L       Y  ++  A+A +    +VHR      
Sbjct: 462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHR------ 515
Query: 145 HLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR 204
               DI   NVL+ A   ++L DFG    +      +++       +++PE +       
Sbjct: 516 ----DIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR---- 567
Query: 205 GRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
            R+    D W  GVCM+E+L +G  PF      +  G+I N
Sbjct: 568 -RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 607

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 100 SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 154
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 155 --------DLKPSNLAVNEDCELKILDFGLARHTDDEMTGY----VATRWYRAPEIML-- 200
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 201 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 100 SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 154
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 155 --------DLKPSNLAVNEDCELKILDFGLARHTDDEMTGY----VATRWYRAPEIML-- 200
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 201 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 94  SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 148
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 149 --------DLKPSNLAVNEDCELKILDFGLARHTDDEMTGY----VATRWYRAPEIML-- 194
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 195 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 222

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 101 SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 155
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 156 --------DLKPSNLAVNEDCELKILDFGLARHTDDEMTGY----VATRWYRAPEIML-- 201
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 202 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 97  SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 151
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 152 --------DLKPSNLAVNEDCELKILDFGLARHTDDEMTGY----VATRWYRAPEIML-- 197
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 198 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 97  SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 151
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 152 --------DLKPSNLAVNEDCELKILDFGLARHTDDEMTGY----VATRWYRAPEIML-- 197
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 198 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 96/229 (41%), Gaps = 23/229 (10%)
Query: 7   LEALFLGGPIQGKG---RVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREE 63
            EA +  GP+ GKG    VF+   L D L V       + +     +SD +    ++   
Sbjct: 29  FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALL 88
Query: 64  RDVLVYGDRRWITNLHYAFQDDSNLYLVMDY-YCGGDLLTLLSKFEDRLPEDMAKFYIAE 122
             V   G    +  L   F+      LV++      DL   +++ +  L E  ++ +  +
Sbjct: 89  WKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQ 147
Query: 123 MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD-ANGHIRLADFGSCLRLGGDGTVQ 181
           +V AI   H    VHR          DIK +N+L+D   G  +L DFGS   L  +    
Sbjct: 148 VVAAIQHCHSRGVVHR----------DIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD 197
Query: 182 SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
            +   GT  Y  PE ++  +     +      WSLG+ +Y+M+ G+ PF
Sbjct: 198 FD---GTRVYSPPEWISRHQ----YHALPATVWSLGILLYDMVCGDIPF 239

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 95  SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 149
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 150 --------DLKPSNLAVNEDCELKILDFGLARHTDDEMTGY----VATRWYRAPEIML-- 195
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 91  SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 145
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 146 --------DLKPSNLAVNEDCELKILDFGLARHTDDEMTGY----VATRWYRAPEIML-- 191
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 192 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 101 SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 155
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG    L      +    V T  Y +PEI+   
Sbjct: 156 --------DLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIML-- 201
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 202 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 95  SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 149
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 150 --------DLKPSNLAVNEDCELKILDFGLARHTDDEMTGY----VATRWYRAPEIML-- 195
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 71/150 (47%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 118 SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 172
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG  L    D  +   VA  T  Y +PEI+   
Sbjct: 173 --------DLKPSNLAVNEDCELKILDFG--LARHTDDEMXGYVA--TRWYRAPEIML-- 218
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 219 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 246

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 92  SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 146
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG    L      +    V T  Y +PEI+   
Sbjct: 147 --------DLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIML-- 192
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 193 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 91  SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 145
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 146 --------DLKPSNLAVNEDCELKILDFGLARHTDDEMTGY----VATRWYRAPEIML-- 191
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 192 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 92  SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 146
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG    L      +    V T  Y +PEI+   
Sbjct: 147 --------DLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIML-- 192
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 193 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 220

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 107 SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 161
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG    L      +    V T  Y +PEI+   
Sbjct: 162 --------DLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIML-- 207
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 208 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 97  SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 151
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 152 --------DLKPSNLAVNEDCELKILDFGLARHTDDEMTGY----VATRWYRAPEIML-- 197
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 198 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 80/214 (37%), Gaps = 28/214 (13%)
Query: 20  GRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLH 79
           G VFS     D  LV    C      RE    D     AK  +E  +L       I  L 
Sbjct: 128 GEVFSGRLRADNTLVAVKSC------RETLPPDL---KAKFLQEARILKQYSHPNIVRLI 178
Query: 80  YAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRP 139
                   +Y+VM+   GGD LT L     RL        + +    +  +     +HR 
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHR- 237
Query: 140 NHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAV-GTP-DYISPEIL 197
                    D+   N L+     ++++DFG   R   DG   ++  +   P  + +PE L
Sbjct: 238 ---------DLAARNCLVTEKNVLKISDFGMS-REEADGVYAASGGLRQVPVKWTAPEAL 287
Query: 198 TAMEEGRGRYGPECDWWSLGVCMYEML-YGETPF 230
                  GRY  E D WS G+ ++E    G +P+
Sbjct: 288 NY-----GRYSSESDVWSFGILLWETFSLGASPY 316

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 107 SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 161
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG    L      +    V T  Y +PEI+   
Sbjct: 162 --------DLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIML-- 207
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 208 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 107 SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 161
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 162 --------DLKPSNLAVNEDCELKILDFGLARHTDDEMTGY----VATRWYRAPEIML-- 207
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 208 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 106 SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 160
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG    L      +    V T  Y +PEI+   
Sbjct: 161 --------DLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIML-- 206
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 207 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 234

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 93  SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 147
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 148 --------DLKPSNLAVNEDCELKILDFGLARHTDDEMTGY----VATRWYRAPEIML-- 193
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 194 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 221

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 71/150 (47%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 95  SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 149
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG  L    D  +   VA  T  Y +PEI+   
Sbjct: 150 --------DLKPSNLAVNEDCELKILDFG--LARHTDDEMAGFVA--TRWYRAPEIML-- 195
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 71/150 (47%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 95  SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 149
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG  L    D  +   VA  T  Y +PEI+   
Sbjct: 150 --------DLKPSNLAVNEDCELKILDFG--LARHTDDEMAGFVA--TRWYRAPEIML-- 195
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 115 SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 169
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 170 --------DLKPSNLAVNEDCELKILDFGLARHTDDEMTGY----VATRWYRAPEIML-- 215
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 216 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 115 SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 169
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 170 --------DLKPSNLAVNEDCELKILDFGLARHTDDEMTGY----VATRWYRAPEIML-- 215
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 216 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 114 SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 168
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 169 --------DLKPSNLAVNEDCELKILDFGLARHTDDEMTGY----VATRWYRAPEIML-- 214
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 215 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 242

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/175 (24%), Positives = 78/175 (44%), Gaps = 19/175 (10%)
Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           ++  E  ++   D  +I  L    Q ++ L LVM+   GG L   L    + +P      
Sbjct: 382 EMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAE 440
Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
            + ++ + +  + + ++VHR          ++   NVLL    + +++DFG    LG D 
Sbjct: 441 LLHQVSMGMKYLEEKNFVHR----------NLAARNVLLVNRHYAKISDFGLSKALGADD 490
Query: 179 TVQSNVAVGT-P-DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPF 230
           +  +  + G  P  + +PE +        ++    D WS GV M+E L YG+ P+
Sbjct: 491 SYYTARSAGKWPLKWYAPECINFR-----KFSSRSDVWSYGVTMWEALSYGQKPY 540

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 47/99 (47%), Gaps = 15/99 (15%)
Query: 149 DIKPDNVLL--DANGHIRLADFGSCLRLGGD--GTVQSNVAVGTPDYISPEILTAMEEGR 204
           D+KP+N+LL       I++ DFGS  +LG      +QS        Y SPE+L  M    
Sbjct: 165 DLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXIQSRF------YRSPEVLLGMP--- 215
Query: 205 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
             Y    D WSLG  + EM  GE  F   + V+   KI+
Sbjct: 216 --YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 252

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 47/99 (47%), Gaps = 15/99 (15%)
Query: 149 DIKPDNVLL--DANGHIRLADFGSCLRLGGD--GTVQSNVAVGTPDYISPEILTAMEEGR 204
           D+KP+N+LL       I++ DFGS  +LG      +QS        Y SPE+L  M    
Sbjct: 184 DLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXIQSRF------YRSPEVLLGMP--- 234
Query: 205 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
             Y    D WSLG  + EM  GE  F   + V+   KI+
Sbjct: 235 --YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 271

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 79/183 (43%), Gaps = 38/183 (20%)
Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFED---RL 111
           + + KLR E+ V +Y           A   +  +Y+V +Y   G LL  L        RL
Sbjct: 65  QVMKKLRHEKLVQLY-----------AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRL 113
Query: 112 PE--DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG 169
           P+  DMA    A++   +A +  ++YVHR          D++  N+L+  N   ++ADFG
Sbjct: 114 PQLVDMA----AQIASGMAYVERMNYVHR----------DLRAANILVGENLVCKVADFG 159
Query: 170 SCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM-LYGE 227
              RL  D    +      P  + +PE         GR+  + D WS G+ + E+   G 
Sbjct: 160 -LARLIEDNEYTARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELTTKGR 213
Query: 228 TPF 230
            P+
Sbjct: 214 VPY 216

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 118 SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 172
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG    L      +    V T  Y +PEI+   
Sbjct: 173 --------DLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIML-- 218
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 219 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 246

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 114 SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 168
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 169 --------DLKPSNLAVNEDCELKILDFGLARHTDDEMTGY----VATRWYRAPEIML-- 214
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 215 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 242

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 79/183 (43%), Gaps = 38/183 (20%)
Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFED---RL 111
           + + KLR E+ V +Y           A   +  +Y+V +Y   G LL  L        RL
Sbjct: 54  QVMKKLRHEKLVQLY-----------AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRL 102
Query: 112 PE--DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG 169
           P+  DMA    A++   +A +  ++YVHR          D++  N+L+  N   ++ADFG
Sbjct: 103 PQLVDMA----AQIASGMAYVERMNYVHR----------DLRAANILVGENLVCKVADFG 148
Query: 170 SCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM-LYGE 227
              RL  D    +      P  + +PE         GR+  + D WS G+ + E+   G 
Sbjct: 149 LA-RLIEDNEYTARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELTTKGR 202
Query: 228 TPF 230
            P+
Sbjct: 203 VPY 205

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 79/183 (43%), Gaps = 38/183 (20%)
Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFED---RL 111
           + + KLR E+ V +Y           A   +  +Y+V +Y   G LL  L        RL
Sbjct: 56  QVMKKLRHEKLVQLY-----------AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRL 104
Query: 112 PE--DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG 169
           P+  DMA    A++   +A +  ++YVHR          D++  N+L+  N   ++ADFG
Sbjct: 105 PQLVDMA----AQIASGMAYVERMNYVHR----------DLRAANILVGENLVCKVADFG 150
Query: 170 SCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM-LYGE 227
              RL  D    +      P  + +PE         GR+  + D WS G+ + E+   G 
Sbjct: 151 LA-RLIEDNEYTARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELTTKGR 204
Query: 228 TPF 230
            P+
Sbjct: 205 VPY 207

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 71/150 (47%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 91  SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 145
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG  L    D  +   VA  T  Y +PEI+   
Sbjct: 146 --------DLKPSNLAVNEDCELKILDFG--LARHTDDEMAGFVA--TRWYRAPEIML-- 191
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 192 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 71/165 (43%), Gaps = 27/165 (16%)
Query: 99  DLLTLLSKFEDR-LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL 157
           DL T L K     LP +  K  + + +  +  +H    VHR          D+KP+N+L+
Sbjct: 104 DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHR----------DLKPENILV 153
Query: 158 DANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLG 217
            + G ++LADFG   R+       + V V T  Y +PE+L      +  Y    D WS+G
Sbjct: 154 TSGGTVKLADFG-LARIYSYQMALTPVVV-TLWYRAPEVLL-----QSTYATPVDMWSVG 206
Query: 218 VCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDD 262
               EM   +  F   S  +  GKI      FDL   +G    DD
Sbjct: 207 CIFAEMFRRKPLFCGNSEADQLGKI------FDL---IGLPPEDD 242

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 79/183 (43%), Gaps = 38/183 (20%)
Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFED---RL 111
           + + KLR E+ V +Y           A   +  +Y+V +Y   G LL  L        RL
Sbjct: 232 QVMKKLRHEKLVQLY-----------AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRL 280
Query: 112 PE--DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG 169
           P+  DMA    A++   +A +  ++YVHR          D++  N+L+  N   ++ADFG
Sbjct: 281 PQLVDMA----AQIASGMAYVERMNYVHR----------DLRAANILVGENLVCKVADFG 326
Query: 170 SCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM-LYGE 227
              RL  D    +      P  + +PE         GR+  + D WS G+ + E+   G 
Sbjct: 327 -LGRLIEDNEYTARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELTTKGR 380
Query: 228 TPF 230
            P+
Sbjct: 381 VPY 383

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 70/158 (44%), Gaps = 27/158 (17%)
Query: 80  YAFQDDSNLYLVMDYYCGGDLLTLLSKFED---RLPE--DMAKFYIAEMVLAIASIHDLH 134
           YA   +  +Y+V +Y   G LL  L        RLP+  DMA    A++   +A +  ++
Sbjct: 79  YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMA----AQIASGMAYVERMN 134
Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYIS 193
           YVHR          D++  N+L+  N   ++ADFG   RL  D    +      P  + +
Sbjct: 135 YVHR----------DLRAANILVGENLVCKVADFG-LARLIEDNEYTARQGAKFPIKWTA 183
Query: 194 PEILTAMEEGRGRYGPECDWWSLGVCMYEM-LYGETPF 230
           PE         GR+  + D WS G+ + E+   G  P+
Sbjct: 184 PEAALY-----GRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 92/223 (41%), Gaps = 25/223 (11%)
Query: 47  EKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSK 106
           EK +SD +  +  ++      + G  + I NL  A   D  LY++++Y   G+L   L  
Sbjct: 81  EKDLSDLVSEMEMMK------MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA 134
Query: 107 FEDRLPEDMAKFY----IAEMVLAIASIHDLHY--VHRPNHFAFHLC--RDIKPDNVLLD 158
              R P  M   Y    + E  +    +    Y       + A   C  RD+   NVL+ 
Sbjct: 135 ---RRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 191
Query: 159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLG 217
            N  +++ADFG    +      ++      P  +++PE L         Y  + D WS G
Sbjct: 192 ENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDR-----VYTHQSDVWSFG 246
Query: 218 VCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEI 259
           V M+E+   G +P Y    VE   K++   +  D P++   E+
Sbjct: 247 VLMWEIFTLGGSP-YPGIPVEELFKLLKEGHRMDKPANCTNEL 288

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 71/165 (43%), Gaps = 27/165 (16%)
Query: 99  DLLTLLSKFEDR-LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL 157
           DL T L K     LP +  K  + + +  +  +H    VHR          D+KP+N+L+
Sbjct: 96  DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHR----------DLKPENILV 145
Query: 158 DANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLG 217
            + G ++LADFG   R+       + V V T  Y +PE+L      +  Y    D WS+G
Sbjct: 146 TSGGTVKLADFG-LARIYSYQMALAPVVV-TLWYRAPEVLL-----QSTYATPVDMWSVG 198
Query: 218 VCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDD 262
               EM   +  F   S  +  GKI      FDL   +G    DD
Sbjct: 199 CIFAEMFRRKPLFCGNSEADQLGKI------FDL---IGLPPEDD 234

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 91  SLEEFNDVYLVT-HLMGADLNNIVKC--AKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 145
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DFG       + T      V T  Y +PEI+   
Sbjct: 146 --------DLKPSNLAVNEDCELKILDFGLARHTDDEMTGY----VATRWYRAPEIML-- 191
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 192 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 91/223 (40%), Gaps = 25/223 (11%)
Query: 47  EKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSK 106
           EK +SD +  +  ++      + G  + I NL  A   D  LY++++Y   G+L   L  
Sbjct: 68  EKDLSDLVSEMEMMK------MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA 121
Query: 107 FEDRLPEDMAKFY----IAEMVLAIASIHDLHY--VHRPNHFAFHLC--RDIKPDNVLLD 158
              R P  M   Y    + E  +    +    Y       + A   C  RD+   NVL+ 
Sbjct: 122 ---RRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVT 178
Query: 159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLG 217
            N  +++ADFG    +      +       P  +++PE L         Y  + D WS G
Sbjct: 179 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-----VYTHQSDVWSFG 233
Query: 218 VCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEI 259
           V M+E+   G +P Y    VE   K++   +  D P++   E+
Sbjct: 234 VLMWEIFTLGGSP-YPGIPVEELFKLLKEGHRMDKPANCTNEL 275

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 91/223 (40%), Gaps = 25/223 (11%)
Query: 47  EKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSK 106
           EK +SD +  +  ++      + G  + I NL  A   D  LY++++Y   G+L   L  
Sbjct: 70  EKDLSDLVSEMEMMK------MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA 123
Query: 107 FEDRLPEDMAKFY----IAEMVLAIASIHDLHY--VHRPNHFAFHLC--RDIKPDNVLLD 158
              R P  M   Y    + E  +    +    Y       + A   C  RD+   NVL+ 
Sbjct: 124 ---RRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 180
Query: 159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLG 217
            N  +++ADFG    +      +       P  +++PE L         Y  + D WS G
Sbjct: 181 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-----VYTHQSDVWSFG 235
Query: 218 VCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEI 259
           V M+E+   G +P Y    VE   K++   +  D P++   E+
Sbjct: 236 VLMWEIFTLGGSP-YPGIPVEELFKLLKEGHRMDKPANCTNEL 277

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 91/223 (40%), Gaps = 25/223 (11%)
Query: 47  EKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSK 106
           EK +SD +  +  ++      + G  + I NL  A   D  LY++++Y   G+L   L  
Sbjct: 127 EKDLSDLVSEMEMMK------MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA 180
Query: 107 FEDRLPEDMAKFY----IAEMVLAIASIHDLHY--VHRPNHFAFHLC--RDIKPDNVLLD 158
              R P  M   Y    + E  +    +    Y       + A   C  RD+   NVL+ 
Sbjct: 181 ---RRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 237
Query: 159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLG 217
            N  +++ADFG    +      +       P  +++PE L         Y  + D WS G
Sbjct: 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-----YTHQSDVWSFG 292
Query: 218 VCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEI 259
           V M+E+   G +P Y    VE   K++   +  D P++   E+
Sbjct: 293 VLMWEIFTLGGSP-YPGIPVEELFKLLKEGHRMDKPANCTNEL 334

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 79/183 (43%), Gaps = 38/183 (20%)
Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFED---RL 111
           + + KLR E+ V +Y           A   +  +Y+V +Y   G LL  L        RL
Sbjct: 65  QVMKKLRHEKLVQLY-----------AVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRL 113
Query: 112 PE--DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG 169
           P+  DMA    A++   +A +  ++YVHR          D++  N+L+  N   ++ADFG
Sbjct: 114 PQLVDMA----AQIASGMAYVERMNYVHR----------DLRAANILVGENLVCKVADFG 159
Query: 170 SCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM-LYGE 227
              RL  D    +      P  + +PE         GR+  + D WS G+ + E+   G 
Sbjct: 160 LA-RLIEDNEYTARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELTTKGR 213
Query: 228 TPF 230
            P+
Sbjct: 214 VPY 216

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 47/99 (47%), Gaps = 15/99 (15%)
Query: 149 DIKPDNVLL--DANGHIRLADFGSCLRLGGD--GTVQSNVAVGTPDYISPEILTAMEEGR 204
           D+KP+N+LL       I++ DFGS  +LG      +QS        Y SPE+L  M    
Sbjct: 184 DLKPENILLCNPKRXAIKIVDFGSSCQLGQRIYQXIQSRF------YRSPEVLLGMP--- 234
Query: 205 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
             Y    D WSLG  + EM  GE  F   + V+   KI+
Sbjct: 235 --YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 271

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 91/223 (40%), Gaps = 25/223 (11%)
Query: 47  EKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSK 106
           EK +SD +  +  ++      + G  + I NL  A   D  LY++++Y   G+L   L  
Sbjct: 73  EKDLSDLVSEMEMMK------MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA 126
Query: 107 FEDRLPEDMAKFY----IAEMVLAIASIHDLHY--VHRPNHFAFHLC--RDIKPDNVLLD 158
              R P  M   Y    + E  +    +    Y       + A   C  RD+   NVL+ 
Sbjct: 127 ---RRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 183
Query: 159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLG 217
            N  +++ADFG    +      +       P  +++PE L         Y  + D WS G
Sbjct: 184 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-----VYTHQSDVWSFG 238
Query: 218 VCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEI 259
           V M+E+   G +P Y    VE   K++   +  D P++   E+
Sbjct: 239 VLMWEIFTLGGSP-YPGIPVEELFKLLKEGHRMDKPANCTNEL 280

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/140 (24%), Positives = 58/140 (41%), Gaps = 17/140 (12%)
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NL L+M+Y   G L   L K ++R+       Y +++   +  +    Y+HR        
Sbjct: 86  NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR-------- 137
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD--YISPEILTAMEEGR 204
             D+   N+L++    +++ DFG    L  D         G     + +PE LT      
Sbjct: 138 --DLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE----- 190
Query: 205 GRYGPECDWWSLGVCMYEML 224
            ++    D WS GV +YE+ 
Sbjct: 191 SKFSVASDVWSFGVVLYELF 210

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/140 (24%), Positives = 58/140 (41%), Gaps = 17/140 (12%)
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NL L+M+Y   G L   L K ++R+       Y +++   +  +    Y+HR        
Sbjct: 87  NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR-------- 138
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD--YISPEILTAMEEGR 204
             D+   N+L++    +++ DFG    L  D         G     + +PE LT      
Sbjct: 139 --DLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE----- 191
Query: 205 GRYGPECDWWSLGVCMYEML 224
            ++    D WS GV +YE+ 
Sbjct: 192 SKFSVASDVWSFGVVLYELF 211

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/140 (24%), Positives = 58/140 (41%), Gaps = 17/140 (12%)
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NL L+M+Y   G L   L K ++R+       Y +++   +  +    Y+HR        
Sbjct: 92  NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR-------- 143
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD--YISPEILTAMEEGR 204
             D+   N+L++    +++ DFG    L  D         G     + +PE LT      
Sbjct: 144 --DLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE----- 196
Query: 205 GRYGPECDWWSLGVCMYEML 224
            ++    D WS GV +YE+ 
Sbjct: 197 SKFSVASDVWSFGVVLYELF 216

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 93/226 (41%), Gaps = 22/226 (9%)
Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTL 103
           L+ + T  D  + V+++   +   + G  + I NL  A   D  LY++++Y   G+L   
Sbjct: 75  LKDDATEEDLSDLVSEMEMMK---MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 131
Query: 104 LSKFEDRLPEDMAKFY----IAEMVLAIASIHDLHY--VHRPNHFAFHLC--RDIKPDNV 155
           L     R P  M   Y    + E  +    +    Y       + A   C  RD+   NV
Sbjct: 132 LRA---RRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188
Query: 156 LLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWW 214
           L+  N  +++ADFG    +      +       P  +++PE L         Y  + D W
Sbjct: 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-----VYTHQSDVW 243
Query: 215 SLGVCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEI 259
           S GV M+E+   G +P Y    VE   K++   +  D P++   E+
Sbjct: 244 SFGVLMWEIFTLGGSP-YPGIPVEELFKLLKEGHRMDKPANCTNEL 288

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/140 (24%), Positives = 58/140 (41%), Gaps = 17/140 (12%)
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NL L+M+Y   G L   L K ++R+       Y +++   +  +    Y+HR        
Sbjct: 94  NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR-------- 145
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD--YISPEILTAMEEGR 204
             D+   N+L++    +++ DFG    L  D         G     + +PE LT      
Sbjct: 146 --DLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE----- 198
Query: 205 GRYGPECDWWSLGVCMYEML 224
            ++    D WS GV +YE+ 
Sbjct: 199 SKFSVASDVWSFGVVLYELF 218

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/140 (24%), Positives = 58/140 (41%), Gaps = 17/140 (12%)
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NL L+M+Y   G L   L K ++R+       Y +++   +  +    Y+HR        
Sbjct: 118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR-------- 169
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD--YISPEILTAMEEGR 204
             D+   N+L++    +++ DFG    L  D         G     + +PE LT      
Sbjct: 170 --DLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE----- 222
Query: 205 GRYGPECDWWSLGVCMYEML 224
            ++    D WS GV +YE+ 
Sbjct: 223 SKFSVASDVWSFGVVLYELF 242

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/140 (24%), Positives = 58/140 (41%), Gaps = 17/140 (12%)
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NL L+M+Y   G L   L K ++R+       Y +++   +  +    Y+HR        
Sbjct: 90  NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR-------- 141
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD--YISPEILTAMEEGR 204
             D+   N+L++    +++ DFG    L  D         G     + +PE LT      
Sbjct: 142 --DLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE----- 194
Query: 205 GRYGPECDWWSLGVCMYEML 224
            ++    D WS GV +YE+ 
Sbjct: 195 SKFSVASDVWSFGVVLYELF 214

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/140 (24%), Positives = 58/140 (41%), Gaps = 17/140 (12%)
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NL L+M+Y   G L   L K ++R+       Y +++   +  +    Y+HR        
Sbjct: 93  NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR-------- 144
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD--YISPEILTAMEEGR 204
             D+   N+L++    +++ DFG    L  D         G     + +PE LT      
Sbjct: 145 --DLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE----- 197
Query: 205 GRYGPECDWWSLGVCMYEML 224
            ++    D WS GV +YE+ 
Sbjct: 198 SKFSVASDVWSFGVVLYELF 217

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 95  SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 149
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ D+G    L      +    V T  Y +PEI+   
Sbjct: 150 --------DLKPSNLAVNEDCELKILDYG----LARHTDDEMTGYVATRWYRAPEIML-- 195
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/140 (24%), Positives = 58/140 (41%), Gaps = 17/140 (12%)
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NL L+M+Y   G L   L K ++R+       Y +++   +  +    Y+HR        
Sbjct: 85  NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR-------- 136
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD--YISPEILTAMEEGR 204
             D+   N+L++    +++ DFG    L  D         G     + +PE LT      
Sbjct: 137 --DLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE----- 189
Query: 205 GRYGPECDWWSLGVCMYEML 224
            ++    D WS GV +YE+ 
Sbjct: 190 SKFSVASDVWSFGVVLYELF 209

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/140 (24%), Positives = 58/140 (41%), Gaps = 17/140 (12%)
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NL L+M+Y   G L   L K ++R+       Y +++   +  +    Y+HR        
Sbjct: 87  NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR-------- 138
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD--YISPEILTAMEEGR 204
             D+   N+L++    +++ DFG    L  D         G     + +PE LT      
Sbjct: 139 --DLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE----- 191
Query: 205 GRYGPECDWWSLGVCMYEML 224
            ++    D WS GV +YE+ 
Sbjct: 192 SKFSVASDVWSFGVVLYELF 211

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/140 (24%), Positives = 58/140 (41%), Gaps = 17/140 (12%)
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NL L+M+Y   G L   L K ++R+       Y +++   +  +    Y+HR        
Sbjct: 91  NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR-------- 142
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD--YISPEILTAMEEGR 204
             D+   N+L++    +++ DFG    L  D         G     + +PE LT      
Sbjct: 143 --DLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE----- 195
Query: 205 GRYGPECDWWSLGVCMYEML 224
            ++    D WS GV +YE+ 
Sbjct: 196 SKFSVASDVWSFGVVLYELF 215

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 70/165 (42%), Gaps = 27/165 (16%)
Query: 99  DLLTLLSKFEDR-LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL 157
           DL T L K     LP +  K  + + +  +  +H    VHR          D+KP+N+L+
Sbjct: 96  DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHR----------DLKPENILV 145
Query: 158 DANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLG 217
            + G ++LADFG   R+         V V T  Y +PE+L      +  Y    D WS+G
Sbjct: 146 TSGGTVKLADFG-LARIYSYQMALDPVVV-TLWYRAPEVLL-----QSTYATPVDMWSVG 198
Query: 218 VCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDD 262
               EM   +  F   S  +  GKI      FDL   +G    DD
Sbjct: 199 CIFAEMFRRKPLFCGNSEADQLGKI------FDL---IGLPPEDD 234

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 78/183 (42%), Gaps = 38/183 (20%)
Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFED---RL 111
           + + KLR E+ V +Y           A   +  +Y+V +Y   G LL  L        RL
Sbjct: 65  QVMKKLRHEKLVQLY-----------AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRL 113
Query: 112 PE--DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG 169
           P+  DMA    A++   +A +  ++YVHR          D+   N+L+  N   ++ADFG
Sbjct: 114 PQLVDMA----AQIASGMAYVERMNYVHR----------DLAAANILVGENLVCKVADFG 159
Query: 170 SCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM-LYGE 227
              RL  D    +      P  + +PE         GR+  + D WS G+ + E+   G 
Sbjct: 160 -LARLIEDNEYTARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELTTKGR 213
Query: 228 TPF 230
            P+
Sbjct: 214 VPY 216

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/140 (24%), Positives = 58/140 (41%), Gaps = 17/140 (12%)
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NL L+M+Y   G L   L K ++R+       Y +++   +  +    Y+HR        
Sbjct: 105 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR-------- 156
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD--YISPEILTAMEEGR 204
             D+   N+L++    +++ DFG    L  D         G     + +PE LT      
Sbjct: 157 --DLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE----- 209
Query: 205 GRYGPECDWWSLGVCMYEML 224
            ++    D WS GV +YE+ 
Sbjct: 210 SKFSVASDVWSFGVVLYELF 229

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 79/183 (43%), Gaps = 38/183 (20%)
Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFED---RL 111
           + + KLR E+ V +Y           A   +  +Y+V +Y   G LL  L        RL
Sbjct: 62  QVMKKLRHEKLVQLY-----------AVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRL 110
Query: 112 PE--DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG 169
           P+  DM+    A++   +A +  ++YVHR          D++  N+L+  N   ++ADFG
Sbjct: 111 PQLVDMS----AQIASGMAYVERMNYVHR----------DLRAANILVGENLVCKVADFG 156
Query: 170 SCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM-LYGE 227
              RL  D    +      P  + +PE         GR+  + D WS G+ + E+   G 
Sbjct: 157 -LARLIEDNEYTARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELTTKGR 210
Query: 228 TPF 230
            P+
Sbjct: 211 VPY 213

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/140 (24%), Positives = 58/140 (41%), Gaps = 17/140 (12%)
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NL L+M+Y   G L   L K ++R+       Y +++   +  +    Y+HR        
Sbjct: 105 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR-------- 156
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD--YISPEILTAMEEGR 204
             D+   N+L++    +++ DFG    L  D         G     + +PE LT      
Sbjct: 157 --DLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE----- 209
Query: 205 GRYGPECDWWSLGVCMYEML 224
            ++    D WS GV +YE+ 
Sbjct: 210 SKFSVASDVWSFGVVLYELF 229

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 79/183 (43%), Gaps = 38/183 (20%)
Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFED---RL 111
           + + KLR E+ V +Y           A   +  +Y+V +Y   G LL  L        RL
Sbjct: 65  QVMKKLRHEKLVQLY-----------AVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRL 113
Query: 112 PE--DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG 169
           P+  DMA    A++   +A +  ++YVHR          D++  N+L+  N   ++ADFG
Sbjct: 114 PQLVDMA----AQIASGMAYVERMNYVHR----------DLRAANILVGENLVCKVADFG 159
Query: 170 SCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM-LYGE 227
              RL  D    +      P  + +PE         GR+  + D WS G+ + E+   G 
Sbjct: 160 LA-RLIEDNEYTARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELTTKGR 213
Query: 228 TPF 230
            P+
Sbjct: 214 VPY 216

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 71/161 (44%), Gaps = 21/161 (13%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
            ++YLV  +  G DL  LL      L  D   +++ +++  +  IH  + +HR       
Sbjct: 119 KDVYLVT-HLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHR------- 168
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGG---DGTVQSNVAVGTPDYISPEILTAMEE 202
              D+KP N+LL+    +++ DFG   R+     D T      V T  Y +PEI   M  
Sbjct: 169 ---DLKPSNLLLNTTXDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEI---MLN 221
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
            +G Y    D WS+G  + EML     F  +  ++    I+
Sbjct: 222 SKG-YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 261

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/193 (22%), Positives = 85/193 (44%), Gaps = 19/193 (9%)
Query: 41  NSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDL 100
           NS+    KT+      V    EE +++       +  L+     +  +Y++ ++   G L
Sbjct: 35  NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSL 94
Query: 101 LTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD-LHYVHRPNHFAFHLCRDIKPDNVLLDA 159
           L  L   E        K  + +++   A I + + Y+ R N+    + RD++  NVL+  
Sbjct: 95  LDFLKSDEG------GKVLLPKLIDFSAQIAEGMAYIERKNY----IHRDLRAANVLVSE 144
Query: 160 NGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLGV 218
           +   ++ADFG   R+  D    +      P  + +PE +       G +  + + WS G+
Sbjct: 145 SLMCKIADFG-LARVIEDNEYTAREGAKFPIKWTAPEAINF-----GCFTIKSNVWSFGI 198
Query: 219 CMYEML-YGETPF 230
            +YE++ YG+ P+
Sbjct: 199 LLYEIVTYGKIPY 211

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/177 (21%), Positives = 70/177 (39%), Gaps = 19/177 (10%)
Query: 71  DRRWITNLHYAFQDDSNLYLVMDYYCGGDLL--TLLSKFEDRLPEDMAKFYIAEMVLAIA 128
           + + I +L   F     L    D Y   +L+   L       L  +   + + +M+  I 
Sbjct: 79  NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIK 138
Query: 129 SIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGT 188
            +H    +HR          D+KP N+++ ++  +++ DFG  L             V T
Sbjct: 139 HLHSAGIIHR----------DLKPSNIVVKSDCTLKILDFG--LARTASTNFMMTPYVVT 186
Query: 189 PDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
             Y +PE++  M      Y    D WS+G  M E++ G   F     ++ + K++  
Sbjct: 187 RYYRAPEVILGM-----GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQ 238

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 90/223 (40%), Gaps = 25/223 (11%)
Query: 47  EKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSK 106
           EK +SD +  +  ++      + G  + I NL  A   D  LY+++ Y   G+L   L  
Sbjct: 81  EKDLSDLVSEMEMMK------MIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRA 134
Query: 107 FEDRLPEDMAKFY----IAEMVLAIASIHDLHY--VHRPNHFAFHLC--RDIKPDNVLLD 158
              R P  M   Y    + E  +    +    Y       + A   C  RD+   NVL+ 
Sbjct: 135 ---RRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 191
Query: 159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLG 217
            N  +++ADFG    +      +       P  +++PE L         Y  + D WS G
Sbjct: 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-----VYTHQSDVWSFG 246
Query: 218 VCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEI 259
           V M+E+   G +P Y    VE   K++   +  D P++   E+
Sbjct: 247 VLMWEIFTLGGSP-YPGIPVEELFKLLKEGHRMDKPANCTNEL 288

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 90/223 (40%), Gaps = 25/223 (11%)
Query: 47  EKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSK 106
           EK +SD +  +  ++      + G  + I NL  A   D  LY+++ Y   G+L   L  
Sbjct: 81  EKDLSDLVSEMEMMK------MIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRA 134
Query: 107 FEDRLPEDMAKFY----IAEMVLAIASIHDLHY--VHRPNHFAFHLC--RDIKPDNVLLD 158
              R P  M   Y    + E  +    +    Y       + A   C  RD+   NVL+ 
Sbjct: 135 ---RRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 191
Query: 159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLG 217
            N  +++ADFG    +      +       P  +++PE L         Y  + D WS G
Sbjct: 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-----VYTHQSDVWSFG 246
Query: 218 VCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEI 259
           V M+E+   G +P Y    VE   K++   +  D P++   E+
Sbjct: 247 VLMWEIFTLGGSP-YPGIPVEELFKLLKEGHRMDKPANCTNEL 288

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 79/183 (43%), Gaps = 38/183 (20%)
Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFED---RL 111
           + + KLR E+ V +Y           A   +  +Y+V +Y   G LL  L        RL
Sbjct: 62  QVMKKLRHEKLVQLY-----------AVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRL 110
Query: 112 PE--DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG 169
           P+  DM+    A++   +A +  ++YVHR          D++  N+L+  N   ++ADFG
Sbjct: 111 PQLVDMS----AQIASGMAYVERMNYVHR----------DLRAANILVGENLVCKVADFG 156
Query: 170 SCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM-LYGE 227
              RL  D    +      P  + +PE         GR+  + D WS G+ + E+   G 
Sbjct: 157 -LARLIEDNEWTARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELTTKGR 210
Query: 228 TPF 230
            P+
Sbjct: 211 VPY 213

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 58/140 (41%), Gaps = 17/140 (12%)
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
            L LVM+Y   G L   L +   RL       Y +++   +  +     VHR        
Sbjct: 84  ELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHR-------- 135
Query: 147 CRDIKPDNVLLDANGHIRLADFG--SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR 204
             D+   N+L+++  H+++ADFG    L L  D  V          + +PE L+     R
Sbjct: 136 --DLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSR 193
Query: 205 GRYGPECDWWSLGVCMYEML 224
                + D WS GV +YE+ 
Sbjct: 194 -----QSDVWSFGVVLYELF 208

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 70/165 (42%), Gaps = 27/165 (16%)
Query: 99  DLLTLLSKFEDR-LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL 157
           DL T L K     LP +  K  + + +  +  +H    VHR          D+KP+N+L+
Sbjct: 96  DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHR----------DLKPENILV 145
Query: 158 DANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLG 217
            + G ++LADFG   R+         V V T  Y +PE+L      +  Y    D WS+G
Sbjct: 146 TSGGTVKLADFG-LARIYSYQMALFPVVV-TLWYRAPEVLL-----QSTYATPVDMWSVG 198
Query: 218 VCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDD 262
               EM   +  F   S  +  GKI      FDL   +G    DD
Sbjct: 199 CIFAEMFRRKPLFCGNSEADQLGKI------FDL---IGLPPEDD 234

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 72/159 (45%), Gaps = 23/159 (14%)
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD-ANGHIRLADFGSCLRLG 175
           +FY+ E++ A+   H +  +HR          D+KP NVL+D  +  +RL D+G      
Sbjct: 134 RFYMYEILKALDYCHSMGIMHR----------DVKPHNVLIDHEHRKLRLIDWG-LAEFY 182
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA--- 232
             G  + NV V +  +  PE+L   +     Y    D WSLG  +  M++ + PF+    
Sbjct: 183 HPGQ-EYNVRVASRYFKGPELLVDYQ----MYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237
Query: 233 --ESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRR 269
             + LV    K++  ++ +D       E+     D++ R
Sbjct: 238 NYDQLVRI-AKVLGTEDLYDYIDKYNIELDPRFNDILGR 275

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/140 (23%), Positives = 58/140 (41%), Gaps = 17/140 (12%)
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NL L+M++   G L   L K ++R+       Y +++   +  +    Y+HR        
Sbjct: 90  NLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR-------- 141
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD--YISPEILTAMEEGR 204
             D+   N+L++    +++ DFG    L  D         G     + +PE LT      
Sbjct: 142 --DLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE----- 194
Query: 205 GRYGPECDWWSLGVCMYEML 224
            ++    D WS GV +YE+ 
Sbjct: 195 SKFSVASDVWSFGVVLYELF 214

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/140 (24%), Positives = 58/140 (41%), Gaps = 17/140 (12%)
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NL L+M+Y   G L   L K ++R+       Y +++   +  +    Y+HR        
Sbjct: 87  NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR-------- 138
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD--YISPEILTAMEEGR 204
             D+   N+L++    +++ DFG    L  D         G     + +PE LT      
Sbjct: 139 --DLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE----- 191
Query: 205 GRYGPECDWWSLGVCMYEML 224
            ++    D WS GV +YE+ 
Sbjct: 192 SKFSVASDVWSFGVVLYELF 211

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 78/183 (42%), Gaps = 38/183 (20%)
Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFED---RL 111
           + + KLR E+ V +Y           A   +  + +V +Y   G LL  L        RL
Sbjct: 55  QVMKKLRHEKLVQLY-----------AVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRL 103
Query: 112 PE--DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG 169
           P+  DMA    A++   +A +  ++YVHR          D++  N+L+  N   ++ADFG
Sbjct: 104 PQLVDMA----AQIASGMAYVERMNYVHR----------DLRAANILVGENLVCKVADFG 149
Query: 170 SCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM-LYGE 227
              RL  D    +      P  + +PE         GR+  + D WS G+ + E+   G 
Sbjct: 150 -LARLIEDNEXTARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELTTKGR 203
Query: 228 TPF 230
            P+
Sbjct: 204 VPY 206

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 30  DILLVLYDECCNSSLRREKTVSDFIE-FVAKLREERDVLVYGDRRWITNLHYAFQDDSNL 88
           ++ +  Y++    +++  K  S  +E F+A    E +V+       +  LH A      +
Sbjct: 30  EVWMATYNKHTKVAVKTMKPGSMSVEAFLA----EANVMKTLQHDKLVKLH-AVVTKEPI 84
Query: 89  YLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           Y++ ++   G LL  L   E  + P      + A++   +A I   +Y+HR         
Sbjct: 85  YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR--------- 135
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGR 206
            D++  N+L+ A+   ++ADFG   R+  D    +      P  + +PE +       G 
Sbjct: 136 -DLRAANILVSASLVCKIADFG-LARVIEDNEYTAREGAKFPIKWTAPEAINF-----GS 188
Query: 207 YGPECDWWSLGVCMYEML-YGETPF 230
           +  + D WS G+ + E++ YG  P+
Sbjct: 189 FTIKSDVWSFGILLMEIVTYGRIPY 213

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 39/193 (20%), Positives = 87/193 (45%), Gaps = 17/193 (8%)
Query: 87  NLYLVMDYYCGGDLLTLL-----SKFEDRLPEDMAKFYIAEMV-LAIASIHDLHYVHRPN 140
           N+ L M Y     L  +      S     L     KF + +++ +A  +   + Y+H  +
Sbjct: 69  NILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 128
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFG-SCLRLGGDGTVQSNVAVGTPDYISPEILTA 199
                + RD+K +N+ L  +  +++ DFG + ++    G+ Q     G+  +++PE++  
Sbjct: 129 I----IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 184
Query: 200 MEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEI 259
            +     Y  + D ++ G+ +YE++ G+ P+   S +    +I+       L  D+  ++
Sbjct: 185 QDS--NPYSFQSDVYAFGIVLYELMTGQLPY---SNINNRDQIIEMVGRGSLSPDLS-KV 238
Query: 260 SDDAKDLMRRLIC 272
             +    M+RL+ 
Sbjct: 239 RSNCPKRMKRLMA 251

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 59/140 (42%), Gaps = 17/140 (12%)
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           +L LVM+Y   G L   L +   RL       Y +++   +  +     VHR        
Sbjct: 87  SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHR-------- 138
Query: 147 CRDIKPDNVLLDANGHIRLADFG--SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR 204
             D+   N+L+++  H+++ADFG    L L  D  V          + +PE L+     R
Sbjct: 139 --DLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSR 196
Query: 205 GRYGPECDWWSLGVCMYEML 224
                + D WS GV +YE+ 
Sbjct: 197 -----QSDVWSFGVVLYELF 211

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 68/150 (45%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 95  SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 149
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++  FG       + T      V T  Y +PEI+   
Sbjct: 150 --------DLKPSNLAVNEDCELKILGFGLARHTDDEMTGY----VATRWYRAPEIML-- 195
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 30  DILLVLYDECCNSSLRREKTVSDFIE-FVAKLREERDVLVYGDRRWITNLHYAFQDDSNL 88
           ++ +  Y++    +++  K  S  +E F+A    E +V+       +  LH A      +
Sbjct: 203 EVWMATYNKHTKVAVKTMKPGSMSVEAFLA----EANVMKTLQHDKLVKLH-AVVTKEPI 257
Query: 89  YLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           Y++ ++   G LL  L   E  + P      + A++   +A I   +Y+HR         
Sbjct: 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR--------- 308
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGR 206
            D++  N+L+ A+   ++ADFG   R+  D    +      P  + +PE +       G 
Sbjct: 309 -DLRAANILVSASLVCKIADFG-LARVIEDNEYTAREGAKFPIKWTAPEAINF-----GS 361
Query: 207 YGPECDWWSLGVCMYEML-YGETPF 230
           +  + D WS G+ + E++ YG  P+
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPY 386

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 23/159 (14%)
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD-ANGHIRLADFGSCLRLG 175
           +FY+ E++ A+   H +  +HR          D+KP NV++D  +  +RL D+G      
Sbjct: 132 RFYMYEILKALDYCHSMGIMHR----------DVKPHNVMIDHEHRKLRLIDWG-LAEFY 180
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA--- 232
             G  + NV V +  +  PE+L   +     Y    D WSLG  +  M++ + PF+    
Sbjct: 181 HPGQ-EYNVRVASRYFKGPELLVDYQ----MYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235
Query: 233 --ESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRR 269
             + LV    K++  ++ +D       E+     D++ R
Sbjct: 236 NYDQLVRI-AKVLGTEDLYDYIDKYNIELDPRFNDILGR 273

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 23/159 (14%)
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD-ANGHIRLADFGSCLRLG 175
           +FY+ E++ A+   H +  +HR          D+KP NV++D  +  +RL D+G      
Sbjct: 133 RFYMYEILKALDYCHSMGIMHR----------DVKPHNVMIDHEHRKLRLIDWG-LAEFY 181
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA--- 232
             G  + NV V +  +  PE+L   +     Y    D WSLG  +  M++ + PF+    
Sbjct: 182 HPGQ-EYNVRVASRYFKGPELLVDYQ----MYDYSLDMWSLGCMLASMIFRKEPFFHGHD 236
Query: 233 --ESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRR 269
             + LV    K++  ++ +D       E+     D++ R
Sbjct: 237 NYDQLVRI-AKVLGTEDLYDYIDKYNIELDPRFNDILGR 274

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 23/159 (14%)
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD-ANGHIRLADFGSCLRLG 175
           +FY+ E++ A+   H +  +HR          D+KP NV++D  +  +RL D+G      
Sbjct: 134 RFYMYEILKALDYCHSMGIMHR----------DVKPHNVMIDHEHRKLRLIDWGLA-EFY 182
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA--- 232
             G  + NV V +  +  PE+L   +     Y    D WSLG  +  M++ + PF+    
Sbjct: 183 HPGQ-EYNVRVASRYFKGPELLVDYQ----MYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237
Query: 233 --ESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRR 269
             + LV    K++  ++ +D       E+     D++ R
Sbjct: 238 NYDQLVRI-AKVLGTEDLYDYIDKYNIELDPRFNDILGR 275

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 39/184 (21%), Positives = 81/184 (44%), Gaps = 30/184 (16%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           +F++ + +Y++ +     DL  ++S     L +D  +++I + + A+  +H  + +HR  
Sbjct: 82  SFENFNEVYIIQEL-MQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHR-- 136
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL---GGDGTVQSNVAVGTPDYI----- 192
                   D+KP N+L+++N  +++ DFG    +     D +  +    G  +Y+     
Sbjct: 137 --------DLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWY 188
Query: 193 -SPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF----YAESLVETYGKIMNHQN 247
            +PE++        +Y    D WS G  + E+      F    Y   L+  +G I    +
Sbjct: 189 RAPEVMLT----SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 248 SFDL 251
             DL
Sbjct: 245 DNDL 248

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 23/159 (14%)
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD-ANGHIRLADFGSCLRLG 175
           +FY+ E++ A+   H +  +HR          D+KP NV++D  +  +RL D+G      
Sbjct: 134 RFYMYEILKALDYCHSMGIMHR----------DVKPHNVMIDHEHRKLRLIDWG-LAEFY 182
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA--- 232
             G  + NV V +  +  PE+L   +     Y    D WSLG  +  M++ + PF+    
Sbjct: 183 HPGQ-EYNVRVASRYFKGPELLVDYQ----MYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237
Query: 233 --ESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRR 269
             + LV    K++  ++ +D       E+     D++ R
Sbjct: 238 NYDQLVRI-AKVLGTEDLYDYIDKYNIELDPRFNDILGR 275

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 84/240 (35%), Gaps = 59/240 (24%)
Query: 68  VYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAI 127
           V G +  +  + Y F+ + ++ + M Y      L +L    + L     + Y+  +  A+
Sbjct: 75  VAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDIL----NSLSFQEVREYMLNLFKAL 130
Query: 128 ASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFGSCLRLGGDGT------- 179
             IH    VHR          D+KP N L +       L DFG  L  G   T       
Sbjct: 131 KRIHQFGIVHR----------DVKPSNFLYNRRLKKYALVDFG--LAQGTHDTKIELLKF 178
Query: 180 VQSNVA----------------------VGTPDYISPEILTAMEEGRGRYGPECDWWSLG 217
           VQS                          GTP + +PE+LT             D WS G
Sbjct: 179 VQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPN----QTTAIDMWSAG 234
Query: 218 VCMYEMLYGETPFY-AESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT 276
           V    +L G  PFY A   +    +IM  + S         E    AK   + ++CS + 
Sbjct: 235 VIFLSLLSGRYPFYKASDDLTALAQIMTIRGS--------RETIQAAKTFGKSILCSKEV 286

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 23/159 (14%)
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD-ANGHIRLADFGSCLRLG 175
           +FY+ E++ A+   H +  +HR          D+KP NV++D  +  +RL D+G      
Sbjct: 134 RFYMYEILKALDYCHSMGIMHR----------DVKPHNVMIDHEHRKLRLIDWG-LAEFY 182
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA--- 232
             G  + NV V +  +  PE+L   +     Y    D WSLG  +  M++ + PF+    
Sbjct: 183 HPGQ-EYNVRVASRYFKGPELLVDYQ----MYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237
Query: 233 --ESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRR 269
             + LV    K++  ++ +D       E+     D++ R
Sbjct: 238 NYDQLVRI-AKVLGTEDLYDYIDKYNIELDPRFNDILGR 275

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 23/159 (14%)
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD-ANGHIRLADFGSCLRLG 175
           +FY+ E++ A+   H +  +HR          D+KP NV++D  +  +RL D+G      
Sbjct: 133 RFYMYEILKALDYCHSMGIMHR----------DVKPHNVMIDHEHRKLRLIDWG-LAEFY 181
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA--- 232
             G  + NV V +  +  PE+L   +     Y    D WSLG  +  M++ + PF+    
Sbjct: 182 HPGQ-EYNVRVASRYFKGPELLVDYQ----MYDYSLDMWSLGCMLASMIFRKEPFFHGHD 236
Query: 233 --ESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRR 269
             + LV    K++  ++ +D       E+     D++ R
Sbjct: 237 NYDQLVRI-AKVLGTEDLYDYIDKYNIELDPRFNDILGR 274

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 23/159 (14%)
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD-ANGHIRLADFGSCLRLG 175
           +FY+ E++ A+   H +  +HR          D+KP NV++D  +  +RL D+G      
Sbjct: 134 RFYMYEILKALDYCHSMGIMHR----------DVKPHNVMIDHEHRKLRLIDWG-LAEFY 182
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA--- 232
             G  + NV V +  +  PE+L   +     Y    D WSLG  +  M++ + PF+    
Sbjct: 183 HPGQ-EYNVRVASRYFKGPELLVDYQ----MYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237
Query: 233 --ESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRR 269
             + LV    K++  ++ +D       E+     D++ R
Sbjct: 238 NYDQLVRI-AKVLGTEDLYDYIDKYNIELDPRFNDILGR 275

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 23/159 (14%)
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD-ANGHIRLADFGSCLRLG 175
           +FY+ E++ A+   H +  +HR          D+KP NV++D  +  +RL D+G      
Sbjct: 134 RFYMYEILKALDYCHSMGIMHR----------DVKPHNVMIDHEHRKLRLIDWG-LAEFY 182
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA--- 232
             G  + NV V +  +  PE+L   +     Y    D WSLG  +  M++ + PF+    
Sbjct: 183 HPGQ-EYNVRVASRYFKGPELLVDYQ----MYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237
Query: 233 --ESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRR 269
             + LV    K++  ++ +D       E+     D++ R
Sbjct: 238 NYDQLVRI-AKVLGTEDLYDYIDKYNIELDPRFNDILGR 275

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 23/159 (14%)
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD-ANGHIRLADFGSCLRLG 175
           +FY+ E++ A+   H +  +HR          D+KP NV++D  +  +RL D+G      
Sbjct: 134 RFYMYEILKALDYCHSMGIMHR----------DVKPHNVMIDHEHRKLRLIDWG-LAEFY 182
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA--- 232
             G  + NV V +  +  PE+L   +     Y    D WSLG  +  M++ + PF+    
Sbjct: 183 HPGQ-EYNVRVASRYFKGPELLVDYQ----MYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237
Query: 233 --ESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRR 269
             + LV    K++  ++ +D       E+     D++ R
Sbjct: 238 NYDQLVRI-AKVLGTEDLYDYIDKYNIELDPRFNDILGR 275

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 23/159 (14%)
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD-ANGHIRLADFGSCLRLG 175
           +FY+ E++ A+   H +  +HR          D+KP NV++D  +  +RL D+G      
Sbjct: 134 RFYMYEILKALDYCHSMGIMHR----------DVKPHNVMIDHEHRKLRLIDWG-LAEFY 182
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA--- 232
             G  + NV V +  +  PE+L   +     Y    D WSLG  +  M++ + PF+    
Sbjct: 183 HPGQ-EYNVRVASRYFKGPELLVDYQ----MYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237
Query: 233 --ESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRR 269
             + LV    K++  ++ +D       E+     D++ R
Sbjct: 238 NYDQLVRI-AKVLGTEDLYDYIDKYNIELDPRFNDILGR 275

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 59/140 (42%), Gaps = 17/140 (12%)
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           +L LVM+Y   G L   L +   RL       Y +++   +  +     VHR        
Sbjct: 100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHR-------- 151
Query: 147 CRDIKPDNVLLDANGHIRLADFG--SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR 204
             D+   N+L+++  H+++ADFG    L L  D  V          + +PE L+     R
Sbjct: 152 --DLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSR 209
Query: 205 GRYGPECDWWSLGVCMYEML 224
                + D WS GV +YE+ 
Sbjct: 210 -----QSDVWSFGVVLYELF 224

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 23/159 (14%)
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD-ANGHIRLADFGSCLRLG 175
           +FY+ E++ A+   H +  +HR          D+KP NV++D  +  +RL D+G      
Sbjct: 134 RFYMYEILKALDYCHSMGIMHR----------DVKPHNVMIDHEHRKLRLIDWG-LAEFY 182
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA--- 232
             G  + NV V +  +  PE+L   +     Y    D WSLG  +  M++ + PF+    
Sbjct: 183 HPGQ-EYNVRVASRYFKGPELLVDYQ----MYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237
Query: 233 --ESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRR 269
             + LV    K++  ++ +D       E+     D++ R
Sbjct: 238 NYDQLVRI-AKVLGTEDLYDYIDKYNIELDPRFNDILGR 275

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 23/159 (14%)
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD-ANGHIRLADFGSCLRLG 175
           +FY+ E++ A+   H +  +HR          D+KP NV++D  +  +RL D+G      
Sbjct: 134 RFYMYEILKALDYCHSMGIMHR----------DVKPHNVMIDHEHRKLRLIDWG-LAEFY 182
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA--- 232
             G  + NV V +  +  PE+L   +     Y    D WSLG  +  M++ + PF+    
Sbjct: 183 HPGQ-EYNVRVASRYFKGPELLVDYQ----MYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237
Query: 233 --ESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRR 269
             + LV    K++  ++ +D       E+     D++ R
Sbjct: 238 NYDQLVRI-AKVLGTEDLYDYIDKYNIELDPRFNDILGR 275

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 59/140 (42%), Gaps = 17/140 (12%)
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           +L LVM+Y   G L   L +   RL       Y +++   +  +     VHR        
Sbjct: 88  SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHR-------- 139
Query: 147 CRDIKPDNVLLDANGHIRLADFG--SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR 204
             D+   N+L+++  H+++ADFG    L L  D  V          + +PE L+     R
Sbjct: 140 --DLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSR 197
Query: 205 GRYGPECDWWSLGVCMYEML 224
                + D WS GV +YE+ 
Sbjct: 198 -----QSDVWSFGVVLYELF 212

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 90/223 (40%), Gaps = 25/223 (11%)
Query: 47  EKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSK 106
           EK +SD +  +  ++      + G  + I  L  A   D  LY++++Y   G+L   L  
Sbjct: 81  EKDLSDLVSEMEMMK------MIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRA 134
Query: 107 FEDRLPEDMAKFY----IAEMVLAIASIHDLHY--VHRPNHFAFHLC--RDIKPDNVLLD 158
              R P  M   Y    + E  +    +    Y       + A   C  RD+   NVL+ 
Sbjct: 135 ---RRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 191
Query: 159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLG 217
            N  +++ADFG    +      +       P  +++PE L         Y  + D WS G
Sbjct: 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-----VYTHQSDVWSFG 246
Query: 218 VCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEI 259
           V M+E+   G +P Y    VE   K++   +  D P++   E+
Sbjct: 247 VLMWEIFTLGGSP-YPGIPVEELFKLLKEGHRMDKPANCTNEL 288

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 23/159 (14%)
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD-ANGHIRLADFGSCLRLG 175
           +FY+ E++ A+   H +  +HR          D+KP NV++D  +  +RL D+G  L   
Sbjct: 134 RFYMYEILKALDYCHSMGIMHR----------DVKPHNVMIDHEHRKLRLIDWG--LAEF 181
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA--- 232
                + NV V +  +  PE+L   +     Y    D WSLG  +  M++ + PF+    
Sbjct: 182 YHPGQEYNVRVASRYFKGPELLVDYQ----MYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237
Query: 233 --ESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRR 269
             + LV    K++  ++ +D       E+     D++ R
Sbjct: 238 NYDQLVRI-AKVLGTEDLYDYIDKYNIELDPRFNDILGR 275

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 23/159 (14%)
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD-ANGHIRLADFGSCLRLG 175
           +FY+ E++ A+   H +  +HR          D+KP NV++D  +  +RL D+G      
Sbjct: 139 RFYMYEILKALDYCHSMGIMHR----------DVKPHNVMIDHEHRKLRLIDWG-LAEFY 187
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA--- 232
             G  + NV V +  +  PE+L   +     Y    D WSLG  +  M++ + PF+    
Sbjct: 188 HPGQ-EYNVRVASRYFKGPELLVDYQ----MYDYSLDMWSLGCMLASMIFRKEPFFHGHD 242
Query: 233 --ESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRR 269
             + LV    K++  ++ +D       E+     D++ R
Sbjct: 243 NYDQLVRI-AKVLGTEDLYDYIDKYNIELDPRFNDILGR 280

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 95  SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 149
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ DF   L    D  +   VA  T  Y +PEI+   
Sbjct: 150 --------DLKPSNLAVNEDCELKILDF--YLARHTDDEMTGYVA--TRWYRAPEIML-- 195
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 64/146 (43%), Gaps = 27/146 (18%)
Query: 90  LVMDYYCGGD---LLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           LV +Y    D   L  +L+ F+ R       FY+ E++ A+   H    +HR        
Sbjct: 117 LVFEYINNTDFKQLYQILTDFDIR-------FYMYELLKALDYCHSKGIMHR-------- 161
Query: 147 CRDIKPDNVLLD-ANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRG 205
             D+KP NV++D     +RL D+G  L        + NV V +  +  PE+L   +    
Sbjct: 162 --DVKPHNVMIDHQQKKLRLIDWG--LAEFYHPAQEYNVRVASRYFKGPELLVDYQ---- 213
Query: 206 RYGPECDWWSLGVCMYEMLYGETPFY 231
            Y    D WSLG  +  M++   PF+
Sbjct: 214 MYDYSLDMWSLGCMLASMIFRREPFF 239

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 91/223 (40%), Gaps = 25/223 (11%)
Query: 47  EKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSK 106
           EK +SD +  +  ++      + G  + I +L  A   D  LY++++Y   G+L   L  
Sbjct: 81  EKDLSDLVSEMEMMK------MIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRA 134
Query: 107 FEDRLPEDMAKFY----IAEMVLAIASIHDLHY--VHRPNHFAFHLC--RDIKPDNVLLD 158
              R P  M   Y    + E  +    +    Y       + A   C  RD+   NVL+ 
Sbjct: 135 ---RRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 191
Query: 159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLG 217
            N  +++ADFG    +      +       P  +++PE L         Y  + D WS G
Sbjct: 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-----VYTHQSDVWSFG 246
Query: 218 VCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEI 259
           V M+E+   G +P Y    VE   K++   +  D P++   E+
Sbjct: 247 VLMWEIFTLGGSP-YPGIPVEELFKLLKEGHRMDKPANCTNEL 288

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 64/146 (43%), Gaps = 27/146 (18%)
Query: 90  LVMDYYCGGD---LLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           LV +Y    D   L  +L+ F+ R       FY+ E++ A+   H    +HR        
Sbjct: 112 LVFEYINNTDFKQLYQILTDFDIR-------FYMYELLKALDYCHSKGIMHR-------- 156
Query: 147 CRDIKPDNVLLD-ANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRG 205
             D+KP NV++D     +RL D+G  L        + NV V +  +  PE+L   +    
Sbjct: 157 --DVKPHNVMIDHQQKKLRLIDWG--LAEFYHPAQEYNVRVASRYFKGPELLVDYQ---- 208
Query: 206 RYGPECDWWSLGVCMYEMLYGETPFY 231
            Y    D WSLG  +  M++   PF+
Sbjct: 209 MYDYSLDMWSLGCMLASMIFRREPFF 234

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/204 (22%), Positives = 90/204 (44%), Gaps = 33/204 (16%)
Query: 30  DILLVLYDECCNSSLRREKTVSDFIE-FVAKLREERDVLVYGDRRWITNLHYAFQDDSNL 88
           ++ +  Y++    +++  K  S  +E F+A    E +V+       +  LH A      +
Sbjct: 197 EVWMATYNKHTKVAVKTMKPGSMSVEAFLA----EANVMKTLQHDKLVKLH-AVVTKEPI 251
Query: 89  YLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
           Y++ ++   G LL  L   E  + P      + A++   +A I   +Y+HR         
Sbjct: 252 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR--------- 302
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
            D++  N+L+ A+   ++ADFG   R+G    ++         + +PE +       G +
Sbjct: 303 -DLRAANILVSASLVCKIADFG-LARVGAKFPIK---------WTAPEAINF-----GSF 346
Query: 208 GPECDWWSLGVCMYEML-YGETPF 230
             + D WS G+ + E++ YG  P+
Sbjct: 347 TIKSDVWSFGILLMEIVTYGRIPY 370

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 68/150 (45%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 95  SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 149
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ D G       + T      V T  Y +PEI+   
Sbjct: 150 --------DLKPSNLAVNEDCELKILDAGLARHTDDEMTGY----VATRWYRAPEIML-- 195
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/140 (23%), Positives = 58/140 (41%), Gaps = 17/140 (12%)
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NL L+M+Y   G L   L K ++R+       Y +++   +  +    Y+HR        
Sbjct: 88  NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR-------- 139
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD--YISPEILTAMEEGR 204
             ++   N+L++    +++ DFG    L  D         G     + +PE LT      
Sbjct: 140 --NLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE----- 192
Query: 205 GRYGPECDWWSLGVCMYEML 224
            ++    D WS GV +YE+ 
Sbjct: 193 SKFSVASDVWSFGVVLYELF 212

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 67/164 (40%), Gaps = 24/164 (14%)
Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH 141
           FQD   +YLVM+         L       L  +   + + +M+  I  +H    +HR   
Sbjct: 101 FQD---VYLVMELMDAN----LCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHR--- 150
Query: 142 FAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAME 201
                  D+KP N+++ ++  +++ DFG  L             V T  Y +PE++  M 
Sbjct: 151 -------DLKPSNIVVKSDCTLKILDFG--LARTACTNFMMTPYVVTRYYRAPEVILGM- 200
Query: 202 EGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 245
                Y    D WS+G  M E++ G   F     ++ + K++  
Sbjct: 201 ----GYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQ 240

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 68/150 (45%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 95  SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 149
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ D G    L      +    V T  Y +PEI+   
Sbjct: 150 --------DLKPSNLAVNEDCELKILDRG----LARHTDDEMTGYVATRWYRAPEIML-- 195
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/153 (22%), Positives = 68/153 (44%), Gaps = 15/153 (9%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
            Y+++++   G+LL  L +   +    +   Y+A  + +      + Y+ + N     + 
Sbjct: 85  FYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA-----MEYLEKKNF----IH 135
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
           RD+   N L+  N  +++ADFG    + GD       A     + +PE L        ++
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL-----AYNKF 190
Query: 208 GPECDWWSLGVCMYEM-LYGETPFYAESLVETY 239
             + D W+ GV ++E+  YG +P+    L + Y
Sbjct: 191 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 223

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 64/155 (41%), Gaps = 41/155 (26%)
Query: 83  QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHF 142
           Q + +L LVM+Y   G L   L +    L + +   +  ++   +A +H  HY+HR    
Sbjct: 88  QGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLL--LFAQQICEGMAYLHSQHYIHR---- 141
Query: 143 AFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEE 202
                 ++   NVLLD +  +++ DFG              +A   P+    E     E+
Sbjct: 142 ------NLAARNVLLDNDRLVKIGDFG--------------LAKAVPE--GHEYYRVRED 179
Query: 203 GRGR---YGPEC----------DWWSLGVCMYEML 224
           G      Y PEC          D WS GV +YE+L
Sbjct: 180 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 41/88 (46%), Gaps = 5/88 (5%)
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
           RD+KP+N+L+ A+    L DFG       +   Q    VGT  Y +PE  +   E    Y
Sbjct: 158 RDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFS---ESHATY 214
Query: 208 GPECDWWSLGVCMYEMLYGETPFYAESL 235
               D ++L   +YE L G  P+  + L
Sbjct: 215 --RADIYALTCVLYECLTGSPPYQGDQL 240

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/193 (20%), Positives = 86/193 (44%), Gaps = 17/193 (8%)
Query: 87  NLYLVMDYYCGGDLLTLL-----SKFEDRLPEDMAKFYIAEMV-LAIASIHDLHYVHRPN 140
           N+ L M Y     L  +      S     L     KF + +++ +A  +   + Y+H  +
Sbjct: 81  NILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFG-SCLRLGGDGTVQSNVAVGTPDYISPEILTA 199
                + RD+K +N+ L  +  +++ DFG +  +    G+ Q     G+  +++PE++  
Sbjct: 141 I----IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 200 MEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEI 259
            +     Y  + D ++ G+ +YE++ G+ P+   S +    +I+       L  D+  ++
Sbjct: 197 QDS--NPYSFQSDVYAFGIVLYELMTGQLPY---SNINNRDQIIEMVGRGSLSPDLS-KV 250
Query: 260 SDDAKDLMRRLIC 272
             +    M+RL+ 
Sbjct: 251 RSNCPKRMKRLMA 263

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/154 (22%), Positives = 65/154 (42%), Gaps = 30/154 (19%)
Query: 85  DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAF 144
           D  L  + +Y  GG L  ++   + + P      +  ++   +A +H ++ +H       
Sbjct: 79  DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIH------- 131
Query: 145 HLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSN--------------VAVGTPD 190
              RD+   N L+  N ++ +ADFG   RL  D   Q                  VG P 
Sbjct: 132 ---RDLNSHNCLVRENKNVVVADFG-LARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEML 224
           +++PE++     GR  Y  + D +S G+ + E++
Sbjct: 188 WMAPEMIN----GRS-YDEKVDVFSFGIVLCEII 216

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 104/250 (41%), Gaps = 28/250 (11%)
Query: 34  VLYDECCNSSLRREKTVSDFIEFVAK-----LREERDVLV-YGDRRWITNLHYAFQDDSN 87
           VL        LR +  +    E+ +K        E +VL   G    I NL  A +    
Sbjct: 41  VLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLA-IASIHDLHY---VHRPNHFA 143
           LYL ++Y   G+LL  L K   R+ E    F IA    + ++S   LH+   V R   + 
Sbjct: 101 LYLAIEYAPHGNLLDFLRK--SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 158
Query: 144 FH---LCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                + RD+   N+L+  N   ++ADFG  L  G +  V+  +      +++ E L   
Sbjct: 159 SQKQFIHRDLAARNILVGENYVAKIADFG--LSRGQEVYVKKTMGRLPVRWMAIESLNY- 215
Query: 201 EEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEI 259
                 Y    D WS GV ++E++  G TP+   +  E Y K+      + L   +    
Sbjct: 216 ----SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL---PQGYRLEKPLN--C 266
Query: 260 SDDAKDLMRR 269
            D+  DLMR+
Sbjct: 267 DDEVYDLMRQ 276

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/195 (20%), Positives = 86/195 (44%), Gaps = 23/195 (11%)
Query: 38  ECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCG 97
           +  N +    + +  F   V  LR+ R V +         L   +     L +V  +  G
Sbjct: 41  KMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL--------LFMGYSTKPQLAIVTQWCEG 92
Query: 98  GDLLTLLSKFEDRLPEDMAKFYIAEMV-LAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL 156
             L   L   E        KF + +++ +A  +   + Y+H  +     + RD+K +N+ 
Sbjct: 93  SSLYHHLHIIE-------TKFEMIKLIDIARQTAQGMDYLHAKSI----IHRDLKSNNIF 141
Query: 157 LDANGHIRLADFG-SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWS 215
           L  +  +++ DFG + ++    G+ Q     G+  +++PE++   +  +  Y  + D ++
Sbjct: 142 LHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD--KNPYSFQSDVYA 199
Query: 216 LGVCMYEMLYGETPF 230
            G+ +YE++ G+ P+
Sbjct: 200 FGIVLYELMTGQLPY 214

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 68/150 (45%), Gaps = 21/150 (14%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           + ++ +++YLV  +  G DL  ++     +L +D  +F I +++  +  IH    +HR  
Sbjct: 95  SLEEFNDVYLVT-HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR-- 149
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                   D+KP N+ ++ +  +++ D G       + T      V T  Y +PEI+   
Sbjct: 150 --------DLKPSNLAVNEDCELKILDGGLARHTDDEMTGY----VATRWYRAPEIML-- 195
Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                 Y    D WS+G  M E+L G T F
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/195 (20%), Positives = 86/195 (44%), Gaps = 23/195 (11%)
Query: 38  ECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCG 97
           +  N +    + +  F   V  LR+ R V +         L   +     L +V  +  G
Sbjct: 36  KMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL--------LFMGYSTKPQLAIVTQWCEG 87
Query: 98  GDLLTLLSKFEDRLPEDMAKFYIAEMV-LAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL 156
             L   L   E        KF + +++ +A  +   + Y+H  +     + RD+K +N+ 
Sbjct: 88  SSLYHHLHIIE-------TKFEMIKLIDIARQTAQGMDYLHAKSI----IHRDLKSNNIF 136
Query: 157 LDANGHIRLADFG-SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWS 215
           L  +  +++ DFG + ++    G+ Q     G+  +++PE++   +  +  Y  + D ++
Sbjct: 137 LHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD--KNPYSFQSDVYA 194
Query: 216 LGVCMYEMLYGETPF 230
            G+ +YE++ G+ P+
Sbjct: 195 FGIVLYELMTGQLPY 209

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 104/250 (41%), Gaps = 28/250 (11%)
Query: 34  VLYDECCNSSLRREKTVSDFIEFVAK-----LREERDVLV-YGDRRWITNLHYAFQDDSN 87
           VL        LR +  +    E+ +K        E +VL   G    I NL  A +    
Sbjct: 31  VLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 90
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLA-IASIHDLHY---VHRPNHFA 143
           LYL ++Y   G+LL  L K   R+ E    F IA    + ++S   LH+   V R   + 
Sbjct: 91  LYLAIEYAPHGNLLDFLRK--SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 148
Query: 144 FH---LCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                + RD+   N+L+  N   ++ADFG  L  G +  V+  +      +++ E L   
Sbjct: 149 SQKQFIHRDLAARNILVGENYVAKIADFG--LSRGQEVYVKKTMGRLPVRWMAIESLNY- 205
Query: 201 EEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEI 259
                 Y    D WS GV ++E++  G TP+   +  E Y K+      + L   +    
Sbjct: 206 ----SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL---PQGYRLEKPLN--C 256
Query: 260 SDDAKDLMRR 269
            D+  DLMR+
Sbjct: 257 DDEVYDLMRQ 266

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/195 (20%), Positives = 86/195 (44%), Gaps = 23/195 (11%)
Query: 38  ECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCG 97
           +  N +    + +  F   V  LR+ R V +         L   +     L +V  +  G
Sbjct: 38  KMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL--------LFMGYSTKPQLAIVTQWCEG 89
Query: 98  GDLLTLLSKFEDRLPEDMAKFYIAEMV-LAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL 156
             L   L   E        KF + +++ +A  +   + Y+H  +     + RD+K +N+ 
Sbjct: 90  SSLYHHLHIIE-------TKFEMIKLIDIARQTAQGMDYLHAKSI----IHRDLKSNNIF 138
Query: 157 LDANGHIRLADFG-SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWS 215
           L  +  +++ DFG + ++    G+ Q     G+  +++PE++   +  +  Y  + D ++
Sbjct: 139 LHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD--KNPYSFQSDVYA 196
Query: 216 LGVCMYEMLYGETPF 230
            G+ +YE++ G+ P+
Sbjct: 197 FGIVLYELMTGQLPY 211

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/161 (22%), Positives = 70/161 (43%), Gaps = 19/161 (11%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
            ++Y+V+D     DL  ++   +  L  +  ++++ +++  +  +H    +HR       
Sbjct: 132 KSVYVVLDL-MESDLHQIIHSSQP-LTLEHVRYFLYQLLRGLKYMHSAQVIHR------- 182
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQS---NVAVGTPDYISPEILTAMEE 202
              D+KP N+L++ N  +++ DFG    L              V T  Y +PE++ ++ E
Sbjct: 183 ---DLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHE 239
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
               Y    D WS+G    EML     F  ++ V     IM
Sbjct: 240 ----YTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIM 276

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/195 (20%), Positives = 86/195 (44%), Gaps = 23/195 (11%)
Query: 38  ECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCG 97
           +  N +    + +  F   V  LR+ R V +         L   +     L +V  +  G
Sbjct: 41  KMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL--------LFMGYSTKPQLAIVTQWCEG 92
Query: 98  GDLLTLLSKFEDRLPEDMAKFYIAEMV-LAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL 156
             L   L   E        KF + +++ +A  +   + Y+H  +     + RD+K +N+ 
Sbjct: 93  SSLYHHLHIIE-------TKFEMIKLIDIARQTAQGMDYLHAKSI----IHRDLKSNNIF 141
Query: 157 LDANGHIRLADFG-SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWS 215
           L  +  +++ DFG + ++    G+ Q     G+  +++PE++   +  +  Y  + D ++
Sbjct: 142 LHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD--KNPYSFQSDVYA 199
Query: 216 LGVCMYEMLYGETPF 230
            G+ +YE++ G+ P+
Sbjct: 200 FGIVLYELMTGQLPY 214

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/153 (22%), Positives = 68/153 (44%), Gaps = 15/153 (9%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
            Y+++++   G+LL  L +   +    +   Y+A  + +      + Y+ + N     + 
Sbjct: 84  FYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA-----MEYLEKKNF----IH 134
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
           RD+   N L+  N  +++ADFG    + GD       A     + +PE L        ++
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-----AYNKF 189
Query: 208 GPECDWWSLGVCMYEM-LYGETPFYAESLVETY 239
             + D W+ GV ++E+  YG +P+    L + Y
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 222

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/153 (22%), Positives = 68/153 (44%), Gaps = 15/153 (9%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
            Y+++++   G+LL  L +   +    +   Y+A  + +      + Y+ + N     + 
Sbjct: 89  FYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA-----MEYLEKKNF----IH 139
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
           RD+   N L+  N  +++ADFG    + GD       A     + +PE L        ++
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-----AYNKF 194
Query: 208 GPECDWWSLGVCMYEM-LYGETPFYAESLVETY 239
             + D W+ GV ++E+  YG +P+    L + Y
Sbjct: 195 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 227

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 112/283 (39%), Gaps = 49/283 (17%)
Query: 37  DECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC 96
           D     +++  K+ +   E  A + E + +   G    I NL  A      + ++ +Y C
Sbjct: 74  DAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCC 133
Query: 97  GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH----FAFHLC--RDI 150
            GDLL  L + + R+ E    F IA   L+   +  LH+  +        A   C  RD+
Sbjct: 134 YGDLLNFLRR-KSRVLETDPAFAIANSTLSTRDL--LHFSSQVAQGMAFLASKNCIHRDV 190
Query: 151 KPDNVLLDANGHI-RLADFGSCLRLGGDGT--VQSNVAVGTPDYISPEILTAMEEGRGRY 207
              NVLL  NGH+ ++ DFG    +  D    V+ N  +    +++PE +         Y
Sbjct: 191 AARNVLL-TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV-KWMAPESIFDC-----VY 243
Query: 208 GPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
             + D WS G+ ++E+   G  P         Y  I+ +   + L  D GY+        
Sbjct: 244 TVQSDVWSYGILLWEIFSLGLNP---------YPGILVNSKFYKLVKD-GYQ-------- 285
Query: 267 MRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI 309
                      + Q   A   ++S +    ++ P + P FQ I
Sbjct: 286 -----------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 317

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 83/198 (41%), Gaps = 26/198 (13%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
           + LYL+ DY+  G L   L K      + M K   +  V  +  +H   +  +      H
Sbjct: 108 TQLYLITDYHENGSLYDYL-KSTTLDAKSMLKLAYSS-VSGLCHLHTEIFSTQGKPAIAH 165
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT---VQSNVAVGTPDYISPEIL-TAME 201
             RD+K  N+L+  NG   +AD G  ++   D     +  N  VGT  Y+ PE+L  ++ 
Sbjct: 166 --RDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLN 223
Query: 202 EGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD--LPSDVGYEI 259
               +     D +S G+ ++E+        A   V + G +  +Q  +   +PSD  YE 
Sbjct: 224 RNHFQSYIMADMYSFGLILWEV--------ARRCV-SGGIVEEYQLPYHDLVPSDPSYED 274
Query: 260 SDDAKDLMRRLICSSDTR 277
                  MR ++C    R
Sbjct: 275 -------MREIVCIKKLR 285

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/195 (20%), Positives = 86/195 (44%), Gaps = 23/195 (11%)
Query: 38  ECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCG 97
           +  N +    + +  F   V  LR+ R V +         L   +     L +V  +  G
Sbjct: 63  KMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL--------LFMGYSTKPQLAIVTQWCEG 114
Query: 98  GDLLTLLSKFEDRLPEDMAKFYIAEMV-LAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL 156
             L   L   E        KF + +++ +A  +   + Y+H  +     + RD+K +N+ 
Sbjct: 115 SSLYHHLHIIE-------TKFEMIKLIDIARQTAQGMDYLHAKSI----IHRDLKSNNIF 163
Query: 157 LDANGHIRLADFG-SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWS 215
           L  +  +++ DFG + ++    G+ Q     G+  +++PE++   +  +  Y  + D ++
Sbjct: 164 LHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD--KNPYSFQSDVYA 221
Query: 216 LGVCMYEMLYGETPF 230
            G+ +YE++ G+ P+
Sbjct: 222 FGIVLYELMTGQLPY 236

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/153 (22%), Positives = 68/153 (44%), Gaps = 15/153 (9%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
            Y+++++   G+LL  L +   +    +   Y+A  + +      + Y+ + N     + 
Sbjct: 84  FYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA-----MEYLEKKNF----IH 134
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
           RD+   N L+  N  +++ADFG    + GD       A     + +PE L        ++
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-----AYNKF 189
Query: 208 GPECDWWSLGVCMYEM-LYGETPFYAESLVETY 239
             + D W+ GV ++E+  YG +P+    L + Y
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 222

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 21/161 (13%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
            ++Y+V D     DL  LL      L  D   +++ +++  +  IH  + +HR       
Sbjct: 101 KDVYIVQDL-METDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHR------- 150
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGG---DGTVQSNVAVGTPDYISPEILTAMEE 202
              D+KP N+LL+    +++ DFG   R+     D T      V T  Y +PEI   M  
Sbjct: 151 ---DLKPSNLLLNTTSDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEI---MLN 203
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
            +G Y    D WS+G  + EML     F  +  ++    I+
Sbjct: 204 SKG-YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 243

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 64/155 (41%), Gaps = 41/155 (26%)
Query: 83  QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHF 142
           Q + +L LVM+Y   G L   L +    L + +   +  ++   +A +H  HY+HR    
Sbjct: 88  QGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLL--LFAQQICEGMAYLHAQHYIHR---- 141
Query: 143 AFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEE 202
                 ++   NVLLD +  +++ DFG              +A   P+    E     E+
Sbjct: 142 ------NLAARNVLLDNDRLVKIGDFG--------------LAKAVPE--GHEYYRVRED 179
Query: 203 GRGR---YGPEC----------DWWSLGVCMYEML 224
           G      Y PEC          D WS GV +YE+L
Sbjct: 180 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/185 (20%), Positives = 83/185 (44%), Gaps = 23/185 (12%)
Query: 48  KTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKF 107
           + +  F   V  LR+ R V +         L   +     L +V  +  G  L   L   
Sbjct: 74  QQLQAFKNEVGVLRKTRHVNIL--------LFMGYSTKPQLAIVTQWCEGSSLYHHLHII 125
Query: 108 EDRLPEDMAKFYIAEMV-LAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLA 166
           E        KF + +++ +A  +   + Y+H  +     + RD+K +N+ L  +  +++ 
Sbjct: 126 E-------TKFEMIKLIDIARQTAQGMDYLHAKSI----IHRDLKSNNIFLHEDLTVKIG 174
Query: 167 DFG-SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY 225
           DFG + ++    G+ Q     G+  +++PE++   +  +  Y  + D ++ G+ +YE++ 
Sbjct: 175 DFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD--KNPYSFQSDVYAFGIVLYELMT 232
Query: 226 GETPF 230
           G+ P+
Sbjct: 233 GQLPY 237

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 21/161 (13%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
            ++Y+V D     DL  LL      L  D   +++ +++  +  IH  + +HR       
Sbjct: 99  KDVYIVQDL-METDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHR------- 148
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGG---DGTVQSNVAVGTPDYISPEILTAMEE 202
              D+KP N+LL+    +++ DFG   R+     D T      V T  Y +PEI   M  
Sbjct: 149 ---DLKPSNLLLNTTXDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEI---MLN 201
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
            +G Y    D WS+G  + EML     F  +  ++    I+
Sbjct: 202 SKG-YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/161 (22%), Positives = 70/161 (43%), Gaps = 19/161 (11%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
            ++Y+V+D     DL  ++   +  L  +  ++++ +++  +  +H    +HR       
Sbjct: 133 KSVYVVLDL-MESDLHQIIHSSQP-LTLEHVRYFLYQLLRGLKYMHSAQVIHR------- 183
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQS---NVAVGTPDYISPEILTAMEE 202
              D+KP N+L++ N  +++ DFG    L              V T  Y +PE++ ++ E
Sbjct: 184 ---DLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHE 240
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
               Y    D WS+G    EML     F  ++ V     IM
Sbjct: 241 ----YTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIM 277

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/117 (21%), Positives = 63/117 (53%), Gaps = 8/117 (6%)
Query: 116 AKFYIAEMV-LAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG-SCLR 173
            KF + +++ +A  +   + Y+H  +     + RD+K +N+ L  +  +++ DFG + ++
Sbjct: 99  TKFEMIKLIDIARQTAQGMDYLHAKSI----IHRDLKSNNIFLHEDLTVKIGDFGLATVK 154
Query: 174 LGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
               G+ Q     G+  +++PE++   +  +  Y  + D ++ G+ +YE++ G+ P+
Sbjct: 155 SRWSGSHQFEQLSGSILWMAPEVIRMQD--KNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/140 (23%), Positives = 56/140 (40%), Gaps = 17/140 (12%)
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NL L+M+Y   G L   L    +R+       Y +++   +  +    Y+HR        
Sbjct: 90  NLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKRYIHR-------- 141
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD--YISPEILTAMEEGR 204
             D+   N+L++    +++ DFG    L  D         G     + +PE LT      
Sbjct: 142 --DLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE----- 194
Query: 205 GRYGPECDWWSLGVCMYEML 224
            ++    D WS GV +YE+ 
Sbjct: 195 SKFSVASDVWSFGVVLYELF 214

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 63/152 (41%), Gaps = 41/152 (26%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
           ++L LVM+Y   G L   L +    L + +   +  ++   +A +H  HY+HR       
Sbjct: 108 ASLQLVMEYVPLGSLRDYLPRHSIGLAQLL--LFAQQICEGMAYLHAQHYIHR------- 158
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRG 205
              D+   NVLLD +  +++ DFG              +A   P+    E     E+G  
Sbjct: 159 ---DLAARNVLLDNDRLVKIGDFG--------------LAKAVPE--GHEXYRVREDGDS 199
Query: 206 R---YGPEC----------DWWSLGVCMYEML 224
               Y PEC          D WS GV +YE+L
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELL 231

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/153 (22%), Positives = 67/153 (43%), Gaps = 15/153 (9%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
            Y++ ++   G+LL  L +   +    +   Y+A  + +      + Y+ + N     + 
Sbjct: 89  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA-----MEYLEKKNF----IH 139
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
           RD+   N L+  N  +++ADFG    + GD       A     + +PE L        ++
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL-----AYNKF 194
Query: 208 GPECDWWSLGVCMYEM-LYGETPFYAESLVETY 239
             + D W+ GV ++E+  YG +P+    L + Y
Sbjct: 195 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 227

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 21/161 (13%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
            ++Y+V D     DL  LL      L  D   +++ +++  +  IH  + +HR       
Sbjct: 99  KDVYIVQDL-METDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHR------- 148
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGG---DGTVQSNVAVGTPDYISPEILTAMEE 202
              D+KP N+LL+    +++ DFG   R+     D T      V T  Y +PEI   M  
Sbjct: 149 ---DLKPSNLLLNTTXDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEI---MLN 201
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
            +G Y    D WS+G  + EML     F  +  ++    I+
Sbjct: 202 SKG-YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 21/161 (13%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
            ++Y+V D     DL  LL      L  D   +++ +++  +  IH  + +HR       
Sbjct: 99  KDVYIVQDL-METDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHR------- 148
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGG---DGTVQSNVAVGTPDYISPEILTAMEE 202
              D+KP N+LL+    +++ DFG   R+     D T      V T  Y +PEI   M  
Sbjct: 149 ---DLKPSNLLLNTTXDLKIXDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEI---MLN 201
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
            +G Y    D WS+G  + EML     F  +  ++    I+
Sbjct: 202 SKG-YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 21/161 (13%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
            ++Y+V D     DL  LL      L  D   +++ +++  +  IH  + +HR       
Sbjct: 103 KDVYIVQDL-METDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHR------- 152
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGG---DGTVQSNVAVGTPDYISPEILTAMEE 202
              D+KP N+LL+    +++ DFG   R+     D T      V T  Y +PEI   M  
Sbjct: 153 ---DLKPSNLLLNTTXDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEI---MLN 205
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
            +G Y    D WS+G  + EML     F  +  ++    I+
Sbjct: 206 SKG-YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 21/161 (13%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
            ++Y+V D     DL  LL      L  D   +++ +++  +  IH  + +HR       
Sbjct: 103 KDVYIVQDL-METDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHR------- 152
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGG---DGTVQSNVAVGTPDYISPEILTAMEE 202
              D+KP N+LL+    +++ DFG   R+     D T      V T  Y +PEI   M  
Sbjct: 153 ---DLKPSNLLLNTTXDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEI---MLN 205
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
            +G Y    D WS+G  + EML     F  +  ++    I+
Sbjct: 206 SKG-YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 68/284 (23%), Positives = 113/284 (39%), Gaps = 51/284 (17%)
Query: 37  DECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC 96
           D     +++  K+ +   E  A + E + +   G    I NL  A      + ++ +Y C
Sbjct: 74  DAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCC 133
Query: 97  GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD-LHYVHRPNH----FAFHLC--RD 149
            GDLL  L + + R+ E    F IA    + AS  D LH+  +        A   C  RD
Sbjct: 134 YGDLLNFLRR-KSRVLETDPAFAIAN---STASTRDLLHFSSQVAQGMAFLASKNCIHRD 189
Query: 150 IKPDNVLLDANGHI-RLADFGSCLRLGGDGT--VQSNVAVGTPDYISPEILTAMEEGRGR 206
           +   NVLL  NGH+ ++ DFG    +  D    V+ N  +    +++PE +         
Sbjct: 190 VAARNVLL-TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV-KWMAPESIFDC-----V 242
Query: 207 YGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKD 265
           Y  + D WS G+ ++E+   G  P         Y  I+ +   + L  D GY+       
Sbjct: 243 YTVQSDVWSYGILLWEIFSLGLNP---------YPGILVNSKFYKLVKD-GYQ------- 285
Query: 266 LMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI 309
                       + Q   A   ++S +    ++ P + P FQ I
Sbjct: 286 ------------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 317

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/193 (20%), Positives = 86/193 (44%), Gaps = 17/193 (8%)
Query: 87  NLYLVMDYYCGGDLLTLL-----SKFEDRLPEDMAKFYIAEMV-LAIASIHDLHYVHRPN 140
           N+ L M Y     L  +      S     L     KF + +++ +A  +   + Y+H  +
Sbjct: 81  NILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFG-SCLRLGGDGTVQSNVAVGTPDYISPEILTA 199
                + RD+K +N+ L  +  +++ DFG +  +    G+ Q     G+  +++PE++  
Sbjct: 141 I----IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 200 MEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEI 259
            +     Y  + D ++ G+ +YE++ G+ P+   S +    +I+       L  D+  ++
Sbjct: 197 QDS--NPYSFQSDVYAFGIVLYELMTGQLPY---SNINNRDQIIEMVGRGSLSPDLS-KV 250
Query: 260 SDDAKDLMRRLIC 272
             +    M+RL+ 
Sbjct: 251 RSNCPKRMKRLMA 263

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 55/116 (47%), Gaps = 17/116 (14%)
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFGSCLRLG 175
           ++YI E++ A+   H    +HR          D+KP NV++D     +RL D+G  L   
Sbjct: 130 RYYIYELLKALDYCHSQGIMHR----------DVKPHNVMIDHELRKLRLIDWG--LAEF 177
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
                + NV V +  +  PE+L  +++    Y    D WSLG     M++ + PF+
Sbjct: 178 YHPGKEYNVRVASRYFKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFF 229

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 55/116 (47%), Gaps = 17/116 (14%)
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFGSCLRLG 175
           ++YI E++ A+   H    +HR          D+KP NV++D     +RL D+G  L   
Sbjct: 129 RYYIYELLKALDYCHSQGIMHR----------DVKPHNVMIDHELRKLRLIDWG--LAEF 176
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
                + NV V +  +  PE+L  +++    Y    D WSLG     M++ + PF+
Sbjct: 177 YHPGKEYNVRVASRYFKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFF 228

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/144 (22%), Positives = 65/144 (45%), Gaps = 15/144 (10%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
            Y+++++   G+LL  L +   +    +   Y+A  + +      + Y+ + N     + 
Sbjct: 82  FYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA-----MEYLEKKNF----IH 132
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
           RD+   N L+  N  +++ADFG    + GD       A     + +PE L        ++
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL-----AYNKF 187
Query: 208 GPECDWWSLGVCMYEM-LYGETPF 230
             + D W+ GV ++E+  YG +P+
Sbjct: 188 SIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 55/116 (47%), Gaps = 17/116 (14%)
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFGSCLRLG 175
           ++YI E++ A+   H    +HR          D+KP NV++D     +RL D+G      
Sbjct: 129 RYYIYELLKALDYCHSQGIMHR----------DVKPHNVMIDHELRKLRLIDWGLA-EFY 177
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
             G  + NV V +  +  PE+L  +++    Y    D WSLG     M++ + PF+
Sbjct: 178 HPGK-EYNVRVASRYFKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFF 228

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 73/177 (41%), Gaps = 35/177 (19%)
Query: 90  LVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASI-------HDLHYVHRPNHF 142
           +V +Y   G L T L   +        +F I ++V  +  +        DL YVHR    
Sbjct: 127 IVTEYMENGSLDTFLRTHD-------GQFTIMQLVGMLRGVGAGMRYLSDLGYVHR---- 175
Query: 143 AFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD--YISPEILTAM 200
                 D+   NVL+D+N   +++DFG    L  D         G     + +PE +   
Sbjct: 176 ------DLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFR 229
Query: 201 EEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVG 256
                 +    D WS GV M+E+L YGE P++  +  +    +   +  + LP+ +G
Sbjct: 230 T-----FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV---EEGYRLPAPMG 278

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 55/116 (47%), Gaps = 17/116 (14%)
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFGSCLRLG 175
           ++YI E++ A+   H    +HR          D+KP NV++D     +RL D+G      
Sbjct: 128 RYYIYELLKALDYCHSQGIMHR----------DVKPHNVMIDHELRKLRLIDWGLA-EFY 176
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
             G  + NV V +  +  PE+L  +++    Y    D WSLG     M++ + PF+
Sbjct: 177 HPGK-EYNVRVASRYFKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFF 227

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/184 (21%), Positives = 78/184 (42%), Gaps = 30/184 (16%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           +F++ + +Y++ +     DL  ++S     L +D  +++I + + A+  +H  + +HR  
Sbjct: 82  SFENFNEVYIIQEL-MQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHR-- 136
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVA---------VGTPDY 191
                   D+KP N+L+++N  +++ DFG    +       S            V T  Y
Sbjct: 137 --------DLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188
Query: 192 ISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF----YAESLVETYGKIMNHQN 247
            +PE++        +Y    D WS G  + E+      F    Y   L+  +G I    +
Sbjct: 189 RAPEVMLT----SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 248 SFDL 251
             DL
Sbjct: 245 DNDL 248

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 21/161 (13%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
            ++Y+V D     DL  LL      L  D   +++ +++  +  IH  + +HR       
Sbjct: 103 KDVYIVQDL-METDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHR------- 152
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGG---DGTVQSNVAVGTPDYISPEILTAMEE 202
              D+KP N+LL+    +++ DFG   R+     D T      V T  Y +PEI   M  
Sbjct: 153 ---DLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLXEXVATRWYRAPEI---MLN 205
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
            +G Y    D WS+G  + EML     F  +  ++    I+
Sbjct: 206 SKG-YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 21/161 (13%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
            ++Y+V D     DL  LL      L  D   +++ +++  +  IH  + +HR       
Sbjct: 104 KDVYIVQDL-METDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHR------- 153
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGG---DGTVQSNVAVGTPDYISPEILTAMEE 202
              D+KP N+LL+    +++ DFG   R+     D T      V T  Y +PEI   M  
Sbjct: 154 ---DLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLXEXVATRWYRAPEI---MLN 206
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
            +G Y    D WS+G  + EML     F  +  ++    I+
Sbjct: 207 SKG-YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 246

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 21/161 (13%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
            ++Y+V D     DL  LL      L  D   +++ +++  +  IH  + +HR       
Sbjct: 103 KDVYIVQDL-METDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHR------- 152
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGG---DGTVQSNVAVGTPDYISPEILTAMEE 202
              D+KP N+LL+    +++ DFG   R+     D T      V T  Y +PEI   M  
Sbjct: 153 ---DLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEI---MLN 205
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
            +G Y    D WS+G  + EML     F  +  ++    I+
Sbjct: 206 SKG-YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 55/116 (47%), Gaps = 17/116 (14%)
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFGSCLRLG 175
           ++YI E++ A+   H    +HR          D+KP NV++D     +RL D+G      
Sbjct: 128 RYYIYELLKALDYCHSQGIMHR----------DVKPHNVMIDHELRKLRLIDWGLA-EFY 176
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
             G  + NV V +  +  PE+L  +++    Y    D WSLG     M++ + PF+
Sbjct: 177 HPGK-EYNVRVASRYFKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFF 227

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 55/116 (47%), Gaps = 17/116 (14%)
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFGSCLRLG 175
           ++YI E++ A+   H    +HR          D+KP NV++D     +RL D+G  L   
Sbjct: 128 RYYIYELLKALDYCHSQGIMHR----------DVKPHNVMIDHELRKLRLIDWG--LAEF 175
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
                + NV V +  +  PE+L  +++    Y    D WSLG     M++ + PF+
Sbjct: 176 YHPGKEYNVRVASRYFKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFF 227

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 55/116 (47%), Gaps = 17/116 (14%)
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFGSCLRLG 175
           ++YI E++ A+   H    +HR          D+KP NV++D     +RL D+G  L   
Sbjct: 128 RYYIYELLKALDYCHSQGIMHR----------DVKPHNVMIDHELRKLRLIDWG--LAEF 175
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
                + NV V +  +  PE+L  +++    Y    D WSLG     M++ + PF+
Sbjct: 176 YHPGKEYNVRVASRYFKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFF 227

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 21/161 (13%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
            ++Y+V D     DL  LL      L  D   +++ +++  +  IH  + +HR       
Sbjct: 99  KDVYIVQDL-METDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHR------- 148
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGG---DGTVQSNVAVGTPDYISPEILTAMEE 202
              D+KP N+LL+    +++ DFG   R+     D T      V T  Y +PEI   M  
Sbjct: 149 ---DLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEI---MLN 201
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
            +G Y    D WS+G  + EML     F  +  ++    I+
Sbjct: 202 SKG-YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 55/116 (47%), Gaps = 17/116 (14%)
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFGSCLRLG 175
           ++YI E++ A+   H    +HR          D+KP NV++D     +RL D+G      
Sbjct: 128 RYYIYELLKALDYCHSQGIMHR----------DVKPHNVMIDHELRKLRLIDWGLA-EFY 176
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
             G  + NV V +  +  PE+L  +++    Y    D WSLG     M++ + PF+
Sbjct: 177 HPGK-EYNVRVASRYFKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFF 227

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 55/116 (47%), Gaps = 17/116 (14%)
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFGSCLRLG 175
           ++YI E++ A+   H    +HR          D+KP NV++D     +RL D+G      
Sbjct: 128 RYYIYELLKALDYCHSQGIMHR----------DVKPHNVMIDHELRKLRLIDWGLA-EFY 176
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
             G  + NV V +  +  PE+L  +++    Y    D WSLG     M++ + PF+
Sbjct: 177 HPGK-EYNVRVASRYFKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFF 227

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/153 (22%), Positives = 67/153 (43%), Gaps = 15/153 (9%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
            Y++ ++   G+LL  L +   +    +   Y+A  + +      + Y+ + N     + 
Sbjct: 97  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA-----MEYLEKKNF----IH 147
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
           RD+   N L+  N  +++ADFG    + GD       A     + +PE L        ++
Sbjct: 148 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-----AYNKF 202
Query: 208 GPECDWWSLGVCMYEM-LYGETPFYAESLVETY 239
             + D W+ GV ++E+  YG +P+    L + Y
Sbjct: 203 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 235

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 21/161 (13%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
            ++Y+V D     DL  LL      L  D   +++ +++  +  IH  + +HR       
Sbjct: 97  KDVYIVQDL-METDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHR------- 146
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGG---DGTVQSNVAVGTPDYISPEILTAMEE 202
              D+KP N+LL+    +++ DFG   R+     D T      V T  Y +PEI   M  
Sbjct: 147 ---DLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEI---MLN 199
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
            +G Y    D WS+G  + EML     F  +  ++    I+
Sbjct: 200 SKG-YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 239

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 21/161 (13%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
            ++Y+V D     DL  LL      L  D   +++ +++  +  IH  + +HR       
Sbjct: 101 KDVYIVQDL-METDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHR------- 150
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGG---DGTVQSNVAVGTPDYISPEILTAMEE 202
              D+KP N+LL+    +++ DFG   R+     D T      V T  Y +PEI   M  
Sbjct: 151 ---DLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEI---MLN 203
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
            +G Y    D WS+G  + EML     F  +  ++    I+
Sbjct: 204 SKG-YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 243

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 71/160 (44%), Gaps = 21/160 (13%)
Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           ++Y+V D     DL  LL     +L  D   +++ +++  +  IH  + +HR        
Sbjct: 120 DVYIVQDL-METDLYKLLKS--QQLSNDHICYFLYQILRGLKYIHSANVLHR-------- 168
Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGG---DGTVQSNVAVGTPDYISPEILTAMEEG 203
             D+KP N+L++    +++ DFG   R+     D T      V T  Y +PEI   M   
Sbjct: 169 --DLKPSNLLINTTCDLKICDFGLA-RIADPEHDHTGFLTEXVATRWYRAPEI---MLNS 222
Query: 204 RGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
           +G Y    D WS+G  + EML     F  +  ++    I+
Sbjct: 223 KG-YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 261

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 55/116 (47%), Gaps = 17/116 (14%)
Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFGSCLRLG 175
           ++YI E++ A+   H    +HR          D+KP NV++D     +RL D+G      
Sbjct: 149 RYYIYELLKALDYCHSQGIMHR----------DVKPHNVMIDHELRKLRLIDWGLA-EFY 197
Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
             G  + NV V +  +  PE+L  +++    Y    D WSLG     M++ + PF+
Sbjct: 198 HPGK-EYNVRVASRYFKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFF 248

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/153 (22%), Positives = 67/153 (43%), Gaps = 15/153 (9%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
            Y++ ++   G+LL  L +   +    +   Y+A  + +      + Y+ + N     + 
Sbjct: 86  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA-----MEYLEKKNF----IH 136
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
           RD+   N L+  N  +++ADFG    + GD       A     + +PE L        ++
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-----AYNKF 191
Query: 208 GPECDWWSLGVCMYEM-LYGETPFYAESLVETY 239
             + D W+ GV ++E+  YG +P+    L + Y
Sbjct: 192 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 224

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/153 (22%), Positives = 67/153 (43%), Gaps = 15/153 (9%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
            Y++ ++   G+LL  L +   +    +   Y+A  + +      + Y+ + N     + 
Sbjct: 84  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA-----MEYLEKKNF----IH 134
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
           RD+   N L+  N  +++ADFG    + GD       A     + +PE L        ++
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-----AYNKF 189
Query: 208 GPECDWWSLGVCMYEM-LYGETPFYAESLVETY 239
             + D W+ GV ++E+  YG +P+    L + Y
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 222

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/184 (21%), Positives = 78/184 (42%), Gaps = 30/184 (16%)
Query: 81  AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
           +F++ + +Y++ +     DL  ++S     L +D  +++I + + A+  +H  + +HR  
Sbjct: 82  SFENFNEVYIIQEL-MQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHR-- 136
Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVA---------VGTPDY 191
                   D+KP N+L+++N  +++ DFG    +       S            V T  Y
Sbjct: 137 --------DLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWY 188
Query: 192 ISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF----YAESLVETYGKIMNHQN 247
            +PE++        +Y    D WS G  + E+      F    Y   L+  +G I    +
Sbjct: 189 RAPEVMLT----SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 248 SFDL 251
             DL
Sbjct: 245 DNDL 248

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/153 (22%), Positives = 67/153 (43%), Gaps = 15/153 (9%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
            Y++ ++   G+LL  L +   +    +   Y+A  + +      + Y+ + N     + 
Sbjct: 86  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA-----MEYLEKKNF----IH 136
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
           RD+   N L+  N  +++ADFG    + GD       A     + +PE L        ++
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-----AYNKF 191
Query: 208 GPECDWWSLGVCMYEM-LYGETPFYAESLVETY 239
             + D W+ GV ++E+  YG +P+    L + Y
Sbjct: 192 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 224

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 21/161 (13%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
            ++Y+V D     DL  LL      L  D   +++ +++  +  IH  + +HR       
Sbjct: 104 KDVYIVQDL-METDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHR------- 153
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGG---DGTVQSNVAVGTPDYISPEILTAMEE 202
              D+KP N+LL+    +++ DFG   R+     D T      V T  Y +PEI   M  
Sbjct: 154 ---DLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEI---MLN 206
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
            +G Y    D WS+G  + EML     F  +  ++    I+
Sbjct: 207 SKG-YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 246

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 21/161 (13%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
            ++Y+V D     DL  LL      L  D   +++ +++  +  IH  + +HR       
Sbjct: 105 KDVYIVQDL-METDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHR------- 154
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGG---DGTVQSNVAVGTPDYISPEILTAMEE 202
              D+KP N+LL+    +++ DFG   R+     D T      V T  Y +PEI   M  
Sbjct: 155 ---DLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEI---MLN 207
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
            +G Y    D WS+G  + EML     F  +  ++    I+
Sbjct: 208 SKG-YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 247

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 21/161 (13%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
            ++Y+V D     DL  LL      L  D   +++ +++  +  IH  + +HR       
Sbjct: 96  KDVYIVQDL-METDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHR------- 145
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGG---DGTVQSNVAVGTPDYISPEILTAMEE 202
              D+KP N+LL+    +++ DFG   R+     D T      V T  Y +PEI   M  
Sbjct: 146 ---DLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEI---MLN 198
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
            +G Y    D WS+G  + EML     F  +  ++    I+
Sbjct: 199 SKG-YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 238

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 21/161 (13%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
            ++Y+V D     DL  LL      L  D   +++ +++  +  IH  + +HR       
Sbjct: 103 KDVYIVQDL-METDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHR------- 152
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGG---DGTVQSNVAVGTPDYISPEILTAMEE 202
              D+KP N+LL+    +++ DFG   R+     D T      V T  Y +PEI   M  
Sbjct: 153 ---DLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEI---MLN 205
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
            +G Y    D WS+G  + EML     F  +  ++    I+
Sbjct: 206 SKG-YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/153 (22%), Positives = 67/153 (43%), Gaps = 15/153 (9%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
            Y++ ++   G+LL  L +   +    +   Y+A  + +      + Y+ + N     + 
Sbjct: 89  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA-----MEYLEKKNF----IH 139
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
           RD+   N L+  N  +++ADFG    + GD       A     + +PE L        ++
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-----AYNKF 194
Query: 208 GPECDWWSLGVCMYEM-LYGETPFYAESLVETY 239
             + D W+ GV ++E+  YG +P+    L + Y
Sbjct: 195 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 227

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/153 (22%), Positives = 67/153 (43%), Gaps = 15/153 (9%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
            Y++ ++   G+LL  L +   +    +   Y+A  + +      + Y+ + N     + 
Sbjct: 86  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA-----MEYLEKKNF----IH 136
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
           RD+   N L+  N  +++ADFG    + GD       A     + +PE L        ++
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESL-----AYNKF 191
Query: 208 GPECDWWSLGVCMYEM-LYGETPFYAESLVETY 239
             + D W+ GV ++E+  YG +P+    L + Y
Sbjct: 192 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 224

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 21/161 (13%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
            ++Y+V D     DL  LL      L  D   +++ +++  +  IH  + +HR       
Sbjct: 97  KDVYIVQDL-METDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHR------- 146
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGG---DGTVQSNVAVGTPDYISPEILTAMEE 202
              D+KP N+LL+    +++ DFG   R+     D T      V T  Y +PEI   M  
Sbjct: 147 ---DLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEI---MLN 199
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
            +G Y    D WS+G  + EML     F  +  ++    I+
Sbjct: 200 SKG-YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 239

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/153 (22%), Positives = 67/153 (43%), Gaps = 15/153 (9%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
            Y++ ++   G+LL  L +   +    +   Y+A  + +      + Y+ + N     + 
Sbjct: 84  FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA-----MEYLEKKNF----IH 134
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
           RD+   N L+  N  +++ADFG    + GD       A     + +PE L        ++
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-----AYNKF 189
Query: 208 GPECDWWSLGVCMYEM-LYGETPFYAESLVETY 239
             + D W+ GV ++E+  YG +P+    L + Y
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 222

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/153 (22%), Positives = 67/153 (43%), Gaps = 15/153 (9%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
            Y++ ++   G+LL  L +   +    +   Y+A  + +      + Y+ + N     + 
Sbjct: 89  FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA-----MEYLEKKNF----IH 139
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
           RD+   N L+  N  +++ADFG    + GD       A     + +PE L        ++
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-----AYNKF 194
Query: 208 GPECDWWSLGVCMYEM-LYGETPFYAESLVETY 239
             + D W+ GV ++E+  YG +P+    L + Y
Sbjct: 195 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 227

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 21/161 (13%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
            ++Y+V D     DL  LL      L  D   +++ +++  +  IH  + +HR       
Sbjct: 101 KDVYIVQDL-METDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHR------- 150
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGG---DGTVQSNVAVGTPDYISPEILTAMEE 202
              D+KP N+LL+    +++ DFG   R+     D T      V T  Y +PEI   M  
Sbjct: 151 ---DLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEI---MLN 203
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
            +G Y    D WS+G  + EML     F  +  ++    I+
Sbjct: 204 SKG-YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 243

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/153 (22%), Positives = 67/153 (43%), Gaps = 15/153 (9%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
            Y++ ++   G+LL  L +   +    +   Y+A  + +      + Y+ + N     + 
Sbjct: 85  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA-----MEYLEKKNF----IH 135
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
           RD+   N L+  N  +++ADFG    + GD       A     + +PE L        ++
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESL-----AYNKF 190
Query: 208 GPECDWWSLGVCMYEM-LYGETPFYAESLVETY 239
             + D W+ GV ++E+  YG +P+    L + Y
Sbjct: 191 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 223

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/153 (22%), Positives = 67/153 (43%), Gaps = 15/153 (9%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
            Y++ ++   G+LL  L +   +    +   Y+A  + +      + Y+ + N     + 
Sbjct: 89  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA-----MEYLEKKNF----IH 139
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
           RD+   N L+  N  +++ADFG    + GD       A     + +PE L        ++
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-----AYNKF 194
Query: 208 GPECDWWSLGVCMYEM-LYGETPFYAESLVETY 239
             + D W+ GV ++E+  YG +P+    L + Y
Sbjct: 195 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 227

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/153 (22%), Positives = 67/153 (43%), Gaps = 15/153 (9%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
            Y++ ++   G+LL  L +   +    +   Y+A  + +      + Y+ + N     + 
Sbjct: 84  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA-----MEYLEKKNF----IH 134
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
           RD+   N L+  N  +++ADFG    + GD       A     + +PE L        ++
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-----AYNKF 189
Query: 208 GPECDWWSLGVCMYEM-LYGETPFYAESLVETY 239
             + D W+ GV ++E+  YG +P+    L + Y
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 222

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/153 (22%), Positives = 67/153 (43%), Gaps = 15/153 (9%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
            Y++ ++   G+LL  L +   +    +   Y+A  + +      + Y+ + N     + 
Sbjct: 84  FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA-----MEYLEKKNF----IH 134
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
           RD+   N L+  N  +++ADFG    + GD       A     + +PE L        ++
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-----AYNKF 189
Query: 208 GPECDWWSLGVCMYEM-LYGETPFYAESLVETY 239
             + D W+ GV ++E+  YG +P+    L + Y
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 222

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 21/161 (13%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
            ++Y+V D     DL  LL      L  D   +++ +++  +  IH  + +HR       
Sbjct: 107 KDVYIVQDL-METDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHR------- 156
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGG---DGTVQSNVAVGTPDYISPEILTAMEE 202
              D+KP N+LL+    +++ DFG   R+     D T      V T  Y +PEI   M  
Sbjct: 157 ---DLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEI---MLN 209
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
            +G Y    D WS+G  + EML     F  +  ++    I+
Sbjct: 210 SKG-YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 249

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 21/161 (13%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
            ++Y+V D     DL  LL      L  D   +++ +++  +  IH  + +HR       
Sbjct: 99  KDVYIVQDL-METDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHR------- 148
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGG---DGTVQSNVAVGTPDYISPEILTAMEE 202
              D+KP N+LL+    +++ DFG   R+     D T      V T  Y +PEI   M  
Sbjct: 149 ---DLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEI---MLN 201
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
            +G Y    D WS+G  + EML     F  +  ++    I+
Sbjct: 202 SKG-YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 75/176 (42%), Gaps = 33/176 (18%)
Query: 90  LVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASI-------HDLHYVHRPNHF 142
           +V +Y   G L T L   +        +F I ++V  +  +        DL YVHR    
Sbjct: 127 IVTEYMENGSLDTFLRTHD-------GQFTIMQLVGMLRGVGAGMRYLSDLGYVHR---- 175
Query: 143 AFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEE 202
                 D+   NVL+D+N   +++DFG    L  D     + A  T     P   TA E 
Sbjct: 176 ------DLAARNVLVDSNLVCKVSDFGLSRVLEDD----PDAAYTTTGGKIPIRWTAPEA 225
Query: 203 GRGR-YGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVG 256
              R +    D WS GV M+E+L YGE P++  +  +    +   +  + LP+ +G
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV---EEGYRLPAPMG 278

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/153 (22%), Positives = 67/153 (43%), Gaps = 15/153 (9%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
            Y++ ++   G+LL  L +   +    +   Y+A  + +      + Y+ + N     + 
Sbjct: 88  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA-----MEYLEKKNF----IH 138
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
           RD+   N L+  N  +++ADFG    + GD       A     + +PE L        ++
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-----AYNKF 193
Query: 208 GPECDWWSLGVCMYEM-LYGETPFYAESLVETY 239
             + D W+ GV ++E+  YG +P+    L + Y
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 226

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 21/161 (13%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
            ++Y+V D     DL  LL      L  D   +++ +++  +  IH  + +HR       
Sbjct: 119 KDVYIVQDL-METDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHR------- 168
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGG---DGTVQSNVAVGTPDYISPEILTAMEE 202
              D+KP N+LL+    +++ DFG   R+     D T      V T  Y +PEI   M  
Sbjct: 169 ---DLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEI---MLN 221
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
            +G Y    D WS+G  + EML     F  +  ++    I+
Sbjct: 222 SKG-YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 261

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/144 (22%), Positives = 64/144 (44%), Gaps = 15/144 (10%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
            Y++ ++   G+LL  L +   +    +   Y+A  + +      + Y+ + N     + 
Sbjct: 82  FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA-----MEYLEKKNF----IH 132
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
           RD+   N L+  N  +++ADFG    + GD       A     + +PE L        ++
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL-----AYNKF 187
Query: 208 GPECDWWSLGVCMYEM-LYGETPF 230
             + D W+ GV ++E+  YG +P+
Sbjct: 188 SIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 104/250 (41%), Gaps = 28/250 (11%)
Query: 34  VLYDECCNSSLRREKTVSDFIEFVAK-----LREERDVLV-YGDRRWITNLHYAFQDDSN 87
           VL        LR +  +    E+ +K        E +VL   G    I NL  A +    
Sbjct: 38  VLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 97
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLA-IASIHDLHY---VHRPNHFA 143
           LYL ++Y   G+LL  L K   R+ E    F IA    + ++S   LH+   V R   + 
Sbjct: 98  LYLAIEYAPHGNLLDFLRK--SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 155
Query: 144 FH---LCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                + R++   N+L+  N   ++ADFG  L  G +  V+  +      +++ E L   
Sbjct: 156 SQKQFIHRNLAARNILVGENYVAKIADFG--LSRGQEVYVKKTMGRLPVRWMAIESLNY- 212
Query: 201 EEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEI 259
                 Y    D WS GV ++E++  G TP+   +  E Y K+      + L   +    
Sbjct: 213 ----SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL---PQGYRLEKPLN--C 263
Query: 260 SDDAKDLMRR 269
            D+  DLMR+
Sbjct: 264 DDEVYDLMRQ 273

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 74/160 (46%), Gaps = 26/160 (16%)
Query: 79  HYAFQDDSNLYLVMDY-YCGGDLLTLLSKFEDR-LPEDMAKFYIAEMVLAIASIHDLHYV 136
           H+  +  + +++VM +   G +LL L+ K+E R +P    K    +++L       L Y+
Sbjct: 94  HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG------LDYM 147
Query: 137 HRPNHFAFHLCRDIKPDNVLLDANG------HIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
           HR       +  DIKP+NVL++          I++AD G+        T     ++ T +
Sbjct: 148 HRRCGI---IHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT----NSIQTRE 200
Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
           Y SPE+L     G G      D WS    ++E++ G+  F
Sbjct: 201 YRSPEVLLGAPWGCG-----ADIWSTACLIFELITGDFLF 235

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/195 (20%), Positives = 85/195 (43%), Gaps = 23/195 (11%)
Query: 38  ECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCG 97
           +  N +    + +  F   V  LR+ R V +         L   +     L +V  +  G
Sbjct: 36  KMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL--------LFMGYSTKPQLAIVTQWCEG 87
Query: 98  GDLLTLLSKFEDRLPEDMAKFYIAEMV-LAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL 156
             L   L   E        KF + +++ +A  +   + Y+H  +     + RD+K +N+ 
Sbjct: 88  SSLYHHLHIIE-------TKFEMIKLIDIARQTAQGMDYLHAKSI----IHRDLKSNNIF 136
Query: 157 LDANGHIRLADFG-SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWS 215
           L  +  +++ DFG +  +    G+ Q     G+  +++PE++   +  +  Y  + D ++
Sbjct: 137 LHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD--KNPYSFQSDVYA 194
Query: 216 LGVCMYEMLYGETPF 230
            G+ +YE++ G+ P+
Sbjct: 195 FGIVLYELMTGQLPY 209

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 67/153 (43%), Gaps = 15/153 (9%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
            Y+V +Y   G+LL  L +      E++    +  M   I+S   + Y+ + N     + 
Sbjct: 103 FYIVTEYMPYGNLLDYLRECNR---EEVTAVVLLYMATQISSA--MEYLEKKNF----IH 153
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRY 207
           RD+   N L+  N  +++ADFG    + GD       A     + +PE L         +
Sbjct: 154 RDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-----AYNTF 208
Query: 208 GPECDWWSLGVCMYEM-LYGETPFYAESLVETY 239
             + D W+ GV ++E+  YG +P+    L + Y
Sbjct: 209 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 241

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 43/220 (19%)
Query: 36  YDECCNSSLR--REKTVSDFIE-----FVAKLRE----ERDVLVYGDRRWITNLHYAFQD 84
           + E C+  L+   +K +S  I+     +  K R     E  ++   D   I  L      
Sbjct: 58  FGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 85  DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE---MVLAIAS----IHDLHYVH 137
              + +V +Y   G L + L K +       A+F + +   M+  IAS    + D+ YVH
Sbjct: 118 SKPVMIVTEYMENGSLDSFLRKHD-------AQFTVIQLVGMLRGIASGMKYLSDMGYVH 170
Query: 138 RPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD--YISPE 195
           R          D+   N+L+++N   +++DFG    L  D         G     + SPE
Sbjct: 171 R----------DLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 196 ILTAMEEGRGRYGPECDWWSLGVCMYE-MLYGETPFYAES 234
            +        ++    D WS G+ ++E M YGE P++  S
Sbjct: 221 AIAYR-----KFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/185 (20%), Positives = 82/185 (44%), Gaps = 23/185 (12%)
Query: 48  KTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKF 107
           + +  F   V  LR+ R V +         L   +     L +V  +  G  L   L   
Sbjct: 66  QQLQAFKNEVGVLRKTRHVNIL--------LFMGYSTKPQLAIVTQWCEGSSLYHHLHII 117
Query: 108 EDRLPEDMAKFYIAEMV-LAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLA 166
           E        KF + +++ +A  +   + Y+H  +     + RD+K +N+ L  +  +++ 
Sbjct: 118 E-------TKFEMIKLIDIARQTAQGMDYLHAKSI----IHRDLKSNNIFLHEDLTVKIG 166
Query: 167 DFG-SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY 225
           DFG +  +    G+ Q     G+  +++PE++   +  +  Y  + D ++ G+ +YE++ 
Sbjct: 167 DFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD--KNPYSFQSDVYAFGIVLYELMT 224
Query: 226 GETPF 230
           G+ P+
Sbjct: 225 GQLPY 229

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 74/160 (46%), Gaps = 26/160 (16%)
Query: 79  HYAFQDDSNLYLVMDY-YCGGDLLTLLSKFEDR-LPEDMAKFYIAEMVLAIASIHDLHYV 136
           H+  +  + +++VM +   G +LL L+ K+E R +P    K    +++L       L Y+
Sbjct: 94  HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG------LDYM 147
Query: 137 HRPNHFAFHLCRDIKPDNVLLDANG------HIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
           HR       +  DIKP+NVL++          I++AD G+        T     ++ T +
Sbjct: 148 HRRCGI---IHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT----NSIQTRE 200
Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
           Y SPE+L     G G      D WS    ++E++ G+  F
Sbjct: 201 YRSPEVLLGAPWGCG-----ADIWSTACLIFELITGDFLF 235

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 21/161 (13%)
Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
            ++Y+V D     DL  LL      L  D   +++ +++  +  IH  + +HR       
Sbjct: 103 KDVYIVQDL-METDLYKLLKC--QHLSNDHICYFLYQILRGLKYIHSANVLHR------- 152
Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGG---DGTVQSNVAVGTPDYISPEILTAMEE 202
              D+KP N+LL+    +++ DFG   R+     D T      V T  Y +PEI   M  
Sbjct: 153 ---DLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEI---MLN 205
Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
            +G Y    D WS+G  + EML     F  +  ++    I+
Sbjct: 206 SKG-YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/185 (20%), Positives = 82/185 (44%), Gaps = 23/185 (12%)
Query: 48  KTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKF 107
           + +  F   V  LR+ R V +         L   +     L +V  +  G  L   L   
Sbjct: 74  QQLQAFKNEVGVLRKTRHVNIL--------LFMGYSTKPQLAIVTQWCEGSSLYHHLHII 125
Query: 108 EDRLPEDMAKFYIAEMV-LAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLA 166
           E        KF + +++ +A  +   + Y+H  +     + RD+K +N+ L  +  +++ 
Sbjct: 126 E-------TKFEMIKLIDIARQTAQGMDYLHAKSI----IHRDLKSNNIFLHEDLTVKIG 174
Query: 167 DFG-SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY 225
           DFG +  +    G+ Q     G+  +++PE++   +  +  Y  + D ++ G+ +YE++ 
Sbjct: 175 DFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD--KNPYSFQSDVYAFGIVLYELMT 232
Query: 226 GETPF 230
           G+ P+
Sbjct: 233 GQLPY 237

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 43/220 (19%)
Query: 36  YDECCNSSLR--REKTVSDFIE-----FVAKLRE----ERDVLVYGDRRWITNLHYAFQD 84
           + E C+  L+   +K +S  I+     +  K R     E  ++   D   I  L      
Sbjct: 58  FGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 85  DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE---MVLAIAS----IHDLHYVH 137
              + +V +Y   G L + L K +       A+F + +   M+  IAS    + D+ YVH
Sbjct: 118 SKPVMIVTEYMENGSLDSFLRKHD-------AQFTVIQLVGMLRGIASGMKYLSDMGYVH 170
Query: 138 RPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD--YISPE 195
           R          D+   N+L+++N   +++DFG    L  D         G     + SPE
Sbjct: 171 R----------DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 196 ILTAMEEGRGRYGPECDWWSLGVCMYE-MLYGETPFYAES 234
            +        ++    D WS G+ ++E M YGE P++  S
Sbjct: 221 AIAYR-----KFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 43/220 (19%)
Query: 36  YDECCNSSLR--REKTVSDFIE-----FVAKLRE----ERDVLVYGDRRWITNLHYAFQD 84
           + E C+  L+   +K +S  I+     +  K R     E  ++   D   I  L      
Sbjct: 46  FGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 105
Query: 85  DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE---MVLAIAS----IHDLHYVH 137
              + +V +Y   G L + L K +       A+F + +   M+  IAS    + D+ YVH
Sbjct: 106 SKPVMIVTEYMENGSLDSFLRKHD-------AQFTVIQLVGMLRGIASGMKYLSDMGYVH 158
Query: 138 RPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD--YISPE 195
           R          D+   N+L+++N   +++DFG    L  D         G     + SPE
Sbjct: 159 R----------DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 208
Query: 196 ILTAMEEGRGRYGPECDWWSLGVCMYE-MLYGETPFYAES 234
            +        ++    D WS G+ ++E M YGE P++  S
Sbjct: 209 AIAYR-----KFTSASDVWSYGIVLWEVMSYGERPYWEMS 243

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 43/220 (19%)
Query: 36  YDECCNSSLR--REKTVSDFIE-----FVAKLRE----ERDVLVYGDRRWITNLHYAFQD 84
           + E C+  L+   +K +S  I+     +  K R     E  ++   D   I  L      
Sbjct: 58  FGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 85  DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE---MVLAIAS----IHDLHYVH 137
              + +V +Y   G L + L K +       A+F + +   M+  IAS    + D+ YVH
Sbjct: 118 SKPVMIVTEYMENGSLDSFLRKHD-------AQFTVIQLVGMLRGIASGMKYLSDMGYVH 170
Query: 138 RPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD--YISPE 195
           R          D+   N+L+++N   +++DFG    L  D         G     + SPE
Sbjct: 171 R----------DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 196 ILTAMEEGRGRYGPECDWWSLGVCMYE-MLYGETPFYAES 234
            +        ++    D WS G+ ++E M YGE P++  S
Sbjct: 221 AIAYR-----KFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 43/220 (19%)
Query: 36  YDECCNSSLR--REKTVSDFIE-----FVAKLRE----ERDVLVYGDRRWITNLHYAFQD 84
           + E C+  L+   +K +S  I+     +  K R     E  ++   D   I  L      
Sbjct: 58  FGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 85  DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE---MVLAIAS----IHDLHYVH 137
              + +V +Y   G L + L K +       A+F + +   M+  IAS    + D+ YVH
Sbjct: 118 SKPVMIVTEYMENGSLDSFLRKHD-------AQFTVIQLVGMLRGIASGMKYLSDMGYVH 170
Query: 138 RPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD--YISPE 195
           R          D+   N+L+++N   +++DFG    L  D         G     + SPE
Sbjct: 171 R----------DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 196 ILTAMEEGRGRYGPECDWWSLGVCMYE-MLYGETPFYAES 234
            +        ++    D WS G+ ++E M YGE P++  S
Sbjct: 221 AIAYR-----KFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/145 (22%), Positives = 67/145 (46%), Gaps = 17/145 (11%)
Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
            Y++ ++   G+LL  L +   +    +   Y+A  + +      + Y+ + N     + 
Sbjct: 82  FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA-----MEYLEKKNF----IH 132
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGR 206
           RD+   N L+  N  +++ADFG    + GD T  ++     P  + +PE L        +
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TFTAHAGAKFPIKWTAPESL-----AYNK 186
Query: 207 YGPECDWWSLGVCMYEM-LYGETPF 230
           +  + D W+ GV ++E+  YG +P+
Sbjct: 187 FSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 43/220 (19%)
Query: 36  YDECCNSSLR--REKTVSDFIE-----FVAKLRE----ERDVLVYGDRRWITNLHYAFQD 84
           + E C+  L+   +K +S  I+     +  K R     E  ++   D   I  L      
Sbjct: 58  FGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 85  DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE---MVLAIAS----IHDLHYVH 137
              + +V +Y   G L + L K +       A+F + +   M+  IAS    + D+ YVH
Sbjct: 118 SKPVMIVTEYMENGSLDSFLRKHD-------AQFTVIQLVGMLRGIASGMKYLSDMGYVH 170
Query: 138 RPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD--YISPE 195
           R          D+   N+L+++N   +++DFG    L  D         G     + SPE
Sbjct: 171 R----------DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 196 ILTAMEEGRGRYGPECDWWSLGVCMYE-MLYGETPFYAES 234
            +        ++    D WS G+ ++E M YGE P++  S
Sbjct: 221 AIAYR-----KFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 43/220 (19%)
Query: 36  YDECCNSSLR--REKTVSDFIE-----FVAKLRE----ERDVLVYGDRRWITNLHYAFQD 84
           + E C+  L+   +K +S  I+     +  K R     E  ++   D   I  L      
Sbjct: 56  FGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 115
Query: 85  DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE---MVLAIAS----IHDLHYVH 137
              + +V +Y   G L + L K +       A+F + +   M+  IAS    + D+ YVH
Sbjct: 116 SKPVMIVTEYMENGSLDSFLRKHD-------AQFTVIQLVGMLRGIASGMKYLSDMGYVH 168
Query: 138 RPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD--YISPE 195
           R          D+   N+L+++N   +++DFG    L  D         G     + SPE
Sbjct: 169 R----------DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 218
Query: 196 ILTAMEEGRGRYGPECDWWSLGVCMYE-MLYGETPFYAES 234
            +        ++    D WS G+ ++E M YGE P++  S
Sbjct: 219 AIAYR-----KFTSASDVWSYGIVLWEVMSYGERPYWEMS 253

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 92/222 (41%), Gaps = 23/222 (10%)
Query: 47  EKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSK 106
           EK +SD I  +  ++      + G  + I NL  A   D  LY++++Y   G+L   L  
Sbjct: 74  EKDLSDLISEMEMMK------MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQA 127
Query: 107 FEDRLPEDMAKFYIAEMVLAIASIHDL----HYVHRP-NHFAFHLC--RDIKPDNVLLDA 159
              R P     F  +       S  DL    + V R   + A   C  RD+   NVL+  
Sbjct: 128 --RRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 185
Query: 160 NGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLGV 218
           +  +++ADFG    +      +       P  +++PE L         Y  + D WS GV
Sbjct: 186 DNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDR-----IYTHQSDVWSFGV 240
Query: 219 CMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEI 259
            ++E+   G +P Y    VE   K++   +  D PS+   E+
Sbjct: 241 LLWEIFTLGGSP-YPGVPVEELFKLLKEGHRMDKPSNCTNEL 281

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 58/130 (44%), Gaps = 29/130 (22%)
Query: 120 IAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA-------------NGHIRLA 166
           + ++   +A +H L  +HR          D+KP N+L+               N  I ++
Sbjct: 121 LRQIASGVAHLHSLKIIHR----------DLKPQNILVSTSSRFTADQQTGAENLRILIS 170
Query: 167 DFGSCLRL-GGDGTVQSNV--AVGTPDYISPEILTAME--EGRGRYGPECDWWSLGVCMY 221
           DFG C +L  G  + ++N+    GT  + +PE+L      + + R     D +S+G   Y
Sbjct: 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY 230
Query: 222 EML-YGETPF 230
            +L  G+ PF
Sbjct: 231 YILSKGKHPF 240

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 71/170 (41%), Gaps = 32/170 (18%)
Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE---MVLAIAS-- 129
           I  L         + +V +Y   G L + L K +       A+F + +   M+  IAS  
Sbjct: 79  IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-------AQFTVIQLVGMLRGIASGM 131
Query: 130 --IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVG 187
             + D+ YVHR          D+   N+L+++N   +++DFG    L  D         G
Sbjct: 132 KYLSDMGYVHR----------DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 181
Query: 188 TPD--YISPEILTAMEEGRGRYGPECDWWSLGVCMYE-MLYGETPFYAES 234
                + SPE +        ++    D WS G+ ++E M YGE P++  S
Sbjct: 182 KIPIRWTSPEAIAYR-----KFTSASDVWSYGIVLWEVMSYGERPYWEMS 226

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 42/90 (46%), Gaps = 16/90 (17%)
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVA-----------VGTPDYISPEI 196
           RD+KP N+    +  +++ DFG    +  D   Q+ +            VGT  Y+SPE 
Sbjct: 188 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQ 247
Query: 197 LTAMEEGRGRYGPECDWWSLGVCMYEMLYG 226
           +         Y  + D +SLG+ ++E+LY 
Sbjct: 248 IHG-----NNYSHKVDIFSLGLILFELLYS 272

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 56/128 (43%), Gaps = 29/128 (22%)
Query: 120 IAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA-------------NGHIRLA 166
           + ++   +A +H L  +HR          D+KP N+L+               N  I ++
Sbjct: 139 LRQIASGVAHLHSLKIIHR----------DLKPQNILVSTSSRFTADQQTGAENLRILIS 188
Query: 167 DFGSCLRL-GGDGTVQSNV--AVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM 223
           DFG C +L  G    + N+    GT  + +PE+L   E  + R     D +S+G   Y +
Sbjct: 189 DFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLE--ESTKRRLTRSIDIFSMGCVFYYI 246
Query: 224 L-YGETPF 230
           L  G+ PF
Sbjct: 247 LSKGKHPF 254

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 25/223 (11%)
Query: 47  EKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSK 106
           EK +SD I  +  ++      + G  + I NL  A   D  LY++++Y   G+L   L  
Sbjct: 59  EKDLSDLISEMEMMK------MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-- 110
Query: 107 FEDRLPEDMAKFY-----IAEMVLAIASIHDLHYVHRP-NHFAFHLC--RDIKPDNVLLD 158
            + R P  +   Y       E + +   +   + V R   + A   C  RD+   NVL+ 
Sbjct: 111 -QARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 169
Query: 159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLG 217
            +  +++ADFG    +      +       P  +++PE L         Y  + D WS G
Sbjct: 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-----IYTHQSDVWSFG 224
Query: 218 VCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEI 259
           V ++E+   G +P Y    VE   K++   +  D PS+   E+
Sbjct: 225 VLLWEIFTLGGSP-YPGVPVEELFKLLKEGHRMDKPSNCTNEL 266

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 56/128 (43%), Gaps = 29/128 (22%)
Query: 120 IAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA-------------NGHIRLA 166
           + ++   +A +H L  +HR          D+KP N+L+               N  I ++
Sbjct: 139 LRQIASGVAHLHSLKIIHR----------DLKPQNILVSTSSRFTADQQTGAENLRILIS 188
Query: 167 DFGSCLRL-GGDGTVQSNV--AVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM 223
           DFG C +L  G    + N+    GT  + +PE+L   E  + R     D +S+G   Y +
Sbjct: 189 DFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLE--ESTKRRLTRSIDIFSMGCVFYYI 246
Query: 224 L-YGETPF 230
           L  G+ PF
Sbjct: 247 LSKGKHPF 254

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 36/171 (21%), Positives = 70/171 (40%), Gaps = 18/171 (10%)
Query: 62  EERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA 121
           EE  V++      +  L+        ++++ +Y   G LL  L +   R           
Sbjct: 52  EEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK 111
Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ 181
           ++  A+  +    ++HR          D+   N L++  G ++++DFG   R   D    
Sbjct: 112 DVCEAMEYLESKQFLHR----------DLAARNCLVNDQGVVKVSDFGLS-RYVLDDEYT 160
Query: 182 SNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPF 230
           S+V    P  +  PE+L        ++  + D W+ GV M+E+   G+ P+
Sbjct: 161 SSVGSKFPVRWSPPEVLMY-----SKFSSKSDIWAFGVLMWEIYSLGKMPY 206

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 43/220 (19%)
Query: 36  YDECCNSSLR--REKTVSDFIE-----FVAKLRE----ERDVLVYGDRRWITNLHYAFQD 84
           + E C+  L+   +K +S  I+     +  K R     E  ++   D   I  L      
Sbjct: 58  FGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 85  DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE---MVLAIAS----IHDLHYVH 137
              + +V +Y   G L + L K +       A+F + +   M+  IAS    + D+ YVH
Sbjct: 118 SKPVMIVTEYMENGSLDSFLRKHD-------AQFTVIQLVGMLRGIASGMKYLSDMGYVH 170
Query: 138 RPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD--YISPE 195
           R          D+   N+L+++N   +++DFG    L  D         G     + SPE
Sbjct: 171 R----------DLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 196 ILTAMEEGRGRYGPECDWWSLGVCMYE-MLYGETPFYAES 234
            +        ++    D WS G+ ++E M YGE P++  S
Sbjct: 221 AIAYR-----KFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 45/97 (46%), Gaps = 19/97 (19%)
Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVA-----------VGTPDYISPEI 196
           RD+KP N+    +  +++ DFG    +  D   Q+ +            VGT  Y+SPE 
Sbjct: 142 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQ 201
Query: 197 LTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE 233
           +         Y  + D +SLG+ ++E+LY   PF  +
Sbjct: 202 IHG-----NSYSHKVDIFSLGLILFELLY---PFSTQ 230

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/170 (19%), Positives = 68/170 (40%), Gaps = 16/170 (9%)
Query: 62  EERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA 121
           EE  V++      +  L+        ++++ +Y   G LL  L +   R           
Sbjct: 53  EEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK 112
Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ 181
           ++  A+  +    ++HR          D+   N L++  G ++++DFG    +  D    
Sbjct: 113 DVCEAMEYLESKQFLHR----------DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 162
Query: 182 SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPF 230
           S  +     +  PE+L        ++  + D W+ GV M+E+   G+ P+
Sbjct: 163 SRGSKFPVRWSPPEVLMY-----SKFSSKSDIWAFGVLMWEIYSLGKMPY 207

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 36/171 (21%), Positives = 70/171 (40%), Gaps = 18/171 (10%)
Query: 62  EERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA 121
           EE  V++      +  L+        ++++ +Y   G LL  L +   R           
Sbjct: 48  EEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK 107
Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ 181
           ++  A+  +    ++HR          D+   N L++  G ++++DFG   R   D    
Sbjct: 108 DVCEAMEYLESKQFLHR----------DLAARNCLVNDQGVVKVSDFGLS-RYVLDDEYT 156
Query: 182 SNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPF 230
           S+V    P  +  PE+L        ++  + D W+ GV M+E+   G+ P+
Sbjct: 157 SSVGSKFPVRWSPPEVLMY-----SKFSSKSDIWAFGVLMWEIYSLGKMPY 202

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 25/223 (11%)
Query: 47  EKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSK 106
           EK +SD I  +  ++      + G  + I NL  A   D  LY++++Y   G+L   L  
Sbjct: 63  EKDLSDLISEMEMMK------MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-- 114
Query: 107 FEDRLPEDMAKFY-----IAEMVLAIASIHDLHYVHRP-NHFAFHLC--RDIKPDNVLLD 158
            + R P  +   Y       E + +   +   + V R   + A   C  RD+   NVL+ 
Sbjct: 115 -QARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 173
Query: 159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLG 217
            +  +++ADFG    +      +       P  +++PE L         Y  + D WS G
Sbjct: 174 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-----IYTHQSDVWSFG 228
Query: 218 VCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEI 259
           V ++E+   G +P Y    VE   K++   +  D PS+   E+
Sbjct: 229 VLLWEIFTLGGSP-YPGVPVEELFKLLKEGHRMDKPSNCTNEL 270

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 35/113 (30%), Positives = 56/113 (49%), Gaps = 14/113 (12%)
Query: 119 YIAE-MVLAIASIHD----LHYVHRP--NHFAFHLCRDIKPDNVLLDANGHIRLADFGSC 171
           +IAE M   +A +H+    L   H+P  +H      RDIK  NVLL  N    +ADFG  
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISH------RDIKSKNVLLKNNLTACIADFGLA 178
Query: 172 LRL-GGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM 223
           L+   G     ++  VGT  Y++PE+L      +       D +++G+ ++E+
Sbjct: 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 25/223 (11%)
Query: 47  EKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSK 106
           EK +SD I  +  ++      + G  + I NL  A   D  LY++++Y   G+L   L  
Sbjct: 66  EKDLSDLISEMEMMK------MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-- 117
Query: 107 FEDRLPEDMAKFY-----IAEMVLAIASIHDLHYVHRP-NHFAFHLC--RDIKPDNVLLD 158
            + R P  +   Y       E + +   +   + V R   + A   C  RD+   NVL+ 
Sbjct: 118 -QARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 176
Query: 159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEEGRGRYGPECDWWSLG 217
            +  +++ADFG    +      +       P  +++PE L         Y  + D WS G
Sbjct: 177 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-----IYTHQSDVWSFG 231
Query: 218 VCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEI 259
           V ++E+   G +P Y    VE   K++   +  D PS+   E+
Sbjct: 232 VLLWEIFTLGGSP-YPGVPVEELFKLLKEGHRMDKPSNCTNEL 273

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	372
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-166
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-157
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-147
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-85
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-85
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-85
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	6e-85
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-84
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-84
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-83
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-82
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	6e-82
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	7e-82
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-82
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-81
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-78
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	9e-78
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-77
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	7e-77
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-75
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-72
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-71
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-63
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-61
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-59
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-57
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-55
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	7e-55
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	7e-53
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-53
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-50
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-50
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-50
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-50
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-49
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	7e-49
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-48
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-48
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-48
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-48
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-47
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-47
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-46
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-46
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-46
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-46
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	8e-46
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-45
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	8e-45
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-44
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-44
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-44
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-44
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-44
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-44
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-43
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-43
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-43
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-42
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-42
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-42
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-42
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-42
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-42
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-41
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-41
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-41
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-41
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-41
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-41
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-41
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-41
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-41
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-41
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	9e-41
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-40
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-40
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-40
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-40
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-40
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	8e-40
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	8e-39
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-38
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-37
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-37
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-37
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	7e-37
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-36
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-36
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	8e-36
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-35
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-35
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-35
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-35
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-35
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-34
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-34
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-33
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-31
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-31
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-30
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-30
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	7e-30
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-29
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-29
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-29
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	7e-29
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-28
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-28
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-27
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-26
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-26
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-26
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-26
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	7e-26
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-24
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-23
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	9e-23
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-22
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-22
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-21
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-20
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-20
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-20
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-20
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-19
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-19
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-19
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-19
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-19
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-18
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-18
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-18
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-18
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-18
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-17
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-17
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-17
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-17
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-17
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-17
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	9e-17
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-16
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-16
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	8e-16
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-15
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-15
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-14
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-13
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-13
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-13
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	6e-13
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-13
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	9e-13
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-12
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-12
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-12
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-12
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	7e-12
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	8e-12
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-11
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-11
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-11
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-11
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-11
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-11
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-11
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-10
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-10
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-10
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-10
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-10
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	9e-10
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	9e-10
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	9e-10
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-09
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-09
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-09
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-09
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-09
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-09
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-09
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-09
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-09
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	6e-09
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-09
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	8e-09
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-09
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	8e-09
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-09
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-08
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-08
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-08
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-08
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-08
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-08
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-08
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	6e-08
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-08
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	6e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-04
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	8e-08
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	9e-08
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-07
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-07
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-07
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-07
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	7e-07
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-06
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-06
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-06
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-06
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-06
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-05
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-05
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-04
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-04
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-04
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-04
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-04
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-04
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	8e-04

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  470 bits (1211), Expect = e-166
 Identities = 247/429 (57%), Positives = 286/429 (66%), Gaps = 87/429 (20%)

Query: 1   DERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNS------------------ 42
           + RLR+LE   L GP Q  G+ FS+ETLLDIL+ LYDEC NS                  
Sbjct: 3   EVRLRQLEQFILDGPAQTNGQCFSVETLLDILICLYDECNNSPLRREKNILEYLEWAKPF 62

Query: 43  --SLRREK-TVSDFIEF---------------------------------------VAKL 60
              +++ +    DF E                                         A  
Sbjct: 63  TSKVKQMRLHREDF-EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACF 121

Query: 61  REERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYI 120
           REERDVLV GD +WIT LHYAFQDD+NLYLVMDYY GGDLLTLLSKFEDRLPE+MA+FY+
Sbjct: 122 REERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYL 181

Query: 121 AEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTV 180
           AEMV+AI S+H LHYVHR          DIKPDN+L+D NGHIRLADFGSCL+L  DGTV
Sbjct: 182 AEMVIAIDSVHQLHYVHR----------DIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231

Query: 181 QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 240
           QS+VAVGTPDYISPEIL AME G+GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG
Sbjct: 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 291

Query: 241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISP 300
           KIMNH+  F  P+ V  ++S++AKDL+RRLICS + RLGQNGI DFK             
Sbjct: 292 KIMNHKERFQFPTQVT-DVSENAKDLIRRLICSREHRLGQNGIEDFK------------- 337

Query: 301 RNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALH 360
             HP+F GI WD+IR+  APYIPEVSSPTDTS+FDVD+  ++ S+ +PP     A S  H
Sbjct: 338 -KHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPP-PTHTAFSGHH 395

Query: 361 LPFVGFTFT 369
           LPFVGFT+T
Sbjct: 396 LPFVGFTYT 404

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  447 bits (1152), Expect = e-157
 Identities = 183/416 (43%), Positives = 238/416 (57%), Gaps = 92/416 (22%)

Query: 20  GRVFSIETLLDILLVLYDECCNSSLRREK---------------------TVSDFIEF-- 56
                +E LLD+LL ++ E   S L ++K                        DF E   
Sbjct: 9   PGFLGLEPLLDLLLGVHQELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDF-EILK 67

Query: 57  -------------------------------------VAKLREERDVLVYGDRRWITNLH 79
                                                V+  REERDVLV GDRRWIT LH
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127

Query: 80  YAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRP 139
           +AFQD++ LYLVM+YY GGDLLTLLSKF +R+P +MA+FY+AE+V+AI S+H L YVH  
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVH-- 185

Query: 140 NHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTA 199
                   RDIKPDN+LLD  GHIRLADFGSCL+L  DGTV+S VAVGTPDY+SPEIL A
Sbjct: 186 --------RDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237

Query: 200 ME--EGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGY 257
           +    G G YGPECDWW+LGV  YEM YG+TPFYA+S  ETYGKI++++    LP     
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE- 296

Query: 258 EISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDS 317
            + ++A+D ++RL+C  +TRLG+ G  DF+               HP+F G+ WD +RDS
Sbjct: 297 GVPEEARDFIQRLLCPPETRLGRGGAGDFR--------------THPFFFGLDWDGLRDS 342

Query: 318 NAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASP----ALSALHLPFVGFTFT 369
             P+ P+    TDT +FD+ E G+ A  +      S     A   +HLPFVG++++
Sbjct: 343 VPPFTPDFEGATDTCNFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPFVGYSYS 398

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  421 bits (1083), Expect = e-147
 Identities = 140/315 (44%), Positives = 197/315 (62%), Gaps = 34/315 (10%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
            A   EERD++ + +  W+  L YAFQDD  LY+VM+Y  GGDL+ L+S +   +PE  A
Sbjct: 113 SAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWA 170

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FY AE+VLA+ +IH + ++HR          D+KPDN+LLD +GH++LADFG+C+++  
Sbjct: 171 RFYTAEVVLALDAIHSMGFIHR----------DVKPDNMLLDKSGHLKLADFGTCMKMNK 220

Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
           +G V+ + AVGTPDYISPE+L + + G G YG ECDWWS+GV +YEML G+TPFYA+SLV
Sbjct: 221 EGMVRCDTAVGTPDYISPEVLKS-QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 279

Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSL 296
            TY KIMNH+NS   P D   +IS +AK+L+   +   + RLG+NG+ + K         
Sbjct: 280 GTYSKIMNHKNSLTFPDDN--DISKEAKNLICAFLTDREVRLGRNGVEEIK--------- 328

Query: 297 SISPRNHPWFQGIAWDS--IRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASP 354
                 H +F+   W    +RD+ AP +P++SS  DTS+FD  E      +  P      
Sbjct: 329 -----RHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPI---PK 380

Query: 355 ALSALHLPFVGFTFT 369
           A     LPFVGFT+ 
Sbjct: 381 AFVGNQLPFVGFTYY 395

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  262 bits (673), Expect = 2e-85
 Identities = 98/322 (30%), Positives = 154/322 (47%), Gaps = 46/322 (14%)

Query: 57  VAKLREERDVLVYGDRR-WITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDM 115
              +  ER+VL+   +  ++  LH++FQ    LY V+DY  GG+L   L + E    E  
Sbjct: 82  EKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR-ERCFLEPR 140

Query: 116 AKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG 175
           A+FY AE+  A+  +H L+ V+R          D+KP+N+LLD+ GHI L DFG C +  
Sbjct: 141 ARFYAAEIASALGYLHSLNIVYR----------DLKPENILLDSQGHIVLTDFGLC-KEN 189

Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
            +    ++   GTP+Y++PE+L      +  Y    DWW LG  +YEMLYG  PFY+ + 
Sbjct: 190 IEHNSTTSTFCGTPEYLAPEVLH----KQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNT 244

Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLG-QNGIADFKMWSALF 293
            E Y  I+N         +    I++ A+ L+  L+      RLG ++   + K      
Sbjct: 245 AEMYDNILNKPLQL--KPN----ITNSARHLLEGLLQKDRTKRLGAKDDFMEIK------ 292

Query: 294 VSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFDVD--EAGVRASDALPP 349
                   +H +F  I WD +  +    P+ P VS P D  HFD +  E  V  +    P
Sbjct: 293 --------SHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNAIGKAP 344

Query: 350 --AAASPALSALHLPFVGFTFT 369
                + ++      F+GF++ 
Sbjct: 345 DSVLVTASVKEAAEAFLGFSYA 366

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  260 bits (667), Expect = 3e-85
 Identities = 105/285 (36%), Positives = 148/285 (51%), Gaps = 46/285 (16%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           V    +ER +L      +I  +   FQD   ++++MDY  GG+L +LL K   R P  +A
Sbjct: 50  VEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK-SQRFPNPVA 108

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           KFY AE+ LA+  +H    ++R          D+KP+N+LLD NGHI++ DFG   +   
Sbjct: 109 KFYAAEVCLALEYLHSKDIIYR----------DLKPENILLDKNGHIKITDFGFA-KYVP 157

Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
           D T       GTPDYI+PE++      +  Y    DWWS G+ +YEML G TPFY  + +
Sbjct: 158 DVT---YTLCGTPDYIAPEVV----STKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTM 209

Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT-RLG--QNGIADFKMWSALF 293
           +TY KI+N +  F  P       ++D KDL+ RLI    + RLG  QNG  D K      
Sbjct: 210 KTYEKILNAELRF--PPF----FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK------ 257

Query: 294 VSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSS-PTDTSHFD 335
                   NHPWF+ + W+ +  R+   PY P +     DTS FD
Sbjct: 258 --------NHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFD 294

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  260 bits (666), Expect = 4e-85
 Identities = 89/297 (29%), Positives = 149/297 (50%), Gaps = 43/297 (14%)

Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTL 103
           L++   V +  +  A  + ER++L      +I +L YAFQ    LYL+++Y  GG+L   
Sbjct: 53  LKKAMIVRNAKD-TAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQ 111

Query: 104 LSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI 163
           L + E    ED A FY+AE+ +A+  +H    ++R          D+KP+N++L+  GH+
Sbjct: 112 LER-EGIFMEDTACFYLAEISMALGHLHQKGIIYR----------DLKPENIMLNHQGHV 160

Query: 164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM 223
           +L DFG C +        ++   GT +Y++PEIL       G +    DWWSLG  MY+M
Sbjct: 161 KLTDFGLC-KESIHDGTVTHTFCGTIEYMAPEILM----RSG-HNRAVDWWSLGALMYDM 214

Query: 224 LYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLG--Q 280
           L G  PF  E+  +T  KI+  + +   P      ++ +A+DL+++L+  ++ +RLG   
Sbjct: 215 LTGAPPFTGENRKKTIDKILKCKLNL--PPY----LTQEARDLLKKLLKRNAASRLGAGP 268

Query: 281 NGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFD 335
               + +               HP+F+ I W+ +  R    P+ P + S  D S FD
Sbjct: 269 GDAGEVQ--------------AHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFD 311

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  259 bits (665), Expect = 6e-85
 Identities = 97/278 (34%), Positives = 143/278 (51%), Gaps = 42/278 (15%)

Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE 122
           ERD+LV  +  +I  LHYAFQ +  LYL++D+  GGDL T LSK E    E+  KFY+AE
Sbjct: 76  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAE 134

Query: 123 MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQS 182
           + LA+  +H L  ++R          D+KP+N+LLD  GHI+L DFG   +   D   ++
Sbjct: 135 LALALDHLHSLGIIYR----------DLKPENILLDEEGHIKLTDFGLS-KESIDHEKKA 183

Query: 183 NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
               GT +Y++PE++      RG +    DWWS GV M+EML G  PF  +   ET   I
Sbjct: 184 YSFCGTVEYMAPEVV----NRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 238

Query: 243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLG--QNGIADFKMWSALFVSLSIS 299
           +  +     P      +S +A+ L+R L   +   RLG   +G+ + K            
Sbjct: 239 LKAKLGM--PQF----LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIK------------ 280

Query: 300 PRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFD 335
              H +F  I W+ +  R+ + P+ P    P DT +FD
Sbjct: 281 --RHSFFSTIDWNKLYRREIHPPFKPATGRPEDTFYFD 316

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  260 bits (666), Expect = 1e-84
 Identities = 97/284 (34%), Positives = 151/284 (53%), Gaps = 45/284 (15%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           +     E+ +L   +  ++  L ++F+D+SNLY+VM+Y  GG++ + L +   R  E  A
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHA 143

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FY A++VL    +H L  ++R          D+KP+N+L+D  G+I++ DFG   R+ G
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYR----------DLKPENLLIDQQGYIQVTDFGFAKRVKG 193

Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
               ++    GTP+ ++PEI+      +G Y    DWW+LGV +YEM  G  PF+A+  +
Sbjct: 194 ----RTWTLCGTPEALAPEII----LSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT-RLG--QNGIADFKMWSALF 293
           + Y KI++ +  F  PS      S D KDL+R L+    T R G  +NG+ D K      
Sbjct: 245 QIYEKIVSGKVRF--PSH----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIK------ 292

Query: 294 VSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFD 335
                   NH WF    W +I  R   AP+IP+   P DTS+FD
Sbjct: 293 --------NHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  260 bits (666), Expect = 1e-84
 Identities = 93/282 (32%), Positives = 144/282 (51%), Gaps = 44/282 (15%)

Query: 63  ERDVLVYGDRR-WITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA 121
           ER VL +  +  ++  LHYAFQ ++ L+L++DY  GG+L T LS+  +R  E   + Y+ 
Sbjct: 108 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVG 166

Query: 122 EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ 181
           E+VLA+  +H L  ++          RDIK +N+LLD+NGH+ L DFG       D T +
Sbjct: 167 EIVLALEHLHKLGIIY----------RDIKLENILLDSNGHVVLTDFGLSKEFVADETER 216

Query: 182 SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE----SLVE 237
           +    GT +Y++P+I+   + G   +    DWWSLGV MYE+L G +PF  +    S  E
Sbjct: 217 AYDFCGTIEYMAPDIVRGGDSG---HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE 273

Query: 238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLG--QNGIADFKMWSALFV 294
              +I+  +  +  P +    +S  AKDL++RL+      RLG       + K       
Sbjct: 274 ISRRILKSEPPY--PQE----MSALAKDLIQRLLMKDPKKRLGCGPRDADEIK------- 320

Query: 295 SLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHF 334
                   H +FQ I WD +  +   AP+ P +    D S+F
Sbjct: 321 -------EHLFFQKINWDDLAAKKVPAPFKPVIRDELDVSNF 355

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  255 bits (655), Expect = 4e-83
 Identities = 99/318 (31%), Positives = 148/318 (46%), Gaps = 47/318 (14%)

Query: 57  VAKLREERDVLVYGDRRW-ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDM 115
           V     E+ VL        +T++   FQ   NL+ VM+Y  GGDL+  +     +     
Sbjct: 61  VECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSR 119

Query: 116 AKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSC-LRL 174
           A FY AE++L +  +H    V+R          D+K DN+LLD +GHI++ADFG C   +
Sbjct: 120 ATFYAAEIILGLQFLHSKGIVYR----------DLKLDNILLDKDGHIKIADFGMCKENM 169

Query: 175 GGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES 234
            GD    +    GTPDYI+PEIL   +     Y    DWWS GV +YEML G++PF+ + 
Sbjct: 170 LGDAKTNT--FCGTPDYIAPEILLGQK-----YNHSVDWWSFGVLLYEMLIGQSPFHGQD 222

Query: 235 LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLGQNGIADFKMWSALF 293
             E +  I      +  P      +  +AKDL+ +L     + RLG  G  D +      
Sbjct: 223 EEELFHSIRMDNPFY--PRW----LEKEAKDLLVKLFVREPEKRLGVRG--DIR------ 268

Query: 294 VSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAA 351
                    HP F+ I W+ +  ++ + P+ P+V SP D S+F  D+  +     L  A 
Sbjct: 269 --------QHPLFREINWEELERKEIDPPFRPKVKSPFDCSNF--DKEFLNEKPRLSFAD 318

Query: 352 ASPALSALHLPFVGFTFT 369
            +   S     F  F+F 
Sbjct: 319 RALINSMDQNMFRNFSFM 336

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  253 bits (649), Expect = 2e-82
 Identities = 95/326 (29%), Positives = 139/326 (42%), Gaps = 47/326 (14%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           VA    E  VL      ++T L YAFQ    L  VM+Y  GG+L   LS+ E    E+ A
Sbjct: 49  VAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERA 107

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FY AE+V A+  +H    V+R          DIK +N++LD +GHI++ DFG C + G 
Sbjct: 108 RFYGAEIVSALEYLHSRDVVYR----------DIKLENLMLDKDGHIKITDFGLC-KEGI 156

Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
                     GTP+Y++PE+L         YG   DWW LGV MYEM+ G  PFY +   
Sbjct: 157 SDGATMKTFCGTPEYLAPEVLE-----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211

Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLG--QNGIADFKMWSALF 293
             +  I+  +  F  P      +S +AK L+  L+      RLG   +   +        
Sbjct: 212 RLFELILMEEIRF--PRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM------ 259

Query: 294 VSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFDVD--EAGVRAS---DA 346
                    H +F  I W  +  +    P+ P+V+S  DT +FD +     +  +     
Sbjct: 260 --------EHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRY 311

Query: 347 LPPAAASPALSALHLPFVGFTFTQGW 372
                           F  F +   W
Sbjct: 312 DSLGLLELDQREEQEMFEDFDYIADW 337

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  251 bits (643), Expect = 6e-82
 Identities = 77/266 (28%), Positives = 124/266 (46%), Gaps = 41/266 (15%)

Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE 122
           ERDV+   D  +   L++ FQDD  LY  + Y   G+LL  + K      E   +FY AE
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAE 138

Query: 123 MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG-TVQ 181
           +V A+  +H    +HR          D+KP+N+LL+ + HI++ DFG+   L  +    +
Sbjct: 139 IVSALEYLHGKGIIHR----------DLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 188

Query: 182 SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 241
           +N  VGT  Y+SPE+LT     +       D W+LG  +Y+++ G  PF A +    + K
Sbjct: 189 ANSFVGTAQYVSPELLT----EKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK 243

Query: 242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDT-RLG---QNGIADFKMWSALFVSLS 297
           I+  +  +D P          A+DL+ +L+    T RLG     G    K          
Sbjct: 244 IIKLE--YDFPEK----FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK---------- 287

Query: 298 ISPRNHPWFQGIAWDSIRDSNAPYIP 323
                HP+F+ + W+++     P + 
Sbjct: 288 ----AHPFFESVTWENLHQQTPPKLT 309

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  254 bits (650), Expect = 7e-82
 Identities = 73/279 (26%), Positives = 128/279 (45%), Gaps = 47/279 (16%)

Query: 63  ERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE 122
           E  ++   +  ++ NL Y+FQD+ ++++V+D   GGDL   L +      E+  K +I E
Sbjct: 65  ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICE 123

Query: 123 MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQS 182
           +V+A+  + +   +H          RD+KPDN+LLD +GH+ + DF     L  +  + +
Sbjct: 124 LVMALDYLQNQRIIH----------RDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT 173

Query: 183 NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY---AESLVETY 239
               GT  Y++PE+ +   +G G Y    DWWSLGV  YE+L G  P++   + S  E  
Sbjct: 174 --MAGTKPYMAPEMFS-SRKGAG-YSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229

Query: 240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLGQNGIADFKMWSALFVSLSI 298
                   ++  PS      S +   L+++L+  + D R     ++D +           
Sbjct: 230 HTFETTVVTY--PSA----WSQEMVSLLKKLLEPNPDQRFS--QLSDVQ----------- 270

Query: 299 SPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFD 335
              N P+   I WD++  +     +IP         + D
Sbjct: 271 ---NFPYMNDINWDAVFQKRLIPGFIP----NKGRLNCD 302

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  252 bits (647), Expect = 7e-82
 Identities = 98/321 (30%), Positives = 145/321 (45%), Gaps = 48/321 (14%)

Query: 57  VAKLREERDVLVYGDRR-WITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDM 115
           V     E+ +L       ++T L   FQ    L+ VM++  GGDL+  + K   R  E  
Sbjct: 67  VECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEAR 125

Query: 116 AKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSC-LRL 174
           A+FY AE++ A+  +HD   ++R          D+K DNVLLD  GH +LADFG C   +
Sbjct: 126 ARFYAAEIISALMFLHDKGIIYR----------DLKLDNVLLDHEGHCKLADFGMCKEGI 175

Query: 175 GGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES 234
               T  +    GTPDYI+PEIL   E     YGP  DWW++GV +YEML G  PF AE+
Sbjct: 176 CNGVT--TATFCGTPDYIAPEILQ--EML---YGPAVDWWAMGVLLYEMLCGHAPFEAEN 228

Query: 235 LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLG---QNGIADFKMWS 290
             + +  I+N +  +  P+     + +DA  +++  +  +   RLG   Q G        
Sbjct: 229 EDDLFEAILNDEVVY--PTW----LHEDATGILKSFMTKNPTMRLGSLTQGGEHAIL--- 279

Query: 291 ALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALP 348
                       HP+F+ I W  +  R    P+ P + S  D S+F  D   ++    L 
Sbjct: 280 -----------RHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNF--DPDFIKEEPVLT 326

Query: 349 PAAASPALSALHLPFVGFTFT 369
           P             F  F + 
Sbjct: 327 PIDEGHLPMINQDEFRNFEYV 347

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  251 bits (643), Expect = 3e-81
 Identities = 96/319 (30%), Positives = 141/319 (44%), Gaps = 46/319 (14%)

Query: 57  VAKLREERDVLVYGDRR-WITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDM 115
           V     E+ VL    +  ++T LH  FQ    LY VM+Y  GGDL+  + +   R  E  
Sbjct: 64  VECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGRFKEPH 122

Query: 116 AKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG 175
           A FY AE+ + +  +     ++R          D+K DNV+LD+ GHI++ADFG C +  
Sbjct: 123 AVFYAAEIAIGLFFLQSKGIIYR----------DLKLDNVMLDSEGHIKIADFGMC-KEN 171

Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
               V +    GTPDYI+PEI+         YG   DWW+ GV +YEML G+ PF  E  
Sbjct: 172 IWDGVTTKTFCGTPDYIAPEIIAYQP-----YGKSVDWWAFGVLLYEMLAGQAPFEGEDE 226

Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLG--QNGIADFKMWSAL 292
            E +  IM H  ++  P      +S +A  + + L+      RLG    G  D K     
Sbjct: 227 DELFQSIMEHNVAY--PKS----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIK----- 275

Query: 293 FVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPA 350
                     H +F+ I W+ +  ++   PY P+     +  +F  D    R    L P 
Sbjct: 276 ---------EHAFFRYIDWEKLERKEIQPPYKPKACGR-NAENF--DRFFTRHPPVLTPP 323

Query: 351 AASPALSALHLPFVGFTFT 369
                 +     F GF+F 
Sbjct: 324 DQEVIRNIDQSEFEGFSFV 342

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  242 bits (621), Expect = 4e-78
 Identities = 93/329 (28%), Positives = 146/329 (44%), Gaps = 55/329 (16%)

Query: 57  VAKLREERDVLVYGDRRW-ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDM 115
           +  ++ E+ V         +  LH  FQ +S L+ V++Y  GGDL+  + + + +LPE+ 
Sbjct: 53  IDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEH 111

Query: 116 AKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG 175
           A+FY AE+ LA+  +H+   ++R          D+K DNVLLD+ GHI+L D+G C + G
Sbjct: 112 ARFYSAEISLALNYLHERGIIYR----------DLKLDNVLLDSEGHIKLTDYGMC-KEG 160

Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF----- 230
                 ++   GTP+YI+PEIL    E    YG   DWW+LGV M+EM+ G +PF     
Sbjct: 161 LRPGDTTSTFCGTPNYIAPEILR--GED---YGFSVDWWALGVLMFEMMAGRSPFDIVGS 215

Query: 231 ----YAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLG---QNG 282
                  +    +  I+  Q     P      +S  A  +++  +      RLG   Q G
Sbjct: 216 SDNPDQNTEDYLFQVILEKQIRI--PRS----LSVKAASVLKSFLNKDPKERLGCHPQTG 269

Query: 283 IADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFDVDEAG 340
            AD +               HP+F+ + WD +  +    P+ P +S      +F  D   
Sbjct: 270 FADIQ--------------GHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNF--DSQF 313

Query: 341 VRASDALPPAAASPALSALHLPFVGFTFT 369
                 L P             F GF + 
Sbjct: 314 TNEPVQLTPDDDDIVRKIDQSEFEGFEYI 342

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  245 bits (627), Expect = 9e-78
 Identities = 93/284 (32%), Positives = 136/284 (47%), Gaps = 41/284 (14%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
           VA    E  VL      ++T L Y+FQ    L  VM+Y  GG+L   LS+ E    ED A
Sbjct: 192 VAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRA 250

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
           +FY AE+V A      L Y+H   +  +   RD+K +N++LD +GHI++ DFG C + G 
Sbjct: 251 RFYGAEIVSA------LDYLHSEKNVVY---RDLKLENLMLDKDGHIKITDFGLC-KEGI 300

Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
                     GTP+Y++PE+L   +     YG   DWW LGV MYEM+ G  PFY +   
Sbjct: 301 KDGATMKTFCGTPEYLAPEVLEDND-----YGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 355

Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLG--QNGIADFKMWSALF 293
           + +  I+  +  F  P      +  +AK L+  L+      RLG       +        
Sbjct: 356 KLFELILMEEIRF--PRT----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIM------ 403

Query: 294 VSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFD 335
                    H +F GI W  +  +  + P+ P+V+S TDT +FD
Sbjct: 404 --------QHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFD 439

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  242 bits (619), Expect = 3e-77
 Identities = 93/329 (28%), Positives = 146/329 (44%), Gaps = 55/329 (16%)

Query: 57  VAKLREERDVLVYGDRRW-ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDM 115
           +  ++ E+ V         +  LH  FQ +S L+ V++Y  GGDL+  + + + +LPE+ 
Sbjct: 96  IDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEH 154

Query: 116 AKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG 175
           A+FY AE+ LA+  +H+   ++R          D+K DNVLLD+ GHI+L D+G C + G
Sbjct: 155 ARFYSAEISLALNYLHERGIIYR----------DLKLDNVLLDSEGHIKLTDYGMC-KEG 203

Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF----- 230
                 ++   GTP+YI+PEIL    E    YG   DWW+LGV M+EM+ G +PF     
Sbjct: 204 LRPGDTTSTFCGTPNYIAPEILR--GED---YGFSVDWWALGVLMFEMMAGRSPFDIVGS 258

Query: 231 ----YAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLG---QNG 282
                  +    +  I+  Q     P      +S  A  +++  +      RLG   Q G
Sbjct: 259 SDNPDQNTEDYLFQVILEKQIRI--PRS----LSVKAASVLKSFLNKDPKERLGCHPQTG 312

Query: 283 IADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFDVDEAG 340
            AD +               HP+F+ + WD +  +    P+ P +S      +F  D   
Sbjct: 313 FADIQ--------------GHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNF--DSQF 356

Query: 341 VRASDALPPAAASPALSALHLPFVGFTFT 369
                 L P             F GF + 
Sbjct: 357 TNEPVQLTPDDDDIVRKIDQSEFEGFEYI 385

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  249 bits (636), Expect = 7e-77
 Identities = 97/319 (30%), Positives = 141/319 (44%), Gaps = 46/319 (14%)

Query: 57  VAKLREERDVLVYGDRRW-ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDM 115
           V     E+ VL    +   +T LH  FQ    LY VM+Y  GGDL+  + +   R  E  
Sbjct: 385 VECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGRFKEPH 443

Query: 116 AKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG 175
           A FY AE+ + +  +     ++R          D+K DNV+LD+ GHI++ADFG C +  
Sbjct: 444 AVFYAAEIAIGLFFLQSKGIIYR----------DLKLDNVMLDSEGHIKIADFGMC-KEN 492

Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
               V +    GTPDYI+PEI+         YG   DWW+ GV +YEML G+ PF  E  
Sbjct: 493 IWDGVTTKTFCGTPDYIAPEIIAYQP-----YGKSVDWWAFGVLLYEMLAGQAPFEGEDE 547

Query: 236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLG--QNGIADFKMWSAL 292
            E +  IM H  ++  P      +S +A  + + L+      RLG    G  D K     
Sbjct: 548 DELFQSIMEHNVAY--PKS----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIK----- 596

Query: 293 FVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPA 350
                     H +F+ I W+ +  ++   PY P+  S  +  +F  D    R    L P 
Sbjct: 597 ---------EHAFFRYIDWEKLERKEIQPPYKPKA-SGRNAENF--DRFFTRHPPVLTPP 644

Query: 351 AASPALSALHLPFVGFTFT 369
                 +     F GF+F 
Sbjct: 645 DQEVIRNIDQSEFEGFSFV 663

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  244 bits (625), Expect = 4e-75
 Identities = 78/327 (23%), Positives = 123/327 (37%), Gaps = 61/327 (18%)

Query: 57  VAKLREERDVLV---YGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPE 113
                 ER +L     GD  +I  + YAF     L  ++D   GGDL   LS+      E
Sbjct: 233 ETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSE 291

Query: 114 DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR 173
              +FY AE++L +  +H+   V+R          D+KP N+LLD +GH+R++D G    
Sbjct: 292 ADMRFYAAEIILGLEHMHNRFVVYR----------DLKPANILLDEHGHVRISDLGLACD 341

Query: 174 LGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE 233
                    + +VGT  Y++PE+L         Y    DW+SLG  ++++L G +PF   
Sbjct: 342 FSKKKP---HASVGTHGYMAPEVLQKGV----AYDSSADWFSLGCMLFKLLRGHSPFRQH 394

Query: 234 S---LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLG--QNGIADFK 287
                 E     +        P       S + + L+  L+    + RLG    G  + K
Sbjct: 395 KTKDKHEIDRMTLTMAVEL--PD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448

Query: 288 MWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFDV---DEAGVR 342
                           P+F+ + W  +  +    P IP          FD+   DE   +
Sbjct: 449 --------------ESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTK 494

Query: 343 ASDALPPAAASPALSALHLPFVGFTFT 369
               L               +  F  T
Sbjct: 495 GIKLLDSDQEL---------YRNFPLT 512

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  233 bits (595), Expect = 5e-72
 Identities = 72/293 (24%), Positives = 126/293 (43%), Gaps = 48/293 (16%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDL---LTLLSKFEDRLPE 113
                 E+ +L     R+I +L YAF+  ++L LVM    GGD+   +  + +      E
Sbjct: 229 YQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE 288

Query: 114 DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR 173
             A FY A++V  +  +H  + ++          RD+KP+NVLLD +G++R++D G  + 
Sbjct: 289 PRAIFYTAQIVSGLEHLHQRNIIY----------RDLKPENVLLDDDGNVRISDLGLAVE 338

Query: 174 LGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE 233
           L    T ++    GTP +++PE+L         Y    D+++LGV +YEM+    PF A 
Sbjct: 339 LKAGQT-KTKGYAGTPGFMAPELLL-----GEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

Query: 234 ----SLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLG--QNGIADF 286
                  E   +++    ++  P       S  +KD    L+    + RLG         
Sbjct: 393 GEKVENKELKQRVLEQAVTY--PDK----FSPASKDFCEALLQKDPEKRLGFRDGSCDGL 446

Query: 287 KMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFDVD 337
           +               HP F+ I+W  +       P++P+  +    +  DV 
Sbjct: 447 R--------------THPLFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQDVG 485

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  231 bits (592), Expect = 3e-71
 Identities = 76/323 (23%), Positives = 127/323 (39%), Gaps = 55/323 (17%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDM 115
            A    E+ +L   + R++ +L YA++    L LV+    GGDL   +    +   PE  
Sbjct: 228 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEAR 287

Query: 116 AKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG 175
           A FY AE+   +  +H    V+          RD+KP+N+LLD +GHIR++D G  + + 
Sbjct: 288 AVFYAAEICCGLEDLHRERIVY----------RDLKPENILLDDHGHIRISDLGLAVHVP 337

Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE-- 233
              T++    VGT  Y++PE++        RY    DWW+LG  +YEM+ G++PF     
Sbjct: 338 EGQTIKG--RVGTVGYMAPEVVK-----NERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 390

Query: 234 --SLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLG--QNGIADFKM 288
                E    +      +          S  A+ L  +L+C     RLG       + K 
Sbjct: 391 KIKREEVERLVKEVPEEY--SER----FSPQARSLCSQLLCKDPAERLGCRGGSAREVK- 443

Query: 289 WSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFDVDEAGVRASDA 346
                         HP F+ + +  +       P+ P+  +       D+++        
Sbjct: 444 -------------EHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDVLDIEQFSTVKGVE 490

Query: 347 LPPAAASPALSALHLPFVGFTFT 369
           L P             +  F   
Sbjct: 491 LEPTD--------QDFYQKFATG 505

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  203 bits (518), Expect = 2e-63
 Identities = 69/272 (25%), Positives = 113/272 (41%), Gaps = 47/272 (17%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
             +LR E ++  +     I  ++  F D   +YL++++   G+L   L K   R  E  +
Sbjct: 58  EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK-HGRFDEQRS 116

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG 176
             ++ E+  A+   H+   +HR          DIKP+N+L+   G +++ADFG  +    
Sbjct: 117 ATFMEELADALHYCHERKVIHR----------DIKPENLLMGYKGELKIADFGWSVHAPS 166

Query: 177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
                     GT DY+ PE++    EG+  +  + D W  GV  YE L G  PF + S  
Sbjct: 167 LRR---RTMCGTLDYLPPEMI----EGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHT 218

Query: 237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICS-SDTRLGQNGIADFKMWSALFVS 295
           ET+ +I+N       P  +    SD +KDL+ +L+      RL   G+            
Sbjct: 219 ETHRRIVNVD--LKFPPFL----SDGSKDLISKLLRYHPPQRLPLKGV------------ 260

Query: 296 LSISPRNHPWFQGIAWDSIRDSNAPYIPEVSS 327
                  HPW +  +    R    P      S
Sbjct: 261 -----MEHPWVKANS----RRVLPPVYQSTQS 283

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  198 bits (506), Expect = 1e-61
 Identities = 69/245 (28%), Positives = 104/245 (42%), Gaps = 43/245 (17%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L+  F D + +YL+++Y   G +   L K   +  E     YI E+  A++  H   
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKR 129

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          DIKP+N+LL + G +++ADFG  +              GT DY+ P
Sbjct: 130 VIHR----------DIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLCGTLDYLPP 176

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSD 254
           E++    EGR  +  + D WSLGV  YE L G+ PF A +  ETY +I   +  F  P  
Sbjct: 177 EMI----EGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--FTFPDF 229

Query: 255 VGYEISDDAKDLMRRLICS-SDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDS 313
           V    ++ A+DL+ RL+      R     +                   HPW    +   
Sbjct: 230 V----TEGARDLISRLLKHNPSQRPMLREV-----------------LEHPWITANSSKP 268

Query: 314 IRDSN 318
               N
Sbjct: 269 SNCQN 273

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  194 bits (494), Expect = 3e-59
 Identities = 53/276 (19%), Positives = 99/276 (35%), Gaps = 58/276 (21%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKF-------EDRLPEDMAKFYIAEMVLAI 127
                    +   +Y++ +Y     +L     F          +P  + K  I  ++ + 
Sbjct: 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNS- 163

Query: 128 ASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG-SCLRLGGDGTVQSNVAV 186
                  Y+H   +   H  RD+KP N+L+D NG ++L+DFG S      D  ++   + 
Sbjct: 164 -----FSYIHNEKNI-CH--RDVKPSNILMDKNGRVKLSDFGES--EYMVDKKIKG--SR 211

Query: 187 GTPDYISPEILTAMEEGRGRY-GPECDWWSLGVCMYEMLYGETPFYAE-SLVETYGKIMN 244
           GT +++ PE           Y G + D WSLG+C+Y M Y   PF  + SLVE +  I  
Sbjct: 212 GTYEFMPPEFF----SNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT 267

Query: 245 -------------HQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLGQNGIADFKMWS 290
                        +  +    +     +S++  D ++  +  +   R+            
Sbjct: 268 KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA------- 320

Query: 291 ALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIPEVS 326
                       H W      + +R+ +     +  
Sbjct: 321 ----------LKHEWLADTNIEDLREFSKELYKKRK 346

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  187 bits (477), Expect = 5e-57
 Identities = 55/214 (25%), Positives = 87/214 (40%), Gaps = 28/214 (13%)

Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           KL E       G       L  A+++   LYL  +  CG  L      +   LPE     
Sbjct: 103 KLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWG 161

Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
           Y+ + +LA+A +H    VH           D+KP N+ L   G  +L DFG  + LG  G
Sbjct: 162 YLRDTLLALAHLHSQGLVH----------LDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211

Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYG-ETPFYAESLVE 237
             +     G P Y++PE+L      +G YG   D +SLG+ + E+    E P   E   +
Sbjct: 212 AGEV--QEGDPRYMAPELL------QGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQ 263

Query: 238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
                        LP +    +S + + ++  ++
Sbjct: 264 LRQGY--------LPPEFTAGLSSELRSVLVMML 289

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  185 bits (471), Expect = 4e-55
 Identities = 43/324 (13%), Positives = 99/324 (30%), Gaps = 53/324 (16%)

Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS--NLYLVMDYYCG---- 97
           LR  K      +   +     D++    ++ +  +    +D    + + +          
Sbjct: 135 LRGIKNQKQ-AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 193

Query: 98  -GDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL 156
            G++L   S     L          +++  +AS+H    VH            ++P +++
Sbjct: 194 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT----------YLRPVDIV 243

Query: 157 LDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSL 216
           LD  G + L  F   +R G             P+  +  +L   +          D W+L
Sbjct: 244 LDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303

Query: 217 GVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-D 275
           G+ +Y +   + P   ++ +     I                I    + L+   +    +
Sbjct: 304 GLAIYWIWCADLPNTDDAALGGSEWIFRSC----------KNIPQPVRALLEGFLRYPKE 353

Query: 276 TRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFD 335
            RL      +                  P ++      +R   +  +P   +  + +   
Sbjct: 354 DRLLPLQAME-----------------TPEYE-----QLRTELSAALPLYQTDGEPTRE- 390

Query: 336 VDEAGVRASDALPPAAASPALSAL 359
              A    +     A A+ A++A+
Sbjct: 391 -GGAPPSGTSQPDEAGAAEAVTAI 413

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  181 bits (462), Expect = 7e-55
 Identities = 54/283 (19%), Positives = 101/283 (35%), Gaps = 62/283 (21%)

Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSN-------------LYLVMDYYCGGDLLTLLS 105
            +  E  +L   + +++   + A+ +  N             L++ M+Y   G L  L+ 
Sbjct: 48  TILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH 107

Query: 106 KFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRL 165
                   D       +++ A++ IH    +H          RD+KP N+ +D + ++++
Sbjct: 108 SENLNQQRDEYWRLFRQILEALSYIHSQGIIH----------RDLKPMNIFIDESRNVKI 157

Query: 166 ADFGSCLRLGGDGTVQSNV-------------AVGTPDYISPEILTAMEEGRGRYGPECD 212
            DFG    +     +                 A+GT  Y++ E+L    +G G Y  + D
Sbjct: 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVL----DGTGHYNEKID 213

Query: 213 WWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC 272
            +SLG+  +EM+Y          V    K+ +   S + P D         K ++R LI 
Sbjct: 214 MYSLGIIFFEMIYP--FSTGMERVNILKKLRS--VSIEFPPDFDDNKMKVEKKIIRLLID 269

Query: 273 SS-DTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI 314
              + R G   +                  N  W      D +
Sbjct: 270 HDPNKRPGARTL-----------------LNSGWLPVKHQDEV 295

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  177 bits (451), Expect = 7e-53
 Identities = 69/286 (24%), Positives = 112/286 (39%), Gaps = 57/286 (19%)

Query: 31  ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYL 90
           + L   D     S R E      I ++ KL+             I  L+     D  +Y+
Sbjct: 41  VNLEEADNQTLDSYRNE------IAYLNKLQ--------QHSDKIIRLYDYEITDQYIYM 86

Query: 91  VMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDI 150
           VM+     DL + L K +  +     K Y   M+ A+ +IH    VH           D+
Sbjct: 87  VMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHS----------DL 134

Query: 151 KPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAM------EEG 203
           KP N L+  +G ++L DFG   ++  D T V  +  VGT +Y+ PE +  M       + 
Sbjct: 135 KPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 193

Query: 204 RGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHQNSFDLPSDVGYEISDD 262
           + +  P+ D WSLG  +Y M YG+TPF    + +     I++  +  + P         D
Sbjct: 194 KSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI----PEKD 249

Query: 263 AKDLMRR-LICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ 307
            +D+++  L      R+             L          HP+ Q
Sbjct: 250 LQDVLKCCLKRDPKQRIS---------IPELL--------AHPYVQ 278

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  176 bits (449), Expect = 7e-53
 Identities = 61/242 (25%), Positives = 100/242 (41%), Gaps = 43/242 (17%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L+     D  +Y+VM+     DL + L K +  +     K Y   M+ A+ +IH   
Sbjct: 90  IIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG 147

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYIS 193
            VH           D+KP N L+  +G ++L DFG   ++  D T V  +  VGT +Y+ 
Sbjct: 148 IVHS----------DLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196

Query: 194 PEILTAM------EEGRGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHQ 246
           PE +  M       + + +  P+ D WSLG  +Y M YG+TPF    + +     I++  
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 256

Query: 247 NSFDLPSDVGYEISDDAKDLMRR-LICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPW 305
           +  + P         D +D+++  L      R+             L          HP+
Sbjct: 257 HEIEFPDI----PEKDLQDVLKCCLKRDPKQRIS---------IPELL--------AHPY 295

Query: 306 FQ 307
            Q
Sbjct: 296 VQ 297

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  169 bits (430), Expect = 2e-50
 Identities = 61/238 (25%), Positives = 106/238 (44%), Gaps = 48/238 (20%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L+  F+D + +YLV++    G++   L        E+ A+ ++ +++  +  +H   
Sbjct: 73  ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG 132

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG----TVQSNVAVGTPD 190
            +HR          D+   N+LL  N +I++ADFG   +L        T+      GTP+
Sbjct: 133 ILHR----------DLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL-----CGTPN 177

Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD 250
           YISPEI          +G E D WSLG   Y +L G  PF  +++  T  K++     ++
Sbjct: 178 YISPEIA----TRSA-HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL--ADYE 230

Query: 251 LPSDVGYEISDDAKDLMRR-LICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ 307
           +PS +    S +AKDL+ + L  +   RL  + +                  +HP+  
Sbjct: 231 MPSFL----SIEAKDLIHQLLRRNPADRLSLSSV-----------------LDHPFMS 267

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  172 bits (437), Expect = 3e-50
 Identities = 67/280 (23%), Positives = 109/280 (38%), Gaps = 57/280 (20%)

Query: 37  DECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC 96
           D     S R E      I ++ KL+             I  L+     D  +Y+VM+   
Sbjct: 94  DNQTLDSYRNE------IAYLNKLQ--------QHSDKIIRLYDYEITDQYIYMVMEC-G 138

Query: 97  GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL 156
             DL + L K +  +     K Y   M+ A+ +IH    VH           D+KP N L
Sbjct: 139 NIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHS----------DLKPANFL 187

Query: 157 LDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAM------EEGRGRYGP 209
           +  +G ++L DFG   ++  D T V  +  VG  +Y+ PE +  M       + + +  P
Sbjct: 188 IV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISP 246

Query: 210 ECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMR 268
           + D WSLG  +Y M YG+TPF    + +     I++  +  + P         D +D+++
Sbjct: 247 KSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI----PEKDLQDVLK 302

Query: 269 R-LICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ 307
             L      R+             L          HP+ Q
Sbjct: 303 CCLKRDPKQRIS---------IPELL--------AHPYVQ 325

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  171 bits (435), Expect = 4e-50
 Identities = 39/294 (13%), Positives = 88/294 (29%), Gaps = 62/294 (21%)

Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS--NLYLVM-----DYYC 96
           LR  K      +   +     D++    ++ +  +    +D    + + +      +   
Sbjct: 130 LRGIKNQKQ-AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 188

Query: 97  GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL 156
            G++L   S     L          +++  +AS+H    VH            ++P +++
Sbjct: 189 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT----------YLRPVDIV 238

Query: 157 LDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEIL------TAMEEGRGRYGPE 210
           LD  G + L  F   +R G            +  +  PE+       +   + R      
Sbjct: 239 LDQRGGVFLTGFEHLVRDGARVVS-----SVSRGFEPPELEARRATISYHRDRRTLMTFS 293

Query: 211 CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRL 270
            D W+LG+ +Y +   + P   ++ +     I                I    + L+   
Sbjct: 294 FDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSC----------KNIPQPVRALLEGF 343

Query: 271 IC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIP 323
           +    + RL                         P ++      +R   +  +P
Sbjct: 344 LRYPKEDRLLPLQA-----------------METPEYE-----QLRTELSAALP 375

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  174 bits (442), Expect = 4e-50
 Identities = 72/277 (25%), Positives = 120/277 (43%), Gaps = 42/277 (15%)

Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPED 114
           +  + +  E ++L   D   I  L    +D S+ Y+V + Y GG+L   + K   R  E 
Sbjct: 63  KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEH 121

Query: 115 MAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL---DANGHIRLADFGSC 171
            A   I ++   I  +H  + VHR          D+KP+N+LL   + +  I++ DFG  
Sbjct: 122 DAARIIKQVFSGITYMHKHNIVHR----------DLKPENILLESKEKDCDIKIIDFGLS 171

Query: 172 LRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
                +  ++    +GT  YI+PE+L      RG Y  +CD WS GV +Y +L G  PFY
Sbjct: 172 TCFQQNTKMKD--RIGTAYYIAPEVL------RGTYDEKCDVWSAGVILYILLSGTPPFY 223

Query: 232 AESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLGQNGIADFKMWS 290
            ++  +   ++      +         ISDDAKDL+R+++      R+            
Sbjct: 224 GKNEYDILKRVET--GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI--------TATQ 273

Query: 291 ALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIPEVSS 327
            L          HPW Q  + ++   S+ P +    +
Sbjct: 274 CL---------EHPWIQKYSSETPTISDLPSLESAMT 301

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  172 bits (437), Expect = 2e-49
 Identities = 71/275 (25%), Positives = 117/275 (42%), Gaps = 42/275 (15%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
            +KL EE  VL   D   I  L+  F+D  N YLVM+ Y GG+L   +     +  E  A
Sbjct: 80  NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH-RMKFNEVDA 138

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL---DANGHIRLADFGSCLR 173
              I +++  +  +H  + VHR          D+KP+N+LL   + +  I++ DFG    
Sbjct: 139 AVIIKQVLSGVTYLHKHNIVHR----------DLKPENLLLESKEKDALIKIVDFGLSAV 188

Query: 174 LGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE 233
                 ++    +GT  YI+PE+L      R +Y  +CD WS+GV ++ +L G  PF  +
Sbjct: 189 FENQKKMKE--RLGTAYYIAPEVL------RKKYDEKCDVWSIGVILFILLAGYPPFGGQ 240

Query: 234 SLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLGQNGIADFKMWSAL 292
           +  E   K+      +   S     +S+ AKDL+++++      R+            AL
Sbjct: 241 TDQEILRKVEK--GKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRI--------SAQQAL 290

Query: 293 FVSLSISPRNHPWFQGIAWDSIRDSNAPYIPEVSS 327
                     HPW + +          P +     
Sbjct: 291 ---------EHPWIKEMCSKKESGIELPSLANAIE 316

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  171 bits (434), Expect = 7e-49
 Identities = 70/277 (25%), Positives = 120/277 (43%), Gaps = 43/277 (15%)

Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPED 114
           +F  ++  E  +L   D   I  L   F+D    YLV ++Y GG+L   +     +  E 
Sbjct: 88  KFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDEC 146

Query: 115 MAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL---DANGHIRLADFGSC 171
            A   + +++  I  +H  + VHR          DIKP+N+LL   ++  +I++ DFG  
Sbjct: 147 DAANIMKQILSGICYLHKHNIVHR----------DIKPENILLENKNSLLNIKIVDFGLS 196

Query: 172 LRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
                D  ++    +GT  YI+PE+L      + +Y  +CD WS GV MY +L G  PF 
Sbjct: 197 SFFSKDYKLRD--RLGTAYYIAPEVL------KKKYNEKCDVWSCGVIMYILLCGYPPFG 248

Query: 232 AESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLGQNGIADFKMWS 290
            ++  +   K+      +    +    ISD+AK+L++ ++    + R             
Sbjct: 249 GQNDQDIIKKVEK--GKYYFDFNDWKNISDEAKELIKLMLTYDYNKRC--------TAEE 298

Query: 291 ALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIPEVSS 327
           AL         N  W +  A ++I  S+   +    S
Sbjct: 299 AL---------NSRWIKKYA-NNINKSDQKTLCGALS 325

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  170 bits (432), Expect = 1e-48
 Identities = 70/277 (25%), Positives = 110/277 (39%), Gaps = 43/277 (15%)

Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPED 114
                L  E  +L   D   I  L+  F+D    YLV + Y GG+L   +     R  E 
Sbjct: 68  TDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS-RKRFSEV 126

Query: 115 MAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL---DANGHIRLADFGSC 171
            A   I +++  I  +H    VHR          D+KP+N+LL     + +IR+ DFG  
Sbjct: 127 DAARIIRQVLSGITYMHKNKIVHR----------DLKPENLLLESKSKDANIRIIDFGLS 176

Query: 172 LRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
                   ++    +GT  YI+PE+L       G Y  +CD WS GV +Y +L G  PF 
Sbjct: 177 THFEASKKMKD--KIGTAYYIAPEVL------HGTYDEKCDVWSTGVILYILLSGCPPFN 228

Query: 232 AESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLGQNGIADFKMWS 290
             +  +   K+      +        ++S+ AKDL+R+++      R+            
Sbjct: 229 GANEYDILKKVEK--GKYTFELPQWKKVSESAKDLIRKMLTYVPSMRI--------SARD 278

Query: 291 ALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIPEVSS 327
           AL         +H W Q    + I   + P +     
Sbjct: 279 AL---------DHEWIQTYTKEQI-SVDVPSLDNAIL 305

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  166 bits (423), Expect = 1e-48
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 22/198 (11%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDL 133
           I     +F+++ +LY+VMDY  GGDL   ++  +     ED    +  ++ LA+  +HD 
Sbjct: 85  IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR 144

Query: 134 HYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYIS 193
             +HR          DIK  N+ L  +G ++L DFG   R+       +   +GTP Y+S
Sbjct: 145 KILHR----------DIKSQNIFLTKDGTVQLGDFGIA-RVLNSTVELARACIGTPYYLS 193

Query: 194 PEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPS 253
           PEI     E +  Y  + D W+LG  +YE+   +  F A S+     KI++      +  
Sbjct: 194 PEIC----ENKP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-PVSL 247

Query: 254 DVGYEISDDAKDLMRRLI 271
                 S D + L+ +L 
Sbjct: 248 H----YSYDLRSLVSQLF 261

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  165 bits (421), Expect = 2e-48
 Identities = 65/278 (23%), Positives = 119/278 (42%), Gaps = 49/278 (17%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +   H  F+D+  +++V++      LL L  +    L E  A++Y+ ++VL    +H   
Sbjct: 103 VVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNR 161

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          D+K  N+ L+ +  +++ DFG   ++  DG  +  V  GTP+YI+P
Sbjct: 162 VIHR----------DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK-KVLCGTPNYIAP 210

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSD 254
           E+L      +G +  E D WS+G  MY +L G+ PF    L ETY +I   +N + +P  
Sbjct: 211 EVL----SKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIPKH 263

Query: 255 VGYEISDDAKDLMRRLICSS-DTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDS 313
               I+  A  L+++++ +    R   N +                  N  +F       
Sbjct: 264 ----INPVAASLIQKMLQTDPTARPTINEL-----------------LNDEFFT------ 296

Query: 314 IRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAA 351
                   +P ++  T    F +  + +  S+  P   
Sbjct: 297 -SGYIPARLP-ITCLTIPPRFSIAPSSLDPSNRKPLTV 332

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  163 bits (416), Expect = 4e-48
 Identities = 60/234 (25%), Positives = 107/234 (45%), Gaps = 41/234 (17%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +   H  F+D+  +++V++      LL L  +    L E  A++Y+ ++VL    +H   
Sbjct: 77  VVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNR 135

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          D+K  N+ L+ +  +++ DFG   ++  DG  +  V  GTP+YI+P
Sbjct: 136 VIHR----------DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK-KVLCGTPNYIAP 184

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSD 254
           E+L      +G +  E D WS+G  MY +L G+ PF    L ETY +I   +N + +P  
Sbjct: 185 EVL----SKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIPKH 237

Query: 255 VGYEISDDAKDLMRRLICSS-DTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ 307
               I+  A  L+++++ +    R   N +                  N  +F 
Sbjct: 238 ----INPVAASLIQKMLQTDPTARPTINEL-----------------LNDEFFT 270

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  163 bits (415), Expect = 2e-47
 Identities = 64/310 (20%), Positives = 110/310 (35%), Gaps = 77/310 (24%)

Query: 43  SLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLL- 101
            + + K      + V +++ E  ++       I  L+  ++D+  + LVM+   GG LL 
Sbjct: 58  IMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLD 117

Query: 102 --------------------------------------TLLSKFEDRLPEDMAKFYIAEM 123
                                                       +    E +    + ++
Sbjct: 118 KLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177

Query: 124 VLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL--DANGHIRLADFGS---CLRLGGDG 178
             A+  +H+    H          RDIKP+N L   + +  I+L DFG      +L    
Sbjct: 178 FSALHYLHNQGICH----------RDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE 227

Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 238
                   GTP +++PE+L    E    YGP+CD WS GV ++ +L G  PF   +  +T
Sbjct: 228 YYGMTTKAGTPYFVAPEVLNTTNE---SYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADT 284

Query: 239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICS-SDTRLGQNGIADFKMWSALFVSLS 297
             +++N +      +     +S  A+DL+  L+    D R             AL     
Sbjct: 285 ISQVLNKK--LCFENPNYNVLSPLARDLLSNLLNRNVDERF---DAMR-----AL----- 329

Query: 298 ISPRNHPWFQ 307
                HPW  
Sbjct: 330 ----QHPWIS 335

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  161 bits (410), Expect = 3e-47
 Identities = 67/249 (26%), Positives = 106/249 (42%), Gaps = 46/249 (18%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR------LPEDMAKFYIAEMVLAIA 128
           I  L   ++ ++  +LV D    G+L        D       L E   +  +  ++  I 
Sbjct: 86  IIQLKDTYETNTFFFLVFDLMKKGELF-------DYLTEKVTLSEKETRKIMRALLEVIC 138

Query: 129 SIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGT 188
           ++H L+ VHR          D+KP+N+LLD + +I+L DFG   +L     ++     GT
Sbjct: 139 ALHKLNIVHR----------DLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE--VCGT 186

Query: 189 PDYISPEIL-TAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQN 247
           P Y++PEI+  +M +    YG E D WS GV MY +L G  PF+    +     IM    
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM--SG 244

Query: 248 SFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWF 306
           ++   S    + SD  KDL+ R +      R            +A           HP+F
Sbjct: 245 NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY-----------TAEEA------LAHPFF 287

Query: 307 QGIAWDSIR 315
           Q    + +R
Sbjct: 288 QQYVVEEVR 296

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  158 bits (403), Expect = 3e-46
 Identities = 62/226 (27%), Positives = 110/226 (48%), Gaps = 41/226 (18%)

Query: 85  DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAF 144
           + +LY+V +    G ++ + +     L ED A+FY  +++  I  +H    +HR      
Sbjct: 110 EDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQKIIHR------ 161

Query: 145 HLCRDIKPDNVLLDANGHIRLADFG-SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEG 203
               DIKP N+L+  +GHI++ADFG S    G D  + +   VGTP +++PE L+     
Sbjct: 162 ----DIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSN--TVGTPAFMAPESLSE---T 212

Query: 204 RGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDD 262
           R  + G   D W++GV +Y  ++G+ PF  E ++  + KI +     + P     +I++D
Sbjct: 213 RKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQA--LEFPDQP--DIAED 268

Query: 263 AKDLMRRLICSS-DTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ 307
            KDL+ R++  + ++R+    I                 + HPW  
Sbjct: 269 LKDLITRMLDKNPESRIVVPEI-----------------KLHPWVT 297

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  158 bits (401), Expect = 4e-46
 Identities = 66/272 (24%), Positives = 112/272 (41%), Gaps = 49/272 (18%)

Query: 43  SLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLL- 101
           ++ ++++       + ++  E +VL   D   I  +   F+D  N+Y+VM+   GG+LL 
Sbjct: 54  TINKDRSQVP----MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLE 109

Query: 102 --TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL-- 157
                      L E      + +M+ A+A  H  H VH+          D+KP+N+L   
Sbjct: 110 RIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHK----------DLKPENILFQD 159

Query: 158 -DANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSL 216
              +  I++ DFG    L       +N   GT  Y++PE+       +     +CD WS 
Sbjct: 160 TSPHSPIKIIDFG-LAELFKSDEHSTNA-AGTALYMAPEVF------KRDVTFKCDIWSA 211

Query: 217 GVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICS-SD 275
           GV MY +L G  PF   SL E   K        +   +    ++  A DL+++++    +
Sbjct: 212 GVVMYFLLTGCLPFTGTSLEEVQQKATY--KEPNYAVEC-RPLTPQAVDLLKQMLTKDPE 268

Query: 276 TRLGQNGIADFKMWSALFVSLSISPRNHPWFQ 307
            R            SA  V       +H WF+
Sbjct: 269 RRP-----------SAAQV------LHHEWFK 283

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  158 bits (401), Expect = 4e-46
 Identities = 76/259 (29%), Positives = 119/259 (45%), Gaps = 42/259 (16%)

Query: 54  IEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPE 113
           +E V + ++E +++   D   I  L+  F+D++++YLVM+   GG+L   +   +    E
Sbjct: 47  VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVH-KRVFRE 105

Query: 114 DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL---DANGHIRLADFGS 170
             A   + +++ A+A  H L+  HR          D+KP+N L      +  ++L DFG 
Sbjct: 106 SDAARIMKDVLSAVAYCHKLNVAHR----------DLKPENFLFLTDSPDSPLKLIDFG- 154

Query: 171 CLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                  G +     VGTP Y+SP++L       G YGPECD WS GV MY +L G  PF
Sbjct: 155 LAARFKPGKMMRTK-VGTPYYVSPQVL------EGLYGPECDEWSAGVMMYVLLCGYPPF 207

Query: 231 YAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMW 289
            A +  E   KI     +F  P      +S  A+ L+RRL+  S   R+           
Sbjct: 208 SAPTDSEVMLKIRE--GTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRI----------- 254

Query: 290 SALFVSLSISPRNHPWFQG 308
           ++L          H WF+ 
Sbjct: 255 TSLQA------LEHEWFEK 267

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  157 bits (400), Expect = 6e-46
 Identities = 71/260 (27%), Positives = 113/260 (43%), Gaps = 46/260 (17%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
            + +  E ++L   D   I  L    +D S+ Y+V + Y GG+L   + K   R  E  A
Sbjct: 65  TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDA 123

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL---DANGHIRLADFGSCLR 173
              I ++   I  +H  + VHR          D+KP+N+LL   + +  I++ DFG    
Sbjct: 124 ARIIKQVFSGITYMHKHNIVHR----------DLKPENILLESKEKDCDIKIIDFGLSTC 173

Query: 174 LGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE 233
              +  ++    +GT  YI+PE+L      RG Y  +CD WS GV +Y +L G  PFY +
Sbjct: 174 FQQNTKMKD--RIGTAYYIAPEVL------RGTYDEKCDVWSAGVILYILLSGTPPFYGK 225

Query: 234 SLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICS-SDTRL--GQNGIADFKMWS 290
           +  +   ++      +         ISDDAKDL+R+++      R+   Q          
Sbjct: 226 NEYDILKRVE--TGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQ---------- 273

Query: 291 ALFVSLSISPRNHPWFQGIA 310
            L          HPW Q  +
Sbjct: 274 CL---------EHPWIQKYS 284

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  158 bits (402), Expect = 8e-46
 Identities = 52/202 (25%), Positives = 96/202 (47%), Gaps = 23/202 (11%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLT-LLSKFEDRLPEDMAKFYIAEMVLAIASIHDL 133
           + NLH  +++ S + L+++Y  GG++ +  L +  + + E+     I +++  +  +H  
Sbjct: 91  VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN 150

Query: 134 HYVHRPNHFAFHLCRDIKPDNVLL---DANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
           + VH           D+KP N+LL      G I++ DFG   ++G    ++    +GTP+
Sbjct: 151 NIVHL----------DLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR--EIMGTPE 198

Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD 250
           Y++PEIL              D W++G+  Y +L   +PF  E   ETY  I   Q + D
Sbjct: 199 YLAPEILN-----YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS--QVNVD 251

Query: 251 LPSDVGYEISDDAKDLMRRLIC 272
              +    +S  A D ++ L+ 
Sbjct: 252 YSEETFSSVSQLATDFIQSLLV 273

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  155 bits (393), Expect = 7e-45
 Identities = 68/280 (24%), Positives = 124/280 (44%), Gaps = 42/280 (15%)

Query: 45  RREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLL 104
           +R  + S       ++  E ++L       I  LH  F++ +++ L+++   GG+L   L
Sbjct: 40  KRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL 99

Query: 105 SKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL----DAN 160
           ++ ++ L ED A  ++ +++  +  +H     H           D+KP+N++L      N
Sbjct: 100 AE-KESLTEDEATQFLKQILDGVHYLHSKRIAHF----------DLKPENIMLLDKNVPN 148

Query: 161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCM 220
             I+L DFG   ++      +     GTP++++PEI+          G E D WS+GV  
Sbjct: 149 PRIKLIDFGIAHKIEAGNEFK--NIFGTPEFVAPEIVN-----YEPLGLEADMWSIGVIT 201

Query: 221 YEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLG 279
           Y +L G +PF  E+  ET   I     ++D   +     S+ AKD +RRL+      R+ 
Sbjct: 202 YILLSGASPFLGETKQETLTNIS--AVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRM- 258

Query: 280 QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNA 319
              IA      +L          H W + I   ++R  ++
Sbjct: 259 --TIAQ-----SL---------EHSWIKAIRRRNVRGEDS 282

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  154 bits (392), Expect = 8e-45
 Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 23/203 (11%)

Query: 75  ITNLHYAFQDDSN--LYLVMDYYCGGDLLTLLSKF---EDRLPEDMAKFYIAEMVLAIAS 129
           I   +    D +N  LY+VM+Y  GGDL ++++K       L E+     + ++ LA   
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA--- 123

Query: 130 IHDLHYVHRPNHFAFH-LCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGT 188
              L   HR +      L RD+KP NV LD   +++L DFG   R+    T  +   VGT
Sbjct: 124 ---LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA-RILNHDTSFAKTFVGT 179

Query: 189 PDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNS 248
           P Y+SPE +         Y  + D WSLG  +YE+     PF A S  E  GKI   +  
Sbjct: 180 PYYMSPEQM----NRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 234

Query: 249 FDLPSDVGYEISDDAKDLMRRLI 271
             +P       SD+  +++ R++
Sbjct: 235 R-IPYR----YSDELNEIITRML 252

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  156 bits (397), Expect = 1e-44
 Identities = 67/241 (27%), Positives = 106/241 (43%), Gaps = 46/241 (19%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR------LPEDMAKFYIAEMVLAIA 128
           I  L  +++  S ++LV D    G+L        D       L E   +  +  ++ A++
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELF-------DYLTEKVALSEKETRSIMRSLLEAVS 214

Query: 129 SIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGT 188
            +H  + VHR          D+KP+N+LLD N  IRL+DFG    L     ++     GT
Sbjct: 215 FLHANNIVHR----------DLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE--LCGT 262

Query: 189 PDYISPEILT-AMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQN 247
           P Y++PEIL  +M+E    YG E D W+ GV ++ +L G  PF+    +     IM  + 
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM--EG 320

Query: 248 SFDLPSDVGYEISDDAKDLMRRLICSS-DTRLGQNGIADFKMWSALFVSLSISPRNHPWF 306
            +   S    + S   KDL+ RL+    + RL           +A           HP+F
Sbjct: 321 QYQFSSPEWDDRSSTVKDLISRLLQVDPEARL-----------TAEQA------LQHPFF 363

Query: 307 Q 307
           +
Sbjct: 364 E 364

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  154 bits (392), Expect = 2e-44
 Identities = 57/232 (24%), Positives = 107/232 (46%), Gaps = 24/232 (10%)

Query: 45  RREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLL 104
           +R+   S       ++  E  +L       +  LH  +++ +++ L+++   GG+L   L
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL 106

Query: 105 SKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL----DAN 160
           ++ ++ L E+ A  +I +++  +  +H     H           D+KP+N++L       
Sbjct: 107 AQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHF----------DLKPENIMLLDKNIPI 155

Query: 161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCM 220
            HI+L DFG    +      +     GTP++++PEI+          G E D WS+GV  
Sbjct: 156 PHIKLIDFGLAHEIEDGVEFK--NIFGTPEFVAPEIVN-----YEPLGLEADMWSIGVIT 208

Query: 221 YEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC 272
           Y +L G +PF  ++  ET   I     S+D   +     S+ AKD +R+L+ 
Sbjct: 209 YILLSGASPFLGDTKQETLANIT--SVSYDFDEEFFSHTSELAKDFIRKLLV 258

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  154 bits (391), Expect = 3e-44
 Identities = 53/232 (22%), Positives = 105/232 (45%), Gaps = 24/232 (10%)

Query: 45  RREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLL 104
           +R    S        +  E  +L       +  LH  +++ +++ L+++   GG+L   L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105

Query: 105 SKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL----DAN 160
           ++ ++ L E+ A  ++ +++  +  +H L   H           D+KP+N++L       
Sbjct: 106 AE-KESLTEEEATEFLKQILNGVYYLHSLQIAHF----------DLKPENIMLLDRNVPK 154

Query: 161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCM 220
             I++ DFG   ++      +     GTP++++PEI+          G E D WS+GV  
Sbjct: 155 PRIKIIDFGLAHKIDFGNEFK--NIFGTPEFVAPEIVN-----YEPLGLEADMWSIGVIT 207

Query: 221 YEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC 272
           Y +L G +PF  ++  ET   +     +++   +     S  AKD +RRL+ 
Sbjct: 208 YILLSGASPFLGDTKQETLANVS--AVNYEFEDEYFSNTSALAKDFIRRLLV 257

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  155 bits (394), Expect = 4e-44
 Identities = 52/218 (23%), Positives = 100/218 (45%), Gaps = 21/218 (9%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
              ++ E  ++       + NLH AF+D   + L++++  GG+L   ++  + ++ E   
Sbjct: 92  KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV 151

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL--DANGHIRLADFGSCLRL 174
             Y+ +    +  +H+   VH           DIKP+N++        +++ DFG   +L
Sbjct: 152 INYMRQACEGLKHMHEHSIVH----------LDIKPENIMCETKKASSVKIIDFGLATKL 201

Query: 175 GGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES 234
             D  V+  V   T ++ +PEI+      R   G   D W++GV  Y +L G +PF  E 
Sbjct: 202 NPDEIVK--VTTATAEFAAPEIVD-----REPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254

Query: 235 LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC 272
            +ET   +   +  ++   D    +S +AKD ++ L+ 
Sbjct: 255 DLETLQNVK--RCDWEFDEDAFSSVSPEAKDFIKNLLQ 290

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  155 bits (393), Expect = 4e-44
 Identities = 58/231 (25%), Positives = 107/231 (46%), Gaps = 24/231 (10%)

Query: 46  REKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLS 105
           R+   S       ++  E  +L       I  LH  +++ +++ L+++   GG+L   L+
Sbjct: 48  RQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLA 107

Query: 106 KFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL----DANG 161
           + ++ L E+ A  +I +++  +  +H     H           D+KP+N++L        
Sbjct: 108 Q-KESLSEEEATSFIKQILDGVNYLHTKKIAHF----------DLKPENIMLLDKNIPIP 156

Query: 162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMY 221
           HI+L DFG    +      +     GTP++++PEI+          G E D WS+GV  Y
Sbjct: 157 HIKLIDFGLAHEIEDGVEFK--NIFGTPEFVAPEIVN-----YEPLGLEADMWSIGVITY 209

Query: 222 EMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC 272
            +L G +PF  ++  ET   I     S+D   +   + S+ AKD +R+L+ 
Sbjct: 210 ILLSGASPFLGDTKQETLANIT--AVSYDFDEEFFSQTSELAKDFIRKLLV 258

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  153 bits (390), Expect = 4e-44
 Identities = 50/218 (22%), Positives = 92/218 (42%), Gaps = 21/218 (9%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
              +++E  +L     R I +LH +F+    L ++ ++  G D+   ++     L E   
Sbjct: 45  QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREI 104

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL--DANGHIRLADFGSCLRL 174
             Y+ ++  A+  +H  +  H           DI+P+N++     +  I++ +FG   +L
Sbjct: 105 VSYVHQVCEALQFLHSHNIGH----------FDIRPENIIYQTRRSSTIKIIEFGQARQL 154

Query: 175 GGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES 234
                    +    P+Y +PE+               D WSLG  +Y +L G  PF AE+
Sbjct: 155 KPGDNF--RLLFTAPEYYAPEVHQ-----HDVVSTATDMWSLGTLVYVLLSGINPFLAET 207

Query: 235 LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC 272
             +    IMN    +    +   EIS +A D + RL+ 
Sbjct: 208 NQQIIENIMN--AEYTFDEEAFKEISIEAMDFVDRLLV 243

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  158 bits (401), Expect = 1e-43
 Identities = 56/218 (25%), Positives = 105/218 (48%), Gaps = 21/218 (9%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA 116
              +R+E   +       + NLH AF+DD+ + ++ ++  GG+L   ++   +++ ED A
Sbjct: 198 KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA 257

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL--DANGHIRLADFGSCLRL 174
             Y+ ++   +  +H+ +YVH           D+KP+N++     +  ++L DFG    L
Sbjct: 258 VEYMRQVCKGLCHMHENNYVH----------LDLKPENIMFTTKRSNELKLIDFGLTAHL 307

Query: 175 GGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES 234
               +V   V  GT ++ +PE+           G   D WS+GV  Y +L G +PF  E+
Sbjct: 308 DPKQSV--KVTTGTAEFAAPEVAE-----GKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 360

Query: 235 LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC 272
             ET   + +    +++       IS+D KD +R+L+ 
Sbjct: 361 DDETLRNVKSCD--WNMDDSAFSGISEDGKDFIRKLLL 396

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  154 bits (390), Expect = 1e-43
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 21/221 (9%)

Query: 54  IEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPE 113
           ++   +++ E  V+   D   +  L+ AF+  +++ LVM+Y  GG+L   +      L E
Sbjct: 127 MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTE 186

Query: 114 DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL--DANGHIRLADFGSC 171
                ++ ++   I  +H ++ +H           D+KP+N+L        I++ DFG  
Sbjct: 187 LDTILFMKQICEGIRHMHQMYILH----------LDLKPENILCVNRDAKQIKIIDFGLA 236

Query: 172 LRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
            R      ++  V  GTP++++PE++              D WS+GV  Y +L G +PF 
Sbjct: 237 RRYKPREKLK--VNFGTPEFLAPEVVN-----YDFVSFPTDMWSVGVIAYMLLSGLSPFL 289

Query: 232 AESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC 272
            ++  ET   I+     +DL  +   +IS++AK+ + +L+ 
Sbjct: 290 GDNDAETLNNILA--CRWDLEDEEFQDISEEAKEFISKLLI 328

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  151 bits (383), Expect = 3e-43
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 38/208 (18%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRL------PEDMAKFYIAEMVLAIA 128
           I  L   ++  ++ YLVM    GG+L        DR+       E  A   I +++ A+ 
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGELF-------DRILERGVYTEKDASLVIQQVLSAVK 120

Query: 129 SIHDLHYVHRPNHFAFHLCRDIKPDNVLL---DANGHIRLADFG-SCLRLGGDGTVQSNV 184
            +H+   VHR          D+KP+N+L    + N  I + DFG S  ++  +G + +  
Sbjct: 121 YLHENGIVHR----------DLKPENLLYLTPEENSKIMITDFGLS--KMEQNGIMST-- 166

Query: 185 AVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
           A GTP Y++PE+L      +  Y    D WS+GV  Y +L G  PFY E+  + + KI  
Sbjct: 167 ACGTPGYVAPEVLA-----QKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE 221

Query: 245 HQNSFDLPSDVGYEISDDAKDLMRRLIC 272
               ++  S    +IS+ AKD +  L+ 
Sbjct: 222 --GYYEFESPFWDDISESAKDFICHLLE 247

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  150 bits (381), Expect = 2e-42
 Identities = 61/236 (25%), Positives = 101/236 (42%), Gaps = 25/236 (10%)

Query: 43  SLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLL- 101
            +   K  S        L+ E  +        I  L   +  D  LY+V ++  G DL  
Sbjct: 56  IVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCF 115

Query: 102 --TLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL-- 157
                +       E +A  Y+ +++ A+   HD + +HR          D+KP  VLL  
Sbjct: 116 EIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHR----------DVKPHCVLLAS 165

Query: 158 -DANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSL 216
            + +  ++L  FG  ++LG  G V     VGTP +++PE++      R  YG   D W  
Sbjct: 166 KENSAPVKLGGFGVAIQLGESGLVAGGR-VGTPHFMAPEVVK-----REPYGKPVDVWGC 219

Query: 217 GVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC 272
           GV ++ +L G  PFY       +  I+  +  + +       IS+ AKDL+RR++ 
Sbjct: 220 GVILFILLSGCLPFYGTKE-RLFEGII--KGKYKMNPRQWSHISESAKDLVRRMLM 272

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  149 bits (378), Expect = 2e-42
 Identities = 44/213 (20%), Positives = 81/213 (38%), Gaps = 32/213 (15%)

Query: 75  ITNLHYAFQDDSN----LYLVMDYYCGGDLLTLLSKFE---DRLPEDMAKFYIAEMVLAI 127
           I  L      +       +L++ ++  G L   + + +   + L ED   + +  +   +
Sbjct: 88  ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147

Query: 128 ASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSC--LRLGGDGTVQSNVA 185
            +IH   Y HR          D+KP N+LL   G   L D GS     +  +G+ Q+   
Sbjct: 148 EAIHAKGYAHR----------DLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197

Query: 186 ------VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL-VET 238
                   T  Y +PE+ +   +         D WSLG  +Y M++GE P+       ++
Sbjct: 198 QDWAAQRCTISYRAPELFS--VQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS 255

Query: 239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
               +   N   +P    +  S     L+  ++
Sbjct: 256 VALAVQ--NQLSIPQSPRH--SSALWQLLNSMM 284

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  148 bits (376), Expect = 2e-42
 Identities = 69/261 (26%), Positives = 103/261 (39%), Gaps = 51/261 (19%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFED-----RL 111
             KL  E  +        I  LH + Q++S  YLV D   GG+L      FED       
Sbjct: 49  FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL------FEDIVAREFY 102

Query: 112 PEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL---DANGHIRLADF 168
            E  A   I +++ +IA  H    VHR          ++KP+N+LL        ++LADF
Sbjct: 103 SEADASHCIQQILESIAYCHSNGIVHR----------NLKPENLLLASKAKGAAVKLADF 152

Query: 169 GSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGET 228
           G       D         GTP Y+SPE+L      +  Y    D W+ GV +Y +L G  
Sbjct: 153 G-LAIEVNDSEAWHGF-AGTPGYLSPEVLK-----KDPYSKPVDIWACGVILYILLVGYP 205

Query: 229 PFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK 287
           PF+ E     Y +I     ++D PS     ++ +AK L+  ++  +   R+         
Sbjct: 206 PFWDEDQHRLYAQIKA--GAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI--------- 254

Query: 288 MWSALFVSLSISPRNHPWFQG 308
             +A            PW   
Sbjct: 255 --TADQA------LKVPWICN 267

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  148 bits (377), Expect = 3e-42
 Identities = 73/278 (26%), Positives = 115/278 (41%), Gaps = 61/278 (21%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRL------PEDMAKFYIAEMVLAIA 128
           I  LH  F D  + +LVM+   GG+L        +R+       E  A + + ++V A++
Sbjct: 68  IVKLHEVFHDQLHTFLVMELLNGGELF-------ERIKKKKHFSETEASYIMRKLVSAVS 120

Query: 129 SIHDLHYVHRPNHFAFHLCRDIKPDNVLL---DANGHIRLADFG-SCLRLGGDGTVQSNV 184
            +HD+  VHR          D+KP+N+L    + N  I++ DFG + L+   +  +++  
Sbjct: 121 HMHDVGVVHR----------DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-- 168

Query: 185 AVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE-------SLVE 237
              T  Y +PE+L      +  Y   CD WSLGV +Y ML G+ PF +        S VE
Sbjct: 169 PCFTLHYAAPELL-----NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE 223

Query: 238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICS-SDTRLGQNGIADFKMWSALFVSL 296
              KI      F    +    +S +AKDL++ L+    + RL        KM        
Sbjct: 224 IMKKIKKGD--FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRL--------KMSGLR---- 269

Query: 297 SISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHF 334
                 + W Q  +  S      P I   S     +  
Sbjct: 270 -----YNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCV 302

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  150 bits (379), Expect = 4e-42
 Identities = 42/261 (16%), Positives = 70/261 (26%), Gaps = 47/261 (18%)

Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDS--NLYLVMDYYCGGDLLTLLSKFED------R 110
           +L    D +    +     L     D +  N  L+M      DL  L S  +        
Sbjct: 132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA-ASVDLELLFSTLDFVYVFRGD 190

Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGS 170
                     A+++   A++     VH              PDN+ +  +G + L D  +
Sbjct: 191 EGILALHILTAQLIRLAANLQSKGLVHG----------HFTPDNLFIMPDGRLMLGDVSA 240

Query: 171 CLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
             ++G  G            Y   E L A       +    + W LG+ +Y +     PF
Sbjct: 241 LWKVGTRGPAS----SVPVTYAPREFLNA---STATFTHALNAWQLGLSIYRVWCLFLPF 293

Query: 231 YAESLVETYGKIMNHQ---NSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLGQNGIADF 286
              +                +  L       + D  K L+ R +      RL        
Sbjct: 294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA--- 350

Query: 287 KMWSALFVSLSISPRNHPWFQ 307
                            P F 
Sbjct: 351 --------------METPEFL 357

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  149 bits (377), Expect = 5e-42
 Identities = 57/254 (22%), Positives = 94/254 (37%), Gaps = 54/254 (21%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYC-GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDL 133
           I  +   F++     LVM+ +  G DL   + +   RL E +A +   ++V A+  +   
Sbjct: 91  IIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLK 149

Query: 134 HYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYIS 193
             +HR          DIK +N+++  +  I+L DFGS   L            GT +Y +
Sbjct: 150 DIIHR----------DIKDENIVIAEDFTIKLIDFGSAAYLERGKLF--YTFCGTIEYCA 197

Query: 194 PEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPS 253
           PE+L     G    GPE + WSLGV +Y +++ E PF          + +        P 
Sbjct: 198 PEVL----MGNPYRGPELEMWSLGVTLYTLVFEENPFC------ELEETVEAA--IHPP- 244

Query: 254 DVGYEISDDAKDLMRR-LICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ----- 307
              Y +S +   L+   L    + R     +                    PW       
Sbjct: 245 ---YLVSKELMSLVSGLLQPVPERRTTLEKL-----------------VTDPWVTQPVNL 284

Query: 308 -GIAWDSIRDSNAP 320
               W+ +   N P
Sbjct: 285 ADYTWEEVFRVNKP 298

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  146 bits (371), Expect = 1e-41
 Identities = 40/199 (20%), Positives = 82/199 (41%), Gaps = 30/199 (15%)

Query: 76  TNLHYAFQDDSNLYLVMDYYCGGDLLTLLSK-FEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           ++ + +      L++ M++   G L   + K   ++L + +A     ++   +  IH   
Sbjct: 83  SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK 142

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            ++R          D+KP N+ L     +++ DFG    L  DG    +   GT  Y+SP
Sbjct: 143 LINR----------DLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS--KGTLRYMSP 190

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHQNSFDLPS 253
           E +      +  YG E D ++LG+ + E+L+  +T F        +  + +      +  
Sbjct: 191 EQI----SSQD-YGKEVDLYALGLILAELLHVCDTAFETSKF---FTDLRDGI----ISD 238

Query: 254 DVGYEISDDAKDLMRRLIC 272
                     K L+++L+ 
Sbjct: 239 ----IFDKKEKTLLQKLLS 253

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  147 bits (373), Expect = 1e-41
 Identities = 65/245 (26%), Positives = 106/245 (43%), Gaps = 51/245 (20%)

Query: 80  YAFQDDSNLYLVMDYYCGGDLLTLLSKFED-----RLPEDMAKFYIAEMVLAIASIHDLH 134
             F D  + Y+V++   GG+L      F+      RL E   K Y  +M+LA+  +H+  
Sbjct: 81  KNFFDAEDYYIVLELMEGGEL------FDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 134

Query: 135 YVHRPNHFAFHLCRDIKPDNVLL---DANGHIRLADFG-SCLRLGGDGTVQSNVAVGTPD 190
            +HR          D+KP+NVLL   + +  I++ DFG S  ++ G+ ++   +  GTP 
Sbjct: 135 IIHR----------DLKPENVLLSSQEEDCLIKITDFGHS--KILGETSLMRTL-CGTPT 181

Query: 191 YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL-VETYGKIMNHQNSF 249
           Y++PE+L     G   Y    D WSLGV ++  L G  PF      V    +I +    +
Sbjct: 182 YLAPEVLV--SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS--GKY 237

Query: 250 DLPSDVGYEISDDAKDLMRRLICS-SDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG 308
           +   +V  E+S+ A DL+++L+      R            +            HPW Q 
Sbjct: 238 NFIPEVWAEVSEKALDLVKKLLVVDPKARF-----------TTEEA------LRHPWLQD 280

Query: 309 IAWDS 313
                
Sbjct: 281 EDMKR 285

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  149 bits (379), Expect = 1e-41
 Identities = 66/239 (27%), Positives = 108/239 (45%), Gaps = 40/239 (16%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  +   F D  + Y+V++   GG+L   +     RL E   K Y  +M+LA+  +H+  
Sbjct: 202 IIKIKNFF-DAEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENG 259

Query: 135 YVHRPNHFAFHLCRDIKPDNVLL---DANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDY 191
            +HR          D+KP+NVLL   + +  I++ DFG   ++ G+ ++   +  GTP Y
Sbjct: 260 IIHR----------DLKPENVLLSSQEEDCLIKITDFG-HSKILGETSLMRTL-CGTPTY 307

Query: 192 ISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL-VETYGKIMNHQNSFD 250
           ++PE+L     G   Y    D WSLGV ++  L G  PF      V    +I +    ++
Sbjct: 308 LAPEVLV--SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS--GKYN 363

Query: 251 LPSDVGYEISDDAKDLMRRLICS-SDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG 308
              +V  E+S+ A DL+++L+      R       +     AL          HPW Q 
Sbjct: 364 FIPEVWAEVSEKALDLVKKLLVVDPKARF---TTEE-----AL---------RHPWLQD 405

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  149 bits (377), Expect = 1e-41
 Identities = 58/236 (24%), Positives = 101/236 (42%), Gaps = 32/236 (13%)

Query: 48  KTVSDFIEFVAKLREERDVLV-YGDRRWITNLHYAFQD----DSNLYLVMDYYCGGDLLT 102
           K + D      K R E ++         I  +   +++       L +VM+   GG+L +
Sbjct: 93  KMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFS 148

Query: 103 -LLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL---D 158
            +  + +    E  A   +  +  AI  +H ++  HR          D+KP+N+L     
Sbjct: 149 RIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR----------DVKPENLLYTSKR 198

Query: 159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGV 218
            N  ++L DFG         ++ +     TP Y++PE+L     G  +Y   CD WSLGV
Sbjct: 199 PNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVL-----GPEKYDKSCDMWSLGV 251

Query: 219 CMYEMLYGETPFYAESLVETYGKIMNH--QNSFDLPSDVGYEISDDAKDLMRRLIC 272
            MY +L G  PFY+   +     +        ++ P+    E+S++ K L+R L+ 
Sbjct: 252 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 307

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  148 bits (374), Expect = 2e-41
 Identities = 38/199 (19%), Positives = 72/199 (36%), Gaps = 33/199 (16%)

Query: 60  LREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKF----EDRLPEDM 115
             +  + L    +      + A    +   LV + Y  G LL  ++ +    E  +P+ +
Sbjct: 114 GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGL 173

Query: 116 AKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL-----------DANGHIR 164
              +   M+  I  +HD   +H           DIKPDN +L           D +  + 
Sbjct: 174 VISFAMRMLYMIEQVHDCEIIHG----------DIKPDNFILGNGFLEQDDEDDLSAGLA 223

Query: 165 LADFGSC--LRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYE 222
           L D G    ++L   GT+ +     T  +   E+L      +  +  + D++ +   +Y 
Sbjct: 224 LIDLGQSIDMKLFPKGTIFTAKC-ETSGFQCVEML----SNKP-WNYQIDYFGVAATVYC 277

Query: 223 MLYGETPFYAESLVETYGK 241
           ML+G          E   +
Sbjct: 278 MLFGTYMKVKNEGGECKPE 296

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  146 bits (370), Expect = 3e-41
 Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 25/202 (12%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKF---EDRLPEDMAKFYIAEMVLAIASIH 131
           +   + +F +D+ L +V++    GDL  ++  F   +  +PE     Y  ++  A+  +H
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153

Query: 132 DLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDY 191
               +HR          DIKP NV + A G ++L D G         T   ++ VGTP Y
Sbjct: 154 SRRVMHR----------DIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYY 202

Query: 192 ISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHQNSF 249
           +SPE +       G Y  + D WSLG  +YEM   ++PFY +  +L     KI       
Sbjct: 203 MSPERI----HENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP- 256

Query: 250 DLPSDVGYEISDDAKDLMRRLI 271
            LPSD     S++ + L+   I
Sbjct: 257 PLPSDH---YSEELRQLVNMCI 275

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  147 bits (372), Expect = 3e-41
 Identities = 76/276 (27%), Positives = 117/276 (42%), Gaps = 56/276 (20%)

Query: 57  VAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFED-----RL 111
              +R E  VL+      I  L   F+  + + LV++   GG+L      F+        
Sbjct: 92  KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL------FDRIVEKGYY 145

Query: 112 PEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL---DANGHIRLADF 168
            E  A   + +++ A+A +H+   VHR          D+KP+N+L      +  +++ADF
Sbjct: 146 SERDAADAVKQILEAVAYLHENGIVHR----------DLKPENLLYATPAPDAPLKIADF 195

Query: 169 GSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGET 228
           G    +     +++    GTP Y +PEIL         YGPE D WS+G+  Y +L G  
Sbjct: 196 GLSKIVEHQVLMKT--VCGTPGYCAPEILR-----GCAYGPEVDMWSVGIITYILLCGFE 248

Query: 229 PFYAE-SLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRL--GQNGIA 284
           PFY E      + +I+N    +   S    E+S +AKDL+R+LI      RL   Q    
Sbjct: 249 PFYDERGDQFMFRRILN--CEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQ---- 302

Query: 285 DFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAP 320
                 AL          HPW  G A + +    A 
Sbjct: 303 ------AL---------QHPWVTGKAANFVHMDTAQ 323

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  148 bits (377), Expect = 4e-41
 Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 32/206 (15%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFED-----RLPEDMAKFYIAEMVLAIAS 129
           I  LH +  ++ + YL+ D   GG+L      FED        E  A   I +++ A+  
Sbjct: 72  IVRLHDSISEEGHHYLIFDLVTGGEL------FEDIVAREYYSEADASHCIQQILEAVLH 125

Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLL---DANGHIRLADFGSCLRLGGDGTVQSNVAV 186
            H +  VHR          ++KP+N+LL        ++LADFG  + + G+         
Sbjct: 126 CHQMGVVHR----------NLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF-A 174

Query: 187 GTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQ 246
           GTP Y+SPE+L      +  YG   D W+ GV +Y +L G  PF+ E     Y +I    
Sbjct: 175 GTPGYLSPEVLR-----KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK--A 227

Query: 247 NSFDLPSDVGYEISDDAKDLMRRLIC 272
            ++D PS     ++ +AKDL+ +++ 
Sbjct: 228 GAYDFPSPEWDTVTPEAKDLINKMLT 253

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  147 bits (372), Expect = 4e-41
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 33/206 (16%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFED-----RLPEDMAKFYIAEMVLAIAS 129
           I  LH + Q++S  YLV D   GG+L      FED        E  A   I +++ +IA 
Sbjct: 90  IVRLHDSIQEESFHYLVFDLVTGGEL------FEDIVAREFYSEADASHCIQQILESIAY 143

Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLL---DANGHIRLADFGSCLRLGGDGTVQSNVAV 186
            H    VHR          ++KP+N+LL        ++LADFG  + +            
Sbjct: 144 CHSNGIVHR----------NLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FA 191

Query: 187 GTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQ 246
           GTP Y+SPE+L      +  Y    D W+ GV +Y +L G  PF+ E     Y +I    
Sbjct: 192 GTPGYLSPEVLK-----KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA-- 244

Query: 247 NSFDLPSDVGYEISDDAKDLMRRLIC 272
            ++D PS     ++ +AK L+  ++ 
Sbjct: 245 GAYDYPSPEWDTVTPEAKSLIDSMLT 270

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  145 bits (369), Expect = 5e-41
 Identities = 62/265 (23%), Positives = 101/265 (38%), Gaps = 63/265 (23%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRL------PEDMAKFYIAEMVLAIA 128
           +  L   F+++   YLV +   GG +L         +       E  A   + ++  A+ 
Sbjct: 73  VLELIEFFEEEDRFYLVFEKMRGGSIL-------SHIHKRRHFNELEASVVVQDVASALD 125

Query: 129 SIHDLHYVHRPNHFAFHLCRDIKPDNVLL---DANGHIRLADFG--SCLRLGGDGTVQSN 183
            +H+    HR          D+KP+N+L    +    +++ DF   S ++L GD +  S 
Sbjct: 126 FLHNKGIAHR----------DLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175

Query: 184 V----AVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 239
                  G+ +Y++PE++ A  E    Y   CD WSLGV +Y +L G  PF      +  
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG 235

Query: 240 GKIMNHQNS-------------FDLPSDVGYEISDDAKDLMRRLICS-SDTRLGQNGIAD 285
                   +             ++ P      IS  AKDL+ +L+   +  RL       
Sbjct: 236 WDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRL------- 288

Query: 286 FKMWSALFVSLSISPRNHPWFQGIA 310
                 L          HPW QG A
Sbjct: 289 -SAAQVL---------QHPWVQGCA 303

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  145 bits (368), Expect = 9e-41
 Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 28/208 (13%)

Query: 75  ITNLHYAFQD----DSNLYLVMDYYCGGDLLT-LLSKFEDRLPEDMAKFYIAEMVLAIAS 129
           I  +   +++       L ++M+   GG+L + +  + +    E  A   + ++  AI  
Sbjct: 84  IVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQF 143

Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLL---DANGHIRLADFGSCLRLGGDGTVQSNVAV 186
           +H  +  HR          D+KP+N+L    + +  ++L DFG   +      +Q+    
Sbjct: 144 LHSHNIAHR----------DVKPENLLYTSKEKDAVLKLTDFG-FAKETTQNALQT--PC 190

Query: 187 GTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH- 245
            TP Y++PE+L     G  +Y   CD WSLGV MY +L G  PFY+ +       +    
Sbjct: 191 YTPYYVAPEVL-----GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI 245

Query: 246 -QNSFDLPSDVGYEISDDAKDLMRRLIC 272
               +  P+    E+S+DAK L+R L+ 
Sbjct: 246 RLGQYGFPNPEWSEVSEDAKQLIRLLLK 273

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  143 bits (363), Expect = 4e-40
 Identities = 66/263 (25%), Positives = 112/263 (42%), Gaps = 44/263 (16%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L    + +  LYL+M+Y  GG++   L     R+ E  A+    ++V A+   H   
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKR 134

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            VHR          D+K +N+LLDA+ +I++ADFG        G + +    G P Y +P
Sbjct: 135 IVHR----------DLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA--FCGAPPYAAP 182

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSD 254
           E+     +G+   GPE D WSLGV +Y ++ G  PF  ++L E   +++  +  + +P  
Sbjct: 183 ELF----QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK--YRIPFY 236

Query: 255 VGYEISDDAKDLMRR-LICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDS 313
           +    S D ++L++R L+ +   R     I                     W        
Sbjct: 237 M----STDCENLLKRFLVLNPIKRGTLEQI-----------------MKDRWIN---AGH 272

Query: 314 IRDSNAPYIPEVSSPTDTSHFDV 336
             D   P++      +D    D+
Sbjct: 273 EEDELKPFVEPELDISDQKRIDI 295

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  143 bits (364), Expect = 5e-40
 Identities = 62/229 (27%), Positives = 99/229 (43%), Gaps = 41/229 (17%)

Query: 59  KLREERDVLV-YGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRL------ 111
              EE ++L+ YG    I  L   + D   +Y+V +   GG+LL       D++      
Sbjct: 61  DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELL-------DKILRQKFF 113

Query: 112 PEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL----DANGHIRLAD 167
            E  A   +  +   +  +H    VHR          D+KP N+L          IR+ D
Sbjct: 114 SEREASAVLFTITKTVEYLHAQGVVHR----------DLKPSNILYVDESGNPESIRICD 163

Query: 168 FG-SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYG 226
           FG +      +G + +     T ++++PE+L      R  Y   CD WSLGV +Y ML G
Sbjct: 164 FGFAKQLRAENGLLMT--PCYTANFVAPEVL-----ERQGYDAACDIWSLGVLLYTMLTG 216

Query: 227 ETPFYA---ESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC 272
            TPF     ++  E   +I + +  F L       +SD AKDL+ +++ 
Sbjct: 217 YTPFANGPDDTPEEILARIGSGK--FSLSGGYWNSVSDTAKDLVSKMLH 263

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  146 bits (369), Expect = 5e-40
 Identities = 41/206 (19%), Positives = 75/206 (36%), Gaps = 24/206 (11%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +       +D    Y+ ++  C   L   + + +           + +    +A +H L+
Sbjct: 80  VIRYFCTEKDRQFQYIAIEL-CAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN 138

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGH-----IRLADFGSCLRLGGDGTVQSNV--AVG 187
            VHR          D+KP N+L+            ++DFG C +L       S      G
Sbjct: 139 IVHR----------DLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPG 188

Query: 188 TPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMNHQ 246
           T  +I+PE+L   E+ +       D +S G   Y ++  G  PF      +    I+   
Sbjct: 189 TEGWIAPEML--SEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN--ILLGA 244

Query: 247 NSFDLPSDVGYEISDDAKDLMRRLIC 272
            S D            A++L+ ++I 
Sbjct: 245 CSLDCLHPEK-HEDVIARELIEKMIA 269

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  145 bits (368), Expect = 6e-40
 Identities = 50/261 (19%), Positives = 89/261 (34%), Gaps = 57/261 (21%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLL------TLLSKFEDRLPEDMAKFYIAEMVLAIA 128
           +   + +   D  LY+ ++  C  +L        +  +      E      + ++   +A
Sbjct: 71  VIRYYCSETTDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 129 SIHDLHYVHRPNHFAFHLCRDIKPDNVLLD-------------ANGHIRLADFGSCLRLG 175
            +H L  +HR          D+KP N+L+               N  I ++DFG C +L 
Sbjct: 130 HLHSLKIIHR----------DLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179

Query: 176 GD---GTVQSNVAVGTPDYISPEIL--TAMEEGRGRYGPECDWWSLGVCMYEML-YGETP 229
                     N   GT  + +PE+L  +   + + R     D +S+G   Y +L  G+ P
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239

Query: 230 FYAESLVETYGKIMNHQNSFD-LPSDVGYEISDDAKDLMRRLICS-SDTRLGQNGIADFK 287
           F  +        I+    S D +       +  +A DL+ ++I      R          
Sbjct: 240 FGDKY--SRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRP--------T 289

Query: 288 MWSALFVSLSISPRNHPWFQG 308
               L          HP F  
Sbjct: 290 AMKVL---------RHPLFWP 301

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  144 bits (365), Expect = 7e-40
 Identities = 47/227 (20%), Positives = 84/227 (37%), Gaps = 42/227 (18%)

Query: 75  ITNLHYAFQDDS--NLYLVMDYYCGGDLLTLLSKFE--DRLPEDMAKFYIAEMVLAIASI 130
           I  L    ++ +  +  L+M++   G L T+L +      LPE      + ++V  +  +
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 131 HDLHYVHRPNHFAFHLCRDIKPDNVLL----DANGHIRLADFGSCLRLGGDGTVQSNVAV 186
            +   VHR          +IKP N++     D     +L DFG+   L  D    S    
Sbjct: 129 RENGIVHR----------NIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LY 176

Query: 187 GTPDYISPEILTAM---EEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
           GT +Y+ P++       ++ + +YG   D WS+GV  Y    G  PF          ++M
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236

Query: 244 -------------------NHQNSFDLPSDVGYEISDDAKDLMRRLI 271
                              N    +     V   +S   + L+  ++
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVL 283

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  142 bits (360), Expect = 8e-40
 Identities = 48/268 (17%), Positives = 85/268 (31%), Gaps = 64/268 (23%)

Query: 75  ITNLHYAFQDDS--NLYLVMDYYCGGDLLTLLSKFE--DRLPEDMAKFYIAEMVLAIASI 130
           I  L    ++ +  +  L+M++   G L T+L +      LPE      + ++V  +  +
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 131 HDLHYVHRPNHFAFHLCRDIKPDNVLL----DANGHIRLADFGSCLRLGGDGTVQSNVAV 186
            +   VHR          +IKP N++     D     +L DFG+   L  D    S    
Sbjct: 129 RENGIVHR----------NIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LY 176

Query: 187 GTPDYISPEILTAMEEGRGR---YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
           GT +Y+ P++       +     YG   D WS+GV  Y    G  PF          ++M
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236

Query: 244 -------------------NHQNSFDLPSDVGYEISDDAKDLMRRLICS-----SDTRLG 279
                              N    +     V   +S   + L+  ++ +      +   G
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296

Query: 280 QNGIADFKMWSALFVSLSISPRNHPWFQ 307
            +                          
Sbjct: 297 FDQF-----------------FAETSDI 307

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  138 bits (351), Expect = 8e-39
 Identities = 63/234 (26%), Positives = 102/234 (43%), Gaps = 41/234 (17%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L+      ++ ++VM+Y  GG+L   + K   R+ E  A+    +++ A+   H   
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHM 131

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            VHR          D+KP+NVLLDA+ + ++ADFG    +     +++  + G+P+Y +P
Sbjct: 132 VVHR----------DLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT--SCGSPNYAAP 179

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSD 254
           E++     GR   GPE D WS GV +Y +L G  PF  E +   + KI      F +P  
Sbjct: 180 EVI----SGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV--FYIPE- 232

Query: 255 VGYEISDDAKDLMRR-LICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ 307
               ++     L+   L      R     I                 R H WF+
Sbjct: 233 ---YLNRSVATLLMHMLQVDPLKRATIKDI-----------------REHEWFK 266

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  136 bits (345), Expect = 1e-37
 Identities = 56/236 (23%), Positives = 88/236 (37%), Gaps = 50/236 (21%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYC-GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDL 133
           +  L   F+      LV++      DL   +++ +  L E  ++ +  ++V AI   H  
Sbjct: 100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSR 158

Query: 134 HYVHRPNHFAFHLCRDIKPDNVLLDA-NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYI 192
             VHR          DIK +N+L+D   G  +L DFGS   L  D         GT  Y 
Sbjct: 159 GVVHR----------DIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYT--DFDGTRVYS 205

Query: 193 SPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLP 252
            PE +         +      WSLG+ +Y+M+ G+ PF  +       +I+  +     P
Sbjct: 206 PPEWI----SRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAE--LHFP 253

Query: 253 SDVGYEISDDAKDLMRRLICSS-DTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ 307
           + V    S D   L+RR +     +R     I                    PW Q
Sbjct: 254 AHV----SPDCCALIRRCLAPKPSSRPSLEEI-----------------LLDPWMQ 288

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  136 bits (345), Expect = 2e-37
 Identities = 61/234 (26%), Positives = 110/234 (47%), Gaps = 42/234 (17%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L+      +++ +V++Y  GG+L   + + + R+ ED  + +  +++ AI   H   
Sbjct: 71  IIKLYDVITTPTDIVMVIEY-AGGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHK 128

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            VHR          D+KP+N+LLD N ++++ADFG    +     +++  + G+P+Y +P
Sbjct: 129 IVHR----------DLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT--SCGSPNYAAP 176

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSD 254
           E++     G+   GPE D WS G+ +Y ML G  PF  E +   + K+ +    + +P  
Sbjct: 177 EVI----NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV--YVMPDF 230

Query: 255 VGYEISDDAKDLMRR-LICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ 307
               +S  A+ L+RR ++     R+    I                 R  PWF 
Sbjct: 231 ----LSPGAQSLIRRMIVADPMQRITIQEI-----------------RRDPWFN 263

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  133 bits (338), Expect = 6e-37
 Identities = 48/236 (20%), Positives = 95/236 (40%), Gaps = 39/236 (16%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +   +   ++ +  YL ++Y  GG+L   +   +  +PE  A+ +  +++  +  +H + 
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG 125

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG-SCLRLGGDGTVQSNVAVGTPDYIS 193
             HR          DIKP+N+LLD   +++++DFG + +    +     N   GT  Y++
Sbjct: 126 ITHR----------DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 194 PEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHQNSFDLP 252
           PE+L    + R  +    D WS G+ +  ML GE P+       + Y      +    L 
Sbjct: 176 PELL----KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--TYLN 229

Query: 253 SDVGYEISDDAKDLMRR-LICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ 307
                +I      L+ + L+ +   R+    I                 +   W+ 
Sbjct: 230 PWK--KIDSAPLALLHKILVENPSARITIPDI-----------------KKDRWYN 266

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  137 bits (348), Expect = 7e-37
 Identities = 62/234 (26%), Positives = 103/234 (44%), Gaps = 41/234 (17%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L+      S++++VM+Y  GG+L   + K   RL E  ++    +++  +   H   
Sbjct: 78  IIKLYQVISTPSDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHM 136

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            VHR          D+KP+NVLLDA+ + ++ADFG    +     +++  + G+P+Y +P
Sbjct: 137 VVHR----------DLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT--SCGSPNYAAP 184

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSD 254
           E++     GR   GPE D WS GV +Y +L G  PF  + +   + KI +    F  P  
Sbjct: 185 EVI----SGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI--FYTPQY 238

Query: 255 VGYEISDDAKDLMRR-LICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ 307
               ++     L++  L      R     I                 R H WF+
Sbjct: 239 ----LNPSVISLLKHMLQVDPMKRATIKDI-----------------REHEWFK 271

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  133 bits (337), Expect = 2e-36
 Identities = 56/271 (20%), Positives = 95/271 (35%), Gaps = 59/271 (21%)

Query: 75  ITNLH--YAFQDDSNLYLVMDYYCGG--DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASI 130
           +  L      ++   +Y+VM+Y   G  ++L  + +   R P   A  Y  +++  +  +
Sbjct: 68  VIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYL 125

Query: 131 HDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG--SCLRLGGDG----TVQSNV 184
           H    VH+          DIKP N+LL   G ++++  G    L          T Q   
Sbjct: 126 HSQGIVHK----------DIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--- 172

Query: 185 AVGTPDYISPEILTAMEEGRGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
             G+P +  PEI      G   + G + D WS GV +Y +  G  PF  +++ + +  I 
Sbjct: 173 --GSPAFQPPEIA----NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG 226

Query: 244 NHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLGQNGIADFKMWSALFVSLSISPRN 302
                + +P D          DL++ ++      R     I                 R 
Sbjct: 227 KGS--YAIPGD----CGPPLSDLLKGMLEYEPAKRFSIRQI-----------------RQ 263

Query: 303 HPWFQGIAWDSIRDSNAPYIPEVSSPTDTSH 333
           H WF+              IP      D   
Sbjct: 264 HSWFRK---KHPPAEAPVPIPPSPDTKDRWR 291

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  133 bits (337), Expect = 2e-36
 Identities = 51/264 (19%), Positives = 101/264 (38%), Gaps = 42/264 (15%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +   +   ++ +  YL ++Y  GG+L   +   +  +PE  A+ +  +++  +  +H + 
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG 125

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG-SCLRLGGDGTVQSNVAVGTPDYIS 193
             HR          DIKP+N+LLD   +++++DFG + +    +     N   GT  Y++
Sbjct: 126 ITHR----------DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 194 PEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHQNSFDLP 252
           PE+L    + R  +    D WS G+ +  ML GE P+       + Y      +     P
Sbjct: 176 PELL----KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-NP 230

Query: 253 SDVGYEISDDAKDLMRR-LICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAW 311
                +I      L+ + L+ +   R+    I                 +   W+     
Sbjct: 231 WK---KIDSAPLALLHKILVENPSARITIPDI-----------------KKDRWYNK--- 267

Query: 312 DSIRDSNAPYIPEVSSPTDTSHFD 335
              + +  P +         S F 
Sbjct: 268 PLKKGAKRPRVTSGGVSESPSGFS 291

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  132 bits (335), Expect = 8e-36
 Identities = 66/288 (22%), Positives = 110/288 (38%), Gaps = 48/288 (16%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I          ++L ++M+Y  GG+L   +     R  ED A+F+  +++  ++  H + 
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQ 136

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDAN--GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYI 192
             HR          D+K +N LLD +    +++ DFG           +S   VGTP YI
Sbjct: 137 ICHR----------DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS--TVGTPAYI 184

Query: 193 SPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNS--FD 250
           +PE+L      +   G   D WS GV +Y ML G  PF        Y K +    S  + 
Sbjct: 185 APEVL----LRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS 240

Query: 251 LPSDVGYEISDDAKDLMRR-LICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI 309
           +P D    IS +   L+ R  +    TR+    I                 + H WF   
Sbjct: 241 IPDD--IRISPECCHLISRIFVADPATRISIPEI-----------------KTHSWFL-- 279

Query: 310 AWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALS 357
                ++  A  + E ++ +     +     +     +   A  PA+ 
Sbjct: 280 -----KNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIPAVR 322

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  131 bits (332), Expect = 1e-35
 Identities = 56/237 (23%), Positives = 94/237 (39%), Gaps = 50/237 (21%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCG-GDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDL 133
           +  L   F+   +  L+++      DL   +++    L E++A+ +  +++ A+   H+ 
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNC 168

Query: 134 HYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYI 192
             +HR          DIK +N+L+D N G ++L DFGS   L  D         GT  Y 
Sbjct: 169 GVLHR----------DIKDENILIDLNRGELKLIDFGSG-ALLKDTVYT--DFDGTRVYS 215

Query: 193 SPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLP 252
            PE +         +G     WSLG+ +Y+M+ G+ PF  +       +I+  Q      
Sbjct: 216 PPEWI----RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ--VFFR 263

Query: 253 SDVGYEISDDAKDLMRR-LICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG 308
             V    S + + L+R  L      R     I                 +NHPW Q 
Sbjct: 264 QRV----SSECQHLIRWCLALRPSDRPTFEEI-----------------QNHPWMQD 299

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  130 bits (329), Expect = 2e-35
 Identities = 52/236 (22%), Positives = 90/236 (38%), Gaps = 53/236 (22%)

Query: 48  KTVSDFIEFVAKLREERDVLV-YGDRRWITNLHYAFQD----DSNLYLVMDYYCGGDLLT 102
           K + D      K R E ++         I  +   +++       L +VM+   GG+L +
Sbjct: 49  KMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFS 104

Query: 103 -LLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL---D 158
            +  + +    E  A   +  +  AI  +H ++  HR          D+KP+N+L     
Sbjct: 105 RIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR----------DVKPENLLYTSKR 154

Query: 159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGV 218
            N  ++L DFG                       + E          +Y   CD WSLGV
Sbjct: 155 PNAILKLTDFG----------------------FAKETT------GEKYDKSCDMWSLGV 186

Query: 219 CMYEMLYGETPFYAESLVETYGKIMNH--QNSFDLPSDVGYEISDDAKDLMRRLIC 272
            MY +L G  PFY+   +     +        ++ P+    E+S++ K L+R L+ 
Sbjct: 187 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 242

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  130 bits (329), Expect = 2e-35
 Identities = 39/204 (19%), Positives = 76/204 (37%), Gaps = 37/204 (18%)

Query: 83  QDDSNLYLVMDYYCGGDLLTLLS--KFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN 140
                LY+ M      +L   ++     +     +      ++  A+  +H    +HR  
Sbjct: 85  SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHR-- 142

Query: 141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVA-----------VGTP 189
                   D+KP N+    +  +++ DFG    +  D   Q+ +            VGT 
Sbjct: 143 --------DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTK 194

Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKIMNHQNS 248
            Y+SPE +     G   Y  + D +SLG+ ++E+LY   PF  +   V T   + N +  
Sbjct: 195 LYMSPEQI----HGNS-YSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFP 246

Query: 249 FDLPSDVGYEISDDAKDLMRRLIC 272
             L +            +++ ++ 
Sbjct: 247 -PLFTQ----KYPCEYVMVQDMLS 265

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  131 bits (331), Expect = 2e-35
 Identities = 52/249 (20%), Positives = 93/249 (37%), Gaps = 43/249 (17%)

Query: 37  DECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC 96
           +E  N ++ +E      + F+ KL    +++ +     I             +L++   C
Sbjct: 65  EEEKNRAIIQE------VCFMKKLSGHPNIVQFCSAASIGKEE--SDTGQAEFLLLTELC 116

Query: 97  GGDLLTLLSKFE--DRLPEDMAKFYIAEMVLAIASIHDLH--YVHRPNHFAFHLCRDIKP 152
            G L+  L K E    L  D       +   A+  +H      +HR          D+K 
Sbjct: 117 KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHR----------DLKV 166

Query: 153 DNVLLDANGHIRLADFGSC----------LRLGGDGTVQSNVA-VGTPDYISPEILTAME 201
           +N+LL   G I+L DFGS                   V+  +    TP Y +PEI+    
Sbjct: 167 ENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY- 225

Query: 202 EGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISD 261
                 G + D W+LG  +Y + + + PF   + +    +I+N +  + +P         
Sbjct: 226 -SNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL----RIVNGK--YSIPPHDTQ--YT 276

Query: 262 DAKDLMRRL 270
               L+R +
Sbjct: 277 VFHSLIRAM 285

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  134 bits (339), Expect = 5e-35
 Identities = 49/236 (20%), Positives = 86/236 (36%), Gaps = 30/236 (12%)

Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFE--DRLPEDMAKFYIAEMVLAIASIHDLHYVHRP 139
              +    L M+Y  GGDL   L++FE    L E   +  ++++  A+  +H+   +HR 
Sbjct: 87  LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHR- 145

Query: 140 NHFAFHLCRDIKPDNVLLDANGH---IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEI 196
                    D+KP+N++L         ++ D G    L           VGT  Y++PE+
Sbjct: 146 ---------DLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE--FVGTLQYLAPEL 194

Query: 197 LTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVG 256
           L    E + +Y    D+WS G   +E + G  PF        +   +  +++  +     
Sbjct: 195 L----EQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV---V 246

Query: 257 YEISDDAKDLMRRL-----ICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ 307
           Y+    A      L     +        +  +    MW            N   FQ
Sbjct: 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  129 bits (325), Expect = 1e-34
 Identities = 35/251 (13%), Positives = 77/251 (30%), Gaps = 37/251 (14%)

Query: 36  YDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYY 95
             +                  +     +   +     +              LY+ M   
Sbjct: 84  EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLC 143

Query: 96  CGGDLLTLLS--KFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPD 153
              +L   ++     +     +      ++  A+  +H    +HR          D+KP 
Sbjct: 144 RKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHR----------DLKPS 193

Query: 154 NVLLDANGHIRLADFGSCLRLGGDGTVQSNVA-----------VGTPDYISPEILTAMEE 202
           N+    +  +++ DFG    +  D   Q+ +            VGT  Y+SPE +     
Sbjct: 194 NIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIH---- 249

Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKIMNHQNSFDLPSDVGYEISD 261
               Y  + D +SLG+ ++E+LY    F  +   V     + N +           +   
Sbjct: 250 -GNNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRNLKFPLLFT-----QKYP 300

Query: 262 DAKDLMRRLIC 272
               +++ ++ 
Sbjct: 301 QEHMMVQDMLS 311

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  126 bits (318), Expect = 7e-34
 Identities = 37/234 (15%), Positives = 75/234 (32%), Gaps = 49/234 (20%)

Query: 60  LREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKF---EDRLPEDMA 116
           LRE     V G    +     A+ +D ++ +  +Y  GG L   +S+         E   
Sbjct: 58  LREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 117

Query: 117 KFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI------------- 163
           K  + ++   +  IH +  VH           DIKP N+ +                   
Sbjct: 118 KDLLLQVGRGLRYIHSMSLVHM----------DIKPSNIFISRTSIPNAASEEGDEDDWA 167

Query: 164 ------RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLG 217
                 ++ D G   R+            G   +++ E+L    +    + P+ D ++L 
Sbjct: 168 SNKVMFKIGDLGHVTRISSPQVE-----EGDSRFLANEVL----QENYTHLPKADIFALA 218

Query: 218 VCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           + +      E               +       +P      +S +  +L++ +I
Sbjct: 219 LTVVCAAGAEPLPRNGDQW----HEIRQGRLPRIPQV----LSQEFTELLKVMI 264

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  124 bits (314), Expect = 6e-33
 Identities = 51/222 (22%), Positives = 86/222 (38%), Gaps = 26/222 (11%)

Query: 54  IEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPE 113
           +       EE           I  L+ A ++   + + M+   GG L  L+ +    LPE
Sbjct: 91  VRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM-GCLPE 149

Query: 114 DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG-HIRLADFGSCL 172
           D A +Y+ + +  +  +H    +H           D+K DNVLL ++G    L DFG  L
Sbjct: 150 DRALYYLGQALEGLEYLHTRRILHG----------DVKADNVLLSSDGSRAALCDFGHAL 199

Query: 173 RLGGDGTVQSNVA----VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGET 228
            L  DG  +S +      GT  +++PE++     G+     + D WS    M  ML G  
Sbjct: 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVV----MGKP-CDAKVDIWSSCCMMLHMLNGCH 254

Query: 229 PFYAESLVETYGKIMNHQN-SFDLPSDVGYEISDDAKDLMRR 269
           P+          KI +      ++P       +      ++ 
Sbjct: 255 PWTQYFRGPLCLKIASEPPPIREIPPS----CAPLTAQAIQE 292

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  118 bits (299), Expect = 4e-31
 Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 26/221 (11%)

Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLP-- 112
            +   L EE  +  +   + I     +F ++  + + M+   GG L  LL      L   
Sbjct: 61  RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN 120

Query: 113 EDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA-NGHIRLADFGSC 171
           E    FY  +++  +  +HD   VHR          DIK DNVL++  +G ++++DFG+ 
Sbjct: 121 EQTIGFYTKQILEGLKYLHDNQIVHR----------DIKGDNVLINTYSGVLKISDFGTS 170

Query: 172 LRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
            RL G          GT  Y++PEI+     G   YG   D WSLG  + EM  G+ PFY
Sbjct: 171 KRLAGINPCTETF-TGTLQYMAPEIIDKGPRG---YGKAADIWSLGCTIIEMATGKPPFY 226

Query: 232 AESLVETYG---KIMNHQNSFDLPSDVGYEISDDAKDLMRR 269
              L E      K+   +   ++P      +S +AK  + +
Sbjct: 227 --ELGEPQAAMFKVGMFKVHPEIPES----MSAEAKAFILK 261

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  120 bits (302), Expect = 6e-31
 Identities = 40/164 (24%), Positives = 71/164 (43%), Gaps = 20/164 (12%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLL-SKFEDRLPEDMAKFYIAEMVLAIASIHDL 133
           I      F  D+ L++V  +   G    L+ + F D + E    + +  ++ A+  IH +
Sbjct: 88  IVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM 147

Query: 134 HYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNV------AVG 187
            YVHR           +K  ++L+  +G + L+   S L +   G  Q  V      +V 
Sbjct: 148 GYVHR----------SVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197

Query: 188 TPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
              ++SPE+L    +G   Y  + D +S+G+   E+  G  PF 
Sbjct: 198 VLPWLSPEVLQQNLQG---YDAKSDIYSVGITACELANGHVPFK 238

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  116 bits (293), Expect = 3e-30
 Identities = 46/174 (26%), Positives = 82/174 (47%), Gaps = 12/174 (6%)

Query: 60  LREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFY 119
              E ++L   D  +I  L  A+  D  L++++++  GG +  ++ + +  L E   +  
Sbjct: 63  YIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVV 122

Query: 120 IAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT 179
             +M+ A+  +H    +HR          D+K  NVL+   G IRLADFG   +      
Sbjct: 123 CRQMLEALNFLHSKRIIHR----------DLKAGNVLMTLEGDIRLADFGVSAKN-LKTL 171

Query: 180 VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE 233
            + +  +GTP +++PE++         Y  + D WSLG+ + EM   E P + E
Sbjct: 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP-HHE 224

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  117 bits (294), Expect = 4e-30
 Identities = 43/156 (27%), Positives = 70/156 (44%), Gaps = 18/156 (11%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
                  +  +   +LVM+Y C G    LL   +  L E          +  +A +H  +
Sbjct: 116 TIQYRGCYLREHTAWLVMEY-CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 174

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          D+K  N+LL   G ++L DFGS   +    +      VGTP +++P
Sbjct: 175 MIHR----------DVKAGNILLSEPGLVKLGDFGSASIMAPANSF-----VGTPYWMAP 219

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
           E++ AM+E  G+Y  + D WSLG+   E+   + P 
Sbjct: 220 EVILAMDE--GQYDGKVDVWSLGITCIELAERKPPL 253

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  115 bits (290), Expect = 7e-30
 Identities = 47/168 (27%), Positives = 78/168 (46%), Gaps = 27/168 (16%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGG----DLLTLLSKFEDRLPEDMAKFYIA----EMVLA 126
           I + + +F     L+LVM     G    D++  +    +     + +  IA    E++  
Sbjct: 75  IVSYYTSFVVKDELWLVMKL-LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133

Query: 127 IASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG--SCLRLGGDGTVQS-- 182
           +  +H    +HR          D+K  N+LL  +G +++ADFG  + L  GGD T     
Sbjct: 134 LEYLHKNGQIHR----------DVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 183

Query: 183 NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
              VGTP +++PE+   ME+ RG Y  + D WS G+   E+  G  P+
Sbjct: 184 KTFVGTPCWMAPEV---MEQVRG-YDFKADIWSFGITAIELATGAAPY 227

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  115 bits (289), Expect = 1e-29
 Identities = 44/172 (25%), Positives = 82/172 (47%), Gaps = 16/172 (9%)

Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           ++ +E  ++   D   +   + ++  +++L++VM+Y   G +  ++      L ED    
Sbjct: 70  EIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT 129

Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDG 178
            +   +  +  +H +  +HR          DIK  N+LL+  GH +LADFG   +L  D 
Sbjct: 130 ILQSTLKGLEYLHFMRKIHR----------DIKAGNILLNTEGHAKLADFGVAGQL-TDT 178

Query: 179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
             + N  +GTP +++PE++         Y    D WSLG+   EM  G+ P+
Sbjct: 179 MAKRNTVIGTPFWMAPEVIQ-----EIGYNCVADIWSLGITAIEMAEGKPPY 225

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  113 bits (285), Expect = 4e-29
 Identities = 39/153 (25%), Positives = 63/153 (41%), Gaps = 16/153 (10%)

Query: 83  QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHF 142
           + D  LY+ M    G DL  +L + +  L    A   + ++  A+ + H     HR    
Sbjct: 104 EIDGQLYVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATHR---- 158

Query: 143 AFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEE 202
                 D+KP+N+L+ A+    L DFG       +   Q    VGT  Y++PE  +    
Sbjct: 159 ------DVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE--- 209

Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
                    D ++L   +YE L G  P+  + L
Sbjct: 210 --SHATYRADIYALTCVLYECLTGSPPYQGDQL 240

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  113 bits (285), Expect = 5e-29
 Identities = 43/156 (27%), Positives = 74/156 (47%), Gaps = 12/156 (7%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I      F  ++++++ M+   G     L  + +  +PE      + +M +AI  +  L+
Sbjct: 86  IVQCFGTFITNTDVFIAMEL-MGTCAEKLKKRMQGPIPER----ILGKMTVAI--VKALY 138

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
           Y+    H   H  RD+KP N+LLD  G I+L DFG   RL        + + G   Y++P
Sbjct: 139 YLKE-KHGVIH--RDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSAGCAAYMAP 193

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
           E +   +  +  Y    D WSLG+ + E+  G+ P+
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY 229

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  112 bits (283), Expect = 7e-29
 Identities = 50/154 (32%), Positives = 72/154 (46%), Gaps = 16/154 (10%)

Query: 83  QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHF 142
           ++D   YLVM+Y  G  L   +      L  D A  +  +++  I   HD+  VHR    
Sbjct: 81  EEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRIVHR---- 135

Query: 143 AFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEE 202
                 DIKP N+L+D+N  +++ DFG    L      Q+N  +GT  Y SPE       
Sbjct: 136 ------DIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK---- 185

Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 236
                    D +S+G+ +YEML GE PF  E+ V
Sbjct: 186 -GEATDECTDIYSIGIVLYEMLVGEPPFNGETAV 218

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  111 bits (279), Expect = 2e-28
 Identities = 55/179 (30%), Positives = 90/179 (50%), Gaps = 26/179 (14%)

Query: 60  LREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFY 119
           +  E  V+       I N   ++     L++VM+Y  GG L  +++  E  + E      
Sbjct: 64  IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEG----Q 117

Query: 120 IA----EMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG 175
           IA    E + A+  +H    +HR          DIK DN+LL  +G ++L DFG C ++ 
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHR----------DIKSDNILLGMDGSVKLTDFGFCAQIT 167

Query: 176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES 234
            + + + +  VGTP +++PE++T     R  YGP+ D WSLG+   EM+ GE P+  E+
Sbjct: 168 PEQS-KRSTMVGTPYWMAPEVVT-----RKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  110 bits (278), Expect = 5e-28
 Identities = 47/160 (29%), Positives = 88/160 (55%), Gaps = 18/160 (11%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +  ++ ++     L+++M++  GG L  ++S  + RL E+        ++ A+A +H   
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQG 161

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          DIK D++LL  +G ++L+DFG C ++  D   +    VGTP +++P
Sbjct: 162 VIHR----------DIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAP 210

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES 234
           E+++     R  Y  E D WSLG+ + EM+ GE P++++S
Sbjct: 211 EVIS-----RSLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  108 bits (273), Expect = 2e-27
 Identities = 52/171 (30%), Positives = 86/171 (50%), Gaps = 18/171 (10%)

Query: 60  LREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFY 119
           +++E  VL   D  ++T  + ++  D+ L+++M+Y  GG  L LL      L E      
Sbjct: 67  IQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATI 124

Query: 120 IAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT 179
           + E++  +  +H    +HR          DIK  NVLL  +G ++LADFG   +L  D  
Sbjct: 125 LREILKGLDYLHSEKKIHR----------DIKAANVLLSEHGEVKLADFGVAGQL-TDTQ 173

Query: 180 VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
           ++ N  VGTP +++PE++      +  Y  + D WSLG+   E+  GE P 
Sbjct: 174 IKRNTFVGTPFWMAPEVIK-----QSAYDSKADIWSLGITAIELARGEPPH 219

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  107 bits (269), Expect = 1e-26
 Identities = 47/207 (22%), Positives = 89/207 (42%), Gaps = 11/207 (5%)

Query: 60  LREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFY 119
           L +   V+   D  +I   + A   + + ++ M+                 L + + +  
Sbjct: 68  LMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL-MSTSFDKFYKYVYSVLDDVIPEEI 126

Query: 120 IAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT 179
           + ++ LA   +  L+++   N    H  RDIKP N+LLD +G+I+L DFG   +L    +
Sbjct: 127 LGKITLAT--VKALNHLKE-NLKIIH--RDIKPSNILLDRSGNIKLCDFGISGQL--VDS 179

Query: 180 VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVET 238
           +      G   Y++PE +      +G Y    D WSLG+ +YE+  G  P+    S+ + 
Sbjct: 180 IAKTRDAGCRPYMAPERIDPSASRQG-YDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ 238

Query: 239 YGKIMNHQNSFDLPSDVGYEISDDAKD 265
             +++   +   L +    E S    +
Sbjct: 239 LTQVVK-GDPPQLSNSEEREFSPSFIN 264

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  106 bits (267), Expect = 2e-26
 Identities = 45/151 (29%), Positives = 70/151 (46%), Gaps = 20/151 (13%)

Query: 89  YLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCR 148
           Y+VM+Y  G  L  ++   E  +    A   IA+   A+   H    +HR          
Sbjct: 92  YIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHR---------- 140

Query: 149 DIKPDNVLLDANGHIRLADFG--SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGR 206
           D+KP N+++ A   +++ DFG    +   G+   Q+   +GT  Y+SP      E+ RG 
Sbjct: 141 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP------EQARGD 194

Query: 207 Y-GPECDWWSLGVCMYEMLYGETPFYAESLV 236
                 D +SLG  +YE+L GE PF  +S V
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  106 bits (267), Expect = 2e-26
 Identities = 46/163 (28%), Positives = 73/163 (44%), Gaps = 18/163 (11%)

Query: 75  ITNLHYAF------QDDSNLYLVMDYYCGGDLLTLLSKFEDR-LPEDMAKFYIAEMVLAI 127
           I   + AF        D  L+LVM++   G +  L+   +   L E+   +   E++  +
Sbjct: 83  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142

Query: 128 ASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVG 187
           + +H    +HR          DIK  NVLL  N  ++L DFG   +L      + N  +G
Sbjct: 143 SHLHQHKVIHR----------DIKGQNVLLTENAEVKLVDFGVSAQLD-RTVGRRNTFIG 191

Query: 188 TPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
           TP +++PE++   E     Y  + D WSLG+   EM  G  P 
Sbjct: 192 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  106 bits (266), Expect = 4e-26
 Identities = 55/230 (23%), Positives = 85/230 (36%), Gaps = 33/230 (14%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I   + AF  D  + + M++   G  L  + K   R+PE      + ++ +A+  I  L 
Sbjct: 93  IVGFYGAFYSDGEISICMEH-MDGGSLDQVLKKAGRIPEQ----ILGKVSIAV--IKGLT 145

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
           Y+    H   H  RD+KP N+L+++ G I+L DFG   +L       +N  VGT  Y+SP
Sbjct: 146 YLRE-KHKIMH--RDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSP 199

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSD 254
           E L         Y  + D WS+G+ + EM  G  P       E               + 
Sbjct: 200 ERLQ-----GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 254

Query: 255 VGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHP 304
                              +  R       D +   A+F  L       P
Sbjct: 255 PRP---------------RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP 289

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  105 bits (263), Expect = 4e-26
 Identities = 37/201 (18%), Positives = 80/201 (39%), Gaps = 28/201 (13%)

Query: 75  ITNLHYAFQD----DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASI 130
           I   + +++        + LV +    G L T L +F   +   + + +  +++      
Sbjct: 87  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKG---- 141

Query: 131 HDLHYVHRPNHFAFHLCRDIKPDNVLLDA-NGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
             L ++H       H  RD+K DN+ +    G +++ D G            +   +GTP
Sbjct: 142 --LQFLHTRTPPIIH--RDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTP 194

Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHQNS 248
           ++++PE+    EE    Y    D ++ G+CM EM   E P+   ++  + Y ++ +    
Sbjct: 195 EFMAPEMY---EEK---YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP 248

Query: 249 FDLPSDVGYEISDDAKDLMRR 269
                        + K+++  
Sbjct: 249 ASFDKV----AIPEVKEIIEG 265

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  105 bits (263), Expect = 5e-26
 Identities = 37/159 (23%), Positives = 70/159 (44%), Gaps = 16/159 (10%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGG---DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIH 131
               + A   + ++++ M+             +      +PED     + ++ ++I  + 
Sbjct: 68  TVTFYGALFREGDVWICMEL-MDTSLDKFYKQVIDKGQTIPED----ILGKIAVSI--VK 120

Query: 132 DLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDY 191
            L ++H       H  RD+KP NVL++A G +++ DFG    L     V  ++  G   Y
Sbjct: 121 ALEHLHS-KLSVIH--RDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDAGCKPY 175

Query: 192 ISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
           ++PE +      +G Y  + D WSLG+ M E+     P+
Sbjct: 176 MAPERINPELNQKG-YSVKSDIWSLGITMIELAILRFPY 213

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  104 bits (261), Expect = 1e-24
 Identities = 35/157 (22%), Positives = 64/157 (40%), Gaps = 25/157 (15%)

Query: 79  HYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHR 138
           H     D   Y+VM+Y  G  L         +LP   A  Y+ E++ A++ +H +  V+ 
Sbjct: 150 HTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSYLHSIGLVYN 206

Query: 139 PNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILT 198
                     D+KP+N++L     ++L D G+  R+   G +      GTP + +PEI+ 
Sbjct: 207 ----------DLKPENIMLTEEQ-LKLIDLGAVSRINSFGYL-----YGTPGFQAPEIV- 249

Query: 199 AMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL 235
                R       D +++G  +  +           +
Sbjct: 250 -----RTGPTVATDIYTVGRTLAALTLDLPTRNGRYV 281

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 97.0 bits (242), Expect = 4e-23
 Identities = 29/149 (19%), Positives = 63/149 (42%), Gaps = 21/149 (14%)

Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRPNHF 142
            L +V  +  G  L   L   E +         + ++    A     +H    +HR    
Sbjct: 93  QLAIVTQWCEGSSLYHHLHASETKFEMKK----LIDIARQTARGMDYLHAKSIIHR---- 144

Query: 143 AFHLCRDIKPDNVLLDANGHIRLADFG-SCLRLGGDGTVQSNVAVGTPDYISPEILTAME 201
                 D+K +N+ L  +  +++ DFG +  +    G+ Q     G+  +++PE++    
Sbjct: 145 ------DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI--RM 196

Query: 202 EGRGRYGPECDWWSLGVCMYEMLYGETPF 230
           +    Y  + D ++ G+ +YE++ G+ P+
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPY 225

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 96.2 bits (240), Expect = 9e-23
 Identities = 43/185 (23%), Positives = 83/185 (44%), Gaps = 20/185 (10%)

Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           NL +V +Y   G L  LL K   R   D  +     M   +A    ++Y+H  N    H 
Sbjct: 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERR--RLSMAYDVA--KGMNYLHNRNPPIVH- 162

Query: 147 CRDIKPDNVLLDANGHIRLADFG-SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRG 205
            R++K  N+L+D    +++ DFG S L+     + +S  A GTP++++PE+L      R 
Sbjct: 163 -RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS--AAGTPEWMAPEVL------RD 213

Query: 206 -RYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAK 264
                + D +S GV ++E+   + P+   +  +    +       ++P ++  ++     
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQV----A 269

Query: 265 DLMRR 269
            ++  
Sbjct: 270 AIIEG 274

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 93.6 bits (233), Expect = 8e-22
 Identities = 32/193 (16%), Positives = 68/193 (35%), Gaps = 27/193 (13%)

Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN--HFAF 144
           +L ++     G  L +++   +  L  +       ++   I     + Y+H     H   
Sbjct: 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNK----TRQIAQEIV--KGMGYLHAKGILH--- 153

Query: 145 HLCRDIKPDNVLLDANGHIRLADFG-SCLRLGGDGTVQSNV---AVGTPDYISPEILTAM 200
              +D+K  NV  D NG + + DFG   +        + +      G   +++PEI+  +
Sbjct: 154 ---KDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209

Query: 201 EEGRGR----YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVG 256
                     +    D ++LG   YE+   E PF  +       ++         P+   
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM----KPNLSQ 265

Query: 257 YEISDDAKDLMRR 269
             +  +  D++  
Sbjct: 266 IGMGKEISDILLF 278

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 48/169 (28%), Positives = 78/169 (46%), Gaps = 16/169 (9%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           + NL    +     YLV ++     +L  L  F + L   + + Y+ +++  I   H  +
Sbjct: 86  LVNLLEVCKKKKRWYLVFEF-VDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN 144

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          DIKP+N+L+  +G ++L DFG    L   G V  +  V T  Y +P
Sbjct: 145 IIHR----------DIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE-VATRWYRAP 193

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
           E+L     G  +YG   D W++G  + EM  GE  F  +S ++    IM
Sbjct: 194 ELLV----GDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM 238

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 89.9 bits (224), Expect = 1e-20
 Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 16/169 (9%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           + NL   F+    L+LV +Y C   +L  L +++  +PE + K    + + A+   H  +
Sbjct: 64  LVNLLEVFRRKRRLHLVFEY-CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          D+KP+N+L+  +  I+L DFG    L G      +  V T  Y SP
Sbjct: 123 CIHR----------DVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE-VATRWYRSP 171

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
           E+L     G  +YGP  D W++G    E+L G   +  +S V+    I 
Sbjct: 172 ELLV----GDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIR 216

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 89.2 bits (222), Expect = 2e-20
 Identities = 33/184 (17%), Positives = 67/184 (36%), Gaps = 19/184 (10%)

Query: 86  SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH 145
            +  L+  +   G L  +L +  + + +       A   L +A    + ++H        
Sbjct: 82  PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFA---LDMA--RGMAFLHTLEPLIPR 136

Query: 146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRG 205
               +   +V++D +   R++            + QS   +  P +++PE L   ++   
Sbjct: 137 --HALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEAL--QKKPED 186

Query: 206 RYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKD 265
                 D WS  V ++E++  E PF   S +E   K+        +P      IS     
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPG----ISPHVSK 242

Query: 266 LMRR 269
           LM+ 
Sbjct: 243 LMKI 246

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 88.4 bits (220), Expect = 5e-20
 Identities = 44/168 (26%), Positives = 77/168 (45%), Gaps = 16/168 (9%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I +L      +  L LV ++    DL  +L + +  L +   K Y+ +++  +A  H   
Sbjct: 81  IVSLIDVIHSERCLTLVFEF-MEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR 139

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          D+KP N+L++++G ++LADFG     G      ++  V T  Y +P
Sbjct: 140 ILHR----------DLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAP 188

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
           ++L     G  +Y    D WS+G    EM+ G+  F   +  +   KI
Sbjct: 189 DVLM----GSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI 232

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 88.0 bits (219), Expect = 5e-20
 Identities = 47/168 (27%), Positives = 73/168 (43%), Gaps = 16/168 (9%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L+        L LV ++    DL  LL   E  L    AK ++ +++  IA  HD  
Sbjct: 62  IVKLYDVIHTKKRLVLVFEH-LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          D+KP N+L++  G +++ADFG     G      ++  V T  Y +P
Sbjct: 121 VLHR----------DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAP 169

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
           ++L     G  +Y    D WS+G    EM+ G   F   S  +   +I
Sbjct: 170 DVLM----GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI 213

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 87.2 bits (217), Expect = 1e-19
 Identities = 43/169 (25%), Positives = 68/169 (40%), Gaps = 17/169 (10%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  LH     D  L LV ++ C  DL          L  ++ K ++ +++  +   H  +
Sbjct: 63  IVRLHDVLHSDKKLTLVFEF-CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          D+KP N+L++ NG ++LA+FG     G      S   V T  Y  P
Sbjct: 122 VLHR----------DLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPP 170

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP-FYAESLVETYGKI 242
           ++L     G   Y    D WS G    E+     P F    + +   +I
Sbjct: 171 DVLF----GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 87.4 bits (217), Expect = 1e-19
 Identities = 39/146 (26%), Positives = 62/146 (42%), Gaps = 17/146 (11%)

Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAF-H 145
            + LVM+Y  GG L  +L   E       A        L  +    + Y+H     A  H
Sbjct: 73  PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAH--AMSWCLQCS--QGVAYLHSMQPKALIH 128

Query: 146 LCRDIKPDNVLLDANG-HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR 204
             RD+KP N+LL A G  +++ DFG       D         G+  +++PE+        
Sbjct: 129 --RDLKPPNLLLVAGGTVLKICDFG----TACDIQTHMTNNKGSAAWMAPEVFE-----G 177

Query: 205 GRYGPECDWWSLGVCMYEMLYGETPF 230
             Y  +CD +S G+ ++E++    PF
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPF 203

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 87.2 bits (216), Expect = 2e-19
 Identities = 38/167 (22%), Positives = 61/167 (36%), Gaps = 22/167 (13%)

Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
              LVM+YY  G L   LS                 +  ++     L Y+H       H 
Sbjct: 86  EYLLVMEYYPNGSLXKYLSLHTSDWVSSC------RLAHSVTR--GLAYLHTELPRGDHY 137

Query: 147 C-----RDIKPDNVLLDANGHIRLADFG-------SCLRLGGDGTVQSNVAVGTPDYISP 194
                 RD+   NVL+  +G   ++DFG       + L   G+    +   VGT  Y++P
Sbjct: 138 KPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAP 197

Query: 195 EIL--TAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 239
           E+L              + D ++LG+  +E+    T  +    V  Y
Sbjct: 198 EVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 86.9 bits (216), Expect = 2e-19
 Identities = 45/168 (26%), Positives = 68/168 (40%), Gaps = 16/168 (9%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  LH     + +L LV +Y    DL   L    + +     K ++ +++  +A  H   
Sbjct: 62  IVTLHDIIHTEKSLTLVFEY-LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK 120

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
            +HR          D+KP N+L++  G ++LADFG             N  V T  Y  P
Sbjct: 121 VLHR----------DLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPP 169

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
           +IL     G   Y  + D W +G   YEM  G   F   ++ E    I
Sbjct: 170 DILL----GSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFI 213

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 83.9 bits (208), Expect = 1e-18
 Identities = 36/149 (24%), Positives = 62/149 (41%), Gaps = 22/149 (14%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
             +VM++   GDL   L      +   +       ++L IA    + Y+   N    H  
Sbjct: 96  PRMVMEFVPCGDLYHRLLDKAHPIKWSV----KLRLMLDIA--LGIEYMQNQNPPIVH-- 147

Query: 148 RDIKPDNVLLDANG-----HIRLADFG-SCLRLGGDGTVQSNVAVGTPDYISPEILTAME 201
           RD++  N+ L +         ++ADFG S            +  +G   +++PE + A E
Sbjct: 148 RDLRSPNIFLQSLDENAPVCAKVADFGLSQQS-----VHSVSGLLGNFQWMAPETIGAEE 202

Query: 202 EGRGRYGPECDWWSLGVCMYEMLYGETPF 230
           E    Y  + D +S  + +Y +L GE PF
Sbjct: 203 E---SYTEKADTYSFAMILYTILTGEGPF 228

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 83.6 bits (207), Expect = 2e-18
 Identities = 32/148 (21%), Positives = 59/148 (39%), Gaps = 8/148 (5%)

Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
            L+L+  Y+  G L   L      L        +  +   +A +H   +  +      H 
Sbjct: 80  QLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAH- 136

Query: 147 CRDIKPDNVLLDANGHIRLADFG-SCLRLGGDGTVQ--SNVAVGTPDYISPEILT-AMEE 202
            RD+K  N+L+  NG   +AD G + +       +   +N  VGT  Y++PE+L   ++ 
Sbjct: 137 -RDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV 195

Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPF 230
                    D W+ G+ ++E+       
Sbjct: 196 DCFDSYKRVDIWAFGLVLWEVARRMVSN 223

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 83.0 bits (206), Expect = 4e-18
 Identities = 42/184 (22%), Positives = 71/184 (38%), Gaps = 43/184 (23%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-----LPEDMAKFYIAEMVLAIAS 129
           I  L+     ++ L LV ++    DL   +           L  ++ K++  +++  +A 
Sbjct: 65  IVRLYDVIHTENKLTLVFEF-MDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123

Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            H+   +HR          D+KP N+L++  G ++L DFG    L          A G P
Sbjct: 124 CHENKILHR----------DLKPQNLLINKRGQLKLGDFG----LAR--------AFGIP 161

Query: 190 D-----------YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 238
                       Y +P++L     G   Y    D WS G  + EM+ G+  F   +  E 
Sbjct: 162 VNTFSSEVVTLWYRAPDVLM----GSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ 217

Query: 239 YGKI 242
              I
Sbjct: 218 LKLI 221

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 81.9 bits (203), Expect = 6e-18
 Identities = 45/153 (29%), Positives = 71/153 (46%), Gaps = 27/153 (17%)

Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAF-H 145
           NL LVM++  GG L  +LS    R+P D+    +    + IA    ++Y+H        H
Sbjct: 80  NLCLVMEFARGGPLNRVLSG--KRIPPDI----LVNWAVQIAR--GMNYLHDEAIVPIIH 131

Query: 146 LCRDIKPDNVLLD--------ANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEIL 197
             RD+K  N+L+         +N  +++ DFG   R     T  S  A G   +++PE++
Sbjct: 132 --RDLKSSNILILQKVENGDLSNKILKITDFGLA-REWHRTTKMS--AAGAYAWMAPEVI 186

Query: 198 TAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                    +    D WS GV ++E+L GE PF
Sbjct: 187 R-----ASMFSKGSDVWSYGVLLWELLTGEVPF 214

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 82.6 bits (205), Expect = 7e-18
 Identities = 48/162 (29%), Positives = 75/162 (46%), Gaps = 21/162 (12%)

Query: 83  QDDSNLYLVMDYYCGGDLLTLLSKFEDR-LPEDMAKFYIAEMVLAIASIHDLHYVHRPNH 141
             ++ L LV ++    DL T L K  +  +P +  K  + +++  +  +H    VHR   
Sbjct: 89  DRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHR--- 144

Query: 142 FAFHLCRDIKPDNVLLDANGHIRLADFGSCL-RLGGDGTVQSNVAVGTPDYISPEILTAM 200
                  D+KP N+L+ ++G I+LADFG  L R+       ++V V T  Y +PE+L   
Sbjct: 145 -------DLKPQNILVTSSGQIKLADFG--LARIYSFQMALTSVVV-TLWYRAPEVLL-- 192

Query: 201 EEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
                 Y    D WS+G    EM   +  F   S V+  GKI
Sbjct: 193 --QS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 231

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 82.1 bits (203), Expect = 1e-17
 Identities = 34/154 (22%), Positives = 58/154 (37%), Gaps = 23/154 (14%)

Query: 88  LYLVMDYYCGGDLLTLLSK----FEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFA 143
           L+L+  ++  G L   L      + +             +   +A    L Y+H      
Sbjct: 97  LWLITAFHEKGSLSDFLKANVVSWNELC----------HIAETMAR--GLAYLHEDIPGL 144

Query: 144 FHLC------RDIKPDNVLLDANGHIRLADFG-SCLRLGGDGTVQSNVAVGTPDYISPEI 196
                     RDIK  NVLL  N    +ADFG +     G     ++  VGT  Y++PE+
Sbjct: 145 KDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEV 204

Query: 197 LTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
           L      +       D +++G+ ++E+    T  
Sbjct: 205 LEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 46/161 (28%), Positives = 70/161 (43%), Gaps = 21/161 (13%)

Query: 84  DDSNLYLVMDYYCGGDLLTLLSKFEDR-LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHF 142
            +  + LV ++    DL T L K     LP +  K  + + +  +  +H    VHR    
Sbjct: 90  REIKVTLVFEH-VDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHR---- 144

Query: 143 AFHLCRDIKPDNVLLDANGHIRLADFGSCL-RLGGDGTVQSNVAVGTPDYISPEILTAME 201
                 D+KP+N+L+ + G ++LADFG  L R+       + V V T  Y +PE+L    
Sbjct: 145 ------DLKPENILVTSGGTVKLADFG--LARIYSYQMALTPVVV-TLWYRAPEVLL--- 192

Query: 202 EGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
                Y    D WS+G    EM   +  F   S  +  GKI
Sbjct: 193 -QS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 231

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 80.1 bits (198), Expect = 4e-17
 Identities = 33/165 (20%), Positives = 61/165 (36%), Gaps = 36/165 (21%)

Query: 84  DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRP 139
            D  L  + +Y  GG L  ++   + + P              IAS    +H ++ +HR 
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQ----RVSFAKDIASGMAYLHSMNIIHR- 132

Query: 140 NHFAFHLCRDIKPDNVLLDANGHIRLADFG-SCL------------RLGGDGTVQSNVAV 186
                    D+   N L+  N ++ +ADFG + L             L      +    V
Sbjct: 133 ---------DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183

Query: 187 GTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
           G P +++PE++         Y  + D +S G+ + E++       
Sbjct: 184 GNPYWMAPEMIN-----GRSYDEKVDVFSFGIVLCEIIGRVNADP 223

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 80.3 bits (199), Expect = 4e-17
 Identities = 48/180 (26%), Positives = 76/180 (42%), Gaps = 40/180 (22%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L  AF   SN+ LV D+    DL  ++      L     K Y+   +  +  +H   
Sbjct: 74  IIGLLDAFGHKSNISLVFDF-METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 132

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCL-RLGGDGTVQSNVAVGTPD--- 190
            +HR          D+KP+N+LLD NG ++LADFG  L +           + G+P+   
Sbjct: 133 ILHR----------DLKPNNLLLDENGVLKLADFG--LAK-----------SFGSPNRAY 169

Query: 191 --------YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
                   Y +PE+L     G   YG   D W++G  + E+L        +S ++   +I
Sbjct: 170 THQVVTRWYRAPELLF----GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 225

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 80.5 bits (199), Expect = 4e-17
 Identities = 36/169 (21%), Positives = 65/169 (38%), Gaps = 9/169 (5%)

Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
            LYL+ DY+  G L   L      L            V  +  +H   +  +      H 
Sbjct: 109 QLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAH- 165

Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRL---GGDGTVQSNVAVGTPDYISPEIL-TAMEE 202
            RD+K  N+L+  NG   +AD G  ++      +  +  N  VGT  Y+ PE+L  ++  
Sbjct: 166 -RDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNR 224

Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGKIMNHQNSFD 250
              +     D +S G+ ++E+             +  Y  ++    S++
Sbjct: 225 NHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 79.4 bits (196), Expect = 5e-17
 Identities = 22/197 (11%), Positives = 46/197 (23%), Gaps = 47/197 (23%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           +  +       +   +V ++  GG L  +    +       A   +  +  A  + H   
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADAAHRAG 149

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISP 194
                            P  V +  +G + LA                         +  
Sbjct: 150 VALS----------IDHPSRVRVSIDGDVVLAYPA---------------------TMPD 178

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH-QNSFDLPS 253
                         P+ D   +G  +Y +L    P     +                 P+
Sbjct: 179 A------------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPA 226

Query: 254 DVGYEISDDAKDLMRRL 270
           D+  +I      +  R 
Sbjct: 227 DIDRDIPFQISAVAARS 243

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 80.0 bits (198), Expect = 6e-17
 Identities = 48/227 (21%), Positives = 83/227 (36%), Gaps = 46/227 (20%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  L      +  L+L+ +Y    DL   + K  D +   + K ++ +++  +   H   
Sbjct: 95  IIELKSVIHHNHRLHLIFEY-AENDLKKYMDKNPD-VSMRVIKSFLYQLINGVNFCHSRR 152

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDAN-----GHIRLADFGSCLRLGGDGTVQSNVAVGTP 189
            +HR          D+KP N+LL  +       +++ DFG     G      ++  + T 
Sbjct: 153 CLHR----------DLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TL 201

Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM------ 243
            Y  PEIL     G   Y    D WS+     EML     F  +S ++   KI       
Sbjct: 202 WYRPPEILL----GSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLP 257

Query: 244 ------------NHQNSF------DLPSDVGYEISDDAKDLMRRLIC 272
                       + + SF       L   +G  + D+  DL+  ++ 
Sbjct: 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLE 304

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 46/173 (26%), Positives = 63/173 (36%), Gaps = 24/173 (13%)

Query: 76  TNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHY 135
           T      +   ++YLV D+ C  DL  LLS    +      K  +  ++  +  IH    
Sbjct: 87  TKASPYNRCKGSIYLVFDF-CEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKI 145

Query: 136 VHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCL-RLGGDGTVQSNVAVGTPD---- 190
           +HR          D+K  NVL+  +G ++LADFG  L R        S     T      
Sbjct: 146 LHR----------DMKAANVLITRDGVLKLADFG--LARAFSLA-KNSQPNRYTNRVVTL 192

Query: 191 -YISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 242
            Y  PE+L     G   YGP  D W  G  M EM          +       I
Sbjct: 193 WYRPPELLL----GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 241

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 79.1 bits (195), Expect = 1e-16
 Identities = 41/196 (20%), Positives = 75/196 (38%), Gaps = 22/196 (11%)

Query: 87  NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
            L+LV DY+  G L   L++    +  +            +A +H      +      H 
Sbjct: 114 QLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH- 170

Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRL---GGDGTVQSNVAVGTPDYISPEIL-TAMEE 202
            RD+K  N+L+  NG   +AD G  +R         +  N  VGT  Y++PE+L  ++  
Sbjct: 171 -RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 229

Query: 203 GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDD 262
                    D +++G+  +E+                G   ++Q  +          SD 
Sbjct: 230 KHFESFKRADIYAMGLVFWEIA---------RRCSIGGIHEDYQLPYY-----DLVPSDP 275

Query: 263 AKDLMRRLICSSDTRL 278
           + + MR+++C    R 
Sbjct: 276 SVEEMRKVVCEQKLRP 291

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 77.0 bits (190), Expect = 8e-16
 Identities = 65/294 (22%), Positives = 100/294 (34%), Gaps = 88/294 (29%)

Query: 75  ITNLHYAF------QDDSNLYLVMDYYCGGDL---LTLLSKFEDRLPEDMAKFYIAEMVL 125
           + +L   F      +D+  L LV++Y     +       +K +  +P  + K Y+ +++ 
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEY-VPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152

Query: 126 AIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFGSCLRLGGDGTVQSNV 184
           ++A IH +   HR          DIKP N+LLD   G ++L DFGS   L      + NV
Sbjct: 153 SLAYIHSIGICHR----------DIKPQNLLLDPPSGVLKLIDFGSAKILIAG---EPNV 199

Query: 185 AVGTPDYIS------PE-ILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV- 236
                 YI       PE I  A       Y    D WS G  M E++ G+  F  ES + 
Sbjct: 200 -----SYICSRYYRAPELIFGATN-----YTTNIDIWSTGCVMAELMQGQPLFPGESGID 249

Query: 237 --------------ETYGKIMNHQNSFDLP--------SDVGYEISDDAKDLMRR-LICS 273
                         E    +  +      P                 DA DL+ R L  +
Sbjct: 250 QLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYT 309

Query: 274 SDTRLGQNGIADFKMWSALFVSLSISPR---NHPWFQGIAWDSIRDSNAPYIPE 324
              R                    ++      HP+F  +     R  N   +P 
Sbjct: 310 PSAR--------------------LTAIEALCHPFFDELRTGEARMPNGRELPP 343

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 54/187 (28%), Positives = 79/187 (42%), Gaps = 41/187 (21%)

Query: 75  ITNLHYAF------QDDSNLYLVMDYYCGGDL---LTLLSKFEDRLPEDMAKFYIAEMVL 125
           I  L Y F      +D+  L LV+DY     +       S+ +  LP    K Y+ ++  
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDY-VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167

Query: 126 AIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADFGSCLRLGGDGTVQSNV 184
           ++A IH     HR          DIKP N+LLD +   ++L DFGS  +L      + NV
Sbjct: 168 SLAYIHSFGICHR----------DIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNV 214

Query: 185 AVGTPDYIS------PE-ILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 237
                 YI       PE I  A +     Y    D WS G  + E+L G+  F  +S V+
Sbjct: 215 -----SYICSRYYRAPELIFGATD-----YTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 264

Query: 238 TYGKIMN 244
              +I+ 
Sbjct: 265 QLVEIIK 271

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 41/159 (25%), Positives = 67/159 (42%), Gaps = 23/159 (14%)

Query: 75  ITNLHYAFQDDS--NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD 132
           I  L    +D       LV ++    D   L       L +   +FY+ E++ A+   H 
Sbjct: 93  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHS 148

Query: 133 LHYVHRPNHFAFHLCRDIKPDNVLLD-ANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDY 191
           +  +HR          D+KP NV++D  +  +RL D+G  L        + NV V +  +
Sbjct: 149 MGIMHR----------DVKPHNVMIDHEHRKLRLIDWG--LAEFYHPGQEYNVRVASRYF 196

Query: 192 ISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
             PE+L   +     Y    D WSLG  +  M++ + PF
Sbjct: 197 KGPELLVDYQM----YDYSLDMWSLGCMLASMIFRKEPF 231

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 72.2 bits (177), Expect = 4e-14
 Identities = 36/190 (18%), Positives = 78/190 (41%), Gaps = 25/190 (13%)

Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH 141
            ++  ++YLVM+     +L  ++      L  +   + + +M+  I  +H    +HR   
Sbjct: 136 LEEFQDVYLVMELM-DANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHR--- 188

Query: 142 FAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAME 201
                  D+KP N+++ ++  +++ DFG     G    +   V   T  Y +PE++  M 
Sbjct: 189 -------DLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGM- 238

Query: 202 EGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYE-IS 260
                Y    D WS+G  M EM+  +  F     ++ + K++    +   P     + + 
Sbjct: 239 ----GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT---PCPEFMKKLQ 291

Query: 261 DDAKDLMRRL 270
              ++ +   
Sbjct: 292 PTVRNYVENR 301

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 58/234 (24%), Positives = 93/234 (39%), Gaps = 54/234 (23%)

Query: 75  ITNLHYAF-------QDDSNLYLVMDYYCGGDL---LTLLSKFEDRLPEDMAKFYIAEMV 124
           I  L   F       + D  L +VM+Y     L        + +   P  + K ++ +++
Sbjct: 81  IVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139

Query: 125 LAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD-ANGHIRLADFGSCLRLGGDGTVQSN 183
            +I        +H P+    H  RDIKP NVL++ A+G ++L DFGS  +L      + N
Sbjct: 140 RSIG------CLHLPSVNVCH--RDIKPHNVLVNEADGTLKLCDFGSAKKLSPS---EPN 188

Query: 184 VA-VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ 236
           VA + +  Y +PE++     G   Y    D WS+G    EM+ GE  F  ++        
Sbjct: 189 VAYICSRYYRAPELIF----GNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI 244

Query: 237 ---------ETYGKIMNHQNSFDLP-----------SDVGYEISDDAKDLMRRL 270
                    E   K+       DL            SD   + + +A DL+  L
Sbjct: 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSAL 298

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 71.3 bits (175), Expect = 6e-14
 Identities = 45/168 (26%), Positives = 78/168 (46%), Gaps = 25/168 (14%)

Query: 83  QDDSNLYLVMDYYCGGDL---LTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRP 139
             +  L ++M+Y     L   L    +    +P ++   YI ++  A+  IH L   HR 
Sbjct: 108 SQNKYLNVIMEYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHR- 165

Query: 140 NHFAFHLCRDIKPDNVLLDAN-GHIRLADFGSCLRLGGDGTVQSNVA-VGTPDYISPE-I 196
                    DIKP N+L+++    ++L DFGS  +L      + +VA + +  Y +PE +
Sbjct: 166 ---------DIKPQNLLVNSKDNTLKLCDFGSAKKLIPS---EPSVAYICSRFYRAPELM 213

Query: 197 LTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
           L A E     Y P  D WS+G    E++ G+  F  E+ ++   +I+ 
Sbjct: 214 LGATE-----YTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQ 256

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 44/189 (23%), Positives = 79/189 (41%), Gaps = 23/189 (12%)

Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH 141
            ++  + YLVM +    DL  ++     +  E+  ++ + +M+  +  IH    VHR   
Sbjct: 98  LRNFYDFYLVMPFM-QTDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAGVVHR--- 150

Query: 142 FAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAME 201
                  D+KP N+ ++ +  +++ DFG  L    D  +   V   T  Y +PE++    
Sbjct: 151 -------DLKPGNLAVNEDCELKILDFG--LARHADAEMTGYVV--TRWYRAPEVIL--- 196

Query: 202 EGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISD 261
                Y    D WS+G  M EML G+T F  +  ++   +I+           V      
Sbjct: 197 -SWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG-TEFVQKLNDK 254

Query: 262 DAKDLMRRL 270
            AK  ++ L
Sbjct: 255 AAKSYIQSL 263

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 54/189 (28%), Positives = 86/189 (45%), Gaps = 25/189 (13%)

Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH 141
           F D    YLVM +  G DL  L+    ++L ED  +F + +M+  +  IH    +HR   
Sbjct: 102 FTD---FYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHR--- 152

Query: 142 FAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAME 201
                  D+KP N+ ++ +  +++ DFG  L    D  +   V   T  Y +PE++    
Sbjct: 153 -------DLKPGNLAVNEDCELKILDFG--LARQADSEMTGYVV--TRWYRAPEVIL--- 198

Query: 202 EGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISD 261
               RY    D WS+G  M EM+ G+T F     ++   +IM    +      V    SD
Sbjct: 199 -NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP-AEFVQRLQSD 256

Query: 262 DAKDLMRRL 270
           +AK+ M+ L
Sbjct: 257 EAKNYMKGL 265

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 39/190 (20%), Positives = 77/190 (40%), Gaps = 28/190 (14%)

Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH 141
           FQD   +Y+VM+     +L  ++      L  +   + + +M+  I  +H    +HR   
Sbjct: 102 FQD---VYIVMELM-DANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHR--- 151

Query: 142 FAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAME 201
                  D+KP N+++ ++  +++ DFG  L      +      V T  Y +PE++  M 
Sbjct: 152 -------DLKPSNIVVKSDCTLKILDFG--LARTAGTSFMMTPYVVTRYYRAPEVILGM- 201

Query: 202 EGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYE-IS 260
                Y    D WS+G  M EM+ G   F     ++ + K++    +   P     + + 
Sbjct: 202 ----GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT---PCPEFMKKLQ 254

Query: 261 DDAKDLMRRL 270
              +  +   
Sbjct: 255 PTVRTYVENR 264

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 44/179 (24%), Positives = 71/179 (39%), Gaps = 37/179 (20%)

Query: 75  ITNLHYAFQD--DSNLYLVMDYYCGGDLLTLL--------SKFEDRLPEDMAKFYIAEMV 124
           + +L   F    D  ++L+ DY    DL  ++        +K   +LP  M K  + +++
Sbjct: 80  VISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138

Query: 125 LAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA----NGHIRLADFGSCL-RLGGDG- 178
             I  +H    +HR          D+KP N+L+       G +++AD G    RL     
Sbjct: 139 DGIHYLHANWVLHR----------DLKPANILVMGEGPERGRVKIADMG--FARLFNSPL 186

Query: 179 ---TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES 234
                   V V T  Y +PE+L     G   Y    D W++G    E+L  E  F+   
Sbjct: 187 KPLADLDPVVV-TFWYRAPELLL----GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 68.9 bits (169), Expect = 4e-13
 Identities = 41/188 (21%), Positives = 67/188 (35%), Gaps = 21/188 (11%)

Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH 141
                 LYLV +     DL  ++      +     ++++  ++L +  +H+   VHR   
Sbjct: 106 MHK---LYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHR--- 158

Query: 142 FAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAME 201
                  D+ P N+LL  N  I + DF        D      V      Y +PE++    
Sbjct: 159 -------DLHPGNILLADNNDITICDFNLAREDTADANKTHYVT--HRWYRAPELVM--- 206

Query: 202 EGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISD 261
                +    D WS G  M EM   +  F   +      KI+    +     DV    S 
Sbjct: 207 -QFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK-IEDVVMFSSP 264

Query: 262 DAKDLMRR 269
            A+D +R 
Sbjct: 265 SARDYLRN 272

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 68.1 bits (167), Expect = 6e-13
 Identities = 44/189 (23%), Positives = 82/189 (43%), Gaps = 22/189 (11%)

Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH 141
            ++ +++YLV     G DL  ++     +L +D  +F I +++  +  IH    +HR   
Sbjct: 103 LEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR--- 156

Query: 142 FAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAME 201
                  D+KP N+ ++ +  +++ DFG  L       +   VA  T  Y +PEI+    
Sbjct: 157 -------DLKPSNLAVNEDCELKILDFG--LARHTADEMTGYVA--TRWYRAPEIML--- 202

Query: 202 EGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISD 261
                Y    D WS+G  M E+L G T F     ++    I+    +      +    S+
Sbjct: 203 -NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 260

Query: 262 DAKDLMRRL 270
            A++ ++ L
Sbjct: 261 SARNYIQSL 269

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 67.7 bits (166), Expect = 9e-13
 Identities = 40/165 (24%), Positives = 63/165 (38%), Gaps = 29/165 (17%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRPNHFA 143
           +Y+VM+   GGD LT L     RL        + +MV   A+    +     +HR     
Sbjct: 187 IYIVMELVQGGDFLTFLRTEGARLRVKT----LLQMVGDAAAGMEYLESKCCIHR----- 237

Query: 144 FHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYI---SPEILTAM 200
                D+   N L+     ++++DFG            S      P  +   +PE L   
Sbjct: 238 -----DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVP--VKWTAPEALN-- 288

Query: 201 EEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
               GRY  E D WS G+ ++E    G +P+   S  +T   +  
Sbjct: 289 ---YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK 330

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 67.4 bits (165), Expect = 9e-13
 Identities = 38/166 (22%), Positives = 73/166 (43%), Gaps = 30/166 (18%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRPNHFA 143
           + ++ +Y   G L   L + +           +  M+  IA+    + +++YVHR     
Sbjct: 121 MMIITEYMENGALDKFLREKDGEFSVLQ----LVGMLRGIAAGMKYLANMNYVHR----- 171

Query: 144 FHLCRDIKPDNVLLDANGHIRLADFGSCL-RLGGDGTVQSNVAVGTPDYI---SPEILTA 199
                D+   N+L+++N   +++DFG  L R+  D    +    G    I   +PE ++ 
Sbjct: 172 -----DLAARNILVNSNLVCKVSDFG--LSRVLEDDPEATYTTSGGKIPIRWTAPEAIS- 223

Query: 200 MEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
                 ++    D WS G+ M+E++ YGE P++  S  E    I +
Sbjct: 224 ----YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 265

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 36/178 (20%), Positives = 72/178 (40%), Gaps = 27/178 (15%)

Query: 71  DRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-LPEDMAKFYIAEMVLAIAS 129
           +   + ++   F   +++ +  +     +L  L+ K + +     + + +   ++  + +
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDA 215

Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH--IRLADFGSCLRLGGDGT--VQSNVA 185
           +H    +H         C D+KP+N+LL   G   I++ DFGS           +QS   
Sbjct: 216 LHKNRIIH---------C-DLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF- 264

Query: 186 VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
                Y +PE++        RYG   D WSLG  + E+L G      E   +    ++
Sbjct: 265 -----YRAPEVILGA-----RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMI 312

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 40/166 (24%), Positives = 72/166 (43%), Gaps = 30/166 (18%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRPNHFA 143
           + +V +Y   G L + L K + +         +  M+  IAS    + D+ YVHR     
Sbjct: 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQ----LVGMLRGIASGMKYLSDMGYVHR----- 171

Query: 144 FHLCRDIKPDNVLLDANGHIRLADFGSCL-RLGGDGTVQSNVAVGTPDYI---SPEILTA 199
                D+   N+L+++N   +++DFG  L R+  D    +    G    I   SPE +  
Sbjct: 172 -----DLAARNILINSNLVCKVSDFG--LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA- 223

Query: 200 MEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
                 ++    D WS G+ ++E++ YGE P++  S  +    +  
Sbjct: 224 ----YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE 265

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 65.0 bits (159), Expect = 4e-12
 Identities = 32/164 (19%), Positives = 56/164 (34%), Gaps = 30/164 (18%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRPNHFA 143
           + +V +    G LL  L K +           ++   + +A     +    ++HR     
Sbjct: 95  MKMVTELAPLGSLLDRLRKHQGHFLLGT----LSRYAVQVAEGMGYLESKRFIHR----- 145

Query: 144 FHLCRDIKPDNVLLDANGHIRLADFG-SCLRLGGDGTVQSNVAVGTPDYI---SPEILTA 199
                D+   N+LL     +++ DFG        D           P      +PE L  
Sbjct: 146 -----DLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP--FAWCAPESLK- 197

Query: 200 MEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKI 242
                  +    D W  GV ++EM  YG+ P+   +  +   KI
Sbjct: 198 ----TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 65.0 bits (159), Expect = 6e-12
 Identities = 41/166 (24%), Positives = 68/166 (40%), Gaps = 30/166 (18%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRPNHFA 143
             +V +Y   G L T L   + +         +  M+  + +    + DL YVHR     
Sbjct: 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQ----LVGMLRGVGAGMRYLSDLGYVHR----- 175

Query: 144 FHLCRDIKPDNVLLDANGHIRLADFGSCL-RLGGDGTVQSNVAVGTPDYI---SPEILTA 199
                D+   NVL+D+N   +++DFG  L R+  D    +    G    I   +PE +  
Sbjct: 176 -----DLAARNVLVDSNLVCKVSDFG--LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA- 227

Query: 200 MEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
                  +    D WS GV M+E+L YGE P++  +  +    +  
Sbjct: 228 ----FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE 269

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 65.0 bits (159), Expect = 7e-12
 Identities = 37/198 (18%), Positives = 82/198 (41%), Gaps = 26/198 (13%)

Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH 141
           F++ + +Y++ +     DL  ++S     L +D  +++I + + A+  +H  + +HR   
Sbjct: 83  FENFNEVYIIQELM-QTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHR--- 136

Query: 142 FAFHLCRDIKPDNVLLDANGHIRLADFG---SCLRLGGDGTVQSNVAVGTPDYIS----- 193
                  D+KP N+L+++N  +++ DFG          D +  +    G  ++++     
Sbjct: 137 -------DLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR 189

Query: 194 -PEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLP 252
            PE++        +Y    D WS G  + E+      F           I     +    
Sbjct: 190 APEVML----TSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245

Query: 253 SDVGYEISDDAKDLMRRL 270
           +D+    S  A++ ++ L
Sbjct: 246 NDLRCIESPRAREYIKSL 263

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 65.4 bits (159), Expect = 8e-12
 Identities = 40/162 (24%), Positives = 67/162 (41%), Gaps = 26/162 (16%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRPNHFA 143
           L LVM+   GG L   L    + +P       +AE++  ++     + + ++VHR     
Sbjct: 410 LMLVMEMAGGGPLHKFLVGKREEIPVSN----VAELLHQVSMGMKYLEEKNFVHR----- 460

Query: 144 FHLCRDIKPDNVLLDANGHIRLADFG-SCLRLGGDGTVQSNVAVGTP-DYISPEILTAME 201
                ++   NVLL    + +++DFG S      D    +  A   P  + +PE +    
Sbjct: 461 -----NLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN--- 512

Query: 202 EGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKI 242
               ++    D WS GV M+E L YG+ P+      E    I
Sbjct: 513 --FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 63.8 bits (156), Expect = 1e-11
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 30/164 (18%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRPNHFA 143
           L LVM+   GG L   L    + +P       +AE++  ++     + + ++VH      
Sbjct: 84  LMLVMEMAGGGPLHKFLVGKREEIPVSN----VAELLHQVSMGMKYLEEKNFVH------ 133

Query: 144 FHLCRDIKPDNVLLDANGHIRLADFG-SCLRLGGDGTVQSNVAVGTPDYI---SPEILTA 199
               RD+   NVLL    + +++DFG S      D    +  A   P  +   +PE +  
Sbjct: 134 ----RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP--LKWYAPECIN- 186

Query: 200 MEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKI 242
                 ++    D WS GV M+E L YG+ P+      E    I
Sbjct: 187 ----FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 37/148 (25%), Positives = 63/148 (42%), Gaps = 31/148 (20%)

Query: 97  GGDLLTLLSKFEDR-LPEDMAKFYIAEMVLAIASIHD-LHYVHRPNHFAFHLCRDIKPDN 154
           G +LL L+ K+E R +P    K    +++L +  +H     +H           DIKP+N
Sbjct: 113 GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIH---------T-DIKPEN 162

Query: 155 VLLD------ANGHIRLADFGSCLRLGGDGT--VQSNVAVGTPDYISPEILTAMEEGRGR 206
           VL++          I++AD G+        T  +Q+        Y SPE+L         
Sbjct: 163 VLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE------YRSPEVLLGA-----P 211

Query: 207 YGPECDWWSLGVCMYEMLYGETPFYAES 234
           +G   D WS    ++E++ G+  F  + 
Sbjct: 212 WGCGADIWSTACLIFELITGDFLFEPDE 239

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 63.8 bits (156), Expect = 2e-11
 Identities = 45/193 (23%), Positives = 77/193 (39%), Gaps = 24/193 (12%)

Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH 141
            +   ++Y+V D     DL  LL      L  D   +++ +++  +  IH  + +HR   
Sbjct: 99  IEQMKDVYIVQDLM-ETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHR--- 152

Query: 142 FAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVA----VGTPDYISPEIL 197
                  D+KP N+LL+    +++ DFG  L    D            V T  Y +PEI+
Sbjct: 153 -------DLKPSNLLLNTTCDLKICDFG--LARVADPDHDHTGFLTEYVATRWYRAPEIM 203

Query: 198 TAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGY 257
                    Y    D WS+G  + EML     F  +  ++    I+    S     D+  
Sbjct: 204 L----NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS-QEDLNC 258

Query: 258 EISDDAKDLMRRL 270
            I+  A++ +  L
Sbjct: 259 IINLKARNYLLSL 271

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 35/162 (21%), Positives = 67/162 (41%), Gaps = 24/162 (14%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRPNHFA 143
           ++++M+    G+L + L   +  L        +      +++    +    +VH      
Sbjct: 465 VWIIMELCTLGELRSFLQVRKFSLDLAS----LILYAYQLSTALAYLESKRFVH------ 514

Query: 144 FHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEG 203
               RDI   NVL+ +N  ++L DFG    +      +++       +++PE +      
Sbjct: 515 ----RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF---- 566

Query: 204 RGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
             R+    D W  GVCM+E+L +G  PF      +  G+I N
Sbjct: 567 -RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 607

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 62.2 bits (152), Expect = 3e-11
 Identities = 39/175 (22%), Positives = 65/175 (37%), Gaps = 50/175 (28%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRPNHFA 143
            +++M+ Y  G+L   L + ++ L        +    L I      +  ++ VH      
Sbjct: 87  TWIIMELYPYGELGHYLERNKNSLKVLT----LVLYSLQICKAMAYLESINCVH------ 136

Query: 144 FHLCRDIKPDNVLLDANGHIRLADFGSCL-RLGGDGTVQSNVAVGTPDYI---------- 192
               RDI   N+L+ +   ++L DFG  L R   D            DY           
Sbjct: 137 ----RDIAVRNILVASPECVKLGDFG--LSRYIEDE-----------DYYKASVTRLPIK 179

Query: 193 --SPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
             SPE +        R+    D W   VCM+E+L +G+ PF+     +  G +  
Sbjct: 180 WMSPESINF-----RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK 229

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 62.3 bits (152), Expect = 5e-11
 Identities = 33/164 (20%), Positives = 60/164 (36%), Gaps = 31/164 (18%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRPNHFA 143
           + L+      G LL  + + +D +        +    + IA     + D   VHR     
Sbjct: 91  VQLITQLMPFGCLLDYVREHKDNIGSQY----LLNWCVQIAKGMNYLEDRRLVHR----- 141

Query: 144 FHLCRDIKPDNVLLDANGHIRLADFG-SCLRLGGDGTVQSNVAVGTPDYI---SPEILTA 199
                D+   NVL+    H+++ DFG + L    +    +      P  I   + E +  
Sbjct: 142 -----DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK-VP--IKWMALESIL- 192

Query: 200 MEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKI 242
                  Y  + D WS GV ++E++ +G  P+      E    +
Sbjct: 193 ----HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 61.5 bits (150), Expect = 5e-11
 Identities = 35/162 (21%), Positives = 67/162 (41%), Gaps = 24/162 (14%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRPNHFA 143
           ++++M+    G+L + L   +  L        +      +++    +    +VH      
Sbjct: 90  VWIIMELCTLGELRSFLQVRKYSLDLAS----LILYAYQLSTALAYLESKRFVH------ 139

Query: 144 FHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEG 203
               RDI   NVL+ +N  ++L DFG    +      +++       +++PE +      
Sbjct: 140 ----RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF---- 191

Query: 204 RGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
             R+    D W  GVCM+E+L +G  PF      +  G+I N
Sbjct: 192 -RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 232

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 60.7 bits (148), Expect = 1e-10
 Identities = 38/164 (23%), Positives = 62/164 (37%), Gaps = 32/164 (19%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRPNHFA 143
           + LV ++   G L   L         +     +  M L +      + +   +H      
Sbjct: 78  ICLVTEFMEHGCLSDYLRTQRGLFAAET----LLGMCLDVCEGMAYLEEACVIH------ 127

Query: 144 FHLCRDIKPDNVLLDANGHIRLADFGSCL-RLGGDGTVQSNVAVGTPDYI---SPEILTA 199
               RD+   N L+  N  I+++DFG  + R   D    S+     P  +   SPE+ + 
Sbjct: 128 ----RDLAARNCLVGENQVIKVSDFG--MTRFVLDDQYTSSTGTKFP--VKWASPEVFS- 178

Query: 200 MEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKI 242
                 RY  + D WS GV M+E+   G+ P+   S  E    I
Sbjct: 179 ----FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 60.3 bits (147), Expect = 2e-10
 Identities = 34/164 (20%), Positives = 64/164 (39%), Gaps = 31/164 (18%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRPNHFA 143
             LVM+    G L   L +      +++      E+V  ++     + + ++VHR     
Sbjct: 92  WMLVMEMAELGPLNKYLQQNRHVKDKNII-----ELVHQVSMGMKYLEESNFVHR----- 141

Query: 144 FHLCRDIKPDNVLLDANGHIRLADFG-SCLRLGGDGTVQSNVAVGTPDYI---SPEILTA 199
                D+   NVLL    + +++DFG S      +   ++      P  +   +PE +  
Sbjct: 142 -----DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP--VKWYAPECIN- 193

Query: 200 MEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKI 242
                 ++  + D WS GV M+E   YG+ P+      E    +
Sbjct: 194 ----YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 39/115 (33%), Positives = 53/115 (46%), Gaps = 17/115 (14%)

Query: 133 LHYVHRPNHFAFHLCRDIKPDNVLLDANGH--IRLADFGSCLRLGGDGT--VQSNVAVGT 188
           L ++  P     H C D+KP+N+LL       I++ DFGS  +LG      +QS      
Sbjct: 170 LLFLATPELSIIH-C-DLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF---- 223

Query: 189 PDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
             Y SPE+L  M      Y    D WSLG  + EM  GE  F   + V+   KI+
Sbjct: 224 --YRSPEVLLGM-----PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 271

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 59.5 bits (145), Expect = 4e-10
 Identities = 34/112 (30%), Positives = 55/112 (49%), Gaps = 19/112 (16%)

Query: 133 LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCL-RLG--GDGTVQSNVAVGTP 189
           ++++H  +H   H  RDIK  N+LLD     +++DFG  L R       TV ++  VGT 
Sbjct: 146 INFLHENHHI--H--RDIKSANILLDEAFTAKISDFG--LARASEKFAQTVMTSRIVGTT 199

Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA----ESLVE 237
            Y++PE L       G   P+ D +S GV + E++ G          + L++
Sbjct: 200 AYMAPEALR------GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 59.3 bits (144), Expect = 4e-10
 Identities = 33/163 (20%), Positives = 60/163 (36%), Gaps = 25/163 (15%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRPNHFA 143
           + L+      G LL  + + +D +        +    + IA     + D   VHR     
Sbjct: 91  VQLITQLMPFGCLLDYVREHKDNIGSQY----LLNWCVQIAKGMNYLEDRRLVHR----- 141

Query: 144 FHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEE 202
                D+   NVL+    H+++ DFG    LG +           P  +++ E +     
Sbjct: 142 -----DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL---- 192

Query: 203 GRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
               Y  + D WS GV ++E++ +G  P+      E    +  
Sbjct: 193 -HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 58.4 bits (142), Expect = 6e-10
 Identities = 37/166 (22%), Positives = 67/166 (40%), Gaps = 32/166 (19%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRPNHFA 143
           ++++ +Y   G LL  L +   R         + EM   +      +    ++H      
Sbjct: 94  IFIITEYMANGCLLNYLREMRHRFQTQQ----LLEMCKDVCEAMEYLESKQFLH------ 143

Query: 144 FHLCRDIKPDNVLLDANGHIRLADFGSCL-RLGGDGTVQSNVAVGTPDYI---SPEILTA 199
               RD+   N L++  G ++++DFG  L R   D    S+V    P  +    PE+L  
Sbjct: 144 ----RDLAARNCLVNDQGVVKVSDFG--LSRYVLDDEYTSSVGSKFP--VRWSPPEVLM- 194

Query: 200 MEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
                 ++  + D W+ GV M+E+   G+ P+   +  ET   I  
Sbjct: 195 ----YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 58.4 bits (142), Expect = 9e-10
 Identities = 39/168 (23%), Positives = 69/168 (41%), Gaps = 27/168 (16%)

Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH 141
                 +Y+V +Y    DL  +L +    L E+ A+ ++ +++  +  IH  + +HR   
Sbjct: 94  LNS---VYIVQEYM-ETDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHR--- 144

Query: 142 FAFHLCRDIKPDNVLLDA-NGHIRLADFGSCLRLGGDGTVQSNVA----VGTPDYISPEI 196
                  D+KP N+ ++  +  +++ DFG  L    D            + T  Y SP +
Sbjct: 145 -------DLKPANLFINTEDLVLKIGDFG--LARIMDPHYSHKGHLSEGLVTKWYRSPRL 195

Query: 197 LTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 244
           L +       Y    D W+ G    EML G+T F     +E    I+ 
Sbjct: 196 LLSPN----NYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 59.0 bits (143), Expect = 9e-10
 Identities = 33/166 (19%), Positives = 70/166 (42%), Gaps = 23/166 (13%)

Query: 84  DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRP 139
            +   Y++ ++   G+LL  L +      ++++   +  M   I+S    +   +++HR 
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKNFIHR- 342

Query: 140 NHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTA 199
                    ++   N L+  N  +++ADFG    + GD       A     + +PE L  
Sbjct: 343 ---------NLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA- 392

Query: 200 MEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
                 ++  + D W+ GV ++E+  YG +P+    L + Y  +  
Sbjct: 393 ----YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 57.6 bits (140), Expect = 9e-10
 Identities = 36/166 (21%), Positives = 66/166 (39%), Gaps = 32/166 (19%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRPNHFA 143
           +Y+V +Y   G LL  L      L        + EM   +      +    ++HR     
Sbjct: 78  IYIVTEYISNGCLLNYLRSHGKGLEPSQ----LLEMCYDVCEGMAFLESHQFIHR----- 128

Query: 144 FHLCRDIKPDNVLLDANGHIRLADFGSCL-RLGGDGTVQSNVAVGTPDYI---SPEILTA 199
                D+   N L+D +  ++++DFG  + R   D    S+V    P  +   +PE+   
Sbjct: 129 -----DLAARNCLVDRDLCVKVSDFG--MTRYVLDDQYVSSVGTKFP--VKWSAPEVFH- 178

Query: 200 MEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
                 +Y  + D W+ G+ M+E+   G+ P+   +  E   K+  
Sbjct: 179 ----YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ 220

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 40/164 (24%), Positives = 67/164 (40%), Gaps = 27/164 (16%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRPNHFA 143
           +Y+V +Y   G LL  L        + +    + +M   IAS    +  ++YVHR     
Sbjct: 253 IYIVTEYMSKGSLLDFLKG---ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR----- 304

Query: 144 FHLCRDIKPDNVLLDANGHIRLADFGSCL-RLGGDGTVQSNVAVGTP-DYISPEILTAME 201
                D++  N+L+  N   ++ADFG  L RL  D    +      P  + +PE      
Sbjct: 305 -----DLRAANILVGENLVCKVADFG--LARLIEDNEYTARQGAKFPIKWTAPEAAL--- 354

Query: 202 EGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
              GR+  + D WS G+ + E+   G  P+      E   ++  
Sbjct: 355 --YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 41/171 (23%), Positives = 64/171 (37%), Gaps = 41/171 (23%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPE-----DMAK------FYIAEMVLAIASIHDLHYV 136
           +Y+V +Y   G LL  L     +        DMA        Y+  M          +YV
Sbjct: 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM----------NYV 385

Query: 137 HRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCL-RLGGDGTVQSNVAVGTP-DYISP 194
           HR          D++  N+L+  N   ++ADFG  L RL  D    +      P  + +P
Sbjct: 386 HR----------DLRAANILVGENLVCKVADFG--LARLIEDNEYTARQGAKFPIKWTAP 433

Query: 195 EILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
           E         GR+  + D WS G+ + E+   G  P+      E   ++  
Sbjct: 434 EAAL-----YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 57/220 (25%), Positives = 91/220 (41%), Gaps = 44/220 (20%)

Query: 75  ITNLHYAFQDDSN--LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD 132
           I NL    + D++  +YLV DY    DL  ++    + L     ++ + +++  I  +H 
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHS 127

Query: 133 LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG-----------SCLRLGGDGTVQ 181
              +HR          D+KP N+LL+A  H+++ADFG           +           
Sbjct: 128 GGLLHR----------DMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 182 SNVAVGTP---DYIS------PEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA 232
            N     P   DY++      PEIL     G  +Y    D WSLG  + E+L G+  F  
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILL----GSTKYTKGIDMWSLGCILGEILCGKPIFPG 233

Query: 233 ESLVETYGKIMNHQNSFDLPS--DVGYEISDDAKDLMRRL 270
            S +    +I+   +    PS  DV    S  AK ++  L
Sbjct: 234 SSTMNQLERIIGVIDF---PSNEDVESIQSPFAKTMIESL 270

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 57.7 bits (140), Expect = 1e-09
 Identities = 46/290 (15%), Positives = 86/290 (29%), Gaps = 80/290 (27%)

Query: 71  DRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-LPEDMAKFYIAEMVLAIAS 129
                  +   F+   ++ +V +   G      + +        D  +    ++  ++  
Sbjct: 75  STFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNF 133

Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH-------------------IRLADFGS 170
           +H     H           D+KP+N+L   + +                   I++ DFGS
Sbjct: 134 LHSNKLTH---------T-DLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183

Query: 171 -CLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
                  D    S + V T  Y +PE++ A+      +   CD WS+G  + E   G T 
Sbjct: 184 ATY----DDEHHSTL-VSTRHYRAPEVILAL-----GWSQPCDVWSIGCILIEYYLGFTV 233

Query: 230 FYAESLVETYGKIM---------------------NHQNSFDLPSDVGYEISDDAKDLMR 268
           F      E    +                      + +  +D  S  G  +S   K L  
Sbjct: 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKE 293

Query: 269 RLICSSDTRLGQNGIADFKMWSALFVSLSISPR---------NHPWFQGI 309
            ++           + D      +   L   P           HP+F  +
Sbjct: 294 FMLSQDVEH---ERLFDL-----IQKMLEYDPAKRITLREALKHPFFDLL 335

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 31/169 (18%), Positives = 57/169 (33%), Gaps = 42/169 (24%)

Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH 141
            +    LY+V++     D   L  +    L E   K  +  +++ +  +H    +HR   
Sbjct: 126 VEKFDELYVVLEI-ADSDFKKLF-RTPVYLTELHIKTLLYNLLVGVKYVHSAGILHR--- 180

Query: 142 FAFHLCRDIKPDNVLLDANGHIRLADFG-----------SCLRLGGDGTVQSNVAVGTPD 190
                  D+KP N L++ +  +++ DFG           +            N+      
Sbjct: 181 -------DLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHT 233

Query: 191 ---------------YISPEILTAMEEGRGRYGPECDWWSLGVCMYEML 224
                          Y +PE++   E     Y    D WS+G    E+L
Sbjct: 234 KNLKRQLTGHVVTRWYRAPELILLQE----NYTEAIDVWSIGCIFAELL 278

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 38/161 (23%), Positives = 64/161 (39%), Gaps = 25/161 (15%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRPNHFA 143
           L LV  Y   G LL  + +    L   +    +    + IA     + +   VHR     
Sbjct: 89  LQLVTQYLPLGSLLDHVRQHRGALGPQL----LLNWGVQIAKGMYYLEEHGMVHR----- 139

Query: 144 FHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTP-DYISPEILTAMEE 202
                ++   NVLL +   +++ADFG    L  D          TP  +++ E +     
Sbjct: 140 -----NLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF--- 191

Query: 203 GRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKI 242
             G+Y  + D WS GV ++E++ +G  P+    L E    +
Sbjct: 192 --GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 49/305 (16%), Positives = 91/305 (29%), Gaps = 83/305 (27%)

Query: 71  DRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-LPEDMAKFYIAEMVLAIAS 129
           ++     +   F    ++ +  +   G +    L +   +  P    +    ++  A+  
Sbjct: 80  NKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRF 138

Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH-------------------IRLADFGS 170
           +H+    H           D+KP+N+L   +                     IR+ADFGS
Sbjct: 139 LHENQLTH---------T-DLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188

Query: 171 CLRLGGDGT--VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGET 228
                   T  V +        Y  PE++  +      +   CD WS+G  ++E   G T
Sbjct: 189 ATFDHEHHTTIVATRH------YRPPEVILEL-----GWAQPCDVWSIGCILFEYYRGFT 237

Query: 229 PFYAESLVETYGKIM---------------------NHQNSFDLPSDVGYEISDDAKDLM 267
            F      E    +                           +D  S  G  + ++ K L 
Sbjct: 238 LFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLK 297

Query: 268 RRLICSSDTRLGQNGIADFKMWSALFVSLSISPR---------NHPWFQGIAWDSIRDSN 318
             ++  S   +    + D      +   L   P           HP+F G+     R  +
Sbjct: 298 SYMLQDSLEHV---QLFDL-----MRRMLEFDPAQRITLAEALLHPFFAGLT-PEERSFH 348

Query: 319 APYIP 323
               P
Sbjct: 349 TSRNP 353

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 56.2 bits (136), Expect = 4e-09
 Identities = 31/183 (16%), Positives = 67/183 (36%), Gaps = 55/183 (30%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRPNHFA 143
           + L+M++   G L   L K ++++          +  + I      +    YVH      
Sbjct: 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQ----QLKYAVQICKGMDYLGSRQYVH------ 149

Query: 144 FHLCRDIKPDNVLLDANGHIRLADFGSCL-RLGGDGTVQSNVAVGTPDYISPEILTAMEE 202
               RD+   NVL+++   +++ DFG  L +                +Y      T  ++
Sbjct: 150 ----RDLAARNVLVESEHQVKIGDFG--LTKAIETDK----------EYY-----TVKDD 188

Query: 203 GR-------------GRYGPECDWWSLGVCMYEML-YGETPF-----YAESLVETYGKIM 243
                           ++    D WS GV ++E+L Y ++       + + +  T+G++ 
Sbjct: 189 RDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT 248

Query: 244 NHQ 246
             +
Sbjct: 249 VTR 251

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 55.7 bits (135), Expect = 6e-09
 Identities = 31/183 (16%), Positives = 62/183 (33%), Gaps = 51/183 (27%)

Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVH 137
            + + +  +V+ Y   GDL   +               +    L +A     +    +VH
Sbjct: 96  LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD----LIGFGLQVAKGMKYLASKKFVH 151

Query: 138 RPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDY------ 191
           R          D+   N +LD    +++ADFG    L  D        +   +Y      
Sbjct: 152 R----------DLAARNCMLDEKFTVKVADFG----LARD--------MYDKEYYSVHNK 189

Query: 192 ---------ISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGK 241
                    ++ E L        ++  + D WS GV ++E++  G  P+   +  +    
Sbjct: 190 TGAKLPVKWMALESLQ-----TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 244

Query: 242 IMN 244
           ++ 
Sbjct: 245 LLQ 247

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 55.8 bits (135), Expect = 6e-09
 Identities = 35/162 (21%), Positives = 55/162 (33%), Gaps = 48/162 (29%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRPNHFA 143
           L LVM+Y   G L   L +   RL        +      I      +     VH      
Sbjct: 101 LRLVMEYLPSGCLRDFLQRHRARLDASR----LLLYSSQICKGMEYLGSRRCVH------ 150

Query: 144 FHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEG 203
               RD+   N+L+++  H+++ADFG  L         + +     DY         E G
Sbjct: 151 ----RDLAARNILVESEAHVKIADFG--L---------AKLLPLDKDYY-----VVREPG 190

Query: 204 R-------------GRYGPECDWWSLGVCMYEML-YGETPFY 231
           +               +  + D WS GV +YE+  Y +    
Sbjct: 191 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS 232

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 55.4 bits (134), Expect = 7e-09
 Identities = 37/176 (21%), Positives = 64/176 (36%), Gaps = 40/176 (22%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRPNHFA 143
           L L+M+Y   G L   L K ++R+        + +    I      +    Y+H      
Sbjct: 88  LKLIMEYLPYGSLRDYLQKHKERIDHIK----LLQYTSQICKGMEYLGTKRYIH------ 137

Query: 144 FHLCRDIKPDNVLLDANGHIRLADFGSCL-RLGGDGTVQSNVAVGT--PDYI---SPEIL 197
               RD+   N+L++    +++ DFG  L ++         V      P  I   +PE L
Sbjct: 138 ----RDLATRNILVENENRVKIGDFG--LTKVLPQDKEFFKVKEPGESP--IFWYAPESL 189

Query: 198 TAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVET------YGKIMNHQ 246
           T       ++    D WS GV +YE+  Y E      +           G+++   
Sbjct: 190 TE-----SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 55.4 bits (134), Expect = 8e-09
 Identities = 34/180 (18%), Positives = 62/180 (34%), Gaps = 50/180 (27%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA-----EMVLAIAS----IHDLHYVHR 138
             ++M+    GDL + L      +  +      +     +M   IA     ++   +VHR
Sbjct: 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHR 162

Query: 139 PNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDY------- 191
                     D+   N ++  +  +++ DFG    +  D        +   DY       
Sbjct: 163 ----------DLAARNCMVAEDFTVKIGDFG----MTRD--------IYETDYYRKGGKG 200

Query: 192 ------ISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
                 +SPE L       G +    D WS GV ++E+    E P+   S  +    +M 
Sbjct: 201 LLPVRWMSPESLKD-----GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 55.5 bits (134), Expect = 8e-09
 Identities = 30/183 (16%), Positives = 62/183 (33%), Gaps = 51/183 (27%)

Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVH 137
            + + +  +V+ Y   GDL   +               +    L +A     +    +VH
Sbjct: 160 LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD----LIGFGLQVAKGMKFLASKKFVH 215

Query: 138 RPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDY------ 191
           R          D+   N +LD    +++ADFG    L  D        +   ++      
Sbjct: 216 R----------DLAARNCMLDEKFTVKVADFG----LARD--------MYDKEFDSVHNK 253

Query: 192 ---------ISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGK 241
                    ++ E L        ++  + D WS GV ++E++  G  P+   +  +    
Sbjct: 254 TGAKLPVKWMALESLQ-----TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 308

Query: 242 IMN 244
           ++ 
Sbjct: 309 LLQ 311

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 55.5 bits (134), Expect = 8e-09
 Identities = 37/176 (21%), Positives = 64/176 (36%), Gaps = 40/176 (22%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRPNHFA 143
           L L+M+Y   G L   L K ++R+        + +    I      +    Y+HR     
Sbjct: 119 LKLIMEYLPYGSLRDYLQKHKERIDHIK----LLQYTSQICKGMEYLGTKRYIHR----- 169

Query: 144 FHLCRDIKPDNVLLDANGHIRLADFGSCL-RLGGDGTVQSNVAVGT--PDYI---SPEIL 197
                D+   N+L++    +++ DFG  L ++         V      P  I   +PE L
Sbjct: 170 -----DLATRNILVENENRVKIGDFG--LTKVLPQDKEYYKVKEPGESP--IFWYAPESL 220

Query: 198 TAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVET------YGKIMNHQ 246
           T       ++    D WS GV +YE+  Y E      +           G+++   
Sbjct: 221 TE-----SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 55.4 bits (134), Expect = 9e-09
 Identities = 34/176 (19%), Positives = 65/176 (36%), Gaps = 46/176 (26%)

Query: 88  LYLVMDYYCGGDLLT-LLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRPNHF 142
             +++ +   GDL   LL+      P ++    +   ++ IA     +   +++HR    
Sbjct: 106 PMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHR---- 161

Query: 143 AFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDY----------- 191
                 D+   N +L  +  + +ADFG    L           + + DY           
Sbjct: 162 ------DLAARNCMLAEDMTVCVADFG----LSRK--------IYSGDYYRQGCASKLPV 203

Query: 192 --ISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
             ++ E L         Y    D W+ GV M+E++  G+TP+      E Y  ++ 
Sbjct: 204 KWLALESLA-----DNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 54.9 bits (133), Expect = 9e-09
 Identities = 36/164 (21%), Positives = 72/164 (43%), Gaps = 27/164 (16%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRPNHFA 143
            Y++ ++   G+LL  L    +   ++++   +  M   I+S    +   +++HR     
Sbjct: 84  FYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR----- 135

Query: 144 FHLCRDIKPDNVLLDANGHIRLADFGSCL-RLGGDGTVQSNVAVGTP-DYISPEILTAME 201
                D+   N L+  N  +++ADFG  L RL    T  ++     P  + +PE L    
Sbjct: 136 -----DLAARNCLVGENHLVKVADFG--LSRLMTGDTYTAHAGAKFPIKWTAPESLA--- 185

Query: 202 EGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
               ++  + D W+ GV ++E+  YG +P+    L + Y  +  
Sbjct: 186 --YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 40/184 (21%), Positives = 65/184 (35%), Gaps = 32/184 (17%)

Query: 78  LHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA-EMVLAIASIHDLHYV 136
           LH         +++MD + G DL  +      R         ++  ++  +  IH+  YV
Sbjct: 118 LHDKNGKSYR-FMIMDRF-GSDLQKIYEANAKRFSRKTV-LQLSLRILDILEYIHEHEYV 174

Query: 137 HRPNHFAFHLCRDIKPDNVLL---DANGHIRLADFGSCLRLGGDGTVQ-----SNVA-VG 187
           H           DIK  N+LL   + +  + L D+G   R   +G  +           G
Sbjct: 175 HG----------DIKASNLLLNYKNPD-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDG 223

Query: 188 TPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP---FYAESLVETYGKIMN 244
           T ++ S +    +   R R     D   LG CM + L G  P      +       KI  
Sbjct: 224 TIEFTSIDAHNGVAPSR-R----GDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRY 278

Query: 245 HQNS 248
            +N 
Sbjct: 279 RENI 282

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 54.6 bits (132), Expect = 1e-08
 Identities = 30/180 (16%), Positives = 55/180 (30%), Gaps = 52/180 (28%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRPNHFA 143
             LV ++   G L T L K ++ +          E+   +A+    + +   +H      
Sbjct: 87  NILVQEFVKFGSLDTYLKKNKNCINILW----KLEVAKQLAAAMHFLEENTLIH------ 136

Query: 144 FHLCRDIKPDNVLLDA--------NGHIRLADFGSCL-RLGGDGTVQSNVAVGTPDY--- 191
                ++   N+LL             I+L+D G  +        V         D    
Sbjct: 137 ----GNVCAKNILLIREEDRKTGNPPFIKLSDPG--ISIT-----VLPK------DILQE 179

Query: 192 ----ISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMNHQ 246
               + PE    +E  +       D WS G  ++E+   G+ P  A           +  
Sbjct: 180 RIPWVPPE---CIENPK-NLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH 235

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 38/183 (20%), Positives = 64/183 (34%), Gaps = 57/183 (31%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRPNHFA 143
           L LVM+Y   G L   L +    L +      +      I      +H  HY+HR     
Sbjct: 110 LQLVMEYVPLGSLRDYLPRHSIGLAQ------LLLFAQQICEGMAYLHAQHYIHR----- 158

Query: 144 FHLCRDIKPDNVLLDANGHIRLADFGSCL-RLGGDGTVQSNVAVGTPDYISPEILTAMEE 202
                D+   NVLLD +  +++ DFG  L +   +G           +Y         E+
Sbjct: 159 -----DLAARNVLLDNDRLVKIGDFG--LAKAVPEG----------HEYY-----RVRED 196

Query: 203 GR-------------GRYGPECDWWSLGVCMYEML-YGETPFYAESLVET-----YGKIM 243
           G               ++    D WS GV +YE+L + ++     +          G++ 
Sbjct: 197 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT 256

Query: 244 NHQ 246
             +
Sbjct: 257 VLR 259

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 54.6 bits (132), Expect = 1e-08
 Identities = 34/181 (18%), Positives = 63/181 (34%), Gaps = 47/181 (25%)

Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVH 137
              +   ++++ Y C GDLL  +   +           +    L +A     + +  +VH
Sbjct: 92  LPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKD----LISFGLQVARGMEYLAEQKFVH 147

Query: 138 RPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEIL 197
           R          D+   N +LD +  +++ADFG    L  D  +         +Y S +  
Sbjct: 148 R----------DLAARNCMLDESFTVKVADFG----LARD--ILDR------EYYSVQ-- 183

Query: 198 TAMEEGR-------------GRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIM 243
                 R              R+  + D WS GV ++E+L  G  P+      +    + 
Sbjct: 184 -QHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA 242

Query: 244 N 244
            
Sbjct: 243 Q 243

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 36/198 (18%), Positives = 58/198 (29%), Gaps = 75/198 (37%)

Query: 90  LVMDYYCGGDLLTLLSKFEDR-LPEDMAKFYIAEMVLAIASIH-DLHYVHRPNHFAFHLC 147
           +V +   G  LL  + K   + LP    K  I +++  +  +H     +H          
Sbjct: 122 MVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHT--------- 171

Query: 148 RDIKPDNVLL-------------------------------------------------D 158
            DIKP+N+LL                                                  
Sbjct: 172 -DIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNA 230

Query: 159 ANGHIRLADFGSCLRLGGDGT--VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSL 216
               +++AD G+   +    T  +Q      T  Y S E+L         Y    D WS 
Sbjct: 231 EKLKVKIADLGNACWVHKHFTEDIQ------TRQYRSLEVLIGSG-----YNTPADIWST 279

Query: 217 GVCMYEMLYGETPFYAES 234
               +E+  G+  F   S
Sbjct: 280 ACMAFELATGDYLFEPHS 297

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 36/169 (21%), Positives = 57/169 (33%), Gaps = 37/169 (21%)

Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNH 141
                 LY+V++     DL  L  K    L E+  K  +  ++L    IH+   +HR   
Sbjct: 99  LLKFDELYIVLEI-ADSDLKKLF-KTPIFLTEEHIKTILYNLLLGENFIHESGIIHR--- 153

Query: 142 FAFHLCRDIKPDNVLLDANGHIRLADFG---------------SCLRLGGDGTVQSNVAV 186
                  D+KP N LL+ +  +++ DFG                       G    N+  
Sbjct: 154 -------DLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206

Query: 187 GTPDYIS------PEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
               ++       PE++   E     Y    D WS G    E+L     
Sbjct: 207 QLTSHVVTRWYRAPELILLQE----NYTKSIDIWSTGCIFAELLNMLQS 251

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 53.8 bits (130), Expect = 2e-08
 Identities = 32/172 (18%), Positives = 67/172 (38%), Gaps = 37/172 (21%)

Query: 83  QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHR 138
           ++   LY+V +Y   G L+  L     R    +    + +  L +      +   ++VH 
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH- 140

Query: 139 PNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGT--PDYI---S 193
                    RD+   NVL+  +   +++DFG    L  + +   +       P  +   +
Sbjct: 141 ---------RDLAARNVLVSEDNVAKVSDFG----LTKEASSTQD---TGKLP--VKWTA 182

Query: 194 PEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
           PE L        ++  + D WS G+ ++E+  +G  P+    L +   ++  
Sbjct: 183 PEALR-----EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 229

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 29/159 (18%), Positives = 51/159 (32%), Gaps = 46/159 (28%)

Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH-------- 162
              +  K Y  E++ A+  +  +   H           D+KP+N+LLD            
Sbjct: 134 FHIEDIKLYCIEILKALNYLRKMSLTH---------T-DLKPENILLDDPYFEKSLITVR 183

Query: 163 -----------------IRLADFGS-CLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGR 204
                            I+L DFG              ++ + T  Y +PE++  +    
Sbjct: 184 RVTDGKKIQIYRTKSTGIKLIDFGCATF----KSDYHGSI-INTRQYRAPEVILNL---- 234

Query: 205 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 243
             +    D WS G  + E+  G   F     +E    + 
Sbjct: 235 -GWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMME 272

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 53.1 bits (127), Expect = 6e-08
 Identities = 43/181 (23%), Positives = 64/181 (35%), Gaps = 28/181 (15%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I N+ +   +     LVMD   G  L  L +    +L          +M+  +  +H   
Sbjct: 65  IPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGH---IRLADFGSCLRLGGDGTVQ------SNVA 185
           ++HR          DIKPDN L+        + + DFG   +     T Q      +   
Sbjct: 124 FLHR----------DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173

Query: 186 VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP---FYAESLVETYGKI 242
            GT  Y S      +E+ R       D  SLG  +   L G  P     A +  + Y KI
Sbjct: 174 TGTARYASVNTHLGIEQSRRD-----DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228

Query: 243 M 243
            
Sbjct: 229 S 229

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 52.7 bits (127), Expect = 6e-08
 Identities = 37/181 (20%), Positives = 69/181 (38%), Gaps = 46/181 (25%)

Query: 83  QDDSNLYLVMDYYCGGDLLT-LLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVH 137
           Q      +++ +   GDL T LL    +  P+ +    + + ++ IA     + + +++H
Sbjct: 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLH 170

Query: 138 RPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDY------ 191
           R          D+   N +L  +  + +ADFG    L           + + DY      
Sbjct: 171 R----------DLAARNCMLRDDMTVCVADFG----LSKK--------IYSGDYYRQGRI 208

Query: 192 -------ISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIM 243
                  I+ E L         Y  + D W+ GV M+E+   G TP+      E Y  ++
Sbjct: 209 AKMPVKWIAIESLA-----DRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL 263

Query: 244 N 244
           +
Sbjct: 264 H 264

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 53.1 bits (128), Expect = 6e-08
 Identities = 31/167 (18%), Positives = 66/167 (39%), Gaps = 27/167 (16%)

Query: 83  QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHR 138
           ++   LY+V +Y   G L+  L     R    +    + +  L +      +   ++VHR
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR 313

Query: 139 PNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILT 198
                     D+   NVL+  +   +++DFG    L  + +   +       + +PE L 
Sbjct: 314 ----------DLAARNVLVSEDNVAKVSDFG----LTKEASSTQDTGKLPVKWTAPEALR 359

Query: 199 AMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
                  ++  + D WS G+ ++E+  +G  P+    L +   ++  
Sbjct: 360 -----EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 401

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 53.3 bits (127), Expect = 7e-08
 Identities = 66/378 (17%), Positives = 117/378 (30%), Gaps = 113/378 (29%)

Query: 30  DILLVLYD------ECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRR-------WI- 75
           DIL V  D      +C        K V D  + +    E   +++  D         W  
Sbjct: 20  DILSVFEDAFVDNFDC--------KDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTL 71

Query: 76  ----TNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIH 131
                 +   F ++    L ++Y      L    K E R P  M + YI +         
Sbjct: 72  LSKQEEMVQKFVEEV---LRINY----KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQ 124

Query: 132 DL--HYVHRPNHFAF---HLCRDIKPDNVLLDANGHIRLADFG-SCLRLGGDGTVQSNVA 185
               + V R   +      L       NVL+D  G   +   G + +             
Sbjct: 125 VFAKYNVSRLQPYLKLRQALLELRPAKNVLID--G---VLGSGKTWV-----------AL 168

Query: 186 VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE----TYGK 241
                Y   ++   M+     +     W +L  C        +P   E+++E       +
Sbjct: 169 DVCLSY---KVQCKMD--FKIF-----WLNLKNC-------NSP---ETVLEMLQKLLYQ 208

Query: 242 IM-NHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNG------IADFKMWSALFV 294
           I  N  +  D  S++   I    +  +RRL+ S   +  +N       + + K W+A  +
Sbjct: 209 IDPNWTSRSDHSSNIKLRI-HSIQAELRRLLKS---KPYENCLLVLLNVQNAKAWNAFNL 264

Query: 295 S---LSISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEA--------GVRA 343
           S   L  + R     + +  D +   +A     +S    +     DE           R 
Sbjct: 265 SCKILLTT-RF----KQVT-DFL---SAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRP 315

Query: 344 SDALPPAAA--SPALSAL 359
            D LP      +P   ++
Sbjct: 316 QD-LPREVLTTNPRRLSI 332

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 41.0 bits (95), Expect = 6e-04
 Identities = 66/369 (17%), Positives = 111/369 (30%), Gaps = 113/369 (30%)

Query: 11  FLGGPIQGKGRVFSIETLLDILLVLYDEC----CNS-------SLRREKTVSDFIEFVAK 59
           FL  PI+ + R  S+ T       +Y E      N        ++ R +      + + +
Sbjct: 93  FLMSPIKTEQRQPSMMT------RMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLE 146

Query: 60  LREERDVLVYGD----RRWITNLHYAFQDDSNLYLVMD---YYCGGDLLTLLSKFEDR-L 111
           LR  ++VL+ G     + W+            +   MD   ++     L L +      +
Sbjct: 147 LRPAKNVLIDGVLGSGKTWVALD--VCLSYK-VQCKMDFKIFW-----LNLKNCNSPETV 198

Query: 112 PEDMAKFY-IAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKP---DNVLL------DANG 161
            E + K     +      S H  +   R +     L R +K    +N LL      +A  
Sbjct: 199 LEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAK- 257

Query: 162 HIRLADFGSC--LRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVC 219
                +   C  L      T    V     D++S    T                   + 
Sbjct: 258 AWNAFNLS-CKILLT----TRFKQVT----DFLSAATTTH------------------IS 290

Query: 220 MYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDV-----------GYEISDDA----- 263
           +       TP   +SL     K ++     DLP +V              I D       
Sbjct: 291 LDHHSMTLTPDEVKSL---LLKYLDC-RPQDLPREVLTTNPRRLSIIAESIRDGLATWDN 346

Query: 264 -----KDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHP---------WFQGI 309
                 D +  +I SS   L     A+++    +F  LS+ P +           WF  I
Sbjct: 347 WKHVNCDKLTTIIESSLNVLEP---AEYR---KMFDRLSVFPPSAHIPTILLSLIWFDVI 400

Query: 310 AWDSIRDSN 318
             D +   N
Sbjct: 401 KSDVMVVVN 409

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 52.4 bits (126), Expect = 8e-08
 Identities = 38/176 (21%), Positives = 68/176 (38%), Gaps = 42/176 (23%)

Query: 88  LYLVMDYYCGGDLLTLL--SKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRPNH 141
            +++++   GGDL + L  ++     P  +A   +  +   IA     + + H++HR   
Sbjct: 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHR--- 205

Query: 142 FAFHLCRDIKPDNVLLDANGH---IRLADFG--------SCLRLGGDGTVQSNVAVGTP- 189
                  DI   N LL   G     ++ DFG           R GG   +        P 
Sbjct: 206 -------DIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML--------PV 250

Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
            ++ PE         G +  + D WS GV ++E+   G  P+ ++S  E    + +
Sbjct: 251 KWMPPEAFM-----EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 52.8 bits (127), Expect = 9e-08
 Identities = 33/169 (19%), Positives = 63/169 (37%), Gaps = 37/169 (21%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPE-----DMAK------FYIAEMVLAIASIHDLHYV 136
           +Y++ ++   G LL  L   E          D +        +I +           +Y+
Sbjct: 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR----------NYI 306

Query: 137 HRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEI 196
           HR          D++  N+L+ A+   ++ADFG    +  +       A     + +PE 
Sbjct: 307 HR----------DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 356

Query: 197 LTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
           +       G +  + D WS G+ + E++ YG  P+   S  E    +  
Sbjct: 357 IN-----FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 51.8 bits (125), Expect = 1e-07
 Identities = 39/176 (22%), Positives = 67/176 (38%), Gaps = 51/176 (28%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPE-----DMAKFYIAEMVLAIASIHDLHYVHRPNHF 142
           +Y++ +Y   G L+  L              DMA   IAE    +A I + +Y+HR    
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA-QIAE---GMAFIEERNYIHR---- 133

Query: 143 AFHLCRDIKPDNVLLDANGHIRLADFGSCL-RLGGDGTVQSNVAVGTPDYIS-------- 193
                 D++  N+L+      ++ADFG  L RL  D            +Y +        
Sbjct: 134 ------DLRAANILVSDTLSCKIADFG--LARLIEDN-----------EYTAREGAKFPI 174

Query: 194 ----PEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
               PE +       G +  + D WS G+ + E++ +G  P+   +  E    +  
Sbjct: 175 KWTAPEAIN-----YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 37/178 (20%), Positives = 61/178 (34%), Gaps = 30/178 (16%)

Query: 79  HYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR-LPEDMAKFYIA-EMVLAIASIHDLHYV 136
            +    D   +LV+    G  L + L       L E      +A  ++ A+  +H+  YV
Sbjct: 124 GFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSV-LQVACRLLDALEFLHENEYV 181

Query: 137 HRPNHFAFHLCRDIKPDNVLLDAN--GHIRLADFGSCLRLGGDGT------VQSNVAVGT 188
           H           ++  +N+ +D      + LA +G   R    G          +   G 
Sbjct: 182 HG----------NVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGD 231

Query: 189 PDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP---FYAESLVETYGKIM 243
            ++IS ++       R R     D  SLG CM + LYG  P       +      K  
Sbjct: 232 LEFISMDLHKGCGPSR-R----SDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQK 284

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 51.5 bits (124), Expect = 1e-07
 Identities = 40/176 (22%), Positives = 69/176 (39%), Gaps = 42/176 (23%)

Query: 88  LYLVMDYYCGGDLLTLL--SKFEDRLPEDMAKFYIAEMVLAIAS----IHDLHYVHRPNH 141
            +++M+   GGDL + L  ++     P  +A   +  +   IA     + + H++HR   
Sbjct: 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHR--- 164

Query: 142 FAFHLCRDIKPDNVLLDANGH---IRLADFG--------SCLRLGGDGTVQSNVAVGTP- 189
                  DI   N LL   G     ++ DFG        S  R GG   +        P 
Sbjct: 165 -------DIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML--------PV 209

Query: 190 DYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
            ++ PE         G +  + D WS GV ++E+   G  P+ ++S  E    + +
Sbjct: 210 KWMPPEAFM-----EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 51.6 bits (124), Expect = 1e-07
 Identities = 45/183 (24%), Positives = 64/183 (34%), Gaps = 30/183 (16%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I N++Y  Q+  +  LV+D   G  L  LL     +           +M+  + SIH+  
Sbjct: 68  IPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 126

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGH-----IRLADFGSCLRLGGDGTVQ------SN 183
            V+R          DIKPDN L+          I + DFG         T Q        
Sbjct: 127 LVYR----------DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 176

Query: 184 VAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP---FYAESLVETYG 240
              GT  Y+S       E+ R       D  +LG      L G  P     A +  + Y 
Sbjct: 177 NLSGTARYMSINTHLGREQSRRD-----DLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 231

Query: 241 KIM 243
           +I 
Sbjct: 232 RIG 234

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 50.8 bits (122), Expect = 2e-07
 Identities = 43/185 (23%), Positives = 69/185 (37%), Gaps = 55/185 (29%)

Query: 88  LYLVMDYYCGGDLLTLL----------SKFEDRLPEDMAKFYIAEMVLAIAS----IHDL 133
           L +V +Y   GDL   L          +  ED  P  +    +  +   +A+    +  L
Sbjct: 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL 177

Query: 134 HYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCL----------RLGGDGTVQSN 183
           H+VH          RD+   N L+     +++ DFG  +          R+GG   +   
Sbjct: 178 HFVH----------RDLATRNCLVGQGLVVKIGDFG--MSRDIYSTDYYRVGGRTML--- 222

Query: 184 VAVGTPDYI---SPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETY 239
                P  I    PE +        ++  E D WS GV ++E+  YG+ P+Y  S  E  
Sbjct: 223 -----P--IRWMPPESIL-----YRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 270

Query: 240 GKIMN 244
             I  
Sbjct: 271 DCITQ 275

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 50.1 bits (120), Expect = 4e-07
 Identities = 38/181 (20%), Positives = 62/181 (34%), Gaps = 28/181 (15%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  + +   +     +VM+   G  L  L +    +           +M+  I  IH  +
Sbjct: 67  IPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 125

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGH---IRLADFGSCLRLGGDGTVQ------SNVA 185
           ++HR          D+KPDN L+        + + DFG   +     T Q      +   
Sbjct: 126 FIHR----------DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 175

Query: 186 VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP---FYAESLVETYGKI 242
            GT  Y S      +E+ R       D  SLG  +     G  P     A +  + Y +I
Sbjct: 176 TGTARYASINTHLGIEQSRRD-----DLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 230

Query: 243 M 243
            
Sbjct: 231 S 231

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 49.9 bits (120), Expect = 5e-07
 Identities = 40/178 (22%), Positives = 62/178 (34%), Gaps = 40/178 (22%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE-----------MVLAIAS----IHD 132
           L +V +Y   GDL   L          +                  +   IAS    +  
Sbjct: 92  LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS 151

Query: 133 LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYI 192
            H+VHR          D+   N L+ AN  +++ DFG    +  D        VG    +
Sbjct: 152 QHFVHR----------DLATRNCLVGANLLVKIGDFG----MSRDVYSTDYYRVGGHTML 197

Query: 193 -----SPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 244
                 PE +        ++  E D WS GV ++E+  YG+ P++  S  E    I  
Sbjct: 198 PIRWMPPESIM-----YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 250

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 49.3 bits (118), Expect = 7e-07
 Identities = 39/168 (23%), Positives = 61/168 (36%), Gaps = 31/168 (18%)

Query: 75  ITNLHY----AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIA-EMVLAIAS 129
           I   +      F+  S  ++VM+   G DL  +  +      +      +   M+  +  
Sbjct: 110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTV-LQLGIRMLDVLEY 166

Query: 130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN--GHIRLADFGSCLRLGGDGTVQ------ 181
           IH+  YVH           DIK  N+LL       + LAD+G   R   +G  +      
Sbjct: 167 IHENEYVHG----------DIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENP 216

Query: 182 SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
                GT ++ S +    +   R R     D   LG CM   L G+ P
Sbjct: 217 RKGHNGTIEFTSLDAHKGVALSR-R----SDVEILGYCMLRWLCGKLP 259

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 37/184 (20%), Positives = 63/184 (34%), Gaps = 30/184 (16%)

Query: 75  ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH 134
           I  ++Y         +V++   G  L  L    +             +++  +  +H  +
Sbjct: 67  IPQVYYFGPCGKYNAMVLEL-LGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN 125

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGH-----IRLADFGSCLRLGGDGTVQ------SN 183
            ++R          D+KP+N L+   G+     I + DF          T +        
Sbjct: 126 LIYR----------DVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHK 175

Query: 184 VAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP---FYAESLVETYG 240
              GT  Y+S       E+ R R     D  +LG      L G  P     A++L E Y 
Sbjct: 176 SLTGTARYMSINTHLGKEQSR-RD----DLEALGHMFMYFLRGSLPWQGLKADTLKERYQ 230

Query: 241 KIMN 244
           KI +
Sbjct: 231 KIGD 234

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 48.7 bits (117), Expect = 1e-06
 Identities = 35/105 (33%), Positives = 45/105 (42%), Gaps = 24/105 (22%)

Query: 133 LHYVHRPN--HFAFHLCRDIKPDNVLLDANGHIRLADFG-SCLRLGGDGTVQSNVAVGTP 189
           LHY+H     H      RD+K  N+LLD N   ++ DFG S      D T  S V  GT 
Sbjct: 152 LHYLHTRAIIH------RDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205

Query: 190 DYISPE-----ILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
            YI PE      LT             D +S GV ++E+L   + 
Sbjct: 206 GYIDPEYFIKGRLTEK----------SDVYSFGVVLFEVLCARSA 240

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 48.0 bits (115), Expect = 2e-06
 Identities = 38/186 (20%), Positives = 64/186 (34%), Gaps = 56/186 (30%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE-----------MVLAIAS----IHD 132
           L ++  Y   GDL   L                             +V  IA+    +  
Sbjct: 87  LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS 146

Query: 133 LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCL----------RLGGDGTVQS 182
            H VH+          D+   NVL+    +++++D G  L          +L G+  +  
Sbjct: 147 HHVVHK----------DLATRNVLVYDKLNVKISDLG--LFREVYAADYYKLLGNSLL-- 192

Query: 183 NVAVGTPDYI---SPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVET 238
                 P  I   +PE +       G++  + D WS GV ++E+  YG  P+   S  + 
Sbjct: 193 ------P--IRWMAPEAIM-----YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 239

Query: 239 YGKIMN 244
              I N
Sbjct: 240 VEMIRN 245

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 36/194 (18%), Positives = 67/194 (34%), Gaps = 64/194 (32%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE-------------------MVLAIA 128
           + L+ +Y   GDL   L          ++   ++                    +   +A
Sbjct: 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA 184

Query: 129 S----IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNV 184
           +    + +  +VHR          D+   N L+  N  +++ADFG    L  +       
Sbjct: 185 AGMAYLSERKFVHR----------DLATRNCLVGENMVVKIADFG----LSRN------- 223

Query: 185 AVGTPDY-------------ISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPF 230
            + + DY             + PE +        RY  E D W+ GV ++E+  YG  P+
Sbjct: 224 -IYSADYYKADGNDAIPIRWMPPESIF-----YNRYTTESDVWAYGVVLWEIFSYGLQPY 277

Query: 231 YAESLVETYGKIMN 244
           Y  +  E    + +
Sbjct: 278 YGMAHEEVIYYVRD 291

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 48.0 bits (115), Expect = 2e-06
 Identities = 26/86 (30%), Positives = 40/86 (46%), Gaps = 11/86 (12%)

Query: 148 RDIKPDNVLLDANGHIRLADFGSCL-RLGGDGT--VQSNVAVGTPDYISPEILTAMEEGR 204
           RD+K  N+LLD      + DFG  L +L       V + V  GT  +I+PE         
Sbjct: 158 RDVKAANILLDEEFEAVVGDFG--LAKLMDYKDTHVTTAVR-GTIGHIAPE--YLS---T 209

Query: 205 GRYGPECDWWSLGVCMYEMLYGETPF 230
           G+   + D +  GV + E++ G+  F
Sbjct: 210 GKSSEKTDVFGYGVMLLELITGQRAF 235

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 37/186 (19%), Positives = 61/186 (32%), Gaps = 56/186 (30%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE-----------MVLAIAS----IHD 132
           LY++++Y   G+L   L        E                        +A     +  
Sbjct: 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 221

Query: 133 LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDY- 191
              +H          RD+   NVL+  N  +++ADFG    L  D        +   DY 
Sbjct: 222 QKCIH----------RDLAARNVLVTENNVMKIADFG----LARD--------INNIDYY 259

Query: 192 ------------ISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVET 238
                       ++PE L         Y  + D WS GV M+E+   G +P+    + E 
Sbjct: 260 KKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314

Query: 239 YGKIMN 244
           +  +  
Sbjct: 315 FKLLKE 320

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 44.9 bits (107), Expect = 2e-05
 Identities = 34/175 (19%), Positives = 55/175 (31%), Gaps = 58/175 (33%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDL-------------- 133
             ++ +Y C GDLL  L +  D          I E       + DL              
Sbjct: 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161

Query: 134 ---HYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
              + +H          RD+   N+LL      ++ DFG    L  D        +    
Sbjct: 162 ASKNCIH----------RDLAARNILLTHGRITKICDFG----LARD--------IKNDS 199

Query: 191 Y-------------ISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFY 231
                         ++PE +         Y  E D WS G+ ++E+   G +P+ 
Sbjct: 200 NYVVKGNARLPVKWMAPESIF-----NCVYTFESDVWSYGIFLWELFSLGSSPYP 249

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 44.2 bits (105), Expect = 3e-05
 Identities = 37/186 (19%), Positives = 61/186 (32%), Gaps = 56/186 (30%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE-----------MVLAIAS----IHD 132
           LY++++Y   G+L   L        E                        +A     +  
Sbjct: 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175

Query: 133 LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDY- 191
              +H          RD+   NVL+  N  +++ADFG    L  D        +   DY 
Sbjct: 176 QKCIH----------RDLAARNVLVTENNVMKIADFG----LARD--------INNIDYY 213

Query: 192 ------------ISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVET 238
                       ++PE L         Y  + D WS GV M+E+   G +P+    + E 
Sbjct: 214 KKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268

Query: 239 YGKIMN 244
           +  +  
Sbjct: 269 FKLLKE 274

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 42.9 bits (100), Expect = 1e-04
 Identities = 22/103 (21%), Positives = 39/103 (37%), Gaps = 15/103 (14%)

Query: 69  YGDRRWITNLHYAFQDDSNLYLVMDY-YCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAI 127
           Y   +   N    F  D  L++V+++ + G DL  + +K         AK  + ++  ++
Sbjct: 118 YNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSS---LATAKSILHQLTASL 174

Query: 128 ASIHD-LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG 169
           A     L + HR          D+   NVLL      +L    
Sbjct: 175 AVAEASLRFEHR----------DLHWGNVLLKKTSLKKLHYTL 207

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 42.6 bits (101), Expect = 1e-04
 Identities = 36/163 (22%), Positives = 57/163 (34%), Gaps = 38/163 (23%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE---------MVLAIAS----IHDLH 134
           + ++ +Y C GDLL  L +    L  D A                   +A     +   +
Sbjct: 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN 184

Query: 135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYI-- 192
            +H          RD+   NVLL      ++ DFG    L  D    SN  V     +  
Sbjct: 185 CIH----------RDVAARNVLLTNGHVAKIGDFG----LARDIMNDSNYIVKGNARLPV 230

Query: 193 ---SPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFY 231
              +PE +         Y  + D WS G+ ++E+   G  P+ 
Sbjct: 231 KWMAPESIF-----DCVYTVQSDVWSYGILLWEIFSLGLNPYP 268

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 42.6 bits (101), Expect = 1e-04
 Identities = 28/179 (15%), Positives = 54/179 (30%), Gaps = 56/179 (31%)

Query: 82  FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE-----------MVLAIAS- 129
            +    L +++++   G+L T L    +                            +A  
Sbjct: 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 160

Query: 130 ---IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAV 186
              +     +H          RD+   N+LL     +++ DFG    L  D        +
Sbjct: 161 MEFLASRKCIH----------RDLAARNILLSEKNVVKICDFG----LARD--------I 198

Query: 187 GTPDY-------------ISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFY 231
                             ++PE +         Y  + D WS GV ++E+   G +P+ 
Sbjct: 199 YKDPDYVRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVLLWEIFSLGASPYP 252

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 42/188 (22%), Positives = 64/188 (34%), Gaps = 63/188 (33%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDL-------------- 133
           LYL ++Y   G+LL  L K   R+ E    F IA    +  S   L              
Sbjct: 101 LYLAIEYAPHGNLLDFLRK--SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 158

Query: 134 ---HYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPD 190
               ++H          RD+   N+L+  N   ++ADFG    L               +
Sbjct: 159 SQKQFIH----------RDLAARNILVGENYVAKIADFG----LSRGQ-----------E 193

Query: 191 Y-------------ISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLV 236
                         ++ E L         Y    D WS GV ++E++  G TP+   +  
Sbjct: 194 VYVKKTMGRLPVRWMAIESLN-----YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 248

Query: 237 ETYGKIMN 244
           E Y K+  
Sbjct: 249 ELYEKLPQ 256

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 37/186 (19%), Positives = 67/186 (36%), Gaps = 56/186 (30%)

Query: 88  LYLVMDYYCGGDLLT-LLSKFEDRLPEDMAKFYIAEMVLA----------IAS----IHD 132
           LY++++Y   G+L   L ++    L       +  E  L+          +A     +  
Sbjct: 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 209

Query: 133 LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDY- 191
              +HR          D+   NVL+  +  +++ADFG    L  D        +   DY 
Sbjct: 210 KKCIHR----------DLAARNVLVTEDNVMKIADFG----LARD--------IHHIDYY 247

Query: 192 ------------ISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVET 238
                       ++PE L         Y  + D WS GV ++E+   G +P+    + E 
Sbjct: 248 KKTTNGRLPVKWMAPEALF-----DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302

Query: 239 YGKIMN 244
           +  +  
Sbjct: 303 FKLLKE 308

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 41.5 bits (98), Expect = 2e-04
 Identities = 32/194 (16%), Positives = 59/194 (30%), Gaps = 64/194 (32%)

Query: 88  LYLVMDYYCGGDLLTLL----SKFEDRLPEDMAKFYIAE---------------MVLAIA 128
           L L+++Y   G L   L          L    ++   +                    I+
Sbjct: 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQIS 160

Query: 129 S----IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNV 184
                + ++  VHR          D+   N+L+     ++++DFG    L  D       
Sbjct: 161 QGMQYLAEMKLVHR----------DLAARNILVAEGRKMKISDFG----LSRD------- 199

Query: 185 AVGTPDY-------------ISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPF 230
            V   D              ++ E L         Y  + D WS GV ++E++  G  P+
Sbjct: 200 -VYEEDSYVKRSQGRIPVKWMAIESLFD-----HIYTTQSDVWSFGVLLWEIVTLGGNPY 253

Query: 231 YAESLVETYGKIMN 244
                   +  +  
Sbjct: 254 PGIPPERLFNLLKT 267

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 40.0 bits (94), Expect = 8e-04
 Identities = 36/180 (20%), Positives = 62/180 (34%), Gaps = 63/180 (35%)

Query: 88  LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDL-------------- 133
           +YL+ +Y C GDLL  L    ++  ED  ++   + +     ++ L              
Sbjct: 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 183

Query: 134 --------HYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVA 185
                     VH          RD+   NVL+     +++ DFG    L  D        
Sbjct: 184 GMEFLEFKSCVH----------RDLAARNVLVTHGKVVKICDFG----LARD-------- 221

Query: 186 VGTPDY-------------ISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFY 231
           + +                ++PE L       G Y  + D WS G+ ++E+   G  P+ 
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLF-----EGIYTIKSDVWSYGILLWEIFSLGVNPYP 276

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	372
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.85
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.72
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.5
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.11
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.97
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.84
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.67
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.42
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.28
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.22
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.7
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.67
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.61
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.34
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.2
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.18
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.15
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.7
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.25
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.09
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	95.71
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	94.61
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	92.91
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	89.17
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	87.7
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	87.48
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	85.67
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	85.36
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	84.5
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	84.47
2x6h_A	696	GH13170P, VPS34, phosphotidylinositol 3 kinase 59F	80.65
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	80.07

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.8e-67  Score=486.66  Aligned_cols=273  Identities=30%  Similarity=0.545  Sum_probs=240.9

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      .|+.++.+|.|    |+|.||++++..+++.||+|.+.........       ..+.+.+|+.+|+.++|||||+++++|
T Consensus        33 dy~i~~~lG~G----~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~-------~~~~~~~E~~il~~l~HpnIv~l~~~~  101 (311)
T 4aw0_A           33 DFKFGKILGEG----SFSTVVLARELATSREYAIKILEKRHIIKEN-------KVPYVTRERDVMSRLDHPFFVKLYFTF  101 (311)
T ss_dssp             GEEEEEEEEEE----TTEEEEEEEETTTCCEEEEEEEEHHHHHHTT-------CHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ccEEEEEEecc----cCeEEEEEEECCCCCEEEEEEEEHHHCCCHH-------HHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            35566667777    8999999999999999999998765544332       345688999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      ++++.+|+|||||+||+|.+++.+ .+.+++.+++.++.||+.||+|||++||+|          |||||+|||++.+|+
T Consensus       102 ~~~~~~yivmEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiH----------RDlKPeNILl~~~g~  170 (311)
T 4aw0_A          102 QDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIH----------RDLKPENILLNEDMH  170 (311)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSGGGEEECTTSC
T ss_pred             EeCCEEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcc----------CCCCHHHeEEcCCCC
Confidence            999999999999999999999987 578999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCC-cccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDG-TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      +||+|||+|+...... .....+.+||+.|||||++.+     ..|+.++|||||||++|+|++|++||.+.+..+++.+
T Consensus       171 vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-----~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~  245 (311)
T 4aw0_A          171 IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-----KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAK  245 (311)
T ss_dssp             EEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHH-----SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             EEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999875332 223456799999999999984     5689999999999999999999999999999999999


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh---hhhhhhhhhhccCCCCCCCCCcCCCCccccccC
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA---DFKMWSALFVSLSISPRNHPWFQGIAWDSIRDS  317 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~---~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~~~  317 (372)
                      |.+..  +.+|.    .+|+++++||++||+ ||++|||+++++   +++              +||||+++||+.|++.
T Consensus       246 i~~~~--~~~p~----~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~--------------~Hp~F~~idw~~l~~~  305 (311)
T 4aw0_A          246 IIKLE--YDFPE----KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK--------------AHPFFESVTWENLHQQ  305 (311)
T ss_dssp             HHHTC--CCCCT----TCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHH--------------TSGGGTTCCCTTGGGS
T ss_pred             HHcCC--CCCCc----ccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHH--------------CCCCcCCCCHHHhcCC
Confidence            98865  44555    689999999999999 999999998763   456              9999999999999888


Q ss_pred             CCCCc
Q psy11571        318 NAPYI  322 (372)
Q Consensus       318 ~~p~~  322 (372)
                      +||.+
T Consensus       306 ~pP~l  310 (311)
T 4aw0_A          306 TPPKL  310 (311)
T ss_dssp             CCCCC
T ss_pred             CCCCC
Confidence            87754

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.7e-66  Score=478.86  Aligned_cols=273  Identities=36%  Similarity=0.663  Sum_probs=232.3

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeeh---hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLL---DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNL   78 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~---~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l   78 (372)
                      ++|+.++.+|.|    |+|.||++++..   +++.||+|.+.........        ..++.+|+.+|+.++|||||++
T Consensus        24 ~~Y~i~~~lG~G----~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~--------~~~~~~E~~il~~l~HpnIv~l   91 (304)
T 3ubd_A           24 SQFELLKVLGQG----SFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD--------RVRTKMERDILVEVNHPFIVKL   91 (304)
T ss_dssp             GGEEEEEEEECG----GGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE--------CC------CCCCCCCCTTEECE
T ss_pred             cccEEEEEEecC----CCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH--------HHHHHHHHHHHHHCCCCCCCeE
Confidence            357777788887    899999998754   5778999998766554331        1236779999999999999999


Q ss_pred             eEEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC
Q psy11571         79 HYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD  158 (372)
Q Consensus        79 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~  158 (372)
                      +++|++++.+|+|||||+||+|.+++.+ .+.+++.+++.++.||+.||+|||++||+|          |||||+|||++
T Consensus        92 ~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiH----------RDlKp~NILl~  160 (304)
T 3ubd_A           92 HYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIY----------RDLKPENILLD  160 (304)
T ss_dssp             EEEEEETTEEEEEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SSCCGGGEEEC
T ss_pred             EEEEEECCEEEEEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcC----------CCCCHHHeEEc
Confidence            9999999999999999999999999987 578999999999999999999999999999          99999999999


Q ss_pred             CCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHH
Q psy11571        159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET  238 (372)
Q Consensus       159 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~  238 (372)
                      .+|++||+|||+|+....... ...+.+||+.|||||++.+     ..|+.++|||||||++|||+||++||.+.+..++
T Consensus       161 ~~g~vKl~DFGla~~~~~~~~-~~~~~~GT~~YmAPE~~~~-----~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~  234 (304)
T 3ubd_A          161 EEGHIKLTDFGLSKESIDHEK-KAYSFCGTVEYMAPEVVNR-----RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET  234 (304)
T ss_dssp             TTSCEEEESSEEEEC-----C-CCCSCCCCGGGCCHHHHHT-----SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             CCCCEEecccccceeccCCCc-cccccccCcccCCHHHhcc-----CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH
Confidence            999999999999987543322 3345789999999999983     6789999999999999999999999999999999


Q ss_pred             HHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCC--ChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc-
Q psy11571        239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQN--GIADFKMWSALFVSLSISPRNHPWFQGIAWDSI-  314 (372)
Q Consensus       239 ~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~--~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~-  314 (372)
                      +.+|.+..  +.+|.    .+|+++++||++||+ ||++|||+.  .+.+++              +||||+++||+.+ 
T Consensus       235 ~~~i~~~~--~~~p~----~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil--------------~Hp~f~~idw~~l~  294 (304)
T 3ubd_A          235 MTMILKAK--LGMPQ----FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIK--------------RHSFFSTIDWNKLY  294 (304)
T ss_dssp             HHHHHHCC--CCCCT----TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHH--------------TSGGGTTCCHHHHH
T ss_pred             HHHHHcCC--CCCCC----cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHH--------------cCccccCCCHHHHH
Confidence            99998864  34454    689999999999999 999999974  477888              9999999999998 


Q ss_pred             -ccCCCCCcC
Q psy11571        315 -RDSNAPYIP  323 (372)
Q Consensus       315 -~~~~~p~~p  323 (372)
                       ++..|||+|
T Consensus       295 ~~~~~pP~~P  304 (304)
T 3ubd_A          295 RREIHPPFKP  304 (304)
T ss_dssp             TTCSCCSSCC
T ss_pred             hCCCCcCcCC
Confidence             567899998

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.7e-63  Score=499.98  Aligned_cols=315  Identities=25%  Similarity=0.472  Sum_probs=254.3

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+.+..+|.|    |+|.||.|++..+++.||+|.+....+......    ......+.++.+++.++|||||+++++|+
T Consensus       191 f~i~k~LG~G----~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~----~~~~~E~~~l~ll~~~~HP~IV~l~~~f~  262 (689)
T 3v5w_A          191 FSVHRIIGRG----GFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE----TLALNERIMLSLVSTGDCPFIVCMSYAFH  262 (689)
T ss_dssp             EEEEEEEEEC----SSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCH----HHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred             eEEEEEEecc----cCeEEEEEEECCCCCEEEEEEEeHHHcchhhhH----HHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence            4445566666    899999999999999999999877655443222    12223345567778889999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcE
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI  163 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~v  163 (372)
                      +.+.+|+|||||+||+|.++|.+ .+.+++..++.|++||+.||+|||++||||          |||||+|||++.+|++
T Consensus       263 ~~~~lylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~gIiH----------RDLKPeNILld~~G~v  331 (689)
T 3v5w_A          263 TPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVY----------RDLKPANILLDEHGHV  331 (689)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTTTEEC----------CCCSGGGEEECTTSCE
T ss_pred             ECCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------cCCchHHeEEeCCCCE
Confidence            99999999999999999999987 578999999999999999999999999999          9999999999999999


Q ss_pred             EEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC---CHHHHHH
Q psy11571        164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYG  240 (372)
Q Consensus       164 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~---~~~~~~~  240 (372)
                      ||+|||+|+......   ..+.+||+.|||||++..    ...|+.++|||||||++|||++|.+||.+.   +..++..
T Consensus       332 KL~DFGlA~~~~~~~---~~t~~GTp~YmAPEvl~~----~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~  404 (689)
T 3v5w_A          332 RISDLGLACDFSKKK---PHASVGTHGYMAPEVLQK----GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR  404 (689)
T ss_dssp             EECCCTTCEECSSCC---CCSCCSCGGGCCHHHHST----TCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH
T ss_pred             EecccceeeecCCCC---CCCccCCcCccCHHHHhC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            999999998765432   345799999999999963    346899999999999999999999999764   3445566


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCC--CChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--c
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQ--NGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--R  315 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~--~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~  315 (372)
                      .+....  +.+|.    .+|+++++||.+||+ ||++|+|.  .++.+++              +||||+++||+.+  +
T Consensus       405 ~i~~~~--~~~p~----~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~--------------~HpfF~~idW~~l~~~  464 (689)
T 3v5w_A          405 MTLTMA--VELPD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK--------------ESPFFRSLDWQMVFLQ  464 (689)
T ss_dssp             HHHHCC--CCCCT----TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT--------------TSGGGTTCCHHHHHTT
T ss_pred             hhcCCC--CCCCc----cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh--------------cCccccCCCHHHHHcC
Confidence            666543  34454    789999999999999 99999995  5688888              9999999999998  5


Q ss_pred             cCCCCCcCCCCCCCCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceeeC
Q psy11571        316 DSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQ  370 (372)
Q Consensus       316 ~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (372)
                      +..|||+|.+.+..++++||...-+.....      ..+.....+..|.||+|+.
T Consensus       465 ~~~pP~~P~~~~~~~~~~fD~~~fd~e~~~------~~~~~~~d~~~f~~Fs~~~  513 (689)
T 3v5w_A          465 KYPPPLIPPRGEVNAADAFDIGSFDEEDTK------GIKLLDSDQELYRNFPLTI  513 (689)
T ss_dssp             CSCCSCCCCTTCSSTTBCCC---------C------CCCCCHHHHTTTTTCCEEC
T ss_pred             CCCcCccCCCCCCCcCCCCCCccCCccccC------CCCCCchHHHHHhCCCccC
Confidence            688999999999888888885443221111      1122234567799999864

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4.6e-62  Score=475.44  Aligned_cols=328  Identities=66%  Similarity=1.132  Sum_probs=264.8

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||+++...+++.||+|.+.........       ..+.+.+|..++..++||||++++++|
T Consensus        75 ~y~~~~~LG~G----~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~-------~~~~~~~E~~il~~~~hp~Iv~l~~~~  143 (437)
T 4aw2_A           75 DFEILKVIGRG----AFGEVAVVKLKNADKVFAMKILNKWEMLKRA-------ETACFREERDVLVNGDSKWITTLHYAF  143 (437)
T ss_dssp             GEEEEEEEEEC----SSEEEEEEEETTTTEEEEEEEEEHHHHHHTT-------TTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             heEEEEEEEeC----CCEEEEEEEEcCCCcEEEEEEEEHHHhhhHH-------HHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            34444556666    8999999999989999999988654332221       123367899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+.+.+|+|||||+||+|.+++.+..+.+++..++.++.||+.||.|||++||+|          |||||+|||++.+|.
T Consensus       144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiH----------rDLKp~NILl~~~g~  213 (437)
T 4aw2_A          144 QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVH----------RDIKPDNILMDMNGH  213 (437)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEECTTSC
T ss_pred             eeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEe----------cccCHHHeeEcCCCC
Confidence            9999999999999999999999875578999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||+|+.............+||+.|+|||++.....+...++.++|||||||++|||++|++||.+.+..+.+.+|
T Consensus       214 vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i  293 (437)
T 4aw2_A          214 IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  293 (437)
T ss_dssp             EEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             EEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh
Confidence            99999999987765555445557899999999999744333466899999999999999999999999999999999999


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCC--CCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccccccCCC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDT--RLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNA  319 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~--R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~~~~~  319 (372)
                      +.....+.+|... ..+|+++++||++||+ +|++  |++   +.+++              +||||+++||+.+++..|
T Consensus       294 ~~~~~~~~~p~~~-~~~s~~~~dLi~~lL~~~~~r~~r~~---~~eil--------------~Hpff~~i~w~~l~~~~~  355 (437)
T 4aw2_A          294 MNHKERFQFPTQV-TDVSENAKDLIRRLICSREHRLGQNG---IEDFK--------------KHPFFSGIDWDNIRNCEA  355 (437)
T ss_dssp             HTHHHHCCCCSSC-CCSCHHHHHHHHTTSSCGGGCTTTTT---THHHH--------------TSGGGTTCCTTTGGGSCC
T ss_pred             hhccccccCCccc-ccCCHHHHHHHHHHhcccccccCCCC---HHHHh--------------CCCccCCCCHHHHhhCCC
Confidence            8765445555432 2589999999999999 6655  665   45555              999999999999999999


Q ss_pred             CCcCCCCCCCCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceeeC
Q psy11571        320 PYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQ  370 (372)
Q Consensus       320 p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (372)
                      ||+|.+.++.|+++||.++.........++ ....++++.+.+|.||||++
T Consensus       356 p~~P~~~~~~d~~~fd~~~~~~~~~~~~~~-~~~~~~~~~~~~f~~~~~~~  405 (437)
T 4aw2_A          356 PYIPEVSSPTDTSNFDVDDDCLKNSETMPP-PTHTAFSGHHLPFVGFTYTS  405 (437)
T ss_dssp             SCCCCCSSTTCCTTSCCC-------------------CCTTGGGTTCCEES
T ss_pred             CCCCcCCCccchhhcCCcccccccccCCCC-CccccccccCccccCCCcCC
Confidence            999999999999999988765544433333 22355667788999999986

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.9e-60  Score=448.41  Aligned_cols=322  Identities=31%  Similarity=0.543  Sum_probs=264.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||.+++..+++.||+|.+........       +..+.+.+|..+++.++||||+++++++
T Consensus         6 ~y~~~~~lG~G----~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~~~E~~~l~~l~hp~iv~l~~~~   74 (337)
T 1o6l_A            6 DFDYLKLLGKG----TFGKVILVREKATGRYYAMKILRKEVIIAK-------DEVAHTVTESRVLQNTRHPFLTALKYAF   74 (337)
T ss_dssp             GEEEEEEEEEC----SSEEEEEEEETTTCCEEEEEEEEHHHHHHT-------TCHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             HeEEEEEEecC----CCeEEEEEEECCCCCEEEEEEEeHHHhhhh-------hHHHHHHHHHHHHHhCCCCcCcceEEEE
Confidence            45566677777    899999999999999999998865433222       1245577899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      ++.+.+|+||||++||+|.+++.+ .+.+++..++.++.||+.||.|||++||+|          |||||+|||++.+|+
T Consensus        75 ~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH----------rDlkp~NIll~~~g~  143 (337)
T 1o6l_A           75 QTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVY----------RDIKLENLMLDKDGH  143 (337)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBC----------CCCCGGGEEECTTSC
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeec----------CcCCHHHEEECCCCC
Confidence            999999999999999999999987 578999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||+++....... .....+||+.|+|||++.+     ..++.++|||||||++|||++|.+||.+.+..+.+..+
T Consensus       144 vkL~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i  217 (337)
T 1o6l_A          144 IKITDFGLCKEGISDGA-TMKTFCGTPEYLAPEVLED-----NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI  217 (337)
T ss_dssp             EEECCCTTCBCSCCTTC-CBCCCEECGGGCCGGGGSS-----SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             EEEeeccchhhcccCCC-cccccccChhhCChhhhcC-----CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            99999999986433322 2345789999999999973     56899999999999999999999999999998888888


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCC--CChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQ--NGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDS  317 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~--~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~  317 (372)
                      ....  +.+|.    .+++++++||.+||+ ||++||+.  ..+.+++              +||||++++|+.+  ++.
T Consensus       218 ~~~~--~~~p~----~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~--------------~h~~f~~~~~~~~~~~~~  277 (337)
T 1o6l_A          218 LMEE--IRFPR----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM--------------EHRFFLSINWQDVVQKKL  277 (337)
T ss_dssp             HHCC--CCCCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHH--------------TSGGGTTCCHHHHHTTCS
T ss_pred             HcCC--CCCCC----CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHH--------------cCCCcCCCCHHHHHhCCC
Confidence            8754  33454    689999999999999 99999964  3577777              9999999999998  567


Q ss_pred             CCCCcCCCCCCCCCCCCCCCccccCCCCCCCCCCC-Ccc----cccCCCCccCceeeCCC
Q psy11571        318 NAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAA-SPA----LSALHLPFVGFTFTQGW  372 (372)
Q Consensus       318 ~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~  372 (372)
                      .|||+|.+.++.|+++||.+.+.......++.... ...    ....+..|.||+|.++|
T Consensus       278 ~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~  337 (337)
T 1o6l_A          278 LPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQREEQEMFEDFDYIADW  337 (337)
T ss_dssp             CCSCCCCCSSTTCCTTSCHHHHTSCCC--------------------CCTTTTCCEECCC
T ss_pred             CCCCCCCCCCcchhhcccchhccCccCcCCCcccccccccccccccccccCCCceecCCC
Confidence            89999999999999999976554332211111111 011    11256889999999999

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.2e-61  Score=452.45  Aligned_cols=255  Identities=25%  Similarity=0.438  Sum_probs=220.7

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++++|.|    |+|.||++.+..+++.||+|.+........          +.+.+|+.+|+.++|||||+++++|
T Consensus        75 ~y~~~~~iG~G----~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~----------~~~~~Ei~il~~l~HpnIV~l~~~~  140 (346)
T 4fih_A           75 YLDNFIKIGEG----STGIVCIATVRSSGKLVAVKKMDLRKQQRR----------ELLFNEVVIMRDYQHENVVEMYNSY  140 (346)
T ss_dssp             TEEEEEEEEEC----SSCEEEEEEETTTCCEEEEEEEEGGGCSSG----------GGGHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hcEEeEEeecC----cCeEEEEEEECCCCCEEEEEEEecCchhHH----------HHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            46666777777    899999999999999999998865433222          3467899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      ++++.+|||||||+||+|.+++.+  +.+++.+++.++.||+.||+|||++||+|          |||||+|||++.+|+
T Consensus       141 ~~~~~~~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiH----------RDlKp~NILl~~~g~  208 (346)
T 4fih_A          141 LVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIH----------RDIKSDSILLTHDGR  208 (346)
T ss_dssp             EETTEEEEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEECTTCC
T ss_pred             EECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccc----------ccCCHHHEEECCCCC
Confidence            999999999999999999999987  67999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||+|+....... ...+.+||+.|||||++.     ...|+.++|||||||++|||++|++||.+.+..+.+..|
T Consensus       209 vKl~DFGla~~~~~~~~-~~~~~~GTp~YmAPEvl~-----~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i  282 (346)
T 4fih_A          209 VKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPELIS-----RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI  282 (346)
T ss_dssp             EEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHT-----TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             EEEecCcCceecCCCCC-cccccccCcCcCCHHHHC-----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH
Confidence            99999999988754433 234578999999999997     356899999999999999999999999999999998888


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      ..... ..++.  ...+|+++++||.+||+ ||++|||+++++                 +||||+..
T Consensus       283 ~~~~~-~~~~~--~~~~s~~~~dli~~~L~~dP~~R~ta~e~l-----------------~Hp~~~~~  330 (346)
T 4fih_A          283 RDNLP-PRLKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELL-----------------KHPFLAKA  330 (346)
T ss_dssp             HHSSC-CCCSC--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHT-----------------TCGGGGGC
T ss_pred             HcCCC-CCCCc--cccCCHHHHHHHHHHcCCChhHCcCHHHHh-----------------cCHhhcCC
Confidence            76432 22221  23689999999999999 999999866555                 99999853

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.9e-61  Score=454.79  Aligned_cols=257  Identities=27%  Similarity=0.405  Sum_probs=219.5

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      +||+.++.+|.|    |+|.||++++..+++.||+|.+........        ..+.+.+|+.+|+.++|||||+++++
T Consensus        24 e~Y~~~~~lG~G----~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~--------~~~~~~~E~~il~~l~HpnIV~~~~~   91 (350)
T 4b9d_A           24 EKYVRLQKIGEG----SFGKAILVKSTEDGRQYVIKEINISRMSSK--------EREESRREVAVLANMKHPNIVQYRES   91 (350)
T ss_dssp             CCEEEEEEC----------CEEEEEETTTCCEEEEEEEECTTSCHH--------HHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cceEEeEEEecC----CCeEEEEEEECCCCCEEEEEEEehHHCCHH--------HHHHHHHHHHHHHHCCCCCCCcEEEE
Confidence            467788888888    899999999999999999999876554332        34668899999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      |++++.+|+|||||+||+|.++|... ...+++..++.++.||+.||.|||++||+|          |||||+|||++.+
T Consensus        92 ~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiH----------RDlKp~NILl~~~  161 (350)
T 4b9d_A           92 FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILH----------RDIKSQNIFLTKD  161 (350)
T ss_dssp             EEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEE----------TTCCGGGEEECTT
T ss_pred             EEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeee----------ccCCHHHEEECCC
Confidence            99999999999999999999999764 345799999999999999999999999999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG  240 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~  240 (372)
                      |.+||+|||+|+....... .....+||+.|||||++.+     ..|+.++|||||||++|||+||++||.+.+..+++.
T Consensus       162 g~vKl~DFGla~~~~~~~~-~~~~~~GT~~YmAPE~l~~-----~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~  235 (350)
T 4b9d_A          162 GTVQLGDFGIARVLNSTVE-LARACIGTPYYLSPEICEN-----KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL  235 (350)
T ss_dssp             CCEEECSTTEESCCCHHHH-HHHHHHSCCTTCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             CCEEEcccccceeecCCcc-cccccCCCccccCHHHHCC-----CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH
Confidence            9999999999987643221 2345689999999999984     568999999999999999999999999999999999


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      +|..+... +.+.    .+|+++++||.+||+ ||++|||+++++                 +||||+.
T Consensus       236 ~i~~~~~~-~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l-----------------~hp~~~~  282 (350)
T 4b9d_A          236 KIISGSFP-PVSL----HYSYDLRSLVSQLFKRNPRDRPSVNSIL-----------------EKGFIAK  282 (350)
T ss_dssp             HHHHTCCC-CCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHH-----------------TSHHHHT
T ss_pred             HHHcCCCC-CCCc----cCCHHHHHHHHHHccCChhHCcCHHHHh-----------------cCHHhhc
Confidence            99886532 2232    689999999999999 999999866555                 9999975

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-60  Score=461.77  Aligned_cols=331  Identities=52%  Similarity=0.951  Sum_probs=262.4

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+.++.+|.|    |+|.||.+++..+++.||+|.+........       ...+.+.+|..++..++||||++++++++
T Consensus        63 f~~~~~lG~G----~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~-------~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           63 FEILKVIGRG----AFSEVAVVKMKQTGQVYAMKIMNKWDMLKR-------GEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             EEEEEEEEEC----SSCEEEEEEETTTCCEEEEEEEEHHHHHHH-------GGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             EEEEEEEeeC----CCeEEEEEEECCCCCEEEEEEEeHHHhhhH-------HHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            4444555555    899999999999999999998865433222       12345778999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcE
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI  163 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~v  163 (372)
                      +.+.+|+||||++||+|.+++.+.+..+++..++.++.||+.||.|||++||+|          |||||+|||++.+|++
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiH----------rDLKp~NILld~~g~v  201 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVH----------RDIKPDNILLDRCGHI  201 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEECTTSCE
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeee----------cccCHHHeeecCCCCE
Confidence            999999999999999999999875568999999999999999999999999999          9999999999999999


Q ss_pred             EEeecCcccccCCCCcccccccccCCcccCccccccccc--CCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEE--GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       164 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      ||+|||+++.............+||+.|+|||++.....  +...++.++|||||||++|||++|++||.+.+..+.+.+
T Consensus       202 kL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~  281 (412)
T 2vd5_A          202 RLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGK  281 (412)
T ss_dssp             EECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred             EEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999998876555444455789999999999973211  124589999999999999999999999999999999999


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccccccCCCCC
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPY  321 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~~~~~p~  321 (372)
                      |......+.+|.. ...+|+++++||++||++|++|++...+.+++              +||||++++|+.+++..|||
T Consensus       282 i~~~~~~~~~p~~-~~~~s~~~~dli~~lL~~p~~Rlgr~~~~ei~--------------~Hpff~~i~w~~l~~~~~p~  346 (412)
T 2vd5_A          282 IVHYKEHLSLPLV-DEGVPEEARDFIQRLLCPPETRLGRGGAGDFR--------------THPFFFGLDWDGLRDSVPPF  346 (412)
T ss_dssp             HHTHHHHCCCC-----CCCHHHHHHHHTTSSCGGGCTTTTTHHHHH--------------TSGGGTTCCSTTSTTSCCSC
T ss_pred             HHhcccCcCCCcc-ccCCCHHHHHHHHHHcCChhhcCCCCCHHHHh--------------cCCCcCCCCHHHHhhcCCCC
Confidence            8865433333421 12689999999999999999998766788888              99999999999999999999


Q ss_pred             cCCCCCCCCCCCCCCCccccCCC-----CCCCCCCCCcccccCCCCccCceeeCC
Q psy11571        322 IPEVSSPTDTSHFDVDEAGVRAS-----DALPPAAASPALSALHLPFVGFTFTQG  371 (372)
Q Consensus       322 ~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (372)
                      +|.+.++.|+++||....+....     +.+.+. ......+.+.+|.||||.+.
T Consensus       347 ~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~f~g~~~~~~  400 (412)
T 2vd5_A          347 TPDFEGATDTCNFDLVEDGLTAMVSGGGETLSDI-REGAPLGVHLPFVGYSYSCM  400 (412)
T ss_dssp             CCC-----CCSSCC--CCCCCTTSSSSSCCTTTC------CCTTGGGTTCCBSCC
T ss_pred             CCcCCCcccccccCcccccccccccccCCCcccc-cCCCccccCCCCCCCcccCc
Confidence            99999999999999755432221     111111 11223467789999999863

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=8.8e-61  Score=462.93  Aligned_cols=322  Identities=43%  Similarity=0.805  Sum_probs=263.5

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+.++.+|.|    |+|.||++++..+++.||+|.+.........       ..+.+.+|+.++..++||||++++++++
T Consensus        71 y~~~~~LG~G----~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~-------~~~~~~~E~~il~~l~hp~Iv~l~~~~~  139 (410)
T 3v8s_A           71 YEVVKVIGRG----AFGEVQLVRHKSTRKVYAMKLLSKFEMIKRS-------DSAFFWEERDIMAFANSPWVVQLFYAFQ  139 (410)
T ss_dssp             EEEEEEEEEC----SSEEEEEEEETTTCCEEEEEEEEHHHHHHTC-------CCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             cEEEEEEEcC----CCEEEEEEEECCCCcEEEEEEEehhhhhhhH-------HHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            3344455665    8999999999999999999988653332221       1233678999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcE
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI  163 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~v  163 (372)
                      +...+|+|||||+||+|.+++.+  ..+++..++.++.||+.||.|||++||+|          |||||+|||++.+|++
T Consensus       140 ~~~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givH----------rDLKp~NILl~~~g~i  207 (410)
T 3v8s_A          140 DDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIH----------RDVKPDNMLLDKSGHL  207 (410)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEECTTSCE
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEe----------ccCCHHHeeECCCCCE
Confidence            99999999999999999999987  57999999999999999999999999999          9999999999999999


Q ss_pred             EEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHh
Q psy11571        164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM  243 (372)
Q Consensus       164 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~  243 (372)
                      ||+|||+|+.............+||+.|+|||++.+.. +...++.++|||||||++|||++|++||.+.+..+.+.+|+
T Consensus       208 kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~  286 (410)
T 3v8s_A          208 KLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG-GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM  286 (410)
T ss_dssp             EECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTT-TTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             EEeccceeEeeccCCcccccCCcCCccccCHHHhhccC-CCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHH
Confidence            99999999887655544455678999999999998421 11237889999999999999999999999999999999998


Q ss_pred             hccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCC--CCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccCC
Q psy11571        244 NHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDT--RLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSN  318 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~--R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~~  318 (372)
                      .....+.+|..  ..+|+++++||++||+ +|.+  |++   +.+++              +||||++++|+.+  ++..
T Consensus       287 ~~~~~~~~p~~--~~~s~~~~~li~~lL~~~~~rlgR~~---~~ei~--------------~Hp~f~~~~w~~~~~~~~~  347 (410)
T 3v8s_A          287 NHKNSLTFPDD--NDISKEAKNLICAFLTDREVRLGRNG---VEEIK--------------RHLFFKNDQWAWETLRDTV  347 (410)
T ss_dssp             THHHHCCCCTT--CCCCHHHHHHHHHHSSCGGGCTTSSC---HHHHH--------------TSGGGCCSSCCSTTGGGSC
T ss_pred             hccccccCCCc--ccccHHHHHHHHHHccChhhhCCCCC---HHHHh--------------cCccccCCCHHHHhhcccC
Confidence            76544444542  2689999999999999 6666  775   55555              9999999999765  7789


Q ss_pred             CCCcCCCCCCCCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceeeCC
Q psy11571        319 APYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQG  371 (372)
Q Consensus       319 ~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (372)
                      |||+|.++++.|+++||..+.........+   .+....+.+.+|.||||+++
T Consensus       348 ~p~~p~~~~~~d~~~fd~~~~~~~~~~~~~---~~~~~~~~~~~f~~f~~~~~  397 (410)
T 3v8s_A          348 APVVPDLSSDIDTSNFDDLEEDKGEEETFP---IPKAFVGNQLPFVGFTYYSN  397 (410)
T ss_dssp             CSCCCCCSSTTCCTTSCCCCSCCSCCCCCC---CCSSCCCTTGGGTTCCEECC
T ss_pred             CCCCCcCCCccchhhcCCccccccccccCC---CchhhcccccccccceEeCc
Confidence            999999999999999997765433222211   12233456889999999974

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.6e-61  Score=438.36  Aligned_cols=253  Identities=26%  Similarity=0.457  Sum_probs=206.8

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||++.+..+++.||+|.+........       +..+++.+|+.+|+.++|||||++++++
T Consensus        14 ~Y~i~~~lG~G----~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~-------~~~~~~~~Ei~il~~l~HpnIv~~~~~~   82 (275)
T 3hyh_A           14 NYQIVKTLGEG----SFGKVKLAYHTTTGQKVALKIINKKVLAKS-------DMQGRIEREISYLRLLRHPHIIKLYDVI   82 (275)
T ss_dssp             CCEEEEEEEC-------CCEEEEECTTTCCEEEEEEEECC-------------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CeEEEEEEecC----cCeEEEEEEECCCCCEEEEEEEeHHHcCCH-------HHHHHHHHHHHHHHHCCCCCCCeEEEEE
Confidence            35556666776    899999999999999999999876655443       2345688999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      ++++.+|+||||| +|+|.+++.+ .+.+++.+++.++.||+.||+|||++||+|          |||||+|||++.+++
T Consensus        83 ~~~~~~~ivmEy~-~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiH----------RDiKP~NILl~~~~~  150 (275)
T 3hyh_A           83 KSKDEIIMVIEYA-GNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVH----------RDLKPENLLLDEHLN  150 (275)
T ss_dssp             ECSSEEEEEEECC-CEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCC----------CCCCTTTEEECTTCC
T ss_pred             EECCEEEEEEeCC-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------ccCChHHeEECCCCC
Confidence            9999999999999 7899999987 578999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||+|+.......  ..+.+||+.|||||++.+    ...++.++|||||||++|+|+||++||.+.+..+++.+|
T Consensus       151 vkl~DFGla~~~~~~~~--~~~~~GT~~Y~APE~~~~----~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i  224 (275)
T 3hyh_A          151 VKIADFGLSNIMTDGNF--LKTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI  224 (275)
T ss_dssp             EEECCSSCC-----------------CTTSCHHHHSS----SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             EEEeecCCCeecCCCCc--cCCeeECcccCChhhhcC----CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            99999999987654332  334789999999999984    333568999999999999999999999999999999998


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ  307 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~  307 (372)
                      ..+.  +.+|.    .+|+++++||++||+ ||++|||+++++                 +||||+
T Consensus       225 ~~~~--~~~p~----~~s~~~~~li~~~L~~dP~~R~s~~eil-----------------~hpw~k  267 (275)
T 3hyh_A          225 SNGV--YTLPK----FLSPGAAGLIKRMLIVNPLNRISIHEIM-----------------QDDWFK  267 (275)
T ss_dssp             HHTC--CCCCT----TSCHHHHHHHHHHSCSSGGGSCCHHHHH-----------------HCHHHH
T ss_pred             HcCC--CCCCC----CCCHHHHHHHHHHccCChhHCcCHHHHH-----------------cCcccc
Confidence            8754  34454    689999999999999 999999866655                 999997

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.1e-60  Score=451.06  Aligned_cols=319  Identities=32%  Similarity=0.560  Sum_probs=262.5

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYA   81 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~   81 (372)
                      +|+.++.+|.|    |+|.||.+++..+++.||+|.+........       ...+.+.+|..++..+ +||||++++++
T Consensus        24 ~y~~~~~lG~G----~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~-------~~~~~~~~E~~il~~~~~hp~Iv~l~~~   92 (353)
T 3txo_A           24 NFEFIRVLGKG----SFGKVMLARVKETGDLYAVKVLKKDVILQD-------DDVECTMTEKRILSLARNHPFLTQLFCC   92 (353)
T ss_dssp             CEEEEEEEEEE----TTEEEEEEEETTTCCEEEEEEEEHHHHHHH-------TTHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             heEEEEEEeeC----CCEEEEEEEEcCCCCEEEEEEEEHHHhcch-------hHHHHHHHHHHHHHhccCCCceeeEEEE
Confidence            34555666666    899999999999999999998876443332       2345577899999887 79999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +++.+.+|+|||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++||+|          |||||+|||++.+|
T Consensus        93 ~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH----------rDlkp~NILl~~~g  161 (353)
T 3txo_A           93 FQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDKGIIY----------RDLKLDNVLLDHEG  161 (353)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBC----------CCCCGGGEEECTTS
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcc----------cCCCHHHEEECCCC
Confidence            9999999999999999999999987 478999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      ++||+|||+++....... .....+||+.|+|||++.+     ..++.++|||||||++|||++|.+||.+.+..+++.+
T Consensus       162 ~ikL~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~  235 (353)
T 3txo_A          162 HCKLADFGMCKEGICNGV-TTATFCGTPDYIAPEILQE-----MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA  235 (353)
T ss_dssp             CEEECCCTTCBCSCC----------CCGGGCCHHHHHH-----HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             CEEEccccceeecccCCc-cccccCCCcCeEChhhcCC-----CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999986443322 3345789999999999984     4588999999999999999999999999999999999


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCC---CChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--c
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQ---NGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--R  315 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~---~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~  315 (372)
                      |.....  .+|.    .+++++++||++||+ ||++||++   .++.+++              +||||++++|+.+  +
T Consensus       236 i~~~~~--~~p~----~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il--------------~hp~f~~~~w~~l~~~  295 (353)
T 3txo_A          236 ILNDEV--VYPT----WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAIL--------------RHPFFKEIDWAQLNHR  295 (353)
T ss_dssp             HHHCCC--CCCT----TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHH--------------TSGGGTTCCHHHHHTT
T ss_pred             HHcCCC--CCCC----CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHh--------------hCCcccCCCHHHHhcC
Confidence            988653  3444    689999999999999 99999997   3456777              9999999999998  5


Q ss_pred             cCCCCCcCCCCCCCCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceeeCC
Q psy11571        316 DSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQG  371 (372)
Q Consensus       316 ~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (372)
                      +..|||+|.+.+..|.++||.+.....  +.+.|..........+..|.||+|.+.
T Consensus       296 ~~~~p~~p~~~~~~~~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~f~~f~~~~~  349 (353)
T 3txo_A          296 QIEPPFRPRIKSREDVSNFDPDFIKEE--PVLTPIDEGHLPMINQDEFRNFEYVSP  349 (353)
T ss_dssp             CSCCSCCCCCCSTTCCTTSCHHHHTSC--CCCCCCCTTSGGGSCGGGGTTCCEECC
T ss_pred             cCCCCccCCCCCcccccccCcccccCC--CcCCCccccccCcccccccCCceeeCc
Confidence            688999999999999999997765433  223333222222334678999999874

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.8e-60  Score=455.58  Aligned_cols=319  Identities=30%  Similarity=0.574  Sum_probs=259.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYA   81 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~   81 (372)
                      +|+.++.+|.|    |+|.||+++...+++.||+|.+........       +..+.+.+|..++..+ +||||++++++
T Consensus        53 ~y~~~~~LG~G----~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~-------~~~~~~~~E~~il~~~~~hp~Iv~l~~~  121 (396)
T 4dc2_A           53 DFDLLRVIGRG----SYAKVLLVRLKKTDRIYAMRVVKKELVNDD-------EDIDWVQTEKHVFEQASNHPFLVGLHSC  121 (396)
T ss_dssp             GEEEEEEEEEC----SSEEEEEEEETTTTEEEEEEEEEGGGTC-----------CCHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             HcEEEEEEeeC----CCeEEEEEEECCCCCEEEEEEEEhhhccCH-------HHHHHHHHHHHHHHhcCCCCCcCeeEEE
Confidence            34455566666    899999999999999999999876554433       2234567788888765 89999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      |++.+.+|+|||||+||+|..++.+ .+.+++..++.++.||+.||.|||++||+|          |||||+|||++.+|
T Consensus       122 ~~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH----------rDLKp~NILl~~~g  190 (396)
T 4dc2_A          122 FQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIY----------RDLKLDNVLLDSEG  190 (396)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBC----------CCCCGGGEEECTTS
T ss_pred             EEECCEEEEEEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEe----------ccCCHHHEEECCCC
Confidence            9999999999999999999999987 578999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC--------
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE--------  233 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~--------  233 (372)
                      ++||+|||+|+....... .....+||+.|+|||++.+     ..++.++|||||||++|||++|++||...        
T Consensus       191 ~ikL~DFGla~~~~~~~~-~~~~~~gt~~Y~aPE~l~~-----~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~  264 (396)
T 4dc2_A          191 HIKLTDYGMCKEGLRPGD-TTSTFCGTPNYIAPEILRG-----EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ  264 (396)
T ss_dssp             CEEECCCTTCBCCCCTTC-CBCCCCBCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------
T ss_pred             CEEEeecceeeecccCCC-ccccccCCcccCCchhhcC-----CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch
Confidence            999999999986433222 3345789999999999984     56899999999999999999999999642        


Q ss_pred             -CHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCC---ChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        234 -SLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQN---GIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       234 -~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~---~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                       ....++..+....  +.+|.    .+++++++||++||+ ||.+||++.   ++.+++              +||||++
T Consensus       265 ~~~~~~~~~i~~~~--~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~--------------~Hpff~~  324 (396)
T 4dc2_A          265 NTEDYLFQVILEKQ--IRIPR----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQ--------------GHPFFRN  324 (396)
T ss_dssp             CCHHHHHHHHHHCC--CCCCT----TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHH--------------HSTTTTT
T ss_pred             hhHHHHHHHHhccc--cCCCC----cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHh--------------cCccccC
Confidence             2334556666543  34455    689999999999999 999999984   578888              9999999


Q ss_pred             CCcccc--ccCCCCCcCCCCCCCCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceeeCC
Q psy11571        309 IAWDSI--RDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQG  371 (372)
Q Consensus       309 ~~w~~~--~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (372)
                      +||+.+  ++..|||+|.++++.|.++||...+....  .+.|.......+..+..|.||+|.++
T Consensus       325 i~w~~l~~~~~~pp~~p~~~~~~d~~~fd~~~~~~~~--~~~~~~~~~~~~~~~~~f~~f~~~~~  387 (396)
T 4dc2_A          325 VDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPV--QLTPDDDDIVRKIDQSEFEGFEYINP  387 (396)
T ss_dssp             CCHHHHHTTCSCCSCCCCCCSSTTGGGSCHHHHTSCC--CCCCCCHHHHTTSCGGGGTTCCEECC
T ss_pred             CCHHHHHcCCCCCCCcCCCCCccchhhcChhhccCCC--ccCCCcchhhccccccccCCcEeECc
Confidence            999998  56789999999999999999987664332  22222221112234568999999985

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=8.6e-60  Score=453.30  Aligned_cols=255  Identities=25%  Similarity=0.434  Sum_probs=221.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      .|+.++++|.|    |+|.||++.+..+++.||+|.+........          +.+.+|+.+|+.++|||||+++++|
T Consensus       152 ~y~~~~~iG~G----~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~----------~~~~~Ei~il~~l~HpnIV~l~~~~  217 (423)
T 4fie_A          152 YLDNFIKIGEG----STGIVCIATVRSSGKLVAVKKMDLRKQQRR----------ELLFNEVVIMRDYQHENVVEMYNSY  217 (423)
T ss_dssp             TEEEEEEEEEC----SSCEEEEEEETTTCCEEEEEEEESTTCSSG----------GGHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hcEeeeEeccC----cCcEEEEEEECCCCCEEEEEEEeccchhHH----------HHHHHHHHHHHhCCCCCCCceEEEE
Confidence            46667777777    899999999999999999999875443222          3467899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+++.+|||||||+||+|.++++.  +.+++.+++.++.||+.||+|||++||||          |||||+|||++.+|.
T Consensus       218 ~~~~~~~iVmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiH----------RDiKp~NILl~~~g~  285 (423)
T 4fie_A          218 LVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIH----------RDIKSDSILLTHDGR  285 (423)
T ss_dssp             EETTEEEEEEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSTTTEEECTTCC
T ss_pred             EECCEEEEEEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeec----------ccCCHHHEEEcCCCC
Confidence            999999999999999999999986  67999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||+|+....... ...+.+||+.|||||++.     ...|+.++|||||||++|||++|++||.+.+..+.+..|
T Consensus       286 vKl~DFGla~~~~~~~~-~~~~~~GTp~YmAPEvl~-----~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i  359 (423)
T 4fie_A          286 VKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPELIS-----RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI  359 (423)
T ss_dssp             EEECCCTTCEECCSSCC-CBCCCEECTTTCCHHHHT-----TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             EEEecCccceECCCCCc-cccccccCcCcCCHHHHC-----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH
Confidence            99999999987754433 334578999999999998     366999999999999999999999999999999998888


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      ..... ..++  ....+|+++++||.+||+ ||++|+|+++++                 +||||+..
T Consensus       360 ~~~~~-~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell-----------------~Hp~~~~~  407 (423)
T 4fie_A          360 RDNLP-PRLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELL-----------------KHPFLAKA  407 (423)
T ss_dssp             HHSCC-CCCS--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHT-----------------TCGGGGGC
T ss_pred             HcCCC-CCCc--ccccCCHHHHHHHHHHcCCChhHCcCHHHHh-----------------cCHHhcCC
Confidence            76532 2222  123789999999999999 999999866555                 99999853

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.7e-59  Score=442.21  Aligned_cols=316  Identities=33%  Similarity=0.550  Sum_probs=236.2

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYA   81 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~   81 (372)
                      +|+.++.+|.|    |+|.||.+++..+++.||+|.+.........       ..+.+..|..++..+ +||||++++++
T Consensus        18 ~y~~~~~lG~G----~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~-------~~~~~~~E~~il~~~~~hp~iv~l~~~   86 (345)
T 1xjd_A           18 DFILHKMLGKG----SFGKVFLAEFKKTNQFFAIKALKKDVVLMDD-------DVECTMVEKRVLSLAWEHPFLTHMFCT   86 (345)
T ss_dssp             TEEEEEEEEEC----SSSEEEEEEETTTTEEEEEEEEEHHHHHHTT-------CHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             HeEEEEEEeeC----CCeEEEEEEECCCCCEEEEEEEEhHHhhhhh-------hHHHHHHHHHHHHhcCCCCCCCcEEEE
Confidence            34445556666    8999999999999999999988765433221       234466788888765 89999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +++.+.+|+||||++||+|.+++.+ .+.+++..++.++.||+.||.|||++||+|          |||||+|||++.+|
T Consensus        87 ~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH----------rDlkp~NIll~~~g  155 (345)
T 1xjd_A           87 FQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVY----------RDLKLDNILLDKDG  155 (345)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBC----------CCCCGGGEEECTTS
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEe----------CCCChhhEEECCCC
Confidence            9999999999999999999999987 468999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      ++||+|||+++....... .....+||+.|+|||++.+     ..++.++|||||||++|||++|.+||.+.+..+++.+
T Consensus       156 ~vkL~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~  229 (345)
T 1xjd_A          156 HIKIADFGMCKENMLGDA-KTNTFCGTPDYIAPEILLG-----QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS  229 (345)
T ss_dssp             CEEECCCTTCBCCCCTTC-CBCCCCSCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             CEEEeEChhhhhcccCCC-cccCCCCCcccCChhhhcC-----CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            999999999986433222 2345789999999999983     5689999999999999999999999999999999998


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCC-ChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccC
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQN-GIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDS  317 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~-~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~  317 (372)
                      |.....  .+|.    .+++++++||.+||+ ||++||++. ++.                 +||||++++|+.+  ++.
T Consensus       230 i~~~~~--~~p~----~~s~~~~~li~~lL~~dp~~R~~~~~~i~-----------------~hp~f~~~~w~~l~~~~~  286 (345)
T 1xjd_A          230 IRMDNP--FYPR----WLEKEAKDLLVKLFVREPEKRLGVRGDIR-----------------QHPLFREINWEELERKEI  286 (345)
T ss_dssp             HHHCCC--CCCT----TSCHHHHHHHHHHSCSSGGGSBTTBSCGG-----------------GSGGGTTCCHHHHHTTCS
T ss_pred             HHhCCC--CCCc----ccCHHHHHHHHHHhcCCHhHcCCChHHHH-----------------cCccccCCCHHHHhhCCC
Confidence            887543  3444    689999999999999 999999986 554                 9999999999998  567


Q ss_pred             CCCCcCCCCCCCCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceeeCC
Q psy11571        318 NAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQG  371 (372)
Q Consensus       318 ~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (372)
                      .|||+|.+.++.|+++||........  .+.+.......+..+..|.||+|.+.
T Consensus       287 ~~p~~p~~~~~~d~~~f~~~~~~~~~--~~~~~~~~~~~~~~~~~f~~f~~~~~  338 (345)
T 1xjd_A          287 DPPFRPKVKSPFDCSNFDKEFLNEKP--RLSFADRALINSMDQNMFRNFSFMNP  338 (345)
T ss_dssp             CC----------------------------------------CCTTTTCCC---
T ss_pred             CCCcCCCCCCcchhhhcchhhcccCc--cCCcccccccccccccccCCCeeeCh
Confidence            89999999999999999976553322  22222221222356678999999864

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.9e-59  Score=443.36  Aligned_cols=318  Identities=32%  Similarity=0.548  Sum_probs=262.0

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYA   81 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~   81 (372)
                      +|+.++.+|.|    |+|.||.+++..+++.||+|.+........       ...+.+..|..++..+ .||||++++++
T Consensus        21 ~y~~~~~lG~G----~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~-------~~~~~~~~E~~~l~~~~~hp~iv~l~~~   89 (353)
T 2i0e_A           21 DFNFLMVLGKG----SFGKVMLSERKGTDELYAVKILKKDVVIQD-------DDVECTMVEKRVLALPGKPPFLTQLHSC   89 (353)
T ss_dssp             TEEEEEEEEEE----TTEEEEEEEETTEEEEEEEEEEEHHHHHHT-------TCHHHHHHHHHHHTCTTCCTTBCCEEEE
T ss_pred             HcEEEEEEeeC----CCEEEEEEEECCCCCEEEEEEEEHHHhhcc-------hHHHHHHHHHHHHHhcCCCCEEeeEEEE
Confidence            34445556666    899999999998999999998876543322       1235577899999887 79999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +++.+.+|+||||++||+|.+++.+ .+.+++..++.++.||+.||.|||++||+|          |||||+|||++.+|
T Consensus        90 ~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH----------rDlkp~NIll~~~g  158 (353)
T 2i0e_A           90 FQTMDRLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIY----------RDLKLDNVMLDSEG  158 (353)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBC----------CCCCGGGEEECTTS
T ss_pred             EEcCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEe----------ccCCHHHEEEcCCC
Confidence            9999999999999999999999987 468999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      ++||+|||+++....... .....+||+.|+|||++.+     ..++.++|||||||++|||++|++||.+.+..+++.+
T Consensus       159 ~vkL~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~  232 (353)
T 2i0e_A          159 HIKIADFGMCKENIWDGV-TTKTFCGTPDYIAPEIIAY-----QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS  232 (353)
T ss_dssp             CEEECCCTTCBCCCCTTC-CBCCCCSCGGGCCHHHHTT-----CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             cEEEEeCCcccccccCCc-ccccccCCccccChhhhcC-----CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence            999999999986433222 2345789999999999983     5689999999999999999999999999999999999


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCC--CChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--cc
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQ--NGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RD  316 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~--~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~  316 (372)
                      |.....  .+|.    .+++++++||++||+ ||.+||++  ..+.+++              .||||++++|+.+  ++
T Consensus       233 i~~~~~--~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~--------------~h~~f~~~~w~~l~~~~  292 (353)
T 2i0e_A          233 IMEHNV--AYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK--------------EHAFFRYIDWEKLERKE  292 (353)
T ss_dssp             HHHCCC--CCCT----TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHH--------------TSGGGTTCCHHHHHTTC
T ss_pred             HHhCCC--CCCC----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh--------------cCccccCCCHHHHHhCC
Confidence            988643  3454    689999999999999 99999986  3577888              9999999999998  66


Q ss_pred             CCCCCcCCCCCCCCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceeeCC
Q psy11571        317 SNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQG  371 (372)
Q Consensus       317 ~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (372)
                      ..|||+|.+.++ |.++||........  .+.+.......+..+..|.||||.+.
T Consensus       293 ~~~p~~p~~~~~-~~~~f~~~~~~~~~--~~~~~~~~~~~~~~~~~f~~f~~~~~  344 (353)
T 2i0e_A          293 IQPPYKPKACGR-NAENFDRFFTRHPP--VLTPPDQEVIRNIDQSEFEGFSFVNS  344 (353)
T ss_dssp             SCCSCCCCCCCC---CHHHHHHHHSCC--CCCCCCHHHHHHSCTTTTCSCCEECT
T ss_pred             CCCCcCCCCCCc-chhhccchhccCCc--ccCCccccccccccccccCCCeeeCc
Confidence            889999999998 99999876543322  22222221122246678999999874

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.4e-58  Score=425.93  Aligned_cols=243  Identities=19%  Similarity=0.359  Sum_probs=205.2

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe----CCeEEEEE
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQD----DSNLYLVM   92 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~----~~~~~lv~   92 (372)
                      ||+|.||++.+..++..||+|.+........        ..+.+.+|+.+|+.++|||||+++++|++    +..+|+||
T Consensus        37 G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~--------~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           37 GSFKTVYKGLDTETTVEVAWCELQDRKLTKS--------ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEEEGGGSCHH--------HHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             CcCcEEEEEEECCCCeEEEEEEEchhhCCHH--------HHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            3899999999999999999998876544332        24668899999999999999999999976    34689999


Q ss_pred             eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCCCcCCCCCcCcEEeC-CCCcEEEeecC
Q psy11571         93 DYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH--YVHRPNHFAFHLCRDIKPDNVLLD-ANGHIRLADFG  169 (372)
Q Consensus        93 E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~~~~~~~~vhrDlkp~NIll~-~~~~vkl~Dfg  169 (372)
                      |||+||+|.+++.+ .+.+++..++.++.||+.||+|||++|  |+|          |||||+|||++ .+|.+||+|||
T Consensus       109 Ey~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiH----------RDlKp~NILl~~~~g~vKl~DFG  177 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIH----------RDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             ECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCC----------CCCCGGGEEESSTTSCEEECCTT
T ss_pred             eCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEe----------cccChhheeEECCCCCEEEEeCc
Confidence            99999999999987 578999999999999999999999998  999          99999999998 47899999999


Q ss_pred             cccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCC-HHHHHHHHhhccCC
Q psy11571        170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKIMNHQNS  248 (372)
Q Consensus       170 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~-~~~~~~~i~~~~~~  248 (372)
                      +|+.....   ...+.+||+.|||||++.      +.|+.++|||||||++|||+||++||.+.+ ...++..+..+..+
T Consensus       178 la~~~~~~---~~~~~~GTp~YmAPE~~~------~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~  248 (290)
T 3fpq_A          178 LATLKRAS---FAKAVIGTPEFMAPEMYE------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP  248 (290)
T ss_dssp             GGGGCCTT---SBEESCSSCCCCCGGGGG------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC
T ss_pred             CCEeCCCC---ccCCcccCccccCHHHcC------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC
Confidence            99865432   234578999999999986      359999999999999999999999997654 45555666554333


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        249 FDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       249 ~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      ..++    ...++++++||.+||+ ||++|||+++++                 +||||+.
T Consensus       249 ~~~~----~~~~~~~~~li~~~L~~dP~~R~s~~e~l-----------------~Hp~~~~  288 (290)
T 3fpq_A          249 ASFD----KVAIPEVKEIIEGCIRQNKDERYSIKDLL-----------------NHAFFQE  288 (290)
T ss_dssp             GGGG----GCCCHHHHHHHHHHSCSSGGGSCCHHHHH-----------------TSGGGC-
T ss_pred             CCCC----ccCCHHHHHHHHHHccCChhHCcCHHHHh-----------------cCccccC
Confidence            2233    2678999999999999 999999866555                 9999984

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6.5e-59  Score=444.92  Aligned_cols=321  Identities=32%  Similarity=0.626  Sum_probs=233.0

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHH-HhcCCCCceeeeeEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDV-LVYGDRRWITNLHYA   81 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~i-l~~l~hp~Iv~l~~~   81 (372)
                      +|+.++.+|.|    ++|.||.+++..+++.||+|.+.........       ..+.+.+|..+ ++.++||||++++++
T Consensus        39 ~y~~~~~lG~G----~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~-------~~~~~~~e~~~ll~~~~hp~Iv~l~~~  107 (373)
T 2r5t_A           39 DFHFLKVIGKG----SFGKVLLARHKAEEVFYAVKVLQKKAILKKK-------EEKHIMSERNVLLKNVKHPFLVGLHFS  107 (373)
T ss_dssp             GEEEEEEEECC----TTCEEEEEEETTTCCEEEEEEEEGGGBC--------------------CCBCCCCCTTBCCEEEE
T ss_pred             heEEEEEEeeC----CCeEEEEEEEcCCCCEEEEEEEEHHHhhhhH-------HHHHHHHHHHHHHHhCCCCCCCCEEEE
Confidence            45556666666    8999999999999999999998766544321       23345567666 467899999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +++.+.+|+||||++||+|.+++.+ .+.+++..++.++.||+.||+|||++||+|          |||||+|||++.+|
T Consensus       108 ~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH----------rDlkp~NIll~~~g  176 (373)
T 2r5t_A          108 FQTADKLYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVY----------RDLKPENILLDSQG  176 (373)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCC----------CCCCGGGEEECTTS
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcee----------cCCCHHHEEECCCC
Confidence            9999999999999999999999987 478999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      ++||+|||+++....... .....+||+.|+|||++.+     ..++.++|||||||++|||++|.+||.+.+..+++.+
T Consensus       177 ~ikL~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~  250 (373)
T 2r5t_A          177 HIVLTDFGLCKENIEHNS-TTSTFCGTPEYLAPEVLHK-----QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN  250 (373)
T ss_dssp             CEEECCCCBCGGGBCCCC-CCCSBSCCCCCCCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHH
T ss_pred             CEEEeeCccccccccCCC-ccccccCCccccCHHHhCC-----CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence            999999999986433222 2345789999999999983     5689999999999999999999999999999999999


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCC-ChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccC
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQN-GIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDS  317 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~-~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~  317 (372)
                      |....  ..++.    .++.++++||++||+ ||.+||++. ++.+++              .||||++++|+.+  ++.
T Consensus       251 i~~~~--~~~~~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~--------------~h~~f~~~~w~~l~~~~~  310 (373)
T 2r5t_A          251 ILNKP--LQLKP----NITNSARHLLEGLLQKDRTKRLGAKDDFMEIK--------------SHVFFSLINWDDLINKKI  310 (373)
T ss_dssp             HHHSC--CCCCS----SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHH--------------TSGGGTTCCHHHHHTTCS
T ss_pred             HHhcc--cCCCC----CCCHHHHHHHHHHcccCHHhCCCCCCCHHHHh--------------CCccccCCCHHHHHhCCC
Confidence            98754  33444    689999999999999 999999974 577888              9999999999998  567


Q ss_pred             CCCCcCCCCCCCCCCCCCCCccccCCCCCCCCCCC----CcccccCCCCccCceeeCC
Q psy11571        318 NAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAA----SPALSALHLPFVGFTFTQG  371 (372)
Q Consensus       318 ~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~  371 (372)
                      .|||+|.+.++.|.++||.+..+.........+..    .......+..|.||||.+.
T Consensus       311 ~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~  368 (373)
T 2r5t_A          311 TPPFNPNVSGPNDLRHFDPEFTEEPVPNAIGKAPDSVLVTASVKEAAEAFLGFSYAPP  368 (373)
T ss_dssp             CCSCCCSCCC------------------------------------------------
T ss_pred             CCCCCCCCCCcchhhhcCcccccccccccccCCccccccccccccccccCCCCcccCc
Confidence            89999999999999999976554332221111111    1112244677999999863

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.4e-58  Score=435.80  Aligned_cols=320  Identities=30%  Similarity=0.576  Sum_probs=260.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYA   81 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~   81 (372)
                      +|+.++.+|.|    ++|.||.+++..+++.||+|.+........       +..+.+.+|..++..+ +||||++++++
T Consensus        10 ~y~~~~~lG~G----~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~~~E~~~l~~~~~hp~iv~l~~~   78 (345)
T 3a8x_A           10 DFDLLRVIGRG----SYAKVLLVRLKKTDRIYAMKVVKKELVNDD-------EDIDWVQTEKHVFEQASNHPFLVGLHSC   78 (345)
T ss_dssp             GEEEEEEEEEC----SSEEEEEEEETTTTEEEEEEEEEGGGSCSH-------HHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             heEEEEEEEec----CCeEEEEEEECCCCCEEEEEEEEhHHhcch-------HHHHHHHHHHHHHHhcCCCCccCeEEEE
Confidence            45556666776    899999999999999999999876554332       2345678899999887 89999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+.+.+|+||||++||+|.+++.+ .+.+++..++.++.||+.||.|||++||+|          |||||+|||++.+|
T Consensus        79 ~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH----------rDlkp~NIll~~~g  147 (345)
T 3a8x_A           79 FQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIY----------RDLKLDNVLLDSEG  147 (345)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBC----------CCCCGGGEEECTTS
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcee----------cCCCHHHEEECCCC
Confidence            9999999999999999999999987 468999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCC---------
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA---------  232 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~---------  232 (372)
                      ++||+|||+++....... .....+||+.|+|||++.+     ..++.++|||||||++|||++|++||..         
T Consensus       148 ~~kL~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  221 (345)
T 3a8x_A          148 HIKLTDYGMCKEGLRPGD-TTSTFCGTPNYIAPEILRG-----EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ  221 (345)
T ss_dssp             CEEECCGGGCBCSCCTTC-CBCCCCSCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC------
T ss_pred             CEEEEeccccccccCCCC-cccccCCCccccCccccCC-----CCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc
Confidence            999999999986433222 2344689999999999983     5689999999999999999999999975         


Q ss_pred             CCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCC---ChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        233 ESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQN---GIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       233 ~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~---~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      ......+..+....  +.+|.    .++.++++||++||+ ||.+||++.   ++.+++              +||||++
T Consensus       222 ~~~~~~~~~i~~~~--~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~--------------~hp~f~~  281 (345)
T 3a8x_A          222 NTEDYLFQVILEKQ--IRIPR----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQ--------------GHPFFRN  281 (345)
T ss_dssp             -CHHHHHHHHHHCC--CCCCT----TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHH--------------TSGGGTT
T ss_pred             ccHHHHHHHHHcCC--CCCCC----CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHh--------------cCCccCC
Confidence            33445566666543  34454    689999999999999 999999974   467788              9999999


Q ss_pred             CCcccc--ccCCCCCcCCCCCCCCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceeeCCC
Q psy11571        309 IAWDSI--RDSNAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQGW  372 (372)
Q Consensus       309 ~~w~~~--~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (372)
                      ++|+.+  ++..|||+|.++++.|.++||.........  ..+.......+..+..|.||||.+++
T Consensus       282 ~~w~~~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~f~~f~~~~~~  345 (345)
T 3a8x_A          282 VDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQ--LTPDDDDIVRKIDQSEFEGFEYINPL  345 (345)
T ss_dssp             CCHHHHHTTCSCCSCCCCCCTTTCGGGSCHHHHTSCSS--CCCCCHHHHTTSCGGGGTTCCEECCC
T ss_pred             CCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCccc--CCCccccccccccccccCCCEeeCCC
Confidence            999998  567899999999999999999754432221  11211111112455689999999864

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.1e-59  Score=436.23  Aligned_cols=254  Identities=22%  Similarity=0.294  Sum_probs=212.2

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      ||+|.||++++..+++.||+|.+......               .+|+.+++.++|||||++++++++++.+|||||||+
T Consensus        69 G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~---------------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~  133 (336)
T 4g3f_A           69 GSFGEVHRMKDKQTGFQCAVKKVRLEVFR---------------VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE  133 (336)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEETTTCC---------------THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             CCCeEEEEEEECCCCCEEEEEEECHHHhH---------------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence            38999999999999999999988654322               358999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC-cEEEeecCcccccC
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG-HIRLADFGSCLRLG  175 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~-~vkl~Dfg~a~~~~  175 (372)
                      ||+|.+++++ .+.+++.+++.++.||+.||.|||++||+|          |||||+|||++.+| ++||+|||+|+...
T Consensus       134 gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiH----------RDlKp~NILl~~~g~~vKl~DFGla~~~~  202 (336)
T 4g3f_A          134 GGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTRRILH----------GDVKADNVLLSSDGSRAALCDFGHALCLQ  202 (336)
T ss_dssp             TCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEEC----------SCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred             CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcee----------cccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence            9999999987 578999999999999999999999999999          99999999999887 69999999998765


Q ss_pred             CCCc----ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCc-C
Q psy11571        176 GDGT----VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSF-D  250 (372)
Q Consensus       176 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-~  250 (372)
                      ....    ......+||+.|||||++.+     ..|+.++|||||||++|||+||++||.+.+..+++.+|......+ .
T Consensus       203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~-----~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~  277 (336)
T 4g3f_A          203 PDGLGKSLLTGDYIPGTETHMAPEVVMG-----KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIRE  277 (336)
T ss_dssp             -----------CCCCCCGGGCCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGG
T ss_pred             CCCcccceecCCccccCccccCHHHHCC-----CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchh
Confidence            4322    12234689999999999984     569999999999999999999999999988878888887765332 2


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        251 LPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       251 ~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      +|.    .+|+++++||.+||+ ||++|||+.++++.+. .++   .....++|||+...
T Consensus       278 ~~~----~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~-~~l---~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          278 IPP----SCAPLTAQAIQEGLRKEPVHRASAMELRRKVG-KAL---QEVGGLKSPWKGEY  329 (336)
T ss_dssp             SCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH-HHH---HHTTSSCSCSSSSC
T ss_pred             cCc----cCCHHHHHHHHHHccCCHhHCcCHHHHHHHHH-HHH---hhhhhccCCCcCCC
Confidence            333    789999999999999 9999999887765431 111   12233589999754

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.3e-57  Score=464.87  Aligned_cols=317  Identities=33%  Similarity=0.552  Sum_probs=264.8

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYAF   82 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~~   82 (372)
                      |+.+..+|.|    |+|.||++++..+++.||+|.+.........       ..+.+..|..++..+ +||||+++++++
T Consensus       343 f~~~~~LG~G----~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~-------~~~~~~~E~~~l~~~~~~~~i~~l~~~~  411 (674)
T 3pfq_A          343 FNFLMVLGKG----SFGKVMLSERKGTDELYAVKILKKDVVIQDD-------DVECTMVEKRVLALPGKPPFLTQLHSCF  411 (674)
T ss_dssp             EEEEEESSBT----TTBCEEEEEESSSCCEEEEEEEEHHHHHHTT-------TTHHHHHHHHHHTCTTCCTTBCCEEEEC
T ss_pred             eEEEEEEccC----CCEEEEEEEECCCCcEEEEEEEeccccccHH-------HHHHHHHHHHHHHhccCCCeEEEEEEEE
Confidence            3344455555    8999999999999999999988764433321       234567788999887 699999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      ++.+.+|+||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+|          |||||+|||++.+|+
T Consensus       412 ~~~~~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~gIiH----------rDLKp~NILl~~~g~  480 (674)
T 3pfq_A          412 QTMDRLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIY----------RDLKLDNVMLDSEGH  480 (674)
T ss_dssp             BCSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTSEEC----------CCCCSTTEEECSSSC
T ss_pred             EeCCEEEEEEeCcCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEe----------ccCChhhEEEcCCCc
Confidence            999999999999999999999987 478999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||+++....... .....+||+.|+|||++.     ...++.++|||||||++|||++|.+||.+.+..+++.+|
T Consensus       481 ikL~DFGla~~~~~~~~-~~~~~~GT~~Y~APE~l~-----~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i  554 (674)
T 3pfq_A          481 IKIADFGMCKENIWDGV-TTKTFCGTPDYIAPEIIA-----YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI  554 (674)
T ss_dssp             EEECCCTTCEECCCTTC-CBCCCCSCSSSCCHHHHT-----CCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             EEEeecceeeccccCCc-ccccccCCCcccCHhhhc-----CCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            99999999986443322 334578999999999998     367899999999999999999999999999999999999


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCC--CChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQ--NGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDS  317 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~--~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~  317 (372)
                      ....  +.+|.    .+++++++||++||+ ||++||++  +.+.+++              +||||+++||+.+  ++.
T Consensus       555 ~~~~--~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~--------------~h~ff~~i~w~~l~~~~~  614 (674)
T 3pfq_A          555 MEHN--VAYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK--------------EHAFFRYIDWEKLERKEI  614 (674)
T ss_dssp             HSSC--CCCCT----TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHH--------------SSGGGSSCCHHHHTTTCS
T ss_pred             HhCC--CCCCc----cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHh--------------cCccccCCCHHHHHhCCC
Confidence            8854  34454    689999999999999 99999997  4567777              9999999999998  567


Q ss_pred             CCCCcCCCCCCCCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCceeeCC
Q psy11571        318 NAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTFTQG  371 (372)
Q Consensus       318 ~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (372)
                      .|||+|.+++ .|.++||...+...  +.+.+.......+..+..|.||+|.+.
T Consensus       615 ~pp~~p~~~~-~~~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~f~~f~~~~~  665 (674)
T 3pfq_A          615 QPPYKPKASG-RNAENFDRFFTRHP--PVLTPPDQEVIRNIDQSEFEGFSFVNS  665 (674)
T ss_dssp             CCSCCCBCCG-GGHHHHTTTTTSSC--SSCCCCCHHHHTTCCGGGGTTCCEECS
T ss_pred             CCCCCCcCCC-CchhhcCchhccCC--CccCCCchhhhhcccccccCCCcccCh
Confidence            8999999988 89999998776443  223333221222234678999999985

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=5.4e-56  Score=421.45  Aligned_cols=283  Identities=35%  Similarity=0.676  Sum_probs=248.2

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    ++|.||.+++..+++.||+|.+........       ...+.+.+|+.+++.++||||+++++++
T Consensus        42 ~y~~~~~lG~G----~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~~~E~~~l~~l~hp~iv~~~~~~  110 (350)
T 1rdq_E           42 QFDRIKTLGTG----SFGRVMLVKHKESGNHYAMKILDKQKVVKL-------KQIEHTLNEKRILQAVNFPFLVKLEFSF  110 (350)
T ss_dssp             GEEEEEEEEEC----SSCEEEEEEETTTCCEEEEEEEEHHHHHHT-------TCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             HCEEEEEeecC----cCcEEEEEEECCCCCEEEEEEEEhHHhccH-------HHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            45555666666    899999999999999999998865443322       2345678899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+...+|+||||++||+|.+++.+ .+.+++..++.++.||+.||.|||++||+|          |||||+|||++.+|.
T Consensus       111 ~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH----------rDlkp~NIll~~~g~  179 (350)
T 1rdq_E          111 KDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIY----------RDLKPENLLIDQQGY  179 (350)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEECTTSC
T ss_pred             EcCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------ccCccceEEECCCCC
Confidence            999999999999999999999987 468999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||+++.....    ....+||+.|+|||++.+     ..++.++|||||||++|+|++|.+||.+.+..+.+.+|
T Consensus       180 ~kL~DFg~a~~~~~~----~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i  250 (350)
T 1rdq_E          180 IQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILS-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI  250 (350)
T ss_dssp             EEECCCTTCEECSSC----BCCCEECGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             EEEcccccceeccCC----cccccCCccccCHHHhcC-----CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHH
Confidence            999999999876432    234689999999999983     56899999999999999999999999999999999999


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCC--CChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQ--NGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDS  317 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~--~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~  317 (372)
                      ..+.  +.+|.    .+++++++||.+||+ ||.+||+.  +.+.+++              +||||++++|+.+  ++.
T Consensus       251 ~~~~--~~~p~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~--------------~h~~f~~~~w~~~~~~~~  310 (350)
T 1rdq_E          251 VSGK--VRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRKV  310 (350)
T ss_dssp             HHCC--CCCCT----TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHH--------------TSGGGTTCCHHHHHTTCS
T ss_pred             HcCC--CCCCC----CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHH--------------hCcCcCCCCHHHHhhccC
Confidence            8764  34454    689999999999999 99999983  4467777              9999999999998  567


Q ss_pred             CCCCcCCCCCCCCCCCCCC
Q psy11571        318 NAPYIPEVSSPTDTSHFDV  336 (372)
Q Consensus       318 ~~p~~p~~~~~~~~~~~~~  336 (372)
                      .|||+|.+.++.|+++||.
T Consensus       311 ~~p~~p~~~~~~~~~~f~~  329 (350)
T 1rdq_E          311 EAPFIPKFKGPGDTSNFDD  329 (350)
T ss_dssp             CCSCCCCCCSTTCCTTSCC
T ss_pred             CCCCCCCCCCccccccccc
Confidence            8999999999999999984

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-56  Score=430.01  Aligned_cols=265  Identities=21%  Similarity=0.286  Sum_probs=219.5

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    ++|.||++.+..+++.||+|.+........        ..+++.+|+.+|+.++|||||+++++
T Consensus        54 ~~Y~~~~~lG~G----~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~--------~~~~~~~Ei~il~~l~HpnIv~l~~~  121 (398)
T 4b99_A           54 DEYEIIETIGNG----AYGVVSSARRRLTGQQVAIKKIPNAFDVVT--------NAKRTLRELKILKHFKHDNIIAIKDI  121 (398)
T ss_dssp             SSEEEEEEEEEC----SSCEEEEEEETTTCCEEEEEEETTTTSSHH--------HHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCeEEEEEEecc----cCeEEEEEEECCCCCEEEEEEECccccchH--------HHHHHHHHHHHHHhcCCCCcceEeee
Confidence            357777778887    899999999999999999998865433221        34567789999999999999999999


Q ss_pred             EEeC------CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcE
Q psy11571         82 FQDD------SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNV  155 (372)
Q Consensus        82 ~~~~------~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NI  155 (372)
                      +.+.      +.+|+|||||. |+|.+++.+ .+.+++..++.++.||+.||.|||++||+|          |||||+||
T Consensus       122 ~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiH----------RDlKP~NI  189 (398)
T 4b99_A          122 LRPTVPYGEFKSVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIH----------RDLKPSNL  189 (398)
T ss_dssp             CCCSSCTTTCCCEEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBC----------CCCCGGGE
T ss_pred             eecccccccCCEEEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcC----------CCcCcccc
Confidence            8643      57999999995 689999987 578999999999999999999999999999          99999999


Q ss_pred             EeCCCCcEEEeecCcccccCCCC---cccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCC
Q psy11571        156 LLDANGHIRLADFGSCLRLGGDG---TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA  232 (372)
Q Consensus       156 ll~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~  232 (372)
                      |++.+|.+||+|||+|+.+....   .....+.+||+.|+|||++.+    ...++.++||||+||++|||++|++||.+
T Consensus       190 l~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~----~~~~~~~~DiWSlG~il~ell~G~~pF~g  265 (398)
T 4b99_A          190 LVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLS----LHEYTQAIDLWSVGCIFGEMLARRQLFPG  265 (398)
T ss_dssp             EECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTT----CSCCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred             ccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcC----CCCCCChhheehhHHHHHHHHHCCCCCCC
Confidence            99999999999999998764321   122345789999999999884    45679999999999999999999999999


Q ss_pred             CCHHHHHHHHhhccCCcCC------------------CCC-------CCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhh
Q psy11571        233 ESLVETYGKIMNHQNSFDL------------------PSD-------VGYEISDDAKDLMRRLIC-SSDTRLGQNGIADF  286 (372)
Q Consensus       233 ~~~~~~~~~i~~~~~~~~~------------------~~~-------~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i  286 (372)
                      .+..+.+..|......+..                  |..       ....+|++++|||++||+ ||++|||+++++  
T Consensus       266 ~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L--  343 (398)
T 4b99_A          266 KNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAAL--  343 (398)
T ss_dssp             SSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHT--
T ss_pred             CCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHh--
Confidence            9999988888764332211                  100       012579999999999999 999999876665  


Q ss_pred             hhhhhhhhccCCCCCCCCCcCCCCc
Q psy11571        287 KMWSALFVSLSISPRNHPWFQGIAW  311 (372)
Q Consensus       287 ~~~~~~~~~~~~~~~~hp~f~~~~w  311 (372)
                                     +||||+....
T Consensus       344 ---------------~Hp~f~~~~~  353 (398)
T 4b99_A          344 ---------------RHPFLAKYHD  353 (398)
T ss_dssp             ---------------TSGGGTTTCC
T ss_pred             ---------------cCHhhCcCCC
Confidence                           9999997654

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-55  Score=413.18  Aligned_cols=286  Identities=38%  Similarity=0.695  Sum_probs=237.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    ++|.||.+++..+++.||+|.+........       ...+.+.+|..+++.++||||+++++++
T Consensus         7 ~y~~~~~lG~G----~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~~~E~~~l~~l~hp~Iv~~~~~~   75 (318)
T 1fot_A            7 DFQILRTLGTG----SFGRVHLIRSRHNGRYYAMKVLKKEIVVRL-------KQVEHTNDERLMLSIVTHPFIIRMWGTF   75 (318)
T ss_dssp             GEEEEEEEEEC----SSCEEEEEEETTTCCEEEEEEEEHHHHHHT-------TCHHHHHHHHHHHHSCCBTTBCCEEEEE
T ss_pred             HcEEEEEEeeC----CCEEEEEEEECCCCCEEEEEEEEHHHhhhh-------hHHHHHHHHHHHHhhCCCCCCceEeEEE
Confidence            45566677777    899999999999999999998865443322       2345577899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+...+|+||||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+|          |||||+|||++.+|.
T Consensus        76 ~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH----------rDlkp~NIll~~~g~  144 (318)
T 1fot_A           76 QDAQQIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIY----------RDLKPENILLDKNGH  144 (318)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEEC----------CCCCGGGEEECTTSC
T ss_pred             EeCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------cCCChheEEEcCCCC
Confidence            999999999999999999999987 578999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||+++.....    ....+||+.|+|||++.+     ..++.++|||||||++|||++|.+||.+.+..+.+.++
T Consensus       145 ~kL~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i  215 (318)
T 1fot_A          145 IKITDFGFAKYVPDV----TYTLCGTPDYIAPEVVST-----KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI  215 (318)
T ss_dssp             EEECCCSSCEECSSC----BCCCCSCTTTCCHHHHTT-----CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             EEEeecCcceecCCc----cccccCCccccCHhHhcC-----CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999876432    234689999999999983     56899999999999999999999999999999999998


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCC--ChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQN--GIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDS  317 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~--~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~  317 (372)
                      ....  +.+|.    .+++++++||++||. ||++|++..  .+.+++              +||||++++|+.+  ++.
T Consensus       216 ~~~~--~~~p~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~--------------~hp~f~~~~~~~~~~~~~  275 (318)
T 1fot_A          216 LNAE--LRFPP----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK--------------NHPWFKEVVWEKLLSRNI  275 (318)
T ss_dssp             HHCC--CCCCT----TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH--------------TSGGGSSCCHHHHHTTCS
T ss_pred             HhCC--CCCCC----CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHh--------------cCccccCCCHHHHHhCCC
Confidence            8764  33444    689999999999999 999999642  466777              9999999999998  567


Q ss_pred             CCCCcCCCC-CCCCCCCCCCCcc
Q psy11571        318 NAPYIPEVS-SPTDTSHFDVDEA  339 (372)
Q Consensus       318 ~~p~~p~~~-~~~~~~~~~~~~~  339 (372)
                      .|||.|.+. +..|+++||....
T Consensus       276 ~~p~~p~~~~~~~d~~~f~~~~~  298 (318)
T 1fot_A          276 ETPYEPPIQQGQGDTSQFDKYPE  298 (318)
T ss_dssp             CCSCCCCC---------------
T ss_pred             CCCCCCCcCCCccchhhcCCCCc
Confidence            899999998 5899999986443

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.8e-56  Score=414.79  Aligned_cols=257  Identities=20%  Similarity=0.293  Sum_probs=194.1

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      .|+.++.+|.|    |+|.||++++..+++.||+|.+......         ...+++.+|+.+|+.++|||||+++++|
T Consensus         6 dy~~~~~lG~G----~fg~V~~a~~~~~~~~vAiK~i~~~~~~---------~~~~~~~~E~~il~~l~HpnIV~~~~~~   72 (299)
T 4g31_A            6 DFEPIQCLGRG----GFGVVFEAKNKVDDCNYAIKRIRLPNRE---------LAREKVMREVKALAKLEHPGIVRYFNAW   72 (299)
T ss_dssp             HEEEEEEEEEC----C--EEEEEEETTTCCEEEEEEEEECSSH---------HHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hCEEeeEEecC----CCeEEEEEEECCCCCEEEEEEEeccCCH---------HHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            35566777777    8999999999999999999988654321         1235678899999999999999999999


Q ss_pred             EeCC------------eEEEEEeccCCCCHHHHHHhcCCC---CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcC
Q psy11571         83 QDDS------------NLYLVMDYYCGGDLLTLLSKFEDR---LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC  147 (372)
Q Consensus        83 ~~~~------------~~~lv~E~~~gg~L~~~l~~~~~~---l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vh  147 (372)
                      .+.+            .+|+|||||+||+|.+++... ..   .++..++.++.||+.||+|||++||+|          
T Consensus        73 ~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiH----------  141 (299)
T 4g31_A           73 LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFLQIAEAVEFLHSKGLMH----------  141 (299)
T ss_dssp             EEEC----------CEEEEEEEECCCSCCHHHHHHTC-CSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCC----------
T ss_pred             EecCccccccccCCCcEEEEEEecCCCCcHHHHHHhc-CCCChhHHHHHHHHHHHHHHHHHHHHHCcCcc----------
Confidence            7654            379999999999999999873 33   455678999999999999999999999          


Q ss_pred             CCCCcCcEEeCCCCcEEEeecCcccccCCCCcc-----------cccccccCCcccCcccccccccCCCCCCCccceeeh
Q psy11571        148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTV-----------QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSL  216 (372)
Q Consensus       148 rDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diwsl  216 (372)
                      |||||+|||++.+|.+||+|||+|+........           ...+.+||+.|||||++.+     ..|+.++|||||
T Consensus       142 RDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-----~~y~~~~DiwSl  216 (299)
T 4g31_A          142 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-----NSYSHKVDIFSL  216 (299)
T ss_dssp             CCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTT-----CCCCTHHHHHHH
T ss_pred             ccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC-----CCCCCHHHHHHH
Confidence            999999999999999999999999876543211           1234689999999999983     579999999999


Q ss_pred             hHHHHHHhhCCCCCCCCCHH-HHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhh
Q psy11571        217 GVCMYEMLYGETPFYAESLV-ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFV  294 (372)
Q Consensus       217 Gvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~  294 (372)
                      ||++|||++   ||.+.... ..+..+...    .+|+. ....++.+.+||++||+ ||++|||+.+++          
T Consensus       217 Gvilyell~---Pf~~~~~~~~~~~~~~~~----~~p~~-~~~~~~~~~~li~~~L~~dP~~Rps~~eil----------  278 (299)
T 4g31_A          217 GLILFELLY---PFSTQMERVRTLTDVRNL----KFPPL-FTQKYPCEYVMVQDMLSPSPMERPEAINII----------  278 (299)
T ss_dssp             HHHHHHHHS---CCSSHHHHHHHHHHHHTT----CCCHH-HHHHCHHHHHHHHHHTCSSGGGSCCHHHHH----------
T ss_pred             HHHHHHHcc---CCCCccHHHHHHHHHhcC----CCCCC-CcccCHHHHHHHHHHcCCChhHCcCHHHHh----------
Confidence            999999996   78654322 233333332    22211 11357788999999999 999999866555          


Q ss_pred             ccCCCCCCCCCcCCCCccc
Q psy11571        295 SLSISPRNHPWFQGIAWDS  313 (372)
Q Consensus       295 ~~~~~~~~hp~f~~~~w~~  313 (372)
                             +||||++++|..
T Consensus       279 -------~h~~~~~~~~p~  290 (299)
T 4g31_A          279 -------ENAVFEDLDFPG  290 (299)
T ss_dssp             -------TSGGGCCC----
T ss_pred             -------cCHhhCCCCCCC
Confidence                   999999999943

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-55  Score=408.36  Aligned_cols=246  Identities=17%  Similarity=0.172  Sum_probs=195.5

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      ||+|.||+++..   ..||+|.++......        +..+.+.+|+.+++.++|||||++++++.+ +.+|||||||+
T Consensus        47 G~fG~Vy~~~~~---~~vAvK~~~~~~~~~--------~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~  114 (307)
T 3omv_A           47 GSFGTVYKGKWH---GDVAVKILKVVDPTP--------EQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCE  114 (307)
T ss_dssp             CSSSEEEEEESS---SEEEEEECCCSSCCH--------HHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCS
T ss_pred             CCCcEEEEEEEC---CcEEEEEEEecCCCH--------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCC
Confidence            389999998643   348999876543322        235678999999999999999999998754 57899999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCC
Q psy11571         97 GGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG  176 (372)
Q Consensus        97 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  176 (372)
                      ||+|.++|......+++.++..++.||+.||+|||+++|||          |||||+|||+++++.+||+|||+|+....
T Consensus       115 gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiH----------RDlKp~NILl~~~~~~Ki~DFGla~~~~~  184 (307)
T 3omv_A          115 GSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIH----------RDMKSNNIFLHEGLTVKIGDFGLATVKSR  184 (307)
T ss_dssp             SCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBC----------SCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred             CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccC----------CccCHHHEEECCCCcEEEeeccCceeccc
Confidence            99999999876678999999999999999999999999999          99999999999999999999999987643


Q ss_pred             CC-cccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCC
Q psy11571        177 DG-TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDV  255 (372)
Q Consensus       177 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  255 (372)
                      .. .......+||+.|||||++.+..  .+.|+.++|||||||++|||+||+.||.+.+.......+.......+.....
T Consensus       185 ~~~~~~~~~~~GT~~ymAPE~l~~~~--~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~  262 (307)
T 3omv_A          185 WSGSQQVEQPTGSVLWMAPEVIRMQD--NNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKL  262 (307)
T ss_dssp             ---------CCCCTTSCCHHHHHCCS--SCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTS
T ss_pred             CCcceeecccccCCCccCHHHhhccC--CCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Confidence            22 22334568999999999997421  3458999999999999999999999999876655555444433222222233


Q ss_pred             CCCCCHHHHHHHHHhcc-CCCCCCCCCChhhh
Q psy11571        256 GYEISDDAKDLMRRLIC-SSDTRLGQNGIADF  286 (372)
Q Consensus       256 ~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i  286 (372)
                      ...+++++.+||.+||+ ||++|||+.++.+.
T Consensus       263 ~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          263 YKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             cccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            34789999999999999 99999998877643

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=6.4e-55  Score=414.74  Aligned_cols=257  Identities=23%  Similarity=0.368  Sum_probs=201.2

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeee---hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETL---LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNL   78 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~---~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l   78 (372)
                      +|+.++.+|.|    |+|.||++++.   .+++.||+|.+.....            ..++.+|+.+|+.+ +||||+++
T Consensus        22 ~Y~i~~~lG~G----~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~------------~~~~~~E~~~l~~~~~h~nIv~l   85 (361)
T 4f9c_A           22 VFKIEDKIGEG----TFSSVYLATAQLQVGPEEKIALKHLIPTSH------------PIRIAAELQCLTVAGGQDNVMGV   85 (361)
T ss_dssp             TCEEEEEEEEC----SSEEEEEEEEEBTTSCEEEEEEEEECTTSC------------HHHHHHHHHHHHHTCSBTTBCCC
T ss_pred             cEEEEEEEecc----cCcEEEEEEEcccCCCCCEEEEEEEccccC------------HHHHHHHHHHHHHhcCCCCCceE
Confidence            45555566666    89999999764   3578999998755332            12366799999887 69999999


Q ss_pred             eEEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC
Q psy11571         79 HYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD  158 (372)
Q Consensus        79 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~  158 (372)
                      +++|++.+++|+|||||+||+|.++++    .+++.+++.++.||+.||+|||++||+|          |||||+|||++
T Consensus        86 ~~~~~~~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiH----------RDiKPeNiLl~  151 (361)
T 4f9c_A           86 KYCFRKNDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVH----------RDVKPSNFLYN  151 (361)
T ss_dssp             SEEEEETTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSGGGEEEE
T ss_pred             EEEEEECCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEe----------CcCCHHHeEEe
Confidence            999999999999999999999999983    4899999999999999999999999999          99999999998


Q ss_pred             CC-CcEEEeecCcccccCCCCc---------------------------ccccccccCCcccCcccccccccCCCCCCCc
Q psy11571        159 AN-GHIRLADFGSCLRLGGDGT---------------------------VQSNVAVGTPDYISPEILTAMEEGRGRYGPE  210 (372)
Q Consensus       159 ~~-~~vkl~Dfg~a~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~  210 (372)
                      .+ +.+||+|||+|+.......                           ....+.+||+.|+|||++.+    ...|+.+
T Consensus       152 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~----~~~y~~~  227 (361)
T 4f9c_A          152 RRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK----CPNQTTA  227 (361)
T ss_dssp             TTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTT----CSCCCTH
T ss_pred             CCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcC----CCCCCCc
Confidence            76 8999999999976543211                           11233579999999999974    3468999


Q ss_pred             cceeehhHHHHHHhhCCCCCCC-CCHHHHHHHHhhccCC------------------------------------cCC--
Q psy11571        211 CDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHQNS------------------------------------FDL--  251 (372)
Q Consensus       211 ~DiwslGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~------------------------------------~~~--  251 (372)
                      +||||+||++|||++|++||.. .+..+.+.+|......                                    ...  
T Consensus       228 ~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~  307 (361)
T 4f9c_A          228 IDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPK  307 (361)
T ss_dssp             HHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC--------
T ss_pred             cchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccc
Confidence            9999999999999999999954 4444554444321000                                    000  


Q ss_pred             ----------CCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCC
Q psy11571        252 ----------PSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       252 ----------~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~  310 (372)
                                ....+..+|++++|||++||+ ||++|+|+++++                 +||||++++
T Consensus       308 ~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL-----------------~Hp~f~~i~  360 (361)
T 4f9c_A          308 LTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEAL-----------------LHPFFKDMS  360 (361)
T ss_dssp             --------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHH-----------------TSGGGTTC-
T ss_pred             cccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHh-----------------cCcccCCCC
Confidence                      011233689999999999999 999999977666                 999999875

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.5e-55  Score=440.13  Aligned_cols=262  Identities=25%  Similarity=0.411  Sum_probs=228.1

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    +||.||++.+..+++.||+|.+.......          .+.+.+|+.+|+.++|||||+++++|
T Consensus       158 ~Y~i~~~lG~G----~fg~V~~~~~~~tg~~~AiK~i~~~~~~~----------~~~~~~Ei~il~~l~hpnIv~l~~~~  223 (573)
T 3uto_A          158 HYDIHEELGTG----AFGVVHRVTERATGNNFAAKFVMTPHESD----------KETVRKEIQTMSVLRHPTLVNLHDAF  223 (573)
T ss_dssp             TEEEEEEEEEE----TTEEEEEEEETTTCCEEEEEEEECCSHHH----------HHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred             ccEEEEEEeec----cCeEEEEEEECCCCCEEEEEEEeccchhh----------HHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            46666777776    89999999999999999999886644322          24577899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC--
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN--  160 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~--  160 (372)
                      ++.+.+|+|||||+||+|.++|....+.+++.+++.++.||+.||.|||++||+|          |||||+|||++.+  
T Consensus       224 ~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiH----------RDlKp~Nill~~~~~  293 (573)
T 3uto_A          224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVH----------LDLKPENIMFTTKRS  293 (573)
T ss_dssp             ECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCCGGGEEESSSSC
T ss_pred             EECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeee----------ccCChhhccccCCCC
Confidence            9999999999999999999999765578999999999999999999999999999          9999999999854  


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG  240 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~  240 (372)
                      +.+||+|||+|+.......  ....+||+.|||||++.+     ..|+.++|||||||++|||++|.+||.+.+..+++.
T Consensus       294 ~~vKl~DFG~a~~~~~~~~--~~~~~GT~~y~APEv~~~-----~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~  366 (573)
T 3uto_A          294 NELKLIDFGLTAHLDPKQS--VKVTTGTAEFAAPEVAEG-----KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR  366 (573)
T ss_dssp             CCEEECCCSSCEECCTTSE--EEEECSSGGGCCHHHHTT-----CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH
T ss_pred             CCEEEeeccceeEccCCCc--eeeeEECccccCHHHhCC-----CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH
Confidence            8999999999998765443  234689999999999984     568999999999999999999999999999999999


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI  314 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~  314 (372)
                      +|......  ++......+|+++++||++||+ ||.+|||+++++                 +||||+..+|...
T Consensus       367 ~i~~~~~~--~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l-----------------~Hpw~~~~~~~~~  422 (573)
T 3uto_A          367 NVKSCDWN--MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQAL-----------------EHPWLTPGNAPGR  422 (573)
T ss_dssp             HHHTTCCC--CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHH-----------------HSTTTSCCCCTTT
T ss_pred             HHHhCCCC--CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHh-----------------cCcCcCCCCCCCc
Confidence            99876543  3444444799999999999999 999999876655                 9999999988643

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=9.1e-55  Score=402.93  Aligned_cols=247  Identities=22%  Similarity=0.326  Sum_probs=207.6

Q ss_pred             HHhhhcCCcccCCccEEEeeee-----hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          7 LEALFLGGPIQGKGRVFSIETL-----LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         7 l~~~~~~~~~~g~G~v~~v~~~-----~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      .+++|.|    |||.||+++..     .++..||+|.+.....          +..+.+.+|+.+|++++|||||+++++
T Consensus        18 ~~~lG~G----~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~----------~~~~~f~~E~~il~~l~HpnIV~l~g~   83 (299)
T 4asz_A           18 KRELGEG----AFGKVFLAECYNLCPEQDKILVAVKTLKDASD----------NARKDFHREAELLTNLQHEHIVKFYGV   83 (299)
T ss_dssp             EEEEEC------CCCEEEEEECSCC----CEEEEEEEECSCCH----------HHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             eeEEeeC----CCcEEEEEEECCcccCCCCEEEEEEEeCCCCh----------HHHHHHHHHHHHHHhCCCCCCccEEEE
Confidence            3455555    89999999753     3578899998865432          123568899999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKF------------EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRD  149 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~------------~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrD  149 (372)
                      +.+++.+|+|||||++|+|.++|.+.            ...+++.++..++.||+.||.|||+++|+|          ||
T Consensus        84 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiH----------RD  153 (299)
T 4asz_A           84 CVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVH----------RD  153 (299)
T ss_dssp             ECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SC
T ss_pred             EeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc----------Cc
Confidence            99999999999999999999999763            236999999999999999999999999999          99


Q ss_pred             CCcCcEEeCCCCcEEEeecCcccccCCCCcc-cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CC
Q psy11571        150 IKPDNVLLDANGHIRLADFGSCLRLGGDGTV-QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GE  227 (372)
Q Consensus       150 lkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~  227 (372)
                      |||+|||++.++.+||+|||+|+........ ......||+.|||||++.+     ..|+.++|||||||++|||+| |+
T Consensus       154 lKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-----~~~~~k~DVwS~Gvvl~Ellt~G~  228 (299)
T 4asz_A          154 LATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-----RKFTTESDVWSLGVVLWEIFTYGK  228 (299)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             cCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcC-----CCCCchhhHHHHHHHHHHHHcCCC
Confidence            9999999999999999999999876443222 2234579999999999984     679999999999999999998 99


Q ss_pred             CCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        228 TPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       228 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .||.+.+..+++..+..+. .++.|.    .+|+++.+||.+||+ ||++|||++++.+.+
T Consensus       229 ~Pf~~~~~~~~~~~i~~~~-~~~~p~----~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L  284 (299)
T 4asz_A          229 QPWYQLSNNEVIECITQGR-VLQRPR----TCPQEVYELMLGCWQREPHMRKNIKGIHTLL  284 (299)
T ss_dssp             CTTTTSCHHHHHHHHHHTC-CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHcCC-CCCCCc----cchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            9999999999998888764 334454    689999999999999 999999988776544

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=5.7e-54  Score=403.84  Aligned_cols=292  Identities=34%  Similarity=0.651  Sum_probs=226.7

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeee---hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETL---LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNL   78 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~---~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l   78 (372)
                      ++|+.++.+|.|    |+|.||.+++.   .+++.||+|.+........      ......+.+|+.+++.++||||+++
T Consensus        17 ~~y~~~~~lG~G----~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~------~~~~~~~~~E~~~l~~l~hp~iv~~   86 (327)
T 3a62_A           17 ECFELLRVLGKG----GYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN------AKDTAHTKAERNILEEVKHPFIVDL   86 (327)
T ss_dssp             GGEEEEEEEEEE----TTEEEEEEEECSSTTTTCEEEEEEECCC--------------------HHHHHHHCCCTTBCCE
T ss_pred             HHeEEEEEEEeC----CCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhh------hhHHHHHHHHHHHHHhCCCCCccce
Confidence            355566666766    89999999875   5789999998876543322      1234557789999999999999999


Q ss_pred             eEEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC
Q psy11571         79 HYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD  158 (372)
Q Consensus        79 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~  158 (372)
                      ++++.+.+.+|+||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+|          |||||+|||++
T Consensus        87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH----------~Dlkp~Nill~  155 (327)
T 3a62_A           87 IYAFQTGGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIY----------RDLKPENIMLN  155 (327)
T ss_dssp             EEEEECSSCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCC----------CCCCTTTEEEC
T ss_pred             eEEEEcCCEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEc----------ccCCHHHeEEC
Confidence            9999999999999999999999999987 467999999999999999999999999999          99999999999


Q ss_pred             CCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHH
Q psy11571        159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET  238 (372)
Q Consensus       159 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~  238 (372)
                      .++.+||+|||+++....... .....+||+.|+|||++.+     ..++.++|||||||++|+|++|..||.+.+..+.
T Consensus       156 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  229 (327)
T 3a62_A          156 HQGHVKLTDFGLCKESIHDGT-VTHTFCGTIEYMAPEILMR-----SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT  229 (327)
T ss_dssp             TTSCEEECCCSCC-----------CTTSSCCTTSCHHHHTT-----SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             CCCcEEEEeCCcccccccCCc-cccccCCCcCccCHhhCcC-----CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH
Confidence            999999999999976443322 2334679999999999973     5689999999999999999999999999999888


Q ss_pred             HHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCC--ChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc-
Q psy11571        239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQN--GIADFKMWSALFVSLSISPRNHPWFQGIAWDSI-  314 (372)
Q Consensus       239 ~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~--~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~-  314 (372)
                      ..++....  ..+|.    .+++++++||.+||. ||++||++.  .+.+++              +||||++++|+.+ 
T Consensus       230 ~~~i~~~~--~~~p~----~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l--------------~hp~f~~~~~~~~~  289 (327)
T 3a62_A          230 IDKILKCK--LNLPP----YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQ--------------AHPFFRHINWEELL  289 (327)
T ss_dssp             HHHHHHTC--CCCCT----TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHH--------------HSGGGSSCCHHHHH
T ss_pred             HHHHHhCC--CCCCC----CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHH--------------cCCcccCCCHHHHh
Confidence            88888754  33444    689999999999999 999999876  678888              9999999999987 


Q ss_pred             -ccCCCCCcCCCCCCCCCCCCCCCccc
Q psy11571        315 -RDSNAPYIPEVSSPTDTSHFDVDEAG  340 (372)
Q Consensus       315 -~~~~~p~~p~~~~~~~~~~~~~~~~~  340 (372)
                       +...|||.|.+.+..+.++|+.....
T Consensus       290 ~~~~~~p~~p~~~~~~~~~~~~~~~~~  316 (327)
T 3a62_A          290 ARKVEPPFKPLLQSEEDVSQFDSKFTR  316 (327)
T ss_dssp             TTCSCCSCCCC----------------
T ss_pred             hccCCCCCCCCcCChhhhhhcchhhhc
Confidence             56789999999999999999876543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.5e-53  Score=398.50  Aligned_cols=245  Identities=21%  Similarity=0.317  Sum_probs=200.7

Q ss_pred             hhhcCCcccCCccEEEeeee-----hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          9 ALFLGGPIQGKGRVFSIETL-----LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         9 ~~~~~~~~~g~G~v~~v~~~-----~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      ++|.|    |||.||+++..     .+++.||+|.+.....          ...+.+.+|+.+|+.++|||||++++++.
T Consensus        48 ~LG~G----~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~----------~~~~~f~~E~~il~~l~HpnIV~l~g~~~  113 (329)
T 4aoj_A           48 ELGEG----AFGKVFLAECHNLLPEQDKMLVAVKALKEASE----------SARQDFQREAELLTMLQHQHIVRFFGVCT  113 (329)
T ss_dssp             EEEEC----SSEEEEEEEESSSCC---CEEEEEEEESCCSH----------HHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             EEccC----CCcEEEEEEECCcccCCCCeEEEEEEECcCCH----------HHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            45555    89999999642     4678999998865321          12356889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCC
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFE--------------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRD  149 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~--------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrD  149 (372)
                      +.+.+|+|||||++|+|.+++++..              +.+++.++..++.||+.||.|||+++|||          ||
T Consensus       114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiH----------RD  183 (329)
T 4aoj_A          114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVH----------RD  183 (329)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeec----------cc
Confidence            9999999999999999999997631              35899999999999999999999999999          99


Q ss_pred             CCcCcEEeCCCCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CC
Q psy11571        150 IKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GE  227 (372)
Q Consensus       150 lkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~  227 (372)
                      |||+|||++.++.+||+|||+|+....... ......+||+.|||||++.     ...|+.++|||||||++|||+| |+
T Consensus       184 LKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~-----~~~~~~~sDvwS~Gvvl~Ellt~G~  258 (329)
T 4aoj_A          184 LATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL-----YRKFTTESDVWSFGVVLWEIFTYGK  258 (329)
T ss_dssp             CCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHT-----TCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             ccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhc-----CCCCCccccccchHHHHHHHHcCCC
Confidence            999999999999999999999987643322 2233467999999999998     4679999999999999999999 99


Q ss_pred             CCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        228 TPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       228 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .||.+.+..+++..+..+. .++.|.    .+++++.+||.+||+ ||++|||++++.+.+
T Consensus       259 ~Pf~~~~~~~~~~~i~~g~-~~~~p~----~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L  314 (329)
T 4aoj_A          259 QPWYQLSNTEAIDCITQGR-ELERPR----ACPPEVYAIMRGCWQREPQQRHSIKDVHARL  314 (329)
T ss_dssp             CTTCSSCHHHHHHHHHHTC-CCCCCT----TCCHHHHHHHHHHCCSSTTTSCCHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHcCC-CCCCcc----cccHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence            9999999999888887753 345555    689999999999999 999999988876544

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=6.8e-54  Score=398.72  Aligned_cols=248  Identities=19%  Similarity=0.223  Sum_probs=208.0

Q ss_pred             HHhhhcCCcccCCccEEEeee-----ehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          7 LEALFLGGPIQGKGRVFSIET-----LLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         7 l~~~~~~~~~~g~G~v~~v~~-----~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++++|.|    |||.||++..     ..+++.||+|.+.......         ..+.+.+|+.++++++|||||+++++
T Consensus        31 ~~~lG~G----~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~---------~~~~f~~E~~il~~l~HpNIV~l~g~   97 (308)
T 4gt4_A           31 MEELGED----RFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP---------LREEFRHEAMLRARLQHPNVVCLLGV   97 (308)
T ss_dssp             EEEEEEC----SSCEEEEEEEC-------CEEEEEEECCC-CCC----------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             eeEeccC----CCcEEEEEEEcCCccCCCCeEEEEEEECcccChH---------HHHHHHHHHHHHHhCCCCCCCCcceE
Confidence            4556666    8999999874     2466889999886543221         23558899999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCc
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKF---------------EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL  146 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~---------------~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~v  146 (372)
                      +.+++.+|+|||||++|||.++|...               ...+++.++..++.||+.||+|||+++|||         
T Consensus        98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiH---------  168 (308)
T 4gt4_A           98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVH---------  168 (308)
T ss_dssp             ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCC---------
T ss_pred             EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCC---------
Confidence            99999999999999999999999652               235899999999999999999999999999         


Q ss_pred             CCCCCcCcEEeCCCCcEEEeecCcccccCCCC-cccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh
Q psy11571        147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDG-TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY  225 (372)
Q Consensus       147 hrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt  225 (372)
                       |||||+|||+++++.+||+|||+|+...... .......+||+.|||||++.+     +.|+.++|||||||++|||+|
T Consensus       169 -RDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-----~~~s~ksDVwSfGvvl~El~t  242 (308)
T 4gt4_A          169 -KDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-----GKFSIDSDIWSYGVVLWEVFS  242 (308)
T ss_dssp             -SCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHT
T ss_pred             -CCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-----CCCCccchhhhHHHHHHHHHh
Confidence             9999999999999999999999998654322 122344679999999999984     679999999999999999998


Q ss_pred             -CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        226 -GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       226 -G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                       |..||.+.+..++...+..+. .++.|.    .+++++.+|+.+||+ ||++|||+.++.+.+
T Consensus       243 ~g~~Pf~~~~~~~~~~~i~~~~-~~~~p~----~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L  301 (308)
T 4gt4_A          243 YGLQPYCGYSNQDVVEMIRNRQ-VLPCPD----DCPAWVYALMIECWNEFPSRRPRFKDIHSRL  301 (308)
T ss_dssp             TTCCTTTTCCHHHHHHHHHTTC-CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHcCC-CCCCcc----cchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence             899999999999888887653 344454    689999999999999 999999988887655

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=7.6e-54  Score=419.60  Aligned_cols=289  Identities=34%  Similarity=0.603  Sum_probs=235.3

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||.+.+..+++.||+|.+........       .....+.+|+.+++.++||||+++++++
T Consensus       149 ~y~~~~~lG~G----~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~l~~~~  217 (446)
T 4ejn_A          149 EFEYLKLLGKG----TFGKVILVKEKATGRYYAMKILKKEVIVAK-------DEVAHTLTENRVLQNSRHPFLTALKYSF  217 (446)
T ss_dssp             GEEEEEEEEEE----TTEEEEEEEETTTCCEEEEEEEEHHHHC--------------------CCCCCSCTTSCCEEEEE
T ss_pred             HcEEeEEEeeC----cCEEEEEEEEcCCCCEEEEEEEEhhhhhhh-------HHHHHHHHHHHHHHhCCCCeEeeEEEEE
Confidence            34455566666    899999999999999999998865433222       2345567899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD-LHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      .+.+.+|+||||+++|+|.+++.. ...+++..++.++.||+.||+|||+ .||+|          |||||+|||++.++
T Consensus       218 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiH----------rDlkp~NIll~~~~  286 (446)
T 4ejn_A          218 QTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVY----------RDLKLENLMLDKDG  286 (446)
T ss_dssp             EETTEEEEEECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCC----------CCCCGGGEEECSSS
T ss_pred             eeCCEEEEEEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEE----------CCCCHHHEEECCCC
Confidence            999999999999999999999987 4789999999999999999999998 99999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .+||+|||+++....... .....+||+.|+|||++.     ...++.++|||||||++|||++|+.||.+.+..+....
T Consensus       287 ~~kl~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~  360 (446)
T 4ejn_A          287 HIKITDFGLCKEGIKDGA-TMKTFCGTPEYLAPEVLE-----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL  360 (446)
T ss_dssp             CEEECCCCCCCTTCC------CCSSSCGGGCCHHHHH-----TSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             CEEEccCCCceeccCCCc-ccccccCCccccCHhhcC-----CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH
Confidence            999999999986443322 234468999999999997     35689999999999999999999999999999988888


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCC--CChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--cc
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQ--NGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RD  316 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~--~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~  316 (372)
                      +.....  .+|.    .+++++++||.+||+ ||.+||+.  ..+.+++              +||||++++|+.+  +.
T Consensus       361 i~~~~~--~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell--------------~hp~f~~~~~~~~~~~~  420 (446)
T 4ejn_A          361 ILMEEI--RFPR----TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIM--------------QHRFFAGIVWQHVYEKK  420 (446)
T ss_dssp             HHHCCC--CCCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHH--------------TSGGGTTCCHHHHHTTC
T ss_pred             HHhCCC--CCCc----cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHH--------------hCccccCCCHHHHhhCc
Confidence            877543  3444    689999999999999 99999942  2456666              9999999999988  56


Q ss_pred             CCCCCcCCCCCCCCCCCCCCCcc
Q psy11571        317 SNAPYIPEVSSPTDTSHFDVDEA  339 (372)
Q Consensus       317 ~~~p~~p~~~~~~~~~~~~~~~~  339 (372)
                      ..|||+|.+.++.|.++||.+.+
T Consensus       421 ~~pp~~p~~~~~~~~~~~~~~~~  443 (446)
T 4ejn_A          421 LSPPFKPQVTSETDTRYFDEEFT  443 (446)
T ss_dssp             SCCSCCCSCSSTTCCTTC-----
T ss_pred             CCCCccCCCCCccchhhcchhhh
Confidence            78999999999999999998765

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.7e-52  Score=401.56  Aligned_cols=288  Identities=27%  Similarity=0.528  Sum_probs=238.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||.+.+..+++.||+|.+........       ...+.+.+|+.+++.++||||++++++|
T Consensus        16 ~y~i~~~LG~G----~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~-------~~~~~~~~E~~il~~l~hp~Iv~l~~~~   84 (384)
T 4fr4_A           16 HFEILRAIGKG----SFGKVCIVQKNDTKKMYAMKYMNKQKCVER-------NEVRNVFKELQIMQGLEHPFLVNLWYSF   84 (384)
T ss_dssp             GEEEEEEEECC----TTCCEEEEEETTTCCEEEEEEEEHHHHHHT-------TCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             HeEEEEEEeeC----CCeEEEEEEECCCCCEEEEEEEehhhcccH-------HHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            45566667776    899999999999999999998865443332       1345678899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+.+.+|+||||+.||+|.+++.. ...+++..++.++.||+.||.|||++||+|          |||||+|||++.+|.
T Consensus        85 ~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH----------rDlkp~NIll~~~g~  153 (384)
T 4fr4_A           85 QDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIH----------RDMKPDNILLDEHGH  153 (384)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEECTTSC
T ss_pred             EeCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcee----------ccCcHHHeEECCCCC
Confidence            999999999999999999999987 578999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC---CHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETY  239 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~---~~~~~~  239 (372)
                      +||+|||+++.......  ....+||+.|+|||++....  ...++.++|||||||++|+|++|..||...   ...+..
T Consensus       154 vkL~DFG~a~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~--~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~  229 (384)
T 4fr4_A          154 VHITDFNIAAMLPRETQ--ITTMAGTKPYMAPEMFSSRK--GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV  229 (384)
T ss_dssp             EEECCCTTCEECCTTCC--BCCCCSCGGGCCGGGTCCCS--SCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH
T ss_pred             EEEeccceeeeccCCCc--eeccCCCccccCCeeeccCC--CCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH
Confidence            99999999987654332  34478999999999997311  235889999999999999999999999743   444555


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--cc
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RD  316 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~  316 (372)
                      ..+....  ..+|.    .+++++.+||.+||+ ||.+||++  +.+++              .||||++++|+.+  +.
T Consensus       230 ~~~~~~~--~~~p~----~~s~~~~~li~~lL~~dP~~R~s~--~~~l~--------------~hp~f~~~~w~~~~~~~  287 (384)
T 4fr4_A          230 HTFETTV--VTYPS----AWSQEMVSLLKKLLEPNPDQRFSQ--LSDVQ--------------NFPYMNDINWDAVFQKR  287 (384)
T ss_dssp             HHHHHCC--CCCCT----TSCHHHHHHHHHHSCSSGGGSCCS--HHHHH--------------TSGGGTTCCHHHHHTTC
T ss_pred             HHHhhcc--cCCCC----cCCHHHHHHHHHHhcCCHhHhccc--HHHHH--------------cChhhhcCCHHHHHhCC
Confidence            5555432  33444    689999999999999 99999983  55666              9999999999998  56


Q ss_pred             CCCCCcCCCCCCCCCCCCCCCc
Q psy11571        317 SNAPYIPEVSSPTDTSHFDVDE  338 (372)
Q Consensus       317 ~~~p~~p~~~~~~~~~~~~~~~  338 (372)
                      ..|||+|..........|+.++
T Consensus       288 ~~p~~~p~~~~~~~~~~~~~~~  309 (384)
T 4fr4_A          288 LIPGFIPNKGRLNCDPTFELEE  309 (384)
T ss_dssp             SCCCCCCSCCSSCCCCCCCSTT
T ss_pred             CCCCCCCCCCCCCCCCccChhh
Confidence            7899999876555555555443

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=8.9e-52  Score=411.85  Aligned_cols=273  Identities=29%  Similarity=0.537  Sum_probs=231.8

Q ss_pred             HhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCe
Q psy11571          8 EALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSN   87 (372)
Q Consensus         8 ~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~   87 (372)
                      +.+|.|    |+|.||.+++..+++.||+|.+........       +..+.+.+|..+++.++||||+++++++++...
T Consensus       191 ~~LG~G----~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~-------~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  259 (543)
T 3c4z_A          191 RVLGRG----GFGEVFACQMKATGKLYACKKLNKKRLKKR-------KGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD  259 (543)
T ss_dssp             EEEEEC----SSSEEEEEEETTTCCEEEEEEEEHHHHHHT-------TCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             EEEeeC----CCeEEEEEEECCCCcEEEEEEEEhHHhhhh-------HHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence            335555    899999999988999999998876544332       123557789999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEE
Q psy11571         88 LYLVMDYYCGGDLLTLLSKF---EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIR  164 (372)
Q Consensus        88 ~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vk  164 (372)
                      +|+||||++||+|.+++...   ...+++..++.++.||+.||.|||++||+|          |||||+|||++.+|++|
T Consensus       260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvH----------rDLKP~NILl~~~g~vk  329 (543)
T 3c4z_A          260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIY----------RDLKPENVLLDDDGNVR  329 (543)
T ss_dssp             EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCCGGGEEECTTSCEE
T ss_pred             EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcc----------cCCChHHEEEeCCCCEE
Confidence            99999999999999999763   236999999999999999999999999999          99999999999999999


Q ss_pred             EeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC----CHHHHHH
Q psy11571        165 LADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE----SLVETYG  240 (372)
Q Consensus       165 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~----~~~~~~~  240 (372)
                      |+|||+++....... .....+||+.|+|||++.+     ..++.++|||||||++|||++|++||.+.    ...++..
T Consensus       330 L~DFGla~~~~~~~~-~~~~~~GT~~Y~APE~l~~-----~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~  403 (543)
T 3c4z_A          330 ISDLGLAVELKAGQT-KTKGYAGTPGFMAPELLLG-----EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ  403 (543)
T ss_dssp             ECCCTTCEECCTTCC-CBCCCCSCTTTSCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH
T ss_pred             EeecceeeeccCCCc-ccccccCCccccChhhhcC-----CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH
Confidence            999999987654332 2334689999999999983     56899999999999999999999999875    3456667


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCC--ChhhhhhhhhhhhccCCCCCCCCCcCCCCccccc--
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQN--GIADFKMWSALFVSLSISPRNHPWFQGIAWDSIR--  315 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~--~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~--  315 (372)
                      .+....  ..+|.    .+++++++||++||+ ||++||++.  .+.+++              .||||++++|+.+.  
T Consensus       404 ~i~~~~--~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~--------------~Hpff~~i~w~~l~~~  463 (543)
T 3c4z_A          404 RVLEQA--VTYPD----KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLR--------------THPLFRDISWRQLEAG  463 (543)
T ss_dssp             HHHHCC--CCCCT----TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHH--------------TSGGGTTCCHHHHHTT
T ss_pred             HHhhcc--cCCCc----ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHH--------------cCccccCCCHHHHHcC
Confidence            776643  33444    689999999999999 999999975  367788              99999999999984  


Q ss_pred             cCCCCCcCCCCC
Q psy11571        316 DSNAPYIPEVSS  327 (372)
Q Consensus       316 ~~~~p~~p~~~~  327 (372)
                      ...|||+|....
T Consensus       464 ~~~pp~~P~~~~  475 (543)
T 3c4z_A          464 MLTPPFVPDSRT  475 (543)
T ss_dssp             CSCCSCCCCSSS
T ss_pred             CCCCCCCCCccc
Confidence            578999998753

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.6e-52  Score=394.74  Aligned_cols=253  Identities=19%  Similarity=0.254  Sum_probs=206.0

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehh-----hhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCC-Ccee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLD-----ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDR-RWIT   76 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~-----~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~h-p~Iv   76 (372)
                      +|+..+.+|.|    |||.||++.....     ++.||+|.+.......         ..+.+.+|+.+|.++.| ||||
T Consensus        65 ~~~l~~~LG~G----~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~---------~~~~~~~E~~il~~l~hhpnIV  131 (353)
T 4ase_A           65 RLKLGKPLGRG----AFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS---------EHRALMSELKILIHIGHHLNVV  131 (353)
T ss_dssp             GEEEEEEEEEC----SSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHH---------HHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HeEEeeEEecC----CCeEEEEEEEcCCCcccCCeEEEEEEEccccChH---------HHHHHHHHHHHHHHcCCCCcEE
Confidence            44445566666    8999999986554     3567777765543322         23567889999999865 9999


Q ss_pred             eeeEEEEeC-CeEEEEEeccCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCC
Q psy11571         77 NLHYAFQDD-SNLYLVMDYYCGGDLLTLLSKF---------------EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN  140 (372)
Q Consensus        77 ~l~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~---------------~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~  140 (372)
                      +++++|.+. +.+|+|||||++|+|.++|++.               ...+++..+..++.||+.||.|||+++|||   
T Consensus       132 ~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiH---  208 (353)
T 4ase_A          132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIH---  208 (353)
T ss_dssp             CEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCC---
T ss_pred             EEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeec---
Confidence            999998764 5789999999999999999753               134899999999999999999999999999   


Q ss_pred             CCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHH
Q psy11571        141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVC  219 (372)
Q Consensus       141 ~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvi  219 (372)
                             |||||+|||+++++.+||+|||+|+....... ......+||+.|||||++.+     ..|+.++|||||||+
T Consensus       209 -------RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-----~~y~~ksDVwS~Gv~  276 (353)
T 4ase_A          209 -------RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-----RVYTIQSDVWSFGVL  276 (353)
T ss_dssp             -------SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-----CCCCHHHHHHHHHHH
T ss_pred             -------CccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-----CCCCCcccEeehHHH
Confidence                   99999999999999999999999987654332 23445689999999999984     679999999999999


Q ss_pred             HHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        220 MYEMLY-GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       220 l~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      +|||+| |+.||.+.+..+.+.+++.....++.|.    .+++++.+||.+||+ ||++|||+.++.+.+
T Consensus       277 l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~----~~~~~~~~li~~c~~~dP~~RPt~~eil~~L  342 (353)
T 4ase_A          277 LWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL  342 (353)
T ss_dssp             HHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCc----cCCHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence            999998 9999998765554544444445556665    689999999999999 999999988877554

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.1e-51  Score=410.51  Aligned_cols=276  Identities=29%  Similarity=0.522  Sum_probs=230.8

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+.++.+|.|    |+|.||.+.+..+++.||+|.+.........       ..+.+.+|+.+|..++||||++++++++
T Consensus       186 f~~~~~LG~G----~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~-------~~~~~~~E~~iL~~l~hp~Iv~l~~~~~  254 (576)
T 2acx_A          186 FRQYRVLGKG----GFGEVCACQVRATGKMYACKKLEKKRIKKRK-------GEAMALNEKQILEKVNSRFVVSLAYAYE  254 (576)
T ss_dssp             EEEEEEEEEE----TTEEEEEEEETTTCCEEEEEEEEHHHHHHTT-------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             eEEEEEEeeC----CCEEEEEEEECCCCCEEEEEEEEhHhhhhhH-------HHHHHHHHHHHHHHcCCCCEeeEEEEEe
Confidence            3334445555    8999999999989999999988765443321       2345678999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      +.+.+|+||||++||+|.+++.... ..+++..++.++.||+.||.|||++||+|          |||||+|||++.+|+
T Consensus       255 ~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvH----------rDLKPeNILld~~g~  324 (576)
T 2acx_A          255 TKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY----------RDLKPENILLDDHGH  324 (576)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCCGGGEEECTTSC
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEec----------cCCchheEEEeCCCC
Confidence            9999999999999999999998642 34999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCC----HHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES----LVET  238 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~----~~~~  238 (372)
                      +||+|||+++.......  ....+||+.|+|||++.+     ..++.++|||||||++|||++|.+||.+.+    ..++
T Consensus       325 vKL~DFGla~~~~~~~~--~~~~~GT~~Y~APEvl~~-----~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i  397 (576)
T 2acx_A          325 IRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKN-----ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV  397 (576)
T ss_dssp             EEECCCTTCEECCTTCC--EECCCSCGGGCCHHHHTT-----CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHH
T ss_pred             eEEEecccceecccCcc--ccccCCCccccCHHHHcC-----CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHH
Confidence            99999999987654432  233589999999999983     568999999999999999999999998753    3455


Q ss_pred             HHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCC--ChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc-
Q psy11571        239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQN--GIADFKMWSALFVSLSISPRNHPWFQGIAWDSI-  314 (372)
Q Consensus       239 ~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~--~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~-  314 (372)
                      ...+....  ..++.    .+++++++||++||+ ||.+||++.  .+.+++              +||||++++|+.+ 
T Consensus       398 ~~~i~~~~--~~~p~----~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil--------------~HpfF~~i~w~~l~  457 (576)
T 2acx_A          398 ERLVKEVP--EEYSE----RFSPQARSLCSQLLCKDPAERLGCRGGSAREVK--------------EHPLFKKLNFKRLG  457 (576)
T ss_dssp             HHHHHHCC--CCCCT----TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHH--------------TSGGGTTCCHHHHH
T ss_pred             HHHhhccc--ccCCc----cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHH--------------hChhhccCCHHHHh
Confidence            55555432  33343    689999999999999 999999764  577788              9999999999998 


Q ss_pred             -ccCCCCCcCCCCC
Q psy11571        315 -RDSNAPYIPEVSS  327 (372)
Q Consensus       315 -~~~~~p~~p~~~~  327 (372)
                       +...|||+|....
T Consensus       458 ~~~~~pp~~p~~~~  471 (576)
T 2acx_A          458 AGMLEPPFKPDPQA  471 (576)
T ss_dssp             TTCSCCSCCCCCCC
T ss_pred             cCCCCCCCCCCccc
Confidence             4578999997653

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.8e-50  Score=378.88  Aligned_cols=257  Identities=27%  Similarity=0.445  Sum_probs=222.1

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||.+.+..+++.||+|.+........        ..+++.+|+.+++.++||||+++++++
T Consensus        16 ~y~~~~~lG~G----~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~l~~~~   83 (328)
T 3fe3_A           16 NYRLLKTIGKG----NFAKVKLARHILTGREVAIKIIDKTQLNPT--------SLQKLFREVRIMKILNHPNIVKLFEVI   83 (328)
T ss_dssp             TEEEEEEEEEC----SSEEEEEEEETTTCCEEEEEEEEGGGSCHH--------HHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CEEEEEEEeeC----CCEEEEEEEECCCCCEEEEEEEEhhcCCHH--------HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            45556667776    899999999999999999998876544322        345678899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+.+.+|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+|          |||||+|||++.++.
T Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivH----------rDlkp~NIll~~~~~  152 (328)
T 3fe3_A           84 ETEKTLYLIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVH----------RDLKAENLLLDADMN  152 (328)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCCGGGEEECTTSC
T ss_pred             EECCEEEEEEECCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEec----------cCCCHHHEEEcCCCC
Confidence            999999999999999999999987 478999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||++........  ....+||+.|+|||++.+    ....+.++|||||||++|+|++|+.||.+.+..+...++
T Consensus       153 ~kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i  226 (328)
T 3fe3_A          153 IKIADFGFSNEFTVGGK--LDAFCGAPPYAAPELFQG----KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV  226 (328)
T ss_dssp             EEECSTTCCGGGSSSCG--GGTTSSSGGGCCHHHHHT----CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             EEEeeccCceecCCCCc--cccccCCcceeCcccccC----CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999987654332  244689999999999984    333457999999999999999999999999999998888


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCc
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAW  311 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w  311 (372)
                      ..+..  ..|.    .+++++.+||++||+ ||.+|||+++++                 +||||+...+
T Consensus       227 ~~~~~--~~p~----~~s~~~~~li~~~L~~dP~~R~t~~eil-----------------~h~~~~~~~~  273 (328)
T 3fe3_A          227 LRGKY--RIPF----YMSTDCENLLKRFLVLNPIKRGTLEQIM-----------------KDRWINAGHE  273 (328)
T ss_dssp             HHCCC--CCCT----TSCHHHHHHHHHHCCSSTTTSCCHHHHT-----------------TCTTTTTTCT
T ss_pred             HhCCC--CCCC----CCCHHHHHHHHHHCCCChhHCcCHHHHh-----------------cCHhhcCCCc
Confidence            87643  3444    679999999999999 999999866555                 9999997543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.3e-50  Score=385.98  Aligned_cols=267  Identities=24%  Similarity=0.385  Sum_probs=226.0

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    ++|.||++.+..+++.||+|.+...........    ...+.+.+|+.+++.++||||+++++++
T Consensus        13 ~y~~~~~LG~G----~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~   84 (361)
T 2yab_A           13 FYDIGEELGSG----QFAIVKKCREKSTGLEYAAKFIKKRQSRASRRG----VCREEIEREVSILRQVLHPNIITLHDVY   84 (361)
T ss_dssp             TEEEEEEEEEE----TTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSS----BCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ceEEeeEEeeC----cCEEEEEEEECCCCCEEEEEEEEccccccccch----hHHHHHHHHHHHHHhCCCcCCCcEEEEE
Confidence            45555666666    899999999999999999998876654322100    0124578899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC-
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG-  161 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~-  161 (372)
                      .+...+|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+|          |||||+|||++.++ 
T Consensus        85 ~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH----------rDlkp~NIll~~~~~  153 (361)
T 2yab_A           85 ENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAH----------FDLKPENIMLLDKNI  153 (361)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEESCTTS
T ss_pred             EeCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------CCCCHHHEEEeCCCC
Confidence            999999999999999999999977 578999999999999999999999999999          99999999998776 


Q ss_pred             ---cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHH
Q psy11571        162 ---HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET  238 (372)
Q Consensus       162 ---~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~  238 (372)
                         .+||+|||+++.......  ....+||+.|+|||++.     ...++.++|||||||++|+|++|.+||.+.+..+.
T Consensus       154 ~~~~vkl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~  226 (361)
T 2yab_A          154 PIPHIKLIDFGLAHEIEDGVE--FKNIFGTPEFVAPEIVN-----YEPLGLEADMWSIGVITYILLSGASPFLGDTKQET  226 (361)
T ss_dssp             SSCCEEECCCSSCEECCTTCC--CCCCCSCGGGCCHHHHT-----TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred             CccCEEEEecCCceEcCCCCc--cccCCCCccEECchHHc-----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence               799999999987654332  23467999999999997     35689999999999999999999999999999999


Q ss_pred             HHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc
Q psy11571        239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI  314 (372)
Q Consensus       239 ~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~  314 (372)
                      +.+|......  ++...+..+++++++||.+||. ||.+|||+++++                 +||||++++|...
T Consensus       227 ~~~i~~~~~~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l-----------------~hp~~~~~~~~~~  284 (361)
T 2yab_A          227 LANITAVSYD--FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEAL-----------------RHPWITPVDTQQA  284 (361)
T ss_dssp             HHHHHTTCCC--CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH-----------------TSTTTSCSSHHHH
T ss_pred             HHHHHhcCCC--CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHh-----------------cCcCcCCCchhhh
Confidence            9888875433  3333334789999999999999 999999876555                 9999999998653

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-50  Score=383.81  Aligned_cols=288  Identities=35%  Similarity=0.612  Sum_probs=229.7

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeee---hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETL---LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNL   78 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~---~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l   78 (372)
                      +|+.++.+|.|    |+|.||++++.   .+++.||+|.+..........      ..+.+.+|+.++..+ +||||+++
T Consensus        55 ~y~~~~~lG~G----~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~------~~~~~~~E~~~l~~l~~h~~iv~~  124 (355)
T 1vzo_A           55 NFELLKVLGTG----AYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK------TTEHTRTERQVLEHIRQSPFLVTL  124 (355)
T ss_dssp             GEEEEEEEEET----TTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEES------SGGGCCCHHHHHHHHHTCTTBCCE
T ss_pred             ceEEEEEeccC----CCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhh------HHHHHHHHHHHHHHccCCCceeEE
Confidence            45556666666    89999999885   478999999887544321100      112345688888888 69999999


Q ss_pred             eEEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC
Q psy11571         79 HYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD  158 (372)
Q Consensus        79 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~  158 (372)
                      ++++.+.+.+|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+|          |||||+|||++
T Consensus       125 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH----------~Dlkp~NIll~  193 (355)
T 1vzo_A          125 HYAFQTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIY----------RDIKLENILLD  193 (355)
T ss_dssp             EEEEEETTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------CCCCGGGEEEC
T ss_pred             EEEEeeCceEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------CCCCHHHEEEC
Confidence            9999999999999999999999999987 468999999999999999999999999999          99999999999


Q ss_pred             CCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC----C
Q psy11571        159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE----S  234 (372)
Q Consensus       159 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~----~  234 (372)
                      .++.+||+|||+++.............+||+.|+|||++.+.   ...++.++|||||||++|+|++|..||...    .
T Consensus       194 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~  270 (355)
T 1vzo_A          194 SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG---DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS  270 (355)
T ss_dssp             TTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTC---C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC
T ss_pred             CCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCC---CCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch
Confidence            999999999999987654433344456899999999999731   234788999999999999999999999753    3


Q ss_pred             HHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCC--ChhhhhhhhhhhhccCCCCCCCCCcCCCCc
Q psy11571        235 LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQN--GIADFKMWSALFVSLSISPRNHPWFQGIAW  311 (372)
Q Consensus       235 ~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~--~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w  311 (372)
                      ...+...+....  ...+.    .++..+++||.+||. ||.+||++.  .+.+++              +||||+.++|
T Consensus       271 ~~~~~~~~~~~~--~~~~~----~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell--------------~h~~f~~~~~  330 (355)
T 1vzo_A          271 QAEISRRILKSE--PPYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK--------------EHLFFQKINW  330 (355)
T ss_dssp             HHHHHHHHHHCC--CCCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH--------------TSGGGTTCCH
T ss_pred             HHHHHHHHhccC--CCCCc----ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHH--------------cCcchhcCCh
Confidence            344444554432  23333    689999999999999 999999643  566777              9999999999


Q ss_pred             ccc--ccCCCCCcCCCCCCCCCCCC
Q psy11571        312 DSI--RDSNAPYIPEVSSPTDTSHF  334 (372)
Q Consensus       312 ~~~--~~~~~p~~p~~~~~~~~~~~  334 (372)
                      +.+  +...+||.|.+++..|.++|
T Consensus       331 ~~l~~~~~~~p~~p~~~~~~d~~~~  355 (355)
T 1vzo_A          331 DDLAAKKVPAPFKPVIRDELDVSNF  355 (355)
T ss_dssp             HHHHTTCSCCSCCCCCCC-CCC---
T ss_pred             hHhhhccCCCCCCCccccccccccC
Confidence            988  45678999999998888876

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.5e-49  Score=365.44  Aligned_cols=255  Identities=25%  Similarity=0.443  Sum_probs=216.7

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      .+|+.++.+|.|    |+|.||.+.+..+++.||+|.+........          +.+.+|+.+++.++||||++++++
T Consensus        20 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~E~~~l~~l~hp~iv~~~~~   85 (297)
T 3fxz_A           20 KKYTRFEKIGQG----ASGTVYTAMDVATGQEVAIRQMNLQQQPKK----------ELIINEILVMRENKNPNIVNYLDS   85 (297)
T ss_dssp             GTBCCCEEEEEE----TTEEEEEEEBTTTCCEEEEEEEEGGGCSCH----------HHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hceeeeeeeccC----CCeEEEEEEECCCCcEEEEEEeecccccHH----------HHHHHHHHHHhcCCCCCCCeEeEE
Confidence            356666677766    899999999999999999998765433221          346789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+.+.+|+||||++||+|.+++..  ..+++..++.++.|++.||.|||++||+|          |||||+|||++.++
T Consensus        86 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H----------~Dlkp~Nil~~~~~  153 (297)
T 3fxz_A           86 YLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIH----------RDIKSDNILLGMDG  153 (297)
T ss_dssp             EEETTEEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEECTTC
T ss_pred             EEECCEEEEEEECCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCcee----------CCCCHHHEEECCCC
Confidence            9999999999999999999999987  57999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .+||+|||++........ ......||+.|+|||++.+     ..++.++|||||||++|+|++|..||.+.+.......
T Consensus       154 ~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  227 (297)
T 3fxz_A          154 SVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTR-----KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL  227 (297)
T ss_dssp             CEEECCCTTCEECCSTTC-CBCCCCSCGGGCCHHHHHC-----SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred             CEEEeeCCCceecCCccc-ccCCccCCcCccChhhhcC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999987654333 2344679999999999983     5689999999999999999999999999888777666


Q ss_pred             HhhccC-CcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        242 IMNHQN-SFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       242 i~~~~~-~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      +..... ....+.    .+++.+++||.+||+ ||++|||+++++                 +||||+..
T Consensus       228 ~~~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell-----------------~h~~~~~~  276 (297)
T 3fxz_A          228 IATNGTPELQNPE----KLSAIFRDFLNRCLEMDVEKRGSAKELL-----------------QHQFLKIA  276 (297)
T ss_dssp             HHHHCSCCCSCGG----GSCHHHHHHHHHHSCSSTTTSCCHHHHT-----------------TCGGGGGC
T ss_pred             HHhCCCCCCCCcc----ccCHHHHHHHHHHccCChhHCcCHHHHh-----------------hChhhccc
Confidence            654332 222232    689999999999999 999999866655                 99999854

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=7.7e-49  Score=383.24  Aligned_cols=259  Identities=27%  Similarity=0.448  Sum_probs=222.6

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    |+|.||++.+..+++.+|+|.+........        ..+.+.+|+.+++.++||||++++++
T Consensus        11 ~~Y~i~~~LG~G----~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~--------~~~~~~~E~~il~~l~hpnIv~l~~~   78 (444)
T 3soa_A           11 EEYQLFEELGKG----AFSVVRRCVKVLAGQEYAAMIINTKKLSAR--------DHQKLEREARICRLLKHPNIVRLHDS   78 (444)
T ss_dssp             HHEEEEEEEEEC------CEEEEEEETTTTEEEEEEEEESCSCHHH--------HHHHHHHHHHHHHHCCBTTBCCEEEE
T ss_pred             CCeEEEEEeccC----CCeEEEEEEECCCCcEEEEEEEEcccCCHH--------HHHHHHHHHHHHHhCCCcCCCeEEEE
Confidence            456666777777    899999999999999999998877654332        24567889999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC---
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD---  158 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~---  158 (372)
                      +.+.+..|+|||||.||+|.+++.. .+.+++..+..++.||+.||.|||++||+|          |||||+|||++   
T Consensus        79 ~~~~~~~~lv~E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givH----------rDlKp~NIll~~~~  147 (444)
T 3soa_A           79 ISEEGHHYLIFDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVH----------RNLKPENLLLASKL  147 (444)
T ss_dssp             EECSSEEEEEECCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBC----------CCCSSTTEEESBSS
T ss_pred             EEECCEEEEEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------cCCCHHHEEEeccC
Confidence            9999999999999999999999987 578999999999999999999999999999          99999999998   


Q ss_pred             CCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHH
Q psy11571        159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET  238 (372)
Q Consensus       159 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~  238 (372)
                      .++.+||+|||++........ .....+||+.|+|||++.     ...++.++|||||||++|+|++|.+||.+.+..+.
T Consensus       148 ~~~~vkL~DFG~a~~~~~~~~-~~~~~~gt~~Y~APE~l~-----~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~  221 (444)
T 3soa_A          148 KGAAVKLADFGLAIEVEGEQQ-AWFGFAGTPGYLSPEVLR-----KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL  221 (444)
T ss_dssp             TTCCEEECCCSSCBCCCTTCC-BCCCSCSCGGGCCHHHHT-----TCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             CCCcEEEccCceeEEecCCCc-eeecccCCcccCCHHHhc-----CCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH
Confidence            457899999999987654332 223468999999999997     35689999999999999999999999999999999


Q ss_pred             HHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       239 ~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      +.++..+...+  +...+..+++++++||.+||+ ||++|||+.+++                 +||||+.
T Consensus       222 ~~~i~~~~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L-----------------~hp~~~~  273 (444)
T 3soa_A          222 YQQIKAGAYDF--PSPEWDTVTPEAKDLINKMLTINPSKRITAAEAL-----------------KHPWISH  273 (444)
T ss_dssp             HHHHHHTCCCC--CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHH-----------------HSCTTHH
T ss_pred             HHHHHhCCCCC--CccccccCCHHHHHHHHHHcCCChhHCCCHHHHh-----------------cCccccC
Confidence            99988865444  433444789999999999999 999999876665                 9999974

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5e-49  Score=367.53  Aligned_cols=265  Identities=23%  Similarity=0.365  Sum_probs=213.1

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    ++|.||++++ .+++.||+|.+........        ..+.+.+|+.+++.++||||++++++
T Consensus        21 ~~y~~~~~lG~G----~~g~V~~~~~-~~~~~vavK~~~~~~~~~~--------~~~~~~~E~~~l~~l~hp~iv~~~~~   87 (311)
T 3niz_A           21 EKYQKLEKVGEG----TYGVVYKAKD-SQGRIVALKRIRLDAEDEG--------IPSTAIREISLLKELHHPNIVSLIDV   87 (311)
T ss_dssp             CEEEEEEEEEEC----SSCEEEEEEE-TTSCEEEEEEEC------C--------HHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhhHhhhhccCC----CCeEEEEEEE-CCCCEEEEEEEecccccch--------hhHHHHHHHHHHHHcCCCCEeeeeeE
Confidence            466777778877    8999999987 4689999998865433221        33557789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+...+++||||++ ++|.+++......+++..++.++.||+.||.|||++||+|          |||||+|||++.++
T Consensus        88 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH----------~Dikp~NIl~~~~~  156 (311)
T 3niz_A           88 IHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILH----------RDLKPQNLLINSDG  156 (311)
T ss_dssp             ECCSSCEEEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCCGGGEEECTTC
T ss_pred             EccCCEEEEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------CCCchHhEEECCCC
Confidence            999999999999996 5899988875667999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .+||+|||+++....... ......||+.|+|||++.+    ...++.++|||||||++|+|++|++||.+.+..+...+
T Consensus       157 ~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  231 (311)
T 3niz_A          157 ALKLADFGLARAFGIPVR-SYTHEVVTLWYRAPDVLMG----SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK  231 (311)
T ss_dssp             CEEECCCTTCEETTSCCC----CCCCCCTTCCHHHHTT----CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHH
T ss_pred             CEEEccCcCceecCCCcc-cccCCcccCCcCCHHHhcC----CCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            999999999987653322 2233578999999999873    35689999999999999999999999998776666666


Q ss_pred             HhhccCCcCCCC------------------------CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhcc
Q psy11571        242 IMNHQNSFDLPS------------------------DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSL  296 (372)
Q Consensus       242 i~~~~~~~~~~~------------------------~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~  296 (372)
                      +...........                        .....+++++.+||++||+ ||++|||+++++            
T Consensus       232 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell------------  299 (311)
T 3niz_A          232 IFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAM------------  299 (311)
T ss_dssp             HHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHH------------
T ss_pred             HHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHh------------
Confidence            543211111000                        0012478999999999999 999999876665            


Q ss_pred             CCCCCCCCCcCCCCcc
Q psy11571        297 SISPRNHPWFQGIAWD  312 (372)
Q Consensus       297 ~~~~~~hp~f~~~~w~  312 (372)
                           +||||++++++
T Consensus       300 -----~hp~f~~~~~~  310 (311)
T 3niz_A          300 -----NHPYFKDLDPQ  310 (311)
T ss_dssp             -----TSGGGTTSCTT
T ss_pred             -----cCcccccCCcc
Confidence                 99999999874

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=9.6e-49  Score=373.33  Aligned_cols=257  Identities=27%  Similarity=0.406  Sum_probs=219.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    ++|.||++.+..+++.||+|.+........        ..+.+.+|+.+++.++||||+++++++
T Consensus        30 ~y~~~~~lG~G----~~g~V~~~~~~~~~~~~avK~~~~~~~~~~--------~~~~~~~E~~il~~l~hpnIv~~~~~~   97 (362)
T 2bdw_A           30 NYDVKEELGKG----AFSVVRRCVHKTTGLEFAAKIINTKKLSAR--------DFQKLEREARICRKLQHPNIVRLHDSI   97 (362)
T ss_dssp             HEEEEEEEEEE----TTEEEEEEEETTTCCEEEEEEEETTTCCHH--------HHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CeEEeeEEecC----CCeEEEEEEECCCCCEEEEEEEEcccCCHH--------HHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            45555566666    899999999999999999998876554322        345688999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC-
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG-  161 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~-  161 (372)
                      .+.+..|+|||||+||+|.+++.. ...+++..+..++.||+.||.|||++||+|          |||||+|||++.++ 
T Consensus        98 ~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH----------~Dlkp~NIll~~~~~  166 (362)
T 2bdw_A           98 QEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVH----------RNLKPENLLLASKAK  166 (362)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBC----------CCCSGGGEEESCSST
T ss_pred             EeCCEEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEe----------ccCchHHEEEecCCC
Confidence            999999999999999999999977 567999999999999999999999999999          99999999998654 


Q ss_pred             --cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHH
Q psy11571        162 --HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY  239 (372)
Q Consensus       162 --~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~  239 (372)
                        .+||+|||++........  ....+||+.|+|||++.     ...++.++|||||||++|+|++|.+||.+.+..+.+
T Consensus       167 ~~~~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~  239 (362)
T 2bdw_A          167 GAAVKLADFGLAIEVNDSEA--WHGFAGTPGYLSPEVLK-----KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY  239 (362)
T ss_dssp             TCCEEECCCTTCBCCTTCCS--CCCSCSCTTTCCHHHHT-----TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             CCCEEEeecCcceEecCCcc--cccCCCCccccCHHHHc-----cCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence              599999999987654332  23467999999999997     356899999999999999999999999999998888


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      ..+..+...+  +...+..+++++++||.+||+ ||++||++.+++                 +||||.+
T Consensus       240 ~~i~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l-----------------~hp~~~~  290 (362)
T 2bdw_A          240 AQIKAGAYDY--PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQAL-----------------KVPWICN  290 (362)
T ss_dssp             HHHHHTCCCC--CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHT-----------------TSHHHHT
T ss_pred             HHHHhCCCCC--CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHh-----------------cCcccCC
Confidence            8888765433  433334689999999999999 999999866655                 9999975

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3e-49  Score=367.50  Aligned_cols=251  Identities=21%  Similarity=0.193  Sum_probs=188.2

Q ss_pred             HhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC-
Q psy11571          8 EALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS-   86 (372)
Q Consensus         8 ~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~-   86 (372)
                      +.+|.|    |||.||+++.  +|+.||+|.+.......           .....|+..+..++|||||++++++.+++ 
T Consensus         9 ~~iG~G----~fG~Vy~~~~--~g~~VAvK~l~~~~~~~-----------~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~   71 (303)
T 3hmm_A            9 ESIGKG----RFGEVWRGKW--RGEEVAVKIFSSREERS-----------WFREAEIYQTVMLRHENILGFIAADNKDNG   71 (303)
T ss_dssp             EEEEEC----SSSEEEEEEE--TTEEEEEEEECGGGHHH-----------HHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred             EEEeeC----CCeEEEEEEE--CCEEEEEEEECccchhh-----------HHHHHHHHHHhcCCCCCCCcEEEEEEecCC
Confidence            445666    8999999964  68999999875432111           11234666667889999999999998664 


Q ss_pred             ---eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhc--------CceecCCCCCCCcCCCCCcCcE
Q psy11571         87 ---NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDL--------HYVHRPNHFAFHLCRDIKPDNV  155 (372)
Q Consensus        87 ---~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~--------~ivH~~~~~~~~vhrDlkp~NI  155 (372)
                         .+|||||||++|+|.++++.  ..++++.+..++.|++.||+|||++        +|+|          |||||+||
T Consensus        72 ~~~~~~lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiH----------RDlKp~NI  139 (303)
T 3hmm_A           72 TWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH----------RDLKSKNI  139 (303)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEEC----------SCCCGGGE
T ss_pred             CceEEEEEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEee----------ccCCcccE
Confidence               58999999999999999987  6799999999999999999999987        8999          99999999


Q ss_pred             EeCCCCcEEEeecCcccccCCCCcc---cccccccCCcccCccccccccc-CCCCCCCccceeehhHHHHHHhhCCCCCC
Q psy11571        156 LLDANGHIRLADFGSCLRLGGDGTV---QSNVAVGTPDYISPEILTAMEE-GRGRYGPECDWWSLGVCMYEMLYGETPFY  231 (372)
Q Consensus       156 ll~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~DiwslGvil~elltG~~Pf~  231 (372)
                      |++.++.+||+|||+|+........   .....+||+.|||||++.+... ....++.++|||||||++|||+||.+||.
T Consensus       140 Ll~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~  219 (303)
T 3hmm_A          140 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  219 (303)
T ss_dssp             EECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred             EECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence            9999999999999999876443221   2234589999999999974210 01136779999999999999999987664


Q ss_pred             CC---------------CHHHHHHHHhhccCCcCCCCCCC-CCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        232 AE---------------SLVETYGKIMNHQNSFDLPSDVG-YEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       232 ~~---------------~~~~~~~~i~~~~~~~~~~~~~~-~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ..               ...+....+.....++.+|.... ...+..+.+|+.+||+ ||++|||+.++.+.+
T Consensus       220 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L  292 (303)
T 3hmm_A          220 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL  292 (303)
T ss_dssp             BCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHH
T ss_pred             ccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence            21               22344444554444444443211 1234578899999999 999999988877654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.1e-48  Score=368.00  Aligned_cols=265  Identities=23%  Similarity=0.308  Sum_probs=209.8

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    ++|.||++.+..+++.||+|.+.......        ...+.+.+|+.+++.++||||++++++
T Consensus        34 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~~  101 (329)
T 3gbz_A           34 DRYRRITKLGEG----TYGEVYKAIDTVTNETVAIKRIRLEHEEE--------GVPGTAIREVSLLKELQHRNIIELKSV  101 (329)
T ss_dssp             GGEEEEEEEEEC----SSSEEEEEEETTTTEEEEEEECCCCC----------------CHHHHHHGGGCCCTTBCCEEEE
T ss_pred             hhEEEEEEEEec----CCeEEEEEEECCCCceEEEEEEccccccc--------ccchhHHHHHHHHHHcCCCCcceEEEE
Confidence            356667777777    89999999999999999999887554322        133456789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe----
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL----  157 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll----  157 (372)
                      +.+++.+|+||||+. |+|.+++.. ...+++..++.++.||+.||.|||++||+|          |||||+|||+    
T Consensus       102 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH----------~Dlkp~NIll~~~~  169 (329)
T 3gbz_A          102 IHHNHRLHLIFEYAE-NDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLH----------RDLKPQNLLLSVSD  169 (329)
T ss_dssp             EEETTEEEEEEECCS-EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCCGGGEEEEC--
T ss_pred             EecCCEEEEEEecCC-CCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEC----------CCCCHHHEEEecCC
Confidence            999999999999996 599999987 567999999999999999999999999999          9999999999    


Q ss_pred             -CCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH
Q psy11571        158 -DANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV  236 (372)
Q Consensus       158 -~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~  236 (372)
                       +..+.+||+|||+++....... ......||+.|+|||++.+    ...++.++|||||||++|+|++|.+||.+.+..
T Consensus       170 ~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  244 (329)
T 3gbz_A          170 ASETPVLKIGDFGLARAFGIPIR-QFTHEIITLWYRPPEILLG----SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI  244 (329)
T ss_dssp             ---CCEEEECCTTHHHHHC------------CCTTCCHHHHTT----CCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             CCccceEEECcCCCccccCCccc-ccCCCcCCccccCHHHhcC----CCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH
Confidence             4555699999999987653322 2233578999999999974    345899999999999999999999999999888


Q ss_pred             HHHHHHhhccCCcCCCCCC------------------------CCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhh
Q psy11571        237 ETYGKIMNHQNSFDLPSDV------------------------GYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSA  291 (372)
Q Consensus       237 ~~~~~i~~~~~~~~~~~~~------------------------~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~  291 (372)
                      +...++......+......                        ...+++++++||.+||+ ||++|||+++++       
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l-------  317 (329)
T 3gbz_A          245 DQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNAL-------  317 (329)
T ss_dssp             HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHH-------
T ss_pred             HHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHh-------
Confidence            8777776532211100000                        00168999999999999 999999866655       


Q ss_pred             hhhccCCCCCCCCCcCCCCcc
Q psy11571        292 LFVSLSISPRNHPWFQGIAWD  312 (372)
Q Consensus       292 ~~~~~~~~~~~hp~f~~~~w~  312 (372)
                                +||||++++|+
T Consensus       318 ----------~hp~f~~~~~~  328 (329)
T 3gbz_A          318 ----------EHPYFSHNDFD  328 (329)
T ss_dssp             ----------TSGGGSSSCSC
T ss_pred             ----------CCcccCCCCCC
Confidence                      99999999996

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.1e-49  Score=368.20  Aligned_cols=267  Identities=22%  Similarity=0.382  Sum_probs=223.8

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+..+.+|.|    ++|.||++.+..+++.||+|.+...........    ...+.+.+|+.+++.++||||+++++++
T Consensus        12 ~y~~~~~lG~G----~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~   83 (326)
T 2y0a_A           12 YYDTGEELGSG----QFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRG----VSREDIEREVSILKEIQHPNVITLHEVY   83 (326)
T ss_dssp             HEEEEEEEECC----SSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSS----BCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ceEeceEEeeC----CCeEEEEEEECCCCcEEEEEEEEccccccccch----hhHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            45555666666    899999999999999999998876554322100    0124577899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC-
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG-  161 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~-  161 (372)
                      .+...+|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+|          |||||+|||++.++ 
T Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH----------~Dlkp~NIll~~~~~  152 (326)
T 2y0a_A           84 ENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAH----------FDLKPENIMLLDRNV  152 (326)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCCGGGEEESCSSS
T ss_pred             EeCCEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEc----------CCCCHHHEEEecCCC
Confidence            999999999999999999999977 578999999999999999999999999999          99999999999877 


Q ss_pred             ---cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHH
Q psy11571        162 ---HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET  238 (372)
Q Consensus       162 ---~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~  238 (372)
                         .+||+|||+++.......  .....||+.|+|||++.     ...++.++|||||||++|+|++|..||.+.+..+.
T Consensus       153 ~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  225 (326)
T 2y0a_A          153 PKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVN-----YEPLGLEADMWSIGVITYILLSGASPFLGDTKQET  225 (326)
T ss_dssp             SSCCEEECCCTTCEECCTTSC--CCCCCSCTTTCCHHHHT-----TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred             CCCCEEEEECCCCeECCCCCc--cccccCCcCcCCceeec-----CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH
Confidence               899999999987654332  23357999999999997     35689999999999999999999999999988888


Q ss_pred             HHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc
Q psy11571        239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI  314 (372)
Q Consensus       239 ~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~  314 (372)
                      ...+.....  .++......+++.+++||.+||+ ||++|||+++++                 +||||++.+|...
T Consensus       226 ~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l-----------------~hp~~~~~~~~~~  283 (326)
T 2y0a_A          226 LANVSAVNY--EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL-----------------QHPWIKPKDTQQA  283 (326)
T ss_dssp             HHHHHHTCC--CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHH-----------------HSTTTSCCSHHHH
T ss_pred             HHHHHhcCC--CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHh-----------------cCCCccCCcchhh
Confidence            888776443  22322223689999999999999 999999866655                 9999999988654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-49  Score=369.47  Aligned_cols=257  Identities=24%  Similarity=0.373  Sum_probs=220.6

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    ++|.||++.+..+++.+|+|.+.....           ..+.+.+|+.+++.++||||++++++
T Consensus         5 ~~y~~~~~lG~G----~~g~Vy~~~~~~~~~~~a~K~~~~~~~-----------~~~~~~~E~~~l~~l~hpnIv~~~~~   69 (321)
T 1tki_A            5 EKYMIAEDLGRG----EFGIVHRCVETSSKKTYMAKFVKVKGT-----------DQVLVKKEISILNIARHRNILHLHES   69 (321)
T ss_dssp             TTEEEEEEEEEC----SSEEEEEEEETTTTEEEEEEEECCCTH-----------HHHHHHHHHHHHHHSCCTTBCCEEEE
T ss_pred             hceEeeeEEecC----CCeEEEEEEECCCCcEEEEEEEecCcc-----------cHHHHHHHHHHHHhCCCCCCCeEeEE
Confidence            456667777777    899999999999999999998764322           12347789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC--
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA--  159 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~--  159 (372)
                      +.+.+.+|+|||||+||+|.+++......+++..++.++.||+.||.|||++||+|          |||||+|||++.  
T Consensus        70 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH----------~Dlkp~NIl~~~~~  139 (321)
T 1tki_A           70 FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGH----------FDIRPENIIYQTRR  139 (321)
T ss_dssp             EEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCCGGGEEESSSS
T ss_pred             EecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCc----------CCCCHHHEEEccCC
Confidence            99999999999999999999999874557999999999999999999999999999          999999999987  


Q ss_pred             CCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHH
Q psy11571        160 NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY  239 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~  239 (372)
                      ++.+||+|||++........  .....||+.|+|||++.+     ..++.++|||||||++|+|++|.+||.+.+..+..
T Consensus       140 ~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  212 (321)
T 1tki_A          140 SSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQH-----DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII  212 (321)
T ss_dssp             CCCEEECCCTTCEECCTTCE--EEEEESCGGGSCHHHHTT-----CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred             CCCEEEEECCCCeECCCCCc--cccccCChhhcCcHHhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHH
Confidence            78999999999987754432  234679999999999983     55789999999999999999999999999999998


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      ..+......+  +......+++++++||.+||. ||.+|||+.+++                 +||||+..
T Consensus       213 ~~i~~~~~~~--~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l-----------------~hp~~~~~  264 (321)
T 1tki_A          213 ENIMNAEYTF--DEEAFKEISIEAMDFVDRLLVKERKSRMTASEAL-----------------QHPWLKQK  264 (321)
T ss_dssp             HHHHHTCCCC--CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHH-----------------HSHHHHSC
T ss_pred             HHHHcCCCCC--ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHh-----------------cChhhccC
Confidence            8888765433  322233689999999999999 999999876665                 89999853

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.8e-48  Score=357.18  Aligned_cols=263  Identities=22%  Similarity=0.339  Sum_probs=213.7

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    |+|.||++.+..+++.||+|.+........        ..+.+.+|+.+++.++||||++++++
T Consensus         2 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~iv~~~~~   69 (292)
T 3o0g_A            2 QKYEKLEKIGEG----TYGTVFKAKNRETHEIVALKRVRLDDDDEG--------VPSSALREICLLKELKHKNIVRLHDV   69 (292)
T ss_dssp             CSEEEEEEEEEC----SSSEEEEEEETTTCCEEEEEEEESSCSSTT--------HHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             CCceeeeEecCC----CCeEEEEEEECCCCceEEEEeeeccCCcCC--------cchHHHHHHHHHhcCCCCCEeeEEeE
Confidence            356677778887    899999999999999999998876543322        23456789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+++.+|+||||+.+ +|.+.+....+.+++..++.++.||+.||.|||++||+|          |||||+|||++.++
T Consensus        70 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH----------~dikp~Nil~~~~~  138 (292)
T 3o0g_A           70 LHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLH----------RDLKPQNLLINRNG  138 (292)
T ss_dssp             EEETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEECTTS
T ss_pred             EEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec----------CCCCHHHEEEcCCC
Confidence            9999999999999965 777777665678999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCC-CCCCCHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP-FYAESLVETYG  240 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~P-f~~~~~~~~~~  240 (372)
                      .+||+|||+++....... ......||+.|+|||++.+    ...++.++|||||||++|+|++|..| |.+.+..+...
T Consensus       139 ~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~  213 (292)
T 3o0g_A          139 ELKLANFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFG----AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK  213 (292)
T ss_dssp             CEEECCCTTCEECCSCCS-CCCSCCSCGGGCCHHHHTT----CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHH
T ss_pred             CEEEeecccceecCCccc-cccCCccccCCcChHHHcC----CCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHH
Confidence            999999999987654322 2234578999999999974    34589999999999999999987777 56667666666


Q ss_pred             HHhhccCCcCCC-----------------------CCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhcc
Q psy11571        241 KIMNHQNSFDLP-----------------------SDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSL  296 (372)
Q Consensus       241 ~i~~~~~~~~~~-----------------------~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~  296 (372)
                      .+......+...                       ......+++++++||++||+ ||++|||+++++            
T Consensus       214 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l------------  281 (292)
T 3o0g_A          214 RIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL------------  281 (292)
T ss_dssp             HHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH------------
T ss_pred             HHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHh------------
Confidence            665422111000                       01112578999999999999 999999876665            


Q ss_pred             CCCCCCCCCcCCC
Q psy11571        297 SISPRNHPWFQGI  309 (372)
Q Consensus       297 ~~~~~~hp~f~~~  309 (372)
                           +||||+++
T Consensus       282 -----~hp~f~~~  289 (292)
T 3o0g_A          282 -----QHPYFSDF  289 (292)
T ss_dssp             -----TSGGGTTC
T ss_pred             -----cCcccccC
Confidence                 99999975

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.7e-48  Score=361.83  Aligned_cols=267  Identities=22%  Similarity=0.327  Sum_probs=206.5

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    |+|.||++.+..+++.||+|.+........         .+.+.+|+.+++.++||||++++++
T Consensus         5 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---------~~~~~~E~~~l~~l~hp~iv~~~~~   71 (317)
T 2pmi_A            5 SQFKQLEKLGNG----TYATVYKGLNKTTGVYVALKEVKLDSEEGT---------PSTAIREISLMKELKHENIVRLYDV   71 (317)
T ss_dssp             ------------------CEEEEEECSSSCCEEEEEEEECCSTTCS---------CHHHHHHHHHHTTCCBTTBCCEEEE
T ss_pred             cceeEeeEECCC----CCEEEEEEEECCCCcEEEEEEeeccccccc---------HHHHHHHHHHHHhcCCCCcceEEEE
Confidence            578999999988    899999999998999999998865542211         2346679999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEE
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFE-----DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL  156 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIl  156 (372)
                      +.+++.+|+||||++ |+|.+++....     ..+++..++.++.||+.||.|||++||+|          |||||+|||
T Consensus        72 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH----------~Dlkp~NIl  140 (317)
T 2pmi_A           72 IHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILH----------RDLKPQNLL  140 (317)
T ss_dssp             ECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCCGGGEE
T ss_pred             EEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeee----------CCCChHHeE
Confidence            999999999999996 69999987532     35899999999999999999999999999          999999999


Q ss_pred             eCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH
Q psy11571        157 LDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV  236 (372)
Q Consensus       157 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~  236 (372)
                      ++.++.+||+|||+++....... ......||+.|+|||++.+    ...++.++|||||||++|+|++|++||.+.+..
T Consensus       141 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~  215 (317)
T 2pmi_A          141 INKRGQLKLGDFGLARAFGIPVN-TFSSEVVTLWYRAPDVLMG----SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE  215 (317)
T ss_dssp             ECTTCCEEECCCSSCEETTSCCC-CCCCCCSCCTTCCHHHHTT----CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             EcCCCCEEECcCccceecCCCcc-cCCCCcccccccCchHhhC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence            99999999999999987653322 1233578999999999973    346899999999999999999999999999888


Q ss_pred             HHHHHHhhccCCcC----------------CC------------CCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        237 ETYGKIMNHQNSFD----------------LP------------SDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       237 ~~~~~i~~~~~~~~----------------~~------------~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      +....+........                .+            ......++.++++||.+||+ ||++|||+++++   
T Consensus       216 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l---  292 (317)
T 2pmi_A          216 EQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQAL---  292 (317)
T ss_dssp             HHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHT---
T ss_pred             HHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHh---
Confidence            87777654211100                00            00112578999999999999 999999876655   


Q ss_pred             hhhhhhhccCCCCCCCCCcCCCCcccc
Q psy11571        288 MWSALFVSLSISPRNHPWFQGIAWDSI  314 (372)
Q Consensus       288 ~~~~~~~~~~~~~~~hp~f~~~~w~~~  314 (372)
                                    +||||++..|.+.
T Consensus       293 --------------~hp~f~~~~~~~~  305 (317)
T 2pmi_A          293 --------------HHPWFAEYYHHAS  305 (317)
T ss_dssp             --------------TSGGGGGGCC---
T ss_pred             --------------CChhhhcccchhh
Confidence                          9999998877543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.4e-48  Score=360.13  Aligned_cols=263  Identities=22%  Similarity=0.313  Sum_probs=210.9

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    ++|.||++.+ .+++.+|+|.+........        ..+.+.+|+.+++.++||||++++++
T Consensus         2 ~~y~~~~~lg~G----~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~iv~~~~~   68 (288)
T 1ob3_A            2 EKYHGLEKIGEG----TYGVVYKAQN-NYGETFALKKIRLEKEDEG--------IPSTTIREISILKELKHSNIVKLYDV   68 (288)
T ss_dssp             CSEEEEEEEEEE----TTEEEEEEEE-TTSCEEEEEEECCSSGGGC--------CCHHHHHHHHGGGGCCCTTBCCEEEE
T ss_pred             ccchhhhhcccC----CCEEEEEEEc-CCCCEEEEEEEeccccccc--------cchhHHHHHHHHHhcCCCCEeeeeeE
Confidence            356667777777    8999999987 6789999998866543321        12346789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+.+.+|+||||+.+ +|.+++....+.+++..++.++.||+.||.|||++||+|          |||||+||+++.++
T Consensus        69 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H----------~dlkp~Nil~~~~~  137 (288)
T 1ob3_A           69 IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH----------RDLKPQNLLINREG  137 (288)
T ss_dssp             EECSSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCCGGGEEECTTS
T ss_pred             EccCCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeec----------CCCCHHHEEEcCCC
Confidence            9999999999999965 999999876678999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .+||+|||+++....... ......||+.|+|||++.+    ...++.++|||||||++|+|++|.+||.+.+..+...+
T Consensus       138 ~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  212 (288)
T 1ob3_A          138 ELKIADFGLARAFGIPVR-KYTHEIVTLWYRAPDVLMG----SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR  212 (288)
T ss_dssp             CEEECCTTHHHHHCC----------CCCTTCCHHHHTT----CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             CEEEeECccccccCcccc-ccccccccccccCchheeC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999987643222 2233578999999999973    35689999999999999999999999999888777766


Q ss_pred             HhhccCCcC---CC--------------------CCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccC
Q psy11571        242 IMNHQNSFD---LP--------------------SDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLS  297 (372)
Q Consensus       242 i~~~~~~~~---~~--------------------~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~  297 (372)
                      +........   ++                    ......+++++++||.+||+ ||++|||+++++             
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l-------------  279 (288)
T 1ob3_A          213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL-------------  279 (288)
T ss_dssp             HHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH-------------
T ss_pred             HHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHh-------------
Confidence            654211110   00                    01113579999999999999 999999876665             


Q ss_pred             CCCCCCCCcCCCC
Q psy11571        298 ISPRNHPWFQGIA  310 (372)
Q Consensus       298 ~~~~~hp~f~~~~  310 (372)
                          +||||++.|
T Consensus       280 ----~hp~f~~~n  288 (288)
T 1ob3_A          280 ----EHAYFKENN  288 (288)
T ss_dssp             ----TSGGGGC--
T ss_pred             ----cCcchhhcC
Confidence                999998753

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.3e-48  Score=370.03  Aligned_cols=262  Identities=24%  Similarity=0.330  Sum_probs=204.7

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeeeEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLHYA   81 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~~~   81 (372)
                      +|+.++.+|.|    ++|.||++.+..+++.||+|.+........        ..+++.+|+.++..+. ||||++++++
T Consensus        10 ~y~~~~~lG~G----~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~   77 (388)
T 3oz6_A           10 KYELVKKLGKG----AYGIVWKSIDRRTGEVVAVKKIFDAFQNST--------DAQRTFREIMILTELSGHENIVNLLNV   77 (388)
T ss_dssp             TEEEEEC-----------CEEEEEETTTCCEEEEEEECC--CCHH--------HHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             ceEEEEEeeeC----CCeEEEEEEECCCCCEEEEEEecccccChH--------HHHHHHHHHHHHHhccCCCCCCeeeeE
Confidence            56666677777    899999999999999999998864432221        2355678999999997 9999999999


Q ss_pred             EEeCC--eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC
Q psy11571         82 FQDDS--NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA  159 (372)
Q Consensus        82 ~~~~~--~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~  159 (372)
                      +...+  .+|+|||||. ++|.+++..  +.+++..++.++.||+.||.|||+.||+|          |||||+|||++.
T Consensus        78 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH----------rDlkp~NIll~~  144 (388)
T 3oz6_A           78 LRADNDRDVYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLH----------RDMKPSNILLNA  144 (388)
T ss_dssp             EECTTSSCEEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCCGGGEEECT
T ss_pred             EecCCCCEEEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEe----------CCCCHHHeEEcC
Confidence            98654  7999999996 699999987  68999999999999999999999999999          999999999999


Q ss_pred             CCcEEEeecCcccccCCCC--------------------cccccccccCCcccCcccccccccCCCCCCCccceeehhHH
Q psy11571        160 NGHIRLADFGSCLRLGGDG--------------------TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVC  219 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvi  219 (372)
                      ++.+||+|||+|+......                    .......+||+.|+|||++.+    ...++.++|||||||+
T Consensus       145 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~i  220 (388)
T 3oz6_A          145 ECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG----STKYTKGIDMWSLGCI  220 (388)
T ss_dssp             TCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT----CCCCCTHHHHHHHHHH
T ss_pred             CCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcC----CCCCCChhhHHHHHHH
Confidence            9999999999998653211                    111233579999999999974    4568999999999999


Q ss_pred             HHHHhhCCCCCCCCCHHHHHHHHhhccCCcCC-----------------------------CC------------CCCCC
Q psy11571        220 MYEMLYGETPFYAESLVETYGKIMNHQNSFDL-----------------------------PS------------DVGYE  258 (372)
Q Consensus       220 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-----------------------------~~------------~~~~~  258 (372)
                      +|||++|++||.+.+..+.+.+|......+..                             ..            .....
T Consensus       221 l~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (388)
T 3oz6_A          221 LGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKAD  300 (388)
T ss_dssp             HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCC
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhccccccccc
Confidence            99999999999999988888777642211100                             00            00115


Q ss_pred             CCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCC
Q psy11571        259 ISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       259 ~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~  310 (372)
                      +++++.+||++||+ ||++|||+++++                 +||||+.+.
T Consensus       301 ~~~~~~dll~~~L~~dP~~R~t~~e~l-----------------~Hp~~~~~~  336 (388)
T 3oz6_A          301 CNEEALDLLDKLLQFNPNKRISANDAL-----------------KHPFVSIFH  336 (388)
T ss_dssp             CCHHHHHHHHHHCCSSGGGSCCHHHHT-----------------TSTTTTTTC
T ss_pred             CCHHHHHHHHHhhccCcccCCCHHHHh-----------------CCHHHHHhc
Confidence            78999999999999 999999876665                 999988663

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-48  Score=370.40  Aligned_cols=259  Identities=24%  Similarity=0.395  Sum_probs=219.5

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||++.+..+++.+|+|.+.......          ...+.+|+.+++.++||||+++++++
T Consensus        52 ~y~i~~~LG~G----~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~----------~~~~~~E~~il~~l~hpnIv~~~~~~  117 (387)
T 1kob_A           52 YYDILEELGSG----AFGVVHRCVEKATGRVFVAKFINTPYPLD----------KYTVKNEISIMNQLHHPKLINLHDAF  117 (387)
T ss_dssp             TEEEEEEEEEE----TTEEEEEEEETTTCCEEEEEEEECCSHHH----------HHHHHHHHHHHTTCCSTTBCCEEEEE
T ss_pred             ceEEEEEEecC----CCEEEEEEEECCCCCEEEEEEecccchhh----------HHHHHHHHHHHHhCCCcCCCeEEEEE
Confidence            34555566666    89999999999999999999886543221          23577899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC--C
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA--N  160 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~--~  160 (372)
                      .+...+|+|||||+||+|.+++......+++..++.++.||+.||.|||++||+|          |||||+|||++.  .
T Consensus       118 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH----------rDlkp~NIll~~~~~  187 (387)
T 1kob_A          118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVH----------LDIKPENIMCETKKA  187 (387)
T ss_dssp             ECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCCGGGEEESSTTC
T ss_pred             EeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeee----------cccchHHeEEecCCC
Confidence            9999999999999999999999864557999999999999999999999999999          999999999974  4


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG  240 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~  240 (372)
                      +.+||+|||+++........  ....||+.|+|||++.+     ..++.++|||||||++|+|++|..||.+.+..+.+.
T Consensus       188 ~~vkL~DFG~a~~~~~~~~~--~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~  260 (387)
T 1kob_A          188 SSVKIIDFGLATKLNPDEIV--KVTTATAEFAAPEIVDR-----EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ  260 (387)
T ss_dssp             CCEEECCCTTCEECCTTSCE--EEECSSGGGCCHHHHTT-----CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH
T ss_pred             CceEEEecccceecCCCcce--eeeccCCCccCchhccC-----CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHH
Confidence            78999999999877544322  33579999999999983     568899999999999999999999999999888888


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCc
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAW  311 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w  311 (372)
                      ++......  ++......+++++++||.+||+ ||.+||++++++                 +||||++..+
T Consensus       261 ~i~~~~~~--~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell-----------------~hp~~~~~~~  313 (387)
T 1kob_A          261 NVKRCDWE--FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDAL-----------------EHPWLKGDHS  313 (387)
T ss_dssp             HHHHCCCC--CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHH-----------------TSTTTSSCCT
T ss_pred             HHHhCCCC--CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHh-----------------hCccccCCcc
Confidence            88775433  3333334789999999999999 999999866655                 9999997654

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.6e-48  Score=368.91  Aligned_cols=266  Identities=26%  Similarity=0.407  Sum_probs=216.5

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYA   81 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~   81 (372)
                      +|+.++.+|.|    ++|.||.+.+..+++.||+|.+......              ..+|+.++..+ .||||++++++
T Consensus        23 ~y~~~~~lG~G----~~g~V~~~~~~~~~~~~avK~~~~~~~~--------------~~~E~~~l~~~~~hp~iv~~~~~   84 (342)
T 2qr7_A           23 GYEVKEDIGVG----SYSVCKRCIHKATNMEFAVKIIDKSKRD--------------PTEEIEILLRYGQHPNIITLKDV   84 (342)
T ss_dssp             HEEEEEEEEEC----SSEEEEEEEETTTTEEEEEEEEETTTCC--------------CHHHHHHHHHHTTSTTBCCEEEE
T ss_pred             cEEEEEEEeeC----CCEEEEEEEECCCCCEEEEEEEEcccCC--------------hHHHHHHHHHhcCCCCcCeEEEE
Confidence            44555566666    8999999999999999999988654321              23466666665 79999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC-
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-  160 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~-  160 (372)
                      +.+...+|+|||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+|          |||||+|||+... 
T Consensus        85 ~~~~~~~~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH----------rDlkp~NIl~~~~~  153 (342)
T 2qr7_A           85 YDDGKYVYVVTELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVH----------RDLKPSNILYVDES  153 (342)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCCGGGEEESSSS
T ss_pred             EEcCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEe----------ccCCHHHEEEecCC
Confidence            9999999999999999999999987 578999999999999999999999999999          9999999998533 


Q ss_pred             ---CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCC---CC
Q psy11571        161 ---GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA---ES  234 (372)
Q Consensus       161 ---~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~---~~  234 (372)
                         +.+||+|||+++....... .....+||+.|+|||++.+     ..++.++|||||||++|+|++|.+||.+   .+
T Consensus       154 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~  227 (342)
T 2qr7_A          154 GNPESIRICDFGFAKQLRAENG-LLMTPCYTANFVAPEVLER-----QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT  227 (342)
T ss_dssp             CSGGGEEECCCTTCEECBCTTC-CBCCSSCCSSCCCHHHHHH-----HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC
T ss_pred             CCcCeEEEEECCCcccCcCCCC-ceeccCCCccccCHHHhcC-----CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC
Confidence               3599999999987644322 2334689999999999974     3478899999999999999999999986   45


Q ss_pred             HHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccc
Q psy11571        235 LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDS  313 (372)
Q Consensus       235 ~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~  313 (372)
                      ..+++..+..+..  .++...+..+++++++||++||. ||++||++.+++                 +||||.  +|+.
T Consensus       228 ~~~~~~~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il-----------------~hp~~~--~~~~  286 (342)
T 2qr7_A          228 PEEILARIGSGKF--SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVL-----------------RHPWIV--HWDQ  286 (342)
T ss_dssp             HHHHHHHHHHCCC--CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHT-----------------TSHHHH--TGGG
T ss_pred             HHHHHHHHccCCc--ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHh-----------------cCCeec--Cccc
Confidence            6677777776543  33444445789999999999999 999999866554                 999995  5877


Q ss_pred             c--ccCCCCCcCC
Q psy11571        314 I--RDSNAPYIPE  324 (372)
Q Consensus       314 ~--~~~~~p~~p~  324 (372)
                      +  ....+|+.|.
T Consensus       287 ~~~~~~~~~~~p~  299 (342)
T 2qr7_A          287 LPQYQLNRQDAPH  299 (342)
T ss_dssp             SCCSCCCCCCCHH
T ss_pred             cccccCCCccchh
Confidence            6  3445666654

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-47  Score=376.57  Aligned_cols=270  Identities=20%  Similarity=0.280  Sum_probs=199.9

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    ++|.||++.+..+++.||+|.+.......        ...+++.+|+.+|+.++||||++++++
T Consensus        53 ~~y~~~~~lG~G----~~g~V~~~~~~~~~~~vaiK~i~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~  120 (458)
T 3rp9_A           53 DRYEIRHLIGTG----SYGHVCEAYDKLEKRVVAIKKILRVFEDL--------IDCKRILREIAILNRLNHDHVVKVLDI  120 (458)
T ss_dssp             TTEEECCC-----------CEEEEEECC--CEEEEEEECSTTSSH--------HHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCeEEeeEeeec----CCeEEEEEEECCCCcEEEEEEechhhcCH--------HHHHHHHHHHHHHHhCCCCCCCceEEE
Confidence            356666777777    89999999999999999999886543222        234568889999999999999999999


Q ss_pred             EEeC-----CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEE
Q psy11571         82 FQDD-----SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL  156 (372)
Q Consensus        82 ~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIl  156 (372)
                      +...     ..+|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+|          |||||+|||
T Consensus       121 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH----------rDlKp~NIL  188 (458)
T 3rp9_A          121 VIPKDVEKFDELYVVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILH----------RDLKPANCL  188 (458)
T ss_dssp             CCCSCTTTCCCEEEEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBC----------CCCCGGGEE
T ss_pred             EecCCcccCceEEEEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCC----------CCCChhhEE
Confidence            9543     5799999997 6799999987 578999999999999999999999999999          999999999


Q ss_pred             eCCCCcEEEeecCcccccCCCCc--------------------------ccccccccCCcccCcccccccccCCCCCCCc
Q psy11571        157 LDANGHIRLADFGSCLRLGGDGT--------------------------VQSNVAVGTPDYISPEILTAMEEGRGRYGPE  210 (372)
Q Consensus       157 l~~~~~vkl~Dfg~a~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~  210 (372)
                      ++.++.+||+|||+++.......                          ......+||+.|+|||++..    ...++.+
T Consensus       189 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~~~~~~  264 (458)
T 3rp9_A          189 VNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL----QENYTEA  264 (458)
T ss_dssp             ECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTT----CCCCCTH
T ss_pred             ECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhC----CCCCCcH
Confidence            99999999999999987642211                          11234578999999998753    4568999


Q ss_pred             cceeehhHHHHHHhh-----------CCCCCCCCCH--------------------HHHHHHHhhccCCc----------
Q psy11571        211 CDWWSLGVCMYEMLY-----------GETPFYAESL--------------------VETYGKIMNHQNSF----------  249 (372)
Q Consensus       211 ~DiwslGvil~ellt-----------G~~Pf~~~~~--------------------~~~~~~i~~~~~~~----------  249 (372)
                      +|||||||++|||++           |+++|.+.+.                    .+.+..|......+          
T Consensus       265 ~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  344 (458)
T 3rp9_A          265 IDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK  344 (458)
T ss_dssp             HHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSC
T ss_pred             hHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCC
Confidence            999999999999998           7788876541                    12222222110000          


Q ss_pred             --------CCC-------CCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccc
Q psy11571        250 --------DLP-------SDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDS  313 (372)
Q Consensus       250 --------~~~-------~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~  313 (372)
                              .++       .......++++.+||++||+ ||++|||+++++                 +||||++++|..
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L-----------------~Hp~f~~~~~~~  407 (458)
T 3rp9_A          345 EDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECL-----------------AHPFFKEVRIAE  407 (458)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHH-----------------HSGGGTTTCCGG
T ss_pred             HHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHh-----------------cCHhhhhcCCCc
Confidence                    000       01112569999999999999 999999876655                 999999999987


Q ss_pred             ccc
Q psy11571        314 IRD  316 (372)
Q Consensus       314 ~~~  316 (372)
                      +..
T Consensus       408 ~e~  410 (458)
T 3rp9_A          408 VET  410 (458)
T ss_dssp             GCC
T ss_pred             cCC
Confidence            743

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.1e-47  Score=349.83  Aligned_cols=264  Identities=26%  Similarity=0.387  Sum_probs=224.9

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    |+|.||.+.+..+++.||+|.+........        ..+.+.+|+.+++.++||||++++++
T Consensus         6 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~   73 (284)
T 3kk8_A            6 DNYDVKEELGKG----AFSVVRRCVHKTTGLEFAAKIINTKKLSAR--------DFQKLEREARICRKLQHPNIVRLHDS   73 (284)
T ss_dssp             TTEEEEEEEEEE----TTEEEEEEEETTTCCEEEEEEEEGGGCCHH--------HHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhhhhhhhhcCc----CCeEEEEEEEcCCCceEEEEEeecccCCHH--------HHHHHHHHHHHHHHcCCCCcCeEEEE
Confidence            456667777777    899999999999999999998876554332        34567889999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+.+..++||||+++++|.+.+.. ...+++..+..++.|++.||.|||++|++|          |||||+||+++.++
T Consensus        74 ~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H----------~dikp~Nil~~~~~  142 (284)
T 3kk8_A           74 IQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVH----------RNLKPENLLLASKA  142 (284)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCCGGGEEESSSS
T ss_pred             EEcCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCc----------CCCCHHHEEEecCC
Confidence            9999999999999999999999887 477999999999999999999999999999          99999999998665


Q ss_pred             c---EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHH
Q psy11571        162 H---IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET  238 (372)
Q Consensus       162 ~---vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~  238 (372)
                      .   +||+|||++........  .....||+.|+|||++.+     ..++.++||||||+++|+|++|..||.+.+....
T Consensus       143 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  215 (284)
T 3kk8_A          143 KGAAVKLADFGLAIEVNDSEA--WHGFAGTPGYLSPEVLKK-----DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL  215 (284)
T ss_dssp             TTCCEEECCCTTCEECCSSCB--CCCSCSCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             CCCcEEEeeceeeEEcccCcc--ccCCCCCcCCcCchhhcC-----CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH
Confidence            5   99999999987654332  233679999999999983     5689999999999999999999999999998888


Q ss_pred             HHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc
Q psy11571        239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI  314 (372)
Q Consensus       239 ~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~  314 (372)
                      ...+.......  +......+++++.+||.+||+ ||++||++++++                 +||||++..+...
T Consensus       216 ~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l-----------------~h~~~~~~~~~~~  273 (284)
T 3kk8_A          216 YAQIKAGAYDY--PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQAL-----------------KVPWICNRERVAS  273 (284)
T ss_dssp             HHHHHHTCCCC--CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHT-----------------TSHHHHSCCCGGG
T ss_pred             HHHHHhccccC--CchhhcccCHHHHHHHHHHcccChhhCCCHHHHh-----------------cCccccCChhHHh
Confidence            88887765443  333334789999999999999 999999876665                 9999998766443

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=9e-48  Score=369.85  Aligned_cols=272  Identities=19%  Similarity=0.251  Sum_probs=211.7

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|  ..|+|.||++.+..+++.||+|.+.......        +..+.+.+|+.+++.++||||+++++++
T Consensus        26 ~y~~~~~lG~G--~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~   95 (389)
T 3gni_B           26 CYELLTVIGKG--FEDLMTVNLARYKPTGEYVTVRRINLEACSN--------EMVTFLQGELHVSKLFNHPNIVPYRATF   95 (389)
T ss_dssp             GEEEEEEEEEE--TTTTEEEEEEEETTTCCEEEEEEEEGGGSCH--------HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cEEEEecccCC--cCCceEEEEEEEcCCCCEEEEEEecccccCh--------HHHHHHHHHHHHHHhCCCCCCCcEeEEE
Confidence            45555566655  2268999999999999999999887654332        2456688899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      .+.+.+|+|||||++|+|.+++... ...+++..++.++.||+.||.|||++||+|          |||||+|||++.++
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH----------rDlkp~NIll~~~~  165 (389)
T 3gni_B           96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVH----------RSVKASHILISVDG  165 (389)
T ss_dssp             EETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEECTTC
T ss_pred             EECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeec----------CCCCHHHEEEcCCC
Confidence            9999999999999999999999873 257999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCc------ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCH
Q psy11571        162 HIRLADFGSCLRLGGDGT------VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL  235 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~  235 (372)
                      .+||+|||.+........      .......||+.|+|||++.+.   ...++.++|||||||++|+|++|++||.+.+.
T Consensus       166 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  242 (389)
T 3gni_B          166 KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQN---LQGYDAKSDIYSVGITACELANGHVPFKDMPA  242 (389)
T ss_dssp             CEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTT---SSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred             CEEEcccccceeeccccccccccccccccccccccccCHHHHhcc---CCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCH
Confidence            999999998865422111      111224789999999999741   14689999999999999999999999988665


Q ss_pred             HHHHHHHhhccCCcC----------------------------------------CCCCCCCCCCHHHHHHHHHhcc-CC
Q psy11571        236 VETYGKIMNHQNSFD----------------------------------------LPSDVGYEISDDAKDLMRRLIC-SS  274 (372)
Q Consensus       236 ~~~~~~i~~~~~~~~----------------------------------------~~~~~~~~~s~~~~~li~~lL~-~p  274 (372)
                      .+....+..+.....                                        ........+++++++||++||+ ||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP  322 (389)
T 3gni_B          243 TQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNP  322 (389)
T ss_dssp             TTHHHHC--------------------------------------------------------CCHHHHHHHHHHTCSCT
T ss_pred             HHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCc
Confidence            555444332211000                                        0001123578999999999999 99


Q ss_pred             CCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc
Q psy11571        275 DTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI  314 (372)
Q Consensus       275 ~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~  314 (372)
                      ++|||+++++                 +||||+.+.|...
T Consensus       323 ~~Rpta~ell-----------------~hp~f~~~~~~~~  345 (389)
T 3gni_B          323 DARPSASTLL-----------------NHSFFKQIKRRAS  345 (389)
T ss_dssp             TTSCCHHHHT-----------------TSGGGGGC---CC
T ss_pred             ccCCCHHHHh-----------------cCHHHHHHhhcch
Confidence            9999876655                 9999999887543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.8e-48  Score=363.54  Aligned_cols=261  Identities=21%  Similarity=0.335  Sum_probs=209.8

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    |+|.||++.+..+++.||+|.+.......         ..+.+.+|+.+++.++||||++++++
T Consensus         7 ~~y~i~~~lG~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~E~~~l~~l~hpnIv~~~~~   73 (323)
T 3tki_A            7 EDWDLVQTLGEG----AYGEVQLAVNRVTEEAVAVKIVDMKRAVD---------CPENIKKEICINKMLNHENVVKFYGH   73 (323)
T ss_dssp             TCEEEEEEEEEE----TTEEEEEEEETTTCCEEEEEEEECC----------------CHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhceeeeEEecC----CCEEEEEEEECCCCcEEEEEEEEcccccc---------hHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            356666677777    89999999999999999999886543322         22457789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+.+..|+|||||+||+|.+++.. ...+++..++.++.||+.||.|||++||+|          |||||+|||++.++
T Consensus        74 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH----------~Dlkp~NIll~~~~  142 (323)
T 3tki_A           74 RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITH----------RDIKPENLLLDERD  142 (323)
T ss_dssp             EECSSEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSGGGEEECTTC
T ss_pred             EecCCeEEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------cccchHHEEEeCCC
Confidence            9999999999999999999999976 567999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH-HHH
Q psy11571        162 HIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETY  239 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-~~~  239 (372)
                      .+||+|||+++....... ......+||+.|+|||++.+    ...++.++|||||||++|+|++|..||.+.+.. ..+
T Consensus       143 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  218 (323)
T 3tki_A          143 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR----REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY  218 (323)
T ss_dssp             CEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHC----SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH
T ss_pred             CEEEEEeeccceeccCCcccccCCCccCcCccCcHHhcc----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH
Confidence            999999999976532221 12234679999999999974    333477899999999999999999999876543 233


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCc
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAW  311 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w  311 (372)
                      ..+........  .  ...+++.+.+||.+||+ ||++|||+++++                 +||||+..-.
T Consensus       219 ~~~~~~~~~~~--~--~~~~~~~~~~li~~~L~~dP~~R~t~~eil-----------------~h~~~~~~~~  270 (323)
T 3tki_A          219 SDWKEKKTYLN--P--WKKIDSAPLALLHKILVENPSARITIPDIK-----------------KDRWYNKPLK  270 (323)
T ss_dssp             HHHHTTCTTST--T--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHT-----------------TCTTTTCCCC
T ss_pred             HHHhcccccCC--c--cccCCHHHHHHHHHHccCChhhCcCHHHHh-----------------hChhhccccc
Confidence            33333222111  1  12689999999999999 999999866554                 9999986543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.8e-48  Score=366.99  Aligned_cols=265  Identities=25%  Similarity=0.403  Sum_probs=215.5

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    |+|.||++.+..+++.||+|.+...........     ..+.+.+|+.+++.++||||++++++
T Consensus        24 ~~y~~~~~lG~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~~~~~   94 (351)
T 3c0i_A           24 DVYELCEVIGKG----PFSVVRRCINRETGQQFAVKIVDVAKFTSSPGL-----STEDLKREASICHMLKHPHIVELLET   94 (351)
T ss_dssp             HHEEEEEEEEEC----SSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSC-----CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cceEEeeEEeeC----CCEEEEEEEECCCCCEEEEEEEEhhhccccccc-----hHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            355566666666    899999999999999999998765433221100     12457889999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKF---EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD  158 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~  158 (372)
                      +.+.+.+|+|||||+|++|.+++...   ...+++..++.++.||+.||.|||++||+|          |||||+|||++
T Consensus        95 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH----------rDlkp~NIl~~  164 (351)
T 3c0i_A           95 YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIH----------RDVKPHCVLLA  164 (351)
T ss_dssp             EEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSGGGEEEC
T ss_pred             EEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCcee----------ccCChHHeEEe
Confidence            99999999999999999999888643   235899999999999999999999999999          99999999998


Q ss_pred             CCCc---EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCH
Q psy11571        159 ANGH---IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL  235 (372)
Q Consensus       159 ~~~~---vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~  235 (372)
                      .++.   +||+|||++........ .....+||+.|+|||++.+     ..++.++|||||||++|+|++|..||.+.. 
T Consensus       165 ~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~-  237 (351)
T 3c0i_A          165 SKENSAPVKLGGFGVAIQLGESGL-VAGGRVGTPHFMAPEVVKR-----EPYGKPVDVWGCGVILFILLSGCLPFYGTK-  237 (351)
T ss_dssp             SSSTTCCEEECCCTTCEECCTTSC-BCCCCCSCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-
T ss_pred             cCCCCCcEEEecCcceeEecCCCe-eecCCcCCcCccCHHHHcC-----CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-
Confidence            6654   99999999987755432 2334679999999999983     568999999999999999999999998754 


Q ss_pred             HHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCc
Q psy11571        236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAW  311 (372)
Q Consensus       236 ~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w  311 (372)
                      .+.+..+..+...  .+...+..+++++++||.+||. ||++||++.+++                 +||||++.++
T Consensus       238 ~~~~~~i~~~~~~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l-----------------~hp~~~~~~~  295 (351)
T 3c0i_A          238 ERLFEGIIKGKYK--MNPRQWSHISESAKDLVRRMLMLDPAERITVYEAL-----------------NHPWLKERDR  295 (351)
T ss_dssp             HHHHHHHHHTCCC--CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHH-----------------TSHHHHTHHH
T ss_pred             HHHHHHHHcCCCC--CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHh-----------------cChhhcCCcc
Confidence            4566666664432  2222223689999999999999 999999866555                 9999997654

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=6.9e-49  Score=370.41  Aligned_cols=254  Identities=27%  Similarity=0.476  Sum_probs=211.1

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||.+.+..+++.||+|.+........       +..+.+.+|+.+++.++||||+++++++
T Consensus        10 ~Y~i~~~lG~G----~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~~~E~~~l~~l~hpnIv~l~~~~   78 (336)
T 3h4j_B           10 PYIIRETLGEG----SFGKVKLATHYKTQQKVALKFISRQLLKKS-------DMHMRVEREISYLKLLRHPHIIKLYDVI   78 (336)
T ss_dssp             TEEEEEEEEEE----TTEEEEEEEETTTCCEEEEEEEEHHHHHHT-------TCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             CEEEEEEEecC----CCeEEEEEEECCCCCEEEEEEEehHHccch-------hHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            45556666666    899999999999999999998765443322       1234578899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+.+.+|+||||+ +|+|.+++.. .+.+++.+++.++.||+.||.|||++||+|          |||||+|||++.++.
T Consensus        79 ~~~~~~~lv~E~~-~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH----------~Dlkp~NIll~~~~~  146 (336)
T 3h4j_B           79 TTPTDIVMVIEYA-GGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVH----------RDLKPENLLLDDNLN  146 (336)
T ss_dssp             ECSSEEEEEECCC-CEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCC----------CCCSTTTEEECTTCC
T ss_pred             EeCCEEEEEEECC-CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEe----------cCCchhhEEEcCCCC
Confidence            9999999999999 7899999877 478999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||++........  ....+||+.|+|||++.+    ....+.++|||||||++|+|++|..||.+........++
T Consensus       147 ~kl~DFG~s~~~~~~~~--~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i  220 (336)
T 3h4j_B          147 VKIADFGLSNIMTDGNF--LKTSCGSPNYAAPEVING----KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV  220 (336)
T ss_dssp             EEECCSSCTBTTTTSBT--TCCCTTSTTTSCGGGSCC----SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC
T ss_pred             EEEEEeccceeccCCcc--cccccCCcCcCCHHHHcC----CCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence            99999999987654332  234689999999999984    233478999999999999999999999877655444443


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      ...  ....|.    .+++++++||++||+ ||.+|||+++++                 +||||+.
T Consensus       221 ~~~--~~~~p~----~~s~~~~~li~~~L~~dP~~Rpt~~eil-----------------~hp~~~~  264 (336)
T 3h4j_B          221 NSC--VYVMPD----FLSPGAQSLIRRMIVADPMQRITIQEIR-----------------RDPWFNV  264 (336)
T ss_dssp             CSS--CCCCCT----TSCHHHHHHHHTTSCSSGGGSCCHHHHT-----------------TCHHHHT
T ss_pred             HcC--CCCCcc----cCCHHHHHHHHHHcCCChhHCcCHHHHH-----------------hChhhcc
Confidence            332  223343    689999999999999 999999866555                 9999985

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.1e-48  Score=357.06  Aligned_cols=265  Identities=26%  Similarity=0.455  Sum_probs=209.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHH----------------HHHHHHHHHHHHHHH
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVS----------------DFIEFVAKLREERDV   66 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~----------------~~~~~~~~l~~E~~i   66 (372)
                      +|+.++.+|.|    |+|.||.+.+..+++.||+|.+..........+.                ......+.+.+|+.+
T Consensus        14 ~y~~~~~lG~G----~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           14 QYTLKDEIGKG----SYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             TEEEEEEEEC------CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             ceEEEeEEeec----CCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            45555666666    8999999999999999999998766543321110                011234668899999


Q ss_pred             HhcCCCCceeeeeEEEEe--CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCC
Q psy11571         67 LVYGDRRWITNLHYAFQD--DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAF  144 (372)
Q Consensus        67 l~~l~hp~Iv~l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~  144 (372)
                      ++.++||||+++++++.+  ...+|+||||+++++|.+++..  ..+++..++.++.||+.||.|||++||+|       
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH-------  160 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQKIIH-------  160 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHTTEEC-------
T ss_pred             HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeec-------
Confidence            999999999999999987  5689999999999999887643  67999999999999999999999999999       


Q ss_pred             CcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHh
Q psy11571        145 HLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML  224 (372)
Q Consensus       145 ~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ell  224 (372)
                         |||||+|||++.++.+||+|||+++........ .....||+.|+|||++.+..  ...++.++|||||||++|+|+
T Consensus       161 ---~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~--~~~~~~~~Di~slG~~l~~l~  234 (298)
T 2zv2_A          161 ---RDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL-LSNTVGTPAFMAPESLSETR--KIFSGKALDVWAMGVTLYCFV  234 (298)
T ss_dssp             ---CCCCGGGEEECTTSCEEECCCTTCEECSSSSCE-ECCCCSCGGGCCGGGCCTTC--CCEESHHHHHHHHHHHHHHHH
T ss_pred             ---cCCCHHHEEECCCCCEEEecCCCcccccccccc-ccCCcCCccccChhhhccCC--CCCCCchhhhHhHHHHHHHHH
Confidence               999999999999999999999999876543322 23457999999999997411  111467899999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCC
Q psy11571        225 YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNH  303 (372)
Q Consensus       225 tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~h  303 (372)
                      +|..||.+.+.......+......++.+    ..+++++++||.+||+ ||++||++.+++                 +|
T Consensus       235 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~R~s~~e~l-----------------~h  293 (298)
T 2zv2_A          235 FGQCPFMDERIMCLHSKIKSQALEFPDQ----PDIAEDLKDLITRMLDKNPESRIVVPEIK-----------------LH  293 (298)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHCCCCCCSS----SCCCHHHHHHHHHHTCSCTTTSCCHHHHT-----------------TC
T ss_pred             HCCCCCCCccHHHHHHHHhcccCCCCCc----cccCHHHHHHHHHHhhcChhhCCCHHHHh-----------------cC
Confidence            9999999988887777776654333222    2689999999999999 999999866555                 99


Q ss_pred             CCcC
Q psy11571        304 PWFQ  307 (372)
Q Consensus       304 p~f~  307 (372)
                      |||+
T Consensus       294 p~~~  297 (298)
T 2zv2_A          294 PWVT  297 (298)
T ss_dssp             HHHH
T ss_pred             cccc
Confidence            9995

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.5e-47  Score=355.21  Aligned_cols=267  Identities=25%  Similarity=0.328  Sum_probs=212.6

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    |+|.||++.+..+++.||+|.+.......        ...+.+.+|+.+++.++||||++++++
T Consensus         3 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~i~~~~~~   70 (311)
T 4agu_A            3 EKYEKIGKIGEG----SYGVVFKCRNRDTGQIVAIKKFLESEDDP--------VIKKIALREIRMLKQLKHPNLVNLLEV   70 (311)
T ss_dssp             CCEEEEEEEEEC----SSEEEEEEEETTTCCEEEEEEECCCCC-H--------HHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccceEeeEEeec----CCeEEEEEEeCCCCcEEEEEEeeccccch--------HHHHHHHHHHHHHHhCCCCCccchhhe
Confidence            356677777777    89999999999999999999876554322        134557789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+.+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++|          |||||+||+++.++
T Consensus        71 ~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH----------~dlkp~Nil~~~~~  139 (311)
T 4agu_A           71 FRRKRRLHLVFEYCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHNCIH----------RDVKPENILITKHS  139 (311)
T ss_dssp             EEETTEEEEEEECCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEECTTS
T ss_pred             eecCCeEEEEEEeCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHCCCcC----------CCCChhhEEEcCCC
Confidence            9999999999999999999998876 577999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .+||+|||++......... .....||+.|+|||++.+    ...++.++|||||||++|+|++|.+||.+.+..+....
T Consensus       140 ~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  214 (311)
T 4agu_A          140 VIKLCDFGFARLLTGPSDY-YDDEVATRWYRSPELLVG----DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYL  214 (311)
T ss_dssp             CEEECCCTTCEECC-------------GGGCCHHHHHT----CSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             CEEEeeCCCchhccCcccc-cCCCcCCccccChHHHhc----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999876543322 233578999999999973    45689999999999999999999999999887776655


Q ss_pred             HhhccCC-----------------cCCCC--C------CCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhc
Q psy11571        242 IMNHQNS-----------------FDLPS--D------VGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVS  295 (372)
Q Consensus       242 i~~~~~~-----------------~~~~~--~------~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~  295 (372)
                      +......                 ...+.  .      ....+++++.+||.+||+ ||++|||+++++           
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell-----------  283 (311)
T 4agu_A          215 IRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL-----------  283 (311)
T ss_dssp             HHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHH-----------
T ss_pred             HHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHh-----------
Confidence            4332110                 01111  0      012678999999999999 999999876665           


Q ss_pred             cCCCCCCCCCcCCCCccc
Q psy11571        296 LSISPRNHPWFQGIAWDS  313 (372)
Q Consensus       296 ~~~~~~~hp~f~~~~w~~  313 (372)
                            +||||+++.|..
T Consensus       284 ------~hp~f~~~~~~~  295 (311)
T 4agu_A          284 ------HHPYFENIREIE  295 (311)
T ss_dssp             ------TSGGGTTCC---
T ss_pred             ------cChHHHhccCHH
Confidence                  999999988754

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.3e-47  Score=375.51  Aligned_cols=254  Identities=28%  Similarity=0.460  Sum_probs=217.8

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+..+.+|.|    ++|.||.+.+..+++.||+|.+........       +..+.+.+|+.+++.++||||+++++++.
T Consensus        18 Y~l~~~LG~G----~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~-------~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~   86 (476)
T 2y94_A           18 YILGDTLGVG----TFGKVKVGKHELTGHKVAVKILNRQKIRSL-------DVVGKIRREIQNLKLFRHPHIIKLYQVIS   86 (476)
T ss_dssp             EEEEEEEECC----SSSCEEEEEETTTCCEEEEEEEEHHHHHHT-------TTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             EEEEEEEeeC----CCeEEEEEEECCCCCEEEEEEEEhhhccCH-------HHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            4444555665    899999999999999999998865443222       23456889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcE
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI  163 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~v  163 (372)
                      +.+.+|+||||++||+|.+++.+ .+.+++..++.++.||+.||.|||++||+|          |||||+|||++.++.+
T Consensus        87 ~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH----------rDLkp~NIll~~~~~v  155 (476)
T 2y94_A           87 TPSDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVH----------RDLKPENVLLDAHMNA  155 (476)
T ss_dssp             CSSEEEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEEC----------SCCSGGGEEECTTCCE
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCc----------ccccHHHEEEecCCCe
Confidence            99999999999999999999976 578999999999999999999999999999          9999999999999999


Q ss_pred             EEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHh
Q psy11571        164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM  243 (372)
Q Consensus       164 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~  243 (372)
                      ||+|||++........  ....+||+.|+|||++.+    ....+.++|||||||++|+|++|..||.+.+....+.++.
T Consensus       156 kL~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~  229 (476)
T 2y94_A          156 KIADFGLSNMMSDGEF--LRTSCGSPNYAAPEVISG----RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC  229 (476)
T ss_dssp             EECCCSSCEECCTTCC--BCCCCSCSTTCCHHHHTT----CCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHH
T ss_pred             EEEeccchhhcccccc--ccccCCCcCeEChhhccC----CCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHh
Confidence            9999999987654332  234689999999999984    3334789999999999999999999999998888888887


Q ss_pred             hccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        244 NHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      .+.  +..|.    .+++++++||++||+ ||.+|||+++++                 +||||+.
T Consensus       230 ~~~--~~~p~----~~s~~~~~Li~~~L~~dP~~Rpt~~eil-----------------~hp~~~~  272 (476)
T 2y94_A          230 DGI--FYTPQ----YLNPSVISLLKHMLQVDPMKRATIKDIR-----------------EHEWFKQ  272 (476)
T ss_dssp             TTC--CCCCT----TCCHHHHHHHHHHTCSSTTTSCCHHHHH-----------------TCHHHHT
T ss_pred             cCC--cCCCc----cCCHHHHHHHHHHcCCCchhCcCHHHHH-----------------hCHHhhh
Confidence            754  33343    689999999999999 999999866555                 9999985

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.1e-47  Score=380.76  Aligned_cols=260  Identities=29%  Similarity=0.480  Sum_probs=217.5

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    |+|.||++.+..++..+|+|.+........        ..+.+.+|+.+++.++||||++++++
T Consensus        37 ~~y~~~~~lG~G----~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--------~~~~~~~E~~~l~~l~hpniv~~~~~  104 (494)
T 3lij_A           37 EMYQRVKKLGSG----AYGEVLLCRDKVTHVERAIKIIRKTSVSTS--------SNSKLLEEVAVLKLLDHPNIMKLYDF  104 (494)
T ss_dssp             HHEEEEEEEECC-------EEEEEEETTTCCEEEEEEEEC-----C--------TTHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cCeEEeeEEecC----CCEEEEEEEECCCCcEEEEEEEeccccCch--------HHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            356677777777    899999999999999999998876554332        12457789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC-
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-  160 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~-  160 (372)
                      +.+...+|+|||||++|+|.+++.. ...+++..++.++.||+.||.|||++||+|          |||||+|||++.. 
T Consensus       105 ~~~~~~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH----------~Dlkp~Nil~~~~~  173 (494)
T 3lij_A          105 FEDKRNYYLVMECYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHNIVH----------RDLKPENLLLESKE  173 (494)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSGGGEEESCSS
T ss_pred             EEeCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcee----------ccCChhhEEEeCCC
Confidence            9999999999999999999999877 478999999999999999999999999999          9999999999764 


Q ss_pred             --CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHH
Q psy11571        161 --GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET  238 (372)
Q Consensus       161 --~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~  238 (372)
                        +.+||+|||++........  ....+||+.|+|||++.      ..++.++|||||||++|+|++|.+||.+.+..+.
T Consensus       174 ~~~~~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  245 (494)
T 3lij_A          174 KDALIKIVDFGLSAVFENQKK--MKERLGTAYYIAPEVLR------KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI  245 (494)
T ss_dssp             TTCCEEECCCTTCEECBTTBC--BCCCCSCTTTCCHHHHT------TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             CCCcEEEEECCCCeECCCCcc--ccccCCCcCeeCHHHHc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence              4599999999987654332  23467999999999986      3589999999999999999999999999999999


Q ss_pred             HHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCc
Q psy11571        239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAW  311 (372)
Q Consensus       239 ~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w  311 (372)
                      +.++..+...+.  ...+..+|+++++||++||+ ||.+|||+.+++                 +||||+....
T Consensus       246 ~~~i~~~~~~~~--~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l-----------------~hp~~~~~~~  300 (494)
T 3lij_A          246 LRKVEKGKYTFD--SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQAL-----------------EHPWIKEMCS  300 (494)
T ss_dssp             HHHHHHTCCCCC--SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHH-----------------TCHHHHHHHH
T ss_pred             HHHHHhCCCCCC--chhcccCCHHHHHHHHHHCCCChhhCccHHHHh-----------------cCcccccCcc
Confidence            999887654443  33334789999999999999 999999876665                 9999987543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.3e-47  Score=357.58  Aligned_cols=267  Identities=24%  Similarity=0.389  Sum_probs=223.8

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+..+.+|.|    |+|.||++.+..+++.||+|.+...........    ...+.+.+|+.+++.+.||||+++++++
T Consensus        13 ~y~~~~~lg~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~   84 (321)
T 2a2a_A           13 FYDIGEELGSG----QFAIVKKCREKSTGLEYAAKFIKKRQSRASRRG----VSREEIEREVSILRQVLHHNVITLHDVY   84 (321)
T ss_dssp             HEEEEEEEEEC----SSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSS----BCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cEEEeeEeeec----CCEEEEEEEECCCCeEEEEEEEecccccccccc----hhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            45556666666    899999999999999999998876544322100    0124577899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC-
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG-  161 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~-  161 (372)
                      .+...+|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++|++|          |||||+||+++.++ 
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH----------~dikp~NIl~~~~~~  153 (321)
T 2a2a_A           85 ENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAH----------FDLKPENIMLLDKNI  153 (321)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEESCTTS
T ss_pred             ecCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeec----------CCCChHHEEEecCCC
Confidence            999999999999999999999987 567999999999999999999999999999          99999999999887 


Q ss_pred             ---cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHH
Q psy11571        162 ---HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET  238 (372)
Q Consensus       162 ---~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~  238 (372)
                         .+||+|||++........  .....||+.|+|||++.     ...++.++|+|||||++|+|++|..||.+.+..+.
T Consensus       154 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  226 (321)
T 2a2a_A          154 PIPHIKLIDFGLAHEIEDGVE--FKNIFGTPEFVAPEIVN-----YEPLGLEADMWSIGVITYILLSGASPFLGDTKQET  226 (321)
T ss_dssp             SSCCEEECCCTTCEECCTTCC--CCCCCSCGGGCCHHHHT-----TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred             CcCCEEEccCccceecCcccc--ccccCCCCCccCccccc-----CCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence               799999999987654332  23357999999999997     35689999999999999999999999999998888


Q ss_pred             HHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc
Q psy11571        239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI  314 (372)
Q Consensus       239 ~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~  314 (372)
                      ...+.....  ..+......+++.+++||.+||. ||++|||+++++                 +||||.+++|+..
T Consensus       227 ~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l-----------------~hp~~~~~~~~~~  284 (321)
T 2a2a_A          227 LANITSVSY--DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEAL-----------------RHPWITPVDNQQA  284 (321)
T ss_dssp             HHHHHTTCC--CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHH-----------------HSTTTSCSSHHHH
T ss_pred             HHHHHhccc--ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHh-----------------cCccccCCCcccc
Confidence            888776443  22322223689999999999999 999999876655                 9999999998764

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.8e-48  Score=361.05  Aligned_cols=265  Identities=24%  Similarity=0.338  Sum_probs=210.3

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    |+|.||++.+..+++.||+|.+........         ...+.+|+.+++.++||||++++++
T Consensus         2 ~~y~~~~~lG~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~   68 (324)
T 3mtl_A            2 ETYIKLDKLGEG----TYATVYKGKSKLTDNLVALKEIRLEHEEGA---------PCTAIREVSLLKDLKHANIVTLHDI   68 (324)
T ss_dssp             CSEEEEEEEEEC----SSEEEEEEEETTTCCEEEEEEECC---------------CCCCCCCHHHHSCCCCTTBCCEEEE
T ss_pred             CceEEEEEEcCC----CCEEEEEEEECCCCcEEEEEEEeccccccc---------chhHHHHHHHHHhcCCCCCCeeeeE
Confidence            356677777877    899999999999999999998865432211         1124468999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+.+.+++||||+. |+|.+++......+++..++.++.||+.||.|||++||+|          |||||+|||++.++
T Consensus        69 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH----------~Dikp~NIl~~~~~  137 (324)
T 3mtl_A           69 IHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLH----------RDLKPQNLLINERG  137 (324)
T ss_dssp             EECSSCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEE----------SSCCGGGEEECTTC
T ss_pred             EeeCCEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccC----------CCcCHHHEEECCCC
Confidence            999999999999996 5999999886667999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .+||+|||++........ ......||+.|+|||++.+    ...++.++|||||||++|+|++|++||.+.+..+....
T Consensus       138 ~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  212 (324)
T 3mtl_A          138 ELKLADFGLARAKSIPTK-TYDNEVVTLWYRPPDILLG----STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHF  212 (324)
T ss_dssp             CEEECSSSEEECC-------------CGGGCCHHHHTT----CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             CEEEccCcccccccCCcc-ccccccCcccccChhhhcC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999986543322 2233578999999999873    35689999999999999999999999999988887777


Q ss_pred             HhhccCCcC---CCCC---------------------CCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhcc
Q psy11571        242 IMNHQNSFD---LPSD---------------------VGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSL  296 (372)
Q Consensus       242 i~~~~~~~~---~~~~---------------------~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~  296 (372)
                      +......+.   ++..                     ....+++++++||.+||+ ||.+|||+++++            
T Consensus       213 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l------------  280 (324)
T 3mtl_A          213 IFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAM------------  280 (324)
T ss_dssp             HHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHT------------
T ss_pred             HHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHh------------
Confidence            655322111   0000                     012478999999999999 999999866655            


Q ss_pred             CCCCCCCCCcCCCCcc
Q psy11571        297 SISPRNHPWFQGIAWD  312 (372)
Q Consensus       297 ~~~~~~hp~f~~~~w~  312 (372)
                           +||||.++...
T Consensus       281 -----~hp~f~~~~~~  291 (324)
T 3mtl_A          281 -----KHPFFLSLGER  291 (324)
T ss_dssp             -----TSGGGGGGCST
T ss_pred             -----cChhhhhcccc
Confidence                 99999987653

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2e-47  Score=365.67  Aligned_cols=252  Identities=24%  Similarity=0.405  Sum_probs=213.0

Q ss_pred             ccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         16 IQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        16 ~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      .|++|.||++.+..+++.||+|.+......          ..+.+.+|+.+++.++||||+++++++.+.+.+|+||||+
T Consensus        99 ~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~  168 (373)
T 2x4f_A           99 GGRFGQVHKCEETATGLKLAAKIIKTRGMK----------DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV  168 (373)
T ss_dssp             -----CEEEEEETTTCCEEEEEEEECCSHH----------HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cCcCEEEEEEEEcCCCcEEEEEEEcccccc----------cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence            348999999999889999999988764432          2345788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe--CCCCcEEEeecCcccc
Q psy11571         96 CGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL--DANGHIRLADFGSCLR  173 (372)
Q Consensus        96 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll--~~~~~vkl~Dfg~a~~  173 (372)
                      ++++|.+++......+++..++.++.||+.||.|||+.||+|          |||||+|||+  +.++.+||+|||+++.
T Consensus       169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH----------~Dlkp~NIll~~~~~~~~kl~DFG~a~~  238 (373)
T 2x4f_A          169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILH----------LDLKPENILCVNRDAKQIKIIDFGLARR  238 (373)
T ss_dssp             TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCCGGGEEEEETTTTEEEECCCSSCEE
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------ccCCHHHEEEecCCCCcEEEEeCCCcee
Confidence            999999999775567999999999999999999999999999          9999999999  5678999999999987


Q ss_pred             cCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCC
Q psy11571        174 LGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPS  253 (372)
Q Consensus       174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~  253 (372)
                      ......  ....+||+.|+|||++.     ...++.++|||||||++|+|++|..||.+.+..+.+.++......+  +.
T Consensus       239 ~~~~~~--~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~--~~  309 (373)
T 2x4f_A          239 YKPREK--LKVNFGTPEFLAPEVVN-----YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDL--ED  309 (373)
T ss_dssp             CCTTCB--CCCCCSSCTTCCHHHHT-----TCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCS--CS
T ss_pred             cCCccc--cccccCCCcEeChhhcc-----CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--Ch
Confidence            654332  23357999999999997     3568899999999999999999999999999988888888764333  33


Q ss_pred             CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccc
Q psy11571        254 DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDS  313 (372)
Q Consensus       254 ~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~  313 (372)
                      .....+++++++||.+||+ ||.+||++++++                 +||||++..|..
T Consensus       310 ~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l-----------------~hp~~~~~~~~~  353 (373)
T 2x4f_A          310 EEFQDISEEAKEFISKLLIKEKSWRISASEAL-----------------KHPWLSDHKLHS  353 (373)
T ss_dssp             GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHH-----------------HSHHHHCHHHHH
T ss_pred             hhhccCCHHHHHHHHHHcCCChhhCCCHHHHh-----------------cCcCcCCCchhh
Confidence            3334689999999999999 999999866655                 999999887643

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.7e-48  Score=381.69  Aligned_cols=262  Identities=28%  Similarity=0.472  Sum_probs=223.3

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||.+.+..+++.||+|.+.........       ..+.+.+|+.+++.++||||+++++++
T Consensus        27 ~y~~~~~lg~G----~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~-------~~~~~~~E~~~l~~l~hpniv~~~~~~   95 (484)
T 3nyv_A           27 RYKGQRVLGKG----SFGEVILCKDKITGQECAVKVISKRQVKQKT-------DKESLLREVQLLKQLDHPNIMKLYEFF   95 (484)
T ss_dssp             HEEEEEEEEEE----TTEEEEEEEETTTCCEEEEEEEETTTCCBSS-------CHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ceEEeeEEecC----CCEEEEEEEECCCCCEEEEEEEEhhhcccch-------HHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            55556666666    8999999999999999999988665443221       134578899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe---CC
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL---DA  159 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll---~~  159 (372)
                      .+.+.+|+|||||.+|+|.+++.. ...+++..++.++.||+.||.|||++||+|          |||||+|||+   +.
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH----------~Dlkp~Nil~~~~~~  164 (484)
T 3nyv_A           96 EDKGYFYLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVH----------RDLKPENLLLESKSK  164 (484)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCCGGGEEESSSST
T ss_pred             EeCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeee----------CCCCHHHEEEecCCC
Confidence            999999999999999999999987 578999999999999999999999999999          9999999999   46


Q ss_pred             CCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHH
Q psy11571        160 NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY  239 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~  239 (372)
                      ++.+||+|||+++.......  ....+||+.|+|||++.      +.++.++|||||||++|+|++|.+||.+.+..+..
T Consensus       165 ~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  236 (484)
T 3nyv_A          165 DANIRIIDFGLSTHFEASKK--MKDKIGTAYYIAPEVLH------GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL  236 (484)
T ss_dssp             TCCEEECCTTHHHHBCCCCS--HHHHTTGGGTCCHHHHH------TCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             CCcEEEEeeeeeEEcccccc--cccCCCCccccCceeec------CCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence            78999999999987654432  23357999999999987      35899999999999999999999999999999999


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccc
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDS  313 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~  313 (372)
                      .++..+...+..|.  +..+|+++++||++||+ ||.+|||+++++                 +||||+...++.
T Consensus       237 ~~i~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dp~~R~s~~e~l-----------------~h~~~~~~~~~~  292 (484)
T 3nyv_A          237 KKVEKGKYTFELPQ--WKKVSESAKDLIRKMLTYVPSMRISARDAL-----------------DHEWIQTYTKEQ  292 (484)
T ss_dssp             HHHHHCCCCCCSGG--GGGSCHHHHHHHHHHTCSSGGGSCCHHHHH-----------------TSHHHHHHTC--
T ss_pred             HHHHcCCCCCCCcc--cccCCHHHHHHHHHHCCCChhHCcCHHHHh-----------------hChhhccccccc
Confidence            99988765544333  33689999999999999 999999876665                 999999766543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.2e-47  Score=379.64  Aligned_cols=260  Identities=30%  Similarity=0.514  Sum_probs=220.9

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    |+|.||++.+..+++.||+|.+........        ..+.+.+|+.+++.++||||++++++
T Consensus        22 ~~y~~~~~lG~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~~E~~~l~~l~hpniv~~~~~   89 (486)
T 3mwu_A           22 ERYNIVCMLGKG----SFGEVLKCKDRITQQEYAVKVINKASAKNK--------DTSTILREVELLKKLDHPNIMKLFEI   89 (486)
T ss_dssp             HHEEEEEEEECC----SSSEEEEEEETTTCCEEEEEEEEHHHHBCS--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cceEEeEEEeec----CCEEEEEEEECCCCCEEEEEEEecccccch--------HHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence            466777777777    899999999999999999998765433221        13457789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC---
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD---  158 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~---  158 (372)
                      +.+...+|+|||||.||+|.+++.. ...+++..++.++.||+.||.|||++||+|          |||||+|||++   
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH----------~Dlkp~Nil~~~~~  158 (486)
T 3mwu_A           90 LEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVH----------RDLKPENILLESKE  158 (486)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCSGGGEEESSSS
T ss_pred             EEcCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEe----------ccCchHHEEEecCC
Confidence            9999999999999999999999977 478999999999999999999999999999          99999999995   


Q ss_pred             CCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHH
Q psy11571        159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET  238 (372)
Q Consensus       159 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~  238 (372)
                      .++.+||+|||+++.......  ....+||+.|+|||++.      +.++.++|||||||++|+|++|.+||.+.+..+.
T Consensus       159 ~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  230 (486)
T 3mwu_A          159 KDCDIKIIDFGLSTCFQQNTK--MKDRIGTAYYIAPEVLR------GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI  230 (486)
T ss_dssp             TTCCEEECSCSCTTTBCCC------CCTTGGGGCCGGGGG------SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             CCCCEEEEECCcCeECCCCCc--cCCCcCCCCCCCHHHhC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            456799999999987654332  23457999999999997      3489999999999999999999999999999999


Q ss_pred             HHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCc
Q psy11571        239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAW  311 (372)
Q Consensus       239 ~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w  311 (372)
                      +.++..+...+..|.  +..+|+++++||++||+ ||.+|||+.+++                 +||||+....
T Consensus       231 ~~~i~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dp~~R~t~~~~l-----------------~hp~~~~~~~  285 (486)
T 3mwu_A          231 LKRVETGKYAFDLPQ--WRTISDDAKDLIRKMLTFHPSLRITATQCL-----------------EHPWIQKYSS  285 (486)
T ss_dssp             HHHHHHTCCCSCSGG--GGGSCHHHHHHHHHHTCSSTTTSCCHHHHH-----------------HCHHHHHTCC
T ss_pred             HHHHHhCCCCCCCcc--cCCCCHHHHHHHHHHcCCChhhCcCHHHHh-----------------cCHhhccCcc
Confidence            999888665544433  33689999999999999 999999876665                 8999987643

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=6.1e-47  Score=348.81  Aligned_cols=256  Identities=27%  Similarity=0.436  Sum_probs=209.9

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+..+.+|.|    |+|.||++.+..++..+|+|.+........         .+.+.+|+.+++.++||||++++++
T Consensus        22 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---------~~~~~~E~~~l~~l~hp~iv~~~~~   88 (285)
T 3is5_A           22 DLFIFKRKLGSG----AFGDVHLVEERSSGLERVIKTINKDRSQVP---------MEQIEAEIEVLKSLDHPNIIKIFEV   88 (285)
T ss_dssp             HHEEEEEEEEEC----SSCEEEEEEETTTCCEEEEEEEEGGGCCSC---------HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hheeecceeccC----CCeEEEEEEEccCCceEEEEEeeccccchh---------HHHHHHHHHHHHhCCCchHHhHHHh
Confidence            355556666766    899999999999999999998866443221         3457789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe-
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKF---EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL-  157 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll-  157 (372)
                      +.+....|+||||+++|+|.+++...   ...+++..++.++.||+.||.|||+.||+|          |||||+||++ 
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH----------~dikp~NIl~~  158 (285)
T 3is5_A           89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVH----------KDLKPENILFQ  158 (285)
T ss_dssp             EECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------CCCSGGGEEES
T ss_pred             eecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEE----------CCCCHHHEEEe
Confidence            99999999999999999999998642   367999999999999999999999999999          9999999999 


Q ss_pred             --CCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCH
Q psy11571        158 --DANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL  235 (372)
Q Consensus       158 --~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~  235 (372)
                        +.++.+||+|||++........  .....||+.|+|||++.      ..++.++|||||||++|+|++|+.||.+.+.
T Consensus       159 ~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~------~~~~~~~Di~slG~il~~ll~g~~pf~~~~~  230 (285)
T 3is5_A          159 DTSPHSPIKIIDFGLAELFKSDEH--STNAAGTALYMAPEVFK------RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL  230 (285)
T ss_dssp             SSSTTCCEEECCCCCCCC------------CTTGGGCCHHHHT------TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cCCCCCCEEEEeeecceecCCccc--CcCcccccCcCChHHhc------cCCCcccCeehHHHHHHHHHhCCCCCCCCCH
Confidence              4567899999999976544322  23467899999999986      4588999999999999999999999999988


Q ss_pred             HHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       236 ~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      .+....+...........   ..+++++.+||.+||+ ||++||++.+++                 +||||+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~L~~dP~~Rps~~e~l-----------------~hp~f~~  284 (285)
T 3is5_A          231 EEVQQKATYKEPNYAVEC---RPLTPQAVDLLKQMLTKDPERRPSAAQVL-----------------HHEWFKQ  284 (285)
T ss_dssp             HHHHHHHHHCCCCCCC-----CCCCHHHHHHHHHHTCSCTTTSCCHHHHH-----------------TSGGGGC
T ss_pred             HHHHhhhccCCccccccc---CcCCHHHHHHHHHHccCChhhCcCHHHHh-----------------cCHHhhc
Confidence            887777765543332221   2579999999999999 999999866655                 9999985

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-47  Score=361.39  Aligned_cols=261  Identities=25%  Similarity=0.381  Sum_probs=209.5

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    ++|.||.+.+..+++.||+|.+.......        ...+++.+|+.+++.++||||+++++++
T Consensus        26 ~y~~~~~lG~G----~~g~V~~a~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~l~~~~   93 (367)
T 1cm8_A           26 VYRDLQPVGSG----AYGAVCSAVDGRTGAKVAIKKLYRPFQSE--------LFAKRAYRELRLLKHMRHENVIGLLDVF   93 (367)
T ss_dssp             SEEEEEEC----------CEEEEEETTTCCEEEEEECSSTTSSH--------HHHHHHHHHHHHHHHCCBTTBCCCSEEE
T ss_pred             eEEEeEEeeec----CCeEEEEEEECCCCCEEEEEEeCccccCH--------HHHHHHHHHHHHHHhCCCcCCCCceeeE
Confidence            45666666766    89999999999999999999886543221        2345678899999999999999999999


Q ss_pred             EeCC------eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEE
Q psy11571         83 QDDS------NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL  156 (372)
Q Consensus        83 ~~~~------~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIl  156 (372)
                      ....      .+|+||||+ +++|.+++..  ..+++..++.++.||+.||.|||++||+|          |||||+|||
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH----------~Dlkp~NIl  160 (367)
T 1cm8_A           94 TPDETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIH----------RDLKPGNLA  160 (367)
T ss_dssp             CSCSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCCGGGEE
T ss_pred             ecCCccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccc----------cCcCHHHEE
Confidence            8763      469999999 8899999987  67999999999999999999999999999          999999999


Q ss_pred             eCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH
Q psy11571        157 LDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV  236 (372)
Q Consensus       157 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~  236 (372)
                      ++.++.+||+|||+++.....    .....||+.|+|||++.+    ...++.++|||||||++|+|++|++||.+.+..
T Consensus       161 l~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  232 (367)
T 1cm8_A          161 VNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILN----WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL  232 (367)
T ss_dssp             ECTTCCEEECCCTTCEECCSS----CCSSCSCGGGCCTHHHHT----TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             EcCCCCEEEEeeecccccccc----cCcCcCCCCcCCHHHHhC----CCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            999999999999999876432    233578999999999974    356899999999999999999999999998888


Q ss_pred             HHHHHHhhccCCcC------------------CC-------CCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhh
Q psy11571        237 ETYGKIMNHQNSFD------------------LP-------SDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWS  290 (372)
Q Consensus       237 ~~~~~i~~~~~~~~------------------~~-------~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~  290 (372)
                      +.+..|......++                  +|       .......++++.+||.+||+ ||.+|||+++++      
T Consensus       233 ~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l------  306 (367)
T 1cm8_A          233 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL------  306 (367)
T ss_dssp             HHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHH------
T ss_pred             HHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHh------
Confidence            77776654321110                  00       01123579999999999999 999999876665      


Q ss_pred             hhhhccCCCCCCCCCcCCCCccc
Q psy11571        291 ALFVSLSISPRNHPWFQGIAWDS  313 (372)
Q Consensus       291 ~~~~~~~~~~~~hp~f~~~~w~~  313 (372)
                                 +||||+.+.+..
T Consensus       307 -----------~hp~f~~~~~~~  318 (367)
T 1cm8_A          307 -----------AHPYFESLHDTE  318 (367)
T ss_dssp             -----------HSGGGTTTC---
T ss_pred             -----------cChHHHhhcCCc
Confidence                       999999876543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.3e-47  Score=358.71  Aligned_cols=255  Identities=23%  Similarity=0.381  Sum_probs=212.8

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCeEEEEEecc
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      ||+|.||++.+..+++.||+|.+........        ....+.+|+.++..+. ||||+++++++.+...+|+||||+
T Consensus        40 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~  111 (327)
T 3lm5_A           40 GKFAVVRQCISKSTGQEYAAKFLKKRRRGQD--------CRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYA  111 (327)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEESEETTEE--------CHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEehhhcchH--------HHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEec
Confidence            3899999999999999999998876554332        1244678899998884 699999999999999999999999


Q ss_pred             CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC---CCcEEEeecCcc
Q psy11571         96 CGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA---NGHIRLADFGSC  171 (372)
Q Consensus        96 ~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~---~~~vkl~Dfg~a  171 (372)
                      ++|+|.+++... ...+++..++.++.||+.||+|||++||+|          |||||+|||++.   ++.+||+|||++
T Consensus       112 ~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH----------~Dikp~NIl~~~~~~~~~~kL~Dfg~a  181 (327)
T 3lm5_A          112 AGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVH----------LDLKPQNILLSSIYPLGDIKIVDFGMS  181 (327)
T ss_dssp             TTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred             CCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeec----------CcCChHHEEEecCCCCCcEEEeeCccc
Confidence            999999998542 357999999999999999999999999999          999999999987   789999999999


Q ss_pred             cccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCC
Q psy11571        172 LRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDL  251 (372)
Q Consensus       172 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~  251 (372)
                      +.......  .....||+.|+|||++.     ...++.++|||||||++|+|++|..||.+.+..+....+......+  
T Consensus       182 ~~~~~~~~--~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--  252 (327)
T 3lm5_A          182 RKIGHACE--LREIMGTPEYLAPEILN-----YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDY--  252 (327)
T ss_dssp             EEC-----------CCCGGGCCHHHHT-----TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--
T ss_pred             cccCCccc--cccccCCcCccCCeeec-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccccc--
Confidence            87654332  23357999999999997     3568999999999999999999999999999888888777654333  


Q ss_pred             CCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccccc
Q psy11571        252 PSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIR  315 (372)
Q Consensus       252 ~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~  315 (372)
                      +......+++.+++||.+||+ ||.+||++++++                 +||||++++|+.+.
T Consensus       253 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll-----------------~h~~~~~~~~~~~~  300 (327)
T 3lm5_A          253 SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICL-----------------SHSWLQQWDFENLF  300 (327)
T ss_dssp             CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHT-----------------TCGGGCCCCTTCC-
T ss_pred             CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHh-----------------CCHhhccccccccc
Confidence            333334789999999999999 999999866655                 99999999998763

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.7e-47  Score=364.66  Aligned_cols=253  Identities=26%  Similarity=0.432  Sum_probs=199.6

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      +||+.++.+|.|    |+|.||.+++..+++.||+|.+.......           +.+.+|+.+++.++||||++++++
T Consensus        20 ~~y~~~~~lG~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~E~~~l~~l~hpniv~~~~~   84 (361)
T 3uc3_A           20 DRYDFVKDIGSG----NFGVARLMRDKLTKELVAVKYIERGAAID-----------ENVQREIINHRSLRHPNIVRFKEV   84 (361)
T ss_dssp             TTEEEEEEESSS----TTSSEEEEEETTTCCEEEEEEEESSTTSC-----------HHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CcEEEEEEeccC----CCEEEEEEEECCCCcEEEEEEEecCcccc-----------HHHHHHHHHHHhCCCCCCCcEEEE
Confidence            467777788877    89999999999999999999886543322           236689999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+.+.+|+||||+++|+|.+++.. .+.+++..++.++.||+.||.|||++||+|          |||||+|||++.++
T Consensus        85 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH----------~Dlkp~Nill~~~~  153 (361)
T 3uc3_A           85 ILTPTHLAIIMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICH----------RDLKLENTLLDGSP  153 (361)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCS----------CCCCGGGEEECSSS
T ss_pred             EeeCCEEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------CCCCHHHEEEcCCC
Confidence            9999999999999999999999987 468999999999999999999999999999          99999999998776


Q ss_pred             c--EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCC-CccceeehhHHHHHHhhCCCCCCCCCH---
Q psy11571        162 H--IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYG-PECDWWSLGVCMYEMLYGETPFYAESL---  235 (372)
Q Consensus       162 ~--vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~DiwslGvil~elltG~~Pf~~~~~---  235 (372)
                      .  +||+|||+++......  ......||+.|+|||++.+     ..++ .++|||||||++|+|++|+.||.+.+.   
T Consensus       154 ~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~  226 (361)
T 3uc3_A          154 APRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLR-----QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD  226 (361)
T ss_dssp             SCCEEECCCCCC-----------------CTTSCHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC
T ss_pred             CceEEEeecCccccccccC--CCCCCcCCCCcCChhhhcC-----CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH
Confidence            5  9999999997543322  2233579999999999974     3344 459999999999999999999987543   


Q ss_pred             -HHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        236 -VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       236 -~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                       ......+.....  .+|..  ..+++++++||++||+ ||++|||+++++                 +||||..
T Consensus       227 ~~~~~~~~~~~~~--~~~~~--~~~s~~~~~li~~~L~~dP~~Rps~~ell-----------------~hp~f~~  280 (361)
T 3uc3_A          227 YRKTIQRILSVKY--SIPDD--IRISPECCHLISRIFVADPATRISIPEIK-----------------THSWFLK  280 (361)
T ss_dssp             HHHHHHHHHTTCC--CCCTT--SCCCHHHHHHHHHHSCSCTTTSCCHHHHH-----------------TSHHHHT
T ss_pred             HHHHHHHHhcCCC--CCCCc--CCCCHHHHHHHHHHccCChhHCcCHHHHH-----------------hCcchhc
Confidence             344455554333  22332  2689999999999999 999999866655                 9999954

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.9e-47  Score=360.42  Aligned_cols=256  Identities=29%  Similarity=0.435  Sum_probs=199.9

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+..+.+|.|    |+|.||++.+..+++.||+|.+.....            .+.+.+|+.+++.++||||+++++++.
T Consensus        55 y~~~~~lG~G----~~g~Vy~~~~~~~~~~vavK~~~~~~~------------~~~~~~E~~~l~~l~h~niv~~~~~~~  118 (349)
T 2w4o_A           55 FEVESELGRG----ATSIVYRCKQKGTQKPYALKVLKKTVD------------KKIVRTEIGVLLRLSHPNIIKLKEIFE  118 (349)
T ss_dssp             EEEEEEEEEC----SSEEEEEEEETTTCCEEEEEEEEC----------------------CHHHHHCCCTTBCCEEEEEE
T ss_pred             EEEeeEEeeC----CCEEEEEEEECCCCcEEEEEEeccchh------------HHHHHHHHHHHHhCCCCCCcceeeeEe
Confidence            4445555665    899999999988899999998765321            234678999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC---C
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA---N  160 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~---~  160 (372)
                      +.+.+++||||+++|+|.+++.. .+.+++..++.++.||+.||.|||+.||+|          |||||+|||++.   +
T Consensus       119 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH----------~Dikp~NIll~~~~~~  187 (349)
T 2w4o_A          119 TPTEISLVLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVH----------RDLKPENLLYATPAPD  187 (349)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCC----------CCCCGGGEEESSSSTT
T ss_pred             cCCeEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEe----------cCCCcccEEEecCCCC
Confidence            99999999999999999999987 567999999999999999999999999999          999999999975   8


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHH-HH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TY  239 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~-~~  239 (372)
                      +.+||+|||+++.......  .....||+.|+|||++.+     ..++.++|||||||++|+|++|..||.+....+ .+
T Consensus       188 ~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  260 (349)
T 2w4o_A          188 APLKIADFGLSKIVEHQVL--MKTVCGTPGYCAPEILRG-----CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF  260 (349)
T ss_dssp             CCEEECCCC------------------CGGGSCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHH
T ss_pred             CCEEEccCccccccCcccc--cccccCCCCccCHHHhcC-----CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHH
Confidence            8999999999987643322  234679999999999983     568999999999999999999999998765544 66


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcc
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWD  312 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~  312 (372)
                      ..+......+  +......++.++++||++||+ ||++||++.+++                 +||||.+..+.
T Consensus       261 ~~i~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l-----------------~hp~~~~~~~~  315 (349)
T 2w4o_A          261 RRILNCEYYF--ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQAL-----------------QHPWVTGKAAN  315 (349)
T ss_dssp             HHHHTTCCCC--CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHH-----------------HSTTTTSTTCC
T ss_pred             HHHHhCCCcc--CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHh-----------------cCcccCCCccc
Confidence            6666644332  333334789999999999999 999999876655                 99999976653

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.6e-46  Score=347.49  Aligned_cols=276  Identities=27%  Similarity=0.405  Sum_probs=223.0

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeeeEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLHYA   81 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~~~   81 (372)
                      +|+.++.+|.|    ++|.||.+.+..+++.||+|.+........ .........+.+.+|+.+++.+. ||||++++++
T Consensus        18 ~y~~~~~lg~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           18 NYEPKEILGRG----VSSVVRRCIHKPTCKEYAVKIIDVTGGGSF-SAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             TEEEEEEEEEC----SSEEEEEEEETTTTEEEEEEEEETTCSTTC-CHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             ccceeeeecCC----CceEEEEEEEcCcCceEEEEEEeccccccc-CHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            45555666666    799999999998999999998865542111 11111234566788999999985 9999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+....|+||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++|          |||||+||+++.++
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H----------~dl~p~Nil~~~~~  161 (298)
T 1phk_A           93 YETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVH----------RDLKPENILLDDDM  161 (298)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSGGGEEECTTC
T ss_pred             eccCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------CCCCcceEEEcCCC
Confidence            9999999999999999999999987 468999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCccccccccc-CCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEE-GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG  240 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~  240 (372)
                      .+||+|||++........  .....||+.|+|||++.+... ....++.++|+||||+++|+|++|..||.+.+......
T Consensus       162 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~  239 (298)
T 1phk_A          162 NIKLTDFGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR  239 (298)
T ss_dssp             CEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             cEEEecccchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHH
Confidence            999999999987654332  233578999999999863211 13457889999999999999999999999998888888


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccccc
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIR  315 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~  315 (372)
                      .+......+..+  ....++..+.+||.+||+ ||.+||++++++                 +||||++..|+.++
T Consensus       240 ~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll-----------------~h~~~~~~~~~~~~  296 (298)
T 1phk_A          240 MIMSGNYQFGSP--EWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL-----------------AHPFFQQYVVEEVR  296 (298)
T ss_dssp             HHHHTCCCCCTT--TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT-----------------TSGGGCTTC-----
T ss_pred             HHhcCCcccCcc--cccccCHHHHHHHHHHccCCcccCCCHHHHH-----------------hChHhhhccchhhc
Confidence            887765443322  223689999999999999 999999866555                 99999999988765

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.1e-46  Score=367.26  Aligned_cols=269  Identities=22%  Similarity=0.274  Sum_probs=207.9

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    ++|.||++.+..+++.||+|.+.......        ...+++.+|+.+|+.++||||++++++
T Consensus        26 ~~y~~~~~lG~G----~~g~V~~a~~~~~~~~vAiK~~~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~l~~~   93 (432)
T 3n9x_A           26 DNYIIKHLIGRG----SYGYVYLAYDKNTEKNVAIKKVNRMFEDL--------IDCKRILREITILNRLKSDYIIRLYDL   93 (432)
T ss_dssp             TTEEEEEEEEEE----TTEEEEEEEETTTTEEEEEEEECSTTTSH--------HHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCEEEEEEEeec----CCEEEEEEEECCCCcEEEEEEeCchhcCh--------HHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence            456666677776    89999999999999999999886543221        234567889999999999999999999


Q ss_pred             EEeC-----CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEE
Q psy11571         82 FQDD-----SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL  156 (372)
Q Consensus        82 ~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIl  156 (372)
                      +...     ..+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.||+|          |||||+|||
T Consensus        94 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givH----------rDlkp~NIL  161 (432)
T 3n9x_A           94 IIPDDLLKFDELYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIH----------RDLKPANCL  161 (432)
T ss_dssp             CCCSCTTTCCCEEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCCGGGEE
T ss_pred             EecCCCCcCCeEEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCC----------CCCCHHHeE
Confidence            9876     57999999985 699999987 567999999999999999999999999999          999999999


Q ss_pred             eCCCCcEEEeecCcccccCCCCcc---------------------cccccccCCcccCcccccccccCCCCCCCccceee
Q psy11571        157 LDANGHIRLADFGSCLRLGGDGTV---------------------QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWS  215 (372)
Q Consensus       157 l~~~~~vkl~Dfg~a~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diws  215 (372)
                      ++.++.+||+|||+++........                     .....+||+.|+|||++..    ...++.++||||
T Consensus       162 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~----~~~~~~~~DiwS  237 (432)
T 3n9x_A          162 LNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL----QENYTKSIDIWS  237 (432)
T ss_dssp             ECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTT----CSCCCTHHHHHH
T ss_pred             ECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhc----CCCCCcccccch
Confidence            999999999999999876433211                     1245689999999999753    456899999999


Q ss_pred             hhHHHHHHhh-----------CCCCCCCCC-----------------HHHHHHHHhhccCC-------------------
Q psy11571        216 LGVCMYEMLY-----------GETPFYAES-----------------LVETYGKIMNHQNS-------------------  248 (372)
Q Consensus       216 lGvil~ellt-----------G~~Pf~~~~-----------------~~~~~~~i~~~~~~-------------------  248 (372)
                      |||++|||++           |.++|.+.+                 ..+.+..|......                   
T Consensus       238 lG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~  317 (432)
T 3n9x_A          238 TGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIK  317 (432)
T ss_dssp             HHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHH
T ss_pred             HHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHH
Confidence            9999999998           455554433                 11222222111000                   


Q ss_pred             ---cCCCC---CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccccc
Q psy11571        249 ---FDLPS---DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIR  315 (372)
Q Consensus       249 ---~~~~~---~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~  315 (372)
                         ...+.   .....+++++.+||++||+ ||++|||+++++                 +||||+++.|....
T Consensus       318 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L-----------------~Hp~f~~~~~~~~e  374 (432)
T 3n9x_A          318 LFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQAL-----------------DHPYLKDVRKKKLE  374 (432)
T ss_dssp             TSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHH-----------------TCGGGTTTCCTTTC
T ss_pred             hCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHh-----------------cChhhhhccCcccC
Confidence               00000   0012579999999999999 999999876665                 99999999998764

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7.8e-47  Score=347.54  Aligned_cols=265  Identities=28%  Similarity=0.467  Sum_probs=220.1

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    ++|.||.+.+..+++.||+|.+........       ...+.+.+|+.+++.++||||+++++++
T Consensus        15 ~y~~~~~lg~G----~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~   83 (284)
T 2vgo_A           15 DFDIGRPLGKG----KFGNVYLAREKQNKFIMALKVLFKSQLEKE-------GVEHQLRREIEIQSHLRHPNILRMYNYF   83 (284)
T ss_dssp             GEEEEEEEEEC----SSEEEEEEEETTTTEEEEEEEEEHHHHHHT-------TCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hceeeheecCC----CCeEEEEEEEcCCCcEEEEEEEcccccchH-------HHHHHHHHHHHHHhcCCCCCEeeEEEEE
Confidence            44455556666    899999999988999999998765443322       1234578899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+.+..|+||||+++++|.+++.. .+.+++..++.++.||+.||.|||++|++|          |||||+||+++.++.
T Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H----------~dl~p~Nil~~~~~~  152 (284)
T 2vgo_A           84 HDRKRIYLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIH----------RDIKPENLLMGYKGE  152 (284)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEEC----------CCCSGGGEEECTTCC
T ss_pred             EcCCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcee----------cCCCHHHEEEcCCCC
Confidence            999999999999999999999987 467999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      ++|+|||++.......   .....||+.|+|||++.+     ..++.++|+||||+++|+|++|..||...+..+....+
T Consensus       153 ~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  224 (284)
T 2vgo_A          153 LKIADFGWSVHAPSLR---RRTMCGTLDYLPPEMIEG-----KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI  224 (284)
T ss_dssp             EEECCCTTCEECSSSC---BCCCCSCGGGCCHHHHTT-----CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             EEEecccccccCcccc---cccccCCCCcCCHHHhcc-----CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHH
Confidence            9999999987654322   234678999999999983     56789999999999999999999999998888888777


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccccccCCCCC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPY  321 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~~~~~p~  321 (372)
                      ....  ..+|.    .++.++++||.+||. ||.+||++++++                 +||||+...    ++..||.
T Consensus       225 ~~~~--~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll-----------------~h~~~~~~~----~~~~p~~  277 (284)
T 2vgo_A          225 VNVD--LKFPP----FLSDGSKDLISKLLRYHPPQRLPLKGVM-----------------EHPWVKANS----RRVLPPV  277 (284)
T ss_dssp             HTTC--CCCCT----TSCHHHHHHHHHHSCSSGGGSCCHHHHH-----------------TCHHHHHHC----CCCCCCC
T ss_pred             hccc--cCCCC----cCCHHHHHHHHHHhhcCHhhCCCHHHHh-----------------hCHHHHhhc----cccCCCc
Confidence            7643  33444    689999999999999 999999866555                 999998432    3445554


Q ss_pred             cCC
Q psy11571        322 IPE  324 (372)
Q Consensus       322 ~p~  324 (372)
                      .+.
T Consensus       278 ~~~  280 (284)
T 2vgo_A          278 YQS  280 (284)
T ss_dssp             C--
T ss_pred             ccc
Confidence            443

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.6e-46  Score=352.72  Aligned_cols=245  Identities=28%  Similarity=0.453  Sum_probs=188.6

Q ss_pred             ccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCeEEEEEec
Q psy11571         16 IQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLHYAFQDDSNLYLVMDY   94 (372)
Q Consensus        16 ~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv~E~   94 (372)
                      .||+|.||++.+..+++.||+|.+....             ...+.+|+.+++.+. ||||+++++++.+....|+||||
T Consensus        21 ~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~   87 (325)
T 3kn6_A           21 EGSFSICRKCVHKKSNQAFAVKIISKRM-------------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMEL   87 (325)
T ss_dssp             EETTEEEEEEEETTTCCEEEEEEEEGGG-------------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cCCCeEEEEEEECCCCCEEEEEEEChhh-------------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEc
Confidence            3489999999999999999999875431             133567889999887 99999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC---cEEEeecCcc
Q psy11571         95 YCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG---HIRLADFGSC  171 (372)
Q Consensus        95 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~---~vkl~Dfg~a  171 (372)
                      ++||+|.+++.. ...+++..++.++.||+.||.|||++||+|          |||||+|||++.++   .+||+|||++
T Consensus        88 ~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH----------~Dlkp~NIll~~~~~~~~~kl~Dfg~a  156 (325)
T 3kn6_A           88 LNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVH----------RDLKPENLLFTDENDNLEIKIIDFGFA  156 (325)
T ss_dssp             CCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCCGGGEEEEC----CEEEECCCTTC
T ss_pred             cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCee----------cCCCHHHEEEecCCCcccEEEeccccc
Confidence            999999999988 578999999999999999999999999999          99999999997665   8999999999


Q ss_pred             cccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCC-------HHHHHHHHhh
Q psy11571        172 LRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES-------LVETYGKIMN  244 (372)
Q Consensus       172 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~-------~~~~~~~i~~  244 (372)
                      +....... .....+||+.|+|||++.+     ..++.++|||||||++|+|++|..||.+.+       ..+...++..
T Consensus       157 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~  230 (325)
T 3kn6_A          157 RLKPPDNQ-PLKTPCFTLHYAAPELLNQ-----NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK  230 (325)
T ss_dssp             EECCC----------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT
T ss_pred             eecCCCCC-cccccCCCcCccCHHHhcC-----CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc
Confidence            87654332 2234678999999999973     568999999999999999999999998643       3456666766


Q ss_pred             ccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        245 HQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      +..  .++...+..+++++++||.+||+ ||.+||++++++                 +||||++.
T Consensus       231 ~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell-----------------~h~w~~~~  277 (325)
T 3kn6_A          231 GDF--SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR-----------------YNEWLQDG  277 (325)
T ss_dssp             TCC--CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST-----------------TCGGGCTT
T ss_pred             CCC--CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHh-----------------cChhhccC
Confidence            443  33332233689999999999999 999999988877                 99999863

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2e-46  Score=351.53  Aligned_cols=247  Identities=25%  Similarity=0.440  Sum_probs=210.1

Q ss_pred             ccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         16 IQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        16 ~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      .||+|.||++....+++.||+|.+.......          .+.+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus        55 ~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  124 (321)
T 2c30_A           55 EGSTGIVCLAREKHSGRQVAVKMMDLRKQQR----------RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL  124 (321)
T ss_dssp             EETTEEEEEEEETTTCCEEEEEEEETTTCCS----------HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCCCeEEEEEEECCCCcEEEEEEEeccchhH----------HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecC
Confidence            3489999999988899999999876543221          244678999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccC
Q psy11571         96 CGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG  175 (372)
Q Consensus        96 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~  175 (372)
                      ++++|.+++..  ..+++..+..++.||+.||.|||+.|++|          |||||+||+++.++.+||+|||++....
T Consensus       125 ~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH----------~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  192 (321)
T 2c30_A          125 QGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIH----------RDIKSDSILLTLDGRVKLSDFGFCAQIS  192 (321)
T ss_dssp             CSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeec----------CCCCHHHEEECCCCcEEEeeeeeeeecc
Confidence            99999999875  67999999999999999999999999999          9999999999999999999999998765


Q ss_pred             CCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCC
Q psy11571        176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDV  255 (372)
Q Consensus       176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  255 (372)
                      .... ......||+.|+|||++.     ...++.++|||||||++|+|++|+.||.+.+..+....+...... ....  
T Consensus       193 ~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~--  263 (321)
T 2c30_A          193 KDVP-KRKSLVGTPYWMAPEVIS-----RSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP-KLKN--  263 (321)
T ss_dssp             SSSC-CBCCCCSCGGGCCHHHHT-----TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC-CCTT--
T ss_pred             cCcc-ccccccCCccccCHhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-CcCc--
Confidence            4322 223467999999999997     356889999999999999999999999998888887777654321 1111  


Q ss_pred             CCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCC
Q psy11571        256 GYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       256 ~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~  310 (372)
                      ...+++.+++||.+||+ ||++||++++++                 +||||....
T Consensus       264 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell-----------------~hp~~~~~~  302 (321)
T 2c30_A          264 SHKVSPVLRDFLERMLVRDPQERATAQELL-----------------DHPFLLQTG  302 (321)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHH-----------------TSGGGGGCC
T ss_pred             cccCCHHHHHHHHHHccCChhhCcCHHHHh-----------------cChhhccCC
Confidence            12579999999999999 999999866655                 999998654

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.7e-47  Score=354.88  Aligned_cols=257  Identities=25%  Similarity=0.446  Sum_probs=198.8

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhc-CCCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVY-GDRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~-l~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      |++|.||.+.+..+++.||+|.+......          ..+.+.+|+.++.+ ..||||+++++++.+.+.+|+||||+
T Consensus        24 G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   93 (316)
T 2ac3_A           24 GAHARVQTCINLITSQEYAVKIIEKQPGH----------IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKM   93 (316)
T ss_dssp             CSSEEEEEEECSSSCCEEEEEEEECCSSC----------CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CceEEEEEEEEcCCCcEEEEEEEeeCcch----------hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcC
Confidence            38999999999889999999988654321          12446779999987 47999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc---EEEeecCccc
Q psy11571         96 CGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH---IRLADFGSCL  172 (372)
Q Consensus        96 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~---vkl~Dfg~a~  172 (372)
                      ++|+|.+++.. ...+++..++.++.||+.||.|||++||+|          |||||+|||++.++.   +||+|||++.
T Consensus        94 ~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH----------~dlkp~Nil~~~~~~~~~~kl~Dfg~~~  162 (316)
T 2ac3_A           94 RGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAH----------RDLKPENILCEHPNQVSPVKICDFDLGS  162 (316)
T ss_dssp             TTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCC----------CCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred             CCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcee----------CCCCHHHEEEccCCCcCceEEEEccCcc
Confidence            99999999987 467999999999999999999999999999          999999999987765   9999999987


Q ss_pred             ccCCCCc------ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCC------------
Q psy11571        173 RLGGDGT------VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES------------  234 (372)
Q Consensus       173 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~------------  234 (372)
                      .......      ......+||+.|+|||++.+.......++.++|||||||++|+|++|+.||.+..            
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  242 (316)
T 2ac3_A          163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC  242 (316)
T ss_dssp             -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred             ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence            6532211      1112346999999999987321111347889999999999999999999998754            


Q ss_pred             ---HHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCC
Q psy11571        235 ---LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       235 ---~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~  310 (372)
                         .......+.....  .+|......+++++++||++||+ ||.+|||+++++                 +||||++..
T Consensus       243 ~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l-----------------~hp~~~~~~  303 (316)
T 2ac3_A          243 PACQNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL-----------------QHPWVQGCA  303 (316)
T ss_dssp             HHHHHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH-----------------HSTTCC---
T ss_pred             hhHHHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHh-----------------cChhhcCCC
Confidence               2345555655432  33322223689999999999999 999999876665                 999999887


Q ss_pred             ccc
Q psy11571        311 WDS  313 (372)
Q Consensus       311 w~~  313 (372)
                      |+.
T Consensus       304 ~~~  306 (316)
T 2ac3_A          304 PEN  306 (316)
T ss_dssp             ---
T ss_pred             Ccc
Confidence            653

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=4.4e-47  Score=377.21  Aligned_cols=267  Identities=27%  Similarity=0.434  Sum_probs=219.5

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhh---HHHHHHHHHHHHHHHHHHhcCCCCceeee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKT---VSDFIEFVAKLREERDVLVYGDRRWITNL   78 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~---~~~~~~~~~~l~~E~~il~~l~hp~Iv~l   78 (372)
                      ++|+.++.+|.|    |+|.||++.+..+++.+|+|.+..........   ........+.+.+|+.+++.++||||+++
T Consensus        36 ~~Y~~~~~lG~G----~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  111 (504)
T 3q5i_A           36 ESYFKVRKLGSG----AYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL  111 (504)
T ss_dssp             GTEEEEEEEEC------CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             cceEEEeEeccc----CCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            356667777777    89999999999999999999987665432210   01111234668899999999999999999


Q ss_pred             eEEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC
Q psy11571         79 HYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD  158 (372)
Q Consensus        79 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~  158 (372)
                      ++++.+...+|+|||||+||+|.+++.. ...+++..++.++.||+.||.|||++||+|          |||||+|||++
T Consensus       112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH----------~Dlkp~Nil~~  180 (504)
T 3q5i_A          112 FDVFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHNIVH----------RDIKPENILLE  180 (504)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSGGGEEES
T ss_pred             EEEEEcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEe----------CCCcHHHEEEe
Confidence            9999999999999999999999999987 478999999999999999999999999999          99999999998


Q ss_pred             CCC---cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCH
Q psy11571        159 ANG---HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL  235 (372)
Q Consensus       159 ~~~---~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~  235 (372)
                      .++   .+||+|||++........  ....+||+.|+|||++.      +.++.++|||||||++|+|++|.+||.+.+.
T Consensus       181 ~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  252 (504)
T 3q5i_A          181 NKNSLLNIKIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK------KKYNEKCDVWSCGVIMYILLCGYPPFGGQND  252 (504)
T ss_dssp             STTCCSSEEECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT------TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cCCCCccEEEEECCCCEEcCCCCc--cccccCCcCCCCHHHhc------cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            776   699999999987654432  23467999999999986      3589999999999999999999999999999


Q ss_pred             HHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCC
Q psy11571        236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       236 ~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~  310 (372)
                      .+.+..+..+...+..+  .+..+|+++++||++||+ ||.+|||+++++                 +||||+...
T Consensus       253 ~~~~~~i~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l-----------------~h~~~~~~~  309 (504)
T 3q5i_A          253 QDIIKKVEKGKYYFDFN--DWKNISDEAKELIKLMLTYDYNKRCTAEEAL-----------------NSRWIKKYA  309 (504)
T ss_dssp             HHHHHHHHHCCCCCCHH--HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHH-----------------TSHHHHHTC
T ss_pred             HHHHHHHHcCCCCCCcc--ccCCCCHHHHHHHHHHcCCChhHCCCHHHHh-----------------cCHhhhhch
Confidence            99999988765433222  223689999999999999 999999876665                 999998653

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=7.9e-47  Score=346.08  Aligned_cols=254  Identities=30%  Similarity=0.479  Sum_probs=216.3

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+..+.+|.|    |+|.||.+.+..++..+|+|.+.......          .+.+.+|+.+++.++||||+++++++
T Consensus        10 ~y~~~~~lg~G----~~g~V~~~~~~~~~~~~a~k~~~~~~~~~----------~~~~~~E~~~l~~l~h~~i~~~~~~~   75 (277)
T 3f3z_A           10 YYTLENTIGRG----SWGEVKIAVQKGTRIRRAAKKIPKYFVED----------VDRFKQEIEIMKSLDHPNIIRLYETF   75 (277)
T ss_dssp             HEEEEEEEEEE----TTEEEEEEEETTTCCEEEEEEEEGGGCSC----------HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hEEeeeEEeec----CCEEEEEEEeCCCCcEEEEEeehhhccch----------HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            45556666666    89999999998899999999876543322          24577899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe---CC
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL---DA  159 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll---~~  159 (372)
                      .+....|+||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++|          |||||+||++   +.
T Consensus        76 ~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H----------~dlkp~Nil~~~~~~  144 (277)
T 3f3z_A           76 EDNTDIYLVMELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAH----------RDLKPENFLFLTDSP  144 (277)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEESSSST
T ss_pred             ecCCeEEEEEeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccC----------CCCCHHHEEEecCCC
Confidence            999999999999999999999987 477999999999999999999999999999          9999999999   78


Q ss_pred             CCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHH
Q psy11571        160 NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY  239 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~  239 (372)
                      ++.++|+|||++........  .....||+.|+|||++.      +.++.++||||||+++|+|++|..||.+.+..+..
T Consensus       145 ~~~~~l~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~  216 (277)
T 3f3z_A          145 DSPLKLIDFGLAARFKPGKM--MRTKVGTPYYVSPQVLE------GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM  216 (277)
T ss_dssp             TCCEEECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT------TCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             CCcEEEEecccceeccCccc--hhccCCCCCccChHHhc------ccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence            88999999999987654332  23357999999999986      34899999999999999999999999999988888


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      .++......  .+......+++++.+||.+||+ ||++||++.+++                 +||||++
T Consensus       217 ~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l-----------------~h~~~~~  267 (277)
T 3f3z_A          217 LKIREGTFT--FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQAL-----------------EHEWFEK  267 (277)
T ss_dssp             HHHHHCCCC--CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHT-----------------TSHHHHH
T ss_pred             HHHHhCCCC--CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHh-----------------cCHHHhc
Confidence            888775433  3332223679999999999999 999999866555                 9999974

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2e-47  Score=360.94  Aligned_cols=270  Identities=26%  Similarity=0.401  Sum_probs=216.5

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      .+|+.++.+|.|    |+|.||.+.+..+++.||+|.+........     .....+.+.+|+.+++.++||||++++++
T Consensus        26 ~~y~~~~~lG~G----~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~~~~~   96 (345)
T 3hko_A           26 KKYHLKGAIGQG----SYGVVRVAIENQTRAIRAIKIMNKNKIRQI-----NPKDVERIKTEVRLMKKLHHPNIARLYEV   96 (345)
T ss_dssp             HHEEEEEEEEEC----SSCEEEEEEETTTCCEEEEEEEEHHHHHC--------CHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hheeecceeeec----CCeEEEEEEECCCCceEEEeehhhhhhccc-----CHHHHHHHHHHHHHHHhCCCCCcceeehh
Confidence            355566666666    899999999999999999998765443211     01234668889999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhc---------------------------------------CCCCCHHHHHHHHHH
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKF---------------------------------------EDRLPEDMAKFYIAE  122 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~---------------------------------------~~~l~~~~~~~~~~q  122 (372)
                      +.+.+..++|||||+||+|.+++...                                       ...+++..++.++.|
T Consensus        97 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q  176 (345)
T 3hko_A           97 YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ  176 (345)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHH
T ss_pred             hccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHH
Confidence            99999999999999999999998521                                       112367889999999


Q ss_pred             HHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC--cEEEeecCcccccCC---CCcccccccccCCcccCcccc
Q psy11571        123 MVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG--HIRLADFGSCLRLGG---DGTVQSNVAVGTPDYISPEIL  197 (372)
Q Consensus       123 i~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~--~vkl~Dfg~a~~~~~---~~~~~~~~~~gt~~y~aPE~~  197 (372)
                      |+.||.|||++||+|          |||||+||+++.++  .+||+|||++.....   ..........||+.|+|||++
T Consensus       177 i~~~l~~LH~~~ivH----------~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  246 (345)
T 3hko_A          177 IFSALHYLHNQGICH----------RDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVL  246 (345)
T ss_dssp             HHHHHHHHHHTTEEC----------CCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHH
T ss_pred             HHHHHHHHHHCCccc----------cCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhh
Confidence            999999999999999          99999999998776  899999999986532   111123346799999999999


Q ss_pred             cccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCC
Q psy11571        198 TAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDT  276 (372)
Q Consensus       198 ~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~  276 (372)
                      .+.   ...++.++|||||||++|+|++|+.||.+.+..+...++......+..+.  ...+++++++||.+||+ ||.+
T Consensus       247 ~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~  321 (345)
T 3hko_A          247 NTT---NESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPN--YNVLSPLARDLLSNLLNRNVDE  321 (345)
T ss_dssp             TCS---SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGG--GGGSCHHHHHHHHHHSCSCTTT
T ss_pred             ccC---CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcc--cccCCHHHHHHHHHHcCCChhH
Confidence            731   25688999999999999999999999999999888888887654443322  23579999999999999 9999


Q ss_pred             CCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcc
Q psy11571        277 RLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWD  312 (372)
Q Consensus       277 R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~  312 (372)
                      ||++.+++                 +||||+++.|.
T Consensus       322 Rps~~~~l-----------------~hp~~~~~~~~  340 (345)
T 3hko_A          322 RFDAMRAL-----------------QHPWISQFSDK  340 (345)
T ss_dssp             SCCHHHHH-----------------HSHHHHTTSSC
T ss_pred             CCCHHHHh-----------------cChhhccChHh
Confidence            99866555                 99999988764

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.6e-46  Score=356.14  Aligned_cols=257  Identities=21%  Similarity=0.324  Sum_probs=214.9

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+.++.+|.|    |+|.||++.+..+++.||+|.+........       +..+.+.+|+.+++.++||||+++++++.
T Consensus        56 y~~~~~lG~G----~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~~~E~~~l~~l~hpniv~~~~~~~  124 (348)
T 1u5q_A           56 FSDLREIGHG----SFGAVYFARDVRNSEVVAIKKMSYSGKQSN-------EKWQDIIKEVRFLQKLRHPNTIQYRGCYL  124 (348)
T ss_dssp             EEEEEEEEEC----SSEEEEEEEETTTTEEEEEEEEESCSSCHH-------HHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             eeeeeEEccC----CCEEEEEEEEccCCeEEEEEEEccccccch-------HHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            4445556666    899999999989999999998875543322       23456788999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcE
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI  163 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~v  163 (372)
                      +++..|+||||+. |+|.+++......+++..+..++.|++.||.|||++||+|          |||||+|||++.++.+
T Consensus       125 ~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH----------~Dlkp~NIll~~~~~~  193 (348)
T 1u5q_A          125 REHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH----------RDVKAGNILLSEPGLV  193 (348)
T ss_dssp             ETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBC----------CCCSGGGEEEETTTEE
T ss_pred             ECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeee----------CCCCHHHEEECCCCCE
Confidence            9999999999996 6898888765678999999999999999999999999999          9999999999999999


Q ss_pred             EEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHh
Q psy11571        164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM  243 (372)
Q Consensus       164 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~  243 (372)
                      ||+|||++......     ....||+.|+|||++.+..  ...++.++|||||||++|||++|.+||.+.+..+....+.
T Consensus       194 kL~DfG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~--~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~  266 (348)
T 1u5q_A          194 KLGDFGSASIMAPA-----NSFVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA  266 (348)
T ss_dssp             EECCCTTCBSSSSB-----CCCCSCGGGCCHHHHHTTS--SCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred             EEeeccCceecCCC-----CcccCCcceeCHhhhcccc--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            99999999765432     2357999999999985321  3568899999999999999999999999988877777776


Q ss_pred             hccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCC
Q psy11571        244 NHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~  310 (372)
                      ........    ...+++.+++||.+||+ ||++|||+++++                 +||||....
T Consensus       267 ~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll-----------------~h~~~~~~~  313 (348)
T 1u5q_A          267 QNESPALQ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLL-----------------KHRFVLRER  313 (348)
T ss_dssp             HSCCCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHT-----------------TCHHHHSCC
T ss_pred             hcCCCCCC----CCCCCHHHHHHHHHHcccChhhCcCHHHHh-----------------hChhhhccC
Confidence            65432222    22689999999999999 999999866655                 999997543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.1e-46  Score=348.92  Aligned_cols=255  Identities=27%  Similarity=0.390  Sum_probs=207.6

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      +||+.++.+|.|    |+|.||.+.+..+++.||+|.+........       +..+.+.+|+.+++.++||||++++++
T Consensus        11 ~~y~i~~~lg~G----~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~~~e~~~l~~l~hp~iv~~~~~   79 (294)
T 4eqm_A           11 ERYKIVDKLGGG----GMSTVYLAEDTILNIKVAIKAIFIPPREKE-------ETLKRFEREVHNSSQLSHQNIVSMIDV   79 (294)
T ss_dssp             TTEEEEEEEEEE----TTEEEEEEEETTTCSEEEEEEEECCSSCCH-------HHHHHHHHHHHHHTTCCBTTBCCEEEE
T ss_pred             ccEEEEEEEccC----CCEEEEEEEECCCCCeEEEEEeccCccccH-------HHHHHHHHHHHHHhcCCCCCCceEEEe
Confidence            467777777777    899999999999999999998865443332       245668899999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+.+.+|+||||++|++|.+++.. .+.+++..++.++.|++.||.|||++|++|          |||||+||+++.++
T Consensus        80 ~~~~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H----------~Dlkp~Nil~~~~~  148 (294)
T 4eqm_A           80 DEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRIVH----------RDIKPQNILIDSNK  148 (294)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCC----------CCCCGGGEEECTTS
T ss_pred             eeeCCeEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------CCCCHHHEEECCCC
Confidence            9999999999999999999999987 468999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .+||+|||++...............||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.+.+..+...+
T Consensus       149 ~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  223 (294)
T 4eqm_A          149 TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG-----EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK  223 (294)
T ss_dssp             CEEECCCSSSTTC-------------CCSSCCHHHHHT-----CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHH
T ss_pred             CEEEEeCCCccccccccccccCccccCccccCHhHhcC-----CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            99999999998765444334445679999999999983     5688999999999999999999999999888776665


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCC-CCChh
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLG-QNGIA  284 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s-~~~~~  284 (372)
                      ....... ..+......+++.+.++|.+||. ||++||+ ++++.
T Consensus       224 ~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~  267 (294)
T 4eqm_A          224 HIQDSVP-NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMK  267 (294)
T ss_dssp             HHSSCCC-CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHH
T ss_pred             HhhccCC-CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHH
Confidence            5543221 11122233689999999999999 9999995 44443

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9e-47  Score=357.36  Aligned_cols=271  Identities=24%  Similarity=0.290  Sum_probs=215.1

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      .+|+.++.+|.|    |+|.||.+.+..+++.||+|.+.........     ....+.+.+|+.+++.++||||++++++
T Consensus        10 ~~y~~~~~lg~G----~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~   80 (346)
T 1ua2_A           10 KRYEKLDFLGEG----QFATVYKARDKNTNQIVAIKKIKLGHRSEAK-----DGINRTALREIKLLQELSHPNIIGLLDA   80 (346)
T ss_dssp             ---CEEEEEEEE----TTEEEEEEECSSCCSEEEEEEC-----------------CTHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEEEeEEeec----CCEEEEEEEECCCCcEEEEEEEecCCcchhh-----hhhhHHHHHHHHHHhhCCCCCCCeEEEE
Confidence            356667777776    8999999999889999999988654332211     1122457789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+.+..++||||+.+ +|.+++......+++..++.++.|++.||.|||++||+|          |||||+|||++.++
T Consensus        81 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH----------~Dlkp~Nil~~~~~  149 (346)
T 1ua2_A           81 FGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH----------RDLKPNNLLLDENG  149 (346)
T ss_dssp             ECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCC----------CCCCGGGEEECTTC
T ss_pred             EeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEEC----------CCCCHHHEEEcCCC
Confidence            9999999999999965 999999875567999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .+||+|||+++....... ......||+.|+|||++.+    ...++.++|||||||++|+|++|.+||.+.+..+.+.+
T Consensus       150 ~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~  224 (346)
T 1ua2_A          150 VLKLADFGLAKSFGSPNR-AYTHQVVTRWYRAPELLFG----ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR  224 (346)
T ss_dssp             CEEECCCGGGSTTTSCCC-CCCCSCCCCTTCCHHHHTT----CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             CEEEEecccceeccCCcc-cCCcccccccccCchHhhC----CCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            999999999987654332 2234578999999999973    34588999999999999999999999999998888877


Q ss_pred             HhhccCCcC---CCCC-------------------CCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCC
Q psy11571        242 IMNHQNSFD---LPSD-------------------VGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSI  298 (372)
Q Consensus       242 i~~~~~~~~---~~~~-------------------~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~  298 (372)
                      +........   ++..                   ....+++++++||++||+ ||++|||+++++              
T Consensus       225 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell--------------  290 (346)
T 1ua2_A          225 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL--------------  290 (346)
T ss_dssp             HHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH--------------
T ss_pred             HHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHh--------------
Confidence            765322111   0000                   013568999999999999 999999876665              


Q ss_pred             CCCCCCCcCCCCcccc
Q psy11571        299 SPRNHPWFQGIAWDSI  314 (372)
Q Consensus       299 ~~~~hp~f~~~~w~~~  314 (372)
                         +||||++..|...
T Consensus       291 ---~h~~f~~~~~~~~  303 (346)
T 1ua2_A          291 ---KMKYFSNRPGPTP  303 (346)
T ss_dssp             ---TSGGGTSSSCCCC
T ss_pred             ---cChhhhcCCCCCC
Confidence               9999998766543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.5e-47  Score=346.41  Aligned_cols=257  Identities=27%  Similarity=0.454  Sum_probs=191.2

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+..+.++.|    ++|.||.+.+..+++.||+|.+........       ...+.+.+|+.+++.++||||+++++++
T Consensus        12 ~y~~~~~lg~G----~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~   80 (278)
T 3cok_A           12 DFKVGNLLGKG----SFAGVYRAESIHTGLEVAIKMIDKKAMYKA-------GMVQRVQNEVKIHCQLKHPSILELYNYF   80 (278)
T ss_dssp             GEEEEEEEEEC----SSEEEEEEEETTTCCEEEEEEEEHHHHHHT-------TCHHHHHHHHHHHTTBCCTTBCCEEEEE
T ss_pred             cceeeeeecCC----CceEEEEEEEccCCceEEEEEeehhhhhhh-------hHHHHHHHHHHHHHhCCCCCeEeEEEEE
Confidence            34455556665    899999999988999999998865433222       2345678899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+.+..|+||||+++++|.+++......+++..++.++.|++.||.|||++|++|          |||||+||+++.++.
T Consensus        81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H----------~dl~p~Nili~~~~~  150 (278)
T 3cok_A           81 EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILH----------RDLTLSNLLLTRNMN  150 (278)
T ss_dssp             ECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SSCCGGGEEECTTCC
T ss_pred             ccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeec----------CCCCHHHEEEcCCCC
Confidence            9999999999999999999999875567999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||++........ ......||+.|+|||++.+     ..++.++|+||||+++|+|++|+.||...+..+...++
T Consensus       151 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  224 (278)
T 3cok_A          151 IKIADFGLATQLKMPHE-KHYTLCGTPNYISPEIATR-----SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV  224 (278)
T ss_dssp             EEECCCTTCEECC----------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C
T ss_pred             EEEEeecceeeccCCCC-cceeccCCCCcCCcchhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH
Confidence            99999999987653322 2233578999999999973     56788999999999999999999999887665555554


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      ....  ...|.    .++.++++||.+||+ ||++||++++++                 .||||...
T Consensus       225 ~~~~--~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l-----------------~h~~~~~~  269 (278)
T 3cok_A          225 VLAD--YEMPS----FLSIEAKDLIHQLLRRNPADRLSLSSVL-----------------DHPFMSRN  269 (278)
T ss_dssp             CSSC--CCCCT----TSCHHHHHHHHHHSCSSGGGSCCHHHHT-----------------TSTTTC--
T ss_pred             hhcc--cCCcc----ccCHHHHHHHHHHcccCHhhCCCHHHHh-----------------cCccccCC
Confidence            4322  23333    689999999999999 999999866555                 99999864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-46  Score=349.03  Aligned_cols=264  Identities=22%  Similarity=0.287  Sum_probs=206.6

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhc---CCCCceeee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVY---GDRRWITNL   78 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~---l~hp~Iv~l   78 (372)
                      +||+.++.+|.|    |+|.||++.+..+++.||+|.+...........     ....+.+|+.+++.   ++||||+++
T Consensus         9 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~h~niv~~   79 (308)
T 3g33_A            9 SRYEPVAEIGVG----AYGTVYKARDPHSGHFVALKSVRVPNGGGGGGG-----LPISTVREVALLRRLEAFEHPNVVRL   79 (308)
T ss_dssp             -CCEEEEEECCS----SSCCEEEEECTTTCCEEEEEEEEEECCCTTSSC-----CCHHHHHHHHHHHHHHHHCCTTBCCE
T ss_pred             cceEEEEEEecC----CCeEEEEEEECCCCcEEEEEEEecccccccccc-----cchhHHHHHHHHHHHhhcCCCCeEEe
Confidence            466677777777    899999999999999999998865432211000     00123345555544   469999999


Q ss_pred             eEEEEeCC-----eEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCc
Q psy11571         79 HYAFQDDS-----NLYLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKP  152 (372)
Q Consensus        79 ~~~~~~~~-----~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp  152 (372)
                      ++++.+..     .+++||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+|          |||||
T Consensus        80 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH----------~Dlkp  148 (308)
T 3g33_A           80 MDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVH----------RDLKP  148 (308)
T ss_dssp             EEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCCT
T ss_pred             eeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------CCCCH
Confidence            99998765     5899999995 69999998742 23999999999999999999999999999          99999


Q ss_pred             CcEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCC
Q psy11571        153 DNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA  232 (372)
Q Consensus       153 ~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~  232 (372)
                      +|||++.++.+||+|||+++.......  .....||+.|+|||++.+     ..++.++|||||||++|+|++|++||.+
T Consensus       149 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~  221 (308)
T 3g33_A          149 ENILVTSGGTVKLADFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQ-----STYATPVDMWSVGCIFAEMFRRKPLFCG  221 (308)
T ss_dssp             TTEEECTTSCEEECSCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHT-----SCCCSTHHHHHHHHHHHHTTTSSCSCCC
T ss_pred             HHEEEcCCCCEEEeeCccccccCCCcc--cCCccccccccCchHHcC-----CCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999987654332  234679999999999983     5689999999999999999999999999


Q ss_pred             CCHHHHHHHHhhccCCcCC---CCC------------------CCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhh
Q psy11571        233 ESLVETYGKIMNHQNSFDL---PSD------------------VGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWS  290 (372)
Q Consensus       233 ~~~~~~~~~i~~~~~~~~~---~~~------------------~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~  290 (372)
                      .+..+...++.........   +..                  ....+++++.+||.+||+ ||++|||+.+++      
T Consensus       222 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l------  295 (308)
T 3g33_A          222 NSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL------  295 (308)
T ss_dssp             SSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHH------
T ss_pred             CCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHh------
Confidence            9988888777653221110   000                  012578999999999999 999999876665      


Q ss_pred             hhhhccCCCCCCCCCcCCC
Q psy11571        291 ALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       291 ~~~~~~~~~~~~hp~f~~~  309 (372)
                                 +||||+..
T Consensus       296 -----------~h~~~~~~  303 (308)
T 3g33_A          296 -----------QHSYLHKD  303 (308)
T ss_dssp             -----------TSTTC---
T ss_pred             -----------cCccccCC
Confidence                       99999864

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.3e-46  Score=354.94  Aligned_cols=264  Identities=23%  Similarity=0.279  Sum_probs=213.7

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||.+.+..+++.||+|.+........        ....+.+|+.+++.++||||+++++++
T Consensus        18 ~y~~~~~lg~G----~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~iv~~~~~~   85 (351)
T 3mi9_A           18 KYEKLAKIGQG----TFGEVFKARHRKTGQKVALKKVLMENEKEG--------FPITALREIKILQLLKHENVVNLIEIC   85 (351)
T ss_dssp             GEEEEEECSSC----STTSEEEEEETTTCCEEEEEECCCSSCSSS--------SCHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ceeEEEEEecC----CCcEEEEEEECCCCCEEEEEEEeccccccc--------chHHHHHHHHHHHhccCCCcccHhhee
Confidence            56666777777    899999999999999999998865543322        123356799999999999999999999


Q ss_pred             Ee--------CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCc
Q psy11571         83 QD--------DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDN  154 (372)
Q Consensus        83 ~~--------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~N  154 (372)
                      .+        .+.+|+||||+. ++|.+.+......+++..++.++.||+.||.|||++||+|          |||||+|
T Consensus        86 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH----------~Dlkp~N  154 (351)
T 3mi9_A           86 RTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILH----------RDMKAAN  154 (351)
T ss_dssp             EEC--------CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGG
T ss_pred             eccccccccCCceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeC----------CCCCHHH
Confidence            87        346899999996 5888888775678999999999999999999999999999          9999999


Q ss_pred             EEeCCCCcEEEeecCcccccCCCC---cccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCC
Q psy11571        155 VLLDANGHIRLADFGSCLRLGGDG---TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY  231 (372)
Q Consensus       155 Ill~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~  231 (372)
                      ||++.++.+||+|||+++......   ........||+.|+|||++.+    ...++.++|||||||++|+|++|.+||.
T Consensus       155 Il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~  230 (351)
T 3mi9_A          155 VLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG----ERDYGPPIDLWGAGCIMAEMWTRSPIMQ  230 (351)
T ss_dssp             EEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTT----CCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             EEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcC----CCCCCcHhHHHHHHHHHHHHHhCCCCCC
Confidence            999999999999999998764221   112234578999999999974    4568999999999999999999999999


Q ss_pred             CCCHHHHHHHHhhccCCcCCCCCCCCC----------------------------CCHHHHHHHHHhcc-CCCCCCCCCC
Q psy11571        232 AESLVETYGKIMNHQNSFDLPSDVGYE----------------------------ISDDAKDLMRRLIC-SSDTRLGQNG  282 (372)
Q Consensus       232 ~~~~~~~~~~i~~~~~~~~~~~~~~~~----------------------------~s~~~~~li~~lL~-~p~~R~s~~~  282 (372)
                      +.+.......+......+...  .+..                            .++++++||.+||+ ||++|||+++
T Consensus       231 ~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  308 (351)
T 3mi9_A          231 GNTEQHQLALISQLCGSITPE--VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD  308 (351)
T ss_dssp             CSSHHHHHHHHHHHHCCCCTT--TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             CCChHHHHHHHHHHhCCCChh--hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHH
Confidence            998888777765533222111  1001                            27889999999999 9999998766


Q ss_pred             hhhhhhhhhhhhccCCCCCCCCCcCCCCcc
Q psy11571        283 IADFKMWSALFVSLSISPRNHPWFQGIAWD  312 (372)
Q Consensus       283 ~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~  312 (372)
                      ++                 +||||.+..+.
T Consensus       309 ~l-----------------~hp~f~~~~~~  321 (351)
T 3mi9_A          309 AL-----------------NHDFFWSDPMP  321 (351)
T ss_dssp             HH-----------------TSGGGGSSSCC
T ss_pred             Hh-----------------CCCCcCCCCCc
Confidence            65                 99999876554

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.1e-46  Score=345.59  Aligned_cols=254  Identities=28%  Similarity=0.477  Sum_probs=214.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||.+.+..++..||+|.+........       .....+.+|+.+++.++||||+++++++
T Consensus        10 ~y~~~~~lg~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~   78 (279)
T 3fdn_A           10 DFEIGRPLGKG----KFGNVYLAREKQSKFILALKVLFKAQLEKA-------GVEHQLRREVEIQSHLRHPNILRLYGYF   78 (279)
T ss_dssp             GEEEEEEEEEC----SSEEEEEEEETTTCCEEEEEEEEHHHHHHH-------TCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cEEEeeEEecC----CCeEEEEEEEccCCcEEEEEEEeccccchh-------hHHHHHHHHHHHHHcCCCCCCcchhheE
Confidence            45566667776    899999999999999999998765443322       1235578899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+....++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.|++|          |||||+||+++.++.
T Consensus        79 ~~~~~~~lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H----------~dlkp~Nili~~~~~  147 (279)
T 3fdn_A           79 HDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIH----------RDIKPENLLLGSAGE  147 (279)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTCEE----------CCCCGGGEEECTTSC
T ss_pred             ecCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEec----------ccCChHhEEEcCCCC
Confidence            999999999999999999999987 467999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      ++|+|||++.......   .....||+.|+|||++.+     ..++.++||||||+++|+|++|..||...+..+....+
T Consensus       148 ~~l~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  219 (279)
T 3fdn_A          148 LKIADFGWSVHAPSSR---RTDLCGTLDYLPPEMIEG-----RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI  219 (279)
T ss_dssp             EEECSCCEESCC-----------CCCCTTCCHHHHTT-----CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             EEEEeccccccCCccc---ccccCCCCCccCHhHhcc-----CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH
Confidence            9999999986554322   233578999999999973     56789999999999999999999999999988888887


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      ....  ..+|.    .+++++++||.+||+ ||.+||++++++                 +||||++.
T Consensus       220 ~~~~--~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l-----------------~h~~~~~~  264 (279)
T 3fdn_A          220 SRVE--FTFPD----FVTEGARDLISRLLKHNPSQRPMLREVL-----------------EHPWITAN  264 (279)
T ss_dssp             HHTC--CCCCT----TSCHHHHHHHHHHCCSSGGGSCCHHHHH-----------------HCHHHHHH
T ss_pred             HhCC--CCCCC----cCCHHHHHHHHHHhccChhhCCCHHHHh-----------------hCccccCC
Confidence            7643  33344    689999999999999 999999866555                 99999863

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.5e-46  Score=369.47  Aligned_cols=257  Identities=20%  Similarity=0.340  Sum_probs=203.5

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      +||+.++.+|.|    |+|.||.+.+..+++.||+|.+.......        ...+++.+|+.+++.++||||++++++
T Consensus        62 ~~y~~~~~lG~G----~~g~V~~a~~~~~~~~vAiK~~~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~l~~~  129 (464)
T 3ttj_A           62 KRYQNLKPIGSG----AQGIVCAAYDAVLDRNVAIKKLSRPFQNQ--------THAKRAYRELVLMKCVNHKNIISLLNV  129 (464)
T ss_dssp             TTEEEEEEEEEC----SSCEEEEEEETTTTEEEEEEEEESGGGSH--------HHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             CCeEEEEEeecC----CCeEEEEEEECCCCCEEEEEEECccccCh--------HHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            356666777777    89999999999999999999887643222        234567889999999999999999999


Q ss_pred             EEeC------CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcE
Q psy11571         82 FQDD------SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNV  155 (372)
Q Consensus        82 ~~~~------~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NI  155 (372)
                      +...      ..+|+||||+.+ +|.+.+.   ..+++..++.++.||+.||.|||++||+|          |||||+||
T Consensus       130 ~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiH----------rDlkp~NI  195 (464)
T 3ttj_A          130 FTPQKTLEEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIH----------RDLKPSNI  195 (464)
T ss_dssp             ECSCCSTTTCCEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------CCCCGGGE
T ss_pred             EccCCccccCCeEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCccc----------CCCChHhE
Confidence            9755      467999999965 6777774   35999999999999999999999999999          99999999


Q ss_pred             EeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCH
Q psy11571        156 LLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL  235 (372)
Q Consensus       156 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~  235 (372)
                      |++.++.+||+|||+++.......  ....+||+.|+|||++.+     ..++.++|||||||++|||++|++||.+.+.
T Consensus       196 ll~~~~~~kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ell~g~~pF~g~~~  268 (464)
T 3ttj_A          196 VVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMVRHKILFPGRDY  268 (464)
T ss_dssp             EECTTSCEEECCCCCC-----CCC--C----CCCTTCCHHHHTT-----CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EEeCCCCEEEEEEEeeeecCCCcc--cCCCcccccccCHHHHcC-----CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999999999999987654322  234689999999999984     5689999999999999999999999999998


Q ss_pred             HHHHHHHhhccCCcC-------------------------CCCCCCC-----------CCCHHHHHHHHHhcc-CCCCCC
Q psy11571        236 VETYGKIMNHQNSFD-------------------------LPSDVGY-----------EISDDAKDLMRRLIC-SSDTRL  278 (372)
Q Consensus       236 ~~~~~~i~~~~~~~~-------------------------~~~~~~~-----------~~s~~~~~li~~lL~-~p~~R~  278 (372)
                      .+.+.+|......+.                         ++.....           ..++++++||++||+ ||++||
T Consensus       269 ~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~  348 (464)
T 3ttj_A          269 IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI  348 (464)
T ss_dssp             HHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSC
T ss_pred             HHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCC
Confidence            888777765322110                         0000000           015689999999999 999999


Q ss_pred             CCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        279 GQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       279 s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      |+++++                 +||||+.
T Consensus       349 ta~e~L-----------------~Hp~~~~  361 (464)
T 3ttj_A          349 SVDDAL-----------------QHPYINV  361 (464)
T ss_dssp             CHHHHH-----------------TSTTTGG
T ss_pred             CHHHHh-----------------cChhhhh
Confidence            876665                 9999984

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4e-46  Score=347.77  Aligned_cols=252  Identities=24%  Similarity=0.384  Sum_probs=200.5

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||++.+..+++.||+|.+........       ...+.+.++..+.....||||+++++++
T Consensus        58 ~y~~~~~LG~G----~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~e~~~~~~~~~h~~iv~l~~~~  126 (311)
T 3p1a_A           58 SFQRLSRLGHG----SYGEVFKVRSKEDGRLYAVKRSMSPFRGPK-------DRARKLAEVGSHEKVGQHPCCVRLEQAW  126 (311)
T ss_dssp             HEEEEEEEEEE----TTEEEEEEEETTTSCEEEEEEESSSCCSHH-------HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             heeeeheeccC----CCeEEEEEEECCCCeEEEEEEecccccChH-------HHHHHHHHHHHHHHhcCCCcEEEEEEEE
Confidence            45556667776    899999999999999999998655433222       1222334444445566999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+.+.+|+||||+ +++|.+++......+++..++.++.||+.||.|||+.||+|          |||||+|||++.++.
T Consensus       127 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH----------~Dikp~NIll~~~~~  195 (311)
T 3p1a_A          127 EEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVH----------LDVKPANIFLGPRGR  195 (311)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEECGGGC
T ss_pred             EeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEec----------CCCCHHHEEECCCCC
Confidence            9999999999999 77999999876677999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||++........  .....||+.|+|||++.      +.++.++|||||||++|||++|..||.+..   ....+
T Consensus       196 ~kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~  264 (311)
T 3p1a_A          196 CKLGDFGLLVELGTAGA--GEVQEGDPRYMAPELLQ------GSYGTAADVFSLGLTILEVACNMELPHGGE---GWQQL  264 (311)
T ss_dssp             EEECCCTTCEECC--------CCCCCGGGCCGGGGG------TCCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHH
T ss_pred             EEEccceeeeecccCCC--CcccCCCccccCHhHhc------CCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHH
Confidence            99999999987654332  23357999999999987      358999999999999999999977775543   23344


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      ........++.    .+++++.+||.+||+ ||++||++++++                 +||||+.
T Consensus       265 ~~~~~~~~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~ell-----------------~hp~~~~  310 (311)
T 3p1a_A          265 RQGYLPPEFTA----GLSSELRSVLVMMLEPDPKLRATAEALL-----------------ALPVLRQ  310 (311)
T ss_dssp             TTTCCCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHH-----------------TSGGGSC
T ss_pred             hccCCCccccc----CCCHHHHHHHHHHcCCChhhCcCHHHHH-----------------hCccccC
Confidence            43322222222    689999999999999 999999876665                 9999974

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.3e-46  Score=348.69  Aligned_cols=267  Identities=23%  Similarity=0.338  Sum_probs=215.4

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    |+|.||.+.+..+++.+|+|.+......          ..+.+.+|+.+++.++||||++++++
T Consensus        19 ~~y~i~~~lg~G----~~g~V~~~~~~~~~~~~aiK~~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (302)
T 2j7t_A           19 EVWEIVGELGDG----AFGKVYKAKNKETGALAAAKVIETKSEE----------ELEDYIVEIEILATCDHPYIVKLLGA   84 (302)
T ss_dssp             GTEEEEEEEECS----TTCCEEEEEETTTCCEEEEEEEC----C----------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cceeecceeccC----CCeEEEEEEEcCCCcEEEEEEecCCCHH----------HHHHHHHHHHHHhcCCCCCEeeeeee
Confidence            456666777776    8999999999889999999987654321          23457789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+.+.+++||||+++++|.+++......+++..++.++.||+.||.|||+.|++|          |||||+||+++.++
T Consensus        85 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H----------~dlkp~Nil~~~~~  154 (302)
T 2j7t_A           85 YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIH----------RDLKAGNVLMTLEG  154 (302)
T ss_dssp             EECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------CCCSGGGEEECTTS
T ss_pred             eeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCccc----------CCCCHHHEEECCCC
Confidence            99999999999999999999998875678999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .+||+|||++....... .......||+.|+|||++.........++.++|||||||++|+|++|..||...+.......
T Consensus       155 ~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  233 (302)
T 2j7t_A          155 DIRLADFGVSAKNLKTL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK  233 (302)
T ss_dssp             CEEECCCHHHHHHHHHH-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred             CEEEEECCCCccccccc-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH
Confidence            99999999875432111 11223578999999999853221245688999999999999999999999999888877777


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccc
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDS  313 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~  313 (372)
                      +.........   ....++.++.+||.+||. ||++|||+++++                 +||||+++.|..
T Consensus       234 ~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll-----------------~h~~~~~~~~~~  286 (302)
T 2j7t_A          234 IAKSDPPTLL---TPSKWSVEFRDFLKIALDKNPETRPSAAQLL-----------------EHPFVSSITSNK  286 (302)
T ss_dssp             HHHSCCCCCS---SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHT-----------------TSTTTTTCCCCH
T ss_pred             HhccCCcccC---CccccCHHHHHHHHHHcccChhhCCCHHHHh-----------------cChHHhhhccch
Confidence            7664322111   112679999999999999 999999866555                 999999998865

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9e-46  Score=342.14  Aligned_cols=257  Identities=26%  Similarity=0.440  Sum_probs=218.8

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+..+.+|.|    |+|.||.+.+..+++.+|+|.+........       ...+.+.+|+.+++.+.||||+++++++
T Consensus        16 ~y~~~~~lg~G----~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~   84 (294)
T 2rku_A           16 RYVRGRFLGKG----GFAKCFEISDADTKEVFAGKIVPKSLLLKP-------HQREKMSMEISIHRSLAHQHVVGFHGFF   84 (294)
T ss_dssp             EEEEEEEEEEE----TTEEEEEEEETTTCCEEEEEEEEGGGCCSH-------HHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ceEEEEEEeec----CCEEEEEEEECCCCceEEEEEechhhccCH-------HHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence            45555556666    899999999998999999998765443322       2345678899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+.+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++|          |||||+||+++.++.
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H----------~dl~p~Nil~~~~~~  153 (294)
T 2rku_A           85 EDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIH----------RDLKLGNLFLNEDLE  153 (294)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCCGGGEEECTTCC
T ss_pred             ccCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------cCCChHhEEEcCCCC
Confidence            999999999999999999999987 468999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||++........ ......||+.|+|||++.+     ..++.++|+||||+++|+|++|..||...+..+....+
T Consensus       154 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  227 (294)
T 2rku_A          154 VKIGDFGLATKVEYDGE-RKKVLCGTPNYIAPEVLSK-----KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI  227 (294)
T ss_dssp             EEECCCTTCEECCSTTC-CBCCCCSCCSSCCHHHHTT-----SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             EEEEeccCceecccCcc-ccccccCCCCcCCcchhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999987653322 2234578999999999973     55788999999999999999999999998888887777


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~  310 (372)
                      ....  ...|.    .+++.+.+||.+||+ ||++||++++++                 +||||....
T Consensus       228 ~~~~--~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll-----------------~~~~~~~~~  273 (294)
T 2rku_A          228 KKNE--YSIPK----HINPVAASLIQKMLQTDPTARPTINELL-----------------NDEFFTSGY  273 (294)
T ss_dssp             HTTC--CCCCT----TSCHHHHHHHHHHTCSSGGGSCCGGGGG-----------------GSHHHHTSC
T ss_pred             hhcc--CCCcc----ccCHHHHHHHHHHcccChhhCcCHHHHh-----------------hChheecCC
Confidence            6643  33344    689999999999999 999999987776                 999998643

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.7e-46  Score=358.35  Aligned_cols=262  Identities=23%  Similarity=0.343  Sum_probs=198.3

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    ++|.||++.+..+++.||+|.+.......        ...+.+.+|+.+++.++||||++++++
T Consensus        29 ~~y~~~~~lG~G----~~g~V~~a~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~~~~~   96 (367)
T 2fst_X           29 ERYQNLSPVGSG----AYGSVCAAFDTKTGLRVAVKKLSRPFQSI--------IHAKRTYRELRLLKHMKHENVIGLLDV   96 (367)
T ss_dssp             TTEEEEEECC--------CCEEEEEETTTTEEEEEEECSSTTSSH--------HHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             CceEEeeEEeec----CCeEEEEEEECCCCCEEEEEEeCccccCH--------HHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            456667777777    89999999999999999999886543221        134567789999999999999999999


Q ss_pred             EEeC------CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcE
Q psy11571         82 FQDD------SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNV  155 (372)
Q Consensus        82 ~~~~------~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NI  155 (372)
                      +...      ..+|+|||++ +++|.+++..  ..+++..++.++.||+.||.|||++||+|          |||||+||
T Consensus        97 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH----------~Dlkp~NI  163 (367)
T 2fst_X           97 FTPARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIH----------RDLKPSNL  163 (367)
T ss_dssp             ECSCSSGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------CCCCGGGE
T ss_pred             EecCCccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeee----------CCCCHhhE
Confidence            9764      5689999998 8899999976  67999999999999999999999999999          99999999


Q ss_pred             EeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCH
Q psy11571        156 LLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL  235 (372)
Q Consensus       156 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~  235 (372)
                      |++.++.+||+|||+++.....    .....||+.|+|||++.+    ...++.++|||||||++|+|++|++||.+.+.
T Consensus       164 ll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  235 (367)
T 2fst_X          164 AVNEDCELKILDFGLARHTADE----MTGYVATRWYRAPEIMLN----WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH  235 (367)
T ss_dssp             EECTTCCEEECC-------------------CCCTTCCHHHHTT----CCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             EECCCCCEEEeecccccccccc----CCCcCcCcCccChHHHcC----CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            9999999999999999875432    233679999999999973    35689999999999999999999999999888


Q ss_pred             HHHHHHHhhccCCc---------------------CCCC----CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhh
Q psy11571        236 VETYGKIMNHQNSF---------------------DLPS----DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMW  289 (372)
Q Consensus       236 ~~~~~~i~~~~~~~---------------------~~~~----~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~  289 (372)
                      .+.+..|......+                     ..+.    ......++++.+||++||+ ||++|||+++++     
T Consensus       236 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L-----  310 (367)
T 2fst_X          236 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL-----  310 (367)
T ss_dssp             HHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHH-----
T ss_pred             HHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHh-----
Confidence            77777665421111                     0000    0012568999999999999 999999876665     


Q ss_pred             hhhhhccCCCCCCCCCcCCCCccc
Q psy11571        290 SALFVSLSISPRNHPWFQGIAWDS  313 (372)
Q Consensus       290 ~~~~~~~~~~~~~hp~f~~~~w~~  313 (372)
                                  .||||+.+....
T Consensus       311 ------------~hp~~~~~~~~~  322 (367)
T 2fst_X          311 ------------AHAYFAQYHDPD  322 (367)
T ss_dssp             ------------TSGGGTTTCCGG
T ss_pred             ------------cChhhhhccCCC
Confidence                        999999876543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.9e-46  Score=346.35  Aligned_cols=255  Identities=30%  Similarity=0.464  Sum_probs=215.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    ++|.||.+.+..+++.||+|.+.......          .+.+.+|+.+++.++||||+++++++
T Consensus        10 ~y~~~~~lg~G----~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~~   75 (304)
T 2jam_A           10 TFIFMEVLGSG----AFSEVFLVKQRLTGKLFALKCIKKSPAFR----------DSSLENEIAVLKKIKHENIVTLEDIY   75 (304)
T ss_dssp             HEEEEEEEEEC----SSEEEEEEEETTTCCEEEEEEEECC----------------HHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cceeeeeccCC----CCceEEEEEECCCCCEEEEEEEecccccc----------hHHHHHHHHHHHhCCCCCeeehhhhc
Confidence            45556666666    89999999999899999999887543221          23467899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe---CC
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL---DA  159 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll---~~  159 (372)
                      .+...+|+||||+++++|.+++.. .+.+++..++.++.||+.||.|||+.|++|          |||||+||++   +.
T Consensus        76 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H----------~dikp~NIl~~~~~~  144 (304)
T 2jam_A           76 ESTTHYYLVMQLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVH----------RDLKPENLLYLTPEE  144 (304)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------CSCCGGGCEESSSST
T ss_pred             ccCCEEEEEEEcCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------cCCCHHHEEEecCCC
Confidence            999999999999999999999977 467999999999999999999999999999          9999999999   77


Q ss_pred             CCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHH
Q psy11571        160 NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY  239 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~  239 (372)
                      ++.++|+|||++......   ......||+.|+|||++.     ...++.++|||||||++|+|++|..||.+.+..+..
T Consensus       145 ~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  216 (304)
T 2jam_A          145 NSKIMITDFGLSKMEQNG---IMSTACGTPGYVAPEVLA-----QKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLF  216 (304)
T ss_dssp             TCCEEBCSCSTTCCCCCB---TTHHHHSCCCBCCTTTBS-----SCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred             CCCEEEccCCcceecCCC---ccccccCCCCccChHHhc-----cCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence            889999999998765432   123357999999999997     356899999999999999999999999999988888


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      ..+..+...+  +......+++++.+||.+||. ||++||++++++                 +||||++.
T Consensus       217 ~~i~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l-----------------~h~~~~~~  268 (304)
T 2jam_A          217 EKIKEGYYEF--ESPFWDDISESAKDFICHLLEKDPNERYTCEKAL-----------------SHPWIDGN  268 (304)
T ss_dssp             HHHHHCCCCC--CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHH-----------------TSHHHHSS
T ss_pred             HHHHcCCCCC--CccccccCCHHHHHHHHHHcCCChhHCcCHHHHh-----------------cCccccCC
Confidence            8887764333  333334789999999999999 999999876655                 99999864

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.5e-46  Score=357.71  Aligned_cols=273  Identities=20%  Similarity=0.331  Sum_probs=207.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||.+.+..+++.||+|.+.......        ...+.+.+|+.+++.++||||+++++++
T Consensus        26 ~y~~~~~lG~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~~~~~~   93 (371)
T 2xrw_A           26 RYQNLKPIGSG----AQGIVCAAYDAILERNVAIKKLSRPFQNQ--------THAKRAYRELVLMKCVNHKNIIGLLNVF   93 (371)
T ss_dssp             TEEEEEEEEEC----SSEEEEEEEETTTTEEEEEEEEECTTSSH--------HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             heeEeeeeEec----CCEEEEEEEECCCCceEEEEEeccccCCh--------HHHHHHHHHHHHHHhcCCCCccceEEee
Confidence            55666667776    89999999999999999999887543222        2345677899999999999999999999


Q ss_pred             EeCC------eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEE
Q psy11571         83 QDDS------NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL  156 (372)
Q Consensus        83 ~~~~------~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIl  156 (372)
                      ....      .+|+||||+. ++|.+++.   ..+++..+..++.||+.||.|||++||+|          |||||+|||
T Consensus        94 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH----------~Dlkp~NIl  159 (371)
T 2xrw_A           94 TPQKSLEEFQDVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIH----------RDLKPSNIV  159 (371)
T ss_dssp             CSCCSTTTCCEEEEEEECCS-EEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCCGGGEE
T ss_pred             ccccccccccceEEEEEcCC-CCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeec----------ccCCHHHEE
Confidence            8765      7899999996 58988885   45899999999999999999999999999          999999999


Q ss_pred             eCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH
Q psy11571        157 LDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV  236 (372)
Q Consensus       157 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~  236 (372)
                      ++.++.+||+|||+++......  ......||+.|+|||++.+     ..++.++|||||||++|+|++|..||.+.+..
T Consensus       160 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~  232 (371)
T 2xrw_A          160 VKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI  232 (371)
T ss_dssp             ECTTSCEEECCCCC------------------CTTCCHHHHTT-----CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             EcCCCCEEEEEeeccccccccc--ccCCceecCCccCHHHhcC-----CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999999999999998764332  2233679999999999983     56899999999999999999999999999888


Q ss_pred             HHHHHHhhccCCcC-----------------CCCCC------------C-------CCCCHHHHHHHHHhcc-CCCCCCC
Q psy11571        237 ETYGKIMNHQNSFD-----------------LPSDV------------G-------YEISDDAKDLMRRLIC-SSDTRLG  279 (372)
Q Consensus       237 ~~~~~i~~~~~~~~-----------------~~~~~------------~-------~~~s~~~~~li~~lL~-~p~~R~s  279 (372)
                      +.+.++........                 .+...            .       ...++++++||++||+ ||++|||
T Consensus       233 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t  312 (371)
T 2xrw_A          233 DQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS  312 (371)
T ss_dssp             HHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred             HHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCC
Confidence            87777765321110                 00000            0       0115789999999999 9999998


Q ss_pred             CCChhhhhhhhhhhhccCCCCCCCCCcCCCCccccccCCCCCcCCC
Q psy11571        280 QNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIPEV  325 (372)
Q Consensus       280 ~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~~~~~p~~p~~  325 (372)
                      +++++                 +||||+...........+|..|..
T Consensus       313 ~~e~l-----------------~hp~~~~~~~~~~~~~~~~~~~~~  341 (371)
T 2xrw_A          313 VDEAL-----------------QHPYINVWYDPSEAEAPPPKIPDK  341 (371)
T ss_dssp             HHHHH-----------------HSHHHHTTCCHHHHTCCCCCCCTT
T ss_pred             HHHHh-----------------CCcchhhhcCccccCCCCCCCCCh
Confidence            76665                 999998643333344556666543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.7e-46  Score=350.81  Aligned_cols=267  Identities=24%  Similarity=0.313  Sum_probs=214.3

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    |+|.||++.+..+++.||+|.+........        ..+.+.+|+.+++.++||||++++++
T Consensus        25 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~iv~~~~~   92 (331)
T 4aaa_A           25 EKYENLGLVGEG----SYGMVMKCRNKDTGRIVAIKKFLESDDDKM--------VKKIAMREIKLLKQLRHENLVNLLEV   92 (331)
T ss_dssp             GGEEEEEEGGGG----TTSSEEEEEETTTCCEEEEEEEESCSSCHH--------HHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhheeeeEEeec----CCEEEEEEEECCCCceEEEEEEecCCCchH--------HHHHHHHHHHHHhhCCCCCEeeEEEE
Confidence            466777777777    899999999999999999998865443221        23456789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+.+..|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+.|++|          |||||+||+++.++
T Consensus        93 ~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH----------~dlkp~Nil~~~~~  161 (331)
T 4aaa_A           93 CKKKKRWYLVFEFVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSHNIIH----------RDIKPENILVSQSG  161 (331)
T ss_dssp             EEETTEEEEEEECCSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------CCCCGGGEEECTTS
T ss_pred             eecCCEEEEEEecCCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCEEc----------cCcChheEEEcCCC
Confidence            9999999999999999888888765 578999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .+||+|||++........ ......||+.|+|||++.+    ...++.++|||||||++|+|++|.+||.+.+..+....
T Consensus       162 ~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  236 (331)
T 4aaa_A          162 VVKLCDFGFARTLAAPGE-VYDDEVATRWYRAPELLVG----DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYH  236 (331)
T ss_dssp             CEEECCCTTC-------------CCCCCTTCCHHHHTT----CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             cEEEEeCCCceeecCCcc-ccCCCcCCccccCcccccC----CCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence            999999999977644322 2233578999999999973    34688999999999999999999999999887776665


Q ss_pred             HhhccCC-----------------cCCCCC--------CCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhc
Q psy11571        242 IMNHQNS-----------------FDLPSD--------VGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVS  295 (372)
Q Consensus       242 i~~~~~~-----------------~~~~~~--------~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~  295 (372)
                      +......                 ...+..        ....+++.+.+||.+||+ ||++|||+.+++           
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell-----------  305 (331)
T 4aaa_A          237 IMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL-----------  305 (331)
T ss_dssp             HHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGG-----------
T ss_pred             HHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHh-----------
Confidence            5432111                 001110        012578999999999999 999999988776           


Q ss_pred             cCCCCCCCCCcCCCCccc
Q psy11571        296 LSISPRNHPWFQGIAWDS  313 (372)
Q Consensus       296 ~~~~~~~hp~f~~~~w~~  313 (372)
                            +||||+..+|..
T Consensus       306 ------~hp~f~~~~~~~  317 (331)
T 4aaa_A          306 ------HHDFFQMDGFAE  317 (331)
T ss_dssp             ------GSHHHHGGGHHH
T ss_pred             ------cCchhccCChhh
Confidence                  999999876643

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.1e-45  Score=348.46  Aligned_cols=257  Identities=26%  Similarity=0.440  Sum_probs=219.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+..+.+|.|    |+|.||.+.+..+++.+|+|.+........       ...+.+.+|+.+++.++||||+++++++
T Consensus        42 ~y~~~~~lg~G----~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~  110 (335)
T 2owb_A           42 RYVRGRFLGKG----GFAKCFEISDADTKEVFAGKIVPKSLLLKP-------HQREKMSMEISIHRSLAHQHVVGFHGFF  110 (335)
T ss_dssp             EEEEEEEEEEE----TTEEEEEEEETTTCCEEEEEEEEGGGCCSH-------HHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ceEEEEEEeeC----CCeEEEEEEECCCCCEEEEEEechhhhcCH-------HHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            45555566666    899999999998999999998765543322       2345678899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+.+.+|+||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+|          |||||+||+++.++.
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH----------~dlkp~NIl~~~~~~  179 (335)
T 2owb_A          111 EDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIH----------RDLKLGNLFLNEDLE  179 (335)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCCGGGEEECTTCC
T ss_pred             ecCCeEEEEEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEe----------cCCCchhEEEcCCCC
Confidence            999999999999999999999987 478999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||++........ ......||+.|+|||++.+     ..++.++|||||||++|+|++|+.||......+.+..+
T Consensus       180 ~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  253 (335)
T 2owb_A          180 VKIGDFGLATKVEYDGE-RKKVLCGTPNYIAPEVLSK-----KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI  253 (335)
T ss_dssp             EEECCCTTCEECCSTTC-CBCCCCSCCSSCCHHHHHT-----SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             EEEeeccCceecccCcc-cccccCCCccccCHHHhcc-----CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH
Confidence            99999999987653322 2234679999999999973     56789999999999999999999999998888887777


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~  310 (372)
                      ....  +.++.    .+++.+.+||.+||+ ||++||++++++                 +||||....
T Consensus       254 ~~~~--~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell-----------------~~~~~~~~~  299 (335)
T 2owb_A          254 KKNE--YSIPK----HINPVAASLIQKMLQTDPTARPTINELL-----------------NDEFFTSGY  299 (335)
T ss_dssp             HHTC--CCCCT----TSCHHHHHHHHHHTCSSGGGSCCGGGGG-----------------GSHHHHTSC
T ss_pred             hcCC--CCCCc----cCCHHHHHHHHHHccCChhHCcCHHHHh-----------------cCccccCCC
Confidence            6643  33344    679999999999999 999999987776                 999998654

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1e-45  Score=341.16  Aligned_cols=243  Identities=19%  Similarity=0.356  Sum_probs=202.3

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe----CCeEEEEE
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQD----DSNLYLVM   92 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~----~~~~~lv~   92 (372)
                      ||+|.||++.+..++..||+|.+........        ..+.+.+|+.+++.++||||+++++++..    ...+|+||
T Consensus        37 G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~  108 (290)
T 1t4h_A           37 GSFKTVYKGLDTETTVEVAWCELQDRKLTKS--------ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEEEGGGSCHH--------HHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             CCCeEEEEeEecCCceEEEEEEecchhhCHH--------HHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEE
Confidence            3899999999998999999998876544332        34668889999999999999999999876    35689999


Q ss_pred             eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCCCcCCCCCcCcEEeC-CCCcEEEeecC
Q psy11571         93 DYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH--YVHRPNHFAFHLCRDIKPDNVLLD-ANGHIRLADFG  169 (372)
Q Consensus        93 E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~~~~~~~~vhrDlkp~NIll~-~~~~vkl~Dfg  169 (372)
                      ||+++++|.+++.. ...+++..++.++.||+.||.|||+.|  ++|          |||||+||+++ .++.+||+|||
T Consensus       109 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H----------~dikp~Nil~~~~~~~~kl~Dfg  177 (290)
T 1t4h_A          109 ELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIH----------RDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             ECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCC----------SCCCGGGEEESSTTSCEEECCTT
T ss_pred             EecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEE----------CCCCHHHEEEECCCCCEEEeeCC
Confidence            99999999999987 477999999999999999999999999  999          99999999998 78999999999


Q ss_pred             cccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCC-HHHHHHHHhhccCC
Q psy11571        170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKIMNHQNS  248 (372)
Q Consensus       170 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~-~~~~~~~i~~~~~~  248 (372)
                      ++.......   .....||+.|+|||++.      +.++.++|||||||++|+|++|..||.... .......+......
T Consensus       178 ~~~~~~~~~---~~~~~~t~~y~aPE~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  248 (290)
T 1t4h_A          178 LATLKRASF---AKAVIGTPEFMAPEMYE------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP  248 (290)
T ss_dssp             GGGGCCTTS---BEESCSSCCCCCGGGGG------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC
T ss_pred             Ccccccccc---cccccCCcCcCCHHHHh------ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc
Confidence            997654332   23357999999999886      348999999999999999999999998844 44445555443322


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        249 FDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       249 ~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      ...+    ...++++.+||.+||. ||.+||++++++                 +||||++
T Consensus       249 ~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell-----------------~h~~f~~  288 (290)
T 1t4h_A          249 ASFD----KVAIPEVKEIIEGCIRQNKDERYSIKDLL-----------------NHAFFQE  288 (290)
T ss_dssp             GGGG----GCCCHHHHHHHHHHSCSSGGGSCCHHHHH-----------------TSGGGC-
T ss_pred             cccC----CCCCHHHHHHHHHHccCChhhCCCHHHHh-----------------hCccccc
Confidence            2222    2678999999999999 999999866555                 9999985

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=9.3e-46  Score=345.15  Aligned_cols=251  Identities=21%  Similarity=0.262  Sum_probs=203.7

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+..+.+|.|    |+|.||+++.  +++.||+|.+........        ..+.+.+|+.+++.++||||+++++++
T Consensus        38 ~y~i~~~lG~G----~~g~V~~~~~--~~~~vavK~~~~~~~~~~--------~~~~~~~E~~~l~~l~hp~iv~~~~~~  103 (309)
T 3p86_A           38 DLNIKEKIGAG----SFGTVHRAEW--HGSDVAVKILMEQDFHAE--------RVNEFLREVAIMKRLRHPNIVLFMGAV  103 (309)
T ss_dssp             GEEEEEEEEEC----SSEEEEEEEE--TTEEEEEEEECCCCCSHH--------HHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HceeeeEeecC----CCeEEEEEEE--CCCcEEEEEecCCCCCHH--------HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            45555666666    8999999964  678899998876554332        345678899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCCCcCCCCCcCcEEeC
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFE--DRLPEDMAKFYIAEMVLAIASIHDLH--YVHRPNHFAFHLCRDIKPDNVLLD  158 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~~~~~~~~vhrDlkp~NIll~  158 (372)
                      .+...+++||||+++|+|.+++....  ..+++..++.++.||+.||+|||++|  |+|          |||||+||+++
T Consensus       104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH----------~Dikp~NIll~  173 (309)
T 3p86_A          104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVH----------RNLKSPNLLVD  173 (309)
T ss_dssp             CSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCC----------TTCCGGGEEEC
T ss_pred             EECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEC----------CCCChhhEEEe
Confidence            99999999999999999999998632  13999999999999999999999999  999          99999999999


Q ss_pred             CCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHH
Q psy11571        159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET  238 (372)
Q Consensus       159 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~  238 (372)
                      .++.+||+|||+++....... ......||+.|+|||++.+     ..++.++|||||||++|+|++|..||.+.+..+.
T Consensus       174 ~~~~~kL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~  247 (309)
T 3p86_A          174 KKYTVKVCDFGLSRLKASTFL-SSKSAAGTPEWMAPEVLRD-----EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV  247 (309)
T ss_dssp             TTCCEEECCCC------------------CCTTSCHHHHTT-----CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH
T ss_pred             CCCcEEECCCCCCcccccccc-ccccCCCCccccChhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999999999999976543322 2334679999999999983     5688999999999999999999999999998888


Q ss_pred             HHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       239 ~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ...+.........|.    .+++++.+||.+||. +|.+||++.++.+.+
T Consensus       248 ~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L  293 (309)
T 3p86_A          248 VAAVGFKCKRLEIPR----NLNPQVAAIIEGCWTNEPWKRPSFATIMDLL  293 (309)
T ss_dssp             HHHHHHSCCCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHhcCCCCCCCc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            777765555555555    789999999999999 999999988887655

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.7e-46  Score=351.06  Aligned_cols=264  Identities=23%  Similarity=0.385  Sum_probs=210.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||.+.+..+++.||+|.+............  ....+.+.+|+.+++.++||||+++++++
T Consensus        25 ~y~~~~~lG~G----~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~   98 (335)
T 3dls_A           25 KYSTMSPLGSG----AFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIE--DPKLGKVTLEIAILSRVEHANIIKVLDIF   98 (335)
T ss_dssp             HEEEEEECSSS----SSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEE--ETTTEEEEHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ceEEEeEEEec----CCEEEEEEEECCCCcEEEEEEEehhhcccccccc--hHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            45556666666    8999999999999999999988765432210000  00122356799999999999999999999


Q ss_pred             EeCCeEEEEEeccCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         83 QDDSNLYLVMDYYCGG-DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg-~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      .+.+.+++||||+.+| +|.+++.. ...+++..++.++.||+.||.|||++||+|          |||||+|||++.++
T Consensus        99 ~~~~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH----------~Dlkp~NIll~~~~  167 (335)
T 3dls_A           99 ENQGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIH----------RDIKDENIVIAEDF  167 (335)
T ss_dssp             ECSSEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSGGGEEECTTS
T ss_pred             eeCCEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEE----------eccCHHHEEEcCCC
Confidence            9999999999998776 99999987 568999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .+||+|||++........  ....+||+.|+|||++.+    ...++.++|||||||++|+|++|..||.....      
T Consensus       168 ~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------  235 (335)
T 3dls_A          168 TIKLIDFGSAAYLERGKL--FYTFCGTIEYCAPEVLMG----NPYRGPELEMWSLGVTLYTLVFEENPFCELEE------  235 (335)
T ss_dssp             CEEECCCTTCEECCTTCC--BCEECSCGGGCCHHHHTT----CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------
T ss_pred             cEEEeecccceECCCCCc--eeccCCCccccChhhhcC----CCCCCCcccchhHHHHHHHHHhCCCchhhHHH------
Confidence            999999999987654432  234679999999999984    33347899999999999999999999976321      


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC------CCcccc
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG------IAWDSI  314 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~------~~w~~~  314 (372)
                      ....  ....|.    .+++++.+||.+||+ ||++||++++++                 +||||+.      ++|+.+
T Consensus       236 ~~~~--~~~~~~----~~~~~l~~li~~~L~~dP~~Rps~~ell-----------------~hp~~~~~~~~~~~~~~~~  292 (335)
T 3dls_A          236 TVEA--AIHPPY----LVSKELMSLVSGLLQPVPERRTTLEKLV-----------------TDPWVTQPVNLADYTWEEV  292 (335)
T ss_dssp             GTTT--CCCCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHH-----------------HCTTTTCCCCGGGCCHHHH
T ss_pred             HHhh--ccCCCc----ccCHHHHHHHHHHccCChhhCcCHHHHh-----------------cCccccCCccccccCHHHH
Confidence            1111  122222    589999999999999 999999866555                 9999965      567666


Q ss_pred             ccCC
Q psy11571        315 RDSN  318 (372)
Q Consensus       315 ~~~~  318 (372)
                      ....
T Consensus       293 ~~~~  296 (335)
T 3dls_A          293 FRVN  296 (335)
T ss_dssp             C---
T ss_pred             hhhc
Confidence            5443

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=8e-46  Score=353.52  Aligned_cols=263  Identities=28%  Similarity=0.416  Sum_probs=216.1

Q ss_pred             HHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeC
Q psy11571          7 LEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYAFQDD   85 (372)
Q Consensus         7 l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~~~~~   85 (372)
                      .+.+|.|    ++|.||++....+++.||+|.+........  .....+..+.+.+|..+++.+ +||||+++++++...
T Consensus        99 ~~~lg~G----~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  172 (365)
T 2y7j_A           99 KDVIGRG----VSSVVRRCVHRATGHEFAVKIMEVTAERLS--PEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS  172 (365)
T ss_dssp             EEEEEEC----SSEEEEEEEETTTCCEEEEEEEETTSSCCC--HHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred             ceEEecC----CCEEEEEEEECCCCcEEEEEEEEccccccC--HHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence            3445555    799999999888999999998765432211  111123456788999999998 799999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEE
Q psy11571         86 SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRL  165 (372)
Q Consensus        86 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl  165 (372)
                      ...|+||||++|++|.+++.. ...+++..++.++.||+.||.|||+.|++|          |||||+|||++.+|.++|
T Consensus       173 ~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H----------~Dlkp~NIl~~~~~~ikl  241 (365)
T 2y7j_A          173 SFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVH----------RDLKPENILLDDNMQIRL  241 (365)
T ss_dssp             SEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSGGGEEECTTCCEEE
T ss_pred             CEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeec----------CCCCHHHEEECCCCCEEE
Confidence            999999999999999999987 468999999999999999999999999999          999999999999999999


Q ss_pred             eecCcccccCCCCcccccccccCCcccCccccccccc-CCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhh
Q psy11571        166 ADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEE-GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN  244 (372)
Q Consensus       166 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~  244 (372)
                      +|||++........  ....+||+.|+|||++.+... ....++.++|||||||++|+|++|..||.+.+.......+..
T Consensus       242 ~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~  319 (365)
T 2y7j_A          242 SDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME  319 (365)
T ss_dssp             CCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence            99999987654332  234679999999999864211 123578899999999999999999999999888888888877


Q ss_pred             ccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcC
Q psy11571        245 HQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ  307 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~  307 (372)
                      +...+..+  .+..++..+.+||.+||+ ||++||++++++                 +||||+
T Consensus       320 ~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~ell-----------------~hp~f~  364 (365)
T 2y7j_A          320 GQYQFSSP--EWDDRSSTVKDLISRLLQVDPEARLTAEQAL-----------------QHPFFE  364 (365)
T ss_dssp             TCCCCCHH--HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHH-----------------HSGGGC
T ss_pred             CCCCCCCc--ccccCCHHHHHHHHHHcCCChhHCcCHHHHh-----------------cCcccC
Confidence            55433222  123679999999999999 999999866655                 999997

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.4e-46  Score=345.34  Aligned_cols=268  Identities=24%  Similarity=0.389  Sum_probs=220.0

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    ++|.||.+.+..+++.+|+|.+...........    ...+.+.+|+.+++.++||||++++++
T Consensus         5 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~   76 (283)
T 3bhy_A            5 DHYEMGEELGSG----QFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRG----VSREEIEREVNILREIRHPNIITLHDI   76 (283)
T ss_dssp             HHEEEEEEEEEC----SSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSS----BCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhhhhHHhhccc----CceEEEEEEEcCCCCeeehHHhhhccccccccc----hHHHHHHHHHHHHHhCCCCCeeehhhe
Confidence            356666777777    899999999998999999998876554332110    013457789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+....++||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++|          |||||+||+++.++
T Consensus        77 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H----------~dl~p~Nil~~~~~  145 (283)
T 3bhy_A           77 FENKTDVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAH----------FDLKPENIMLLDKN  145 (283)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSGGGEEESCSS
T ss_pred             ecCCCeEEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccC----------CCCChHHEEEecCC
Confidence            9999999999999999999999987 468999999999999999999999999999          99999999998877


Q ss_pred             ----cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHH
Q psy11571        162 ----HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE  237 (372)
Q Consensus       162 ----~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~  237 (372)
                          .+||+|||++........  .....||+.|+|||++.     ...++.++|+||||+++|+|++|..||.+.+..+
T Consensus       146 ~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~  218 (283)
T 3bhy_A          146 VPNPRIKLIDFGIAHKIEAGNE--FKNIFGTPEFVAPEIVN-----YEPLGLEADMWSIGVITYILLSGASPFLGETKQE  218 (283)
T ss_dssp             SSSCCEEECCCTTCEECC----------CCCGGGCCHHHHT-----TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred             CCCCceEEEecccceeccCCCc--ccccCCCcCccCcceec-----CCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH
Confidence                899999999987654332  22356899999999997     3568999999999999999999999999998888


Q ss_pred             HHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc
Q psy11571        238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI  314 (372)
Q Consensus       238 ~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~  314 (372)
                      ....+......  .+......+++.+.+||.+||. ||++||++.+++                 +||||+.+.+..+
T Consensus       219 ~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l-----------------~h~~~~~~~~~~~  277 (283)
T 3bhy_A          219 TLTNISAVNYD--FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSL-----------------EHSWIKAIRRRNV  277 (283)
T ss_dssp             HHHHHHTTCCC--CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHH-----------------HCHHHHHHHHCCC
T ss_pred             HHHHhHhcccC--CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHH-----------------hCHHHHHHHHHhh
Confidence            88777654332  2222223679999999999999 999999866555                 9999998876544

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=9.9e-46  Score=352.58  Aligned_cols=261  Identities=23%  Similarity=0.349  Sum_probs=212.0

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      .||+.++.+|.|    |+|.||.+.+..+++.||+|.+......         ...+.+.+|+.+++.++||||++++++
T Consensus        27 ~~y~~~~~lG~G----~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~~~~~   93 (364)
T 3qyz_A           27 PRYTNLSYIGEG----AYGMVCSAYDNLNKVRVAIKKISPFEHQ---------TYCQRTLREIKILLRFRHENIIGINDI   93 (364)
T ss_dssp             TTEEEEEEEEEC----SSEEEEEEEETTTTEEEEEEEECCTTCH---------HHHHHHHHHHHHHHHCCCTTBCCCCEE
T ss_pred             ccEEEEEEeecC----CCeEEEEEEECCCCeEEEEEEeccccCc---------HHHHHHHHHHHHHHhcCCCCCccceeE
Confidence            356667777777    8999999999999999999988643221         134567889999999999999999999


Q ss_pred             EEeC-----CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEE
Q psy11571         82 FQDD-----SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL  156 (372)
Q Consensus        82 ~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIl  156 (372)
                      +...     ...|+||||+. |+|.+++..  ..+++..++.++.||+.||.|||++||+|          |||||+|||
T Consensus        94 ~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH----------~Dikp~NIl  160 (364)
T 3qyz_A           94 IRAPTIEQMKDVYIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLH----------RDLKPSNLL  160 (364)
T ss_dssp             ECCSSTTTCCCEEEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCCGGGEE
T ss_pred             EecCCccccceEEEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeec----------CCCChHhEE
Confidence            9765     36899999995 699999987  67999999999999999999999999999          999999999


Q ss_pred             eCCCCcEEEeecCcccccCCCCcc--cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCC
Q psy11571        157 LDANGHIRLADFGSCLRLGGDGTV--QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES  234 (372)
Q Consensus       157 l~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~  234 (372)
                      ++.++.+||+|||++.........  .....+||+.|+|||++.+    ...++.++|||||||++|+|++|++||.+.+
T Consensus       161 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~  236 (364)
T 3qyz_A          161 LNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN----SKGYTKSIDIWSVGCILAEMLSNRPIFPGKH  236 (364)
T ss_dssp             ECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHT----BCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcC----CCCCCcchhHHHHHHHHHHHHHCCCCCCCCC
Confidence            999999999999999876432211  1233579999999998763    3558999999999999999999999999888


Q ss_pred             HHHHHHHHhhccCCcC------------------CCC-------CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhh
Q psy11571        235 LVETYGKIMNHQNSFD------------------LPS-------DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKM  288 (372)
Q Consensus       235 ~~~~~~~i~~~~~~~~------------------~~~-------~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~  288 (372)
                      ..+.+..+......+.                  .+.       .....+++++.+||.+||+ ||.+|||+++++    
T Consensus       237 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l----  312 (364)
T 3qyz_A          237 YLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL----  312 (364)
T ss_dssp             GGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHH----
T ss_pred             hHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHh----
Confidence            7776666543211110                  000       0112578999999999999 999999866655    


Q ss_pred             hhhhhhccCCCCCCCCCcCCC
Q psy11571        289 WSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       289 ~~~~~~~~~~~~~~hp~f~~~  309 (372)
                                   +||||+..
T Consensus       313 -------------~hp~~~~~  320 (364)
T 3qyz_A          313 -------------AHPYLEQY  320 (364)
T ss_dssp             -------------TSGGGTTT
T ss_pred             -------------cCcchhhc
Confidence                         99999976

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5.3e-46  Score=358.32  Aligned_cols=260  Identities=25%  Similarity=0.370  Sum_probs=204.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||.++...++. +|+|++......              ..+|+.+++.++||||+++++++
T Consensus        41 ~Y~~~~~lG~G----~~g~V~~a~~~~~~~-~aikk~~~~~~~--------------~~~E~~il~~l~h~niv~l~~~~  101 (394)
T 4e7w_A           41 AYTNCKVIGNG----SFGVVFQAKLVESDE-VAIKKVLQDKRF--------------KNRELQIMRIVKHPNVVDLKAFF  101 (394)
T ss_dssp             EEEEEEEEEEE----TTEEEEEEEETTTEE-EEEEEEECCTTS--------------CCHHHHHHHTCCCTTBCCEEEEE
T ss_pred             eEEEeEEEeeC----CCeEEEEEEECCCCe-EEEEEEecCcch--------------HHHHHHHHHhCCCCCcceEEEEE
Confidence            45555666666    899999998776665 788876543221              12589999999999999999999


Q ss_pred             EeCC------eEEEEEeccCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcC
Q psy11571         83 QDDS------NLYLVMDYYCGGDLLTLLS---KFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPD  153 (372)
Q Consensus        83 ~~~~------~~~lv~E~~~gg~L~~~l~---~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~  153 (372)
                      ....      .+++||||+++ +|...+.   .....+++..++.++.||+.||.|||++||+|          |||||+
T Consensus       102 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH----------rDlkp~  170 (394)
T 4e7w_A          102 YSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICH----------RDIKPQ  170 (394)
T ss_dssp             EEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSGG
T ss_pred             EecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccC----------CCCCHH
Confidence            6544      38899999976 4444433   22467999999999999999999999999999          999999


Q ss_pred             cEEeC-CCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCC
Q psy11571        154 NVLLD-ANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA  232 (372)
Q Consensus       154 NIll~-~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~  232 (372)
                      |||++ .++.+||+|||+++.......  .....||+.|+|||++.+    ...++.++|||||||++|+|++|++||.+
T Consensus       171 Nill~~~~~~~kL~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~  244 (394)
T 4e7w_A          171 NLLLDPPSGVLKLIDFGSAKILIAGEP--NVSYICSRYYRAPELIFG----ATNYTTNIDIWSTGCVMAELMQGQPLFPG  244 (394)
T ss_dssp             GEEEETTTTEEEECCCTTCEECCTTCC--CCSSCSCGGGCCHHHHTT----CSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HEEEcCCCCcEEEeeCCCcccccCCCC--CcccccCcCccCHHHHcC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            99998 789999999999987644332  233678999999999974    45689999999999999999999999999


Q ss_pred             CCHHHHHHHHhhccCC---------------cCCCC--------CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhh
Q psy11571        233 ESLVETYGKIMNHQNS---------------FDLPS--------DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKM  288 (372)
Q Consensus       233 ~~~~~~~~~i~~~~~~---------------~~~~~--------~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~  288 (372)
                      .+..+.+..+.+....               ..++.        .....+++++++||.+||+ ||.+|||+.+++    
T Consensus       245 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l----  320 (394)
T 4e7w_A          245 ESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEAL----  320 (394)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH----
T ss_pred             CCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHh----
Confidence            9887777666542111               11111        1112478999999999999 999999866555    


Q ss_pred             hhhhhhccCCCCCCCCCcCCCCccccc
Q psy11571        289 WSALFVSLSISPRNHPWFQGIAWDSIR  315 (372)
Q Consensus       289 ~~~~~~~~~~~~~~hp~f~~~~w~~~~  315 (372)
                                   .||||+++.|....
T Consensus       321 -------------~hp~f~~~~~~~~~  334 (394)
T 4e7w_A          321 -------------CHPFFDELRTGEAR  334 (394)
T ss_dssp             -------------TSGGGSTTTSSCCC
T ss_pred             -------------cChhhhhhcccccc
Confidence                         99999999886553

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=8.3e-46  Score=338.77  Aligned_cols=258  Identities=21%  Similarity=0.337  Sum_probs=209.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    ++|.||.+.+..+++.||+|.+.......         ..+.+.+|+.+++.++||||+++++++
T Consensus         8 ~y~~~~~lg~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~   74 (276)
T 2yex_A            8 DWDLVQTLGEG----AYGEVQLAVNRVTEEAVAVKIVDMKRAVD---------CPENIKKEICINKMLNHENVVKFYGHR   74 (276)
T ss_dssp             HEEEEEEEEEC----SSSEEEEEEETTTCCEEEEEEEEGGGCTT---------HHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ceEEEEEeecC----CCcEEEEEEECCCCcEEEEEEeeeccchh---------hhHHHHHHHHHHHhcCCCCceeeeeEE
Confidence            55566667776    89999999998899999999876543221         235578899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+.+..|+||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++|          |||||+||+++.++.
T Consensus        75 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H----------~dl~p~Nil~~~~~~  143 (276)
T 2yex_A           75 REGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITH----------RDIKPENLLLDERDN  143 (276)
T ss_dssp             EETTEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSGGGEEECTTCC
T ss_pred             EcCCEEEEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeec----------cCCChHHEEEccCCC
Confidence            999999999999999999999876 467999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH-HHHH
Q psy11571        163 IRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYG  240 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-~~~~  240 (372)
                      ++|+|||++........ .......||+.|+|||++.+    ...++.++|+||||+++|+|++|..||.+.+.. ..+.
T Consensus       144 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  219 (276)
T 2yex_A          144 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR----REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS  219 (276)
T ss_dssp             EEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTC----SSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHH
T ss_pred             EEEeeCCCccccCCCcchhcccCCccccCccChHHHhc----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Confidence            99999999976532221 12234578999999999974    233477899999999999999999999876543 2333


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      .+.........    ...+++.+.+||.+||+ ||++|||+++++                 +||||+..
T Consensus       220 ~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il-----------------~~~~~~~~  268 (276)
T 2yex_A          220 DWKEKKTYLNP----WKKIDSAPLALLHKILVENPSARITIPDIK-----------------KDRWYNKP  268 (276)
T ss_dssp             HHHTTCTTSTT----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHT-----------------TCTTTTCC
T ss_pred             HhhhcccccCc----hhhcCHHHHHHHHHHCCCCchhCCCHHHHh-----------------cCccccCh
Confidence            33332221111    12689999999999999 999999866555                 99999864

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=5.6e-46  Score=340.07  Aligned_cols=255  Identities=28%  Similarity=0.454  Sum_probs=207.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+..+.++.|    ++|.||.+.+..+++.||+|.+........       +..+.+.+|+.+++.++||||+++++++
T Consensus        12 ~y~i~~~lg~G----~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~   80 (276)
T 2h6d_A           12 HYVLGDTLGVG----TFGKVKIGEHQLTGHKVAVKILNRQKIRSL-------DVVGKIKREIQNLKLFRHPHIIKLYQVI   80 (276)
T ss_dssp             TEEEEEEEEEC----SSEEEEEEEETTTCCEEEEEEEEHHHHHHT-------TCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cEEEEeeecCC----CCeEEEEEEECCCCceEEEEEeccccccch-------hHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence            45555666666    899999999988999999998765433221       2345678899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+.+..|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++|++|          |||||+||+++.++.
T Consensus        81 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H----------~dl~p~Nil~~~~~~  149 (276)
T 2h6d_A           81 STPTDFFMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVH----------RDLKPENVLLDAHMN  149 (276)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHCSSC----------CCCCGGGEEECTTSC
T ss_pred             ecCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcc----------CCCChhhEEECCCCC
Confidence            999999999999999999999987 467999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      ++|+|||++........  .....||+.|+|||++.+    ....+.++|+||||+++|+|++|..||...+.......+
T Consensus       150 ~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  223 (276)
T 2h6d_A          150 AKIADFGLSNMMSDGEF--LRTSCGSPNYAAPEVISG----RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI  223 (276)
T ss_dssp             EEECCCCGGGCCCC---------------CCTGGGTT----SCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             EEEeecccccccCCCcc--eecccCCccccCHHHHcC----CCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh
Confidence            99999999987654322  233578999999999974    223467999999999999999999999998888888777


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      ....  ...|.    .++..+.++|.+||+ ||.+||++++++                 +||||+.
T Consensus       224 ~~~~--~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~~l-----------------~h~~~~~  267 (276)
T 2h6d_A          224 RGGV--FYIPE----YLNRSVATLLMHMLQVDPLKRATIKDIR-----------------EHEWFKQ  267 (276)
T ss_dssp             HHCC--CCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHH-----------------HSHHHHT
T ss_pred             hcCc--ccCch----hcCHHHHHHHHHHccCChhhCCCHHHHH-----------------hChhhcc
Confidence            6643  23343    679999999999999 999999866655                 8999974

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3e-46  Score=355.36  Aligned_cols=260  Identities=24%  Similarity=0.377  Sum_probs=213.3

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    ++|.||++.+..+++.||+|.+......         ...+.+.+|+.+++.++||||++++++
T Consensus        33 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~va~K~~~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv~~~~~   99 (360)
T 3eqc_A           33 DDFEKISELGAG----NGGVVFKVSHKPSGLVMARKLIHLEIKP---------AIRNQIIRELQVLHECNSPYIVGFYGA   99 (360)
T ss_dssp             GGEEEEEEEEEC----SSCEEEEEEETTTCCEEEEEEEECCCCH---------HHHHHHHHHHGGGGGCCCTTBCCEEEE
T ss_pred             ccceeeeeecCC----CCeEEEEEEECCCCcEEEEEEeccccCH---------HHHHHHHHHHHHHHHCCCCCEEEEeEE
Confidence            355566666666    8999999999999999999988764321         134567889999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDL-HYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      +.+.+.+|+||||+++++|.+++.. .+.+++..+..++.|++.||.|||+. ||+|          |||||+|||++.+
T Consensus       100 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H----------~dlkp~Nil~~~~  168 (360)
T 3eqc_A          100 FYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMH----------RDVKPSNILVNSR  168 (360)
T ss_dssp             EEETTEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCC----------SCCSGGGEEECTT
T ss_pred             EEECCEEEEEEECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEc----------CCccHHHEEECCC
Confidence            9999999999999999999999987 46899999999999999999999996 9999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG  240 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~  240 (372)
                      +.+||+|||++......   ......||+.|+|||++.+     ..++.++|||||||++|+|++|+.||...+..+...
T Consensus       169 ~~~kl~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  240 (360)
T 3eqc_A          169 GEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQG-----THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL  240 (360)
T ss_dssp             CCEEECCCCCCHHHHHH---C----CCCCTTCCHHHHTT-----CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHH
T ss_pred             CCEEEEECCCCcccccc---cccCCCCCCCeECHHHHcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999998754321   1233579999999999983     568999999999999999999999998766554322


Q ss_pred             H------------------------------------------HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCC
Q psy11571        241 K------------------------------------------IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTR  277 (372)
Q Consensus       241 ~------------------------------------------i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R  277 (372)
                      .                                          +.... ....+   ...++.++++||.+||+ ||++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~li~~~L~~dP~~R  316 (360)
T 3eqc_A          241 MFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEP-PPKLP---SGVFSLEFQDFVNKCLIKNPAER  316 (360)
T ss_dssp             HHC------------------------------CCCHHHHHHHHHHSC-CCCCC---TTTSCHHHHHHHHHHHCSSTTTS
T ss_pred             HhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccC-CCCCC---cccccHHHHHHHHHHhhcChhhC
Confidence            1                                          22211 11111   22579999999999999 99999


Q ss_pred             CCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc
Q psy11571        278 LGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI  314 (372)
Q Consensus       278 ~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~  314 (372)
                      ||+++++                 +||||++.+|+.+
T Consensus       317 pt~~ell-----------------~hp~~~~~~~~~~  336 (360)
T 3eqc_A          317 ADLKQLM-----------------VHAFIKRSDAEEV  336 (360)
T ss_dssp             CCHHHHH-----------------TSHHHHHHHHSCC
T ss_pred             CCHHHHh-----------------hChHhhcchHhhh
Confidence            9876665                 9999998888765

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.6e-45  Score=350.28  Aligned_cols=254  Identities=19%  Similarity=0.296  Sum_probs=207.2

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-----CCcee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-----RRWIT   76 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-----hp~Iv   76 (372)
                      .+|+.++.+|.|    |+|.||++.+..+++.||+|.+.....           ..+.+..|..+++.+.     ||||+
T Consensus        35 ~~y~~~~~lG~G----~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~e~~~l~~l~~~~~~h~~iv   99 (360)
T 3llt_A           35 NAFLVIRKMGDG----TFGRVLLCQHIDNKKYYAVKVVRNIKK-----------YTRSAKIEADILKKIQNDDINNNNIV   99 (360)
T ss_dssp             TTEEEEEEEEEC----SSEEEEEEEETTTCCEEEEEEECSCHH-----------HHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred             CEEEEEEEEccc----CCeEEEEEEECCCCeEEEEEEeccchh-----------hhhhhHHHHHHHHHhcccCCCCCCee
Confidence            466677777777    899999999999999999998864221           2234566888888775     99999


Q ss_pred             eeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcE
Q psy11571         77 NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNV  155 (372)
Q Consensus        77 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NI  155 (372)
                      ++++++...+..|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+|          |||||+||
T Consensus       100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH----------rDlkp~NI  168 (360)
T 3llt_A          100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTH----------TDLKPENI  168 (360)
T ss_dssp             CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSGGGE
T ss_pred             cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeee----------CCCCcccE
Confidence            9999999999999999999 999999998742 35999999999999999999999999999          99999999


Q ss_pred             EeCC-------------------------CCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCc
Q psy11571        156 LLDA-------------------------NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPE  210 (372)
Q Consensus       156 ll~~-------------------------~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~  210 (372)
                      |++.                         ++.+||+|||+++......    ....||+.|+|||++.+     ..++.+
T Consensus       169 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~-----~~~~~~  239 (360)
T 3llt_A          169 LLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILN-----LGWDVS  239 (360)
T ss_dssp             EESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTT-----CCCCTT
T ss_pred             EEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcC-----CCCCCc
Confidence            9975                         7889999999998754322    33678999999999983     568999


Q ss_pred             cceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcC------------------------CCCCC-----------
Q psy11571        211 CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD------------------------LPSDV-----------  255 (372)
Q Consensus       211 ~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~------------------------~~~~~-----------  255 (372)
                      +|||||||++|+|++|+.||.+.+..+....+......++                        +|...           
T Consensus       240 ~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  319 (360)
T 3llt_A          240 SDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKK  319 (360)
T ss_dssp             HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHT
T ss_pred             cchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhh
Confidence            9999999999999999999999887777666544321111                        11100           


Q ss_pred             -----CCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcC
Q psy11571        256 -----GYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ  307 (372)
Q Consensus       256 -----~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~  307 (372)
                           ....++.+.+||.+||+ ||++|||+++++                 +||||+
T Consensus       320 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL-----------------~hp~f~  360 (360)
T 3llt_A          320 CLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELL-----------------KHKFLE  360 (360)
T ss_dssp             CCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHT-----------------TSGGGC
T ss_pred             cccccccchHHHHHHHHHHHhcCChhhCCCHHHHh-----------------cCcccC
Confidence                 00124788899999999 999999876665                 999996

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5.1e-47  Score=368.26  Aligned_cols=270  Identities=26%  Similarity=0.431  Sum_probs=204.1

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||++.+..+++.||+|.+..........  ........+.+|+.+|+.++||||+++++++
T Consensus       136 ~y~~~~~LG~G----~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  209 (419)
T 3i6u_A          136 EYIMSKTLGSG----ACGEVKLAFERKTCKKVAIRIISKRKFAIGSA--READPALNVETEIEILKKLNHPCIIKIKNFF  209 (419)
T ss_dssp             TEEEEEEEEEC----SSSEEEEEEETTTCCEEEEEEEEGGGGTTC----------CCHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred             cEEEEeEEeeC----CCeEEEEEEECCCCcEEEEEEEEechhccccc--ccchhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            34444556666    89999999999999999999887654432211  1112334577899999999999999999998


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC-
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG-  161 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~-  161 (372)
                      .. ..+|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+|          |||||+|||++.++ 
T Consensus       210 ~~-~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH----------rDlkp~NIll~~~~~  277 (419)
T 3i6u_A          210 DA-EDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIH----------RDLKPENVLLSSQEE  277 (419)
T ss_dssp             ES-SEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCCGGGEEESSSSS
T ss_pred             ec-CceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------cCCChHhEEEecCCC
Confidence            64 568999999999999999876 578999999999999999999999999999          99999999997544 


Q ss_pred             --cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH-HH
Q psy11571        162 --HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-ET  238 (372)
Q Consensus       162 --~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-~~  238 (372)
                        .+||+|||+++.......  ....+||+.|+|||++.+..  ...++.++|||||||++|+|++|.+||.+.... ..
T Consensus       278 ~~~~kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~  353 (419)
T 3i6u_A          278 DCLIKITDFGHSKILGETSL--MRTLCGTPTYLAPEVLVSVG--TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL  353 (419)
T ss_dssp             SCCEEECCSSTTTSCC-------------CTTCCTTTTC------CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH
T ss_pred             cceEEEeecccceecCCCcc--ccccCCCCCccCceeeecCC--CCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH
Confidence              599999999987654322  23468999999999986321  345788999999999999999999999875433 23


Q ss_pred             HHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccc
Q psy11571        239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDS  313 (372)
Q Consensus       239 ~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~  313 (372)
                      ...+..+.  ...+...+..+++.+.+||.+||+ ||++||++++++                 +||||++.+|..
T Consensus       354 ~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l-----------------~hp~~~~~~~~~  410 (419)
T 3i6u_A          354 KDQITSGK--YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL-----------------RHPWLQDEDMKR  410 (419)
T ss_dssp             HHHHHTTC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH-----------------HSGGGCCHHHHH
T ss_pred             HHHHhcCC--CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHh-----------------CCcccCChhHHH
Confidence            33444332  222222223689999999999999 999999876655                 999999888754

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1e-45  Score=347.68  Aligned_cols=277  Identities=16%  Similarity=0.147  Sum_probs=216.1

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYA   81 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~   81 (372)
                      +|+.++.+|.|    |+|.||.+.+..+++.||+|.+.......            .+.+|+.+++.+ +||||++++++
T Consensus        10 ~y~~~~~lg~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------~~~~E~~~l~~l~~h~~i~~~~~~   73 (330)
T 2izr_A           10 NFRVGKKIGCG----NFGELRLGKNLYTNEYVAIKLEPMKSRAP------------QLHLEYRFYKQLGSGDGIPQVYYF   73 (330)
T ss_dssp             TEEEEEECCC-----CTTSEEEEEETTTTEEEEEEEEETTCSSC------------CHHHHHHHHHHHCSCTTSCCEEEE
T ss_pred             CeEEEEEeecc----CCceEEEEEECCCCcEEEEEEeccccchH------------HHHHHHHHHHHhhCCCCCCEEEEE
Confidence            45556666666    89999999999999999999876543222            266799999998 89999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+.+..|+||||+ +++|.+++......+++..++.++.||+.||+|||+.||+|          |||||+|||++.++
T Consensus        74 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH----------rDlkp~Nill~~~~  142 (330)
T 2izr_A           74 GPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIY----------RDVKPENFLIGRPG  142 (330)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCCGGGEEECCGG
T ss_pred             EecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeec----------cCCCHHHeeeccCC
Confidence            99999999999999 99999999875578999999999999999999999999999          99999999999888


Q ss_pred             c-----EEEeecCcccccCCCCcc------cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCC
Q psy11571        162 H-----IRLADFGSCLRLGGDGTV------QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF  230 (372)
Q Consensus       162 ~-----vkl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf  230 (372)
                      .     +||+|||+++........      ......||+.|+|||++.+     ..++.++|||||||++|||++|..||
T Consensus       143 ~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~ell~g~~Pf  217 (330)
T 2izr_A          143 NKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG-----KEQSRRDDLEALGHMFMYFLRGSLPW  217 (330)
T ss_dssp             GTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcC-----CCCCchhHHHHHHHHHHHHhcCCCCc
Confidence            7     999999999876433221      1234689999999999983     56899999999999999999999999


Q ss_pred             CCC---CHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCc
Q psy11571        231 YAE---SLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWF  306 (372)
Q Consensus       231 ~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f  306 (372)
                      .+.   +..+.+.++......... .......+ ++.++|.+||. +|.+||+++++.+.+. +...+.      ..++.
T Consensus       218 ~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~-~~~~~~------~~~~~  288 (330)
T 2izr_A          218 QGLKADTLKERYQKIGDTKRATPI-EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFT-DLFDRK------GYMFD  288 (330)
T ss_dssp             TTCCCSSHHHHHHHHHHHHHHSCH-HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHH-HHHHHT------TCCCS
T ss_pred             cccccccHHHHHHHHHhhhccCCH-HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHH-HHHHHc------CCCCC
Confidence            874   444555555443221111 10111234 99999999999 9999999888876552 221111      44566


Q ss_pred             CCCCccccccCCCCC
Q psy11571        307 QGIAWDSIRDSNAPY  321 (372)
Q Consensus       307 ~~~~w~~~~~~~~p~  321 (372)
                      ..+||+. +...+|+
T Consensus       289 ~~~dw~~-~~~~~p~  302 (330)
T 2izr_A          289 YEYDWIG-KQLPTPV  302 (330)
T ss_dssp             CCCTTTT-SCCCCCC
T ss_pred             CCccCCC-CCcCCCC
Confidence            6789983 3334444

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.8e-46  Score=343.63  Aligned_cols=261  Identities=30%  Similarity=0.516  Sum_probs=218.7

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.++.|    |+|.||.+.+..+++.||+|.+........        ..+.+.+|+.+++.++||||++++++
T Consensus        22 ~~y~i~~~lg~G----~~g~V~~~~~~~~~~~valK~~~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~   89 (287)
T 2wei_A           22 ERYNIVCMLGKG----SFGEVLKCKDRITQQEYAVKVINKASAKNK--------DTSTILREVELLKKLDHPNIMKLFEI   89 (287)
T ss_dssp             HHEEEEEEEEEE----TTEEEEEEEETTTCCEEEEEEEEGGGBSSS--------CHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hcceeeEEEcCC----CCEEEEEEEEcCCCcEEEEEEecccccchH--------HHHHHHHHHHHHHhccCCCccEEEEE
Confidence            356666666666    899999999988999999998765443221        23457789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC-
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-  160 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~-  160 (372)
                      +.+.+.+|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++|++|          |||||+||+++.+ 
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H----------~dl~p~NIlv~~~~  158 (287)
T 2wei_A           90 LEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVH----------RDLKPENILLESKE  158 (287)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCCGGGEEESCSS
T ss_pred             EeCCCeEEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeec----------cCCChhhEEEecCC
Confidence            9999999999999999999999877 468999999999999999999999999999          9999999999754 


Q ss_pred             --CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHH
Q psy11571        161 --GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET  238 (372)
Q Consensus       161 --~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~  238 (372)
                        +.+||+|||++........  .....||+.|+|||++.      +.++.++|+||||+++|+|++|..||.+.+..+.
T Consensus       159 ~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  230 (287)
T 2wei_A          159 KDCDIKIIDFGLSTCFQQNTK--MKDRIGTAYYIAPEVLR------GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI  230 (287)
T ss_dssp             TTCCEEECSTTGGGTBCCCSS--CSCHHHHHTTCCHHHHT------TCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             CcccEEEeccCcceeecCCCc--cccccCcccccChHHhc------CCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence              4699999999987654332  22346899999999987      3488999999999999999999999999998888


Q ss_pred             HHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcc
Q psy11571        239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWD  312 (372)
Q Consensus       239 ~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~  312 (372)
                      ...+..+...+..+.  ...+++++.+||.+||. ||++||++++++                 +||||+...|+
T Consensus       231 ~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~ell-----------------~hp~~~~~~~~  286 (287)
T 2wei_A          231 LKRVETGKYAFDLPQ--WRTISDDAKDLIRKMLTFHPSLRITATQCL-----------------EHPWIQKYSSE  286 (287)
T ss_dssp             HHHHHHCCCCCCSGG--GTTSCHHHHHHHHHHTCSSGGGSCCHHHHH-----------------HSHHHHHHCCC
T ss_pred             HHHHHcCCCCCCchh--hhhcCHHHHHHHHHHcccChhhCcCHHHHh-----------------cCHHHhccccC
Confidence            888877654433332  23689999999999999 999999866665                 89999977664

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=6.1e-46  Score=348.21  Aligned_cols=255  Identities=19%  Similarity=0.293  Sum_probs=199.7

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||++.+..+++.||+|.+.......         ..+.+.+|+.+++.++||||+++++++
T Consensus         7 ~y~~~~~lG~G----~~g~V~~a~~~~~~~~vavK~~~~~~~~~---------~~~~~~~E~~~l~~l~hpniv~~~~~~   73 (332)
T 3qd2_B            7 DFEPIQCMGRG----GFGVVFEAKNKVDDCNYAIKRIRLPNREL---------AREKVMREVKALAKLEHPGIVRYFNAW   73 (332)
T ss_dssp             HEEEEEEEECC-----CSEEEEEEETTTCCEEEEEEEECCSTTT---------HHHHHHHHHHHHTSCCCTTBCCEEEEE
T ss_pred             cCceeeEecCC----CCeEEEEEEEcCCCcEEEEEEeecCCchh---------HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            45566667776    89999999999999999999887544221         235578899999999999999999998


Q ss_pred             EeCC---------------------------------------------------------eEEEEEeccCCCCHHHHHH
Q psy11571         83 QDDS---------------------------------------------------------NLYLVMDYYCGGDLLTLLS  105 (372)
Q Consensus        83 ~~~~---------------------------------------------------------~~~lv~E~~~gg~L~~~l~  105 (372)
                      .+..                                                         .+|+|||||++++|.+++.
T Consensus        74 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~  153 (332)
T 3qd2_B           74 LETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMN  153 (332)
T ss_dssp             EECCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHH
T ss_pred             EEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHh
Confidence            6543                                                         3899999999999999998


Q ss_pred             hcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCc----
Q psy11571        106 KFE--DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT----  179 (372)
Q Consensus       106 ~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~----  179 (372)
                      ...  ...++..++.++.||+.||.|||++||+|          |||||+|||++.++.+||+|||+++.......    
T Consensus       154 ~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH----------~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~  223 (332)
T 3qd2_B          154 RRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMH----------RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV  223 (332)
T ss_dssp             TCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCCGGGEEECTTCCEEECCCTTCEECSCC------
T ss_pred             cccCccchhhHHHHHHHHHHHHHHHHHHhCCeee----------cCCCcccEEEeCCCCEEEeecCcccccccchhhccc
Confidence            732  23466678999999999999999999999          99999999999999999999999987654321    


Q ss_pred             -------ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCC
Q psy11571        180 -------VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLP  252 (372)
Q Consensus       180 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  252 (372)
                             .......||+.|+|||++.+     ..++.++|||||||++|+|++|..|+..  .......+...    ..+
T Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~----~~~  292 (332)
T 3qd2_B          224 LTPMPAYATHTGQVGTKLYMSPEQIHG-----NNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNL----KFP  292 (332)
T ss_dssp             --------CCCSCC-CGGGSCHHHHHC-----CCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTT----CCC
T ss_pred             cccccccccccccCCCcCccChHHhcC-----CCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhcc----CCC
Confidence                   12233579999999999983     5689999999999999999999877532  12222233222    111


Q ss_pred             CCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        253 SDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       253 ~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      .. ....++++.+||.+||+ ||++||++++++                 +||||+++
T Consensus       293 ~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~~l-----------------~~~~f~~~  332 (332)
T 3qd2_B          293 LL-FTQKYPQEHMMVQDMLSPSPTERPEATDII-----------------ENAIFENL  332 (332)
T ss_dssp             HH-HHHHCHHHHHHHHHHHCSSGGGSCCHHHHH-----------------HSTTCCCC
T ss_pred             cc-cccCChhHHHHHHHHccCCCCcCCCHHHHh-----------------hchhhhcC
Confidence            11 11457889999999999 999999866655                 99999875

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.6e-45  Score=342.02  Aligned_cols=260  Identities=23%  Similarity=0.356  Sum_probs=212.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    ++|.||.+.+..+++.||+|.+.....            .+.+.+|+.+++.+.||||+++++++
T Consensus        30 ~y~~~~~lg~G----~~g~Vy~~~~~~~~~~vaiK~~~~~~~------------~~~~~~e~~~l~~l~h~~i~~~~~~~   93 (314)
T 3com_A           30 VFDVLEKLGEG----SYGSVYKAIHKETGQIVAIKQVPVESD------------LQEIIKEISIMQQCDSPHVVKYYGSY   93 (314)
T ss_dssp             CEEEEEECC--------CEEEEEEETTTCCEEEEEEEETTSC------------CHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhhhheeeccC----CCeEEEEEEECCCCCEEEEEecCchHH------------HHHHHHHHHHHHhCCCCCCccEEEEE
Confidence            34444555555    899999999888899999998865331            23467899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+.+.+|+||||+++++|.+++......+++..+..++.||+.||.|||+.|++|          |||||+||+++.++.
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H----------~dl~p~Nil~~~~~~  163 (314)
T 3com_A           94 FKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIH----------RDIKAGNILLNTEGH  163 (314)
T ss_dssp             EETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEECTTCC
T ss_pred             EeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcC----------CCcCHHHEEECCCCC
Confidence            9999999999999999999999855678999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||++........ ......||+.|+|||++.+     ..++.++||||||+++|+|++|..||...+.......+
T Consensus       164 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  237 (314)
T 3com_A          164 AKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQE-----IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI  237 (314)
T ss_dssp             EEECCCTTCEECBTTBS-CBCCCCSCGGGCCHHHHSS-----SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             EEEeecccchhhhhhcc-ccCccCCCCCccChhhcCC-----CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            99999999977644322 2234578999999999973     56889999999999999999999999988777665555


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI  314 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~  314 (372)
                      ..... ..+.  ....++..+.+||.+||. ||.+||++++++                 +||||++..+...
T Consensus       238 ~~~~~-~~~~--~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll-----------------~~~~~~~~~~~~~  290 (314)
T 3com_A          238 PTNPP-PTFR--KPELWSDNFTDFVKQCLVKSPEQRATATQLL-----------------QHPFVRSAKGVSI  290 (314)
T ss_dssp             HHSCC-CCCS--SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHT-----------------TSHHHHTCCCGGG
T ss_pred             hcCCC-cccC--CcccCCHHHHHHHHHHccCChhhCcCHHHHH-----------------hCHHHhcCCcchH
Confidence            44321 1111  112578999999999999 999999866555                 9999999877654

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1e-46  Score=351.60  Aligned_cols=254  Identities=24%  Similarity=0.335  Sum_probs=204.2

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    |+|.||.+.+..+++.||+|.+........       +..+.+.+|+.++..++||||++++++
T Consensus        12 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~~E~~~l~~l~hp~iv~~~~~   80 (311)
T 3ork_A           12 DRYELGEILGFG----GMSEVHLARDLRDHRDVAVKVLRADLARDP-------SFYLRFRREAQNAAALNHPAIVAVYDT   80 (311)
T ss_dssp             TTEEEEEEEEEC----SSEEEEEEEETTTTEEEEEEEECTTTTTSH-------HHHHHHHHHHTTCCCCCCTTBCCEEEE
T ss_pred             CcEEEEEEEccC----CCEEEEEEEECCCCceEEEEEeCccccCCH-------HHHHHHHHHHHHHHcCCCCCcceEEEe
Confidence            466667777777    899999999999999999998876544332       244668889999999999999999999


Q ss_pred             EEeCC----eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe
Q psy11571         82 FQDDS----NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        82 ~~~~~----~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      +....    ..|+||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+|          |||||+|||+
T Consensus        81 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH----------~dlkp~Nil~  149 (311)
T 3ork_A           81 GEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIH----------RDVKPANIMI  149 (311)
T ss_dssp             EEEEETTEEEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCC----------CCCCGGGEEE
T ss_pred             eeccCCCCcccEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCc----------CCCCHHHEEE
Confidence            87654    35999999999999999987 468999999999999999999999999999          9999999999


Q ss_pred             CCCCcEEEeecCcccccCCCCc--ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCH
Q psy11571        158 DANGHIRLADFGSCLRLGGDGT--VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL  235 (372)
Q Consensus       158 ~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~  235 (372)
                      +.++.+||+|||++........  .......||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.+.+.
T Consensus       150 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  224 (311)
T 3ork_A          150 SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-----DSVDARSDVYSLGCVLYEVLTGEPPFTGDSP  224 (311)
T ss_dssp             ETTSCEEECCCSCC------------------CCTTCCHHHHHT-----CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcC-----CCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence            9999999999999986643321  12233578999999999983     5689999999999999999999999999988


Q ss_pred             HHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       236 ~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      .+....+.......  +......+++++.+||.+||+ ||++||++.+++
T Consensus       225 ~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l  272 (311)
T 3ork_A          225 VSVAYQHVREDPIP--PSARHEGLSADLDAVVLKALAKNPENRYQTAAEM  272 (311)
T ss_dssp             HHHHHHHHHCCCCC--HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHH
T ss_pred             HHHHHHHhcCCCCC--cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHH
Confidence            88777666543222  211223689999999999999 999999866554

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.1e-45  Score=347.01  Aligned_cols=266  Identities=20%  Similarity=0.287  Sum_probs=211.2

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+..+.+|.|    |+|.||.+.+..+++.||+|.+......         .....+.+|+.+++.++||||+++++++
T Consensus        12 ~y~~~~~lg~G----~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv~~~~~~   78 (353)
T 2b9h_A           12 DFQLKSLLGEG----AYGVVCSATHKPTGEIVAIKKIEPFDKP---------LFALRTLREIKILKHFKHENIITIFNIQ   78 (353)
T ss_dssp             TEEEEEEEEEC----SSEEEEEEEETTTTEEEEEEEECCCSSH---------HHHHHHHHHHHHHHHCCCTTBCCEEEEC
T ss_pred             ceEEeeEEcCC----CCeEEEEEEECCCCcEEEEEeecccccc---------hHHHHHHHHHHHHHhCcCCCcCCeeeee
Confidence            45555666666    8999999999889999999988543221         1234567899999999999999999988


Q ss_pred             EeC-----CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe
Q psy11571         83 QDD-----SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        83 ~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      ...     ...|+||||+. ++|.+++..  ..+++..++.++.||+.||.|||++|++|          |||||+|||+
T Consensus        79 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH----------~Dlkp~Nil~  145 (353)
T 2b9h_A           79 RPDSFENFNEVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIH----------RDLKPSNLLI  145 (353)
T ss_dssp             CCSCSTTCCCEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCCGGGEEE
T ss_pred             cccccCccceEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeec----------CCCCHHHeEE
Confidence            764     67899999995 699999987  67999999999999999999999999999          9999999999


Q ss_pred             CCCCcEEEeecCcccccCCCCcc---------cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCC
Q psy11571        158 DANGHIRLADFGSCLRLGGDGTV---------QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGET  228 (372)
Q Consensus       158 ~~~~~vkl~Dfg~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~  228 (372)
                      +.++.+||+|||++.........         ......||+.|+|||++.+    ...++.++|||||||++|+|++|.+
T Consensus       146 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~  221 (353)
T 2b9h_A          146 NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT----SAKYSRAMDVWSCGCILAELFLRRP  221 (353)
T ss_dssp             CTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHS----CCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeecc----CCCccchhhHHHHHHHHHHHHhCCC
Confidence            99999999999999876432211         1123478999999999863    3568899999999999999999999


Q ss_pred             CCCCCCHHHHHHHHhhccCCcC----------------------CCC----CCCCCCCHHHHHHHHHhcc-CCCCCCCCC
Q psy11571        229 PFYAESLVETYGKIMNHQNSFD----------------------LPS----DVGYEISDDAKDLMRRLIC-SSDTRLGQN  281 (372)
Q Consensus       229 Pf~~~~~~~~~~~i~~~~~~~~----------------------~~~----~~~~~~s~~~~~li~~lL~-~p~~R~s~~  281 (372)
                      ||.+.+..+....+......+.                      .+.    .....+++++++||.+||+ ||++|||++
T Consensus       222 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  301 (353)
T 2b9h_A          222 IFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK  301 (353)
T ss_dssp             SCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             CCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHH
Confidence            9999887766555433211110                      000    0112679999999999999 999999866


Q ss_pred             ChhhhhhhhhhhhccCCCCCCCCCcCCCCccccc
Q psy11571        282 GIADFKMWSALFVSLSISPRNHPWFQGIAWDSIR  315 (372)
Q Consensus       282 ~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~  315 (372)
                      +++                 +||||+.+.+....
T Consensus       302 ell-----------------~hp~~~~~~~~~~~  318 (353)
T 2b9h_A          302 EAL-----------------EHPYLQTYHDPNDE  318 (353)
T ss_dssp             HHH-----------------TSGGGTTTCCTTSS
T ss_pred             HHh-----------------cCccccccCCcccc
Confidence            655                 99999988775543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.5e-45  Score=346.01  Aligned_cols=257  Identities=23%  Similarity=0.340  Sum_probs=204.3

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeeeE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLHY   80 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~~   80 (372)
                      ++|+.++.+|.|    |+|.||.+.+..+++.||+|.+.....             +.+.+|+.+++.+. ||||+++++
T Consensus        36 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~vavK~~~~~~~-------------~~~~~E~~~l~~l~~~~~i~~~~~   98 (330)
T 3nsz_A           36 DDYQLVRKLGRG----KYSEVFEAINITNNEKVVVKILKPVKK-------------KKIKREIKILENLRGGPNIITLAD   98 (330)
T ss_dssp             GGEEEEEEEEEC----SSEEEEEEEETTTCCEEEEEEECSCCH-------------HHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred             CceEEEEEeccc----CCeEEEEEEECCCCcEEEEEEecccch-------------HHHHHHHHHHHHcCCCCCEEEeee
Confidence            356666677776    899999999999999999998764321             34678999999987 999999999


Q ss_pred             EEEe--CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC
Q psy11571         81 AFQD--DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD  158 (372)
Q Consensus        81 ~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~  158 (372)
                      ++.+  ....++||||+.+++|.+++..    +++..++.++.||+.||.|||++||+|          |||||+|||++
T Consensus        99 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivH----------~Dikp~Nil~~  164 (330)
T 3nsz_A           99 IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMH----------RDVKPHNVMID  164 (330)
T ss_dssp             EEECTTTCCEEEEEECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEEE
T ss_pred             eeccCCCCceEEEEeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCeee----------CCCCHHHEEEc
Confidence            9998  6679999999999999998853    899999999999999999999999999          99999999999


Q ss_pred             CCC-cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC-CHH
Q psy11571        159 ANG-HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE-SLV  236 (372)
Q Consensus       159 ~~~-~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~-~~~  236 (372)
                      .++ .+||+|||+++.......  .....||+.|+|||++.+    ...++.++|||||||++|+|++|..||... +..
T Consensus       165 ~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~  238 (330)
T 3nsz_A          165 HEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVD----YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY  238 (330)
T ss_dssp             TTTTEEEECCCTTCEECCTTCC--CCSCCSCGGGCCHHHHTT----CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred             CCCCEEEEEeCCCceEcCCCCc--cccccccccccChhhhcC----CCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH
Confidence            776 899999999987654332  233578999999999973    356899999999999999999999999543 333


Q ss_pred             HHHHHHhh-------------ccCCc------------------CCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        237 ETYGKIMN-------------HQNSF------------------DLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       237 ~~~~~i~~-------------~~~~~------------------~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      +.+..+..             .....                  ..+......+++++++||.+||+ ||++|||+++++
T Consensus       239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l  318 (330)
T 3nsz_A          239 DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM  318 (330)
T ss_dssp             HHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence            32222211             00000                  00111112379999999999999 999999876665


Q ss_pred             hhhhhhhhhhccCCCCCCCCCcCCCCcc
Q psy11571        285 DFKMWSALFVSLSISPRNHPWFQGIAWD  312 (372)
Q Consensus       285 ~i~~~~~~~~~~~~~~~~hp~f~~~~w~  312 (372)
                                       +||||+++.|+
T Consensus       319 -----------------~hp~f~~~~~~  329 (330)
T 3nsz_A          319 -----------------EHPYFYTVVKD  329 (330)
T ss_dssp             -----------------TSGGGTTCC--
T ss_pred             -----------------cCccHhhhccC
Confidence                             99999999876

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.9e-45  Score=350.33  Aligned_cols=261  Identities=23%  Similarity=0.319  Sum_probs=209.0

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||++.+..+++.||+|.+.......        ...+.+.+|+.+++.++||||+++++++
T Consensus        43 ~y~~~~~lG~G----~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~  110 (371)
T 4exu_A           43 TYVSPTHVGSG----AYGSVCSAIDKRSGEKVAIKKLSRPFQSE--------IFAKRAYRELLLLKHMQHENVIGLLDVF  110 (371)
T ss_dssp             TEEEEEEEEEC----SSEEEEEEEETTTTEEEEEEEECSTTSSH--------HHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             cEEEEeEEecC----CCeEEEEEEECCCCCEEEEEEecccccch--------hHHHHHHHHHHHHHhcCCCCchhhhhhe
Confidence            45555666666    89999999999999999999887543322        1345678899999999999999999999


Q ss_pred             EeCCeE------EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEE
Q psy11571         83 QDDSNL------YLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL  156 (372)
Q Consensus        83 ~~~~~~------~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIl  156 (372)
                      ...+..      |+||||+. ++|.+++.   ..+++..++.++.||+.||.|||++||+|          |||||+|||
T Consensus       111 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH----------~Dikp~NIl  176 (371)
T 4exu_A          111 TPASSLRNFYDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVH----------RDLKPGNLA  176 (371)
T ss_dssp             CSCSSSTTCCCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCCGGGEE
T ss_pred             eccCCcccceeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcC----------CCcCHHHeE
Confidence            877654      99999995 68988874   45999999999999999999999999999          999999999


Q ss_pred             eCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH
Q psy11571        157 LDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV  236 (372)
Q Consensus       157 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~  236 (372)
                      ++.++.+||+|||+++.....    .....||+.|+|||++.+    ...++.++|||||||++|+|++|+.||.+.+..
T Consensus       177 l~~~~~~kL~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~  248 (371)
T 4exu_A          177 VNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILS----WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL  248 (371)
T ss_dssp             ECTTCCEEECSTTCC------------CTTCCCTTSCHHHHSC----CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ECCCCCEEEEecCcccccccC----cCCcccCccccCHHHhcC----CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH
Confidence            999999999999999865432    233578999999999973    356899999999999999999999999998887


Q ss_pred             HHHHHHhhccCCcC---------------------CCC----CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhh
Q psy11571        237 ETYGKIMNHQNSFD---------------------LPS----DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWS  290 (372)
Q Consensus       237 ~~~~~i~~~~~~~~---------------------~~~----~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~  290 (372)
                      +.+.++........                     .+.    .....+++++++||.+||+ ||++|||+++++      
T Consensus       249 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell------  322 (371)
T 4exu_A          249 DQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL------  322 (371)
T ss_dssp             HHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHH------
T ss_pred             HHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHh------
Confidence            77776654221110                     000    0012568999999999999 999999876655      


Q ss_pred             hhhhccCCCCCCCCCcCCCCcccc
Q psy11571        291 ALFVSLSISPRNHPWFQGIAWDSI  314 (372)
Q Consensus       291 ~~~~~~~~~~~~hp~f~~~~w~~~  314 (372)
                                 +||||+.+.....
T Consensus       323 -----------~hp~f~~~~~~~~  335 (371)
T 4exu_A          323 -----------THPFFEPFRDPEE  335 (371)
T ss_dssp             -----------TSGGGTTTCCGGG
T ss_pred             -----------cCcccccCCCccc
Confidence                       9999998765443

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=6.1e-46  Score=358.57  Aligned_cols=241  Identities=27%  Similarity=0.451  Sum_probs=192.0

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHH-hcCCCCceeeeeEEEEe----CCeEEEE
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVL-VYGDRRWITNLHYAFQD----DSNLYLV   91 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il-~~l~hp~Iv~l~~~~~~----~~~~~lv   91 (372)
                      |++|.||.+.+..+++.||+|.+...               ..+.+|+.++ +..+||||+++++++..    ...+|+|
T Consensus        73 G~~g~V~~~~~~~~~~~vAiK~~~~~---------------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv  137 (400)
T 1nxk_A           73 GINGKVLQIFNKRTQEKFALKMLQDC---------------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV  137 (400)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEECS---------------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             ccCeEEEEEEECCCCCEEEEEEeCcc---------------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEE
Confidence            48999999999999999999987532               1244567766 45689999999999876    5679999


Q ss_pred             EeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC---CCcEEEee
Q psy11571         92 MDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA---NGHIRLAD  167 (372)
Q Consensus        92 ~E~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~---~~~vkl~D  167 (372)
                      ||||+||+|.+++.... ..+++..++.++.||+.||.|||++||+|          |||||+|||++.   ++.+||+|
T Consensus       138 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH----------rDlkp~Nill~~~~~~~~~kl~D  207 (400)
T 1nxk_A          138 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH----------RDVKPENLLYTSKRPNAILKLTD  207 (400)
T ss_dssp             EECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCCGGGEEESSSSTTCCEEECC
T ss_pred             EEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------cCcCcceEEEecCCCCccEEEEe
Confidence            99999999999998632 35999999999999999999999999999          999999999997   78999999


Q ss_pred             cCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHH----HHHHHh
Q psy11571        168 FGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE----TYGKIM  243 (372)
Q Consensus       168 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~----~~~~i~  243 (372)
                      ||+++.......  ....+||+.|+|||++.     ...++.++|||||||++|+|++|..||.+.+...    ....+.
T Consensus       208 FG~a~~~~~~~~--~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~  280 (400)
T 1nxk_A          208 FGFAKETTSHNS--LTTPCYTPYYVAPEVLG-----PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR  280 (400)
T ss_dssp             CTTCEECC-------------CTTCCGGGSC-----CCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH
T ss_pred             cccccccCCCCc--cccCCCCCCccCHhhcC-----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH
Confidence            999987654322  23468999999999997     3678999999999999999999999998764322    344555


Q ss_pred             hccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        244 NHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      .+..  .++...+..+++++++||++||+ ||++|||+++++                 +||||..
T Consensus       281 ~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil-----------------~hp~~~~  327 (400)
T 1nxk_A          281 MGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM-----------------NHPWIMQ  327 (400)
T ss_dssp             HTCC--CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHH-----------------HSHHHHT
T ss_pred             cCcc--cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHh-----------------cCccccC
Confidence            5433  33333334789999999999999 999999866555                 9999975

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=349.31  Aligned_cols=260  Identities=25%  Similarity=0.393  Sum_probs=205.0

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCC--Cceeeee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDR--RWITNLH   79 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~h--p~Iv~l~   79 (372)
                      .+|+.++.+|.|    |+|.||++.+ .+++.||+|.+.......        ...+.+.+|+.++..+.|  |||++++
T Consensus         9 ~~y~i~~~lG~G----~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--------~~~~~~~~E~~~l~~l~~~~~~iv~~~   75 (343)
T 3dbq_A            9 RIYSILKQIGSG----GSSKVFQVLN-EKKQIYAIKYVNLEEADN--------QTLDSYRNEIAYLNKLQQHSDKIIRLY   75 (343)
T ss_dssp             CEEEEEEEESCC----SSEEEEEEEC-TTSCEEEEEEEECTTCCH--------HHHHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             CEEEEEEEEecC----CCeEEEEEEe-CCCCEEEEEEeeccccch--------HHHHHHHHHHHHHHhhhhcCCceEEEe
Confidence            356667777777    8999999976 468899999887554332        234668889999999876  9999999


Q ss_pred             EEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC
Q psy11571         80 YAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA  159 (372)
Q Consensus        80 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~  159 (372)
                      +++.+...+|+|||+ .+++|.+++.. ...+++.+++.++.||+.||.|||++||+|          |||||+|||++ 
T Consensus        76 ~~~~~~~~~~lv~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiH----------rDikp~NIll~-  142 (343)
T 3dbq_A           76 DYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVH----------SDLKPANFLIV-  142 (343)
T ss_dssp             EEEECSSEEEEEECC-CSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------CCCCGGGEEEE-
T ss_pred             eeEeeCCEEEEEEeC-CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeec----------CCCCcceEEEE-
Confidence            999999999999995 68899999988 578999999999999999999999999999          99999999996 


Q ss_pred             CCcEEEeecCcccccCCCCcc-cccccccCCcccCccccccccc------CCCCCCCccceeehhHHHHHHhhCCCCCCC
Q psy11571        160 NGHIRLADFGSCLRLGGDGTV-QSNVAVGTPDYISPEILTAMEE------GRGRYGPECDWWSLGVCMYEMLYGETPFYA  232 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~------~~~~~~~~~DiwslGvil~elltG~~Pf~~  232 (372)
                      ++.+||+|||+++........ .....+||+.|+|||++.+...      +...++.++|||||||++|+|++|+.||..
T Consensus       143 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  222 (343)
T 3dbq_A          143 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  222 (343)
T ss_dssp             TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence            688999999999876443221 2234679999999999863110      125688899999999999999999999987


Q ss_pred             CC-HHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        233 ES-LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       233 ~~-~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      .. ....+..+........+|.    ..+.++.+||.+||+ ||.+|||+.+++                 +||||+.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~L~~dp~~Rpt~~e~l-----------------~hp~~~~  279 (343)
T 3dbq_A          223 IINQISKLHAIIDPNHEIEFPD----IPEKDLQDVLKCCLKRDPKQRISIPELL-----------------AHPYVQI  279 (343)
T ss_dssp             CCSHHHHHHHHHCTTSCCCCCC----CSCHHHHHHHHHHTCSSTTTSCCHHHHH-----------------TSHHHHS
T ss_pred             hhhHHHHHHHHhcCCcccCCcc----cCCHHHHHHHHHHcCCChhHCCCHHHHH-----------------hCccccc
Confidence            43 3344555554444444444    568999999999999 999999866655                 9999984

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.8e-45  Score=339.34  Aligned_cols=254  Identities=26%  Similarity=0.385  Sum_probs=215.6

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    |+|.||.+.+..+++.||+|.+.......         ..+.+.+|+.+++.+.||||++++++
T Consensus        22 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~   88 (303)
T 3a7i_A           22 ELFTKLEKIGKG----SFGEVFKGIDNRTQKVVAIKIIDLEEAED---------EIEDIQQEITVLSQCDSPYVTKYYGS   88 (303)
T ss_dssp             GTEEEEEEEEEC----SSSEEEEEEETTTCCEEEEEEEETTTCST---------THHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             HHHHHhhhhccc----CCeEEEEEEECCCCcEEEEEEecccccHH---------HHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence            456666677776    89999999988899999999886554322         23557889999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+...+|+||||+++++|.+++..  +.+++..+..++.||+.||.|||+.|++|          |||||+||+++.++
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H----------~dl~p~Nil~~~~~  156 (303)
T 3a7i_A           89 YLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIH----------RDIKAANVLLSEHG  156 (303)
T ss_dssp             EEETTEEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEECTTS
T ss_pred             EecCCeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcc----------CCCChheEEECCCC
Confidence            9999999999999999999999975  67999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .++|+|||++........ ......||+.|+|||++.+     ..++.++|+||||+++|+|++|..||...+.......
T Consensus       157 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  230 (303)
T 3a7i_A          157 EVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQ-----SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL  230 (303)
T ss_dssp             CEEECCCTTCEECBTTBC-CBCCCCSCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred             CEEEeecccceecCcccc-ccCccCCCcCccCHHHHhc-----CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH
Confidence            999999999977654322 2334678999999999973     5688999999999999999999999998888777766


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      +.... ....+    ..++..+.+||.+||. ||.+||++++++                 +||||..
T Consensus       231 ~~~~~-~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll-----------------~~~~~~~  276 (303)
T 3a7i_A          231 IPKNN-PPTLE----GNYSKPLKEFVEACLNKEPSFRPTAKELL-----------------KHKFILR  276 (303)
T ss_dssp             HHHSC-CCCCC----SSCCHHHHHHHHHHCCSSGGGSCCHHHHT-----------------TCHHHHH
T ss_pred             hhcCC-CCCCc----cccCHHHHHHHHHHcCCChhhCcCHHHHh-----------------hChhhhc
Confidence            65532 22222    2689999999999999 999999866555                 9999964

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=6.1e-46  Score=348.60  Aligned_cols=291  Identities=19%  Similarity=0.204  Sum_probs=212.0

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhh----hhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLY----DECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITN   77 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~----K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~   77 (372)
                      ++|+.++.+|.|    |+|.||++.+..++..+++    |.+.......         ..+.+.+|+.++..++||||++
T Consensus        13 ~~y~~~~~lG~G----~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~---------~~~~~~~e~~~l~~l~h~~iv~   79 (325)
T 3kex_A           13 TELRKLKVLGSG----VFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ---------SFQAVTDHMLAIGSLDHAHIVR   79 (325)
T ss_dssp             TTEEEEEEEECC----SSCEEEEEEECCTTCSCCEEEEEEEECCTTSCS---------CBCSCCHHHHHHHTCCCTTBCC
T ss_pred             hHceeeeeeeec----CCceEEEEEEcCCCceEEEEEEEEeccccccHH---------HHHHHHHHHHHHhcCCCCCcCe
Confidence            456666777777    8999999998888887544    4433222111         1223567889999999999999


Q ss_pred             eeEEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe
Q psy11571         78 LHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        78 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      +++++. .+..++||||+++|+|.+++....+.+++..+..++.||+.||.|||++||+|          |||||+|||+
T Consensus        80 ~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH----------~Dikp~Nil~  148 (325)
T 3kex_A           80 LLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVH----------RNLAARNVLL  148 (325)
T ss_dssp             EEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCC----------SCCSSTTEEE
T ss_pred             EEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCC----------CccchheEEE
Confidence            999986 45689999999999999999875568999999999999999999999999999          9999999999


Q ss_pred             CCCCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCH
Q psy11571        158 DANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESL  235 (372)
Q Consensus       158 ~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~  235 (372)
                      +.++.+||+|||+++....... .......||+.|+|||++.+     ..++.++|||||||++|+|++ |..||.+.+.
T Consensus       149 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  223 (325)
T 3kex_A          149 KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF-----GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL  223 (325)
T ss_dssp             SSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT
T ss_pred             CCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhcc-----CCCChhhHhHHhHHHHHHHHhCCCCCccccCH
Confidence            9999999999999987654322 12234567889999999984     568999999999999999999 9999998887


Q ss_pred             HHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhh--------hhhccCCCCCCCCCc
Q psy11571        236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSA--------LFVSLSISPRNHPWF  306 (372)
Q Consensus       236 ~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~--------~~~~~~~~~~~hp~f  306 (372)
                      .+....+.... ....+.    .++.++.++|.+||. ||.+||++.++.+.+.-..        ..+........+|.+
T Consensus       224 ~~~~~~~~~~~-~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~p~~  298 (325)
T 3kex_A          224 AEVPDLLEKGE-RLAQPQ----ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGIAPGPEP  298 (325)
T ss_dssp             THHHHHHHTTC-BCCCCT----TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHHHHBCCCSSSSCCCBCCCCC
T ss_pred             HHHHHHHHcCC-CCCCCC----cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhhccccCCCCCCCCCCcc
Confidence            77776665542 333343    578899999999999 9999999888776542111        111222333578888


Q ss_pred             CCCCccccc--cCCCCCcCCCC
Q psy11571        307 QGIAWDSIR--DSNAPYIPEVS  326 (372)
Q Consensus       307 ~~~~w~~~~--~~~~p~~p~~~  326 (372)
                      .+++|+.+.  ...+|+.|...
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~d  320 (325)
T 3kex_A          299 HGLTNKKLEEVELEPELDLDLD  320 (325)
T ss_dssp             CC--------------------
T ss_pred             ccchhhcccccccchhccCCcc
Confidence            889888873  34567766543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.2e-45  Score=338.36  Aligned_cols=260  Identities=21%  Similarity=0.326  Sum_probs=196.8

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    |+|.||++.+..+++.||+|.+........        ..+.+.++...++.+.||||++++++
T Consensus         7 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~~~~~~~~~~~h~~iv~~~~~   74 (290)
T 3fme_A            7 DDLEPIMELGRG----AYGVVEKMRHVPSGQIMAVKRIRATVNSQE--------QKRLLMDLDISMRTVDCPFTVTFYGA   74 (290)
T ss_dssp             GGEEEEEEEEEC----SSEEEEEEEETTTTEEEEEEEEC---CHHH--------HHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             HhhhhHHhcCCC----CCeEEEEEEecCCCeEEEEEEeecccCcHH--------HHHHHHHHHHHHHhCCCCeEEEEeee
Confidence            456667777777    899999999999999999998865432221        23345556666888999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCCCcCCCCCcCcEEe
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSK---FEDRLPEDMAKFYIAEMVLAIASIHDL-HYVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      +.+.+..|+||||++ |+|.+++..   ....+++..++.++.||+.||.|||++ |++|          |||||+||++
T Consensus        75 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H----------~dlkp~Nil~  143 (290)
T 3fme_A           75 LFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIH----------RDVKPSNVLI  143 (290)
T ss_dssp             EECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCC----------CCCSGGGCEE
T ss_pred             eeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeec----------CCCCHHHEEE
Confidence            999999999999996 588887754   256899999999999999999999998 9999          9999999999


Q ss_pred             CCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCC-CCHH
Q psy11571        158 DANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLV  236 (372)
Q Consensus       158 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~-~~~~  236 (372)
                      +.++.+||+|||++........  .....||+.|+|||++.... ....++.++|||||||++|+|++|..||.. ....
T Consensus       144 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~  220 (290)
T 3fme_A          144 NALGQVKMCDFGISGYLVDDVA--KDIDAGCKPYMAPERINPEL-NQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF  220 (290)
T ss_dssp             CTTCCEEBCCC-----------------CCCCCCSCHHHHSCCT-TC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH
T ss_pred             CCCCCEEEeecCCccccccccc--ccccCCCccccChhhcChhh-cCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH
Confidence            9999999999999987654322  23357999999999973110 135688999999999999999999999986 3444


Q ss_pred             HHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       237 ~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      .....+..... ...+.   ..+++++.+||.+||+ ||++|||+++++                 +||||+.
T Consensus       221 ~~~~~~~~~~~-~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~e~l-----------------~hp~f~~  272 (290)
T 3fme_A          221 QQLKQVVEEPS-PQLPA---DKFSAEFVDFTSQCLKKNSKERPTYPELM-----------------QHPFFTL  272 (290)
T ss_dssp             HHHHHHHHSCC-CCCCT---TTSCHHHHHHHHHHTCSSGGGSCCHHHHT-----------------TSHHHHH
T ss_pred             HHHHHHhccCC-CCccc---ccCCHHHHHHHHHHhhcChhhCcCHHHHH-----------------hCccccc
Confidence            44444444322 22222   2689999999999999 999999866555                 9999974

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=6.4e-45  Score=334.20  Aligned_cols=251  Identities=18%  Similarity=0.249  Sum_probs=202.2

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYA   81 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~   81 (372)
                      +|+.++.+|.|    |+|.||.+.+..+++.||+|.+........        ....+.+|...+..+ +||||++++++
T Consensus        12 ~y~~~~~lg~G----~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~~e~~~~~~l~~h~~iv~~~~~   79 (289)
T 1x8b_A           12 EFHELEKIGSG----EFGSVFKCVKRLDGCIYAIKRSKKPLAGSV--------DEQNALREVYAHAVLGQHSHVVRYFSA   79 (289)
T ss_dssp             HEEEEEEEEEE----TTEEEEEEEETTTCCEEEEEEEECCCTTSH--------HHHHHHHHHHHHHHSCSCTTBCCEEEE
T ss_pred             hhhhhhhhcCC----CceEEEEEEEcCCCceEEEEEecccccccH--------HHHHHHHHHHHHHHhCCCCCeeeeeee
Confidence            45556666666    899999999998999999998876543322        124466788888887 89999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKF---EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD  158 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~  158 (372)
                      +.+.+.+++||||+++++|.+++...   ...+++..++.++.||+.||.|||++||+|          |||||+||+++
T Consensus        80 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH----------~Dikp~NIl~~  149 (289)
T 1x8b_A           80 WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVH----------MDIKPSNIFIS  149 (289)
T ss_dssp             EEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSGGGEEEC
T ss_pred             eecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEee----------cCCCHHHEEEc
Confidence            99999999999999999999999763   266999999999999999999999999999          99999999998


Q ss_pred             CC-------------------CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHH
Q psy11571        159 AN-------------------GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVC  219 (372)
Q Consensus       159 ~~-------------------~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvi  219 (372)
                      .+                   ..+||+|||++.......     ...||+.|+|||++.+    ...++.++|||||||+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~----~~~~~~~~Di~slG~i  220 (289)
T 1x8b_A          150 RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQE----NYTHLPKADIFALALT  220 (289)
T ss_dssp             --------------------CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTT----CCTTHHHHHHHHHHHH
T ss_pred             CCCCCcccccccccccccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcC----CCCCCchhhHHHHHHH
Confidence            44                   479999999998765432     2458999999999974    3356679999999999


Q ss_pred             HHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCC
Q psy11571        220 MYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSI  298 (372)
Q Consensus       220 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~  298 (372)
                      +|+|++|.+|+.....   ...+.... ...++.    .+++++.+||.+||. ||++||++.+++              
T Consensus       221 l~~l~~~~~~~~~~~~---~~~~~~~~-~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll--------------  278 (289)
T 1x8b_A          221 VVCAAGAEPLPRNGDQ---WHEIRQGR-LPRIPQ----VLSQEFTELLKVMIHPDPERRPSAMALV--------------  278 (289)
T ss_dssp             HHHHTTCCCCCSSSHH---HHHHHTTC-CCCCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHH--------------
T ss_pred             HHHHhcCCCCCcchhH---HHHHHcCC-CCCCCc----ccCHHHHHHHHHHhCCCcccCCCHHHHh--------------
Confidence            9999999988765432   33444332 223333    689999999999999 999999866655              


Q ss_pred             CCCCCCCcCCC
Q psy11571        299 SPRNHPWFQGI  309 (372)
Q Consensus       299 ~~~~hp~f~~~  309 (372)
                         +||||.+.
T Consensus       279 ---~h~~~~~~  286 (289)
T 1x8b_A          279 ---KHSVLLSA  286 (289)
T ss_dssp             ---TCTTC---
T ss_pred             ---hChHhhhh
Confidence               99999864

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.2e-45  Score=342.05  Aligned_cols=267  Identities=19%  Similarity=0.300  Sum_probs=191.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||.+.+..+++.||+|.+......         ...+.+.+|+.+++.++||||+++++++
T Consensus        16 ~y~~~~~lg~G----~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~   82 (303)
T 2vwi_A           16 DYELQEVIGSG----ATAVVQAAYCAPKKEKVAIKRINLEKCQ---------TSMDELLKEIQAMSQCHHPNIVSYYTSF   82 (303)
T ss_dssp             CCEEEEECC-------CCCEEEEEC----CEEEEECCC-------------------------CCCCCCCTTBCCEEEEE
T ss_pred             hhhhhheeccc----cceEEEEEEECCCCcEEEEEEEEhhhcc---------hhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence            45555566666    8999999999889999999987654321         1245577899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcE
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSK-------FEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNV  155 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~-------~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NI  155 (372)
                      .+.+..++||||+++++|.+++..       ....+++..++.++.||+.||.|||++|++|          |||||+||
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H----------~dl~p~Ni  152 (303)
T 2vwi_A           83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIH----------RDVKAGNI  152 (303)
T ss_dssp             ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCC----------CCCSGGGE
T ss_pred             eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC----------CCCChhhE
Confidence            999999999999999999999974       1356899999999999999999999999999          99999999


Q ss_pred             EeCCCCcEEEeecCcccccCCCCc----ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCC
Q psy11571        156 LLDANGHIRLADFGSCLRLGGDGT----VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY  231 (372)
Q Consensus       156 ll~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~  231 (372)
                      +++.++.+||+|||++........    .......||+.|+|||++.+    ...++.++|||||||++|+|++|..||.
T Consensus       153 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~  228 (303)
T 2vwi_A          153 LLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ----VRGYDFKADIWSFGITAIELATGAAPYH  228 (303)
T ss_dssp             EECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHH----HHCCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             EEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhcc----ccCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence            999999999999999876643221    11233578999999999863    2347899999999999999999999999


Q ss_pred             CCCHHHHHHHHhhccCCcCCC-----CCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCC
Q psy11571        232 AESLVETYGKIMNHQNSFDLP-----SDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPW  305 (372)
Q Consensus       232 ~~~~~~~~~~i~~~~~~~~~~-----~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~  305 (372)
                      ..+.............. ..+     ......+++++++||.+||+ ||.+||++.+++                 +|||
T Consensus       229 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll-----------------~h~~  290 (303)
T 2vwi_A          229 KYPPMKVLMLTLQNDPP-SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL-----------------RHKF  290 (303)
T ss_dssp             TSCGGGHHHHHHTSSCC-CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHH-----------------TSTT
T ss_pred             cCchhhHHHHHhccCCC-ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHh-----------------hChh
Confidence            87766555544433211 111     11223678999999999999 999999866555                 9999


Q ss_pred             cCCCCcccc
Q psy11571        306 FQGIAWDSI  314 (372)
Q Consensus       306 f~~~~w~~~  314 (372)
                      |+...++.+
T Consensus       291 ~~~~~~~~~  299 (303)
T 2vwi_A          291 FQKAKNKEF  299 (303)
T ss_dssp             C--------
T ss_pred             hhcCCCCcc
Confidence            998877654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.6e-45  Score=352.97  Aligned_cols=259  Identities=25%  Similarity=0.396  Sum_probs=205.3

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC--CCceeeeeEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD--RRWITNLHYA   81 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~--hp~Iv~l~~~   81 (372)
                      |+.++.+|.|    |+|.||++.+. +++.||+|.+.......        ...+.+.+|+.++..+.  ||||++++++
T Consensus        58 y~~~~~LG~G----~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~--------~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~  124 (390)
T 2zmd_A           58 YSILKQIGSG----GSSKVFQVLNE-KKQIYAIKYVNLEEADN--------QTLDSYRNEIAYLNKLQQHSDKIIRLYDY  124 (390)
T ss_dssp             EEEEEEEECC----SSEEEEEEECT-TCCEEEEEEEECTTCCH--------HHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             eEEEEEEccC----CCeEEEEEEcC-CCCEEEEEEEecccccH--------HHHHHHHHHHHHHHHcccCCCeEEEEEEE
Confidence            5555666666    89999999765 48899999887654322        23466888999999886  5999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+.+.+|+||| +.+++|.+++.. ...+++.+++.++.||+.||.|||++||+|          |||||+|||++ ++
T Consensus       125 ~~~~~~~~lv~E-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH----------rDlkp~NIll~-~~  191 (390)
T 2zmd_A          125 EITDQYIYMVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVH----------SDLKPANFLIV-DG  191 (390)
T ss_dssp             EECSSEEEEEEE-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCC----------CCCCGGGEEES-SS
T ss_pred             EecCCEEEEEEe-cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeee----------cCCCHHHEEEE-CC
Confidence            999999999999 568899999988 568999999999999999999999999999          99999999995 58


Q ss_pred             cEEEeecCcccccCCCCc-ccccccccCCcccCccccccccc------CCCCCCCccceeehhHHHHHHhhCCCCCCCCC
Q psy11571        162 HIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEE------GRGRYGPECDWWSLGVCMYEMLYGETPFYAES  234 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~------~~~~~~~~~DiwslGvil~elltG~~Pf~~~~  234 (372)
                      .+||+|||+++....... ......+||+.|+|||++.+...      ....++.++|||||||++|+|++|++||....
T Consensus       192 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~  271 (390)
T 2zmd_A          192 MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII  271 (390)
T ss_dssp             CEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             eEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence            999999999987643322 12234679999999999874211      11358899999999999999999999998753


Q ss_pred             -HHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        235 -LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       235 -~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                       ....+..+........+|.    ..+.++++||.+||+ ||.+||++.+++                 +||||+..
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~ell-----------------~hp~~~~~  327 (390)
T 2zmd_A          272 NQISKLHAIIDPNHEIEFPD----IPEKDLQDVLKCCLKRDPKQRISIPELL-----------------AHPYVQIQ  327 (390)
T ss_dssp             CHHHHHHHHHCTTSCCCCCC----CSCHHHHHHHHHHTCSSTTTSCCHHHHH-----------------TSHHHHSC
T ss_pred             HHHHHHHHHhCccccCCCCc----cchHHHHHHHHHHcccChhhCCCHHHHh-----------------hCcCcccc
Confidence             3455566665544444554    568999999999999 999999866555                 99999854

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.1e-45  Score=332.79  Aligned_cols=250  Identities=20%  Similarity=0.231  Sum_probs=212.0

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    |+|.||.+... ++..||+|.+.......           +.+.+|+.+++.++||||++++++
T Consensus        10 ~~y~~~~~lg~G----~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----------~~~~~E~~~l~~l~h~~i~~~~~~   73 (269)
T 4hcu_A           10 SELTFVQEIGSG----QFGLVHLGYWL-NKDKVAIKTIREGAMSE-----------EDFIEEAEVMMKLSHPKLVQLYGV   73 (269)
T ss_dssp             GGEEEEEEEEEC----SSCEEEEEEET-TTEEEEEEEECTTSBCH-----------HHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hhceeeheecCC----CccEEEEEEec-CCCeEEEEEecccccCH-----------HHHHHHHHHHHhCCCCCEeeEEEE
Confidence            356666677777    89999999865 56779999887654332           336789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+.+..|+||||+++++|.+++......+++..+..++.|++.||.|||+.|++|          |||||+||+++.++
T Consensus        74 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H----------~dikp~Nil~~~~~  143 (269)
T 4hcu_A           74 CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH----------RDLAARNCLVGENQ  143 (269)
T ss_dssp             ECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCCGGGEEECGGG
T ss_pred             EecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeec----------CCcchheEEEcCCC
Confidence            99999999999999999999999875667999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYG  240 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~  240 (372)
                      .+||+|||++...............+|+.|+|||++.+     ..++.++|+||||+++|+|++ |..||.+.+..+...
T Consensus       144 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~  218 (269)
T 4hcu_A          144 VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-----SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE  218 (269)
T ss_dssp             CEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred             CEEeccccccccccccccccccCcccccccCCHHHhcC-----CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence            99999999998765433333334567788999999974     568999999999999999999 999999999888888


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .+.... ....+.    ..++++.++|.+||+ ||++||++.++++.+
T Consensus       219 ~~~~~~-~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l  261 (269)
T 4hcu_A          219 DISTGF-RLYKPR----LASTHVYQIMNHCWRERPEDRPAFSRLLRQL  261 (269)
T ss_dssp             HHHTTC-CCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHhcCc-cCCCCC----cCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence            877652 222333    579999999999999 999999988777554

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=4.8e-45  Score=354.50  Aligned_cols=260  Identities=25%  Similarity=0.357  Sum_probs=205.2

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    ++|.||++++..+++.||+|.+......              ..+|+.+++.++||||+++++++
T Consensus        55 ~y~~~~~lG~G----~fg~Vy~~~~~~~~~~vaiK~~~~~~~~--------------~~~E~~il~~l~hpniv~l~~~~  116 (420)
T 1j1b_A           55 SYTDTKVIGNG----SFGVVYQAKLCDSGELVAIKKVLQDKRF--------------KNRELQIMRKLDHCNIVRLRYFF  116 (420)
T ss_dssp             EEEEEEEEEEC----SSEEEEEEEETTTCCEEEEEEEECCTTS--------------CCHHHHHHHTCCCTTBCCEEEEE
T ss_pred             eEEeeeEEeeC----CCEEEEEEEECCCCcEEEEEEecccchh--------------HHHHHHHHHHcCCCCccceeeEE
Confidence            34555566666    8999999999889999999987543211              23589999999999999999998


Q ss_pred             EeC------CeEEEEEeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcC
Q psy11571         83 QDD------SNLYLVMDYYCGGDLLTLLSK---FEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPD  153 (372)
Q Consensus        83 ~~~------~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~  153 (372)
                      ...      ..+++||||+++ +|.+.+..   ....+++..++.++.||+.||.|||++||+|          |||||+
T Consensus       117 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH----------rDlkp~  185 (420)
T 1j1b_A          117 YSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH----------RDIKPQ  185 (420)
T ss_dssp             EEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEEC----------SCCSGG
T ss_pred             eccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------cCCChh
Confidence            542      247899999965 77766642   2567999999999999999999999999999          999999


Q ss_pred             cEEeCCC-CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCC
Q psy11571        154 NVLLDAN-GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA  232 (372)
Q Consensus       154 NIll~~~-~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~  232 (372)
                      |||++.+ +.+||+|||+++.......  .....||+.|+|||++.+    ...++.++|||||||++|||++|++||.+
T Consensus       186 NILl~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~G~~pf~~  259 (420)
T 1j1b_A          186 NLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAPELIFG----ATDYTSSIDVWSAGCVLAELLLGQPIFPG  259 (420)
T ss_dssp             GEEEETTTTEEEECCCTTCEECCTTCC--CCSCCSCTTSCCHHHHTT----CSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             hEEEeCCCCeEEeccchhhhhcccCCC--ceeeeeCCCcCCHHHHcC----CCCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            9999955 6789999999987644332  233678999999999973    34689999999999999999999999999


Q ss_pred             CCHHHHHHHHhhccC---------------CcCCCCC--------CCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhh
Q psy11571        233 ESLVETYGKIMNHQN---------------SFDLPSD--------VGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKM  288 (372)
Q Consensus       233 ~~~~~~~~~i~~~~~---------------~~~~~~~--------~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~  288 (372)
                      .+..+.+.++++...               .+.+|..        ....+++++++||++||+ ||.+||++.+++    
T Consensus       260 ~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l----  335 (420)
T 1j1b_A          260 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC----  335 (420)
T ss_dssp             SSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH----
T ss_pred             CCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHh----
Confidence            887777666654211               1112211        112568999999999999 999999866555    


Q ss_pred             hhhhhhccCCCCCCCCCcCCCCcccc
Q psy11571        289 WSALFVSLSISPRNHPWFQGIAWDSI  314 (372)
Q Consensus       289 ~~~~~~~~~~~~~~hp~f~~~~w~~~  314 (372)
                                   +||||+++.+...
T Consensus       336 -------------~hp~f~~~~~~~~  348 (420)
T 1j1b_A          336 -------------AHSFFDELRDPNV  348 (420)
T ss_dssp             -------------TSGGGGGGGCTTC
T ss_pred             -------------CCHhhcccccccc
Confidence                         9999998766543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=5.3e-46  Score=348.37  Aligned_cols=270  Identities=26%  Similarity=0.437  Sum_probs=209.1

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||++.+..+++.||+|.+.........  .........+.+|+.+++.++||||+++++++
T Consensus        11 ~y~~~~~lg~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   84 (322)
T 2ycf_A           11 EYIMSKTLGSG----ACGEVKLAFERKTCKKVAIKIISKRKFAIGS--AREADPALNVETEIEILKKLNHPCIIKIKNFF   84 (322)
T ss_dssp             HEEEEEEEEEC----SSEEEEEEEETTTTEEEEEEEECC-----------------CHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ceeEeeEEecC----CCEEEEEEEEcCCCcEEEEEEeehhhhhhcc--cccchhhhhHHHHHHHHHhCCCCCCceEeeEE
Confidence            55556666666    8999999999999999999988765432110  01112334578899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      ..+. .|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++|++|          |||||+||+++.++.
T Consensus        85 ~~~~-~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH----------~dlkp~NIl~~~~~~  152 (322)
T 2ycf_A           85 DAED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIH----------RDLKPENVLLSSQEE  152 (322)
T ss_dssp             ESSS-EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEESSSSS
T ss_pred             cCCc-eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeec----------cCCCHHHEEEecCCC
Confidence            7665 8999999999999999976 578999999999999999999999999999          999999999987664


Q ss_pred             ---EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH-HH
Q psy11571        163 ---IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-ET  238 (372)
Q Consensus       163 ---vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-~~  238 (372)
                         +||+|||++........  .....||+.|+|||++.+.  +...++.++|||||||++|+|++|..||...... ..
T Consensus       153 ~~~~kl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  228 (322)
T 2ycf_A          153 DCLIKITDFGHSKILGETSL--MRTLCGTPTYLAPEVLVSV--GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL  228 (322)
T ss_dssp             SCCEEECCCTTCEECCCCHH--HHHHHSCCTTCCHHHHHHT--TTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH
T ss_pred             CCeEEEccCccceecccccc--cccccCCcCccCchhhccC--CCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH
Confidence               99999999987654322  2335799999999998521  1356889999999999999999999999865433 23


Q ss_pred             HHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccc
Q psy11571        239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDS  313 (372)
Q Consensus       239 ~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~  313 (372)
                      ...+..+..  .........+++++.+||.+||. ||++||++++++                 +||||++.+|..
T Consensus       229 ~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l-----------------~h~~~~~~~~~~  285 (322)
T 2ycf_A          229 KDQITSGKY--NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL-----------------RHPWLQDEDMKR  285 (322)
T ss_dssp             HHHHHHTCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH-----------------TSGGGCCHHHHH
T ss_pred             HHHHHhCcc--ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHh-----------------hCcCcCCHHHHH
Confidence            333443322  22222223679999999999999 999999866655                 999999988754

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.1e-45  Score=342.48  Aligned_cols=264  Identities=22%  Similarity=0.357  Sum_probs=207.3

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYA   81 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~   81 (372)
                      +|+.++.+|.|    |+|.||.+.+..+++.||+|.+.......           +.+.+|+.+++.+ .||||++++++
T Consensus        25 ~y~~~~~lg~G----~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~e~~~l~~l~~h~~i~~~~~~   89 (326)
T 2x7f_A           25 IFELVELVGNG----TYGQVYKGRHVKTGQLAAIKVMDVTGDEE-----------EEIKQEINMLKKYSHHRNIATYYGA   89 (326)
T ss_dssp             TEEEEEEEEEE----TTEEEEEEEETTTCCEEEEEEEECCSSTT-----------HHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred             cEEEEEEeccC----CCEEEEEEEECCCCCeEEEEEEecCcccH-----------HHHHHHHHHHHhccCCCCeeeeeeE
Confidence            45555666666    89999999998899999999886543221           3466788888887 79999999999


Q ss_pred             EEe------CCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCc
Q psy11571         82 FQD------DSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDN  154 (372)
Q Consensus        82 ~~~------~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~N  154 (372)
                      +..      ...+|+||||+++++|.+++... ...+++..++.++.||+.||.|||+.|++|          |||||+|
T Consensus        90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH----------~dlkp~N  159 (326)
T 2x7f_A           90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIH----------RDIKGQN  159 (326)
T ss_dssp             EEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------CCCSGGG
T ss_pred             EeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------cCCcHHH
Confidence            987      46899999999999999999863 257999999999999999999999999999          9999999


Q ss_pred             EEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCC
Q psy11571        155 VLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES  234 (372)
Q Consensus       155 Ill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~  234 (372)
                      |+++.++.+||+|||++........ ......||+.|+|||++.........++.++|||||||++|+|++|..||.+.+
T Consensus       160 Il~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  238 (326)
T 2x7f_A          160 VLLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH  238 (326)
T ss_dssp             EEECTTCCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             EEEcCCCCEEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence            9999999999999999876543221 223457899999999987432223568899999999999999999999999888


Q ss_pred             HHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccc
Q psy11571        235 LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDS  313 (372)
Q Consensus       235 ~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~  313 (372)
                      .......+......    ......+++.+++||.+||. ||.+||++++++                 +||||++..++.
T Consensus       239 ~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll-----------------~hp~~~~~~~~~  297 (326)
T 2x7f_A          239 PMRALFLIPRNPAP----RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLM-----------------KHPFIRDQPNER  297 (326)
T ss_dssp             HHHHHHHHHHSCCC----CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHH-----------------TSHHHHCCTTHH
T ss_pred             HHHHHHHhhcCccc----cCCccccCHHHHHHHHHHhccChhhCCCHHHHh-----------------hChHHhhCcccc
Confidence            77776666554322    22223689999999999999 999999866555                 999999887654

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.4e-45  Score=351.25  Aligned_cols=258  Identities=23%  Similarity=0.367  Sum_probs=207.6

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      .+|+.++.+|.|    |+|.||.+.+..+++.||+|.+......              ..+|+.+++.++||||++++++
T Consensus         7 ~~y~~~~~lG~G----~fg~V~~a~~~~~~~~vAiK~~~~~~~~--------------~~~E~~il~~l~hpnIv~l~~~   68 (383)
T 3eb0_A            7 KKYSLGKTLGTG----SFGIVCEVFDIESGKRFALKKVLQDPRY--------------KNRELDIMKVLDHVNIIKLVDY   68 (383)
T ss_dssp             TTEEEEEEEECC-----CEEEEEEEETTTCCEEEEEEEECCTTS--------------CCHHHHHHTTCCCTTBCCEEEE
T ss_pred             ceEEEEEEEEec----cCEEEEEEEECCCCCEEEEEEEecCcch--------------HHHHHHHHHHcCCCCccchhhe
Confidence            356666777777    8999999999999999999987644221              2358999999999999999999


Q ss_pred             EEe--------------------------------------CCeEEEEEeccCCCCHHHHHHh---cCCCCCHHHHHHHH
Q psy11571         82 FQD--------------------------------------DSNLYLVMDYYCGGDLLTLLSK---FEDRLPEDMAKFYI  120 (372)
Q Consensus        82 ~~~--------------------------------------~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~~~  120 (372)
                      +..                                      ...+++||||++ |+|.+.+..   ....+++..++.++
T Consensus        69 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~  147 (383)
T 3eb0_A           69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYI  147 (383)
T ss_dssp             EEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHH
T ss_pred             eeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHH
Confidence            844                                      334899999997 588777653   25679999999999


Q ss_pred             HHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC-CCCcEEEeecCcccccCCCCcccccccccCCcccCcccccc
Q psy11571        121 AEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD-ANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTA  199 (372)
Q Consensus       121 ~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~-~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~  199 (372)
                      .||+.||.|||++||+|          |||||+|||++ .++.+||+|||+++.......  .....||+.|+|||++.+
T Consensus       148 ~qi~~aL~~LH~~gi~H----------~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~  215 (383)
T 3eb0_A          148 YQLFRAVGFIHSLGICH----------RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLG  215 (383)
T ss_dssp             HHHHHHHHHHHTTTEEC----------SCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTT
T ss_pred             HHHHHHHHHHHHCcCcc----------CccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcC
Confidence            99999999999999999          99999999997 688999999999987654332  233578999999999874


Q ss_pred             cccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCC---------------cCCCCC--------CC
Q psy11571        200 MEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNS---------------FDLPSD--------VG  256 (372)
Q Consensus       200 ~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~~~--------~~  256 (372)
                          ...++.++|||||||++|+|++|++||.+.+..+.+.++......               ..+|..        ..
T Consensus       216 ----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (383)
T 3eb0_A          216 ----ATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILP  291 (383)
T ss_dssp             ----CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSC
T ss_pred             ----CCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCC
Confidence                455899999999999999999999999999888877776542111               111110        12


Q ss_pred             CCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCc
Q psy11571        257 YEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAW  311 (372)
Q Consensus       257 ~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w  311 (372)
                      ..+++++.+||.+||+ ||.+|||+.+++                 +||||+.+.+
T Consensus       292 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l-----------------~hp~f~~~~~  330 (383)
T 3eb0_A          292 EGTPSLAIDLLEQILRYEPDLRINPYEAM-----------------AHPFFDHLRN  330 (383)
T ss_dssp             TTCCHHHHHHHHHHCCSSGGGSCCHHHHH-----------------TSGGGHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHh-----------------cCHHHHHHHh
Confidence            2578999999999999 999999876655                 9999987643

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=7e-45  Score=337.59  Aligned_cols=263  Identities=22%  Similarity=0.380  Sum_probs=213.3

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||.+.+..+++.+|+|.+........      .+..+.+.+|+.+++.++||||+++++++
T Consensus         6 ~y~i~~~lg~G----~~g~V~~~~~~~~~~~~avK~~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   75 (305)
T 2wtk_C            6 KYLMGDLLGEG----SYGKVKEVLDSETLCRRAVKILKKKKLRRI------PNGEANVKKEIQLLRRLRHKNVIQLVDVL   75 (305)
T ss_dssp             CBCCCCEEEEC----SSCEEEEEEBTTTCCEEEEEEECHHHHHHS------TTHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ceeEeeEEecC----CCeEEEEEEECCCCcEEEEEEecccccccc------chhHHHHHHHHHHHHhcCCCCeeEEEEEE
Confidence            45666667776    899999999988999999998876543321      12245688899999999999999999998


Q ss_pred             E--eCCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC
Q psy11571         83 Q--DDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA  159 (372)
Q Consensus        83 ~--~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~  159 (372)
                      .  +....|+||||+.++ |.+++... ...+++..+..++.||+.||.|||++|++|          |||||+||+++.
T Consensus        76 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H----------~dlkp~NIl~~~  144 (305)
T 2wtk_C           76 YNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVH----------KDIKPGNLLLTT  144 (305)
T ss_dssp             ECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSGGGEEECT
T ss_pred             EcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeee----------cCCCcccEEEcC
Confidence            4  456899999999766 77777653 457999999999999999999999999999          999999999999


Q ss_pred             CCcEEEeecCcccccCCCC-cccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHH
Q psy11571        160 NGHIRLADFGSCLRLGGDG-TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET  238 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~  238 (372)
                      ++.+||+|||++....... ........||+.|+|||++.+.   ...++.++||||||+++|+|++|..||.+.+..+.
T Consensus       145 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~  221 (305)
T 2wtk_C          145 GGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGL---DTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL  221 (305)
T ss_dssp             TCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCC---SCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             CCcEEeeccccccccCccccccccccCCCCCCCcChhhccCc---ccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Confidence            9999999999998764321 1122345689999999998731   12346799999999999999999999999998888


Q ss_pred             HHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcc
Q psy11571        239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWD  312 (372)
Q Consensus       239 ~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~  312 (372)
                      ...+....  ..++.    .+++.+.+||.+||. ||.+||++++++                 +||||+.....
T Consensus       222 ~~~i~~~~--~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll-----------------~~~~~~~~~~~  273 (305)
T 2wtk_C          222 FENIGKGS--YAIPG----DCGPPLSDLLKGMLEYEPAKRFSIRQIR-----------------QHSWFRKKHPP  273 (305)
T ss_dssp             HHHHHHCC--CCCCS----SSCHHHHHHHHHHTCSSTTTSCCHHHHH-----------------HSHHHHSCCCC
T ss_pred             HHHHhcCC--CCCCC----ccCHHHHHHHHHHccCChhhCCCHHHHh-----------------cCcccccCCCC
Confidence            88887653  33344    679999999999999 999999866655                 89999876543

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.9e-45  Score=338.85  Aligned_cols=273  Identities=21%  Similarity=0.208  Sum_probs=215.8

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHY   80 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~   80 (372)
                      .+|+.++.++.|    ++|.||.+.+..+++.||+|.+.......            .+.+|+.+++.+ .||||+++++
T Consensus        10 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------~~~~e~~~~~~l~~~~~i~~~~~   73 (298)
T 1csn_A           10 VHYKVGRRIGEG----SFGVIFEGTNLLNNQQVAIKFEPRRSDAP------------QLRDEYRTYKLLAGCTGIPNVYY   73 (298)
T ss_dssp             TTEEEEEEEEEC----SSCEEEEEEETTTTEEEEEEEEECCTTSC------------CHHHHHHHHHHTTTCTTCCCEEE
T ss_pred             cceEEEEEEeec----CCEEEEEEEECCCCcEEEEEEeccCCccH------------HHHHHHHHHHHHhcCCCCCeEEe
Confidence            355666667766    89999999998999999999876443222            256788888888 7999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         81 AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        81 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      ++.+....++||||+ +++|.+++......+++..+..++.||+.||.|||++||+|          |||||+||+++.+
T Consensus        74 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH----------~Dlkp~NIl~~~~  142 (298)
T 1csn_A           74 FGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY----------RDIKPDNFLIGRP  142 (298)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEEC----------CCCCGGGEEECCS
T ss_pred             ecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEec----------CCCCHHHEEeccC
Confidence            999999999999999 99999999875567999999999999999999999999999          9999999999877


Q ss_pred             Cc-----EEEeecCcccccCCCCcc------cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCC
Q psy11571        161 GH-----IRLADFGSCLRLGGDGTV------QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP  229 (372)
Q Consensus       161 ~~-----vkl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~P  229 (372)
                      +.     +||+|||+++........      ......||+.|+|||++.+     ..++.++|||||||++|+|++|+.|
T Consensus       143 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~g~~p  217 (298)
T 1csn_A          143 NSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-----REQSRRDDLEALGHVFMYFLRGSLP  217 (298)
T ss_dssp             SSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             CCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcC-----CCCChHHHHHHHHHHHHHHHcCCCC
Confidence            65     999999999876543221      2234679999999999973     5689999999999999999999999


Q ss_pred             CCCC---CHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCC
Q psy11571        230 FYAE---SLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPW  305 (372)
Q Consensus       230 f~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~  305 (372)
                      |.+.   ...+.+..+.........+ .....+++++.+||.+||+ ||++||+++++.+.+.  .+.     .......
T Consensus       218 f~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~--~~~-----~~~~~~~  289 (298)
T 1csn_A          218 WQGLKAATNKQKYERIGEKKQSTPLR-ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS--KVL-----ERLNTTE  289 (298)
T ss_dssp             TSSCCSCCHHHHHHHHHHHHHHSCHH-HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH--HHH-----HHTTCCS
T ss_pred             cchhhccccHHHHHHHHhhccCccHH-HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHH--HHH-----HhcCCCC
Confidence            9874   4445555554432212111 1112679999999999999 9999999887766551  111     1125566


Q ss_pred             cCCCCcccc
Q psy11571        306 FQGIAWDSI  314 (372)
Q Consensus       306 f~~~~w~~~  314 (372)
                      ...+||+.+
T Consensus       290 ~~~~dw~~l  298 (298)
T 1csn_A          290 DENFDWNLL  298 (298)
T ss_dssp             CSCCGGGCC
T ss_pred             CCccccCCC
Confidence            777888753

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=7.3e-45  Score=341.45  Aligned_cols=252  Identities=20%  Similarity=0.235  Sum_probs=208.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhh---hhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILL---VLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLH   79 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~---va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~   79 (372)
                      +|+..+.+|.|    |+|.||.+....++..   ||+|.+.......         ..+.+.+|+.+++.++||||++++
T Consensus        50 ~y~i~~~lG~G----~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~E~~~l~~l~h~~iv~~~  116 (325)
T 3kul_A           50 RIHIEKIIGSG----DSGEVCYGRLRVPGQRDVPVAIKALKAGYTER---------QRRDFLSEASIMGQFDHPNIIRLE  116 (325)
T ss_dssp             GEEEEEEEEET----TTEEEEEEEECCTTSCCEEEEEEEECTTCCHH---------HHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             HeEEeeEEEeC----CCcEEEEEEEecCCCCCceEEEEecCCCCCHH---------HHHHHHHHHHHHHhCCCCCCCcEE
Confidence            44455556666    8999999988766554   9999886543221         235678899999999999999999


Q ss_pred             EEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC
Q psy11571         80 YAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA  159 (372)
Q Consensus        80 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~  159 (372)
                      +++.+.+..|+||||+++|+|.+++....+.+++..+..++.||+.||.|||+.||+|          |||||+|||++.
T Consensus       117 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH----------~Dlkp~NIll~~  186 (325)
T 3kul_A          117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVH----------RDLAARNVLVDS  186 (325)
T ss_dssp             EEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSGGGEEECT
T ss_pred             EEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeC----------CCCCcceEEECC
Confidence            9999999999999999999999999875678999999999999999999999999999          999999999999


Q ss_pred             CCcEEEeecCcccccCCCCc--ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHH
Q psy11571        160 NGHIRLADFGSCLRLGGDGT--VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLV  236 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~  236 (372)
                      ++.+||+|||+++.......  .......+|+.|+|||++.+     ..++.++|||||||++|+|++ |..||.+.+..
T Consensus       187 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~  261 (325)
T 3kul_A          187 NLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF-----RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR  261 (325)
T ss_dssp             TCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHH-----CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH
T ss_pred             CCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcC-----CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH
Confidence            99999999999987654322  12222346778999999974     568899999999999999999 99999999988


Q ss_pred             HHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       237 ~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      +....+... ...+.+.    .+++.+.+||.+||. ||.+||++.++++.+
T Consensus       262 ~~~~~~~~~-~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~eil~~L  308 (325)
T 3kul_A          262 DVISSVEEG-YRLPAPM----GCPHALHQLMLDCWHKDRAQRPRFSQIVSVL  308 (325)
T ss_dssp             HHHHHHHTT-CCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHcC-CCCCCCC----CcCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            888877665 2333333    689999999999999 999999988887665

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.6e-44  Score=345.24  Aligned_cols=251  Identities=20%  Similarity=0.289  Sum_probs=206.4

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeee-------hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCce
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETL-------LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWI   75 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~-------~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~I   75 (372)
                      |+..+.+|.|    |+|.||.++..       .++..||+|.+......         ...+.+.+|+.+++.+ +||||
T Consensus        83 ~~~~~~LG~G----~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~E~~~l~~l~~hpnI  149 (370)
T 2psq_A           83 LTLGKPLGEG----CFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE---------KDLSDLVSEMEMMKMIGKHKNI  149 (370)
T ss_dssp             EEEEEEESCC----SSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBH---------HHHHHHHHHHHHHHHSCCCTTB
T ss_pred             CEeeeEEeeC----CCeeEEEEEEecccCcCcCcceeEEEEEecCCcCH---------HHHHHHHHHHHHHHHhcCCCCE
Confidence            3334445555    89999999865       34567999988654321         2345688899999999 89999


Q ss_pred             eeeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCC
Q psy11571         76 TNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE---------------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPN  140 (372)
Q Consensus        76 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~  140 (372)
                      +++++++.+.+.+|+||||+++|+|.+++....               ..+++.++..++.||+.||.|||++||+|   
T Consensus       150 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH---  226 (370)
T 2psq_A          150 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIH---  226 (370)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEEC---
T ss_pred             eeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeec---
Confidence            999999999999999999999999999998732               24789999999999999999999999999   


Q ss_pred             CCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHH
Q psy11571        141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVC  219 (372)
Q Consensus       141 ~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvi  219 (372)
                             |||||+|||++.++.+||+|||+++....... .......+|+.|+|||++.+     ..++.++|||||||+
T Consensus       227 -------rDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DvwslG~i  294 (370)
T 2psq_A          227 -------RDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-----RVYTHQSDVWSFGVL  294 (370)
T ss_dssp             -------SCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-----CCCCHHHHHHHHHHH
T ss_pred             -------cccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-----CCCCcHHHHHHHHHH
Confidence                   99999999999999999999999987654322 12233457889999999983     568999999999999


Q ss_pred             HHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        220 MYEMLY-GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       220 l~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      +|||++ |..||.+.+..+.+..+..+. ....|.    .+++++.+||.+||. +|++||++.++.+.+
T Consensus       295 l~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L  359 (370)
T 2psq_A          295 MWEIFTLGGSPYPGIPVEELFKLLKEGH-RMDKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  359 (370)
T ss_dssp             HHHHHTTSCCSSTTCCGGGHHHHHHTTC-CCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHcCCCCCCCCCCHHHHHHHHhcCC-CCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            999999 999999988887777666543 333343    689999999999999 999999988776544

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.5e-45  Score=334.57  Aligned_cols=257  Identities=29%  Similarity=0.419  Sum_probs=213.2

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    |+|.||++.+..+++.||+|.+........        ..+.+.+|+.+++.++||||++++++
T Consensus         6 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~   73 (279)
T 2w5a_A            6 EDYEVLYTIGTG----SYGRCQKIRRKSDGKILVWKELDYGSMTEA--------EKQMLVSEVNLLRELKHPNIVRYYDR   73 (279)
T ss_dssp             GGEEEEEEEEEC----SSSEEEEEEETTTCCEEEEEEEECTTCCHH--------HHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hheeeehhccCC----CCcEEEEEEECCCCcEEEEEEEEcccCCHH--------HHHHHHHHHHHHHhcCCCCCCeEEEE
Confidence            356666777777    899999999999999999998876544322        34568889999999999999999998


Q ss_pred             EEe--CCeEEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhcC-----ceecCCCCCCCcCCCCC
Q psy11571         82 FQD--DSNLYLVMDYYCGGDLLTLLSKF---EDRLPEDMAKFYIAEMVLAIASIHDLH-----YVHRPNHFAFHLCRDIK  151 (372)
Q Consensus        82 ~~~--~~~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~-----ivH~~~~~~~~vhrDlk  151 (372)
                      +.+  ...+|+||||+++++|.+++...   ...+++..++.++.||+.||.|||+.|     ++|          ||||
T Consensus        74 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH----------~dl~  143 (279)
T 2w5a_A           74 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH----------RDLK  143 (279)
T ss_dssp             EEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CC----------CCCS
T ss_pred             EecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEE----------eccc
Confidence            854  56899999999999999999753   234999999999999999999999999     999          9999


Q ss_pred             cCcEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCC
Q psy11571        152 PDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY  231 (372)
Q Consensus       152 p~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~  231 (372)
                      |+||+++.++.+||+|||++........ ......||+.|+|||++.+     ..++.++||||||+++|+|++|..||.
T Consensus       144 p~NIl~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~  217 (279)
T 2w5a_A          144 PANVFLDGKQNVKLGDFGLARILNHDTS-FAKTFVGTPYYMSPEQMNR-----MSYNEKSDIWSLGCLLYELCALMPPFT  217 (279)
T ss_dssp             GGGEEECSSSCEEECCCCHHHHC---CH-HHHHHHSCCTTCCHHHHHC-----C-CCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             hhhEEEcCCCCEEEecCchheeeccccc-cccccCCCccccChHHhcc-----CCCCchhhHHHHHHHHHHHHHCCCCCc
Confidence            9999999999999999999987654322 2233578999999999983     568899999999999999999999999


Q ss_pred             CCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        232 AESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       232 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      ..+..+....+..+.. ..++.    .+++++.++|.+||+ ||++||++++++                 .|+|+.+
T Consensus       218 ~~~~~~~~~~i~~~~~-~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll-----------------~~~~~~~  273 (279)
T 2w5a_A          218 AFSQKELAGKIREGKF-RRIPY----RYSDELNEIITRMLNLKDYHRPSVEEIL-----------------ENPLILE  273 (279)
T ss_dssp             CSSHHHHHHHHHHTCC-CCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHH-----------------TSTTCCG
T ss_pred             ccCHHHHHHHHhhccc-ccCCc----ccCHHHHHHHHHHcCCCcccCCCHHHHH-----------------hChhhhh
Confidence            9888888777776542 23333    689999999999999 999999866555                 9999974

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.1e-45  Score=346.37  Aligned_cols=273  Identities=21%  Similarity=0.434  Sum_probs=217.7

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHH-------HHHHHHHHHHHHHHHHhcCCCCce
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVS-------DFIEFVAKLREERDVLVYGDRRWI   75 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~-------~~~~~~~~l~~E~~il~~l~hp~I   75 (372)
                      +|+.++.+|.|    ++|.||.+.+  +++.||+|.+............       ......+.+.+|+.+++.++||||
T Consensus        32 ~y~~~~~lg~G----~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i  105 (348)
T 2pml_X           32 DYRIIRTLNQG----KFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC  105 (348)
T ss_dssp             TEEEEEEEECC----SSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred             ceEEEEEEcCC----CCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence            45556666666    8999999988  8999999987654433211000       000012557889999999999999


Q ss_pred             eeeeEEEEeCCeEEEEEeccCCCCHHHH------HHhc-CCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCCcC
Q psy11571         76 TNLHYAFQDDSNLYLVMDYYCGGDLLTL------LSKF-EDRLPEDMAKFYIAEMVLAIASIHD-LHYVHRPNHFAFHLC  147 (372)
Q Consensus        76 v~l~~~~~~~~~~~lv~E~~~gg~L~~~------l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~~~~~~~~vh  147 (372)
                      +++++++.+.+.+|+||||+++++|.++      +... ...+++..++.++.||+.||.|||+ .|++|          
T Consensus       106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H----------  175 (348)
T 2pml_X          106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICH----------  175 (348)
T ss_dssp             CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEEC----------
T ss_pred             ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEee----------
Confidence            9999999999999999999999999998      5442 4679999999999999999999999 99999          


Q ss_pred             CCCCcCcEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCC-ccceeehhHHHHHHhhC
Q psy11571        148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGP-ECDWWSLGVCMYEMLYG  226 (372)
Q Consensus       148 rDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~DiwslGvil~elltG  226 (372)
                      |||||+||+++.++.++|+|||++......   ......||+.|+|||++.+    ...++. ++|||||||++|+|++|
T Consensus       176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~----~~~~~~~~~Di~slG~il~~l~~g  248 (348)
T 2pml_X          176 RDVKPSNILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSN----ESSYNGAKVDIWSLGICLYVMFYN  248 (348)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSS----CCCEEHHHHHHHHHHHHHHHHHHS
T ss_pred             cCCChHhEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcC----CCCCCcchhhHHHHHHHHHHHHhC
Confidence            999999999999999999999999876433   2234678999999999984    224555 99999999999999999


Q ss_pred             CCCCCCCCH-HHHHHHHhhccCCcCCCCC-------------CCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhh
Q psy11571        227 ETPFYAESL-VETYGKIMNHQNSFDLPSD-------------VGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSA  291 (372)
Q Consensus       227 ~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~-------------~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~  291 (372)
                      ..||.+.+. .+....+......++....             ....+++++.+||.+||+ ||.+||++++++       
T Consensus       249 ~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l-------  321 (348)
T 2pml_X          249 VVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDAL-------  321 (348)
T ss_dssp             SCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHH-------
T ss_pred             CCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHh-------
Confidence            999998776 7777777665433221100             013689999999999999 999999866555       


Q ss_pred             hhhccCCCCCCCCCcCCCCccccc
Q psy11571        292 LFVSLSISPRNHPWFQGIAWDSIR  315 (372)
Q Consensus       292 ~~~~~~~~~~~hp~f~~~~w~~~~  315 (372)
                                +||||++.+|+.+.
T Consensus       322 ----------~hp~f~~~~~~~~~  335 (348)
T 2pml_X          322 ----------KHEWLADTNIEDLR  335 (348)
T ss_dssp             ----------TSGGGTTCCHHHHH
T ss_pred             ----------cCccccCCCHHHHH
Confidence                      99999999998763

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=342.65  Aligned_cols=259  Identities=23%  Similarity=0.325  Sum_probs=207.1

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+..+.+|.|    |+|.||.+.+..+++.||+|.+.......        ...+.+.+|+.+++.++||||+++++++
T Consensus        25 ~y~~~~~lg~G----~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~~~   92 (353)
T 3coi_A           25 TYVSPTHVGSG----AYGSVCSAIDKRSGEKVAIKKLSRPFQSE--------IFAKRAYRELLLLKHMQHENVIGLLDVF   92 (353)
T ss_dssp             TEEEEEEEEEC----SSEEEEEEEETTTTEEEEEEEESSTTSSH--------HHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             eEEEeeeEecC----CCeEEEEEEECCCCCEEEEEEecccccch--------HHHHHHHHHHHHHHhcCCCCcccHhheE
Confidence            44455556666    89999999999999999999886543222        1345678899999999999999999999


Q ss_pred             EeCCe------EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEE
Q psy11571         83 QDDSN------LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL  156 (372)
Q Consensus        83 ~~~~~------~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIl  156 (372)
                      .+...      +|+||||+. ++|.+++.   ..+++..++.++.||+.||.|||++|++|          |||||+||+
T Consensus        93 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH----------~dlkp~NIl  158 (353)
T 3coi_A           93 TPASSLRNFYDFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVH----------RDLKPGNLA  158 (353)
T ss_dssp             CSCSSGGGCCCCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SSCCGGGEE
T ss_pred             ecccccccceeEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccc----------CCCCHHHEe
Confidence            87654      599999996 68888774   45999999999999999999999999999          999999999


Q ss_pred             eCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH
Q psy11571        157 LDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV  236 (372)
Q Consensus       157 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~  236 (372)
                      ++.++.+||+|||++......    .....||+.|+|||++.+    ...++.++|||||||++|+|++|..||.+.+..
T Consensus       159 ~~~~~~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~----~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  230 (353)
T 3coi_A          159 VNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILS----WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL  230 (353)
T ss_dssp             ECTTCCEEECSTTCTTC------------CCSBCCSCHHHHSC----CSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH
T ss_pred             ECCCCcEEEeecccccCCCCC----ccccccCcCcCCHHHHhC----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            999999999999999765432    223578999999999873    356889999999999999999999999998877


Q ss_pred             HHHHHHhhccCC--------------------------cCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhh
Q psy11571        237 ETYGKIMNHQNS--------------------------FDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMW  289 (372)
Q Consensus       237 ~~~~~i~~~~~~--------------------------~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~  289 (372)
                      +.+..+......                          ..++ .....+++++++||.+||+ ||++|||+++++     
T Consensus       231 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l-----  304 (353)
T 3coi_A          231 DQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQAL-----  304 (353)
T ss_dssp             HHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHH-----
T ss_pred             HHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHh-----
Confidence            766665432110                          0111 1123679999999999999 999999876655     


Q ss_pred             hhhhhccCCCCCCCCCcCCCCccc
Q psy11571        290 SALFVSLSISPRNHPWFQGIAWDS  313 (372)
Q Consensus       290 ~~~~~~~~~~~~~hp~f~~~~w~~  313 (372)
                                  +||||+.+....
T Consensus       305 ------------~hp~f~~~~~~~  316 (353)
T 3coi_A          305 ------------THPFFEPFRDPE  316 (353)
T ss_dssp             ------------TSGGGTTTCCGG
T ss_pred             ------------cCcchhhccCcc
Confidence                        999999876543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-45  Score=342.84  Aligned_cols=259  Identities=22%  Similarity=0.308  Sum_probs=205.4

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      .+|+..+.+|.|    |+|.||++.+..+++.||+|.+........         .+.+.+|+.+++.++||||++++++
T Consensus         9 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~   75 (319)
T 4euu_A            9 HLWLLSDILGQG----ATANVFRGRHKKTGDLFAIKVFNNISFLRP---------VDVQMREFEVLKKLNHKNIVKLFAI   75 (319)
T ss_dssp             EEEEEEEEEEEC----SSEEEEEEEETTTCCEEEEEEECGGGGGSC---------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCEEEEEEecCC----CCeEEEEEEECCCCcEEEEEEeccccccch---------HHHHHHHHHHHHhcCCCCcceEEEE
Confidence            456666777777    899999999999999999998875443322         2445689999999999999999999


Q ss_pred             EEeCC--eEEEEEeccCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe
Q psy11571         82 FQDDS--NLYLVMDYYCGGDLLTLLSKFE--DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        82 ~~~~~--~~~lv~E~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      +....  ..|+||||+++++|.+++....  ..+++..++.++.||+.||.|||++||+|          |||||+|||+
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH----------~Dlkp~NIll  145 (319)
T 4euu_A           76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVH----------RNIKPGNIMR  145 (319)
T ss_dssp             EECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSGGGEEE
T ss_pred             eecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEec----------CCCCHHHEEE
Confidence            98765  7899999999999999998642  23999999999999999999999999999          9999999999


Q ss_pred             ----CCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccc---cCCCCCCCccceeehhHHHHHHhhCCCCC
Q psy11571        158 ----DANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAME---EGRGRYGPECDWWSLGVCMYEMLYGETPF  230 (372)
Q Consensus       158 ----~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~DiwslGvil~elltG~~Pf  230 (372)
                          +.++.+||+|||+++........  ....||+.|+|||++....   .....++.++|||||||++|||++|+.||
T Consensus       146 ~~~~~~~~~~kL~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf  223 (319)
T 4euu_A          146 VIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF  223 (319)
T ss_dssp             EECTTSCEEEEECCCTTCEECCTTCCB--CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSE
T ss_pred             eccCCCCceEEEccCCCceecCCCCce--eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence                77888999999999876554332  3357999999999986211   01256889999999999999999999999


Q ss_pred             CCC----CHHHHHHHHhhccCC-------------------cCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhh
Q psy11571        231 YAE----SLVETYGKIMNHQNS-------------------FDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIAD  285 (372)
Q Consensus       231 ~~~----~~~~~~~~i~~~~~~-------------------~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~  285 (372)
                      ...    ...+.+.++..+...                   ++.+......+++.+.+||++||+ ||++|||++++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~  302 (319)
T 4euu_A          224 RPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (319)
T ss_dssp             ECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             CCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhh
Confidence            743    334555556554321                   111122222456789999999999 9999999877763

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.1e-44  Score=350.87  Aligned_cols=255  Identities=20%  Similarity=0.294  Sum_probs=204.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC------CCCcee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG------DRRWIT   76 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l------~hp~Iv   76 (372)
                      ||+.++.+|.|    |+|.||++.+..+++.||+|.+.....           ..+.+.+|+.+++.+      +|+||+
T Consensus        98 ry~~~~~LG~G----~fg~V~~a~~~~~~~~vAvK~~~~~~~-----------~~~~~~~E~~~l~~l~~~~~~~~~~iv  162 (429)
T 3kvw_A           98 RYEVLKVIGKG----SFGQVVKAYDHKVHQHVALKMVRNEKR-----------FHRQAAEEIRILEHLRKQDKDNTMNVI  162 (429)
T ss_dssp             TEEEEEEEEES----SSEEEEEEEETTTTEEEEEEEECSCHH-----------HHHHHHHHHHHHHHHHTTCTTSCSCBC
T ss_pred             cEEEEEEcccC----ccEEEEEEEECCCCcEEEEEEECCccc-----------hHHHHHHHHHHHHHHhhccccCCcCEE
Confidence            56667777777    899999999999999999998865321           122344555555543      688999


Q ss_pred             eeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcE
Q psy11571         77 NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNV  155 (372)
Q Consensus        77 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NI  155 (372)
                      ++++++.....+++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+|          |||||+||
T Consensus       163 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH----------rDlKp~NI  231 (429)
T 3kvw_A          163 HMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIH----------CDLKPENI  231 (429)
T ss_dssp             CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEEC----------SCCSGGGE
T ss_pred             EEEeecccCCeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeec----------CCCCHHHe
Confidence            9999999999999999999 569999998742 35999999999999999999999999999          99999999


Q ss_pred             EeCCCCc--EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC
Q psy11571        156 LLDANGH--IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE  233 (372)
Q Consensus       156 ll~~~~~--vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~  233 (372)
                      |++.++.  +||+|||++......    ....+||+.|+|||++.+     ..++.++|||||||++|||++|.+||.+.
T Consensus       232 Ll~~~~~~~vkL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          232 LLKQQGRSGIKVIDFGSSCYEHQR----VYTYIQSRFYRAPEVILG-----ARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             EESSTTSCCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHHT-----BCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEccCCCcceEEeecccceecCCc----ccccCCCCCccChHHHhC-----CCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            9999887  999999999765432    233679999999999984     56899999999999999999999999999


Q ss_pred             CHHHHHHHHhhccCCcC------------------CC----------------------------C-------CCCCCCC
Q psy11571        234 SLVETYGKIMNHQNSFD------------------LP----------------------------S-------DVGYEIS  260 (372)
Q Consensus       234 ~~~~~~~~i~~~~~~~~------------------~~----------------------------~-------~~~~~~s  260 (372)
                      +..+.+..+......+.                  .|                            .       ......+
T Consensus       303 ~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  382 (429)
T 3kvw_A          303 DEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDD  382 (429)
T ss_dssp             SHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCC
T ss_pred             CHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccch
Confidence            88877766653211000                  00                            0       0011347


Q ss_pred             HHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        261 DDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       261 ~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      +++.+||++||+ ||++|||+++++                 +||||+..
T Consensus       383 ~~~~dli~~~L~~dP~~Rpta~e~L-----------------~Hpw~~~~  415 (429)
T 3kvw_A          383 PLFLDFLKQCLEWDPAVRMTPGQAL-----------------RHPWLRRR  415 (429)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHH-----------------TSTTTC--
T ss_pred             HHHHHHHHHHCCCChhhCCCHHHHh-----------------CChhhccC
Confidence            899999999999 999999877666                 99999853

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.3e-45  Score=339.56  Aligned_cols=263  Identities=23%  Similarity=0.339  Sum_probs=206.5

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      .+|+.++.+|.|    |+|.||++.+..+++.||+|.+.....          ...+.+.+|+.+++.++||||++++++
T Consensus        11 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~~e~~~l~~l~h~~iv~~~~~   76 (320)
T 2i6l_A           11 SRYMDLKPLGCG----GNGLVFSAVDNDCDKRVAIKKIVLTDP----------QSVKHALREIKIIRRLDHDNIVKVFEI   76 (320)
T ss_dssp             TTEEEEEECC---------CEEEEEETTTTEEEEEEEEECCSH----------HHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             CceeEEEEeccC----CCeEEEEEEECCCCeEEEEEEEecCCh----------HHHHHHHHHHHHHHhcCCCCeeEEEEe
Confidence            456666777776    899999999998999999998765421          234567889999999999999999998


Q ss_pred             EE--------------eCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcC
Q psy11571         82 FQ--------------DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC  147 (372)
Q Consensus        82 ~~--------------~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vh  147 (372)
                      +.              +....|+||||+. |+|.+++..  +.+++..++.++.||+.||+|||++|++|          
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H----------  143 (320)
T 2i6l_A           77 LGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLH----------  143 (320)
T ss_dssp             ECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBC----------
T ss_pred             ccccccccccccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEec----------
Confidence            74              3467899999996 699999975  67999999999999999999999999999          


Q ss_pred             CCCCcCcEEeC-CCCcEEEeecCcccccCCCCc--ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHh
Q psy11571        148 RDIKPDNVLLD-ANGHIRLADFGSCLRLGGDGT--VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML  224 (372)
Q Consensus       148 rDlkp~NIll~-~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ell  224 (372)
                      |||||+||+++ .++.+||+|||+++.......  .......+|+.|+|||++.+    ...++.++|||||||++|+|+
T Consensus       144 ~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~el~  219 (320)
T 2i6l_A          144 RDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS----PNNYTKAIDMWAAGCIFAEML  219 (320)
T ss_dssp             CCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHC----TTCCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcC----cccCCchhhhHhHHHHHHHHH
Confidence            99999999997 567999999999987643211  11233567999999999873    356889999999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHHhhccCCcC--------------------CCC----CCCCCCCHHHHHHHHHhcc-CCCCCCC
Q psy11571        225 YGETPFYAESLVETYGKIMNHQNSFD--------------------LPS----DVGYEISDDAKDLMRRLIC-SSDTRLG  279 (372)
Q Consensus       225 tG~~Pf~~~~~~~~~~~i~~~~~~~~--------------------~~~----~~~~~~s~~~~~li~~lL~-~p~~R~s  279 (372)
                      +|+.||.+.+..+....+........                    .+.    .....++.++++||++||+ ||++||+
T Consensus       220 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  299 (320)
T 2i6l_A          220 TGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT  299 (320)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCC
T ss_pred             hCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCC
Confidence            99999999888777776654321100                    000    0112579999999999999 9999998


Q ss_pred             CCChhhhhhhhhhhhccCCCCCCCCCcCCCCcc
Q psy11571        280 QNGIADFKMWSALFVSLSISPRNHPWFQGIAWD  312 (372)
Q Consensus       280 ~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~  312 (372)
                      +++++                 +||||+.++|.
T Consensus       300 ~~ell-----------------~hp~~~~~~~p  315 (320)
T 2i6l_A          300 AEEAL-----------------SHPYMSIYSFP  315 (320)
T ss_dssp             HHHHH-----------------TSHHHHTTCC-
T ss_pred             HHHHh-----------------CCcccccccCc
Confidence            66655                 99999988875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.5e-44  Score=329.34  Aligned_cols=250  Identities=19%  Similarity=0.228  Sum_probs=211.6

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    |+|.||.+.. .++..||+|.+.......           +.+.+|+.++..++||||++++++
T Consensus         8 ~~y~~~~~lg~G----~~g~V~~~~~-~~~~~vavK~~~~~~~~~-----------~~~~~E~~~l~~l~h~~i~~~~~~   71 (268)
T 3sxs_A            8 EEITLLKELGSG----QFGVVKLGKW-KGQYDVAVKMIKEGSMSE-----------DEFFQEAQTMMKLSHPKLVKFYGV   71 (268)
T ss_dssp             GGEEEEEEEEEE----TTEEEEEEEE-TTTEEEEEEEECBTTBCH-----------HHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hheeeeeeeccC----CCceEEEEEe-cCceeEEEEEeccCCCcH-----------HHHHHHHHHHHhCCCCCEeeEEEE
Confidence            456667777777    8999999954 467779999887654332           236789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+....++||||+++++|.+++......+++..++.++.|++.||.|||+.|++|          |||||+||+++.++
T Consensus        72 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H----------~dikp~Nil~~~~~  141 (268)
T 3sxs_A           72 CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIH----------RDLAARNCLVDRDL  141 (268)
T ss_dssp             ECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEE----------SSCSGGGEEECTTC
T ss_pred             EccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeec----------CCcCcceEEECCCC
Confidence            99999999999999999999999875557999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYG  240 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~  240 (372)
                      .++|+|||++...............+|+.|+|||++.+     ..++.++||||||+++|+|++ |..||...+..+...
T Consensus       142 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~  216 (268)
T 3sxs_A          142 CVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHY-----FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL  216 (268)
T ss_dssp             CEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHH-----SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred             CEEEccCccceecchhhhhcccCCCcCcccCCHHHHhc-----cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHH
Confidence            99999999998776554434444556778999999974     458889999999999999999 999999998888877


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .+..... ...|.    ..++.+.++|.+||+ ||++|||+.++++.+
T Consensus       217 ~~~~~~~-~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L  259 (268)
T 3sxs_A          217 KVSQGHR-LYRPH----LASDTIYQIMYSCWHELPEKRPTFQQLLSSI  259 (268)
T ss_dssp             HHHTTCC-CCCCT----TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHcCCC-CCCCC----cChHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            7766432 22233    579999999999999 999999988877655

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=350.41  Aligned_cols=256  Identities=20%  Similarity=0.267  Sum_probs=187.7

Q ss_pred             cccCCccEEEeeee--hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe--CCeEEE
Q psy11571         15 PIQGKGRVFSIETL--LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQD--DSNLYL   90 (372)
Q Consensus        15 ~~~g~G~v~~v~~~--~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~l   90 (372)
                      +.||+|.||++...  .+++.||+|.+.......            .+.+|+.+|+.++||||+++++++.+  ...+|+
T Consensus        30 G~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           30 GRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM------------SACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             C-----EEEEEEESSSSCCCCEEEEECSSSSCCH------------HHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             eecCCeEEEEEEEccCCCCeEEEEEEECCCCCCH------------HHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            34588999999854  578899999887544322            35679999999999999999999965  678999


Q ss_pred             EEeccCCCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe----C
Q psy11571         91 VMDYYCGGDLLTLLSKF--------EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL----D  158 (372)
Q Consensus        91 v~E~~~gg~L~~~l~~~--------~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll----~  158 (372)
                      ||||+. ++|.+++...        ...+++..++.++.||+.||.|||++||+|          |||||+|||+    +
T Consensus        98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH----------~Dlkp~NIll~~~~~  166 (405)
T 3rgf_A           98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLH----------RDLKPANILVMGEGP  166 (405)
T ss_dssp             EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCC----------CCCCGGGEEECCSST
T ss_pred             EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeC----------CCcCHHHeEEecCCC
Confidence            999985 5898888632        124999999999999999999999999999          9999999999    6


Q ss_pred             CCCcEEEeecCcccccCCCCc--ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH
Q psy11571        159 ANGHIRLADFGSCLRLGGDGT--VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV  236 (372)
Q Consensus       159 ~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~  236 (372)
                      .++.+||+|||+++.......  ......+||+.|+|||++.+    ...++.++|||||||++|+|++|.+||.+.+..
T Consensus       167 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  242 (405)
T 3rgf_A          167 ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG----ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED  242 (405)
T ss_dssp             TTTCEEECCTTCCC----------------CCCTTCCHHHHTT----CCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC--
T ss_pred             CCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcC----CCcccchhhhHHHHHHHHHHHhCCCCCCCcccc
Confidence            778999999999987643211  12234679999999999974    356899999999999999999999999876542


Q ss_pred             ---------HHHHHHhhccCCcCCCCC--------------------------------CCCCCCHHHHHHHHHhcc-CC
Q psy11571        237 ---------ETYGKIMNHQNSFDLPSD--------------------------------VGYEISDDAKDLMRRLIC-SS  274 (372)
Q Consensus       237 ---------~~~~~i~~~~~~~~~~~~--------------------------------~~~~~s~~~~~li~~lL~-~p  274 (372)
                               +.+..+......+....+                                .....++.+.+||.+||+ ||
T Consensus       243 ~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP  322 (405)
T 3rgf_A          243 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP  322 (405)
T ss_dssp             ----CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSG
T ss_pred             ccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCc
Confidence                     334444332111110000                                001237889999999999 99


Q ss_pred             CCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc
Q psy11571        275 DTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI  314 (372)
Q Consensus       275 ~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~  314 (372)
                      .+|||+++++                 +||||.+..|...
T Consensus       323 ~~R~ta~e~L-----------------~hp~f~~~~~~~~  345 (405)
T 3rgf_A          323 IKRITSEQAM-----------------QDPYFLEDPLPTS  345 (405)
T ss_dssp             GGSCCHHHHH-----------------TSGGGTSSSCCCS
T ss_pred             ccCCCHHHHh-----------------cChhhccCCCCcc
Confidence            9999876665                 9999998776543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7.6e-45  Score=340.49  Aligned_cols=265  Identities=25%  Similarity=0.340  Sum_probs=209.3

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeee-hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhc---CCCCceee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETL-LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVY---GDRRWITN   77 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~-~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~---l~hp~Iv~   77 (372)
                      .+|+.++.+|.|    |+|.||.+.+. .+++.||+|.+..........        ..+.+|+.+++.   +.||||++
T Consensus        11 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~--------~~~~~e~~~l~~l~~~~h~~i~~   78 (326)
T 1blx_A           11 QQYECVAEIGEG----AYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP--------LSTIREVAVLRHLETFEHPNVVR   78 (326)
T ss_dssp             GTEEEEEEEEEE----TTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB--------CTHHHHHHHHHHHHHTCCTTBCC
T ss_pred             hceeeeeeeccc----ccEEEEEEEecCCCCEEEEEEEeccCcccccCC--------chhhHHHHHHHhhhccCCCCeEe
Confidence            456667777776    89999999885 678899999886544322100        113345555544   48999999


Q ss_pred             eeEEEE-----eCCeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCC
Q psy11571         78 LHYAFQ-----DDSNLYLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIK  151 (372)
Q Consensus        78 l~~~~~-----~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlk  151 (372)
                      +++++.     ....+++||||+. |+|.+++.... ..+++..++.++.||+.||.|||++|++|          ||||
T Consensus        79 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H----------~dlk  147 (326)
T 1blx_A           79 LFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVH----------RDLK  147 (326)
T ss_dssp             EEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCC----------CCCC
T ss_pred             eeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCcee----------ccCC
Confidence            999987     4567899999996 69999998742 35999999999999999999999999999          9999


Q ss_pred             cCcEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCC
Q psy11571        152 PDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY  231 (372)
Q Consensus       152 p~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~  231 (372)
                      |+||+++.++.+||+|||++.......  ......||+.|+|||++.+     ..++.++|||||||++|+|++|++||.
T Consensus       148 p~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~  220 (326)
T 1blx_A          148 PQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQ-----SSYATPVDLWSVGCIFAEMFRRKPLFR  220 (326)
T ss_dssp             GGGEEECTTCCEEECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             HHHeEEcCCCCEEEecCcccccccCCC--CccccccccceeCHHHHhc-----CCCCcchhHHHHHHHHHHHHcCCCCCC
Confidence            999999999999999999997654322  2234678999999999983     568999999999999999999999999


Q ss_pred             CCCHHHHHHHHhhccCCc---CCC------------------CCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhh
Q psy11571        232 AESLVETYGKIMNHQNSF---DLP------------------SDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMW  289 (372)
Q Consensus       232 ~~~~~~~~~~i~~~~~~~---~~~------------------~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~  289 (372)
                      +.+..+.+.++.......   .++                  ......+++.+++||.+||. ||.+||++.+++     
T Consensus       221 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l-----  295 (326)
T 1blx_A          221 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL-----  295 (326)
T ss_dssp             CSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH-----
T ss_pred             CCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHh-----
Confidence            998888777765421110   000                  01123689999999999999 999999866555     


Q ss_pred             hhhhhccCCCCCCCCCcCCCCccc
Q psy11571        290 SALFVSLSISPRNHPWFQGIAWDS  313 (372)
Q Consensus       290 ~~~~~~~~~~~~~hp~f~~~~w~~  313 (372)
                                  +||||+++++..
T Consensus       296 ------------~hp~~~~~~~~~  307 (326)
T 1blx_A          296 ------------SHPYFQDLERCK  307 (326)
T ss_dssp             ------------TSGGGTTCCCCC
T ss_pred             ------------cCccccccchhh
Confidence                        999999987653

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.4e-44  Score=332.04  Aligned_cols=252  Identities=22%  Similarity=0.329  Sum_probs=196.1

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehh---hhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLD---ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNL   78 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~---~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l   78 (372)
                      ++|+..+.+|.|    |+|.||++.+..+   +..||+|.+......         ...+.+.+|+.+++.++||||+++
T Consensus        15 ~~y~~~~~lg~G----~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~e~~~l~~l~h~~iv~~   81 (281)
T 1mp8_A           15 ERIELGRCIGEG----QFGDVHQGIYMSPENPALAVAIKTCKNCTSD---------SVREKFLQEALTMRQFDHPHIVKL   81 (281)
T ss_dssp             GGEEEEEEEEEC----SSSEEEEEEECCC--CCEEEEEEECTTTTSH---------HHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             HHeEEEeEeeec----CCeeEEEEEEecCCCCceEEEEEeccccCCH---------HHHHHHHHHHHHHHhCCCCccceE
Confidence            355556666666    8999999987654   346888877643221         234567889999999999999999


Q ss_pred             eEEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC
Q psy11571         79 HYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD  158 (372)
Q Consensus        79 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~  158 (372)
                      ++++. .+..|+||||+++++|.+++......+++..+..++.|++.||.|||++|++|          |||||+|||++
T Consensus        82 ~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H----------~dlkp~Nil~~  150 (281)
T 1mp8_A           82 IGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVH----------RDIAARNVLVS  150 (281)
T ss_dssp             EEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCSGGGEEEE
T ss_pred             EEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeec----------ccccHHHEEEC
Confidence            99985 45789999999999999999875557999999999999999999999999999          99999999999


Q ss_pred             CCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHH
Q psy11571        159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVE  237 (372)
Q Consensus       159 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~  237 (372)
                      .++.+||+|||+++..............+|+.|+|||++.+     ..++.++|||||||++|+|++ |..||.+.+..+
T Consensus       151 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~  225 (281)
T 1mp8_A          151 SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND  225 (281)
T ss_dssp             ETTEEEECC-------------------CCGGGCCHHHHHH-----CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred             CCCCEEECccccccccCcccccccccCCCcccccChhhccc-----CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH
Confidence            99999999999998765443333334457889999999973     568899999999999999996 999999988877


Q ss_pred             HHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       238 ~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ....+.... ....+.    .+++++.++|.+||. ||++||++.++.+.+
T Consensus       226 ~~~~i~~~~-~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  271 (281)
T 1mp8_A          226 VIGRIENGE-RLPMPP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQL  271 (281)
T ss_dssp             HHHHHHTTC-CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHcCC-CCCCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            777776543 233333    689999999999999 999999988776544

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7.9e-45  Score=338.44  Aligned_cols=248  Identities=17%  Similarity=0.239  Sum_probs=201.9

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+..+.+|.|    |+|.||++.+..+++.||+|.+.....          +..+.+.+|+.+++.++||||+++++++
T Consensus        11 ~~~~~~~lG~G----~~g~V~~~~~~~~~~~va~K~~~~~~~----------~~~~~~~~E~~~l~~l~hp~iv~~~~~~   76 (310)
T 3s95_A           11 DLIHGEVLGKG----CFGQAIKVTHRETGEVMVMKELIRFDE----------ETQRTFLKEVKVMRCLEHPNVLKFIGVL   76 (310)
T ss_dssp             GEEEEEEEECC----SSEEEEEEEETTTCCEEEEEEESCCCH----------HHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             HeeccceecCC----CCEEEEEEEECCCCcEEEEEEeccCCH----------HHHHHHHHHHHHHHhCCCcCcccEEEEE
Confidence            45555666666    899999999999999999997754321          2345678899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+++..++||||+++|+|.+++......+++..+..++.||+.||+|||++|++|          |||||+||+++.++.
T Consensus        77 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH----------~dlkp~Nil~~~~~~  146 (310)
T 3s95_A           77 YKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIH----------RDLNSHNCLVRENKN  146 (310)
T ss_dssp             EETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSTTSEEECTTSC
T ss_pred             ecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccC----------CCCCcCeEEECCCCC
Confidence            9999999999999999999999886678999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCccc-------------ccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCC
Q psy11571        163 IRLADFGSCLRLGGDGTVQ-------------SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP  229 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~P  229 (372)
                      +||+|||+++.........             .....||+.|+|||++.     ...++.++|||||||++|+|++|..|
T Consensus       147 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~~  221 (310)
T 3s95_A          147 VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN-----GRSYDEKVDVFSFGIVLCEIIGRVNA  221 (310)
T ss_dssp             EEECCCTTCEECC--------------------CCCCSCGGGCCHHHHT-----TCCCCTHHHHHHHHHHHHHHHHTCCS
T ss_pred             EEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhc-----CCCCCcHHHHHHHHHHHHHHhcCCCC
Confidence            9999999998764332211             11457999999999998     36689999999999999999999999


Q ss_pred             CCCCCHHH-----HHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        230 FYAESLVE-----TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       230 f~~~~~~~-----~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      |.......     .......    ...+.    .+++.+.++|.+||+ ||++||++.++.+.+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~----~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L  277 (310)
T 3s95_A          222 DPDYLPRTMDFGLNVRGFLD----RYCPP----NCPPSFFPITVRCCDLDPEKRPSFVKLEHWL  277 (310)
T ss_dssp             STTTSCBCTTSSBCHHHHHH----HTCCT----TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CcchhhhHHHHhhhhhcccc----ccCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            87532211     0111111    11122    678899999999999 999999988776544

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.1e-44  Score=333.22  Aligned_cols=261  Identities=24%  Similarity=0.409  Sum_probs=205.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||.+.+..+++.||+|.+....           ...+.+.+|+.+++.++||||+++++++
T Consensus         7 ~y~~~~~lg~G----~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~E~~~l~~l~h~~i~~~~~~~   71 (303)
T 1zy4_A            7 DFEEIAVLGQG----AFGQVVKARNALDSRYYAIKKIRHTE-----------EKLSTILSEVMLLASLNHQYVVRYYAAW   71 (303)
T ss_dssp             HEEEEEEEEEC----SSEEEEEEEETTTCCEEEEEEEEEEH-----------HHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cchhhheeccC----CcEEEEEEEEcCCCeEEEEEEEeccH-----------HHHHHHHHHHHHHHhcCchHHHHHHHHH
Confidence            55566666666    89999999998899999999875321           1345678899999999999999999988


Q ss_pred             Ee-------------CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCC
Q psy11571         83 QD-------------DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRD  149 (372)
Q Consensus        83 ~~-------------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrD  149 (372)
                      .+             ...+|+||||+++|+|.+++......+++..++.++.||+.||+|||++|++|          ||
T Consensus        72 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H----------~d  141 (303)
T 1zy4_A           72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIH----------RD  141 (303)
T ss_dssp             EECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCC----------SC
T ss_pred             HhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeec----------cc
Confidence            65             35689999999999999999875557889999999999999999999999999          99


Q ss_pred             CCcCcEEeCCCCcEEEeecCcccccCCCC-------------cccccccccCCcccCcccccccccCCCCCCCccceeeh
Q psy11571        150 IKPDNVLLDANGHIRLADFGSCLRLGGDG-------------TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSL  216 (372)
Q Consensus       150 lkp~NIll~~~~~vkl~Dfg~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diwsl  216 (372)
                      |||+||+++.++.+||+|||++.......             ........||+.|+|||++.+    ...++.++|||||
T Consensus       142 lkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~sl  217 (303)
T 1zy4_A          142 LKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG----TGHYNEKIDMYSL  217 (303)
T ss_dssp             CCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTS----CSCCCTHHHHHHH
T ss_pred             CCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccC----CCCCcchhhHHHH
Confidence            99999999999999999999997654221             111234568999999999973    3468999999999


Q ss_pred             hHHHHHHhhCCCCCCCC-CHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhh
Q psy11571        217 GVCMYEMLYGETPFYAE-SLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFV  294 (372)
Q Consensus       217 Gvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~  294 (372)
                      ||++|+|++   ||... +..+....+...  ...+|.......++.+++||.+||+ ||.+|||+++++          
T Consensus       218 G~il~~l~~---p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll----------  282 (303)
T 1zy4_A          218 GIIFFEMIY---PFSTGMERVNILKKLRSV--SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL----------  282 (303)
T ss_dssp             HHHHHHHHS---CCSSHHHHHHHHHHHHST--TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHH----------
T ss_pred             HHHHHHHHh---ccCCchhHHHHHHhcccc--ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHh----------
Confidence            999999998   55432 333444454442  2344554455778999999999999 999999866665          


Q ss_pred             ccCCCCCCCCCcCCCCcccc
Q psy11571        295 SLSISPRNHPWFQGIAWDSI  314 (372)
Q Consensus       295 ~~~~~~~~hp~f~~~~w~~~  314 (372)
                             +||||+...++..
T Consensus       283 -------~h~~~~~~~~~~~  295 (303)
T 1zy4_A          283 -------NSGWLPVKHQDEV  295 (303)
T ss_dssp             -------HSSCSCCCCHHHH
T ss_pred             -------CCCCcCCCChHHH
Confidence                   9999998777654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.5e-44  Score=338.27  Aligned_cols=271  Identities=17%  Similarity=0.210  Sum_probs=193.3

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhh---hhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDIL---LVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLH   79 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~---~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~   79 (372)
                      +|+.++.+|.|    |+|.||++....++.   .||+|.+........        ..+.+.+|+.+++.++||||++++
T Consensus        24 ~y~~~~~lg~G----~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~iv~~~   91 (323)
T 3qup_A           24 QFTLGRMLGKG----EFGSVREAQLKQEDGSFVKVAVKMLKADIIASS--------DIEEFLREAACMKEFDHPHVAKLV   91 (323)
T ss_dssp             -CEEEEEEEEE----TTEEEEEEEC-------CEEEEEEC------CH--------HHHHHHHHHHHHTTCCCTTBCCCC
T ss_pred             HeEEeceeccc----CCeEEEEEEEcccCCcceeEEEEEecccccCHH--------HHHHHHHHHHHHHHCCCCceehhh
Confidence            45555566666    899999998877665   789998865443322        246688899999999999999999


Q ss_pred             EEEEeCCeE------EEEEeccCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCC
Q psy11571         80 YAFQDDSNL------YLVMDYYCGGDLLTLLSKFE-----DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCR  148 (372)
Q Consensus        80 ~~~~~~~~~------~lv~E~~~gg~L~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhr  148 (372)
                      +++.+....      ++||||+++|+|.+++....     ..+++..++.++.||+.||.|||++|++|          |
T Consensus        92 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH----------~  161 (323)
T 3qup_A           92 GVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIH----------R  161 (323)
T ss_dssp             EEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------S
T ss_pred             ceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCccc----------C
Confidence            999887655      99999999999999996531     15899999999999999999999999999          9


Q ss_pred             CCCcCcEEeCCCCcEEEeecCcccccCCCCcc-cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-C
Q psy11571        149 DIKPDNVLLDANGHIRLADFGSCLRLGGDGTV-QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-G  226 (372)
Q Consensus       149 Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G  226 (372)
                      ||||+|||++.++.+||+|||+++........ ......+|+.|+|||++.+     ..++.++|||||||++|+|++ |
T Consensus       162 Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~ell~~g  236 (323)
T 3qup_A          162 DLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-----NLYTVHSDVWAFGVTMWEIMTRG  236 (323)
T ss_dssp             CCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTS
T ss_pred             CCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcC-----CCCCCccchhhHHHHHHHHHhCC
Confidence            99999999999999999999999876443221 2223456789999999984     568999999999999999999 9


Q ss_pred             CCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCC
Q psy11571        227 ETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPW  305 (372)
Q Consensus       227 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~  305 (372)
                      .+||.+.+..+....+.... ....+.    .+++++.+||.+||+ ||++||++.++.+.+.          +...|||
T Consensus       237 ~~p~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~----------~~l~~~~  301 (323)
T 3qup_A          237 QTPYAGIENAEIYNYLIGGN-RLKQPP----ECMEEVYDLMYQCWSADPKQRPSFTCLRMELE----------NILGHLS  301 (323)
T ss_dssp             CCTTTTCCGGGHHHHHHTTC-CCCCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH----------HHHHC--
T ss_pred             CCCccccChHHHHHHHhcCC-CCCCCC----ccCHHHHHHHHHHccCChhhCcCHHHHHHHHH----------HHHHHhh
Confidence            99999988888887776653 233333    689999999999999 9999999665433221          1118999


Q ss_pred             cCCCCccccc
Q psy11571        306 FQGIAWDSIR  315 (372)
Q Consensus       306 f~~~~w~~~~  315 (372)
                      +.+..++.+.
T Consensus       302 ~~~~~~~pl~  311 (323)
T 3qup_A          302 VLSTSQDPLY  311 (323)
T ss_dssp             ----------
T ss_pred             hcCCCCCCCC
Confidence            9987766553

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=9.7e-45  Score=345.08  Aligned_cols=268  Identities=20%  Similarity=0.287  Sum_probs=202.4

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhh-hHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREK-TVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~-~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      |+.++.+|.|    |+|.||.+.+. +++.||+|.+......... .........+.+.+|+.+++.++||||+++++++
T Consensus        24 y~~~~~lg~G----~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   98 (362)
T 3pg1_A           24 YTVQRFISSG----SYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF   98 (362)
T ss_dssp             CEEEEEEEEE----TTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             eEEeEEeccC----CCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence            3444445554    89999999765 4899999988654432211 0111123456788999999999999999999998


Q ss_pred             Ee-----CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe
Q psy11571         83 QD-----DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        83 ~~-----~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      ..     ...+|+||||+. |+|.+++......+++..++.++.||+.||.|||++||+|          |||||+|||+
T Consensus        99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH----------~Dlkp~NIl~  167 (362)
T 3pg1_A           99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVH----------RDLHPGNILL  167 (362)
T ss_dssp             EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------CCCCGGGEEE
T ss_pred             EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEe----------cCCChHHEEE
Confidence            54     336899999996 6999998875567999999999999999999999999999          9999999999


Q ss_pred             CCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHH
Q psy11571        158 DANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE  237 (372)
Q Consensus       158 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~  237 (372)
                      +.++.+||+|||++........  .....||+.|+|||++.+    ...++.++|||||||++|+|++|+.||.+.+..+
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  241 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQ----FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN  241 (362)
T ss_dssp             CTTCCEEECCTTC-----------------CGGGCCHHHHTT----CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             cCCCCEEEEecCcccccccccc--cceecccceecCcHHhcC----CCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999999999999976543322  233578999999999873    3568999999999999999999999999988877


Q ss_pred             HHHHHhhccCCcC----------------------CCC----CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhh
Q psy11571        238 TYGKIMNHQNSFD----------------------LPS----DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWS  290 (372)
Q Consensus       238 ~~~~i~~~~~~~~----------------------~~~----~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~  290 (372)
                      ...++........                      .+.    ......++.+.+||.+||+ ||++|||+++++      
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell------  315 (362)
T 3pg1_A          242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL------  315 (362)
T ss_dssp             HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHH------
T ss_pred             HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHH------
Confidence            7776654221110                      000    0112568999999999999 999999866655      


Q ss_pred             hhhhccCCCCCCCCCcCCCC
Q psy11571        291 ALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       291 ~~~~~~~~~~~~hp~f~~~~  310 (372)
                                 +||||+++.
T Consensus       316 -----------~hp~f~~~~  324 (362)
T 3pg1_A          316 -----------RHPYFESLF  324 (362)
T ss_dssp             -----------TSGGGTTTC
T ss_pred             -----------cCchhhhcc
Confidence                       999999863

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.8e-44  Score=342.74  Aligned_cols=261  Identities=23%  Similarity=0.315  Sum_probs=196.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||++.+..+++.||+|.+........           ...+|...+..++||||+++++++
T Consensus        24 ~y~~~~~lg~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~~~l~~l~h~niv~~~~~~   88 (360)
T 3e3p_A           24 RFQVERMAGQG----TFGTVQLGKEKSTGMSVAIKKVIQDPRFRN-----------RELQIMQDLAVLHHPNIVQLQSYF   88 (360)
T ss_dssp             TEEEC--------------CEEEEETTTCCEEEEEEEECCTTCCC-----------HHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred             ceEEEEEEecC----CCeEEEEEEECCCCCEEEEEEEecCccccH-----------HHHHHHHHHHhcCCCCcccHHHhh
Confidence            45555666666    899999999999999999998755432221           234466667778999999999999


Q ss_pred             EeCCe-------EEEEEeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH--hcCceecCCCCCCCcCCCC
Q psy11571         83 QDDSN-------LYLVMDYYCGGDLLTLLSK---FEDRLPEDMAKFYIAEMVLAIASIH--DLHYVHRPNHFAFHLCRDI  150 (372)
Q Consensus        83 ~~~~~-------~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~LH--~~~ivH~~~~~~~~vhrDl  150 (372)
                      .+...       +++||||+++ +|...+..   ....+++..++.++.|++.||.|||  ++||+|          |||
T Consensus        89 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH----------~Dl  157 (360)
T 3e3p_A           89 YTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCH----------RDI  157 (360)
T ss_dssp             EEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBC----------SCC
T ss_pred             hccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeec----------CcC
Confidence            76443       8999999965 65554432   2567899999999999999999999  999999          999


Q ss_pred             CcCcEEeCC-CCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCC
Q psy11571        151 KPDNVLLDA-NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP  229 (372)
Q Consensus       151 kp~NIll~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~P  229 (372)
                      ||+|||++. ++.+||+|||+++.......  .....||+.|+|||++.+    ...++.++|||||||++|+|++|++|
T Consensus       158 kp~NIll~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~----~~~~~~~~Di~slG~il~ell~g~~p  231 (360)
T 3e3p_A          158 KPHNVLVNEADGTLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFG----NQHYTTAVDIWSVGCIFAEMMLGEPI  231 (360)
T ss_dssp             CGGGEEEETTTTEEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTT----CSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CHHHEEEeCCCCcEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcC----CCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            999999996 89999999999987654332  233578999999999873    45589999999999999999999999


Q ss_pred             CCCCCHHHHHHHHhhccCCcC---------------C-----------CCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCC
Q psy11571        230 FYAESLVETYGKIMNHQNSFD---------------L-----------PSDVGYEISDDAKDLMRRLIC-SSDTRLGQNG  282 (372)
Q Consensus       230 f~~~~~~~~~~~i~~~~~~~~---------------~-----------~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~  282 (372)
                      |.+.+....+..+........               .           ........++++++||.+||+ ||.+|||+.+
T Consensus       232 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  311 (360)
T 3e3p_A          232 FRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYE  311 (360)
T ss_dssp             SCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHH
Confidence            999988877777654211100               0           000111357899999999999 9999998666


Q ss_pred             hhhhhhhhhhhhccCCCCCCCCCcCCCCcc
Q psy11571        283 IADFKMWSALFVSLSISPRNHPWFQGIAWD  312 (372)
Q Consensus       283 ~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~  312 (372)
                      ++                 +||||+++.+.
T Consensus       312 ~l-----------------~hp~f~~~~~~  324 (360)
T 3e3p_A          312 AL-----------------CHPYFDELHDP  324 (360)
T ss_dssp             HT-----------------TSGGGGGGGCT
T ss_pred             Hh-----------------cCccccccCCc
Confidence            55                 99999987653

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=344.31  Aligned_cols=252  Identities=18%  Similarity=0.245  Sum_probs=204.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEee-----eehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIE-----TLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITN   77 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~-----~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~   77 (372)
                      +|+.++.+|.|    |+|.||++.     +..+++.||+|.+.......         ....+.+|+.+++.++||||++
T Consensus        72 ~~~~~~~LG~G----~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~E~~~l~~l~hpnIv~  138 (367)
T 3l9p_A           72 NITLIRGLGHG----AFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ---------DELDFLMEALIISKFNHQNIVR  138 (367)
T ss_dssp             GEEEEEECCCC----SSSCEEEEEECC-----CCEEEEEEECCSSCCHH---------HHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HeEEeeEeeeC----CCEEEEEEEEccCCCCCcceeEEEEecccccChh---------hHHHHHHHHHHHHhCCCCCCCe
Confidence            34444555555    899999998     44567789999886433222         2234678999999999999999


Q ss_pred             eeEEEEeCCeEEEEEeccCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCC
Q psy11571         78 LHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIK  151 (372)
Q Consensus        78 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlk  151 (372)
                      +++++.+....|+|||||+||+|.+++....      ..+++..++.++.||+.||.|||++||+|          ||||
T Consensus       139 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH----------rDlk  208 (367)
T 3l9p_A          139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIH----------RDIA  208 (367)
T ss_dssp             EEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCC
T ss_pred             EEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeC----------CCCC
Confidence            9999999999999999999999999998743      35899999999999999999999999999          9999


Q ss_pred             cCcEEeCCCC---cEEEeecCcccccCCCC-cccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-C
Q psy11571        152 PDNVLLDANG---HIRLADFGSCLRLGGDG-TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-G  226 (372)
Q Consensus       152 p~NIll~~~~---~vkl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G  226 (372)
                      |+|||++.+|   .+||+|||+++...... ........||+.|+|||++.+     ..++.++|||||||++|||++ |
T Consensus       209 p~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DvwslG~il~ellt~g  283 (367)
T 3l9p_A          209 ARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-----GIFTSKTDTWSFGVLLWEIFSLG  283 (367)
T ss_dssp             GGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTS
T ss_pred             hhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcC-----CCCCcHHHHHHHHHHHHHHHhCC
Confidence            9999999555   59999999997542211 112233568999999999974     568999999999999999998 9


Q ss_pred             CCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        227 ETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       227 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ..||.+.+..+....+..+. ....+.    .+++.+.+||.+||+ ||++||++.++++.+
T Consensus       284 ~~pf~~~~~~~~~~~i~~~~-~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~eil~~l  340 (367)
T 3l9p_A          284 YMPYPSKSNQEVLEFVTSGG-RMDPPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERI  340 (367)
T ss_dssp             CCSSTTCCHHHHHHHHHTTC-CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHcCC-CCCCCc----cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            99999999888888877653 233333    689999999999999 999999988777544

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.3e-44  Score=329.66  Aligned_cols=249  Identities=20%  Similarity=0.256  Sum_probs=207.3

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||.+... ++..||+|.+.......           +.+.+|+.++..++||||+++++++
T Consensus        25 ~y~~~~~lg~G----~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----------~~~~~E~~~l~~l~h~~i~~~~~~~   88 (283)
T 3gen_A           25 DLTFLKELGTG----QFGVVKYGKWR-GQYDVAIKMIKEGSMSE-----------DEFIEEAKVMMNLSHEKLVQLYGVC   88 (283)
T ss_dssp             GEEEEEECC-------CEEEEEEEET-TTEEEEEEEECTTSBCH-----------HHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             HHHhHhhcCCC----CCceEEEEEEc-CCCeEEEEEecCCCCCH-----------HHHHHHHHHHhcCCCCCEeeEEEEE
Confidence            45556666666    89999999544 67789999887654332           2367899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+.+.+|+||||+++++|.+++......+++..++.++.|++.||.|||++|++|          |||||+||+++.++.
T Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H----------~dikp~Nili~~~~~  158 (283)
T 3gen_A           89 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH----------RDLAARNCLVNDQGV  158 (283)
T ss_dssp             CSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SSCSGGGEEECTTSC
T ss_pred             ecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccC----------CCCccceEEEcCCCC
Confidence            9999999999999999999999875578999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGK  241 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~  241 (372)
                      +||+|||++...............+|+.|+|||++.+     ..++.++||||||+++|+|++ |..||...+..+....
T Consensus       159 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~  233 (283)
T 3gen_A          159 VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-----SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH  233 (283)
T ss_dssp             EEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHH-----CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred             EEEccccccccccccccccccCCccCcccCCHHHhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHH
Confidence            9999999998765433333333457788999999984     568999999999999999998 9999999998888887


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      +.... ....+.    ..++.+.+||.+||+ +|.+||+++++++.+
T Consensus       234 ~~~~~-~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L  275 (283)
T 3gen_A          234 IAQGL-RLYRPH----LASEKVYTIMYSCWHEKADERPTFKILLSNI  275 (283)
T ss_dssp             HHTTC-CCCCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             Hhccc-CCCCCC----cCCHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence            77653 222333    579999999999999 999999988776544

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.2e-44  Score=343.87  Aligned_cols=254  Identities=19%  Similarity=0.259  Sum_probs=206.6

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEee-----eehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCce
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIE-----TLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWI   75 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~-----~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~I   75 (372)
                      ++|+..+.+|.|    |+|.||++.     +..+++.||+|.+.......         ..+.+.+|+.++..+ +||||
T Consensus        22 ~~y~~~~~lG~G----~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~E~~~l~~l~~hpni   88 (359)
T 3vhe_A           22 DRLKLGKPLGRG----AFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS---------EHRALMSELKILIHIGHHLNV   88 (359)
T ss_dssp             GGEEEEEEEEEC----SSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH---------HHHHHHHHHHHHHHHCCCTTB
T ss_pred             cceeeceeecCC----CCceEEEEEeccccccccceEEEEEEecCcCCHH---------HHHHHHHHHHHHHhhcCCcce
Confidence            355566667776    899999998     55677899999886543322         245678899999998 79999


Q ss_pred             eeeeEEEEeCCe-EEEEEeccCCCCHHHHHHhcCC---------------------------------------------
Q psy11571         76 TNLHYAFQDDSN-LYLVMDYYCGGDLLTLLSKFED---------------------------------------------  109 (372)
Q Consensus        76 v~l~~~~~~~~~-~~lv~E~~~gg~L~~~l~~~~~---------------------------------------------  109 (372)
                      +++++++.+.+. +++|||||++|+|.+++.....                                             
T Consensus        89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (359)
T 3vhe_A           89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV  168 (359)
T ss_dssp             CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred             eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence            999999987654 8999999999999999986321                                             


Q ss_pred             --------------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecC
Q psy11571        110 --------------------RLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG  169 (372)
Q Consensus       110 --------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg  169 (372)
                                          .+++..++.++.||+.||.|||++||+|          |||||+|||++.++.+||+|||
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH----------~Dikp~NIll~~~~~~kl~Dfg  238 (359)
T 3vhe_A          169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIH----------RDLAARNILLSEKNVVKICDFG  238 (359)
T ss_dssp             ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCSGGGEEECGGGCEEECCCG
T ss_pred             cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCccc----------CCCChhhEEEcCCCcEEEEecc
Confidence                                1899999999999999999999999999          9999999999999999999999


Q ss_pred             cccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHHhhccC
Q psy11571        170 SCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHQN  247 (372)
Q Consensus       170 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~  247 (372)
                      +++....... .......||+.|+|||++.+     ..++.++|||||||++|+|++ |..||.+....+..........
T Consensus       239 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~  313 (359)
T 3vhe_A          239 LARDIYKDPDYVRKGDARLPLKWMAPETIFD-----RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT  313 (359)
T ss_dssp             GGSCTTSCTTCEEC--CEECGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC
T ss_pred             ceeeecccccchhccccCCCceeEChhhhcC-----CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCC
Confidence            9986643322 22334578999999999984     568999999999999999998 9999998765555555444444


Q ss_pred             CcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        248 SFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       248 ~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ....|.    .+++++.++|.+||. ||.+||+++++++.+
T Consensus       314 ~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  350 (359)
T 3vhe_A          314 RMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL  350 (359)
T ss_dssp             CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCCCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence            444444    689999999999999 999999988877554

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.1e-45  Score=353.19  Aligned_cols=261  Identities=19%  Similarity=0.229  Sum_probs=189.0

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHH---HHHhcCCCCceeeee-
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREER---DVLVYGDRRWITNLH-   79 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~---~il~~l~hp~Iv~l~-   79 (372)
                      |+.++.+|.|    |+|.||++.+..+++.||+|.+........       ...+.+++|.   .+|+. +||||++++ 
T Consensus        64 y~~~~~lG~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~~E~~~~~~l~~-~hp~iv~~~~  131 (371)
T 3q60_A           64 LKLVEPLRVG----DRSVVFLVRDVERLEDFALKVFTMGAENSR-------SELERLHEATFAAARLLG-ESPEEARDRR  131 (371)
T ss_dssp             EEEEEEEEEC----SSEEEEEEEETTTTEEEEEEEEECCSTTHH-------HHHHHHHHHHHHHHHHHC-----------
T ss_pred             eeeeeeccCC----CCEEEEEEEECCCCceeEEEEEEecccccc-------cHHHHHHHHHHHHHHhcc-cChhhhhhce
Confidence            3344455555    899999999999999999999887654332       2334566774   45555 799988765 


Q ss_pred             ------EEEEeC-----------------CeEEEEEeccCCCCHHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHH
Q psy11571         80 ------YAFQDD-----------------SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMA------KFYIAEMVLAIASI  130 (372)
Q Consensus        80 ------~~~~~~-----------------~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~------~~~~~qi~~~L~~L  130 (372)
                            +++...                 ..+|+|||||+ |+|.+++...+..+++...      ..++.||+.||+||
T Consensus       132 ~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~L  210 (371)
T 3q60_A          132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANL  210 (371)
T ss_dssp             CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHH
Confidence                  455443                 34899999997 8999999874344555444      56779999999999


Q ss_pred             HhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCc
Q psy11571        131 HDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPE  210 (372)
Q Consensus       131 H~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~  210 (372)
                      |++||+|          |||||+|||++.+|.+||+|||+++......    ....+|+.|+|||++.+   +...++.+
T Consensus       211 H~~~ivH----------rDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~---~~~~~~~~  273 (371)
T 3q60_A          211 QSKGLVH----------GHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNA---STATFTHA  273 (371)
T ss_dssp             HHTTEEE----------TTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTC---SEEECCHH
T ss_pred             HHCCCcc----------CcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccC---CCCCcCcc
Confidence            9999999          9999999999999999999999998764321    13467799999999973   12468999


Q ss_pred             cceeehhHHHHHHhhCCCCCCCCCHHHH--HHH---HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        211 CDWWSLGVCMYEMLYGETPFYAESLVET--YGK---IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       211 ~DiwslGvil~elltG~~Pf~~~~~~~~--~~~---i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      +|||||||++|+|++|+.||.+......  +..   .......+.++.  ...+++++.+||.+||+ ||++||++.+++
T Consensus       274 ~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l  351 (371)
T 3q60_A          274 LNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGS--CTPLPDFVKTLIGRFLNFDRRRRLLPLEAM  351 (371)
T ss_dssp             HHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTT--SSCCCHHHHHHHHHHTCSSTTTCCCHHHHT
T ss_pred             ccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhh--ccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence            9999999999999999999987643211  111   011111222222  23789999999999999 999999876555


Q ss_pred             hhhhhhhhhhccCCCCCCCCCcCCCCccc
Q psy11571        285 DFKMWSALFVSLSISPRNHPWFQGIAWDS  313 (372)
Q Consensus       285 ~i~~~~~~~~~~~~~~~~hp~f~~~~w~~  313 (372)
                                       +||||+++.|..
T Consensus       352 -----------------~hp~f~~~~~~~  363 (371)
T 3q60_A          352 -----------------ETPEFLQLQNEI  363 (371)
T ss_dssp             -----------------TSHHHHHHHHHH
T ss_pred             -----------------cCHHHHHHHHHH
Confidence                             999999988753

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.8e-46  Score=359.46  Aligned_cols=251  Identities=15%  Similarity=0.173  Sum_probs=191.9

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHH---HHhcCCCCceeeee-
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERD---VLVYGDRRWITNLH-   79 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~---il~~l~hp~Iv~l~-   79 (372)
                      |+..+.+|.|    |+|.||++.+..+++.||+|.+.........       ..+.+.+|+.   +++.++||||++++ 
T Consensus        75 y~~~~~lG~G----~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~-------~~~~~~~E~~~l~~l~~l~hpniv~~~~  143 (377)
T 3byv_A           75 LVRGTVLGQE----DPYAYLEATDQETGESFEVHVPYFTERPPSN-------AIKQMKEEVLRLRLLRGIKNQKQAKVHL  143 (377)
T ss_dssp             EEEEEEEEEE----TTEEEEEEEC-CCCCEEEEEEEEECC-CCTT-------HHHHHHHHHHGGGGSTTCCSHHHHHHHH
T ss_pred             EEEcceeecC----CCEEEEEEEECCCCcEEEEEEEeeccccchH-------HHHHHHHHHHHHHhccccCCHHHHHHHh
Confidence            3344455555    8999999999889999999998754333321       2355778984   45566899999998 


Q ss_pred             ------EEEEeCCe-----------------EEEEEeccCCCCHHHHHHhcCCCCCH-------HHHHHHHHHHHHHHHH
Q psy11571         80 ------YAFQDDSN-----------------LYLVMDYYCGGDLLTLLSKFEDRLPE-------DMAKFYIAEMVLAIAS  129 (372)
Q Consensus        80 ------~~~~~~~~-----------------~~lv~E~~~gg~L~~~l~~~~~~l~~-------~~~~~~~~qi~~~L~~  129 (372)
                            +++.+.+.                 .|+||||+ +|+|.+++... +.+++       ..+..++.||+.||+|
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~  221 (377)
T 3byv_A          144 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL-LSHSSTHKSLVHHARLQLTLQVIRLLAS  221 (377)
T ss_dssp             CBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH-HHTTTTTHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc-cccccccccccHHHHHHHHHHHHHHHHH
Confidence                  77776542                 89999999 68999999863 34444       7888899999999999


Q ss_pred             HHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCccccccc------ccC
Q psy11571        130 IHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAM------EEG  203 (372)
Q Consensus       130 LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~  203 (372)
                      ||++||+|          |||||+|||++.++.+||+|||+++....    .....+| +.|+|||++.+.      ...
T Consensus       222 LH~~~ivH----------rDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~  286 (377)
T 3byv_A          222 LHHYGLVH----------TYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDR  286 (377)
T ss_dssp             HHHTTEEC----------SCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCC
T ss_pred             HHhCCeec----------CCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccc
Confidence            99999999          99999999999999999999999986433    2234567 999999999842      000


Q ss_pred             CCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCC
Q psy11571        204 RGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNG  282 (372)
Q Consensus       204 ~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~  282 (372)
                      ...++.++|||||||++|||++|+.||.+.+.......+...      +    ..+++++.+||.+||+ ||++||++.+
T Consensus       287 ~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~------~----~~~~~~~~~li~~~L~~dp~~Rpt~~e  356 (377)
T 3byv_A          287 RTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRS------C----KNIPQPVRALLEGFLRYPKEDRLLPLQ  356 (377)
T ss_dssp             EEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGSS------C----CCCCHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred             cccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhhh------c----cCCCHHHHHHHHHHcCCCchhCCCHHH
Confidence            026899999999999999999999999876654433333221      1    2689999999999999 9999998666


Q ss_pred             hhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        283 IADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       283 ~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      ++                 +||||+++
T Consensus       357 ~l-----------------~hp~f~~~  366 (377)
T 3byv_A          357 AM-----------------ETPEYEQL  366 (377)
T ss_dssp             HH-----------------TSHHHHHH
T ss_pred             Hh-----------------hChHHHHH
Confidence            55                 99999865

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8.7e-44  Score=331.58  Aligned_cols=255  Identities=22%  Similarity=0.285  Sum_probs=199.0

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.++.|    ++|.||.+.+..+++.||+|.+........       ...+.+.+|+.+++.++||||+++++++
T Consensus        35 ~y~~~~~lg~G----~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~~~e~~~l~~l~hp~iv~~~~~~  103 (309)
T 2h34_A           35 PYRLRRLVGRG----GMGDVYEAEDTVRERIVALKLMSETLSSDP-------VFRTRMQREARTAGRLQEPHVVPIHDFG  103 (309)
T ss_dssp             CEEEEEEEEEC----SSSEEEEEEETTTTEEEEEEECGGGGGGSH-------HHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cEEEEEEEcCC----CCeeEEEEEEcCCCeEEEEEecCcccccCH-------HHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence            34445556665    899999999988999999998865443322       2346688899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+.+.+|+||||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+|          |||||+||+++.++.
T Consensus       104 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H----------~dlkp~NIl~~~~~~  172 (309)
T 2h34_A          104 EIDGQLYVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATH----------RDVKPENILVSADDF  172 (309)
T ss_dssp             EETTEEEEEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCCGGGEEECTTSC
T ss_pred             eeCCeEEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCCc----------CCCChHHEEEcCCCC
Confidence            999999999999999999999987 467999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||++...............||+.|+|||++.+     ..++.++||||||+++|+|++|+.||.+.+.......+
T Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  247 (309)
T 2h34_A          173 AYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE-----SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI  247 (309)
T ss_dssp             EEECSCCC----------------CCGGGCCGGGTCC---------CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH
T ss_pred             EEEecCccCccccccccccccccCCCcCccCHHHHcC-----CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh
Confidence            9999999997765443333334678999999999973     56889999999999999999999999987766444444


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCC-CCCChhhhh
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRL-GQNGIADFK  287 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~-s~~~~~~i~  287 (372)
                      ....   ..+......+++++.++|.+||+ ||++|| +++++.+.+
T Consensus       248 ~~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l  291 (309)
T 2h34_A          248 NQAI---PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAA  291 (309)
T ss_dssp             HSCC---CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred             ccCC---CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHH
Confidence            3322   11222233789999999999999 999999 677766544

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=9.5e-45  Score=347.56  Aligned_cols=252  Identities=23%  Similarity=0.306  Sum_probs=208.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+..+.+|.|    ++|.||.+....+++.||+|.+......         +..+.+.+|+.+++.++||||+++++++
T Consensus       115 ~~~~~~~lG~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~E~~~l~~l~hpniv~~~~~~  181 (377)
T 3cbl_A          115 DLVLGEQIGRG----NFGEVFSGRLRADNTLVAVKSCRETLPP---------DLKAKFLQEARILKQYSHPNIVRLIGVC  181 (377)
T ss_dssp             GEEEEEEEEEE----TTEEEEEEEETTTCCEEEEEECCTTSCH---------HHHTTTTHHHHHHTTCCCTTBCCEEEEE
T ss_pred             HeEEeeEeccC----CCCeEEEEEEecCCeEEEEEEccccCCH---------HHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            34444555555    8999999998889999999987654221         1234577899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+.+.+|+||||+++|+|.+++......+++..+..++.||+.||+|||++|++|          |||||+|||++.++.
T Consensus       182 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH----------rDlkp~Nil~~~~~~  251 (377)
T 3cbl_A          182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIH----------RDLAARNCLVTEKNV  251 (377)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSGGGEEECTTCC
T ss_pred             ecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCC----------cccCHHHEEEcCCCc
Confidence            9999999999999999999999875567999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccc-cccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQS-NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYG  240 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~  240 (372)
                      +||+|||+++.......... ....+++.|+|||++..     ..++.++|||||||++|||++ |..||.+.+..+...
T Consensus       252 ~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~  326 (377)
T 3cbl_A          252 LKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY-----GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE  326 (377)
T ss_dssp             EEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHH-----CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHH
T ss_pred             EEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999999986543221111 12235678999999973     568899999999999999998 999999988887776


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .+..+ ...+.|.    .+++++.+||.+||+ ||++|||++++.+.+
T Consensus       327 ~~~~~-~~~~~~~----~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L  369 (377)
T 3cbl_A          327 FVEKG-GRLPCPE----LCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL  369 (377)
T ss_dssp             HHHTT-CCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHcC-CCCCCCC----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            66554 3344444    689999999999999 999999988776544

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=5e-44  Score=337.28  Aligned_cols=252  Identities=20%  Similarity=0.275  Sum_probs=208.8

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeee-----hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETL-----LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITN   77 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~-----~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~   77 (372)
                      +|+.++.+|.|    |+|.||++...     .+++.||+|.+......         +..+.+.+|+.+++.++||||++
T Consensus        48 ~~~~~~~lg~G----~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~E~~~l~~l~hp~iv~  114 (343)
T 1luf_A           48 NIEYVRDIGEG----AFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA---------DMQADFQREAALMAEFDNPNIVK  114 (343)
T ss_dssp             GCEEEEEEEEC----SSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH---------HHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             HCeeeeeeeec----CCeeEEEEEecCcCCCCCceeEEEEEeccccCH---------HHHHHHHHHHHHHHhCCCCCEEE
Confidence            34445556665    89999999876     35588999988754321         23456889999999999999999


Q ss_pred             eeEEEEeCCeEEEEEeccCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcC
Q psy11571         78 LHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE-----------------------DRLPEDMAKFYIAEMVLAIASIHDLH  134 (372)
Q Consensus        78 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-----------------------~~l~~~~~~~~~~qi~~~L~~LH~~~  134 (372)
                      +++++.+.+.+|+||||+++|+|.+++....                       ..+++.+++.++.||+.||.|||++|
T Consensus       115 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~  194 (343)
T 1luf_A          115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK  194 (343)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999998632                       56899999999999999999999999


Q ss_pred             ceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccce
Q psy11571        135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDW  213 (372)
Q Consensus       135 ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Di  213 (372)
                      |+|          |||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+     ..++.++||
T Consensus       195 ivH----------~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di  259 (343)
T 1luf_A          195 FVH----------RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-----NRYTTESDV  259 (343)
T ss_dssp             CCC----------SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-----CCCCHHHHH
T ss_pred             eec----------CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-----CCcCccccc
Confidence            999          99999999999999999999999976543221 12233567899999999984     568999999


Q ss_pred             eehhHHHHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        214 WSLGVCMYEMLY-GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       214 wslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      |||||++|+|++ |..||.+.+..+....+..+.. ...|.    .+++++.+||.+||. ||++||++.++.+.+
T Consensus       260 ~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L  330 (343)
T 1luf_A          260 WAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI-LACPE----NCPLELYNLMRLCWSKLPADRPSFCSIHRIL  330 (343)
T ss_dssp             HHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC-CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCc-CCCCC----CCCHHHHHHHHHHcccCcccCCCHHHHHHHH
Confidence            999999999999 9999999998888877766532 23333    689999999999999 999999988877655

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.1e-43  Score=326.74  Aligned_cols=256  Identities=19%  Similarity=0.237  Sum_probs=206.9

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+..+.+|.|    |+|.||++.+..+++.||+|.+..........   ..+..+.+.+|+.+++.++||||++++++
T Consensus        19 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   91 (287)
T 4f0f_A           19 NEIEYEKQIGKG----GFGLVHKGRLVKDKSVVAIKSLILGDSEGETE---MIEKFQEFQREVFIMSNLNHPNIVKLYGL   91 (287)
T ss_dssp             TTEEEEEECCCC----SSSCEEEEEETTTCCEEEEEECCCCTTTCCHH---HHCCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             ccceehhccccC----CceeEEEEEEcCCceEEEEEEeeccccccchh---HHHHHHHHHHHHHHHHhCCCCCchhhhee
Confidence            355556666666    89999999999999999999886654433211   11223568889999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCCCcCCCCCcCcEEeCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH--YVHRPNHFAFHLCRDIKPDNVLLDA  159 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~~~~~~~~vhrDlkp~NIll~~  159 (372)
                      +.+..  ++||||+++|+|.+++......+++..+..++.|++.||.|||++|  ++|          |||||+||+++.
T Consensus        92 ~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH----------~dikp~Nil~~~  159 (287)
T 4f0f_A           92 MHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVH----------RDLRSPNIFLQS  159 (287)
T ss_dssp             ETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBC----------SCCSGGGEEESC
T ss_pred             ecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeec----------CCCCcceEEEec
Confidence            97765  6999999999999999775668999999999999999999999999  999          999999999988


Q ss_pred             CCc-----EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCC
Q psy11571        160 NGH-----IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES  234 (372)
Q Consensus       160 ~~~-----vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~  234 (372)
                      ++.     +||+|||+++.....    .....||+.|+|||++...   ...++.++|||||||++|+|++|+.||...+
T Consensus       160 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  232 (287)
T 4f0f_A          160 LDENAPVCAKVADFGLSQQSVHS----VSGLLGNFQWMAPETIGAE---EESYTEKADTYSFAMILYTILTGEGPFDEYS  232 (287)
T ss_dssp             CCTTCSCCEEECCCTTCBCCSSC----EECCCCCCTTSCGGGSSCS---SCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             cCCCCceeEEeCCCCcccccccc----ccccCCCccccCchhhccC---CCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence            776     999999999754332    2336799999999998521   3457889999999999999999999998754


Q ss_pred             HHH--HHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        235 LVE--TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       235 ~~~--~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ...  ....+.........+.    .+++++.+||.+||+ ||.+||+++++.+.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  284 (287)
T 4f0f_A          233 YGKIKFINMIREEGLRPTIPE----DCPPRLRNVIELCWSGDPKKRPHFSYIVKEL  284 (287)
T ss_dssp             CCHHHHHHHHHHSCCCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ccHHHHHHHHhccCCCCCCCc----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence            333  3444444444444444    789999999999999 999999988877544

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.1e-44  Score=335.11  Aligned_cols=269  Identities=18%  Similarity=0.215  Sum_probs=218.3

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeee-----hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETL-----LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITN   77 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~-----~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~   77 (372)
                      +|+..+.+|.|    |+|.||++...     .+++.||+|.+.......         ....+.+|+.+++.++||||++
T Consensus        26 ~y~~~~~lg~G----~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~   92 (322)
T 1p4o_A           26 KITMSRELGQG----SFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR---------ERIEFLNEASVMKEFNCHHVVR   92 (322)
T ss_dssp             GEEEEEEEEEC----SSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH---------HHHHHHHHHHHGGGCCCTTBCC
T ss_pred             heeeeeEeccC----CceEEEeeeecCccCCCCceEEEEEecccccCHH---------HHHHHHHHHHHHHhcCCCCEee
Confidence            45555666666    89999998776     467889999886543222         2345788999999999999999


Q ss_pred             eeEEEEeCCeEEEEEeccCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCC
Q psy11571         78 LHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE---------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCR  148 (372)
Q Consensus        78 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhr  148 (372)
                      +++++.+.+..++||||+++|+|.+++....         ..+++..+..++.||+.||.|||++||+|          |
T Consensus        93 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H----------~  162 (322)
T 1p4o_A           93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVH----------R  162 (322)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBC----------S
T ss_pred             eEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCcc----------C
Confidence            9999999999999999999999999997532         45799999999999999999999999999          9


Q ss_pred             CCCcCcEEeCCCCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-C
Q psy11571        149 DIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-G  226 (372)
Q Consensus       149 Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G  226 (372)
                      ||||+||+++.++.+||+|||+++....... .......||+.|+|||++.+     ..++.++|||||||++|+|++ |
T Consensus       163 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~~g  237 (322)
T 1p4o_A          163 DLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-----GVFTTYSDVWSFGVVLWEIATLA  237 (322)
T ss_dssp             CCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHHTS
T ss_pred             CCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhcc-----CCCCchhhHHHHHHHHHHHHhcC
Confidence            9999999999999999999999976543221 12223457889999999974     568899999999999999999 8


Q ss_pred             CCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCC
Q psy11571        227 ETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPW  305 (372)
Q Consensus       227 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~  305 (372)
                      ..||.+.+..+....+..... ...+.    .+++.+.+||.+||. ||.+||++.++.+.+.           ....|+
T Consensus       238 ~~p~~~~~~~~~~~~~~~~~~-~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~-----------~~~~~~  301 (322)
T 1p4o_A          238 EQPYQGLSNEQVLRFVMEGGL-LDKPD----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK-----------EEMEPG  301 (322)
T ss_dssp             CCTTTTSCHHHHHHHHHTTCC-CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHG-----------GGSCTT
T ss_pred             CCccccCCHHHHHHHHHcCCc-CCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH-----------HhhccC
Confidence            999999988888877766432 22333    689999999999999 9999999888776551           114588


Q ss_pred             cCCCCccccc
Q psy11571        306 FQGIAWDSIR  315 (372)
Q Consensus       306 f~~~~w~~~~  315 (372)
                      |+.++|....
T Consensus       302 ~~~~~~~~~~  311 (322)
T 1p4o_A          302 FREVSFYYSE  311 (322)
T ss_dssp             HHHHCSTTST
T ss_pred             Cccccccccc
Confidence            8887775543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=327.59  Aligned_cols=249  Identities=26%  Similarity=0.403  Sum_probs=199.3

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      ||+|.||.+.+..+++.||+|.+......          ..+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus        33 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           33 GTYGIVYAGRDLSNQVRIAIKEIPERDSR----------YSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             CSSSEEEEEEETTTCCEEEEEEEECCCC-------------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             cCcEEEEEEEECCCCeEEEEEEccCCchH----------HHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            38999999999999999999987654321          23557889999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC-CCcEEEeecCcccc
Q psy11571         97 GGDLLTLLSKFED--RLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA-NGHIRLADFGSCLR  173 (372)
Q Consensus        97 gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~-~~~vkl~Dfg~a~~  173 (372)
                      +++|.+++.....  .+++..++.++.||+.||.|||++|++|          |||||+||+++. ++.+||+|||++..
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H----------~dl~p~Nil~~~~~~~~kl~Dfg~~~~  172 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVH----------RDIKGDNVLINTYSGVLKISDFGTSKR  172 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEEETTTCCEEECCTTTCEE
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEc----------cCCChhhEEEECCCCCEEEeecccccc
Confidence            9999999987422  4678999999999999999999999999          999999999987 89999999999987


Q ss_pred             cCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH-HHHHHHhhccCCcCCC
Q psy11571        174 LGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKIMNHQNSFDLP  252 (372)
Q Consensus       174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~  252 (372)
                      ...... ......||+.|+|||++.+.   ...++.++||||||+++|+|++|+.||...... ..............++
T Consensus       173 ~~~~~~-~~~~~~~~~~y~aPE~~~~~---~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  248 (295)
T 2clq_A          173 LAGINP-CTETFTGTLQYMAPEIIDKG---PRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIP  248 (295)
T ss_dssp             SCC------CCCCCCGGGCCHHHHHHG---GGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCC
T ss_pred             cCCCCC-cccccCCCccccChhhhcCC---CCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccccc
Confidence            654322 22345789999999999742   123788999999999999999999999764332 2222222222223333


Q ss_pred             CCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCC
Q psy11571        253 SDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       253 ~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~  310 (372)
                      .    .+++++.+||.+||+ ||++||++++++                 .||||+...
T Consensus       249 ~----~~~~~~~~li~~~l~~dp~~Rps~~~ll-----------------~~~~~~~~~  286 (295)
T 2clq_A          249 E----SMSAEAKAFILKCFEPDPDKRACANDLL-----------------VDEFLKVSS  286 (295)
T ss_dssp             T----TSCHHHHHHHHHTTCSSTTTSCCHHHHH-----------------TSGGGCC--
T ss_pred             c----cCCHHHHHHHHHHccCChhhCCCHHHHh-----------------cChhhhhcc
Confidence            3    689999999999999 999999866655                 999998643

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=9.9e-44  Score=327.15  Aligned_cols=250  Identities=19%  Similarity=0.289  Sum_probs=211.9

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+..+.+|.|    |+|.||.+.+..++..||+|.+......           .+.+.+|+.+++.++||||+++++++
T Consensus        14 ~~~~~~~lg~G----~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~~E~~~l~~l~h~~i~~~~~~~   78 (288)
T 3kfa_A           14 DITMKHKLGGG----QYGEVYEGVWKKYSLTVAVKTLKEDTME-----------VEEFLKEAAVMKEIKHPNLVQLLGVC   78 (288)
T ss_dssp             GEEEEEESGGG----TTCSEEEEEEGGGTEEEEEEEECSCSTH-----------HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ceeEEeecCCC----CceeEEEeEecCCCEEEEEEecCcCHHH-----------HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            44455556666    8999999999989999999988654322           34577899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      .+.+.+|+||||+++++|.+++... ...+++..++.++.||+.||.|||++|++|          |||||+||+++.++
T Consensus        79 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H----------~dikp~Nil~~~~~  148 (288)
T 3kfa_A           79 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH----------RDLAARNCLVGENH  148 (288)
T ss_dssp             CSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCC----------SCCSGGGEEECGGG
T ss_pred             ccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccC----------CCCCcceEEEcCCC
Confidence            9999999999999999999999863 345899999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYG  240 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~  240 (372)
                      .++|+|||++...............+|+.|+|||++.+     ..++.++||||||+++|+|++ |.+||.+.+......
T Consensus       149 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~  223 (288)
T 3kfa_A          149 LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-----NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE  223 (288)
T ss_dssp             CEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred             CEEEccCccceeccCCccccccCCccccCcCChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999999998776554444444567889999999984     568899999999999999999 999999888777766


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .+... .....+.    .+++.+.+||.+||. ||.+||+++++.+.+
T Consensus       224 ~~~~~-~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l  266 (288)
T 3kfa_A          224 LLEKD-YRMERPE----GCPEKVYELMRACWQWNPSDRPSFAEIHQAF  266 (288)
T ss_dssp             HHHTT-CCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHhcc-CCCCCCC----CCCHHHHHHHHHHhCCChhhCcCHHHHHHHH
Confidence            66543 2333333    689999999999999 999999988877654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=339.79  Aligned_cols=252  Identities=20%  Similarity=0.284  Sum_probs=208.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeeh-------hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCc
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLL-------DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRW   74 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~-------~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~   74 (372)
                      +|+..+.+|.|    |+|.||++....       ++..||+|.+......         ...+.+.+|+.+++.+ +|||
T Consensus        70 ~y~i~~~LG~G----~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~E~~~l~~l~~hpn  136 (382)
T 3tt0_A           70 RLVLGKPLGEG----AFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE---------KDLSDLISEMEMMKMIGKHKN  136 (382)
T ss_dssp             GEEEEEEEEEC----SSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCH---------HHHHHHHHHHHHHHHHCCCTT
T ss_pred             heEeeeEEecC----CCeEEEEEEEccccccccccceEEEEEeeccccCH---------HHHHHHHHHHHHHHHhcCCch
Confidence            44445556666    899999998653       3357999987654322         1345678899999998 8999


Q ss_pred             eeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecC
Q psy11571         75 ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE---------------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRP  139 (372)
Q Consensus        75 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~  139 (372)
                      |+++++++.+.+..|+||||+++|+|.+++....               ..+++..++.++.||+.||.|||+.||+|  
T Consensus       137 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH--  214 (382)
T 3tt0_A          137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIH--  214 (382)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCC--
T ss_pred             hhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEec--
Confidence            9999999999999999999999999999998742               34899999999999999999999999999  


Q ss_pred             CCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhH
Q psy11571        140 NHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGV  218 (372)
Q Consensus       140 ~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGv  218 (372)
                              |||||+|||++.++.+||+|||+++....... .......||+.|+|||++.     ...++.++|||||||
T Consensus       215 --------~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~  281 (382)
T 3tt0_A          215 --------RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-----DRIYTHQSDVWSFGV  281 (382)
T ss_dssp             --------SCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHH-----SCCCCHHHHHHHHHH
T ss_pred             --------CCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhc-----CCCCCchhHHHHHHH
Confidence                    99999999999999999999999987644322 1223345788999999998     366899999999999


Q ss_pred             HHHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        219 CMYEMLY-GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       219 il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ++|+|++ |..||.+.+..+....+.... ....+.    .+++++.+||.+||+ ||++||+++++++.+
T Consensus       282 il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  347 (382)
T 3tt0_A          282 LLWEIFTLGGSPYPGVPVEELFKLLKEGH-RMDKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  347 (382)
T ss_dssp             HHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCCCS----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            9999999 999999998888877776543 333343    689999999999999 999999988877554

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.9e-44  Score=324.03  Aligned_cols=249  Identities=20%  Similarity=0.230  Sum_probs=209.3

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.++.|    ++|.||.+... ++..||+|.+.......           +.+.+|+.+++.++||||+++++++
T Consensus         9 ~y~~~~~lg~G----~~g~V~~~~~~-~~~~vaiK~~~~~~~~~-----------~~~~~e~~~l~~l~h~~i~~~~~~~   72 (267)
T 3t9t_A            9 ELTFVQEIGSG----QFGLVHLGYWL-NKDKVAIKTIREGAMSE-----------EDFIEEAEVMMKLSHPKLVQLYGVC   72 (267)
T ss_dssp             GEEEEEEEEEE----TTEEEEEEEET-TTEEEEEEEECTTTBCH-----------HHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             heeeeeEecCC----CceeEEEEEec-CCCeEEEEEccccCCCH-----------HHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            45555666666    89999999765 67789999887654322           3467899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+.+..|+||||+++++|.+++......+++..+..++.|++.||.|||++|++|          |||||+||+++.++.
T Consensus        73 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H----------~dl~p~Nili~~~~~  142 (267)
T 3t9t_A           73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH----------RDLAARNCLVGENQV  142 (267)
T ss_dssp             CSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SSCCGGGEEECGGGC
T ss_pred             ccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCccc----------CCCchheEEECCCCC
Confidence            9999999999999999999999875567999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGK  241 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~  241 (372)
                      +||+|||++...............+|+.|+|||++.+     ..++.++|+||||+++|+|++ |..||.+.+..+....
T Consensus       143 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~  217 (267)
T 3t9t_A          143 IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-----SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED  217 (267)
T ss_dssp             EEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred             EEEcccccccccccccccccccccccccccChhhhcC-----CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHH
Confidence            9999999998764432222233457889999999974     568899999999999999999 9999999988888887


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      +..... ...+.    ..++.+.++|.+||+ ||++||++.++.+.+
T Consensus       218 i~~~~~-~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L  259 (267)
T 3t9t_A          218 ISTGFR-LYKPR----LASTHVYQIMNHCWRERPEDRPAFSRLLRQL  259 (267)
T ss_dssp             HHTTCC-CCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HhcCCc-CCCCc----cCcHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            766532 22233    579999999999999 999999988776544

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=330.25  Aligned_cols=263  Identities=23%  Similarity=0.380  Sum_probs=194.9

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.++.|    |+|.||.+.+..+++.||+|.+........        ..+.+.++..+++.++||||+++++++
T Consensus        26 ~y~~~~~lg~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~~~~~~~~~~~h~~i~~~~~~~   93 (318)
T 2dyl_A           26 DLENLGEMGSG----TCGQVWKMRFRKTGHVIAVKQMRRSGNKEE--------NKRILMDLDVVLKSHDCPYIVQCFGTF   93 (318)
T ss_dssp             GEEEEEEC----------CEEEEEETTTCCEEEEEEEETTSCHHH--------HHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             cccccceeeec----CCeeEEEEEEecCCeEEEEEEecccccchH--------HHHHHHHHHHHHHhcCCCceeeEEEEE
Confidence            44445556665    899999999988999999998876543221        223345566678889999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDL-HYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      .+.+.+|+||||+ ++.+..+.......+++..++.++.||+.||.|||+. |++|          |||||+||+++.++
T Consensus        94 ~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H----------~dlkp~Nil~~~~~  162 (318)
T 2dyl_A           94 ITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIH----------RDVKPSNILLDERG  162 (318)
T ss_dssp             ECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCC----------CCCCGGGEEECTTS
T ss_pred             ecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEe----------CCCCHHHEEECCCC
Confidence            9999999999999 6677776665467899999999999999999999995 9999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCC-CCHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYG  240 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~-~~~~~~~~  240 (372)
                      .+||+|||++........  .....||+.|+|||++.........++.++|||||||++|+|++|+.||.. ....+...
T Consensus       163 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  240 (318)
T 2dyl_A          163 QIKLCDFGISGRLVDDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLT  240 (318)
T ss_dssp             CEEECCCTTC----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH
T ss_pred             CEEEEECCCchhccCCcc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHH
Confidence            999999999976544322  223578999999999963222245688999999999999999999999987 45556666


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCC
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~  310 (372)
                      .+..... ...+..  ..+++++.+||.+||+ ||.+||++++++                 +||||+..+
T Consensus       241 ~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll-----------------~h~~~~~~~  291 (318)
T 2dyl_A          241 KVLQEEP-PLLPGH--MGFSGDFQSFVKDCLTKDHRKRPKYNKLL-----------------EHSFIKRYE  291 (318)
T ss_dssp             HHHHSCC-CCCCSS--SCCCHHHHHHHHHHTCSCTTTSCCHHHHT-----------------TSHHHHHHH
T ss_pred             HHhccCC-CCCCcc--CCCCHHHHHHHHHHccCChhHCcCHHHHh-----------------hCHHHHhcc
Confidence            6665432 222221  2589999999999999 999999866555                 999998654

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=6.9e-44  Score=325.30  Aligned_cols=249  Identities=24%  Similarity=0.344  Sum_probs=196.2

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+..+.+|.|    |+|.||++.+  .+..+|+|.+........      ....+.+.+|..+++.++||||+++++++
T Consensus         8 ~~~~~~~lg~G----~~g~V~~~~~--~~~~vavK~~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   75 (271)
T 3dtc_A            8 ELTLEEIIGIG----GFGKVYRAFW--IGDEVAVKAARHDPDEDI------SQTIENVRQEAKLFAMLKHPNIIALRGVC   75 (271)
T ss_dssp             SEEEEEEEEEE----TTEEEEEEEE--TTEEEEEEEC----------------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             heeeeeeeccC----CCeEEEEEEE--cCCeEEEEEEecCCcccH------HHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            34445555665    8999999975  478899998765433221      12345688899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcC---ceecCCCCCCCcCCCCCcCcEEeCC
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH---YVHRPNHFAFHLCRDIKPDNVLLDA  159 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~~~~~~~~vhrDlkp~NIll~~  159 (372)
                      .+.+..++||||+++++|.+++..  ..+++..++.++.|++.||.|||++|   ++|          |||||+||+++.
T Consensus        76 ~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H----------~dikp~Nil~~~  143 (271)
T 3dtc_A           76 LKEPNLCLVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIH----------RDLKSSNILILQ  143 (271)
T ss_dssp             CCC--CEEEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCC----------SCCSGGGEEESS
T ss_pred             ecCCceEEEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceee----------cCCchHHEEEec
Confidence            999999999999999999999965  68999999999999999999999999   788          999999999985


Q ss_pred             --------CCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCC
Q psy11571        160 --------NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY  231 (372)
Q Consensus       160 --------~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~  231 (372)
                              ++.+||+|||++........   ....||+.|+|||++.+     ..++.++||||||+++|+|++|+.||.
T Consensus       144 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~  215 (271)
T 3dtc_A          144 KVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWMAPEVIRA-----SMFSKGSDVWSYGVLLWELLTGEVPFR  215 (271)
T ss_dssp             CCSSSCCSSCCEEECCCCC----------------CCGGGSCHHHHHH-----CCCSHHHHHHHHHHHHHHHHHCCCTTT
T ss_pred             ccccccccCcceEEccCCcccccccccc---cCCCCccceeCHHHhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence                    67899999999986543322   23578999999999984     568899999999999999999999999


Q ss_pred             CCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        232 AESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       232 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      +.+.......+.........+.    .+++.+.++|.+||+ ||.+||++.++++.+
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L  268 (271)
T 3dtc_A          216 GIDGLAVAYGVAMNKLALPIPS----TCPEPFAKLMEDCWNPDPHSRPSFTNILDQL  268 (271)
T ss_dssp             TSCHHHHHHHHHTSCCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCCHHHHHHhhhcCCCCCCCCc----ccCHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence            9888887777766555555444    689999999999999 999999988877654

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.3e-43  Score=339.20  Aligned_cols=252  Identities=18%  Similarity=0.230  Sum_probs=196.5

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeee---hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETL---LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLH   79 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~---~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~   79 (372)
                      +|+..+.+|.|    |+|.||+++..   .++..||+|.+......         ...+.+.+|+.++..++||||++++
T Consensus        46 ~~~~~~~lG~G----~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~~~  112 (373)
T 2qol_A           46 NISIDKVVGAG----EFGEVCSGRLKLPSKKEISVAIKTLKVGYTE---------KQRRDFLGEASIMGQFDHPNIIRLE  112 (373)
T ss_dssp             GCCCCEEEEEC----SSSEEEEC-CBCTTSCBCCEEEEECCTTCCH---------HHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             hceeeeEEeeC----CCeEEEEEEEecCCCCceeEEEEEecCccCH---------HHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            34444555555    89999999776   45778999988654321         1235688899999999999999999


Q ss_pred             EEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC
Q psy11571         80 YAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA  159 (372)
Q Consensus        80 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~  159 (372)
                      +++.+.+.+|+||||+++|+|.+++......+++..+..++.||+.||.|||++||+|          |||||+|||++.
T Consensus       113 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH----------~Dlkp~NIll~~  182 (373)
T 2qol_A          113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVH----------RDLAARNILINS  182 (373)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCCGGGEEECT
T ss_pred             EEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeC----------CCCCcceEEEcC
Confidence            9999999999999999999999999875567999999999999999999999999999          999999999999


Q ss_pred             CCcEEEeecCcccccCCCCcc--cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHH
Q psy11571        160 NGHIRLADFGSCLRLGGDGTV--QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLV  236 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~  236 (372)
                      ++.+||+|||+++........  ......+|+.|+|||++.+     ..++.++|||||||++|||++ |..||...+..
T Consensus       183 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~  257 (373)
T 2qol_A          183 NLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY-----RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ  257 (373)
T ss_dssp             TCCEEECCC----------------------CTTSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH
T ss_pred             CCCEEECcCccccccccCCccceeccCCCcCCCccChhhhcc-----CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999876543221  1112345778999999984     568999999999999999998 99999998888


Q ss_pred             HHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       237 ~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      +....+..+. ..+.+.    .++..+.+||.+||+ ||++||+++++.+.+
T Consensus       258 ~~~~~i~~~~-~~~~~~----~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L  304 (373)
T 2qol_A          258 DVIKAVDEGY-RLPPPM----DCPAALYQLMLDCWQKDRNNRPKFEQIVSIL  304 (373)
T ss_dssp             HHHHHHHTTE-ECCCCT----TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHcCC-CCCCCc----cccHHHHHHHHHHhCcChhhCcCHHHHHHHH
Confidence            8877776542 222233    679999999999999 999999988877655

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.6e-44  Score=336.87  Aligned_cols=253  Identities=21%  Similarity=0.285  Sum_probs=204.9

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeee-----hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCcee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETL-----LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWIT   76 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~-----~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv   76 (372)
                      +|+..+.+|.|    |+|.||.+...     .++..||+|.+......         ...+.+.+|+.++..+ .||||+
T Consensus        46 ~y~~~~~lG~G----~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~E~~~l~~l~~hp~iv  112 (344)
T 1rjb_A           46 NLEFGKVLGSG----AFGKVMNATAYGISKTGVSIQVAVKMLKEKADS---------SEREALMSELKMMTQLGSHENIV  112 (344)
T ss_dssp             GEEEEEEEEEC----SSEEEEEEEEESCSSSSCEEEEEEEEECC---------------CHHHHHHHHHHHHHCCCTTBC
T ss_pred             HceeeeeecCC----CCceeEEeeeeccccCCcceEEEEEecccccCH---------HHHHHHHHHHHHHHhhcCCCCee
Confidence            34444555655    89999999863     35678999988653321         1235678899999999 899999


Q ss_pred             eeeEEEEeCCeEEEEEeccCCCCHHHHHHhcCC----------------------CCCHHHHHHHHHHHHHHHHHHHhcC
Q psy11571         77 NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFED----------------------RLPEDMAKFYIAEMVLAIASIHDLH  134 (372)
Q Consensus        77 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~----------------------~l~~~~~~~~~~qi~~~L~~LH~~~  134 (372)
                      ++++++.+.+.+|+||||+++|+|.+++.....                      .+++..++.++.||+.||.|||++|
T Consensus       113 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  192 (344)
T 1rjb_A          113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS  192 (344)
T ss_dssp             CEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999999999999999999999999999987432                      2789999999999999999999999


Q ss_pred             ceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccce
Q psy11571        135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDW  213 (372)
Q Consensus       135 ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Di  213 (372)
                      |+|          |||||+|||++.++.+||+|||++........ .......||+.|+|||++.+     ..++.++||
T Consensus       193 ivH----------~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di  257 (344)
T 1rjb_A          193 CVH----------RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-----GIYTIKSDV  257 (344)
T ss_dssp             EEE----------TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-----CCCCHHHHH
T ss_pred             ccc----------CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-----CCCChhHhH
Confidence            999          99999999999999999999999986543322 12334567889999999974     568999999


Q ss_pred             eehhHHHHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        214 WSLGVCMYEMLY-GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       214 wslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      |||||++|+|+| |..||.+.+....+..+.........+.    .+++++.+||.+||. ||.+||++.++.+.+
T Consensus       258 ~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          258 WSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPF----YATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             HHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCC----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            999999999998 9999998776665656555544444444    679999999999999 999999988887655

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.6e-43  Score=329.62  Aligned_cols=252  Identities=19%  Similarity=0.238  Sum_probs=207.1

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeeh-----hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLL-----DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITN   77 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~-----~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~   77 (372)
                      +|+..+.+|.|    |+|.||++.+..     +++.||+|.+......         ...+.+.+|+.+++.++||||++
T Consensus        24 ~y~~~~~lg~G----~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~E~~~l~~l~hp~iv~   90 (314)
T 2ivs_A           24 NLVLGKTLGEG----EFGKVVKATAFHLKGRAGYTTVAVKMLKENASP---------SELRDLLSEFNVLKQVNHPHVIK   90 (314)
T ss_dssp             GEEEEEEEEEC----SSSEEEEEEEETGGGCSSEEEEEEEECCTTCCH---------HHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             heeeeeeeccc----CCeeEEEEEEeccCcccCcceEEEEeccCCCCH---------HHHHHHHHHHHHHhhCCCCceee
Confidence            44445556665    899999998743     4478999988654321         23466888999999999999999


Q ss_pred             eeEEEEeCCeEEEEEeccCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcC
Q psy11571         78 LHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE-----------------------DRLPEDMAKFYIAEMVLAIASIHDLH  134 (372)
Q Consensus        78 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-----------------------~~l~~~~~~~~~~qi~~~L~~LH~~~  134 (372)
                      +++++.+.+..|+||||+++++|.+++....                       ..+++..++.++.||+.||.|||++|
T Consensus        91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  170 (314)
T 2ivs_A           91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK  170 (314)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999999999999999999998732                       23899999999999999999999999


Q ss_pred             ceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCcc-cccccccCCcccCcccccccccCCCCCCCccce
Q psy11571        135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTV-QSNVAVGTPDYISPEILTAMEEGRGRYGPECDW  213 (372)
Q Consensus       135 ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Di  213 (372)
                      ++|          |||||+||+++.++.+||+|||++......... ......+|+.|+|||++.+     ..++.++||
T Consensus       171 ivH----------~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di  235 (314)
T 2ivs_A          171 LVH----------RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-----HIYTTQSDV  235 (314)
T ss_dssp             EEC----------CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-----CEECHHHHH
T ss_pred             Ccc----------cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-----CCcCchhhH
Confidence            999          999999999999999999999999876443221 2233457889999999984     568899999


Q ss_pred             eehhHHHHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        214 WSLGVCMYEMLY-GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       214 wslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      |||||++|+|++ |..||.+.+..+....+.... ....+.    .+++++.+||.+||. ||++||++.++.+.+
T Consensus       236 ~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l  306 (314)
T 2ivs_A          236 WSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGH-RMERPD----NCSEEMYRLMLQCWKQEPDKRPVFADISKDL  306 (314)
T ss_dssp             HHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCC-cCCCCc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            999999999999 999999988877776665542 233333    689999999999999 999999988776544

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.1e-43  Score=327.50  Aligned_cols=258  Identities=17%  Similarity=0.197  Sum_probs=192.1

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      .+|+..+.+|.|    |+|.||+++..   ..+|+|.+........        ..+.+.+|+.+++.++||||++++++
T Consensus        24 ~~y~~~~~lG~G----~~g~Vy~~~~~---~~vavK~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (289)
T 3og7_A           24 GQITVGQRIGSG----SFGTVYKGKWH---GDVAVKMLNVTAPTPQ--------QLQAFKNEVGVLRKTRHVNILLFMGY   88 (289)
T ss_dssp             TSCEEEEEEEEC----SSEEEEEEESS---SEEEEEEESCSSCCHH--------HHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cceeeeeEecCC----CCeEEEEEEEc---CceEEEEEeccCCCHH--------HHHHHHHHHHHHHhCCCCcEEEEEee
Confidence            355556666666    89999988643   3489998765543322        34668889999999999999999996


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      . .....++||||+++++|.+++......+++..+..++.||+.||.|||++|++|          |||||+||+++.++
T Consensus        89 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H----------~Dlkp~Nil~~~~~  157 (289)
T 3og7_A           89 S-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIH----------RDLKSNNIFLHEDN  157 (289)
T ss_dssp             E-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCCGGGEEEETTT
T ss_pred             c-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCccc----------ccCccceEEECCCC
Confidence            4 556789999999999999999765678999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCC-CcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGD-GTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG  240 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~  240 (372)
                      .+||+|||++...... .........||+.|+|||++....  ...++.++|||||||++|+|++|+.||.+.+..+...
T Consensus       158 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~  235 (289)
T 3og7_A          158 TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD--SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII  235 (289)
T ss_dssp             EEEECCCC------------------CCCTTCCHHHHC------CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHH
T ss_pred             CEEEccceeccccccccccccccccCCCccccCchhhcccC--CCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHH
Confidence            9999999999765421 112223357899999999986321  3457889999999999999999999998866555444


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .+................+++++.+||.+||. ||.+||+++++++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L  283 (289)
T 3og7_A          236 EMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI  283 (289)
T ss_dssp             HHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence            44333222222223334789999999999999 999999988777554

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.1e-44  Score=345.00  Aligned_cols=255  Identities=20%  Similarity=0.321  Sum_probs=197.4

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC--------CC
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD--------RR   73 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~--------hp   73 (372)
                      .+|+.++.+|.|    |+|.||++.+..+++.||+|.+.....           ..+.+.+|+.+++.+.        ||
T Consensus        37 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~E~~~l~~l~~~~~~~~~~~  101 (397)
T 1wak_A           37 GRYHVIRKLGWG----HFSTVWLSWDIQGKKFVAMKVVKSAEH-----------YTETALDEIRLLKSVRNSDPNDPNRE  101 (397)
T ss_dssp             TTEEEEEEEEEC----SSEEEEEEEETTTTEEEEEEEECSCHH-----------HHHHHHHHHHHHHHHHHSCTTCGGGG
T ss_pred             CeEEEEEEeeec----CCeeEEEEEecCCCeEEEEEEEecCCc-----------chHHHHHHHHHHHHHhhcCCCCCCcc
Confidence            456666777777    899999999999999999998864321           2344667888887764        88


Q ss_pred             ceeeeeEEEE----eCCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCCCcC
Q psy11571         74 WITNLHYAFQ----DDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDL-HYVHRPNHFAFHLC  147 (372)
Q Consensus        74 ~Iv~l~~~~~----~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~~~~~~~~vh  147 (372)
                      ||+++++++.    +...+|+||||+ +++|.+.+... ...+++..++.++.||+.||.|||++ ||+|          
T Consensus       102 ~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givH----------  170 (397)
T 1wak_A          102 MVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIH----------  170 (397)
T ss_dssp             GBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEEC----------
T ss_pred             eeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEec----------
Confidence            8999999998    456899999999 66777777653 25699999999999999999999998 9999          


Q ss_pred             CCCCcCcEEeCCCC-------------------------------------------------cEEEeecCcccccCCCC
Q psy11571        148 RDIKPDNVLLDANG-------------------------------------------------HIRLADFGSCLRLGGDG  178 (372)
Q Consensus       148 rDlkp~NIll~~~~-------------------------------------------------~vkl~Dfg~a~~~~~~~  178 (372)
                      |||||+|||++.++                                                 .+||+|||++...... 
T Consensus       171 rDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-  249 (397)
T 1wak_A          171 TDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-  249 (397)
T ss_dssp             CCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-
T ss_pred             CCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-
Confidence            99999999999775                                                 7999999999876432 


Q ss_pred             cccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCC------HHHHHHHHhhccCCcC--
Q psy11571        179 TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHQNSFD--  250 (372)
Q Consensus       179 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~------~~~~~~~i~~~~~~~~--  250 (372)
                         .....||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.+.+      .......+......++  
T Consensus       250 ---~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~  321 (397)
T 1wak_A          250 ---FTEDIQTRQYRSLEVLIG-----SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRK  321 (397)
T ss_dssp             ---SCSCCSCGGGCCHHHHHT-----SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHH
T ss_pred             ---CccCCCCCcccCChhhcC-----CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChH
Confidence               223578999999999984     568999999999999999999999998654      2222222222111000  


Q ss_pred             --------------------CCC--------------CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhc
Q psy11571        251 --------------------LPS--------------DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVS  295 (372)
Q Consensus       251 --------------------~~~--------------~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~  295 (372)
                                          ...              ......++.+++||.+||+ ||++|||+++++           
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l-----------  390 (397)
T 1wak_A          322 LIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECL-----------  390 (397)
T ss_dssp             HHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHH-----------
T ss_pred             HhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHh-----------
Confidence                                000              0011235678999999999 999999876665           


Q ss_pred             cCCCCCCCCCcCC
Q psy11571        296 LSISPRNHPWFQG  308 (372)
Q Consensus       296 ~~~~~~~hp~f~~  308 (372)
                            +||||++
T Consensus       391 ------~hp~~~~  397 (397)
T 1wak_A          391 ------RHPWLNS  397 (397)
T ss_dssp             ------TSGGGGC
T ss_pred             ------hCccccC
Confidence                  9999974

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.1e-43  Score=333.48  Aligned_cols=252  Identities=18%  Similarity=0.235  Sum_probs=200.1

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhh----hhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLV----LYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITN   77 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~v----a~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~   77 (372)
                      ++|+.++.+|.|    |+|.||++.+..+++.+    |+|.+.....         ....+.+.+|+.+++.++||||++
T Consensus        15 ~~y~~~~~lG~G----~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~~E~~~l~~l~h~~iv~   81 (327)
T 3poz_A           15 TEFKKIKVLGSG----AFGTVYKGLWIPEGEKVKIPVAIKELREATS---------PKANKEILDEAYVMASVDNPHVCR   81 (327)
T ss_dssp             GGEEEEEEEEEE----TTEEEEEEEECC----CCEEEEEEEC----------------CHHHHHHHHHHHHHCCBTTBCC
T ss_pred             HHcccceEEeeC----CCeEEEEEEEcCCCceEEEEEEEeecccccC---------HHHHHHHHHHHHHHHhCCCCCEeE
Confidence            456666777777    89999999988888776    4444432211         122356788999999999999999


Q ss_pred             eeEEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe
Q psy11571         78 LHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        78 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      +++++.+.. .++|+||+.+|+|.+++......+++..++.++.||+.||.|||++||+|          |||||+|||+
T Consensus        82 ~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH----------~Dikp~NIll  150 (327)
T 3poz_A           82 LLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH----------RDLAARNVLV  150 (327)
T ss_dssp             EEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCCGGGEEE
T ss_pred             EEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeC----------CCCChheEEE
Confidence            999998765 78999999999999999886678999999999999999999999999999          9999999999


Q ss_pred             CCCCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCH
Q psy11571        158 DANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESL  235 (372)
Q Consensus       158 ~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~  235 (372)
                      +.++.+||+|||+++....... .......||+.|+|||++.+     ..++.++|||||||++|+|++ |..||.+.+.
T Consensus       151 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  225 (327)
T 3poz_A          151 KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-----RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA  225 (327)
T ss_dssp             EETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred             CCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhcc-----CCCCchhhhhhhHHHHHHHHhcCCCCccCCCH
Confidence            9999999999999987654322 12223456889999999984     568999999999999999999 9999998887


Q ss_pred             HHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       236 ~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .+....+... .....+.    .++.++.++|.+||+ +|.+||++.++++.+
T Consensus       226 ~~~~~~~~~~-~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~ell~~l  273 (327)
T 3poz_A          226 SEISSILEKG-ERLPQPP----ICTIDVYMIMVKCWMIDADSRPKFRELIIEF  273 (327)
T ss_dssp             GGHHHHHHTT-CCCCCCT----TBCHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHcC-CCCCCCc----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence            7766655543 2333333    679999999999999 999999988776544

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.5e-43  Score=322.47  Aligned_cols=249  Identities=17%  Similarity=0.170  Sum_probs=206.5

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||++..  +++.+|+|.+........        ..+.+.+|+.+++.++||||+++++++
T Consensus        11 ~y~~~~~lg~G----~~g~V~~~~~--~~~~~avK~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~iv~~~~~~   76 (271)
T 3kmu_A           11 QLNFLTKLNEN----HSGELWKGRW--QGNDIVVKVLKVRDWSTR--------KSRDFNEECPRLRIFSHPNVLPVLGAC   76 (271)
T ss_dssp             GCEEEEEEEEE----TTEEEEEEEE--TTEEEEEEEECCTTCCHH--------HHHHHHHHGGGGCCCSCTTEECEEEEE
T ss_pred             HhHHHHHhcCC----CcceEEEEEE--CCeeEEEEEecccccCHH--------HHHHHHHHHHHHHhcCCCchhheEEEE
Confidence            45556666666    8999999976  478899998876543322        235688899999999999999999999


Q ss_pred             EeC--CeEEEEEeccCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCCCcCCCCCcCcEEe
Q psy11571         83 QDD--SNLYLVMDYYCGGDLLTLLSKFED-RLPEDMAKFYIAEMVLAIASIHDLH--YVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        83 ~~~--~~~~lv~E~~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      .+.  ...++||||+++|+|.+++..... .+++..+..++.||+.||.|||++|  ++|          |||||+||++
T Consensus        77 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H----------~dikp~Nil~  146 (271)
T 3kmu_A           77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPR----------HALNSRSVMI  146 (271)
T ss_dssp             CTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTT----------CCCSGGGEEE
T ss_pred             ccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceec----------CCCccceEEE
Confidence            887  788999999999999999987432 5899999999999999999999999  999          9999999999


Q ss_pred             CCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHH
Q psy11571        158 DANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE  237 (372)
Q Consensus       158 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~  237 (372)
                      +.++.++|+|||++.....      ....||+.|+|||++.+..  ...++.++|||||||++|+|++|+.||.+.+..+
T Consensus       147 ~~~~~~~l~~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~--~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~  218 (271)
T 3kmu_A          147 DEDMTARISMADVKFSFQS------PGRMYAPAWVAPEALQKKP--EDTNRRSADMWSFAVLLWELVTREVPFADLSNME  218 (271)
T ss_dssp             CTTSCEEEEGGGSCCTTSC------TTCBSCGGGSCHHHHHSCG--GGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH
T ss_pred             cCCcceeEEeccceeeecc------cCccCCccccChhhhccCC--CCCCCchhhHHHHHHHHHHHHhCCCCccccChHH
Confidence            9999999999888754322      2256899999999998421  1223347999999999999999999999998888


Q ss_pred             HHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       238 ~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ....+.........+.    .+++++.++|.+||+ ||++|||++++++.+
T Consensus       219 ~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~L  265 (271)
T 3kmu_A          219 IGMKVALEGLRPTIPP----GISPHVSKLMKICMNEDPAKRPKFDMIVPIL  265 (271)
T ss_dssp             HHHHHHHSCCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHhcCCCCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            8777776655555554    689999999999999 999999988877654

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=6.4e-44  Score=337.51  Aligned_cols=261  Identities=22%  Similarity=0.270  Sum_probs=205.5

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhh-hhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCc------
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDI-LLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRW------   74 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~-~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~------   74 (372)
                      ++|+.++.+|.|    ++|.||.+.+..++ +.||+|.+.....           ..+.+.+|+.+++.+.|++      
T Consensus        19 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~E~~~l~~l~~~~~~~~~~   83 (355)
T 2eu9_A           19 ERYEIVGNLGEG----TFGKVVECLDHARGKSQVALKIIRNVGK-----------YREAARLEINVLKKIKEKDKENKFL   83 (355)
T ss_dssp             TTEEEEEEEEEE----TTEEEEEEEETTTTTEEEEEEEECSCHH-----------HHHHHHHHHHHHHHHHHHCTTSCSC
T ss_pred             ccEEEEEEeecc----CCeEEEEEEecCCCceEEEEEEEccccc-----------chhHHHHHHHHHHHHhhcCCCCcee
Confidence            466677777777    89999999887776 6899998864321           1234566777777665544      


Q ss_pred             eeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcC
Q psy11571         75 ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPD  153 (372)
Q Consensus        75 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~  153 (372)
                      ++.+++++...+.+|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+|          |||||+
T Consensus        84 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH----------~Dlkp~  152 (355)
T 2eu9_A           84 CVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTH----------TDLKPE  152 (355)
T ss_dssp             BCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEEC----------CCCCGG
T ss_pred             EEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCccc----------CCCCHH
Confidence            999999999999999999999 778888776632 46999999999999999999999999999          999999


Q ss_pred             cEEe-------------------CCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCcccee
Q psy11571        154 NVLL-------------------DANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWW  214 (372)
Q Consensus       154 NIll-------------------~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diw  214 (372)
                      |||+                   +.++.+||+|||+++......    ....||+.|+|||++.+     ..++.++|||
T Consensus       153 NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~-----~~~~~~~Di~  223 (355)
T 2eu9_A          153 NILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILE-----LGWAQPCDVW  223 (355)
T ss_dssp             GEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTT-----CCCCTHHHHH
T ss_pred             HEEEecccccccccccccccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeec-----CCCCCccchH
Confidence            9999                   567899999999998754322    33579999999999983     5689999999


Q ss_pred             ehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcC-------------------CCC-------------------CCC
Q psy11571        215 SLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD-------------------LPS-------------------DVG  256 (372)
Q Consensus       215 slGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------------~~~-------------------~~~  256 (372)
                      ||||++|+|++|..||.+.+..+....+......++                   ++.                   ...
T Consensus       224 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (355)
T 2eu9_A          224 SIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQD  303 (355)
T ss_dssp             HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCC
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCccccccccc
Confidence            999999999999999998887765554433211110                   000                   000


Q ss_pred             CCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc
Q psy11571        257 YEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI  314 (372)
Q Consensus       257 ~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~  314 (372)
                      ...+.++.+||.+||+ ||++|||+.+++                 +||||++++|+..
T Consensus       304 ~~~~~~l~~li~~~L~~dP~~Rpt~~e~l-----------------~hp~f~~~~~~~~  345 (355)
T 2eu9_A          304 SLEHVQLFDLMRRMLEFDPAQRITLAEAL-----------------LHPFFAGLTPEER  345 (355)
T ss_dssp             SHHHHHHHHHHHHHTCSSTTTSCCHHHHT-----------------TSGGGGGCCHHHH
T ss_pred             chhHHHHHHHHHHHhcCChhhCcCHHHHh-----------------cChhhcCCChhhc
Confidence            1224689999999999 999999876555                 9999999998765

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=9.4e-44  Score=330.97  Aligned_cols=253  Identities=22%  Similarity=0.274  Sum_probs=207.0

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeee-----ehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCcee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIET-----LLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWIT   76 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~-----~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv   76 (372)
                      +|+..+.+|.|    |+|.||.+..     ..+++.||+|.+.......         ..+.+.+|+.+++.+ +||||+
T Consensus        24 ~y~~~~~lg~G----~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~E~~~l~~l~~h~~i~   90 (313)
T 1t46_A           24 RLSFGKTLGAG----AFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT---------EREALMSELKVLSYLGNHMNIV   90 (313)
T ss_dssp             GEEEEEEEEEC----SSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH---------HHHHHHHHHHHHHHHCCCTTBC
T ss_pred             hhhHHHhhCcc----CCcceEEEEEeeccccchhhhhHHHhcCcchhHH---------HHHHHHHHHHHHhhcccCCCee
Confidence            45555556666    8999999974     3467899999886543221         235678899999999 899999


Q ss_pred             eeeEEEEeCCeEEEEEeccCCCCHHHHHHhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCceecC
Q psy11571         77 NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFED-----------------RLPEDMAKFYIAEMVLAIASIHDLHYVHRP  139 (372)
Q Consensus        77 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~-----------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~  139 (372)
                      ++++++.+.+..++||||+++|+|.+++.....                 .+++..++.++.||+.||.|||++|++|  
T Consensus        91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H--  168 (313)
T 1t46_A           91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIH--  168 (313)
T ss_dssp             CEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC--
T ss_pred             eEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeec--
Confidence            999999999999999999999999999987432                 4899999999999999999999999999  


Q ss_pred             CCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCcc-cccccccCCcccCcccccccccCCCCCCCccceeehhH
Q psy11571        140 NHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTV-QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGV  218 (372)
Q Consensus       140 ~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGv  218 (372)
                              |||||+||+++.++.+||+|||++......... ......||+.|+|||++.+     ..++.++|||||||
T Consensus       169 --------~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~  235 (313)
T 1t46_A          169 --------RDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-----CVYTFESDVWSYGI  235 (313)
T ss_dssp             --------SCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-----CCCCHHHHHHHHHH
T ss_pred             --------CCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-----CCCChHHHHHHHHH
Confidence                    999999999999999999999999876543321 2233457889999999974     56899999999999


Q ss_pred             HHHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        219 CMYEMLY-GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       219 il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ++|+|++ |..||.+.........+.........+.    .+++++.++|.+||. ||.+||+++++++.+
T Consensus       236 il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  302 (313)
T 1t46_A          236 FLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPE----HAPAEMYDIMKTCWDADPLKRPTFKQIVQLI  302 (313)
T ss_dssp             HHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCcc----cCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            9999999 9999988766555555554433333333    689999999999999 999999988877655

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.5e-43  Score=328.07  Aligned_cols=253  Identities=19%  Similarity=0.240  Sum_probs=202.0

Q ss_pred             HHHHHHhhhcCCcccCCccEEEee----eehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIE----TLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNL   78 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~----~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l   78 (372)
                      +|+.++.+|.|    |+|.||.+.    +..+++.||+|.+.......         ..+.+.+|+.+++.++||||+++
T Consensus        22 ~~~~~~~lg~G----~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~   88 (302)
T 4e5w_A           22 FLKRIRDLGEG----HFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN---------HIADLKKEIEILRNLYHENIVKY   88 (302)
T ss_dssp             GEEEEEEEEEC----SSEEEEEEEECTTSSSCSEEEEEEEEC-----C---------CHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             hhhhhhccCCC----CceEEEEEEEccccCccCeEEEEEEecccccch---------hHHHHHHHHHHHHhCCCCCeeee
Confidence            45666677776    899999998    56789999999887543221         23557889999999999999999


Q ss_pred             eEEEEeC--CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEE
Q psy11571         79 HYAFQDD--SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL  156 (372)
Q Consensus        79 ~~~~~~~--~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIl  156 (372)
                      ++++.+.  ..+++||||+++++|.+++......+++..++.++.|++.||.|||++|++|          |||||+||+
T Consensus        89 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H----------~dikp~Nil  158 (302)
T 4e5w_A           89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVH----------RDLAARNVL  158 (302)
T ss_dssp             EEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSGGGEE
T ss_pred             eeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCccc----------CCCchheEE
Confidence            9999877  6789999999999999999765678999999999999999999999999999          999999999


Q ss_pred             eCCCCcEEEeecCcccccCCCCc--ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC-
Q psy11571        157 LDANGHIRLADFGSCLRLGGDGT--VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE-  233 (372)
Q Consensus       157 l~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~-  233 (372)
                      ++.++.++|+|||++........  .......||..|+|||++.+     ..++.++|||||||++|+|++|..|+... 
T Consensus       159 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~  233 (302)
T 4e5w_A          159 VESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ-----SKFYIASDVWSFGVTLHELLTYCDSDSSPM  233 (302)
T ss_dssp             EEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHH-----CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred             EcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecC-----CCCCcchhHHHHHHHHHHHHHccCCCcchh
Confidence            99999999999999987654432  12233568888999999974     55788999999999999999999876422 


Q ss_pred             -------------CHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        234 -------------SLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       234 -------------~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                                   ..................+.    .+++++.+||.+||+ ||.+|||++++++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  297 (302)
T 4e5w_A          234 ALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPP----NCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF  297 (302)
T ss_dssp             HHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             hHHhhccCCcccccCHHHHHHHHhccCCCCCCC----CCCHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence                         12222222223333334444    689999999999999 999999988877654

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1e-43  Score=333.78  Aligned_cols=257  Identities=19%  Similarity=0.260  Sum_probs=202.4

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeee-ehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCC------Cc
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIET-LLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDR------RW   74 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~-~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~h------p~   74 (372)
                      ++|+.++.+|.|    ++|.||.+.+ ..+++.||+|.+.....           ..+.+.+|+.+++.+.|      ++
T Consensus        14 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~e~~~l~~l~~~~~~~~~~   78 (339)
T 1z57_A           14 ARYEIVDTLGEG----AFGKVVECIDHKAGGRHVAVKIVKNVDR-----------YCEAARSEIQVLEHLNTTDPNSTFR   78 (339)
T ss_dssp             TTEEEEEEEEEE----TTEEEEEEEETTTTTEEEEEEEECSSHH-----------HHHHHHHHHHHHHHHHHHCTTCTTC
T ss_pred             CceEEEEEEecC----CCeEEEEEEecCCCCcEEEEEEEecCCc-----------hhHHHHHHHHHHHHhhhcCCCCcee
Confidence            466677777777    8999999987 45788999998764321           23445667777766654      45


Q ss_pred             eeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcC
Q psy11571         75 ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPD  153 (372)
Q Consensus        75 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~  153 (372)
                      |+++++++.+.+.+|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+|          |||||+
T Consensus        79 i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH----------~Dlkp~  147 (339)
T 1z57_A           79 CVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTH----------TDLKPE  147 (339)
T ss_dssp             BCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCCGG
T ss_pred             eEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcC----------CCCCHH
Confidence            999999999999999999999 899999998742 26899999999999999999999999999          999999


Q ss_pred             cEEeCC-------------------CCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCcccee
Q psy11571        154 NVLLDA-------------------NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWW  214 (372)
Q Consensus       154 NIll~~-------------------~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diw  214 (372)
                      |||++.                   ++.+||+|||++......    .....||+.|+|||++.+     ..++.++|||
T Consensus       148 Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~  218 (339)
T 1z57_A          148 NILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILA-----LGWSQPCDVW  218 (339)
T ss_dssp             GEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTT-----SCCCTHHHHH
T ss_pred             HEEEeccccccccCCccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhC-----CCCCcchhhH
Confidence            999987                   668999999999875432    223578999999999983     5689999999


Q ss_pred             ehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcC-------------------CC-------------------CCCC
Q psy11571        215 SLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFD-------------------LP-------------------SDVG  256 (372)
Q Consensus       215 slGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------------~~-------------------~~~~  256 (372)
                      ||||++|+|++|..||.+.+..+....+......++                   ++                   ....
T Consensus       219 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (339)
T 1z57_A          219 SIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQ  298 (339)
T ss_dssp             HHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCC
T ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccc
Confidence            999999999999999998887765554432211100                   00                   0001


Q ss_pred             CCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCC
Q psy11571        257 YEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       257 ~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~  310 (372)
                      ...++++.+||.+||+ ||.+|||+.+++                 +||||+.+.
T Consensus       299 ~~~~~~l~~li~~~L~~dP~~Rpt~~ell-----------------~hp~f~~~~  336 (339)
T 1z57_A          299 DVEHERLFDLIQKMLEYDPAKRITLREAL-----------------KHPFFDLLK  336 (339)
T ss_dssp             SHHHHHHHHHHHHHTCSSTTTSCCHHHHT-----------------TSGGGGGGG
T ss_pred             hhhHHHHHHHHHHHhCcCcccccCHHHHh-----------------cCHHHHHHh
Confidence            1235789999999999 999999866555                 999998653

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.7e-44  Score=329.70  Aligned_cols=252  Identities=20%  Similarity=0.249  Sum_probs=199.3

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEee----eehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIE----TLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITN   77 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~----~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~   77 (372)
                      ++|+.++.+|.|    |+|.||.++    +..+++.||+|.+.....          +..+.+.+|+.+++.++||||++
T Consensus        10 ~~~~~~~~lg~G----~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~~iv~   75 (295)
T 3ugc_A           10 RHLKFLQQLGKG----NFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE----------EHLRDFEREIEILKSLQHDNIVK   75 (295)
T ss_dssp             GGEEEEEEEEEC----SSEEEEEEEECTTCSSCCEEEEEEEESCCCH----------HHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             HHhhhhheeecc----CCEEEEEEEEecccCCCCcEEEEEEcccCCH----------HHHHHHHHHHHHHHhCCCCCEee
Confidence            466777777777    899999997    566889999998765431          23456788999999999999999


Q ss_pred             eeEEEEeC--CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcE
Q psy11571         78 LHYAFQDD--SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNV  155 (372)
Q Consensus        78 l~~~~~~~--~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NI  155 (372)
                      +++++...  ..+++||||+++|+|.+++......+++..+..++.|++.||.|||+.|++|          |||||+||
T Consensus        76 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH----------~Dikp~Ni  145 (295)
T 3ugc_A           76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH----------RDLATRNI  145 (295)
T ss_dssp             EEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCSGGGE
T ss_pred             EEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCccc----------CCCCHhhE
Confidence            99998653  5689999999999999999885556999999999999999999999999999          99999999


Q ss_pred             EeCCCCcEEEeecCcccccCCCCc--ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC
Q psy11571        156 LLDANGHIRLADFGSCLRLGGDGT--VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE  233 (372)
Q Consensus       156 ll~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~  233 (372)
                      |++.++.+||+|||++........  .......+|+.|+|||++.+     ..++.++||||||+++|+|++|..||...
T Consensus       146 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~~~~~~  220 (295)
T 3ugc_A          146 LVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE-----SKFSVASDVWSFGVVLYELFTYIEKSKSP  220 (295)
T ss_dssp             EEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred             EEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcC-----CCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence            999999999999999987644322  11222356778999999984     56899999999999999999999998653


Q ss_pred             CHH----------------HHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        234 SLV----------------ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       234 ~~~----------------~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ...                .....+ ......+.+.    .+++++.+||.+||. ||++|||+.++.+.+
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~el~~~L  286 (295)
T 3ugc_A          221 PAEFMRMIGNDKQGQMIVFHLIELL-KNNGRLPRPD----GCPDEIYMIMTECWNNNVNQRPSFRDLALRV  286 (295)
T ss_dssp             HHHHHHHHCTTCCTHHHHHHHHHHH-HTTCCCCCCT----TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             hHHHHhhhcCccccchhHHHHHHHH-hccCcCCCCc----CcCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence            221                112222 2223333343    689999999999999 999999988877544

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.7e-44  Score=330.89  Aligned_cols=274  Identities=17%  Similarity=0.193  Sum_probs=207.9

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeE-
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHY-   80 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~-   80 (372)
                      ++|+.++.+|.|    |+|.||.+.+..+++.||+|.........            .+.+|..+++.+.|++++..+. 
T Consensus         9 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------~~~~e~~~l~~l~~~~~i~~~~~   72 (296)
T 4hgt_A            9 NRYRLGRKIGSG----SFGDIYLGTDIAAGEEVAIKLECVKTKHP------------QLHIESKIYKMMQGGVGIPTIRW   72 (296)
T ss_dssp             --CEEEEEEEEC----SSSEEEEEEETTTTEEEEEEEEEC---CC------------CHHHHHHHHHHHTTSTTCCCEEE
T ss_pred             CceEEeeeecCC----CCeEEEEEEEcCCCceEEEEeecccccch------------HHHHHHHHHHHhcCCCCCCeeee
Confidence            356666677776    89999999999999999999755443322            2567888999888776655554 


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe---
Q psy11571         81 AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL---  157 (372)
Q Consensus        81 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll---  157 (372)
                      ++.+.+..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+|          |||||+|||+   
T Consensus        73 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH----------~Dlkp~NIl~~~~  141 (296)
T 4hgt_A           73 CGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH----------RDVKPDNFLMGLG  141 (296)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSGGGEEECCG
T ss_pred             ecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeec----------CCCCHHHeeeecc
Confidence            457778899999999 99999999865678999999999999999999999999999          9999999999   


Q ss_pred             CCCCcEEEeecCcccccCCCCc------ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCC
Q psy11571        158 DANGHIRLADFGSCLRLGGDGT------VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY  231 (372)
Q Consensus       158 ~~~~~vkl~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~  231 (372)
                      +.++.+||+|||+++.......      .......||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.
T Consensus       142 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~  216 (296)
T 4hgt_A          142 KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-----IEQSRRDDLESLGYVLMYFNLGSLPWQ  216 (296)
T ss_dssp             GGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred             CCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcC-----CCCCchhHHHHHHHHHHHHhcCCCCCc
Confidence            7889999999999987654322      12234579999999999983     568999999999999999999999998


Q ss_pred             CCCHH---HHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcC
Q psy11571        232 AESLV---ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ  307 (372)
Q Consensus       232 ~~~~~---~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~  307 (372)
                      +.+..   ..+..+.......+.+ .....+++++.+||.+||+ ||++||+++++.+.+.  .+..     ....++-.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~--~~~~-----~~~~~~~~  288 (296)
T 4hgt_A          217 GLKAATKRQKYERISEKKMSTPIE-VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR--NLFH-----RQGFSYDY  288 (296)
T ss_dssp             SCCCSSSSSHHHHHHHHHHHSCHH-HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHH--HHHH-----HHTCCTTC
T ss_pred             ccchhhhhhhhhhhhcccccchhh-hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHH--HHHH-----HhCCCccC
Confidence            64322   2333333222111111 1112679999999999999 9999999888776551  1110     01467778


Q ss_pred             CCCccccc
Q psy11571        308 GIAWDSIR  315 (372)
Q Consensus       308 ~~~w~~~~  315 (372)
                      .+||+.++
T Consensus       289 ~~dw~~~~  296 (296)
T 4hgt_A          289 VFDWNMLK  296 (296)
T ss_dssp             CCGGGGCC
T ss_pred             ccchhhcC
Confidence            88998763

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.6e-43  Score=339.54  Aligned_cols=257  Identities=25%  Similarity=0.330  Sum_probs=201.3

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CC-----cee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RR-----WIT   76 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp-----~Iv   76 (372)
                      +|+.++.+|.|    |+|.||++.+..+++.||+|.+.....           ..+.+..|..++..+. |+     +|+
T Consensus        55 ~y~~~~~lG~G----~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~e~~~l~~l~~~~~~~~~~iv  119 (382)
T 2vx3_A           55 RYEIDSLIGKG----SFGQVVKAYDRVEQEWVAIKIIKNKKA-----------FLNQAQIEVRLLELMNKHDTEMKYYIV  119 (382)
T ss_dssp             TEEEEEEEEEE----TTEEEEEEEETTTTEEEEEEEECSSHH-----------HHHHHHHHHHHHHHHHHCSSGGGGGBC
T ss_pred             eEEEEEEEeec----CCEEEEEEEEcCCCcEEEEEEEeccHH-----------HHHHHHHHHHHHHHHHhcccccceeEE
Confidence            45555666666    899999999999999999998864321           2334556777776653 44     599


Q ss_pred             eeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hcCceecCCCCCCCcCCCCCcC
Q psy11571         77 NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIH--DLHYVHRPNHFAFHLCRDIKPD  153 (372)
Q Consensus        77 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH--~~~ivH~~~~~~~~vhrDlkp~  153 (372)
                      ++++++...+.+|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||  +.||+|          |||||+
T Consensus       120 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH----------rDlkp~  188 (382)
T 2vx3_A          120 HLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIH----------CDLKPE  188 (382)
T ss_dssp             CEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEEC----------CCCSGG
T ss_pred             EeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEc----------CCCCcc
Confidence            99999999999999999995 59999998743 46999999999999999999999  579999          999999


Q ss_pred             cEEeC--CCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCC
Q psy11571        154 NVLLD--ANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY  231 (372)
Q Consensus       154 NIll~--~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~  231 (372)
                      |||++  .++.+||+|||+++.....    .....||+.|+|||++.+     ..++.++|||||||++|||++|++||.
T Consensus       189 NIll~~~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~pf~  259 (382)
T 2vx3_A          189 NILLCNPKRSAIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLG-----MPYDLAIDMWSLGCILVEMHTGEPLFS  259 (382)
T ss_dssp             GEEESSTTSCCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cEEEecCCCCcEEEEeccCceecccc----cccccCCccccChHHHcC-----CCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            99995  4778999999999876432    223678999999999984     568999999999999999999999999


Q ss_pred             CCCHHHHHHHHhhccCCcC----------------CCCC-----------------CCCC--------------------
Q psy11571        232 AESLVETYGKIMNHQNSFD----------------LPSD-----------------VGYE--------------------  258 (372)
Q Consensus       232 ~~~~~~~~~~i~~~~~~~~----------------~~~~-----------------~~~~--------------------  258 (372)
                      +.+..+.+.++......++                ++..                 ....                    
T Consensus       260 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  339 (382)
T 2vx3_A          260 GANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGES  339 (382)
T ss_dssp             CSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCT
T ss_pred             CCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccc
Confidence            9988887777764321110                0000                 0000                    


Q ss_pred             -----CCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCc
Q psy11571        259 -----ISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAW  311 (372)
Q Consensus       259 -----~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w  311 (372)
                           .++++++||.+||+ ||++|||+++++                 +||||+...|
T Consensus       340 ~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L-----------------~hp~f~~~~~  381 (382)
T 2vx3_A          340 GHTVADYLKFKDLILRMLDYDPKTRIQPYYAL-----------------QHSFFKKTAD  381 (382)
T ss_dssp             TCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHT-----------------TSGGGCC---
T ss_pred             cccchhhHHHHHHHHHhcCCChhhCCCHHHHh-----------------cCcccccCCC
Confidence                 01478999999999 999999877665                 9999997655

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=7.9e-44  Score=334.15  Aligned_cols=267  Identities=21%  Similarity=0.347  Sum_probs=187.9

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHH-HHhcCCCCceeeeeEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERD-VLVYGDRRWITNLHYA   81 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~-il~~l~hp~Iv~l~~~   81 (372)
                      +|+.++.+|.|    |+|.||++.+..+++.||+|.+........         ...+..|.. +++.++||||++++++
T Consensus        23 ~y~~~~~lg~G----~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---------~~~~~~e~~~~~~~~~h~niv~~~~~   89 (327)
T 3aln_A           23 DLKDLGEIGRG----AYGSVNKMVHKPSGQIMAVKRIRSTVDEKE---------QKQLLMDLDVVMRSSDCPYIVQFYGA   89 (327)
T ss_dssp             SEEC-CEEEEC----SSEEEEEEEETTTTEEEEEEEEECCCCHHH---------HHHHHHHHHHHHSSCCCTTBCCEEEE
T ss_pred             HhhehheeccC----CCEEEEEEEEcCCCCEEEEEEeecccCchH---------HHHHHHHHHHHHHcCCCCcEeeeeeE
Confidence            55666677776    899999999988999999998875432211         122333444 7788899999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCCCcCCCCCcCcEE
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSK----FEDRLPEDMAKFYIAEMVLAIASIHDL-HYVHRPNHFAFHLCRDIKPDNVL  156 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~~~~~~~~vhrDlkp~NIl  156 (372)
                      +.+.+..|+||||+.+ +|.+++..    ....+++..+..++.|++.||.|||+. |++|          |||||+||+
T Consensus        90 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH----------~dlkp~NIl  158 (327)
T 3aln_A           90 LFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIH----------RDIKPSNIL  158 (327)
T ss_dssp             EECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCC----------SCCCGGGEE
T ss_pred             EEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeE----------CCCCHHHEE
Confidence            9999999999999965 88888763    146799999999999999999999998 9999          999999999


Q ss_pred             eCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH
Q psy11571        157 LDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV  236 (372)
Q Consensus       157 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~  236 (372)
                      ++.++.+||+|||+++.......  .....||+.|+|||++.... ....++.++|||||||++|+|++|..||.+.+..
T Consensus       159 l~~~~~~kl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  235 (327)
T 3aln_A          159 LDRSGNIKLCDFGISGQLVDSIA--KTRDAGCRPYMAPERIDPSA-SRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV  235 (327)
T ss_dssp             EETTTEEEECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---
T ss_pred             EcCCCCEEEccCCCceecccccc--cccCCCCccccCceeecccc-CcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH
Confidence            99999999999999977644322  22347899999999984211 1345889999999999999999999999875432


Q ss_pred             -HHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc
Q psy11571        237 -ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI  314 (372)
Q Consensus       237 -~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~  314 (372)
                       +....+..+ ....++......+++++.+||.+||. ||++||++.+++                 +||||...++..+
T Consensus       236 ~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell-----------------~hp~~~~~~~~~~  297 (327)
T 3aln_A          236 FDQLTQVVKG-DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELL-----------------KHPFILMYEERAV  297 (327)
T ss_dssp             ----CCCCCS-CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHT-----------------TSHHHHHHHHSCC
T ss_pred             HHHHHHHhcC-CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHH-----------------hChHHHHhHhhHH
Confidence             223233322 22223333334689999999999999 999999866555                 9999997766543

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.4e-43  Score=349.45  Aligned_cols=249  Identities=18%  Similarity=0.287  Sum_probs=209.6

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+..+.+|.|    |+|.||++....++..||+|.+......           .+.+.+|+.+++.++||||+++++++.
T Consensus       222 ~~~~~~lG~G----~fg~Vy~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~E~~~l~~l~hpniv~l~~~~~  286 (495)
T 1opk_A          222 ITMKHKLGGG----QYGEVYEGVWKKYSLTVAVKTLKEDTME-----------VEEFLKEAAVMKEIKHPNLVQLLGVCT  286 (495)
T ss_dssp             EEEEEESGGG----TTSSEEEEEEGGGTEEEEEEECCSSSSC-----------HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ceeeeEecCC----CCeEEEEEEEcCCCeEEEEEEecCcccc-----------hHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            3334455555    8999999998888999999988754322           244778999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      +...+|+||||+++|+|.+++... ...+++..+..++.||+.||.|||++||+|          |||||+|||++.++.
T Consensus       287 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH----------rDlkp~NIll~~~~~  356 (495)
T 1opk_A          287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH----------RNLAARNCLVGENHL  356 (495)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSGGGEEECGGGC
T ss_pred             cCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCccc----------CCCChhhEEECCCCc
Confidence            999999999999999999999864 346899999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGK  241 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~  241 (372)
                      +||+|||+++..............+++.|+|||++..     ..++.++|||||||++|||++ |..||.+.+..+....
T Consensus       357 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~  431 (495)
T 1opk_A          357 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-----NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL  431 (495)
T ss_dssp             EEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHH-----CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred             EEEeecccceeccCCceeecCCCcCCcceeCHhHHhc-----CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            9999999998765443333333456789999999984     568899999999999999999 9999999887777766


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      +... .....|.    .+++++.+||.+||+ ||++||++.++.+.+
T Consensus       432 ~~~~-~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~el~~~L  473 (495)
T 1opk_A          432 LEKD-YRMERPE----GCPEKVYELMRACWQWNPSDRPSFAEIHQAF  473 (495)
T ss_dssp             HHTT-CCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHcC-CCCCCCC----CCCHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence            6543 3334444    689999999999999 999999988887655

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-43  Score=323.11  Aligned_cols=250  Identities=21%  Similarity=0.272  Sum_probs=205.1

Q ss_pred             HHHHH-hhhcCCcccCCccEEEeeee--hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeE
Q psy11571          4 LRELE-ALFLGGPIQGKGRVFSIETL--LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHY   80 (372)
Q Consensus         4 ~~~l~-~~~~~~~~~g~G~v~~v~~~--~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~   80 (372)
                      |..++ .+|.|    |+|.||.+...  .++..||+|.+......         ...+.+.+|+.+++.++||||+++++
T Consensus        11 ~~i~~~~lg~G----~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~E~~~l~~l~h~~i~~~~~   77 (287)
T 1u59_A           11 LLIADIELGCG----NFGSVRQGVYRMRKKQIDVAIKVLKQGTEK---------ADTEEMMREAQIMHQLDNPYIVRLIG   77 (287)
T ss_dssp             EEEEEEEEECC----TTEEEEEEEEC---CCEEEEEEEECSSCCH---------HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhhhhcccccc----CceeEEEeEeccCCCcceEEEEecCCccch---------hHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence            33344 45555    89999998743  35778999988764321         23456888999999999999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         81 AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        81 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      ++ ..+..++||||+++++|.+++......+++..++.++.||+.||.|||+.|++|          |||||+||+++.+
T Consensus        78 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H----------~dlkp~Nili~~~  146 (287)
T 1u59_A           78 VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH----------RDLAARNVLLVNR  146 (287)
T ss_dssp             EE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEEEET
T ss_pred             Ee-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEee----------CCCchheEEEcCC
Confidence            99 455799999999999999999765567999999999999999999999999999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcc--cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTV--QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVE  237 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~  237 (372)
                      +.++|+|||++.........  ......||+.|+|||++.+     ..++.++|||||||++|+|++ |..||.+.+..+
T Consensus       147 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  221 (287)
T 1u59_A          147 HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-----RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE  221 (287)
T ss_dssp             TEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH-----CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH
T ss_pred             CCEEECcccceeeeccCcceeeccccccccccccCHHHhcc-----CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence            99999999999876543321  1223456889999999974     558889999999999999998 999999988888


Q ss_pred             HHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       238 ~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ....+..+. ....+.    .+++++.++|.+||. ||++||++.++.+.+
T Consensus       222 ~~~~i~~~~-~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          222 VMAFIEQGK-RMECPP----ECPPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             HHHHHHTTC-CCCCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHhcCC-cCCCCC----CcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            777776543 233343    689999999999999 999999988877655

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=7.1e-43  Score=327.76  Aligned_cols=250  Identities=22%  Similarity=0.294  Sum_probs=203.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhh--hhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLV--LYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLH   79 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~v--a~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~   79 (372)
                      +|+..+.+|.|    |+|.||.+....++..+  ++|.+......         ...+.+.+|+.+++.+ +||||++++
T Consensus        26 ~y~~~~~lg~G----~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~---------~~~~~~~~E~~~l~~l~~hp~iv~~~   92 (327)
T 1fvr_A           26 DIKFQDVIGEG----NFGQVLKARIKKDGLRMDAAIKRMKEYASK---------DDHRDFAGELEVLCKLGHHPNIINLL   92 (327)
T ss_dssp             GCEEEEEEECG----GGCEEEEEEEEETTEEEEEEEEEEECC---------------CHHHHHHHHHTTCCCCTTBCCEE
T ss_pred             HccceeeeecC----CCceEEEEEEccCCcccceeeeeeccccch---------HHHHHHHHHHHHHHhccCCCchhhhc
Confidence            44445555555    89999999988888755  88877643221         1235578899999999 899999999


Q ss_pred             EEEEeCCeEEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCC
Q psy11571         80 YAFQDDSNLYLVMDYYCGGDLLTLLSKFE---------------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAF  144 (372)
Q Consensus        80 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~  144 (372)
                      +++.+.+.+|+||||+++++|.+++....               ..+++..++.++.||+.||.|||++||+|       
T Consensus        93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH-------  165 (327)
T 1fvr_A           93 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIH-------  165 (327)
T ss_dssp             EEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEEC-------
T ss_pred             eeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccC-------
Confidence            99999999999999999999999997632               36999999999999999999999999999       


Q ss_pred             CcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHh
Q psy11571        145 HLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML  224 (372)
Q Consensus       145 ~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ell  224 (372)
                         |||||+||+++.++.+||+|||+++......  ......+++.|+|||++.+     ..++.++|||||||++|+|+
T Consensus       166 ---~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~ell  235 (327)
T 1fvr_A          166 ---RDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNY-----SVYTTNSDVWSYGVLLWEIV  235 (327)
T ss_dssp             ---SCCSGGGEEECGGGCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHH-----CEECHHHHHHHHHHHHHHHH
T ss_pred             ---CCCccceEEEcCCCeEEEcccCcCccccccc--cccCCCCCccccChhhhcc-----ccCCchhcchHHHHHHHHHH
Confidence               9999999999999999999999987543211  1223457889999999974     55789999999999999999


Q ss_pred             h-CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        225 Y-GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       225 t-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      + |..||.+.+..+....+..+ .....+.    .+++++.+||.+||. ||.+||+++++++.+
T Consensus       236 t~g~~pf~~~~~~~~~~~~~~~-~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  295 (327)
T 1fvr_A          236 SLGGTPYCGMTCAELYEKLPQG-YRLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSL  295 (327)
T ss_dssp             TTSCCTTTTCCHHHHHHHGGGT-CCCCCCT----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cCCCCCCCCCcHHHHHHHhhcC-CCCCCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            8 99999999988888777654 2233333    689999999999999 999999988877655

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.1e-43  Score=330.64  Aligned_cols=256  Identities=18%  Similarity=0.228  Sum_probs=201.0

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    |+|.||++.+..+++.+++|...+.......     ....+.+.+|+.+++.++||||++++++
T Consensus        15 ~~y~~~~~lG~G----~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~~~~~   85 (327)
T 3lzb_A           15 TEFKKIKVLGSG----AFGTVYKGLWIPEGEKVKIPVAIKELREATS-----PKANKEILDEAYVMASVDNPHVCRLLGI   85 (327)
T ss_dssp             TTEEEEEEEEEC----SSEEEEEEEECCTTCSCCEEEEEEEECCCSS-----CCCHHHHHHHHHHHTTCCBTTBCCCCEE
T ss_pred             hHceEEEEeeeC----CCeEEEEEEEcCCCceEEEEEEEEeeccccC-----HHHHHHHHHHHHHHHhCCCCCeeEEEEE
Confidence            466677777777    8999999999888887755543221111000     0123457789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+.. .++||||+.+|+|.+++......+++..++.++.||+.||.|||++||+|          |||||+|||++.++
T Consensus        86 ~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH----------~Dikp~NIl~~~~~  154 (327)
T 3lzb_A           86 CLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH----------RDLAARNVLVKTPQ  154 (327)
T ss_dssp             EESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCCGGGEEEEETT
T ss_pred             EecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcC----------CCCCHHHEEEcCCC
Confidence            98765 78999999999999999886678999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETY  239 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~  239 (372)
                      .+||+|||+++....... .......||+.|+|||++.+     ..++.++|||||||++|+|++ |..||.+.+..+..
T Consensus       155 ~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~  229 (327)
T 3lzb_A          155 HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-----RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS  229 (327)
T ss_dssp             EEEECCTTC----------------CCCGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred             CEEEccCcceeEccCccccccccCCCccccccCHHHHcC-----CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
Confidence            999999999987643222 12223456789999999984     568999999999999999999 99999998877776


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ..+... .....+.    .++.++.+||.+||. ||.+||++.++++.+
T Consensus       230 ~~~~~~-~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  273 (327)
T 3lzb_A          230 SILEKG-ERLPQPP----ICTIDVYMIMRKCWMIDADSRPKFRELIIEF  273 (327)
T ss_dssp             HHHHTT-CCCCCCT----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHcC-CCCCCCc----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            666554 2333333    689999999999999 999999988877655

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5.3e-43  Score=321.46  Aligned_cols=251  Identities=21%  Similarity=0.280  Sum_probs=201.5

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehh---hhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLD---ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLH   79 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~---~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~   79 (372)
                      +|+..+.+|.|    |+|.||++....+   +..||+|.+......         +..+.+.+|+.+++.++||||++++
T Consensus        13 ~y~~~~~lg~G----~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~E~~~l~~l~h~~i~~~~   79 (281)
T 3cc6_A           13 DVVLNRILGEG----FFGEVYEGVYTNHKGEKINVAVKTCKKDCTL---------DNKEKFMSEAVIMKNLDHPHIVKLI   79 (281)
T ss_dssp             GEEEEEEEEEC----SSSEEEEEEEECTTCCEEEEEEEECCTTSCH---------HHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred             ceEEEEEEEec----CCeeEEEeEEcCCCCCcceEEEEecccccCc---------hHHHHHHHHHHHHHhCCCCCcceEE
Confidence            44445556666    8999999976543   446999987654322         1235678899999999999999999


Q ss_pred             EEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC
Q psy11571         80 YAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA  159 (372)
Q Consensus        80 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~  159 (372)
                      +++.++ ..|+||||+++++|.+++......+++..+..++.||+.||.|||++|++|          |||||+||+++.
T Consensus        80 ~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H----------~dlkp~Nil~~~  148 (281)
T 3cc6_A           80 GIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVH----------RDIAVRNILVAS  148 (281)
T ss_dssp             EEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCC----------CCCSGGGEEEEE
T ss_pred             EEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCccc----------CCCccceEEECC
Confidence            998754 568999999999999999875667999999999999999999999999999          999999999999


Q ss_pred             CCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHH
Q psy11571        160 NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVET  238 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~  238 (372)
                      ++.+||+|||++...............+|+.|+|||++.+     ..++.++||||||+++|+|++ |+.||...+..+.
T Consensus       149 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~  223 (281)
T 3cc6_A          149 PECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF-----RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV  223 (281)
T ss_dssp             TTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH
T ss_pred             CCcEEeCccCCCcccccccccccccCCCCcceeCchhhcc-----CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH
Confidence            9999999999998765443333334567889999999973     568899999999999999998 9999988777776


Q ss_pred             HHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       239 ~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ...+.... ....+.    .+++.+.++|.+||. ||++||++.++.+.+
T Consensus       224 ~~~~~~~~-~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L  268 (281)
T 3cc6_A          224 IGVLEKGD-RLPKPD----LCPPVLYTLMTRCWDYDPSDRPRFTELVCSL  268 (281)
T ss_dssp             HHHHHHTC-CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHhcCC-CCCCCC----CCCHHHHHHHHHHccCCchhCcCHHHHHHHH
Confidence            66665542 233333    689999999999999 999999988776544

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=7.9e-44  Score=339.43  Aligned_cols=282  Identities=15%  Similarity=0.139  Sum_probs=204.5

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehh-----hhhhhhhhhcccchhhhhhHHHHHHHHHH-----HHHHHHHHhcCCC
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLD-----ILLVLYDECCNSSLRREKTVSDFIEFVAK-----LREERDVLVYGDR   72 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~-----~~~va~K~~~~~~~~~~~~~~~~~~~~~~-----l~~E~~il~~l~h   72 (372)
                      +|+.++.+|.|    |+|.||++.+..+     ++.||+|.+......    ...+.+.+++     +..|...+..+.|
T Consensus        36 ~y~~~~~lG~G----~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~e~~~~~~~~~~~~~~e~~~~~~l~h  107 (364)
T 3op5_A           36 AWKVGLPIGQG----GFGCIYLADMNSSESVGSDAPCVVKVEPSDNGP----LFTELKFYQRAAKPEQIQKWIRTRKLKY  107 (364)
T ss_dssp             EEEEEEECCCC-----CCEEEEEEECCSSCCCTTCSEEEEEEETTCHH----HHHHHHHHHHHCCHHHHHHHHHHTTCSC
T ss_pred             eEEEEEEEecC----CCeEEEEeeecCccccccccceEEEEeeccchh----HHHHHHHHHhhhhhHHHHHHHHHhhccC
Confidence            45555666666    8999999977554     578999987654422    2223333333     3456677888999


Q ss_pred             CceeeeeEEEEeC----CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCC
Q psy11571         73 RWITNLHYAFQDD----SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCR  148 (372)
Q Consensus        73 p~Iv~l~~~~~~~----~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhr  148 (372)
                      |||+++++++.+.    ...|+||||+ |++|.+++......+++..++.++.||+.||.|||++||+|          |
T Consensus       108 ~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiH----------r  176 (364)
T 3op5_A          108 LGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVH----------G  176 (364)
T ss_dssp             CCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------C
T ss_pred             CCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEE----------e
Confidence            9999999998765    4589999999 99999999885578999999999999999999999999999          9


Q ss_pred             CCCcCcEEeC--CCCcEEEeecCcccccCCCCcc------cccccccCCcccCcccccccccCCCCCCCccceeehhHHH
Q psy11571        149 DIKPDNVLLD--ANGHIRLADFGSCLRLGGDGTV------QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCM  220 (372)
Q Consensus       149 Dlkp~NIll~--~~~~vkl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil  220 (372)
                      ||||+|||++  .++.+||+|||+++........      ......||+.|+|||++.+     ..++.++|||||||++
T Consensus       177 Dlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~~l  251 (364)
T 3op5_A          177 DIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-----VAPSRRGDLEILGYCM  251 (364)
T ss_dssp             CCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-----CCCCHHHHHHHHHHHH
T ss_pred             cCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-----CCCCchhhHHHHHHHH
Confidence            9999999998  8899999999999776432211      1123469999999999983     5689999999999999


Q ss_pred             HHHhhCCCCCCCCCHHHHHHHHhhccCCcCCC-----CCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhh
Q psy11571        221 YEMLYGETPFYAESLVETYGKIMNHQNSFDLP-----SDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFV  294 (372)
Q Consensus       221 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-----~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~  294 (372)
                      |||++|+.||.+..................++     ......+++++.++|.+||. +|.+||+++++.+++.- .+. 
T Consensus       252 ~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~-~~~-  329 (364)
T 3op5_A          252 IQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQ-GLK-  329 (364)
T ss_dssp             HHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH-HHH-
T ss_pred             HHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH-HHH-
Confidence            99999999998643222211111100000000     00012679999999999999 99999998887765510 000 


Q ss_pred             ccCCCCCCCCCcCCCCccccc
Q psy11571        295 SLSISPRNHPWFQGIAWDSIR  315 (372)
Q Consensus       295 ~~~~~~~~hp~f~~~~w~~~~  315 (372)
                           ....++...+||....
T Consensus       330 -----~~~~~~~~~~dw~~~~  345 (364)
T 3op5_A          330 -----AIGSKDDGKLDLSVVE  345 (364)
T ss_dssp             -----HTTCCCCCCCCC----
T ss_pred             -----HcCCCcCCccceEecc
Confidence                 1145677778887654

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-42  Score=327.46  Aligned_cols=248  Identities=17%  Similarity=0.242  Sum_probs=198.3

Q ss_pred             HHhhhcCCcccCCccEEEeeeehhh----hhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          7 LEALFLGGPIQGKGRVFSIETLLDI----LLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         7 l~~~~~~~~~~g~G~v~~v~~~~~~----~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      .+.+|.|    |+|.||++....++    ..||+|.+.......         ....+.+|+.+++.++||||+++++++
T Consensus        49 ~~~lG~G----~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~E~~~l~~l~h~~iv~~~~~~  115 (333)
T 1mqb_A           49 QKVIGAG----EFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK---------QRVDFLGEAGIMGQFSHHNIIRLEGVI  115 (333)
T ss_dssp             EEEEEEC----SSSEEEEEEEEC---CCEEEEEEEEECTTCCHH---------HHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccEEecC----CCeEEEEEEEecCCCCccccEEEEEcCCCCCHH---------HHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            3445555    89999999876543    358999876543211         234578899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+.+..++||||+++|+|.+++......+++..+..++.||+.||.|||++|++|          |||||+||+++.++.
T Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH----------~Dikp~NIl~~~~~~  185 (333)
T 1mqb_A          116 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVH----------RDLAARNILVNSNLV  185 (333)
T ss_dssp             CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCCGGGEEECTTCC
T ss_pred             ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeC----------CCCChheEEECCCCc
Confidence            9999999999999999999999875578999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcc--cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTV--QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETY  239 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~  239 (372)
                      +||+|||+++........  ......+|+.|+|||++.     ...++.++|||||||++|+|++ |..||.+.+..+..
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~  260 (333)
T 1mqb_A          186 CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS-----YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM  260 (333)
T ss_dssp             EEECCCCC-----------------CCCGGGSCHHHHH-----SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred             EEECCCCcchhhccccccccccCCCCccccccCchhcc-----cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence            999999999876433211  112234678899999997     3568899999999999999998 99999998888888


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ..+..+. ..+.+.    .+++.+.++|.+||+ +|++||++.++.+.+
T Consensus       261 ~~~~~~~-~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L  304 (333)
T 1mqb_A          261 KAINDGF-RLPTPM----DCPSAIYQLMMQCWQQERARRPKFADIVSIL  304 (333)
T ss_dssp             HHHHTTC-CCCCCT----TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred             HHHHCCC-cCCCcc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            7776542 233333    689999999999999 999999988777654

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.8e-42  Score=322.32  Aligned_cols=254  Identities=27%  Similarity=0.396  Sum_probs=194.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.++.|    |+|.||++....+++.||+|.+........       ...+.+.+|+.+++.++||||+++++++
T Consensus        33 ~y~~~~~lg~G----~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~i~~~~~~~  101 (310)
T 2wqm_A           33 NFRIEKKIGRG----QFSEVYRAACLLDGVPVALKKVQIFDLMDA-------KARADCIKEIDLLKQLNHPNVIKYYASF  101 (310)
T ss_dssp             GEEEEEEEECC------CEEEEEEETTTCCEEEEEEECTTSSCCH-------HHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ceEEEEeecCC----CCceEEEEEEcCCCceEEEEeeehhhccCH-------HHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            44455556665    899999999988999999998875433222       2345678899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKF---EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA  159 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~  159 (372)
                      .+.+..++||||+.+++|.+++...   ...+++..++.++.||+.||.|||+.|++|          |||||+||+++.
T Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H----------~dl~p~NIl~~~  171 (310)
T 2wqm_A          102 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMH----------RDIKPANVFITA  171 (310)
T ss_dssp             EETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------CCCCGGGEEECT
T ss_pred             EcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeC----------CCCcHHHEEEcC
Confidence            9999999999999999999998642   456899999999999999999999999999          999999999999


Q ss_pred             CCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC--CHHH
Q psy11571        160 NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVE  237 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~--~~~~  237 (372)
                      ++.+||+|||++........ ......||+.|+|||++.     ...++.++||||||+++|+|++|..||.+.  +...
T Consensus       172 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~  245 (310)
T 2wqm_A          172 TGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIH-----ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS  245 (310)
T ss_dssp             TSCEEECCC-------------------CCSSCCHHHHT-----TCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH
T ss_pred             CCCEEEEeccceeeecCCCc-cccccCCCeeEeChHHhC-----CCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH
Confidence            99999999999876644322 223357899999999997     356889999999999999999999999764  3334


Q ss_pred             HHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       238 ~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ....+.....    +......+++++.+||.+||. ||.+||+++++.+.+
T Consensus       246 ~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l  292 (310)
T 2wqm_A          246 LCKKIEQCDY----PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVA  292 (310)
T ss_dssp             HHHHHHTTCS----CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHhhcccC----CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence            4445544322    211223689999999999999 999999988877655

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5.5e-43  Score=323.07  Aligned_cols=245  Identities=20%  Similarity=0.243  Sum_probs=200.5

Q ss_pred             hhhcCCcccCCccEEEeee--ehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC
Q psy11571          9 ALFLGGPIQGKGRVFSIET--LLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS   86 (372)
Q Consensus         9 ~~~~~~~~~g~G~v~~v~~--~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~   86 (372)
                      .+|.|    |+|.||++..  ..+++.||+|.+.......        ...+.+.+|+.+++.++||||+++++++ ..+
T Consensus        24 ~lg~G----~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~   90 (291)
T 1xbb_A           24 ELGSG----NFGTVKKGYYQMKKVVKTVAVKILKNEANDP--------ALKDELLAEANVMQQLDNPYIVRMIGIC-EAE   90 (291)
T ss_dssp             EEEEC----SSEEEEEEEEECSSSEEEEEEEEEC-----C--------HHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred             ccccc----cCeeeEeeeecCCCceeeEEEEeecccccCH--------HHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence            45555    8999999943  4567899999886543221        2345688999999999999999999999 566


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEe
Q psy11571         87 NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLA  166 (372)
Q Consensus        87 ~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~  166 (372)
                      ..|+||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++|          |||||+||+++.++.+||+
T Consensus        91 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H----------~dikp~Nil~~~~~~~kl~  159 (291)
T 1xbb_A           91 SWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVH----------RDLAARNVLLVTQHYAKIS  159 (291)
T ss_dssp             SEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSGGGEEEEETTEEEEC
T ss_pred             CcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEc----------CCCCcceEEEeCCCcEEEc
Confidence            78999999999999999987 567999999999999999999999999999          9999999999999999999


Q ss_pred             ecCcccccCCCCccc--ccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHHh
Q psy11571        167 DFGSCLRLGGDGTVQ--SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIM  243 (372)
Q Consensus       167 Dfg~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i~  243 (372)
                      |||++..........  .....+|+.|+|||++.+     ..++.++||||||+++|+|++ |..||.+.+..+....+.
T Consensus       160 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~  234 (291)
T 1xbb_A          160 DFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-----YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE  234 (291)
T ss_dssp             CCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH-----CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred             cCCcceeeccCCCcccccccCCCCceeeChHHhcc-----CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            999998765433221  122346788999999974     457889999999999999999 999999998888777776


Q ss_pred             hccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        244 NHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ... ....+.    .+++++.++|.+||+ ||.+||++.++.+.+
T Consensus       235 ~~~-~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L  274 (291)
T 1xbb_A          235 KGE-RMGCPA----GCPREMYDLMNLCWTYDVENRPGFAAVELRL  274 (291)
T ss_dssp             TTC-CCCCCT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred             cCC-CCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            543 233333    689999999999999 999999988877554

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.2e-43  Score=323.27  Aligned_cols=255  Identities=20%  Similarity=0.250  Sum_probs=201.4

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeeh-hh--hhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLL-DI--LLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNL   78 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~-~~--~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l   78 (372)
                      ++|+.++.++.|    |+|.||.+.... ++  ..||+|.+........       +..+.+.+|+.+++.++||||+++
T Consensus        18 ~~y~~~~~lg~G----~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~   86 (291)
T 1u46_A           18 KDLRLLEKLGDG----SFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP-------EAMDDFIREVNAMHSLDHRNLIRL   86 (291)
T ss_dssp             GGEEEEEECC--------CCCEEEEEECTTSCEEEEEEEC--------C-------HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hHeeeeeeecCC----CceeEEEEEeccCCCceeEEEEEEEccCccCCH-------HHHHHHHHHHHHHHhCCCCCcccE
Confidence            356666666666    899999997543 33  3689998765443322       245668889999999999999999


Q ss_pred             eEEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC
Q psy11571         79 HYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD  158 (372)
Q Consensus        79 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~  158 (372)
                      ++++.+.. .++||||+++++|.+++......+++..+..++.||+.||.|||++|++|          |||||+||+++
T Consensus        87 ~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H----------~dikp~Nili~  155 (291)
T 1u46_A           87 YGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH----------RDLAARNLLLA  155 (291)
T ss_dssp             EEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCCGGGEEEE
T ss_pred             EEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCccc----------CCCchheEEEc
Confidence            99998765 88999999999999999875567999999999999999999999999999          99999999999


Q ss_pred             CCCcEEEeecCcccccCCCCcc--cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCH
Q psy11571        159 ANGHIRLADFGSCLRLGGDGTV--QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESL  235 (372)
Q Consensus       159 ~~~~vkl~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~  235 (372)
                      .++.+||+|||++.........  ......+|+.|+|||++.+     ..++.++||||||+++|+|++ |..||.+.+.
T Consensus       156 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~  230 (291)
T 1u46_A          156 TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-----RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG  230 (291)
T ss_dssp             ETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH-----CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             CCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCcccCCH
Confidence            9999999999999876543221  1223457889999999974     457889999999999999999 9999999998


Q ss_pred             HHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       236 ~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .+....+.........+.    .++.++.++|.+||. ||++||++.++.+.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  279 (291)
T 1u46_A          231 SQILHKIDKEGERLPRPE----DCPQDIYNVMVQCWAHKPEDRPTFVALRDFL  279 (291)
T ss_dssp             HHHHHHHHTSCCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHccCCCCCCCc----CcCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence            888888876554444443    689999999999999 999999988877654

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2e-43  Score=336.96  Aligned_cols=256  Identities=21%  Similarity=0.372  Sum_probs=195.8

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC----------
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD----------   71 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~----------   71 (372)
                      .+|+.++.+|.|    |+|.||.+.+..+++.||+|.+......           .+.+.+|+.+++.+.          
T Consensus        19 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~~e~~~l~~l~~~~~~~~~~~   83 (373)
T 1q8y_A           19 ARYILVRKLGWG----HFSTVWLAKDMVNNTHVAMKIVRGDKVY-----------TEAAEDEIKLLQRVNDADNTKEDSM   83 (373)
T ss_dssp             TTEEEEEEEEEC----SSEEEEEEEETTTTEEEEEEEECSCHHH-----------HHHHHHHHHHHHHHHHTCCSHHHHH
T ss_pred             CeEEEEEeeeec----CCeEEEEEEecCCCcEEEEEEecCCccc-----------hhhhhHHHHHHHHhhcccccchhcc
Confidence            456667777777    8999999999999999999988653322           233455666666554          


Q ss_pred             -CCceeeeeEEEEeCC----eEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCC
Q psy11571         72 -RRWITNLHYAFQDDS----NLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDL-HYVHRPNHFAF  144 (372)
Q Consensus        72 -hp~Iv~l~~~~~~~~----~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~~~~~~~  144 (372)
                       ||||+++++++...+    .+++||||+ +++|.+++... ...+++..++.++.||+.||.|||++ ||+|       
T Consensus        84 ~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH-------  155 (373)
T 1q8y_A           84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIH-------  155 (373)
T ss_dssp             HHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEEC-------
T ss_pred             ccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEe-------
Confidence             899999999998654    789999999 99999999864 34599999999999999999999998 9999       


Q ss_pred             CcCCCCCcCcEEeC------CCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhH
Q psy11571        145 HLCRDIKPDNVLLD------ANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGV  218 (372)
Q Consensus       145 ~vhrDlkp~NIll~------~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGv  218 (372)
                         |||||+|||++      ..+.+||+|||++......    .....||+.|+|||++.+     ..++.++|||||||
T Consensus       156 ---~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~  223 (373)
T 1q8y_A          156 ---TDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLG-----APWGCGADIWSTAC  223 (373)
T ss_dssp             ---SCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHT-----CCCCTHHHHHHHHH
T ss_pred             ---cCCChHHeEEeccCCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhC-----CCCCchHhHHHHHH
Confidence               99999999994      4458999999999876432    223578999999999983     56899999999999


Q ss_pred             HHHHHhhCCCCCCCCC------HHHHHHHHhhccCCcCC------------------------------------CCCCC
Q psy11571        219 CMYEMLYGETPFYAES------LVETYGKIMNHQNSFDL------------------------------------PSDVG  256 (372)
Q Consensus       219 il~elltG~~Pf~~~~------~~~~~~~i~~~~~~~~~------------------------------------~~~~~  256 (372)
                      ++|+|++|..||.+.+      .......+......++.                                    .....
T Consensus       224 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (373)
T 1q8y_A          224 LIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFS  303 (373)
T ss_dssp             HHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCC
T ss_pred             HHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCC
Confidence            9999999999998654      22223333221110000                                    00001


Q ss_pred             CCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        257 YEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       257 ~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      ..+++++.+||.+||+ ||++|||+++++                 +||||++.
T Consensus       304 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell-----------------~hp~f~~~  340 (373)
T 1q8y_A          304 KDEAKEISDFLSPMLQLDPRKRADAGGLV-----------------NHPWLKDT  340 (373)
T ss_dssp             HHHHHHHHHHHGGGGCSSTTTCBCHHHHH-----------------TCGGGTTC
T ss_pred             cchHHHHHHHHHHHhccCccccCCHHHHh-----------------hChhhhcc
Confidence            1346789999999999 999999876665                 99999964

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.5e-43  Score=326.16  Aligned_cols=246  Identities=17%  Similarity=0.167  Sum_probs=199.1

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhh-------hhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCc
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDI-------LLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRW   74 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~-------~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~   74 (372)
                      ++|+..+.+|.|    ++|.||++.+..++       ..||+|.+......          ..+.+.+|+.+++.++|||
T Consensus         8 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~----------~~~~~~~E~~~l~~l~h~~   73 (289)
T 4fvq_A            8 EDLIFNESLGQG----TFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN----------YSESFFEAASMMSKLSHKH   73 (289)
T ss_dssp             GGEEEEEEEEEE----TTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGG----------GHHHHHHHHHHHHTSCCTT
T ss_pred             hHeeeeeeeccC----CCceEEEEEEecccccccccchhhhhhhcccccHH----------HHHHHHHHHHHHHhCCCCC
Confidence            456666677776    89999999888766       46888877543321          2345788999999999999


Q ss_pred             eeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCc
Q psy11571         75 ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDN  154 (372)
Q Consensus        75 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~N  154 (372)
                      |+++++++.+.+..++||||+++|+|.+++......+++..++.++.||+.||.|||++|++|          |||||+|
T Consensus        74 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH----------~Dlkp~N  143 (289)
T 4fvq_A           74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIH----------GNVCAKN  143 (289)
T ss_dssp             BCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCC----------CCCCGGG
T ss_pred             EeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeEC----------CCcCcce
Confidence            999999999999999999999999999999885445999999999999999999999999999          9999999


Q ss_pred             EEeCCCCc--------EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhC
Q psy11571        155 VLLDANGH--------IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYG  226 (372)
Q Consensus       155 Ill~~~~~--------vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG  226 (372)
                      ||++.++.        +||+|||++......     ....||+.|+|||++.+    ...++.++|||||||++|+|++|
T Consensus       144 Ill~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g  214 (289)
T 4fvq_A          144 ILLIREEDRKTGNPPFIKLSDPGISITVLPK-----DILQERIPWVPPECIEN----PKNLNLATDKWSFGTTLWEICSG  214 (289)
T ss_dssp             EEEEECCBGGGTBCCEEEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHC----GGGCCHHHHHHHHHHHHHHHHTT
T ss_pred             EEEecCCcccccccceeeeccCcccccccCc-----cccCCcCcccCHHHhCC----CCCCCchhHHHHHHHHHHHHHcC
Confidence            99988876        999999998765322     23568999999999973    35688999999999999999995


Q ss_pred             -CCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        227 -ETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       227 -~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                       .+||...+...... +....  ...+.    ..++++.+||.+||+ ||++|||++++++.+
T Consensus       215 ~~~~~~~~~~~~~~~-~~~~~--~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  270 (289)
T 4fvq_A          215 GDKPLSALDSQRKLQ-FYEDR--HQLPA----PKAAELANLINNCMDYEPDHRPSFRAIIRDL  270 (289)
T ss_dssp             TCCTTTTSCHHHHHH-HHHTT--CCCCC----CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             CCCCccccchHHHHH-Hhhcc--CCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence             55555555544433 33322  22333    468889999999999 999999988877554

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.6e-43  Score=332.13  Aligned_cols=253  Identities=21%  Similarity=0.271  Sum_probs=205.6

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEee----eehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIE----TLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITN   77 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~----~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~   77 (372)
                      ++|+.++.+|.|    ++|.||++.    +..+++.||+|.+......          ..+.+.+|+.+++.++||||++
T Consensus        23 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~h~~i~~   88 (327)
T 3lxl_A           23 RHLKYISQLGKG----NFGSVELCRYDPLGDNTGALVAVKQLQHSGPD----------QQRDFQREIQILKALHSDFIVK   88 (327)
T ss_dssp             GGEEEEEEEEEE----TTEEEEEEEECTTSSSCSEEEEEEEESSCCHH----------HHHHHHHHHHHHHTCCCTTBCC
T ss_pred             hhhhhhhhccCC----CCeEEEEEEeccCCCCcceEEEEEEeccCCHH----------HHHHHHHHHHHHHhcCCCceeE
Confidence            466667777777    899999998    5668899999988654321          2355788999999999999999


Q ss_pred             eeEEEE--eCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcE
Q psy11571         78 LHYAFQ--DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNV  155 (372)
Q Consensus        78 l~~~~~--~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NI  155 (372)
                      +++++.  +...+|+||||+++++|.+++......+++..++.++.||+.||.|||+.|++|          |||||+||
T Consensus        89 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH----------~Dikp~NI  158 (327)
T 3lxl_A           89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVH----------RDLAARNI  158 (327)
T ss_dssp             EEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSGGGE
T ss_pred             EEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccC----------CCCChhhE
Confidence            999987  456799999999999999999875567999999999999999999999999999          99999999


Q ss_pred             EeCCCCcEEEeecCcccccCCCCc--ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC
Q psy11571        156 LLDANGHIRLADFGSCLRLGGDGT--VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE  233 (372)
Q Consensus       156 ll~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~  233 (372)
                      |++.++.+||+|||++........  .......||+.|+|||++.+     ..++.++|||||||++|+|++|..||...
T Consensus       159 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~ll~g~~p~~~~  233 (327)
T 3lxl_A          159 LVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD-----NIFSRQSDVWSFGVVLYELFTYCDKSCSP  233 (327)
T ss_dssp             EEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHH-----CEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred             EECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhcc-----CCCChHHhHHHHHHHHHHHHhCCCCCccc
Confidence            999999999999999987654332  12233467888999999974     55788999999999999999999999654


Q ss_pred             CHH--------------HHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        234 SLV--------------ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       234 ~~~--------------~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ...              ...............+.    .+++++.+||.+||+ ||.+||+++++.+.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  298 (327)
T 3lxl_A          234 SAEFLRMMGCERDVPALSRLLELLEEGQRLPAPP----ACPAEVHELMKLCWAPSPQDRPSFSALGPQL  298 (327)
T ss_dssp             HHHHHHHCC----CCHHHHHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cchhhhhcccccccccHHHHHHHhhcccCCCCCC----cccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            322              11222222223333333    689999999999999 999999999888777

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1e-42  Score=327.76  Aligned_cols=252  Identities=20%  Similarity=0.295  Sum_probs=206.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeee-------hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCc
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETL-------LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRW   74 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~-------~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~   74 (372)
                      +|+..+.+|.|    |+|.||.+...       .++..||+|.+......         ...+.+.+|+.+++.+ +|||
T Consensus        36 ~y~~~~~lG~G----~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~E~~~l~~l~~hp~  102 (334)
T 2pvf_A           36 KLTLGKPLGEG----AFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE---------KDLSDLVSEMEMMKMIGKHKN  102 (334)
T ss_dssp             GEEEEEEEEEC----SSCEEEEEEETTCSTTCC---CEEEEEECCTTCCH---------HHHHHHHHHHHHHHHHCCCTT
T ss_pred             HeEEeeEEeec----CceeEEEeEeccccccccccceEEEEeeeccCCcH---------HHHHHHHHHHHHHHHhhcCCC
Confidence            45555666666    89999999865       46678999988654321         2345678899999998 8999


Q ss_pred             eeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecC
Q psy11571         75 ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE---------------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRP  139 (372)
Q Consensus        75 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~  139 (372)
                      |+++++++.+.+.+|+||||+++|+|.+++....               ..+++..++.++.||+.||.|||++|++|  
T Consensus       103 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH--  180 (334)
T 2pvf_A          103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIH--  180 (334)
T ss_dssp             BCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEEC--
T ss_pred             EeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeC--
Confidence            9999999999999999999999999999998632               23899999999999999999999999999  


Q ss_pred             CCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCcc-cccccccCCcccCcccccccccCCCCCCCccceeehhH
Q psy11571        140 NHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTV-QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGV  218 (372)
Q Consensus       140 ~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGv  218 (372)
                              |||||+||+++.++.+||+|||++......... ......+|+.|+|||++.+     ..++.++|||||||
T Consensus       181 --------~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~  247 (334)
T 2pvf_A          181 --------RDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-----RVYTHQSDVWSFGV  247 (334)
T ss_dssp             --------SCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-----CEECHHHHHHHHHH
T ss_pred             --------CCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-----CCcChHHHHHHHHH
Confidence                    999999999999999999999999876543321 2223457889999999974     55889999999999


Q ss_pred             HHHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        219 CMYEMLY-GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       219 il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ++|+|++ |..||.+.+..+....+.... ....+.    .++.++.++|.+||. +|.+||++.++.+.+
T Consensus       248 il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  313 (334)
T 2pvf_A          248 LMWEIFTLGGSPYPGIPVEELFKLLKEGH-RMDKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  313 (334)
T ss_dssp             HHHHHHTTSCCSSTTCCHHHHHHHHHHTC-CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHhCCCCCcCcCCHHHHHHHHhcCC-CCCCCc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            9999999 999999998888877776543 233333    689999999999999 999999988877554

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.2e-43  Score=327.19  Aligned_cols=260  Identities=26%  Similarity=0.394  Sum_probs=202.0

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC--CCceeeeeE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD--RRWITNLHY   80 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~--hp~Iv~l~~   80 (372)
                      +|+.++.+|.|    |+|.||++.+. +++.||+|.+........        ..+.+.+|+.++..+.  ||||+++++
T Consensus        29 ~y~~~~~lg~G----~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--------~~~~~~~E~~~l~~l~~~~~~iv~~~~   95 (313)
T 3cek_A           29 IYSILKQIGSG----GSSKVFQVLNE-KKQIYAIKYVNLEEADNQ--------TLDSYRNEIAYLNKLQQHSDKIIRLYD   95 (313)
T ss_dssp             EEEEEEEEECC----SSEEEEEEECT-TCCEEEEEEEECSSCCHH--------HHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred             eEEEEEEecCC----CCEEEEEEEcC-CCcEEEEEEecccccccc--------chHHHHHHHHHHHhccccCCceEEEEE
Confidence            45566666766    89999999774 588899998866543322        3456788999999886  599999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         81 AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        81 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      ++.+.+.+|+||| +.+++|.+++.. ...+++..++.++.||+.||.|||++|++|          |||||+||+++ +
T Consensus        96 ~~~~~~~~~lv~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH----------~dlkp~NIl~~-~  162 (313)
T 3cek_A           96 YEITDQYIYMVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVH----------SDLKPANFLIV-D  162 (313)
T ss_dssp             EEECSSEEEEEEC-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCC----------CCCCGGGEEEE-T
T ss_pred             EeecCCEEEEEEe-cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcee----------cCCCcccEEEE-C
Confidence            9999999999999 568899999987 578999999999999999999999999999          99999999995 5


Q ss_pred             CcEEEeecCcccccCCCCc-ccccccccCCcccCccccccccc------CCCCCCCccceeehhHHHHHHhhCCCCCCCC
Q psy11571        161 GHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEE------GRGRYGPECDWWSLGVCMYEMLYGETPFYAE  233 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~------~~~~~~~~~DiwslGvil~elltG~~Pf~~~  233 (372)
                      +.+||+|||++........ .......||+.|+|||++.+...      ....++.++|||||||++|+|++|..||...
T Consensus       163 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (313)
T 3cek_A          163 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI  242 (313)
T ss_dssp             TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence            8999999999987643322 12234578999999999874211      0136788999999999999999999999875


Q ss_pred             C-HHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        234 S-LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       234 ~-~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      . .......+........++.    ..+.++.+||.+||. ||.+||++.+++                 +||||+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell-----------------~h~~~~~~  299 (313)
T 3cek_A          243 INQISKLHAIIDPNHEIEFPD----IPEKDLQDVLKCCLKRDPKQRISIPELL-----------------AHPYVQIQ  299 (313)
T ss_dssp             CSHHHHHHHHHCTTSCCCCCC----CSCHHHHHHHHHHTCSSTTTSCCHHHHH-----------------TSHHHHCC
T ss_pred             HHHHHHHHHHHhcccccCCcc----cchHHHHHHHHHHccCCcccCcCHHHHh-----------------cCccccCC
Confidence            3 3344445554444444444    568999999999999 999999866555                 99999853

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.7e-43  Score=331.52  Aligned_cols=256  Identities=20%  Similarity=0.172  Sum_probs=195.7

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||+++..  ++.||+|.+......           ......|+.+++.++||||+++++++
T Consensus        25 ~y~~~~~lg~G----~~g~Vy~~~~~--~~~vavK~~~~~~~~-----------~~~~~~E~~~l~~l~hpniv~~~~~~   87 (322)
T 3soc_A           25 PLQLLEVKARG----RFGCVWKAQLL--NEYVAVKIFPIQDKQ-----------SWQNEYEVYSLPGMKHENILQFIGAE   87 (322)
T ss_dssp             EEEEEEEEECS----TTCEEEEEEET--TEEEEEEEECGGGHH-----------HHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred             hchhhheeccc----CceEEEEEEEC--CCEEEEEEeecCchH-----------HHHHHHHHHHHhcCCCCCchhhccee
Confidence            45566667776    89999999654  789999987543221           12234588889999999999999999


Q ss_pred             EeCC----eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhc----------CceecCCCCCCCcCC
Q psy11571         83 QDDS----NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDL----------HYVHRPNHFAFHLCR  148 (372)
Q Consensus        83 ~~~~----~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~----------~ivH~~~~~~~~vhr  148 (372)
                      .+..    .+|+|||||++|+|.+++..  ..+++..++.++.||+.||.|||+.          ||+|          |
T Consensus        88 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH----------~  155 (322)
T 3soc_A           88 KRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISH----------R  155 (322)
T ss_dssp             EEECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEEC----------S
T ss_pred             ccCCCCCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEe----------C
Confidence            8754    47999999999999999987  5699999999999999999999999          9999          9


Q ss_pred             CCCcCcEEeCCCCcEEEeecCcccccCCCCcc-cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCC
Q psy11571        149 DIKPDNVLLDANGHIRLADFGSCLRLGGDGTV-QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGE  227 (372)
Q Consensus       149 Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~  227 (372)
                      ||||+|||++.++.+||+|||+++........ ......||+.|+|||++.+.......++.++|||||||++|||++|+
T Consensus       156 Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~  235 (322)
T 3soc_A          156 DIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC  235 (322)
T ss_dssp             CCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred             CCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCC
Confidence            99999999999999999999999876543221 22335799999999999742111134566889999999999999999


Q ss_pred             CCCCCCC----------------HHHHHHHHhhccCCcCCCCCC-CCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        228 TPFYAES----------------LVETYGKIMNHQNSFDLPSDV-GYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       228 ~Pf~~~~----------------~~~~~~~i~~~~~~~~~~~~~-~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .||.+..                .......+........++... ....++++.+||.+||+ ||++|||+.++++.+
T Consensus       236 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  313 (322)
T 3soc_A          236 TAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERI  313 (322)
T ss_dssp             TTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            9997642                222333333332222222110 01234569999999999 999999988877654

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.7e-43  Score=328.35  Aligned_cols=253  Identities=19%  Similarity=0.260  Sum_probs=203.2

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeee-----ehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCcee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIET-----LLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWIT   76 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~-----~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv   76 (372)
                      +|+..+.+|.|    |+|.||++..     ..+++.||+|.+.......         ..+.+.+|+.++..+ +||||+
T Consensus        28 ~y~~~~~lg~G----~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~E~~~l~~l~~hp~iv   94 (316)
T 2xir_A           28 RLKLGKPLGRG----AFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS---------EHRALMSELKILIHIGHHLNVV   94 (316)
T ss_dssp             GEEEEEEEEEC----SSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH---------HHHHHHHHHHHHHHHCCCTTBC
T ss_pred             heeeeeEEcCC----CceeEEEEEEecCCccccceEEEEEecccCCCcH---------HHHHHHHHHHHHHhcccCCCee
Confidence            45555566666    8999999974     3467899999886543221         235578899999998 699999


Q ss_pred             eeeEEEEeCC-eEEEEEeccCCCCHHHHHHhcCCC---------------CCHHHHHHHHHHHHHHHHHHHhcCceecCC
Q psy11571         77 NLHYAFQDDS-NLYLVMDYYCGGDLLTLLSKFEDR---------------LPEDMAKFYIAEMVLAIASIHDLHYVHRPN  140 (372)
Q Consensus        77 ~l~~~~~~~~-~~~lv~E~~~gg~L~~~l~~~~~~---------------l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~  140 (372)
                      ++++++.+.+ .+++||||+++|+|.+++......               +++..++.++.||+.||.|||++|++|   
T Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H---  171 (316)
T 2xir_A           95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIH---  171 (316)
T ss_dssp             CEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCC---
T ss_pred             eEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCccc---
Confidence            9999988765 589999999999999999874221               899999999999999999999999999   


Q ss_pred             CCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHH
Q psy11571        141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVC  219 (372)
Q Consensus       141 ~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvi  219 (372)
                             |||||+||+++.++.+||+|||+++....... .......||+.|+|||++.+     ..++.++|||||||+
T Consensus       172 -------~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~i  239 (316)
T 2xir_A          172 -------RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-----RVYTIQSDVWSFGVL  239 (316)
T ss_dssp             -------SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-----CCCCHHHHHHHHHHH
T ss_pred             -------ccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-----ccccchhHHHHHHHH
Confidence                   99999999999999999999999986643322 22334568899999999974     568899999999999


Q ss_pred             HHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        220 MYEMLY-GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       220 l~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      +|+|++ |..||.+....+.+............+.    .+++++.++|.+||. ||.+||++.++.+.+
T Consensus       240 l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  305 (316)
T 2xir_A          240 LWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL  305 (316)
T ss_dssp             HHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHhCCCCCCcccchhHHHHHHhccCccCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            999998 9999988764444444333333344444    689999999999999 999999988877554

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.5e-43  Score=343.98  Aligned_cols=247  Identities=20%  Similarity=0.290  Sum_probs=204.7

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+..+.+|.|    ++|.||++... ++..||+|.+......           .+.+.+|+.+++.++||||+++++++.
T Consensus       190 ~~~~~~lG~G----~fg~V~~~~~~-~~~~vavK~~~~~~~~-----------~~~~~~E~~~l~~l~h~~iv~l~~~~~  253 (454)
T 1qcf_A          190 LKLEKKLGAG----QFGEVWMATYN-KHTKVAVKTMKPGSMS-----------VEAFLAEANVMKTLQHDKLVKLHAVVT  253 (454)
T ss_dssp             EEEEEEEECC----SSEEEEEEEET-TTEEEEEEEECTTSBC-----------HHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             eEEEEEcccC----CceEEEEEEEC-CccEEEEEEecCCCcc-----------HHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence            4444555555    89999999653 5678999988754321           245788999999999999999999986


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                       ...+|+||||+++|+|.+++... ...+++..+..++.||+.||.|||++||+|          |||||+|||++.++.
T Consensus       254 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH----------rDlkp~Nill~~~~~  322 (454)
T 1qcf_A          254 -KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH----------RDLRAANILVSASLV  322 (454)
T ss_dssp             -SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SSCSGGGEEECTTCC
T ss_pred             -CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccC----------CCCCHHHEEECCCCc
Confidence             56789999999999999999753 236899999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGK  241 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~  241 (372)
                      +||+|||+++..............+|+.|+|||++..     ..++.++|||||||++|||++ |+.||.+.+..+....
T Consensus       323 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~  397 (454)
T 1qcf_A          323 CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-----GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA  397 (454)
T ss_dssp             EEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred             EEEeeCCCceEcCCCceeccCCCcccccccCHHHhcc-----CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            9999999998765432222233456788999999973     568999999999999999999 9999999998888887


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      +..+ ...+.|.    .+++++.+||.+||. ||++||+++++.+.+
T Consensus       398 i~~~-~~~~~~~----~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L  439 (454)
T 1qcf_A          398 LERG-YRMPRPE----NCPEELYNIMMRCWKNRPEERPTFEYIQSVL  439 (454)
T ss_dssp             HHHT-CCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHcC-CCCCCCC----CCCHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence            7664 3333343    689999999999999 999999988887665

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.1e-43  Score=334.97  Aligned_cols=251  Identities=27%  Similarity=0.425  Sum_probs=175.3

Q ss_pred             HHHHHHh-hhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          3 RLRELEA-LFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         3 ~~~~l~~-~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      +|+.+++ +|.|    |+|.||.+.+..+++.||+|.+......              ..+....++.+.||||++++++
T Consensus        29 ~y~i~~~~lG~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~--------------~~e~~~~~~~~~h~~i~~~~~~   90 (336)
T 3fhr_A           29 DYQLSKQVLGLG----VNGKVLECFHRRTGQKCALKLLYDSPKA--------------RQEVDHHWQASGGPHIVCILDV   90 (336)
T ss_dssp             TEEEEEEEEEEE----TTEEEEEEEETTTCCEEEEEEEESSHHH--------------HHHHHHHHHHTTSTTBCCEEEE
T ss_pred             eeEecceeeeeC----CCeEEEEEEECCCCCEEEEEEecCcHHH--------------HHHHHHHHHhcCCCChHHHHHH
Confidence            3444443 5555    8999999999999999999987543211              1122233567799999999999


Q ss_pred             EEe----CCeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEE
Q psy11571         82 FQD----DSNLYLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL  156 (372)
Q Consensus        82 ~~~----~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIl  156 (372)
                      +..    ...+++|||||+||+|.+++.... ..+++..++.++.||+.||.|||++|++|          |||||+||+
T Consensus        91 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH----------~dlkp~NIl  160 (336)
T 3fhr_A           91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAH----------RDVKPENLL  160 (336)
T ss_dssp             EEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSGGGEE
T ss_pred             HhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec----------CCCCHHHEE
Confidence            986    456899999999999999998742 36999999999999999999999999999          999999999


Q ss_pred             eCC---CCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC
Q psy11571        157 LDA---NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE  233 (372)
Q Consensus       157 l~~---~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~  233 (372)
                      ++.   ++.+||+|||+++......   .....||+.|+|||++.     ...++.++|||||||++|+|++|..||.+.
T Consensus       161 l~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~~~  232 (336)
T 3fhr_A          161 YTSKEKDAVLKLTDFGFAKETTQNA---LQTPCYTPYYVAPEVLG-----PEKYDKSCDMWSLGVIMYILLCGFPPFYSN  232 (336)
T ss_dssp             ESCSSTTCCEEECCCTTCEEC------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             EEecCCCceEEEeccccceeccccc---cccCCCCcCccChhhhC-----CCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            986   4559999999998664322   23357899999999997     356888999999999999999999999876


Q ss_pred             CHHHHH----HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        234 SLVETY----GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       234 ~~~~~~----~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      ......    ..+....  ...+......+++++++||.+||. ||.+|||+++++                 +||||++
T Consensus       233 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell-----------------~hp~~~~  293 (336)
T 3fhr_A          233 TGQAISPGMKRRIRLGQ--YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFM-----------------NHPWINQ  293 (336)
T ss_dssp             --------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH-----------------HSHHHHT
T ss_pred             cchhhhhhHHHhhhccc--cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHh-----------------cCccccc
Confidence            654432    2222222  223333334789999999999999 999999866655                 9999985

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-43  Score=344.28  Aligned_cols=255  Identities=19%  Similarity=0.265  Sum_probs=191.0

Q ss_pred             HHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeC
Q psy11571          7 LEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYAFQDD   85 (372)
Q Consensus         7 l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~~~~~   85 (372)
                      .+.+|.|    |+|.|+. ....+++.||+|.+.......             +.+|+.+|+.+ +||||+++++++.+.
T Consensus        29 ~~~LG~G----~~G~V~~-~~~~~~~~vAvK~~~~~~~~~-------------~~~E~~~l~~l~~HpnIv~l~~~~~~~   90 (432)
T 3p23_A           29 KDVLGHG----AEGTIVY-RGMFDNRDVAVKRILPECFSF-------------ADREVQLLRESDEHPNVIRYFCTEKDR   90 (432)
T ss_dssp             EEEEEEC----GGGCEEE-EEESSSSEEEEEEECTTTEEE-------------CHHHHHHHHHSCCCTTBCCEEEEEEET
T ss_pred             CCeeecC----cCEEEEE-EEEeCCeEEEEEEECHHHHHH-------------HHHHHHHHHhccCCCCcCeEEEEEecC
Confidence            3344555    7888764 456689999999886543322             34688899888 799999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC-----C
Q psy11571         86 SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA-----N  160 (372)
Q Consensus        86 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~-----~  160 (372)
                      ...|+|||||. |+|.+++......+.+..+..++.||+.||.|||++||+|          |||||+|||++.     .
T Consensus        91 ~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH----------rDlKp~NIll~~~~~~~~  159 (432)
T 3p23_A           91 QFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVH----------RDLKPHNILISMPNAHGK  159 (432)
T ss_dssp             TEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCC----------CCCSTTSEEECCCBTTTB
T ss_pred             CEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEe----------CCCCHHHEEEecCCCCCc
Confidence            99999999995 6999999875556677778899999999999999999999          999999999953     2


Q ss_pred             CcEEEeecCcccccCCCCc--ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGT--VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVE  237 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~  237 (372)
                      ..+||+|||+++.......  ......+||+.|+|||++.+..  ...++.++|||||||++|+|++ |.+||.......
T Consensus       160 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~  237 (432)
T 3p23_A          160 IKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDC--KENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ  237 (432)
T ss_dssp             CCEEECCTTEEECC------------CCSCTTSCCGGGTSCC-----CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH
T ss_pred             eeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhccc--ccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH
Confidence            3688999999987653321  1233467999999999997321  2456789999999999999999 999997665544


Q ss_pred             HHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcc
Q psy11571        238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWD  312 (372)
Q Consensus       238 ~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~  312 (372)
                      ....+..  ....... .....+..+++||.+||+ ||.+|||+++++                 +||||.+++|.
T Consensus       238 ~~~~~~~--~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~evl-----------------~hp~f~~~~~~  293 (432)
T 3p23_A          238 ANILLGA--CSLDCLH-PEKHEDVIARELIEKMIAMDPQKRPSAKHVL-----------------KHPFFWSLEKQ  293 (432)
T ss_dssp             HHHHTTC--CCCTTSC-TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH-----------------TSTTTCCHHHH
T ss_pred             HHHHhcc--CCccccC-ccccccHHHHHHHHHHHhCCHhhCCCHHHHH-----------------hCccccChHHH
Confidence            3322221  1111111 111346778999999999 999999866555                 99999999883

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.3e-43  Score=325.80  Aligned_cols=253  Identities=17%  Similarity=0.182  Sum_probs=199.4

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeee-E
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLH-Y   80 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~-~   80 (372)
                      ++|+.++.++.|    ++|.||.+.+..+++.||+|.+.......            .+.+|..+++.+.|++++..+ .
T Consensus         9 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------~~~~e~~~l~~l~~~~~i~~~~~   72 (296)
T 3uzp_A            9 NRYRLGRKIGSG----SFGDIYLGTDIAAGEEVAIKLECVKTKHP------------QLHIESKIYKMMQGGVGIPTIRW   72 (296)
T ss_dssp             TTEEEEEEEEEE----TTEEEEEEEETTTTEEEEEEEEESCSSCC------------HHHHHHHHHHHHTTSTTCCCEEE
T ss_pred             cEEEEEEEEccC----CCeEEEEEEEcCCCcEEEEEEecCCcchh------------HHHHHHHHHHHhhcCCCCCcccc
Confidence            355566666666    89999999998999999999876544322            267799999999887755554 4


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC--
Q psy11571         81 AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD--  158 (372)
Q Consensus        81 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~--  158 (372)
                      +..+....++||||+ +++|.+++......+++..++.++.||+.||.|||++|++|          |||||+|||++  
T Consensus        73 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH----------~dlkp~NIl~~~~  141 (296)
T 3uzp_A           73 CGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH----------RDVKPDNFLMGLG  141 (296)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCCGGGEEECCG
T ss_pred             ccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeee----------CCCCHHHeEEecC
Confidence            456778899999999 99999999865678999999999999999999999999999          99999999994  


Q ss_pred             -CCCcEEEeecCcccccCCCCcc------cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCC
Q psy11571        159 -ANGHIRLADFGSCLRLGGDGTV------QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY  231 (372)
Q Consensus       159 -~~~~vkl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~  231 (372)
                       .++.+||+|||++.........      ......||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.
T Consensus       142 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~  216 (296)
T 3uzp_A          142 KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-----IEQSRRDDLESLGYVLMYFNLGSLPWQ  216 (296)
T ss_dssp             GGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred             CCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcC-----CCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence             7889999999999876543221      1234679999999999983     568999999999999999999999998


Q ss_pred             CCC---HHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        232 AES---LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       232 ~~~---~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      +.+   ..+.+..+.......+. ......+++++.+||.+||+ ||++||+++++.+.+
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  275 (296)
T 3uzp_A          217 GLKAATKRQKYERISEKKMSTPI-EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF  275 (296)
T ss_dssp             SCCCSSSSSHHHHHHHHHHHSCH-HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHH
T ss_pred             CcCchhhhhhhhhhcccccCCch-HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHH
Confidence            643   22333343332211110 01112679999999999999 999999988887665

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3e-43  Score=346.78  Aligned_cols=274  Identities=18%  Similarity=0.207  Sum_probs=216.2

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCC-CceeeeeE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDR-RWITNLHY   80 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~h-p~Iv~l~~   80 (372)
                      ++|+.++.+|.|    ++|.||++.+..+++.||+|.+.......            .+.+|..+++.+.| ++|..+..
T Consensus         7 ~~y~i~~~LG~G----~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~------------~~~~E~~il~~L~~~~~i~~i~~   70 (483)
T 3sv0_A            7 NKFRLGRKIGSG----SFGEIYLGTNIQTNEEVAIKLENVKTKHP------------QLLYESKIYRILQGGTGIPNVRW   70 (483)
T ss_dssp             TTEECCCCCEEC----SSCEEEEEEETTTCCEEEEEEEETTCSSC------------CHHHHHHHHHHTTTSTTCCCEEE
T ss_pred             CcEEEEEEEeeC----CCEEEEEEEECCCCcEEEEEEeccccccH------------HHHHHHHHHHHhcCCCCCCeEEE
Confidence            456667777777    89999999999999999999766544322            25678899998876 66777777


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe---
Q psy11571         81 AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL---  157 (372)
Q Consensus        81 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll---  157 (372)
                      ++.+....++||||+ +++|.+++......+++..++.++.||+.||.|||++||+|          |||||+|||+   
T Consensus        71 ~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvH----------rDIKP~NILl~~~  139 (483)
T 3sv0_A           71 FGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH----------RDIKPDNFLMGLG  139 (483)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCCGGGEEECCG
T ss_pred             EEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEee----------cccCcceEEEecC
Confidence            778888999999999 99999999876678999999999999999999999999999          9999999999   


Q ss_pred             CCCCcEEEeecCcccccCCCCcc------cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCC
Q psy11571        158 DANGHIRLADFGSCLRLGGDGTV------QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY  231 (372)
Q Consensus       158 ~~~~~vkl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~  231 (372)
                      +.++.+||+|||+++........      ......||+.|+|||++.+     ..++.++|||||||++|||++|+.||.
T Consensus       140 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~sDvwSlGvil~elltG~~Pf~  214 (483)
T 3sv0_A          140 RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQ  214 (483)
T ss_dssp             GGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred             CCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcC-----CCCChHHHHHHHHHHHHHHHhCCCCCc
Confidence            57889999999999876543221      1224679999999999983     568999999999999999999999998


Q ss_pred             CCC---HHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcC
Q psy11571        232 AES---LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ  307 (372)
Q Consensus       232 ~~~---~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~  307 (372)
                      +..   ..+.+.++......... ......+++++.+||.+||. +|++||+++++.+++.  .+.     ....++|+.
T Consensus       215 ~~~~~~~~~~~~~i~~~~~~~~~-~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~--~l~-----~~~~~~~~~  286 (483)
T 3sv0_A          215 GLKAGTKKQKYEKISEKKVATSI-EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFR--DLF-----IREGFQFDY  286 (483)
T ss_dssp             SCCCSSHHHHHHHHHHHHHHSCH-HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH--HHH-----HHTTCCCSS
T ss_pred             cccchhHHHHHHHHhhccccccH-HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHH--HHH-----HHcCCCccC
Confidence            743   34444444332211110 01112679999999999999 9999999887766541  110     123799999


Q ss_pred             CCCccccc
Q psy11571        308 GIAWDSIR  315 (372)
Q Consensus       308 ~~~w~~~~  315 (372)
                      .+||+.++
T Consensus       287 ~~dW~~~~  294 (483)
T 3sv0_A          287 VFDWTILK  294 (483)
T ss_dssp             CCHHHHHT
T ss_pred             CcCchhhc
Confidence            99999874

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.9e-42  Score=339.17  Aligned_cols=242  Identities=19%  Similarity=0.289  Sum_probs=200.0

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+.++.+|.|    ++|.||++..  .++.||+|.+.....            .+.+.+|+.+++.++||||+++++++.
T Consensus       195 ~~~~~~lG~G----~fg~V~~~~~--~~~~vavK~~~~~~~------------~~~~~~E~~~l~~l~h~niv~~~~~~~  256 (450)
T 1k9a_A          195 LKLLQTIGKG----EFGDVMLGDY--RGNKVAVKCIKNDAT------------AQAFLAEASVMTQLRHSNLVQLLGVIV  256 (450)
T ss_dssp             EEEEEEEEEC----SSEEEEEEEE--TTEEEEEEEESSCTT------------SHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             eEEEeeecCc----CCeeEEEEEe--cCCeEEEEEeCCchH------------HHHHHHHHHHHHhccCCCEEEEEEEEE
Confidence            3334455555    8999999865  477999998875431            234778999999999999999999987


Q ss_pred             eCC-eEEEEEeccCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         84 DDS-NLYLVMDYYCGGDLLTLLSKFED-RLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        84 ~~~-~~~lv~E~~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.. .+|+|||||++|+|.+++..... .+++..+..++.||+.||+|||++|++|          |||||+|||++.++
T Consensus       257 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH----------rDlkp~Nill~~~~  326 (450)
T 1k9a_A          257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH----------RDLAARNVLVSEDN  326 (450)
T ss_dssp             CTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCCGGGEEECTTS
T ss_pred             cCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeC----------CCCCHhhEEECCCC
Confidence            665 79999999999999999987433 3799999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYG  240 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~  240 (372)
                      .+||+|||+++......    ....+++.|+|||++.     ...++.++|||||||++|||++ |..||.+.+..+...
T Consensus       327 ~~kl~DfG~a~~~~~~~----~~~~~~~~y~aPE~~~-----~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~  397 (450)
T 1k9a_A          327 VAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALR-----EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP  397 (450)
T ss_dssp             CEEECCCTTCEECC----------CCCTTTSCHHHHH-----SSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH
T ss_pred             CEEEeeCCCcccccccc----cCCCCCcceeCHHHhc-----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999999998653321    2235788999999998     3568999999999999999998 999999888777777


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .+..+ .....|.    .+++++.+||.+||. ||++||++.++.+.+
T Consensus       398 ~i~~~-~~~~~p~----~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L  440 (450)
T 1k9a_A          398 RVEKG-YKMDAPD----GCPPAVYDVMKNCWHLDAATRPTFLQLREQL  440 (450)
T ss_dssp             HHHTT-CCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHcC-CCCCCCC----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            77654 3344444    689999999999999 999999988776544

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=334.68  Aligned_cols=258  Identities=18%  Similarity=0.138  Sum_probs=195.7

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeeh---hhhhhhhhhhcccchhhhhhHHHHHHHH-----HHHHHHHHHHhcCCCCc
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLL---DILLVLYDECCNSSLRREKTVSDFIEFV-----AKLREERDVLVYGDRRW   74 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~---~~~~va~K~~~~~~~~~~~~~~~~~~~~-----~~l~~E~~il~~l~hp~   74 (372)
                      +|+..+.+|.|    |+|.||++....   ++..+|+|.........    ..+.+.+     +.+.+|..++..+.|||
T Consensus        38 ~y~~~~~lg~G----~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~----~~e~~~~~~~~~~~~~~e~~~~~~l~h~n  109 (345)
T 2v62_A           38 QWVLGKKIGSG----GFGLIYLAFPTNKPEKDARHVVKVEYQENGPL----FSELKFYQRVAKKDCIKKWIERKQLDYLG  109 (345)
T ss_dssp             EEEEEEEC----------CEEEEEESSSCGGGCCEEEEEEECC-CHH----HHHHHHHHHHCCHHHHHHHHHHHTCSCCC
T ss_pred             eEEEEeeEeec----CCeEEEEEEecCCCCccceEEEEeeecCCcch----HHHHHHHHHHhhhHHHHHHHhhccccccC
Confidence            45555666666    899999999877   78899999876553221    1222222     33567889999999999


Q ss_pred             eeeeeEEEEe----CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCC
Q psy11571         75 ITNLHYAFQD----DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDI  150 (372)
Q Consensus        75 Iv~l~~~~~~----~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDl  150 (372)
                      |+++++++.+    ....|+||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+|          |||
T Consensus       110 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH----------~Dl  177 (345)
T 2v62_A          110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ-NGTFKKSTVLQLGIRMLDVLEYIHENEYVH----------GDI  177 (345)
T ss_dssp             CCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBG-GGBCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCC
T ss_pred             cceeecccccccCCCcEEEEEEecc-CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeC----------CCc
Confidence            9999999988    67899999999 9999999987 358999999999999999999999999999          999


Q ss_pred             CcCcEEeCCCC--cEEEeecCcccccCCCCc------ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHH
Q psy11571        151 KPDNVLLDANG--HIRLADFGSCLRLGGDGT------VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYE  222 (372)
Q Consensus       151 kp~NIll~~~~--~vkl~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~e  222 (372)
                      ||+|||++.++  .+||+|||+++.......      .......||+.|+|||++.+     ..++.++|||||||++|+
T Consensus       178 kp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~e  252 (345)
T 2v62_A          178 KAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-----VALSRRSDVEILGYCMLR  252 (345)
T ss_dssp             SGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-----CCCCHHHHHHHHHHHHHH
T ss_pred             CHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC-----CCCCchhhHHHHHHHHHH
Confidence            99999998777  999999999987643211      11134579999999999983     568999999999999999


Q ss_pred             HhhCCCCCCCC--CHHHHHHHHhhccCCcCCCCC-----CCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        223 MLYGETPFYAE--SLVETYGKIMNHQNSFDLPSD-----VGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       223 lltG~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~-----~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      |++|+.||.+.  +...........  ....+..     ....+++++.++|.+||. ||++||+++++.+.+
T Consensus       253 ll~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L  323 (345)
T 2v62_A          253 WLCGKLPWEQNLKDPVAVQTAKTNL--LDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKIL  323 (345)
T ss_dssp             HHHSSCTTGGGTTCHHHHHHHHHHH--HHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred             HHhCCCCccccccccHHHHHHHHhh--cccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence            99999999652  322222111110  1111110     011578999999999999 999999998888776

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=8.9e-43  Score=319.46  Aligned_cols=249  Identities=19%  Similarity=0.264  Sum_probs=205.6

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    |+|.||.+.. .++..||+|.+......           .+.+.+|+.+++.++||||++++++
T Consensus        13 ~~y~~~~~lg~G----~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----------~~~~~~E~~~l~~l~h~~i~~~~~~   76 (279)
T 1qpc_A           13 ETLKLVERLGAG----QFGEVWMGYY-NGHTKVAVKSLKQGSMS-----------PDAFLAEANLMKQLQHQRLVRLYAV   76 (279)
T ss_dssp             GGEEEEEEEEEE----TTEEEEEEEE-TTTEEEEEEEECTTSSC-----------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             HhhhheeeecCC----CCeEEEEEEE-cCCcEEEEEEecCCccc-----------HHHHHHHHHHHHhCCCcCcceEEEE
Confidence            355556666666    8999999974 46678999987654322           1347789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      +.+ +..++||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++|          |||||+||+++.+
T Consensus        77 ~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H----------~dikp~Nil~~~~  145 (279)
T 1qpc_A           77 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH----------RDLRAANILVSDT  145 (279)
T ss_dssp             ECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSGGGEEECTT
T ss_pred             EcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeec----------cCCCHhhEEEcCC
Confidence            864 46899999999999999997531 26999999999999999999999999999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETY  239 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~  239 (372)
                      +.+||+|||++...............+++.|+|||++.+     ..++.++||||||+++|+|++ |..||.+.+..+..
T Consensus       146 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  220 (279)
T 1qpc_A          146 LSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-----GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI  220 (279)
T ss_dssp             SCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH-----CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred             CCEEECCCcccccccCcccccccCCCCccCccChhhhcc-----CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH
Confidence            999999999998775543333334557889999999973     568889999999999999999 99999998888887


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ..+.... ....+.    .+++++.+||.+||. ||++||+++++.+.+
T Consensus       221 ~~~~~~~-~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  264 (279)
T 1qpc_A          221 QNLERGY-RMVRPD----NCPEELYQLMRLCWKERPEDRPTFDYLRSVL  264 (279)
T ss_dssp             HHHHTTC-CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHhccc-CCCCcc----cccHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence            7776542 222333    689999999999999 999999988877655

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.2e-43  Score=330.68  Aligned_cols=252  Identities=19%  Similarity=0.261  Sum_probs=203.8

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhh-----hhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceee
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDIL-----LVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITN   77 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~-----~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~   77 (372)
                      |+..+.+|.|    |+|.||.+.+..++.     .||+|.+.......         ..+.+.+|+.+++.+ +||||++
T Consensus        48 ~~~~~~lG~G----~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~E~~~l~~l~~h~~iv~  114 (333)
T 2i1m_A           48 LQFGKTLGAG----AFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD---------EKEALMSELKIMSHLGQHENIVN  114 (333)
T ss_dssp             EEEEEEEEEC----SSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHH---------HHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ceeeeEeccC----CCcceEEEEecCCCcccchhHHHHHhcccccChH---------HHHHHHHHHHHHHhhcCCCCeee
Confidence            3334455555    899999998766554     67888775543221         245678899999999 8999999


Q ss_pred             eeEEEEeCCeEEEEEeccCCCCHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCC
Q psy11571         78 LHYAFQDDSNLYLVMDYYCGGDLLTLLSKF-------------EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAF  144 (372)
Q Consensus        78 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-------------~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~  144 (372)
                      +++++.+.+.+|+||||+++|+|.+++...             ...+++..+..++.||+.||.|||++||+|       
T Consensus       115 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH-------  187 (333)
T 2i1m_A          115 LLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIH-------  187 (333)
T ss_dssp             EEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEEC-------
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCccc-------
Confidence            999999999999999999999999999753             245899999999999999999999999999       


Q ss_pred             CcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHH
Q psy11571        145 HLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM  223 (372)
Q Consensus       145 ~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~el  223 (372)
                         |||||+|||++.++.+||+|||++........ .......||+.|+|||++.+     ..++.++|||||||++|+|
T Consensus       188 ---~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el  259 (333)
T 2i1m_A          188 ---RDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-----CVYTVQSDVWSYGILLWEI  259 (333)
T ss_dssp             ---SCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHH
T ss_pred             ---CCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhcc-----CCCChHHHHHHHHHHHHHH
Confidence               99999999999999999999999986533221 12233457889999999984     5689999999999999999


Q ss_pred             hh-CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        224 LY-GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       224 lt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ++ |..||.+.........+.........+.    ..++.+.+||.+||+ ||.+||+++++.+.+
T Consensus       260 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L  321 (333)
T 2i1m_A          260 FSLGLNPYPGILVNSKFYKLVKDGYQMAQPA----FAPKNIYSIMQACWALEPTHRPTFQQICSFL  321 (333)
T ss_dssp             TTTSCCSSTTCCSSHHHHHHHHHTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HcCCCCCCcccchhHHHHHHHhcCCCCCCCC----CCCHHHHHHHHHHhccChhhCcCHHHHHHHH
Confidence            98 9999998766555555555444443343    579999999999999 999999988877654

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.2e-43  Score=332.44  Aligned_cols=257  Identities=25%  Similarity=0.367  Sum_probs=206.3

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC--CCceeeee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD--RRWITNLH   79 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~--hp~Iv~l~   79 (372)
                      ++|+..+.+|.|    |+|.||.+.+..+++.||+|.+...........    ...+.+.+|+.+++.+.  ||||++++
T Consensus        43 ~~y~~~~~lg~G----~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~----~~~~~~~~E~~~l~~l~~~~~~i~~~~  114 (320)
T 3a99_A           43 SQYQVGPLLGSG----GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL----PNGTRVPMEVVLLKKVSSGFSGVIRLL  114 (320)
T ss_dssp             TTEEEEEECSSS----SSCEEEEEEETTTTEEEEEEEEEGGGCCCEEEC----TTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred             CceEEEEEEeeC----CCeEEEEEEECCCCcEEEEEEEecccchhhhhh----hhhhHHHHHHHHHHhhccCCCCceEEE
Confidence            345556666666    899999999999999999998876543321000    01122456888888875  69999999


Q ss_pred             EEEEeCCeEEEEEeccCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC
Q psy11571         80 YAFQDDSNLYLVMDYYCG-GDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD  158 (372)
Q Consensus        80 ~~~~~~~~~~lv~E~~~g-g~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~  158 (372)
                      +++.+.+..++|||++.+ ++|.+++.. .+.+++..++.++.||+.||.|||+.||+|          |||||+|||++
T Consensus       115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH----------~Dlkp~NIll~  183 (320)
T 3a99_A          115 DWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLH----------RDIKDENILID  183 (320)
T ss_dssp             EEEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEEE
T ss_pred             EEEecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEe----------CCCCHHHEEEe
Confidence            999999999999999976 899999987 578999999999999999999999999999          99999999998


Q ss_pred             -CCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHH
Q psy11571        159 -ANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE  237 (372)
Q Consensus       159 -~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~  237 (372)
                       .++.+||+|||++.......   .....||+.|+|||++.+    ...++.++|||||||++|+|++|+.||...+   
T Consensus       184 ~~~~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~----~~~~~~~~Di~slG~il~el~~g~~pf~~~~---  253 (320)
T 3a99_A          184 LNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRY----HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---  253 (320)
T ss_dssp             TTTTEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHH----SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---
T ss_pred             CCCCCEEEeeCcccccccccc---ccCCCCCccCCChHHhcc----CCCCCccchHHhHHHHHHHHHHCCCCCCChh---
Confidence             78899999999998765432   223579999999999874    3344778999999999999999999997542   


Q ss_pred             HHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccc
Q psy11571        238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDS  313 (372)
Q Consensus       238 ~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~  313 (372)
                         .+....  ...+.    .+++++.+||.+||+ ||++||++++++                 +||||+++.+..
T Consensus       254 ---~~~~~~--~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll-----------------~hp~~~~~~~~~  304 (320)
T 3a99_A          254 ---EIIRGQ--VFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQ-----------------NHPWMQDVLLPQ  304 (320)
T ss_dssp             ---HHHHCC--CCCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHH-----------------TSGGGSSCCCHH
T ss_pred             ---hhhccc--ccccc----cCCHHHHHHHHHHccCChhhCcCHHHHh-----------------cCHhhcCccCcc
Confidence               222222  22233    689999999999999 999999866555                 999999887643

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.6e-42  Score=325.35  Aligned_cols=253  Identities=18%  Similarity=0.231  Sum_probs=201.7

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEee-----eehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCcee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIE-----TLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWIT   76 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~-----~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv   76 (372)
                      ++|+.++.+|.|    |+|.||++.     +..+++.||+|.+.......         ....+.+|+.+++.+.||||+
T Consensus        30 ~~y~~~~~lg~G----~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~E~~~l~~l~h~~iv   96 (327)
T 2yfx_A           30 KNITLIRGLGHG----AFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ---------DELDFLMEALIISKFNHQNIV   96 (327)
T ss_dssp             GGCEEEEECC------CSSCEEEEEC--------CCEEEEEECCSSCCHH---------HHHHHHHHHHHHHHCCCTTBC
T ss_pred             hheEEEEEEcCC----CCeeEEEEEEcCCCCCCccceEEEEEeccccchh---------hHHHHHHHHHHHhhCCCCCCC
Confidence            355556666666    899999998     45677899999886433221         234577899999999999999


Q ss_pred             eeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCC
Q psy11571         77 NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDI  150 (372)
Q Consensus        77 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDl  150 (372)
                      ++++++.+....|+||||+++++|.+++....      ..+++..++.++.||+.||.|||++|++|          |||
T Consensus        97 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H----------~dl  166 (327)
T 2yfx_A           97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIH----------RDI  166 (327)
T ss_dssp             CEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCC
T ss_pred             eEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeec----------CcC
Confidence            99999999999999999999999999998742      34899999999999999999999999999          999


Q ss_pred             CcCcEEeCC---CCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-
Q psy11571        151 KPDNVLLDA---NGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-  225 (372)
Q Consensus       151 kp~NIll~~---~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-  225 (372)
                      ||+|||++.   +..+||+|||++........ .......||+.|+|||++.+     ..++.++|||||||++|+|++ 
T Consensus       167 kp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~ellt~  241 (327)
T 2yfx_A          167 AARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-----GIFTSKTDTWSFGVLLWEIFSL  241 (327)
T ss_dssp             CGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTT
T ss_pred             CHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcC-----CCCCchhhHHHHHHHHHHHHcC
Confidence            999999984   44699999999875432221 12233568899999999974     568999999999999999998 


Q ss_pred             CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        226 GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       226 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      |..||.+.+..+....+.... ....+.    .+++.+.++|.+||. ||.+||++.++++.+
T Consensus       242 g~~p~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  299 (327)
T 2yfx_A          242 GYMPYPSKSNQEVLEFVTSGG-RMDPPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERI  299 (327)
T ss_dssp             SCCSSTTCCHHHHHHHHHTTC-CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCCCCCCcCHHHHHHHHhcCC-CCCCCC----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence            999999988888777776643 223333    689999999999999 999999987776433

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.4e-42  Score=340.27  Aligned_cols=247  Identities=21%  Similarity=0.266  Sum_probs=199.1

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+..+.+|.|    ++|.||++... .+..||+|.+.......           +.+.+|+.+++.++||||+++++++.
T Consensus       186 ~~~~~~lG~G----~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-----------~~~~~E~~~l~~l~hp~iv~~~~~~~  249 (452)
T 1fmk_A          186 LRLEVKLGQG----CFGEVWMGTWN-GTTRVAIKTLKPGTMSP-----------EAFLQEAQVMKKLRHEKLVQLYAVVS  249 (452)
T ss_dssp             EEEEEEEEEC----SSCEEEEEEET-TTEEEEEEECCTTSSCH-----------HHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ceeeeeecCC----CCeEEEEEEEC-CCceEEEEEeccCCCCH-----------HHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            4444555555    89999999764 44669999887544321           34678999999999999999999987


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      + +.+|+||||+++|+|.+++... ...+++..+..++.||+.||+|||++||+|          |||||+|||++.++.
T Consensus       250 ~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH----------rDlkp~Nill~~~~~  318 (452)
T 1fmk_A          250 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH----------RDLRAANILVGENLV  318 (452)
T ss_dssp             S-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCSGGGEEECGGGC
T ss_pred             C-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeC----------CCCChhhEEECCCCC
Confidence            6 6789999999999999999753 346999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGK  241 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~  241 (372)
                      +||+|||+++..............+++.|+|||++..     ..++.++|||||||++|||++ |..||.+.+..+....
T Consensus       319 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~  393 (452)
T 1fmk_A          319 CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ  393 (452)
T ss_dssp             EEECCCCTTC--------------CCGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH
T ss_pred             EEECCCccceecCCCceecccCCcccccccCHhHHhc-----CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            9999999998765433222233457789999999983     568999999999999999999 9999999988888887


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      +..+ ...+.|.    .+++.+.+||.+||. ||++|||++++.+.+
T Consensus       394 i~~~-~~~~~~~----~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L  435 (452)
T 1fmk_A          394 VERG-YRMPCPP----ECPESLHDLMCQCWRKEPEERPTFEYLQAFL  435 (452)
T ss_dssp             HHTT-CCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHcC-CCCCCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            7654 2333344    689999999999999 999999988887655

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3e-42  Score=321.35  Aligned_cols=253  Identities=19%  Similarity=0.215  Sum_probs=196.0

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeeh---hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLL---DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLH   79 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~---~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~   79 (372)
                      +|+..+.+|.|    |+|.||++....   ++..||+|.+........        ..+.+.+|+.+++.++||||++++
T Consensus        35 ~y~~~~~lg~G----~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~~  102 (313)
T 3brb_A           35 LLILGKILGEG----EFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR--------EIEEFLSEAACMKDFSHPNVIRLL  102 (313)
T ss_dssp             GEEEEEEEEC-----CCCCEEEEEEECTTSCEEEEEEEEC---CCCHH--------HHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred             Heeeccceeec----CCeEEEEEEEeccCCceeEEEEEEEeccccchh--------HHHHHHHHHHHHhcCCCCCeeeee
Confidence            34444455555    899999997765   455899998865443222        345678899999999999999999


Q ss_pred             EEEEeCC-----eEEEEEeccCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCC
Q psy11571         80 YAFQDDS-----NLYLVMDYYCGGDLLTLLSKF-----EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRD  149 (372)
Q Consensus        80 ~~~~~~~-----~~~lv~E~~~gg~L~~~l~~~-----~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrD  149 (372)
                      +++.+..     ..++||||+++|+|.+++...     ...+++..++.++.||+.||.|||++|++|          ||
T Consensus       103 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH----------~d  172 (313)
T 3brb_A          103 GVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLH----------RD  172 (313)
T ss_dssp             EEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCC----------CC
T ss_pred             EEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCccc----------CC
Confidence            9998765     359999999999999999531     356999999999999999999999999999          99


Q ss_pred             CCcCcEEeCCCCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CC
Q psy11571        150 IKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GE  227 (372)
Q Consensus       150 lkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~  227 (372)
                      |||+||+++.++.+||+|||++........ .......+++.|+|||++.     ...++.++|||||||++|+|++ |.
T Consensus       173 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~~g~  247 (313)
T 3brb_A          173 LAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA-----DRVYTSKSDVWAFGVTMWEIATRGM  247 (313)
T ss_dssp             CSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHH-----SSCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhc-----CCCccchhhhHHHHHHHHHHHhcCC
Confidence            999999999999999999999987643321 1222345788999999997     3568999999999999999999 99


Q ss_pred             CCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        228 TPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       228 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      +||.+.+..+....+.... ....+.    .+++++.+||.+||. ||.+||+++++.+.+
T Consensus       248 ~p~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L  303 (313)
T 3brb_A          248 TPYPGVQNHEMYDYLLHGH-RLKQPE----DCLDELYEIMYSCWRTDPLDRPTFSVLRLQL  303 (313)
T ss_dssp             CSSTTCCGGGHHHHHHTTC-CCCCBT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             CCCccCCHHHHHHHHHcCC-CCCCCc----cccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            9999988887777776643 233333    689999999999999 999999988877554

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.4e-43  Score=339.98  Aligned_cols=259  Identities=22%  Similarity=0.304  Sum_probs=203.6

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      .+|+..+.+|.|    |+|.||++.+..+++.||+|.+........         .+.+.+|+.+++.++||||++++++
T Consensus         9 ~~y~i~~~LG~G----~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---------~~~~~~E~~~l~~l~hpnIv~~~~~   75 (396)
T 4eut_A            9 HLWLLSDILGQG----ATANVFRGRHKKTGDLFAIKVFNNISFLRP---------VDVQMREFEVLKKLNHKNIVKLFAI   75 (396)
T ss_dssp             EEEEEEEEEEEC----SSEEEEEEEETTTCCEEEEEEECGGGGGSC---------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CceEEEEEEEcC----CCeEEEEEEECCCCcEEEEEEeccccccch---------HHHHHHHHHHHHhcCCCCCCeEEEe
Confidence            456666777777    899999999999999999998875443322         2446689999999999999999999


Q ss_pred             EEeCC--eEEEEEeccCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe
Q psy11571         82 FQDDS--NLYLVMDYYCGGDLLTLLSKFE--DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        82 ~~~~~--~~~lv~E~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      +.+..  ..|+|||||++|+|.+++....  ..+++..++.++.||+.||.|||++||+|          |||||+|||+
T Consensus        76 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH----------~Dlkp~NIll  145 (396)
T 4eut_A           76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVH----------RNIKPGNIMR  145 (396)
T ss_dssp             EECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCCGGGEEE
T ss_pred             eccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEE----------CCcCHHHEEE
Confidence            98765  7899999999999999997632  23999999999999999999999999999          9999999999


Q ss_pred             ----CCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccC---CCCCCCccceeehhHHHHHHhhCCCCC
Q psy11571        158 ----DANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEG---RGRYGPECDWWSLGVCMYEMLYGETPF  230 (372)
Q Consensus       158 ----~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~~~~~~DiwslGvil~elltG~~Pf  230 (372)
                          +.++.+||+|||+++.......  .....||+.|+|||++.+....   ...++.++|||||||++|+|++|+.||
T Consensus       146 ~~~~~~~~~~kL~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf  223 (396)
T 4eut_A          146 VIGEDGQSVYKLTDFGAARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF  223 (396)
T ss_dssp             EECTTSCEEEEECCGGGCEECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSE
T ss_pred             eecCCCceeEEEecCCCceEccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence                7778899999999987654332  2346799999999998631100   034678999999999999999999999


Q ss_pred             CC----CCHHHHHHHHhhccCC-------------------cCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhh
Q psy11571        231 YA----ESLVETYGKIMNHQNS-------------------FDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIAD  285 (372)
Q Consensus       231 ~~----~~~~~~~~~i~~~~~~-------------------~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~  285 (372)
                      ..    ....+.+.++..+...                   ++.+......+++.+.++|++||+ ||++|++++++.+
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          224 RPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             ECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             CCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            64    3344556666554321                   111111122456788999999999 9999999877643

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-42  Score=316.69  Aligned_cols=242  Identities=17%  Similarity=0.203  Sum_probs=197.4

Q ss_pred             cCCccEEEeeeehhhh---hhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeE-EEEE
Q psy11571         17 QGKGRVFSIETLLDIL---LVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNL-YLVM   92 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~---~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~-~lv~   92 (372)
                      ||+|.||++....++.   .+|+|.+......         ...+.+.+|+.+++.++||||+++++++.+.+.. ++||
T Consensus        32 G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~  102 (298)
T 3pls_A           32 GHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM---------QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL  102 (298)
T ss_dssp             ETTEEEEEEEEECSSSCEEEEEEEEETTCCSH---------HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred             CCCceEEEEEEecCCCceeeeeeeeccccccH---------HHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence            4899999998655444   7899877643322         2346678899999999999999999999877665 9999


Q ss_pred             eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCccc
Q psy11571         93 DYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCL  172 (372)
Q Consensus        93 E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~  172 (372)
                      ||+.+|+|.+++......+++..+..++.|++.||.|||++|++|          |||||+||+++.++.+||+|||+++
T Consensus       103 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H----------~dikp~Nili~~~~~~kl~Dfg~~~  172 (298)
T 3pls_A          103 PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVH----------RDLAARNCMLDESFTVKVADFGLAR  172 (298)
T ss_dssp             CCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCSGGGEEECTTCCEEECCTTSSC
T ss_pred             ecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccc----------CCCCcceEEEcCCCcEEeCcCCCcc
Confidence            999999999999875677999999999999999999999999999          9999999999999999999999997


Q ss_pred             ccCCCCc---ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHHhhccCC
Q psy11571        173 RLGGDGT---VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHQNS  248 (372)
Q Consensus       173 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~  248 (372)
                      .......   .......+|+.|+|||.+.     ...++.++|||||||++|+|++ |.+||...+..+....+.... .
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-~  246 (298)
T 3pls_A          173 DILDREYYSVQQHRHARLPVKWTALESLQ-----TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR-R  246 (298)
T ss_dssp             TTTTGGGGCSCCSSCTTCGGGGSCHHHHT-----TCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC-C
T ss_pred             cccCCcccccccCcCCCCCccccChhhhc-----cCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC-C
Confidence            6543221   1222346788999999998     3568999999999999999999 566666666666666655543 2


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        249 FDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       249 ~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ...+.    .+++.+.+||.+||+ ||.+|||++++++.+
T Consensus       247 ~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l  282 (298)
T 3pls_A          247 LPQPE----YCPDSLYQVMQQCWEADPAVRPTFRVLVGEV  282 (298)
T ss_dssp             CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCCCc----cchHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            33333    689999999999999 999999988776554

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.7e-42  Score=324.10  Aligned_cols=252  Identities=19%  Similarity=0.251  Sum_probs=200.3

Q ss_pred             hHH-HHHHhhhcCCcccCCccEEEe----eeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCcee
Q psy11571          2 ERL-RELEALFLGGPIQGKGRVFSI----ETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWIT   76 (372)
Q Consensus         2 ~~~-~~l~~~~~~~~~~g~G~v~~v----~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv   76 (372)
                      .|| +.++.+|.|    |+|.||.+    .+..+++.||+|.+......         ...+.+.+|+.+++.++||||+
T Consensus        30 ~r~~~~~~~lG~G----~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv   96 (318)
T 3lxp_A           30 KRYLKKIRDLGEG----HFGKVSLYCYDPTNDGTGEMVAVKALKADAGP---------QHRSGWKQEIDILRTLYHEHII   96 (318)
T ss_dssp             GGGEEEEEEEEEC----SSEEEEEEEECSCC--CCEEEEEEEECTTCCH---------HHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHhhhheecCC----CCeEEEEEEEccCCCCCCcEEEEEEeccccCh---------HHHHHHHHHHHHHHhCCCcchh
Confidence            344 666777777    89999665    34557889999988754321         1345678899999999999999


Q ss_pred             eeeEEEEeC--CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCc
Q psy11571         77 NLHYAFQDD--SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDN  154 (372)
Q Consensus        77 ~l~~~~~~~--~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~N  154 (372)
                      ++++++.+.  ..+++||||+++|+|.+++..  ..+++..++.++.||+.||.|||+.|++|          |||||+|
T Consensus        97 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~ivH----------~Dikp~N  164 (318)
T 3lxp_A           97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIH----------RDLAARN  164 (318)
T ss_dssp             CEEEEEEETTTTEEEEEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSGGG
T ss_pred             hEEEEEecCCCceEEEEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCCccC----------CCCchhe
Confidence            999999884  678999999999999999987  56999999999999999999999999999          9999999


Q ss_pred             EEeCCCCcEEEeecCcccccCCCCc--ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCC
Q psy11571        155 VLLDANGHIRLADFGSCLRLGGDGT--VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA  232 (372)
Q Consensus       155 Ill~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~  232 (372)
                      |+++.++.+||+|||++........  .......||+.|+|||++.+     ..++.++|||||||++|+|++|..||..
T Consensus       165 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~ll~g~~p~~~  239 (318)
T 3lxp_A          165 VLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE-----YKFYYASDVWSFGVTLYELLTHCDSSQS  239 (318)
T ss_dssp             EEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHH-----CEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred             EEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcC-----CCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence            9999999999999999987654332  12233467888999999984     4578899999999999999999999975


Q ss_pred             CCHH--------------HHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        233 ESLV--------------ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       233 ~~~~--------------~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ....              ...............+.    .+++++.+||++||+ ||.+||+++++++.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  305 (318)
T 3lxp_A          240 PPTKFLELIGIAQGQMTVLRLTELLERGERLPRPD----KCPAEVYHLMKNCWETEASFRPTFENLIPIL  305 (318)
T ss_dssp             HHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cchhhhhhhcccccchhHHHHHHHHhcccCCCCCc----cccHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            4321              11122222223333333    689999999999999 999999988887655

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.1e-42  Score=319.93  Aligned_cols=248  Identities=16%  Similarity=0.185  Sum_probs=197.1

Q ss_pred             HHhhhcCCcccCCccEEEeeeehhh---hhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE-
Q psy11571          7 LEALFLGGPIQGKGRVFSIETLLDI---LLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF-   82 (372)
Q Consensus         7 l~~~~~~~~~~g~G~v~~v~~~~~~---~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~-   82 (372)
                      .+.+|.|    |+|.||++....++   ..+|+|.+......         ...+.+.+|..+++.++||||+++++++ 
T Consensus        30 ~~~lg~G----~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   96 (298)
T 3f66_A           30 NEVIGRG----HFGCVYHGTLLDNDGKKIHCAVKSLNRITDI---------GEVSQFLTEGIIMKDFSHPNVLSLLGICL   96 (298)
T ss_dssp             EEEEEEE----TTEEEEEEEEC-----CEEEEEEEETTCCSH---------HHHHHHHHHHHHHHTCCCTTBCCCCEEEC
T ss_pred             cceeeec----CCceEEEEEEecCCCceeEEEEEecccCCCH---------HHHHHHHHHHHHHHhCCCCCEeeeeeEEE
Confidence            3444554    89999999865443   35788876643321         2345678899999999999999999985 


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+++..++||||+++|+|.+++......+++..+..++.|++.||.|||++|++|          |||||+||+++.++.
T Consensus        97 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H----------~dikp~Nil~~~~~~  166 (298)
T 3f66_A           97 RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH----------RDLAARNCMLDEKFT  166 (298)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCSGGGEEECTTCC
T ss_pred             cCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccC----------CCCchheEEECCCCC
Confidence            4556789999999999999999875667899999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCc---ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHH
Q psy11571        163 IRLADFGSCLRLGGDGT---VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVET  238 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~  238 (372)
                      +||+|||+++.......   .......||+.|+|||++.+     ..++.++|+||||+++|+|++ |.+||.+.+..+.
T Consensus       167 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~  241 (298)
T 3f66_A          167 VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT-----QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI  241 (298)
T ss_dssp             EEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH
T ss_pred             EEECcccccccccccchhccccccCCCCCccccChHHhcC-----CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH
Confidence            99999999986643221   11233467889999999974     568899999999999999999 7788887777776


Q ss_pred             HHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        239 YGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       239 ~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ...+..... ...+.    .+++.+.++|.+||. ||.+||+++++++.+
T Consensus       242 ~~~~~~~~~-~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L  286 (298)
T 3f66_A          242 TVYLLQGRR-LLQPE----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRI  286 (298)
T ss_dssp             HHHHHTTCC-CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHhcCCC-CCCCc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            666665432 22233    679999999999999 999999988877654

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.7e-42  Score=324.80  Aligned_cols=256  Identities=20%  Similarity=0.251  Sum_probs=197.3

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+..+.+|.|    |+|.||++. ..+++.||+|.+........         ...+.+|+.+++.++||||+++++++
T Consensus        31 ~y~~~~~lg~G----~~g~V~~~~-~~~~~~vavK~~~~~~~~~~---------~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           31 NFSNKNILGRG----GFGKVYKGR-LADGTLVAVKRLKEERTQGG---------ELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             SSCSTTEEECC----SSSEEEEEC-CSSSCCEEEEECCC-----C---------CCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             ccccceeEecC----CCcEEEEEE-ecCCCEEEEEEeccccCchH---------HHHHHHHHHHHHhccCCCccceEEEE
Confidence            45555566666    899999996 44789999998876543322         12367899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhc---CceecCCCCCCCcCCCCCcCcEE
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFE---DRLPEDMAKFYIAEMVLAIASIHDL---HYVHRPNHFAFHLCRDIKPDNVL  156 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~~~~~~~~vhrDlkp~NIl  156 (372)
                      .+.+..++||||+++|+|.+++....   ..+++..+..++.|++.||.|||++   ||+|          |||||+|||
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH----------~Dlkp~Nil  166 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIH----------RDVKAANIL  166 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEEC----------CCCSGGGEE
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe----------CCCchhhEE
Confidence            99999999999999999999998632   2489999999999999999999999   9999          999999999


Q ss_pred             eCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC---
Q psy11571        157 LDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE---  233 (372)
Q Consensus       157 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~---  233 (372)
                      ++.++.+||+|||++...............||+.|+|||++.+     ..++.++|||||||++|+|++|..||...   
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  241 (326)
T 3uim_A          167 LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGVMLLELITGQRAFDLARLA  241 (326)
T ss_dssp             ECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHH-----SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHT
T ss_pred             ECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhcc-----CCCCccccchhHHHHHHHHHhCCCcccccccc
Confidence            9999999999999998775544444445679999999999974     55889999999999999999999999521   


Q ss_pred             --C---HHHHHHHHhhccC-----CcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        234 --S---LVETYGKIMNHQN-----SFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       234 --~---~~~~~~~i~~~~~-----~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                        .   ..+..........     ............+..+.+++.+||+ ||.+|||+.++++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  306 (326)
T 3uim_A          242 NDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML  306 (326)
T ss_dssp             TTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred             cccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence              1   1111111111100     0001111111234789999999999 999999988888766

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6.8e-42  Score=348.07  Aligned_cols=241  Identities=19%  Similarity=0.242  Sum_probs=199.0

Q ss_pred             cCCccEEEeee--ehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEec
Q psy11571         17 QGKGRVFSIET--LLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDY   94 (372)
Q Consensus        17 ~g~G~v~~v~~--~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~   94 (372)
                      ||+|.||++..  ..+++.||+|.+........        ..+.+.+|+.+++.++||||+++++++.+ +.+++||||
T Consensus       380 G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~--------~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~  450 (635)
T 4fl3_A          380 GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA--------LKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEM  450 (635)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEEEECGGGGCGG--------GHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred             CCCEEEEEEEEcCCCcceEEEEEEeccccCCHH--------HHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEc
Confidence            48999999843  34678899998865433221        23557889999999999999999999975 468999999


Q ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCccccc
Q psy11571         95 YCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL  174 (372)
Q Consensus        95 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~  174 (372)
                      |++|+|.+++.. ...+++..++.++.||+.||.|||++||+|          |||||+|||++.++.+||+|||+++..
T Consensus       451 ~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiH----------rDLkp~NILl~~~~~~kL~DFGla~~~  519 (635)
T 4fl3_A          451 AELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVH----------RDLAARNVLLVTQHYAKISDFGLSKAL  519 (635)
T ss_dssp             CTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred             cCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeC----------CCCChHhEEEeCCCCEEEEEcCCcccc
Confidence            999999999987 578999999999999999999999999999          999999999999999999999999876


Q ss_pred             CCCCcc--cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCC
Q psy11571        175 GGDGTV--QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHQNSFDL  251 (372)
Q Consensus       175 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~  251 (372)
                      ......  ......+|+.|+|||++.+     ..++.++|||||||++|||++ |+.||.+.+..+....+..+. ....
T Consensus       520 ~~~~~~~~~~~~~~~t~~y~APE~~~~-----~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~-~~~~  593 (635)
T 4fl3_A          520 RADENYYKAQTHGKWPVKWYAPECINY-----YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-RMGC  593 (635)
T ss_dssp             TC-------------CGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCCC
T ss_pred             ccCccccccccCCCCceeeeChhhhcC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCC
Confidence            543221  1222356789999999973     568999999999999999998 999999999888888776653 3344


Q ss_pred             CCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        252 PSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       252 ~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      |.    .+++++.+||.+||. ||++||+++++.+.+
T Consensus       594 p~----~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L  626 (635)
T 4fl3_A          594 PA----GCPREMYDLMNLCWTYDVENRPGFAAVELRL  626 (635)
T ss_dssp             CT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred             CC----CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            44    689999999999999 999999988877655

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=345.06  Aligned_cols=242  Identities=20%  Similarity=0.268  Sum_probs=199.4

Q ss_pred             ccCCccEEEeeee--hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEe
Q psy11571         16 IQGKGRVFSIETL--LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMD   93 (372)
Q Consensus        16 ~~g~G~v~~v~~~--~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E   93 (372)
                      .||+|.||++...  .++..||+|.+.......         ..+.+.+|+.+++.++||||+++++++.+ +.+|+|||
T Consensus       346 ~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~---------~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E  415 (613)
T 2ozo_A          346 CGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA---------DTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME  415 (613)
T ss_dssp             ECSSSEEEEEEEECSSCEEEEEEEECCCCCSST---------THHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             cCCCcEEEEEEEecCCCcEEEEEEEcCCCCChH---------HHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEE
Confidence            3489999998654  356679999887653221         23557889999999999999999999986 56999999


Q ss_pred             ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571         94 YYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus        94 ~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                      ||++|+|.+++......+++..+..++.||+.||.|||++||+|          |||||+|||++.++.+||+|||+++.
T Consensus       416 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH----------rDlkp~NILl~~~~~vkL~DFGla~~  485 (613)
T 2ozo_A          416 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH----------RNLAARNVLLVNRHYAKISDFGLSKA  485 (613)
T ss_dssp             CCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred             eCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEc----------CcCCHHHEEEcCCCcEEEeeccCccc
Confidence            99999999999775567999999999999999999999999999          99999999999999999999999987


Q ss_pred             cCCCCccc--ccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHHhhccCCcC
Q psy11571        174 LGGDGTVQ--SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHQNSFD  250 (372)
Q Consensus       174 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~  250 (372)
                      ........  .....+|+.|+|||++.+     ..++.++|||||||++|||++ |+.||.+.+..+....+..+. ...
T Consensus       486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~-----~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~-~~~  559 (613)
T 2ozo_A          486 LGADDSYYTARSAGKWPLKWYAPECINF-----RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RME  559 (613)
T ss_dssp             CC--------------CCTTSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC-CCC
T ss_pred             ccCCCceeeeccCCCCccceeCHhhhcC-----CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CCC
Confidence            64332211  122345689999999973     568999999999999999998 999999998888888877653 344


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        251 LPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       251 ~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .|.    .+++++.+||.+||. +|++||+++++.+.+
T Consensus       560 ~p~----~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L  593 (613)
T 2ozo_A          560 CPP----ECPPELYALMSDCWIYKWEDRPDFLTVEQRM  593 (613)
T ss_dssp             CCT----TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHH
T ss_pred             CCC----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            444    689999999999999 999999988887666

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.6e-43  Score=331.10  Aligned_cols=250  Identities=16%  Similarity=0.209  Sum_probs=193.2

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeeh--------hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCc
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLL--------DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRW   74 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~--------~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~   74 (372)
                      +|+..+.+|.|    |+|.||++.+..        +++.||+|.....               +.+.+|+.+++.++|||
T Consensus        43 ~y~~~~~lg~G----~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------------~~~~~E~~~l~~l~h~n  103 (352)
T 2jii_A           43 QWKLKSFQTRD----NQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------------GRLFNEQNFFQRAAKPL  103 (352)
T ss_dssp             EEEEEEEEEEE----TTEEEEEEEECC-----------CEEEEEEETT---------------STHHHHHHHHHHHCCHH
T ss_pred             eEEEEEEecCC----CCeEEEEEeecCCccccccccCceEEEEEeccc---------------chHHHHHHHHHHhcccc
Confidence            45555666666    899999999877        4889999987643               12556778888888888


Q ss_pred             eee---------------eeEEEEe-CCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCcee
Q psy11571         75 ITN---------------LHYAFQD-DSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVH  137 (372)
Q Consensus        75 Iv~---------------l~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH  137 (372)
                      |++               +++++.. ....|+||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+|
T Consensus       104 iv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH  182 (352)
T 2jii_A          104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVH  182 (352)
T ss_dssp             HHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred             hhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence            777               6777776 67899999999 99999999873 367999999999999999999999999999


Q ss_pred             cCCCCCCCcCCCCCcCcEEeCCCC--cEEEeecCcccccCCCCcc------cccccccCCcccCcccccccccCCCCCCC
Q psy11571        138 RPNHFAFHLCRDIKPDNVLLDANG--HIRLADFGSCLRLGGDGTV------QSNVAVGTPDYISPEILTAMEEGRGRYGP  209 (372)
Q Consensus       138 ~~~~~~~~vhrDlkp~NIll~~~~--~vkl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~  209 (372)
                                |||||+|||++.++  .+||+|||+++........      ......||+.|+|||++.+     ..++.
T Consensus       183 ----------~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~  247 (352)
T 2jii_A          183 ----------GNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-----CGPSR  247 (352)
T ss_dssp             ----------SCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-----CCCCH
T ss_pred             ----------CCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-----CCCCc
Confidence                      99999999999988  8999999999776432211      1133479999999999983     56899


Q ss_pred             ccceeehhHHHHHHhhCCCCCCCCC--HHHHHHHHh---hccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCCh
Q psy11571        210 ECDWWSLGVCMYEMLYGETPFYAES--LVETYGKIM---NHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGI  283 (372)
Q Consensus       210 ~~DiwslGvil~elltG~~Pf~~~~--~~~~~~~i~---~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~  283 (372)
                      ++|||||||++|+|++|+.||.+..  .........   .....+..+...+..+++++.+||.+||. ||++||+++++
T Consensus       248 ~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  327 (352)
T 2jii_A          248 RSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAML  327 (352)
T ss_dssp             HHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred             hhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHH
Confidence            9999999999999999999998753  333322221   11111111111122579999999999999 99999998887


Q ss_pred             hhhh
Q psy11571        284 ADFK  287 (372)
Q Consensus       284 ~~i~  287 (372)
                      .+.+
T Consensus       328 ~~~L  331 (352)
T 2jii_A          328 RNNL  331 (352)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7655

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=7e-43  Score=325.43  Aligned_cols=253  Identities=27%  Similarity=0.382  Sum_probs=196.8

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC----CCCceeee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG----DRRWITNL   78 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l----~hp~Iv~l   78 (372)
                      +|+..+.+|.|    |+|.||++.+..+++.||+|.+...........    .....+.+|+.++..+    .||||+++
T Consensus        32 ~y~~~~~lg~G----~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~~h~~i~~~  103 (312)
T 2iwi_A           32 EYRLGPLLGKG----GFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPL----SDSVTCPLEVALLWKVGAGGGHPGVIRL  103 (312)
T ss_dssp             -CEEEEEEEEE----TTEEEEEEECTTTCCEEEEEECCSTTTC------------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred             ceEEeeEEEcC----CCEEEEEEEEccCCeEEEEEEEecccccccccc----hhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence            45555566665    899999999988999999998876544322111    1223345677777777    89999999


Q ss_pred             eEEEEeCCeEEEEEec-cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe
Q psy11571         79 HYAFQDDSNLYLVMDY-YCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        79 ~~~~~~~~~~~lv~E~-~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      ++++.+.+..++|||+ +.+++|.+++.. .+.+++..++.++.||+.||.|||++|++|          |||||+||++
T Consensus       104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H----------~dlkp~Nil~  172 (312)
T 2iwi_A          104 LDWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVH----------RDIKDENILI  172 (312)
T ss_dssp             EEEC-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEEC----------CCCSGGGEEE
T ss_pred             EEEEecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeee----------cCCChhhEEE
Confidence            9999999999999999 789999999987 467999999999999999999999999999          9999999999


Q ss_pred             C-CCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH
Q psy11571        158 D-ANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV  236 (372)
Q Consensus       158 ~-~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~  236 (372)
                      + .++.+||+|||++.......   .....||+.|+|||++.+    ....+.++|||||||++|+|++|+.||....  
T Consensus       173 ~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--  243 (312)
T 2iwi_A          173 DLRRGCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISR----HQYHALPATVWSLGILLYDMVCGDIPFERDQ--  243 (312)
T ss_dssp             ETTTTEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHH----SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--
T ss_pred             eCCCCeEEEEEcchhhhcccCc---ccccCCcccccCceeeec----CCCCCccchHHHHHHHHHHHHHCCCCCCChH--
Confidence            8 88999999999998765432   233578999999999874    2334568999999999999999999997542  


Q ss_pred             HHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCC
Q psy11571        237 ETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       237 ~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~  310 (372)
                          .+...  ...++.    .++.++++||.+||+ ||++||++++++                 +||||+...
T Consensus       244 ----~~~~~--~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l-----------------~~~~~~~~~  291 (312)
T 2iwi_A          244 ----EILEA--ELHFPA----HVSPDCCALIRRCLAPKPSSRPSLEEIL-----------------LDPWMQTPA  291 (312)
T ss_dssp             ----HHHHT--CCCCCT----TSCHHHHHHHHHHTCSSTTTSCCHHHHH-----------------HSTTTCC--
T ss_pred             ----HHhhh--ccCCcc----cCCHHHHHHHHHHccCChhhCcCHHHHh-----------------cChhhcCch
Confidence                22222  223333    689999999999999 999999866655                 999998653

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.8e-42  Score=320.53  Aligned_cols=255  Identities=20%  Similarity=0.253  Sum_probs=191.4

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhc--CCCCceeeee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVY--GDRRWITNLH   79 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~--l~hp~Iv~l~   79 (372)
                      ++|+.++.+|.|    |+|.||++..  +++.||+|.+.....             +.+.+|.+++..  ++||||++++
T Consensus         8 ~~y~~~~~lg~G----~~g~V~~~~~--~~~~vavK~~~~~~~-------------~~~~~e~~~~~~~~l~h~niv~~~   68 (301)
T 3q4u_A            8 RDITLLECVGKG----RYGEVWRGSW--QGENVAVKIFSSRDE-------------KSWFRETELYNTVMLRHENILGFI   68 (301)
T ss_dssp             GGCEEEEEEEEC----SSEEEEEEEE--TTEEEEEEEECGGGH-------------HHHHHHHHHHHHTCCCCTTBCCEE
T ss_pred             CcEEEEEeeccC----CCcEEEEEEE--CCEEEEEEEeccccc-------------hhhHHHHHHHHHhhccCcCeeeEE
Confidence            456667777777    8999999965  788999998754321             223445566555  7999999999


Q ss_pred             EEEEeC----CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------hcCceecCCCCCCCcC
Q psy11571         80 YAFQDD----SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIH--------DLHYVHRPNHFAFHLC  147 (372)
Q Consensus        80 ~~~~~~----~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH--------~~~ivH~~~~~~~~vh  147 (372)
                      +++.+.    ..+|+||||+++|+|.++++.  ..+++..+..++.||+.||.|||        +.||+|          
T Consensus        69 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH----------  136 (301)
T 3q4u_A           69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAH----------  136 (301)
T ss_dssp             EEEEEEETTEEEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEEC----------
T ss_pred             EeeccccCCCceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeec----------
Confidence            986543    468999999999999999965  67999999999999999999999        999999          


Q ss_pred             CCCCcCcEEeCCCCcEEEeecCcccccCCCCccc---ccccccCCcccCcccccccccCCC-CCCCccceeehhHHHHHH
Q psy11571        148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQ---SNVAVGTPDYISPEILTAMEEGRG-RYGPECDWWSLGVCMYEM  223 (372)
Q Consensus       148 rDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~-~~~~~~DiwslGvil~el  223 (372)
                      |||||+|||++.++.+||+|||+++.........   .....||+.|+|||++.+...... .++.++|||||||++|||
T Consensus       137 ~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el  216 (301)
T 3q4u_A          137 RDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV  216 (301)
T ss_dssp             SCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHH
Confidence            9999999999999999999999997654332211   223479999999999974210000 345789999999999999


Q ss_pred             hhC----------CCCCCCC----CHHHHHHH-HhhccCCcCCCCC-CCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhh
Q psy11571        224 LYG----------ETPFYAE----SLVETYGK-IMNHQNSFDLPSD-VGYEISDDAKDLMRRLIC-SSDTRLGQNGIADF  286 (372)
Q Consensus       224 ltG----------~~Pf~~~----~~~~~~~~-i~~~~~~~~~~~~-~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i  286 (372)
                      ++|          ..||...    ........ +.........+.. .....++++.+||.+||+ ||++|||+.++.+.
T Consensus       217 ~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~  296 (301)
T 3q4u_A          217 ARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT  296 (301)
T ss_dssp             HTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             HhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            999          8898653    22222333 2222222222221 111356789999999999 99999998887765


Q ss_pred             h
Q psy11571        287 K  287 (372)
Q Consensus       287 ~  287 (372)
                      +
T Consensus       297 L  297 (301)
T 3q4u_A          297 L  297 (301)
T ss_dssp             H
T ss_pred             H
Confidence            4

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5.6e-43  Score=327.64  Aligned_cols=254  Identities=21%  Similarity=0.207  Sum_probs=196.5

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+..+.+|.|    |+|.||++.. .+++.||+|........          ..+.+.+|+.+++.++||||+++++++.
T Consensus        41 y~~~~~lg~G----~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~h~~iv~~~~~~~  105 (321)
T 2qkw_B           41 FDHKFLIGHG----VFGKVYKGVL-RDGAKVALKRRTPESSQ----------GIEEFETEIETLSFCRHPHLVSLIGFCD  105 (321)
T ss_dssp             CSCCCCSCBC----SSSEEEEEEC-TTCCEEEEEECCSCCSS----------HHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred             cCccceeecC----CCeeEEEEEE-CCCCEEEEEEecccChH----------HHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            4444445555    8999999974 47889999977654321          2355788999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFE---DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      +.+..|+||||+++|+|.+++....   ..+++..+..++.||+.||.|||++|++|          |||||+||+++.+
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH----------~dlkp~Nil~~~~  175 (321)
T 2qkw_B          106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIH----------RDVKSINILLDEN  175 (321)
T ss_dssp             CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCCSTTEEECTT
T ss_pred             CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeec----------CCCCHHHEEECCC
Confidence            9999999999999999999986532   25899999999999999999999999999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCC-cccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDG-TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY  239 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~  239 (372)
                      +.+||+|||+++...... ........||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.+....+..
T Consensus       176 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~  250 (321)
T 2qkw_B          176 FVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK-----GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV  250 (321)
T ss_dssp             CCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHH-----CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCC
T ss_pred             CCEEEeecccccccccccccccccccCCCccccCHHHhcC-----CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHH
Confidence            999999999998654322 112233568999999999974     56899999999999999999999999764332111


Q ss_pred             -------HHHhhcc----CCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        240 -------GKIMNHQ----NSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       240 -------~~i~~~~----~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                             .......    .............+..+.+++.+||+ ||++||++.++++.+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          251 NLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             CHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence                   0111110    00111111122346789999999999 999999988877554

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.2e-42  Score=315.74  Aligned_cols=243  Identities=19%  Similarity=0.282  Sum_probs=194.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.++.|    |+|.||.++.  +++.||+|.+....            ..+.+.+|+.+++.++||||+++++++
T Consensus        22 ~y~~~~~lg~G----~~g~V~~~~~--~~~~vavK~~~~~~------------~~~~~~~E~~~l~~l~h~~iv~~~~~~   83 (278)
T 1byg_A           22 ELKLLQTIGKG----EFGDVMLGDY--RGNKVAVKCIKNDA------------TAQAFLAEASVMTQLRHSNLVQLLGVI   83 (278)
T ss_dssp             GEEEEEEEEEC----SSCEEEEEEE--TTEEEEEEECCCCC--------------HHHHHTHHHHTTCCCTTBCCEEEEE
T ss_pred             hceEEeEEecC----CCceEEEEEE--cCCEEEEEEecchh------------HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            45555666666    8999999865  57899999876543            124577899999999999999999997


Q ss_pred             EeC-CeEEEEEeccCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         83 QDD-SNLYLVMDYYCGGDLLTLLSKFED-RLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        83 ~~~-~~~~lv~E~~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      .+. +.+|+||||+++++|.+++..... .+++..+..++.|++.||.|||++|++|          |||||+||+++.+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H----------~dlkp~Nil~~~~  153 (278)
T 1byg_A           84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH----------RDLAARNVLVSED  153 (278)
T ss_dssp             CCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCSGGGEEECTT
T ss_pred             EcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccc----------cCCCcceEEEeCC
Confidence            554 478999999999999999976322 3899999999999999999999999999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETY  239 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~  239 (372)
                      +.++|+|||++.......    ....+++.|+|||++.+     ..++.++||||||+++|+|++ |..||...+..+..
T Consensus       154 ~~~~l~Dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~  224 (278)
T 1byg_A          154 NVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALRE-----KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV  224 (278)
T ss_dssp             SCEEECCCCC----------------CCTTTSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH
T ss_pred             CcEEEeeccccccccccc----cCCCccccccCHHHhCC-----CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            999999999987654322    22457889999999973     568899999999999999998 99999988877777


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ..+... .....+.    .+++.+.++|.+||. ||++||++.++.+.+
T Consensus       225 ~~~~~~-~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L  268 (278)
T 1byg_A          225 PRVEKG-YKMDAPD----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQL  268 (278)
T ss_dssp             HHHTTT-CCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHhcC-CCCCCcc----cCCHHHHHHHHHHhcCChhhCCCHHHHHHHH
Confidence            776554 2233333    689999999999999 999999988776544

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-42  Score=329.46  Aligned_cols=242  Identities=15%  Similarity=0.180  Sum_probs=188.2

Q ss_pred             cCCccEEEeeeehh---hhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE-eCCeEEEEE
Q psy11571         17 QGKGRVFSIETLLD---ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ-DDSNLYLVM   92 (372)
Q Consensus        17 ~g~G~v~~v~~~~~---~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~-~~~~~~lv~   92 (372)
                      ||+|.||++....+   ...||+|.+......         ...+.+.+|+.+++.++||||+++++++. .++..|+||
T Consensus       100 G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~  170 (373)
T 3c1x_A          100 GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI---------GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  170 (373)
T ss_dssp             CSSSEEEEEEEEETTTEEEEEEEEECCSCSCS---------HHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred             CCCeEEEEEEEECCCCcEEEEEEEEcCCCCCH---------HHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence            38999999986543   246888877543221         13456888999999999999999999865 456789999


Q ss_pred             eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCccc
Q psy11571         93 DYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCL  172 (372)
Q Consensus        93 E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~  172 (372)
                      ||+++|+|.+++......+++..+..++.||+.||.|||++||+|          |||||+|||++.++.+||+|||+++
T Consensus       171 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH----------rDlkp~NIll~~~~~~kL~DFG~a~  240 (373)
T 3c1x_A          171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH----------RDLAARNCMLDEKFTVKVADFGLAR  240 (373)
T ss_dssp             ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCCGGGEEECTTCCEEECCC----
T ss_pred             ECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEec----------CccchheEEECCCCCEEEeeccccc
Confidence            999999999999875567899999999999999999999999999          9999999999999999999999998


Q ss_pred             ccCCCCc---ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHHhhccCC
Q psy11571        173 RLGGDGT---VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHQNS  248 (372)
Q Consensus       173 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~  248 (372)
                      .......   .......+|+.|+|||++.+     ..++.++|||||||++|||++ |.+||.+.+..+....+..+. .
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~-~  314 (373)
T 3c1x_A          241 DMYDKEFDSVHNKTGAKLPVKWMALESLQT-----QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-R  314 (373)
T ss_dssp             -----------------CCGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC-C
T ss_pred             cccccccccccccCCCCCcccccChHHhcC-----CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC-C
Confidence            6543221   11223457789999999984     568999999999999999999 788998877666666665543 2


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        249 FDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       249 ~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ...|.    .+++.+.++|.+||. ||++||+++++.+.+
T Consensus       315 ~~~p~----~~~~~l~~li~~cl~~dp~~RPs~~ell~~L  350 (373)
T 3c1x_A          315 LLQPE----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRI  350 (373)
T ss_dssp             CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            23333    689999999999999 999999988877554

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.8e-42  Score=321.95  Aligned_cols=255  Identities=20%  Similarity=0.233  Sum_probs=197.0

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    |+|.||.+.+..+++.||+|.+.....          ...+.+.+|+.+++.++||||++++++
T Consensus        29 ~~y~~~~~lg~G----~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~~iv~~~~~   94 (317)
T 2buj_A           29 KHYLFIQKLGEG----GFSYVDLVEGLHDGHFYALKRILCHEQ----------QDREEAQREADMHRLFNHPNILRLVAY   94 (317)
T ss_dssp             EEEEEEEEEEC------CEEEEEEEETTTCCEEEEEEEEESSH----------HHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred             eEEEEEEEecCC----CCeEEEEEEecCCCcEEEEEEEecCCH----------HHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            356666777776    899999999989999999998754321          123557889999999999999999999


Q ss_pred             EEe----CCeEEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCc
Q psy11571         82 FQD----DSNLYLVMDYYCGGDLLTLLSKF---EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDN  154 (372)
Q Consensus        82 ~~~----~~~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~N  154 (372)
                      +..    ....|+||||+.+|+|.+++...   ...+++..++.++.||+.||.|||++|++|          |||||+|
T Consensus        95 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH----------~dlkp~N  164 (317)
T 2buj_A           95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAH----------RDLKPTN  164 (317)
T ss_dssp             EEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCCGGG
T ss_pred             EEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccc----------CCCCHHH
Confidence            873    34789999999999999999762   467999999999999999999999999999          9999999


Q ss_pred             EEeCCCCcEEEeecCcccccCCCCcc--------cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhC
Q psy11571        155 VLLDANGHIRLADFGSCLRLGGDGTV--------QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYG  226 (372)
Q Consensus       155 Ill~~~~~vkl~Dfg~a~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG  226 (372)
                      |+++.++.+||+|||++.........        ......||+.|+|||++.+..  ...++.++|||||||++|+|++|
T Consensus       165 Il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~Di~slG~il~el~~g  242 (317)
T 2buj_A          165 ILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQS--HCVIDERTDVWSLGCVLYAMMFG  242 (317)
T ss_dssp             EEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCS--EEEECTHHHHHHHHHHHHHHHHS
T ss_pred             EEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCC--CcCCCchhhHHHHHHHHHHHHhC
Confidence            99999999999999998765321110        012245799999999987311  12368899999999999999999


Q ss_pred             CCCCCCCC--HHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        227 ETPFYAES--LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       227 ~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      +.||....  .......+ ......+.+    ..+++++.+||.+||+ ||.+||+++++++.+
T Consensus       243 ~~p~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  301 (317)
T 2buj_A          243 EGPYDMVFQKGDSVALAV-QNQLSIPQS----PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL  301 (317)
T ss_dssp             SCTTHHHHHTTSCHHHHH-HCC--CCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCChhhhhcccchhhHHh-hccCCCCcc----ccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence            99995411  01111122 222222222    2679999999999999 999999988777544

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.1e-41  Score=312.53  Aligned_cols=240  Identities=22%  Similarity=0.369  Sum_probs=197.0

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.++.|    ++|.||.+.+..+++.||+|.+.....              .+.+|+.+++.++||||+++++++
T Consensus        12 ~y~~~~~lg~G----~~g~V~~~~~~~~~~~vavK~~~~~~~--------------~~~~e~~~l~~l~h~~i~~~~~~~   73 (284)
T 2a19_B           12 DFKEIELIGSG----GFGQVFKAKHRIDGKTYVIKRVKYNNE--------------KAEREVKALAKLDHVNIVHYNGCW   73 (284)
T ss_dssp             HEEEEEEEECS----SSCCEEEEEETTTCCEEEEEEEECCSG--------------GGHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccceeeeeccC----CceEEEEEEEcCCCeEEEEEEeccccH--------------HHHHHHHHHHhCCCCCEEEEeeeE
Confidence            45555666666    899999999988999999998865431              245789999999999999999998


Q ss_pred             Ee----------------CCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCC
Q psy11571         83 QD----------------DSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH  145 (372)
Q Consensus        83 ~~----------------~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~  145 (372)
                      ..                ...+|+||||+++++|.+++... ...+++..++.++.||+.||.|||++|++|        
T Consensus        74 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H--------  145 (284)
T 2a19_B           74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIN--------  145 (284)
T ss_dssp             EEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEEC--------
T ss_pred             eccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeee--------
Confidence            65                44589999999999999999763 357999999999999999999999999999        


Q ss_pred             cCCCCCcCcEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh
Q psy11571        146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY  225 (372)
Q Consensus       146 vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt  225 (372)
                        |||||+||+++.++.+||+|||++........  .....||+.|+|||++.+     ..++.++|+||||+++|+|++
T Consensus       146 --~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~  216 (284)
T 2a19_B          146 --RDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISS-----QDYGKEVDLYALGLILAELLH  216 (284)
T ss_dssp             --SCCSGGGEEEEETTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHC-----SCCCTHHHHHHHHHHHHHHHS
T ss_pred             --ccCCHHHEEEcCCCCEEECcchhheecccccc--ccccCCcccccChhhhcc-----CCCcchhhhHHHHHHHHHHHh
Confidence              99999999999999999999999987654432  233578999999999983     568999999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        226 GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       226 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      |..||...  ......+...    .++.    .++..+++||.+||. ||.+||++.++++.+
T Consensus       217 ~~~~~~~~--~~~~~~~~~~----~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l  269 (284)
T 2a19_B          217 VCDTAFET--SKFFTDLRDG----IISD----IFDKKEKTLLQKLLSKKPEDRPNTSEILRTL  269 (284)
T ss_dssp             CCSSHHHH--HHHHHHHHTT----CCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cCCcchhH--HHHHHHhhcc----cccc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            99988532  2233333322    1222    679999999999999 999999987776443

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-41  Score=314.85  Aligned_cols=241  Identities=22%  Similarity=0.305  Sum_probs=187.7

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+..+.+|.|    |+|.||+++.  .++.||+|.+....            ..+.+.+|+.+++.++||||+++++++
T Consensus         9 ~~~~~~~lg~G----~~g~V~~~~~--~~~~vavK~~~~~~------------~~~~~~~E~~~l~~l~hp~iv~~~~~~   70 (307)
T 2eva_A            9 EIEVEEVVGRG----AFGVVCKAKW--RAKDVAIKQIESES------------ERKAFIVELRQLSRVNHPNIVKLYGAC   70 (307)
T ss_dssp             GEEEEEEEECC----SSSEEEEEEE--TTEEEEEEECSSTT------------HHHHHHHHHHHHHHCCCTTBCCEEEBC
T ss_pred             HeeeeeEeecC----CCceEEEEEE--CCeeEEEEEecChh------------HHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence            45555666666    8999999965  46789999875422            124577899999999999999999988


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---cCceecCCCCCCCcCCCCCcCcEEe
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFED--RLPEDMAKFYIAEMVLAIASIHD---LHYVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      .+  ..|+||||+++|+|.+++.....  .+++..+..++.|++.||.|||+   +||+|          |||||+||++
T Consensus        71 ~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH----------~dlkp~NIll  138 (307)
T 2eva_A           71 LN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH----------RDLKPPNLLL  138 (307)
T ss_dssp             TT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCC----------CCCSGGGEEE
T ss_pred             cC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeec----------CCCChhHEEE
Confidence            74  47899999999999999986322  47899999999999999999999   89999          9999999999


Q ss_pred             CCCCc-EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCC--
Q psy11571        158 DANGH-IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES--  234 (372)
Q Consensus       158 ~~~~~-vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~--  234 (372)
                      +.++. +||+|||++.......    ....||+.|+|||++.+     ..++.++|||||||++|+|++|+.||....  
T Consensus       139 ~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~g~~p~~~~~~~  209 (307)
T 2eva_A          139 VAGGTVLKICDFGTACDIQTHM----TNNKGSAAWMAPEVFEG-----SNYSEKCDVFSWGIILWEVITRRKPFDEIGGP  209 (307)
T ss_dssp             ETTTTEEEECCCCC----------------CCTTSSCHHHHTC-----CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS
T ss_pred             eCCCCEEEEccccccccccccc----ccCCCCCceEChhhhCC-----CCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc
Confidence            88886 7999999997654321    23468999999999983     568999999999999999999999998543  


Q ss_pred             HHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        235 LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       235 ~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .......+... .....+.    .+++.+.++|.+||+ ||++||+++++.+.+
T Consensus       210 ~~~~~~~~~~~-~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  258 (307)
T 2eva_A          210 AFRIMWAVHNG-TRPPLIK----NLPKPIESLMTRCWSKDPSQRPSMEEIVKIM  258 (307)
T ss_dssp             HHHHHHHHHTT-CCCCCBT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHhcC-CCCCccc----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence            33333333332 2222232    689999999999999 999999988887655

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.2e-42  Score=342.92  Aligned_cols=248  Identities=21%  Similarity=0.265  Sum_probs=204.5

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+..+.+|.|    ++|.||++... .+..||+|.+.......           +.+.+|+.+|+.++||||+++++++
T Consensus       268 ~~~~~~~lG~G----~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-----------~~~~~E~~~l~~l~hpniv~~~~~~  331 (535)
T 2h8h_A          268 SLRLEVKLGQG----CFGEVWMGTWN-GTTRVAIKTLKPGTMSP-----------EAFLQEAQVMKKLRHEKLVQLYAVV  331 (535)
T ss_dssp             GEEEEEEEEEC----SSEEEEEEEET-TTEEEEEEEECTTSSCH-----------HHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhhhheecccC----CCeEEEEEEEC-CCceEEEEEeCCCCCCH-----------HHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            34444555655    89999999764 44669999887544321           3467899999999999999999998


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      .+ ..+|+||||+.+|+|.+++... ...+++..+..++.||+.||.|||++||+|          |||||+|||++.++
T Consensus       332 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH----------rDlkp~NIll~~~~  400 (535)
T 2h8h_A          332 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH----------RDLRAANILVGENL  400 (535)
T ss_dssp             CS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCSGGGEEECGGG
T ss_pred             ee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeC----------CCCCHhhEEEcCCC
Confidence            76 6789999999999999999753 346999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYG  240 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~  240 (372)
                      .+||+|||+++..............++..|+|||++..     ..++.++|||||||++|||++ |..||.+....+...
T Consensus       401 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~  475 (535)
T 2h8h_A          401 VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD  475 (535)
T ss_dssp             CEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHH
T ss_pred             cEEEcccccceecCCCceecccCCcCcccccCHHHhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999999998765322222223456789999999983     568999999999999999999 999999998888888


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .+..+ .....+.    .+++++.+||.+||. ||++||+++++.+.+
T Consensus       476 ~i~~~-~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L  518 (535)
T 2h8h_A          476 QVERG-YRMPCPP----ECPESLHDLMCQCWRKEPEERPTFEYLQAFL  518 (535)
T ss_dssp             HHHTT-CCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHcC-CCCCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            77654 2333343    689999999999999 999999988887665

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=8e-42  Score=320.57  Aligned_cols=252  Identities=20%  Similarity=0.252  Sum_probs=199.1

Q ss_pred             HHHHHHhhhcCCcccCCccEEEee----eehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIE----TLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNL   78 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~----~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l   78 (372)
                      +|+.++.+|.|    |+|.||.+.    +..+++.||+|.+.....          +..+.+.+|+.+++.++||||+++
T Consensus        42 ~y~~~~~lg~G----~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~~iv~~  107 (326)
T 2w1i_A           42 HLKFLQQLGKG----NFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE----------EHLRDFEREIEILKSLQHDNIVKY  107 (326)
T ss_dssp             GEEEEEEEECC----SSEEEEEEEECTTSSSCCEEEEEEEESSCCS----------HHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             HceeeeeeccC----CCeEEEEEEeccccCCCceEEEEEEeccCCH----------HHHHHHHHHHHHHHhCCCCCeeeE
Confidence            45555666666    899999997    456789999998865321          134567889999999999999999


Q ss_pred             eEEEEeCC--eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEE
Q psy11571         79 HYAFQDDS--NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL  156 (372)
Q Consensus        79 ~~~~~~~~--~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIl  156 (372)
                      ++++...+  .+++||||+++++|.+++......+++..+..++.||+.||.|||+.|++|          |||||+||+
T Consensus       108 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH----------~dikp~NIl  177 (326)
T 2w1i_A          108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH----------RDLATRNIL  177 (326)
T ss_dssp             EEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCCGGGEE
T ss_pred             EEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEec----------cCCCcceEE
Confidence            99987654  789999999999999999885567999999999999999999999999999          999999999


Q ss_pred             eCCCCcEEEeecCcccccCCCCcc--cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCC
Q psy11571        157 LDANGHIRLADFGSCLRLGGDGTV--QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES  234 (372)
Q Consensus       157 l~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~  234 (372)
                      ++.++.+||+|||++.........  ......++..|+|||++.+     ..++.++|||||||++|+|++|..||....
T Consensus       178 i~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~tg~~~~~~~~  252 (326)
T 2w1i_A          178 VENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE-----SKFSVASDVWSFGVVLYELFTYIEKSKSPP  252 (326)
T ss_dssp             EEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHH-----CEEEHHHHHHHHHHHHHHHHHTTCGGGSHH
T ss_pred             EcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcC-----CCCCchhhHHHHHHHHHHHHhcCCCCCCCH
Confidence            999999999999999876543321  1223456778999999984     457889999999999999999999986431


Q ss_pred             HH------------H---HHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        235 LV------------E---TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       235 ~~------------~---~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ..            .   .....+......+.+.    .+++++.+||.+||. ||++||++.++.+.+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rps~~el~~~L  317 (326)
T 2w1i_A          253 AEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD----GCPDEIYMIMTECWNNNVNQRPSFRDLALRV  317 (326)
T ss_dssp             HHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCT----TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHhhccccchhhhHHHHHHHhhcCCCCCCCC----cccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            10            0   1112222222333333    689999999999999 999999988776544

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.9e-41  Score=344.63  Aligned_cols=250  Identities=21%  Similarity=0.317  Sum_probs=202.0

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehh---hhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLD---ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHY   80 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~---~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~   80 (372)
                      |+..+.+|.|    |+|.||.+....+   +..||+|.+......         ...+.+.+|+.+++.++||||+++++
T Consensus       392 y~i~~~LG~G----~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~E~~~l~~l~HpnIv~l~~  458 (656)
T 2j0j_A          392 IELGRCIGEG----QFGDVHQGIYMSPENPAMAVAIKTCKNCTSD---------SVREKFLQEALTMRQFDHPHIVKLIG  458 (656)
T ss_dssp             EEEEEEEECC----SSCCEEEEEECCSSSCCEEEEEEECSSTTCH---------HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             EEEeeEEeeC----CCEEEEEEEEecCCCccEEEEEEEecccCCH---------HHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3444455555    8999999987543   456888876543221         13456788999999999999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         81 AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        81 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      ++. .+..|+||||+++|+|.+++......+++..+..++.||+.||.|||++||+|          |||||+|||++.+
T Consensus       459 ~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH----------rDikp~NILl~~~  527 (656)
T 2j0j_A          459 VIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVH----------RDIAARNVLVSSN  527 (656)
T ss_dssp             EEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCSGGGEEEEET
T ss_pred             EEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccc----------cccchHhEEEeCC
Confidence            985 45689999999999999999875557999999999999999999999999999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETY  239 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~  239 (372)
                      +.+||+|||+++..............+|+.|+|||++.+     ..++.++|||||||++|||++ |.+||.+.+..+..
T Consensus       528 ~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~  602 (656)
T 2j0j_A          528 DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI  602 (656)
T ss_dssp             TEEEECCCCCCCSCCC----------CCGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred             CCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcC-----CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence            999999999998765443333334567889999999974     568999999999999999997 99999999988888


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ..+..+. ..+.|.    .+++.+.+||.+||. ||++||++.++.+.+
T Consensus       603 ~~i~~~~-~~~~~~----~~~~~l~~li~~~l~~dP~~RPs~~el~~~L  646 (656)
T 2j0j_A          603 GRIENGE-RLPMPP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQL  646 (656)
T ss_dssp             HHHHHTC-CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHcCC-CCCCCc----cccHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            8887653 233444    689999999999999 999999988776544

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=8.4e-42  Score=344.87  Aligned_cols=261  Identities=21%  Similarity=0.309  Sum_probs=204.6

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      .+|+.++.+|.|    |+|.||.+.+..+++.||+|.+......         ...+.+.+|+.+++.++||||++++++
T Consensus        14 grY~i~~~LG~G----~fG~Vyla~~~~tg~~VAVKvi~~~~~~---------~~~~~~~~Ei~iL~~L~HpnIV~l~~v   80 (676)
T 3qa8_A           14 GPWEMKERLGTG----GFGYVLRWIHQDTGEQVAIKQCRQELSP---------KNRERWCLEIQIMKKLNHPNVVSAREV   80 (676)
T ss_dssp             ---CCCCCCCBC----SSSBCCCCCCTTTTCCEEECCCCSCCCH---------HHHHHHHHHHHHHHHCCBTTBCCEEEC
T ss_pred             CCeEEEEEEeeC----CCeEEEEEEECCCCcEEEEEEecccCCH---------HHHHHHHHHHHHHHhCCCCCCCceeee
Confidence            356667777777    8999999999889999999988654321         124567889999999999999999998


Q ss_pred             EEe------CCeEEEEEeccCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcC
Q psy11571         82 FQD------DSNLYLVMDYYCGGDLLTLLSKFE--DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPD  153 (372)
Q Consensus        82 ~~~------~~~~~lv~E~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~  153 (372)
                      +..      .+..|+|||||+||+|.+++....  ..+++..++.++.|++.||.|||+.||+|          |||||+
T Consensus        81 ~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVH----------rDLKP~  150 (676)
T 3qa8_A           81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIH----------RDLKPE  150 (676)
T ss_dssp             CTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCC----------CCCCST
T ss_pred             ecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc----------CCCCHH
Confidence            765      667899999999999999998742  26899999999999999999999999999          999999


Q ss_pred             cEEeCCCCc---EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCC
Q psy11571        154 NVLLDANGH---IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF  230 (372)
Q Consensus       154 NIll~~~~~---vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf  230 (372)
                      ||+++.++.   +||+|||++........  .....||+.|+|||++.     ...++.++|||||||++|+|++|..||
T Consensus       151 NILl~~~g~~~~vKL~DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~-----~~~~s~ksDIwSLGviLyeLltG~~Pf  223 (676)
T 3qa8_A          151 NIVLQPGPQRLIHKIIDLGYAKELDQGEL--CTEFVGTLQYLAPELLE-----QKKYTVTVDYWSFGTLAFECITGFRPF  223 (676)
T ss_dssp             TEEEECCSSSCEEEECSCCCCCBTTSCCC--CCCCCSCCTTCSSCSSC-----CSCCSTTHHHHHHHHHHHHHHSSCSSC
T ss_pred             HeEeecCCCceeEEEcccccccccccccc--cccccCCcccCChHHhc-----cCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence            999987664   89999999987654332  23467999999999997     356899999999999999999999999


Q ss_pred             CCCCHHHHHHHH--------------hhcc----CCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhh
Q psy11571        231 YAESLVETYGKI--------------MNHQ----NSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSA  291 (372)
Q Consensus       231 ~~~~~~~~~~~i--------------~~~~----~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~  291 (372)
                      .+......+...              ..+.    ...+.|......+++.+.+||.+||. ||++||++.+++       
T Consensus       224 ~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL-------  296 (676)
T 3qa8_A          224 LPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP-------  296 (676)
T ss_dssp             CSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC-------
T ss_pred             CcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh-------
Confidence            775433221100              0000    11122222333467999999999999 999999998877       


Q ss_pred             hhhccCCCCCCCCCcCCC
Q psy11571        292 LFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       292 ~~~~~~~~~~~hp~f~~~  309 (372)
                                .||||+.+
T Consensus       297 ----------~hp~F~~l  304 (676)
T 3qa8_A          297 ----------NVGCFQAL  304 (676)
T ss_dssp             ----------CCTTHHHH
T ss_pred             ----------cCHHHHHH
Confidence                      99999864

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.2e-41  Score=330.06  Aligned_cols=248  Identities=22%  Similarity=0.289  Sum_probs=182.5

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      ||+|+||.+ ...+++.||+|.+....             .+.+.+|+.++..+ +||||+++++++.+.+.+|+|||||
T Consensus        26 G~~g~V~~~-~~~~g~~vAvK~~~~~~-------------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           26 GSSGTVVFQ-GSFQGRPVAVKRMLIDF-------------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             CSTTCEEEE-EESSSSEEEEEEEEGGG-------------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             CCCeEEEEE-EEECCeEEEEEEEcHHH-------------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            389999865 45679999999775422             12356788888765 8999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCC-------CHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC--------
Q psy11571         96 CGGDLLTLLSKFEDRL-------PEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN--------  160 (372)
Q Consensus        96 ~gg~L~~~l~~~~~~l-------~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~--------  160 (372)
                      . |+|.+++... ...       ++..++.++.||+.||.|||++||+|          |||||+|||++.+        
T Consensus        92 ~-gsL~~~l~~~-~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH----------rDLkp~NILl~~~~~~~~~~~  159 (434)
T 2rio_A           92 N-LNLQDLVESK-NVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIH----------RDLKPQNILVSTSSRFTADQQ  159 (434)
T ss_dssp             S-EEHHHHHHTC-------------CCHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEEECCHHHHSCCT
T ss_pred             C-CCHHHHHhcc-CCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccc----------cCCChHhEEEecCcccccccc
Confidence            5 6999999863 222       23345779999999999999999999          9999999999654        


Q ss_pred             -----CcEEEeecCcccccCCCCcc---cccccccCCcccCccccccccc--CCCCCCCccceeehhHHHHHHhh-CCCC
Q psy11571        161 -----GHIRLADFGSCLRLGGDGTV---QSNVAVGTPDYISPEILTAMEE--GRGRYGPECDWWSLGVCMYEMLY-GETP  229 (372)
Q Consensus       161 -----~~vkl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~DiwslGvil~ellt-G~~P  229 (372)
                           +.+||+|||+++........   .....+||+.|+|||++.+...  ....++.++|||||||++|||++ |..|
T Consensus       160 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~P  239 (434)
T 2rio_A          160 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP  239 (434)
T ss_dssp             TCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCT
T ss_pred             cCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCC
Confidence                 48999999999876543221   1234579999999999974211  12568999999999999999999 9999


Q ss_pred             CCCCCHHHHHHHHhhccCCcCCC-CCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcC
Q psy11571        230 FYAESLVETYGKIMNHQNSFDLP-SDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ  307 (372)
Q Consensus       230 f~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~  307 (372)
                      |.+....+  ..+..+....... ......+++++++||.+||+ ||.+|||+.+++                 +||||.
T Consensus       240 f~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil-----------------~hp~f~  300 (434)
T 2rio_A          240 FGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL-----------------RHPLFW  300 (434)
T ss_dssp             TCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHH-----------------TSGGGS
T ss_pred             CCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHH-----------------hCCccC
Confidence            98765443  2344433222211 11111346899999999999 999999866555                 999997


Q ss_pred             CC
Q psy11571        308 GI  309 (372)
Q Consensus       308 ~~  309 (372)
                      +.
T Consensus       301 ~~  302 (434)
T 2rio_A          301 PK  302 (434)
T ss_dssp             CH
T ss_pred             Cc
Confidence            54

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=319.69  Aligned_cols=250  Identities=21%  Similarity=0.278  Sum_probs=178.9

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeeeEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLHYA   81 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~~~   81 (372)
                      +|+..+.+|.|    |+|.||++.+..+++.||+|.+.....          ...+.+.+|+.++..+. ||||++++++
T Consensus        29 ~y~~~~~lg~G----~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~~h~~iv~~~~~   94 (337)
T 3ll6_A           29 RLRVRRVLAEG----GFAFVYEAQDVGSGREYALKRLLSNEE----------EKNRAIIQEVCFMKKLSGHPNIVQFCSA   94 (337)
T ss_dssp             EEEEEEEEECC----SSEEEEEEEETTTCCEEEEEEEEESSH----------HHHHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred             eEEEEEEEccC----CceEEEEEEECCCCcEEEEEEecCCch----------HHHHHHHHHHHHHHHhccCCChhhcccc
Confidence            45556666666    899999999988999999998754322          12345778999999885 9999999999


Q ss_pred             EE--------eCCeEEEEEeccCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCCCcCCC
Q psy11571         82 FQ--------DDSNLYLVMDYYCGGDLLTLLSKF--EDRLPEDMAKFYIAEMVLAIASIHDLH--YVHRPNHFAFHLCRD  149 (372)
Q Consensus        82 ~~--------~~~~~~lv~E~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~~~~~~~~vhrD  149 (372)
                      +.        ....+++||||+. |+|.+++...  .+.+++..++.++.||+.||.|||+.|  |+|          ||
T Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH----------~D  163 (337)
T 3ll6_A           95 ASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIH----------RD  163 (337)
T ss_dssp             EEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBC----------CC
T ss_pred             ccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEE----------cc
Confidence            94        3345899999994 7999988652  457999999999999999999999999  999          99


Q ss_pred             CCcCcEEeCCCCcEEEeecCcccccCCCCcc-----------cccccccCCcccCcccccccccCCCCCCCccceeehhH
Q psy11571        150 IKPDNVLLDANGHIRLADFGSCLRLGGDGTV-----------QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGV  218 (372)
Q Consensus       150 lkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGv  218 (372)
                      |||+|||++.++.+||+|||+++........           ......||+.|+|||++....  ...++.++|||||||
T Consensus       164 ikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~~~~Dv~slG~  241 (337)
T 3ll6_A          164 LKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYS--NFPIGEKQDIWALGC  241 (337)
T ss_dssp             CCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCT--TSCSSHHHHHHHHHH
T ss_pred             CCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccc--cCCCChHHhHHHHHH
Confidence            9999999999999999999999876543221           111356899999999984211  355788999999999


Q ss_pred             HHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        219 CMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       219 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ++|+|++|..||...........    ......+.    ..+..+.+||.+||+ ||.+||++.++++.+
T Consensus       242 il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          242 ILYLLCFRQHPFEDGAKLRIVNG----KYSIPPHD----TQYTVFHSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             HHHHHHHSSCCC----------------CCCCTTC----CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHhCCCCCcchhHHHhhcC----cccCCccc----ccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            99999999999987654433222    22222222    567889999999999 999999988777554

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.4e-41  Score=313.15  Aligned_cols=247  Identities=22%  Similarity=0.271  Sum_probs=192.8

Q ss_pred             ccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         16 IQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        16 ~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      .||+|.||++..  +++.+|+|.+.........      +..+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        41 ~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  112 (307)
T 2nru_A           41 EGGFGVVYKGYV--NNTTVAVKKLAAMVDITTE------ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM  112 (307)
T ss_dssp             ECSSEEEEEEES--SSCEEEEEEECCCTTSCTT------THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             cCCCeEEEEEEE--CCceEEEEEEecccCcchH------HHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence            347888998864  6889999987654322111      13456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571         96 CGGDLLTLLSKF--EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus        96 ~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                      ++++|.+++...  ...+++..++.++.||+.||.|||++|++|          |||||+||+++.++.+||+|||++..
T Consensus       113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H----------~dlkp~Nili~~~~~~kl~Dfg~~~~  182 (307)
T 2nru_A          113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIH----------RDIKSANILLDEAFTAKISDFGLARA  182 (307)
T ss_dssp             TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeec----------CCCCHHHEEEcCCCcEEEeecccccc
Confidence            999999999743  346899999999999999999999999999          99999999999999999999999987


Q ss_pred             cCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHH----HHHHhhccCC
Q psy11571        174 LGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET----YGKIMNHQNS  248 (372)
Q Consensus       174 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~----~~~i~~~~~~  248 (372)
                      ...... .......||+.|+|||++.      +.++.++||||||+++|+|++|.+||........    ...+......
T Consensus       183 ~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  256 (307)
T 2nru_A          183 SEKFAQTVMTSRIVGTTAYMAPEALR------GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKT  256 (307)
T ss_dssp             CCSCSSCEECSSCCSCGGGCCHHHHT------TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCC
T ss_pred             cccccccccccccCCCcCcCChHHhc------CCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhh
Confidence            654222 1223357899999999986      3478899999999999999999999987543221    1222111100


Q ss_pred             c------CCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        249 F------DLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       249 ~------~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      +      ..+ ......+..+.++|.+||. +|.+||+++++.+.+
T Consensus       257 ~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L  301 (307)
T 2nru_A          257 IEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL  301 (307)
T ss_dssp             HHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred             hhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            0      011 1111345789999999999 999999988877654

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-40  Score=313.48  Aligned_cols=249  Identities=20%  Similarity=0.251  Sum_probs=187.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhc--CCCCceeeeeE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVY--GDRRWITNLHY   80 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~--l~hp~Iv~l~~   80 (372)
                      +|+.++.+|.|    |+|.||.++.  +++.||+|.+.....             .....|.+++..  +.||||+++++
T Consensus        38 ~y~~~~~lg~G----~~g~V~~~~~--~~~~vavK~~~~~~~-------------~~~~~e~~~~~~~~~~h~~i~~~~~   98 (337)
T 3mdy_A           38 QIQMVKQIGKG----RYGEVWMGKW--RGEKVAVKVFFTTEE-------------ASWFRETEIYQTVLMRHENILGFIA   98 (337)
T ss_dssp             HCEEEEEEEEE----TTEEEEEEEE--TTEEEEEEEEEGGGH-------------HHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred             ceEEEeEeecC----CCeEEEEEEE--CCceEEEEEEecccc-------------chhhhHHHHHHHHhhcCCCeeeEEE
Confidence            55566666666    8999999975  488999998753221             112335555544  48999999999


Q ss_pred             EEEeC----CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhc--------CceecCCCCCCCcCC
Q psy11571         81 AFQDD----SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDL--------HYVHRPNHFAFHLCR  148 (372)
Q Consensus        81 ~~~~~----~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~--------~ivH~~~~~~~~vhr  148 (372)
                      ++.+.    ..+|+||||+++|+|.++++.  ..+++..+..++.|++.||.|||+.        ||+|          |
T Consensus        99 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH----------~  166 (337)
T 3mdy_A           99 ADIKGTGSWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAH----------R  166 (337)
T ss_dssp             EEEESCGGGCEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEEC----------S
T ss_pred             EEccCCCCCCceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEe----------c
Confidence            99887    789999999999999999987  5799999999999999999999998        9999          9


Q ss_pred             CCCcCcEEeCCCCcEEEeecCcccccCCCCcc---cccccccCCcccCcccccccccCCCCCCCc------cceeehhHH
Q psy11571        149 DIKPDNVLLDANGHIRLADFGSCLRLGGDGTV---QSNVAVGTPDYISPEILTAMEEGRGRYGPE------CDWWSLGVC  219 (372)
Q Consensus       149 Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~------~DiwslGvi  219 (372)
                      ||||+|||++.++.+||+|||+++........   ......||+.|+|||++.+     ..++..      +|||||||+
T Consensus       167 Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~~~~~~DiwslG~i  241 (337)
T 3mdy_A          167 DLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE-----SLNRNHFQSYIMADMYSFGLI  241 (337)
T ss_dssp             CCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTT-----CCCTTCTHHHHHHHHHHHHHH
T ss_pred             ccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccc-----ccCCccccCccccchHHHHHH
Confidence            99999999999999999999999766443221   1224579999999999974     333443      899999999


Q ss_pred             HHHHhhC----------CCCCCCC-----CHHHHHHHHhhccCCcCCCCCC-CCCCCHHHHHHHHHhcc-CCCCCCCCCC
Q psy11571        220 MYEMLYG----------ETPFYAE-----SLVETYGKIMNHQNSFDLPSDV-GYEISDDAKDLMRRLIC-SSDTRLGQNG  282 (372)
Q Consensus       220 l~elltG----------~~Pf~~~-----~~~~~~~~i~~~~~~~~~~~~~-~~~~s~~~~~li~~lL~-~p~~R~s~~~  282 (372)
                      +|||++|          ..||...     ........+.........+... ...+++++.+||.+||+ ||++||++.+
T Consensus       242 l~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e  321 (337)
T 3mdy_A          242 LWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR  321 (337)
T ss_dssp             HHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHH
Confidence            9999999          7777542     1222222232222222222211 11456789999999999 9999999888


Q ss_pred             hhhhh
Q psy11571        283 IADFK  287 (372)
Q Consensus       283 ~~~i~  287 (372)
                      +++.+
T Consensus       322 ll~~L  326 (337)
T 3mdy_A          322 VKKTL  326 (337)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77655

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=5.5e-42  Score=320.06  Aligned_cols=255  Identities=17%  Similarity=0.175  Sum_probs=198.3

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+..+.+|.|    |+|.||.+...   ..+++|.+........        ..+.+.+|+.+++.++||||+++++++
T Consensus        34 ~~~~~~~lg~G----~~g~V~~~~~~---~~~avk~~~~~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~~~~~   98 (319)
T 2y4i_B           34 QLEIGELIGKG----RFGQVYHGRWH---GEVAIRLIDIERDNED--------QLKAFKREVMAYRQTRHENVVLFMGAC   98 (319)
T ss_dssp             CEECCCBCCCS----SSSEEEEEEES---SSEEEEECCCCSCCCC--------CCCCCCTTGGGGTTCCCTTBCCCCEEE
T ss_pred             HeEEeeEeccC----CceEEEEEEEc---CeEEEEEeecCCCCHH--------HHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence            34444555555    78889988653   3588888765433221        123356788999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+...+++||||+++++|.+++......+++..++.++.||+.||.|||++|++|          |||||+||+++ ++.
T Consensus        99 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H----------~dlkp~NIl~~-~~~  167 (319)
T 2y4i_B           99 MSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILH----------KDLKSKNVFYD-NGK  167 (319)
T ss_dssp             ECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCC----------CCCCSTTEEEC---C
T ss_pred             ecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccc----------cCCChhhEEEe-CCC
Confidence            9999999999999999999999875557999999999999999999999999999          99999999998 679


Q ss_pred             EEEeecCcccccCCCC----cccccccccCCcccCccccccccc----CCCCCCCccceeehhHHHHHHhhCCCCCCCCC
Q psy11571        163 IRLADFGSCLRLGGDG----TVQSNVAVGTPDYISPEILTAMEE----GRGRYGPECDWWSLGVCMYEMLYGETPFYAES  234 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~~~DiwslGvil~elltG~~Pf~~~~  234 (372)
                      ++|+|||++.......    ........||+.|+|||++.....    ....++.++|||||||++|+|++|..||.+.+
T Consensus       168 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~  247 (319)
T 2y4i_B          168 VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP  247 (319)
T ss_dssp             CEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC
T ss_pred             EEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999987543211    111223468999999999974211    12357889999999999999999999999998


Q ss_pred             HHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        235 LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       235 ~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .......+....... .+   ...++.++.++|.+||. ||++||++.++.+.+
T Consensus       248 ~~~~~~~~~~~~~~~-~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l  297 (319)
T 2y4i_B          248 AEAIIWQMGTGMKPN-LS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDML  297 (319)
T ss_dssp             HHHHHHHHHTTCCCC-CC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHH
T ss_pred             HHHHHHHhccCCCCC-CC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence            888877776543222 11   22578999999999999 999999988887665

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=7.8e-41  Score=318.78  Aligned_cols=235  Identities=16%  Similarity=0.182  Sum_probs=183.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEe-----eeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC---CCc
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSI-----ETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD---RRW   74 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v-----~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~---hp~   74 (372)
                      +|+..+.+|.|    |+|.||++     .+..+++.||+|.+.....             ..+..|..++..+.   |+|
T Consensus        66 ~y~~~~~lG~G----~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~e~~~~~~l~~~~~~~  128 (365)
T 3e7e_A           66 LVYVHHLLGEG----AFAQVYEATQGDLNDAKNKQKFVLKVQKPANP-------------WEFYIGTQLMERLKPSMQHM  128 (365)
T ss_dssp             EEEEEEEEEEC----SSEEEEEEEC-------CCCCEEEEEESSCCH-------------HHHHHHHHHHHHSCGGGGGG
T ss_pred             EEEEEEEeecc----CCEEEEEEEecCCcccccCcEEEEEEeCCCCh-------------hHHHHHHHHHHHhhhhhhhh
Confidence            34445556666    89999999     4677899999998865432             12455666666665   999


Q ss_pred             eeeeeEEEEeCCeEEEEEeccCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCC
Q psy11571         75 ITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSK----FEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDI  150 (372)
Q Consensus        75 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDl  150 (372)
                      |+++++++...+..|+|||||++|+|.+++..    ....+++..++.++.||+.||+|||++||+|          |||
T Consensus       129 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivH----------rDi  198 (365)
T 3e7e_A          129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIH----------GDI  198 (365)
T ss_dssp             BCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEEC----------CCC
T ss_pred             hhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeec----------CCC
Confidence            99999999999999999999999999999974    2457999999999999999999999999999          999


Q ss_pred             CcCcEEeCC-----------CCcEEEeecCcccccCC-CCcccccccccCCcccCcccccccccCCCCCCCccceeehhH
Q psy11571        151 KPDNVLLDA-----------NGHIRLADFGSCLRLGG-DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGV  218 (372)
Q Consensus       151 kp~NIll~~-----------~~~vkl~Dfg~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGv  218 (372)
                      ||+|||++.           ++.+||+|||+|+.... .........+||+.|+|||++.+     ..++.++|||||||
T Consensus       199 Kp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~  273 (365)
T 3e7e_A          199 KPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-----KPWNYQIDYFGVAA  273 (365)
T ss_dssp             SGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-----CCBSTHHHHHHHHH
T ss_pred             CHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-----CCCCccccHHHHHH
Confidence            999999998           89999999999975431 11223344679999999999984     55899999999999


Q ss_pred             HHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCC
Q psy11571        219 CMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLG  279 (372)
Q Consensus       219 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s  279 (372)
                      ++|||+||+.||.......     ..  ....+...   ..++.+.+++.+||+ +|.+|++
T Consensus       274 il~elltg~~pf~~~~~~~-----~~--~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~  325 (365)
T 3e7e_A          274 TVYCMLFGTYMKVKNEGGE-----CK--PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLP  325 (365)
T ss_dssp             HHHHHHHSSCCCEEEETTE-----EE--ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCC
T ss_pred             HHHHHHhCCCccccCCCCc-----ee--echhcccc---CcHHHHHHHHHHHcCCCCCCcch
Confidence            9999999999996543211     00  00011111   347889999999999 9988865

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=9.9e-41  Score=314.54  Aligned_cols=254  Identities=21%  Similarity=0.244  Sum_probs=194.0

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhc--CCCCceeeeeE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVY--GDRRWITNLHY   80 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~--l~hp~Iv~l~~   80 (372)
                      +|+..+.+|.|    ++|.||+++.  +++.||+|.+....             .+.+.+|..++..  ++||||+++++
T Consensus        43 ~y~~~~~lg~G----~~g~Vy~~~~--~~~~vavK~~~~~~-------------~~~~~~e~~~~~~~~l~h~ni~~~~~  103 (342)
T 1b6c_B           43 TIVLQESIGKG----RFGEVWRGKW--RGEEVAVKIFSSRE-------------ERSWFREAEIYQTVMLRHENILGFIA  103 (342)
T ss_dssp             HCEEEEEEEEE----TTEEEEEEEE--TTEEEEEEEECGGG-------------HHHHHHHHHHHHHSCCCCTTBCCEEE
T ss_pred             cEEEEeeecCC----CCcEEEEEEE--cCccEEEEEeCchh-------------HHHHHHHHHHHHHhhcCCCcEEEEEe
Confidence            34444455555    7999999876  58899999875422             1235567777776  78999999999


Q ss_pred             EEEeCC----eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------hcCceecCCCCCCCcCC
Q psy11571         81 AFQDDS----NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIH--------DLHYVHRPNHFAFHLCR  148 (372)
Q Consensus        81 ~~~~~~----~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH--------~~~ivH~~~~~~~~vhr  148 (372)
                      ++....    .+|+||||+++|+|.+++.+  ..+++..++.++.||+.||.|||        +.||+|          |
T Consensus       104 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH----------~  171 (342)
T 1b6c_B          104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH----------R  171 (342)
T ss_dssp             EEECCCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEEC----------S
T ss_pred             eecccCCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeee----------C
Confidence            998876    79999999999999999987  57999999999999999999999        899999          9


Q ss_pred             CCCcCcEEeCCCCcEEEeecCcccccCCCCcc---cccccccCCcccCcccccccccCC-CCCCCccceeehhHHHHHHh
Q psy11571        149 DIKPDNVLLDANGHIRLADFGSCLRLGGDGTV---QSNVAVGTPDYISPEILTAMEEGR-GRYGPECDWWSLGVCMYEML  224 (372)
Q Consensus       149 Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~DiwslGvil~ell  224 (372)
                      ||||+|||++.++.+||+|||++.........   ......||+.|+|||++.+..... ..++.++|||||||++|+|+
T Consensus       172 Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~  251 (342)
T 1b6c_B          172 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA  251 (342)
T ss_dssp             CCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHH
Confidence            99999999999999999999999776443321   123457999999999997411000 02336899999999999999


Q ss_pred             hC----------CCCCCCC-----CHHHHHHHHhhccCCcCCCCCC-CCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        225 YG----------ETPFYAE-----SLVETYGKIMNHQNSFDLPSDV-GYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       225 tG----------~~Pf~~~-----~~~~~~~~i~~~~~~~~~~~~~-~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      +|          ..||...     ........+........++... ....++.+.+||.+||+ ||++||++.++.+.+
T Consensus       252 tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L  331 (342)
T 1b6c_B          252 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL  331 (342)
T ss_dssp             TTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred             hccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence            99          7898764     2344444444433333333211 11344689999999999 999999988877654

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=312.86  Aligned_cols=254  Identities=20%  Similarity=0.253  Sum_probs=184.5

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHH--HhcCCCCceeeeeE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDV--LVYGDRRWITNLHY   80 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~i--l~~l~hp~Iv~l~~   80 (372)
                      +|+.++.+|.|    |+|.||+++.  +++.||+|.+......             .+..|..+  +..+.||||+++++
T Consensus        14 ~y~~~~~lg~G----~~g~Vy~~~~--~~~~vavK~~~~~~~~-------------~~~~e~~~~~~~~~~h~~i~~~~~   74 (336)
T 3g2f_A           14 NLKLLELIGRG----RYGAVYKGSL--DERPVAVKVFSFANRQ-------------NFINEKNIYRVPLMEHDNIARFIV   74 (336)
T ss_dssp             SEEEEEEEEEC----SSEEEEEEEE--TTEEEEEEEEEGGGHH-------------HHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred             HhheeeecccC----CCeEEEEEEE--CCeEEEEEEeeccchh-------------hHHHHHHHHHHHhccCcchhhhee
Confidence            45555666666    8999999954  7889999987643221             12233444  45589999999998


Q ss_pred             EEEe-----CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhc---------CceecCCCCCCCc
Q psy11571         81 AFQD-----DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDL---------HYVHRPNHFAFHL  146 (372)
Q Consensus        81 ~~~~-----~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---------~ivH~~~~~~~~v  146 (372)
                      .+..     ...+|+|||||++|+|.+++..  ...++..+..++.||+.||.|||+.         ||+|         
T Consensus        75 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH---------  143 (336)
T 3g2f_A           75 GDERVTADGRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISH---------  143 (336)
T ss_dssp             EEEEECTTSCEEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEEC---------
T ss_pred             cccccccCCCceEEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhccccccccceee---------
Confidence            6543     2367999999999999999987  5569999999999999999999999         9999         


Q ss_pred             CCCCCcCcEEeCCCCcEEEeecCcccccCCCCc-------ccccccccCCcccCcccccccccC--CCCCCCccceeehh
Q psy11571        147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-------VQSNVAVGTPDYISPEILTAMEEG--RGRYGPECDWWSLG  217 (372)
Q Consensus       147 hrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~DiwslG  217 (372)
                       |||||+|||++.++.+||+|||+++.......       .......||+.|+|||++.+....  ...++.++||||||
T Consensus       144 -~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG  222 (336)
T 3g2f_A          144 -RDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALG  222 (336)
T ss_dssp             -SSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHH
T ss_pred             -cccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHH
Confidence             99999999999999999999999987643211       112235799999999999731100  02456789999999


Q ss_pred             HHHHHHhhCCCCCCCCC------------------HHHHHHHHhhccCCcCCCCCCC--CCCCHHHHHHHHHhcc-CCCC
Q psy11571        218 VCMYEMLYGETPFYAES------------------LVETYGKIMNHQNSFDLPSDVG--YEISDDAKDLMRRLIC-SSDT  276 (372)
Q Consensus       218 vil~elltG~~Pf~~~~------------------~~~~~~~i~~~~~~~~~~~~~~--~~~s~~~~~li~~lL~-~p~~  276 (372)
                      |++|||++|..||....                  .......+........+|....  ...++++.+||.+||+ ||++
T Consensus       223 ~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~  302 (336)
T 3g2f_A          223 LIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEA  302 (336)
T ss_dssp             HHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGG
T ss_pred             HHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhh
Confidence            99999999977664321                  1111112222222333333211  1245689999999999 9999


Q ss_pred             CCCCCChhhhh
Q psy11571        277 RLGQNGIADFK  287 (372)
Q Consensus       277 R~s~~~~~~i~  287 (372)
                      |||+.++++.+
T Consensus       303 Rps~~e~l~~L  313 (336)
T 3g2f_A          303 RLTAQXAEERM  313 (336)
T ss_dssp             SCCHHHHHHHH
T ss_pred             CcchHHHHHHH
Confidence            99988876544

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.6e-40  Score=307.90  Aligned_cols=222  Identities=26%  Similarity=0.442  Sum_probs=175.3

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHH-hcCCCCceeeeeEEEEe----CCeEEEE
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVL-VYGDRRWITNLHYAFQD----DSNLYLV   91 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il-~~l~hp~Iv~l~~~~~~----~~~~~lv   91 (372)
                      ||+|.||.+.+..+++.||+|.+...               ..+.+|+.++ +...||||+++++++.+    ...+|+|
T Consensus        29 G~~g~V~~~~~~~~~~~vaiK~~~~~---------------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv   93 (299)
T 3m2w_A           29 GINGKVLQIFNKRTQEKFALKMLQDC---------------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV   93 (299)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEECS---------------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             CCCeEEEEEEEcCCCcEEEEEEeccc---------------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEE
Confidence            38999999999999999999987532               1244577776 66789999999999987    6789999


Q ss_pred             EeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC---CCcEEEee
Q psy11571         92 MDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA---NGHIRLAD  167 (372)
Q Consensus        92 ~E~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~---~~~vkl~D  167 (372)
                      |||+++|+|.+++.... ..+++..++.++.||+.||.|||++|++|          |||||+||+++.   ++.+||+|
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H----------~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           94 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH----------RDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             ECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEESSSSTTCCEEECC
T ss_pred             EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc----------CCCCHHHEEEecCCCCCcEEEec
Confidence            99999999999998742 36999999999999999999999999999          999999999997   78899999


Q ss_pred             cCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhcc-
Q psy11571        168 FGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQ-  246 (372)
Q Consensus       168 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~-  246 (372)
                      ||++....                            ...++.++|||||||++|+|++|..||.+.+.......+.... 
T Consensus       164 fg~a~~~~----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  215 (299)
T 3m2w_A          164 FGFAKETT----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR  215 (299)
T ss_dssp             CTTCEECT----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSC
T ss_pred             cccccccc----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHh
Confidence            99886432                            1236678999999999999999999998766544332222111 


Q ss_pred             -CCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        247 -NSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       247 -~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                       .....+......+++++++||.+||+ ||.+||++++++                 +||||++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l-----------------~hp~~~~  262 (299)
T 3m2w_A          216 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM-----------------NHPWIMQ  262 (299)
T ss_dssp             TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHH-----------------TSHHHHT
T ss_pred             hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHh-----------------cChhhcc
Confidence             11122211113689999999999999 999999866555                 9999985

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.4e-40  Score=320.71  Aligned_cols=244  Identities=14%  Similarity=0.168  Sum_probs=182.4

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCC-Cce--------------------
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDR-RWI--------------------   75 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~h-p~I--------------------   75 (372)
                      ||+|.||++.+..+++.||+|.+........       ...+.+++|..++..+.| +|+                    
T Consensus        89 G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~-------~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (413)
T 3dzo_A           89 EDPYAYLEATDQETGESFEVHVPYFTERPPS-------NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ  161 (413)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEECCSCC-----------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred             CCCEEEEEEEecCCCCceEEEEEecCCCccH-------HHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence            4899999999999999999998774333222       224557788888888876 211                    


Q ss_pred             -eeeeEEEEe-----CCeEEEEEeccCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCC
Q psy11571         76 -TNLHYAFQD-----DSNLYLVMDYYCGGDLLTLLSKF------EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFA  143 (372)
Q Consensus        76 -v~l~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~------~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~  143 (372)
                       ..+...+..     ...++++|+++ +++|.++++..      ...+++..+..++.||+.||+|||++||+|      
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH------  234 (413)
T 3dzo_A          162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH------  234 (413)
T ss_dssp             ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC------
T ss_pred             CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc------
Confidence             111111121     22467888876 78999998521      345778889999999999999999999999      


Q ss_pred             CCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccc-----cCCCCCCCccceeehhH
Q psy11571        144 FHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAME-----EGRGRYGPECDWWSLGV  218 (372)
Q Consensus       144 ~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~~~~DiwslGv  218 (372)
                          |||||+|||++.++.+||+|||+++.....    ....+| +.|+|||++....     .....++.++|||||||
T Consensus       235 ----rDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv  305 (413)
T 3dzo_A          235 ----TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL  305 (413)
T ss_dssp             ----SCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred             ----CCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence                999999999999999999999998875432    334578 9999999994210     01345788999999999


Q ss_pred             HHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccC
Q psy11571        219 CMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLS  297 (372)
Q Consensus       219 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~  297 (372)
                      ++|+|++|+.||.+.+..+....+...          ...+++++++||.+||+ ||++||++.+++             
T Consensus       306 il~elltg~~Pf~~~~~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l-------------  362 (413)
T 3dzo_A          306 AIYWIWCADLPNTDDAALGGSEWIFRS----------CKNIPQPVRALLEGFLRYPKEDRLLPLQAM-------------  362 (413)
T ss_dssp             HHHHHHHSSCCCCTTGGGSCSGGGGSS----------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHT-------------
T ss_pred             HHHHHHHCCCCCCCcchhhhHHHHHhh----------cccCCHHHHHHHHHHccCChhhCcCHHHHH-------------
Confidence            999999999999887654433333221          11578999999999999 999999866555             


Q ss_pred             CCCCCCCCcCCCC
Q psy11571        298 ISPRNHPWFQGIA  310 (372)
Q Consensus       298 ~~~~~hp~f~~~~  310 (372)
                          +||||+.+.
T Consensus       363 ----~~~~~~~~~  371 (413)
T 3dzo_A          363 ----ETPEYEQLR  371 (413)
T ss_dssp             ----TSHHHHHHH
T ss_pred             ----hCHHHHHHH
Confidence                999998764

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5.9e-41  Score=315.97  Aligned_cols=246  Identities=15%  Similarity=0.137  Sum_probs=178.9

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC---------C
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD---------R   72 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~---------h   72 (372)
                      ++|+.++.+|.|    ++|.||++++  +++.||+|.+...........  .....+.+.+|+.+++.++         |
T Consensus        20 ~~y~~~~~lG~G----~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~~l~~~~~~~h   91 (336)
T 2vuw_A           20 EKLQRCEKIGEG----VFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGS--HQKTFEEILPEIIISKELSLLSGEVCNRT   91 (336)
T ss_dssp             HHHHTCEEEEEE----TTEEEEEEEE--TTEEEEEEEEEESCSSCBTTB--CCBCHHHHHHHHHHHHHHHHGGGCSSSBC
T ss_pred             ccchheeeeccc----CceEEEEEEe--CCceEEEEEEecCCccccccc--cchhHHHHHHHHHHHHHHHHhhccccccC
Confidence            478888888887    8999999987  789999999876543210000  0001233556666666554         6


Q ss_pred             CceeeeeEEE-----------------Ee-------------CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHH
Q psy11571         73 RWITNLHYAF-----------------QD-------------DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAE  122 (372)
Q Consensus        73 p~Iv~l~~~~-----------------~~-------------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~q  122 (372)
                      |||+++.+++                 .+             ...+|+|||||++|++.+.+.+  ..+++..++.++.|
T Consensus        92 ~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~q  169 (336)
T 2vuw_A           92 EGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQ  169 (336)
T ss_dssp             CCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHH
T ss_pred             CchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHH
Confidence            6766666654                 32             6789999999999987777754  67899999999999


Q ss_pred             HHHHHHHHH-hcCceecCCCCCCCcCCCCCcCcEEeCCCC--------------------cEEEeecCcccccCCCCccc
Q psy11571        123 MVLAIASIH-DLHYVHRPNHFAFHLCRDIKPDNVLLDANG--------------------HIRLADFGSCLRLGGDGTVQ  181 (372)
Q Consensus       123 i~~~L~~LH-~~~ivH~~~~~~~~vhrDlkp~NIll~~~~--------------------~vkl~Dfg~a~~~~~~~~~~  181 (372)
                      |+.||.||| ++||+|          |||||+|||++.++                    .+||+|||+|+....     
T Consensus       170 i~~aL~~lH~~~~ivH----------rDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----  234 (336)
T 2vuw_A          170 LTASLAVAEASLRFEH----------RDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-----  234 (336)
T ss_dssp             HHHHHHHHHHHHCCBC----------SCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----
T ss_pred             HHHHHHHHHHhCCEeE----------CCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----
Confidence            999999999 999999          99999999999887                    899999999987543     


Q ss_pred             ccccccCCcccCcccccccccCCCCCCCccceeehhHH-HHHHhhCCCCCCCCCH-HHHHHHHhhcc-CCcCCCCCCCCC
Q psy11571        182 SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVC-MYEMLYGETPFYAESL-VETYGKIMNHQ-NSFDLPSDVGYE  258 (372)
Q Consensus       182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvi-l~elltG~~Pf~~~~~-~~~~~~i~~~~-~~~~~~~~~~~~  258 (372)
                       ...+||+.|+|||++.+     . .+.++||||||++ .+++++|..||.+... ......+.... .....+......
T Consensus       235 -~~~~gt~~y~aPE~~~g-----~-~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (336)
T 2vuw_A          235 -GIVVFCDVSMDEDLFTG-----D-GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQ  307 (336)
T ss_dssp             -TEEECCCCTTCSGGGCC-----C-SSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHH
T ss_pred             -CcEEEeecccChhhhcC-----C-CccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhh
Confidence             23579999999999983     2 3789999998777 8889999999954321 12223333211 111111111224


Q ss_pred             CCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        259 ISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       259 ~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      +++++++||++||+ |     |+++++
T Consensus       308 ~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          308 IKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             cCHHHHHHHHHHhccC-----CHHHHH
Confidence            78999999999999 5     655544

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.6e-39  Score=298.31  Aligned_cols=226  Identities=13%  Similarity=0.073  Sum_probs=181.7

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      .||+.++.+|.|    |+|.||++.+..+++.||+|.+........       +..+.+.+|..++..++||||++++++
T Consensus        31 ~~y~i~~~lg~G----~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~~e~~~l~~l~hp~iv~~~~~   99 (286)
T 3uqc_A           31 GRYRLLIFHGGV----PPLQFWQALDTALDRQVALTFVDPQGVLPD-------DVLQETLSRTLRLSRIDKPGVARVLDV   99 (286)
T ss_dssp             TTEEEEEEEEBS----TTCEEEEEEETTTTEEEEEEESCTTCCSCH-------HHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             CcEEEEEEEccc----CCeEEEEEEecCCCceEEEEEECcccccCH-------HHHHHHHHHHHHHhcCCCCCcceeeEE
Confidence            466667777777    899999999998999999999876554332       234567889999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+.+..|+||||++|++|.++++.  + ....++..++.||+.||.|||++||+|          |||||+|||++.+|
T Consensus       100 ~~~~~~~~lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH----------~Dikp~NIll~~~g  166 (286)
T 3uqc_A          100 VHTRAGGLVVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVAL----------SIDHPSRVRVSIDG  166 (286)
T ss_dssp             EEETTEEEEEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCC----------CCCSGGGEEEETTS
T ss_pred             EEECCcEEEEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCcc----------CCCCcccEEEcCCC
Confidence            9999999999999999999999964  3 466678999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHH-
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG-  240 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~-  240 (372)
                      .+||+++|                     |++            .++.++|||||||++|+|++|+.||.+.+..+.+. 
T Consensus       167 ~~kl~~~~---------------------~~~------------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~  213 (286)
T 3uqc_A          167 DVVLAYPA---------------------TMP------------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP  213 (286)
T ss_dssp             CEEECSCC---------------------CCT------------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE
T ss_pred             CEEEEecc---------------------ccC------------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH
Confidence            99998443                     222            25678999999999999999999998765432111 


Q ss_pred             --HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        241 --KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       241 --~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                        +....  ....+......+++++.+||.+||+ ||.+| |+.++.+.+
T Consensus       214 ~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L  260 (286)
T 3uqc_A          214 AERDTAG--QPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLM  260 (286)
T ss_dssp             CCBCTTS--CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHH
T ss_pred             HHHHhcc--CCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHH
Confidence              11111  1111112223689999999999999 99999 988777554

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7.9e-39  Score=328.76  Aligned_cols=230  Identities=22%  Similarity=0.298  Sum_probs=183.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeeh-hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLL-DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~-~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      +|+.++.+|.|    |+|.||.+.+.. +++.||+|.+......         +..+.+.+|+.++..++||||++++++
T Consensus        81 ~y~i~~~lg~G----~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~E~~~l~~l~hp~iv~~~~~  147 (681)
T 2pzi_A           81 QYEVKGCIAHG----GLGWIYLALDRNVNGRPVVLKGLVHSGDA---------EAQAMAMAERQFLAEVVHPSIVQIFNF  147 (681)
T ss_dssp             TEEEEEEEEEE----TTEEEEEEEEGGGTTEEEEEEESCSSCCH---------HHHHHHHHHHGGGGGCCCTTBCCEEEE
T ss_pred             ceEEEEEEeeC----CCeEEEEEEEcCCCCcEEEEEEeCccCCH---------HHHHHHHHHHHHHHhcCCCCcCeEeee
Confidence            45555666666    899999998866 7899999987643221         123557789999999999999999999


Q ss_pred             EEeCCe-----EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEE
Q psy11571         82 FQDDSN-----LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL  156 (372)
Q Consensus        82 ~~~~~~-----~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIl  156 (372)
                      +.+.+.     .|+||||++|++|.+++..   .+++..++.++.||+.||.|||++||+|          |||||+|||
T Consensus       148 ~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiH----------rDlkp~NIl  214 (681)
T 2pzi_A          148 VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVY----------NDLKPENIM  214 (681)
T ss_dssp             EEEECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEE
T ss_pred             EeecCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCee----------cccChHHeE
Confidence            987765     7999999999999988753   7999999999999999999999999999          999999999


Q ss_pred             eCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH
Q psy11571        157 LDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV  236 (372)
Q Consensus       157 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~  236 (372)
                      ++.+ .+||+|||+++.....     ....||+.|+|||++.+      .++.++|||||||++|+|++|.+||.+....
T Consensus       215 l~~~-~~kl~DFG~a~~~~~~-----~~~~gt~~y~aPE~~~~------~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~  282 (681)
T 2pzi_A          215 LTEE-QLKLIDLGAVSRINSF-----GYLYGTPGFQAPEIVRT------GPTVATDIYTVGRTLAALTLDLPTRNGRYVD  282 (681)
T ss_dssp             ECSS-CEEECCCTTCEETTCC-----SCCCCCTTTSCTTHHHH------CSCHHHHHHHHHHHHHHHHSCCCEETTEECS
T ss_pred             EeCC-cEEEEecccchhcccC-----CccCCCccccCHHHHcC------CCCCceehhhhHHHHHHHHhCCCCCcccccc
Confidence            9875 8999999999876543     33579999999999873      2488999999999999999999998753210


Q ss_pred             HHHHHHhhccCCcCCCC-CCCCCCCHHHHHHHHHhcc-CCCCCCCCCCh
Q psy11571        237 ETYGKIMNHQNSFDLPS-DVGYEISDDAKDLMRRLIC-SSDTRLGQNGI  283 (372)
Q Consensus       237 ~~~~~i~~~~~~~~~~~-~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~  283 (372)
                                   ..+. ......++.+.+||.+||+ ||.+||+..+.
T Consensus       283 -------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~  318 (681)
T 2pzi_A          283 -------------GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEE  318 (681)
T ss_dssp             -------------SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHH
T ss_pred             -------------cccccccccccCHHHHHHHhhhccCChhhCCCHHHH
Confidence                         0010 0001246889999999999 99999985443

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=4e-35  Score=294.38  Aligned_cols=192  Identities=16%  Similarity=0.098  Sum_probs=140.8

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCeEEEEEecc
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHYAFQDDSNLYLVMDYY   95 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~E~~   95 (372)
                      ++.|....+++...|..+++|.+............+.....+.+.+|+++|+++ .|+||+++++++++++.+|||||||
T Consensus       245 ~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv  324 (569)
T 4azs_A          245 GAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKL  324 (569)
T ss_dssp             -------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECC
T ss_pred             CCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecC
Confidence            356667777888889999999887665443333333344567899999999999 6999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccC
Q psy11571         96 CGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLG  175 (372)
Q Consensus        96 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~  175 (372)
                      +|++|.++|.. .+.+++.   .++.||+.||+|||++||||          |||||+|||++.+|++||+|||+|+...
T Consensus       325 ~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIH----------RDIKPeNILL~~dg~vKL~DFGlAr~~~  390 (569)
T 4azs_A          325 PGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWH----------DDVRPWNVMVDARQHARLIDFGSIVTTP  390 (569)
T ss_dssp             CSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEE----------SCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred             CCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCcee----------ccCchHhEEECCCCCEEEeecccCeeCC
Confidence            99999999987 5777765   47899999999999999999          9999999999999999999999998775


Q ss_pred             CCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCC
Q psy11571        176 GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP  229 (372)
Q Consensus       176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~P  229 (372)
                      .... ...+.+||+.|+|||++.+      .+..++|+||+|+++++|.++..+
T Consensus       391 ~~~~-~~~t~vGTp~YmAPE~l~g------~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          391 QDCS-WPTNLVQSFFVFVNELFAE------NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ---C-CSHHHHHHHHHHHHHHC-----------------------CCCCTTHHH
T ss_pred             CCCc-cccCceechhhccHHHhCC------CCCCcccccccccchhhhccccch
Confidence            5433 3345789999999999973      467789999999999888765443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=4.5e-27  Score=234.59  Aligned_cols=186  Identities=15%  Similarity=0.108  Sum_probs=146.0

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeEEEEEeccCC
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCG   97 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~E~~~g   97 (372)
                      ++|.||++  ...+..+++|.......... .. ......+++.+|+.+++.++||||+++..++.+.+..|+|||||+|
T Consensus       348 ~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~-~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~g  423 (540)
T 3en9_A          348 AEADIKRD--SYLDFDVIIKERVKKGYRDE-RL-DENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYING  423 (540)
T ss_dssp             CCEEEEEE--ECSSCEEEEEEECCCTTSCH-HH-HHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCS
T ss_pred             CCEEEEEE--EECCCeEEEEEEecccccch-hh-hhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCC
Confidence            78899988  34567778886655333222 11 1122456789999999999999999665555577778999999999


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCC
Q psy11571         98 GDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGD  177 (372)
Q Consensus        98 g~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  177 (372)
                      ++|.+++..         +..++.|++.||.|||++||+|          |||||+|||++.  .+||+|||+++.....
T Consensus       424 gsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiH----------rDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          424 KLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIH----------NDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             EEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEEC----------TTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             CCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCcc----------CCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            999999864         5689999999999999999999          999999999988  9999999999987543


Q ss_pred             Cccc------ccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCC
Q psy11571        178 GTVQ------SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY  231 (372)
Q Consensus       178 ~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~  231 (372)
                      ....      ....+||+.|+|||++....   ..|+..+|+||..+-..+.+.++.+|.
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~---~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFL---EGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHH---HHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHH---HHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            2211      23568999999999997422   346778999999988888887776663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.85  E-value=1.5e-22  Score=185.63  Aligned_cols=144  Identities=15%  Similarity=0.063  Sum_probs=108.9

Q ss_pred             cCCccEEEeeeehhhhhhhhhhhcccchhhhh--hHH------HHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCeE
Q psy11571         17 QGKGRVFSIETLLDILLVLYDECCNSSLRREK--TVS------DFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNL   88 (372)
Q Consensus        17 ~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~--~~~------~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~~   88 (372)
                      |++|.||.+.. .+++.||+|.+.........  ...      ........+.+|+.+++.++  | +++.+++.. +..
T Consensus       101 G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~  175 (282)
T 1zar_A          101 GKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW-EGN  175 (282)
T ss_dssp             CSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETT
T ss_pred             CCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec-cce
Confidence            48999999988 78999999988654322110  000      00123456889999999998  4 666665544 456


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeec
Q psy11571         89 YLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADF  168 (372)
Q Consensus        89 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Df  168 (372)
                      |+||||++|++|.+ +..       .....++.|++.||.|||++||+|          |||||+|||++ ++.+||+||
T Consensus       176 ~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~giiH----------rDlkp~NILl~-~~~vkl~DF  236 (282)
T 1zar_A          176 AVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRGIVH----------GDLSQYNVLVS-EEGIWIIDF  236 (282)
T ss_dssp             EEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTTEEC----------SCCSTTSEEEE-TTEEEECCC
T ss_pred             EEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCCCEe----------CCCCHHHEEEE-CCcEEEEEC
Confidence            99999999999987 421       235579999999999999999999          99999999999 999999999


Q ss_pred             CcccccCCCCcccccccccCCcccCccccc
Q psy11571        169 GSCLRLGGDGTVQSNVAVGTPDYISPEILT  198 (372)
Q Consensus       169 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~  198 (372)
                      |+|+.              +..++|||.+.
T Consensus       237 G~a~~--------------~~~~~a~e~l~  252 (282)
T 1zar_A          237 PQSVE--------------VGEEGWREILE  252 (282)
T ss_dssp             TTCEE--------------TTSTTHHHHHH
T ss_pred             CCCeE--------------CCCCCHHHHHH
Confidence            99853              44578899885

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.72  E-value=1.9e-18  Score=156.35  Aligned_cols=139  Identities=15%  Similarity=0.113  Sum_probs=99.7

Q ss_pred             ccCCccEEEeeeehhhhh--hhhhhhcccchhhhh--hH------------HHHHHHHHHHHHHHHHHhcCCCCce--ee
Q psy11571         16 IQGKGRVFSIETLLDILL--VLYDECCNSSLRREK--TV------------SDFIEFVAKLREERDVLVYGDRRWI--TN   77 (372)
Q Consensus        16 ~~g~G~v~~v~~~~~~~~--va~K~~~~~~~~~~~--~~------------~~~~~~~~~l~~E~~il~~l~hp~I--v~   77 (372)
                      .|++|.||.+....+|+.  ||+|...........  ..            .........+.+|..+|..+.|++|  +.
T Consensus        57 ~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~  136 (258)
T 1zth_A           57 TGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSVPQ  136 (258)
T ss_dssp             ECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             ecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCCCCCe
Confidence            448899999988778888  999986543211100  00            0001122457789999988877753  34


Q ss_pred             eeEEEEeCCeEEEEEeccCC-C----CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hcCceecCCCCCCCcCCCCC
Q psy11571         78 LHYAFQDDSNLYLVMDYYCG-G----DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIH-DLHYVHRPNHFAFHLCRDIK  151 (372)
Q Consensus        78 l~~~~~~~~~~~lv~E~~~g-g----~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH-~~~ivH~~~~~~~~vhrDlk  151 (372)
                      .+..    +..++||||+.+ |    +|.++...    .++..+..++.|++.+|.||| +.||+|          ||||
T Consensus       137 ~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givH----------rDlk  198 (258)
T 1zth_A          137 PYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVH----------ADLS  198 (258)
T ss_dssp             EEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEEC----------SSCS
T ss_pred             EEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEe----------CCCC
Confidence            4432    246899999942 3    77776433    245678899999999999999 999999          9999


Q ss_pred             cCcEEeCCCCcEEEeecCccccc
Q psy11571        152 PDNVLLDANGHIRLADFGSCLRL  174 (372)
Q Consensus       152 p~NIll~~~~~vkl~Dfg~a~~~  174 (372)
                      |+|||++.  .++|+|||+|...
T Consensus       199 p~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          199 EYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TTSEEESS--SEEECCCTTCEET
T ss_pred             HHHEEEcC--cEEEEECcccccC
Confidence            99999988  8999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.50  E-value=5.9e-15  Score=139.63  Aligned_cols=139  Identities=8%  Similarity=0.035  Sum_probs=90.9

Q ss_pred             ccCCccEEEeeeehhhhhhhhhhhcccchh-----h------hhhHHHHHHHH-HHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571         16 IQGKGRVFSIETLLDILLVLYDECCNSSLR-----R------EKTVSDFIEFV-AKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus        16 ~~g~G~v~~v~~~~~~~~va~K~~~~~~~~-----~------~~~~~~~~~~~-~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      .||+|.||.+.+ .+|+.||+|........     .      .....+..... -...+|...|..+.+.++.-. ..+.
T Consensus       105 ~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp-~p~~  182 (397)
T 4gyi_A          105 VGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVP-EPIA  182 (397)
T ss_dssp             ECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCC-CEEE
T ss_pred             eCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCC-eeee
Confidence            348899999976 47899999976543211     0      00011111111 112356677776644443221 1111


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC--
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG--  161 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~--  161 (372)
                      ... .++||||+.|++|..+..       .+.+..++.||+.+|.+||+.||||          |||||.|||++.+|  
T Consensus       183 ~~~-~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~~gIVH----------rDLKp~NILl~~dgd~  244 (397)
T 4gyi_A          183 QSR-HTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAKHGLIH----------GDFNEFNILIREEKDA  244 (397)
T ss_dssp             EET-TEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHHTTEEC----------SCCSTTSEEEEEEECS
T ss_pred             ccC-ceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHHCCCcC----------CCCCHHHEEEeCCCCc
Confidence            122 379999999988855421       2245678899999999999999999          99999999998776  


Q ss_pred             --------cEEEeecCccccc
Q psy11571        162 --------HIRLADFGSCLRL  174 (372)
Q Consensus       162 --------~vkl~Dfg~a~~~  174 (372)
                              .+.|+||+-+...
T Consensus       245 ~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          245 EDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             SCTTSEEEEEEECCCTTCEET
T ss_pred             ccccccccceEEEEeCCcccC
Confidence                    3899999977653

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.11  E-value=1.3e-10  Score=104.61  Aligned_cols=136  Identities=12%  Similarity=0.093  Sum_probs=95.0

Q ss_pred             CccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCeEEEEEeccCC
Q psy11571         19 KGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLHYAFQDDSNLYLVMDYYCG   97 (372)
Q Consensus        19 ~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv~E~~~g   97 (372)
                      .+.||.+..  .+..+++|..........          ..+.+|..+++.+. +..+.++++++.+.+..|+|||+++|
T Consensus        27 ~~~v~~~~~--~~~~~vlK~~~~~~~~~~----------~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G   94 (263)
T 3tm0_A           27 PAKVYKLVG--ENENLYLKMTDSRYKGTT----------YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG   94 (263)
T ss_dssp             SSEEEEEEC--SSCEEEEEEECGGGTTST----------TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred             CCeEEEEEC--CCCcEEEEeCCcccCCCH----------HHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCC
Confidence            345888753  357888887654321111          12567888888764 67788999999998999999999999


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCce------------------------e----------------
Q psy11571         98 GDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYV------------------------H----------------  137 (372)
Q Consensus        98 g~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~iv------------------------H----------------  137 (372)
                      .+|.+.+.      +......++.+++.+|+.||+...-                        .                
T Consensus        95 ~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (263)
T 3tm0_A           95 VLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR  168 (263)
T ss_dssp             EEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred             eehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence            99987631      1123346788999999999982110                        0                


Q ss_pred             ---------cCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCccc
Q psy11571        138 ---------RPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCL  172 (372)
Q Consensus       138 ---------~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~  172 (372)
                               .+..+..++|+|++|.||+++.++.+.|+||+.+.
T Consensus       169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                     00122446779999999999765556799999764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.97  E-value=6.3e-10  Score=99.42  Aligned_cols=131  Identities=16%  Similarity=0.141  Sum_probs=88.6

Q ss_pred             ccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCc--eeeeeEEEEeCCeEEEEEeccCC
Q psy11571         20 GRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRW--ITNLHYAFQDDSNLYLVMDYYCG   97 (372)
Q Consensus        20 G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~--Iv~l~~~~~~~~~~~lv~E~~~g   97 (372)
                      +.||.+. ..++..+++|.......             ..+.+|..+++.+.+.+  +.+++.+..+++..++||||++|
T Consensus        34 ~~v~~~~-~~~g~~~vlK~~~~~~~-------------~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G   99 (264)
T 1nd4_A           34 AAVFRLS-AQGRPVLFVKTDLSGAL-------------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   99 (264)
T ss_dssp             CEEEEEE-CTTSCCEEEEEECSCTT-------------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             ceEEEEe-cCCCCeEEEEeCCcccc-------------hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCC
Confidence            6788884 34667788897654311             12456777777664333  67788888888889999999999


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCcee----------------------------------------
Q psy11571         98 GDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVH----------------------------------------  137 (372)
Q Consensus        98 g~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH----------------------------------------  137 (372)
                      .+|.  ..    ...   ...++.+++..|..||+...-.                                        
T Consensus       100 ~~l~--~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (264)
T 1nd4_A          100 QDLL--SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  170 (264)
T ss_dssp             EETT--TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             cccC--cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence            8883  21    122   2356778888888888754100                                        


Q ss_pred             --------cCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571        138 --------RPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus       138 --------~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                              ....+..++|+|++|.||+++.++.+.|+||+.+..
T Consensus       171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                    001122367799999999997766667999998643

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.84  E-value=6.2e-09  Score=98.03  Aligned_cols=142  Identities=15%  Similarity=0.154  Sum_probs=96.2

Q ss_pred             CCccEEEeeeehhhhhhhhhhhc--ccchhhhhhHHHHHHHHHHHHHHHHHHhcCC--CCceeeeeEEEEeC---CeEEE
Q psy11571         18 GKGRVFSIETLLDILLVLYDECC--NSSLRREKTVSDFIEFVAKLREERDVLVYGD--RRWITNLHYAFQDD---SNLYL   90 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~--~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~--hp~Iv~l~~~~~~~---~~~~l   90 (372)
                      ..+.+|.+...  +..+++|...  ......         ....+.+|..+++.+.  +..+++++.++.+.   +..|+
T Consensus        50 ~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~---------~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~  118 (359)
T 3dxp_A           50 QSNPTFKLVTP--GQTYVMRAKPGPKSKLLP---------SAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY  118 (359)
T ss_dssp             CCSCEEEEECS--SCEEEEECCCC-------------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred             ccceEEEEEEC--CceEEEEeCCCCCCCCCC---------cHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence            44668877542  3566666554  221111         1234667888888776  45688999888776   45899


Q ss_pred             EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceec--------------------------------
Q psy11571         91 VMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHR--------------------------------  138 (372)
Q Consensus        91 v~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~--------------------------------  138 (372)
                      ||||++|..+.+..   -..++..+...++.+++..|+.||+...-..                                
T Consensus       119 vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          119 IMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            99999998775421   2347788889999999999999998421100                                


Q ss_pred             -------------CC---CCCCCcCCCCCcCcEEeCCCCc--EEEeecCcccc
Q psy11571        139 -------------PN---HFAFHLCRDIKPDNVLLDANGH--IRLADFGSCLR  173 (372)
Q Consensus       139 -------------~~---~~~~~vhrDlkp~NIll~~~~~--vkl~Dfg~a~~  173 (372)
                                   +.   .+..++|+|++|.|||++.++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                         00   1345778999999999987653  68999998865

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.67  E-value=2.9e-09  Score=97.94  Aligned_cols=166  Identities=17%  Similarity=0.268  Sum_probs=103.5

Q ss_pred             HHHHHHHHHHhcC-CCCc--eeeeeEEEEeCC---eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Q psy11571         58 AKLREERDVLVYG-DRRW--ITNLHYAFQDDS---NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIH  131 (372)
Q Consensus        58 ~~l~~E~~il~~l-~hp~--Iv~l~~~~~~~~---~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH  131 (372)
                      ..+.+|..+|+.+ .+..  +.+++.......   ..|+|||+++|.+|.....   ..++.++...++.+++..|+.||
T Consensus        55 ~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH  131 (304)
T 3sg8_A           55 TNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELH  131 (304)
T ss_dssp             HHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHH
Confidence            4577888888766 3322  445555443333   3489999999998876443   34788888999999999999999


Q ss_pred             hcCc---------------------------------------------ee---cCCCCCCCcCCCCCcCcEEeCC--CC
Q psy11571        132 DLHY---------------------------------------------VH---RPNHFAFHLCRDIKPDNVLLDA--NG  161 (372)
Q Consensus       132 ~~~i---------------------------------------------vH---~~~~~~~~vhrDlkp~NIll~~--~~  161 (372)
                      +...                                             +.   ....+..++|+|++|.||+++.  .+
T Consensus       132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~  211 (304)
T 3sg8_A          132 SINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNT  211 (304)
T ss_dssp             HSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTE
T ss_pred             cCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCC
Confidence            7321                                             00   0123345788999999999987  45


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcc---cCcccccccccCCC---------CCCCccceeehhHHHHHHhhCCCC
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDY---ISPEILTAMEEGRG---------RYGPECDWWSLGVCMYEMLYGETP  229 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y---~aPE~~~~~~~~~~---------~~~~~~DiwslGvil~elltG~~P  229 (372)
                      .+.|+||+.+........     ......+   ..|+.....-.+.+         ......+.|++|.++|.+.+|..+
T Consensus       212 ~~~~iD~~~~~~~~~~~D-----l~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~  286 (304)
T 3sg8_A          212 ICGIIDFGDAAISDPDND-----FISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMD  286 (304)
T ss_dssp             EEEECCCTTCEEECTTHH-----HHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHH
T ss_pred             EEEEEeCCCCccCChHHH-----HHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHH
Confidence            678999998865321100     0001111   12222110000000         011225889999999999999987


Q ss_pred             CC
Q psy11571        230 FY  231 (372)
Q Consensus       230 f~  231 (372)
                      |.
T Consensus       287 ~~  288 (304)
T 3sg8_A          287 WY  288 (304)
T ss_dssp             HH
T ss_pred             HH
Confidence            73

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.28  E-value=4.1e-06  Score=75.11  Aligned_cols=135  Identities=11%  Similarity=0.130  Sum_probs=94.3

Q ss_pred             cEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCeEEEEEeccCCCC
Q psy11571         21 RVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLHYAFQDDSNLYLVMDYYCGGD   99 (372)
Q Consensus        21 ~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv~E~~~gg~   99 (372)
                      .||.+....++..+.+|......             ...+.+|..+|+.+. +--+.+++.++.+.+..|+|||+++|.+
T Consensus        40 ~v~rl~~~~~~~~~~lk~~~~~~-------------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           40 TIYRLYGKPNAPELFLKHGKGSV-------------ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEEEEECCTTCCCEEEEEEETHH-------------HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             eEEEEEecCCCeEEEEEECCCCC-------------HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            47887766667778887543221             123567888887653 3337788888899999999999999999


Q ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCcee------------------------------------------
Q psy11571        100 LLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVH------------------------------------------  137 (372)
Q Consensus       100 L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH------------------------------------------  137 (372)
                      +.+.....     ......+..++...|..||+...-.                                          
T Consensus       107 ~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          107 AFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             ccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            88876541     2233456778888888888632100                                          


Q ss_pred             ------cCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571        138 ------RPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus       138 ------~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                            ....+..++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                  012234468999999999998777677999997743

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.22  E-value=7.2e-06  Score=75.26  Aligned_cols=113  Identities=17%  Similarity=0.137  Sum_probs=82.7

Q ss_pred             HHHHHHHHHHhcCCCC---ceeeeeEEEE-eCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhc
Q psy11571         58 AKLREERDVLVYGDRR---WITNLHYAFQ-DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDL  133 (372)
Q Consensus        58 ~~l~~E~~il~~l~hp---~Iv~l~~~~~-~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~  133 (372)
                      ..+.+|..+|..+.+.   .+.+.+.+.. ..+..|+|||+++|.+|....-   ..++..+...++.++...|+.||+.
T Consensus        54 ~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~  130 (306)
T 3tdw_A           54 DELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAF  130 (306)
T ss_dssp             HHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHS
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcC
Confidence            4578899999887642   3566666664 3456789999999999877432   3467788888899999999999975


Q ss_pred             Ccee-------------------------------------------------c-CCCCCCCcCCCCCcCcEEeCC---C
Q psy11571        134 HYVH-------------------------------------------------R-PNHFAFHLCRDIKPDNVLLDA---N  160 (372)
Q Consensus       134 ~ivH-------------------------------------------------~-~~~~~~~vhrDlkp~NIll~~---~  160 (372)
                      ..-.                                                 . ...+..++|+|++|.||+++.   +
T Consensus       131 ~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~  210 (306)
T 3tdw_A          131 PVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQ  210 (306)
T ss_dssp             CHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSS
T ss_pred             CcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCC
Confidence            4310                                                 0 013445689999999999987   4


Q ss_pred             CcE-EEeecCcccc
Q psy11571        161 GHI-RLADFGSCLR  173 (372)
Q Consensus       161 ~~v-kl~Dfg~a~~  173 (372)
                      +.+ .|+||+.+..
T Consensus       211 ~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          211 TPLTGIIDFGDAAI  224 (306)
T ss_dssp             CCEEEECCCTTCEE
T ss_pred             CceEEEEehhhcCC
Confidence            554 8999998754

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.61  E-value=0.00021  Score=61.47  Aligned_cols=122  Identities=16%  Similarity=0.137  Sum_probs=81.7

Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCC
Q psy11571         98 GDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD-LHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGG  176 (372)
Q Consensus        98 g~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  176 (372)
                      -+|.++|+..+.+++|++++.++.|.+.+|.-+-. ..-..          +=+.|..|++..+|.|.+.+ +.+.    
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~----------~i~~~~~i~l~~dG~V~f~~-~~s~----   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRH----------RVRSAAQIRVWRDGAVTLAP-AADD----   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCC----------CCCSGGGEEEETTSCEEECC-C-------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCc----------eecCCcceEEecCCceeccc-cccc----
Confidence            38999999988999999999999999999876521 11111          33557899999999887764 1110    


Q ss_pred             CCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhccCCcCCCCCCC
Q psy11571        177 DGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVG  256 (372)
Q Consensus       177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  256 (372)
                               .....+.|||...      ...+.+.=|||||+++|..+-=                       .++....
T Consensus        98 ---------~~~~~~~~pe~~~------~~~te~~~IysLG~tLY~ALDy-----------------------gL~e~eE  139 (229)
T 2yle_A           98 ---------AGEPPPVAGKLGY------SQCMETEVIESLGIIIYKALDY-----------------------GLKENEE  139 (229)
T ss_dssp             ------------------CCSS------SSSCHHHHHHHHHHHHHHHHTT-----------------------TCCTTEE
T ss_pred             ---------ccccCCCChhhcc------ccchHHHHHHHHHHHHHHHhhc-----------------------CCCcccc
Confidence                     1123566888764      2345677899999999988731                       1222222


Q ss_pred             CCCCHHHHHHHHHhcc
Q psy11571        257 YEISDDAKDLMRRLIC  272 (372)
Q Consensus       257 ~~~s~~~~~li~~lL~  272 (372)
                      ..+|+.+..||..|..
T Consensus       140 ~eLS~~LE~LL~~Mt~  155 (229)
T 2yle_A          140 RELSPPLEQLIDHMAN  155 (229)
T ss_dssp             ECCCHHHHHHHHHHTT
T ss_pred             hhhCHHHHHHHHHHHh
Confidence            3789999999999986

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.34  E-value=0.00033  Score=65.23  Aligned_cols=114  Identities=17%  Similarity=0.210  Sum_probs=67.1

Q ss_pred             HHHHHHHHhcCC---CCceeeeeEEEEeC---CeEEEEEeccCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHH
Q psy11571         60 LREERDVLVYGD---RRWITNLHYAFQDD---SNLYLVMDYYCGGDLLTLLSKF-----EDRLPEDMAKFYIAEMVLAIA  128 (372)
Q Consensus        60 l~~E~~il~~l~---hp~Iv~l~~~~~~~---~~~~lv~E~~~gg~L~~~l~~~-----~~~l~~~~~~~~~~qi~~~L~  128 (372)
                      +.+|..+++.+.   .-.+.+++.+..+.   +..|+|||+++|.++.+.+...     -..++..+...++.++...|+
T Consensus        74 ~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La  153 (357)
T 3ats_A           74 LDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALA  153 (357)
T ss_dssp             HHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHH
Confidence            344555555442   23467777776655   3568999999987764321000     002344444455556666666


Q ss_pred             HHHhcCc-------e-------------------------------------------ecCC----CCCCCcCCCCCcCc
Q psy11571        129 SIHDLHY-------V-------------------------------------------HRPN----HFAFHLCRDIKPDN  154 (372)
Q Consensus       129 ~LH~~~i-------v-------------------------------------------H~~~----~~~~~vhrDlkp~N  154 (372)
                      -||+...       +                                           +.+.    .+..++|+|+.|.|
T Consensus       154 ~LH~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l~HgDl~~~N  233 (357)
T 3ats_A          154 TLHSIPNAQNTFSFLTQGRTSDTTLHRHFNWVRSWYDFAVEGIGRSPLLERTFEWLQSHWPDDAAAREPVLLWGDARVGN  233 (357)
T ss_dssp             HHTTCSSHHHHTGGGC-----CCHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHTCCHHHHHSCCEEECSSCSGGG
T ss_pred             HHhCCCCccCChhhccCCCCCCchHHHHHHHHHHHHHhhccCCCCChHHHHHHHHHHHhCCCcccCCCceEEeCCCCCCe
Confidence            6664211       0                                           0000    14566789999999


Q ss_pred             EEeCCCCcEEEeecCcccc
Q psy11571        155 VLLDANGHIRLADFGSCLR  173 (372)
Q Consensus       155 Ill~~~~~vkl~Dfg~a~~  173 (372)
                      ||+++++.+.|+||+.+..
T Consensus       234 il~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          234 VLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             EEEETTEEEEECCGGGCEE
T ss_pred             EEEeCCcEEEEEccccccc
Confidence            9998644578999998754

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.20  E-value=0.0017  Score=59.71  Aligned_cols=26  Identities=27%  Similarity=0.349  Sum_probs=23.4

Q ss_pred             CCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571        148 RDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus       148 rDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                      +|+++.||+++.++.+.|+||+.+..
T Consensus       227 gD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          227 QDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             SSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             CCCCcccEEEeCCCcEEEEehhhccc
Confidence            99999999998888899999997743

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.18  E-value=0.00075  Score=63.89  Aligned_cols=29  Identities=7%  Similarity=0.148  Sum_probs=23.7

Q ss_pred             CCcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571        144 FHLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus       144 ~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                      .++|+|+.|.|||++.+ .++++||..+..
T Consensus       228 ~L~HGDl~~~Nil~~~~-~~~lID~e~a~~  256 (397)
T 2olc_A          228 TLIHGDLHTGSIFASEH-ETKVIDPEFAFY  256 (397)
T ss_dssp             EEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             ceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence            44569999999999765 489999987754

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.15  E-value=0.00095  Score=61.21  Aligned_cols=66  Identities=12%  Similarity=0.081  Sum_probs=44.8

Q ss_pred             ccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC---CCceeeeeEEEEeCCeEEEEEeccC
Q psy11571         20 GRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD---RRWITNLHYAFQDDSNLYLVMDYYC   96 (372)
Q Consensus        20 G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~---hp~Iv~l~~~~~~~~~~~lv~E~~~   96 (372)
                      ..+|.+..  ++..+.+|......             ...+..|...|+.+.   ...+++.+.+....+..|+|||+++
T Consensus        50 n~~y~v~~--~~~~~vlK~~~~~~-------------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           50 NEIWLIND--EVQTVFVKINERSY-------------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             SEEEEEES--SSCEEEEEEEEGGG-------------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eeeeEEEE--CCCeEEEEeCCccc-------------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            44777653  45667777554321             133566777776653   3568888888888888999999999


Q ss_pred             CCCH
Q psy11571         97 GGDL  100 (372)
Q Consensus        97 gg~L  100 (372)
                      |..+
T Consensus       115 G~~~  118 (312)
T 3jr1_A          115 KSKN  118 (312)
T ss_dssp             CCCC
T ss_pred             CCCC
Confidence            8754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.70  E-value=0.0033  Score=57.85  Aligned_cols=32  Identities=19%  Similarity=0.264  Sum_probs=26.4

Q ss_pred             CCCCcCCCCCcCcEEeCCC----CcEEEeecCcccc
Q psy11571        142 FAFHLCRDIKPDNVLLDAN----GHIRLADFGSCLR  173 (372)
Q Consensus       142 ~~~~vhrDlkp~NIll~~~----~~vkl~Dfg~a~~  173 (372)
                      +..++|+|+.+.|||++.+    +.+.|+||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            3456679999999999874    6799999998865

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.25  E-value=0.0029  Score=59.60  Aligned_cols=32  Identities=25%  Similarity=0.281  Sum_probs=25.9

Q ss_pred             CCCCcCCCCCcCcEEeCCC----CcEEEeecCcccc
Q psy11571        142 FAFHLCRDIKPDNVLLDAN----GHIRLADFGSCLR  173 (372)
Q Consensus       142 ~~~~vhrDlkp~NIll~~~----~~vkl~Dfg~a~~  173 (372)
                      +..++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       219 ~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          219 PVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             CEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             CcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            3445669999999999876    7899999998753

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=95.71  E-value=0.017  Score=52.29  Aligned_cols=32  Identities=16%  Similarity=0.017  Sum_probs=25.5

Q ss_pred             CCCCCcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571        141 HFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus       141 ~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                      .+..++|+|+.+.||+ ..++.+.++||..+..
T Consensus       171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            3445678999999999 4667789999998754

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=94.61  E-value=0.052  Score=48.62  Aligned_cols=67  Identities=15%  Similarity=0.092  Sum_probs=39.8

Q ss_pred             CCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-C--CceeeeeEEEEeCCeEEEEEec
Q psy11571         18 GKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-R--RWITNLHYAFQDDSNLYLVMDY   94 (372)
Q Consensus        18 g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-h--p~Iv~l~~~~~~~~~~~lv~E~   94 (372)
                      ..+.||++. ..||+.+.+|..........          ..+..|...|+.+. .  --+++++.+  +.  -++|||+
T Consensus        27 ~~~~vyrv~-l~DG~~~~vK~~~~~~~~~~----------~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e~   91 (288)
T 3f7w_A           27 HRWHLYRVE-LADGTPLFVKALPDDAPALD----------GLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAMEW   91 (288)
T ss_dssp             TTEEEEEEE-ETTSCEEEEEECCTTCCCCT----------THHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEEC
T ss_pred             CCeEEEEEE-ECCCCEEEEEEeCCCCcchh----------hHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEEe
Confidence            345677774 56888899996543322211          12556777777653 1  234555544  22  3789999


Q ss_pred             cCCCC
Q psy11571         95 YCGGD   99 (372)
Q Consensus        95 ~~gg~   99 (372)
                      +.++.
T Consensus        92 l~~~~   96 (288)
T 3f7w_A           92 VDERP   96 (288)
T ss_dssp             CCCCC
T ss_pred             ecccC
Confidence            98764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=92.91  E-value=0.086  Score=50.02  Aligned_cols=26  Identities=12%  Similarity=0.178  Sum_probs=23.1

Q ss_pred             CCCCcCcEEeCCCCcEEEeecCccccc
Q psy11571        148 RDIKPDNVLLDANGHIRLADFGSCLRL  174 (372)
Q Consensus       148 rDlkp~NIll~~~~~vkl~Dfg~a~~~  174 (372)
                      +|++|.|||++.++ +.++||+.+...
T Consensus       237 GDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          237 GDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             SCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             cCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            99999999998776 999999988653

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=89.17  E-value=0.19  Score=45.48  Aligned_cols=30  Identities=23%  Similarity=0.160  Sum_probs=23.8

Q ss_pred             CCcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571        144 FHLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus       144 ~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                      .++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          188 GVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            344599999999998766568999997743

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=87.70  E-value=1.1  Score=38.34  Aligned_cols=83  Identities=7%  Similarity=-0.049  Sum_probs=56.7

Q ss_pred             CCCceeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHH-HHHhcCceecCCCCCCCcCCC
Q psy11571         71 DRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIA-SIHDLHYVHRPNHFAFHLCRD  149 (372)
Q Consensus        71 ~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~-~LH~~~ivH~~~~~~~~vhrD  149 (372)
                      .||++  -..+-.+.+.+.+.++.-+++.=...++    .++..+.++++.+|+.... ++  ..-+|          --
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~----~~~~~eKlrll~nl~~L~~~~~--~~r~t----------f~  109 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR----KTTLLSRIRAAIHLVSKVKHHS--ARRLI----------FI  109 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH----TSCHHHHHHHHHHHHHHHSSCC--SSSEE----------CC
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH----hcCHHHHHHHHHHHHHHHHHhh--hCcee----------EE
Confidence            57888  3334467777777777653443333443    3678888888888877555 33  33445          56


Q ss_pred             CCcCcEEeCCCCcEEEeecCcc
Q psy11571        150 IKPDNVLLDANGHIRLADFGSC  171 (372)
Q Consensus       150 lkp~NIll~~~~~vkl~Dfg~a  171 (372)
                      |.|+||+++.++.+++.-.|+-
T Consensus       110 l~P~NL~f~~~~~p~i~hRGi~  131 (219)
T 4ano_A          110 VCPENLMFNRALEPFFLHVGVK  131 (219)
T ss_dssp             CCGGGEEECTTCCEEESCCEET
T ss_pred             EeCceEEEeCCCcEEEEEcCCc
Confidence            8899999999999999877753

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=87.48  E-value=0.51  Score=42.67  Aligned_cols=29  Identities=17%  Similarity=0.271  Sum_probs=23.4

Q ss_pred             CCCcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571        143 AFHLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus       143 ~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                      ..++|+|+++.||+++ + .+.|+||+.+..
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            3345699999999998 4 899999987643

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=85.67  E-value=0.52  Score=43.18  Aligned_cols=30  Identities=23%  Similarity=0.311  Sum_probs=25.2

Q ss_pred             CCcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571        144 FHLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus       144 ~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                      .++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            344599999999999888899999987754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=85.36  E-value=0.39  Score=46.19  Aligned_cols=36  Identities=11%  Similarity=0.160  Sum_probs=23.3

Q ss_pred             HHHHHHHhcCCCC-ceeeeeEEEEeCCeEEEEEeccCCCCH
Q psy11571         61 REERDVLVYGDRR-WITNLHYAFQDDSNLYLVMDYYCGGDL  100 (372)
Q Consensus        61 ~~E~~il~~l~hp-~Iv~l~~~~~~~~~~~lv~E~~~gg~L  100 (372)
                      .+|..++..+... ...++++.+.  +.  +||||++|.+|
T Consensus       152 ~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~G~~l  188 (458)
T 2qg7_A          152 EREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMDGYAL  188 (458)
T ss_dssp             HHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCCSEEC
T ss_pred             HHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeCCccC
Confidence            3577777776533 3467777763  22  59999987443

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=84.50  E-value=0.29  Score=46.65  Aligned_cols=32  Identities=22%  Similarity=0.233  Sum_probs=23.8

Q ss_pred             CCCCcCCCCCcCcEEeCCC----------------------------CcEEEeecCcccc
Q psy11571        142 FAFHLCRDIKPDNVLLDAN----------------------------GHIRLADFGSCLR  173 (372)
Q Consensus       142 ~~~~vhrDlkp~NIll~~~----------------------------~~vkl~Dfg~a~~  173 (372)
                      +..++|+|+.+.|||++.+                            +.+.|+||..+..
T Consensus       248 ~~v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~  307 (429)
T 1nw1_A          248 PVTFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY  307 (429)
T ss_dssp             CEEEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred             CeEEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence            3445669999999999875                            6788999987653

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=84.47  E-value=1.1  Score=41.30  Aligned_cols=29  Identities=21%  Similarity=0.296  Sum_probs=22.7

Q ss_pred             CCcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571        144 FHLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus       144 ~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                      .++|+|+.+.|||++.++ +.|+||..+..
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            344599999999997654 89999987753

>2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A*

Probab=80.65  E-value=14  Score=37.10  Aligned_cols=25  Identities=44%  Similarity=0.610  Sum_probs=23.2

Q ss_pred             CCCCcCcEEeCCCCcEEEeecCccc
Q psy11571        148 RDIKPDNVLLDANGHIRLADFGSCL  172 (372)
Q Consensus       148 rDlkp~NIll~~~~~vkl~Dfg~a~  172 (372)
                      +|=.++||||+.+|++.=+|||.+-
T Consensus       551 GDRH~~NILid~tG~v~HIDFG~~f  575 (696)
T 2x6h_A          551 GDRHLDNLLLTTNGKLFHIDFGYIL  575 (696)
T ss_dssp             CCCCTTTEEECTTSCEEECCCCSCT
T ss_pred             CCCCCcceEEeCCCCEEEEeehhhh
Confidence            8889999999999999999999873

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=80.07  E-value=2.4  Score=36.02  Aligned_cols=83  Identities=7%  Similarity=0.030  Sum_probs=58.0

Q ss_pred             CCCceeeeeEEEEeCCeEEEEEeccCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCC
Q psy11571         71 DRRWITNLHYAFQDDSNLYLVMDYYCGG-DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRD  149 (372)
Q Consensus        71 ~hp~Iv~l~~~~~~~~~~~lv~E~~~gg-~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrD  149 (372)
                      .||+.+.. .+-++.+.+.+.++.-..+ ++.. +    ..++..+.++++.+|+....+++  .-+|          --
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i----k~~~~~eKlr~l~ni~~l~~~~~--~r~t----------f~  104 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I----KSFTKNEKLRYLLNIKNLEEVNR--TRYT----------FV  104 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G----GGSCHHHHHHHHHHGGGGGGGGG--SSEE----------CC
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H----HhcCHHHHHHHHHHHHHHHHHhc--CceE----------EE
Confidence            58888877 5666667777766654322 3333 3    34678888888888887664443  2345          66


Q ss_pred             CCcCcEEeCCCCcEEEeecCcc
Q psy11571        150 IKPDNVLLDANGHIRLADFGSC  171 (372)
Q Consensus       150 lkp~NIll~~~~~vkl~Dfg~a  171 (372)
                      |.|+||+++.++.+++.-.|+.
T Consensus       105 L~P~NL~f~~~~~p~i~~RGik  126 (215)
T 4ann_A          105 LAPDELFFTRDGLPIAKTRGLQ  126 (215)
T ss_dssp             CSGGGEEECTTSCEEESCCEET
T ss_pred             EecceEEEcCCCCEEEEEccCc
Confidence            8899999999999999877753

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	372
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-59
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	9e-58
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-57
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-54
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	8e-54
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-52
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-50
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-50
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-49
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-49
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	7e-49
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-47
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-46
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-46
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-45
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-45
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-45
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-45
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	8e-45
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-44
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	9e-42
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	9e-42
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-39
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-38
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-38
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-38
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	8e-38
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-37
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-37
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-36
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-36
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	9e-36
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	9e-36
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-35
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-35
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-34
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-33
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-33
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-33
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-33
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	9e-33
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-32
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-32
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-32
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-31
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-31
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-31
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-31
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	9e-31
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-30
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-30
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-30
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-30
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-30
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	9e-30
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-28
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-28
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-28
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-26
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-26
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-24
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-18
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-07

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 3e-59
 Identities = 98/326 (30%), Positives = 155/326 (47%), Gaps = 44/326 (13%)

Query: 46  REKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLS 105
           ++  V    +    + E+R + +  +  ++T++   FQ   NL+ VM+Y  GGDL+  + 
Sbjct: 36  KKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ 95

Query: 106 KFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRL 165
               +     A FY AE++L +  +H    V+R          D+K DN+LLD +GHI++
Sbjct: 96  S-CHKFDLSRATFYAAEIILGLQFLHSKGIVYR----------DLKLDNILLDKDGHIKI 144

Query: 166 ADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY 225
           ADFG C +    G  ++N   GTPDYI+PEIL        +Y    DWWS GV +YEML 
Sbjct: 145 ADFGMC-KENMLGDAKTNTFCGTPDYIAPEILL-----GQKYNHSVDWWSFGVLLYEMLI 198

Query: 226 GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLGQNGIA 284
           G++PF+ +   E +  I      +  P      +  +AKDL+ +L     + RLG  G  
Sbjct: 199 GQSPFHGQDEEELFHSIRMDNPFY--PRW----LEKEAKDLLVKLFVREPEKRLGVRGDI 252

Query: 285 DFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFDVDEAGVR 342
                           R HP F+ I W+ +  ++ + P+ P+V SP D S+FD +   + 
Sbjct: 253 ----------------RQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEF--LN 294

Query: 343 ASDALPPAAASPALSALHLPFVGFTF 368
               L  A  +   S     F  F+F
Sbjct: 295 EKPRLSFADRALINSMDQNMFRNFSF 320

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 9e-58
 Identities = 75/282 (26%), Positives = 129/282 (45%), Gaps = 37/282 (13%)

Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTL 103
           L +   + +    V  +  ERDV+   D  +   L++ FQDD  LY  + Y   G+LL  
Sbjct: 41  LEKRHIIKE--NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKY 98

Query: 104 LSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI 163
           + K      E   +FY AE+V A+  +H    +HR          D+KP+N+LL+ + HI
Sbjct: 99  IRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHR----------DLKPENILLNEDMHI 147

Query: 164 RLADFGSC-LRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYE 222
           ++ DFG+  +        ++N  VGT  Y+SPE+LT             D W+LG  +Y+
Sbjct: 148 QITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT-----EKSACKSSDLWALGCIIYQ 202

Query: 223 MLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQN 281
           ++ G  PF A +    + KI+  +  +D P          A+DL+ +L+   +  RLG  
Sbjct: 203 LVAGLPPFRAGNEYLIFQKIIKLE--YDFPEK----FFPKARDLVEKLLVLDATKRLGCE 256

Query: 282 GIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIP 323
            +  +              + HP+F+ + W+++     P + 
Sbjct: 257 EMEGYGPL-----------KAHPFFESVTWENLHQQTPPKLT 287

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 2e-57
 Identities = 102/339 (30%), Positives = 148/339 (43%), Gaps = 49/339 (14%)

Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTL 103
           LR+E  ++   + VA    E  VL      ++T L YAFQ    L  VM+Y  GG+L   
Sbjct: 38  LRKEVIIAK--DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFH 95

Query: 104 LSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI 163
           LS+ E    E+ A+FY AE+V A+  +H    V+R          DIK +N++LD +GHI
Sbjct: 96  LSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYR----------DIKLENLMLDKDGHI 144

Query: 164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM 223
           ++ DFG C     DG        GTP+Y++PE+L         YG   DWW LGV MYEM
Sbjct: 145 KITDFGLCKEGISDGATMKTF-CGTPEYLAPEVLE-----DNDYGRAVDWWGLGVVMYEM 198

Query: 224 LYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLG--Q 280
           + G  PFY +     +  I+  +     P      +S +AK L+  L+      RLG   
Sbjct: 199 MCGRLPFYNQDHERLFELILMEE--IRFPRT----LSPEAKSLLAGLLKKDPKQRLGGGP 252

Query: 281 NGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFDVDE 338
           +   +                 H +F  I W  +  +    P+ P+V+S  DT +FD + 
Sbjct: 253 SDAKEVM--------------EHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEF 298

Query: 339 AGVRASDALPPAAASPALSAL-----HLPFVGFTFTQGW 372
                +   P    S  L  L        F  F +   W
Sbjct: 299 TAQSITITPPDRYDSLGLLELDQREEQEMFEDFDYIADW 337

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  179 bits (456), Expect = 7e-54
 Identities = 72/330 (21%), Positives = 131/330 (39%), Gaps = 46/330 (13%)

Query: 45  RREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLL 104
           ++   +          R    ++  GD  +I  + YAF     L  ++D   GGDL   L
Sbjct: 39  KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL 98

Query: 105 SKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIR 164
           S+      E   +FY AE++L +  +H+   V+R          D+KP N+LLD +GH+R
Sbjct: 99  SQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYR----------DLKPANILLDEHGHVR 147

Query: 165 LADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML 224
           ++D G           + + +VGT  Y++PE+L    +    Y    DW+SLG  ++++L
Sbjct: 148 ISDLGLACDFSKK---KPHASVGTHGYMAPEVL----QKGVAYDSSADWFSLGCMLFKLL 200

Query: 225 YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLG--QN 281
            G +PF      + +      + +  +  ++    S + + L+  L+    + RLG    
Sbjct: 201 RGHSPFRQHKTKDKHEID---RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGR 257

Query: 282 GIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFDVDEA 339
           G  + K                P+F+ + W  +  +    P IP          FD+   
Sbjct: 258 GAQEVK--------------ESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSF 303

Query: 340 GVRASDALPPAAASPALSALHLPFVGFTFT 369
               +  +    +   L      +  F  T
Sbjct: 304 DEEDTKGIKLLDSDQEL------YRNFPLT 327

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 8e-54
 Identities = 60/264 (22%), Positives = 111/264 (42%), Gaps = 34/264 (12%)

Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPED 114
           E +     E D+L   D   I  L  AF  ++NL++++++  GG +  ++ + E  L E 
Sbjct: 51  EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTES 110

Query: 115 MAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL 174
             +    + + A+  +HD   +H          RD+K  N+L   +G I+LADFG   + 
Sbjct: 111 QIQVVCKQTLDALNYLHDNKIIH----------RDLKAGNILFTLDGDIKLADFGVSAKN 160

Query: 175 GGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES 234
                 + +  +GTP +++PE++         Y  + D WSLG+ + EM   E P +  +
Sbjct: 161 TRTIQRRDSF-IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 219

Query: 235 LVETYGKIMNHQ-NSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSAL 292
            +    KI   +  +   PS      S + KD +++ +  + D R      +        
Sbjct: 220 PMRVLLKIAKSEPPTLAQPSR----WSSNFKDFLKKCLEKNVDARW---TTSQLL----- 267

Query: 293 FVSLSISPRNHPWFQGIAWDSIRD 316
                     HP+    +   IR+
Sbjct: 268 ---------QHPFVTVDSNKPIRE 282

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  173 bits (439), Expect = 5e-52
 Identities = 102/298 (34%), Positives = 146/298 (48%), Gaps = 48/298 (16%)

Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTL 103
           L++E  V    + V    +ER +L      +I  +   FQD   ++++MDY   G  L  
Sbjct: 37  LKKEIVVRL--KQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY-IEGGELFS 93

Query: 104 LSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI 163
           L +   R P  +AKFY AE+ LA+  +H    ++R          D+KP+N+LLD NGHI
Sbjct: 94  LLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYR----------DLKPENILLDKNGHI 143

Query: 164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM 223
           ++ DFG    +            GTPDYI+PE+++        Y    DWWS G+ +YEM
Sbjct: 144 KITDFGFAKYVPDVTYTL----CGTPDYIAPEVVS-----TKPYNKSIDWWSFGILIYEM 194

Query: 224 LYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLG--Q 280
           L G TPFY  + ++TY KI+N +     P       ++D KDL+ RLI      RLG  Q
Sbjct: 195 LAGYTPFYDSNTMKTYEKILNAE--LRFPPF----FNEDVKDLLSRLITRDLSQRLGNLQ 248

Query: 281 NGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEV-SSPTDTSHFD 335
           NG  D K              NHPWF+ + W+ +  R+   PY P +     DTS FD
Sbjct: 249 NGTEDVK--------------NHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFD 292

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 2e-50
 Identities = 92/291 (31%), Positives = 142/291 (48%), Gaps = 36/291 (12%)

Query: 46  REKTVSDFIEFVAKLREERDVLVY-GDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLL 104
           ++ T+    +     R ER VL +     ++  LHYAFQ ++ L+L++DY  GG+L T L
Sbjct: 61  KKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL 120

Query: 105 SKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIR 164
           S+  +R  E   + Y+ E+VLA+  +H L  ++R          DIK +N+LLD+NGH+ 
Sbjct: 121 SQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYR----------DIKLENILLDSNGHVV 169

Query: 165 LADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML 224
           L DFG       D T ++    GT +Y++P+I+   + G   +    DWWSLGV MYE+L
Sbjct: 170 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSG---HDKAVDWWSLGVLMYELL 226

Query: 225 YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLG--QN 281
            G +PF  +    +  +I       + P     E+S  AKDL++RL+      RLG    
Sbjct: 227 TGASPFTVDGEKNSQAEISRRILKSEPPYP--QEMSALAKDLIQRLLMKDPKKRLGCGPR 284

Query: 282 GIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSN--APYIPEVSSPTD 330
              + K               H +FQ I WD +      AP+ P +    D
Sbjct: 285 DADEIK--------------EHLFFQKINWDDLAAKKVPAPFKPVIRDELD 321

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (425), Expect = 2e-50
 Identities = 68/255 (26%), Positives = 109/255 (42%), Gaps = 43/255 (16%)

Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPED 114
               +LR E ++  +     I  L+  F D + +YL+++Y   G +   L K   +  E 
Sbjct: 48  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQ 106

Query: 115 MAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL 174
               YI E+  A++  H    +HR          DIKP+N+LL + G +++ADFG  +  
Sbjct: 107 RTATYITELANALSYCHSKRVIHR----------DIKPENLLLGSAGELKIADFGWSVHA 156

Query: 175 GGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES 234
                 +     GT DY+ PE++         +  + D WSLGV  YE L G+ PF A +
Sbjct: 157 PSS---RRTTLCGTLDYLPPEMIE-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 208

Query: 235 LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLGQNGIADFKMWSALF 293
             ETY +I   +  F  P      +++ A+DL+ RL+  +   R          +   L 
Sbjct: 209 YQETYKRISRVE--FTFPDF----VTEGARDLISRLLKHNPSQRPM--------LREVL- 253

Query: 294 VSLSISPRNHPWFQG 308
                    HPW   
Sbjct: 254 --------EHPWITA 260

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  168 bits (427), Expect = 1e-49
 Identities = 58/288 (20%), Positives = 115/288 (39%), Gaps = 39/288 (13%)

Query: 51  SDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR 110
           + +      ++ E  ++       + NLH AF+D   + L++++  GG+L   ++  + +
Sbjct: 64  TPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK 123

Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA--NGHIRLADF 168
           + E     Y+ +    +  +H+   VH           DIKP+N++ +      +++ DF
Sbjct: 124 MSEAEVINYMRQACEGLKHMHEHSIVH----------LDIKPENIMCETKKASSVKIIDF 173

Query: 169 GSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGET 228
           G   +L  D  V+      T ++ +PEI+      R   G   D W++GV  Y +L G +
Sbjct: 174 GLATKLNPDEIVKVT--TATAEFAAPEIVD-----REPVGFYTDMWAIGVLGYVLLSGLS 226

Query: 229 PFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK 287
           PF  E  +ET   +      ++   D    +S +AKD ++ L+      RL  +      
Sbjct: 227 PFAGEDDLETLQNVKRCD--WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA---- 280

Query: 288 MWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFD 335
                          HPW +G   +      +    ++       + D
Sbjct: 281 -------------LEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYAD 315

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  164 bits (416), Expect = 6e-49
 Identities = 70/256 (27%), Positives = 108/256 (42%), Gaps = 35/256 (13%)

Query: 55  EFVAKLREERDVLV-YGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPE 113
           E      +E D+L        I  L   ++ ++  +LV D    G+L   L++ +  L E
Sbjct: 51  ELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSE 109

Query: 114 DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR 173
              +  +  ++  I ++H L+ VHR          D+KP+N+LLD + +I+L DFG   +
Sbjct: 110 KETRKIMRALLEVICALHKLNIVHR----------DLKPENILLDDDMNIKLTDFGFSCQ 159

Query: 174 LGGDGTVQSNVAVGTPDYISPEILTAME-EGRGRYGPECDWWSLGVCMYEMLYGETPFYA 232
           L  D   +     GTP Y++PEI+     +    YG E D WS GV MY +L G  PF+ 
Sbjct: 160 L--DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 217

Query: 233 ESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSA 291
              +     IM+    F  P     + SD  KDL+ R +      R              
Sbjct: 218 RKQMLMLRMIMSGNYQFGSPEWD--DYSDTVKDLVSRFLVVQPQKRYTAEEA-------- 267

Query: 292 LFVSLSISPRNHPWFQ 307
                      HP+FQ
Sbjct: 268 ---------LAHPFFQ 274

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  166 bits (421), Expect = 7e-49
 Identities = 97/297 (32%), Positives = 151/297 (50%), Gaps = 47/297 (15%)

Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTL 103
           L ++K V    + +     E+ +L   +  ++  L ++F+D+SNLY+VM+Y  GG++ + 
Sbjct: 74  LDKQKVVKL--KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSH 131

Query: 104 LSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI 163
           L +   R  E  A+FY A++VL    +H L  ++R          D+KP+N+L+D  G+I
Sbjct: 132 LRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYR----------DLKPENLLIDQQGYI 180

Query: 164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM 223
           ++ DFG   R+ G          GTP+ ++PEI+         Y    DWW+LGV +YEM
Sbjct: 181 QVTDFGFAKRVKGRTWTL----CGTPEALAPEIIL-----SKGYNKAVDWWALGVLIYEM 231

Query: 224 LYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLG--Q 280
             G  PF+A+  ++ Y KI++ +     PS      S D KDL+R L+      R G  +
Sbjct: 232 AAGYPPFFADQPIQIYEKIVSGK--VRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLK 285

Query: 281 NGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDSNAPYIPEVSSPTDTSHFD 335
           NG+ D K              NH WF    W +I  R   AP+IP+   P DTS+FD
Sbjct: 286 NGVNDIK--------------NHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  162 bits (411), Expect = 2e-47
 Identities = 63/320 (19%), Positives = 126/320 (39%), Gaps = 43/320 (13%)

Query: 51  SDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR 110
           +        +R+E   +       + NLH AF+DD+ + ++ ++  GG+L   ++   ++
Sbjct: 61  TPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK 120

Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL--DANGHIRLADF 168
           + ED A  Y+ ++   +  +H+ +YVH           D+KP+N++     +  ++L DF
Sbjct: 121 MSEDEAVEYMRQVCKGLCHMHENNYVH----------LDLKPENIMFTTKRSNELKLIDF 170

Query: 169 GSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGET 228
           G    L    +V+     GT ++ +PE+           G   D WS+GV  Y +L G +
Sbjct: 171 GLTAHLDPKQSVKVT--TGTAEFAAPEVAE-----GKPVGYYTDMWSVGVLSYILLSGLS 223

Query: 229 PFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK 287
           PF  E+  ET   + +    +++       IS+D KD +R+L+    +TR+  +      
Sbjct: 224 PFGGENDDETLRNVKSCD--WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA---- 277

Query: 288 MWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFDVDEAGVRASDAL 347
                          HPW                       +  + +D     +     +
Sbjct: 278 -------------LEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRI 324

Query: 348 PPAAA----SPALSALHLPF 363
              ++     P   ++   F
Sbjct: 325 SNYSSLRKHRPQEYSIRDAF 344

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 1e-46
 Identities = 37/218 (16%), Positives = 81/218 (37%), Gaps = 14/218 (6%)

Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPED 114
           + +   + E  VL       I      +     L +V  +  G  L   L   E +    
Sbjct: 46  QQLQAFKNEVGVLRKTRHVNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMI 104

Query: 115 MAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG-SCLR 173
                  +    +  +H    +HR          D+K +N+ L  +  +++ DFG + ++
Sbjct: 105 KLIDIARQTAQGMDYLHAKSIIHR----------DLKSNNIFLHEDLTVKIGDFGLATVK 154

Query: 174 LGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE 233
               G+ Q     G+  +++PE++    + +  Y  + D ++ G+ +YE++ G+ P+   
Sbjct: 155 SRWSGSHQFEQLSGSILWMAPEVI--RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212

Query: 234 SLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           +  +    ++         S V        K LM   +
Sbjct: 213 NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECL 250

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 2e-46
 Identities = 50/259 (19%), Positives = 104/259 (40%), Gaps = 37/259 (14%)

Query: 51  SDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR 110
              ++    +++E  +    +   +   +   ++ +  YL ++Y  GG+L   +   +  
Sbjct: 41  KRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIG 99

Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGS 170
           +PE  A+ +  +++  +  +H +   HR          DIKP+N+LLD   +++++DFG 
Sbjct: 100 MPEPDAQRFFHQLMAGVVYLHGIGITHR----------DIKPENLLLDERDNLKISDFGL 149

Query: 171 CLRLGGDGTVQ-SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
                 +   +  N   GT  Y++PE+L    + R  +    D WS G+ +  ML GE P
Sbjct: 150 ATVFRYNNRERLLNKMCGTLPYVAPELL----KRREFHAEPVDVWSCGIVLTAMLAGELP 205

Query: 230 FYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLGQNGIADFKM 288
           +   S           + ++  P     +I      L+ +++  +   R+    I D K 
Sbjct: 206 WDQPSDSCQEYSDWKEKKTYLNPWK---KIDSAPLALLHKILVENPSARI---TIPDIK- 258

Query: 289 WSALFVSLSISPRNHPWFQ 307
                           W+ 
Sbjct: 259 -------------KDRWYN 264

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 1e-45
 Identities = 67/272 (24%), Positives = 110/272 (40%), Gaps = 44/272 (16%)

Query: 60  LREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFY 119
           +  E  V+       I N   ++     L++VM+Y  GG L  ++   E  + E      
Sbjct: 64  IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAV 121

Query: 120 IAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT 179
             E + A+  +H    +HR          DIK DN+LL  +G ++L DFG C ++  + +
Sbjct: 122 CRECLQALEFLHSNQVIHR----------DIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171

Query: 180 VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 239
            +S + VGTP +++PE++T     R  YGP+ D WSLG+   EM+ GE P+  E+ +   
Sbjct: 172 KRSTM-VGTPYWMAPEVVT-----RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225

Query: 240 GKI-MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLS 297
             I  N       P      +S   +D + R +    + R       +            
Sbjct: 226 YLIATNGTPELQNPEK----LSAIFRDFLNRCLDMDVEKRG---SAKELL---------- 268

Query: 298 ISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPT 329
                H + +     S   S  P I      T
Sbjct: 269 ----QHQFLKIAKPLS---SLTPLIAAAKEAT 293

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 2e-45
 Identities = 66/224 (29%), Positives = 101/224 (45%), Gaps = 23/224 (10%)

Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSN--LYLVMDYYCGGDLLTLL---SKFED 109
                L  E ++L       I   +    D +N  LY+VM+Y  GGDL +++   +K   
Sbjct: 45  AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ 104

Query: 110 RLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC-RDIKPDNVLLDANGHIRLADF 168
            L E+     + ++ LA      L   HR +     +  RD+KP NV LD   +++L DF
Sbjct: 105 YLDEEFVLRVMTQLTLA------LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 158

Query: 169 GSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGET 228
           G   R+    T  +   VGTP Y+SPE +      R  Y  + D WSLG  +YE+     
Sbjct: 159 GLA-RILNHDTSFAKAFVGTPYYMSPEQMN-----RMSYNEKSDIWSLGCLLYELCALMP 212

Query: 229 PFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC 272
           PF A S  E  GKI   +        + Y  SD+  +++ R++ 
Sbjct: 213 PFTAFSQKELAGKIREGK-----FRRIPYRYSDELNEIITRMLN 251

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 6e-45
 Identities = 56/263 (21%), Positives = 103/263 (39%), Gaps = 39/263 (14%)

Query: 48  KTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKF 107
           K V         +++E  +L     R I +LH +F+    L ++ ++  G D+   ++  
Sbjct: 36  KFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS 95

Query: 108 EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA--NGHIRL 165
              L E     Y+ ++  A+  +H  +  H           DI+P+N++     +  I++
Sbjct: 96  AFELNEREIVSYVHQVCEALQFLHSHNIGH----------FDIRPENIIYQTRRSSTIKI 145

Query: 166 ADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY 225
            +FG   +L      +       P+Y +PE+               D WSLG  +Y +L 
Sbjct: 146 IEFGQARQLKPGDNFRLL--FTAPEYYAPEVH-----QHDVVSTATDMWSLGTLVYVLLS 198

Query: 226 GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA 284
           G  PF AE+  +    IMN +  +    +   EIS +A D + RL+     +R+  +   
Sbjct: 199 GINPFLAETNQQIIENIMNAE--YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA- 255

Query: 285 DFKMWSALFVSLSISPRNHPWFQ 307
                             HPW +
Sbjct: 256 ----------------LQHPWLK 262

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 7e-45
 Identities = 59/282 (20%), Positives = 99/282 (35%), Gaps = 40/282 (14%)

Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPED 114
               ++  E  VL   +  +I   + AF  D  + + M++  GG L  +L K   R+PE 
Sbjct: 46  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQ 104

Query: 115 MAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL 174
           +       ++  +  + + H +        H  RD+KP N+L+++ G I+L DFG   +L
Sbjct: 105 ILGKVSIAVIKGLTYLREKHKIM-------H--RDVKPSNILVNSRGEIKLCDFGVSGQL 155

Query: 175 GGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES 234
                  +N  VGT  Y+SPE L         Y  + D WS+G+ + EM  G  P     
Sbjct: 156 IDS---MANSFVGTRSYMSPERLQ-----GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207

Query: 235 LVE--------TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADF 286
             E          G           P         D++  M                   
Sbjct: 208 AKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS 267

Query: 287 KMWSALFVS-----LSISPR---------NHPWFQGIAWDSI 314
            ++S  F       L  +P           H + +    + +
Sbjct: 268 GVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 309

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  154 bits (390), Expect = 8e-45
 Identities = 49/218 (22%), Positives = 89/218 (40%), Gaps = 22/218 (10%)

Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPED 114
           E    + +E   L              +  +   +LVM+Y C G    LL   +  L E 
Sbjct: 57  EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY-CLGSASDLLEVHKKPLQEV 115

Query: 115 MAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL 174
                    +  +A +H  + +HR          D+K  N+LL   G ++L DFGS   +
Sbjct: 116 EIAAVTHGALQGLAYLHSHNMIHR----------DVKAGNILLSEPGLVKLGDFGSASIM 165

Query: 175 GGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES 234
               +      VGTP +++PE++ AM+EG+  Y  + D WSLG+   E+   + P +  +
Sbjct: 166 APANSF-----VGTPYWMAPEVILAMDEGQ--YDGKVDVWSLGITCIELAERKPPLFNMN 218

Query: 235 LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC 272
            +     I  +    + P+      S+  ++ +   + 
Sbjct: 219 AMSALYHIAQN----ESPALQSGHWSEYFRNFVDSCLQ 252

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  153 bits (388), Expect = 2e-44
 Identities = 67/286 (23%), Positives = 109/286 (38%), Gaps = 36/286 (12%)

Query: 51  SDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR 110
                    +  E  VL       I  L   ++   +LYL+M    GG+L   + + +  
Sbjct: 45  KALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE-KGF 103

Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGS 170
             E  A   I +++ A+  +HDL  VHR         +        LD +  I ++DFG 
Sbjct: 104 YTERDASRLIFQVLDAVKYLHDLGIVHR-------DLKPENLLYYSLDEDSKIMISDFGL 156

Query: 171 CLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                    + +  A GTP Y++PE+L      +  Y    D WS+GV  Y +L G  PF
Sbjct: 157 SKMEDPGSVLST--ACGTPGYVAPEVL-----AQKPYSKAVDCWSIGVIAYILLCGYPPF 209

Query: 231 YAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMW 289
           Y E+  + + +I+  +  FD P     +ISD AKD +R L+    + R            
Sbjct: 210 YDENDAKLFEQILKAEYEFDSPYWD--DISDSAKDFIRHLMEKDPEKRFTCEQA------ 261

Query: 290 SALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFD 335
                        HPW  G      ++ +     ++      S + 
Sbjct: 262 -----------LQHPWIAGDTALD-KNIHQSVSEQIKKNFAKSKWK 295

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 9e-42
 Identities = 48/259 (18%), Positives = 95/259 (36%), Gaps = 44/259 (16%)

Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQD----DSNLYLVMDYYCGGDLLTLLSKFEDR 110
               + +EE ++L       I   + +++        + LV +    G L T L +F   
Sbjct: 50  SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KV 108

Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA-NGHIRLADFG 169
           +   + + +  +++  +       ++H       H  RD+K DN+ +    G +++ D G
Sbjct: 109 MKIKVLRSWCRQILKGL------QFLHTRTPPIIH--RDLKCDNIFITGPTGSVKIGDLG 160

Query: 170 SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
                       +   +GTP++++PE+         +Y    D ++ G+CM EM   E P
Sbjct: 161 LATLKRAS---FAKAVIGTPEFMAPEMY------EEKYDESVDVYAFGMCMLEMATSEYP 211

Query: 230 FYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKM 288
           +          +I     S   P+        + K+++   I  + D R     I D   
Sbjct: 212 YSECQNAA---QIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY---SIKDLL- 264

Query: 289 WSALFVSLSISPRNHPWFQ 307
                        NH +FQ
Sbjct: 265 -------------NHAFFQ 270

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 9e-42
 Identities = 67/299 (22%), Positives = 116/299 (38%), Gaps = 52/299 (17%)

Query: 48  KTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQD----DSNLYLVMDYYCGGDLLTL 103
           K + D  +     RE            I  +   +++       L +VM+   GG+L + 
Sbjct: 43  KMLQDCPKA---RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSR 99

Query: 104 L-SKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA--- 159
           +  + +    E  A   +  +  AI  +H ++  HR          D+KP+N+L  +   
Sbjct: 100 IQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR----------DVKPENLLYTSKRP 149

Query: 160 NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVC 219
           N  ++L DFG         ++ +     TP Y++PE+L     G  +Y   CD WSLGV 
Sbjct: 150 NAILKLTDFGFAKETTSHNSLTTPC--YTPYYVAPEVL-----GPEKYDKSCDMWSLGVI 202

Query: 220 MYEMLYGETPFYAESLVETYGKIMNH--QNSFDLPSDVGYEISDDAKDLMRRLICSS-DT 276
           MY +L G  PFY+   +     +        ++ P+    E+S++ K L+R L+ +    
Sbjct: 203 MYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 262

Query: 277 RLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSHFD 335
           R+    I +F               NHPW       S +    P         D   ++
Sbjct: 263 RM---TITEFM--------------NHPWIM----QSTKVPQTPLHTSRVLKEDKERWE 300

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 2e-39
 Identities = 58/267 (21%), Positives = 110/267 (41%), Gaps = 42/267 (15%)

Query: 51  SDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR 110
           S        +  E  +L       +  LH  +++ +++ L+++   GG+L   L++ ++ 
Sbjct: 51  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE-KES 109

Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG----HIRLA 166
           L E+ A  ++ +++  +  +H L               D+KP+N++L         I++ 
Sbjct: 110 LTEEEATEFLKQILNGVYYLHSLQIA----------HFDLKPENIMLLDRNVPKPRIKII 159

Query: 167 DFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYG 226
           DFG   ++  D   +     GTP++++PEI+          G E D WS+GV  Y +L G
Sbjct: 160 DFGLAHKI--DFGNEFKNIFGTPEFVAPEIVN-----YEPLGLEADMWSIGVITYILLSG 212

Query: 227 ETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSS-DTRLGQNGIAD 285
            +PF  ++  ET   +      ++   +     S  AKD +RRL+      R+    I D
Sbjct: 213 ASPFLGDTKQETLANVSAVN--YEFEDEYFSNTSALAKDFIRRLLVKDPKKRM---TIQD 267

Query: 286 FKMWSALFVSLSISPRNHPWFQGIAWD 312
                            HPW +     
Sbjct: 268 SL--------------QHPWIKPKDTQ 280

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  136 bits (343), Expect = 3e-38
 Identities = 50/224 (22%), Positives = 89/224 (39%), Gaps = 24/224 (10%)

Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSN----LYLVMDYYCGGDLLTLLSKFEDR 110
            F  + R E       +   I  ++   + ++      Y+VM+Y  G  L  ++      
Sbjct: 49  SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-P 107

Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGS 170
           +    A   IA+   A      L++ H+       + RD+KP N+++ A   +++ DFG 
Sbjct: 108 MTPKRAIEVIADACQA------LNFSHQNGI----IHRDVKPANIMISATNAVKVMDFGI 157

Query: 171 CLRLGGDGT--VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGET 228
              +   G    Q+   +GT  Y+SPE                D +SLG  +YE+L GE 
Sbjct: 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQAR-----GDSVDARSDVYSLGCVLYEVLTGEP 212

Query: 229 PFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC 272
           PF  +S V    + +        PS     +S D   ++ + + 
Sbjct: 213 PFTGDSPVSVAYQHVREDPIP--PSARHEGLSADLDAVVLKALA 254

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 3e-38
 Identities = 39/225 (17%), Positives = 81/225 (36%), Gaps = 21/225 (9%)

Query: 48  KTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKF 107
           K + +      +  EE  V++      +  L+        ++++ +Y   G LL  L + 
Sbjct: 34  KMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM 93

Query: 108 EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLAD 167
             R           ++  A+  +    ++           RD+   N L++  G ++++D
Sbjct: 94  RHRFQTQQLLEMCKDVCEAMEYLESKQFL----------HRDLAARNCLVNDQGVVKVSD 143

Query: 168 FGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YG 226
           FG    +  D    S  +     +  PE+L        ++  + D W+ GV M+E+   G
Sbjct: 144 FGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM-----YSKFSSKSDIWAFGVLMWEIYSLG 198

Query: 227 ETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           + P+   +  ET   I      +  P       S+    +M    
Sbjct: 199 KMPYERFTNSETAEHIAQGLRLYR-PHLA----SEKVYTIMYSCW 238

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 5e-38
 Identities = 46/221 (20%), Positives = 83/221 (37%), Gaps = 24/221 (10%)

Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPED 114
               ++  E  ++   D  +I  L    Q +  L LVM+   GG L   L    + +P  
Sbjct: 51  ADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVS 109

Query: 115 MAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL 174
                + ++ + +  + + ++VH          RD+   NVLL    + +++DFG    L
Sbjct: 110 NVAELLHQVSMGMKYLEEKNFVH----------RDLAARNVLLVNRHYAKISDFGLSKAL 159

Query: 175 GGDGT--VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFY 231
           G D +     +       + +PE +        ++    D WS GV M+E L YG+ P+ 
Sbjct: 160 GADDSYYTARSAGKWPLKWYAPECIN-----FRKFSSRSDVWSYGVTMWEALSYGQKPYK 214

Query: 232 AESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC 272
                E    I   +   + P +       +   LM     
Sbjct: 215 KMKGPEVMAFIEQGKR-MECPPE----CPPELYALMSDCWI 250

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 8e-38
 Identities = 41/220 (18%), Positives = 73/220 (33%), Gaps = 23/220 (10%)

Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPED 114
           E +     E + +   D R +  L+        + +V +    G LL  L K +      
Sbjct: 53  EAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLG 111

Query: 115 MAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG--SCL 172
               Y  ++   +  +    ++HR           +   N+LL     +++ DFG    L
Sbjct: 112 TLSRYAVQVAEGMGYLESKRFIHRD----------LAARNLLLATRDLVKIGDFGLMRAL 161

Query: 173 RLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFY 231
               D  V          + +PE L         +    D W  GV ++EM  YG+ P+ 
Sbjct: 162 PQNDDHYVMQEHRKVPFAWCAPESLK-----TRTFSHASDTWMFGVTLWEMFTYGQEPWI 216

Query: 232 AESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
             +  +   KI         P D       D  ++M +  
Sbjct: 217 GLNGSQILHKIDKEGERLPRPED----CPQDIYNVMVQCW 252

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 2e-37
 Identities = 58/287 (20%), Positives = 94/287 (32%), Gaps = 56/287 (19%)

Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTL 103
           ++                 E  +L       I  L  AF   SN+ LV D+    DL  +
Sbjct: 31  IKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF-METDLEVI 89

Query: 104 LSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI 163
           +      L     K Y+   +  +  +H    +           RD+KP+N+LLD NG +
Sbjct: 90  IKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL----------HRDLKPNNLLLDENGVL 139

Query: 164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM 223
           +LADFG     G      ++  V T  Y +PE+L     G   YG   D W++G  + E+
Sbjct: 140 KLADFGLAKSFGSPNRAYTHQ-VVTRWYRAPELLF----GARMYGVGVDMWAVGCILAEL 194

Query: 224 LYGETPFYAESLVETYGKIMNHQNSFDLP----------------------SDVGYEISD 261
           L        +S ++   +I     +                            +     D
Sbjct: 195 LLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGD 254

Query: 262 DAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ 307
           D  DL++ L   +   R+            AL            +F 
Sbjct: 255 DLLDLIQGLFLFNPCARIT--------ATQAL---------KMKYFS 284

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 4e-37
 Identities = 47/253 (18%), Positives = 91/253 (35%), Gaps = 46/253 (18%)

Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTL 103
           L+ +   S+       + E + +   G    I NL  A      +YL+ +Y C GDLL  
Sbjct: 75  LKEKADSSEREAL---MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNY 131

Query: 104 LSKFEDRLPEDMAKF----------------------YIAEMVLAIASIHDLHYVHRPNH 141
           L    ++  ED  ++                      +  ++   +  +     VH    
Sbjct: 132 LRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH---- 187

Query: 142 FAFHLCRDIKPDNVLLDANGHIRLADFG-SCLRLGGDGTVQSNVAVGTPDYISPEILTAM 200
                 RD+   NVL+     +++ DFG +   +     V    A     +++PE L   
Sbjct: 188 ------RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF-- 239

Query: 201 EEGRGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEI 259
               G Y  + D WS G+ ++E+   G  P+    +   + K++ +    D P       
Sbjct: 240 ---EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFY----A 292

Query: 260 SDDAKDLMRRLIC 272
           +++   +M+    
Sbjct: 293 TEEIYIIMQSCWA 305

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 2e-36
 Identities = 55/262 (20%), Positives = 98/262 (37%), Gaps = 50/262 (19%)

Query: 52  DFIEFVAKLREERDVL--VYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFED 109
             +    ++  E  +L  V      +  L   F+   +  L+++       L        
Sbjct: 46  GELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG 105

Query: 110 RLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-GHIRLADF 168
            L E++A+ +  +++ A+   H+   +H          RDIK +N+L+D N G ++L DF
Sbjct: 106 ALQEELARSFFWQVLEAVRHCHNCGVLH----------RDIKDENILIDLNRGELKLIDF 155

Query: 169 GSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGET 228
           GS   L            GT  Y  PE +         +G     WSLG+ +Y+M+ G+ 
Sbjct: 156 GSGALLKDT---VYTDFDGTRVYSPPEWI----RYHRYHGRSAAVWSLGILLYDMVCGDI 208

Query: 229 PFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK 287
           PF  +       +I+  Q  F         +S + + L+R  +      R       + +
Sbjct: 209 PFEHDE------EIIRGQVFFR------QRVSSECQHLIRWCLALRPSDRP---TFEEIQ 253

Query: 288 MWSALFVSLSISPRNHPWFQGI 309
                         NHPW Q +
Sbjct: 254 --------------NHPWMQDV 261

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 4e-36
 Identities = 40/231 (17%), Positives = 81/231 (35%), Gaps = 34/231 (14%)

Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF-QDDSNLYLVMDYYCGGDLLT 102
           ++ + T   F         E  V+       +  L     ++   LY+V +Y   G L+ 
Sbjct: 38  IKNDATAQAF-------LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 90

Query: 103 LL-SKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG 161
            L S+    L  D    +  ++  A+  +   ++VHR          D+   NVL+  + 
Sbjct: 91  YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR----------DLAARNVLVSEDN 140

Query: 162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMY 221
             +++DFG                     + +PE L        ++  + D WS G+ ++
Sbjct: 141 VAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALR-----EKKFSTKSDVWSFGILLW 191

Query: 222 EML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           E+  +G  P+    L +   ++       D P            ++M+   
Sbjct: 192 EIYSFGRVPYPRIPLKDVVPRVEKGY-KMDAPDG----CPPAVYEVMKNCW 237

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 9e-36
 Identities = 46/219 (21%), Positives = 85/219 (38%), Gaps = 22/219 (10%)

Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPED 114
               K  +E   +   D   I  L     ++  ++++M+    G+L + L   +  L   
Sbjct: 50  SVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLA 108

Query: 115 MAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL 174
               Y  ++  A+A +    +VH          RDI   NVL+ +N  ++L DFG    +
Sbjct: 109 SLILYAYQLSTALAYLESKRFVH----------RDIAARNVLVSSNDCVKLGDFGLSRYM 158

Query: 175 GGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYAE 233
                 +++       +++PE +        R+    D W  GVCM+E+L +G  PF   
Sbjct: 159 EDSTYYKASKGKLPIKWMAPESIN-----FRRFTSASDVWMFGVCMWEILMHGVKPFQGV 213

Query: 234 SLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC 272
              +  G+I N +    +P +           LM +   
Sbjct: 214 KNNDVIGRIENGE-RLPMPPN----CPPTLYSLMTKCWA 247

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  129 bits (326), Expect = 9e-36
 Identities = 38/225 (16%), Positives = 83/225 (36%), Gaps = 20/225 (8%)

Query: 48  KTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKF 107
           KT+ +    V +  +E  V+       +  L      +   Y++ ++   G+LL  L + 
Sbjct: 48  KTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 107

Query: 108 -EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLA 166
               +   +  +   ++  A+  +   +++HR          D+   N L+  N  +++A
Sbjct: 108 NRQEVSAVVLLYMATQISSAMEYLEKKNFIHR----------DLAARNCLVGENHLVKVA 157

Query: 167 DFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYG 226
           DFG    + GD       A     + +PE L        ++  + D W+ GV ++E+   
Sbjct: 158 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-----AYNKFSIKSDVWAFGVLLWEIATY 212

Query: 227 ETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
               Y    +    +++      + P        +   +LMR   
Sbjct: 213 GMSPYPGIDLSQVYELLEKDYRMERPEG----CPEKVYELMRACW 253

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  130 bits (327), Expect = 1e-35
 Identities = 36/222 (16%), Positives = 82/222 (36%), Gaps = 25/222 (11%)

Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPED 114
           +       E  ++   D   + +L       + + ++ ++   G L + L + + +    
Sbjct: 69  KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVI 128

Query: 115 MAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL 174
                +  +   +  + D++YVH          RD+   N+L+++N   +++DFG    L
Sbjct: 129 QLVGMLRGIAAGMKYLADMNYVH----------RDLAARNILVNSNLVCKVSDFGLSRFL 178

Query: 175 GGDGTVQSNVAV----GTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETP 229
             D +  +  +         + +PE +        ++    D WS G+ M+E++ YGE P
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQ-----YRKFTSASDVWSYGIVMWEVMSYGERP 233

Query: 230 FYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           ++  +  +    I       D       +       LM    
Sbjct: 234 YWDMTNQDVINAIEQ-----DYRLPPPMDCPSALHQLMLDCW 270

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 1e-35
 Identities = 44/225 (19%), Positives = 79/225 (35%), Gaps = 21/225 (9%)

Query: 48  KTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKF 107
           KT+ +         EE +V++      +  L+    + + + LV ++   G L   L   
Sbjct: 35  KTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ 94

Query: 108 EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLAD 167
                 +       ++   +A + +   +HR          D+   N L+  N  I+++D
Sbjct: 95  RGLFAAETLLGMCLDVCEGMAYLEEACVIHR----------DLAARNCLVGENQVIKVSD 144

Query: 168 FGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YG 226
           FG    +  D    S        + SPE+ +       RY  + D WS GV M+E+   G
Sbjct: 145 FGMTRFVLDDQYTSSTGTKFPVKWASPEVFS-----FSRYSSKSDVWSFGVLMWEVFSEG 199

Query: 227 ETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           + P+   S  E    I      +  P       S     +M    
Sbjct: 200 KIPYENRSNSEVVEDISTGFRLYK-PRLA----STHVYQIMNHCW 239

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 1e-34
 Identities = 41/221 (18%), Positives = 80/221 (36%), Gaps = 25/221 (11%)

Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPED 114
               +L  E +V+   D  +I  +    + + +  LVM+    G L   L +    + + 
Sbjct: 50  ALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQ-NRHVKDK 107

Query: 115 MAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL 174
                + ++ + +  + + ++VHR          D+   NVLL    + +++DFG    L
Sbjct: 108 NIIELVHQVSMGMKYLEESNFVHR----------DLAARNVLLVTQHYAKISDFGLSKAL 157

Query: 175 GGDGT--VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFY 231
             D               + +PE +        ++  + D WS GV M+E   YG+ P+ 
Sbjct: 158 RADENYYKAQTHGKWPVKWYAPECIN-----YYKFSSKSDVWSFGVLMWEAFSYGQKPYR 212

Query: 232 AESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC 272
                E    +   +     P+        +  DLM     
Sbjct: 213 GMKGSEVTAMLEKGER-MGCPAG----CPREMYDLMNLCWT 248

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 1e-33
 Identities = 65/296 (21%), Positives = 105/296 (35%), Gaps = 65/296 (21%)

Query: 41  NSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQD-----DSNLYLVMDYY 95
                 E      I  VA LR     L   +   +  L           ++ L LV ++ 
Sbjct: 42  RVQTGEEGMPLSTIREVAVLRH----LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV 97

Query: 96  CGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNV 155
                  L    E  +P +  K  + +++  +  +H    VHR          D+KP N+
Sbjct: 98  DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHR----------DLKPQNI 147

Query: 156 LLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWS 215
           L+ ++G I+LADFG          + S V   T  Y +PE+L      +  Y    D WS
Sbjct: 148 LVTSSGQIKLADFGLARIYSFQMALTSVV--VTLWYRAPEVLL-----QSSYATPVDLWS 200

Query: 216 LGVCMYEMLYGETPFYAESLVETYGKIMN---------------------HQNSFDLPSD 254
           +G    EM   +  F   S V+  GKI++                     H  S      
Sbjct: 201 VGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEK 260

Query: 255 VGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI 309
              +I +  KDL+ + +  +   R+          +SAL         +HP+FQ +
Sbjct: 261 FVTDIDELGKDLLLKCLTFNPAKRIS--------AYSAL---------SHPYFQDL 299

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  123 bits (310), Expect = 2e-33
 Identities = 56/277 (20%), Positives = 95/277 (34%), Gaps = 57/277 (20%)

Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPED 114
              +    E  +L       I  L+        L LV   +   DL  LL   E  L   
Sbjct: 42  GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF-EHLDQDLKKLLDVCEGGLESV 100

Query: 115 MAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL 174
            AK ++ +++  IA  HD   +HR          D+KP N+L++  G +++ADFG   R 
Sbjct: 101 TAKSFLLQLLNGIAYCHDRRVLHR----------DLKPQNLLINREGELKIADFGLA-RA 149

Query: 175 GGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES 234
            G    +    + T  Y +P++L     G  +Y    D WS+G    EM+ G   F   S
Sbjct: 150 FGIPVRKYTHEIVTLWYRAPDVL----MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205

Query: 235 LVETYGKIMNHQNSFDLP-----------------------SDVGYEISDDAKDLMRRLI 271
             +   +I     + +                               + +   DL+ +++
Sbjct: 206 EADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKML 265

Query: 272 C-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ 307
               + R+            AL          H +F+
Sbjct: 266 KLDPNQRIT--------AKQAL---------EHAYFK 285

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 3e-33
 Identities = 60/264 (22%), Positives = 98/264 (37%), Gaps = 26/264 (9%)

Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPED 114
              +    E  +L   +   I  L      ++ LYLV ++        + +     +P  
Sbjct: 43  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP 102

Query: 115 MAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL 174
           + K Y+ +++  +A  H    +HR          D+KP N+L++  G I+LADFG     
Sbjct: 103 LIKSYLFQLLQGLAFCHSHRVLHR----------DLKPQNLLINTEGAIKLADFGLARAF 152

Query: 175 GGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAES 234
           G      ++  V T  Y +PEIL     G   Y    D WSLG    EM+     F  +S
Sbjct: 153 GVPVRTYTHE-VVTLWYRAPEIL----LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207

Query: 235 LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALFV 294
            ++   +I     + D     G     D K    +      +++      D +  S L  
Sbjct: 208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGR--SLLSQ 265

Query: 295 SLSISPR---------NHPWFQGI 309
            L   P           HP+FQ +
Sbjct: 266 MLHYDPNKRISAKAALAHPFFQDV 289

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 7e-33
 Identities = 65/303 (21%), Positives = 105/303 (34%), Gaps = 66/303 (21%)

Query: 61  REERDVLVYGDRRWITNLHYAF------QDDSNLYLVMDYYCGGDLLTLL--SKFEDRLP 112
             E  ++   D   I  L Y F      +D+  L LV+DY            S+ +  LP
Sbjct: 61  NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP 120

Query: 113 EDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG-HIRLADFGSC 171
               K Y+ ++  ++A IH     HR          DIKP N+LLD +   ++L DFGS 
Sbjct: 121 VIYVKLYMYQLFRSLAYIHSFGICHR----------DIKPQNLLLDPDTAVLKLCDFGSA 170

Query: 172 LRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY 231
            +L       S +   +  Y +PE++     G   Y    D WS G  + E+L G+  F 
Sbjct: 171 KQLVRGEPNVSYI--CSRYYRAPELI----FGATDYTSSIDVWSAGCVLAELLLGQPIFP 224

Query: 232 AESLVETYGKIMN-----------------------HQNSFDLPSDVGYEISDDAKDLMR 268
            +S V+   +I+                           +             +A  L  
Sbjct: 225 GDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCS 284

Query: 269 RLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIPEVSS 327
           RL+  +   RL            A           H +F  +   +++  N    P + +
Sbjct: 285 RLLEYTPTARLT--------PLEAC---------AHSFFDELRDPNVKLPNGRDTPALFN 327

Query: 328 PTD 330
            T 
Sbjct: 328 FTT 330

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 9e-33
 Identities = 47/289 (16%), Positives = 101/289 (34%), Gaps = 32/289 (11%)

Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPED 114
           +   ++ +E  V+   D   +  L         + L+      G LL  + + +D +   
Sbjct: 53  KANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQ 111

Query: 115 MAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFG-SCLR 173
               +  ++   +  + D   VH          RD+   NVL+    H+++ DFG + L 
Sbjct: 112 YLLNWCVQIAKGMNYLEDRRLVH----------RDLAARNVLVKTPQHVKITDFGLAKLL 161

Query: 174 LGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGETPFYA 232
              +    +        +++ E +         Y  + D WS GV ++E++ +G  P+  
Sbjct: 162 GAEEKEYHAEGGKVPIKWMALESIL-----HRIYTHQSDVWSYGVTVWELMTFGSKPYDG 216

Query: 233 ESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSA 291
               E    +   +     P       + D   +M +     +D+R        F+    
Sbjct: 217 IPASEISSILEKGER-LPQPPIC----TIDVYMIMVKCWMIDADSR------PKFRELII 265

Query: 292 LFVSLSISPRNHPWFQGIAWDSIRD-SNAPYIPEVSSPTDTSHF-DVDE 338
            F  ++  P+ +   QG     +   +++ +   +    D     D DE
Sbjct: 266 EFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADE 314

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  121 bits (305), Expect = 1e-32
 Identities = 46/242 (19%), Positives = 78/242 (32%), Gaps = 45/242 (18%)

Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDR---- 110
           +  A  + E  ++   D   I  L         + L+ +Y   GDL   L          
Sbjct: 58  DMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCS 117

Query: 111 -------------------LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIK 151
                              L          ++   +A + +  +VHR          D+ 
Sbjct: 118 LSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR----------DLA 167

Query: 152 PDNVLLDANGHIRLADFG-SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPE 210
             N L+  N  +++ADFG S      D             ++ PE +        RY  E
Sbjct: 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-----RYTTE 222

Query: 211 CDWWSLGVCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRR 269
            D W+ GV ++E+  YG  P+Y  +  E    + +  N    P +       +  +LMR 
Sbjct: 223 SDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD-GNILACPEN----CPLELYNLMRL 277

Query: 270 LI 271
             
Sbjct: 278 CW 279

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (303), Expect = 2e-32
 Identities = 45/226 (19%), Positives = 81/226 (35%), Gaps = 23/226 (10%)

Query: 48  KTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTL-LSK 106
           KT+           +E  V+       +  L YA   +  +Y+V +Y   G LL     +
Sbjct: 47  KTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGE 105

Query: 107 FEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLA 166
               L         A++   +A +  ++YVHR          D++  N+L+  N   ++A
Sbjct: 106 TGKYLRLPQLVDMAAQIASGMAYVERMNYVHR----------DLRAANILVGENLVCKVA 155

Query: 167 DFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-Y 225
           DFG    +  +       A     + +PE         GR+  + D WS G+ + E+   
Sbjct: 156 DFGLARLIEDNEYTARQGAKFPIKWTAPEAAL-----YGRFTIKSDVWSFGILLTELTTK 210

Query: 226 GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           G  P+      E   ++         P +      +   DLM +  
Sbjct: 211 GRVPYPGMVNREVLDQVERGYR-MPCPPE----CPESLHDLMCQCW 251

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 7e-32
 Identities = 39/230 (16%), Positives = 80/230 (34%), Gaps = 25/230 (10%)

Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTL 103
           L+   T    ++F      E  ++       I  L         + ++ +Y   G L   
Sbjct: 44  LKAGYTEKQRVDF----LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF 99

Query: 104 LSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI 163
           L + +           +  +   +  + +++YVH          RD+   N+L+++N   
Sbjct: 100 LREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVH----------RDLAARNILVNSNLVC 149

Query: 164 RLADFG--SCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMY 221
           +++DFG    L    + T  ++       + +PE ++       ++    D WS G+ M+
Sbjct: 150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS-----YRKFTSASDVWSFGIVMW 204

Query: 222 EMLYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           E++      Y E       K +N       P D           LM +  
Sbjct: 205 EVMTYGERPYWELSNHEVMKAINDGFRLPTPMD----CPSAIYQLMMQCW 250

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 1e-31
 Identities = 52/294 (17%), Positives = 95/294 (32%), Gaps = 38/294 (12%)

Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDS----NLYLVMDYYCGGDLLTLLSKFEDR 110
            +  +   E  +L+      I  ++   +  +        ++ +  G DL  LL      
Sbjct: 48  TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--QH 105

Query: 111 LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGS 170
           L  D   +++ +++  +  IH  + +HR          D+KP N+LL+    +++ DFG 
Sbjct: 106 LSNDHICYFLYQILRGLKYIHSANVLHR----------DLKPSNLLLNTTCDLKICDFGL 155

Query: 171 CLRLGGDGTVQS--NVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGET 228
                 D          V T  Y +PEI+         Y    D WS+G  + EML    
Sbjct: 156 ARVADPDHDHTGFLTEYVATRWYRAPEIML----NSKGYTKSIDIWSVGCILAEMLSNRP 211

Query: 229 PFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKM 288
            F  +  ++    I+    S                 L+     +          AD K 
Sbjct: 212 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 271

Query: 289 WSALFVSLSISPR---------NHPWFQGIAWDSIRDSNAPYIPEVSSPTDTSH 333
              L   L+ +P           HP+ +       +  +    P   +P     
Sbjct: 272 LDLLDKMLTFNPHKRIEVEQALAHPYLE-------QYYDPSDEPIAEAPFKFDM 318

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 1e-31
 Identities = 53/244 (21%), Positives = 91/244 (37%), Gaps = 41/244 (16%)

Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTL 103
           ++   +  D  +F     E   +   G    I NL  A +    LYL ++Y   G+LL  
Sbjct: 45  MKEYASKDDHRDF---AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 101

Query: 104 LSKF---------------EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCR 148
           L K                   L       + A++   +  +    ++HR          
Sbjct: 102 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHR---------- 151

Query: 149 DIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYG 208
           D+   N+L+  N   ++ADFG  L  G +  V+  +      +++ E L         Y 
Sbjct: 152 DLAARNILVGENYVAKIADFG--LSRGQEVYVKKTMGRLPVRWMAIESL-----NYSVYT 204

Query: 209 PECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLM 267
              D WS GV ++E++  G TP+   +  E Y K+       + P +      D+  DLM
Sbjct: 205 TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR-LEKPLN----CDDEVYDLM 259

Query: 268 RRLI 271
           R+  
Sbjct: 260 RQCW 263

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 2e-31
 Identities = 39/226 (17%), Positives = 82/226 (36%), Gaps = 23/226 (10%)

Query: 48  KTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKF 107
           K++            E +++     + +  L YA      +Y++ +Y   G L+  L   
Sbjct: 43  KSLKQGSMSPDAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTP 101

Query: 108 ED-RLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLA 166
              +L  +      A++   +A I + +Y+HR          D++  N+L+      ++A
Sbjct: 102 SGIKLTINKLLDMAAQIAEGMAFIEERNYIHR----------DLRAANILVSDTLSCKIA 151

Query: 167 DFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-Y 225
           DFG    +  +       A     + +PE +       G +  + D WS G+ + E++ +
Sbjct: 152 DFGLARLIEDNEYTAREGAKFPIKWTAPEAIN-----YGTFTIKSDVWSFGILLTEIVTH 206

Query: 226 GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           G  P+   +  E    +                  ++   LMR   
Sbjct: 207 GRIPYPGMTNPEVIQNLERGYRMVRPD-----NCPEELYQLMRLCW 247

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 3e-31
 Identities = 61/276 (22%), Positives = 90/276 (32%), Gaps = 40/276 (14%)

Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQD--------DSNLYLVMDYYCGGDLLTLLSK 106
            F      E  +L       + NL    +           ++YLV D+ C  DL  LLS 
Sbjct: 51  GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDF-CEHDLAGLLSN 109

Query: 107 FEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLA 166
              +      K  +  ++  +  IH    +HR          D+K  NVL+  +G ++LA
Sbjct: 110 VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHR----------DMKAANVLITRDGVLKLA 159

Query: 167 DFGSCLRLGGDGTVQSNVA---VGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEM 223
           DFG           Q N     V T  Y  PE+L     G   YGP  D W  G  M EM
Sbjct: 160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLL----GERDYGPPIDLWGAGCIMAEM 215

Query: 224 LYGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGI 283
                     +       I     S     +V   + +        L+     ++     
Sbjct: 216 WTRSPIMQGNTEQHQLALISQLCGSI--TPEVWPNVDNYELYEKLELVKGQKRKVKDRLK 273

Query: 284 ADFKMWSAL-FVS--LSISPR---------NHPWFQ 307
           A  +   AL  +   L + P          NH +F 
Sbjct: 274 AYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 309

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  116 bits (292), Expect = 9e-31
 Identities = 44/236 (18%), Positives = 68/236 (28%), Gaps = 29/236 (12%)

Query: 48  KTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKF 107
           K      +      E R   +      I N++Y  Q+  +  LV+    G  L  LL   
Sbjct: 36  KFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI-DLLGPSLEDLLDLC 94

Query: 108 EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA-----NGH 162
             +           +M+  + SIH+   V+          RDIKPDN L+          
Sbjct: 95  GRKFSVKTVAMAAKQMLARVQSIHEKSLVY----------RDIKPDNFLIGRPNSKNANM 144

Query: 163 IRLADFGSCLRLGGDGTVQ------SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSL 216
           I + DFG         T Q           GT  Y+S                  D  +L
Sbjct: 145 IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL-----GREQSRRDDLEAL 199

Query: 217 GVCMYEMLYGETPFYAESLVETYGKI--MNHQNSFDLPSDVGYEISDDAKDLMRRL 270
           G      L G  P+          K   +  +       ++     ++    M   
Sbjct: 200 GHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYA 255

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 1e-30
 Identities = 46/245 (18%), Positives = 91/245 (37%), Gaps = 40/245 (16%)

Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTL 103
           L+ + T  D  +    + E   + + G  + I NL  A   D  LY++++Y   G+L   
Sbjct: 53  LKSDATEKDLSDL---ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 109

Query: 104 L---------------SKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCR 148
           L                  E++L          ++   +  +     +HR          
Sbjct: 110 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR---------- 159

Query: 149 DIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRY 207
           D+   NVL+  +  +++ADFG    +       ++        +++PE L         Y
Sbjct: 160 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-----DRIY 214

Query: 208 GPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDL 266
             + D WS GV ++E+   G +P+    + E +  +       D PS+     +++   +
Sbjct: 215 THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR-MDKPSN----CTNELYMM 269

Query: 267 MRRLI 271
           MR   
Sbjct: 270 MRDCW 274

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  116 bits (292), Expect = 1e-30
 Identities = 55/278 (19%), Positives = 98/278 (35%), Gaps = 40/278 (14%)

Query: 55  EFVAKLREERDVL-VYGDRRWITNLHYAFQDDSN--LYLVMDYYCGGDLLTLLSKFEDRL 111
               K++ E  +L        I  L    +D  +    LV ++    D   L       L
Sbjct: 71  VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTL 126

Query: 112 PEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA-NGHIRLADFGS 170
            +   +FY+ E++ A+   H +  +           RD+KP NV++D  +  +RL D+G 
Sbjct: 127 TDYDIRFYMYEILKALDYCHSMGIM----------HRDVKPHNVMIDHEHRKLRLIDWGL 176

Query: 171 CLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF 230
                       NV V +  +  PE    +      Y    D WSLG  +  M++ + PF
Sbjct: 177 AEFYHPGQEY--NVRVASRYFKGPE----LLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230

Query: 231 YAES----LVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADF 286
           +        +    K++  ++ +D       E+     D++ R       R   +     
Sbjct: 231 FHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHL 290

Query: 287 KMWSAL-FVS--LSISPR---------NHPWFQGIAWD 312
               AL F+   L    +          HP+F  +  D
Sbjct: 291 VSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 328

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 2e-30
 Identities = 40/195 (20%), Positives = 71/195 (36%), Gaps = 13/195 (6%)

Query: 59  KLRE-ERDVLVYGDRRWITNLHYAFQDDSN----LYLVMDYYCGGDLLTLLSKFEDRLPE 113
             RE E    V      I     A   D+     L+LV DY+  G L   L+++   +  
Sbjct: 42  WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTV 99

Query: 114 DMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR 173
           +            +A +H      +      H  RD+K  N+L+  NG   +AD G  +R
Sbjct: 100 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAH--RDLKSKNILVKKNGTCCIADLGLAVR 157

Query: 174 LGGDG---TVQSNVAVGTPDYISPEIL-TAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
                    +  N  VGT  Y++PE+L  ++           D +++G+  +E+    + 
Sbjct: 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 217

Query: 230 FYAESLVETYGKIMN 244
                  +     + 
Sbjct: 218 GGIHEDYQLPYYDLV 232

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  115 bits (288), Expect = 3e-30
 Identities = 39/273 (14%), Positives = 72/273 (26%), Gaps = 34/273 (12%)

Query: 59  KLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKF 118
           +L  E  +                  + +  +++    G  L  L +    +        
Sbjct: 48  QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLL 107

Query: 119 YIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL---LDANGHIRLADFGSCLRLG 175
              +M+  I  IH  +++H          RD+KPDN L         + + DFG   +  
Sbjct: 108 LADQMISRIEYIHSKNFIH----------RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157

Query: 176 GDGTVQ------SNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP 229
              T Q      +    GT  Y S                  D  SLG  +     G  P
Sbjct: 158 DARTHQHIPYRENKNLTGTARYASINTHL-----GIEQSRRDDLESLGYVLMYFNLGSLP 212

Query: 230 FYAESLVETYGKIMNHQNSF--DLPSDVGYEISDDAKDLMRRLICSS-DTRLGQNGIADF 286
           +          K               +      +    +        D +       D+
Sbjct: 213 WQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDK------PDY 266

Query: 287 KMWSALFVSLSISPRNHPWFQGIAWDSIRDSNA 319
                LF +L    +   +     W+ ++   +
Sbjct: 267 SYLRQLFRNLFHR-QGFSYDYVFDWNMLKFGAS 298

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 7e-30
 Identities = 44/247 (17%), Positives = 86/247 (34%), Gaps = 41/247 (16%)

Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTL 103
           L+    +++       + E + +   G+   I NL  A        ++ +Y C GDLL  
Sbjct: 61  LKPSAHLTEREAL---MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNF 117

Query: 104 LSKFED-----------------RLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHL 146
           L +  D                  L  +    +  ++   +A +   + +H         
Sbjct: 118 LRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIH--------- 168

Query: 147 CRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRG 205
            RD+   N+LL      ++ DFG    +  D   V    A     +++PE +        
Sbjct: 169 -RDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF-----NC 222

Query: 206 RYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAK 264
            Y  E D WS G+ ++E+   G +P+    +   + K++        P         +  
Sbjct: 223 VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEH----APAEMY 278

Query: 265 DLMRRLI 271
           D+M+   
Sbjct: 279 DIMKTCW 285

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 9e-30
 Identities = 33/223 (14%), Positives = 77/223 (34%), Gaps = 25/223 (11%)

Query: 54  IEFVAKLREERDVLVYGDRRWITNLH-YAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLP 112
           I  V++   E  ++       + +L     + + +  +V+ Y   GDL   +        
Sbjct: 69  IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPT 128

Query: 113 EDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCL 172
                 +  ++   +  +    +VH          RD+   N +LD    +++ADFG   
Sbjct: 129 VKDLIGFGLQVAKGMKFLASKKFVH----------RDLAARNCMLDEKFTVKVADFGLAR 178

Query: 173 RLGGDGTVQSNV---AVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEML-YGET 228
            +        +    A     +++ E L        ++  + D WS GV ++E++  G  
Sbjct: 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQ-----TQKFTTKSDVWSFGVLLWELMTRGAP 233

Query: 229 PFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           P+   +  +    ++  +              D   ++M +  
Sbjct: 234 PYPDVNTFDITVYLLQGRRLLQPE-----YCPDPLYEVMLKCW 271

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 1e-28
 Identities = 40/246 (16%), Positives = 84/246 (34%), Gaps = 40/246 (16%)

Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSN-LYLVMDYYCGGDLLT 102
           L+   T S+       + E + ++  G    + NL  A       L +++++   G+L T
Sbjct: 51  LKEGATHSEHRAL---MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 107

Query: 103 LLSK---------------FEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLC 147
            L                 ++D L  +    Y  ++   +  +     +           
Sbjct: 108 YLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI----------H 157

Query: 148 RDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGR 206
           RD+   N+LL     +++ DFG    +  D   V+   A     +++PE +         
Sbjct: 158 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-----DRV 212

Query: 207 YGPECDWWSLGVCMYEMLYG-ETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKD 265
           Y  + D WS GV ++E+     +P+    + E + + +        P       + +   
Sbjct: 213 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY----TTPEMYQ 268

Query: 266 LMRRLI 271
            M    
Sbjct: 269 TMLDCW 274

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 2e-28
 Identities = 58/294 (19%), Positives = 109/294 (37%), Gaps = 40/294 (13%)

Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDS------NLYLVMDYYCGGDLLTLLSKFE 108
            F  +   E  +L +     +  L   F  D       + YLVM +  G DL  L+    
Sbjct: 59  LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF-MGTDLGKLMKH-- 115

Query: 109 DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADF 168
           ++L ED  +F + +M+  +  IH    +HR          D+KP N+ ++ +  +++ DF
Sbjct: 116 EKLGEDRIQFLVYQMLKGLRYIHAAGIIHR----------DLKPGNLAVNEDCELKILDF 165

Query: 169 GSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGET 228
           G   +   + T      V T  Y +PE++        RY    D WS+G  M EM+ G+T
Sbjct: 166 GLARQADSEMTGY----VVTRWYRAPEVIL----NWMRYTQTVDIWSVGCIMAEMITGKT 217

Query: 229 PFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKM 288
            F     ++   +IM    +   P++    +  D      + +   + +   + + +   
Sbjct: 218 LFKGSDHLDQLKEIMKVTGTP--PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASP 275

Query: 289 WSALFVS--LSISPR---------NHPWFQGIAWDSIRDSNAPYIPEVSSPTDT 331
            +   +   L +             HP+F+ +           Y         T
Sbjct: 276 LAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRT 329

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 2e-28
 Identities = 43/239 (17%), Positives = 80/239 (33%), Gaps = 35/239 (14%)

Query: 44  LRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTL 103
           +    ++ + IEF      E  V+   +   +  L           ++M+    GDL + 
Sbjct: 58  VNEAASMRERIEF----LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 113

Query: 104 LSKFEDR---------LPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDN 154
           L                          E+   +A ++   +VHR          D+   N
Sbjct: 114 LRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHR----------DLAARN 163

Query: 155 VLLDANGHIRLADFGSCLRLG-GDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDW 213
            ++  +  +++ DFG    +   D   +    +    ++SPE L       G +    D 
Sbjct: 164 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK-----DGVFTTYSDV 218

Query: 214 WSLGVCMYEML-YGETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLI 271
           WS GV ++E+    E P+   S  +    +M      D P +      D   +LMR   
Sbjct: 219 WSFGVVLWEIATLAEQPYQGLSNEQVLRFVME-GGLLDKPDN----CPDMLFELMRMCW 272

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (261), Expect = 1e-26
 Identities = 50/265 (18%), Positives = 86/265 (32%), Gaps = 32/265 (12%)

Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPED 114
              +    E  +L     + I  LH     D  L LV ++                L  +
Sbjct: 43  GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLK-KYFDSCNGDLDPE 101

Query: 115 MAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRL 174
           + K ++ +++  +   H  + +HR          D+KP N+L++ NG ++LA+FG     
Sbjct: 102 IVKSFLFQLLKGLGFCHSRNVLHR----------DLKPQNLLINRNGELKLANFGLARAF 151

Query: 175 GGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY-AE 233
           G      S   V T  Y  P++L     G   Y    D WS G    E+     P +   
Sbjct: 152 GIPVRCYSAE-VVTLWYRPPDVL----FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206

Query: 234 SLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKMWSALF 293
            + +   +I     +             D K        +S   +     A  +      
Sbjct: 207 DVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRD----L 262

Query: 294 VS--LSISPR---------NHPWFQ 307
           +   L  +P           HP+F 
Sbjct: 263 LQNLLKCNPVQRISAEEALQHPYFS 287

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 8e-26
 Identities = 48/312 (15%), Positives = 104/312 (33%), Gaps = 53/312 (16%)

Query: 55  EFVAKLREERDVLVYGDRRWITNLHYAF------QDDSNLYLVMDYYCGGDLLTLLSKFE 108
               +   E  ++   + + I +L   F      ++  ++YLVM+         +  +  
Sbjct: 58  THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL- 116

Query: 109 DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADF 168
                +   + + +M+  I  +H    +HR          D+KP N+++ ++  +++ DF
Sbjct: 117 ---DHERMSYLLYQMLCGIKHLHSAGIIHR----------DLKPSNIVVKSDCTLKILDF 163

Query: 169 GSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGET 228
           G     G          V T  Y +PE++  M      Y    D WS+G  M EM+  + 
Sbjct: 164 GLARTAGTSFM--MTPYVVTRYYRAPEVILGM-----GYKENVDIWSVGCIMGEMVRHKI 216

Query: 229 PFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQ-------- 280
            F     ++ + K++    +     +   ++    ++ +      +     +        
Sbjct: 217 LFPGRDYIDQWNKVIEQLGTP--CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFP 274

Query: 281 NGIADFKMWSALFVS-----LSISPR---------NHPWFQGIAWDSIRDSNAPYIPEVS 326
                 K+ ++         L I P           HP+     W    +  AP      
Sbjct: 275 ADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV--WYDPAEVEAPPPQIYD 332

Query: 327 SPTDTSHFDVDE 338
              D     ++E
Sbjct: 333 KQLDEREHTIEE 344

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (251), Expect = 1e-24
 Identities = 54/297 (18%), Positives = 98/297 (32%), Gaps = 44/297 (14%)

Query: 54  IEFVAKLREERDVLVYGDRRWITNLHYAFQD-----DSNLYLVMDYYCGGDLLTLLSKFE 108
           I    +   E  +L +     +  L   F       + N   ++ +  G DL  ++    
Sbjct: 58  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-- 115

Query: 109 DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADF 168
            +L +D  +F I +++  +  IH    +HR          D+KP N+ ++ +  +++ DF
Sbjct: 116 QKLTDDHVQFLIYQILRGLKYIHSADIIHR----------DLKPSNLAVNEDCELKILDF 165

Query: 169 GSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGET 228
           G       + T        T  Y +PEI+         Y    D WS+G  M E+L G T
Sbjct: 166 GLARHTDDEMTGYVA----TRWYRAPEIM----LNWMHYNQTVDIWSVGCIMAELLTGRT 217

Query: 229 PFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLICSSDTRLGQNGIADFKM 288
            F     ++    I+    +      +    S+ A++ ++ L               F  
Sbjct: 218 LFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARNYIQSLTQMPKMNFAN----VFIG 272

Query: 289 WSALFVS-----LSISPR---------NHPWFQGIAWDSIRDSNAPYIPEVSSPTDT 331
            + L V      L +             H +F             PY     S    
Sbjct: 273 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLL 329

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 83.5 bits (205), Expect = 2e-18
 Identities = 48/327 (14%), Positives = 106/327 (32%), Gaps = 49/327 (14%)

Query: 41  NSSLRREKTVSDFIEFVAKLREERDVLVYGDR-----RWITNLHYAFQDDSNLYLVMDYY 95
                  +   D I+ + ++ +  +            + + + ++   +  ++ +V +  
Sbjct: 47  RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL 106

Query: 96  CGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNV 155
               L  +       +P    K    +++L +  +H    +            DIKP+NV
Sbjct: 107 GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGII---------HTDIKPENV 157

Query: 156 LLDANGHIRLADFGSCLRLGGDGTVQSNV--AVGTPDYISPEILTAMEEGRGRYGPECDW 213
           L++               LG       +   ++ T +Y SPE+L         +G   D 
Sbjct: 158 LMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLL-----GAPWGCGADI 212

Query: 214 WSLGVCMYEMLYGETPFYAESLVETYG---------KIMNHQNSFDLPSDVGYEISDDAK 264
           WS    ++E++ G+  F  +                +++    S+ L +        +++
Sbjct: 213 WSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSR 272

Query: 265 DLMRRLICSSDTRLGQNGIADFKMWSAL------FVS--LSISPR---------NHPWFQ 307
            L+R +       L       +K           F+S  L + PR         NHPW +
Sbjct: 273 GLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK 332

Query: 308 GIAWDSIRDSNAPYIPEVSSPTDTSHF 334
                 + +   P      S +D   +
Sbjct: 333 D--TLGMEEIRVPDRELYGSGSDIPGW 357

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 47.1 bits (111), Expect = 7e-07
 Identities = 18/139 (12%), Positives = 40/139 (28%), Gaps = 28/139 (20%)

Query: 84  DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFA 143
                 ++M+                R+  +     +  ++  +A  +    VH      
Sbjct: 81  AWEGNAVLMELIDAK--------ELYRVRVENPDEVLDMILEEVAKFYHRGIVH------ 126

Query: 144 FHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEG 203
                D+   NVL+     I + DF   + +G           G  + +  ++   +   
Sbjct: 127 ----GDLSQYNVLVS-EEGIWIIDFPQSVEVG---------EEGWREILERDVRNIITYF 172

Query: 204 RGRYGPECDWWSLGVCMYE 222
              Y  E D  S    + +
Sbjct: 173 SRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	372
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.83
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.98
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.32
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.7
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	94.62
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	94.32
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	91.18

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-67  Score=489.96  Aligned_cols=322  Identities=31%  Similarity=0.545  Sum_probs=268.1

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      .|+.++.+|.|    |+|.||+|++..+++.||+|.+........       +..+++.+|+.+|+.++||||++++++|
T Consensus         6 dy~~~~~lG~G----~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~-------~~~~~~~~E~~il~~l~hp~Iv~l~~~~   74 (337)
T d1o6la_           6 DFDYLKLLGKG----TFGKVILVREKATGRYYAMKILRKEVIIAK-------DEVAHTVTESRVLQNTRHPFLTALKYAF   74 (337)
T ss_dssp             GEEEEEEEEEC----SSEEEEEEEETTTCCEEEEEEEEHHHHHHT-------TCHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             hcEEEEEEecC----cCeEEEEEEECCCCCEEEEEEEchhhccCH-------HHHHHHHHHHHHHHhCCCCCEEEEEeee
Confidence            45566777777    899999999999999999998876554333       2345678899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      ++.+.+|+|||||+||+|.+++.+ .+.++++.++.++.||+.||+|||++||+|          |||||+|||++.+|+
T Consensus        75 ~~~~~~~iv~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiH----------RDlKP~NILl~~~g~  143 (337)
T d1o6la_          75 QTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVY----------RDIKLENLMLDKDGH  143 (337)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBC----------CCCCGGGEEECTTSC
T ss_pred             ccccccccceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccc----------cccCHHHeEecCCCC
Confidence            999999999999999999999988 578999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||+|+....... .....+||+.|+|||++.+     ..|+.++|||||||++|||++|++||.+.+..+++.++
T Consensus       144 vkl~DFG~a~~~~~~~~-~~~~~~GT~~Y~aPE~~~~-----~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i  217 (337)
T d1o6la_         144 IKITDFGLCKEGISDGA-TMKTFCGTPEYLAPEVLED-----NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI  217 (337)
T ss_dssp             EEECCCTTCBCSCCTTC-CBCCCEECGGGCCGGGGSS-----SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             EEEeecccccccccCCc-ccccceeCHHHhhhhhccC-----CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHH
Confidence            99999999987654332 3345789999999999984     56899999999999999999999999999999999998


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCC--ChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQN--GIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDS  317 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~--~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~  317 (372)
                      ....  +.+|.    .+|+++++||++||+ ||++|++..  .+.+++              +||||++++|+.+  ++.
T Consensus       218 ~~~~--~~~p~----~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil--------------~Hp~f~~i~~~~l~~~~~  277 (337)
T d1o6la_         218 LMEE--IRFPR----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM--------------EHRFFLSINWQDVVQKKL  277 (337)
T ss_dssp             HHCC--CCCCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHH--------------TSGGGTTCCHHHHHTTCS
T ss_pred             hcCC--CCCCc----cCCHHHHHHHHhhccCCchhhcccccccHHHHH--------------cCcccccCCHHHHHhCCC
Confidence            8764  44555    689999999999999 999999843  477888              9999999999998  567


Q ss_pred             CCCCcCCCCCCCCCCCCCCCccccCCCCCCCCCCC-----CcccccCCCCccCceeeCCC
Q psy11571        318 NAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAA-----SPALSALHLPFVGFTFTQGW  372 (372)
Q Consensus       318 ~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~  372 (372)
                      .||++|.+.++.++++|+............+....     .......+..|.||+|.++|
T Consensus       278 ~~p~~P~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~v~d~  337 (337)
T d1o6la_         278 LPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQREEQEMFEDFDYIADW  337 (337)
T ss_dssp             CCSCCCCCSSTTCCTTSCHHHHTSCCC--------------------CCTTTTCCEECCC
T ss_pred             CCCCCCCCCChhhhhhcCchhhhccCCCCCCccccccccccccchhhhhccCCCEeeCCC
Confidence            89999999999999999875443222111111111     12223567789999999999

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-64  Score=467.42  Aligned_cols=313  Identities=33%  Similarity=0.548  Sum_probs=237.5

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHH-hcCCCCceeeeeEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVL-VYGDRRWITNLHYA   81 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il-~~l~hp~Iv~l~~~   81 (372)
                      +|+.++.+|.|    |+|+||++++..+++.||+|.+.........       ..+.+..|..++ +.++||||++++++
T Consensus         3 dy~i~~~iG~G----~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~-------~~~~~~~e~~~l~~~~~hp~Iv~~~~~   71 (320)
T d1xjda_           3 DFILHKMLGKG----SFGKVFLAEFKKTNQFFAIKALKKDVVLMDD-------DVECTMVEKRVLSLAWEHPFLTHMFCT   71 (320)
T ss_dssp             TEEEEEEEEEC----SSSEEEEEEETTTTEEEEEEEEEHHHHHHTT-------CHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             CeEEeeEEecC----CCcEEEEEEECCCCCEEEEEEEchhhccChH-------HHHHHHHHHHHHHHhCCCCcEEEEEEE
Confidence            46666777777    8999999999999999999998765443332       223345565555 47899999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+++.+|+|||||+||+|.+++.. ...+++.+++.++.||+.||.|||++||+|          |||||+|||+++++
T Consensus        72 ~~~~~~~yivmEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiH----------rDikp~NiL~~~~~  140 (320)
T d1xjda_          72 FQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVY----------RDLKLDNILLDKDG  140 (320)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBC----------CCCCGGGEEECTTS
T ss_pred             EccCCceeEEEeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeee----------ccCcccceeecCCC
Confidence            9999999999999999999999987 578999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      ++||+|||+++....... .....+||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.+.+..+++.+
T Consensus       141 ~~kl~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~  214 (320)
T d1xjda_         141 HIKIADFGMCKENMLGDA-KTNTFCGTPDYIAPEILLG-----QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS  214 (320)
T ss_dssp             CEEECCCTTCBCCCCTTC-CBCCCCSCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             ceeccccchhhhcccccc-cccccCCCCCcCCHHHHcC-----CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999987654332 3344689999999999984     6789999999999999999999999999999999999


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCC-ChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccC
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQN-GIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDS  317 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~-~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~  317 (372)
                      |..+.  +.+|.    .+|+++++||++||+ ||++||++. +++                 +||||++++|+.+  ++.
T Consensus       215 i~~~~--~~~p~----~~s~~~~dli~~~L~~dP~~R~s~~~~l~-----------------~hpff~~~~~~~l~~~~~  271 (320)
T d1xjda_         215 IRMDN--PFYPR----WLEKEAKDLLVKLFVREPEKRLGVRGDIR-----------------QHPLFREINWEELERKEI  271 (320)
T ss_dssp             HHHCC--CCCCT----TSCHHHHHHHHHHSCSSGGGSBTTBSCGG-----------------GSGGGTTCCHHHHHTTCS
T ss_pred             HHcCC--CCCCc----cCCHHHHHHHHHhcccCCCCCcCHHHHHH-----------------hCchhccCCHHHHHhcCC
Confidence            88754  34454    689999999999999 999999985 565                 9999999999987  557


Q ss_pred             CCCCcCCCCCCCCCCCCCCCccccCCCCCCCCCCCCcccccCCCCccCcee
Q psy11571        318 NAPYIPEVSSPTDTSHFDVDEAGVRASDALPPAAASPALSALHLPFVGFTF  368 (372)
Q Consensus       318 ~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (372)
                      .||++|.++++.|.++||.....  ..+.+.........+..+..|.||+|
T Consensus       272 ~pp~~p~~~~~~d~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~f~~f~~  320 (320)
T d1xjda_         272 DPPFRPKVKSPFDCSNFDKEFLN--EKPRLSFADRALINSMDQNMFRNFSF  320 (320)
T ss_dssp             CC----------------------------------------CCTTTTCCC
T ss_pred             CCCCCCCCCCccchhhcChHhhh--CCccCCCCcccccCchhhcccCcCcC
Confidence            89999999999999999865543  22333333333344556788999998

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-63  Score=456.28  Aligned_cols=274  Identities=30%  Similarity=0.544  Sum_probs=237.3

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||++++..+++.||+|.+.......+       +..+.+.+|+.+++.++||||+++++++
T Consensus         9 dy~i~~~lG~G----~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~-------~~~~~~~~E~~il~~l~HpnIv~l~~~~   77 (288)
T d1uu3a_           9 DFKFGKILGEG----SFSTVVLARELATSREYAIKILEKRHIIKE-------NKVPYVTRERDVMSRLDHPFFVKLYFTF   77 (288)
T ss_dssp             GEEEEEEEEEC----SSCEEEEEEETTTCCEEEEEEEEHHHHHHT-------TCHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred             CCEEEEEEeeC----CCeEEEEEEECCCCCEEEEEEEehHHccCH-------HHHHHHHHHHHHHHHcCCCCeeEEEEEE
Confidence            56677777777    899999999999999999998876544333       1345688899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+++.+|+|||||+||+|.+++.. .+.+++..++.++.|++.||.|||++||+|          |||||+|||++++|.
T Consensus        78 ~~~~~~~ivmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiH----------rDiKp~NIll~~~~~  146 (288)
T d1uu3a_          78 QDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIH----------RDLKPENILLNEDMH  146 (288)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSGGGEEECTTSC
T ss_pred             EECCEEEEEEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccccEEc----------CcCCccccccCCCce
Confidence            999999999999999999999987 578999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCC-cccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDG-TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      +||+|||+|+...... .......+||+.|+|||++.+     ..++.++|||||||++|+|++|++||.+.+..+++.+
T Consensus       147 vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~  221 (288)
T d1uu3a_         147 IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-----KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK  221 (288)
T ss_dssp             EEECCCTTCEECC----------CCCCGGGCCHHHHHT-----CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             EEecccccceecccCCcccccccccCCccccCceeecc-----CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHH
Confidence            9999999998765332 223344689999999999983     5689999999999999999999999999999999999


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh---hhhhhhhhhhccCCCCCCCCCcCCCCccccccC
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA---DFKMWSALFVSLSISPRNHPWFQGIAWDSIRDS  317 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~---~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~~~  317 (372)
                      |.+..  +.+|.    .+|+++++||++||+ ||++|||+++++   +++              +||||+++||+.+++.
T Consensus       222 i~~~~--~~~p~----~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~--------------~Hpff~~i~w~~l~~~  281 (288)
T d1uu3a_         222 IIKLE--YDFPE----KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK--------------AHPFFESVTWENLHQQ  281 (288)
T ss_dssp             HHTTC--CCCCT----TCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHH--------------TSGGGTTCCCTTGGGS
T ss_pred             HHcCC--CCCCc----cCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHH--------------cCCccCCCCHHHhhcC
Confidence            98764  34454    689999999999999 999999998764   355              9999999999999988


Q ss_pred             CCCCcC
Q psy11571        318 NAPYIP  323 (372)
Q Consensus       318 ~~p~~p  323 (372)
                      .||.+|
T Consensus       282 ~pP~l~  287 (288)
T d1uu3a_         282 TPPKLT  287 (288)
T ss_dssp             CCCCCC
T ss_pred             CCCCCC
Confidence            888766

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.6e-62  Score=453.33  Aligned_cols=285  Identities=38%  Similarity=0.691  Sum_probs=238.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      .|+.++.+|.|    |+|.||+|++..+++.||+|.+........       +..+.+.+|+.+++.++||||+++++++
T Consensus         5 dy~i~~~lG~G----~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~-------~~~~~~~~E~~il~~l~HpnIv~~~~~~   73 (316)
T d1fota_           5 DFQILRTLGTG----SFGRVHLIRSRHNGRYYAMKVLKKEIVVRL-------KQVEHTNDERLMLSIVTHPFIIRMWGTF   73 (316)
T ss_dssp             GEEEEEEEEEC----SSCEEEEEEETTTCCEEEEEEEEHHHHHHT-------TCHHHHHHHHHHHHSCCBTTBCCEEEEE
T ss_pred             HeEEEEEEecC----cCcEEEEEEECCCCCEEEEEEEchHHccCH-------HHHHHHHHHHHHHHhccCcChhheeeeE
Confidence            45667777777    899999999999999999998876544333       2346688999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+++.+|+|||||+||+|..++.. ...+++..++.++.||+.||.|||++||+|          |||||+|||++.+|.
T Consensus        74 ~~~~~~~ivmE~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~iiH----------rDiKp~NILl~~~g~  142 (316)
T d1fota_          74 QDAQQIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIY----------RDLKPENILLDKNGH  142 (316)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEEC----------CCCCGGGEEECTTSC
T ss_pred             eeCCeeeeEeeecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCcEEc----------cccCchheeEcCCCC
Confidence            999999999999999999999988 678999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||+|+.....    ....+||+.|+|||++.+     ..|+.++|||||||++|+|++|+.||.+.+..+.+.++
T Consensus       143 vkL~DFG~a~~~~~~----~~~~~Gt~~Y~APE~l~~-----~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i  213 (316)
T d1fota_         143 IKITDFGFAKYVPDV----TYTLCGTPDYIAPEVVST-----KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI  213 (316)
T ss_dssp             EEECCCSSCEECSSC----BCCCCSCTTTCCHHHHTT-----CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             EEEecCccceEeccc----cccccCcccccCHHHHcC-----CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHH
Confidence            999999999886543    234689999999999983     56899999999999999999999999999999999999


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCC--ChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--ccC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQN--GIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RDS  317 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~--~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~~  317 (372)
                      .++..  .+|.    .+|++++++|.+||+ ||.+|++..  .+.+++              +||||++++|+.+  ++.
T Consensus       214 ~~~~~--~~p~----~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il--------------~Hp~f~~i~~~~l~~~~~  273 (316)
T d1fota_         214 LNAEL--RFPP----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK--------------NHPWFKEVVWEKLLSRNI  273 (316)
T ss_dssp             HHCCC--CCCT----TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH--------------TSGGGSSCCHHHHHTTCS
T ss_pred             HcCCC--CCCC----CCCHHHHHHHHHHhhhCHHhccccchhhHHHHH--------------cCcccccCCHHHHHhCCC
Confidence            88653  4444    689999999999999 999998532  456666              9999999999988  567


Q ss_pred             CCCCcCCCC-CCCCCCCCCCCc
Q psy11571        318 NAPYIPEVS-SPTDTSHFDVDE  338 (372)
Q Consensus       318 ~~p~~p~~~-~~~~~~~~~~~~  338 (372)
                      .+|++|.+. +..|+++||...
T Consensus       274 ~~p~~p~~~~~~~d~~~f~~~~  295 (316)
T d1fota_         274 ETPYEPPIQQGQGDTSQFDKYP  295 (316)
T ss_dssp             CCSCCCCC--------------
T ss_pred             CcCCCCCcCCCcchhhhcCCCc
Confidence            899999864 456888887543

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.7e-62  Score=458.06  Aligned_cols=286  Identities=35%  Similarity=0.670  Sum_probs=250.0

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    |+|.||++.+..+++.||+|.+........       ...+.+.+|+.+|+.++|||||+++++
T Consensus        41 d~y~i~~~lG~G----~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~-------~~~~~~~~E~~il~~l~hpnIv~~~~~  109 (350)
T d1rdqe_          41 DQFDRIKTLGTG----SFGRVMLVKHKESGNHYAMKILDKQKVVKL-------KQIEHTLNEKRILQAVNFPFLVKLEFS  109 (350)
T ss_dssp             GGEEEEEEEEEC----SSCEEEEEEETTTCCEEEEEEEEHHHHHHT-------TCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cCeEEEEEeecC----cCcEEEEEEECCCCCEEEEEEEchHHccCH-------HHHHHHHHHHHHHHHcCCCcEeecccc
Confidence            367778888888    899999999999999999998865444332       234567889999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+...+|+||||+.||+|.+++.+ .+.+++..++.++.||+.||.|||++||+|          |||||+|||++.+|
T Consensus       110 ~~~~~~~~~v~e~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiH----------RDIKP~NILl~~~g  178 (350)
T d1rdqe_         110 FKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIY----------RDLKPENLLIDQQG  178 (350)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEECTTS
T ss_pred             cccccccccccccccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEec----------CcCCHHHcccCCCC
Confidence            9999999999999999999999987 578999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      ++||+|||+|+.....    ....+||+.|||||++.+     ..++.++|||||||++|||+||++||.+.+....+.+
T Consensus       179 ~ikL~DFG~a~~~~~~----~~~~~Gt~~Y~APE~~~~-----~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~  249 (350)
T d1rdqe_         179 YIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILS-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK  249 (350)
T ss_dssp             CEEECCCTTCEECSSC----BCCCEECGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             CEEeeeceeeeecccc----cccccCccccCCHHHHcC-----CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHH
Confidence            9999999999887543    234689999999999984     5689999999999999999999999999999999999


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCC--CChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--cc
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQ--NGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--RD  316 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~--~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--~~  316 (372)
                      |.....  ..|.    .+|+++.+||++||+ ||.+|+..  ..+.+++              +||||++++|+.+  ++
T Consensus       250 i~~~~~--~~p~----~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell--------------~Hp~f~~~~~~~~~~~~  309 (350)
T d1rdqe_         250 IVSGKV--RFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIK--------------NHKWFATTDWIAIYQRK  309 (350)
T ss_dssp             HHHCCC--CCCT----TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHH--------------TSGGGTTCCHHHHHTTC
T ss_pred             HhcCCC--CCCc----cCCHHHHHHHHHHhhhCHHhccccccccHHHHH--------------cCccccCCCHHHHHhcC
Confidence            987643  3344    689999999999999 99999631  1355556              9999999999988  45


Q ss_pred             CCCCCcCCCCCCCCCCCCCCCc
Q psy11571        317 SNAPYIPEVSSPTDTSHFDVDE  338 (372)
Q Consensus       317 ~~~p~~p~~~~~~~~~~~~~~~  338 (372)
                      ..|||+|.+.++.|.++|+...
T Consensus       310 ~~~p~~p~~~~~~d~s~~~~~~  331 (350)
T d1rdqe_         310 VEAPFIPKFKGPGDTSNFDDYE  331 (350)
T ss_dssp             SCCSCCCCCCSTTCCTTSCCCC
T ss_pred             CCcCccCCCCCcchhhhcCCCC
Confidence            7899999999999999998654

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=7.4e-60  Score=447.13  Aligned_cols=288  Identities=26%  Similarity=0.509  Sum_probs=230.2

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||+|++..+++.||+|.+...........    ....+..+|..+++.++|||||+++++|
T Consensus         5 dy~i~~~lG~G----~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~----~~~~~e~~~~~~l~~~~hpnIv~l~~~~   76 (364)
T d1omwa3           5 DFSVHRIIGRG----GFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE----TLALNERIMLSLVSTGDCPFIVCMSYAF   76 (364)
T ss_dssp             TEEEEEEEEEC----SSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCH----HHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred             hCeeeeEEecC----CCeEEEEEEECCCCCEEEEEEEchHHcchhhHH----HHHHHHHHHHHHHhcCCCCcEEEEEEEE
Confidence            45666777777    899999999999999999998875544333211    1222334567788889999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+.+.+|+|||||+||+|.+++.+ ...+++..++.++.||+.||.|||++||+|          |||||+|||++.+|.
T Consensus        77 ~~~~~~~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiH----------rDlKP~NILl~~~g~  145 (364)
T d1omwa3          77 HTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVY----------RDLKPANILLDEHGH  145 (364)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEECSSSC
T ss_pred             EECCEEEEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccc----------eeeccceeEEcCCCc
Confidence            999999999999999999999987 578999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHH---HH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE---TY  239 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~---~~  239 (372)
                      +||+|||+|+......   ....+||+.|+|||++..    ...|+.++|||||||++|||+||+.||.+.+..+   +.
T Consensus       146 iKl~DFGla~~~~~~~---~~~~~GT~~y~APE~~~~----~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~  218 (364)
T d1omwa3         146 VRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQK----GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID  218 (364)
T ss_dssp             EEECCCTTCEECSSSC---CCSCCSCGGGCCHHHHST----TCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH
T ss_pred             EEEeeeceeeecCCCc---ccccccccccchhHHhhc----CCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            9999999998765432   234689999999999973    3468999999999999999999999998754332   22


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCC--CChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc--
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQ--NGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI--  314 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~--~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~--  314 (372)
                      ..+..  ....+|.    .+|+++++||.+||+ ||++|||.  ..+.+++              +||||++++|+.+  
T Consensus       219 ~~~~~--~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil--------------~Hp~f~~i~~~~~~~  278 (364)
T d1omwa3         219 RMTLT--MAVELPD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK--------------ESPFFRSLDWQMVFL  278 (364)
T ss_dssp             HHSSS--CCCCCCS----SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHH--------------TSGGGTTCCHHHHHT
T ss_pred             Hhccc--CCCCCCC----CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHH--------------cCccccCCCHHHHhc
Confidence            22222  2233333    789999999999999 99999995  3467777              9999999999987  


Q ss_pred             ccCCCCCcCCCCCCCCCCCCCC
Q psy11571        315 RDSNAPYIPEVSSPTDTSHFDV  336 (372)
Q Consensus       315 ~~~~~p~~p~~~~~~~~~~~~~  336 (372)
                      ++..||++|........+.||.
T Consensus       279 ~~~~~p~~p~~~~~~~~~~~d~  300 (364)
T d1omwa3         279 QKYPPPLIPPRGEVNAADAFDI  300 (364)
T ss_dssp             TCSCCSCCCCCC----------
T ss_pred             CCCCcCcCCCCCCCCcCCcccc
Confidence            5678999998877777666654

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-59  Score=426.70  Aligned_cols=254  Identities=25%  Similarity=0.440  Sum_probs=219.2

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      +||+.++++|.|    |+|.||++.+..+++.||+|.+.......          .+.+.+|+.+++.++|||||+++++
T Consensus        20 ~~Y~~~~~iG~G----~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~----------~~~~~~E~~il~~l~HpnIv~~~~~   85 (293)
T d1yhwa1          20 KKYTRFEKIGQG----ASGTVYTAMDVATGQEVAIRQMNLQQQPK----------KELIINEILVMRENKNPNIVNYLDS   85 (293)
T ss_dssp             TTBCSCEECCCS----SSCEEEEEEBTTTCCEEEEEEEEGGGCSC----------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEEEEEEecC----cCcEEEEEEECCCCCEEEEEEEecccChH----------HHHHHHHHHHHHhCCCCCEeeEeEE
Confidence            467777777777    89999999999999999999876543222          2457889999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+++.+|+|||||+||+|.+++.+  +.+++.+++.++.||+.||.|||++||+|          |||||+|||++.+|
T Consensus        86 ~~~~~~~~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiH----------rDiKp~NILl~~~~  153 (293)
T d1yhwa1          86 YLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIH----------RDIKSDNILLGMDG  153 (293)
T ss_dssp             EEETTEEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEECTTC
T ss_pred             EEECCEEEEEEEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcc----------cCCcHHHeEECCCC
Confidence            9999999999999999999999876  67999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      ++||+|||+|+....... .....+||+.|+|||++.+     ..++.++|||||||++|+|++|++||.+.+..+....
T Consensus       154 ~vkl~DFG~a~~~~~~~~-~~~~~~gt~~Y~aPE~~~~-----~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~  227 (293)
T d1yhwa1         154 SVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTR-----KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL  227 (293)
T ss_dssp             CEEECCCTTCEECCSTTC-CBCCCCSCGGGCCHHHHSS-----SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred             cEeeccchhheeeccccc-cccccccCCCccChhhhcC-----CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHH
Confidence            999999999987754332 2345689999999999983     5689999999999999999999999999888877777


Q ss_pred             Hhhcc-CCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        242 IMNHQ-NSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       242 i~~~~-~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      +.... ..+..|.    .+|+++++||.+||+ ||++|||+++++                 +||||+.
T Consensus       228 ~~~~~~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~eil-----------------~Hp~~~~  275 (293)
T d1yhwa1         228 IATNGTPELQNPE----KLSAIFRDFLNRCLDMDVEKRGSAKELL-----------------QHQFLKI  275 (293)
T ss_dssp             HHHHCSCCCSSGG----GSCHHHHHHHHHHTCSSTTTSCCHHHHT-----------------TCGGGGG
T ss_pred             HHhCCCCCCCCcc----cCCHHHHHHHHHHccCChhHCcCHHHHh-----------------cCHhhCC
Confidence            66543 2233333    689999999999999 999999866655                 9999974

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-59  Score=423.35  Aligned_cols=253  Identities=28%  Similarity=0.486  Sum_probs=221.4

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||++.+..+++.||+|.+........       ...+.+.+|+.+++.++||||+++++++
T Consensus         7 dy~i~~~iG~G----~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~-------~~~~~~~~E~~il~~l~hpnIv~~~~~~   75 (263)
T d2j4za1           7 DFEIGRPLGKG----KFGNVYLAREKQSKFILALKVLFKAQLEKA-------GVEHQLRREVEIQSHLRHPNILRLYGYF   75 (263)
T ss_dssp             GEEEEEEEEEC----SSEEEEEEEETTTCCEEEEEEEEHHHHHHT-------TCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             HeEEEEEEecC----CCcEEEEEEECCCCcEEEEEEEchHHccCh-------HHHHHHHHHHHHHHhcCCCCCCeEEEEE
Confidence            45566677777    899999999999999999998876544333       1235578899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+++.+|+|||||+||+|.+++.+ .+.+++..++.++.||+.||+|||++||+|          |||||+|||++.++.
T Consensus        76 ~~~~~~~ivmEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivH----------rDiKp~Nill~~~~~  144 (263)
T d2j4za1          76 HDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIH----------RDIKPENLLLGSAGE  144 (263)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCC----------CCCCGGGEEECTTSC
T ss_pred             EECCEEEEEEeecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeee----------eeeccccceecCCCC
Confidence            999999999999999999999987 578999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||+|+......   ....+||+.|+|||++.+     ..++.++|||||||++|+|++|++||.+.+..+.+.++
T Consensus       145 ~kl~DFG~a~~~~~~~---~~~~~Gt~~Y~APE~~~~-----~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i  216 (263)
T d2j4za1         145 LKIADFGWSVHAPSSR---RTTLCGTLDYLPPEMIEG-----RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI  216 (263)
T ss_dssp             EEECCCCSCSCCCCCC---CEETTEEGGGCCHHHHTT-----CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             EeecccceeeecCCCc---ccccCCCCcccCHHHHcC-----CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            9999999998765432   234689999999999984     56899999999999999999999999999999999888


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      .+..  +.+|.    .+|+++++||.+||+ ||++|||+++++                 +||||++
T Consensus       217 ~~~~--~~~p~----~~s~~~~~li~~~L~~dp~~R~t~~eil-----------------~hp~~~~  260 (263)
T d2j4za1         217 SRVE--FTFPD----FVTEGARDLISRLLKHNPSQRPMLREVL-----------------EHPWITA  260 (263)
T ss_dssp             HTTC--CCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHH-----------------TCHHHHH
T ss_pred             HcCC--CCCCc----cCCHHHHHHHHHHccCCHhHCcCHHHHH-----------------cCcCcCC
Confidence            7754  34454    689999999999999 999999866655                 9999963

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-59  Score=424.41  Aligned_cols=257  Identities=21%  Similarity=0.349  Sum_probs=210.2

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    |+|.||++.+..+++.||+|.+.......         ..+.+.+|+.+|+.++||||++++++
T Consensus         5 ~dy~~~~~lG~G----~fg~V~~~~~~~~~~~vAiK~i~~~~~~~---------~~~~~~~Ei~~l~~l~HpnIv~~~~~   71 (271)
T d1nvra_           5 EDWDLVQTLGEG----AYGEVQLAVNRVTEEAVAVKIVDMKRAVD---------CPENIKKEICINKMLNHENVVKFYGH   71 (271)
T ss_dssp             TEEEEEEEEEEE----TTEEEEEEEETTTCCEEEEEEEECC----------------CHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             cceEEEEEEecC----cCeEEEEEEECCCCCEEEEEEEehhhcch---------HHHHHHHHHHHHHhCCCCCEeeEeee
Confidence            346667777777    89999999999999999999886543221         23457889999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+++.+|+|||||+||+|.+++.+ .+.+++.+++.++.||+.||.|||++||+|          |||||+|||++.++
T Consensus        72 ~~~~~~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiH----------rDiKp~NILl~~~~  140 (271)
T d1nvra_          72 RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITH----------RDIKPENLLLDERD  140 (271)
T ss_dssp             EEETTEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCCGGGEEECTTC
T ss_pred             eccCceeEEEEeccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcc----------CcccHHHEEECCCC
Confidence            9999999999999999999999976 578999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHH-HH
Q psy11571        162 HIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TY  239 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~-~~  239 (372)
                      .+||+|||+|+....... ......+||+.|+|||++.+    ...++.++|||||||++|||++|++||...+... .+
T Consensus       141 ~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~----~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~  216 (271)
T d1nvra_         141 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR----REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY  216 (271)
T ss_dssp             CEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHC----SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH
T ss_pred             CEEEccchhheeeccCCccccccceeeCcCccCHhHhcC----CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH
Confidence            999999999987643322 22345689999999999984    3335678999999999999999999998765433 33


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcC
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ  307 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~  307 (372)
                      ..+..... ...+   ...+|+++++||.+||+ ||++|||+++++                 +||||+
T Consensus       217 ~~~~~~~~-~~~~---~~~~s~~~~~li~~~L~~dP~~R~t~~eil-----------------~hpwf~  264 (271)
T d1nvra_         217 SDWKEKKT-YLNP---WKKIDSAPLALLHKILVENPSARITIPDIK-----------------KDRWYN  264 (271)
T ss_dssp             HHHHTTCT-TSTT---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHT-----------------TCTTTT
T ss_pred             HHHhcCCC-CCCc---cccCCHHHHHHHHHHcCCChhHCcCHHHHh-----------------cCHhhC
Confidence            33333222 2111   22689999999999999 999999866555                 999997

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-58  Score=426.30  Aligned_cols=269  Identities=23%  Similarity=0.383  Sum_probs=225.3

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      +||+.++.+|.|    |+|.||++.+..+++.||+|.+...........    ...+.+.+|+.+|+.++|||||+++++
T Consensus        10 d~Y~~~~~lG~G----~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~   81 (293)
T d1jksa_          10 DYYDTGEELGSG----QFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRG----VSREDIEREVSILKEIQHPNVITLHEV   81 (293)
T ss_dssp             GTEEEEEEEEEC----SSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSS----BCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cCEEEeEEEecC----CCeEEEEEEECCCCCEEEEEEEEhhhcchhhhh----HHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            567888888887    899999999999999999999876554432111    123567889999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      |.+.+.+|+|||||+||+|.+++.. .+.+++..++.++.||+.||+|||++||+|          |||||+|||++.++
T Consensus        82 ~~~~~~~~iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~~~ivH----------rDiKp~Nill~~~~  150 (293)
T d1jksa_          82 YENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAH----------FDLKPENIMLLDRN  150 (293)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEESCSS
T ss_pred             EEECCEEEEEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhhcceee----------cccccceEEEecCC
Confidence            9999999999999999999999987 478999999999999999999999999999          99999999998776


Q ss_pred             ----cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHH
Q psy11571        162 ----HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE  237 (372)
Q Consensus       162 ----~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~  237 (372)
                          .+||+|||+|+.......  .....||+.|+|||++.+     ..++.++|||||||++|||++|+.||.+.+..+
T Consensus       151 ~~~~~vkl~DfG~a~~~~~~~~--~~~~~~t~~y~APE~~~~-----~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~  223 (293)
T d1jksa_         151 VPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNY-----EPLGLEADMWSIGVITYILLSGASPFLGDTKQE  223 (293)
T ss_dssp             SSSCCEEECCCTTCEECTTSCB--CSCCCCCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             CcccceEecchhhhhhcCCCcc--ccccCCCCcccCHHHHcC-----CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH
Confidence                599999999988754432  234679999999999983     568999999999999999999999999999999


Q ss_pred             HHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccccc
Q psy11571        238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIR  315 (372)
Q Consensus       238 ~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~  315 (372)
                      .+.++......+  +......+|+++++||++||+ ||++|||+++++                 +||||++.+|+...
T Consensus       224 ~~~~i~~~~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil-----------------~hp~~~~~~~~~~l  283 (293)
T d1jksa_         224 TLANVSAVNYEF--EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL-----------------QHPWIKPKDTQQAL  283 (293)
T ss_dssp             HHHHHHTTCCCC--CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHH-----------------HSTTTCC-------
T ss_pred             HHHHHHhcCCCC--CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHh-----------------cCcccCCCChhHhh
Confidence            999988765432  322223689999999999999 999999866655                 99999999998763

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-58  Score=425.14  Aligned_cols=260  Identities=24%  Similarity=0.374  Sum_probs=221.9

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      .|+.++++|.|    |+|.||++.+..+++.||+|.+.......          .+.+.+|+.+|+.++|||||++++++
T Consensus        13 ~Y~i~~~iG~G----~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~----------~~~~~~E~~il~~l~HpnIv~l~~~~   78 (288)
T d2jfla1          13 FWEIIGELGDG----AFGKVYKAQNKETSVLAAAKVIDTKSEEE----------LEDYMVEIDILASCDHPNIVKLLDAF   78 (288)
T ss_dssp             TEEEEEEEEEE----TTEEEEEEEETTTCCEEEEEEEECSSSGG----------GGGTHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CeEEeEEEeeC----CCcEEEEEEECCCCeEEEEEEECcCCHHH----------HHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            46677778877    89999999999999999999887543322          24467899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+++.+|+|||||+||+|.+++.+..+.+++..++.++.||+.||.|||++||+|          |||||+|||++.+|.
T Consensus        79 ~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivH----------rDiKp~NIll~~~~~  148 (288)
T d2jfla1          79 YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH----------RDLKAGNILFTLDGD  148 (288)
T ss_dssp             EETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEECTTSC
T ss_pred             eeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEE----------eecChhheeECCCCC
Confidence            9999999999999999999998765677999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  242 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i  242 (372)
                      +||+|||+|+...... ......+||+.|+|||++.........|+.++|||||||++|||+||++||.+.+..+.+.++
T Consensus       149 ~Kl~DFG~a~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i  227 (288)
T d2jfla1         149 IKLADFGVSAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI  227 (288)
T ss_dssp             EEECCCTTCEECHHHH-HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH
T ss_pred             EEEEechhhhccCCCc-ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence            9999999997653221 123346899999999999654333566899999999999999999999999999988888888


Q ss_pred             hhccCC-cCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        243 MNHQNS-FDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       243 ~~~~~~-~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      .+.... +..+    ..+|+++++||++||+ ||++|||+++++                 +||||+.
T Consensus       228 ~~~~~~~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~ell-----------------~hp~~~~  274 (288)
T d2jfla1         228 AKSEPPTLAQP----SRWSSNFKDFLKKCLEKNVDARWTTSQLL-----------------QHPFVTV  274 (288)
T ss_dssp             HHSCCCCCSSG----GGSCHHHHHHHHHHSCSSTTTSCCHHHHT-----------------TSGGGCC
T ss_pred             HcCCCCCCCcc----ccCCHHHHHHHHHHccCChhHCcCHHHHh-----------------cCcccCC
Confidence            876432 2222    2689999999999999 999999866555                 9999984

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.3e-58  Score=424.71  Aligned_cols=257  Identities=30%  Similarity=0.463  Sum_probs=206.5

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||++++..+++.||+|.+........         .+.+.+|+.+|+.++|||||++++++
T Consensus        10 ~Y~~~~~lG~G----~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~---------~~~~~~Ei~il~~l~HpnIv~l~~~~   76 (307)
T d1a06a_          10 IYDFRDVLGTG----AFSEVILAEDKRTQKLVAIKCIAKKALEGK---------EGSMENEIAVLHKIKHPNIVALDDIY   76 (307)
T ss_dssp             TEEEEEESBSG----GGGGEEEEEETTTCCEEEEEEEEC-------------------CHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ceEEEEEEeec----cCeEEEEEEECCCCCEEEEEEEchHHhhhH---------HHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            45666666666    899999999999999999999876554322         24577899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC---C
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD---A  159 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~---~  159 (372)
                      .+++.+|+|||||+||+|.+++.. .+.+++.+++.++.||+.||+|||++||+|          |||||+|||+.   .
T Consensus        77 ~~~~~~~lvmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiH----------rDiKp~Nil~~~~~~  145 (307)
T d1a06a_          77 ESGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVH----------RDLKPENLLYYSLDE  145 (307)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCCGGGEEESSSST
T ss_pred             EECCEEEEEEeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeee----------EEecccceeecccCC
Confidence            999999999999999999999987 578999999999999999999999999999          99999999995   5


Q ss_pred             CCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHH
Q psy11571        160 NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY  239 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~  239 (372)
                      ++.+||+|||+|+.......  ..+.+||+.|+|||++.+     ..|+.++|||||||++|+|++|++||.+.+..+..
T Consensus       146 ~~~vkl~DFG~a~~~~~~~~--~~~~~GT~~y~APE~~~~-----~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~  218 (307)
T d1a06a_         146 DSKIMISDFGLSKMEDPGSV--LSTACGTPGYVAPEVLAQ-----KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF  218 (307)
T ss_dssp             TCCEEECCC--------------------CTTSCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             CceEEEeccceeEEccCCCe--eeeeeeCccccCcHHHcC-----CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH
Confidence            78999999999987654332  234689999999999983     56899999999999999999999999999999999


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      .++.+....++  ......+|+++++||.+||+ ||++|||+++++                 +||||++-
T Consensus       219 ~~i~~~~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil-----------------~hp~~~~~  270 (307)
T d1a06a_         219 EQILKAEYEFD--SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQAL-----------------QHPWIAGD  270 (307)
T ss_dssp             HHHHTTCCCCC--TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHH-----------------HSTTTTSS
T ss_pred             HHHhccCCCCC--CccccCCCHHHHHHHHHHccCCHhHCcCHHHHh-----------------cCHhhCCC
Confidence            99988665443  33334789999999999999 999999876655                 99999863

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.6e-57  Score=428.70  Aligned_cols=262  Identities=25%  Similarity=0.402  Sum_probs=226.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||++.+..+++.||+|.+......          ..+.+.+|+.+|+.++|||||++++++
T Consensus        27 ~Y~i~~~lG~G----~fg~Vy~~~~~~~g~~vAvK~i~~~~~~----------~~~~~~~E~~il~~l~HpnIv~~~~~~   92 (350)
T d1koaa2          27 HYDIHEELGTG----AFGVVHRVTERATGNNFAAKFVMTPHES----------DKETVRKEIQTMSVLRHPTLVNLHDAF   92 (350)
T ss_dssp             TEEEEEEEEEE----TTEEEEEEEETTTTEEEEEEEECCCSHH----------HHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred             CeEEEEEEecC----cCeEEEEEEECCCCCEEEEEEEcccchh----------hHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            56667777777    8999999999999999999988654322          135578899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC--CC
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD--AN  160 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~--~~  160 (372)
                      .+++.+|+|||||+||+|.+++.+..+.+++.+++.++.||+.||.|||++||+|          |||||+|||++  .+
T Consensus        93 ~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiH----------rDiKp~NIll~~~~~  162 (350)
T d1koaa2          93 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVH----------LDLKPENIMFTTKRS  162 (350)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCCGGGEEESSTTS
T ss_pred             EECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCee----------eeechhHeeeccCCC
Confidence            9999999999999999999999765678999999999999999999999999999          99999999996  46


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG  240 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~  240 (372)
                      +.+||+|||+|+.......  .....||+.|+|||++.+     ..++.++|||||||++|+|++|++||.+.+..+.+.
T Consensus       163 ~~vkL~DFG~a~~~~~~~~--~~~~~gT~~Y~aPEv~~~-----~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~  235 (350)
T d1koaa2         163 NELKLIDFGLTAHLDPKQS--VKVTTGTAEFAAPEVAEG-----KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR  235 (350)
T ss_dssp             CCEEECCCTTCEECCTTSC--EEEECSCTTTCCHHHHHT-----CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CeEEEeecchheecccccc--cceecCcccccCHHHHcC-----CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHH
Confidence            7899999999988765433  234689999999999983     568899999999999999999999999999999999


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI  314 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~  314 (372)
                      +|......+  +......+|+++++||++||+ ||++|||+++++                 +||||+..+|...
T Consensus       236 ~i~~~~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil-----------------~hp~~~~~~~~~~  291 (350)
T d1koaa2         236 NVKSCDWNM--DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQAL-----------------EHPWLTPGNAPGR  291 (350)
T ss_dssp             HHHHTCCCS--CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHH-----------------HSTTTSCTTCCSC
T ss_pred             HHHhCCCCC--CcccccCCCHHHHHHHHHHccCChhHCcCHHHHh-----------------cCcccCCCCCCCc
Confidence            998765433  333334689999999999999 999999866655                 9999999887544

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.8e-58  Score=423.13  Aligned_cols=257  Identities=21%  Similarity=0.314  Sum_probs=222.3

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++++|.|    |+|.||++.+..+++.||+|.+........       +..+.+.+|+.+|+.++|||||+++++
T Consensus        15 ~~y~~l~~lG~G----~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~-------~~~~~~~~Ei~il~~l~HpnIv~~~~~   83 (309)
T d1u5ra_          15 KLFSDLREIGHG----SFGAVYFARDVRNSEVVAIKKMSYSGKQSN-------EKWQDIIKEVRFLQKLRHPNTIQYRGC   83 (309)
T ss_dssp             HHEEEEEEEEEC----SSSEEEEEEETTTTEEEEEEEEECCSSCHH-------HHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             HhcEeeEEEecC----CCeEEEEEEECCCCcEEEEEEEchhhccCH-------HHHHHHHHHHHHHHHCCCCCEeeEEEE
Confidence            467788888888    899999999999999999999876554433       235668889999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+++.+|+|||||.+|+|..++.. ++.+++.+++.++.||+.||.|||++||+|          |||||+|||++.++
T Consensus        84 ~~~~~~~~iv~E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiH----------rDiKp~NILl~~~~  152 (309)
T d1u5ra_          84 YLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIH----------RDVKAGNILLSEPG  152 (309)
T ss_dssp             EEETTEEEEEEECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBC----------CCCSGGGEEEETTT
T ss_pred             EEECCEEEEEEEecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEec----------cCCCcceEEECCCC
Confidence            9999999999999999999877766 578999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .+||+|||+|+.....     ...+||+.|+|||++.+..  ...|+.++|||||||++|||++|..||.+.+..+.+.+
T Consensus       153 ~~Kl~DFG~a~~~~~~-----~~~~GT~~Y~APE~~~~~~--~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~  225 (309)
T d1u5ra_         153 LVKLGDFGSASIMAPA-----NSFVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH  225 (309)
T ss_dssp             EEEECCCTTCBSSSSB-----CCCCSCGGGCCHHHHTTTT--SCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred             CEEEeecccccccCCC-----CccccCccccCHHHHhccC--CCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            9999999999875432     3367999999999997422  34589999999999999999999999999998888888


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      +.........+    ..+|+++++||.+||+ ||++|||+++++                 +||||..
T Consensus       226 i~~~~~~~~~~----~~~s~~~~~li~~~L~~dP~~Rpt~~ell-----------------~Hp~~~~  272 (309)
T d1u5ra_         226 IAQNESPALQS----GHWSEYFRNFVDSCLQKIPQDRPTSEVLL-----------------KHRFVLR  272 (309)
T ss_dssp             HHHSCCCCCSC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHT-----------------TCHHHHS
T ss_pred             HHhCCCCCCCC----CCCCHHHHHHHHHHCcCChhHCcCHHHHH-----------------hCHHhcC
Confidence            87764332222    2689999999999999 999999876655                 9999974

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-57  Score=412.82  Aligned_cols=250  Identities=30%  Similarity=0.431  Sum_probs=204.0

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      |.|+.++.+|.|    |+|.||++++..+++.||+|.+........        ..+.+.+|+.+++.++|||||+++++
T Consensus         4 edy~~~~~iG~G----~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~--------~~~~~~~E~~il~~l~HpnIv~~~~~   71 (269)
T d2java1           4 EDYEVLYTIGTG----SYGRCQKIRRKSDGKILVWKELDYGSMTEA--------EKQMLVSEVNLLRELKHPNIVRYYDR   71 (269)
T ss_dssp             GGEEEEEEEEEC----SSEEEEEEEETTTCCEEEEEEECCTTSCHH--------HHHHHHHHHHHTTSCCCTTBCCEEEE
T ss_pred             hhCEEeEEEecC----CCeEEEEEEECCCCCEEEEEEEChhhCCHH--------HHHHHHHHHHHHHHCCCCCEeeEEEE
Confidence            457777888887    899999999999999999999877654332        24568899999999999999999999


Q ss_pred             EEe--CCeEEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhcC-----ceecCCCCCCCcCCCCC
Q psy11571         82 FQD--DSNLYLVMDYYCGGDLLTLLSKF---EDRLPEDMAKFYIAEMVLAIASIHDLH-----YVHRPNHFAFHLCRDIK  151 (372)
Q Consensus        82 ~~~--~~~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~-----ivH~~~~~~~~vhrDlk  151 (372)
                      +.+  .+.+|+|||||+||+|.+++.+.   +..+++..++.++.||+.||.|||+.|     |+|          ||||
T Consensus        72 ~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiH----------rDiK  141 (269)
T d2java1          72 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH----------RDLK  141 (269)
T ss_dssp             EEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC-------------------CC
T ss_pred             EEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEe----------CcCc
Confidence            865  45689999999999999998642   467999999999999999999999976     899          9999


Q ss_pred             cCcEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCC
Q psy11571        152 PDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY  231 (372)
Q Consensus       152 p~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~  231 (372)
                      |+|||++.++.+||+|||+|+....... .....+||+.|+|||++.     ...++.++|||||||++|||+||++||.
T Consensus       142 p~NIll~~~~~vkl~DFG~a~~~~~~~~-~~~~~~gt~~Y~APE~l~-----~~~~~~~~DIwSlGvilyel~tg~~Pf~  215 (269)
T d2java1         142 PANVFLDGKQNVKLGDFGLARILNHDTS-FAKAFVGTPYYMSPEQMN-----RMSYNEKSDIWSLGCLLYELCALMPPFT  215 (269)
T ss_dssp             GGGEEECTTSCEEECCHHHHHHC------------CCCSCCCHHHHT-----TCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             hhhcCcCCCCcEEEeeccceeecccCCC-ccccCCCCcccCCHHHHc-----CCCCChHHHHHhhCHHHHHHhhCCCCCC
Confidence            9999999999999999999988754332 234478999999999997     3568999999999999999999999999


Q ss_pred             CCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        232 AESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       232 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      +.+..++..+|..+... .+|.    .+|+++++||++||+ ||++|||+++++
T Consensus       216 ~~~~~~~~~~i~~~~~~-~~~~----~~s~~l~~li~~~L~~dp~~Rps~~ell  264 (269)
T d2java1         216 AFSQKELAGKIREGKFR-RIPY----RYSDELNEIITRMLNLKDYHRPSVEEIL  264 (269)
T ss_dssp             CSSHHHHHHHHHHTCCC-CCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCHHHHHHHHHcCCCC-CCCc----ccCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            99999998888776432 3333    689999999999999 999999866555

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=7e-57  Score=424.55  Aligned_cols=257  Identities=25%  Similarity=0.403  Sum_probs=223.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||+|.+..+++.||+|.+.......          .+.+.+|+.+|+.++|||||+++++|
T Consensus        30 ~Y~i~~~lG~G----~fg~V~~a~~~~~~~~vAiK~i~~~~~~~----------~~~~~~Ei~il~~l~HpnIv~~~~~~   95 (352)
T d1koba_          30 YYDILEELGSG----AFGVVHRCVEKATGRVFVAKFINTPYPLD----------KYTVKNEISIMNQLHHPKLINLHDAF   95 (352)
T ss_dssp             TEEEEEEEEEE----TTEEEEEEEETTTCCEEEEEEEECCSHHH----------HHHHHHHHHHHTTCCSTTBCCEEEEE
T ss_pred             ceEEEEEEecC----CCeEEEEEEECCCCCEEEEEEECCcchhH----------HHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            46667777777    89999999999999999999886543221          24577899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC--CC
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD--AN  160 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~--~~  160 (372)
                      .+++.+|+|||||+||+|.+++......+++.+++.++.||+.||.|||++||+|          |||||+|||++  .+
T Consensus        96 ~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiH----------RDiKp~NILl~~~~~  165 (352)
T d1koba_          96 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVH----------LDIKPENIMCETKKA  165 (352)
T ss_dssp             ECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCCGGGEEESSTTC
T ss_pred             EECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeee----------cccccccccccccCC
Confidence            9999999999999999999988765567999999999999999999999999999          99999999998  57


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG  240 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~  240 (372)
                      +.+||+|||+|+.......  .....||+.|+|||++.     ...++.++|||||||++|+|+||.+||.+.+..+.+.
T Consensus       166 ~~vkL~DFGla~~~~~~~~--~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~  238 (352)
T d1koba_         166 SSVKIIDFGLATKLNPDEI--VKVTTATAEFAAPEIVD-----REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ  238 (352)
T ss_dssp             CCEEECCCTTCEECCTTSC--EEEECSSGGGCCHHHHT-----TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH
T ss_pred             CeEEEeecccceecCCCCc--eeeccCcccccCHHHHc-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            8999999999988765433  23467999999999998     3568999999999999999999999999999999999


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCC
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~  309 (372)
                      +|......  ++......+|+++++||++||+ ||.+|||+++++                 +||||++.
T Consensus       239 ~i~~~~~~--~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil-----------------~Hp~~~~~  289 (352)
T d1koba_         239 NVKRCDWE--FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDAL-----------------EHPWLKGD  289 (352)
T ss_dssp             HHHHCCCC--CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHH-----------------TSTTTSSC
T ss_pred             HHHhCCCC--CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHh-----------------cCHhhCCC
Confidence            99876543  3444445799999999999999 999999866555                 99999974

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-58  Score=426.39  Aligned_cols=261  Identities=25%  Similarity=0.387  Sum_probs=215.5

Q ss_pred             ChHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeE
Q psy11571          1 DERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHY   80 (372)
Q Consensus         1 ~~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~   80 (372)
                      +++|+.++.+|.|    |+|.||++.+..+++.||+|.+.......         ..+++.+|+.+|+.++|||||++++
T Consensus         5 ~d~y~~~~~iG~G----~fg~V~~~~~~~~~~~vAiK~i~~~~~~~---------~~~~~~~Ei~il~~l~HpnIv~l~~   71 (322)
T d1s9ja_           5 DDDFEKISELGAG----NGGVVFKVSHKPSGLVMARKLIHLEIKPA---------IRNQIIRELQVLHECNSPYIVGFYG   71 (322)
T ss_dssp             GGGEEEEEEEECC----SSCCEEEEEETTTTEEEEEEEEECCCCTT---------HHHHHHHHGGGGGGCCCTTBCCEEE
T ss_pred             ccCCEEEEEEecC----CCeEEEEEEECCCCcEEEEEEEChhhCHH---------HHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            3578888888888    89999999999999999999886543221         2345788999999999999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCCcCCCCCcCcEEeCC
Q psy11571         81 AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD-LHYVHRPNHFAFHLCRDIKPDNVLLDA  159 (372)
Q Consensus        81 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~~~~~~~~vhrDlkp~NIll~~  159 (372)
                      +|.+++++|+|||||+||+|.+++.+ .+.+++..++.++.||+.||.|||+ +||+|          |||||+|||++.
T Consensus        72 ~~~~~~~~~iVmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~~IiH----------RDiKP~NILl~~  140 (322)
T d1s9ja_          72 AFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMH----------RDVKPSNILVNS  140 (322)
T ss_dssp             EEECSSEEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCC----------SCCSGGGEEECT
T ss_pred             EEEECCEEEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEc----------cccCHHHeeECC
Confidence            99999999999999999999999987 4789999999999999999999997 59999          999999999999


Q ss_pred             CCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHH
Q psy11571        160 NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY  239 (372)
Q Consensus       160 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~  239 (372)
                      +|++||+|||+|+.....   ...+.+||+.|+|||++.+     ..|+.++|||||||++|||++|+.||.+.+..+..
T Consensus       141 ~~~vkl~DFGla~~~~~~---~~~~~~GT~~Y~APEvl~~-----~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~  212 (322)
T d1s9ja_         141 RGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQG-----THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE  212 (322)
T ss_dssp             TCCEEECCCCCCHHHHHH---TC---CCSSCCCCHHHHHC-----SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHH
T ss_pred             CCCEEEeeCCCccccCCC---ccccccCCccccCchHHcC-----CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence            999999999999875322   2344789999999999984     56999999999999999999999999875433211


Q ss_pred             ------------------------------------------HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCC
Q psy11571        240 ------------------------------------------GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDT  276 (372)
Q Consensus       240 ------------------------------------------~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~  276 (372)
                                                                ..+.. ......+   ...+|.++++||.+||+ ||++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~s~~~~dli~~~L~~dP~~  288 (322)
T d1s9ja_         213 LMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVN-EPPPKLP---SGVFSLEFQDFVNKCLIKNPAE  288 (322)
T ss_dssp             HHC------------------------------CCCCHHHHHHHHHT-SCCCCCC---BTTBCHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhc-cCCccCc---cccCCHHHHHHHHHHcCCChhH
Confidence                                                      01111 0111111   12478999999999999 9999


Q ss_pred             CCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCcccc
Q psy11571        277 RLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSI  314 (372)
Q Consensus       277 R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~  314 (372)
                      |||+++++                 +||||+..+|+.+
T Consensus       289 R~ta~e~L-----------------~Hpf~~~~~~~~~  309 (322)
T d1s9ja_         289 RADLKQLM-----------------VHAFIKRSDAEEV  309 (322)
T ss_dssp             SCCHHHHH-----------------TSHHHHHHHHSCC
T ss_pred             CcCHHHHh-----------------hCHhhCcCCcccc
Confidence            99877666                 9999998887654

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-56  Score=408.27  Aligned_cols=246  Identities=20%  Similarity=0.361  Sum_probs=207.3

Q ss_pred             hhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe----
Q psy11571          9 ALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQD----   84 (372)
Q Consensus         9 ~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~----   84 (372)
                      ++|.|    |+|.||++.+..+++.||+|.+........        ..+.+.+|+.+|++++|||||++++++.+    
T Consensus        16 ~iG~G----~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~--------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   83 (270)
T d1t4ha_          16 EIGRG----SFKTVYKGLDTETTVEVAWCELQDRKLTKS--------ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG   83 (270)
T ss_dssp             EEEEC----SSEEEEEEEETTTCCEEEEEEEEGGGSCHH--------HHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred             EEecC----cCcEEEEEEECCCCeEEEEEEEchhhCCHH--------HHHHHHHHHHHHHhCCCCCeeeEEEEEeecccc
Confidence            46666    899999999999999999998876544332        24568899999999999999999999876    


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCCCcCCCCCcCcEEeC-CCC
Q psy11571         85 DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLH--YVHRPNHFAFHLCRDIKPDNVLLD-ANG  161 (372)
Q Consensus        85 ~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~~~~~~~~vhrDlkp~NIll~-~~~  161 (372)
                      ...+|+|||||++|+|.+++.+ ...+++..++.++.||+.||+|||++|  |+|          |||||+|||++ .++
T Consensus        84 ~~~~~ivmE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiH----------rDiKp~NILl~~~~~  152 (270)
T d1t4ha_          84 KKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIH----------RDLKCDNIFITGPTG  152 (270)
T ss_dssp             CEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCC----------SCCCGGGEEESSTTS
T ss_pred             CCEEEEEEeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHCCCCEEe----------CCcChhhceeeCCCC
Confidence            3468999999999999999987 578999999999999999999999998  999          99999999997 578


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC-CHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE-SLVETYG  240 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~-~~~~~~~  240 (372)
                      .+||+|||+|+......   ....+||+.|+|||++.      +.++.++|||||||++|||++|+.||.+. +..+++.
T Consensus       153 ~~Kl~DFGla~~~~~~~---~~~~~GT~~Y~aPE~~~------~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~  223 (270)
T d1t4ha_         153 SVKIGDLGLATLKRASF---AKAVIGTPEFMAPEMYE------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR  223 (270)
T ss_dssp             CEEECCTTGGGGCCTTS---BEESCSSCCCCCGGGGG------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH
T ss_pred             CEEEeecCcceeccCCc---cCCcccCccccCHHHhC------CCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHH
Confidence            99999999998654332   23468999999999986      35899999999999999999999999765 4555666


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcC
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQ  307 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~  307 (372)
                      ++..+.....++.    ..++++++||.+||+ ||++|||+++++                 +||||+
T Consensus       224 ~i~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~R~s~~ell-----------------~Hp~fk  270 (270)
T d1t4ha_         224 RVTSGVKPASFDK----VAIPEVKEIIEGCIRQNKDERYSIKDLL-----------------NHAFFQ  270 (270)
T ss_dssp             HHTTTCCCGGGGG----CCCHHHHHHHHHHSCSSGGGSCCHHHHH-----------------TSGGGC
T ss_pred             HHHcCCCCcccCc----cCCHHHHHHHHHHccCCHhHCcCHHHHh-----------------CCcccC
Confidence            6665433333332    679999999999999 999999866555                 999996

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2e-56  Score=408.24  Aligned_cols=270  Identities=27%  Similarity=0.404  Sum_probs=230.0

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeeeE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLHY   80 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~~   80 (372)
                      ++|+.++.+|.|    ++|.||++++..+++.||+|.+........ ......+..+.+.+|+.+++.++ ||||+++++
T Consensus         3 ~~y~~~~~iG~G----~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~-~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~   77 (277)
T d1phka_           3 ENYEPKEILGRG----VSSVVRRCIHKPTCKEYAVKIIDVTGGGSF-SAEEVQELREATLKEVDILRKVSGHPNIIQLKD   77 (277)
T ss_dssp             TTEEEEEEEEEC----SSEEEEEEEETTTTEEEEEEEEETTCSTTC-CHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             ccCEEceEEecC----cCeEEEEEEECCCCCEEEEEEEecccccch-hHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEe
Confidence            567777888887    899999999999999999999877654432 11222334567889999999997 999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         81 AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        81 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      ++.+++++|+|||||+||+|.+++.. ++.+++..++.++.||+.||+|||++||+|          |||||+|||++.+
T Consensus        78 ~~~~~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivH----------rDlkp~Nill~~~  146 (277)
T d1phka_          78 TYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVH----------RDLKPENILLDDD  146 (277)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSGGGEEECTT
T ss_pred             ecccCcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcc----------cccccceEEEcCC
Confidence            99999999999999999999999987 578999999999999999999999999999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCccccccccc-CCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEE-GRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY  239 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~  239 (372)
                      +.+||+|||+++.......  .....||+.|+|||++.+... ....++.++||||+||++|+|++|++||.+.+..+..
T Consensus       147 ~~~kl~DFG~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~  224 (277)
T d1phka_         147 MNIKLTDFGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML  224 (277)
T ss_dssp             CCEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             CCeEEccchheeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH
Confidence            9999999999988765432  234679999999999974322 2345788999999999999999999999999999999


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      .++..+...+.  ......+|+++++||.+||+ ||++|||+++++                 +||||+.
T Consensus       225 ~~i~~~~~~~~--~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil-----------------~h~~~~~  275 (277)
T d1phka_         225 RMIMSGNYQFG--SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL-----------------AHPFFQQ  275 (277)
T ss_dssp             HHHHHTCCCCC--TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT-----------------TSGGGCT
T ss_pred             HHHHhCCCCCC--CcccccCCHHHHHHHHHHccCChhHCcCHHHHH-----------------cCHHHHH
Confidence            88888754433  33334799999999999999 999999866555                 9999985

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-56  Score=417.66  Aligned_cols=287  Identities=34%  Similarity=0.591  Sum_probs=235.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeeh---hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCC-Cceeee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLL---DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDR-RWITNL   78 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~---~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~h-p~Iv~l   78 (372)
                      +|+.++.+|.|    |+|.||+|++..   +++.||+|.+.......+..      ..+.+.+|+.+++.++| |||+++
T Consensus        25 ~y~~~~~IG~G----~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~------~~~~~~~E~~il~~l~h~pnIv~~   94 (322)
T d1vzoa_          25 NFELLKVLGTG----AYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK------TTEHTRTERQVLEHIRQSPFLVTL   94 (322)
T ss_dssp             GEEEEEEEEET----TTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEES------SGGGCCCHHHHHHHHHTCTTBCCE
T ss_pred             ceEEEEEEecC----CCeEEEEEEECccCCCCcEEEEEEEehHHhccchH------HHHHHHHHHHHHHhccCCCeEEEe
Confidence            46667778887    899999998754   58899999987655432211      12346679999999976 899999


Q ss_pred             eEEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC
Q psy11571         79 HYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD  158 (372)
Q Consensus        79 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~  158 (372)
                      ++++.+...++++|||+.+|+|.+++.. .+.+++..++.++.||+.||.|||++||+|          |||||+|||++
T Consensus        95 ~~~~~~~~~~~~v~e~~~~~~L~~~i~~-~~~~~e~~~~~~~~Qi~~al~~lH~~~ivH----------rDiKp~Nill~  163 (322)
T d1vzoa_          95 HYAFQTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIY----------RDIKLENILLD  163 (322)
T ss_dssp             EEEEEETTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------CCCCGGGEEEC
T ss_pred             eeeeccCCceeeeeecccccHHHHHHHh-cccccHHHHHHHHHHHHHHHHHhhcCCEEe----------ccCCccceeec
Confidence            9999999999999999999999999988 578899999999999999999999999999          99999999999


Q ss_pred             CCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHH
Q psy11571        159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET  238 (372)
Q Consensus       159 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~  238 (372)
                      .+|.+||+|||+++..............|++.|+|||.+.+.   ...++.++|||||||++|+|++|+.||.+.+..+.
T Consensus       164 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~---~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~  240 (322)
T d1vzoa_         164 SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG---DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS  240 (322)
T ss_dssp             TTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTC---C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC
T ss_pred             CCCCEEEeeccchhhhcccccccccccccccccchhHHhhcC---CcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999999999999987765544445567899999999999742   23578899999999999999999999987655544


Q ss_pred             HHHHhhcc--CCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCC--ChhhhhhhhhhhhccCCCCCCCCCcCCCCccc
Q psy11571        239 YGKIMNHQ--NSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQN--GIADFKMWSALFVSLSISPRNHPWFQGIAWDS  313 (372)
Q Consensus       239 ~~~i~~~~--~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~--~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~  313 (372)
                      ...+.+..  ..+++|.    .+|+++++||++||+ ||++|||+.  .+.|++              +||||++++|+.
T Consensus       241 ~~~i~~~~~~~~~~~~~----~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil--------------~Hpff~~i~~~~  302 (322)
T d1vzoa_         241 QAEISRRILKSEPPYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK--------------EHLFFQKINWDD  302 (322)
T ss_dssp             HHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH--------------TSGGGTTCCHHH
T ss_pred             HHHHHHhcccCCCCCcc----cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHH--------------cCHhhcCCCHHH
Confidence            44444322  2233343    689999999999999 999999853  577788              999999999999


Q ss_pred             c--ccCCCCCcCCCCCCCCC
Q psy11571        314 I--RDSNAPYIPEVSSPTDT  331 (372)
Q Consensus       314 ~--~~~~~p~~p~~~~~~~~  331 (372)
                      +  ++..+|++|.++++.|.
T Consensus       303 l~~~~~~~p~~p~~~~~~~~  322 (322)
T d1vzoa_         303 LAAKKVPAPFKPVIRDELDV  322 (322)
T ss_dssp             HHTTCSCCSCCCCCCC-CCC
T ss_pred             HHhCCCCcCCCCCCCCCCCC
Confidence            8  56889999999888763

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=411.59  Aligned_cols=256  Identities=24%  Similarity=0.388  Sum_probs=222.2

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      +||+.++.+|.|    |+|.||++.+..+++.||+|.+.......           ..+.+|+.+|+.++||||++++++
T Consensus         5 ~rY~i~~~lG~G----~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~-----------~~~~~Ei~il~~l~HpnIv~~~~~   69 (321)
T d1tkia_           5 EKYMIAEDLGRG----EFGIVHRCVETSSKKTYMAKFVKVKGTDQ-----------VLVKKEISILNIARHRNILHLHES   69 (321)
T ss_dssp             TTEEEEEEEEEC----SSEEEEEEEETTTTEEEEEEEECCCTHHH-----------HHHHHHHHHHHHSCCTTBCCEEEE
T ss_pred             cceEEEEEEecC----CCeEEEEEEECCCCcEEEEEEEcCCcccH-----------HHHHHHHHHHHhCCCCCCCeEEEE
Confidence            577788888888    89999999999999999999987654221           346789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC-
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN-  160 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~-  160 (372)
                      |++++++|+|||||+||+|.+++...+..+++.+++.++.||+.||+|||++||+|          |||||+|||++.+ 
T Consensus        70 ~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiH----------rDlKp~NIll~~~~  139 (321)
T d1tkia_          70 FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGH----------FDIRPENIIYQTRR  139 (321)
T ss_dssp             EEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCCGGGEEESSSS
T ss_pred             EEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCc----------ccccccceeecCCC
Confidence            99999999999999999999999874557999999999999999999999999999          9999999999854 


Q ss_pred             -CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHH
Q psy11571        161 -GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY  239 (372)
Q Consensus       161 -~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~  239 (372)
                       +.+||+|||+++.......  .....||+.|+|||.+.     ...++.++|||||||++|+|++|.+||.+.+..+.+
T Consensus       140 ~~~ikl~DFG~~~~~~~~~~--~~~~~~t~~y~ape~~~-----~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~  212 (321)
T d1tkia_         140 SSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQ-----HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII  212 (321)
T ss_dssp             CCCEEECCCTTCEECCTTCE--EEEEESCGGGSCHHHHT-----TCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred             ceEEEEcccchhhccccCCc--ccccccccccccchhcc-----CCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHH
Confidence             4899999999987654332  34467999999999998     356899999999999999999999999999999999


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      .+|.+....+  +......+|+++++||++||+ ||++|||+++++                 +||||+.
T Consensus       213 ~~i~~~~~~~--~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil-----------------~hp~~~~  263 (321)
T d1tkia_         213 ENIMNAEYTF--DEEAFKEISIEAMDFVDRLLVKERKSRMTASEAL-----------------QHPWLKQ  263 (321)
T ss_dssp             HHHHHTCCCC--CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHH-----------------HSHHHHS
T ss_pred             HHHHhCCCCC--ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHh-----------------cCHhhcc
Confidence            9998865433  333333689999999999999 999999866655                 8999974

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-54  Score=398.16  Aligned_cols=263  Identities=25%  Similarity=0.385  Sum_probs=213.6

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+.++.+|.|    |+|.||+|++..+++.||+|.+........        ..+++.+|+.+|++++|||||+++++
T Consensus         2 d~Y~~~~~lG~G----~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~--------~~~~~~~Ei~il~~l~Hp~Iv~~~~~   69 (298)
T d1gz8a_           2 ENFQKVEKIGEG----TYGVVYKARNKLTGEVVALKKIRLDTETEG--------VPSTAIREISLLKELNHPNIVKLLDV   69 (298)
T ss_dssp             TTEEEEEEEEEC----SSSEEEEEEETTTCCEEEEEEEC---------------CCHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             CCCEeccEEecC----cCeEEEEEEECCCCCEEEEEEEehhhcChH--------HHHHHHHHHHHHHhCCCCcEEEeccc
Confidence            467778888888    899999999999999999999865443221        23567889999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLL-SKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l-~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      +.+++++|+|||||.+ ++.+++ ......+++..++.++.||+.||.|||++||+|          |||||+|||++.+
T Consensus        70 ~~~~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiH----------rDiKpeNIl~~~~  138 (298)
T d1gz8a_          70 IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLH----------RDLKPQNLLINTE  138 (298)
T ss_dssp             EEETTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCCGGGEEECTT
T ss_pred             cccccceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEc----------cccCchheeeccc
Confidence            9999999999999965 555554 443567999999999999999999999999999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG  240 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~  240 (372)
                      +.+||+|||+|+....... ......||+.|+|||++..    ...++.++|+|||||++|+|++|+.||.+.+..+.+.
T Consensus       139 ~~~kl~DFG~a~~~~~~~~-~~~~~~gt~~y~apE~~~~----~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~  213 (298)
T d1gz8a_         139 GAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLG----CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF  213 (298)
T ss_dssp             SCEEECSTTHHHHHCCCSB-CTTCCBCCCTTCCHHHHTT----CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             CcceeccCCcceeccCCcc-cceeecccceeeehhhhcc----ccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHH
Confidence            9999999999987754433 2334679999999999874    3456889999999999999999999999998888777


Q ss_pred             HHhhccCCcC----------------CCCC-------CCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhcc
Q psy11571        241 KIMNHQNSFD----------------LPSD-------VGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSL  296 (372)
Q Consensus       241 ~i~~~~~~~~----------------~~~~-------~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~  296 (372)
                      ++......+.                .+..       ....+|+++++||++||+ ||++|||+++++            
T Consensus       214 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell------------  281 (298)
T d1gz8a_         214 RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL------------  281 (298)
T ss_dssp             HHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHH------------
T ss_pred             HHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHh------------
Confidence            6654211110                0000       012578999999999999 999999877666            


Q ss_pred             CCCCCCCCCcCCC
Q psy11571        297 SISPRNHPWFQGI  309 (372)
Q Consensus       297 ~~~~~~hp~f~~~  309 (372)
                           +||||+++
T Consensus       282 -----~H~ff~~~  289 (298)
T d1gz8a_         282 -----AHPFFQDV  289 (298)
T ss_dssp             -----TSGGGTTC
T ss_pred             -----CCHhhccC
Confidence                 99999876

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-55  Score=402.18  Aligned_cols=261  Identities=23%  Similarity=0.285  Sum_probs=210.0

Q ss_pred             HHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC
Q psy11571          7 LEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS   86 (372)
Q Consensus         7 l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~   86 (372)
                      |+.+|.|    ++|.||++++..+++.||+|.+........+     ....+.+.+|+.+|+.++|||||++++++.+++
T Consensus         3 l~~lG~G----~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~   73 (299)
T d1ua2a_           3 LDFLGEG----QFATVYKARDKNTNQIVAIKKIKLGHRSEAK-----DGINRTALREIKLLQELSHPNIIGLLDAFGHKS   73 (299)
T ss_dssp             EEEEEEE----TTEEEEEEECSSCCSEEEEEEC-----------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             ceEeccC----cCeEEEEEEECCCCcEEEEEEEehhhhhhhh-----HHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC
Confidence            4455666    8999999999999999999988665433221     122356788999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEe
Q psy11571         87 NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLA  166 (372)
Q Consensus        87 ~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~  166 (372)
                      ++|+|||||.++++..+... +..+++..++.++.||+.||+|||++||+|          |||||+|||++.++.+||+
T Consensus        74 ~~~ivmE~~~~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~lH~~~iiH----------rDiKp~NIli~~~~~~KL~  142 (299)
T d1ua2a_          74 NISLVFDFMETDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILH----------RDLKPNNLLLDENGVLKLA  142 (299)
T ss_dssp             CCEEEEECCSEEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCC----------CCCCGGGEEECTTCCEEEC
T ss_pred             ceeehhhhhcchHHhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhccceec----------ccCCcceEEecCCCccccc
Confidence            99999999988777666554 578999999999999999999999999999          9999999999999999999


Q ss_pred             ecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHHHhhcc
Q psy11571        167 DFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHQ  246 (372)
Q Consensus       167 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~  246 (372)
                      |||+|+....... .....+||+.|+|||++..    ...|+.++|||||||++|||++|.+||.+.+..+.+.+|.+..
T Consensus       143 DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~  217 (299)
T d1ua2a_         143 DFGLAKSFGSPNR-AYTHQVVTRWYRAPELLFG----ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL  217 (299)
T ss_dssp             CCGGGSTTTSCCC-CCCCSCCCCTTCCHHHHTT----CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             cCccccccCCCcc-cccceecChhhccHHHHcc----CCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhc
Confidence            9999987654332 2234679999999999874    3568999999999999999999999999999888888776532


Q ss_pred             CCcCC---CC-------------------CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCC
Q psy11571        247 NSFDL---PS-------------------DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNH  303 (372)
Q Consensus       247 ~~~~~---~~-------------------~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~h  303 (372)
                      ..+..   +.                   .....+++++++||++||+ ||++|||+++++                 +|
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L-----------------~H  280 (299)
T d1ua2a_         218 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL-----------------KM  280 (299)
T ss_dssp             CCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH-----------------TS
T ss_pred             CCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHh-----------------CC
Confidence            11110   00                   0012578999999999999 999999977666                 99


Q ss_pred             CCcCCC
Q psy11571        304 PWFQGI  309 (372)
Q Consensus       304 p~f~~~  309 (372)
                      |||++.
T Consensus       281 p~f~~~  286 (299)
T d1ua2a_         281 KYFSNR  286 (299)
T ss_dssp             GGGTSS
T ss_pred             HhhCCC
Confidence            999854

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=395.85  Aligned_cols=265  Identities=24%  Similarity=0.316  Sum_probs=212.2

Q ss_pred             ChHHHHHHhhhcCCcccCCccEEEeeeehh-hhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHh---cCCCCcee
Q psy11571          1 DERLRELEALFLGGPIQGKGRVFSIETLLD-ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLV---YGDRRWIT   76 (372)
Q Consensus         1 ~~~~~~l~~~~~~~~~~g~G~v~~v~~~~~-~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~---~l~hp~Iv   76 (372)
                      ++||+.++.+|.|    |+|.||+|.+..+ ++.||+|.+..........        ..+.+|+.+++   ..+||||+
T Consensus         6 ~~~Y~i~~~LG~G----~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~--------~~~~~E~~~l~~l~~~~HpnIv   73 (305)
T d1blxa_           6 DQQYECVAEIGEG----AYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP--------LSTIREVAVLRHLETFEHPNVV   73 (305)
T ss_dssp             GGTEEEEEEEEEE----TTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB--------CTHHHHHHHHHHHHHTCCTTBC
T ss_pred             cCCEEEEEEEecc----cCeEEEEEEEECCCCEEEEEEEEehhhccchHH--------HHHHHHHHHHHHHhhcCCCCcc
Confidence            4689999999988    8999999998765 6679999886654332211        11334555554   45899999


Q ss_pred             eeeEEEEe-----CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCC
Q psy11571         77 NLHYAFQD-----DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIK  151 (372)
Q Consensus        77 ~l~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlk  151 (372)
                      +++++|..     ...+|++||||.++++..........+++..++.++.||+.||+|||++||+|          ||||
T Consensus        74 ~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivH----------rDiK  143 (305)
T d1blxa_          74 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVH----------RDLK  143 (305)
T ss_dssp             CEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCC----------CCCC
T ss_pred             eeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEe----------cCCC
Confidence            99999864     24689999999887776665554667999999999999999999999999999          9999


Q ss_pred             cCcEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCC
Q psy11571        152 PDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY  231 (372)
Q Consensus       152 p~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~  231 (372)
                      |+|||++.++.+||+|||+++......  ......||+.|+|||++.+     ..|+.++|||||||++|||++|++||.
T Consensus       144 p~NILi~~~~~~kl~dfg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~-----~~y~~~~DiwSlG~il~ell~g~~pf~  216 (305)
T d1blxa_         144 PQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQ-----SSYATPVDLWSVGCIFAEMFRRKPLFR  216 (305)
T ss_dssp             GGGEEECTTCCEEECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ccEEEEcCCCCeeecchhhhhhhcccc--cCCCcccChhhcCcchhcC-----CCCChhehhhchHHHHHHHHHCCCCCC
Confidence            999999999999999999987654332  3345789999999999983     679999999999999999999999999


Q ss_pred             CCCHHHHHHHHhhccCCc---CCC------------------CCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhh
Q psy11571        232 AESLVETYGKIMNHQNSF---DLP------------------SDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMW  289 (372)
Q Consensus       232 ~~~~~~~~~~i~~~~~~~---~~~------------------~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~  289 (372)
                      +.+..+.+.++.......   .++                  ......+++.+++||++||+ ||++|||+++++     
T Consensus       217 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L-----  291 (305)
T d1blxa_         217 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL-----  291 (305)
T ss_dssp             CSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH-----
T ss_pred             CCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHh-----
Confidence            999888887775421110   000                  01123679999999999999 999999876665     


Q ss_pred             hhhhhccCCCCCCCCCcCCCCc
Q psy11571        290 SALFVSLSISPRNHPWFQGIAW  311 (372)
Q Consensus       290 ~~~~~~~~~~~~~hp~f~~~~w  311 (372)
                                  +||||+++++
T Consensus       292 ------------~Hpff~~i~~  301 (305)
T d1blxa_         292 ------------SHPYFQDLER  301 (305)
T ss_dssp             ------------TSGGGTTCCC
T ss_pred             ------------cChhhcCchh
Confidence                        9999999875

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.4e-53  Score=388.13  Aligned_cols=250  Identities=18%  Similarity=0.265  Sum_probs=209.5

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+..+.+|.|    |+|.||++.+..+++.||+|.+......           .+++.+|+.+|+.++|||||++++++
T Consensus        18 ~~~~~~~iG~G----~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-----------~~~~~~E~~il~~l~HpnIv~~~~~~   82 (287)
T d1opja_          18 DITMKHKLGGG----QYGEVYEGVWKKYSLTVAVKTLKEDTME-----------VEEFLKEAAVMKEIKHPNLVQLLGVC   82 (287)
T ss_dssp             GEEEEEETTTT----TTSSEEEEEEGGGTEEEEEEECCTTCSC-----------HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HeEEeeEEeeC----CCeEEEEEEECCCCeEEEEEEECCccch-----------HHHHHHHHHHHHhCCCCCEecCCccE
Confidence            44555666766    8999999999989999999987654332           23477899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      .+++.+|+|||||++|+|.+++... ...+++..++.++.||+.||.|||++||+|          |||||+|||++.++
T Consensus        83 ~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiH----------rDlKp~NILl~~~~  152 (287)
T d1opja_          83 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH----------RDLAARNCLVGENH  152 (287)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCSGGGEEECGGG
T ss_pred             eeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCccc----------CccccCeEEECCCC
Confidence            9999999999999999999999763 457899999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCC-CCCCCHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP-FYAESLVETYG  240 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~P-f~~~~~~~~~~  240 (372)
                      .+||+|||+|+..............||+.|+|||++.+     ..++.++|||||||++|||++|..| |.+.+..++..
T Consensus       153 ~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~  227 (287)
T d1opja_         153 LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-----NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE  227 (287)
T ss_dssp             CEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHH-----CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred             cEEEccccceeecCCCCceeeccccccccccChHHHcC-----CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHH
Confidence            99999999998876554444444568999999999984     6689999999999999999996555 55556555555


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .+. ....++.|.    .+++++++||.+||+ ||++|||++++.+.+
T Consensus       228 ~i~-~~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L  270 (287)
T d1opja_         228 LLE-KDYRMERPE----GCPEKVYELMRACWQWNPSDRPSFAEIHQAF  270 (287)
T ss_dssp             HHH-TTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHh-cCCCCCCCc----cchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            444 334445554    789999999999999 999999988776533

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-53  Score=386.42  Aligned_cols=257  Identities=17%  Similarity=0.169  Sum_probs=202.1

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+..+.+|.|    |+|.||+++.   +..||+|.+........        ..+.+.+|+.+++.++|||||++++++
T Consensus         9 ~~~~~~~lG~G----~fg~Vy~~~~---~~~vAvK~~~~~~~~~~--------~~~~~~~E~~~l~~l~HpnIv~~~~~~   73 (276)
T d1uwha_           9 QITVGQRIGSG----SFGTVYKGKW---HGDVAVKMLNVTAPTPQ--------QLQAFKNEVGVLRKTRHVNILLFMGYS   73 (276)
T ss_dssp             CCCCCSEEEEC----SSCEEEEEES---SSEEEEEECCCSSCCTT--------HHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cEEEEEEEeeC----CCcEEEEEEE---CCEEEEEEEEcccCCHH--------HHHHHHHHHHHHHhCCCCCEeeeeEEE
Confidence            45556666766    8999999863   33599998875544332        346688999999999999999999986


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      . .+.+++|||||++|+|.+++...+..+++..+..++.||+.||+|||++||+|          |||||+|||++.++.
T Consensus        74 ~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivH----------rDlKp~NiLl~~~~~  142 (276)
T d1uwha_          74 T-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIH----------RDLKSNNIFLHEDLT  142 (276)
T ss_dssp             C-SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCCGGGEEEETTSS
T ss_pred             e-ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEec----------cccCHHHEEEcCCCC
Confidence            5 45789999999999999999875678999999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCC-cccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDG-TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      +||+|||+|+...... ........||+.|+|||++.+..  ...|+.++|||||||++|||+||+.||.+.+.......
T Consensus       143 ~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~  220 (276)
T d1uwha_         143 VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD--KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF  220 (276)
T ss_dssp             EEECCCCCSCC------------CCCCGGGCCHHHHTTCS--SCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH
T ss_pred             EEEccccceeeccccCCcccccccccCcccCCHHHHhccc--CCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHH
Confidence            9999999998764322 22234467999999999997421  34588999999999999999999999998766555444


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      +.......+........+++++++||.+||. ||++|||++++.+.+
T Consensus       221 ~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~L  267 (276)
T d1uwha_         221 MVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI  267 (276)
T ss_dssp             HHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            4433322222222334789999999999999 999999988877554

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-54  Score=402.69  Aligned_cols=253  Identities=26%  Similarity=0.446  Sum_probs=202.4

Q ss_pred             HHHHHHh-hhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHh-cCCCCceeeeeE
Q psy11571          3 RLRELEA-LFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLV-YGDRRWITNLHY   80 (372)
Q Consensus         3 ~~~~l~~-~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~-~l~hp~Iv~l~~   80 (372)
                      +|+.+++ +|.|    |+|.||+|.+..+++.||+|.+...               +.+.+|+.++. ..+|||||++++
T Consensus        12 ~y~i~~~~lG~G----~fg~Vy~a~~~~~~~~vAiK~i~~~---------------~~~~~E~~~~~~~~~hpnIv~l~~   72 (335)
T d2ozaa1          12 DYKVTSQVLGLG----INGKVLQIFNKRTQEKFALKMLQDC---------------PKARREVELHWRASQCPHIVRIVD   72 (335)
T ss_dssp             TEEEEEEEEEEC----SSCEEEEEEETTTCCEEEEEEEECS---------------HHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred             CEEEeeEEeeec----cCeEEEEEEECCCCCEEEEEEECCc---------------HHHHHHHHHHHHhcCCCCCCeEEE
Confidence            4555655 6776    8999999999999999999987532               22456888764 568999999999


Q ss_pred             EEEe----CCeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcE
Q psy11571         81 AFQD----DSNLYLVMDYYCGGDLLTLLSKFE-DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNV  155 (372)
Q Consensus        81 ~~~~----~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NI  155 (372)
                      +|++    ...+|+|||||+||+|.+++.+.. ..+++.+++.++.||+.||+|||++||+|          |||||+||
T Consensus        73 ~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiH----------RDiKp~NI  142 (335)
T d2ozaa1          73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH----------RDVKPENL  142 (335)
T ss_dssp             EEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGE
T ss_pred             EEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcc----------cccccccc
Confidence            9986    457899999999999999998642 46999999999999999999999999999          99999999


Q ss_pred             EeCC---CCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCC
Q psy11571        156 LLDA---NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYA  232 (372)
Q Consensus       156 ll~~---~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~  232 (372)
                      |++.   .+.+||+|||+|+.......  ....+||+.|+|||++.+     ..|+.++|||||||++|+|+||++||.+
T Consensus       143 ll~~~~~~~~~Kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-----~~y~~~~DiwSlGvily~lltg~~Pf~~  215 (335)
T d2ozaa1         143 LYTSKRPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVAPEVLGP-----EKYDKSCDMWSLGVIMYILLCGYPPFYS  215 (335)
T ss_dssp             EESCSSTTCCEEECCCTTCEECCCCCC--CCCCSCCCSSCCCCCCCG-----GGGSHHHHHHHHHHHHHHHTTSSCSCEE
T ss_pred             ccccccccccccccccceeeeccCCCc--cccccCCcccCCcHHHcC-----CCCCHHHHHHhhchhHHHHhhCCCCCCC
Confidence            9985   46799999999987755433  234689999999999984     5689999999999999999999999988


Q ss_pred             CCHHHHHHHHhhcc--CCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        233 ESLVETYGKIMNHQ--NSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       233 ~~~~~~~~~i~~~~--~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      .+..+....+....  ..+.+|......+|+++++||++||+ ||++|||+++++                 +||||..
T Consensus       216 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil-----------------~hp~~~~  277 (335)
T d2ozaa1         216 NHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM-----------------NHPWIMQ  277 (335)
T ss_dssp             TTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHH-----------------HSHHHHT
T ss_pred             CCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHH-----------------cCHHhhC
Confidence            76544433332211  22334433333689999999999999 999999866555                 9999964

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-53  Score=386.74  Aligned_cols=244  Identities=20%  Similarity=0.248  Sum_probs=203.3

Q ss_pred             hhcCCcccCCccEEEeeee--hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCe
Q psy11571         10 LFLGGPIQGKGRVFSIETL--LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSN   87 (372)
Q Consensus        10 ~~~~~~~~g~G~v~~v~~~--~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~   87 (372)
                      +|.|    |+|.||++...  .+++.||+|.+.......        ...+.+.+|+.+|++++|||||++++++.++ .
T Consensus        15 iG~G----~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~--------~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~   81 (277)
T d1xbba_          15 LGSG----NFGTVKKGYYQMKKVVKTVAVKILKNEANDP--------ALKDELLAEANVMQQLDNPYIVRMIGICEAE-S   81 (277)
T ss_dssp             EEEC----SSEEEEEEEEECSSSEEEEEEEEEC-----C--------HHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-S
T ss_pred             cccC----CCeEEEEEEEccCCcCeEEEEEEEChhhCCH--------HHHHHHHHHHHHHHhCCCCCCceEEEEeccC-C
Confidence            5665    89999998643  356789999886543322        1345688999999999999999999999754 5


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEee
Q psy11571         88 LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLAD  167 (372)
Q Consensus        88 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~D  167 (372)
                      .|+|||||++|+|.+++.+ ...+++..+..++.||+.||+|||++||+|          |||||+|||++.++.+||+|
T Consensus        82 ~~lvmE~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiH----------rDlKp~Nill~~~~~~kl~D  150 (277)
T d1xbba_          82 WMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVH----------RDLAARNVLLVTQHYAKISD  150 (277)
T ss_dssp             EEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSGGGEEEEETTEEEECC
T ss_pred             EEEEEEcCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCccc----------CCCcchhhcccccCcccccc
Confidence            7899999999999999987 578999999999999999999999999999          99999999999999999999


Q ss_pred             cCcccccCCCCcc--cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHHhh
Q psy11571        168 FGSCLRLGGDGTV--QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMN  244 (372)
Q Consensus       168 fg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~  244 (372)
                      ||+++........  ......||+.|+|||++.+     ..++.++|||||||++|||+| |++||.+.+..++...+.+
T Consensus       151 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~  225 (277)
T d1xbba_         151 FGLSKALRADENYYKAQTHGKWPVKWYAPECINY-----YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK  225 (277)
T ss_dssp             CTTCEECCTTCSEEEC----CCCGGGCCHHHHHH-----CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT
T ss_pred             hhhhhhccccccccccccccCCCceecCchhhcC-----CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc
Confidence            9999876543322  2233568999999999984     568999999999999999997 8999999998888877776


Q ss_pred             ccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        245 HQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      + ..++.|.    .+|+++.+||.+||+ ||++|||++++.+.+
T Consensus       226 ~-~~~~~p~----~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L  264 (277)
T d1xbba_         226 G-ERMGCPA----GCPREMYDLMNLCWTYDVENRPGFAAVELRL  264 (277)
T ss_dssp             T-CCCCCCT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred             C-CCCCCCc----ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHh
Confidence            4 3444554    689999999999999 999999998888777

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=384.92  Aligned_cols=244  Identities=21%  Similarity=0.287  Sum_probs=206.2

Q ss_pred             hhcCCcccCCccEEEeeeeh--hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCe
Q psy11571         10 LFLGGPIQGKGRVFSIETLL--DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDSN   87 (372)
Q Consensus        10 ~~~~~~~~g~G~v~~v~~~~--~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~~   87 (372)
                      +|.|    |+|.||++....  ++..||+|.+......         ...+.+.+|+.+|++++|||||++++++.+ +.
T Consensus        17 iG~G----~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~---------~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~   82 (285)
T d1u59a_          17 LGCG----NFGSVRQGVYRMRKKQIDVAIKVLKQGTEK---------ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA   82 (285)
T ss_dssp             EECC----TTEEEEEEEEC---CCEEEEEEEECSSCCH---------HHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred             Eecc----cCeEEEEEEEecCCCcEEEEEEEEChhcCH---------HHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence            5555    899999986543  4457999988654322         134568899999999999999999999875 46


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEee
Q psy11571         88 LYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLAD  167 (372)
Q Consensus        88 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~D  167 (372)
                      +|+|||||++|+|.+++...+..+++..+..++.||+.||+|||++||+|          |||||+|||++.++.+||+|
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiH----------rDlKp~Nill~~~~~~Kl~D  152 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH----------RDLAARNVLLVNRHYAKISD  152 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEEEETTEEEECC
T ss_pred             EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeec----------CcCchhheeeccCCceeecc
Confidence            89999999999999998765678999999999999999999999999999          99999999999999999999


Q ss_pred             cCcccccCCCCcc--cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHHhh
Q psy11571        168 FGSCLRLGGDGTV--QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMN  244 (372)
Q Consensus       168 fg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~  244 (372)
                      ||+|+........  ......||+.|+|||++.+     ..++.++|||||||++|||+| |++||.+.+..++...+.+
T Consensus       153 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~  227 (285)
T d1u59a_         153 FGLSKALGADDSYYTARSAGKWPLKWYAPECINF-----RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ  227 (285)
T ss_dssp             CTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH-----CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT
T ss_pred             chhhhcccccccccccccccccCccccChHHHhC-----CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            9999887554322  2233568999999999984     568999999999999999998 9999999888888888776


Q ss_pred             ccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        245 HQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      +. .++.|.    .+|+++.+||.+||+ ||++||++.++.+.+
T Consensus       228 ~~-~~~~p~----~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L  266 (285)
T d1u59a_         228 GK-RMECPP----ECPPELYALMSDCWIYKWEDRPDFLTVEQRM  266 (285)
T ss_dssp             TC-CCCCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             CC-CCCCCC----cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            53 344554    789999999999999 999999998888777

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=8e-53  Score=386.57  Aligned_cols=261  Identities=21%  Similarity=0.274  Sum_probs=212.5

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      +||+.++++|.|    ++|+||++++ .+++.||+|++........        ..+++.+|+.+|+.++||||++++++
T Consensus         2 ~~Y~~~~~iG~G----~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~--------~~~~~~~E~~il~~l~hpnIv~~~~~   68 (286)
T d1ob3a_           2 EKYHGLEKIGEG----TYGVVYKAQN-NYGETFALKKIRLEKEDEG--------IPSTTIREISILKELKHSNIVKLYDV   68 (286)
T ss_dssp             CSEEEEEEEEEE----TTEEEEEEEE-TTSCEEEEEEECCSSGGGC--------CCHHHHHHHHGGGGCCCTTBCCEEEE
T ss_pred             CCceeccEEecC----CCcEEEEEEe-CCCCEEEEEEEehhhcChH--------HHHHHHHHHHHHHhCCCCcEEeeeee
Confidence            578888999988    8999999977 4789999999876554322        23457789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+.+..|++|||+.++++..+... .+.+++..++.++.||+.||+|||++||+|          |||||+|||++.++
T Consensus        69 ~~~~~~~~i~~e~~~~~~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~IvH----------rDiKp~NIll~~~~  137 (286)
T d1ob3a_          69 IHTKKRLVLVFEHLDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLH----------RDLKPQNLLINREG  137 (286)
T ss_dssp             EECSSCEEEEEECCSEEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCCGGGEEECTTS
T ss_pred             cccCCceeEEEEeehhhhHHHHHhh-cCCcchhhhHHHHHHHHHHHHHhccCcEEe----------cCCCCceeeEcCCC
Confidence            9999999999999977666666554 678999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  241 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  241 (372)
                      .+||+|||.|........ ......|++.|+|||.+.+    ...++.++|+|||||++|||++|++||.+.+..+.+.+
T Consensus       138 ~~kl~DfG~a~~~~~~~~-~~~~~~~~~~y~~pE~~~~----~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~  212 (286)
T d1ob3a_         138 ELKIADFGLARAFGIPVR-KYTHEIVTLWYRAPDVLMG----SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR  212 (286)
T ss_dssp             CEEECCTTHHHHHCC----------CCCTTCCHHHHTT----CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             CEEecccccceecccCcc-ccceecccchhhhHHHHhC----CCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHH
Confidence            999999999987654332 2334578999999999974    45679999999999999999999999999888887777


Q ss_pred             HhhccCCcCCC-----------------------CCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccC
Q psy11571        242 IMNHQNSFDLP-----------------------SDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLS  297 (372)
Q Consensus       242 i~~~~~~~~~~-----------------------~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~  297 (372)
                      +......+...                       ......++++++|||++||+ ||++|||+++++             
T Consensus       213 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell-------------  279 (286)
T d1ob3a_         213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL-------------  279 (286)
T ss_dssp             HHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH-------------
T ss_pred             HHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHh-------------
Confidence            65321111000                       01123678999999999999 999999876665             


Q ss_pred             CCCCCCCCcCC
Q psy11571        298 ISPRNHPWFQG  308 (372)
Q Consensus       298 ~~~~~hp~f~~  308 (372)
                          +||||+.
T Consensus       280 ----~Hp~f~~  286 (286)
T d1ob3a_         280 ----EHAYFKE  286 (286)
T ss_dssp             ----TSGGGGC
T ss_pred             ----cCcccCc
Confidence                9999974

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-53  Score=388.55  Aligned_cols=254  Identities=25%  Similarity=0.373  Sum_probs=207.8

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC--CCceeeee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD--RRWITNLH   79 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~--hp~Iv~l~   79 (372)
                      .||+..+.+|.|    |+|.||++.+..+++.||+|.+............    ...++.+|+.+++.++  |||||+++
T Consensus         4 ~~Y~i~~~lG~G----~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~----~~~~~~~E~~il~~l~~~h~nIv~~~   75 (273)
T d1xwsa_           4 SQYQVGPLLGSG----GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP----NGTRVPMEVVLLKKVSSGFSGVIRLL   75 (273)
T ss_dssp             TTEEEEEEEEEE----TTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECT----TCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred             CeEEEeEEEeeC----CCeEEEEEEECCCCCEEEEEEEehHHccchhhhh----HHHHHHHHHHHHHHhccCCCCccEEE
Confidence            467777777777    8999999999999999999988765443221110    1122456888998876  89999999


Q ss_pred             EEEEeCCeEEEEEeccCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC
Q psy11571         80 YAFQDDSNLYLVMDYYCG-GDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD  158 (372)
Q Consensus        80 ~~~~~~~~~~lv~E~~~g-g~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~  158 (372)
                      +++.+++.+|+||||+.+ +++.+++.+ +..+++.+++.++.||+.||.|||++||+|          |||||+|||++
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiH----------rDiKp~NIll~  144 (273)
T d1xwsa_          76 DWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLH----------RDIKDENILID  144 (273)
T ss_dssp             EEEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSGGGEEEE
T ss_pred             EEEeeCCeEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcc----------ccCcccceEEe
Confidence            999999999999999976 688888877 578999999999999999999999999999          99999999998


Q ss_pred             C-CCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHHH
Q psy11571        159 A-NGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE  237 (372)
Q Consensus       159 ~-~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~  237 (372)
                      . ++.+||+|||+|+......   .....||+.|+|||++.+    ...++.++|||||||++|+|++|+.||.+.+   
T Consensus       145 ~~~~~vkl~DFG~a~~~~~~~---~~~~~GT~~y~aPE~~~~----~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---  214 (273)
T d1xwsa_         145 LNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRY----HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---  214 (273)
T ss_dssp             TTTTEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHH----SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---
T ss_pred             cCCCeEEECccccceeccccc---ccccccCCCcCCHHHHcC----CCCCCcccccccceeeehhHhhCCCCCCCch---
Confidence            4 5799999999998754332   234689999999999984    3445778999999999999999999997642   


Q ss_pred             HHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCC
Q psy11571        238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIA  310 (372)
Q Consensus       238 ~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~  310 (372)
                         .+.+..  ..++.    .+|+++++||++||+ ||++|||+++++                 +||||+++-
T Consensus       215 ---~i~~~~--~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~eil-----------------~hp~~~~~~  262 (273)
T d1xwsa_         215 ---EIIRGQ--VFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQ-----------------NHPWMQDVL  262 (273)
T ss_dssp             ---HHHHCC--CCCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHH-----------------TSGGGSSCC
T ss_pred             ---HHhhcc--cCCCC----CCCHHHHHHHHHHccCCHhHCcCHHHHh-----------------cCHhhCCCC
Confidence               344433  23343    689999999999999 999999876655                 999999764

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.4e-52  Score=384.43  Aligned_cols=247  Identities=17%  Similarity=0.250  Sum_probs=196.2

Q ss_pred             HhhhcCCcccCCccEEEeeeehhhh---hhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe
Q psy11571          8 EALFLGGPIQGKGRVFSIETLLDIL---LVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQD   84 (372)
Q Consensus         8 ~~~~~~~~~~g~G~v~~v~~~~~~~---~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~   84 (372)
                      +.+|.|    |+|.||++....+++   .||+|.+.......         ..+.+.+|+.+|++++|||||++++++.+
T Consensus        32 ~~lG~G----~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~E~~~l~~l~HpnIv~l~g~~~~   98 (299)
T d1jpaa_          32 QVIGAG----EFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK---------QRRDFLSEASIMGQFDHPNVIHLEGVVTK   98 (299)
T ss_dssp             EEEEEC----SSSEEEEEEECC---CCEEEEEEECCSSCCHH---------HHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             eEEeeC----CCeEEEEEEEeCCCCEEEEEEEEEECcccCHH---------HHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence            445555    899999998876665   47777665433322         23567899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEE
Q psy11571         85 DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIR  164 (372)
Q Consensus        85 ~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vk  164 (372)
                      ++.+|+|||||++|+|.+++....+.+++.++..++.||+.||.|||++||+|          |||||+|||++.++.+|
T Consensus        99 ~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiH----------rDlKp~NILl~~~~~~K  168 (299)
T d1jpaa_          99 STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVH----------RDLAARNILVNSNLVCK  168 (299)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCCGGGEEECTTCCEE
T ss_pred             CCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCcc----------CccccceEEECCCCcEE
Confidence            99999999999999999999876668999999999999999999999999999          99999999999999999


Q ss_pred             EeecCcccccCCCCcc----cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHH
Q psy11571        165 LADFGSCLRLGGDGTV----QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETY  239 (372)
Q Consensus       165 l~Dfg~a~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~  239 (372)
                      |+|||+|+........    ......||+.|+|||++.     .+.++.++|||||||++|||+| |.+||.+.+..++.
T Consensus       169 l~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~  243 (299)
T d1jpaa_         169 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ-----YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI  243 (299)
T ss_dssp             ECCC-----------------------CGGGSCHHHHH-----SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred             ECCcccceEccCCCCcceeeecccccCCccccCHHHHh-----cCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999876543221    112245789999999998     4679999999999999999998 89999999998888


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ..+..+ ..++.|.    .+++++.+||.+||+ ||++|||+.++.+.+
T Consensus       244 ~~i~~~-~~~~~~~----~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L  287 (299)
T d1jpaa_         244 NAIEQD-YRLPPPM----DCPSALHQLMLDCWQKDRNHRPKFGQIVNTL  287 (299)
T ss_dssp             HHHHTT-CCCCCCT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred             HHHHcC-CCCCCCc----cchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            888764 3333343    689999999999999 999999988876554

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-52  Score=378.51  Aligned_cols=249  Identities=20%  Similarity=0.231  Sum_probs=200.6

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||++... ++..||+|.+.......           +.+.+|+.+++.++||||+++++++
T Consensus         6 ~~~~~~~iG~G----~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~-----------~~~~~E~~~l~~l~HpnIv~~~g~~   69 (263)
T d1sm2a_           6 ELTFVQEIGSG----QFGLVHLGYWL-NKDKVAIKTIREGAMSE-----------EDFIEEAEVMMKLSHPKLVQLYGVC   69 (263)
T ss_dssp             CEEEEEEEECC----SSCCEEEEEET-TTEEEEEEECCSSSSCH-----------HHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HcEEEEEEeeC----CCeEEEEEEEC-CCCEEEEEEECCCcCcH-----------HHHHHHHHHHHhcCCCCccccccee
Confidence            45556667777    89999999754 67789999887544332           3467899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCc
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGH  162 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~  162 (372)
                      .+++.+|+|||||++|+|.+++......+++..+..++.||+.||.|||+++|+|          |||||+|||++.++.
T Consensus        70 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiH----------rDlKp~Nill~~~~~  139 (263)
T d1sm2a_          70 LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH----------RDLAARNCLVGENQV  139 (263)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------TTCSGGGEEECGGGC
T ss_pred             ccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceee----------cccchhheeecCCCC
Confidence            9999999999999999999999876677899999999999999999999999999          999999999999999


Q ss_pred             EEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHH
Q psy11571        163 IRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGK  241 (372)
Q Consensus       163 vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~  241 (372)
                      +||+|||+++..............||+.|+|||++.+     ..++.++|||||||++|||+| |.+||...+..++...
T Consensus       140 ~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~  214 (263)
T d1sm2a_         140 IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-----SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED  214 (263)
T ss_dssp             EEECSCC------------------CTTSCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH
T ss_pred             eEecccchheeccCCCceeecceecCcccCChHHhcC-----CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH
Confidence            9999999998776544444445678999999999983     569999999999999999999 6788888888888888


Q ss_pred             HhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        242 IMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       242 i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      +..+. ....|.    ..++++.+||.+||+ ||++|||++++++.+
T Consensus       215 i~~~~-~~~~p~----~~~~~l~~li~~cl~~~p~~Rps~~~il~~L  256 (263)
T d1sm2a_         215 ISTGF-RLYKPR----LASTHVYQIMNHCWKERPEDRPAFSRLLRQL  256 (263)
T ss_dssp             HHHTC-CCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHhcC-CCCCcc----ccCHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence            77653 333344    679999999999999 999999988776544

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.6e-52  Score=381.44  Aligned_cols=253  Identities=24%  Similarity=0.330  Sum_probs=208.4

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      +||+.++.+|.|    |+|.||++.+..+++.||+|.+........       +..+.+.+|+.+++.++||||++++++
T Consensus         7 drY~i~~~lG~G----~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-------~~~~~~~~E~~~l~~~~hpniv~~~~~   75 (277)
T d1o6ya_           7 DRYELGEILGFG----GMSEVHLARDLRLHRDVAVKVLRADLARDP-------SFYLRFRREAQNAAALNHPAIVAVYDT   75 (277)
T ss_dssp             TTEEEEEEEEEC----SSEEEEEEEETTTTEEEEEEEECSTTTTCH-------HHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ceeEEeEEEeeC----CCeEEEEEEECCCCCEEEEEEEchhhccCH-------HHHHHHHHHHHHHHhcCCCCCCcccce
Confidence            578888888887    899999999999999999999876554432       234668899999999999999999999


Q ss_pred             EEeCC----eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe
Q psy11571         82 FQDDS----NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        82 ~~~~~----~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      +.+.+    .+|+|||||+|++|.+++.. .+.+++.+++.++.||+.||.|||++||+|          |||||+|||+
T Consensus        76 ~~~~~~~~~~~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiH----------rDiKP~NIll  144 (277)
T d1o6ya_          76 GEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIH----------RDVKPANIMI  144 (277)
T ss_dssp             EEEECSSSEEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEE
T ss_pred             eeeccCCCceEEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccC----------ccccCccccc
Confidence            98754    38999999999999999987 578999999999999999999999999999          9999999999


Q ss_pred             CCCCcEEEeecCcccccCCCC--cccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCH
Q psy11571        158 DANGHIRLADFGSCLRLGGDG--TVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL  235 (372)
Q Consensus       158 ~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~  235 (372)
                      +.++.++|+|||.+.......  .......+||+.|+|||++.+     ..++.++|||||||++|+|+||++||.+.+.
T Consensus       145 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~~~~~DiwSlGvilyelltG~~Pf~~~~~  219 (277)
T d1o6ya_         145 SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-----DSVDARSDVYSLGCVLYEVLTGEPPFTGDSP  219 (277)
T ss_dssp             ETTSCEEECCCTTCEECC----------------TTCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             CccccceeehhhhhhhhccccccccccccccCcccccCHHHHcC-----CCCCcceecccchHHHHHHHhCCCCCCCcCH
Confidence            999999999999987654322  123344689999999999983     5689999999999999999999999999999


Q ss_pred             HHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCC-CCCh
Q psy11571        236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLG-QNGI  283 (372)
Q Consensus       236 ~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s-~~~~  283 (372)
                      .+...++......+  +......+|+++++||.+||+ ||++||+ ++++
T Consensus       220 ~~~~~~~~~~~~~~--~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l  267 (277)
T d1o6ya_         220 VSVAYQHVREDPIP--PSARHEGLSADLDAVVLKALAKNPENRYQTAAEM  267 (277)
T ss_dssp             HHHHHHHHHCCCCC--GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHH
T ss_pred             HHHHHHHHhcCCCC--CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHH
Confidence            88888887765432  333334789999999999999 9999994 4444

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-52  Score=390.29  Aligned_cols=261  Identities=24%  Similarity=0.355  Sum_probs=210.9

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      +||+.++.+|.|    |+|.||++.+..+++.||+|.+.......        ...+++.+|+.+|+.++|||||+++++
T Consensus        18 ~~Y~~i~~lG~G----~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--------~~~~~~~~Ei~il~~l~hpniv~l~~~   85 (346)
T d1cm8a_          18 AVYRDLQPVGSG----AYGAVCSAVDGRTGAKVAIKKLYRPFQSE--------LFAKRAYRELRLLKHMRHENVIGLLDV   85 (346)
T ss_dssp             SSEEEEEEC----------CEEEEEETTTCCEEEEEECSSTTSSH--------HHHHHHHHHHHHHHHCCBTTBCCCSEE
T ss_pred             CcEEEEEEEecC----CCeEEEEEEECCCCCEEEEEEEchhhcCh--------HHHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence            578888888888    89999999999999999999987544322        134668889999999999999999999


Q ss_pred             EEeCC------eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcE
Q psy11571         82 FQDDS------NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNV  155 (372)
Q Consensus        82 ~~~~~------~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NI  155 (372)
                      |.+.+      .+|+||||| +++|..+++.  +.+++..++.++.||+.||.|||++||+|          |||||+||
T Consensus        86 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiH----------rDiKp~NI  152 (346)
T d1cm8a_          86 FTPDETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIH----------RDLKPGNL  152 (346)
T ss_dssp             ECSCSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCCGGGE
T ss_pred             eccCccccccceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcc----------cccCcchh
Confidence            98664      579999999 7788888876  68999999999999999999999999999          99999999


Q ss_pred             EeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCH
Q psy11571        156 LLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL  235 (372)
Q Consensus       156 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~  235 (372)
                      |++.++.+||+|||+|+......    ....||+.|+|||++.+    ...++.++|||||||++|+|++|++||.+.+.
T Consensus       153 L~~~~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~  224 (346)
T d1cm8a_         153 AVNEDCELKILDFGLARQADSEM----TGYVVTRWYRAPEVILN----WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH  224 (346)
T ss_dssp             EECTTCCEEECCCTTCEECCSSC----CSSCSCGGGCCTHHHHT----TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             hcccccccccccccceeccCCcc----ccccccccccCHHHHcC----CCCCCccchhhcchHHHHHHHHCcCCCCCCCh
Confidence            99999999999999998765432    33679999999999974    45678999999999999999999999999887


Q ss_pred             HHHHHHHhhccCCc-------------------------CCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhh
Q psy11571        236 VETYGKIMNHQNSF-------------------------DLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMW  289 (372)
Q Consensus       236 ~~~~~~i~~~~~~~-------------------------~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~  289 (372)
                      ...+..+......+                         .........+++++++||++||+ ||++|||+++++     
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL-----  299 (346)
T d1cm8a_         225 LDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL-----  299 (346)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHH-----
T ss_pred             HHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHh-----
Confidence            76665543321110                         00011123679999999999999 999999876665     


Q ss_pred             hhhhhccCCCCCCCCCcCCCCcc
Q psy11571        290 SALFVSLSISPRNHPWFQGIAWD  312 (372)
Q Consensus       290 ~~~~~~~~~~~~~hp~f~~~~w~  312 (372)
                                  +||||+++.+.
T Consensus       300 ------------~Hp~f~~~~~~  310 (346)
T d1cm8a_         300 ------------AHPYFESLHDT  310 (346)
T ss_dssp             ------------HSGGGTTTC--
T ss_pred             ------------cChhhCcCCCc
Confidence                        99999987653

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-52  Score=390.40  Aligned_cols=253  Identities=21%  Similarity=0.276  Sum_probs=206.7

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhh-----hhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCcee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDIL-----LVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWIT   76 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~-----~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv   76 (372)
                      +|+..+.+|.|    |||.||++.....++     .||+|.+.......         ....+.+|..++..+ +|||||
T Consensus        38 ~~~l~~~lG~G----~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~E~~~l~~l~~HpnIv  104 (325)
T d1rjba_          38 NLEFGKVLGSG----AFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS---------EREALMSELKMMTQLGSHENIV  104 (325)
T ss_dssp             GEEEEEEEEEC----SSEEEEEEEEESCSSSSCEEEEEEEEECC---------------CHHHHHHHHHHHHHCCCTTBC
T ss_pred             HeEEeeEEeeC----CCeEEEEEEEcCCCcccceeEEEEEEeccccCHH---------HHHHHHHHHHHHHHhcCCCcEe
Confidence            34444556666    899999998765443     57887665433221         234577899999887 899999


Q ss_pred             eeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcC
Q psy11571         77 NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE----------------------DRLPEDMAKFYIAEMVLAIASIHDLH  134 (372)
Q Consensus        77 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------------~~l~~~~~~~~~~qi~~~L~~LH~~~  134 (372)
                      ++++++.+.+.+|+|||||++|+|.++|+...                      ..+++..++.++.||+.||+|||++|
T Consensus       105 ~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~  184 (325)
T d1rjba_         105 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS  184 (325)
T ss_dssp             CEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            99999999999999999999999999997632                      24889999999999999999999999


Q ss_pred             ceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccce
Q psy11571        135 YVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDW  213 (372)
Q Consensus       135 ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Di  213 (372)
                      |+|          |||||+|||++.++.+||+|||+|+....... .......||+.|+|||++.+     ..++.++||
T Consensus       185 IiH----------RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~Di  249 (325)
T d1rjba_         185 CVH----------RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-----GIYTIKSDV  249 (325)
T ss_dssp             EEE----------TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-----CCCCHHHHH
T ss_pred             eee----------ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-----CCCCcceec
Confidence            999          99999999999999999999999987644332 22334678999999999984     678999999


Q ss_pred             eehhHHHHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        214 WSLGVCMYEMLY-GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       214 wslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      |||||++|||+| |.+||.+.+..+.+.+++.....++.|.    .+|+++++||.+||+ ||++|||++++++.+
T Consensus       250 wS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~----~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L  321 (325)
T d1rjba_         250 WSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPF----YATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  321 (325)
T ss_dssp             HHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCC----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            999999999997 8999998877777777777666665555    689999999999999 999999988887655

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-52  Score=380.19  Aligned_cols=248  Identities=19%  Similarity=0.260  Sum_probs=206.9

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|.||++.. .+++.||+|.+.......           +.+.+|+.++++++|||||++++++
T Consensus        14 ~~~~~~~iG~G----~fg~Vy~~~~-~~~~~vAvK~~~~~~~~~-----------~~~~~E~~~l~~l~HpnIv~~~g~~   77 (272)
T d1qpca_          14 TLKLVERLGAG----QFGEVWMGYY-NGHTKVAVKSLKQGSMSP-----------DAFLAEANLMKQLQHQRLVRLYAVV   77 (272)
T ss_dssp             GEEEEEEEEEE----TTEEEEEEEE-TTTEEEEEEEECTTSSCH-----------HHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HeEEeEEEecC----CCcEEEEEEE-CCCCEEEEEEEccCcCCH-----------HHHHHHHHHHHhCCCCCEeEEEeee
Confidence            45556667776    8999999974 467889999886543322           3478899999999999999999987


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         83 QDDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        83 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      .+ +.+|+|||||++|+|.+++... ...+++..+..++.||+.||.|||++||+|          |||||+|||+++++
T Consensus        78 ~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivH----------rDiKp~NIll~~~~  146 (272)
T d1qpca_          78 TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH----------RDLRAANILVSDTL  146 (272)
T ss_dssp             CS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCSGGGEEECTTS
T ss_pred             cc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc----------Cccchhheeeeccc
Confidence            54 5679999999999999987543 236999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYG  240 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~  240 (372)
                      .+||+|||+|+..............||+.|+|||++..     ..++.++|||||||++|||+| |.+||...+..+...
T Consensus       147 ~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~  221 (272)
T d1qpca_         147 SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-----GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ  221 (272)
T ss_dssp             CEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH-----CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH
T ss_pred             ceeeccccceEEccCCccccccccCCcccccChHHHhC-----CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999999999876554444455678999999999984     568999999999999999999 566677777778877


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .+..+ ..+..|.    .+++++.+||.+||+ ||++|||++++.+.+
T Consensus       222 ~i~~~-~~~~~p~----~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L  264 (272)
T d1qpca_         222 NLERG-YRMVRPD----NCPEELYQLMRLCWKERPEDRPTFDYLRSVL  264 (272)
T ss_dssp             HHHTT-CCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHhc-CCCCCcc----cChHHHHHHHHHHcCCCHhHCcCHHHHHHHh
Confidence            77664 3334444    689999999999999 999999988887655

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-51  Score=370.16  Aligned_cols=247  Identities=20%  Similarity=0.261  Sum_probs=212.5

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+.++++|.|    ++|.||+++. .+++.||+|.+.......           +.+.+|+.+++.++||||+++++++.
T Consensus         6 ~~~~~~iG~G----~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~-----------~~~~~Ev~~~~~l~HpnIv~~~g~~~   69 (258)
T d1k2pa_           6 LTFLKELGTG----QFGVVKYGKW-RGQYDVAIKMIKEGSMSE-----------DEFIEEAKVMMNLSHEKLVQLYGVCT   69 (258)
T ss_dssp             CCCCCCCCEE----TTEEEEEEEE-TTTEEEEEEEEESSSSCH-----------HHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CEEeEEEecC----CCeEEEEEEE-CCCCEEEEEEECcCcCCH-----------HHHHHHHHHHHhcCCCceeeEEEEEe
Confidence            4444555665    8999999985 578899999987654432           23678999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcE
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI  163 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~v  163 (372)
                      +++.+++||||+++|+|.+++......+++..+..++.||+.||+|||++||+|          |||||+|||++.++.+
T Consensus        70 ~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH----------~dlk~~Nill~~~~~~  139 (258)
T d1k2pa_          70 KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH----------RDLAARNCLVNDQGVV  139 (258)
T ss_dssp             CSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCC----------SCCSGGGEEECTTCCE
T ss_pred             eCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCccc----------ccccceeEEEcCCCcE
Confidence            999999999999999999998776678999999999999999999999999999          9999999999999999


Q ss_pred             EEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHHHH
Q psy11571        164 RLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKI  242 (372)
Q Consensus       164 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~i  242 (372)
                      ||+|||+++..............||+.|+|||++.+     ..++.++|||||||++|||+| |+.||.+.+..++..++
T Consensus       140 kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i  214 (258)
T d1k2pa_         140 KVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-----SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI  214 (258)
T ss_dssp             EECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH
T ss_pred             EECcchhheeccCCCceeecccCCCCCcCCcHHhcC-----CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH
Confidence            999999998765544444444678999999999984     568999999999999999998 89999999999988888


Q ss_pred             hhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhh
Q psy11571        243 MNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADF  286 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i  286 (372)
                      .++. ....|.    ..++++++||++||+ ||++|||++++++.
T Consensus       215 ~~~~-~~~~p~----~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         215 AQGL-RLYRPH----LASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HTTC-CCCCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HhCC-CCCCcc----cccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            7653 344444    689999999999999 99999998776643

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-51  Score=373.07  Aligned_cols=252  Identities=22%  Similarity=0.327  Sum_probs=198.9

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhh---hhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDI---LLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNL   78 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~---~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l   78 (372)
                      ++|+..+.+|.|    |+|.||++....++   ..||+|.+......         ...+.+.+|+.+++.++||||+++
T Consensus         7 ~~~~l~~~iG~G----~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~---------~~~~~~~~E~~~l~~l~HpnIv~l   73 (273)
T d1mp8a_           7 ERIELGRCIGEG----QFGDVHQGIYMSPENPALAVAIKTCKNCTSD---------SVREKFLQEALTMRQFDHPHIVKL   73 (273)
T ss_dssp             GGEEEEEEEEEC----SSSEEEEEEECCC--CCEEEEEEECTTTTSH---------HHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             HHeEEEEEEeeC----CCcEEEEEEEecCCceeEEEEEEEeccccCH---------HHHHHHHHHHHHHHhCCCCCEeeE
Confidence            456666777777    89999999776543   45777766543321         124568889999999999999999


Q ss_pred             eEEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC
Q psy11571         79 HYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD  158 (372)
Q Consensus        79 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~  158 (372)
                      ++++. .+.+|+|||||++|+|.+++......+++..++.++.||+.||.|||++|++|          |||||+||+++
T Consensus        74 ~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiH----------rDlKp~NIll~  142 (273)
T d1mp8a_          74 IGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVH----------RDIAARNVLVS  142 (273)
T ss_dssp             EEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCSGGGEEEE
T ss_pred             EEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeec----------cccchhheeec
Confidence            99986 46789999999999999998776678999999999999999999999999999          99999999999


Q ss_pred             CCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHH
Q psy11571        159 ANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVE  237 (372)
Q Consensus       159 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~  237 (372)
                      .++.+||+|||+|+..............||+.|+|||++.+     ..++.++|||||||++|||+| |.+||.+.+..+
T Consensus       143 ~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~-----~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~  217 (273)
T d1mp8a_         143 SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND  217 (273)
T ss_dssp             ETTEEEECC-------------------CCGGGCCHHHHHH-----CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred             CCCcEEEccchhheeccCCcceeccceecCcccchhhHhcc-----CCCCCccccccchHHHHHHHhcCCCCCCCCCHHH
Confidence            99999999999998765544444455678999999999984     678999999999999999998 899999999988


Q ss_pred             HHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        238 TYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       238 ~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ++.++..+. .++.|.    .+|+++++||.+||+ ||++|||++++.+.+
T Consensus       218 ~~~~i~~~~-~~~~~~----~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L  263 (273)
T d1mp8a_         218 VIGRIENGE-RLPMPP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQL  263 (273)
T ss_dssp             HHHHHHTTC-CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHcCC-CCCCCC----CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            888887653 334444    789999999999999 999999988776543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-50  Score=371.55  Aligned_cols=263  Identities=21%  Similarity=0.308  Sum_probs=217.6

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      +||+.++++|.|    |+|+||++++..+++.||+|.++.......        ..+++.+|+.+|+.++||||++++++
T Consensus         2 ~ry~~i~~LG~G----~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~--------~~~~~~~E~~il~~l~h~niv~~~~~   69 (292)
T d1unla_           2 QKYEKLEKIGEG----TYGTVFKAKNRETHEIVALKRVRLDDDDEG--------VPSSALREICLLKELKHKNIVRLHDV   69 (292)
T ss_dssp             CSEEEEEEEEEC----SSSEEEEEEETTTCCEEEEEEEESSCSSTT--------HHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             CCCEeeeEEecC----cCeEEEEEEECCCCcEEEEEEEehhhCChH--------HHHHHHHHHHHHHhcCcCCEEeeccc
Confidence            478889999988    899999999999999999999866543322        35668889999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      +.+....+++||++.+++|..++.. .+.+++..++.++.|++.||+|||++||+|          |||||+|||++.++
T Consensus        70 ~~~~~~~~iv~~~~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH~~~IvH----------rDiKP~NIli~~~~  138 (292)
T d1unla_          70 LHSDKKLTLVFEFCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLH----------RDLKPQNLLINRNG  138 (292)
T ss_dssp             EECSSEEEEEEECCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEECTTC
T ss_pred             cccccceeEEeeecccccccccccc-ccccchhHHHHHHHHHHHHHHHhhcCCEee----------ecccCcccccccCC
Confidence            9999999999999999998888776 678999999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCC-CCCCHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF-YAESLVETYG  240 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf-~~~~~~~~~~  240 (372)
                      .+||+|||.|+........ .....+++.|+|||++.+    ...++.++|||||||++|||++|+.|| .+.+..+.+.
T Consensus       139 ~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~~~pe~~~~----~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~  213 (292)
T d1unla_         139 ELKLANFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFG----AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK  213 (292)
T ss_dssp             CEEECCCTTCEECCSCCSC-CCSCCSCGGGCCHHHHTT----CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHH
T ss_pred             ceeeeecchhhcccCCCcc-ceeeccccchhhhhHhcc----CCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHH
Confidence            9999999999877544332 233457889999999874    345789999999999999999999885 5566666666


Q ss_pred             HHhhccCCcC-----------------------CCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhhhhhhcc
Q psy11571        241 KIMNHQNSFD-----------------------LPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWSALFVSL  296 (372)
Q Consensus       241 ~i~~~~~~~~-----------------------~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~  296 (372)
                      ++........                       ........+++.+++||++||+ ||.+|||+++++            
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L------------  281 (292)
T d1unla_         214 RIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL------------  281 (292)
T ss_dssp             HHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHT------------
T ss_pred             HHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHh------------
Confidence            5543211110                       0111123678999999999999 999999877665            


Q ss_pred             CCCCCCCCCcCCC
Q psy11571        297 SISPRNHPWFQGI  309 (372)
Q Consensus       297 ~~~~~~hp~f~~~  309 (372)
                           +||||+++
T Consensus       282 -----~Hp~f~~~  289 (292)
T d1unla_         282 -----QHPYFSDF  289 (292)
T ss_dssp             -----TSGGGSSC
T ss_pred             -----cChhhcCC
Confidence                 99999864

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-51  Score=371.82  Aligned_cols=249  Identities=21%  Similarity=0.258  Sum_probs=199.3

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      ++|+..+.+|.|    |+|.||++... ++..||+|.+.......           +.+.+|+.++++++|||||+++++
T Consensus        17 ~~~~i~~~iG~G----~fg~Vy~~~~~-~~~~vAiK~l~~~~~~~-----------~~~~~E~~~l~~l~h~nIv~~~g~   80 (285)
T d1fmka3          17 ESLRLEVKLGQG----CFGEVWMGTWN-GTTRVAIKTLKPGTMSP-----------EAFLQEAQVMKKLRHEKLVQLYAV   80 (285)
T ss_dssp             GGEEEEEEEEEC----SSCEEEEEEET-TTEEEEEEECCTTSSCH-----------HHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             HHEEEeeEEeeC----CCeEEEEEEEC-CCCEEEEEEECcccCCH-----------HHHHHHHHHHHhcccCCEeEEEEE
Confidence            355566667777    89999999764 55679999886544322           347789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCC
Q psy11571         82 FQDDSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDAN  160 (372)
Q Consensus        82 ~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~  160 (372)
                      +.+ +.+|+|||||++|+|..++... ...+++.++..++.||+.||+|||++||+|          |||||+|||++.+
T Consensus        81 ~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH----------~DlKp~NIll~~~  149 (285)
T d1fmka3          81 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH----------RDLRAANILVGEN  149 (285)
T ss_dssp             ECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCSGGGEEECGG
T ss_pred             Eec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheec----------ccccceEEEECCC
Confidence            865 5679999999999999988653 356999999999999999999999999999          9999999999999


Q ss_pred             CcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhC-CCCCCCCCHHHHH
Q psy11571        161 GHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYG-ETPFYAESLVETY  239 (372)
Q Consensus       161 ~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG-~~Pf~~~~~~~~~  239 (372)
                      +.+||+|||+|+..............||+.|+|||++..     ..++.++|||||||++|||++| .+|+.+.+..+.+
T Consensus       150 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~  224 (285)
T d1fmka3         150 LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL  224 (285)
T ss_dssp             GCEEECCCCTTC--------------CCGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred             CcEEEcccchhhhccCCCceeeccccccccccChHHHhC-----CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHH
Confidence            999999999998765444334444678999999999984     6689999999999999999995 5666777777777


Q ss_pred             HHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        240 GKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       240 ~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ..+.++ ...+.+.    .+++++++||.+||+ ||++||+++++.+.+
T Consensus       225 ~~i~~~-~~~~~~~----~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L  268 (285)
T d1fmka3         225 DQVERG-YRMPCPP----ECPESLHDLMCQCWRKEPEERPTFEYLQAFL  268 (285)
T ss_dssp             HHHHTT-CCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHhc-CCCCCCc----ccCHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence            777654 3334444    789999999999999 999999988887554

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-51  Score=378.44  Aligned_cols=263  Identities=22%  Similarity=0.256  Sum_probs=208.6

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      +||+.++.+|.|    ++|+||++++..+++.||+|++........        ..+++.+|+.+|+.++||||++++++
T Consensus        10 ~rY~i~~~LG~G----~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~--------~~~~~~~E~~il~~l~h~nii~~~~~   77 (318)
T d3blha1          10 SKYEKLAKIGQG----TFGEVFKARHRKTGQKVALKKVLMENEKEG--------FPITALREIKILQLLKHENVVNLIEI   77 (318)
T ss_dssp             GGEEEEEEEEEC----SSSEEEEEEETTTCCEEEEEEC----CTTS--------SCHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCEEEEEEEecC----cCeEEEEEEECCCCCEEEEEEEehhhcchH--------HHHHHHHHHHHHHHhcCCCccceEee
Confidence            478888999998    899999999999999999998766544322        23446789999999999999999999


Q ss_pred             EEe--------CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcC
Q psy11571         82 FQD--------DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPD  153 (372)
Q Consensus        82 ~~~--------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~  153 (372)
                      +..        .+.+|+|||||.++++.... .....+++..++.++.||+.||.|||++||+|          |||||+
T Consensus        78 ~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH----------rDlKp~  146 (318)
T d3blha1          78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILH----------RDMKAA  146 (318)
T ss_dssp             EEC----------CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCCGG
T ss_pred             eecccccccccCceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhccCCEEe----------cCcCch
Confidence            865        34689999999776555444 33678999999999999999999999999999          999999


Q ss_pred             cEEeCCCCcEEEeecCcccccCCCCc---ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCC
Q psy11571        154 NVLLDANGHIRLADFGSCLRLGGDGT---VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPF  230 (372)
Q Consensus       154 NIll~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf  230 (372)
                      |||++.++.+||+|||+++.......   ......+||+.|+|||++.+    ...++.++|||||||++|||++|++||
T Consensus       147 NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~----~~~~~~k~DiwSlGvil~el~~g~~pf  222 (318)
T d3blha1         147 NVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG----ERDYGPPIDLWGAGCIMAEMWTRSPIM  222 (318)
T ss_dssp             GEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTT----CSSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             heeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcC----CCCCCcHHHcccCCceeeeHhhCCCCC
Confidence            99999999999999999987653221   12233579999999999974    456899999999999999999999999


Q ss_pred             CCCCHHHHHHHHhhccCCcCCCCCCC--------------------------CCCCHHHHHHHHHhcc-CCCCCCCCCCh
Q psy11571        231 YAESLVETYGKIMNHQNSFDLPSDVG--------------------------YEISDDAKDLMRRLIC-SSDTRLGQNGI  283 (372)
Q Consensus       231 ~~~~~~~~~~~i~~~~~~~~~~~~~~--------------------------~~~s~~~~~li~~lL~-~p~~R~s~~~~  283 (372)
                      .+.+..+....+......+.......                          ...+++++|||.+||+ ||++|||++++
T Consensus       223 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~el  302 (318)
T d3blha1         223 QGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA  302 (318)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             CCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence            99888887776655332221110000                          0137889999999999 99999987766


Q ss_pred             hhhhhhhhhhhccCCCCCCCCCcCC
Q psy11571        284 ADFKMWSALFVSLSISPRNHPWFQG  308 (372)
Q Consensus       284 ~~i~~~~~~~~~~~~~~~~hp~f~~  308 (372)
                      +                 .||||+.
T Consensus       303 L-----------------~Hpff~~  310 (318)
T d3blha1         303 L-----------------NHDFFWS  310 (318)
T ss_dssp             H-----------------HSGGGSS
T ss_pred             H-----------------cChhhcc
Confidence            6                 9999974

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-50  Score=380.48  Aligned_cols=262  Identities=21%  Similarity=0.327  Sum_probs=208.3

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      +||+.++.+|.|    ++|+||+|.+..+++.||+|.+......         ...+.+.+|+.+|+.++||||++++++
T Consensus         8 ~rY~~~~~LG~G----~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---------~~~~~~~~Ei~il~~l~hp~iv~~~~~   74 (345)
T d1pmea_           8 PRYTNLSYIGEG----AYGMVCSAYDNVNKVRVAIKKISPFEHQ---------TYCQRTLREIKILLRFRHENIIGINDI   74 (345)
T ss_dssp             TTEEEEEECC-------CCCEEEEEETTTCSEEEEEEECCTTCH---------HHHHHHHHHHHHHHHCCCTTBCCCCEE
T ss_pred             CCeEEEEEEeec----cCeEEEEEEECCCCcEEEEEEEehhcCh---------HHHHHHHHHHHHHHHcCCCCCCcEEEE
Confidence            688889999998    8999999999999999999988653321         234567889999999999999999999


Q ss_pred             EEeCC----eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe
Q psy11571         82 FQDDS----NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        82 ~~~~~----~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      +....    ..+++|+|+.||+|.+++..  ..+++..++.++.||+.||+|||++||+|          |||||+|||+
T Consensus        75 ~~~~~~~~~~~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiH----------RDIKp~NILl  142 (345)
T d1pmea_          75 IRAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLH----------RDLKPSNLLL  142 (345)
T ss_dssp             ECCSSTTTCCCEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCCGGGEEE
T ss_pred             EeeccccccceEEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcC----------CCCCcceEEE
Confidence            97653    23444455669999999987  57999999999999999999999999999          9999999999


Q ss_pred             CCCCcEEEeecCcccccCCCCc--ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCH
Q psy11571        158 DANGHIRLADFGSCLRLGGDGT--VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL  235 (372)
Q Consensus       158 ~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~  235 (372)
                      +.++.+||+|||+|+.......  ......+||+.|+|||++..    ...++.++||||+||++|+|++|++||.+.+.
T Consensus       143 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~  218 (345)
T d1pmea_         143 NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN----SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY  218 (345)
T ss_dssp             CTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTT----BCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             CCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhc----CCCCCchhhhhccCceehHHhhCCCCCCCCCH
Confidence            9999999999999987643221  12344679999999999864    45678999999999999999999999998877


Q ss_pred             HHHHHHHhhccCCc------------------CCCC-------CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhh
Q psy11571        236 VETYGKIMNHQNSF------------------DLPS-------DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMW  289 (372)
Q Consensus       236 ~~~~~~i~~~~~~~------------------~~~~-------~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~  289 (372)
                      .+...........+                  ..+.       .....+|+++++||.+||+ ||.+|||+++++     
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L-----  293 (345)
T d1pmea_         219 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL-----  293 (345)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHH-----
T ss_pred             HHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHh-----
Confidence            66555443211000                  0000       1122678999999999999 999999876665     


Q ss_pred             hhhhhccCCCCCCCCCcCCC
Q psy11571        290 SALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       290 ~~~~~~~~~~~~~hp~f~~~  309 (372)
                                  +||||+..
T Consensus       294 ------------~hpf~~~~  301 (345)
T d1pmea_         294 ------------AHPYLEQY  301 (345)
T ss_dssp             ------------TSGGGTTT
T ss_pred             ------------cCHhhccC
Confidence                        99999854

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.1e-50  Score=379.34  Aligned_cols=257  Identities=23%  Similarity=0.331  Sum_probs=206.6

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeeeE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLHY   80 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~~   80 (372)
                      ++|+.++.+|.|    |+|+||++++..+++.||+|.+....             .+++.+|+.+|+.+. ||||+++++
T Consensus        35 d~y~i~~~LG~G----~fg~V~~a~~~~~~~~vAiK~i~~~~-------------~~~~~~Ei~il~~l~~hpnIv~~~~   97 (328)
T d3bqca1          35 DDYQLVRKLGRG----KYSEVFEAINITNNEKVVVKILKPVK-------------KKKIKREIKILENLRGGPNIITLAD   97 (328)
T ss_dssp             GGEEEEEEEEEC----SSEEEEEEEETTTTEEEEEEEECSSC-------------HHHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred             cCeEEEEEEecC----cCeEEEEEEECCCCCEEEEEEECHHH-------------HHHHHHHHHHHHhccCCCCCcEEEE
Confidence            467778888888    89999999999999999999876432             134678999999885 999999999


Q ss_pred             EEEeC--CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC
Q psy11571         81 AFQDD--SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD  158 (372)
Q Consensus        81 ~~~~~--~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~  158 (372)
                      +|...  ..+++|||||.+++|..+.    ..+++..++.++.||+.||.|||++||+|          |||||+|||++
T Consensus        98 ~~~~~~~~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvH----------rDiKp~NILi~  163 (328)
T d3bqca1          98 IVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMH----------RDVKPHNVMID  163 (328)
T ss_dssp             EEECTTTCSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEEC----------CCCSGGGEEEE
T ss_pred             EEEecCCCceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhccccc----------ccccccceEEc
Confidence            99854  5699999999999997653    56999999999999999999999999999          99999999998


Q ss_pred             CCC-cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCH-H
Q psy11571        159 ANG-HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL-V  236 (372)
Q Consensus       159 ~~~-~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-~  236 (372)
                      .++ .+||+|||+|+.......  ....+||+.|+|||++.+    ...++.++|+||+||++|+|++|..||..... .
T Consensus       164 ~~~~~vkl~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~  237 (328)
T d3bqca1         164 HEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVD----YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY  237 (328)
T ss_dssp             TTTTEEEECCGGGCEECCTTCC--CCSCCSCGGGCCHHHHTT----CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred             CCCCeeeecccccceeccCCCc--ccccccCccccCcccccC----CCCCCcccchhhhhhhhHHhccCCCCCCCCchhH
Confidence            655 699999999987654432  344679999999999874    45689999999999999999999999976542 2


Q ss_pred             HHHHHHhhc-------------cCC------------------cCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChh
Q psy11571        237 ETYGKIMNH-------------QNS------------------FDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIA  284 (372)
Q Consensus       237 ~~~~~i~~~-------------~~~------------------~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~  284 (372)
                      +....+...             ...                  ...+......+|++++|||++||+ ||++|||+++++
T Consensus       238 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L  317 (328)
T d3bqca1         238 DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM  317 (328)
T ss_dssp             HHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence            222222110             000                  001111123578999999999999 999999977666


Q ss_pred             hhhhhhhhhhccCCCCCCCCCcCCCCcc
Q psy11571        285 DFKMWSALFVSLSISPRNHPWFQGIAWD  312 (372)
Q Consensus       285 ~i~~~~~~~~~~~~~~~~hp~f~~~~w~  312 (372)
                                       +||||+++.|+
T Consensus       318 -----------------~Hp~F~~v~~~  328 (328)
T d3bqca1         318 -----------------EHPYFYTVVKD  328 (328)
T ss_dssp             -----------------TSGGGTTSCCC
T ss_pred             -----------------cCcccCCCCCC
Confidence                             99999999996

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-51  Score=370.29  Aligned_cols=255  Identities=21%  Similarity=0.259  Sum_probs=205.8

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehh---hhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLD---ILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNL   78 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~---~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l   78 (372)
                      ++|+.++.+|.|    |+|.||+++...+   ...||+|.+........       +..+.+.+|+.+|+.++||||+++
T Consensus         8 ~d~~~~~~iG~G----~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~-------~~~~~~~~Ei~~l~~l~H~nIv~~   76 (273)
T d1u46a_           8 KDLRLLEKLGDG----SFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP-------EAMDDFIREVNAMHSLDHRNLIRL   76 (273)
T ss_dssp             GGEEEEEECC--------CCCEEEEEECTTSCEEEEEEEC--------C-------HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             HHeEEEEEEecC----CCeEEEEEEEECCCCcEEEEEEEEEChhhcCCH-------HHHHHHHHHHHHHHhCCCCCEEEE
Confidence            457777788887    8999999976443   24689998766554333       234668899999999999999999


Q ss_pred             eEEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeC
Q psy11571         79 HYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLD  158 (372)
Q Consensus        79 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~  158 (372)
                      ++++.++ .+++|||||++|+|.+++....+.+++..++.++.||+.||.|||++||+|          |||||+||+++
T Consensus        77 ~g~~~~~-~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiH----------rDikp~NIll~  145 (273)
T d1u46a_          77 YGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH----------RDLAARNLLLA  145 (273)
T ss_dssp             EEEECSS-SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCCGGGEEEE
T ss_pred             EEEEeec-chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEee----------eeecHHHhccc
Confidence            9999764 678999999999999988776678999999999999999999999999999          99999999999


Q ss_pred             CCCcEEEeecCcccccCCCCc--ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCH
Q psy11571        159 ANGHIRLADFGSCLRLGGDGT--VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESL  235 (372)
Q Consensus       159 ~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~  235 (372)
                      .++.+||+|||+++.......  .......||..|+|||++.+     ..++.++|||||||++|||+| |.+||.+.+.
T Consensus       146 ~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~  220 (273)
T d1u46a_         146 TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-----RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG  220 (273)
T ss_dssp             ETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH-----CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             cccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhC-----CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH
Confidence            999999999999998754322  12233467889999999984     568999999999999999998 8999999999


Q ss_pred             HHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       236 ~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .+...++.+....++.+.    .+|+++++||.+||+ ||++|||++++.+++
T Consensus       221 ~~~~~~i~~~~~~~~~~~----~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L  269 (273)
T d1u46a_         221 SQILHKIDKEGERLPRPE----DCPQDIYNVMVQCWAHKPEDRPTFVALRDFL  269 (273)
T ss_dssp             HHHHHHHHTSCCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCcc----cccHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            999999887765555554    789999999999999 999999988887655

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=382.07  Aligned_cols=259  Identities=23%  Similarity=0.322  Sum_probs=211.0

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      +||+.++.+|.|    |+|+||++++..+++.||+|.+........        ..+++.+|+.+|+.++|||||+++++
T Consensus        18 ~rY~i~~~LG~G----~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~--------~~~~~~~Ei~il~~l~h~~iv~~~~~   85 (348)
T d2gfsa1          18 ERYQNLSPVGSG----AYGSVCAAFDTKTGLRVAVKKLSRPFQSII--------HAKRTYRELRLLKHMKHENVIGLLDV   85 (348)
T ss_dssp             TTEEEEEECGGG----TTSSEEEEEETTTTEEEEEEECSCTTSSHH--------HHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             CCeEEEEEEecC----CCeEEEEEEECCCCCEEEEEEECchhcChH--------HHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence            578889999988    899999999999999999999876543322        34567889999999999999999999


Q ss_pred             EEeC-----CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEE
Q psy11571         82 FQDD-----SNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVL  156 (372)
Q Consensus        82 ~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIl  156 (372)
                      +...     ...+++|+|+.||+|.+++..  +++++.+++.++.||+.||+|||++||+|          |||||+|||
T Consensus        86 ~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiH----------rDiKp~NIL  153 (348)
T d2gfsa1          86 FTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIH----------RDLKPSNLA  153 (348)
T ss_dssp             ECSCSSTTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------CCCCGGGEE
T ss_pred             EeeccccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcc----------cccCCcccc
Confidence            9743     234666777789999999965  67999999999999999999999999999          999999999


Q ss_pred             eCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCHH
Q psy11571        157 LDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESLV  236 (372)
Q Consensus       157 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~  236 (372)
                      ++.+|.+|++|||++.....    ......||+.|+|||++.+    ...++.++|||||||++|+|++|++||.+.+..
T Consensus       154 i~~~~~~kl~dfg~a~~~~~----~~~~~~g~~~y~apE~~~~----~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~  225 (348)
T d2gfsa1         154 VNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLN----WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI  225 (348)
T ss_dssp             ECTTCCEEECCC----CCTG----GGSSSCHHHHTSCHHHHTT----CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ccccccccccccchhcccCc----ccccccccccccCchhhcC----CccCCcccchhhhhHHHHHHHhCCCCCCCCCHH
Confidence            99999999999999876532    2334678999999999874    455789999999999999999999999999888


Q ss_pred             HHHHHHhhccCCcC---------------------CCC----CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhhh
Q psy11571        237 ETYGKIMNHQNSFD---------------------LPS----DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMWS  290 (372)
Q Consensus       237 ~~~~~i~~~~~~~~---------------------~~~----~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~~  290 (372)
                      .....+........                     .+.    .....++++++|||++||+ ||++|||+++++      
T Consensus       226 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL------  299 (348)
T d2gfsa1         226 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL------  299 (348)
T ss_dssp             HHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH------
T ss_pred             HHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHh------
Confidence            87777754322210                     000    0012579999999999999 999999876665      


Q ss_pred             hhhhccCCCCCCCCCcCCC
Q psy11571        291 ALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       291 ~~~~~~~~~~~~hp~f~~~  309 (372)
                                 +||||+.+
T Consensus       300 -----------~Hp~f~~~  307 (348)
T d2gfsa1         300 -----------AHAYFAQY  307 (348)
T ss_dssp             -----------TSGGGTTT
T ss_pred             -----------cCHhhCCC
Confidence                       99999965

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-50  Score=379.70  Aligned_cols=256  Identities=25%  Similarity=0.352  Sum_probs=204.3

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAF   82 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~   82 (372)
                      +|+.++.+|.|    |+|+||+|++..+++.||+|.+......              ..+|+.+|+.++||||++++++|
T Consensus        21 ~Y~~~k~LG~G----~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--------------~~~Ei~il~~l~h~niv~~~~~~   82 (350)
T d1q5ka_          21 SYTDTKVIGNG----SFGVVYQAKLCDSGELVAIKKVLQDKRF--------------KNRELQIMRKLDHCNIVRLRYFF   82 (350)
T ss_dssp             EEEEEEEEEEE----TTEEEEEEEETTTCCEEEEEEEECCSSS--------------CCHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CcEeeeEEeeC----cCeEEEEEEECCCCCEEEEEEECccchH--------------HHHHHHHHHhcCCCCCCcEEEEE
Confidence            35556667776    8999999999999999999988654321              23589999999999999999998


Q ss_pred             EeC------CeEEEEEeccCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCc
Q psy11571         83 QDD------SNLYLVMDYYCGGDLLTLLS--KFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDN  154 (372)
Q Consensus        83 ~~~------~~~~lv~E~~~gg~L~~~l~--~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~N  154 (372)
                      ...      .++|+|||||+++.+..+..  .....+++..++.++.||+.||+|||++||+|          |||||+|
T Consensus        83 ~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiH----------rDiKp~N  152 (350)
T d1q5ka_          83 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH----------RDIKPQN  152 (350)
T ss_dssp             EEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEEC----------CCCCGGG
T ss_pred             EecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcc----------cCCCcce
Confidence            543      35899999997653333322  22567999999999999999999999999999          9999999


Q ss_pred             EEeCCCC-cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC
Q psy11571        155 VLLDANG-HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE  233 (372)
Q Consensus       155 Ill~~~~-~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~  233 (372)
                      ||++.++ .+||+|||+++.......  ....+||+.|+|||.+.+    ...++.++|||||||++|||++|++||...
T Consensus       153 ILl~~~~~~~kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~----~~~~~~~~DIwSlG~il~el~~g~~pf~~~  226 (350)
T d1q5ka_         153 LLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAPELIFG----ATDYTSSIDVWSAGCVLAELLLGQPIFPGD  226 (350)
T ss_dssp             EEECTTTCCEEECCCTTCEECCTTSC--CCSCCSCTTSCCHHHHTT----CSSCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred             EEEecCCCceeEecccchhhccCCcc--cccccccccccChHHhhc----ccCCCcceeecccceEEEehhhCCCCCCCC
Confidence            9999775 899999999987654432  234679999999999874    456899999999999999999999999998


Q ss_pred             CHHHHHHHHhhccC---------------CcCCCC--------CCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhhhh
Q psy11571        234 SLVETYGKIMNHQN---------------SFDLPS--------DVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFKMW  289 (372)
Q Consensus       234 ~~~~~~~~i~~~~~---------------~~~~~~--------~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~~~  289 (372)
                      +..+.+.++.+...               ...++.        .....+++++++||++||+ ||++|||+.+++     
T Consensus       227 ~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L-----  301 (350)
T d1q5ka_         227 SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC-----  301 (350)
T ss_dssp             SHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH-----
T ss_pred             CHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHh-----
Confidence            88877766643110               011111        1123579999999999999 999999877665     


Q ss_pred             hhhhhccCCCCCCCCCcCCC
Q psy11571        290 SALFVSLSISPRNHPWFQGI  309 (372)
Q Consensus       290 ~~~~~~~~~~~~~hp~f~~~  309 (372)
                                  +||||+++
T Consensus       302 ------------~Hp~f~~~  309 (350)
T d1q5ka_         302 ------------AHSFFDEL  309 (350)
T ss_dssp             ------------TSGGGGGG
T ss_pred             ------------cCHhhccc
Confidence                        99999865

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-49  Score=365.18  Aligned_cols=247  Identities=17%  Similarity=0.228  Sum_probs=196.6

Q ss_pred             HhhhcCCcccCCccEEEeeeehhh----hhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          8 EALFLGGPIQGKGRVFSIETLLDI----LLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         8 ~~~~~~~~~~g~G~v~~v~~~~~~----~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      +.+|.|    |+|.||++....++    ..||+|.+.......         ....+.+|+.++++++|||||++++++.
T Consensus        13 ~~iG~G----~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~---------~~~~~~~E~~il~~l~H~nIv~~~g~~~   79 (283)
T d1mqba_          13 KVIGAG----EFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK---------QRVDFLGEAGIMGQFSHHNIIRLEGVIS   79 (283)
T ss_dssp             EEEEEC----SSSEEEEEEEEC---CCEEEEEEEEECTTCCHH---------HHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             eEEeeC----CCeEEEEEEEeCCCCEEEEEEEEEEECcccChH---------HHHHHHHHHHHHHhcCCCCEeeeeEEEe
Confidence            345555    89999999766544    468999876543322         2345788999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcE
Q psy11571         84 DDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHI  163 (372)
Q Consensus        84 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~v  163 (372)
                      +.+.+++|||||.+++|.+++......+++.++..++.||+.||.|||+++|+|          |||||+|||++.++.+
T Consensus        80 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiH----------rDlKp~NILl~~~~~~  149 (283)
T d1mqba_          80 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVH----------RDLAARNILVNSNLVC  149 (283)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCCGGGEEECTTCCE
T ss_pred             cCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccccccc----------CccccceEEECCCCeE
Confidence            999999999999999999998876678999999999999999999999999999          9999999999999999


Q ss_pred             EEeecCcccccCCCCc--ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhC-CCCCCCCCHHHHHH
Q psy11571        164 RLADFGSCLRLGGDGT--VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYG-ETPFYAESLVETYG  240 (372)
Q Consensus       164 kl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG-~~Pf~~~~~~~~~~  240 (372)
                      ||+|||+|+.......  .......||+.|+|||++.     ...++.++|||||||++|||++| .+|+...+..+++.
T Consensus       150 Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~-----~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~  224 (283)
T d1mqba_         150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS-----YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK  224 (283)
T ss_dssp             EECCCCC-----------------CCCGGGSCHHHHH-----SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred             EEcccchhhcccCCCccceEeccCCCCccccCHHHHc-----cCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHH
Confidence            9999999987644322  1223356899999999998     46799999999999999999995 55666677777777


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .+..+ ..++.|.    .+++.+.+||.+||+ ||++||++.++.+.+
T Consensus       225 ~i~~~-~~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~eil~~L  267 (283)
T d1mqba_         225 AINDG-FRLPTPM----DCPSAIYQLMMQCWQQERARRPKFADIVSIL  267 (283)
T ss_dssp             HHHTT-CCCCCCT----TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred             HHhcc-CCCCCch----hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHH
Confidence            66554 3444444    689999999999999 999999988876544

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=369.75  Aligned_cols=251  Identities=18%  Similarity=0.240  Sum_probs=202.1

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhh----hhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILL----VLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITN   77 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~----va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~   77 (372)
                      +.|+.++.+|.|    |+|.||++....+++.    ||+|.+......         +..+.+.+|+.+++.++|||||+
T Consensus         9 ~dy~~~~~lG~G----~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~E~~~l~~l~HpnIv~   75 (317)
T d1xkka_           9 TEFKKIKVLGSG----AFGTVYKGLWIPEGEKVKIPVAIKELREATSP---------KANKEILDEAYVMASVDNPHVCR   75 (317)
T ss_dssp             TTEEEEEEEEEC----SSEEEEEEEECC----CCEEEEEEEECC-------------CTHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHCEEeeEEecC----CCeEEEEEEEcCCCCEEEEEEEEEEeccccCH---------HHHHHHHHHHHHHHhCCCCCEee
Confidence            357777888887    8999999998888875    455544322111         12456788999999999999999


Q ss_pred             eeEEEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEe
Q psy11571         78 LHYAFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLL  157 (372)
Q Consensus        78 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll  157 (372)
                      +++++.++ ..+++|||+.+|+|.+++......+++..++.++.||+.||.|||++||+|          |||||+|||+
T Consensus        76 l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiH----------rDlKp~NIll  144 (317)
T d1xkka_          76 LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH----------RDLAARNVLV  144 (317)
T ss_dssp             EEEEEESS-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCCGGGEEE
T ss_pred             EEEEEecC-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCccc----------Ccchhhccee
Confidence            99999875 567888999999999999886778999999999999999999999999999          9999999999


Q ss_pred             CCCCcEEEeecCcccccCCCCcc-cccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCH
Q psy11571        158 DANGHIRLADFGSCLRLGGDGTV-QSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESL  235 (372)
Q Consensus       158 ~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~  235 (372)
                      +.++.+||+|||+|+........ ......||+.|+|||++.+     +.++.++|||||||++|||+| |.+||.+.+.
T Consensus       145 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~  219 (317)
T d1xkka_         145 KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-----RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA  219 (317)
T ss_dssp             EETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG
T ss_pred             CCCCCeEeeccccceecccccccccccccccCccccChHHHhc-----CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH
Confidence            99999999999999876543322 2233568999999999984     568999999999999999998 8999999888


Q ss_pred             HHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhh
Q psy11571        236 VETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADF  286 (372)
Q Consensus       236 ~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i  286 (372)
                      .++...+..+ ..++.|.    .+++++.+||.+||. ||++|||+.++.+.
T Consensus       220 ~~~~~~i~~~-~~~~~p~----~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         220 SEISSILEKG-ERLPQPP----ICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             GGHHHHHHHT-CCCCCCT----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcC-CCCCCCc----ccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence            8777776654 3344454    689999999999999 99999998877643

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-50  Score=376.84  Aligned_cols=271  Identities=19%  Similarity=0.315  Sum_probs=205.4

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYA   81 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~   81 (372)
                      +||+.++.+|.|    |+|.||++.+..+++.||+|.+........        ..+++.+|+.+|++++||||++++++
T Consensus        17 ~~Y~i~~~LG~G----~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~--------~~~~~~~Ei~il~~l~hpnIv~~~~~   84 (355)
T d2b1pa1          17 KRYQNLKPIGSG----AQGIVCAAYDAVLDRNVAIKKLSRPFQNQT--------HAKRAYRELVLMKCVNHKNIISLLNV   84 (355)
T ss_dssp             TTEEEEEECSCC------CEEEEEEETTTTEEEEEEEEESTTSSHH--------HHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             CCeEEEEEeecC----cCeEEEEEEECCCCCEEEEEEEChhhcCHH--------HHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence            478888899998    899999999999999999999876554322        34567899999999999999999999


Q ss_pred             EEe------CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcE
Q psy11571         82 FQD------DSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNV  155 (372)
Q Consensus        82 ~~~------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NI  155 (372)
                      |..      ..++|+|||||.+ ++.+.+.   ..+++..++.++.||+.||.|||++||+|          |||||+||
T Consensus        85 f~~~~~~~~~~~~~iv~Ey~~~-~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiH----------rDlKP~Ni  150 (355)
T d2b1pa1          85 FTPQKTLEEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIH----------RDLKPSNI  150 (355)
T ss_dssp             ECSCCSTTTCCEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCCGGGE
T ss_pred             EecccccccCceeEEEEeccch-HHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhccccc----------ccCCcccc
Confidence            964      3689999999965 5555553   56899999999999999999999999999          99999999


Q ss_pred             EeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCCCH
Q psy11571        156 LLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAESL  235 (372)
Q Consensus       156 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~  235 (372)
                      |++.++.++++|||+++......  .....+||+.|+|||++.+     ..+++++||||+||++|+|++|++||.+.+.
T Consensus       151 l~~~~~~~kl~df~~~~~~~~~~--~~~~~~~t~~y~aPE~l~~-----~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~  223 (355)
T d2b1pa1         151 VVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMVRHKILFPGRDY  223 (355)
T ss_dssp             EECTTCCEEECCCCC-----------------CCTTCCHHHHTT-----CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ccccccceeeechhhhhcccccc--ccccccccccccChhhhcC-----CCCCCCcccccccchHHHHhhCCCCCCCCCH
Confidence            99999999999999988765433  2334679999999999984     5689999999999999999999999999887


Q ss_pred             HHHHHHHhhccCCc--------------------CCCC---------C-------CCCCCCHHHHHHHHHhcc-CCCCCC
Q psy11571        236 VETYGKIMNHQNSF--------------------DLPS---------D-------VGYEISDDAKDLMRRLIC-SSDTRL  278 (372)
Q Consensus       236 ~~~~~~i~~~~~~~--------------------~~~~---------~-------~~~~~s~~~~~li~~lL~-~p~~R~  278 (372)
                      .....++.......                    ....         .       .....|+++++||++||. ||++||
T Consensus       224 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~  303 (355)
T d2b1pa1         224 IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI  303 (355)
T ss_dssp             HHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSC
T ss_pred             HHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCc
Confidence            77666654321110                    0000         0       001246789999999999 999999


Q ss_pred             CCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccccccCCCCCc
Q psy11571        279 GQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPYI  322 (372)
Q Consensus       279 s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~~~~~p~~  322 (372)
                      ||++++                 +||||+..-+.......+|.+
T Consensus       304 ta~elL-----------------~Hpw~~~~~~~~~~~~~~~~~  330 (355)
T d2b1pa1         304 SVDDAL-----------------QHPYINVWYDPAEVEAPPPQI  330 (355)
T ss_dssp             CHHHHH-----------------TSTTTGGGCCHHHHTCCCC--
T ss_pred             CHHHHh-----------------cCcccCCCCCcccccCCCCCC
Confidence            877766                 999999754433334444433

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.2e-49  Score=363.10  Aligned_cols=253  Identities=19%  Similarity=0.265  Sum_probs=210.8

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeee-----hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCcee
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETL-----LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWIT   76 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~-----~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv   76 (372)
                      ++|+.++++|.|    |+|.||+++..     .+++.||+|.+......         +..+.+.+|+.+|+.++||||+
T Consensus        13 ~~~~~~~~lG~G----~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~---------~~~~~~~~E~~il~~l~h~niv   79 (301)
T d1lufa_          13 NNIEYVRDIGEG----AFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA---------DMQADFQREAALMAEFDNPNIV   79 (301)
T ss_dssp             GGCEEEEEEEEC----SSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH---------HHHHHHHHHHHHHHTCCCTTBC
T ss_pred             HHcEEeEEEeeC----CCeEEEEEEECCCccCCCCeEEEEEEEChhcCh---------HHHHHHHHHHHHHHhcCCCCcc
Confidence            346666777777    89999999864     35678999987654322         1345678999999999999999


Q ss_pred             eeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhc
Q psy11571         77 NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE-----------------------DRLPEDMAKFYIAEMVLAIASIHDL  133 (372)
Q Consensus        77 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-----------------------~~l~~~~~~~~~~qi~~~L~~LH~~  133 (372)
                      ++++++.+.+..+++|||+++|+|.+++....                       ..+++..+..++.||+.||+|||++
T Consensus        80 ~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~  159 (301)
T d1lufa_          80 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER  159 (301)
T ss_dssp             CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             cceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC
Confidence            99999999999999999999999999997521                       2388999999999999999999999


Q ss_pred             CceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccc
Q psy11571        134 HYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECD  212 (372)
Q Consensus       134 ~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~D  212 (372)
                      +++|          |||||+|||++.++.+||+|||+|+....... .......||+.|+|||.+.+     ..++.++|
T Consensus       160 ~ivH----------rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~t~ksD  224 (301)
T d1lufa_         160 KFVH----------RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-----NRYTTESD  224 (301)
T ss_dssp             TCCC----------SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-----CCCCHHHH
T ss_pred             CeEe----------eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-----CCCChhhh
Confidence            9999          99999999999999999999999986543322 22334678999999999984     67999999


Q ss_pred             eeehhHHHHHHhhCC-CCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        213 WWSLGVCMYEMLYGE-TPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       213 iwslGvil~elltG~-~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ||||||++|||++|. +||.+.+..++...+..+. .++.|.    .+++++.+||.+||+ +|++|||+.++.+.+
T Consensus       225 VwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~-~~~~p~----~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L  296 (301)
T d1lufa_         225 VWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-ILACPE----NCPLELYNLMRLCWSKLPADRPSFCSIHRIL  296 (301)
T ss_dssp             HHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             hccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCC-CCCCCc----cchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            999999999999984 7899999999988887654 334444    689999999999999 999999988876544

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-49  Score=363.07  Aligned_cols=254  Identities=19%  Similarity=0.271  Sum_probs=194.8

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeeh-----hhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhc-CCCCce
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLL-----DILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVY-GDRRWI   75 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~-----~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~-l~hp~I   75 (372)
                      ++|+.++.+|.|    |||.||++....     +++.||+|.+.......+         .+.+.+|..++.+ .+||||
T Consensus        13 ~~y~~~~~iG~G----~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~---------~~~~~~e~~~l~~~~~h~~i   79 (299)
T d1ywna1          13 DRLKLGKPLGRG----AFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE---------HRALMSELKILIHIGHHLNV   79 (299)
T ss_dssp             GGEEEEEEEEEC----SSCEEEEEEEESTTSSSCEEEEEEEEC----CHHH---------HHHHHHHHHHHHHHCCCTTB
T ss_pred             HHEEEeeEEeec----CCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHH---------HHHHHHHHHHHHhhcCCCeE
Confidence            356666777777    899999998654     456789998764333221         2345556666655 478999


Q ss_pred             eeeeEEEEeC-CeEEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecC
Q psy11571         76 TNLHYAFQDD-SNLYLVMDYYCGGDLLTLLSKFE---------------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRP  139 (372)
Q Consensus        76 v~l~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~  139 (372)
                      +++++++.+. ..+++|||||++|+|.+++....               ..+++.++..++.||+.||.|||++||+|  
T Consensus        80 v~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivH--  157 (299)
T d1ywna1          80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIH--  157 (299)
T ss_dssp             CCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCC--
T ss_pred             EEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcC--
Confidence            9999998665 46899999999999999997531               34889999999999999999999999999  


Q ss_pred             CCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhH
Q psy11571        140 NHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGV  218 (372)
Q Consensus       140 ~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGv  218 (372)
                              |||||+|||++.++.+||+|||+|+....... .......||+.|+|||++.+     ..++.++|||||||
T Consensus       158 --------rDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~sDiwS~Gv  224 (299)
T d1ywna1         158 --------RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-----RVYTIQSDVWSFGV  224 (299)
T ss_dssp             --------SCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-----CCCCHHHHHHHHHH
T ss_pred             --------CcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-----CCCCcccceeehHH
Confidence                    99999999999999999999999987644322 23344679999999999984     66899999999999


Q ss_pred             HHHHHhhC-CCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        219 CMYEMLYG-ETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       219 il~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ++|||+|| .+||.+.+..+.+.+++.....+..|.    .+++++++||.+||+ ||++|||++++++.+
T Consensus       225 il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L  291 (299)
T d1ywna1         225 LLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL  291 (299)
T ss_dssp             HHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCc----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            99999986 578887765555555555555555555    689999999999999 999999988877544

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-49  Score=356.99  Aligned_cols=242  Identities=19%  Similarity=0.285  Sum_probs=196.2

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQ   83 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~   83 (372)
                      |+.++.+|.|    |+|.||++..  .+..||+|.++....            .+.+.+|+.++++++||||+++++++.
T Consensus         9 ~~~~~~lG~G----~fg~Vy~~~~--~~~~vAvK~i~~~~~------------~~~~~~E~~~l~~l~HpnIv~~~g~~~   70 (262)
T d1byga_           9 LKLLQTIGKG----EFGDVMLGDY--RGNKVAVKCIKNDAT------------AQAFLAEASVMTQLRHSNLVQLLGVIV   70 (262)
T ss_dssp             EEEEEEEEEC----SSCEEEEEEE--TTEEEEEEECCCCC--------------HHHHHTHHHHTTCCCTTBCCEEEEEC
T ss_pred             eEEeEEEecC----CCeEEEEEEE--CCeEEEEEEECcHHH------------HHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            4444556666    8999999975  577899998865432            234778999999999999999999885


Q ss_pred             e-CCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCC
Q psy11571         84 D-DSNLYLVMDYYCGGDLLTLLSKF-EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANG  161 (372)
Q Consensus        84 ~-~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~  161 (372)
                      + .+.+|+||||+++|+|.+++.+. ...+++..++.++.||+.||.|||+.+|+|          |||||+|||++.++
T Consensus        71 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH----------~dlkp~Nil~~~~~  140 (262)
T d1byga_          71 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH----------RDLAARNVLVSEDN  140 (262)
T ss_dssp             CC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCSGGGEEECTTS
T ss_pred             ecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceec----------cccchHhheecCCC
Confidence            4 46789999999999999999763 235899999999999999999999999999          99999999999999


Q ss_pred             cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh-CCCCCCCCCHHHHHH
Q psy11571        162 HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYG  240 (372)
Q Consensus       162 ~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~  240 (372)
                      .+||+|||+++.....    .....+|+.|+|||++.+     ..++.++|||||||++|||+| |++||...+..++..
T Consensus       141 ~~kl~dfg~s~~~~~~----~~~~~~~~~y~aPE~l~~-----~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~  211 (262)
T d1byga_         141 VAKVSDFGLTKEASST----QDTGKLPVKWTAPEALRE-----KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP  211 (262)
T ss_dssp             CEEECCCCC----------------CCTTTSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH
T ss_pred             CEeecccccceecCCC----CccccccccCCChHHHhC-----CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence            9999999999875432    223568999999999984     568999999999999999998 799999988888888


Q ss_pred             HHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        241 KIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       241 ~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .+.++ ..++.|.    .+++++++||++||. ||++|||+.++.+.+
T Consensus       212 ~i~~~-~~~~~~~----~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L  254 (262)
T d1byga_         212 RVEKG-YKMDAPD----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQL  254 (262)
T ss_dssp             HHTTT-CCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHcC-CCCCCCc----cCCHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence            88664 3444554    689999999999999 999999988776554

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-48  Score=358.20  Aligned_cols=253  Identities=20%  Similarity=0.275  Sum_probs=204.5

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhh-------hhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCC
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDI-------LLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRR   73 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~-------~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp   73 (372)
                      ++|+..+.+|.|    |+|.||+++....+       ..||+|.+.......         ....+.+|...+.++ +||
T Consensus        13 ~~~~l~~~iG~G----~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~---------~~~~~~~e~~~l~~~~~Hp   79 (299)
T d1fgka_          13 DRLVLGKPLGEG----AFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK---------DLSDLISEMEMMKMIGKHK   79 (299)
T ss_dssp             GGEEEEEECC---------CEEEEEEECC----CCCEEEEEEECCCTTCCHH---------HHHHHHHHHHHHHHHCCCT
T ss_pred             HHeEEeeEEeec----CCcEEEEEEEcCCCcccccCceEEEEEEECcccChH---------HHHHHHHHHHHHHHhcCCC
Confidence            345555666666    89999999865433       478999886544322         234566777777766 799


Q ss_pred             ceeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCceec
Q psy11571         74 WITNLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE---------------DRLPEDMAKFYIAEMVLAIASIHDLHYVHR  138 (372)
Q Consensus        74 ~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~  138 (372)
                      |||++++++.+++.+|+|||||++|+|.+++....               ..+++..+..++.||+.||.|||+.||+| 
T Consensus        80 nIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivH-  158 (299)
T d1fgka_          80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIH-  158 (299)
T ss_dssp             TBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCC-
T ss_pred             eEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEe-
Confidence            99999999999999999999999999999997532               35899999999999999999999999999 


Q ss_pred             CCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehh
Q psy11571        139 PNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLG  217 (372)
Q Consensus       139 ~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG  217 (372)
                               |||||+|||++.++.+||+|||+++....... .......||+.|+|||.+.+     +.|+.++||||||
T Consensus       159 ---------rDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-----~~y~~k~DiwS~G  224 (299)
T d1fgka_         159 ---------RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-----RIYTHQSDVWSFG  224 (299)
T ss_dssp             ---------SCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-----CCCCHHHHHHHHH
T ss_pred             ---------eeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-----CCCCchhhhHHhH
Confidence                     99999999999999999999999987643322 12334578999999999984     6799999999999


Q ss_pred             HHHHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        218 VCMYEMLY-GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       218 vil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      |++|||++ |.+||.+.+..+++..+..+ ..+..|.    .+++++++||.+||+ ||++|||+.++++.+
T Consensus       225 vvl~ell~~g~~p~~~~~~~~~~~~i~~~-~~~~~p~----~~~~~l~~li~~cl~~dP~~Rps~~eil~~L  291 (299)
T d1fgka_         225 VLLWEIFTLGGSPYPGVPVEELFKLLKEG-HRMDKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  291 (299)
T ss_dssp             HHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCCCCCS----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHcC-CCCCCCc----cchHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence            99999998 79999999988888777654 4455554    789999999999999 999999988887654

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-48  Score=360.75  Aligned_cols=253  Identities=22%  Similarity=0.271  Sum_probs=209.5

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeee-----hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCcee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETL-----LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWIT   76 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~-----~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv   76 (372)
                      +|+..+.+|.|    |+|.||++...     .+++.||+|.+.......         ....+.+|+.+++.+ +|||||
T Consensus        24 ~~~l~~~iG~G----~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~---------~~~~~~~E~~~~~~l~~HpnIv   90 (311)
T d1t46a_          24 RLSFGKTLGAG----AFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT---------EREALMSELKVLSYLGNHMNIV   90 (311)
T ss_dssp             GEEEEEEEEEC----SSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH---------HHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HeEEeeEEeec----CCeEEEEEEEeccccCCCCeEEEEEEECcccCHH---------HHHHHHHHHHHHHhccCCCCEE
Confidence            34444556666    89999999742     466789999886544322         234577899999888 699999


Q ss_pred             eeeEEEEeCCeEEEEEeccCCCCHHHHHHhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecC
Q psy11571         77 NLHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE-----------------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRP  139 (372)
Q Consensus        77 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-----------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~  139 (372)
                      ++++++.+...+|+|||||++|+|.+++....                 ..+++..+..++.||+.||+|||++|++|  
T Consensus        91 ~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivH--  168 (311)
T d1t46a_          91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIH--  168 (311)
T ss_dssp             CEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC--
T ss_pred             EEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeee--
Confidence            99999999999999999999999999997632                 25899999999999999999999999999  


Q ss_pred             CCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhH
Q psy11571        140 NHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGV  218 (372)
Q Consensus       140 ~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGv  218 (372)
                              |||||+||+++.++.+||+|||+++....... ......+||+.|+|||++.+     ..++.++|||||||
T Consensus       169 --------rDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DIwS~G~  235 (311)
T d1t46a_         169 --------RDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-----CVYTFESDVWSYGI  235 (311)
T ss_dssp             --------SCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-----CCCCHHHHHHHHHH
T ss_pred             --------cccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-----CCCCCcccccchHH
Confidence                    99999999999999999999999987654332 33344689999999999983     67899999999999


Q ss_pred             HHHHHhh-CCCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        219 CMYEMLY-GETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       219 il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ++|||+| |.+||.+.+..+.+.++......+..|.    .+++++.+||.+||+ ||++|||++++++++
T Consensus       236 ~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~----~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L  302 (311)
T d1t46a_         236 FLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPE----HAPAEMYDIMKTCWDADPLKRPTFKQIVQLI  302 (311)
T ss_dssp             HHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcc----cccHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            9999998 7777878777677777766655555554    689999999999999 999999988887655

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-48  Score=359.40  Aligned_cols=249  Identities=22%  Similarity=0.272  Sum_probs=203.1

Q ss_pred             HHHHHhhhcCCcccCCccEEEeeeehhhhh--hhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcC-CCCceeeeeE
Q psy11571          4 LRELEALFLGGPIQGKGRVFSIETLLDILL--VLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYG-DRRWITNLHY   80 (372)
Q Consensus         4 ~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~--va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l-~hp~Iv~l~~   80 (372)
                      |+..+.+|.|    |+|.||++....++..  ||+|.+.......         ..+.+.+|+.+|..+ +|||||++++
T Consensus        12 ~~~~~~iG~G----~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~~E~~~l~~l~~HpnIv~~~~   78 (309)
T d1fvra_          12 IKFQDVIGEG----NFGQVLKARIKKDGLRMDAAIKRMKEYASKD---------DHRDFAGELEVLCKLGHHPNIINLLG   78 (309)
T ss_dssp             CEEEEEEECG----GGCEEEEEEEEETTEEEEEEEEEEECC---------------CHHHHHHHHHTTCCCCTTBCCEEE
T ss_pred             cEEEEEEeeC----CCcEEEEEEECCCCeEEEEEEEEECcccChH---------HHHHHHHHHHHHHhccCCCCEeeEEE
Confidence            3334556666    8999999988877764  5666654332221         235578899999998 6999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCC
Q psy11571         81 AFQDDSNLYLVMDYYCGGDLLTLLSKF---------------EDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFH  145 (372)
Q Consensus        81 ~~~~~~~~~lv~E~~~gg~L~~~l~~~---------------~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~  145 (372)
                      ++.+++.+|+|||||++|+|.+++...               ...+++..+..++.||+.||.|||++||+|        
T Consensus        79 ~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiH--------  150 (309)
T d1fvra_          79 ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIH--------  150 (309)
T ss_dssp             EEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEEC--------
T ss_pred             EEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccc--------
Confidence            999999999999999999999999752               257899999999999999999999999999        


Q ss_pred             cCCCCCcCcEEeCCCCcEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhh
Q psy11571        146 LCRDIKPDNVLLDANGHIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLY  225 (372)
Q Consensus       146 vhrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~ellt  225 (372)
                        |||||+|||++.++.+||+|||+|+.......  .....||..|+|||.+.+     ..++.++|||||||++|||++
T Consensus       151 --rDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~-----~~~~~~sDvwSfGvil~ell~  221 (309)
T d1fvra_         151 --RDLAARNILVGENYVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNY-----SVYTTNSDVWSYGVLLWEIVS  221 (309)
T ss_dssp             --SCCSGGGEEECGGGCEEECCTTCEESSCEECC--C----CCTTTCCHHHHHH-----CEECHHHHHHHHHHHHHHHHT
T ss_pred             --cccccceEEEcCCCceEEcccccccccccccc--ccceecCCcccchHHhcc-----CCCCccceeehhHHHHHHHHh
Confidence              99999999999999999999999986543222  233568999999999984     668999999999999999999


Q ss_pred             C-CCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        226 G-ETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       226 G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      | .+||.+.+..+++..+.++ ..++.|.    .+++++++||.+||+ ||++|||++++++.+
T Consensus       222 ~~~~p~~~~~~~~~~~~i~~~-~~~~~~~----~~~~~~~~li~~cl~~dP~~RPs~~eil~~L  280 (309)
T d1fvra_         222 LGGTPYCGMTCAELYEKLPQG-YRLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSL  280 (309)
T ss_dssp             TSCCTTTTCCHHHHHHHGGGT-CCCCCCT----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHhc-CCCCCCc----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            6 5689999999988888765 3444444    689999999999999 999999988887543

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-48  Score=358.58  Aligned_cols=252  Identities=19%  Similarity=0.212  Sum_probs=209.7

Q ss_pred             HHHHHHhhhcCCcccCCccEEEeeee-----hhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceee
Q psy11571          3 RLRELEALFLGGPIQGKGRVFSIETL-----LDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITN   77 (372)
Q Consensus         3 ~~~~l~~~~~~~~~~g~G~v~~v~~~-----~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~   77 (372)
                      +|+..+.+|.|    |+|.||++...     .++..||+|.+.......         ....+.+|+.++++++||||++
T Consensus        21 ~~~l~~~lG~G----~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~---------~~~~~~~E~~il~~l~h~nIv~   87 (308)
T d1p4oa_          21 KITMSRELGQG----SFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR---------ERIEFLNEASVMKEFNCHHVVR   87 (308)
T ss_dssp             GEEEEEEEEEC----SSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH---------HHHHHHHHHHHGGGCCCTTBCC
T ss_pred             HeEEeeEEeeC----CCeEEEEEEECCcccCCCCcEEEEEEECcccChH---------HHHHHHHHHHHHHHcCCCCEee
Confidence            44445556666    89999999764     246789999886443222         2345788999999999999999


Q ss_pred             eeEEEEeCCeEEEEEeccCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCC
Q psy11571         78 LHYAFQDDSNLYLVMDYYCGGDLLTLLSKFE---------DRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCR  148 (372)
Q Consensus        78 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhr  148 (372)
                      +++++..+...++|||||++|+|.+++....         ..+++..+..++.|++.||.|||+++|+|          |
T Consensus        88 ~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivH----------r  157 (308)
T d1p4oa_          88 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVH----------R  157 (308)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBC----------S
T ss_pred             eeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeee----------c
Confidence            9999999999999999999999999986531         34688999999999999999999999999          9


Q ss_pred             CCCcCcEEeCCCCcEEEeecCcccccCCCCc-ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhC-
Q psy11571        149 DIKPDNVLLDANGHIRLADFGSCLRLGGDGT-VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYG-  226 (372)
Q Consensus       149 Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG-  226 (372)
                      ||||+|||++.++++||+|||+|+....... .......||+.|+|||.+.+     ..++.++|||||||++|||+|| 
T Consensus       158 Dlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-----~~~~~~~Dv~S~G~il~El~t~~  232 (308)
T d1p4oa_         158 DLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-----GVFTTYSDVWSFGVVLWEIATLA  232 (308)
T ss_dssp             CCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHHTS
T ss_pred             eEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHcc-----CCCCcccccccHHHHHHHHHhCC
Confidence            9999999999999999999999986643322 22333568999999999984     6688999999999999999998 


Q ss_pred             CCCCCCCCHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        227 ETPFYAESLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       227 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .+||.+.+..+.+..+.++. .++.|.    .+++.+.+||.+||+ +|++|||++++.+.+
T Consensus       233 ~~p~~~~~~~~~~~~i~~~~-~~~~p~----~~~~~l~~li~~cl~~~P~~RPs~~~il~~L  289 (308)
T d1p4oa_         233 EQPYQGLSNEQVLRFVMEGG-LLDKPD----NCPDMLFELMRMCWQYNPKMRPSFLEIISSI  289 (308)
T ss_dssp             CCTTTTSCHHHHHHHHHTTC-CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHhCC-CCCCcc----cchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            58999999999998887754 344444    689999999999999 999999988887655

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-46  Score=347.74  Aligned_cols=243  Identities=15%  Similarity=0.170  Sum_probs=194.4

Q ss_pred             ccCCccEEEeeeehhh---hhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe-CCeEEEE
Q psy11571         16 IQGKGRVFSIETLLDI---LLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQD-DSNLYLV   91 (372)
Q Consensus        16 ~~g~G~v~~v~~~~~~---~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~lv   91 (372)
                      .||||+||++....++   ..||+|.+......         ...+.+.+|+.+|++++||||+++++++.+ ++.+++|
T Consensus        37 ~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~---------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv  107 (311)
T d1r0pa_          37 RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI---------GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  107 (311)
T ss_dssp             EETTEEEEEEEECC----CEEEEEEEECCCCCH---------HHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred             ecCCeEEEEEEEECCCCEEEEEEEEEECcccCH---------HHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence            3489999999875543   25888887643221         235668899999999999999999999765 4689999


Q ss_pred             EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcc
Q psy11571         92 MDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSC  171 (372)
Q Consensus        92 ~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a  171 (372)
                      ||||++|+|.+++......+++..+..++.|++.||.|||+.+|+|          |||||+|||+++++.+||+|||++
T Consensus       108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiH----------rDLK~~NILl~~~~~~kL~DFG~~  177 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH----------RDLAARNCMLDEKFTVKVADFGLA  177 (311)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCC----------SCCSGGGEEECTTCCEEECSSGGG
T ss_pred             EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCccc----------CCccHHhEeECCCCCEEEecccch
Confidence            9999999999999876667889999999999999999999999999          999999999999999999999999


Q ss_pred             cccCCCCc---ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCCCC-CHHHHHHHHhhccC
Q psy11571        172 LRLGGDGT---VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFYAE-SLVETYGKIMNHQN  247 (372)
Q Consensus       172 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~  247 (372)
                      +.......   .......||+.|+|||.+..     ..++.++||||||+++|||+||..||... +..+....+..+ .
T Consensus       178 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g-~  251 (311)
T d1r0pa_         178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQT-----QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-R  251 (311)
T ss_dssp             CCTTTTTCCCTTCTTCSSCCGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT-C
T ss_pred             hhccccccccceecccccccccccChHHHhc-----CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-C
Confidence            87654322   12223568999999999984     67899999999999999999977776543 444555556554 3


Q ss_pred             CcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        248 SFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       248 ~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      .+..|.    .+++++.+||.+||+ ||++||+++++.+.+
T Consensus       252 ~~~~p~----~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L  288 (311)
T d1r0pa_         252 RLLQPE----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRI  288 (311)
T ss_dssp             CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCCCcc----cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            344444    689999999999999 999999988776543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-47  Score=354.22  Aligned_cols=253  Identities=17%  Similarity=0.179  Sum_probs=197.7

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCc-eeeeeE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRW-ITNLHY   80 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~-Iv~l~~   80 (372)
                      .||+.++.+|.|    |+|.||++.+..+++.||+|.+.......            ++..|..+++.++|++ |+.+.+
T Consensus         7 ~rY~l~~~iG~G----~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~------------~~~~E~~i~~~l~~~~~i~~~~~   70 (299)
T d1ckia_           7 NRYRLGRKIGSG----SFGDIYLGTDIAAGEEVAIKLECVKTKHP------------QLHIESKIYKMMQGGVGIPTIRW   70 (299)
T ss_dssp             TTEEEEEEEEEC----SSSEEEEEEETTTTEEEEEEEEESCTTSC------------CHHHHHHHHHHSTTSTTCCCEEE
T ss_pred             CEEEEeEEEeeC----CCcEEEEEEECCCCCEEEEEEEchhccCH------------HHHHHHHHHHHccCCCcccEEEE
Confidence            367777888887    89999999999999999999876543322            2567999999997665 566677


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC-
Q psy11571         81 AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA-  159 (372)
Q Consensus        81 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~-  159 (372)
                      ++.+++..++||||+ +++|...+......+++..+..++.|++.||+|||++||+|          |||||+|||++. 
T Consensus        71 ~~~~~~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH----------rDiKp~NIl~~~~  139 (299)
T d1ckia_          71 CGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH----------RDVKPDNFLMGLG  139 (299)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEC----------SCCCGGGEEECCG
T ss_pred             EEecCCEEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeee----------ccCCHhhcccccc
Confidence            778888999999998 67888877765678999999999999999999999999999          999999999864 


Q ss_pred             --CCcEEEeecCcccccCCCCc------ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCCCC
Q psy11571        160 --NGHIRLADFGSCLRLGGDGT------VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETPFY  231 (372)
Q Consensus       160 --~~~vkl~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~Pf~  231 (372)
                        +..++|+|||+|+.......      .......||+.|+|||++.+     ..++.++|||||||++|||+||+.||.
T Consensus       140 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~~l~el~tg~~P~~  214 (299)
T d1ckia_         140 KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-----IEQSRRDDLESLGYVLMYFNLGSLPWQ  214 (299)
T ss_dssp             GGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT-----BCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             CCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhC-----CCCCChhhEEecCHHHHHHHhCCCccc
Confidence              45799999999987654322      12334679999999999984     568999999999999999999999998


Q ss_pred             CCCHHHHHHHHh---hccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        232 AESLVETYGKIM---NHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       232 ~~~~~~~~~~i~---~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ..........+.   ......+ +......+|+++.+||.+||. +|++||+++++.+++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l  273 (299)
T d1ckia_         215 GLKAATKRQKYERISEKKMSTP-IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF  273 (299)
T ss_dssp             CCC-------HHHHHHHHHHSC-HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHH
T ss_pred             ccchHHHHHHHHHhhcccCCCC-hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence            765544333221   1111111 111122689999999999999 999999988777766

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=7.1e-46  Score=341.16  Aligned_cols=253  Identities=21%  Similarity=0.199  Sum_probs=203.4

Q ss_pred             hHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCC-CceeeeeE
Q psy11571          2 ERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDR-RWITNLHY   80 (372)
Q Consensus         2 ~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~h-p~Iv~l~~   80 (372)
                      +||+.++.+|.|    |+|.||+|.+..+++.||+|.........            .+++|..++..+.| +||+.+++
T Consensus         5 ~~Y~i~~~iG~G----~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~------------~~~~e~~~~~~l~~~~~i~~~~~   68 (293)
T d1csna_           5 VHYKVGRRIGEG----SFGVIFEGTNLLNNQQVAIKFEPRRSDAP------------QLRDEYRTYKLLAGCTGIPNVYY   68 (293)
T ss_dssp             TTEEEEEEEEEC----SSCEEEEEEETTTTEEEEEEEEECCTTSC------------CHHHHHHHHHHTTTCTTCCCEEE
T ss_pred             CceEEEEEEecC----CCeEEEEEEECCCCCEEEEEEEccccCcH------------HHHHHHHHHHHhcCCCCCCEEEE
Confidence            467777777777    89999999999999999999765443221            25678888888865 99999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCC-
Q psy11571         81 AFQDDSNLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDA-  159 (372)
Q Consensus        81 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~-  159 (372)
                      ++.++...|+||||+ +++|.+++......+++..+..++.|++.||.|||++||+|          |||||+|||++. 
T Consensus        69 ~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiH----------rDiKp~Nili~~~  137 (293)
T d1csna_          69 FGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY----------RDIKPDNFLIGRP  137 (293)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEEC----------CCCCGGGEEECCS
T ss_pred             EeecCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCcee----------ccCCccceeecCc
Confidence            999999999999998 88999999876678999999999999999999999999999          999999999974 


Q ss_pred             ----CCcEEEeecCcccccCCCCc------ccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCCC
Q psy11571        160 ----NGHIRLADFGSCLRLGGDGT------VQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGETP  229 (372)
Q Consensus       160 ----~~~vkl~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~P  229 (372)
                          .+.+||+|||+|+.......      ......+||+.|+|||++.+     ..++.++|||||||++|||+||..|
T Consensus       138 ~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-----~~~~~~~DiwSlG~~l~elltg~~P  212 (293)
T d1csna_         138 NSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-----REQSRRDDLEALGHVFMYFLRGSLP  212 (293)
T ss_dssp             SSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             ccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcC-----CCCChHHHHHHhhHHHHHHHhCCCc
Confidence                57899999999987643211      12334679999999999983     5689999999999999999999999


Q ss_pred             CCCC---CHHHHHHHHhhccCCcCCCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        230 FYAE---SLVETYGKIMNHQNSFDLPSDVGYEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       230 f~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      |.+.   +..+.+.++.......+ +......+++++.+++..|+. +|++||+.+.+.+++
T Consensus       213 f~~~~~~~~~~~~~~i~~~~~~~~-~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l  273 (293)
T d1csna_         213 WQGLKAATNKQKYERIGEKKQSTP-LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF  273 (293)
T ss_dssp             TSSCCSCCHHHHHHHHHHHHHHSC-HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred             CCCccchhHHHHHHHHHhccCCCC-hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence            9764   33444444433221111 111122689999999999999 999999877665544

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-45  Score=336.87  Aligned_cols=252  Identities=21%  Similarity=0.191  Sum_probs=185.2

Q ss_pred             HHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC
Q psy11571          7 LEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS   86 (372)
Q Consensus         7 l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~   86 (372)
                      .+.+|.|    |+|.||+++  .+++.||+|.+.......           .....|+..+..++||||+++++++.+.+
T Consensus         8 ~~~iG~G----~fg~Vy~~~--~~g~~vAvK~~~~~~~~~-----------~~~e~ei~~~~~~~HpnIv~~~~~~~~~~   70 (303)
T d1vjya_           8 QESIGKG----RFGEVWRGK--WRGEEVAVKIFSSREERS-----------WFREAEIYQTVMLRHENILGFIAADNKDN   70 (303)
T ss_dssp             EEEEECC----SSSEEEEEE--ETTEEEEEEEECGGGHHH-----------HHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             EEEEeeC----CCeEEEEEE--ECCEEEEEEEECccchhH-----------HHHHHHHHHHhhCCCCcCcceEEEEEeCC
Confidence            3445555    899999996  378899999875432111           01123555556789999999999998654


Q ss_pred             ----eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--------cCceecCCCCCCCcCCCCCcCc
Q psy11571         87 ----NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHD--------LHYVHRPNHFAFHLCRDIKPDN  154 (372)
Q Consensus        87 ----~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~--------~~ivH~~~~~~~~vhrDlkp~N  154 (372)
                          .+|+|||||++|+|.+++++  ..+++.....++.|++.||.|||+        +||+|          |||||+|
T Consensus        71 ~~~~~~~lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvH----------rDlKp~N  138 (303)
T d1vjya_          71 GTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH----------RDLKSKN  138 (303)
T ss_dssp             SSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEEC----------SCCCGGG
T ss_pred             CcceEEEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeec----------cccCccc
Confidence                68999999999999999987  579999999999999999999996        58899          9999999


Q ss_pred             EEeCCCCcEEEeecCcccccCCCCcc---cccccccCCcccCcccccccccC-CCCCCCccceeehhHHHHHHhhCCCCC
Q psy11571        155 VLLDANGHIRLADFGSCLRLGGDGTV---QSNVAVGTPDYISPEILTAMEEG-RGRYGPECDWWSLGVCMYEMLYGETPF  230 (372)
Q Consensus       155 Ill~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~DiwslGvil~elltG~~Pf  230 (372)
                      ||++.++.+||+|||+++........   ......||+.|+|||++.+.... ...++.++|||||||++|||+||.+||
T Consensus       139 ILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~  218 (303)
T d1vjya_         139 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG  218 (303)
T ss_dssp             EEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred             eEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCC
Confidence            99999999999999999876443221   22346799999999998742110 112567899999999999999998887


Q ss_pred             CCC---------------CHHHHHHHHhhccCCcCCCCCCC-CCCCHHHHHHHHHhcc-CCCCCCCCCChhhhh
Q psy11571        231 YAE---------------SLVETYGKIMNHQNSFDLPSDVG-YEISDDAKDLMRRLIC-SSDTRLGQNGIADFK  287 (372)
Q Consensus       231 ~~~---------------~~~~~~~~i~~~~~~~~~~~~~~-~~~s~~~~~li~~lL~-~p~~R~s~~~~~~i~  287 (372)
                      ...               ........+......+.+|.... ......+.+|+.+||+ ||++|||+.++.+.+
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L  292 (303)
T d1vjya_         219 GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL  292 (303)
T ss_dssp             TBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHH
T ss_pred             CcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence            431               22233333333333333333211 1223568999999999 999999988876544

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.1e-43  Score=335.77  Aligned_cols=287  Identities=20%  Similarity=0.319  Sum_probs=199.9

Q ss_pred             ChHHHHHHhhhcCCcccCCccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHH-HHHhcCCCCceeeee
Q psy11571          1 DERLRELEALFLGGPIQGKGRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREER-DVLVYGDRRWITNLH   79 (372)
Q Consensus         1 ~~~~~~l~~~~~~~~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~-~il~~l~hp~Iv~l~   79 (372)
                      |.||+.++.+|.|    |+|.||+|++..+++.||+|+++......+ ...++++.++.+.++. .....+.||||++++
T Consensus        12 ~~rY~i~~~LG~G----~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~-~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~   86 (362)
T d1q8ya_          12 DARYILVRKLGWG----HFSTVWLAKDMVNNTHVAMKIVRGDKVYTE-AAEDEIKLLQRVNDADNTKEDSMGANHILKLL   86 (362)
T ss_dssp             TTTEEEEEEEEEC----SSEEEEEEEETTTTEEEEEEEECSCHHHHH-HHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             CCcEEEEEEEeeC----CCeEEEEEEECCCCCEEEEEEEeccccchH-HHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence            3578888999998    899999999999999999999876543322 3333344444433221 122234578999999


Q ss_pred             EEEEe--CCeEEEEEeccCCCCHHHH-H-HhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCCCcCCCCCcCc
Q psy11571         80 YAFQD--DSNLYLVMDYYCGGDLLTL-L-SKFEDRLPEDMAKFYIAEMVLAIASIHD-LHYVHRPNHFAFHLCRDIKPDN  154 (372)
Q Consensus        80 ~~~~~--~~~~~lv~E~~~gg~L~~~-l-~~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~~~~~~~~vhrDlkp~N  154 (372)
                      +++..  ....+++|+++..+..... . ......+++..++.++.||+.||.|||+ .||+|          |||||+|
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvH----------rDlKp~N  156 (362)
T d1q8ya_          87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIH----------TDIKPEN  156 (362)
T ss_dssp             EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEEC----------SCCSGGG
T ss_pred             EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCccc----------ccCChhH
Confidence            88764  3566777777655543332 2 2224678999999999999999999998 89999          9999999


Q ss_pred             EEeCCCC------cEEEeecCcccccCCCCcccccccccCCcccCcccccccccCCCCCCCccceeehhHHHHHHhhCCC
Q psy11571        155 VLLDANG------HIRLADFGSCLRLGGDGTVQSNVAVGTPDYISPEILTAMEEGRGRYGPECDWWSLGVCMYEMLYGET  228 (372)
Q Consensus       155 Ill~~~~------~vkl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslGvil~elltG~~  228 (372)
                      ||++.++      .++++|||.+......    ....+||+.|+|||++.     ...++.++|+||+||++++|++|+.
T Consensus       157 Ill~~~~~~~~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~~g~~  227 (362)
T d1q8ya_         157 VLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLL-----GAPWGCGADIWSTACLIFELITGDF  227 (362)
T ss_dssp             EEEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHH-----TCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             eeeeccCcccccceeeEeecccccccccc----cccccccccccChhhcc-----ccCCCccccccchHHHHHHHHHCCC
Confidence            9998655      3899999999765432    23467999999999998     3568999999999999999999999


Q ss_pred             CCCCCCHH------HHHHHHhhccCC----------------------cCCCC--------------CCCCCCCHHHHHH
Q psy11571        229 PFYAESLV------ETYGKIMNHQNS----------------------FDLPS--------------DVGYEISDDAKDL  266 (372)
Q Consensus       229 Pf~~~~~~------~~~~~i~~~~~~----------------------~~~~~--------------~~~~~~s~~~~~l  266 (372)
                      ||...+..      +....+...-..                      .....              ......+++++||
T Consensus       228 pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl  307 (362)
T d1q8ya_         228 LFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF  307 (362)
T ss_dssp             CC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHH
T ss_pred             CCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHH
Confidence            99754321      111111100000                      00000              0011346889999


Q ss_pred             HHHhcc-CCCCCCCCCChhhhhhhhhhhhccCCCCCCCCCcCCCCccccccCCCCCcCCCCCCCC
Q psy11571        267 MRRLIC-SSDTRLGQNGIADFKMWSALFVSLSISPRNHPWFQGIAWDSIRDSNAPYIPEVSSPTD  330 (372)
Q Consensus       267 i~~lL~-~p~~R~s~~~~~~i~~~~~~~~~~~~~~~~hp~f~~~~w~~~~~~~~p~~p~~~~~~~  330 (372)
                      |.+||+ ||.+|||+++++                 +||||++..+  ..+...|..|...+..|
T Consensus       308 l~~mL~~dP~~Rpta~e~L-----------------~Hp~f~~~~~--~~~~~~p~~~~~~~~~~  353 (362)
T d1q8ya_         308 LSPMLQLDPRKRADAGGLV-----------------NHPWLKDTLG--MEEIRVPDRELYGSGSD  353 (362)
T ss_dssp             HGGGGCSSTTTCBCHHHHH-----------------TCGGGTTCTT--CTTCCCTTSCTTCBSTT
T ss_pred             HHHHCCCChhHCcCHHHHh-----------------cCcccCCCCC--cccCCCCCcccCCCCCC
Confidence            999999 999999977665                 9999996643  23455566655544433

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.83  E-value=4.4e-22  Score=169.98  Aligned_cols=165  Identities=15%  Similarity=0.069  Sum_probs=113.8

Q ss_pred             cccCCccEEEeeeehhhhhhhhhhhcccchhhh--------hhHHHHHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC
Q psy11571         15 PIQGKGRVFSIETLLDILLVLYDECCNSSLRRE--------KTVSDFIEFVAKLREERDVLVYGDRRWITNLHYAFQDDS   86 (372)
Q Consensus        15 ~~~g~G~v~~v~~~~~~~~va~K~~~~~~~~~~--------~~~~~~~~~~~~l~~E~~il~~l~hp~Iv~l~~~~~~~~   86 (372)
                      +.||+|.||.+.+ .+++.||+|..........        ...............|...+..+.|++++..+++..   
T Consensus         9 G~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~~---   84 (191)
T d1zara2           9 GEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEG---   84 (191)
T ss_dssp             EECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEET---
T ss_pred             eeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEecC---
Confidence            3458999999976 4789999997653222100        000011122344567888999999999999886632   


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCCCcCCCCCcCcEEeCCCCcEEEe
Q psy11571         87 NLYLVMDYYCGGDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVHRPNHFAFHLCRDIKPDNVLLDANGHIRLA  166 (372)
Q Consensus        87 ~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~~~~~~~~vhrDlkp~NIll~~~~~vkl~  166 (372)
                       .+++|||+++..+.        .+++..+..++.|++.+|.|||++||+|          |||||+|||++++ .++|+
T Consensus        85 -~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~giiH----------rDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          85 -NAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRGIVH----------GDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             -TEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTTEEC----------SCCSTTSEEEETT-EEEEC
T ss_pred             -CEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCCEEE----------ccCChhheeeeCC-CEEEE
Confidence             27999999876542        2455667889999999999999999999          9999999999865 48999


Q ss_pred             ecCcccccCCCCcccccccccCCcccC------cccccccccCCCCCCCccceeehhH
Q psy11571        167 DFGSCLRLGGDGTVQSNVAVGTPDYIS------PEILTAMEEGRGRYGPECDWWSLGV  218 (372)
Q Consensus       167 Dfg~a~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~~~~~~DiwslGv  218 (372)
                      |||+|.........         .|..      .+.+.      +.|+.++|+||+.-
T Consensus       145 DFG~a~~~~~~~~~---------~~l~rd~~~~~~~f~------r~y~~~~d~~s~~~  187 (191)
T d1zara2         145 DFPQSVEVGEEGWR---------EILERDVRNIITYFS------RTYRTEKDINSAID  187 (191)
T ss_dssp             CCTTCEETTSTTHH---------HHHHHHHHHHHHHHH------HHHCCCCCHHHHHH
T ss_pred             ECCCcccCCCCCcH---------HHHHHHHHHHHHHHc------CCCCCcccHHHHHH
Confidence            99999765432211         1111      12222      45788999999643

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.98  E-value=6.1e-06  Score=71.40  Aligned_cols=136  Identities=12%  Similarity=0.087  Sum_probs=85.3

Q ss_pred             ccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCeEEEEEeccCCC
Q psy11571         20 GRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD-RRWITNLHYAFQDDSNLYLVMDYYCGG   98 (372)
Q Consensus        20 G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv~E~~~gg   98 (372)
                      ..||.+.  .++..+.+|..........          ..+.+|..++..+. +--+.+++.+..+++..|+||++++|.
T Consensus        28 ~~v~rv~--~~~~~~vlk~~~~~~~~~~----------~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~   95 (263)
T d1j7la_          28 AKVYKLV--GENENLYLKMTDSRYKGTT----------YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGV   95 (263)
T ss_dssp             SEEEEEE--CSSCEEEEEEECGGGTTST----------TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSE
T ss_pred             CcEEEEE--eCCCeEEEEEcCCCcccch----------hhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccc
Confidence            3577774  2445566665543322221          12455666666543 333677788888889999999999998


Q ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCcee-----------------------------------------
Q psy11571         99 DLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYVH-----------------------------------------  137 (372)
Q Consensus        99 ~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH-----------------------------------------  137 (372)
                      ++.+....   ..   ....++.++...++.||+...-+                                         
T Consensus        96 ~~~~~~~~---~~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (263)
T d1j7la_          96 LCSEEYED---EQ---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRE  169 (263)
T ss_dssp             EHHHHTTT---CS---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHH
T ss_pred             cccccccc---cc---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHH
Confidence            88765432   11   22334566777777787532110                                         


Q ss_pred             --------cCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571        138 --------RPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus       138 --------~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                              ....+..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       170 ~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         170 LYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                    011223357899999999998766667999997743

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.32  E-value=0.00016  Score=61.72  Aligned_cols=130  Identities=15%  Similarity=0.150  Sum_probs=75.1

Q ss_pred             ccEEEeeeehhhhhhhhhhhcccchhhhhhHHHHHHHHHHHHHHHHHHhcCC--CCceeeeeEEEEeCCeEEEEEeccCC
Q psy11571         20 GRVFSIETLLDILLVLYDECCNSSLRREKTVSDFIEFVAKLREERDVLVYGD--RRWITNLHYAFQDDSNLYLVMDYYCG   97 (372)
Q Consensus        20 G~v~~v~~~~~~~~va~K~~~~~~~~~~~~~~~~~~~~~~l~~E~~il~~l~--hp~Iv~l~~~~~~~~~~~lv~E~~~g   97 (372)
                      ..||.+. ..++..+.+|........             .+..|..+++.+.  .--+.+++.+..+++..++||++++|
T Consensus        25 ~~v~r~~-~~~~~~~vlK~~~~~~~~-------------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          25 AAVFRLS-AQGRPVLFVKTDLSGALN-------------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   90 (255)
T ss_dssp             CEEEEEE-CTTSCCEEEEEECSCTTS-------------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             CeEEEEE-eCCCCEEEEEeCCccCHh-------------HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence            3467764 335556777754433211             1344556555442  23367788888888889999999988


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhcCce------------------------e----------------
Q psy11571         98 GDLLTLLSKFEDRLPEDMAKFYIAEMVLAIASIHDLHYV------------------------H----------------  137 (372)
Q Consensus        98 g~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~iv------------------------H----------------  137 (372)
                      .++.+      .......   .+.++...|+-||+...-                        +                
T Consensus        91 ~~~~~------~~~~~~~---~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (255)
T d1nd4a_          91 QDLLS------SHLAPAE---KVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  161 (255)
T ss_dssp             EETTT------SCCCHHH---HHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             ccccc------ccccHHH---HHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence            66532      1122111   123344444444431100                        0                


Q ss_pred             --------cCCCCCCCcCCCCCcCcEEeCCCCcEEEeecCccc
Q psy11571        138 --------RPNHFAFHLCRDIKPDNVLLDANGHIRLADFGSCL  172 (372)
Q Consensus       138 --------~~~~~~~~vhrDlkp~NIll~~~~~vkl~Dfg~a~  172 (372)
                              ....+..++|+|+.|.|||++.++.+-|+||+.+.
T Consensus       162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                    00122235779999999999876667799999764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.70  E-value=0.00071  Score=61.90  Aligned_cols=28  Identities=7%  Similarity=0.165  Sum_probs=23.4

Q ss_pred             CcCCCCCcCcEEeCCCCcEEEeecCcccc
Q psy11571        145 HLCRDIKPDNVLLDANGHIRLADFGSCLR  173 (372)
Q Consensus       145 ~vhrDlkp~NIll~~~~~vkl~Dfg~a~~  173 (372)
                      ++|+|+.|.|||++.++ ++|+||..|..
T Consensus       225 LiHGDl~~gNIlv~~~~-~~vID~E~a~~  252 (392)
T d2pula1         225 LIHGDLHTGSIFASEHE-TKVIDPEFAFY  252 (392)
T ss_dssp             EECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred             eeccCCcCCceeEcCCc-eEEechhhccc
Confidence            45599999999998664 89999988754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=94.62  E-value=0.031  Score=48.96  Aligned_cols=26  Identities=23%  Similarity=0.341  Sum_probs=20.5

Q ss_pred             CcCCCCCcCcEEeCCCCcEEEeecCccc
Q psy11571        145 HLCRDIKPDNVLLDANGHIRLADFGSCL  172 (372)
Q Consensus       145 ~vhrDlkp~NIll~~~~~vkl~Dfg~a~  172 (372)
                      ++|+|+.|.|||++. + ..++||+.+.
T Consensus       194 liHgDlh~~NvL~~~-~-~~~IDFdd~~  219 (325)
T d1zyla1         194 RLHGDCHAGNILWRD-G-PMFVDLDDAR  219 (325)
T ss_dssp             ECCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred             eecCCCCcccEEEeC-C-ceEEechhcc
Confidence            345999999999964 3 4589999774

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=94.32  E-value=0.013  Score=53.14  Aligned_cols=36  Identities=17%  Similarity=0.076  Sum_probs=24.3

Q ss_pred             HHHHHHHhcCC-CCceeeeeEEEEeCCeEEEEEeccCCCCH
Q psy11571         61 REERDVLVYGD-RRWITNLHYAFQDDSNLYLVMDYYCGGDL  100 (372)
Q Consensus        61 ~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L  100 (372)
                      .+|..+++.+. +....++++++.+    .+||||++|.+|
T Consensus        92 ~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l  128 (395)
T d1nw1a_          92 VAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL  128 (395)
T ss_dssp             HHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred             HHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence            35777776654 4445678887653    589999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=91.18  E-value=0.031  Score=48.53  Aligned_cols=25  Identities=28%  Similarity=0.263  Sum_probs=22.5

Q ss_pred             CCCCcCcEEeCCCCcEEEeecCccc
Q psy11571        148 RDIKPDNVLLDANGHIRLADFGSCL  172 (372)
Q Consensus       148 rDlkp~NIll~~~~~vkl~Dfg~a~  172 (372)
                      +|+.++||+++.+...-++||+.+.
T Consensus       188 gDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         188 ADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             SCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CCcchhhhhcccccceeEecccccc
Confidence            9999999999988777899999874